PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, D; Li, YP; Lee, SG; Wang, L; Fan, JH; Zhang, G; Wu, J; Ji, Y; Li, SL				Wang, Dong; Li, Yanping; Lee, Simin Gharib; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin			Ethnic Differences in Body Composition and Obesity Related Risk Factors: Study in Chinese and White Males Living in China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; MASS INDEX; WAIST CIRCUMFERENCE; METABOLIC-DISORDERS; INSULIN-RESISTANCE; FAT; PREVALENCE; ASIA; POPULATION	The purpose of this cross-sectional observational study was to identify ethnic differences in body composition and obesity-related risk factors between Chinese and white males living in China. 115 Chinese and 114 white male pilots aged 28-63 years were recruited. Fasting body weight, height and blood pressure were measured following standard procedures. Whole-body and segmental body composition were measured using an 8-contact electrode bioimpedance analysis (BIA) system. Fasting serum glucose, fasting plasma total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, and triglycerides (TG) were assessed using automatic biochemistry analyzer. After adjusting for age and body mass index (BMI), Chinese males had significantly higher percentage of body fat (PBF) both with respect to whole body (Chinese: 23.7% +/- 0.2% vs. Whites: 22.4% +/- 0.2%) and the trunk area (Chinese: 25.0% +/- 0.3% vs. Whites: 23.2% +/- 0.3%) compared to their white counterparts. At all BMIs, Chinese males had significantly higher fasting glucose levels (Chinese: 5.7 +/- 1.0 mmol/L vs. Whites: 5.2 +/- 1.0 mmol/L) but lower high-density lipoprotein levels (Chinese: 0.8 +/- 1.0 mmol/L vs. Whites: 1.0 +/- 1.0 mmol/L) than white males. In addition, a marginally significantly higher diastolic blood pressure was found among Chinese men than that among white men (Chinese: 80 +/- 1.0 mmHg vs. Whites: 77 +/- 1.0 mmHg). Chinese males had more body fat and a greater degree of central fat deposition pattern than that seen in white males in the present study. Furthermore, data on blood pressure, fasting glucose and blood lipids suggest that Chinese men may be more prone to obesity-related risk factors than white men.	[Wang, Dong; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin] Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China; [Wang, Dong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yanping] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Lee, Simin Gharib] Tsinghua Univ, Beijing 100084, Peoples R China	Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Tsinghua University	Wang, D (corresponding author), Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China.	wangdong621@live.cn; lsonglin@yahoo.com	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	Civil Aviation Administration of China [200 000 RMB]; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	Civil Aviation Administration of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Civil Aviation Administration of China, grant number 200 000 RMB; (http://www.caac.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; *AM HEART ASS, 2002, HEART DIS STROK STAT; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CJ, 2000, INT J OBESITY, V24, P1699, DOI 10.1038/sj.ijo.0801457; Cheng TO, 2009, INT J CARDIOL, V135, P385, DOI 10.1016/j.ijcard.2007.11.080; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; *CIV AV ADM CHIN, 2001, STAND MED CHECK CERT; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Deurenberg P, 2003, EUR J CLIN NUTR, V57, P405, DOI 10.1038/sj.ejcn.1601569; Deurenberg P, 1997, Asia Pac J Clin Nutr, V6, P102; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Du SM, 2010, BIOMED ENVIRON SCI, V23, P92, DOI 10.1016/S0895-3988(10)60037-2; ESTON R, 1994, BRIT J SPORT MED, V28, P9, DOI 10.1136/bjsm.28.1.9; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; James WPT, 2004, COMP QUANTIFICATION, P497; JIANG ZM, 1991, WORLD J SURG, V15, P95, DOI 10.1007/BF01658974; JIN J, 2008, ZHONG GUO YUN DONG Y, V27, P463; Lee CMY, 2007, ASIA PAC J CLIN NUTR, V16, P187; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rush EC, 2007, INT J OBESITY, V31, P1232, DOI 10.1038/sj.ijo.0803576; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; SLUYTER JD, 2009, OBESITY, V18, P183; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weng X, 2006, EUR J CLIN NUTR, V60, P931, DOI 10.1038/sj.ejcn.1602396; WHO, 2004, LANCET, V363, P902; World Economic Forum, 2010, GLOB RISKS 2010 GLOB; World Health Organization, 2021, OB OV FACT SHEETS; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhao D, 2007, AM J CARDIOL, V100, P835, DOI 10.1016/j.amjcard.2007.03.103	44	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19835	10.1371/journal.pone.0019835	http://dx.doi.org/10.1371/journal.pone.0019835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21602932	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200026
J	Wang, DY; Olman, MA; Stewart, J; Tipps, R; Huang, P; Sanders, PW; Toline, E; Prayson, RA; Lee, J; Weil, RJ; Palmer, CA; Gillespie, GY; Liu, WM; Pieper, RO; Guan, JL; Gladson, CL				Wang, Dongyan; Olman, Mitchell A.; Stewart, Jerry, Jr.; Tipps, Russell; Huang, Ping; Sanders, Paul W.; Toline, Eric; Prayson, Richard A.; Lee, Jeongwu; Weil, Robert J.; Palmer, Cheryl A.; Gillespie, G. Yancey; Liu, Wei Michael; Pieper, Russell O.; Guan, Jun-Lin; Gladson, Candece L.			Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HUMAN BREAST-CANCER; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; TYROSINE KINASE; CYCLE PROGRESSION; INTERACTING PROTEIN; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; SRC KINASE	The expression of focal adhesion kinase family interacting protein of 200-kDa (FIP200) in normal brain is limited to some neurons and glial cells. On immunohistochemical analysis of biopsies of glioblastoma tumors, we detected FIP200 in the tumor cells, tumor-associated endothelial cells, and occasional glial cells. Human glioblastoma tumor cell lines and immortalized human astrocytes cultured in complete media also expressed FIP200 as did primary human brain microvessel endothelial cells (MvEC), which proliferate in culture and resemble reactive endothelial cells. Downregulation of endogenous expression of FIP200 using small interfering RNA resulted in induction of apoptosis in the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC. It has been shown by other investigators using cells from other tissues that FIP200 can interact directly with, and inhibit, proline-rich tyrosine kinase 2 (Pyk2) and focal adhesion kinase (FAK). In the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC, we found that downregulation of FIP200 increased the activity of Pyk2 without increasing its expression, but did not affect the activity or expression of FAK. Coimmunoprecipitation and colocalization studies indicated that the endogenous FIP200 was largely associated with Pyk2, rather than FAK, in the glioblastoma tumor cells and brain MvEC. Moreover, the pro-apoptotic effect of FIP200 downregulation was inhibited significantly by a TAT-Pyk2-fusion protein containing the Pyk2 autophosphorylation site in these cells. In summary, downregulation of endogenous FIP200 protein in glioblastoma tumor cells, astrocytes, and brain MvECs promotes apoptosis, most likely due to the removal of a direct interaction of FIP200 with Pyk2 that inhibits Pyk2 activation, suggesting that FIP200 expression may be required for the survival of all three cell types found in glioblastoma tumors.	[Wang, Dongyan; Stewart, Jerry, Jr.; Toline, Eric; Palmer, Cheryl A.; Liu, Wei Michael; Gladson, Candece L.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA; [Olman, Mitchell A.] Univ Alabama Birmingham, Dept Med, Div Pulm Crit Care, Birmingham, AL 35294 USA; [Sanders, Paul W.] Univ Alabama Birmingham, Dept Nephrol, Birmingham, AL 35294 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Tipps, Russell; Huang, Ping; Liu, Wei Michael; Gladson, Candece L.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Lee, Jeongwu] Cleveland Clin, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Prayson, Richard A.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Weil, Robert J.; Gladson, Candece L.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA; [Pieper, Russell O.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Guan, Jun-Lin] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Wang, DY (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA.	gladsoc@ccf.org	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	National Institutes of Health [DK46199, HL58655, CA109748, CA127620]; Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK46199 to PWS, HL58655 to MAO, CA109748 and CA127620 to CLG, and the Melvin Burkhardt chair in Neurosurgical Oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic for support of RJW. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chano T, 2002, GENE, V291, P29, DOI 10.1016/S0378-1119(02)00585-1; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Dahiya R, 1998, INT J ONCOL, V12, P811; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gutenberg A, 2004, ACTA NEUROPATHOL, V108, P224, DOI 10.1007/s00401-004-0886-3; Han HS, 2003, J EXP MED, V197, P63, DOI 10.1084/jem.20021638; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Kuwabara K, 2004, ENDOCRINOLOGY, V145, P3324, DOI 10.1210/en.2003-1433; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lipinski CA, 2003, MOL CANCER RES, V1, P323; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Ramachandra M, 2002, CANCER RES, V62, P6045; Rege TA, 2009, J CELL PHYSIOL, V218, P94, DOI 10.1002/jcp.21570; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; The WHO, 2020, CLASSIFICATION TUMOU; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang DY, 2000, J CELL SCI, V113, P4221; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Ying WZ, 2008, AM J PHYSIOL-RENAL, V295, pF406, DOI 10.1152/ajprenal.90294.2008; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19629	10.1371/journal.pone.0019629	http://dx.doi.org/10.1371/journal.pone.0019629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602932	Green Published, gold			2022-12-27	WOS:000290558500017
J	Charlton, BD; Ellis, WAH; McKinnon, AJ; Brumm, J; Nilsson, K; Fitch, WT				Charlton, Benjamin D.; Ellis, William A. H.; McKinnon, Allan J.; Brumm, Jacqui; Nilsson, Karen; Fitch, W. Tecumseh			Perception of Male Caller Identity in Koalas (Phascolarctos cinereus): Acoustic Analysis and Playback Experiments	PLOS ONE			English	Article							SOURCE-FILTER THEORY; INDIVIDUAL RECOGNITION; VOCAL RECOGNITION; RED DEER; DISCRIMINATE; FEATURES; CONSTRAINTS; PRIMATES; CONTEXTS; MOTHERS	The ability to signal individual identity using vocal signals and distinguish between conspecifics based on vocal cues is important in several mammal species. Furthermore, it can be important for receivers to differentiate between callers in reproductive contexts. In this study, we used acoustic analyses to determine whether male koala bellows are individually distinctive and to investigate the relative importance of different acoustic features for coding individuality. We then used a habituation-discrimination paradigm to investigate whether koalas discriminate between the bellow vocalisations of different male callers. Our results show that male koala bellows are highly individualized, and indicate that cues related to vocal tract filtering contribute the most to vocal identity. In addition, we found that male and female koalas habituated to the bellows of a specific male showed a significant dishabituation when they were presented with bellows from a novel male. The significant reduction in behavioural response to a final rehabituation playback shows this was not a chance rebound in response levels. Our findings indicate that male koala bellows are highly individually distinctive and that the identity of male callers is functionally relevant to male and female koalas during the breeding season. We go on to discuss the biological relevance of signalling identity in this species' sexual communication and the potential practical implications of our findings for acoustic monitoring of male population levels.	[Charlton, Benjamin D.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Ellis, William A. H.] Univ Queensland, Sch Biol Sci, Koala Ecol Grp, Brisbane, Qld, Australia; [McKinnon, Allan J.] Moggill Koala Hosp, Dept Environm & Resource Management, Bellbowrie, Qld, Australia; [Brumm, Jacqui; Nilsson, Karen] Lone Pine Koala Sanctuary, Brisbane, Qld, Australia	University of Vienna; University of Queensland	Charlton, BD (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	benjamin.charlton@univie.ac.at	Ellis, William/AAP-8955-2021	Charlton, Benjamin/0000-0002-0218-7177; Ellis, William/0000-0001-6017-4692	European Research Council [230604]	European Research Council(European Research Council (ERC)European Commission)	B.D. Charlton was supported by a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to W. Tecumseh Fitch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; Blumstein DT, 2004, ANIM BEHAV, V68, P1257, DOI 10.1016/j.anbehav.2003.12.024; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, BIOL LETTERS, V5, P597, DOI 10.1098/rsbl.2009.0331; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch W. Tecumseh S., 2002, P87; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Handasyde, 1999, KOALA NATURAL HIST C; Hare JF, 1998, ANIM BEHAV, V55, P451, DOI 10.1006/anbe.1997.0613; Hauser MD, 2007, ANIM BEHAV, V73, P1059, DOI 10.1016/j.anbehav.2006.11.006; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; KIMMEL HD, 1957, PSYCHOL BULL, V54, P351, DOI 10.1037/h0046737; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; Mitchell P., 1990, P151; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Reby D, 1999, ANIM BEHAV, V57, P1121, DOI 10.1006/anbe.1998.1056; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2001, ETHOLOGY, V107, P951, DOI 10.1046/j.1439-0310.2001.00732.x; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Riede T, 2003, J ACOUST SOC AM, V113, P2919, DOI 10.1121/1.1567278; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; SHIPLEY C, 1981, ANIM BEHAV, V29, P12, DOI 10.1016/S0003-3472(81)80147-9; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Swaisgood RR, 1999, ANIM BEHAV, V57, P1045, DOI 10.1006/anbe.1998.1070; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; Tripovich JS, 2008, BEHAV PROCESS, V79, P74, DOI 10.1016/j.beproc.2008.04.007; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; ZIMMERMANN E, 1993, ETHOLOGY, V93, P211; [No title captured]; [No title captured]	50	33	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20329	10.1371/journal.pone.0020329	http://dx.doi.org/10.1371/journal.pone.0020329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633499	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500057
J	Prigent, J; Panigai, L; Lamourette, P; Sauvaire, D; Devilliers, K; Plaisance, M; Volland, H; Creminon, C; Simon, S				Prigent, Julie; Panigai, Laetitia; Lamourette, Patricia; Sauvaire, Didier; Devilliers, Karine; Plaisance, Marc; Volland, Herve; Creminon, Christophe; Simon, Stephanie			Neutralising Antibodies against Ricin Toxin	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; BIOLOGICAL WARFARE; PROTECTS MICE; VACCINE; ACETYLCHOLINESTERASE; IDENTIFICATION; MANAGEMENT; TRANSPORT; LECTINS; ANTHRAX	The Centers for Disease Control and Prevention have listed the potential bioweapon ricin as a Category B Agent. Ricin is a so-called A/B toxin produced by plants and is one of the deadliest molecules known. It is easy to prepare and no curative treatment is available. An immunotherapeutic approach could be of interest to attenuate or neutralise the effects of the toxin. We sought to characterise neutralising monoclonal antibodies against ricin and to develop an effective therapy. For this purpose, mouse monoclonal antibodies (mAbs) were produced against the two chains of ricin toxin (RTA and RTB). Seven mAbs were selected for their capacity to neutralise the cytotoxic effects of ricin in vitro. Three of these, two anti-RTB (RB34 and RB37) and one anti-RTA (RA36), when used in combination improved neutralising capacity in vitro with an IC50 of 31 ng/ml. Passive administration of association of these three mixed mAbs (4.7 mu g) protected mice from intranasal challenges with ricin (5 LD50). Among those three antibodies, anti-RTB antibodies protected mice more efficiently than the anti-RTA antibody. The combination of the three antibodies protected mice up to 7.5 hours after ricin challenge. The strong in vivo neutralising capacity of this three mAbs combination makes it potentially useful for immunotherapeutic purposes in the case of ricin poisoning or possibly for prevention.	[Prigent, Julie; Lamourette, Patricia; Devilliers, Karine; Plaisance, Marc; Volland, Herve; Creminon, Christophe; Simon, Stephanie] CEA Saclay, CEA, iBiTec S, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France; [Panigai, Laetitia; Sauvaire, Didier] Unite CBR, AFSSAPS, Montpellier, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Prigent, J (corresponding author), CEA Saclay, CEA, iBiTec S, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables)(French Atomic Energy Commission); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	This study was supported by a grant from the PhD programme of the CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables) (Julie Prigent) and funded by the IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees) and NRBC (Nuclear Radiological Biological and Chemical Risks) programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bigalke H, 2005, TOXICOLOGY, V214, P210, DOI 10.1016/j.tox.2005.06.015; Binder P, 2003, COMP IMMUNOL MICROB, V26, P401, DOI 10.1016/S0147-9571(03)00023-7; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Dokmetjian J, 2000, VACCINE, V18, P2698, DOI 10.1016/S0264-410X(00)00066-9; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENDO Y, 1987, J BIOL CHEM, V262, P5908; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; GRASSI J, 1988, ANAL BIOCHEM, V168, P436, DOI 10.1016/0003-2697(88)90341-7; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; LITTLE SF, 1990, INFECT IMMUN, V58, P1606, DOI 10.1128/IAI.58.6.1606-1613.1990; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NICOLSON GL, 1974, BIOCHEMISTRY-US, V13, P196, DOI 10.1021/bi00698a029; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sandvig K, 1999, FEBS LETT, V452, P67, DOI 10.1016/S0014-5793(99)00529-3; Schep LJ, 2009, ENVIRON INT, V35, P1267, DOI 10.1016/j.envint.2009.08.004; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Tanaka KSE, 2001, BIOCHEMISTRY-US, V40, P6845, DOI 10.1021/bi010499p; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; Yan XJ, 1997, J MOL BIOL, V266, P1043, DOI 10.1006/jmbi.1996.0865	37	58	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20166	10.1371/journal.pone.0020166	http://dx.doi.org/10.1371/journal.pone.0020166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633505	Green Published, gold			2022-12-27	WOS:000291006500034
J	Zhang, H; Campbell, DA; Sturm, NR; Dungan, CF; Lin, SJ				Zhang, Huan; Campbell, David A.; Sturm, Nancy R.; Dungan, Christopher F.; Lin, Senjie			Spliced Leader RNAs, Mitochondrial Gene Frameshifts and Multi-Protein Phylogeny Expand Support for the Genus Perkinsus as a Unique Group of Alveolates	PLOS ONE			English	Article							SP-NOV PERKINSOZOA; CYTOCHROME-B GENE; GENOME SEQUENCE; KARENIA-BREVIS; DINOFLAGELLATE; MARINUS; AMPHIDINIUM; EVOLUTION; HETEROCAPSA; EXPRESSION	The genus Perkinsus occupies a precarious phylogenetic position. To gain a better understanding of the relationship between perkinsids, dinoflagellates and other alveolates, we analyzed the nuclear-encoded spliced-leader (SL) RNA and mitochondrial genes, intron prevalence, and multi-protein phylogenies. In contrast to the canonical 22-nt SL found in dinoflagellates (DinoSL), P. marinus has a shorter (21-nt) and a longer (22-nt) SL with slightly different sequences than DinoSL. The major SL RNA transcripts range in size between 80-83 nt in P. marinus, and similar to 83 nt in P. chesapeaki, significantly larger than the typical <= 56-nt dinoflagellate SL RNA. In most of the phylogenetic trees based on 41 predicted protein sequences, P. marinus branched at the base of the dinoflagellate clade that included the ancient taxa Oxyrrhis and Amoebophrya, sister to the clade of apicomplexans, and in some cases clustered with apicomplexans as a sister to the dinoflagellate clade. Of 104 Perkinsus spp. genes examined 69.2% had introns, a higher intron prevalence than in dinoflagellates. Examination of Perkinsus spp. mitochondrial cytochrome B and cytochrome C oxidase subunit I genes and their cDNAs revealed no mRNA editing, but these transcripts can only be translated when frameshifts are introduced at every AGG and CCC codon as if AGGY codes for glycine and CCCCU for proline. These results, along with the presence of the numerous uncharacterized 'marine alveolate group I' and Perkinsus-like lineages separating perkinsids from core dinoflagellates, expand support for the affiliation of the genus Perkinsus with an independent lineage (Perkinsozoa) positioned between the phyla of Apicomplexa and Dinoflagellata.	[Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Campbell, David A.; Sturm, Nancy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Dungan, Christopher F.] Cooperat Oxford Lab, Maryland Dept Nat Resources, Oxford, MD USA	University of Connecticut; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	zhang, yaqun/J-8478-2014; Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011	Dungan, Christopher/0000-0001-5228-9115	NSF [EF-0629624, EF-0626678]; NOAA ECOHAB [NA05NOS4781196]; NIH [AI056034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056034] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NOAA ECOHAB(National Oceanic Atmospheric Admin (NOAA) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NSF grants EF-0629624 (to SL) and EF-0626678 (to SL and HZ, https://www.fastlane.nsf.gov/fastlane.jsp); the NOAA ECOHAB grant NA05NOS4781196 (to SL and HZ, http://www.cop.noaa.gov/stressors/extremeevents/hab/current/abs_ECOHAB.aspx) and NIH grant AI056034 (http://nih.gov/, to DC and NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beckenbach AT, 2005, J MOL EVOL, V60, P141, DOI 10.1007/s00239-004-0178-5; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Figueroa RI, 2008, PROTIST, V159, P563, DOI 10.1016/j.protis.2008.05.003; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hearne JL, 2011, J EUKARYOT MICROBIOL, V58, P266, DOI 10.1111/j.1550-7408.2011.00538.x; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin S., 2008, RNA DNA EDITING MOL, P280, DOI DOI 10.1002/9780470262269.CH13; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin SJ, 2006, J PHYCOL, V42, P746, DOI 10.1111/j.1529-8817.2006.00213.x; Lin SJ, 2005, J SHELLFISH RES, V24, P733; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; MASUDA S, 2010, NUC ACID RES, P1, DOI DOI 10.1093/NAR/GKQ449; Monroe EA, 2008, PROTIST, V159, P471, DOI 10.1016/j.protis.2008.02.004; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Saunders GW, 1997, PLANT SYST EVOL, P237; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P315, DOI 10.1016/j.ejop.2007.06.003; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083	46	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19933	10.1371/journal.pone.0019933	http://dx.doi.org/10.1371/journal.pone.0019933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629701	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005800018
J	Lei, L; Sonabend, AM; Guarnieri, P; Soderquist, C; Ludwig, T; Rosenfeld, S; Bruce, JN; Canoll, P				Lei, Liang; Sonabend, Adam M.; Guarnieri, Paolo; Soderquist, Craig; Ludwig, Thomas; Rosenfeld, Steven; Bruce, Jeffrey N.; Canoll, Peter			Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype	PLOS ONE			English	Article							NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; MOUSE GLIOMA MODEL; GROWTH-FACTOR-B; GENE-EXPRESSION; IN-VIVO; SUBVENTRICULAR ZONE; PDGF RECEPTORS; WHITE-MATTER; OLIGODENDROCYTE DEVELOPMENT	Background: Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma (GBM). Based on global expression analysis, GBM can be classified into distinct subtypes: Proneural, Neural, Classical and Mesenchymal. The signatures of these different tumor subtypes may reflect the phenotypes of cells giving rise to them. However, the experimental evidence connecting any specific subtype of GBM to particular cells of origin is lacking. In addition, it is unclear how different genetic alterations interact with cells of origin in determining tumor heterogeneity. This issue cannot be addressed by studying end-stage human tumors. Methodology/Principal Findings: To address this issue, we used retroviruses to deliver transforming genetic lesions to glial progenitors in adult mouse brain. We compared the resulting tumors to human GBM. We found that different initiating genetic lesions gave rise to tumors with different growth rates. However all mouse tumors closely resembled the human Proneural GBM. Comparative analysis of these mouse tumors allowed us to identify a set of genes whose expression in humans with Proneural GBM correlates with survival. Conclusions/Significance: This study offers insights into the relationship between adult glial progenitors and Proneural GBM, and allows us to identify molecular alterations that lead to more aggressive tumor growth. In addition, we present a new preclinical model that can be used to test treatments directed at a specific type of GBM in future studies.	[Lei, Liang; Soderquist, Craig; Ludwig, Thomas; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Sonabend, Adam M.; Bruce, Jeffrey N.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Guarnieri, Paolo] Columbia Univ, Bioinformat Div, New York, NY USA; [Rosenfeld, Steven] Columbia Univ, Dept Neurol, New York, NY USA; [Lei, Liang; Guarnieri, Paolo; Ludwig, Thomas; Rosenfeld, Steven; Bruce, Jeffrey N.; Canoll, Peter] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Lei, L (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	pc561@columbia.edu	Soderquist, Craig R/ABC-4677-2020; Bruce, Jeffrey N/AAC-5307-2022; Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585; Soderquist, Craig R/0000-0002-1454-1786	NIH/NINDS;  [1R01NS066955];  [1R56NS066992]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955, R56NS066992] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded by NIH/NINDS (www.ninds.nih.gov). The grant numbers are 1R01NS066955 (P.C.) and 1R56NS066992 (S.R. and P.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BARRES BA, 1993, DEVELOPMENT, V118, P283; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bohman LE, 2010, NEUROSURGERY, V67, P1319, DOI 10.1227/NEU.0b013e3181f556ab; Bolstad B, 2005, BIOINFORMATICS COMPU; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; COOPER LAD, 2009, PLOS ONE, V5; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HAMBARDZUMYAN NMA, 2009, ONCOLOGY, V2, P89; HART IK, 1989, DEVELOPMENT, V105, P595; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; Hesselager G, 2003, CANCER RES, V63, P4305; Horner PJ, 2000, J NEUROSCI, V20, P2218; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; JEAN WRI, JEFF GENTRY GERMA BA; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kappadakunnel M, 2010, J NEURO-ONCOL, V96, P359, DOI 10.1007/s11060-009-9983-4; KATAGIRI F, 2001, PATTERN DISCOVERY EX; Kesari S, 2006, NEURON, V51, P151, DOI 10.1016/j.neuron.2006.07.001; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Leek JT, 2006, BIOINFORMATICS, V22, P1412, DOI 10.1093/bioinformatics/btl149; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McEntyre J, 2002, NCBI HDB; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pei YX, 2010, CANCER CELL, V18, P546, DOI 10.1016/j.ccr.2010.11.031; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rhee W, 2009, GLIA, V57, P510, DOI 10.1002/glia.20780; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; *TEAM R, 2009, R DEV COR TEAM R LAN; Uhrbom L, 1998, CANCER RES, V58, P5275; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wright KD, 2010, CANCER CELL, V17, P419, DOI 10.1016/j.ccr.2010.04.020; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao A, 2005, CANCER RES, V65, P5172, DOI 10.1158/0008-5472.CAN-04-3902; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu Y, 2009, MOL CELL, V36, P351, DOI 10.1016/j.molcel.2009.10.026	102	98	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20041	10.1371/journal.pone.0020041	http://dx.doi.org/10.1371/journal.pone.0020041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625383	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200027
J	Luh, C; Gierth, K; Timaru-Kast, R; Engelhard, K; Werner, C; Thal, SC				Luh, Clara; Gierth, Katharina; Timaru-Kast, Ralph; Engelhard, Kristin; Werner, Christian; Thal, Serge C.			Influence of a Brief Episode of Anesthesia during the Induction of Experimental Brain Trauma on Secondary Brain Damage and Inflammation	PLOS ONE			English	Article							INCOMPLETE CEREBRAL-ISCHEMIA; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD TRAUMA; INTRACRANIAL-PRESSURE; ARTERIAL-HYPERTENSION; RATS; INJURY; ISOFLURANE; MICE; SEVOFLURANE	It is unclear whether a single, brief, 15-minute episode of background anesthesia already modulates delayed secondary processes after experimental brain injury. Therefore, this study was designed to characterize three anesthesia protocols for their effect on molecular and histological study endpoints. Mice were randomly separated into groups that received sevoflurane (sevo), isoflurane (iso) or an intraperitoneal anesthetic combination (midazolam, fentanyl and medetomidine; comb) prior to traumatic brain injury (controlled cortical impact, CCI; 8 m/s, 1 mm impact depth, 3 mm diameter). Twenty-four hours after insult, histological brain damage, neurological function (via neurological severity score), cerebral inflammation (via real-time RT-PCR for IL6, COX-2, iNOS) and microglia (via immunohistochemical staining for Iba1) were determined. Fifteen minutes after CCI, the brain contusion volume did not differ between the anesthetic regimens (sevo = 17.9 +/- 5.5 mm 3; iso = 20.5 +/- 3.7 mm(3); comb = 19.5 +/- 4.6 mm(3)). Within 24 hours after injury, lesion size increased in all groups (sevo = 45.3 +/- 9.0 mm(3); iso = 31.5 +/- 4.0 mm(3); comb = 44.2 +/- 6.2 mm(3)). Sevo and comb anesthesia resulted in a significantly larger contusion compared to iso, which was in line with the significantly better neurological function with iso (sevo = 4.6 +/- 1.3 pts.; iso = 3.9 +/- 0.8 pts.; comb = 5.1 +/- 1.6 pts.). The expression of inflammatory marker genes was not significantly different at 15 minutes and 24 hours after CCI. In contrast, significantly more Iba1-positive cells were present in the pericontusional region after sevo compared to comb anesthesia (sevo = 181 +/- 48/mm(3); iso = 150 +/- 36/mm(3); comb = 113 +/- 40/mm(3)). A brief episode of anesthesia, which is sufficient for surgical preparations of mice for procedures such as delivering traumatic brain injury, already has a significant impact on the extent of secondary brain damage.	[Luh, Clara; Gierth, Katharina; Timaru-Kast, Ralph; Engelhard, Kristin; Werner, Christian; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany; [Luh, Clara] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Luh, C (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729				Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; Friedrich DH, 2000, ACTA NEUROCHIR SUPPL, V76, P257; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HATASHITA S, 1986, J NEUROSURG, V64, P643, DOI 10.3171/jns.1986.64.4.0643; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; JANSSEN BJ, 2004, AM J PHYSL HEART CIR; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; Kongstad L, 2001, J TRAUMA, V51, P490, DOI 10.1097/00005373-200109000-00011; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matchett GA, 2009, NEUROL RES, V31, P128, DOI 10.1179/174313209X393546; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; Solt K, 2006, ANESTH ANALG, V102, P1407, DOI 10.1213/01.ane.0000204252.07406.9f; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; WERNER C, 1995, BRIT J ANAESTH, V75, P756, DOI 10.1093/bja/75.6.756; Yurdakoc A, 2008, ACTA ANAESTH SCAND, V52, P658, DOI 10.1111/j.1399-6576.2008.01635.x; ZORNOW MH, 1992, ANESTH ANALG, V75, P232; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	31	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19948	10.1371/journal.pone.0019948	http://dx.doi.org/10.1371/journal.pone.0019948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625505	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200032
J	Gruber, J; Ng, LF; Fong, S; Wong, YT; Koh, SA; Chen, CB; Shui, GH; Cheong, WF; Schaffer, S; Wenk, MR; Halliwell, B				Gruber, Jan; Ng, Li Fang; Fong, Sheng; Wong, Yee Ting; Koh, Soon Ann; Chen, Ce-Belle; Shui, Guanghou; Cheong, Wei Fun; Schaffer, Sebastian; Wenk, Markus R.; Halliwell, Barry			Mitochondrial Changes in Ageing Caenorhabditis elegans - What Do We Learn from Superoxide Dismutase Knockouts?	PLOS ONE			English	Article							OXIDATIVE DAMAGE THEORY; LIFE-SPAN; UNCOUPLING PROTEINS; REDOX REGULATION; CYTOCHROME-C; NO LONGER; OXYGEN; STRESS; OVEREXPRESSION; METABOLISM	One of the most popular damage accumulation theories of ageing is the mitochondrial free radical theory of ageing (mFRTA). The mFRTA proposes that ageing is due to the accumulation of unrepaired oxidative damage, in particular damage to mitochondrial DNA (mtDNA). Within the mFRTA, the "vicious cycle" theory further proposes that reactive oxygen species (ROS) promote mtDNA mutations, which then lead to a further increase in ROS production. Recently, data have been published on Caenorhabditis elegans mutants deficient in one or both forms of mitochondrial superoxide dismutase (SOD). Surprisingly, even double mutants, lacking both mitochondrial forms of SOD, show no reduction in lifespan. This has been interpreted as evidence against the mFRTA because it is assumed that these mutants suffer from significantly elevated oxidative damage to their mitochondria. Here, using a novel mtDNA damage assay in conjunction with related, well established damage and metabolic markers, we first investigate the age-dependent mitochondrial decline in a cohort of ageing wild-type nematodes, in particular testing the plausibility of the "vicious cycle" theory. We then apply the methods and insights gained from this investigation to a mutant strain for C. elegans that lacks both forms of mitochondrial SOD. While we show a clear age-dependent, linear increase in oxidative damage in WT nematodes, we find no evidence for autocatalytic damage amplification as proposed by the "vicious cycle" theory. Comparing the SOD mutants with wild-type animals, we further show that oxidative damage levels in the mtDNA of SOD mutants are not significantly different from those in wild-type animals, i.e. even the total loss of mitochondrial SOD did not significantly increase oxidative damage to mtDNA. Possible reasons for this unexpected result and some implications for the mFRTA are discussed.	[Gruber, Jan; Ng, Li Fang; Fong, Sheng; Wong, Yee Ting; Koh, Soon Ann; Chen, Ce-Belle; Schaffer, Sebastian; Wenk, Markus R.; Halliwell, Barry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Shui, Guanghou; Cheong, Wei Fun; Wenk, Markus R.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Gruber, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	jan_gruber@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; Fong, Sheng/I-3061-2012; Halliwell, Barry/C-8318-2009	Fong, Sheng/0000-0001-5381-8955; Shui, Guanghou/0000-0002-1621-9643; Halliwell, Barry/0000-0002-3560-7123	Biomedical Research Council of Singapore [BMRC 07/1/21/19/524]; Singapore National Research Foundation [2007-04]; National Institutes of Health National Centre for Research Resources	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore); National Institutes of Health National Centre for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would also like to gratefully acknowledge the Biomedical Research Council of Singapore (Grant number: BMRC 07/1/21/19/524) for support of this study (http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx). Work in the authors' laboratory is supported by grants from the Singapore National Research Foundation under CRP Award No. 2007-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Takao Inoue for his helpful comments during the writing of this manuscript and Dr. Alfredo Amiel Leonardia for his help and support during the design and troubleshooting of the PCR assays. We thank the Caenorhabditis Genetics Centre, which is funded by the National Institutes of Health National Centre for Research Resources, for the provision of worm strains.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back P, 2010, EXP GERONTOL, V45, P603, DOI 10.1016/j.exger.2010.01.014; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Bratic I, 2010, METHODS, V51, P437, DOI 10.1016/j.ymeth.2010.03.003; Brys K, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-91; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Gardner R, 2006, J THEOR BIOL, V242, P798, DOI 10.1016/j.jtbi.2006.04.007; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Gems David, 2009, SEB Exp Biol Ser, V62, P31; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Halliwell B., 2007, FREE RADICALS BIOL M; Hanak P, 2001, FEBS LETT, V495, P137, DOI 10.1016/S0014-5793(01)02338-9; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; Headlam HA, 2004, FREE RADICAL BIO MED, V36, P1175, DOI 10.1016/j.freeradbiomed.2004.02.017; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Iser WB, 2005, MECH AGEING DEV, V126, P1090, DOI 10.1016/j.mad.2005.04.002; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kowald A, 2006, J THEOR BIOL, V238, P828, DOI 10.1016/j.jtbi.2005.06.034; Kowald A, 1996, MUTAT RES-DNAGING G, V316, P209, DOI 10.1016/S0921-8734(96)90005-3; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lemire BD, 2009, MECH AGEING DEV, V130, P461, DOI 10.1016/j.mad.2009.05.001; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liochev SI, 2002, FREE RADICAL BIO MED, V33, P137, DOI 10.1016/S0891-5849(02)00864-X; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; SCHAFFER S, 2010, BIOGERONTOLOGY; Shahrestani Parvin, 2009, Curr Aging Sci, V2, P3; Shoyama T, 2007, MECH AGEING DEV, V128, P529, DOI 10.1016/j.mad.2007.07.003; Shoyama T, 2009, EXP GERONTOL, V44, P784, DOI 10.1016/j.exger.2009.09.006; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Stiernagle Theresa, 2006, WormBook, P1; Suda H, 2005, BIOCHEM BIOPH RES CO, V330, P839, DOI 10.1016/j.bbrc.2005.03.050; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yanase S, 2009, J GERONTOL A-BIOL, V64, P530, DOI 10.1093/gerona/glp020; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; Yasuda K, 2011, BIOCHEM BIOPH RES CO, V404, P751, DOI 10.1016/j.bbrc.2010.12.017	79	66	67	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19444	10.1371/journal.pone.0019444	http://dx.doi.org/10.1371/journal.pone.0019444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611128	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200006
J	Danner, R; Chaudhari, SN; Rosenberger, J; Surls, J; Richie, TL; Brumeanu, TD; Casares, S				Danner, Rebecca; Chaudhari, Snehal N.; Rosenberger, John; Surls, Jacqueline; Richie, Thomas L.; Brumeanu, Teodor-Doru; Casares, Sofia			Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; SEVERE COMBINED IMMUNODEFICIENCY; SCID IL2R-GAMMA(NULL) MICE; FLOW-CYTOMETRIC ANALYSIS; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; HIV-INFECTION; HOST-DISEASE; BONE-MARROW	Background: Humanized mice able to reconstitute a surrogate human immune system (HIS) can be used for studies on human immunology and may provide a predictive preclinical model for human vaccines prior to clinical trials. However, current humanized mouse models show sub-optimal human T cell reconstitution and limited ability to support immunoglobulin class switching by human B cells. This limitation has been attributed to the lack of expression of Human Leukocyte Antigens (HLA) molecules in mouse lymphoid organs. Recently, humanized mice expressing HLA class I molecules have been generated but showed little improvement in human T cell reconstitution and function of T and B cells. Methods: We have generated NOD.Rag1KO.IL2RccKO mice expressing HLA class II (HLA-DR4) molecules under the I-E-d promoter that were infused as adults with HLA-DR-matched human hematopoietic stem cells (HSC). Littermates lacking expression of HLA-DR4 molecules were used as control. Results: HSC-infused HLA-DR4.NOD.Rag1KO.IL-2RccKO mice developed a very high reconstitution rate (>90%) with long-lived and functional human T and B cells. Unlike previous humanized mouse models reported in the literature and our control mice, the HLA-DR4 expressing mice reconstituted serum levels (natural antibodies) of human IgM, IgG (all four subclasses), IgA, and IgE comparable to humans, and elicited high titers of specific human IgG antibodies upon tetanus toxoid vaccination. Conclusions: Our study demonstrates the critical role of HLA class II molecules for development of functional human T cells able to support immunoglobulin class switching and efficiently respond to vaccination.	[Danner, Rebecca; Chaudhari, Snehal N.; Rosenberger, John; Richie, Thomas L.; Casares, Sofia] USN, US Mil Malaria Vaccine Program, Med Res Ctr, Walter Reed Army Inst Res, Silver Spring, MD USA; [Surls, Jacqueline; Brumeanu, Teodor-Doru; Casares, Sofia] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; United States Navy; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA	Danner, R (corresponding author), USN, US Mil Malaria Vaccine Program, Med Res Ctr, Walter Reed Army Inst Res, Silver Spring, MD USA.	sofia.casares@med.navy.mil	Brumeanu, Teodor/AAB-1965-2020	Richie, Thomas/0000-0002-2946-5456	NIH/NIDDK; Juvenile Diabetes Research Foundation; USUHS; USAID; Military Infectious Diseases Research Program;  [6000.RAD1.F]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); USUHS; USAID(United States Agency for International Development (USAID)); Military Infectious Diseases Research Program; 	This work was supported by grants from NIH/NIDDK, Juvenile Diabetes Research Foundation, Military Infectious Diseases Research Program, and USAID to SC and a USUHS grant to TBD. This work was supported by work unit number 6000.RAD1.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; Casares S, 1997, J EXP MED, V186, P1481, DOI 10.1084/jem.186.9.1481; Chung A, 2008, CURR HIV RES, V6, P515, DOI 10.2174/157016208786501472; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Colovai AI, 2004, MODERN PATHOL, V17, P918, DOI 10.1038/modpathol.3800141; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; GREINIX HT, 1991, BLOOD, V78, P2131; GREINIX HT, 1992, BLOOD, V80, P1950; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; HUPPES W, 1992, EUR J IMMUNOL, V22, P197, DOI 10.1002/eji.1830220129; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; KYOIZUMI S, 1992, BLOOD, V79, P1704; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Mamoni RL, 2006, CYTOKINE, V35, P207, DOI 10.1016/j.cyto.2006.08.005; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; NAMIKAWA R, 1990, J EXP MED, V172, P1055, DOI 10.1084/jem.172.4.1055; Nazarov-Stoica C, 2009, J IMMUNOL, V182, P102, DOI 10.4049/jimmunol.182.1.102; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; PFLUMIO F, 1993, INT IMMUNOL, V5, P1509, DOI 10.1093/intimm/5.12.1509; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Takahama Y, 2010, SEMIN IMMUNOL, V22, P287, DOI 10.1016/j.smim.2010.04.012; TORBETT BE, 1991, IMMUNOL REV, V124, P139, DOI 10.1111/j.1600-065X.1991.tb00620.x; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Velasquez-Lopera MM, 2008, CLIN EXP IMMUNOL, V154, P107, DOI 10.1111/j.1365-2249.2008.03734.x; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; WORTIS HH, 1971, CLIN EXP IMMUNOL, V8, P305; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204	51	135	145	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19826	10.1371/journal.pone.0019826	http://dx.doi.org/10.1371/journal.pone.0019826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611197	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500025
J	Kondo, M; Sanuki, R; Ueno, S; Nishizawa, Y; Hashimoto, N; Ohguro, H; Yamamoto, S; Machida, S; Terasaki, H; Adamus, G; Furukawa, T				Kondo, Mineo; Sanuki, Rikako; Ueno, Shinji; Nishizawa, Yuji; Hashimoto, Naozumi; Ohguro, Hiroshi; Yamamoto, Shuichi; Machida, Shigeki; Terasaki, Hiroko; Adamus, Grazyna; Furukawa, Takahisa			Identification of Autoantibodies against TRPM1 in Patients with Paraneoplastic Retinopathy Associated with ON Bipolar Cell Dysfunction	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; MELANOMA-ASSOCIATED RETINOPATHY; CANCER-ASSOCIATED RETINOPATHY; COMPLETE FORM; OPTIC-NERVE; ANTIBODIES; MUTATIONS; ELECTRORETINOGRAM; RECOVERIN; PROTEIN	Background: Paraneoplastic retinopathy (PR), including cancer-associated retinopathy (CAR) and melanoma-associated retinopathy (MAR), is a progressive retinal disease caused by antibodies generated against neoplasms not associated with the eye. While several autoantibodies against retinal antigens have been identified, there has been no known autoantibody reacting specifically against bipolar cell antigens in the sera of patients with PR. We previously reported that the transient receptor potential cation channel, subfamily M, member 1 (TRPM1) is specifically expressed in retinal ON bipolar cells and functions as a component of ON bipolar cell transduction channels. In addition, this and other groups have reported that human TRPM1 mutations are associated with the complete form of congenital stationary night blindness. The purpose of the current study is to investigate whether there are autoantibodies against TRPM1 in the sera of PR patients exhibiting ON bipolar cell dysfunction. Methodology/Principal Findings: We performed Western blot analysis to identify an autoantibody against TRPM1 in the serum of a patient with lung CAR. The electroretinograms of this patient showed a severely reduced ON response with normal OFF response, indicating that the defect is in the signal transmission between photoreceptors and ON bipolar cells. We also investigated the sera of 26 patients with MAR for autoantibodies against TRPM1 because MAR patients are known to exhibit retinal ON bipolar cell dysfunction. Two of the patients were found to have autoantibodies against TRPM1 in their sera. Conclusion/Significance: Our study reveals TRPM1 to be one of the autoantigens targeted by autoantibodies in at least some patients with CAR or MAR associated with retinal ON bipolar cell dysfunction.	[Kondo, Mineo; Ueno, Shinji; Terasaki, Hiroko] Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Sanuki, Rikako; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Sanuki, Rikako; Furukawa, Takahisa] CREST, JST, Osaka, Japan; [Nishizawa, Yuji] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Hashimoto, Naozumi] Nagoya Univ, Dept Resp Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ohguro, Hiroshi] Sapporo Med Univ, Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Yamamoto, Shuichi] Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chiba, Japan; [Machida, Shigeki] Iwate Med Univ, Sch Med, Dept Ophthalmol, Morioka, Iwate 020, Japan; [Adamus, Grazyna] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA	Nagoya University; Japan Science & Technology Agency (JST); Chubu University; Nagoya University; Sapporo Medical University; Chiba University; Iwate Medical University; Oregon Health & Science University	Kondo, M (corresponding author), Nagoya Univ, Dept Ophthalmol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	kondomi@med.nagoya-u.ac.jp; furukawa@obi.or.jp	HASHIMOTO, NAOZUMI/I-1979-2012; Sanuki, Rikako/AAV-7143-2021; Ueno, Shinji/M-5063-2014; Terasaki, Hiroko/M-5054-2014	Sanuki, Rikako/0000-0001-9862-9840; 	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology [20390448, 20390087, 20592075, 20791678]; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Novartis Foundation [20-10]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation [S-2144]; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness; National Institute of Health [E13053]; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness(Japan National Society for the Prevention of Blindness); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST from the Japan Science and Technology Agency (http://www.jst.go.jp/), and a Grant-in-Aid for Scientific Research (B)(C) (#20390448, #20390087, #20592075, #20791678) from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/), the Takeda Science Foundation (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (http://www.ueharazaidan.com/), the Naito Foundation (http://www.naito-f.or.jp/), the Novartis Foundation (#20-10, http://novartisfound.or.jp/), Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/), the Senri Life Science Foundation (#S-2144, http://www.senri-life.or.jp/), the Kato Memorial Bioscience Foundation (http://www.katokinen.or.jp/) and the Japan National Society for the Prevention of Blindness (http://www.nichigan.or.jp/link/situmei.jsp). A grant from the National Institute of Health (E13053), was awarded to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bazhin AV, 2007, INT J CANCER, V120, P1268, DOI 10.1002/ijc.22458; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Goetgebuer G, 2008, DOC OPHTHALMOL, V116, P49, DOI 10.1007/s10633-007-9074-9; Hartmann TB, 2005, INT J CANCER, V114, P88, DOI 10.1002/ijc.20762; Heckenlively JR, 2008, SEMIN IMMUNOPATHOL, V30, P127, DOI 10.1007/s00281-008-0114-7; HOUCHIN KW, 1991, INVEST OPHTH VIS SCI, V32, P1229; JACOBSON DM, 1990, ANN NEUROL, V28, P162, DOI 10.1002/ana.410280208; Jacobson DM, 2001, AM J OPHTHALMOL, V131, P806, DOI 10.1016/S0002-9394(00)00925-9; Keltner JL, 1999, J NEURO-OPHTHALMOL, V19, P71; Khan NW, 2005, J NEUROPHYSIOL, V93, P481, DOI 10.1152/jn.00365.2004; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lu Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1572, DOI 10.1001/archophthalmol.2009.311; Matsubara S, 1996, BRIT J CANCER, V74, P1419, DOI 10.1038/bjc.1996.558; MILAM AH, 1993, INVEST OPHTH VIS SCI, V34, P91; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nakamura M, 2010, MOL VIS, V16, P425; Ohguro H, 2004, TOHOKU J EXP MED, V202, P213, DOI 10.1620/tjem.202.213; POLANS AS, 1995, P NATL ACAD SCI USA, V92, P9176, DOI 10.1073/pnas.92.20.9176; Potter MJ, 2002, AM J OPHTHALMOL, V134, P128, DOI 10.1016/S0002-9394(02)01431-9; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Shimazaki K, 2008, J NEURO-OPHTHALMOL, V28, P5, DOI 10.1097/WNO.0b013e318167549f; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THIRKILL CE, 1987, ARCH OPHTHALMOL-CHIC, V105, P372; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309	35	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19911	10.1371/journal.pone.0019911	http://dx.doi.org/10.1371/journal.pone.0019911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611200	Green Submitted, gold, Green Published			2022-12-27	WOS:000290657500033
J	Alho, JS; Leinonen, T; Merila, J				Alho, Jussi S.; Leinonen, Tuomas; Merila, Juha			Inheritance of Vertebral Number in the Three-Spined Stickleback (Gasterosteus aculeatus)	PLOS ONE			English	Article							MERISTIC VARIATION; LATITUDINAL VARIATION; GENETIC CORRELATION; NATURAL-SELECTION; LATERAL PLATES; LIFE-HISTORY; EVOLUTION; HERITABILITY; TRAITS; MEDAKA	Intraspecific variation in the number of vertebrae is taxonomically widespread, and both genetic and environmental factors are known to contribute to this variation. However, the relative importance of genetic versus environmental influences on variation in vertebral number has seldom been investigated with study designs that minimize bias due to non-additive genetic and maternal influences. We used a paternal half-sib design and animal model analysis to estimate heritability and causal components of variance in vertebral number in three-spined sticklebacks (Gasterosteus aculeatus). We found that both the number of vertebrae (h(2) = 0.36) and body size (h(2) = 0.42) were moderately heritable, whereas the influence of maternal effects was estimated to be negligible. While the number of vertebrae had a positive effect on body size, no evidence for a genetic correlation between body size and vertebral number was detected. However, there was a significant positive environmental correlation between these two traits. Our results support the generalization-in accordance with results from a review of heritability estimates for vertebral number in fish, reptiles and mammals-that the number of vertebrae appears to be moderately to highly heritable in a wide array of species. In the case of the three-spined stickleback, independent evolution of body size and number of vertebrae should be possible given the low genetic correlation between the two traits.	[Alho, Jussi S.; Leinonen, Tuomas; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Alho, JS (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072; Alho, Jussi/0000-0002-7765-2096	Academy of Finland	Academy of Finland(Academy of Finland)	This research was supported by the Academy of Finland (www.aka.fi) with grants to J.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MY, 1974, CAN J ZOOL, V52, P959, DOI 10.1139/z74-128; ANDO D, 1996, FISH GENET BREED SCI, V23, P59; Ando D, 2008, FISHERIES SCI, V74, P293, DOI 10.1111/j.1444-2906.2008.01531.x; Arnold S.J., 1988, P619; Barrett RDH, 2010, J FISH BIOL, V77, P311, DOI 10.1111/j.1095-8649.2010.02640.x; Belk MC, 2002, AM NAT, V160, P803, DOI 10.1086/343880; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BERGE S, 1948, J ANIM SCI, V7, P233, DOI 10.2527/jas1948.72233x; Billerbeck JN, 1997, CAN J FISH AQUAT SCI, V54, P1796, DOI 10.1139/cjfas-54-8-1796; Borchers N, 2004, J ANIM BREED GENET, V121, P392, DOI 10.1111/j.1439-0388.2004.00482.x; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Falconer D. S., 1996, INTRO QUANTITATIVE G; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HAGEN DW, 1973, HEREDITY, V30, P303, DOI 10.1038/hdy.1973.40; Hermida M, 2002, CAN J ZOOL, V80, P532, DOI 10.1139/Z02-022; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; JORDAN DS, 1982, P US NAT MUS, V14, P107; Kirpichnikov V.S, 1981, GENETIC BASIS FISH S; LEARY RF, 1985, EVOLUTION, V39, P308, DOI [10.2307/2408364, 10.1111/j.1558-5646.1985.tb05668.x]; Leinonen T, 2011, HEREDITY, V106, P218, DOI 10.1038/hdy.2010.104; Leinonen T, 2011, J EVOLUTION BIOL, V24, P206, DOI 10.1111/j.1420-9101.2010.02161.x; Lindell LE, 1996, BIOL J LINN SOC, V59, P69, DOI 10.1111/j.1095-8312.1996.tb01453.x; Lindsey C.C., 1988, P197; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P1237, DOI 10.1139/z62-100; LINDSEY CC, 1962, CAN J ZOOLOG, V40, P271, DOI 10.1139/z62-028; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; McDowall RM, 2003, ENVIRON BIOL FISH, V66, P361, DOI 10.1023/A:1023902922843; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Nakajima Masamichi, 1996, Tohoku Journal of Agricultural Research, V47, P29; NENASHEV G. A., 1966, IZV GOS NAUCH ISSLED INST OZER RECHN RYB KHOZ, V61, P125; ORSKA I, 1963, ZOOL POL, V12, P309; OSTLUNDNILSSON S, 2007, BIOL THREESPINE STIC; Sasaki K, 2009, CONSERV BIOL, V23, P93, DOI 10.1111/j.1523-1739.2008.01067.x; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; SHIKANO T, 2007, AQUAC RES, V18, P1248; SNYDER RJ, 1991, COPEIA, P526; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SWAIN DP, 1984, CAN J FISH AQUAT SCI, V41, P1231, DOI 10.1139/f84-146; SWAIN DP, 1992, EVOLUTION, V46, P987, DOI 10.1111/j.1558-5646.1992.tb00614.x; TAVE D, 1984, COPEIA, P794; Wootton RJ, 2009, J FISH BIOL, V75, P1919, DOI 10.1111/j.1095-8649.2009.02412.x; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Yamahira K, 2009, BIOL J LINN SOC, V96, P856, DOI 10.1111/j.1095-8312.2008.01150.x; Yamahira K, 2009, BIOL J LINN SOC, V96, P867, DOI 10.1111/j.1095-8312.2008.01181.x; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	46	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19579	10.1371/journal.pone.0019579	http://dx.doi.org/10.1371/journal.pone.0019579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603609	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300013
J	Nakamura, H; Wang, YW; Kurita, T; Adomat, H; Cunha, GR; Wang, YZ				Nakamura, Hisae; Wang, Yuwei; Kurita, Takeshi; Adomat, Hans; Cunha, Gerald R.; Wang, Yuzhuo			Genistein Increases Epidermal Growth Factor Receptor Signaling and Promotes Tumor Progression in Advanced Human Prostate Cancer	PLOS ONE			English	Article							CELL-CYCLE ARREST; SOY ISOFLAVONES; DIETARY GENISTEIN; ORTHOTOPIC MODEL; PROTEIN-KINASES; UP-REGULATION; SCID MICE; PHYTOESTROGENS; METASTASIS; APOPTOSIS	Genistein is an isoflavone found in soy, and its chemo-preventive and -therapeutic effects have been well established from in vitro studies. Recently, however, its therapeutic actions in vivo have been questioned due to contradictory reports from animal studies, which rely on rodent models or implantation of cell lines into animals. To clarify in vivo effects of genistein in advanced prostate cancer patients, we developed a patient-derived prostate cancer xenograft model, in which a clinical prostatectomy sample was grafted into immune deficient mice. Our results showed an increased lymph node (LN) and secondary organ metastases in genistein-treated mice compared to untreated controls. Interestingly, invasive malignant cells aggregated to form islands/micrometastasis only in the secondary organs of the genistein-treated groups, not in the untreated control group. To understand the underlying mechanism for metastatic progression, we examined cell proliferation and apoptosis on paraffin-sections. Immunohistological data show that tumors of genistein-treated groups have more proliferating and fewer apoptotic cancer cells than those of the untreated group. Our immunoblotting data suggest that increased proliferation and metastasis are linked to enhanced activities of tyrosine kinases, EGFR and its downstream Src, in genistein-treated groups. Despite the chemopreventive effects proposed by earlier in vitro studies, the cancer promoting effect of genistein observed here suggests the need for careful selection of patients and safer planning of clinical trials.	[Nakamura, Hisae; Wang, Yuwei; Wang, Yuzhuo] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Nakamura, Hisae; Adomat, Hans; Wang, Yuzhuo] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Wang, Yuzhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Kurita, Takeshi] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Anat & Urol, San Francisco, CA 94143 USA	British Columbia Cancer Agency; University of British Columbia; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco	Nakamura, H (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada.	ywang@bccrc.ca	Kurita, Takeshi/A-2236-2013	Kurita, Takeshi/0000-0003-4281-5884; Wang, Yuzhuo/0000-0002-9749-8591	Canadian Institute of Health Research [MOP-86730]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institute of Health Research (MOP-86730: YZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1993, LANCET, V342, P1209, DOI 10.1016/0140-6736(93)92188-Y; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.2307/3432518; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alhasan SA, 1999, NUTR CANCER, V34, P12, DOI 10.1207/S15327914NC340102; Aronson WJ, 1999, NUTR CANCER, V35, P130, DOI 10.1207/S15327914NC352_6; Balabhadrapathruni S, 2000, NUTR CANC, V7, P3; Cohen LA, 2003, PROSTATE, V54, P169, DOI 10.1002/pros.10127; Davis JN, 1998, NUTR CANCER, V32, P123, DOI 10.1080/01635589809514730; El Touny LH, 2009, CANCER RES, V69, P3695, DOI 10.1158/0008-5472.CAN-08-2958; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fischer L, 2004, NUTR CANCER, V48, P160, DOI 10.1207/s15327914nc4802_5; Gallagher Richard P., 1997, Can J Urol, V4, P22; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Hillman GG, 2004, MOL CANCER THER, V3, P1271; Hillman GG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-4; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Ishikawa H, 2000, EMBO J, V19, P5406; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knight DC, 1996, OBSTET GYNECOL, V87, P897; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; LACROIX H, 1989, ONCOGENE, V4, P145; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; LEE HP, 1991, LANCET, V337, P1197, DOI 10.1016/0140-6736(91)92867-2; Lee K, 2009, BIOORGAN MED CHEM, V17, P3152, DOI 10.1016/j.bmc.2009.02.054; Li YW, 1999, INT J ONCOL, V15, P525; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Lian FR, 1998, NUTR CANCER, V31, P184, DOI 10.1080/01635589809514701; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; MARKIEWICZ L, 1993, J STEROID BIOCHEM, V45, P399, DOI 10.1016/0960-0760(93)90009-L; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; MAYR U, 1992, TOXICOLOGY, V74, P135, DOI 10.1016/0300-483X(92)90134-Z; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Ohno S, 2003, LIFE SCI, V74, P733, DOI 10.1016/j.lfs.2003.04.006; Pendleton JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-132; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Raffoul JJ, 2007, INT J CANCER, V120, P2491, DOI 10.1002/ijc.22548; Ryan CJ, 2005, J CLIN ONCOL, V23, P8225, DOI 10.1200/JCO.2005.03.5311; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; SPINOZZI F, 1994, LEUKEMIA RES, V18, P431, DOI 10.1016/0145-2126(94)90079-5; Takimoto CH, 2003, CANCER EPIDEM BIOMAR, V12, P1213; Tan M, 1997, CANCER RES, V57, P1199; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang XY, 2006, J NUTR BIOCHEM, V17, P204, DOI 10.1016/j.jnutbio.2005.07.005; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; YU DH, 1994, CANCER RES, V54, P3260; YU DH, 1995, ONCOGENE, V11, P1383; Zava DT, 1998, P SOC EXP BIOL MED, V217, P369	56	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20034	10.1371/journal.pone.0020034	http://dx.doi.org/10.1371/journal.pone.0020034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603581	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300049
J	Panopoulos, AD; Ruiz, S; Yi, F; Herrerias, A; Batchelder, EM; Carlos, J; Belmonte, I				Panopoulos, Athanasia D.; Ruiz, Sergio; Yi, Fei; Herrerias, Aida; Batchelder, Erika M.; Carlos, Juan; Belmonte, Izpisua			Rapid and Highly Efficient Generation of Induced Pluripotent Stem Cells from Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							INDUCTION; CULTURE; BANKING; OCT4	The ability to induce somatic cells to pluripotency by ectopic expression of defined transcription factors (e. g. KLF-4, OCT4, SOX2, c-MYC, or KOSM) has transformed the future of regenerative medicine. Here we report somatic cell reprogramming of human umbilical vein endothelial cells (HUVECs), yielding induced pluripotent stem (iPS) cells with the fastest kinetics, and one of the highest reprogramming efficiencies for a human somatic cell to date. HUVEC-derived iPS (Huv-iPS) cell colonies appeared as early as 6 days after a single KOSM infection, and were generated with a 2.5-3% reprogramming efficiency. Furthermore, when HUVEC reprogramming was performed under hypoxic conditions in the presence of a TGF-beta family signaling inhibitor, colony formation increased an additional similar to 2.5-fold over standard conditions. Huv-iPS cells were indistinguishable from human embryonic stem (ES) cells with regards to morphology, pluripotent marker expression, and their ability to generate all embryonic germ layers in vitro and in vivo. The high efficiency and rapid kinetics of Huv-iPS cell formation, coupled with the ease by which HUVECs can be collected, expanded and stored, make these cells an attractive somatic source for therapeutic application, and for studying the reprogramming process.	[Panopoulos, Athanasia D.; Ruiz, Sergio; Yi, Fei; Batchelder, Erika M.; Carlos, Juan; Belmonte, Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Herrerias, Aida; Belmonte, Izpisua] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Panopoulos, AD (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	; Ruiz, Sergio/G-1561-2016	Panopoulos, Athanasia/0000-0002-9610-2604; Ruiz, Sergio/0000-0002-0177-6965	NIH [T32 CA009370]; Instituto de Salud Carlos III [CGCV-1335/07-3]; Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN); NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ADP was partially supported by NIH training grant T32 CA009370. SR was partially supported by the Instituto de Salud Carlos III (CGCV-1335/07-3). Work in this manuscript was supported by grants from Fundacion Cellex the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER), Terapia Celular (TERCEL), and Ministerio de Ciencia e Innovacion (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Ho PJ, 2010, ARTERIOSCL THROM VAS, V30, P1905, DOI 10.1161/ATVBAHA.110.206540; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	27	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19743	10.1371/journal.pone.0019743	http://dx.doi.org/10.1371/journal.pone.0019743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603572	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300023
J	Rodriguez-Suarez, C; Atienza, SG; Piston, F				Rodriguez-Suarez, Cristina; Atienza, Sergio G.; Piston, Fernando			Allelic Variation, Alternative Splicing and Expression Analysis of Psy1 Gene in Hordeum chilense Roem. et Schult	PLOS ONE			English	Article							PHYTOENE-SYNTHASE GENE; PERFORMANCE LIQUID-CHROMATOGRAPHY; YELLOW PIGMENT CONTENT; DURUM-WHEAT; CAROTENOID BIOSYNTHESIS; COMMON WHEAT; ACCUMULATION; IDENTIFICATION; ASSOCIATION; TRITORDEUM	Background: The wild barley Hordeum chilense Roem. et Schult. is a valuable source of genes for increasing carotenoid content in wheat. Tritordeums, the amphiploids derived from durum or common wheat and H. chilense, systematically show higher values of yellow pigment colour and carotenoid content than durum wheat. Phytoene synthase 1 gene (Psy1) is considered a key step limiting the carotenoid biosynthesis, and the correlation of Psy1 transcripts accumulation and endosperm carotenoid content has been demonstrated in the main grass species. Methodology/Principal findings: We analyze the variability of Psy1 alleles in three lines of H. chilense (H1, H7 and H16) representing the three ecotypes described in this species. Moreover, we analyze Psy1 expression in leaves and in two seed developing stages of H1 and H7, showing mRNA accumulation patterns similar to those of wheat. Finally, we identify thirty-six different transcripts forms originated by alternative splicing of the 59 UTR and/or exons 1 to 5 of Psy1 gene. Transcripts function is tested in a heterologous complementation assay, revealing that from the sixteen different predicted proteins only four types (those of 432, 370, 364 and 271 amino acids), are functional in the bacterial system. Conclusions/Significance: The large number of transcripts originated by alternative splicing of Psy1, and the coexistence of functional and non functional forms, suggest a fine regulation of PSY activity in H. chilense. This work is the first analysis of H. chilense Psy1 gene and the results reported here are the bases for its potential use in carotenoid enhancement in durum wheat.	[Rodriguez-Suarez, Cristina; Atienza, Sergio G.; Piston, Fernando] IAS CSIC, Consejo Super Invest Sci, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Rodriguez-Suarez, C (corresponding author), IAS CSIC, Consejo Super Invest Sci, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	crodriguez@ias.csic.es	Rodríguez-Suárez, Cristina/M-2304-2014; Atienza, Sergio G/K-1080-2014; Piston, Fernando/AAD-6975-2020	Rodríguez-Suárez, Cristina/0000-0002-5409-1839; Atienza, Sergio G/0000-0001-5175-8303; Piston, Fernando/0000-0002-5496-0205	Spanish Ministry of Science and Innovation (MSI) [AGL2008-03720, 200840I137]; CSIC; FEDER; MSI; FSE	Spanish Ministry of Science and Innovation (MSI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; FEDER(European Commission); MSI; FSE(European Social Fund (ESF))	This work was supported by grants (to SGA) AGL2008-03720 and 200840I137 from the Spanish Ministry of Science and Innovation (MSI), CSIC and FEDER. FP acknowledges financial support from the MSI Juan de la Cierva program. CR-S and FP acknowledge financial support from JAE-Doc program (CSIC, co-funded by FSE) and the Ramon y Cajal program (Spanish Ministry of Science and Innovation) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; Alvarez JB, 1999, PLANT BREEDING, V118, P187, DOI 10.1046/j.1439-0523.1999.118002187.x; Alvarez JB, 1998, PLANT BREEDING, V117, P287, DOI 10.1111/j.1439-0523.1998.tb01942.x; Atienza SG, 2007, AUST J AGR RES, V58, P767, DOI 10.1071/AR06338; Atienza SG, 2007, J AGR FOOD CHEM, V55, P4244, DOI 10.1021/jf070342p; Atienza SG, 2005, AUST J AGR RES, V56, P85, DOI 10.1071/AR04154; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Borrelli GM, 2003, CEREAL CHEM, V80, P225, DOI 10.1094/CCHEM.2003.80.2.225; Britton George, 2008, V4, P189, DOI 10.1007/978-3-7643-7499-0_10; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Castillo A, 2010, ANN APPL BIOL, V156, P347, DOI 10.1111/j.1744-7348.2010.00391.x; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cenci A, 2004, GENOME, V47, P911, DOI 10.1139/G04-033; Cong L, 2009, J AGR FOOD CHEM, V57, P8652, DOI 10.1021/jf9012218; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Digesu AM, 2009, J CEREAL SCI, V50, P210, DOI 10.1016/j.jcs.2009.05.002; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fu ZY, 2010, THEOR APPL GENET, V120, P709, DOI 10.1007/s00122-009-1188-x; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; He XY, 2008, THEOR APPL GENET, V116, P213, DOI 10.1007/s00122-007-0660-8; He XY, 2009, MOL BREEDING, V23, P553, DOI 10.1007/s11032-009-9255-1; He XY, 2009, CROP SCI, V49, P2058, DOI 10.2135/cropsci2008.11.0651; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kim IJ, 2003, J MICROBIOL, V41, P212; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Martin A, 1998, TRITICEAE III, P377; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; MISAWA N, 1994, J BIOCHEM-TOKYO, V116, P980, DOI 10.1093/oxfordjournals.jbchem.a124656; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Panfili G, 2004, J AGR FOOD CHEM, V52, P6373, DOI 10.1021/jf0402025; Patto MCV, 2001, CAN J BOT, V79, P204, DOI 10.1139/cjb-79-2-204; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reimer S, 2008, GENOME, V51, P1016, DOI 10.1139/G08-083; Rodriguez-Suarez C, 2010, CROP PASTURE SCI, V61, P743, DOI 10.1071/CP10025; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x; Singh A, 2009, THEOR APPL GENET, V118, P1539, DOI 10.1007/s00122-009-1001-x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Wang JW, 2009, HEREDITAS, V146, P208, DOI 10.1111/j.1601-5223.2009.02132.x; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhang YL, 2009, EUPHYTICA, V165, P435, DOI 10.1007/s10681-008-9744-z	57	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19885	10.1371/journal.pone.0019885	http://dx.doi.org/10.1371/journal.pone.0019885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603624	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300035
J	Schooling, CM; Jiang, CQ; Lam, TH; Zhang, WS; Cheng, KK; Leung, GM				Schooling, C. Mary; Jiang, ChaoQiang; Lam, Tai Hing; Zhang, WeiSen; Cheng, Kar Keung; Leung, Gabriel M.			Parental Death during Childhood and Adult Cardiovascular Risk in a Developing Country: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EARLY-LIFE STRESS; BLOOD-CELL COUNT; METABOLIC SYNDROME; TRUNK LENGTH; EXPERIENCES; PUBERTY; OBESITY; HEALTH; CIRCUMSTANCES	Background: In observational studies from western countries childhood emotional adversity is usually associated with adult cardiovascular disease. These findings are open to contextual biases making evidence from other settings valuable. We examined the association of a potential marker of childhood emotional adversity with cardiovascular disease risk factors in a developing country. Methods: We used multivariable regression in cross-sectional analysis of older (>= 50 years) men (n = 7,885) and women (n = 20,886) from the Guangzhou Biobank Cohort Study (2003-8) to examine the adjusted association of early life (<18 years) parental death (none, one or two deaths) with blood pressure, fasting glucose, LDL-cholesterol, HDL-cholesterol, triglycerides, body mass index (BMI), waist-hip ratio (WHR) and white blood cell count (WBC). We used seated height and delayed 10-word recall to assess content validity of parental death as a measure of childhood emotional adversity. We also examined whether associations varied by sex. Results: Early life parental death was associated with shorter age-and sex-adjusted seated height. It was also associated with lower 10-word recall score adjusted for age, sex, socio-economic position, leg length and lifestyle. Similarly, adjusted early life parental death was not associated with blood pressure, fasting glucose, LDL-cholesterol or HDL-cholesterol but was associated with lower BMI (-0.40, 95% confidence interval (CI) -0.62 to -0.19 for 2 compared with no early life parental deaths) and triglycerides. Associations varied by sex for WHR and WBC. Among men only, early life parental death was associated with lower WHR (-0.008, 95% CI -0.015 to -0.001) and WBC (-0.35 10(9)/L, 95% CI -0.56 to -0.13). Conclusions: In a non-western population from a developing country, childhood emotional adversity was negatively associated with some cardiovascular risk factors, particularly among men. Our study suggests that some of the observed associations in western populations may be socially rather than biologically based or may be population specific.	[Schooling, C. Mary; Lam, Tai Hing; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Jiang, ChaoQiang; Zhang, WeiSen] Guangzhou 12 Hosp, Guangzhou Occupat Dis Prevent & Treatment Ctr, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	The study was funded by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China, and The University of Birmingham, UK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Cerel J, 2006, J AM ACAD CHILD PSY, V45, P681, DOI 10.1097/01.chi.0000215327.58799.05; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Fimmel S, 2005, Aging Male, V8, P166, DOI 10.1080/13685530500233847; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Harrell FE, 2001, REGRESSION MODELING; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Hope S, 1998, ADDICTION, V93, P505, DOI 10.1046/j.1360-0443.1998.9345056.x; Ikeda A, 2008, INT J EPIDEMIOL, V37, P1395, DOI 10.1093/ije/dyn124; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Kavikondala S, 2009, INT J EPIDEMIOL, V38, P72, DOI 10.1093/ije/dyn221; KESSLER RC, 1980, AM SOCIOL REV, V45, P463, DOI 10.2307/2095178; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Little R.J.A., 2002, STAT ANAL MISSING DA; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Luecken LJ, 1998, PSYCHOSOM MED, V60, P765, DOI 10.1097/00006842-199811000-00021; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Nielsen NR, 2006, EPIDEMIOLOGY, V17, P391, DOI 10.1097/01.ede.0000220556.86419.76; O'Rand AM, 2005, J GERONTOL B-PSYCHOL, V60, P117, DOI 10.1093/geronb/60.Special_Issue_2.S117; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Roemmich JN, 1999, AM J HUM BIOL, V11, P209, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;209::AID-AJHB9&gt;3.0.CO;2-G; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Siervogel RM, 2003, HORM RES, V60, P36, DOI 10.1159/000071224; Sumanen M, 2005, J PSYCHOSOM RES, V59, P331, DOI 10.1016/j.jpsychores.2005.04.005; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Taylor SE, 2006, BIOL PSYCHIAT, V60, P819, DOI 10.1016/j.biopsych.2006.03.016; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Yamamoto K, 1996, CHILD PSYCHIAT HUM D, V26, P139, DOI 10.1007/BF02353355	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19675	10.1371/journal.pone.0019675	http://dx.doi.org/10.1371/journal.pone.0019675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603607	Green Published, gold			2022-12-27	WOS:000290656300017
J	Vaddepalli, P; Fulton, L; Batoux, M; Yadav, RK; Schneitz, K				Vaddepalli, Prasad; Fulton, Lynette; Batoux, Martine; Yadav, Ram Kishor; Schneitz, Kay			Structure-Function Analysis of STRUBBELIG, an Arabidopsis Atypical Receptor-Like Kinase Involved in Tissue Morphogenesis	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; RETICULUM-ASSOCIATED DEGRADATION; DEFECTIVE BRASSINOSTEROID RECEPTOR; STEM-CELL SPECIFICATION; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; PROTEIN-KINASES; ORGAN DEVELOPMENT; OVULE DEVELOPMENT; FLORAL DEVELOPMENT	Tissue morphogenesis in plants requires the coordination of cellular behavior across clonally distinct histogenic layers. The underlying signaling mechanisms are presently being unraveled and are known to include the cell surface leucine-rich repeat receptor-like kinase STRUBBELIG in Arabidopsis. To understand better its mode of action an extensive structure-function analysis of STRUBBELIG was performed. The phenotypes of 20 EMS and T-DNA-induced strubbelig alleles were assessed and homology modeling was applied to rationalize their possible effects on STRUBBELIG protein structure. The analysis was complemented by phenotypic, cell biological, and pharmacological investigations of a strubbelig null allele carrying genomic rescue constructs encoding fusions between various mutated STRUBBELIG proteins and GFP. The results indicate that STRUBBELIG accepts quite some sequence variation, reveal the biological importance for the STRUBBELIG N-capping domain, and reinforce the notion that kinase activity is not essential for its function in vivo. Furthermore, individual protein domains of STRUBBELIG cannot be related to specific STRUBBELIG-dependent biological processes suggesting that process specificity is mediated by factors acting together with or downstream of STRUBBELIG. In addition, the evidence indicates that biogenesis of a functional STRUBBELIG receptor is subject to endoplasmic reticulum-mediated quality control, and that an MG132-sensitive process regulates its stability. Finally, STRUBBELIG and the receptor-like kinase gene ERECTA interact synergistically in the control of internode length. The data provide genetic and molecular insight into how STRUBBELIG regulates intercellular communication in tissue morphogenesis.	[Vaddepalli, Prasad; Fulton, Lynette; Batoux, Martine; Yadav, Ram Kishor; Schneitz, Kay] Tech Univ Munich, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Vaddepalli, P (corresponding author), Tech Univ Munich, D-8050 Freising Weihenstephan, Germany.	schneitz@wzw.tum.de	Yadav, Ram Kishor/C-7133-2011; Vaddepalli, Prasad/AAS-9487-2020; Vaddepalli, Prasad/ABG-6642-2021	Vaddepalli, Prasad/0000-0002-9236-6063; Fulton, Lynette/0000-0002-9640-5840; Schneitz, Kay/0000-0001-6688-0539	German Research Council (DFG) [SCHN 723/1-3, SCHN 723/6-1]; Free State of Bavaria	German Research Council (DFG)(German Research Foundation (DFG)); Free State of Bavaria	This work was funded through grants SCHN 723/1-3 and SCHN 723/6-1 from the German Research Council (DFG) to KS and by the Free State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Calderon-Villalobos LIA, 2006, PLANT PHYSIOL, V141, P3, DOI 10.1104/pp.106.078097; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; EVANS MJ, 1989, GENE, V84, P135, DOI 10.1016/0378-1119(89)90147-9; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fulton L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000355; Fulton L, 2010, BIOCHEM SOC T, V38, P583, DOI 10.1042/BST0380583; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Gifford ML, 2005, PLANT CELL, V17, P1154, DOI 10.1105/tpc.104.029975; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ingram GC, 2006, CURR OPIN PLANT BIOL, V9, P12, DOI 10.1016/j.pbi.2005.11.007; Jenik PD, 2000, DEVELOPMENT, V127, P1267; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kolade OO, 2006, BBA-PROTEINS PROTEOM, V1764, P1043, DOI 10.1016/j.bbapap.2006.03.014; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Lease KA, 2001, NEW PHYTOL, V151, P133, DOI 10.1046/j.1469-8137.2001.00150.x; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillitteri LJ, 2007, DEVELOPMENT, V134, P3099, DOI 10.1242/dev.004788; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sambrook J, 1989, MOL CLONING; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Schneitz K, 1997, DEVELOPMENT, V124, P1367; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Watanabe M, 2004, PLANT J, V39, P298, DOI 10.1111/j.1365-313X.2004.02132.x; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yadav RK, 2008, DEV BIOL, V323, P261, DOI 10.1016/j.ydbio.2008.08.010; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	98	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19730	10.1371/journal.pone.0019730	http://dx.doi.org/10.1371/journal.pone.0019730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603601	Green Submitted, Green Published, gold			2022-12-27	WOS:000290656300021
J	Deng, W; Yang, DS; Zhao, BT; Ouyang, Z; Song, J; Fan, NN; Liu, ZM; Zhao, Y; Wu, QH; Nashun, B; Tang, JJ; Wu, ZF; Gu, WW; Lai, LX				Deng, Wei; Yang, Dongshan; Zhao, Bentian; Ouyang, Zhen; Song, Jun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Wu, Qinghong; Nashun, Bayaer; Tang, Jiangjing; Wu, Zhenfang; Gu, Weiwang; Lai, Liangxue			Use of the 2A Peptide for Generation of Multi-Transgenic Pigs through a Single Round of Nuclear Transfer	PLOS ONE			English	Article							MEMBRANE COFACTOR PROTEIN; DECAY-ACCELERATING FACTOR; EXPRESSING HUMAN CD59; IN-VIVO; RETROVIRAL VECTOR; STEM-CELLS; GENE-EXPRESSION; COEXPRESSION; HOXB4; MODEL	Multiple genetic modifications in pigs can essentially benefit research on agriculture, human disease and xenotransplantation. Most multi-transgenic pigs have been produced by complex and time-consuming breeding programs using multiple single-transgenic pigs. This study explored the feasibility of producing multi-transgenic pigs using the viral 2A peptide in the light of previous research indicating that it can be utilized for multi-gene transfer in gene therapy and somatic cell reprogramming. A 2A peptide-based double-promoter expression vector that mediated the expression of four fluorescent proteins was constructed and transfected into primary porcine fetal fibroblasts. Cell colonies (54.3%) formed under G418 selection co-expressed the four fluorescent proteins at uniformly high levels. The reconstructed embryos, which were obtained by somatic cell nuclear transfer and confirmed to express the four fluorescent proteins evenly, were transplanted into seven recipient gilts. Eleven piglets were delivered by two gilts, and seven of them co-expressed the four fluorescent proteins at equivalently high levels in various tissues. The fluorescence intensities were directly observed at the nose, hoof and tongue using goggles. The results suggest that the strategy of combining the 2A peptide and double promoters efficiently mediates the co-expression of the four fluorescent proteins in pigs and is hence a promising methodology to generate multi-transgenic pigs by a single nuclear transfer.	[Deng, Wei; Yang, Dongshan; Zhao, Bentian; Ouyang, Zhen; Song, Jun; Fan, Nana; Liu, Zhaoming; Zhao, Yu; Tang, Jiangjing; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wu, Qinghong; Nashun, Bayaer; Gu, Weiwang] So Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Wu, Qinghong; Nashun, Bayaer; Gu, Weiwang] So Med Univ, Ctr Lab Anim, Guangzhou, Guangdong, Peoples R China; [Wu, Zhenfang] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Southern Medical University - China; Southern Medical University - China; South China Agricultural University	Deng, W (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.	guww100@163.com; Lai_liangxue@gibh.ac.cn	Lai, Liangxue/H-4545-2011; Yang, Dongshan/N-3333-2014; Song, Jun/A-3487-2013	Yang, Dongshan/0000-0003-2449-8651; Song, Jun/0000-0002-6128-6378; Wu, Zhenfang/0000-0002-5586-6771	National High Technology Research and Development Program of China [2006AA02A103]; Chinese Academy of Sciences [A0858]; National 973 Program of China [2009CB941001]; Natural Science Foundation of Guangdong Province, China [9251066302000001, 8451066302001811]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National 973 Program of China(National Basic Research Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work supported by grants from the National High Technology Research and Development Program of China (2006AA02A103), the Hundred Talents Projects of the Chinese Academy of Sciences (A0858), the National 973 Program of China (2009CB941001), and the Natural Science Foundation of Guangdong Province, China (9251066302000001, 8451066302001811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Asano Takako, 2005, Journal of Medical and Dental Sciences, V52, P129; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen RH, 1999, XENOTRANSPLANTATION, V6, P194, DOI 10.1034/j.1399-3089.1999.00017.x; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; de Cicco RL, 2007, MOL CARCINOGEN, V46, P654, DOI 10.1002/mc.20331; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; GALIMBERTI D, INT J CLIN EXP HYP, V3, P129; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Klump H, 2001, GENE THER, V8, P811, DOI 10.1038/sj.gt.3301447; Klymiuk N, 2010, MOL REPROD DEV, V77, P209, DOI 10.1002/mrd.21127; Lai Liangxue, 2003, Reprod Biol Endocrinol, V1, P82, DOI 10.1186/1477-7827-1-82; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Menoret S, 2004, TRANSPLANTATION, V77, P1468, DOI 10.1097/01.TP.0000111758.35048.EA; Milsom MD, 2004, MOL THER, V10, P862, DOI 10.1016/j.ymthe.2004.07.019; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Sachs DH, 2009, CURR OPIN ORGAN TRAN, V14, P148, DOI 10.1097/MOT.0b013e3283292549; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun M, 2003, HUM GENE THER, V14, P415, DOI 10.1089/104303403321467180; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Webster NL, 2005, MOL REPROD DEV, V72, P68, DOI 10.1002/mrd.20316; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Wu ZF, 2008, MOL REPROD DEV, V75, P26, DOI 10.1002/mrd.20778; Xu K, 2005, WORLD J GASTROENTERO, V11, P2885, DOI 10.3748/wjg.v11.i19.2885; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou CY, 2005, XENOTRANSPLANTATION, V12, P142, DOI 10.1111/j.1399-3089.2005.00209.x; Zhou CY, 2002, XENOTRANSPLANTATION, V9, P183, DOI 10.1034/j.1399-3089.2002.01034.x; Zhou Y, 1998, HUM GENE THER, V9, P287, DOI 10.1089/hum.1998.9.3-287	41	57	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19986	10.1371/journal.pone.0019986	http://dx.doi.org/10.1371/journal.pone.0019986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603633	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500040
J	Muralidhara, C; Gross, AM; Gutell, RR; Alter, O				Muralidhara, Chaitanya; Gross, Andrew M.; Gutell, Robin R.; Alter, Orly			Tensor Decomposition Reveals Concurrent Evolutionary Convergences and Divergences and Correlations with Structural Motifs in Ribosomal RNA	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; INTEGRATIVE ANALYSIS; DOMAINS ARCHAEA; SEQUENCE; SUBUNIT; DNA; MICROSPORIDIA; CONSTRAINTS; BACTERIA	Evolutionary relationships among organisms are commonly described by using a hierarchy derived from comparisons of ribosomal RNA (rRNA) sequences. We propose that even on the level of a single rRNA molecule, an organism's evolution is composed of multiple pathways due to concurrent forces that act independently upon different rRNA degrees of freedom. Relationships among organisms are then compositions of coexisting pathway-dependent similarities and dissimilarities, which cannot be described by a single hierarchy. We computationally test this hypothesis in comparative analyses of 16S and 23S rRNA sequence alignments by using a tensor decomposition, i.e., a framework for modeling composite data. Each alignment is encoded in a cuboid, i.e., a third-order tensor, where nucleotides, positions and organisms, each represent a degree of freedom. A tensor mode-1 higher-order singular value decomposition (HOSVD) is formulated such that it separates each cuboid into combinations of patterns of nucleotide frequency variation across organisms and positions, i.e., "eigenpositions" and corresponding nucleotide-specific segments of "eigenorganisms," respectively, independent of a-priori knowledge of the taxonomic groups or rRNA structures. We find, in support of our hypothesis that, first, the significant eigenpositions reveal multiple similarities and dissimilarities among the taxonomic groups. Second, the corresponding eigenorganisms identify insertions or deletions of nucleotides exclusively conserved within the corresponding groups, that map out entire substructures and are enriched in adenosines, unpaired in the rRNA secondary structure, that participate in tertiary structure interactions. This demonstrates that structural motifs involved in rRNA folding and function are evolutionary degrees of freedom. Third, two previously unknown coexisting subgenic relationships between Microsporidia and Archaea are revealed in both the 16S and 23S rRNA alignments, a convergence and a divergence, conferred by insertions and deletions of these motifs, which cannot be described by a single hierarchy. This shows that mode-1 HOSVD modeling of rRNA alignments might be used to computationally predict evolutionary mechanisms.	[Muralidhara, Chaitanya; Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Gross, Andrew M.] Univ Calif San Diego, Bioinformat & Syst Biol Program, San Diego, CA 92103 USA; [Gutell, Robin R.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Gutell, Robin R.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT USA; [Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	University of Texas System; University of Texas Austin; University of California System; University of California San Diego; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Muralidhara, C (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	orly@sci.utah.edu		Gutell, Robin/0000-0002-5919-0801; Alter, Orly/0000-0002-0418-1078	National Institute of General Medical Sciences [GM-067317]; National Human Genome Research Institute [HG-004302]; National Science Foundation [DMS-0847173]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0847173] Funding Source: National Science Foundation	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by National Institute of General Medical Sciences R01 Grant GM-067317 (to RRG) and National Human Genome Research Institute R01 Grant HG-004302 and National Science Foundation CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2006, P NATL ACAD SCI USA, V103, P16063, DOI 10.1073/pnas.0607650103; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BOCK WJ, 1959, EVOLUTION, V13, P194, DOI 10.2307/2405873; Cadima J, 2009, PAK J STAT, V25, P473; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Golub GH., 2013, MATRIX COMPUTATIONS; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Isaksson J, 2004, BIOCHEMISTRY-US, V43, P15996, DOI 10.1021/bi048221v; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Sagara JI, 1998, NUCLEIC ACIDS RES, V26, P1974, DOI 10.1093/nar/26.8.1974; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WINKER S, 1991, SYST APPL MICROBIOL, V14, P305, DOI 10.1016/S0723-2020(11)80303-6; Woese C.R., 1967, GENETIC CODE MOL BAS; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18768	10.1371/journal.pone.0018768	http://dx.doi.org/10.1371/journal.pone.0018768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21625625	Green Submitted, Green Published, gold			2022-12-27	WOS:000290024700024
J	Penner, RC; Knudsen, M; Wiuf, C; Andersen, JE				Penner, Robert Clark; Knudsen, Michael; Wiuf, Carsten; Andersen, Jorgen Ellegaard			An Algebro-Topological Description of Protein Domain Structure	PLOS ONE			English	Article							STRUCTURE CLASSIFICATION; SECONDARY STRUCTURE; CATH; SCOP; IDENTIFICATION; ORGANIZATION; DICTIONARY; DIVERGENCE; DATABASE; SPACE	The space of possible protein structures appears vast and continuous, and the relationship between primary, secondary and tertiary structure levels is complex. Protein structure comparison and classification is therefore a difficult but important task since structure is a determinant for molecular interaction and function. We introduce a novel mathematical abstraction based on geometric topology to describe protein domain structure. Using the locations of the backbone atoms and the hydrogen bonds, we build a combinatorial object - a so-called fatgraph. The description is discrete yet gives rise to a 2-dimensional mathematical surface. Thus, each protein domain corresponds to a particular mathematical surface with characteristic topological invariants, such as the genus (number of holes) and the number of boundary components. Both invariants are global fatgraph features reflecting the interconnectivity of the domain by hydrogen bonds. We introduce the notion of robust variables, that is variables that are robust towards minor changes in the structure/fatgraph, and show that the genus and the number of boundary components are robust. Further, we invesigate the distribution of different fatgraph variables and show how only four variables are capable of distinguishing different folds. We use local (secondary) and global (tertiary) fatgraph features to describe domain structures and illustrate that they are useful for classification of domains in CATH. In addition, we combine our method with two other methods thereby using primary, secondary, and tertiary structure information, and show that we can identify a large percentage of new and unclassified structures in CATH.	[Penner, Robert Clark; Andersen, Jorgen Ellegaard] Aarhus Univ, Ctr Topol & Quantizat Moduli Spaces, Dept Math Sci, Aarhus, Denmark; [Penner, Robert Clark] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; [Penner, Robert Clark] Univ So Calif, Dept Phys Astron, Los Angeles, CA USA; [Knudsen, Michael; Wiuf, Carsten] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Wiuf, Carsten] Aarhus Univ, Ctr Membrane Pumps Cells & Dis, Aarhus, Denmark	Aarhus University; University of Southern California; University of Southern California; Aarhus University; Aarhus University	Penner, RC (corresponding author), Aarhus Univ, Ctr Topol & Quantizat Moduli Spaces, Dept Math Sci, Aarhus, Denmark.	wiuf@birc.au.dk	Wiuf, Carsten/H-6320-2011	Wiuf, Carsten/0000-0002-1302-4445; Knudsen, Michael/0000-0002-6294-2517; Andersen, Jorgen Ellegaard/0000-0001-9721-0722	Centre for Theory in Natural Sciences; Danish Research Councils; Humboldt Foundation, Germany	Centre for Theory in Natural Sciences; Danish Research Councils(Det Frie Forskningsrad (DFF)); Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	MK is supported by the Centre for Theory in Natural Sciences; CW is supported by the Danish Research Councils and by the Humboldt Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung Z, 2005, J COMPUT BIOL, V12, P1221, DOI 10.1089/cmb.2005.12.1221; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Choi IG, 2004, P NATL ACAD SCI USA, V101, P3797, DOI 10.1073/pnas.0308656100; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; Cuff A, 2009, STRUCTURE, V17, P1051, DOI 10.1016/j.str.2009.06.015; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; Finkelstein A. V., 2002, PROTEIN PHYS COURSE; Getz G, 2002, PROTEINS, V46, P405, DOI 10.1002/prot.1176; Gramada A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-242; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim YJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-456; Knudsen Michael, 2010, Human Genomics, V4, P207; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; MASSEY WS, 1997, ALGEBRAIC TOPOLOGY I; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Penner RC, 2010, COMMUN PUR APPL MATH, V63, P1249, DOI 10.1002/cpa.20340; PENNER RC, 1988, J DIFFER GEOM, V27, P35; Rackovsky S, 2009, P NATL ACAD SCI USA, V106, P14345, DOI 10.1073/pnas.0903433106; RACKOVSKY S, 2006, PROTEOMICS PROTOCOLS, P861; Rogen P, 2003, P NATL ACAD SCI USA, V100, P119, DOI 10.1073/pnas.2636460100; Rogen P, 2008, GEOMETRIAE DEDICATA, V134, P91, DOI 10.1007/s10711-008-9247-z; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zotenko E, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-12	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19670	10.1371/journal.pone.0019670	http://dx.doi.org/10.1371/journal.pone.0019670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629687	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800005
J	Sharbati, J; Lewin, A; Kutz-Lohroff, B; Kamal, E; Einspanier, R; Sharbati, S				Sharbati, Jutta; Lewin, Astrid; Kutz-Lohroff, Barbara; Kamal, Elisabeth; Einspanier, Ralf; Sharbati, Soroush			Integrated MicroRNA-mRNA-Analysis of Human Monocyte Derived Macrophages upon Mycobacterium avium subsp hominissuis Infection	PLOS ONE			English	Article							GENE-EXPRESSION; INDUCED APOPTOSIS; IMMUNE-RESPONSES; INNATE IMMUNITY; CELL-DEATH; C-MYC; TUBERCULOSIS; LIPOPOLYSACCHARIDE; RECEPTOR; STRAINS	Background: Many efforts have been made to understand basal mechanisms of mycobacterial infections. Macrophages are the first line of host immune defence to encounter and eradicate mycobacteria. Pathogenic species have evolved different mechanisms to evade host response, e. g. by influencing macrophage apoptotic pathways. However, the underlying molecular regulation is not fully understood. A new layer of eukaryotic regulation of gene expression is constituted by microRNAs. Therefore, we present a comprehensive study for identification of these key regulators and their targets in the context of host macrophage response to mycobacterial infections. Methodology/Principal Findings: We performed microRNA as well as mRNA expression analysis of human monocyte derived macrophages infected with several Mycobacterium avium hominissuis strains by means of microarrays as well as quantitative reverse transcription PCR (qRT-PCR). The data revealed the ability of all strains to inhibit apoptosis by transcriptional regulation of BCL2 family members. Accordingly, at 48 h after infection macrophages infected with all M. avium strains showed significantly decreased caspase 3 and 7 activities compared to the controls. Expression of let-7e, miR-29a and miR-886-5p were increased in response to mycobacterial infection at 48 h. The integrated analysis of microRNA and mRNA expression as well as target prediction pointed out regulative networks identifying caspase 3 and 7 as potential targets of let-7e and miR-29a, respectively. Consecutive reporter assays verified the regulation of caspase 3 and 7 by these microRNAs. Conclusions/Significance: We show for the first time that mycobacterial infection of human macrophages causes a specific microRNA response. We furthermore outlined a regulatory network of potential interactions between microRNAs and mRNAs. This study provides a theoretical concept for unveiling how distinct mycobacteria could manipulate host cell response. In addition, functional relevance was confirmed by uncovering the control of major caspases 3 and 7 by let-7e and miR-29a, respectively.	[Sharbati, Jutta; Kutz-Lohroff, Barbara; Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, D-1000 Berlin, Germany; [Lewin, Astrid; Kamal, Elisabeth] Robert Koch Inst, D-1000 Berlin, Germany	Free University of Berlin; Robert Koch Institute	Sharbati, J (corresponding author), Free Univ Berlin, Inst Vet Biochem, D-1000 Berlin, Germany.	sharbati@zedat.fu-berlin.de	Sharbati, Soroush/D-2548-2014	Sharbati, Soroush/0000-0003-3338-7654	Deutsche Forschungsgemeinschaft [SFB 852, B4]; "Forschungskommission" of the Freie Universitaet Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Forschungskommission" of the Freie Universitaet Berlin	The study was supported by grants from Deutsche Forschungsgemeinschaft (SFB 852 project B4) and the "Forschungskommission" of the Freie Universitaet Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Balcewicz-Sablinska MK, 1999, J INFECT DIS, V180, P1230, DOI 10.1086/315011; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Barry DP, 2006, APOPTOSIS, V11, P1695, DOI 10.1007/s10495-006-9236-3; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BEHAR SM, 2011, MUCOSAL IMMUNOL; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bermudez LE, 1999, CLIN EXP IMMUNOL, V116, P94; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corti M, 2008, EXPERT REV ANTI-INFE, V6, P351, DOI 10.1586/14787210.6.3.351; Dvorska L, 2004, VET MICROBIOL, V99, P239, DOI 10.1016/j.vetmic.2004.01.008; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Ganguly N, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-24; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gey Van Pittius NC, 2001, GENOME BIOL, V2, DOI 10.1186/GB-2001-2-10-RESEARCH004; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Haverkamp MH, 2004, CLIN INFECT DIS, V39, P450, DOI 10.1086/422319; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Hussain S, 1999, J IMMUNOL, V163, P2041; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Li JH, 2011, GYNECOL ONCOL, V120, P145, DOI 10.1016/j.ygyno.2010.09.009; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI [10.1099/ijs.0.02037-0, 10.1099/00207713-52-5-1505]; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Semret M, 2004, J BACTERIOL, V186, P6332, DOI 10.1128/JB.186.18.6332-6334.2004; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sharbati-Tehrani S, 2005, MICROBIOL-SGM, V151, P2403, DOI 10.1099/mic.0.27969-0; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Wang AY, 2010, J BACTERIOL, V192, P2809, DOI 10.1128/JB.01462-09; Wittram C, 2002, BRIT J RADIOL, V75, P340, DOI 10.1259/bjr.75.892.750340; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	63	124	138	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20258	10.1371/journal.pone.0020258	http://dx.doi.org/10.1371/journal.pone.0020258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629653	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800038
J	Cysarz, D; Linhard, M; Edelhauser, F; Langler, A; Van Leeuwen, P; Henze, G; Seifert, G				Cysarz, Dirk; Linhard, Maijana; Edelhaeuser, Friedrich; Laengler, Alfred; Van Leeuwen, Peter; Henze, Guenter; Seifert, Georg			Unexpected Course of Nonlinear Cardiac Interbeat Interval Dynamics during Childhood and Adolescence	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; TIME-SERIES ANALYSIS; NORMAL RANGES; PUBERTAL DEVELOPMENT; APPROXIMATE ENTROPY; HEALTHY-CHILDREN; AGE; INFANTS; MODULATION; PHYSIOLOGY	The fluctuations of the cardiac interbeat series contain rich information because they reflect variations of other functions on different time scales (e. g., respiration or blood pressure control). Nonlinear measures such as complexity and fractal scaling properties derived from 24 h heart rate dynamics of healthy subjects vary from childhood to old age. In this study, the age-related variations during childhood and adolescence were addressed. In particular, the cardiac interbeat interval series was quantified with respect to complexity and fractal scaling properties. The R-R interval series of 409 healthy children and adolescents (age range: 1 to 22 years, 220 females) was analyzed with respect to complexity (Approximate Entropy, ApEn) and fractal scaling properties on three time scales: long-term (slope beta of the power spectrum, log power vs. log frequency, in the frequency range 10(-4) to 10(-2) Hz) intermediate-term (DFA, detrended fluctuation analysis, alpha(2)) and short-term (DFA alpha(1)). Unexpectedly, during age 7 to 13 years beta and ApEn were higher compared to the age < 7 years and age > 13 years (beta: -1.06 vs. -1.21; ApEn: 0.88 vs. 0.74). Hence, the heart rate dynamics were closer to a 1/f power law and most complex between 7 and 13 years. However, DFA alpha(1) and alpha(2) increased with progressing age similar to measures reflecting linear properties. In conclusion, the course of long-term fractal scaling properties and complexity of heart rate dynamics during childhood and adolescence indicates that these measures reflect complex changes possibly linked to hormonal changes during pre-puberty and puberty.	[Cysarz, Dirk; Edelhaeuser, Friedrich; Laengler, Alfred] Univ Witten Herdecke, Integrated Curriculum Anthroposoph Med, Witten, Germany; [Cysarz, Dirk; Edelhaeuser, Friedrich] Univ Witten Herdecke, Chair Theory Med Integrat & Anthroposoph Med, Witten, Germany; [Linhard, Maijana; Henze, Guenter; Seifert, Georg] Charite, Otto Heubner Ctr Pediat & Adolescent Med, Dept Pediat Oncol Hematol, D-13353 Berlin, Germany; [Laengler, Alfred] Gemeinschaftskrankenhaus, Dept Pediat & Adolescent Med, Herdecke, Germany; [Van Leeuwen, Peter] Univ Witten Herdecke, Dept Radiol & Microtherapy, Bochum, Germany	Witten Herdecke University; Witten Herdecke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Witten Herdecke University	Cysarz, D (corresponding author), Univ Witten Herdecke, Integrated Curriculum Anthroposoph Med, Witten, Germany.	d.cysarz@rhythmen.de	Cysarz, Dirk/F-8845-2010	Cysarz, Dirk/0000-0001-8303-0261; Edelhauser, Friedrich/0000-0001-7900-188X; Van Leeuwen, Peter/0000-0003-2394-412X; Breakspear, Michael/0000-0003-4943-3969	Software AG Stiftung, Darmstadt, Germany [DO-ID 3398/P4352]; Mahle-Stiftung, Stuttgart, Germany [050220]	Software AG Stiftung, Darmstadt, Germany; Mahle-Stiftung, Stuttgart, Germany	This work was supported by grants of the Software AG Stiftung, Darmstadt, Germany [DO-ID 3398/P4352 to DC and GS] and the Mahle-Stiftung, Stuttgart, Germany [050220 to DC and GS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; Bassingwaighte JB, 1994, FRACTAL PHYSL; Beckers F, 2006, AM J PHYSIOL-HEART C, V290, pH2560, DOI 10.1152/ajpheart.00903.2005; Bigger JT, 1996, CIRCULATION, V93, P2142, DOI 10.1161/01.CIR.93.12.2142; Camm AJ, 1996, CIRCULATION, V93, P1043; Christ M, 1999, LANCET, V353, P1939, DOI 10.1016/S0140-6736(99)00639-X; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; DiVall SA, 2008, ANN NY ACAD SCI, V1135, P19, DOI 10.1196/annals.1429.026; FINLEY JP, 1995, J AUTONOM NERV SYST, V51, P103, DOI 10.1016/0165-1838(94)00117-3; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goto M, 1997, J PEDIATR-US, V130, P725, DOI 10.1016/S0022-3476(97)80013-3; Grossman P, 2004, AM J PHYSIOL-HEART C, V287, pH728, DOI 10.1152/ajpheart.00825.2003; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Kazuma N, 2002, CLIN EXP HYPERTENS, V24, P83, DOI 10.1081/CEH-100108718; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kliegman RM, 2020, NELSON TXB PEDIAT; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; Malik M., 1995, HEART RATE VARIABILI; Massin M, 1997, PEDIATR CARDIOL, V18, P297, DOI 10.1007/s002469900178; Massin MM, 2001, CARDIOL YOUNG, V11, P619, DOI 10.1017/S104795110100097X; Masten AS, 2004, ANN NY ACAD SCI, V1021, P310, DOI 10.1196/annals.1308.036; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Shaw J, 2007, PEDIATR DIABETES, V8, P7, DOI 10.1111/j.1399-5448.2007.00329.x; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Silvetti MS, 2001, INT J CARDIOL, V81, P169, DOI 10.1016/S0167-5273(01)00537-X; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Weissman A, 2009, EUR J APPL PHYSIOL, V105, P381, DOI 10.1007/s00421-008-0914-4	38	20	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19400	10.1371/journal.pone.0019400	http://dx.doi.org/10.1371/journal.pone.0019400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625487	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400004
J	Lalaoui, N; Morle, A; Merino, D; Jacquemin, G; Iessi, E; Morizot, A; Shirley, S; Robert, B; Solary, E; Garrido, C; Micheau, O				Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Robert, Bruno; Solary, Eric; Garrido, Carmen; Micheau, Olivier			TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT	PLOS ONE			English	Article							KAPPA-B; LIGAND; PROTEIN; CANCER; PROLIFERATION; RECEPTORS; ACTIVATION; COLON; OVEREXPRESSION; EXPRESSION	Background: TRAIL/Apo2L is a pro-apoptotic ligand of the TNF family that engages the apoptotic machinery through two pro-apoptotic receptors, TRAIL-R1 and TRAIL-R2. This cell death program is tightly controlled by two antagonistic receptors, TRAIL-R3 and TRAIL-R4, both devoid of a functional death domain, an intracellular region of the receptor, required for the recruitment and the activation of initiator caspases. Upon TRAIL-binding, TRAIL-R4 forms a heteromeric complex with the agonistic receptor TRAIL-R2 leading to reduced caspase-8 activation and apoptosis. Methodology/Principal Findings: We provide evidence that TRAIL-R4 can also exhibit, in a ligand independent manner, signaling properties in the cervical carcinoma cell line HeLa, through Akt. Ectopic expression of TRAIL-R4 in HeLa cells induced morphological changes, with cell rounding, loss of adherence and markedly enhanced cell proliferation in vitro and tumor growth in vivo. Disruption of the PI3K/Akt pathway using the pharmacological inhibitor LY294002, siRNA targeting the p85 regulatory subunit of phosphatidylinositol-3 kinase, or by PTEN over-expression, partially restored TRAIL-mediated apoptosis in these cells. Moreover, the Akt inhibitor, LY294002, restituted normal cell proliferation index in HeLa cells expressing TRAIL-R4. Conclusions/Significance: Altogether, these results indicate that, besides its ability to directly inhibit TRAIL-induced cell death at the membrane, TRAIL-R4 can also trigger the activation of signaling pathways leading to cell survival and proliferation in HeLa cells. Our findings raise the possibility that TRAIL-R4 may contribute to cervical carcinogenesis.	[Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Garrido, Carmen; Micheau, Olivier] INSERM, U866, Dijon, France; [Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Garrido, Carmen; Micheau, Olivier] Univ Bourgogne, Fac Med & Pharm, Dijon, France; [Robert, Bruno] INSERM, IRCM, U896, Montpellier, France; [Robert, Bruno] Univ Montpellier I, CRLC Val Aurelle Paul Lamarque, Montpellier, France; [Solary, Eric] INSERM, U1009, Villejuif, France; [Solary, Eric] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Garrido, Carmen] Ctr Hosp Univ Dijon, F-21004 Dijon, France; [Micheau, Olivier] Ctr Georges Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Dijon Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Lalaoui, N (corresponding author), INSERM, U866, Dijon, France.	omicheau@u-bourgogne.fr	Lalaoui, Najoua/C-1410-2014; Merino, Delphine/L-9159-2017; ROBERT, Bruno/AAB-7581-2020; Garrido, Carolina/GWM-5557-2022; Iessi, Elisabetta/O-2460-2017; Garrido, carmen/G-1633-2018; micheau, olivier/C-3574-2011	Lalaoui, Najoua/0000-0002-0165-3324; Merino, Delphine/0000-0002-8075-6275; ROBERT, Bruno/0000-0001-5573-6945; Iessi, Elisabetta/0000-0001-7221-9173; Garrido, carmen/0000-0003-1368-1493; micheau, olivier/0000-0001-8499-7984; Solary, Eric/0000-0002-8629-1341	Conseil Regional de Bourgogne; INCa (Institut National du Cancer); Agence Nationale de la Recherche [ANR-06-JCJC-0103, 07-PCV-0031]; European Community (ApopTrain Marie Curie RTN); Ligue Nationale contre le Cancer; Ministry of Research and Education; ARC (Association pour la Recherche sur le Cancer); INSERM; Apoptrain Marie Curie RTN	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community (ApopTrain Marie Curie RTN)(European Commission); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministry of Research and Education; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Apoptrain Marie Curie RTN	This work is supported by grants of the Conseil Regional de Bourgogne, the INCa (Institut National du Cancer) Canceropole Grand-Est, (Agence Nationale de la Recherche, ANR-06-JCJC-0103 and 07-PCV-0031) and the European Community (ApopTrain Marie Curie RTN). NL, A. Morizot, DM, A. Morle and GJ are supported by fellowships from the Ligue Nationale contre le Cancer, the Ministry of Research and Education, the ARC (Association pour la Recherche sur le Cancer), the INSERM and the Conseil Regional de Bourgogne. EI was supported by a fellowship from the Apoptrain Marie Curie RTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Audo R, 2009, CELL DEATH DIFFER, V16, P1227, DOI 10.1038/cdd.2009.38; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Davidovich IA, 2004, CANCER LETT, V211, P189, DOI 10.1016/j.canlet.2004.03.026; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Finnberg N, 2006, CLIN CANCER RES, V12, P4132, DOI 10.1158/1078-0432.CCR-06-0567; Freer-Prokop M, 2009, DIFFERENTIATION, V78, P205, DOI 10.1016/j.diff.2009.05.002; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Lee SH, 2001, ONCOGENE, V20, P399, DOI 10.1038/sj.onc.1204103; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Morel J, 2005, J BIOL CHEM, V280, P15709, DOI 10.1074/jbc.M414469200; Morizot A, 2011, CELL DEATH DIFFER, V18, P700, DOI 10.1038/cdd.2010.144; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Rubio-Moscardo F, 2005, BLOOD, V106, P3214, DOI 10.1182/blood-2005-05-2013; Schmidt U, 2004, J EXP MED, V199, P785, DOI 10.1084/jem.20031109; Schneider DB, 2000, ARTERIOSCL THROM VAS, V20, P298, DOI 10.1161/01.ATV.20.2.298; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, BLOOD, V103, P517, DOI 10.1182/blood-2003-06-2137; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simova S, 2008, APOPTOSIS, V13, P423, DOI 10.1007/s10495-007-0171-8; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Toscano F, 2008, ONCOGENE, V27, P4161, DOI 10.1038/onc.2008.52; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vilimanovich U, 2008, CELL MOL LIFE SCI, V65, P814, DOI 10.1007/s00018-008-7513-8; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003; Zauli G, 2005, J CELL PHYSIOL, V202, P900, DOI 10.1002/jcp.20202; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	41	55	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19679	10.1371/journal.pone.0019679	http://dx.doi.org/10.1371/journal.pone.0019679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625476	Green Published, gold			2022-12-27	WOS:000290793400007
J	Xue, HP; Lu, H; Zhao, X				Xue, Huping; Lu, Hong; Zhao, Xin			Sequence Diversities of Serine-Aspartate Repeat Genes among Staphylococcus aureus Isolates from Different Hosts Presumably by Horizontal Gene Transfer	PLOS ONE			English	Article							CONTINGENCY LOCI; NASAL-CARRIAGE; PROTEIN; EVOLUTION; INSIGHTS; REVEALS; STRAINS; FAMILY	Background: Horizontal gene transfer (HGT) is recognized as one of the major forces for bacterial genome evolution. Many clinically important bacteria may acquire virulence factors and antibiotic resistance through HGT. The comparative genomic analysis has become an important tool for identifying HGT in emerging pathogens. In this study, the Serine-Aspartate Repeat (Sdr) family has been compared among different sources of Staphylococcus aureus (S. aureus) to discover sequence diversities within their genomes. Methodology/Principal Findings: Four sdr genes were analyzed for 21 different S. aureus strains and 218 mastitis-associated S. aureus isolates from Canada. Comparative genomic analyses revealed that S. aureus strains from bovine mastitis (RF122 and mastitis isolates in this study), ovine mastitis (ED133), pig (ST398), chicken (ED98), and human methicillin-resistant S. aureus (MRSA) (TCH130, MRSA252, Mu3, Mu50, N315, 04-02981, JH1 and JH9) were highly associated with one another, presumably due to HGT. In addition, several types of insertion and deletion were found in sdr genes of many isolates. A new insertion sequence was found in mastitis isolates, which was presumably responsible for the HGT of sdrC gene among different strains. Moreover, the sdr genes could be used to type S. aureus. Regional difference of sdr genes distribution was also indicated among the tested S. aureus isolates. Finally, certain associations were found between sdr genes and subclinical or clinical mastitis isolates. Conclusions: Certain sdr gene sequences were shared in S. aureus strains and isolates from different species presumably due to HGT. Our results also suggest that the distributional assay of virulence factors should detect the full sequences or full functional regions of these factors. The traditional assay using short conserved regions may not be accurate or credible. These findings have important implications with regard to animal husbandry practices that may inadvertently enhance the contact of human and animal bacterial pathogens.	[Xue, Huping; Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada; [Xue, Huping; Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	McGill University; Fudan University	Xue, HP (corresponding author), McGill Univ, Dept Anim Sci, Montreal, PQ, Canada.	xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	National Nature Science Foundation of China (NSFC) [30828026]; Natural Science and Engineering Research Council of Canada; Shanghai Municipal Science and Technology Commission [9540707400]; China Scholarship Council	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); China Scholarship Council(China Scholarship Council)	This study was supported by funding from a grant from the National Nature Science Foundation of China (NSFC Grant No. 30828026), a discovery grant from Natural Science and Engineering Research Council of Canada and a grant from Shanghai Municipal Science and Technology Commission (No 9540707400). Mr. Xue is a recipient of a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1996, ANTIMICROB AGENTS CH, V40, P924, DOI 10.1128/AAC.40.4.924; Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lawrence JG, 1996, GENETICS, V143, P1843; Linares JA, 2001, AVIAN DIS, V45, P1068, DOI 10.2307/1592891; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Rodgers JD, 1999, VET MICROBIOL, V69, P189, DOI 10.1016/S0378-1135(99)00112-1; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Said KB, 2010, J CLIN MICROBIOL, V48, P375, DOI 10.1128/JCM.01768-09; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trad S, 2004, J CLIN MICROBIOL, V42, P2054, DOI 10.1128/JCM.42.5.2054-2064.2004; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0	39	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20332	10.1371/journal.pone.0020332	http://dx.doi.org/10.1371/journal.pone.0020332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625460	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400057
J	Bajardi, P; Barrat, A; Natale, F; Savini, L; Colizza, V				Bajardi, Paolo; Barrat, Alain; Natale, Fabrizio; Savini, Lara; Colizza, Vittoria			Dynamical Patterns of Cattle Trade Movements	PLOS ONE			English	Article							NETWORK ANALYSIS; MOUTH-DISEASE; LIVESTOCK MOVEMENTS; COMPLEX NETWORKS; WEIGHTED NETWORK; CENTRALITY; EPIDEMIC; RISK; PREDICTABILITY; OUTBREAKS	Despite their importance for the spread of zoonotic diseases, our understanding of the dynamical aspects characterizing the movements of farmed animal populations remains limited as these systems are traditionally studied as static objects and through simplified approximations. By leveraging on the network science approach, here we are able for the first time to fully analyze the longitudinal dataset of Italian cattle movements that reports the mobility of individual animals among farms on a daily basis. The complexity and inter-relations between topology, function and dynamical nature of the system are characterized at different spatial and time resolutions, in order to uncover patterns and vulnerabilities fundamental for the definition of targeted prevention and control measures for zoonotic diseases. Results show how the stationarity of statistical distributions coexists with a strong and non-trivial evolutionary dynamics at the node and link levels, on all timescales. Traditional static views of the displacement network hide important patterns of structural changes affecting nodes' centrality and farms' spreading potential, thus limiting the efficiency of interventions based on partial longitudinal information. By fully taking into account the longitudinal dimension, we propose a novel definition of dynamical motifs that is able to uncover the presence of a temporal arrow describing the evolution of the system and the causality patterns of its displacements, shedding light on mechanisms that may play a crucial role in the definition of preventive actions.	[Bajardi, Paolo] ISI, Computat Epidemiol Lab, Turin, Italy; [Bajardi, Paolo; Barrat, Alain] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Barrat, Alain] ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Natale, Fabrizio] European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Ispra, Italy; [Savini, Lara] Ist G Caporale, Teramo, Italy; [Colizza, Vittoria] INSERM, U707, Paris, France; [Colizza, Vittoria] Univ Paris 06, UPMC, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; European Commission Joint Research Centre; EC JRC ISPRA Site; IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bajardi, P (corresponding author), ISI, Computat Epidemiol Lab, Turin, Italy.	vittoria.colizza@inserm.fr	Bajardi, Paolo/J-6180-2012; Savini, Lara LS/C-2851-2018; Bajardi, Paolo/AAE-2416-2022	Savini, Lara LS/0000-0001-6175-7793; Bajardi, Paolo/0000-0001-8865-4495; Colizza, Vittoria/0000-0002-2113-2374	European Research Council [ERC-2007-Stg204863 (EPIFOR)]; Italian Ministry of Health [MSRCTE0108]	European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was partially funded by the European Research Council Ideas contract no. ERC-2007-Stg204863 (EPIFOR) to VC and PB and by the MSRCTE0108 project founded by the Italian Ministry of Health to FN, LS, and VC. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anderson I., 2002, FOOT MOUTH DIS 2001; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Caldarelli G., 2007, SCALE FREE NETWORKS; Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Dorogovstev S. N., 2003, EVOLUTION NETWORKS B; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; European Parliament and European council, 2000, OFFICIAL J EUROPEA L, V204, P1; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; GOLDER SA, 2007, P 3 INT C COMM TECHN; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Guerra B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056105; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Klemm K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026120; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; KOSSINETS G, 2008, P 14 ACM SIGKDD INT, P38103; Kostakos V, 2009, PHYSICA A, V388, P1007, DOI 10.1016/j.physa.2008.11.021; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Lerman K., 2010, P 8 WORKSH MIN LEARN, P70, DOI DOI 10.1145/1830252.1830262; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; *MAF BIOS NZ, 2009, REV SEL CATTL ID TRA; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; *MIN HLTH CSN I G, IT NAT AN ID REG DAT; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; PAN RV, 2011, ARXIV11015913; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; RAUTUREAU S, 2010, T BOUNDARY EMERGING, DOI DOI 10.1111/J.1865-1682.2010.01187; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; *UK DEFRA, 2002, OR UK FOOT MOUTH DIS; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	83	133	136	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19869	10.1371/journal.pone.0019869	http://dx.doi.org/10.1371/journal.pone.0019869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625633	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200042
J	Lohscheider, JN; Strittmatter, M; Kupper, H; Adamska, I				Lohscheider, Jens N.; Strittmatter, Martina; Kuepper, Hendrik; Adamska, Iwona			Vertical Distribution of Epibenthic Freshwater Cyanobacterial Synechococcus spp. Strains Depends on Their Ability for Photoprotection	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHOTOSYSTEM-II; CHROMATIC ADAPTATION; LIGHT ENVIRONMENT; XANTHOPHYLL CYCLE; STATE TRANSITIONS; UP-REGULATION; CHLOROPHYLL; MUTANTS; ACCLIMATION	Background: Epibenthic cyanobacteria often grow in environments where the fluctuation of light intensity and quality is extreme and frequent. Different strategies have been developed to cope with this problem depending on the distribution of cyanobacteria in the water column. Principal Findings: Here we provide an experimental proof that the light intensity plays an important role in the vertical distribution of seven, closely related, epibenthic Synechococcus spp. strains isolated from various water depths from the littoral zone of Lake Constance in Germany and cultivated under laboratory conditions. Pigment analysis revealed that the amount of chlorophyll a and total carotenoids decreased with the time of light stress exposure in three phycoerythrin-rich strains collected from 7.0 m water depth and remained low during the recovery phase. In contrast, a constant level of chlorophyll a and either constant or enhanced levels of carotenoids were assayed in phycocyanin-rich strains collected from 1.0 and 0.5 m water depths. Protein analysis revealed that while the amount of biliproteins remained constant in all strains during light stress and recovery, the amount of D1 protein from photosystem II reaction centre was strongly reduced under light stress conditions in strains from 7.0 m and 1.0 m water depth, but not in strains collected from 0.5 m depth. Conclusion: Based on these data we propose that light intensity, in addition to light quality, is an important selective force in the vertical distribution of Synechococcus spp. strains, depending on their genetically fixed mechanisms for photoprotection.	[Lohscheider, Jens N.; Strittmatter, Martina; Kuepper, Hendrik; Adamska, Iwona] Univ Konstanz, Dept Biol, Constance, Germany; [Kuepper, Hendrik] Univ S Bohemia, Fac Biol Sci, Ceske Budejovice, Czech Republic; [Kuepper, Hendrik] Univ S Bohemia, Inst Phys Biol, Ceske Budejovice, Czech Republic	University of Konstanz; Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Lohscheider, JN (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	iwona.adamska@uni-konstanz.de	Küpper, Hendrik/J-5152-2012	Küpper, Hendrik/0000-0003-0712-7023; Strittmatter, Martina/0000-0002-1258-9751	Deutsche Forschungsgemeinschaft [SFB454, 632/04, KU 1495/4]; Konstanz University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Konstanz University	This work was supported by a research grant from Deutsche Forschungsgemeinschaft (SFB454 grant 632/04 to I. A., KU 1495/4 to H. K.) and the Konstanz University grant (to I. A. and H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Andresen E, 2010, NEW PHYTOL, V185, P173, DOI 10.1111/j.1469-8137.2009.03068.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Becker S, 2004, FEMS MICROBIOL ECOL, V49, P181, DOI 10.1016/j.femsec.2004.03.003; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Ernst A, 2003, MICROBIOL-SGM, V149, P217, DOI 10.1099/mic.0.25475-0; Fujita Y., 1994, MOL BIOL CYANOBACTER, P677; Gilmore AM, 2001, PHOTOSYNTH RES, V67, P89, DOI 10.1023/A:1010657000548; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Gude H, 1998, ADV LIMNOL STUTTG, V53, P85; HERBERT SK, 1992, P NATL ACAD SCI USA, V89, P8716, DOI 10.1073/pnas.89.18.8716; HOFMAN H, 2008, VERHANDL INT VEREIN, V30, P627; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2009, RES MICROBIOL, V160, P726, DOI 10.1016/j.resmic.2009.08.005; JEWSON DH, 1984, J PLANKTON RES, V6, P259, DOI 10.1093/plankt/6.2.259; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Kupper H, 2007, ANAL CHEM, V79, P7611, DOI 10.1021/ac070236m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Obinger C, 1999, FREE RADICAL RES, V31, pS243; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Postius C, 1999, ARCH MICROBIOL, V172, P69, DOI 10.1007/s002030050742; Postius C, 1998, FEMS MICROBIOL ECOL, V25, P171, DOI 10.1016/S0168-6496(97)00093-7; Postius C, 2001, FEMS MICROBIOL ECOL, V37, P117, DOI 10.1111/j.1574-6941.2001.tb00859.x; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Schafer L, 2005, J PHOTOCH PHOTOBIO B, V78, P195, DOI 10.1016/j.jphotobiol.2004.11.007; Schagerl M, 2006, J PLANT PHYSIOL, V163, P709, DOI 10.1016/j.jplph.2005.09.015; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; WALTERS RG, 1995, PLANTA, V197, P475, DOI 10.1007/BF00196669; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20134	10.1371/journal.pone.0020134	http://dx.doi.org/10.1371/journal.pone.0020134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625592	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200067
J	Yu, WB; Gao, SH; Yin, CY; Zhou, Y; Ye, BC				Yu, Wen-Bang; Gao, Shu-Hong; Yin, Chun-Yun; Zhou, Ying; Ye, Bang-Ce			Comparative Transcriptome Analysis of Bacillus subtilis Responding to Dissolved Oxygen in Adenosine Fermentation	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; ACID-RELATED SUBSTANCES; GENE-EXPRESSION; ESCHERICHIA-COLI; ANAEROBIC CONDITIONS; SIGNAL-TRANSDUCTION; ENERGY-METABOLISM; RNA-POLYMERASE; RESD-RESE; PROTEIN	Dissolved oxygen (DO) is an important factor for adenosine fermentation. Our previous experiments have shown that low oxygen supply in the growth period was optimal for high adenosine yield. Herein, to better understand the link between oxygen supply and adenosine productivity in B. subtilis (ATCC21616), we sought to systematically explore the effect of DO on genetic regulation and metabolism through transcriptome analysis. The microarrays representing 4,106 genes were used to study temporal transcript profiles of B. subtilis fermentation in response to high oxygen supply (agitation 700 r/min) and low oxygen supply (agitation 450 r/min). The transcriptome data analysis revealed that low oxygen supply has three major effects on metabolism: enhance carbon metabolism (glucose metabolism, pyruvate metabolism and carbon overflow), inhibit degradation of nitrogen sources (glutamate family amino acids and xanthine) and purine synthesis. Inhibition of xanthine degradation was the reason that low oxygen supply enhanced adenosine production. These provide us with potential targets, which can be modified to achieve higher adenosine yield. Expression of genes involved in energy, cell type differentiation, protein synthesis was also influenced by oxygen supply. These results provided new insights into the relationship between oxygen supply and metabolism.	[Yu, Wen-Bang; Gao, Shu-Hong; Yin, Chun-Yun; Zhou, Ying; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China	East China University of Science & Technology	Yu, WB (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn			863 Programs [2007AA02Z331]; NSFC [20776039]; SKLBE; Fundamental Research Funds for the Central Universities;  [NCET-07-0287]	863 Programs(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); SKLBE; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 	This work was supported by grants from 863 Programs (2007AA02Z331), the NSFC (20776039), and NCET-07-0287, SKLBE fund, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Beier L, 2002, J BACTERIOL, V184, P3232, DOI 10.1128/JB.184.12.3232-3241.2002; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; BRODA P, 1971, MONATSH CHEM, V102, P811, DOI 10.1007/BF01167264; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Chen SX, 2005, BIOTECHNOL LETT, V27, P689, DOI 10.1007/s10529-005-4686-1; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; CLARK VL, 1972, J BACTERIOL, V112, P715, DOI 10.1128/JB.112.2.715-725.1972; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DIMARCO JP, 1983, CIRCULATION, V68, P1254, DOI 10.1161/01.CIR.68.6.1254; DIMARCO JP, 1990, ANN INTERN MED, V113, P104, DOI 10.7326/0003-4819-113-2-104; DOMINGUEZ H, 1993, BIOTECHNOL LETT, V15, P449, DOI 10.1007/BF00129316; GAO S, 2007, MULTISCALE STUDY ADE; Geng H, 2007, METHOD ENZYMOL, V422, P448, DOI 10.1016/S0076-6879(06)22023-8; HALBERG R, 1994, J MOL BIOL, V243, P425, DOI 10.1006/jmbi.1994.1670; HALBERG R, 1995, J BACTERIOL, V177, P1888, DOI 10.1128/jb.177.7.1888-1891.1995; HANEDA K, 1971, AGR BIOL CHEM TOKYO, V35, P1906, DOI 10.1080/00021369.1971.10860176; HANEDA K, 1972, AGR BIOL CHEM TOKYO, V36, P1453, DOI 10.1080/00021369.1972.10860447; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hohmann S, 1998, BBA-PROTEIN STRUCT M, V1385, P201, DOI 10.1016/S0167-4838(98)00069-7; HORI M, 1991, HYPERTENSION, V18, P565, DOI 10.1161/01.HYP.18.5.565; Il'chenko AP, 1998, MICROBIOLOGY+, V67, P241; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Kim SY, 1997, J FERMENT BIOENG, V83, P267, DOI 10.1016/S0922-338X(97)80990-7; KODAIRA R, 1980, Patent No. 55006359; KOLE MM, 1988, APPL MICROBIOL BIOT, V28, P404, DOI 10.1007/BF00268204; KONISHI S, 1968, Amino Acid and Nucleic Acid, V18, P15; LASLEY RD, 1995, AM J PHYSIOL-HEART C, V269, pH1460, DOI 10.1152/ajpheart.1995.269.4.H1460; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Li Y, 2002, APPL MICROBIOL BIOT, V60, P101, DOI [10.1007/s0253-002-1064-y, 10.1007/s00253-002-1064-y]; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; MANDICMULEC I, 1995, J BACTERIOL, V177, P4619, DOI 10.1128/jb.177.16.4619-4627.1995; Marino M, 2001, J BACTERIOL, V183, P6815, DOI 10.1128/JB.183.23.6815-6821.2001; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Nakano MM, 2000, J BACTERIOL, V182, P3274, DOI 10.1128/JB.182.11.3274-3277.2000; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Paul S, 2001, J BACTERIOL, V183, P3237, DOI 10.1128/JB.183.10.3237-3246.2001; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; SADAO T, 1989, JAPANESE TECHNOLOGY, V3; Serrano M, 1999, J BACTERIOL, V181, P3632, DOI 10.1128/JB.181.12.3632-3643.1999; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Srivastava RK, 2009, BIOTECHNOL BIOENG, V102, P1387, DOI 10.1002/bit.22184; Stover AG, 1999, J BACTERIOL, V181, P1664; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Tannler S, 2008, METAB ENG, V10, P216, DOI 10.1016/j.ymben.2008.06.002; Tang YJ, 2003, ENZYME MICROB TECH, V32, P478, DOI 10.1016/S0141-0229(02)00338-1; Tsai PS, 1996, BIOTECHNOL BIOENG, V49, P139; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; Xu H, 2009, BIOCHEM ENG J, V43, P41, DOI 10.1016/j.bej.2008.08.007; Ye BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007073; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; YEGNESWARAN PK, 1991, BIOTECHNOL PROGR, V7, P246, DOI 10.1021/bp00009a008; Zheng GL, 1999, J BACTERIOL, V181, P7346, DOI 10.1128/JB.181.23.7346-7355.1999	63	19	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20092	10.1371/journal.pone.0020092	http://dx.doi.org/10.1371/journal.pone.0020092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625606	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200060
J	Suhadev, M; Thomas, BE; Sakthivel, MR; Murugesan, P; Chandrasekaran, V; Charles, N; Durga, R; Auxilia, M; Mathew, TA; Wares, F				Suhadev, Mohanarani; Thomas, Beena E.; Sakthivel, Raja M.; Murugesan, P.; Chandrasekaran, V; Charles, Niruparani; Durga, R.; Auxilia, M.; Mathew, Trini A.; Wares, Fraser			Alcohol Use Disorders (AUD) among Tuberculosis Patients: A Study from Chennai, South India	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; RISK-FACTORS; INDUSTRIAL-WORKERS; HAZARDOUS DRINKING; DEATH; GOA	Background: Alcohol Use Disorders (AUDs) among tuberculosis (TB) patients are associated with nonadherence and poor treatment outcomes. Studies from Tuberculosis Research Centre (TRC), Chennai have reported that alcoholism has been one of the major reasons for default and mortality in under the DOTS programme in South India. Hence, it is planned to conduct a study to estimate prevalence of alcohol use and AUDs among TB patients attending the corporation health centres in Chennai, India. Methodology: This is a cross-sectional cohort study covering 10 corporation zones at Chennai and it included situational assessment followed by screening of TB patients by a WHO developed Alcohol Use Disorders Identification Test AUDIT scale. Four zones were randomly selected and all TB patients treated during July to September 2009 were screened with AUDIT scale for alcohol consumption. Results: Out of 490 patients, 66% were males, 66% were 35 years and above, 57% were married, 58% were from the low monthly income group of <Rs 5000 per month. No females reported alcohol use. Overall, out of 490 TB pts, 29% (141) were found to consume alcohol. Among 141 current drinkers 52% (73) had an AUDIT score of >8. Age (>35 years), education (less educated), income (<Rs 5000 per month), marital status (separated/divorced) and treatment category (Category 2) were statistically significant for TB patients with alcohol use than those TB patients without alcohol use. Conclusions: AUD among TB patients needs to be addressed urgently and the findings suggest the importance of integrating alcohol treatment into TB care.	[Suhadev, Mohanarani; Thomas, Beena E.; Sakthivel, Raja M.; Murugesan, P.; Chandrasekaran, V; Charles, Niruparani; Durga, R.; Auxilia, M.] TB Res Ctr, Madras, Tamilnadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India; [Mathew, Trini A.] Univ Mississipi, Med Ctr, Div Infect Dis, Jackson, MS USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; University of Mississippi Medical Center	Suhadev, M (corresponding author), TB Res Ctr, Madras, Tamilnadu, India.	mohanasuhadev@yahoo.com			WHO; United States Agency for International Development	WHO(World Health Organization); United States Agency for International Development(United States Agency for International Development (USAID))	The study was supported by WHO, with financial assistance provided by the United States Agency for International Development under the Model DOTS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1993, ADDICTION, V88, P1493, DOI 10.1111/j.1360-0443.1993.tb03135.x; [Anonymous], 2003, J SUBST USE, DOI DOI 10.1080/1465989031000109798; [Anonymous], 2001, AUDIT ALCOHOL USE DI; Benegal V, 2005, ADDICTION, V100, P1051, DOI 10.1111/j.1360-0443.2005.01176.x; D'Costa G, 2007, ALCOHOL ALCOHOLISM, V42, P131, DOI 10.1093/alcal/agl103; DEMENESESGAYA C, 2009, PSYCHOL NEUROSCI, V2; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; DORSCHNER J, 1983, J STUD ALCOHOL, V44, P538, DOI 10.15288/jsa.1983.44.538; Edwards G., 1994, ALCOHOL POLICY PUBLI; FLEMING MF, 1991, INT J ADDICT, V26, P1173, DOI 10.3109/10826089109062153; Gaunekar G, 2005, SOC PSYCH PSYCH EPID, V40, P267, DOI 10.1007/s00127-005-0886-1; GAUNEKAR G, 2004, DRINKING PATTERNS HA, P125; GREENFIELD, 2010, ALCOHOLISM CLIN EXPT; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; Mohan D, 2002, INDIAN J MED RES, V116, P150; Mohan D, 2002, INDIAN J MED RES, V115, P128; MUNIYANDI M, 2009, 1 INT C ALC HIV IND; MUNIYANDI M, IJT; NAYAK MB, 2009, ALCOHOLISM CLIN EXPT, V33, P1; PRAKASH R, 2009, 1 INT C ALC HIV IND; RAY R, EXTANT PATTERN TREND; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Saunders J. B., 1987, WHO COLLABORATIVE PR; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Silva MC, 2003, ALCOHOL ALCOHOLISM, V38, P79, DOI 10.1093/alcalc/agg016; Sivaram S, 2008, DRUG ALCOHOL DEPEN, V94, P133, DOI 10.1016/j.drugalcdep.2007.11.016; SIVARAM S, 2007, J URBAN HEALTH, V84, P4; *TB IND, 2009, RNTCP STAT REP, P10011; *WHO, 1980, WHO TECH REP SER, V650; World Health Organization, 2009, GLOB TB REP; XU L, 2001, INT J TUBERC LUNG D, V14; 2009, ALCOHOLISM CLIN EXPT	35	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19485	10.1371/journal.pone.0019485	http://dx.doi.org/10.1371/journal.pone.0019485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611189	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000290657500005
J	Ott, E; Norio, P; Ritzi, M; Schildkraut, C; Schepers, A				Ott, Elisabeth; Norio, Paolo; Ritzi, Marion; Schildkraut, Carl; Schepers, Aloys			The Dyad Symmetry Element of Epstein-Barr Virus Is a Dominant but Dispensable Replication Origin	PLOS ONE			English	Article							EUKARYOTIC DNA-REPLICATION; HUMAN-CELLS; RECOGNITION COMPLEX; NUCLEAR ANTIGEN-1; LATENT ORIGIN; AUTONOMOUS REPLICATION; CHROMATIN ASSOCIATION; SEQUENCE REQUIREMENTS; STABLE REPLICATION; VIRAL GENOMES	OriP, the latent origin of Epstein-Barr virus (EBV), consists of two essential elements: the dyad symmetry (DS) and the family of repeats (FR). The function of these elements has been predominantly analyzed in plasmids transfected into transformed cells. Here, we examined the molecular functions of DS in its native genomic context and at an ectopic position in the mini-EBV episome. Mini-EBV plasmids contain 41% of the EBV genome including all information required for the proliferation of human B cells. Both FR and DS function independently of their genomic context. We show that DS is the most active origin of replication present in the mini-EBV genome regardless of its location, and it is characterized by the binding of the origin recognition complex (ORC) allowing subsequent replication initiation. Surprisingly, the integrity of oriP is not required for the formation of the pre-replicative complex (pre-RC) at or near DS. In addition we show that initiation events occurring at sites other than the DS are also limited to once per cell cycle and that they are ORC-dependent. The deletion of DS increases initiation from alternative origins, which are normally used very infrequently in the mini-EBV genome. The sequence-independent distribution of ORC-binding, pre-RC-assembly, and initiation patterns indicates that a large number of silent origins are present in the mini-EBV genome. We conclude that, in mini-EBV genomes lacking the DS element, the absence of a strong ORC binding site results in an increase of ORC binding at dispersed sites.	[Ott, Elisabeth; Ritzi, Marion; Schepers, Aloys] Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany; [Norio, Paolo; Schildkraut, Carl] Albert Einstein Coll Med, Dept Cell Biol CH 416, New York, NY USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Yeshiva University	Ott, E (corresponding author), Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany.	schildkr@aecom.yu.edu; schepers@helmholtz-muenchen.de		Schepers, Aloys/0000-0002-5442-5608	Deutsche Forschungsgemeinschaft [SFB/TR05, SFB646]; National Institutes of Health (NIH) [GM45751]; NIH/National Cancer Institute [P30CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045751] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported from Institutional grants, the Deutsche Forschungsgemeinschaft (SFB/TR05 and SFB646 to A. S.), the National Institutes of Health (NIH) grants GM45751 (C. L. S.) and by the Cancer Center Support Grant NIH/National Cancer Institute P30CA13330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; BULLOCK PA, 1995, MOL CELL BIOL, V15, P173, DOI 10.1128/MCB.15.1.173; CADDLE MS, 1992, NUCLEIC ACIDS RES, V20, P5971, DOI 10.1093/nar/20.22.5971; Chau CM, 2004, J VIROL, V78, P12308, DOI 10.1128/JVI.78.22.12308-12319.2004; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Deutsch MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Dimitrova DS, 2002, J CELL SCI, V115, P51; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Gilbert DM, 2010, NAT REV GENET, V11, P673, DOI 10.1038/nrg2830; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HAASE SB, 1991, NUCLEIC ACIDS RES, V19, P5053; HARRISON S, 1994, J VIROL, V68, P1913, DOI 10.1128/JVI.68.3.1913-1925.1994; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Julien MD, 2004, VIROLOGY, V326, P317, DOI 10.1016/j.virol.2004.05.026; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kirchmaier AL, 1998, J VIROL, V72, P4657, DOI 10.1128/JVI.72.6.4657-4666.1998; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; KRYSAN PJ, 1993, MOL CELL BIOL, V13, P2688, DOI 10.1128/MCB.13.5.2688; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; LITTLE RD, 1995, MOL CELL BIOL, V15, P2893; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mesner LD, 2003, MOL CELL BIOL, V23, P804, DOI 10.1128/MCB.23.3.804-814.2003; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Norio P, 2000, J VIROL, V74, P8563, DOI 10.1128/JVI.74.18.8563-8574.2000; Norio P, 2004, PLOS BIOL, V2, P816, DOI 10.1371/journal.pbio.0020152; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Ritzi M, 2003, J CELL SCI, V116, P3971, DOI 10.1242/jcs.00708; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Schepers A, 2010, CHROMOSOME RES, V18, P63, DOI 10.1007/s10577-009-9087-1; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Shirakata M, 1998, J BIOCHEM-TOKYO, V123, P175; Sivaprasad Umasundari, 2006, V47, P63; STERNAS L, 1990, J VIROL, V64, P2407; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wang CY, 2008, P NATL ACAD SCI USA, V105, P9639, DOI 10.1073/pnas.0801378105; Wang LD, 2005, J CELL BIOCHEM, V94, P247, DOI 10.1002/jcb.20324; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; Wu H, 2000, EMBO REP, V1, P140, DOI 10.1093/embo-reports/kvd026; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e18609	10.1371/journal.pone.0018609	http://dx.doi.org/10.1371/journal.pone.0018609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603652	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300001
J	Ruzek, D; Salat, J; Singh, SK; Kopecky, J				Ruzek, Daniel; Salat, Jiri; Singh, Sunit K.; Kopecky, Jan			Breakdown of the Blood-Brain Barrier during Tick-Borne Encephalitis in Mice Is Not Dependent on CD8(+) T-Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; WEST-NILE-VIRUS; MICROVASCULAR ENDOTHELIAL-CELLS; TIGHT JUNCTION PROTEINS; MULTIPLE-SCLEROSIS; INFLAMMATORY RESPONSE; PERMEABILITY CHANGES; MOUSE MODEL; IN-VITRO; INFECTION	Tick-borne encephalitis (TBE) virus causes severe encephalitis with serious sequelae in humans. The disease is characterized by fever and debilitating encephalitis that can progress to chronic illness or fatal infection. In this study, changes in permeability of the blood-brain barrier (BBB) in two susceptible animal models (BALB/c, and C57Bl/6 mice) infected with TBE virus were investigated at various days after infection by measuring fluorescence in brain homogenates after intraperitoneal injection of sodium fluorescein, a compound that is normally excluded from the central nervous system. We demonstrate here that TBE virus infection, in addition to causing fatal encephalitis in mice, induces considerable breakdown of the BBB. The permeability of the BBB increased at later stages of TBE infection when high virus load was present in the brain (i.e., BBB breakdown was not necessary for TBE virus entry into the brain), and at the onset of the first severe clinical symptoms of the disease, which included neurological signs associated with sharp declines in body weight and temperature. The increased BBB permeability was in association with dramatic upregulation of proinflammatory cytokine/chemokine mRNA expression in the brain. Breakdown of the BBB was also observed in mice deficient in CD8(+) T-cells, indicating that these cells are not necessary for the increase in BBB permeability that occurs during TBE. These novel findings are highly relevant to the development of future therapies designed to control this important human infectious disease.	[Ruzek, Daniel; Salat, Jiri; Kopecky, Jan] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Salat, Jiri] Vet Res Inst, CS-62132 Brno, Czech Republic; [Singh, Sunit K.] Ctr Cellular & Mol Biol, Sect Infect Dis & Immunobiol, Hyderabad 500007, Andhra Pradesh, India	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Veterinary Research Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Ruzek, D (corresponding author), Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.	ruzekd@paru.cas.cz	Salát, Jiří/F-6295-2019; Růžek, Daniel/G-9275-2014; Kopecky, Jan/G-9347-2014	Salát, Jiří/0000-0002-9915-8953; Růžek, Daniel/0000-0003-4655-2380; 	Czech Science Foundation [P302/10/P438, P502/11/2116]; Ministry of Education, Youth, and Sports of the Czech Republic [Z60220518, LC06009, CZ.1.05/2.1.00/01.006 (ED006/01/01)]; Council and Industrial Research, India; Academy of Sciences of the Czech Republic [22/EU/Czech-CSIR/(18)/09-ISTAD]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Council and Industrial Research, India; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The authors acknowledge financial support by the Czech Science Foundation project No. P302/10/P438 and No. P502/11/2116, and grants Z60220518 and LC06009 from the Ministry of Education, Youth, and Sports of the Czech Republic. JS was supported by the AdmireVet project No. CZ.1.05/2.1.00/01.006 (ED006/01/01) of the Ministry of Education, Youth and Sports of the Czech Republic. SKS was supported by Science and Technology bilateral co-operation between Council and Industrial Research, India, and the Academy of Sciences of the Czech Republic (ref: 22/EU/Czech-CSIR/(18)/09-ISTAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; ANDERSEN IH, 1991, J NEUROIMMUNOL, V31, P155, DOI 10.1016/0165-5728(91)90021-X; Atrasheuskaya AV, 2003, CLIN EXP IMMUNOL, V131, P148, DOI 10.1046/j.1365-2249.2003.02050.x; Babu S, 2003, J IMMUNOL, V171, P6723, DOI 10.4049/jimmunol.171.12.6723; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Beliaeva I A, 1995, Zh Nevrol Psikhiatr Im S S Korsakova, V95, P25; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859; Chekhonin VP, 2002, CLIN CHIM ACTA, V320, P117, DOI 10.1016/S0009-8981(02)00057-8; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Grygorczuk Sambor, 2006, Neurol Neurochir Pol, V40, P106; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Hooper DC, 2001, J IMMUNOL, V167, P3470, DOI 10.4049/jimmunol.167.6.3470; Irani DN, 2001, ADV VIRUS RES, V56, P175, DOI 10.1016/S0065-3527(01)56007-8; Jeohn GH, 1998, J NEUROIMMUNOL, V85, P1, DOI 10.1016/S0165-5728(97)00204-X; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130; Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643; Lou JN, 1997, NEUROREPORT, V8, P629, DOI 10.1097/00001756-199702100-00010; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; McMinn PC, 1996, VIROLOGY, V220, P414, DOI 10.1006/viro.1996.0329; Michalowska-Wender Grazyna, 2006, Pol Merkur Lekarski, V20, P46; MONATH TP, 1983, LAB INVEST, V48, P399; Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pulzova L, 2009, FEMS IMMUNOL MED MIC, V57, P203, DOI 10.1111/j.1574-695X.2009.00594.x; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Ruzek D, 2008, VIRUS RES, V137, P142, DOI 10.1016/j.virusres.2008.05.013; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Silver NC, 2001, MULT SCLER J, V7, P75, DOI 10.1177/135245850100700201; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; SUSS J, 2008, EURO SURVEILL, V13; Thach DC, 2000, J VIROL, V74, P6156, DOI 10.1128/JVI.74.13.6156-6161.2000; Tigabu B, 2010, VIROLOGY, V408, P57, DOI 10.1016/j.virol.2010.08.021; Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63	52	79	82	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20472	10.1371/journal.pone.0020472	http://dx.doi.org/10.1371/journal.pone.0020472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629771	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200058
J	Lyngdoh, T; Marques-Vidal, P; Paccaud, F; Preisig, M; Waeber, G; Bochud, M; Vollenweider, P				Lyngdoh, Tanica; Marques-Vidal, Pedro; Paccaud, Fred; Preisig, Martin; Waeber, Gerard; Bochud, Murielle; Vollenweider, Peter			Elevated Serum Uric Acid Is Associated with High Circulating Inflammatory Cytokines in the Population-Based Colaus Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; C-REACTIVE PROTEIN; METABOLIC SYNDROME; BLOOD-PRESSURE; HEART-FAILURE; RENAL-DISEASE; OBESITY; HYPERURICEMIA; HYPERTENSION; INTERLEUKIN-6	Background: The relation of serum uric acid (SUA) with systemic inflammation has been little explored in humans and results have been inconsistent. We analyzed the association between SUA and circulating levels of interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP). Methods and Findings: This cross-sectional population-based study conducted in Lausanne, Switzerland, included 6085 participants aged 35 to 75 years. SUA was measured using uricase-PAP method. Plasma TNF-alpha, IL-1 beta and IL-6 were measured by a multiplexed particle-based flow cytometric assay and hs-CRP by an immunometric assay. The median levels of SUA, IL-6, TNF-alpha, CRP and IL-1 beta were 355 mu mol/L, 1.46 pg/mL, 3.04 pg/mL, 1.2 mg/L and 0.34 pg/mL in men and 262 mu mol/L, 1.21 pg/mL, 2.74 pg/mL, 1.3 mg/L and 0.45 pg/mL in women, respectively. SUA correlated positively with IL-6, TNF-alpha and CRP and negatively with IL-1 beta (Spearman r: 0.04, 0.07, 0.20 and 0.05 in men, and 0.09, 0.13, 0.30 and 0.07 in women, respectively, P < 0.05). In multivariable analyses, SUA was associated positively with CRP (beta coefficient +/- SE = 0.35 +/- 0.02, P < 0.001), TNF-alpha (0.08 +/- 0.02, P < 0.001) and IL-6 (0.10 +/- 0.03, P < 0.001), and negatively with IL-1 beta (-0.07 +/- 0.03, P = 0.027). Upon further adjustment for body mass index, these associations were substantially attenuated. Conclusions: SUA was associated positively with IL-6, CRP and TNF-alpha and negatively with IL-1 beta, particularly in women. These results suggest that uric acid contributes to systemic inflammation in humans and are in line with experimental data showing that uric acid triggers sterile inflammation.	[Lyngdoh, Tanica; Marques-Vidal, Pedro; Paccaud, Fred; Bochud, Murielle] Univ Lausanne, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Preisig, Martin] CHUV, Dept Psychiat, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHUV, Dept Med, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lyngdoh, T (corresponding author), Univ Lausanne, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	Lyngdoh, Tanica/F-3595-2011; Colaus, PsyColaus/K-6607-2013; Marques-Vidal, Pedro M/C-9449-2009; paccaud, fred/M-7516-2019; Bochud, Murielle/A-3981-2010	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; Preisig, Martin/0000-0001-5689-4259	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation [33CSCO-122661]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The CoLaus study was supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, Switzerland, and the Swiss National Science Foundation (grant no: 33CSCO-122661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bonora E, 1996, INT J OBESITY, V20, P975; Bordoni Valeria, 2005, Curr Drug Discov Technol, V2, P29, DOI 10.2174/1570163053175457; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; Manzato E, 2007, INTERN EMERG MED, V2, P1, DOI 10.1007/s11739-007-0001-6; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Montalcini T, 2007, INTERN EMERG MED, V2, P19, DOI 10.1007/s11739-007-0004-3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Netea MG, 1997, BLOOD, V89, P577, DOI 10.1182/blood.V89.2.577; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Olexa P, 2002, WIEN KLIN WOCHENSCHR, V114, P211; RAO GN, 1991, J BIOL CHEM, V266, P8604; ROBERGE CJ, 1994, J IMMUNOL, V152, P5485; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruggiero C, 2007, AM J CARDIOL, V100, P115, DOI 10.1016/j.amjcard.2007.02.065; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; VON KR, 2010, NEUROIMMUNOMODULAT, V17, P39, DOI DOI 10.1159/000243084; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	37	137	149	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19901	10.1371/journal.pone.0019901	http://dx.doi.org/10.1371/journal.pone.0019901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625475	Green Published, gold			2022-12-27	WOS:000290793400019
J	Horio, N; Yoshida, R; Yasumatsu, K; Yanagawa, Y; Ishimaru, Y; Matsunami, H; Ninomiya, Y				Horio, Nao; Yoshida, Ryusuke; Yasumatsu, Keiko; Yanagawa, Yuchio; Ishimaru, Yoshiro; Matsunami, Hiroaki; Ninomiya, Yuzo			Sour Taste Responses in Mice Lacking PKD Channels	PLOS ONE			English	Article							CHORDA TYMPANI; INTRACELLULAR PH; RECEPTOR-CELLS; ACID; RAT; SWEET; ACTIVATION; EXPRESSION; CURRENTS; COMPLEX	Background: The polycystic kidney disease-like ion channel PKD2L1 and its associated partner PKD1L3 are potential candidates for sour taste receptors. PKD2L1 is expressed in type III taste cells that respond to sour stimuli and genetic elimination of cells expressing PKD2L1 substantially reduces chorda tympani nerve responses to sour taste stimuli. However, the contribution of PKD2L1 and PKD1L3 to sour taste responses remains unclear. Methodology/Principal Findings: We made mice lacking PKD2L1 and/or PKD1L3 gene and investigated whole nerve responses to taste stimuli in the chorda tympani or the glossopharyngeal nerve and taste responses in type III taste cells. In mice lacking PKD2L1 gene, chorda tympani nerve responses to sour, but not sweet, salty, bitter, and umami tastants were reduced by 25-45% compared with those in wild type mice. In contrast, chorda tympani nerve responses in PKD1L3 knockout mice and glossopharyngeal nerve responses in single-and double-knock-out mice were similar to those in wild type mice. Sour taste responses of type III fungiform taste cells (GAD67-expressing taste cells) were also reduced by 25-45% by elimination of PKD2L1. Conclusions/Significance: These findings suggest that PKD2L1 partly contributes to sour taste responses in mice and that receptors other than PKDs would be involved in sour detection.	[Horio, Nao; Yoshida, Ryusuke; Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan; [Yasumatsu, Keiko] Asahi Univ, Sch Dent, Dept Oral Physiol, Gifu, Japan; [Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] CREST, JST, Tokyo, Japan; [Ishimaru, Yoshiro] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ishimaru, Yoshiro; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Kyushu University; Asahi University; Gunma University; Japan Science & Technology Agency (JST); University of Tokyo; Duke University	Horio, N (corresponding author), Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan.	yuninom@dent.kyushu-u.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020		KAKENHI [18109013, 18077004, 19880008, 20780089]; NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005782] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23689076] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI 18109013, 18077004 (YN), 19880008, 20780089 (YI) and by NIH grants (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; DESIMONE JA, 2011, CHEM SENSES; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishii S, 2009, BIOCHEM BIOPH RES CO, V385, P346, DOI 10.1016/j.bbrc.2009.05.069; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Lin W, 2004, J NEUROPHYSIOL, V92, P2909, DOI 10.1152/jn.01198.2003; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2006, J GEN PHYSIOL, V127, P15, DOI 10.1085/jgp.200509384; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; NINOMIYA Y, 1988, BRAIN RES, V451, P319, DOI 10.1016/0006-8993(88)90777-9; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Shigemura N, 2008, BIOCHEM BIOPH RES CO, V367, P356, DOI 10.1016/j.bbrc.2007.12.146; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Ugawa S, 2003, J NEUROSCI, V23, P3616; Yasumatsu K, 2009, AM J CLIN NUTR, V90, p747S, DOI 10.3945/ajcn.2009.27462J; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Yoshida R, 2006, J NEUROPHYSIOL, V96, P3088, DOI 10.1152/jn.00409.2006; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075	43	84	89	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20007	10.1371/journal.pone.0020007	http://dx.doi.org/10.1371/journal.pone.0020007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625513	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200039
J	Lei, T; Liang, XD; Yang, JS; Yan, MY; Zheng, L; Walcheck, B; Ji, YD				Lei, Ting; Liang, Xudong; Yang, Junshu; Yan, Meiying; Zheng, Li; Walcheck, Bruce; Ji, Yinduo			The C-Terminal Domain of the Novel Essential Protein Gcp Is Critical for Interaction with Another Essential Protein YeaZ of Staphylococcus aureus	PLOS ONE			English	Article							SCANNING MUTAGENESIS; GENOME MAINTENANCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ESSENTIAL GENES; KEOPS COMPLEX; GLYCOPROTEASE; IDENTIFICATION; PHENOTYPES; RESOLUTION	Previous studies have demonstrated that the novel protein Gcp is essential for the viability of various bacterial species including Staphylococcus aureus; however, the reason why it is required for bacterial growth remains unclear. In order to explore the potential mechanisms of this essentiality, we performed RT-PCR analysis and revealed that the gcp gene (sa1854) was co-transcribed with sa1855, yeaZ (sa1856) and sa1857 genes, indicating these genes are located in the same operon. Furthermore, we demonstrated that Gcp interacts with YeaZ using a yeast two-hybrid (Y2H) system and in vitro pull down assays. To characterize the Gcp-YeaZ interaction, we performed alanine scanning mutagenesis on the residues of C-terminal segment of Gcp. We found that the mutations of the C-terminal Y317-F322 region abolished the interaction of Gcp and YeaZ, and the mutations of the D324-N329 and S332-Y336 regions alleviated Gcp binding to YeaZ. More importantly, we demonstrated that these key regions of Gcp are also necessary for the bacterial survival since these mutated Gcp could not complement the depletion of endogenous Gcp. Taken together, our data suggest that the interaction of Gcp and YeaZ may contribute to the essentiality of Gcp for S. aureus survival. Our findings provide new insights into the potential mechanisms and biological functions of this novel essential protein.	[Lei, Ting; Liang, Xudong; Yang, Junshu; Yan, Meiying; Zheng, Li; Walcheck, Bruce; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Lei, T (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu			National Institutes of Health [AI065740, AI078951]; MAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078951, R21AI065740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant AI065740, AI078951, and partially by the MAES Competitive Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1992, INFECT IMMUN, V60, P56, DOI 10.1128/IAI.60.1.56-62.1992; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; Fellinger K, 2008, ANAL BIOCHEM, V373, P176, DOI 10.1016/j.ab.2007.10.016; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Haussuehl K, 2009, BIOCHEM J, V423, P333, DOI 10.1042/BJ20091023; HECKER A, 2008, EMBO J; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; James P, 1996, GENETICS, V144, P1425; Jeudy S, 2005, ACTA CRYSTALLOGR F, V61, P848, DOI 10.1107/S1744309105025856; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Ji YD, 2002, PHARMACOGENOMICS, V3, P315, DOI 10.1517/14622416.3.3.315; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loomba PS, 2010, J GLOB INFECT DIS, V2, P275, DOI 10.4103/0974-777X.68535; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Oberto J, 2009, NUCLEIC ACIDS RES, V37, P5343, DOI 10.1093/nar/gkp557; Schmid MB, 2004, NAT REV MICROBIOL, V2, P739, DOI 10.1038/nrmicro978; Watt MAV, 1997, FEMS MICROBIOL LETT, V147, P37, DOI 10.1111/j.1574-6968.1997.tb10217.x; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1230, DOI 10.1107/S1744309109022192; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5; Zheng L, 2005, FEMS MICROBIOL LETT, V245, P279, DOI 10.1016/j.femsle.2005.03.017; Zheng L, 2007, J BACTERIOL, V189, P2734, DOI 10.1128/JB.01806-06	39	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20163	10.1371/journal.pone.0020163	http://dx.doi.org/10.1371/journal.pone.0020163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625506	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200051
J	DiAngelo, JR; Erion, R; Crocker, A; Sehgal, A				DiAngelo, Justin R.; Erion, Renske; Crocker, Amanda; Sehgal, Amita			The Central Clock Neurons Regulate Lipid Storage in Drosophila	PLOS ONE			English	Article							CIRCADIAN OSCILLATORS; RHYTHMS; NEUROPEPTIDE; GENE; METABOLISM; PACEMAKER; BEHAVIOR; NEURODEGENERATION; TRANSCRIPTION; INNERVATION	A proper balance of lipid breakdown and synthesis is essential for achieving energy homeostasis as alterations in either of these processes can lead to pathological states such as obesity. The regulation of lipid metabolism is quite complex with multiple signals integrated to control overall triglyceride levels in metabolic tissues. Based upon studies demonstrating effects of the circadian clock on metabolism, we sought to determine if the central clock cells in the Drosophila brain contribute to lipid levels in the fat body, the main nutrient storage organ of the fly. Here, we show that altering the function of the Drosophila central clock neurons leads to an increase in fat body triglycerides. We also show that although triglyceride levels are not affected by age, they are increased by expression of the amyloid-beta protein in central clock neurons. The effect on lipid storage seems to be independent of circadian clock output as changes in triglycerides are not always observed in genetic manipulations that result in altered locomotor rhythms. These data demonstrate that the activity of the central clock neurons is necessary for proper lipid storage.	[DiAngelo, Justin R.; Erion, Renske; Crocker, Amanda; Sehgal, Amita] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Sehgal, Amita] Hofstra Univ, Howard Hughes Med Inst, Hempstead, NY 11550 USA; [DiAngelo, Justin R.] Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA	University of Pennsylvania; Hofstra University; Howard Hughes Medical Institute; Hofstra University	DiAngelo, JR (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			National Institutes of Health [T32-AG000255, F31-MH080490]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH080490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants T32-AG000255, which provided support for JRD, F31-MH080490 to AC. AS is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Benarroch EE, 2010, NEUROLOGY, V74, P1643, DOI 10.1212/WNL.0b013e3181df0a3f; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Chatterjee A, 2010, CURR BIOL, V20, P300, DOI 10.1016/j.cub.2009.12.055; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hoshizaki D.K., 2005, P315; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nogueiras R, 2010, OBES REV, V11, P185, DOI 10.1111/j.1467-789X.2009.00669.x; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saeb-Parsy K, 2000, J NEUROENDOCRINOL, V12, P635; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Verleyen P, 2004, J NEUROCHEM, V88, P311, DOI 10.1046/j.1471-4159.2003.02161.x; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5	39	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19921	10.1371/journal.pone.0019921	http://dx.doi.org/10.1371/journal.pone.0019921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625640	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200048
J	Guo, F; Carter, DE; Leask, A				Guo, Fen; Carter, David E.; Leask, Andrew			Mechanical Tension Increases CCN2/CTGF Expression and Proliferation in Gingival Fibroblasts via a TGF beta-Dependent Mechanism	PLOS ONE			English	Article							ORTHODONTIC TOOTH MOVEMENT; TISSUE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; TYROSINE KINASE; TGF-BETA-1; FIBROSIS; COLLAGEN; FAMILY; MYOFIBROBLAST; ENDOTHELIN-1	Unlike skin, oral gingival do not scar in response to tissue injury. Fibroblasts, the cell type responsible for connective tissue repair and scarring, are exposed to mechanical tension during normal and pathological conditions including wound healing and fibrogenesis. Understanding how human gingival fibroblasts respond to mechanical tension is likely to yield valuable insights not only into gingival function but also into the molecular basis of scarless repair. CCN2/connective tissue growth factor is potently induced in fibroblasts during tissue repair and fibrogenesis. We subjected gingival fibroblasts to cyclical strain (up to 72 hours) using the Flexercell system and showed that CCN2 mRNA and protein was induced by strain. Strain caused the rapid activation of latent TGF beta, in a fashion that was reduced by blebbistatin and FAK/src inhibition, and the induction of endothelin (ET-1) mRNA and protein expression. Strain did not cause induction of alpha-smooth muscle actin or collagen type I mRNAs (proteins promoting scarring); but induced a cohort of pro-proliferative mRNAs and cell proliferation. Compared to dermal fibroblasts, gingival fibroblasts showed reduced ability to respond to TGF beta by inducing fibrogenic mRNAs; addition of ET-1 rescued this phenotype. Pharmacological inhibition of the TGF beta type I (ALK5) receptor, the endothelin A/B receptors and FAK/src significantly reduced the induction of CCN2 and pro-proliferative mRNAs and cell proliferation. Controlling TGF beta, ET-1 and FAK/src activity may be useful in controlling responses to mechanical strain in the gingiva and may be of value in controlling fibroproliferative conditions such as gingival hyperplasia; controlling ET-1 may be of benefit in controlling scarring in response to injury in the skin.	[Guo, Fen; Leask, Andrew] Univ Western Ontario, Dept Dent, London, ON, Canada; [Carter, David E.] Robarts Res Inst, London Reg Genom Ctr Microarray Facil, London, ON N6A 5C1, Canada; [Leask, Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Guo, F (corresponding author), Univ Western Ontario, Dept Dent, London, ON, Canada.	andrew.leask@schulich.uwo.ca	Leask, Andrew/G-5217-2015; Leask, Andy/ABH-9433-2020		Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institute of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, J BIOL CHEM, V278, P47707, DOI 10.1074/jbc.M306228200; Abraham David J, 2007, Curr Rheumatol Rep, V9, P136, DOI 10.1007/s11926-007-0008-z; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dang C, 2003, CLIN PLAST SURG, V30, P13, DOI 10.1016/S0094-1298(02)00067-6; DOHERTY AM, 1991, J CARDIOVASC PHARM, V17, pS59, DOI 10.1097/00005344-199100177-00016; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Henneman S, 2008, EUR J ORTHODONT, V30, P299, DOI 10.1093/ejo/cjn020; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Hong HH, 1999, LAB INVEST, V79, P1655; Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Ohuchi N, 2010, FUND CLIN PHARMACOL, V24, P501, DOI 10.1111/j.1472-8206.2009.00786.x; Pang CY, 2003, J BIOL CHEM, V278, P47707; Samarin J, 2009, J CELL COMMUN SIGNAL, V3, P79, DOI 10.1007/s12079-009-0055-5; Schor S L, 1996, Oral Dis, V2, P155; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Thompson K, 2010, J DENT RES, V89, P1450, DOI 10.1177/0022034510379020; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008	38	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19756	10.1371/journal.pone.0019756	http://dx.doi.org/10.1371/journal.pone.0019756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611193	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500018
J	Alborzinia, H; Can, S; Holenya, P; Scholl, C; Lederer, E; Kitanovic, I; Wolfl, S				Alborzinia, Hamed; Can, Suzan; Holenya, Pavlo; Scholl, Catharina; Lederer, Elke; Kitanovic, Igor; Woelfl, Stefan			Real-Time Monitoring of Cisplatin-Induced Cell Death	PLOS ONE			English	Article							INDUCED APOPTOSIS; ERK ACTIVATION; DNA; INHIBITION; PLATINUM; P53; COMPLEXES; CANCER; ARRAYS; LISTS	Since the discovery of cisplatin more than 40 years ago and its clinical introduction in the 1970s an enormous amount of research has gone into elucidating the mechanism of action of cisplatin on tumor cells. With a novel cell biosensor chip system allowing continuous monitoring of respiration, glycolysis, and impedance we followed cisplatin treatment of different cancer cell lines in real-time. Our measurements reveal a first effect on respiration, in all cisplatin treated cell lines, followed with a significant delay by interference with glycolysis in HT-29, HCT-116, HepG2, and MCF-7 cells but not in the cisplatin-resistant cell line MDA-MB-231. Most strikingly, cell death started in all cisplatin-sensitive cell lines within 8 to 11 h of treatment, indicating a clear time frame from exposure, first response to cisplatin lesions, to cell fate decision. The time points of most significant changes were selected for more detailed analysis of cisplatin response in the breast cancer cell line MCF-7. Phosphorylation of selected signal transduction mediators connected with cellular proliferation, as well as changes in gene expression, were analyzed in samples obtained directly from sensor chips at the time points when changes in glycolysis and impedance occurred. Our online cell biosensor measurements reveal for the first time the time scale of metabolic response until onset of cell death under cisplatin treatment, which is in good agreement with models of p53-mediated cell fate decision.	[Alborzinia, Hamed; Can, Suzan; Holenya, Pavlo; Scholl, Catharina; Lederer, Elke; Kitanovic, Igor; Woelfl, Stefan] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Alborzinia, H (corresponding author), Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wolfl@uni-hd.de		Alborzinia, Hamed/0000-0001-6903-3001	German Research foundation [DFG-FOR630]; BMBF [01EA0509]	German Research foundation(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research foundation collaborative research project DFG-FOR630 (SW). The BIONAS2500 bisosensorchip system was financed by BMBF research grant 01EA0509 (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Ehret R, 2001, FRESEN J ANAL CHEM, V369, P30, DOI 10.1007/s002160000628; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Harlos M, 2008, J MED CHEM, V51, P3924, DOI 10.1021/jm800173s; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Holenya P, 2011, PROTEOMICS, V11, P2129, DOI 10.1002/pmic.201000690; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Kim HS, 2008, J BIOL CHEM, V283, P3731, DOI 10.1074/jbc.M704432200; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kroll TC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e50; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Panka DJ, 2008, J BIOL CHEM, V283, P726, DOI 10.1074/jbc.M705343200; Pu T, 2010, BIOPHYS J, V99, P1696, DOI 10.1016/j.bpj.2010.07.042; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rubbiani R, 2010, J MED CHEM, V53, P8608, DOI 10.1021/jm100801e; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; WILTSHAW E, 1976, CANCER TREAT REP, V60, P55; Wolfl S, 2005, PROTEIN MICROARRAYS, P159; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200	27	75	77	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19714	10.1371/journal.pone.0019714	http://dx.doi.org/10.1371/journal.pone.0019714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603599	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300019
J	Sharma, NS; Nagrath, D; Yarmush, ML				Sharma, Nripen S.; Nagrath, Deepak; Yarmush, Martin L.			Metabolic Profiling Based Quantitative Evaluation of Hepatocellular Metabolism in Presence of Adipocyte Derived Extracellular Matrix	PLOS ONE			English	Article							CULTURED RAT HEPATOCYTES; CELL-CELL INTERACTIONS; AMINO-ACIDS; SANDWICH CONFIGURATION; BASEMENT-MEMBRANE; PROTEIN-SYNTHESIS; COLLAGEN GEL; IN-VITRO; MEDIATED ENHANCEMENT; BIOLOGICAL-ACTIVITY	The elucidation of the effect of extracellular matrices on hepatocellular metabolism is critical to understand the mechanism of functional upregulation. We have developed a system using natural extracellular matrices [Adipogel] for enhanced albumin synthesis of rat hepatocyte cultures for a period of 10 days as compared to collagen sandwich cultures. Primary rat hepatocytes isolated from livers of female Lewis rats recover within 4 days of culture from isolation induced injury while function is stabilized at 7 days post-isolation. Thus, the culture period can be classified into three distinct stages viz. recovery stage [day 0-4], pre-stable stage [day 5-7] and the stable stage [day 8-10]. A Metabolic Flux Analysis of primary rat hepatocytes cultured in Adipogel was performed to identify the key metabolic pathways modulated as compared to collagen sandwich cultures. In the recovery stage [day 4], the collagen-soluble Adipogel cultures shows an increase in TriCarboxylic Acid [TCA] cycle fluxes; in the pre-stable stage [day 7], there is an increase in PPP and TCA cycle fluxes while in the stable stage [day 10], there is a significant increase in TCA cycle, urea cycle fluxes and amino acid uptake rates concomitant with increased albumin synthesis rate as compared to collagen sandwich cultures throughout the culture period. Metabolic analysis of the collagen-soluble Adipogel condition reveals significantly higher transamination reaction fluxes, amino acid uptake and albumin synthesis rates for the stable vs. recovery stages of culture. The identification of metabolic pathways modulated for hepatocyte cultures in presence of Adipogel will be a useful step to develop an optimization algorithm to further improve hepatocyte function for Bioartificial Liver Devices. The development of this framework for upregulating hepatocyte function in Bioartificial Liver Devices will facilitate the utilization of an integrated experimental and computational approach for broader applications of Adipogel in tissue e engineering and regenerative medicine.	[Sharma, Nripen S.; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med Surg Serv, Boston, MA 02115 USA; [Sharma, Nripen S.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA USA; [Nagrath, Deepak] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Rice University	Sharma, NS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med Surg Serv, Boston, MA 02115 USA.	ireis@sbi.org		Yarmush, Martin/0000-0003-4986-8444; Nagrath, Deepak/0000-0002-8999-2282	NIH [R01 DK059766, R01 AI063795]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 DK059766 and R01 AI063795, and grants from the Shriners Hospitals for Children. Resources were provided by the BioMEMS Resource Center (P41 EB-002503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Banta S, 2005, J SURG RES, V127, P93, DOI 10.1016/j.jss.2005.01.001; Berthiaume F, 2003, METAB ENG, V5, P108, DOI 10.1016/S1096-7176(03)00010-7; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chan C, 2003, BIOTECHNOL PROGR, V19, P580, DOI 10.1021/bp025660h; Chan C, 2002, BIOTECHNOL BIOENG, V78, P753, DOI 10.1002/bit.10275; Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013; Cho CH, 2008, BIOTECHNOL BIOENG, V101, P345, DOI 10.1002/bit.21911; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; DUNN JCY, 1993, BIOTECHNOL BIOENG, V41, P593, DOI 10.1002/bit.260410512; EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; FLAIM KE, 1982, J BIOL CHEM, V257, P2932; FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505; Hoshiba T, 2007, BIOCHEM BIOPH RES CO, V359, P151, DOI 10.1016/j.bbrc.2007.05.079; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022; Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934; Jones CN, 2009, BIOMATERIALS, V30, P3733, DOI 10.1016/j.biomaterials.2009.03.039; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; Kang YH, 2004, EXP CELL RES, V293, P239, DOI 10.1016/j.yexcr.2003.10.011; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; LEE J, 1993, FASEB J, V7, P586, DOI 10.1096/fasebj.7.6.8472895; LEE JW, 1992, BIOTECHNOL BIOENG, V40, P298, DOI 10.1002/bit.260400214; Lee K, 2003, METAB ENG, V5, P221, DOI 10.1016/S1096-7176(03)00042-9; Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P77, DOI 10.1007/BF01606580; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5; MUSAT AI, 1993, HEPATOLOGY, V18, P198, DOI 10.1002/hep.1840180129; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Nagrath D, 2010, METAB ENG, V12, P429, DOI 10.1016/j.ymben.2010.05.003; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Novik EI, 2008, BIOTECHNOL PROGR, V24, P1132, DOI 10.1002/btpr.41; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; RINKES IHMB, 1992, CRYOBIOLOGY, V29, P443, DOI 10.1016/0011-2240(92)90047-6; ROTEM A, 1992, BIOTECHNOL BIOENG, V40, P1286, DOI 10.1002/bit.260401020; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; SEGLEN PO, 1978, BIOCHIM BIOPHYS ACTA, V520, P630, DOI 10.1016/0005-2787(78)90148-X; SEGLEN PO, 1978, EUR J BIOCHEM, V85, P15, DOI 10.1111/j.1432-1033.1978.tb12208.x; Sharma NS, 2006, BIOTECHNOL BIOENG, V94, P1053, DOI 10.1002/bit.20936; Sharma Nripen, 2008, Critical Reviews in Biomedical Engineering, V36, P413; Sharma NS, 2010, FASEB J, V24, P2364, DOI 10.1096/fj.09-135095; Sharma NS, 2009, TISSUE ENG PART C-ME, V15, P297, DOI 10.1089/ten.tec.2008.0303; Sharma NS, 2005, BIOTECHNOL BIOENG, V92, P321, DOI 10.1002/bit.20586; Tilles Arno W, 2002, J Hepatobiliary Pancreat Surg, V9, P686, DOI 10.1007/s005340200095; Van Poll D, 2006, TISSUE ENG, V12, P2965; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Washizu J, 2000, J SURG RES, V93, P237, DOI 10.1006/jsre.2000.5986; Washizu J, 2001, TISSUE ENG, V7, P691, DOI 10.1089/107632701753337654; Zeisberg M, 2006, MOL CELL BIOCHEM, V283, P181, DOI 10.1007/s11010-006-2677-8	62	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20137	10.1371/journal.pone.0020137	http://dx.doi.org/10.1371/journal.pone.0020137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603575	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300052
J	Bigalke, B; Schreitmuller, B; Sopova, K; Paul, A; Stransky, E; Gawaz, M; Stellos, K; Laske, C				Bigalke, Boris; Schreitmueller, Brigitte; Sopova, Kateryna; Paul, Angela; Stransky, Elke; Gawaz, Meinrad; Stellos, Konstantinos; Laske, Christoph			Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; PLASMA LEPTIN LEVELS; INDEPENDENT PREDICTOR; ADIPONECTIN LEVELS; VASCULAR REPAIR; A-BETA; ASSOCIATION; DEMENTIA; DYSFUNCTION	Background: Alzheimer's disease (AD) and atherosclerosis share common vascular risk factors such as arterial hypertension and hypercholesterolemia. Adipocytokines and CD34(+) progenitor cells are associated with the progression and prognosis of atherosclerotic diseases. Their role in AD is not adequately elucidated. Methods and Findings: In the present study, we measured in 41 patients with early AD and 37 age-and weight-matched healthy controls blood concentrations of adiponectin and leptin by enzyme linked immunoabsorbent assay and of CD34(+) progenitor cells using flow cytometry. We found significantly lower plasma levels of leptin in AD patients compared with the controls, whereas plasma levels of adiponectin did not show any significant differences (AD vs. control (mean +/- SD): leptin: 8.9 +/- 5.6 ng/mL vs. 16.3 +/- 15.5 ng/mL; P = 0.038; adiponectin: 18.5 +/- 18.1 mu g/mL vs. 16.7 +/- 8.9 mu g/mL; P = 0.641). In contrast, circulating CD34(+) cells were significantly upregulated in AD patients (mean absolute cell count +/- SD: 253 +/- 51 vs. 203 +/- 37; P = 0.02) and showed an inverse correlation with plasma levels of leptin (r = -0.248; P = 0.037). In logistic regression analysis, decreased leptin concentration (P = 0.021) and increased number of CD34(+) cells (P = 0.036) were both significantly associated with the presence of AD. According to multifactorial analysis of covariance, leptin serum levels were a significant independent predictor for the number of CD34(+) cells (P = 0.002). Conclusions: Our findings suggest that low plasma levels of leptin and increased numbers of CD34(+) progenitor cells are both associated with AD. In addition, the esults of our study provide first evidence that increased leptin plasma levels are associated with a reduced number of CD34(+) progenitor cells in AD patients. These findings point towards a combined involvement of leptin and CD34(+) progenitor cells in the pathogenesis of AD. Thus, plasma levels of leptin and circulating CD34(+) progenitor cells could represent an important molecular link between atherosclerotic diseases and AD. Further studies should clarify the pathophysiological role of both adipocytokines and progenitor cells in AD and possible diagnostic and therapeutic applications.	[Bigalke, Boris; Sopova, Kateryna; Paul, Angela; Gawaz, Meinrad; Stellos, Konstantinos] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Bigalke, Boris] Kings Coll London, Sch Med, Div Imaging Sci, Rayne Inst, London WC2R 2LS, England; [Schreitmueller, Brigitte; Stransky, Elke; Laske, Christoph] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; University of London; King's College London; Eberhard Karls University of Tubingen	Bigalke, B (corresponding author), Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany.	konstantinos.stellos@med.uni-tuebingen.de; christoph.laske@med.uni-tuebingen.de	Stellos, Konstantinos/ABH-1523-2021; Stellos, Konstantinos/AAF-2711-2020; Stellos, Konstantinos/G-8873-2011	Stellos, Konstantinos/0000-0002-0194-0825	University of Tubingen [F1331299, 1795-1-0]; German Cardiac Society (DGK); Hirnliga e.V.; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG:Li849/3-1, SFB:SFB-TR19-B8N]; Sonderforschungsbereich/Transregio-19	University of Tubingen; German Cardiac Society (DGK); Hirnliga e.V.; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Sonderforschungsbereich/Transregio-19(German Research Foundation (DFG))	The study was supported in part by Grants from the Fortune Program of the University of Tubingen F1331299 to CL and 1795-1-0 to KS (Konstantinos Stellos), from the grant of the German Cardiac Society (DGK) 'molecular imaging of atheroslerotic plaques' to BB, from Hirnliga e.V. to KS (Konstantinos Stellos) and from the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG:Li849/3-1;SFB:SFB-TR19-B8N) Sonderforschungsbereich/Transregio-19 "Inflammatory cardiomyopathy - Molecular pathogenesis and treatment'' to KS (Konstantinos Stellos) and MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Becker-Barroso E, 2005, LANCET NEUROL, V4, P598, DOI 10.1016/S1474-4422(05)70182-4; Bigalke B, 2010, PLATELETS, V21, P11, DOI 10.3109/09537100903377584; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Broedl UC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004733; Buerger K, 2009, BIOL PSYCHIAT, V65, P979, DOI 10.1016/j.biopsych.2009.01.032; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Dubey L, 2008, INT J CARDIOL, V126, P183, DOI 10.1016/j.ijcard.2007.03.126; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Giordano V, 2007, NEUROCHEM RES, V32, P555, DOI 10.1007/s11064-006-9125-8; Greco SJ, 2010, J ALZHEIMERS DIS; Gunstad J, 2008, BRAIN RES, V1230, P233, DOI 10.1016/j.brainres.2008.07.045; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Laske C, 2008, J ALZHEIMERS DIS, V15, P83; Laske C, 2008, J PSYCHIATR RES, V42, P746, DOI 10.1016/j.jpsychires.2007.07.017; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Marousi S. G., 2009, NEUROL RES; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; MCKHANN G, 1984, NEUROLOGY, V34, P30; Otsuka F, 2006, J AM COLL CARDIOL, V48, P1155, DOI 10.1016/j.jacc.2006.05.054; Salmina AB, 2010, J ALZHEIMERS DIS, V22, P17, DOI 10.3233/JAD-2010-091690; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Shibata R, 2008, AM J CARDIOL, V101, P1712, DOI 10.1016/j.amjcard.2008.02.057; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stellos K, 2010, J ALZHEIMERS DIS, V19, P591, DOI 10.3233/JAD-2010-1261; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Tobler K, 2010, INT J OBESITY, V34, P687, DOI 10.1038/ijo.2009.280; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wallander M, 2008, DIABETIC MED, V25, P949, DOI 10.1111/j.1464-5491.2008.02509.x; Wolk R, 2005, ATHEROSCLEROSIS, V183, P131, DOI 10.1016/j.atherosclerosis.2005.03.048; Xu QB, 2007, CURR OPIN LIPIDOL, V18, P534, DOI 10.1097/MOL.0b013e3282a66082	42	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20286	10.1371/journal.pone.0020286	http://dx.doi.org/10.1371/journal.pone.0020286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633502	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500051
J	Morris, SK; Bassani, DG; Awasthi, S; Kumar, R; Shet, A; Suraweera, W; Jha, P				Morris, Shaun K.; Bassani, Diego G.; Awasthi, Shally; Kumar, Rajesh; Shet, Anita; Suraweera, Wilson; Jha, Prabhat		MDS Collaborators	Diarrhea, Pneumonia, and Infectious Disease Mortality in Children Aged 5 to 14 Years in India	PLOS ONE			English	Article							VERBAL AUTOPSY; CHILDHOOD MORTALITY; ADULT DEATHS; VALIDATION; IMMUNIZATION; MORBIDITY; VALIDITY; YOUNGER; BURDEN; GENDER	Background: Little is known about the causes of death in children in India after age five years. The objective of this study is to provide the first ever direct national and sub-national estimates of infectious disease mortality in Indian children aged 5 to 14 years. Methods: A verbal autopsy based assessment of 3 855 deaths is children aged 5 to 14 years from a nationally representative survey of deaths occurring in 2001-03 in 1-1 million homes in India. Results: Infectious diseases accounted for 58% of all deaths among children aged 5 to 14 years. About 18% of deaths were due to diarrheal diseases, 10% due to pneumonia, 8% due to central nervous system infections, 4% due to measles, and 12% due to other infectious diseases. Nationally, in 2005 about 59 000 and 34 000 children aged 5 to 14 years died from diarrheal diseases and pneumonia, corresponding to mortality of 24-1 and 13-9 per 100 000 respectively. Mortality was nearly 50% higher in girls than in boys for both diarrheal diseases and pneumonia. Conclusions: Approximately 60% of all deaths in this age group are due to infectious diseases and nearly half of these deaths are due to diarrheal diseases and pneumonia. Mortality in this age group from infectious diseases, and diarrhea in particular, is much higher than previously estimated.	[Morris, Shaun K.; Bassani, Diego G.; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst,Dalla Lana Sch Publ Hl, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Div Infect Dis, Hosp Sick Children, Toronto, ON M5B 1W8, Canada; [Awasthi, Shally] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India; [Shet, Anita] St Johns Natl Acad Hlth Sci, Dept Pediat, Bangalore, Karnataka, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); King George's Medical University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences	Morris, SK (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst,Dalla Lana Sch Publ Hl, Toronto, ON M5B 1W8, Canada.	shaun.morris@utoronto.ca	Suraweera, Wilson MG/O-8962-2014; Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Suraweera, Wilson/0000-0001-9673-5746; Shet, Anita/0000-0002-7204-8164	US National Institutes of Health; International Development Research Centre; Canadian Institutes of Health Research; Li Ka Shing Knowledge Institute; UNICEF; Canada Research Chair programme; Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Development Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); UNICEF; Canada Research Chair programme(Canada Research Chairs); Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes(March of Dimes)	US National Institutes of Health, International Development Research Centre, Canadian Institutes of Health Research, Li Ka Shing Knowledge Institute, and US Fund for UNICEF. PJ is supported by the Canada Research Chair programme. SKM is a Fellow of the Pediatric Scientist Development Program and is supported by grants Sick Kids Foundation, Paediatric Chairs of Canada, and the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER M, 1999, WHOCDSCSRISR994; [Anonymous], GLOBAL BURDEN DIS RI; [Anonymous], 1998, SURV CAUS DEATH RUR; ANWAR Z, 1987, Paediatrica Indonesiana, V27, P93; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Centre for Global Health Research, 2009, MILL DEATH STUD; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; *REG GEN IND, 2009, REP MED CERT CAUS DE; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Srivastava S P, 1995, Indian Pediatr, V32, P911; StataCorp L, 2007, STAT DAT AN STAT SOF; United Nations, WORLD POP PROSP 2008; Walker CLF, 2010, EPIDEMIOL INFECT, V138, P1215, DOI 10.1017/S0950268810000592; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; [No title captured]	34	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20119	10.1371/journal.pone.0020119	http://dx.doi.org/10.1371/journal.pone.0020119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629660	gold, Green Published			2022-12-27	WOS:000291005800027
J	Okell, LC; Griffin, JT; Kleinschmidt, I; Hollingsworth, TD; Churcher, TS; White, MJ; Bousema, T; Drakeley, CJ; Ghani, AC				Okell, Lucy C.; Griffin, Jamie T.; Kleinschmidt, Immo; Hollingsworth, T. Deirdre; Churcher, Thomas S.; White, Michael J.; Bousema, Teun; Drakeley, Chris J.; Ghani, Azra C.			The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria	PLOS ONE			English	Article							INFECTIOUS TRACHOMA; GAMETOCYTE CARRIAGE; RESISTANT MALARIA; ENDEMIC AREA; TRANSMISSION; ARTEMISININ; ELIMINATION; COMMUNITIES; PRIMAQUINE; REDUCTION	Mass treatment as a means to reducing P. falciparum malaria transmission was used during the first global malaria eradication campaign and is increasingly being considered for current control programmes. We used a previously developed mathematical transmission model to explore both the short and long-term impact of possible mass treatment strategies in different scenarios of endemic transmission. Mass treatment is predicted to provide a longer-term benefit in areas with lower malaria transmission, with reduced transmission levels for at least 2 years after mass treatment is ended in a scenario where the baseline slide-prevalence is 5%, compared to less than one year in a scenario with baseline slide-prevalence at 50%. However, repeated annual mass treatment at 80% coverage could achieve around 25% reduction in infectious bites in moderate-to-high transmission settings if sustained. Using vector control could reduce transmission to levels at which mass treatment has a longer-term impact. In a limited number of settings ( which have isolated transmission in small populations of 1000-10,000 with low-to-medium levels of baseline transmission) we find that five closely spaced rounds of mass treatment combined with vector control could make at least temporary elimination a feasible goal. We also estimate the effects of using gametocytocidal treatments such as primaquine and of restricting treatment to parasite-positive individuals. In conclusion, mass treatment needs to be repeated or combined with other interventions for long-term impact in many endemic settings. The benefits of mass treatment need to be carefully weighed against the risks of increasing drug selection pressure.	[Okell, Lucy C.; Griffin, Jamie T.; Hollingsworth, T. Deirdre; Churcher, Thomas S.; White, Michael J.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Bousema, Teun; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Okell, LC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London, England.	l.okell@imperial.ac.uk	Ghani, Azra/B-8560-2009; Bousema, Teun/N-3574-2014; Hollingsworth, Deirdre/D-2421-2009	Bousema, Teun/0000-0003-2666-094X; Hollingsworth, Deirdre/0000-0001-5962-4238; Churcher, Thomas/0000-0002-8442-0525; Okell, Lucy/0000-0001-7202-6873; Ghani, Azra/0000-0002-0007-4910; White, Michael/0000-0002-7472-4138	Bill and Melinda Gates Vaccine Modeling Initiative; UK Medical Research Council; TransMalariaBloc European Commission [HEALTH-F3-2008-223736]; Imperial College Junior; Wellcome Trust; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837, G0600719B] Funding Source: researchfish	Bill and Melinda Gates Vaccine Modeling Initiative; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); TransMalariaBloc European Commission(European Commission); Imperial College Junior; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Bill and Melinda Gates Vaccine Modeling Initiative, the UK Medical Research Council and the TransMalariaBloc European Commission FP7 Collaborative project (HEALTH-F3-2008-223736). TDH is funded by an Imperial College Junior Research Fellowship, and CJD by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2010, GUID TREATM MAL; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; BURGESS RW, 1961, B WORLD HEALTH ORGAN, V24, P451; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Coleman RE, 2002, AM J TROP MED HYG, V66, P379, DOI 10.4269/ajtmh.2002.66.379; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; ESCUDIE A., 1962, Medecine Tropicale, V22, P268; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Hii JLK, 1997, J MED ENTOMOL, V34, P193, DOI 10.1093/jmedent/34.2.193; Ishikawa H., 1996, Japanese Journal of Tropical Medicine and Hygiene, V24, P11; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Lakshmanacharyulu L., 1968, B IND SOC MAL COM, P94; Lensen A, 1999, EXP PARASITOL, V91, P101, DOI 10.1006/expr.1998.4354; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; MACDONALD G, 1967, WHOMAL67615; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001; NAJERA JA, 1973, MASS DRUG ADM DDT IN; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Ray KJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000458; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Singh M, 1968, B INDIAN SOC MALARIA, V5, P207; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Smits HL, 2009, EXPERT REV ANTI-INFE, V7, P37, DOI 10.1586/14787210.7.1.37; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; STEPNIEWSKA K, 2008, ANTIMICROB AGENTS CH; von Seidlein L, 2003, T ROY SOC TROP MED H, V97, P217, DOI 10.1016/S0035-9203(03)90125-8; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; Wernsdorfer W.H., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P123; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1996, TROP MED INT HEALTH, V1, P456, DOI 10.1046/j.1365-3156.1996.d01-88.x; Zulueta J. de., 1964, East African Medical Journal, V41, P102	50	100	100	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20179	10.1371/journal.pone.0020179	http://dx.doi.org/10.1371/journal.pone.0020179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629651	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800031
J	Sander, PM; Chen, XH; Cheng, L; Wang, XF				Sander, P. Martin; Chen, Xiaohong; Cheng, Long; Wang, Xiaofeng			Short-Snouted Toothless Ichthyosaur from China Suggests Late Triassic Diversification of Suction Feeding Ichthyosaurs	PLOS ONE			English	Article							BRITISH-COLUMBIA; BEAKED-WHALES; PARDONET FORMATION; CRANIAL OSTEOLOGY; ODONTOCETI; REPTILIA; EVOLUTION; ICHTHYOPTERYGIA; PHYLOGENY; DIVERSITY	Background: Ichthyosaurs were an important group of Mesozoic marine reptiles and existed from the Early Triassic to the early Late Cretaceous. Despite a great diversity in body shapes and feeding adaptations, all share greatly enlarged eyes, an elongated rostrum with numerous conical teeth, and a streamlined body. Methodology/Principal Findings: Based on new material from China and the restudy of Shastasaurus pacificus, we here reinterpret the classical large-bodied Late Triassic ichthyosaur genus Shastasaurus to differ greatly from the standard ichthyosaurian body plan, indicating much greater morphological diversity and range of feeding adaptations in ichthyosaurs than previously recognized. Phylogenetic analysis indicates a monophyletic clade consisting of the giant Shonisaurus sikanniensis, Guanlingsaurus liangae, and Shastasaurus pacificus to which the genus name Shastasaurus is applied. Shastasaurus liangae comb. nov. is from the Late Triassic (Carnian) Xiaowa Formation of Guizhou Province, southwestern China. The species combines a diminutive head with an entirely toothless and greatly reduced snout. The species also has by far the highest vertebral count among ichthyosaurs (86 presacral vertebrae and > 110 caudal vertebrae), a count that is also very high for tetrapods in general. A reduced toothless snout and a diminutive head is also apparently present in the giant S. sikanniensis and presumably in S. pacificus. Conclusions/Significance: In analogy to many modern odontocetes, Shastasaurus is interpreted as a specialized suction feeder on unshelled cephalopods and fish, suggesting a unique but widespread Late Triassic diversification of toothless, suction-feeding ichthyosaurs. Suction feeding has not been hypothesized for any of the other diverse marine reptiles of the Mesozoic before, but in Shastasaurus may be linked to the Late Triassic minimum in atmospheric oxygen.	[Sander, P. Martin] Univ Bonn, Div Palaeontol, Steinmann Inst, D-5300 Bonn, Germany; [Chen, Xiaohong; Cheng, Long; Wang, Xiaofeng] Wuhan Inst Geol & Mineral Resources, Wuhan, Hubei, Peoples R China	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Div Palaeontol, Steinmann Inst, D-5300 Bonn, Germany.	martin.sander@uni-bonn.de			Deutsche Forschungsgemeinschaft [446 CHV 111/12/06]; Chinese Geolgical Survey [1212010611603]; University of Bonn, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Geolgical Survey; University of Bonn, Germany	Grant from Deutsche Forschungsgemeinschaft (#446 CHV 111/12/06) to PMS, Grant from the Chinese Geolgical Survey (#1212010611603) to XFW and XCH, and funds from the University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton M. J., 2003, LIFE NEARLY DIED GRE; Bianucci G, 2007, GEODIVERSITAS, V29, P561; Brayard A, 2009, SCIENCE, V325, P1118, DOI 10.1126/science.1174638; CALLAWAY JM, 1989, J PALEONTOL, V63, P930, DOI 10.1017/S0022336000036635; CLARKE MR, 1996, RES DOLPHINS, P281; Dal Sasso Cristiano, 1996, Paleontologia Lombarda, V4, P1; de Beer G.R, 1971, DEV VERTEBRATE SKULL; Erwin D. H., 2006, EXTINCTION LIFE EART; Heyning J. E., 1996, NATURAL HIST MUSEUM, V464, P1; Huey RB, 2005, SCIENCE, V308, P398, DOI 10.1126/science.1108019; Jiang DY, 2008, PROG NAT SCI-MATER, V18, P1315, DOI 10.1016/j.pnsc.2008.01.039; Lambert O, 2005, GEODIVERSITAS, V27, P443; Lambert O, 2009, J VERTEBR PALEONTOL, V29, P910, DOI 10.1671/039.029.0304; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; Maisch MW, 2006, J VERTEBR PALEONTOL, V26, P588, DOI 10.1671/0272-4634(2006)26[588:COOGTR]2.0.CO;2; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch MW, 2000, NEUES JAHRB GEOL P-A, V217, P1; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 2005, Paludicola, V5, P20; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 100, P1; McGowan C, 1996, CAN J EARTH SCI, V33, P24, DOI 10.1139/e96-003; MCGOWAN C, 2003, HDB PALAEOHERPETOL 8; MERRIAM JC, 1908, U CALIF MEM, V1, P1; MERRIAM JC, 1895, AM J SCI 3, V50, P55; MERRIAM JC, 1902, B DEP GEOLOGY, V3, P63; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani Ryosuke, 1999, Paludicola, V2, P174; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Nicholls EL, 2002, J VERTEBR PALEONTOL, V22, P759, DOI 10.1671/0272-4634(2002)022[0759:NMOQLR]2.0.CO;2; Nicholls EL, 2001, CAN J EARTH SCI, V38, P983, DOI 10.1139/e00-115; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sander P. Martin, 1993, Paleontologia Lombarda, V2, P145; Schmitz L, 2004, PALAEONTOGR ABT A, V270, P133; Shang Qing-Hua, 2009, Vertebrata Palasiatica, V47, P178; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Ward P., 2006, OUT THIN AIR DINOSAU; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1	46	45	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19480	10.1371/journal.pone.0019480	http://dx.doi.org/10.1371/journal.pone.0019480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625429	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005200002
J	Torres, R; Garcia, A; Paya, M; Ramirez, JC				Torres, Raul; Garcia, Aida; Paya, Monica; Ramirez, Juan C.			Non-Integrative Lentivirus Drives High-Frequency cre-Mediated Cassette Exchange in Human Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; ZINC-FINGER NUCLEASES; GENE-EXPRESSION; HUMAN ESCS; HOMOLOGOUS RECOMBINATION; TRANSGENE EXPRESSION; IN-VIVO; VECTORS; LOCUS	Recombinase mediated cassette exchange (RMCE) is a two-step process leading to genetic modification in a specific genomic target sequence. The process involves insertion of a docking genetic cassette in the genome followed by DNA transfer of a second cassette flanked by compatible recombination signals and expression of the recombinase. Major technical drawbacks are cell viability upon transfection, toxicity of the enzyme, and the ability to target efficiently cell types of different origins. To overcome such drawbacks, we developed an RMCE assay that uses an integrase-deficient lentivirus (IDLV) vector in the second step combined with promoterless trapping of double selectable markers. Additionally, recombinase expression is self-limiting as a result of the exchangeable reaction, thus avoiding toxicity. Our approach provides proof-of-principle of a simple and novel strategy with expected wide applicability modelled on a human cell line with randomly integrated copies of a genetic landing pad. This strategy does not present foreseeable limitations for application to other cell systems modified by homologous recombination. Safety, efficiency, and simplicity are the major advantages of our system, which can be applied in low-to-medium throughput strategies for screening of cDNAs, noncoding RNAs during functional genomic studies, and drug screening.	[Torres, Raul; Garcia, Aida; Paya, Monica; Ramirez, Juan C.] Fdn Ctr Nacl Invest Cardiovasc CNIC, Viral Vector Tech Unit, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Torres, R (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC, Viral Vector Tech Unit, Madrid, Spain.	jcramirez@cnic.es	Ramírez, Juan Carlos/B-7979-2015; Ruiz, Raul Torres/J-1649-2018	Ruiz, Raul Torres/0000-0001-9606-0398	Ministry of Health and Custom Affairs [FIS 06/0911]; Ministry of Science and Innovation [INNPACTO IPT-010000-2010-40]; Fundacion Pro-CNIC	Ministry of Health and Custom Affairs; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Pro-CNIC	This work was supported by grants of the Ministry of Health and Custom Affairs [FIS 06/0911] and Ministry of Science and Innovation [INNPACTO IPT-010000-2010-40] to J.C.R.; and National Centre for Cardiovascular Research (CNIC) institutional funding from the Fundacion Pro-CNIC to the Viral Vector Technical Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Banasik MB, 2010, GENE THER, V17, P150, DOI 10.1038/gt.2009.135; Birling Marie-Christine, 2009, Methods Mol Biol, V561, P245, DOI 10.1007/978-1-60327-019-9_16; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kolb AF, 2001, ANAL BIOCHEM, V290, P260, DOI 10.1006/abio.2000.4984; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Naldini L, 2000, ADV VIRUS RES, V55, P599, DOI 10.1016/S0065-3527(00)55020-9; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Paya M, 2006, J VIROL METHODS, V137, P95, DOI 10.1016/j.jviromet.2006.06.005; Qasim W, 2010, MOL THER, V18, P1263, DOI 10.1038/mt.2010.76; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rodolosse A, 1998, AM J PHYSIOL-GASTR L, V274, pG931, DOI 10.1152/ajpgi.1998.274.5.G931; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Siegel RW, 2001, FEBS LETT, V505, P466, DOI 10.1016/S0014-5793(01)02805-8; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Sorrell DA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq192; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zaiss AK, 2002, J VIROL, V76, P7209, DOI 10.1128/JVI.76.14.7209-7219.2002; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	14	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19794	10.1371/journal.pone.0019794	http://dx.doi.org/10.1371/journal.pone.0019794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625434	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200015
J	Sturm, G; Lamina, C; Zitt, E; Lhotta, K; Haider, F; Neyer, U; Kronenberg, F				Sturm, Gisela; Lamina, Claudia; Zitt, Emanuel; Lhotta, Karl; Haider, Florian; Neyer, Ulrich; Kronenberg, Florian			Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature	PLOS ONE			English	Review							GLYCEMIC CONTROL; HEMODIALYSIS-PATIENTS; GLYCATED ALBUMIN; HEMOGLOBIN VALUES; SURVIVAL; PREDICTOR	Background: Improved glycemic control reduces complications in patients with diabetes mellitus (DM). However, it is discussed controversially whether patients with diabetes mellitus and end-stage renal disease benefit from strict glycemic control. Methods: We followed 78 patients with DM initiating dialysis treatment of the region of Vorarlberg in a prospective cohort study applying a time-dependent Cox regression analysis using all measured laboratory values for up to more than seven years. This resulted in 880 HbA(1c) measurements (with one measurement every 3.16 patient months on average) during the entire observation period. Non-linear P-splines were used to allow flexible modeling of the association with mortality and cardiovascular disease (CVD) events. Results: We observed a decreased mortality risk with increasing HbA(1c) values (HR = 0.72 per 1% increase, p = 0.024). Adjustment for age and sex and additional adjustment for other CVD risk factors only slightly attenuated the association (HR = 0.71, p = 0.044). A non-linear P-spline showed that the association did not follow a fully linear pattern with a highly significant non-linear component (p = 0.001) with an increased risk of all-cause mortality for HbA(1c) values up to 6-7%. Causes of death were associated with HbA(1c) values. The risk for CVD events, however, increased with increasing HbA(1c) values (HR = 1.24 per 1% increase, p = 0.048) but vanished after extended adjustments. Conclusions: This study considered the entire information collected on HbA(1c) over a period of more than seven years. Besides the methodological advantages our data indicate a significant inverse association between HbA(1c) levels and all-cause mortality. However, for CVD events no significant association could be found.	[Sturm, Gisela; Lamina, Claudia; Haider, Florian; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; [Zitt, Emanuel; Lhotta, Karl; Neyer, Ulrich] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Lhotta, Karl; Neyer, Ulrich] Vorarlberg Inst Vasc Invest & Treatment VIVIT, Feldkirch, Austria	Medical University of Innsbruck	Sturm, G (corresponding author), Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria.	Florian.Kronenberg@i-med.ac.at	Lamina, Claudia/F-7608-2010; Zitt, Emanuel/ABE-1926-2020; Kronenberg, Florian/B-1736-2008	Lamina, Claudia/0000-0002-5398-5806; Zitt, Emanuel/0000-0001-6944-6041; Kronenberg, Florian/0000-0003-2229-1120	Hans Drexel; Austrian Heart Fund	Hans Drexel; Austrian Heart Fund	This study was supported by a grant from Hans Drexel to the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) and by a grant from the Austrian Heart Fund to Florian Kronenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari A, 2003, AM J KIDNEY DIS, V41, P523, DOI 10.1053/ajkd.2003.50114; Drechsler C, 2009, CIRCULATION, V120, P2421, DOI 10.1161/CIRCULATIONAHA.109.857268; Fukuoka K, 2008, NEPHROLOGY, V13, P278, DOI 10.1111/j.1440-1797.2007.00864.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gouya G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017803; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ishimura E, 2009, DIABETES RES CLIN PR, V83, P320, DOI 10.1016/j.diabres.2008.11.038; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; Kovesdy CP, 2008, AM J KIDNEY DIS, V52, P766, DOI 10.1053/j.ajkd.2008.04.011; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; McMurray SD, 2002, AM J KIDNEY DIS, V40, P566, DOI 10.1053/ajkd.2002.34915; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; Okada T, 2007, INTERNAL MED, V46, P807, DOI 10.2169/internalmedicine.46.6355; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shima K, 2010, NEPHROLOGY, V15, P632, DOI 10.1111/j.1440-1797.2010.01273.x; Shurraw S, 2010, AM J KIDNEY DIS, V55, P875, DOI 10.1053/j.ajkd.2009.12.038; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Tsujimoto Y, 2009, THER APHER DIAL, V13, P358, DOI 10.1111/j.1744-9987.2009.00691.x; Williams ME, 2009, AM J NEPHROL, V29, P54, DOI 10.1159/000151276; Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789; Wu MS, 1997, NEPHROL DIAL TRANSPL, V12, P2105, DOI 10.1093/ndt/12.10.2105	23	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20093	10.1371/journal.pone.0020093	http://dx.doi.org/10.1371/journal.pone.0020093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625600	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200061
J	Xue, JH; Chen, LH; Zhao, HZ; Pu, YD; Feng, HZ; Ma, YG; Ma, J; Chang, YM; Zhang, ZM; Xie, MJ				Xue, Jun-Hui; Chen, Lian-Hong; Zhao, Hua-Zhou; Pu, Yong-Dong; Feng, Han-Zhong; Ma, Yu-Guang; Ma, Jin; Chang, Yao-Ming; Zhang, Zuo-Ming; Xie, Man-Jiang			Differential Regulation and Recovery of Intracellular Ca2+ in Cerebral and Small Mesenteric Arterial Smooth Muscle Cells of Simulated Microgravity Rat	PLOS ONE			English	Article							ION CHANNELS; ACTIVATION; SPACEFLIGHT; ADAPTATION; K+	Background: The differential adaptations of cerebrovasculature and small mesenteric arteries could be one of critical factors in postspaceflight orthostatic intolerance, but the cellular mechanisms remain unknown. We hypothesize that there is a differential regulation of intracellular Ca2+ determined by the alterations in the functions of plasma membrane Ca-L channels and ryanodine-sensitive Ca2+ releases from sarcoplasmic reticulum (SR) in cerebral and small mesenteric vascular smooth muscle cells (VSMCs) of simulated microgravity rats, respectively. Methodology/Principal Findings: Sprague-Dawley rats were subjected to 28-day hindlimb unweighting to simulate microgravity. In addition, tail-suspended rats were submitted to a recovery period of 3 or 7 days after removal of suspension. The function of Ca-L channels was evaluated by patch clamp and Western blotting. The function of ryanodine-sensitive Ca2+ releases in response to caffeine were assessed by a laser confocal microscope. Our results indicated that simulated microgravity increased the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases in cerebral VSMCs, whereas, simulated microgravity decreased the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases in small mesenteric VSMCs. In addition, 3- or 7-day recovery after removal of suspension could restore the functions of Ca-L channels and ryanodine-sensitive Ca2+ releases to their control levels in cerebral and small mesenteric VSMCs, respectively. Conclusions: The differential regulation of Ca-L channels and ryanodine-sensitive Ca2+ releases in cerebral and small mesenteric VSMCs may be responsible for the differential regulation of intracellular Ca2+, which leads to the altered autoregulation of cerebral vasculature and the inability to adequately elevate peripheral vascular resistance in postspaceflight orthostatic intolerance.	[Xue, Jun-Hui; Chang, Yao-Ming; Zhang, Zuo-Ming] Fourth Mil Med Univ, Dept Aerosp Clin Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China; [Chen, Lian-Hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Chest Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Zhao, Hua-Zhou; Pu, Yong-Dong] Gen Hosp PLA, Clin Div 309, Dept Gen Surg, Beijing, Peoples R China; [Feng, Han-Zhong; Ma, Yu-Guang; Ma, Jin; Chang, Yao-Ming; Xie, Man-Jiang] Fourth Mil Med Univ, Dept Aerosp Physiol, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University	Xue, JH (corresponding author), Fourth Mil Med Univ, Dept Aerosp Clin Med, Key Lab Aerosp Med, Minist Educ, Xian 710032, Shaanxi Provinc, Peoples R China.	xuejunhui@fmmu.edu.cn; manjiangxie@hotmail.com			National Natural Science Foundation of China [30800545, 30900283, 31070768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30800545, 30900283 and 31070768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist GC, 1996, MED SCI SPORT EXER, V28, pS9; Brini M, 2004, BIOCHEM BIOPH RES CO, V322, P1245, DOI 10.1016/j.bbrc.2004.08.029; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Chalmers S, 2007, CELL CALCIUM, V42, P447, DOI 10.1016/j.ceca.2007.05.010; CHANG H, 2010, J CELL PHYSL; Colleran PN, 2008, AM J PHYSIOL-REG I, V294, pR1577, DOI 10.1152/ajpregu.00084.2008; Dong L, 2009, CLIN EXP PHARMACOL P, V36, pe57, DOI 10.1111/j.1440-1681.2009.05222.x; Essin K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/135249; Fu ZJ, 2004, AM J PHYSIOL-HEART C, V287, pH1505, DOI 10.1152/ajpheart.00143.2004; GAZENKO OG, 1981, ACTA ASTRONAUT, V8, P907, DOI 10.1016/0094-5765(81)90061-8; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Li XQ, 2009, PFLUG ARCH EUR J PHY, V457, P771, DOI 10.1007/s00424-008-0556-8; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Ma YG, 2010, APOPTOSIS, V15, P426, DOI 10.1007/s10495-009-0423-x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Peng HL, 2010, PFLUG ARCH EUR J PHY, V460, P791, DOI 10.1007/s00424-010-0850-0; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; Rainbow RD, 2009, CELL CALCIUM, V46, P313, DOI 10.1016/j.ceca.2009.09.001; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Wilkerson MK, 1999, J APPL PHYSIOL, V87, P2115, DOI 10.1152/jappl.1999.87.6.2115; Wray S, 2005, CELL CALCIUM, V38, P397, DOI 10.1016/j.ceca.2005.06.018; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Xue JH, 2007, AM J PHYSIOL-HEART C, V293, pH691, DOI 10.1152/ajpheart.01229.2006; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhao O, 2007, SHOCK, V28, P717, DOI 10.1097/shk.0b013e318050c914	29	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19775	10.1371/journal.pone.0019775	http://dx.doi.org/10.1371/journal.pone.0019775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611118	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200031
J	Luikart, BW; Bensen, AL; Washburn, EK; Perederiy, JV; Su, KG; Li, Y; Kernie, SG; Parada, LF; Westbrook, GL				Luikart, Bryan W.; Bensen, AeSoon L.; Washburn, Eric K.; Perederiy, Julia V.; Su, Kimmy G.; Li, Yun; Kernie, Steven G.; Parada, Luis F.; Westbrook, Gary L.			miR-132 Mediates the Integration of Newborn Neurons into the Adult Dentate Gyrus	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; REGULATED MICRORNA; GRANULE CELLS; EXPRESSION; TRANSCRIPTION; MATURATION; PLASTICITY; MECHANISMS; PROTEINS	Neuronal activity enhances the elaboration of newborn neurons as they integrate into the synaptic circuitry of the adult brain. The role microRNAs play in the transduction of neuronal activity into growth and synapse formation is largely unknown. MicroRNAs can influence the expression of hundreds of genes and thus could regulate gene assemblies during processes like activity-dependent integration. Here, we developed viral-based methods for the in vivo detection and manipulation of the activity-dependent microRNA, miR-132, in the mouse hippocampus. We find, using lentiviral and retroviral reporters of miR-132 activity, that miR-132 is expressed at the right place and right time to influence the integration of newborn neurons. Retroviral knockdown of miR-132 using a specific 'sponge' containing multiple target sequences impaired the integration of newborn neurons into the excitatory synaptic circuitry of the adult brain. To assess potential miR-132 targets, we used a whole-genome microarray in PC12 cells, which have been used as a model of neuronal differentiation. miR-132 knockdown in PC12 cells resulted in the increased expression of hundreds of genes. Functional grouping indicated that genes involved in inflammatory/immune signaling were the most enriched class of genes induced by miR-132 knockdown. The correlation of miR-132 knockdown to increased proinflammatory molecular expression may indicate a mechanistic link whereby miR-132 functions as an endogenous mediator of activity-dependent integration in vivo.	[Luikart, Bryan W.; Bensen, AeSoon L.; Washburn, Eric K.; Perederiy, Julia V.; Su, Kimmy G.; Westbrook, Gary L.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Li, Yun; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Li, Yun; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Res Nerve Growth & Regenerat, Dallas, TX 75390 USA	Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luikart, BW (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	Bryan.W.Luikart@dartmouth.edu	Luikart, Bryan/D-2683-2012; Li, Yun/C-3367-2011; Kernie, Steven/AAT-9912-2020; Parada, luis F/B-9400-2014	Li, Yun/0000-0002-5849-5910; Kernie, Steven/0000-0003-1371-0549	Vertex pharmaceuticals [T32NS007381, F32MH079548, MH46613]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046613, F32MH079548, R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007381, P30NS061800] Funding Source: NIH RePORTER	Vertex pharmaceuticals(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by T32NS007381, F32MH079548, a National Alliance for Research on Schizophrenia and Depression Young Investigator Award (BWL), MH46613 (GLW), and an Oregon Health & Science University sponsored research project grant from Vertex pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gorski JA, 2003, J NEUROSCI, V23, P6856; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee B, 2007, NEUROBIOL DIS, V25, P80, DOI 10.1016/j.nbd.2006.08.015; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Tovar KR, 1999, J NEUROSCI, V19, P4180; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vereyken EJF, 2007, EUR J NEUROSCI, V25, P3605, DOI 10.1111/j.1460-9568.2007.05615.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	118	120	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19077	10.1371/journal.pone.0019077	http://dx.doi.org/10.1371/journal.pone.0019077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611182	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500003
J	Ozaki, TJ				Ozaki, Takashi J.			Frontal-to-Parietal Top-Down Causal Streams along the Dorsal Attention Network Exclusively Mediate Voluntary Orienting of Attention	PLOS ONE			English	Article							GRANGER CAUSALITY; NEURAL MECHANISMS; VISUAL-CORTEX; EYE-MOVEMENTS; HUMAN BRAIN; MONKEYS; FMRI; REPRESENTATION; CONNECTIVITY; MICROSTIMULATION	Previous effective connectivity analyses of functional magnetic resonance imaging (fMRI) have revealed dynamic causal streams along the dorsal attention network (DAN) during voluntary attentional control in the human brain. During resting state, however, fMRI has shown that the DAN is also intrinsically configured by functional connectivity, even in the absence of explicit task demands, and that may conflict with effective connectivity studies. To resolve this contradiction, we performed an effective connectivity analysis based on partial Granger causality (pGC) on event-related fMRI data during Posner's cueing paradigm while optimizing experimental and imaging parameters for pGC analysis. Analysis by pGC can factor out exogenous or latent influences due to unmeasured variables. Typical regions along the DAN with greater activation during orienting than withholding of attention were selected as regions of interest (ROIs). pGC analysis on fMRI data from the ROIs showed that frontal-to-parietal top-down causal streams along the DAN appeared during (voluntary) orienting, but not during other, less-attentive and/or resting-like conditions. These results demonstrate that these causal streams along the DAN exclusively mediate voluntary covert orienting. These findings suggest that neural representations of attention in frontal regions are at the top of the hierarchy of the DAN for embodying voluntary attentional control.	[Ozaki, Takashi J.] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Ozaki, Takashi J.] RIKEN Brain Sci Inst, Lab Dynam Emergent Intelligence, Wako, Saitama, Japan	University of Tokyo; RIKEN	Ozaki, TJ (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	ozt@fechner.c.u-tokyo.ac.jp			MEXT [22700281]; Ogawa Laboratories for Brain Function Research (Hamano Life Science Research Foundation)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ogawa Laboratories for Brain Function Research (Hamano Life Science Research Foundation)	This work was supported by a MEXT Grant-in-Aid for Young Scientists (B) (22700281) and Ogawa Laboratories for Brain Function Research (Hamano Life Science Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BRESSLER SL, 2010, WIENER GRANGER CAUSA; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DAUNIZEAU J, 2009, NEUROIMAGE; DAVID O, 2009, NEUROIMAGE; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; de Graaf TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008307; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Edin F, 2010, NEUROIMAGE, V49, P621, DOI 10.1016/j.neuroimage.2009.07.007; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FRISTON K, 2009, NEUROIMAGE; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GOTTLIEB J, 2010, TRENDS COGN IN PRESS; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Gregoriou GG, 2009, PROG BRAIN RES, V176, P35, DOI 10.1016/S0079-6123(09)17603-3; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Iba M, 2003, J NEUROPHYSIOL, V89, P587, DOI 10.1152/jn.00148.2002; JONIDES J, 1984, PSYCHOL BULL, V96, P29, DOI 10.1037/0033-2909.96.1.29; Kagan I, 2010, P NATL ACAD SCI USA, V107, P7933, DOI 10.1073/pnas.1002825107; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Leh SE, 2006, BRAIN, V129, P1822, DOI 10.1093/brain/awl111; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ozaki TJ, 2009, NEUROREPORT, V20, P1371, DOI 10.1097/WNR.0b013e3283313ef3; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Sawaguchi T, 2001, J NEUROPHYSIOL, V86, P2041, DOI 10.1152/jn.2001.86.4.2041; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Talairach J, 1988, CO PLANAR STEREOTAXI; Tamietto M, 2010, J COGNITIVE NEUROSCI, V22, P888, DOI 10.1162/jocn.2009.21225; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; Westendorff S, 2010, J NEUROSCI, V30, P5426, DOI 10.1523/JNEUROSCI.4628-09.2010; Wright R.D, 2008, ORIENTING ATTENTION; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3; [No title captured]	68	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20079	10.1371/journal.pone.0020079	http://dx.doi.org/10.1371/journal.pone.0020079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611155	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500040
J	Racz, E; Kurek, D; Kant, M; Baerveldt, EM; Florencia, E; Mourits, S; de Ridder, D; Laman, JD; van der Fits, L; Prens, EP				Racz, Emoke; Kurek, Dorota; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; de Ridder, Dick; Laman, Jon D.; van der Fits, Leslie; Prens, Errol P.			GATA3 Expression Is Decreased in Psoriasis and during Epidermal Regeneration; Induction by Narrow-Band UVB and IL-4	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; OLIGONUCLEOTIDE ARRAY; GENE-EXPRESSION; T-CELL; HUMAN KERATINOCYTES; SKIN; INFLAMMATION; PROLIFERATION; NORMALIZATION; DISRUPTION	Psoriasis is characterized by hyperproliferation of keratinocytes and by infiltration of activated Th1 and Th17 cells in the (epi) dermis. By expression microarray, we previously found the GATA3 transcription factor significantly downregulated in lesional psoriatic skin. Since GATA3 serves as a key switch in both epidermal and T helper cell differentiation, we investigated its function in psoriasis. Because psoriatic skin inflammation shares many characteristics of epidermal regeneration during wound healing, we also studied GATA3 expression under such conditions. Psoriatic lesional skin showed decreased GATA3 mRNA and protein expression compared to non-lesional skin. GATA3 expression was also markedly decreased in inflamed skin of mice with a psoriasiform dermatitis induced with imiquimod. Tape-stripping of non-lesional skin of patients with psoriasis, a standardized psoriasis-triggering and skin regeneration-inducing technique, reduced the expression of GATA3. In wounded skin of mice, low GATA3 mRNA and protein expression was detected. Taken together, GATA3 expression is downregulated under regenerative and inflammatory hyperproliferative skin conditions. GATA3 expression could be re-induced by successful narrow-band UVB treatment of both human psoriasis and imiquimod-induced psoriasiform dermatitis in mice. The prototypic Th2 cytokine IL-4 was the only cytokine capable of inducing GATA3 in skin explants from healthy donors. Based on these findings we argue that GATA3 serves as a key regulator in psoriatic inflammation, keratinocyte hyperproliferation and skin barrier dysfunction.	[Racz, Emoke; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; van der Fits, Leslie; Prens, Errol P.] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Racz, Emoke; Kant, Marius; Baerveldt, Ewout M.; Florencia, Edwin; Mourits, Sabine; Laman, Jon D.; van der Fits, Leslie; Prens, Errol P.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Kurek, Dorota] Erasmus Univ, Dept Cell Biol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Racz, E (corresponding author), Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands.	e.prens@erasmusmc.nl	de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310; Florencia, Edwin/0000-0001-9005-4464; Racz, Emoke/0000-0001-5119-6451; Kurek, Dorota/0000-0002-7168-8944; Prens, Errol/0000-0002-8158-660X				Arshad SH, 2008, BRIT J DERMATOL, V158, P1315, DOI 10.1111/j.1365-2133.2008.08565.x; Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breternitz M, 2007, BRIT J DERMATOL, V156, P231, DOI 10.1111/j.1365-2133.2006.07632.x; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Companjen AR, 2001, ARCH DERMATOL RES, V293, P184, DOI 10.1007/s004030100219; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Ghadially R, 1996, J INVEST DERMATOL, V107, P558, DOI 10.1111/1523-1747.ep12582813; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guenova E, 2008, EUR J IMMUNOL, V38, P3138, DOI 10.1002/eji.200838463; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kurek D, 2007, DEVELOPMENT, V134, P261, DOI 10.1242/dev.02721; Loffler H, 2004, BRIT J DERMATOL, V151, P746, DOI 10.1111/j.1365-2133.2004.06084.x; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2006, J INVEST DERM SYMP P, V11, P16, DOI 10.1038/sj.jidsymp.5650010; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Prens E, 1996, AM J PATHOL, V148, P1493; Prens EP, 2008, J INVEST DERMATOL, V128, P932, DOI 10.1038/sj.jid.5701087; Racz E, 2011, J INVEST DERMATOL; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Schuff M, 2007, DEV DYNAM, V236, P226, DOI 10.1002/dvdy.21007; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Son DN, 2009, GENE, V436, P121, DOI 10.1016/j.gene.2009.02.002; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Tschachler E, 2007, CLIN DERMATOL, V25, P589, DOI 10.1016/j.clindermatol.2007.09.021; van der Fits L, 2003, J PATHOL, V199, P107, DOI 10.1002/path.1263; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van der Wees J, 2004, NEUROBIOL DIS, V16, P169, DOI 10.1016/j.nbd.2004.02.004; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	49	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19806	10.1371/journal.pone.0019806	http://dx.doi.org/10.1371/journal.pone.0019806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611195	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500023
J	Carmona, D; Rodriguez-Almazan, C; Munoz-Garay, C; Portugal, L; Perez, C; de Maagd, RA; Bakker, P; Soberon, M; Bravo, A				Carmona, Daniela; Rodriguez-Almazan, Claudia; Munoz-Garay, Carlos; Portugal, Leivi; Perez, Claudia; de Maagd, Ruud A.; Bakker, Petra; Soberon, Mario; Bravo, Alejandra			Dominant Negative Phenotype of Bacillus thuringiensis Cry1Ab, Cry11Aa and Cry4Ba Mutants Suggest Hetero-Oligomer Formation among Different Cry Toxins	PLOS ONE			English	Article							SUBSP ISRAELENSIS; DELTA-ENDOTOXIN; MANDUCA-SEXTA; ALKALINE-PHOSPHATASE; PROTECTIVE ANTIGEN; MOSQUITO; CRYSTAL; AMINOPEPTIDASE; EXPRESSION; COMPONENTS	Background: Bacillus thuringiensis Cry toxins are used worldwide in the control of different insect pests important in agriculture or in human health. The Cry proteins are pore-forming toxins that affect the midgut cell of target insects. It was shown that non-toxic Cry1Ab helix alpha-4 mutants had a dominant negative (DN) phenotype inhibiting the toxicity of wildtype Cry1Ab when used in equimolar or sub-stoichiometric ratios (1:1, 0.5:1, mutant:wt) indicating that oligomer formation is a key step in toxicity of Cry toxins. Methodology/Principal Findings: The DN Cry1Ab-D136N/T143D mutant that is able to block toxicity of Cry1Ab toxin, was used to analyze its capacity to block the activity against Manduca sexta larvae of other Cry1 toxins, such as Cry1Aa, Cry1Ac, Cry1Ca, Cry1Da, Cry1Ea and Cry1Fa. Cry1Ab-DN mutant inhibited toxicity of Cry1Aa, Cry1Ac and Cry1Fa. In addition, we isolated mutants in helix alpha-4 of Cry4Ba and Cry11Aa, and demonstrate that Cry4Ba-E159K and Cry11Aa-V142D are inactive and completely block the toxicity against Aedes aegypti of both wildtype toxins, when used at sub-stoichiometric ratios, confirming a DN phenotype. As controls we analyzed Cry1Ab-R99A or Cry11Aa-E97A mutants that are located in helix alpha-3 and are affected in toxin oligomerization. These mutants do not show a DN phenotype but were able to block toxicity when used in 10:1 or 100:1 ratios (mutant: wt) probably by competition of binding with toxin receptors. Conclusions/Significance: We show that DN phenotype can be observed among different Cry toxins suggesting that may interact in vivo forming hetero-oligomers. The DN phenotype cannot be observed in mutants affected in oligomerization, suggesting that this step is important to inhibit toxicity of other toxins.	[Carmona, Daniela; Rodriguez-Almazan, Claudia; Munoz-Garay, Carlos; Portugal, Leivi; Perez, Claudia; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [de Maagd, Ruud A.; Bakker, Petra] Plant Res Int, Biosci, Wageningen, Netherlands	Universidad Nacional Autonoma de Mexico	Carmona, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico.	bravo@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017; de Maagd, Ruud A/A-5859-2012	de Maagd, Ruud A/0000-0001-7049-2029; Bakker, Petra/0000-0001-7019-0258; Munoz-Garay, Carlos/0000-0002-7218-4027; Bravo, Alejandra/0000-0002-7573-7475	CONACyT [024967, 224926]; DGAPA-UNAM [IN206209]; National Institutes of Health [1R01 AI066014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CONACyT 024967, 224926 (www.conacyt.mx); DGAPA-UNAM IN206209 (http://dgapa.unam.mx/); and National Institutes of Health, 1R01 AI066014 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Mohd Amir F., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-16; Angsuthanasombat C, 2001, J BIOCHEM MOL BIOL, V34, P402; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bravo A., 2005, BACILLUS THURINGIENS, P175, DOI DOI 10.1016/B0-44-451924-6/00081-8; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; CRICKMORE N, 1995, FEMS MICROBIOL LETT, V131, P249; DELECLUSE A, 1993, APPL ENVIRON MICROB, V59, P3922; Canton PE, 2011, PEPTIDES, V32, P595, DOI 10.1016/j.peptides.2010.06.005; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Hernandez-Soto A, 2009, APPL ENVIRON MICROB, V75, P4661, DOI 10.1128/AEM.00409-09; HOFTE H, 1986, EUR J BIOCHEM, V161, P273, DOI 10.1111/j.1432-1033.1986.tb10443.x; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Lee MK, 1996, APPL ENVIRON MICROB, V62, P583, DOI 10.1128/AEM.62.2.583-586.1996; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Munoz-Garay C, 2009, APPL ENVIRON MICROB, V75, P7548, DOI 10.1128/AEM.01303-09; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; PONCET S, 1995, J INVERTEBR PATHOL, V66, P131, DOI 10.1006/jipa.1995.1075; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sharma P, 2010, LETT APPL MICROBIOL, V51, P42, DOI 10.1111/j.1472-765X.2010.02856.x; Siebert MW, 2008, J ECON ENTOMOL, V101, P1950, DOI 10.1603/0022-0493-101.6.1950; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Sramala I., 2001, J BIOCH MOL BIOL BIO, V5, P219; Taveecharoenkool T., 2010, PMC BIOPHYS, V3, P1; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; THOMAS WE, 1983, J CELL SCI, V60, P181; Vachon V, 2002, BIOCHEMISTRY-US, V41, P6178, DOI 10.1021/bi011572e; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Zhang R, 2008, BIOCHEMISTRY-US, V47, P11263, DOI 10.1021/bi801181g	37	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19952	10.1371/journal.pone.0019952	http://dx.doi.org/10.1371/journal.pone.0019952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603577	Green Published, gold			2022-12-27	WOS:000290656300043
J	Lefeuvre, P; Harkins, GW; Lett, JM; Briddon, RW; Chase, MW; Moury, B; Martin, DP				Lefeuvre, Pierre; Harkins, Gordon W.; Lett, Jean-Michel; Briddon, Rob W.; Chase, Mark W.; Moury, Benoit; Martin, Darren P.			Evolutionary Time-Scale of the Begomoviruses: Evidence from Integrated Sequences in the Nicotiana Genome	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; PHYLOGENETIC EVIDENCE; MOLECULAR EVOLUTION; VIRUS EVOLUTION; GEMINIVIRAL DNA; RATES; ORIGIN; PATTERNS; RECOMBINATION; ENDOSYMBIONTS	Despite having single stranded DNA genomes that are replicated by host DNA polymerases, viruses in the family Geminiviridae are apparently evolving as rapidly as some RNA viruses. The observed substitution rates of geminiviruses in the genera Begomovirus and Mastrevirus are so high that the entire family could conceivably have originated less than a million years ago (MYA). However, the existence of geminivirus related DNA (GRD) integrated within the genomes of various Nicotiana species suggests that the geminiviruses probably originated > 10 MYA. Some have even suggested that a distinct New-World (NW) lineage of begomoviruses may have arisen following the separation by continental drift of African and American proto-begomoviruses similar to 110 MYA. We evaluate these various geminivirus origin hypotheses using Bayesian coalescent-based approaches to date firstly the Nicotiana GRD integration events, and then the divergence of the NW and Old-World (OW) begomoviruses. Besides rejecting the possibility of a<2 MYA OW-NW begomovirus split, we could also discount that it may have occurred concomitantly with the breakup of Gondwanaland 110 MYA. Although we could only confidently narrow the date of the split down to between 2 and 80 MYA, the most plausible (and best supported) date for the split is between 20 and 30 MYA - a time when global cooling ended the dispersal of temperate species between Asia and North America via the Beringian land bridge.	[Lefeuvre, Pierre; Lett, Jean-Michel] Univ Reunion, CIRAD, UMR PVBMT CIRAD 53, St Pierre, Reunion, France; [Harkins, Gordon W.] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Briddon, Rob W.] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, England; [Moury, Benoit] INRA, Pathol Vegetale UR407, Montfavet, France; [Lefeuvre, Pierre; Martin, Darren P.] Univ Cape Town, Computat Biol Grp, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	CIRAD; University of La Reunion; South African National Biodiversity Institute; University of the Western Cape; Pakistan Institute of Engineering & Applied Science; Royal Botanic Gardens, Kew; INRAE; University of Cape Town	Lefeuvre, P (corresponding author), Univ Reunion, CIRAD, UMR PVBMT CIRAD 53, St Pierre, Reunion, France.	pierre.lefeuvre@cirad.fr	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008; Chase, Mark W/A-6642-2011; Briddon, Rob W./I-5921-2012	Briddon, Rob W./0000-0001-8738-0365; Lefeuvre, Pierre/0000-0003-2645-8098; LETT, Jean-Michel/0000-0003-1585-5338; harkins, gordon w/0000-0003-0041-8047	GIS CRVOI [PRAO/AIRD/CRVOI/08/03]; CIRAD; European Union; Wellcome Trust; South African National Research Foundation; Higher Education Commission, Government of Pakistan; Royal Botanic Gardens, Kew; GIS CRVOI [PRAO/AIRD/CRVOI/08/03]; CIRAD; European Union; Wellcome Trust; South African National Research Foundation; Higher Education Commission, Government of Pakistan; Royal Botanic Gardens, Kew	GIS CRVOI; CIRAD; European Union(European Commission); Wellcome Trust(Wellcome Trust); South African National Research Foundation(National Research Foundation - South Africa); Higher Education Commission, Government of Pakistan(Higher Education Commission of Pakistan); Royal Botanic Gardens, Kew; GIS CRVOI; CIRAD; European Union(European Commission); Wellcome Trust(Wellcome Trust); South African National Research Foundation(National Research Foundation - South Africa); Higher Education Commission, Government of Pakistan(Higher Education Commission of Pakistan); Royal Botanic Gardens, Kew	PL is funded by GIS CRVOI through the EmerGe grant (N<SUP>o</SUP>PRAO/AIRD/CRVOI/08/03). JML was funded by CIRAD and European Union (FEDER). DPM is funded by the Wellcome Trust. GWH is supported by a grant from the South African National Research Foundation. RWB is supported by the Higher Education Commission, Government of Pakistan, under the "Foreign Faculty Hiring Program". MWC is funded by the Royal Botanic Gardens, Kew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MK, 1997, PLANT MOL BIOL, V35, P313, DOI 10.1023/A:1005885200550; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bejarano ER, 1996, P NATL ACAD SCI USA, V93, P759, DOI 10.1073/pnas.93.2.759; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Fargette D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000125; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Gilbert C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000425; Grasso C, 2004, BIOINFORMATICS, V20, P1546, DOI 10.1093/bioinformatics/bth126; Ha C, 2006, J GEN VIROL, V87, P997, DOI 10.1099/vir.0.81631-0; Harkins GW, 2009, J GEN VIROL, V90, P3066, DOI 10.1099/vir.0.015537-0; Harkins GW, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-104; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isnard M, 1998, J GEN VIROL, V79, P3091, DOI 10.1099/0022-1317-79-12-3091; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; Krupovic M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-112; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; LEMEY P, 2009, PLOS CURR INFLUENZA; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Owor BE, 2007, J GEN VIROL, V88, P3154, DOI 10.1099/vir.0.83144-0; Pagan I, 2010, J MOL EVOL, V71, P298, DOI 10.1007/s00239-010-9385-4; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Polani S, 2010, VIROLOGY, V405, P397, DOI 10.1016/j.virol.2010.06.010; Posada D, 2001, MOL BIOL EVOL, V18, P1976, DOI 10.1093/oxfordjournals.molbev.a003738; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; RYBICKI EP, 1994, ARCH VIROL, V139, P49, DOI 10.1007/BF01309454; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Walt E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-104; Wu BL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-335	57	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19193	10.1371/journal.pone.0019193	http://dx.doi.org/10.1371/journal.pone.0019193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603653	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300002
J	Wang, QD; Zhou, YN; Weiss, HL; Chow, CW; Evers, BM				Wang, Qingding; Zhou, Yuning; Weiss, Heidi L.; Chow, Chi-Wing; Evers, B. Mark			NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INFLAMMATORY-BOWEL-DISEASE; ACTIVATED T-CELLS; GLYCOGEN-SYNTHASE KINASE-3; COLON-CANCER CELLS; NUCLEAR-FACTOR; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR; REPRESS TRANSCRIPTION; EPITHELIAL-CELLS	TNF-related apoptosis-inducing ligand (TRAIL; Apo2) has been shown to promote intestinal cell differentiation. Nuclear factor of activated T cells (NFAT) participates in the regulation of a variety of cellular processes, including differentiation. Here, we examined the role of NFAT in the regulation of TRAIL in human intestinal cells. Treatment with a combination of phorbol 12-myristate 13-acetate (PMA) plus the calcium ionophore A23187 (Io) increased NFAT activation and TRAIL expression; pretreatment with the calcineurin inhibitor cyclosporine A (CsA), an antagonist of NFAT signaling, diminished NFAT activation and TRAIL induction. In addition, knockdown of NFATc1, NFATc2, NFATc3, and NFATc4 blocked PMA/Io increased TRAIL protein expression. Expression of NFATc1 activated TRAIL promoter activity and increased TRAIL mRNA and protein expression. Deletion of NFAT binding sites from the TRAIL promoter did not significantly abrogate NFATc1-increased TRAIL promoter activity, suggesting an indirect regulation of TRAIL expression by NFAT activation. Knockdown of NFATc1 increased Sp1 transcription factor binding to the TRAIL promoter and, importantly, inhibition of Sp1, by chemical inhibition or RNA interference, increased TRAIL expression. These studies identify a novel mechanism for TRAIL regulation by which activation of NFATc1 increases TRAIL expression through negative regulation of Sp1 binding to the TRAIL promoter.	[Wang, Qingding; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Wang, Qingding; Zhou, Yuning; Weiss, Heidi L.; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	University of Kentucky; University of Kentucky; Yeshiva University; Albert Einstein College of Medicine	Wang, QD (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40506 USA.	mark.evers@uky.edu			National Institutes of Health [R01 DK048498, P20CA150343]; NATIONAL CANCER INSTITUTE [P20CA150343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481, R01DK048498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01 DK048498 and P20CA150343 (UK GI SPORE) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Chai WR, 2007, ASIAN J ANDROL, V9, P623, DOI 10.1111/j.1745-7262.2007.00257.x; Chai WR, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-31; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cho YS, 2010, IMMUNOLOGY, V130, P504, DOI 10.1111/j.1365-2567.2010.03266.x; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; EVERS BM, 1995, MOL CELL BIOL, V15, P3870; Feng DX, 2005, P NATL ACAD SCI USA, V102, P9896, DOI 10.1073/pnas.0502041102; Garcia A, 2000, J BIOL CHEM, V275, P9385, DOI 10.1074/jbc.275.13.9385; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kang-Park S, 2003, FEBS LETT, V545, P203, DOI 10.1016/S0014-5793(03)00535-0; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; POTTEN CS, 1997, AM J PHYSIOL, V273, P253; Rankin SL, 2009, BIOCHEM BIOPH RES CO, V379, P721, DOI 10.1016/j.bbrc.2008.12.075; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Shih TC, 2008, WORLD J GASTROENTERO, V14, P1759, DOI 10.3748/wjg.14.1759; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Souza HSP, 2005, INT J COLORECTAL DIS, V20, P277, DOI 10.1007/s00384-004-0639-8; Sternthal MB, 2008, AM J GASTROENTEROL, V103, P937, DOI 10.1111/j.1572-0241.2007.01718.x; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; TRABER PG, 1994, J LAB CLIN MED, V123, P467; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang Q, 2008, CELL DEATH DIFFER, V15, P908, DOI 10.1038/cdd.2008.2; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang QD, 2000, BIOCHEM BIOPH RES CO, V276, P466, DOI 10.1006/bbrc.2000.3512; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Wang QD, 2007, CANCER RES, V67, P7773, DOI 10.1158/0008-5472.CAN-07-0187; Wang XF, 2010, MOL CANCER THER, V9, P2389, DOI 10.1158/1535-7163.MCT-09-1080; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Xu J, 2008, CANCER RES, V68, P6718, DOI 10.1158/0008-5472.CAN-08-0657; Xu J, 2007, CANCER RES, V67, P1203, DOI 10.1158/0008-5472.CAN-06-2310; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19882	10.1371/journal.pone.0019882	http://dx.doi.org/10.1371/journal.pone.0019882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603612	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300034
J	Coelho, FC; Codeco, CT; Gomes, MGM				Coelho, Flavio Codeco; Codeco, Claudia Torres; Gomes, M. Gabriela M.			A Bayesian Framework for Parameter Estimation in Dynamical Models	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; INFECTIOUS-DISEASES; SEASONAL INFLUENZA; INFERENCE; BIOLOGY; SYSTEMS	Mathematical models in biology are powerful tools for the study and exploration of complex dynamics. Nevertheless, bringing theoretical results to an agreement with experimental observations involves acknowledging a great deal of uncertainty intrinsic to our theoretical representation of a real system. Proper handling of such uncertainties is key to the successful usage of models to predict experimental or field observations. This problem has been addressed over the years by many tools for model calibration and parameter estimation. In this article we present a general framework for uncertainty analysis and parameter estimation that is designed to handle uncertainties associated with the modeling of dynamic biological systems while remaining agnostic as to the type of model used. We apply the framework to fit an SIR-like influenza transmission model to 7 years of incidence data in three European countries: Belgium, the Netherlands and Portugal.	[Coelho, Flavio Codeco; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Coelho, Flavio Codeco] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, Brazil; [Codeco, Claudia Torres] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, Brazil	Instituto Gulbenkian de Ciencia; Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Fundacao Oswaldo Cruz	Coelho, FC (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	fccoelho@fgv.br	Gomes, Gabriela/H-7218-2014; Coelho, Flavio Codeço/L-1089-2018; Coelho, Flavio/L-1089-2018	Gomes, Gabriela/0000-0002-1454-4979; Coelho, Flavio Codeço/0000-0003-0635-8989; Coelho, Flavio/0000-0003-3868-4391	Fundacao para a Ciencia e a Tecnologia (FCT); European Commission [MEXT-CT-2004-14338, EC-ICT-231807]; Brazilian Research Council (CNPq)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), the European Commission (grants MEXT-CT-2004-14338 and EC-ICT-231807), and the Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 2003, IEEE T, V19, P23716; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDRIEU C, 2008, STAT COMPUT, V18, P43373; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Calderhead B., 2008, NEURAL INFORM PROCES, V22; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; COELHO FC, 2009, BAYESIAN FRAMEWORK P; COELHO FC, 2009, BAYESIAN INFERENCE P; Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016; *ECDC, 2009, EUR IN SURV NETW; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; GOLIGHTLY A, 2006, J COMPUT BIOL, V13, P38851; GOLIGHTLY A, 2008, COMPUTATIONAL STAT D, V52, P41693; Gran JM, 2010, EPIDEMIOL INFECT, V138, P1559, DOI 10.1017/S0950268810000671; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LAU LL, 2010, VIRAL SHEDDING CLIN; LECCA P, 2009, EUROPEAN BIOPHYSICS, V39, P1019; Ness RB, 2007, ANN EPIDEMIOL, V17, P564, DOI 10.1016/j.annepidem.2006.10.014; Paterson B, 2009, SCIENCE, V325, P1071, DOI 10.1126/science.325_1071b; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Ramsay JO, 2007, J ROY STAT SOC B, V69, P741, DOI 10.1111/j.1467-9868.2007.00610.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SEVCIKOVA H, 2007, TRANSPORTATION RES B, V41, P52669; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STEIN WA, 2009, SAGE MATH SOFTWARE V; VANNOORT SP, 2011, ROLE WEATHER R UNPUB; Vrugt J.A., 2008, ACCELERATING MARKOV; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P1933, DOI 10.1093/bioinformatics/btn338	32	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19616	10.1371/journal.pone.0019616	http://dx.doi.org/10.1371/journal.pone.0019616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629684	Green Published, gold			2022-12-27	WOS:000291005800003
J	Kamgang, B; Brengues, C; Fontenille, D; Njiokou, F; Simard, F; Paupy, C				Kamgang, Basile; Brengues, Cecile; Fontenille, Didier; Njiokou, Flobert; Simard, Frederic; Paupy, Christophe			Genetic Structure of the Tiger Mosquito, Aedes albopictus, in Cameroon (Central Africa)	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHIKUNGUNYA-VIRUS; STATISTICAL TESTS; DIPTERA-CULICIDAE; F-STATISTICS; DENGUE; AEGYPTI; VECTOR; TIRES; DIFFERENTIATION	Background: Aedes albopictus (Skuse, 1884) (Diptera: Culicidae), a mosquito native to Asia, has recently invaded all five continents. In Central Africa it was first reported in the early 2000s, and has since been implicated in the emergence of arboviruses such as dengue and chikungunya in this region. Recent genetic studies of invasive species have shown that multiple introductions are a key factor for successful expansion in new areas. As a result, phenotypic characters such as vector competence and insecticide susceptibility may vary within invasive pest species, potentially affecting vector efficiency and pest management. Here we assessed the genetic variability and population genetics of Ae. albopictus isolates in Cameroon (Central Africa), thereby deducing their likely geographic origin. Methods and Results: Mosquitoes were sampled in 2007 in 12 localities in southern Cameroon and analyzed for polymorphism at six microsatellite loci and in two mitochondrial DNA regions (ND5 and COI). All the microsatellite markers were successfully amplified and were polymorphic, showing moderate genetic structureamong geographic populations (F-ST = 0.068, P<0.0001). Analysis of mtDNA sequences revealed four haplotypes each for the COI and ND5 genes, with a dominant haplotype shared by all Cameroonian samples. The weak genetic variation estimated from the mtDNA genes is consistent with the recent arrival of Ae. albopictus in Cameroon. Phylogeographic analysis based on COI polymorphism indicated that Ae. albopictus populations from Cameroon are related to tropical rather than temperate or subtropical outgroups. Conclusion: The moderate genetic diversity observed among Cameroonian Ae. albopictus isolates is in keeping with recent introduction and spread in this country. The genetic structure of natural populations points to multiple introductions from tropical regions.	[Kamgang, Basile; Brengues, Cecile; Fontenille, Didier; Simard, Frederic; Paupy, Christophe] IRD, CNRS IRD UM1 5290 224, Unite Mixte Rech MIVEGEC, Montpellier, France; [Kamgang, Basile] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Njiokou, Flobert] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Simard, Frederic] IRSS, Bobo Dioulasso, Burkina Faso; [Paupy, Christophe] CIRMF, Unite Rech Ecol Sante, Franceville, Gabon	Institut de Recherche pour le Developpement (IRD); University of Yaounde I	Kamgang, B (corresponding author), IRD, CNRS IRD UM1 5290 224, Unite Mixte Rech MIVEGEC, Montpellier, France.	christophe.paupy@ird.fr	Frederic, SIMARD/AFV-5001-2022; Kamgang, Basile/ABC-8345-2021; FONTENILLE, didier/G-4091-2013; Paupy, Christophe/I-4847-2017; SIMARD, Frederic/J-9489-2016	Frederic, SIMARD/0000-0002-2871-5329; Kamgang, Basile/0000-0002-8883-4557; Paupy, Christophe/0000-0002-7122-2079; SIMARD, Frederic/0000-0002-2871-5329; FONTENILLE, didier/0000-0002-0544-3885	French government (Agence Nationale pour la Recherche) [ANR 05 SEST 010-01]; Institut de Recherche pour le Developpement/Departement Soutien et Formation	French government (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); Institut de Recherche pour le Developpement/Departement Soutien et Formation	This research was supported by the French government (Agence Nationale pour la Recherche) through the Epidengue project (ANR 05 SEST 010-01). Basile Kamgang was supported by an Institut de Recherche pour le Developpement/Departement Soutien et Formation PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022; Belkhir K, 2004, 5000 CNRS UMR; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bonacum J., 2001, Drosophila Information Service, V84, P201; CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318; Gubler DJ, 2003, LANCET INFECT DIS, V3, P751, DOI 10.1016/S1473-3099(03)00826-0; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; HOLM S, 1979, SCAND J STAT, V6, P65; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Mas-Coma S, 2009, ACTA TROP, V110, P112, DOI 10.1016/j.actatropica.2008.10.013; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M, 1983, EVOLUTION GENES PROT; Nylander J, 2004, MRMODELTEST V2 EVOLU; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Smith CEG, 1956, J TROP MED HYG, V59, P3; TAJIMA F, 1989, GENETICS, V123, P597; TESH RB, 1976, AM J TROP MED HYG, V33, P176; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009	58	60	67	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20257	10.1371/journal.pone.0020257	http://dx.doi.org/10.1371/journal.pone.0020257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629655	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800037
J	McHenry, AM; Barnes, SJ; Ntumngia, FB; King, CL; Adams, JH				McHenry, Amy M.; Barnes, Samantha J.; Ntumngia, Francis B.; King, Christopher L.; Adams, John H.			Determination of the Molecular Basis for a Limited Dimorphism, N417K, in the Plasmodium vivax Duffy-Binding Protein	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; INHIBITORY ANTIBODIES; LIGAND DOMAIN; SWISS-MODEL; MALARIA; INVASION; RECOGNITION; FALCIPARUM; RESISTANCE; RESIDUES	Invasion of human red blood cells by Plasmodium merozoites is vital for replication and survival of the parasite and, as such, is an attractive target for therapeutic intervention. Merozoite invasion is mediated by specific interactions between parasite ligands and host erythrocyte receptors. The P. vivax Duffy-binding protein (PvDBP) is heavily dependent on the interaction with the human Duffy blood group antigen/receptor for chemokines (DARC) for invasion. Region II of PvDBP contains many allelic polymorphisms likely to have arisen by host immune selection. Successful vaccine development necessitates a deeper understanding of the role of these polymorphisms in both parasite function and evasion of host immunity. A 3D structure of the homologous P. knowlesi DBP predicts that most variant residues are surface-exposed, including N417K, which is a dimorphic residue change that has previously been shown to be part of a linked haplotype that alters DBP sensitivity to inhibitory antibody. In natural isolates only two residues are found at this site, asparagine (N) and lysine (K). Site-directed mutagenesis of residue 417 was used to create a panel of 20 amino acid variants that were then examined for their binding phenotype and response to immune sera. Our results suggest that the observed dimorphism likely arose due to both structural requirements and immune selection pressure. To our knowledge, this is the first exhaustive examination of this kind of the role of a single amino acid residue in antigenic character and binding ability. Our results demonstrate that a single amino acid substitution can dramatically alter both the ability of the PvDBP to bind to human erythrocytes and its antigenic character.	[McHenry, Amy M.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [McHenry, Amy M.; Barnes, Samantha J.; Ntumngia, Francis B.; Adams, John H.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Barnes, Samantha J.] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL USA; [King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University of Notre Dame; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Case Western Reserve University	McHenry, AM (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Ntumngia, Francis/0000-0001-9867-3534	National Institutes of Health [R01 AI33656]; Veterans Affairs Research Service; Arthur J. Schmitt Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research Service(US Department of Veterans Affairs); Arthur J. Schmitt Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a National Institutes of Health Grant R01 AI33656 to J.H.A., Veterans Affairs Research Service Support to C.L.K. and an Arthur J. Schmitt Presidential Fellowship to A.M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ranjan A, 1999, P NATL ACAD SCI USA, V96, P14067, DOI 10.1073/pnas.96.24.14067; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh SK, 2003, BIOCHEM J, V374, P193, DOI 10.1042/BJ20030622; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; VanBuskirk KM, 2004, P NATL ACAD SCI USA, V101, P15754, DOI 10.1073/pnas.0405421101; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0	36	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20192	10.1371/journal.pone.0020192	http://dx.doi.org/10.1371/journal.pone.0020192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629662	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800033
J	Palomer, X; Alvarez-Guardia, D; Davidson, MM; Chan, TO; Feldman, AM; Vazquez-Carrera, M				Palomer, Xavier; Alvarez-Guardia, David; Davidson, Mercy M.; Chan, Tung O.; Feldman, Arthur M.; Vazquez-Carrera, Manuel			The Interplay between NF-kappaB and E2F1 Coordinately Regulates Inflammation and Metabolism in Human Cardiac Cells (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PYRUVATE-DEHYDROGENASE; HEART-FAILURE; CYCLE PROGRESSION; GLUCOSE-OXIDATION; DOWN-REGULATION; B ACTIVITY; TRANSCRIPTION; EXPRESSION; PGC-1-ALPHA; INHIBITION	Pyruvate dehydrogenase kinase 4 (PDK4) inhibition by nuclear factor-kappa B (NF-kappa B) is related to a shift towards increased glycolysis during cardiac pathological processes such as cardiac hypertrophy and heart failure. The transcription factors estrogen-related receptor-alpha (ERR alpha) and peroxisome proliferator-activated receptor (PPAR) regulate PDK4 expression through the potent transcriptional coactivator PPAR gamma coactivator-1 alpha (PGC-1 alpha). NF-kappa B activation in AC16 cardiac cells inhibit ERR alpha and PPAR beta/delta transcriptional activity, resulting in reduced PGC-1 alpha and PDK4 expression, and an enhanced glucose oxidation rate. However, addition of the NF-kappa B inhibitor parthenolide to these cells prevents the downregulation of PDK4 expression but not ERR alpha and PPAR beta/delta DNA binding activity, thus suggesting that additional transcription factors are regulating PDK4. Interestingly, a recent study has demonstrated that the transcription factor E2F1, which is crucial for cell cycle control, may regulate PDK4 expression. Given that NF-kappa B may antagonize the transcriptional activity of E2F1 in cardiac myocytes, we sought to study whether inflammatory processes driven by NF-kappa B can downregulate PDK4 expression in human cardiac AC16 cells through E2F1 inhibition. Protein coimmunoprecipitation indicated that PDK4 downregulation entailed enhanced physical interaction between the p65 subunit of NF-kappa B and E2F1. Chromatin immunoprecipitation analyses demonstrated that p65 translocation into the nucleus prevented the recruitment of E2F1 to the PDK4 promoter and its subsequent E2F1-dependent gene transcription. Interestingly, the NF-kappa B inhibitor parthenolide prevented the inhibition of E2F1, while E2F1 overexpression reduced interleukin expression in stimulated cardiac cells. Based on these findings, we propose that NF-kappa B acts as a molecular switch that regulates E2F1-dependent PDK4 gene transcription.	[Palomer, Xavier; Alvarez-Guardia, David; Vazquez-Carrera, Manuel] Univ Barcelona, Dept Pharmacol & Therapeut Chem, Fac Pharm, IBUB, Barcelona, Spain; [Palomer, Xavier; Alvarez-Guardia, David; Vazquez-Carrera, Manuel] Univ Barcelona, CIBERDEM, Fac Pharm, Barcelona, Spain; [Davidson, Mercy M.] Columbia Univ, Dept Radiat Oncol, New York, NY USA; [Chan, Tung O.; Feldman, Arthur M.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Columbia University; Jefferson University	Palomer, X (corresponding author), Univ Barcelona, Dept Pharmacol & Therapeut Chem, Fac Pharm, IBUB, Barcelona, Spain.	mvazquezcarrera@ub.edu	Vázquez-Carrera, Manuel/H-2612-2015; Tarridas, Xavier Palomer/H-1494-2015	Vázquez-Carrera, Manuel/0000-0001-7138-8207; Chan, Tung/0000-0001-6574-9555	Ministerio de Ciencia e Innovacion of the Spanish Government [SAF2006-01475, SAF2009-06939]	Ministerio de Ciencia e Innovacion of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Ministerio de Ciencia e Innovacion of the Spanish Government (SAF2006-01475 and SAF2009-06939). CIBERDEM is an Instituto de Salud Carlos III project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Bergman MR, 1999, AM J PHYSIOL-HEART C, V277, pH543, DOI 10.1152/ajpheart.1999.277.2.H543; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Darville MI, 1997, NUCLEIC ACIDS RES, V25, P2759, DOI 10.1093/nar/25.14.2759; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hlaing M, 2004, J BIOL CHEM, V279, P43625, DOI 10.1074/jbc.M408391200; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lydell CP, 2002, CARDIOVASC RES, V53, P841, DOI 10.1016/S0008-6363(01)00560-0; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shaw J, 2008, P NATL ACAD SCI USA, V105, P20734, DOI 10.1073/pnas.0807735105; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tu Z, 2006, J BIOL CHEM, V281, P6699, DOI 10.1074/jbc.M512439200; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	33	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19724	10.1371/journal.pone.0019724	http://dx.doi.org/10.1371/journal.pone.0019724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625432	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200010
J	Druzin, M; Malinina, E; Grimsholm, O; Johansson, S				Druzin, Michael; Malinina, Evgenya; Grimsholm, Ola; Johansson, Staffan			Mechanism of Estradiol-Induced Block of Voltage-Gated K+ Currents in Rat Medial Preoptic Neurons	PLOS ONE			English	Article							OPEN-CHANNEL BLOCK; POTASSIUM CHANNELS; ESTROGEN-RECEPTORS; STEROID-HORMONES; SEXUAL-BEHAVIOR; BRAIN; 17-BETA-ESTRADIOL; NUCLEUS; PREGNENOLONE; ANTIESTROGEN	The present study was conducted to characterize possible rapid effects of 17-beta-estradiol on voltage-gated K+ channels in preoptic neurons and, in particular, to identify the mechanisms by which 17-beta-estradiol affects the K+ channels. Whole-cell currents from dissociated rat preoptic neurons were studied by perforated-patch recording. 17-beta-estradiol rapidly (within seconds) and reversibly reduced the K+ currents, showing an EC50 value of 9.7 mu M. The effect was slightly voltage dependent, but independent of external Ca2+, and not sensitive to an estrogen-receptor blocker. Although 17-alpha-estradiol also significantly reduced the K+ currents, membrane-impermeant forms of estradiol did not reduce the K+ currents and other estrogens, testosterone and cholesterol were considerably less effective. The reduction induced by estradiol was overlapping with that of the K-V-2-channel blocker r-stromatoxin-1. The time course of K+ current in 17-beta-estradiol, with a time-dependent inhibition and a slight dependence on external K+, suggested an open-channel block mechanism. The properties of block were predicted from a computational model where 17-beta-estradiol binds to open K+ channels. It was concluded that 17-beta-estradiol rapidly reduces voltage-gated K+ currents in a way consistent with an open-channel block mechanism. This suggests a new mechanism for steroid action on ion channels.	[Druzin, Michael; Malinina, Evgenya; Grimsholm, Ola; Johansson, Staffan] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden	Umea University	Druzin, M (corresponding author), Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden.	staffan.johansson@physiol.umu.se	Druzin, Michael/G-1273-2014; Grimsholm, Ola/Q-7995-2019; Johansson, Staffan/Q-4736-2018; Grimsholm, Ola/O-9187-2017; Grimsholm, Ola/U-6779-2019	Grimsholm, Ola/0000-0003-2064-2556; Johansson, Staffan/0000-0003-1022-5097; Grimsholm, Ola/0000-0003-2064-2556; 	Swedish Research Council [21401]; Royal Swedish Academy of Sciences; Stiftelsen J C Kempes Minnes Stipendiefond; Umea University; Gunvor och Josef Aners stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Stiftelsen J C Kempes Minnes Stipendiefond; Umea University; Gunvor och Josef Aners stiftelse	This work was supported by the Swedish Research Council (http://www.vr.se/) (Project 21401); the Royal Swedish Academy of Sciences (http://www.kva.se/); Stiftelsen J C Kempes Minnes Stipendiefond (http://medicinska.se/sv/lankar/stipendier_jc_kempe_/); Umea University (http://www.umu.se); and Gunvor och Josef Aners stiftelse (http://www.anerstiftelsen.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Balthazart J, 2004, PHYSIOL BEHAV, V83, P247, DOI 10.1016/j.physbeh.2004.08.025; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Baum MJ, 2003, SCAND J PSYCHOL, V44, P213, DOI 10.1111/1467-9450.00338; Biewenga E, 2005, NEUROSCI LETT, V373, P179, DOI 10.1016/j.neulet.2004.09.067; Brock MW, 2001, J GEN PHYSIOL, V118, P113, DOI 10.1085/jgp.118.1.113; Carrer HF, 2003, J NEUROSCI, V23, P6338; Clancy AN, 2000, HORM BEHAV, V38, P86, DOI 10.1006/hbeh.2000.1602; Clarke R, 2001, PHARMACOL REV, V53, P25; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cross E, 1999, AM J PHYSIOL-REG I, V276, pR1346, DOI 10.1152/ajpregu.1999.276.5.R1346; Drake EB, 2000, NEUROLOGY, V54, P599, DOI 10.1212/WNL.54.3.599; Druzin M, 2004, NEUROPHARMACOLOGY, V46, P285, DOI 10.1016/j.neuropharm.2003.09.003; Fatehi M, 2005, NEUROSCIENCE, V135, P1075, DOI 10.1016/j.neuroscience.2005.07.024; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Hille B., 2001, ION CHANNELS EXCITAB, P814; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; JOHANSSON S, 1992, J PHYSIOL-LONDON, V445, P141, DOI 10.1113/jphysiol.1992.sp018916; Johansson S, 2001, J PHYSIOL-LONDON, V532, P625, DOI 10.1111/j.1469-7793.2001.0625e.x; Karlsson U, 1997, BRAIN RES, V759, P270, DOI 10.1016/S0006-8993(97)00262-X; KELLY MJ, 1977, EXP BRAIN RES, V30, P43; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Liu YC, 2003, BIOCHEM PHARMACOL, V66, P2053, DOI 10.1016/S0006-2952(03)00584-7; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Moller C, 2006, EUR J PHARMACOL, V532, P44, DOI 10.1016/j.ejphar.2006.01.006; Oren I, 2004, BIOPHYS J, V87, P768, DOI 10.1529/biophysj.103.035527; Paredes RG, 2003, SCAND J PSYCHOL, V44, P203, DOI 10.1111/1467-9450.00337; Philp KL, 2006, BRIT J PHARMACOL, V149, P233, DOI 10.1038/sj.bjp.0706850; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Romano N, 2008, ENDOCRINOLOGY, V149, P5335, DOI 10.1210/en.2008-0424; Roselli CE, 2001, J STEROID BIOCHEM, V79, P247, DOI 10.1016/S0960-0760(01)00141-8; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Serra M, 2000, J NEUROCHEM, V75, P732, DOI 10.1046/j.1471-4159.2000.0750732.x; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Sundgren-Andersson AK, 1998, BRAIN RES, V783, P194, DOI 10.1016/S0006-8993(97)01342-5; Taziaux M, 2007, J NEUROSCI, V27, P6563, DOI 10.1523/JNEUROSCI.1797-07.2007; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; WAKELING AE, 1991, CANCER RES, V51, P3867	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20213	10.1371/journal.pone.0020213	http://dx.doi.org/10.1371/journal.pone.0020213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625454	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400046
J	Iwai, Y; Murakami, K; Gomi, Y; Hashimoto, T; Asakawa, Y; Okuno, Y; Ishikawa, T; Hatakeyama, D; Echigo, N; Kuzuhara, T				Iwai, Yuma; Murakami, Kouki; Gomi, Yasuyuki; Hashimoto, Toshihiro; Asakawa, Yoshinori; Okuno, Yoshinobu; Ishikawa, Toyokazu; Hatakeyama, Dai; Echigo, Noriko; Kuzuhara, Takashi			Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; RNA-POLYMERASE; CHEMICAL-CONSTITUENTS; PA SUBUNIT; ENDONUCLEASE; GENES; CHEMOSYSTEMATICS; BIS(BIBENZYLS); OSELTAMIVIR; BRYOPHYTES	The H1N1 influenza A virus of swine-origin caused pandemics throughout the world in 2009 and the highly pathogenic H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. The threat of influenza A thus remains a serious global health issue and novel drugs that target these viruses are highly desirable. Influenza A possesses an endonuclease within its RNA polymerase which comprises PA, PB1 and PB2 subunits. To identify potential new anti-influenza compounds in our current study, we screened 33 different types of phytochemicals using a PA endonuclease inhibition assay in vitro and an anti-influenza A virus assay. The marchantins are macrocyclic bisbibenzyls found in liverworts, and plagiochin A and perrottetin F are marchantin-related phytochemicals. We found from our screen that marchantin A, B, E, plagiochin A and perrottetin F inhibit influenza PA endonuclease activity in vitro. These compounds have a 3,4-dihydroxyphenethyl group in common, indicating the importance of this moiety for the inhibition of PA endonuclease. Docking simulations of marchantin E with PA endonuclease suggest a putative "fitting and chelating model" as the mechanism underlying PA endonuclease inhibition. The docking amino acids are well conserved between influenza A and B. In a cultured cell system, marchantin E was further found to inhibit the growth of both H3N2 and H1N1 influenza A viruses, and marchantin A, E and perrotein F showed inhibitory properties towards the growth of influenza B. These marchantins also decreased the viral infectivity titer, with marchantin E showing the strongest activity in this assay. We additionally identified a chemical group that is conserved among different anti-influenza chemicals including marchantins, green tea catechins and dihydroxy phenethylphenylphthalimides. Our present results indicate that marchantins are candidate anti-influenza drugs and demonstrate the utility of the PA endonuclease assay in the screening of phytochemicals for anti-influenza characteristics.	[Iwai, Yuma; Hatakeyama, Dai; Echigo, Noriko; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 770, Japan; [Murakami, Kouki; Gomi, Yasuyuki; Okuno, Yoshinobu; Ishikawa, Toyokazu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Res Grp,Res & Prod Technol Div, Kagawa, Japan; [Hashimoto, Toshihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Pharmacognosy, Tokushima 770, Japan; [Asakawa, Yoshinori] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Pharmacognosy, Tokushima 770, Japan	Tokushima Bunri University; Osaka University; Tokushima Bunri University; Tokushima Bunri University	Iwai, Y (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro Cho, Tokushima 770, Japan.	kuzuhara@ph.bunri-u.ac.jp	ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Kuzuhara, Takashi/0000-0003-0565-6060	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Tokushima Bunri University	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University	The influenza virus (A/PR/8/34) RNA polymerase PA plasmid, pBMSA-PA, was provided by the DNA Bank, RIKEN BioResource Center (Tsukuba, Japan; originally deposited by Dr. Susumu Nakada) with the support of National Bio-Resources Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).; This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS), and funding from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa Y, 2008, CURR PHARM DESIGN, V14, P3067, DOI 10.2174/138161208786404272; Asakawa Y, 2004, PHYTOCHEMISTRY, V65, P623, DOI 10.1016/j.phytochem.2004.01.003; Asakawa Y., 1999, Phytochemicals in human health protection, nutrition, and plant defense., P319; ASAKAWA Y, 1982, PROG CH ORG NAT PROD, V42, P1; Asakawa Y., 1990, BRYOPHYTES THEIR CHE, P369; Asakawa Y, 1995, PROG CH ORG NAT PROD, V65, P1; Asakawa Y, 2009, HETEROCYCLES, V77, P99, DOI 10.3987/REV-08-SR(F)3; BUCHANAN MS, 1995, PHYTOCHEMISTRY, V40, P1251, DOI 10.1016/0031-9422(95)00467-L; *CHEM COMP GROUP C, 2004, MOL OP ENV MOE; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Harinantenaina L, 2005, J NAT PROD, V68, P1779, DOI 10.1021/np0502589; HASHIMOTO T, 1994, CHEM PHARM BULL, V42, P1376; Hashimoto T, 2003, PHYTOMEDICINE, V10, P309, DOI 10.1078/094471103322004802; HASHIMOTO T, 1994, CHEM PHARM BULL, V42, P2397; HASHIMOTO T, 1994, TETRAHEDRON LETT, V35, P2559, DOI 10.1016/S0040-4039(00)77170-X; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Kuzuhara T., 2009, PLOS CURR INFLUENZA; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; MAHY BWJ, VIROLOGY METHODS MAN, P35; Morita H, 2009, BIOORG MED CHEM LETT, V19, P493, DOI 10.1016/j.bmcl.2008.11.036; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morse SS, 2007, NAT MED, V13, P681, DOI 10.1038/nm1597; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA Y, 1991, J BIOCHEM-TOKYO, V110, P395, DOI 10.1093/oxfordjournals.jbchem.a123592; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suzuki T, 2008, J PHARMACOL SCI, V107, P285, DOI 10.1254/jphs.08006FP; TAIRA Z, 1994, CHEM PHARM BULL, V42, P52; Taub M, 1979, Methods Enzymol, V58, P552; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; THOMPSON, 1997, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	47	66	73	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19825	10.1371/journal.pone.0019825	http://dx.doi.org/10.1371/journal.pone.0019825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625478	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400014
J	Wei, YC; Huan, YJ; Shi, YQ; Liu, ZF; Bou, G; Luo, YB; Zhang, L; Yang, CR; Kong, QR; Tian, JT; Xia, P; Sun, QY; Liu, ZH				Wei, Yanchang; Huan, Yanjun; Shi, Yongqian; Liu, Zhongfeng; Bou, Gerelchimeg; Luo, Yibo; Zhang, Li; Yang, Cairong; Kong, Qingran; Tian, Jiangtian; Xia, Ping; Sun, Qing-Yuan; Liu, ZhongHua			Unfaithful Maintenance of Methylation Imprints Due to Loss of Maternal Nuclear Dnmt1 during Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							DNA METHYLATION; EXPRESSION; GENES; MICE; ABERRANT; LOCALIZATION; INACTIVATION; DISRUPTION; PATTERNS; REGIONS	The low success rate of somatic cell nuclear transfer (SCNT) in mammalian cloning is largely due to imprinting problems. However, little is known about the mechanisms of reprogramming imprinted genes during SCNT. Parental origin-specific DNA methylation regulates the monoallelic expression of imprinted genes. In natural fertilization, methylation imprints are established in the parental germline and maintained throughout embryonic development. However, it is unclear whether methylation imprints are protected from global changes of DNA methylation in cloned preimplantation embryos. Here, we demonstrate that cloned porcine preimplantation embryos exhibit demethylation at differentially methylated regions (DMRs) of imprinted genes; in particular, demethylation occurs during the first two cell cycles. By RNAi-mediated knockdown, we found that Dnmt1 is required for the maintenance of methylation imprints in porcine preimplantation embryos. However, no clear signals were detected in the nuclei of oocytes and preimplantation embryos by immunofluorescence. Thus, Dnmt1 is present at very low levels in the nuclei of porcine oocytes and preimplantation embryos and maintains methylation imprints. We further showed that methylation imprints were rescued in nonenucleated metaphase II (MII) oocytes. Our results indicate that loss of Dnmt1 in the maternal nucleus during SCNT significantly contributes to the unfaithful maintenance of methylation imprints in cloned embryos.	[Wei, Yanchang; Huan, Yanjun; Shi, Yongqian; Liu, Zhongfeng; Bou, Gerelchimeg; Luo, Yibo; Zhang, Li; Kong, Qingran; Tian, Jiangtian; Liu, ZhongHua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Wei, Yanchang; Yang, Cairong; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Xia, Ping] Univ Calif Davis, Dept Obstet & Gynecol, Sch Med, Sacramento, CA 95817 USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; University of California System; University of California Davis	Wei, YC (corresponding author), NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China.	sunqy@ioz.ac.cn; liu086@yahoo.com	Yang, Cairong/AAB-1440-2021; Liu, Zhunghua/F-2485-2010	Yang, Cairong/0000-0001-9594-0529; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	National Natural Science Foundation of China, NSFC [30871431]; Talent Youth Foundation of Heilongjiang Province [JC200905]	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Talent Youth Foundation of Heilongjiang Province	This work was supported by National Natural Science Foundation of China, NSFC (30871431), and the Talent Youth Foundation of Heilongjiang Province(JC200905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Jeong YS, 2009, DEV DYNAM, V238, P1666, DOI 10.1002/dvdy.21975; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Miki H, 2005, GENESIS, V41, P81, DOI 10.1002/gene.20100; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yamazaki Y, 2005, P NATL ACAD SCI USA, V102, P11361, DOI 10.1073/pnas.0504943102; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	40	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20154	10.1371/journal.pone.0020154	http://dx.doi.org/10.1371/journal.pone.0020154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625467	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400042
J	Braun, S; Humphreys, C; Fraser, E; Brancale, A; Bochtler, M; Dale, TC				Braun, Sebastian; Humphreys, Christine; Fraser, Elizabeth; Brancale, Andrea; Bochtler, Matthias; Dale, Trevor C.			Amyloid-Associated Nucleic Acid Hybridisation	PLOS ONE			English	Article							BETA-SHEET PROTEINS; PRION PROTEIN; MOLECULAR-DYNAMICS; DNA HYBRIDIZATION; FIBRIL FORMATION; IN-VITRO; PEPTIDES; AGGREGATION; CYTOCHROME; CONVERSION	Nucleic acids promote amyloid formation in diseases including Alzheimer's and Creutzfeldt-Jakob disease. However, it remains unclear whether the close interactions between amyloid and nucleic acid allow nucleic acid secondary structure to play a role in modulating amyloid structure and function. Here we have used a simplified system of short basic peptides with alternating hydrophobic and hydrophilic amino acid residues to study nucleic acid - amyloid interactions. Employing biophysical techniques including X-ray fibre diffraction, circular dichroism spectroscopy and electron microscopy we show that the polymerized charges of nucleic acids concentrate and enhance the formation of amyloid from short basic peptides, many of which would not otherwise form fibres. In turn, the amyloid component binds nucleic acids and promotes their hybridisation at concentrations below their solution K-d, as shown by time-resolved FRET studies. The self-reinforcing interactions between peptides and nucleic acids lead to the formation of amyloid nucleic acid (ANA) fibres whose properties are distinct from their component polymers. In addition to their importance in disease and potential in engineering, ANA fibres formed from prebiotically-produced peptides and nucleic acids may have played a role in early evolution, constituting the first entities subject to Darwinian evolution.	[Braun, Sebastian; Humphreys, Christine; Fraser, Elizabeth; Bochtler, Matthias; Dale, Trevor C.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Brancale, Andrea] Cardiff Univ, Sch Pharm, Cardiff, S Glam, Wales; [Bochtler, Matthias] Cardiff Univ, Sch Chem, Cardiff, S Glam, Wales; [Bochtler, Matthias] Int Inst Mol & Cell Biol, Warsaw, Poland	Cardiff University; Cardiff University; Cardiff University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Braun, S (corresponding author), Cardiff Univ, Sch Biosci, Redwood Bldg, Cardiff, S Glam, Wales.	daletc@cardiff.ac.uk	Fraser, Elizabeth/M-7049-2015; Dale, Trevor C/D-3749-2009; Brancale, Andrea/N-9445-2014	Fraser, Elizabeth/0000-0001-8420-3208; Dale, Trevor C/0000-0002-4880-9963; Brancale, Andrea/0000-0002-9728-3419; Bochtler, Matthias/0000-0001-7884-4463	Alzheimer's Research Trust [ART4/PHD20084/1]; Leverhulme Trust [F4/00 4074/AX]; Alzheimers Research UK [ART-PhD2008-1] Funding Source: researchfish	Alzheimer's Research Trust; Leverhulme Trust(Leverhulme Trust); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was funded by the Alzheimer's Research Trust (ART4/PHD20084/1) (http://www.alzheimersresearchuk.org) and the Leverhulme Trust (F4/00 4074/AX) (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bian W, 2006, J APPL CRYSTALLOGR, V39, P752, DOI 10.1107/S0021889806025386; BRACK A, 1990, ORIGINS LIFE EVOL B, V20, P139, DOI 10.1007/BF01808274; Brazier SP, 1998, BIOCHEM J, V335, P375, DOI 10.1042/bj3350375; Cairns-Smith A.G., 1982, GENETIC TAKEOVER MIN; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Cherny D, 2004, J MOL BIOL, V344, P929, DOI 10.1016/j.jmb.2004.09.096; Dale T, 2006, J THEOR BIOL, V240, P337, DOI 10.1016/j.jtbi.2005.09.027; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Lewis RNAH, 1999, BIOCHEMISTRY-US, V38, P15193, DOI 10.1021/bi9912342; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; MAKIN OS, 2002, XRAY DIFFRACTION STU, P67; MASKOS U, 1993, NUCLEIC ACIDS RES, V21, P4663, DOI 10.1093/nar/21.20.4663; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Milner-White E. J., 2010, J COSMOL, V10, P3217; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rasband W.S., 1997, IMAGE J; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; Wu LL, 2008, SOFT MATTER, V4, P744, DOI 10.1039/b717478k; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	44	24	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19125	10.1371/journal.pone.0019125	http://dx.doi.org/10.1371/journal.pone.0019125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625537	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000290771200005
J	Li, L; Qiao, D; Fu, XY; Lao, SH; Zhang, XL; Wu, CY				Li, Li; Qiao, Dan; Fu, Xiaoying; Lao, Suihua; Zhang, Xianlan; Wu, Changyou			Identification of Mycobacterium tuberculosis-Specific Th1, Th17 and Th22 Cells Using the Expression of CD40L in Tuberculous Pleurisy	PLOS ONE			English	Article							CD4(+) T-CELLS; ANTIGEN-SPECIFIC CD4(+); FLOW-CYTOMETRIC METHOD; POLYFUNCTIONAL CD4(+); IMMUNE-RESPONSES; INFECTION; IL-4; ACTIVATION; MOLECULES; DIAGNOSIS	Important advances have been made in the immunodiagnosis of tuberculosis (TB) based on the detection of Mycobacterium tuberculosis (MTB)-specific T cells. However, the sensitivity and specificity of the immunological approach are relatively low because there are no specific markers for antigen-specific Th cells, and some of the Th cells that do not produce cytokines can be overlooked using this approach. In this study, we found that MTB-specific peptides of ESAT-6/CFP-10 can stimulate the expression of CD40L specifically in CD4(+) T cells but not other cells from pleural fluid cells (PFCs) in patients with tuberculous pleurisy (TBP). CD4(+)CD40L(+) but not CD4(+)CD40L(-) T cells express IFN-gamma, IL-2, TNF-alpha, IL-17 or IL-22 after stimulation with MTB-specific peptides. In addition, CD4(+)CD40L(+) T cells were found to be mostly polyfunctional T cells that simultaneously produce IFN-gamma, IL-2 and TNF-alpha and display an effector or effector memory phenotype (CD45RA(-)CD45RO(+)CCR7(-)CD62L(-)ICOS(-)). To determine the specificity of CD4(+)CD40L(+) T cells, we incubated PFCs with ESTA-6/CFP-10 peptides and sorted live CD4(+)CD40L(+) and CD4(+)CD40L(-) T cells by flow cytometry. We further demonstrated that sorted CD4(+)CD40L(+), but not CD4(+)CD40L(-) fractions, principally produced IFN-gamma, IL-2, TNF-alpha, IL-17 and IL-22 following restimulation with ESTA-6/CFP-10 peptides. Taken together, our data indicate that the expression of CD40L on MTB-specific CD4(+) T cells could be a good marker for the evaluation and isolation of MTB-specific Th cells and might also be useful in the diagnosis of TB.	[Li, Li; Qiao, Dan; Fu, Xiaoying; Wu, Changyou] Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lao, Suihua; Zhang, Xianlan] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, L (corresponding author), Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			National Nature Science Foundation of China [30872300]; university basic scientific research expense; Youth Development Project [09YKPY76]; China Postdoctoral Science Foundation [20090460804]; National Key Basic Research Program of China (973) [2007CB512404];  [115];  [2008ZX10003011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); university basic scientific research expense; Youth Development Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Basic Research Program of China (973)(National Basic Research Program of China); ; 	This work was supported by grant 115 (no. 2008ZX10003011), the National Nature Science Foundation of China (no. 30872300), university basic scientific research expense, the Youth Development Project (no. 09YKPY76), the China Postdoctoral Science Foundation (no. 20090460804) and the National Key Basic Research Program of China (973; no. 2007CB512404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRINES RD, 1993, INT IMMUNOL, V5, P1445, DOI 10.1093/intimm/5.11.1445; Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.3.CO;2-3; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Erb KJ, 1998, IMMUNOL CELL BIOL, V76, P41, DOI 10.1046/j.1440-1711.1998.00719.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Jafari C, 2008, INFECTION, V36, P510, DOI 10.1007/s15010-008-8089-9; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Kahi S, 1998, CLIN DIAGN LAB IMMUN, V5, P745, DOI 10.1128/CDLI.5.6.745-748.1998; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Michalek J, 2003, P NATL ACAD SCI USA, V100, P1180, DOI 10.1073/pnas.0337543100; Prabha C, 2007, Indian J Med Microbiol, V25, P18; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; ROY M, 1993, J IMMUNOL, V151, P2497; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Sugawara I, 2000, MICROBIOL IMMUNOL, V44, P971, DOI 10.1111/j.1348-0421.2000.tb02592.x; Suni MA, 1998, J IMMUNOL METHODS, V212, P89, DOI 10.1016/S0022-1759(98)00004-0; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yew WW, 2007, AM J RESP CRIT CARE, V175, P541, DOI 10.1164/rccm.200611-1653UP	36	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20165	10.1371/journal.pone.0020165	http://dx.doi.org/10.1371/journal.pone.0020165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625607	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200069
J	Msalya, G; Shimogiri, T; Ohno, S; Okamoto, S; Kawabe, K; Minezawa, M; Maeda, Y				Msalya, George; Shimogiri, Takeshi; Ohno, Shotaro; Okamoto, Shin; Kawabe, Kotaro; Minezawa, Mitsuru; Maeda, Yoshizane			Evaluation of PRNP Expression Based on Genotypes and Alleles of Two Indel Loci in the Medulla Oblongata of Japanese Black and Japanese Brown Cattle	PLOS ONE			English	Article							PRION-PROTEIN GENE; POLYMORPHISMS; SEQUENCE; HOLSTEIN; PROMOTER; MODULATE	Background: Prion protein (PrP) level plays the central role in bovine spongiform encephalopathy (BSE) susceptibility. Increasing the level of PrP decreases incubation period for this disease. Therefore, studying the expression of the cellular PrP or at least the messenger RNA might be used in selection for preventing the propagation of BSE and other prion diseases. Two insertion/deletion (indel) variations have been tentatively associated with susceptibility/resistance of cattle to classical BSE. Methodology/Principal Findings: We studied the expression of each genotype at the two indel sites in Japanese Black (JB) and Japanese Brown (JBr) cattle breeds by a standard curve method of real-time PCR. Five diplotypes subdivided into two categories were selected from each breed. The two cattle breeds were considered differently. Expression of PRNP was significantly (p<0.0001) greater in the homozygous deletion genotype at the 23-bp locus in JB breed. Compared to the homozygous genotypes, the expression of PRNP was significantly greater in the heterozygous genotype at the 12-bp locus in JB (p<0.0001) and in JBr (p = 0.0394) breeds. In addition, there was a statistical significance in the PRNP levels between the insertion and the deletion alleles of the 23-bp locus in JB (p = 0.0003) as well as in JBr (p = 0.0032). There was no significance in relation to sex, age, geographical location or due to their interactions (p>0.05). Conclusion: Our results suggest that the del/del genotype or at least its del allele may modulate the expression of PRNP at the 23-bp locus in the medulla oblongata of these cattle breeds.	[Msalya, George] Kagoshima Univ, United Grad Sch Agr, Kagoshima 890, Japan; [Shimogiri, Takeshi; Ohno, Shotaro; Okamoto, Shin; Maeda, Yoshizane] Kagoshima Univ, Fac Agr, Kagoshima 890, Japan; [Kawabe, Kotaro] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 890, Japan; [Minezawa, Mitsuru] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Msalya, George] NARCO Kikulula Karagwe, Heifer Breeding Project, Kagera, Tanzania	Kagoshima University; Kagoshima University; Kagoshima University; National Institute of Agrobiological Sciences - Japan	Msalya, G (corresponding author), Kagoshima Univ, United Grad Sch Agr, Kagoshima 890, Japan.	msalya@yahoo.com						Brunelle BW, 2008, J DAIRY SCI, V91, P338, DOI 10.3168/jds.2007-0423; Brunelle BW, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-36; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; FALCONER DS, 1961, INTRO QUANTITATIVE G, P54; Haigh CL, 2007, J MOL BIOL, V368, P915, DOI 10.1016/j.jmb.2007.02.086; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Msalya G, 2010, ANIM GENET, V41, P218, DOI 10.1111/j.1365-2052.2009.01983.x; MSALYA G, 2008, THESIS KAGOSHIMA U J; Msalya G, 2009, ANIM SCI J, V80, P520, DOI 10.1111/j.1740-0929.2009.00669.x; Murdoch BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012786; Nakamitsu S, 2006, J VET MED SCI, V68, P27, DOI 10.1292/jvms.68.27; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Seabury CM, 2004, MAMM GENOME, V15, P828, DOI 10.1007/s00335-004-2400-6; Shimogiri T, 2010, BIOCHEM GENET, V48, P829, DOI 10.1007/s10528-010-9364-x; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204	26	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18787	10.1371/journal.pone.0018787	http://dx.doi.org/10.1371/journal.pone.0018787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611160	gold, Green Submitted, Green Published			2022-12-27	WOS:000290720200002
J	Del Carpio, DP; Basnet, RK; De Vos, RCH; Maliepaard, C; Paulo, MJ; Bonnema, G				Del Carpio, Dunia Pino; Basnet, Ram Kumar; De Vos, Ric C. H.; Maliepaard, Chris; Paulo, Maria Joao; Bonnema, Guusje			Comparative Methods for Association Studies: A Case Study on Metabolite Variation in a Brassica rapa Core Collection	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; RANDOM FORESTS; LINKAGE DISEQUILIBRIUM; INFERENCE; RESISTANCE; TRAITS; CLASSIFICATION; COMPONENTS; LOCI	Background: Association mapping is a statistical approach combining phenotypic traits and genetic diversity in natural populations with the goal of correlating the variation present at phenotypic and allelic levels. It is essential to separate the true effect of genetic variation from other confounding factors, such as adaptation to different uses and geographical locations. The rapid availability of large datasets makes it necessary to explore statistical methods that can be computationally less intensive and more flexible for data exploration. Methodology/Principal Findings: A core collection of 168 Brassica rapa accessions of different morphotypes and origins was explored to find genetic association between markers and metabolites: tocopherols, carotenoids, chlorophylls and folate. A widely used linear model with modifications to account for population structure and kinship was followed for association mapping. In addition, a machine learning algorithm called Random Forest (RF) was used as a comparison. Comparison of results across methods resulted in the selection of a set of significant markers as promising candidates for further work. This set of markers associated to the metabolites can potentially be applied for the selection of genotypes with elevated levels of these metabolites. Conclusions/Significance: The incorporation of the kinship correction into the association model did not reduce the number of significantly associated markers. However incorporation of the STRUCTURE correction (Q matrix) in the linear regression model greatly reduced the number of significantly associated markers. Additionally, our results demonstrate that RF is an interesting complementary method with added value in association studies in plants, which is illustrated by the overlap in markers identified using RF and a linear mixed model with correction for kinship and population structure. Several markers that were selected in RF and in the models with correction for kinship, but not for population structure, were also identified as QTLs in two bi-parental DH populations.	[Del Carpio, Dunia Pino; Basnet, Ram Kumar; Maliepaard, Chris; Bonnema, Guusje] Wageningen Univ, Lab Plant Breeding, Wageningen, Netherlands; [De Vos, Ric C. H.; Paulo, Maria Joao] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Basnet, Ram Kumar; De Vos, Ric C. H.; Bonnema, Guusje] Ctr BioSyst Genom, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics	Del Carpio, DP (corresponding author), Wageningen Univ, Lab Plant Breeding, Wageningen, Netherlands.	Guusje.Bonnema@wur.nl	De Vos, Ric/F-5012-2017; Maliepaard, Chris/G-6041-2015	Caldas Paulo, Maria Joao/0000-0002-4180-0763; Bonnema, Guusje/0000-0002-2298-6849	IOP Genomics [IGE 05010]; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	IOP Genomics; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Dunia Pino Del Carpio and Ric De Vos were funded by the IOP Genomics project "Brassica vegetable nutrigenomics'' IGE 05010. This project was co-financed by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Batagelj V, 2004, MATH VIS, P77; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bino RJ, 2005, NEW PHYTOL, V166, P427, DOI 10.1111/j.1469-8137.2005.01362.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREIMAN L, 2001, BREIMAN CUTLERS REAN; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; De Nooy W., 2005, EXPLORATORY SOCIAL N; Del Carpio DP, 2011, THEOR APPL GENET, V122, P1105, DOI 10.1007/s00122-010-1516-1; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Kraakman ATW, 2006, MOL BREEDING, V17, P41, DOI 10.1007/s11032-005-1119-8; Lou P, 2008, NEW PHYTOL, V179, P1017, DOI 10.1111/j.1469-8137.2008.02530.x; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Nemri A, 2010, P NATL ACAD SCI USA, V107, P10302, DOI 10.1073/pnas.0913160107; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perrier X., 2006, DARWIN SOFTWARE; Pollard KS, 2005, MULTTEST RESAMPLING; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Reeves PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004269; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Simko I, 2004, TRENDS PLANT SCI, V9, P441, DOI 10.1016/j.tplants.2004.07.003; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P4542, DOI 10.1128/AEM.69.8.4542-4548.2003; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang MH, 2010, BIOINFORMATICS, V26, P831, DOI 10.1093/bioinformatics/btq038; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Ye YQ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S135; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao J, 2007, GENOME, V50, P963, DOI 10.1139/G07-078; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	46	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19624	10.1371/journal.pone.0019624	http://dx.doi.org/10.1371/journal.pone.0019624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602927	gold, Green Submitted, Green Published			2022-12-27	WOS:000290558500016
J	Hlavackova, P; Franco, C; Diot, B; Vuillerme, N				Hlavackova, Petra; Franco, Celine; Diot, Bruno; Vuillerme, Nicolas			Contribution of Each Leg to the Control of Unperturbed Bipedal Stance in Lower Limb Amputees: New Insights Using Entropy	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; POSTURAL CONTROL; APPROXIMATE ENTROPY; SAMPLE ENTROPY; HEALTHY-YOUNG; SWAY; BALANCE; REGULARITY; PATTERNS; CHILDREN	The present study was designed to assess the relative contribution of each leg to unperturbed bipedal posture in lower limb amputees. To achieve this goal, eight unilateral traumatic trans-femoral amputees (TFA) were asked to stand as still as possible on a plantar pressure data acquisition system with their eyes closed. Four dependent variables were computed to describe the subject's postural behavior: (1) body weight distribution, (2) amplitude, (3) velocity and (4) regularity of centre of foot pressure (CoP) trajectories under the amputated (A) leg and the non-amputated (NA) leg. Results showed a larger body weight distribution applied to the NA leg than to the A leg and a more regular CoP profiles (lower sample entropy values) with greater amplitude and velocity under the NA leg than under the A leg. Taken together, these findings suggest that the NA leg and the A leg do not equally contribute to the control of unperturbed bipedal posture in TFA. The observation that TFA do actively control unperturbed bipedal posture with their NA leg could be viewed as an adaptive process to the loss of the lower leg afferents and efferents because of the unilateral lower-limb amputation. From a methodological point of view, these results demonstrate the suitability of computing bilateral CoP trajectories regularity for the assessment of lateralized postural control under pathological conditions.	[Hlavackova, Petra; Franco, Celine; Vuillerme, Nicolas] EPHE, AGIM, FRE 3405, CNRS,UJF, Grenoble, France; [Hlavackova, Petra] Palacky Univ, Fac Phys Culture, CR-77147 Olomouc, Czech Republic; [Franco, Celine; Vuillerme, Nicolas] IMAG, TIMC, UJF Grenoble 1, CNRS,UMR 5525, Grenoble, France; [Franco, Celine; Diot, Bruno] IDS SA, Montceau Les Mines, France; [Vuillerme, Nicolas] Hop Raymond Poincare, AP HP, INSERM, CIC,IT 805,EA 4497, Garches, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Palacky University Olomouc; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hlavackova, P (corresponding author), EPHE, AGIM, FRE 3405, CNRS,UJF, Grenoble, France.	nicolas.vuillerme@agim.eu	Nicolas, Vuillerme/C-6692-2009; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; VUILLERME, Nicolas/0000-0003-3773-393X	Garches Foundation; AXA Research Fund; Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959221]	Garches Foundation; AXA Research Fund(AXA Research Fund); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This research was granted by the Garches Foundation, the AXA Research Fund and the Ministry of Education, Youth and Sports of the Czech Republic (No. MSM 6198959221) Physical Activity and Inactivity of the Inhabitants of the Czech Republic in the Context of Behavioral Changes to the first author and by the Centre National de La Recherche Scientifique (France) to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Duclos C, 2007, GAIT POSTURE, V26, P595, DOI 10.1016/j.gaitpost.2006.12.005; Duclos Cyril, 2009, J Electromyogr Kinesiol, V19, pe214, DOI 10.1016/j.jelekin.2008.04.007; Gauthier-Gagnon C., 1986, PHYSIOTHER CAN, V38, P137; GHOMASHCHI H, 2010, INT J BIFURCAT CHAOS, V20, P1; Hlavackova P, 2009, ARCH PHYS MED REHAB, V90, P1960, DOI 10.1016/j.apmr.2009.05.016; ISAKOV E, 1992, ARCH PHYS MED REHAB, V73, P174; KIRBY RL, 1987, J BIOMECH, V20, P423, DOI 10.1016/0021-9290(87)90049-2; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Nadollek Heidi, 2002, Physiother Res Int, V7, P203, DOI 10.1002/pri.260; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quai TM, 2005, CLIN REHABIL, V19, P668, DOI 10.1191/0269215505cr857oa; RAMDANI S, 2010, ANN BIOMED ENG, P1; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROERDINK M, 2010, HUM MOV SCI; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P267, DOI 10.1177/1545968308323928; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Stins JF, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-42; Summers G D, 1988, Int Disabil Stud, V10, P1; Vuillerme N, 2010, EUR J APPL PHYSIOL, V110, P207, DOI 10.1007/s00421-010-1449-z; Vuillerme N, 2009, GAIT POSTURE, V30, P122, DOI 10.1016/j.gaitpost.2009.03.004	31	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19661	10.1371/journal.pone.0019661	http://dx.doi.org/10.1371/journal.pone.0019661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603630	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500018
J	Perez-Llamas, C; Lopez-Bigas, N				Perez-Llamas, Christian; Lopez-Bigas, Nuria			Gitools: Analysis and Visualisation of Genomic Data Using Interactive Heat-Maps	PLOS ONE			English	Article							GENE SET ENRICHMENT; ONTOLOGY TOOL; EXPRESSION; PLATFORM; SUITE	Intuitive visualization of data and results is very important in genomics, especially when many conditions are to be analyzed and compared. Heat-maps have proven very useful for the representation of biological data. Here we present Gitools (http://www.gitools.org), an open-source tool to perform analyses and visualize data and results as interactive heat-maps. Gitools contains data import systems from several sources (i.e. IntOGen, Biomart, KEGG, Gene Ontology), which facilitate the integration of novel data with previous knowledge.	[Perez-Llamas, Christian; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain	Pompeu Fabra University	Perez-Llamas, C (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona, Spain.	nuria.lopez@upf.edu	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988	Spanish Ministry of Science and Technology [SAF2009-06954]; Spanish National Institute of Bioinformatics (INB)	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics (INB)	The authors acknowledge funding from the Spanish Ministry of Science and Technology (grant number SAF2009-06954) and the Spanish National Institute of Bioinformatics (INB: http://www.inab.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAV MAV SOFTW PROJ M; [Anonymous], FLEX PROJ MAN WEB AP; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Floratos A, 2010, BIOINFORMATICS, V26, P1779, DOI 10.1093/bioinformatics/btq282; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HOLM S, 1979, SCAND J STAT, V6, P65; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Weinstein John N, 2004, Breast Dis, V19, P11; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	33	202	206	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19541	10.1371/journal.pone.0019541	http://dx.doi.org/10.1371/journal.pone.0019541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602921	gold, Green Published			2022-12-27	WOS:000290558500014
J	Danino, T; Volfson, D; Bhatia, SN; Tsimring, L; Hasty, J				Danino, Tal; Volfson, Dmitri; Bhatia, Sangeeta N.; Tsimring, Lev; Hasty, Jeff			In-Silico Patterning of Vascular Mesenchymal Cells in Three Dimensions	PLOS ONE			English	Article							MATRIX GLA PROTEIN; BONE MORPHOGENETIC PROTEIN-2; MECHANISMS; COMPLEX; DIFFERENTIATION; ORGANIZATION; MIGRATION; FORM; MGP	Cells organize in complex three-dimensional patterns by interacting with proteins along with the surrounding extracellular matrix. This organization provides the mechanical and chemical cues that ultimately influence a cell's differentiation and function. Here, we computationally investigate the pattern formation process of vascular mesenchymal cells arising from their interaction with Bone Morphogenic Protein-2 (BMP-2) and its inhibitor, Matrix Gla Protein (MGP). Using a first-principles approach, we derive a reaction-diffusion model based on the biochemical interactions of BMP-2, MGP and cells. Simulations of the model exhibit a wide variety of three-dimensional patterns not observed in a two-dimensional analysis. We demonstrate the emergence of three types of patterns: spheres, tubes, and sheets, and show that the patterns can be tuned by modifying parameters in the model such as the degradation rates of proteins and chemotactic coefficient of cells. Our model may be useful for improved engineering of three-dimensional tissue structures as well as for understanding three dimensional microenvironments in developmental processes.	[Danino, Tal; Volfson, Dmitri; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, Biocircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Danino, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu		Tsimring, Lev/0000-0003-0709-3548; Volfson, Dmitri/0000-0002-5167-7834	National Institutes of Health and General Medicine [GM69811]; DOE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health and General Medicine (GM69811) and DOE CSGF fellowship (to T. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; AMBROSI D, 2006, B MATH BIOL; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Bostrom KI, 2000, Z KARDIOL, V89, P69; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cross MC, 1994, CHAOS, V4, P607, DOI 10.1063/1.166038; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712; Gamba A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118101; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; GHOSHCHOUDHURY N, 1993, BIOCHEM BIOPH RES CO, V286, P101; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; LOESER R, 1992, BIOCHEM J, V282, P1; MURRAY JD, 1984, J MATH BIOL, V19, P265, DOI 10.1007/BF00277099; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Sage A, 2009, TRENDS CARDIOVAS MED, V19, P118, DOI 10.1016/j.tcm.2009.07.002; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; TSIMRING L, 1995, PHYS REV LETT, V75, P1859, DOI 10.1103/PhysRevLett.75.1859; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Yochelis A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/055002; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	34	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20182	10.1371/journal.pone.0020182	http://dx.doi.org/10.1371/journal.pone.0020182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633504	gold, Green Published			2022-12-27	WOS:000291006500037
J	Lai, YL				Lai, Yinglei			On the Adaptive Partition Approach to the Detection of Multiple Change-Points	PLOS ONE			English	Article							ARRAY CGH DATA; CIRCULAR BINARY SEGMENTATION; COPY-NUMBER; REGRESSION	With an adaptive partition procedure, we can partition a "time course'' into consecutive non-overlapped intervals such that the population means/proportions of the observations in two adjacent intervals are significantly different at a given level alpha(C). However, the widely used recursive combination or partition procedures do not guarantee a global optimization. We propose a modified dynamic programming algorithm to achieve a global optimization. Our method can provide consistent estimation results. In a comprehensive simulation study, our method shows an improved performance when it is compared to the recursive combination/partition procedures. In practice, alpha(C) can be determined based on a cross-validation procedure. As an application, we consider the well-known Pima Indian Diabetes data. We explore the relationship among the diabetes risk and several important variables including the plasma glucose concentration, body mass index and age.	[Lai, Yinglei] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Lai, Yinglei] George Washington Univ, Ctr Biostat, Washington, DC USA	George Washington University; George Washington University	Lai, YL (corresponding author), George Washington Univ, Dept Stat, Washington, DC 20052 USA.	ylai@gwu.edu			National Institutes of Health [R21DK075004, R01GM092963]; Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants R21DK075004, R01GM092963 and Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autio R, 2003, BIOINFORMATICS, V19, P1714, DOI 10.1093/bioinformatics/btg230; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S70; Braun JV, 1998, STAT SCI, V13, P142; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cormen Thomas H., 2009, INTRO ALGORITHMS; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Good P, 2005, PERMUTATION PARAMETR; Groeneboom P, 1995, ANN STAT, V23, P1518, DOI 10.1214/aos/1176324310; Liu J, 2007, BIOINFORMATICS, V23, P450, DOI 10.1093/bioinformatics/btl624; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Picard F, 2007, BIOMETRICS, V63, P758, DOI 10.1111/j.1541-0420.2006.00729.x; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Robertson T., 1988, ORDER RESTRICTED STA; Schell MJ, 1997, J AM STAT ASSOC, V92, P128, DOI 10.2307/2291456; SIEGMUND D, 1995, ANN STAT, V23, P255, DOI 10.1214/aos/1176324466; Silvapulle M., 2004, CONSTRAINED STAT INF; Smith J. W., 1988, Proceedings. The Twelfth Annual Symposium on Computer Applications in Medical Care (IEEE Cat. No.88CH2616-1), P261; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wu WB, 2001, BIOMETRIKA, V88, P793, DOI 10.1093/biomet/88.3.793	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19754	10.1371/journal.pone.0019754	http://dx.doi.org/10.1371/journal.pone.0019754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629694	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800008
J	Minassian, AM; Ronan, EO; Poyntz, H; Hill, AVS; McShane, H				Minassian, Angela M.; Ronan, Edward O.; Poyntz, Hazel; Hill, Adrian V. S.; McShane, Helen			Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; CALMETTE-GUERIN INFECTION; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; VIRUS ANKARA; ENHANCED IMMUNOGENICITY; ANTIGEN 85A; IFN-GAMMA; MICE; CELLS	There is an urgent need for an immunological correlate of protection against tuberculosis (TB) with which to evaluate candidate TB vaccines in clinical trials. Development of a human challenge model of Mycobacterium tuberculosis (M.tb) could facilitate the detection of such correlate(s). Here we propose a novel in vivo Bacille Calmette-Guerin (BCG) challenge model using BCG immunization as a surrogate for M.tb infection. Culture and quantitative PCR methods have been developed to quantify BCG in the skin, using the mouse ear as a surrogate for human skin. Candidate TB vaccines have been evaluated for their ability to protect against a BCG skin challenge, using this model, and the results indicate that protection against a BCG skin challenge is predictive of BCG vaccine efficacy against aerosol M.tb challenge. Translation of these findings to a human BCG challenge model could enable more rapid assessment and down selection of candidate TB vaccines and ultimately the identification of an immune correlate of protection.	[Minassian, Angela M.; Ronan, Edward O.; Poyntz, Hazel; Hill, Adrian V. S.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Minassian, AM (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	minassian.angela@gmail.com		Minassian, Angela/0000-0001-7832-9824; McShane, Helen/0000-0002-2126-5142	Wellcome Trust; European Union	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	This work was funded by the Wellcome Trust and the European Union FP5 framework program project AFTBVAC. H.M. and A.V.S.H. are both Jenner Investigators. H.M. is a Wellcome Trust Senior Clinical Research Fellow, and A.V.S.H. is a Wellcome Trust Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COLLINS FM, 1971, INFECT IMMUN, V4, P688, DOI 10.1128/IAI.4.6.688-696.1971; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; Dobakhti F, 2009, MICROBES INFECT, V11, P296, DOI 10.1016/j.micinf.2008.12.003; Feng CG, 2000, J INFECT DIS, V181, P1846, DOI 10.1086/315466; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gruppo V, 2002, TUBERCULOSIS, V82, P267, DOI 10.1054/tube.2002.0340; Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010; Horwitz MA, 2006, VACCINE, V24, P443, DOI 10.1016/j.vaccine.2005.08.001; IZUMI T, 1971, J EXP MED, V133, P376, DOI 10.1084/jem.133.2.376; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lagranderie MRR, 1996, INFECT IMMUN, V64, P1; LEFFORD MJ, 1980, INFECT IMMUN, V28, P508; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Magdalena J, 1998, J CLIN MICROBIOL, V36, P2471, DOI 10.1128/JCM.36.9.2471-2476.1998; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1423, DOI 10.1001/jama.279.18.1423; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Minassian Angela M, 2008, Expert Rev Respir Med, V2, P721, DOI 10.1586/17476348.2.6.721; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Wangoo A, 2001, J IMMUNOL, V166, P3432, DOI 10.4049/jimmunol.166.5.3432	41	25	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19840	10.1371/journal.pone.0019840	http://dx.doi.org/10.1371/journal.pone.0019840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629699	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800014
J	Swarbrick, JD; Shaw, DJ; Chhabra, S; Ghai, R; Valkov, E; Norwood, SJ; Seaman, MNJ; Collins, BM				Swarbrick, James D.; Shaw, Daniel J.; Chhabra, Sandeep; Ghai, Rajesh; Valkov, Eugene; Norwood, Suzanne J.; Seaman, Matthew N. J.; Collins, Brett M.			VPS29 Is Not an Active Metallo-Phosphatase but Is a Rigid Scaffold Required for Retromer Interaction with Accessory Proteins	PLOS ONE			English	Article							MAMMALIAN RETROMER; DIPOLAR COUPLINGS; RESIDUAL DIPOLAR; SORTING NEXIN-1; IDENTIFICATION; COMPLEX; TRANSPORT; DYNAMICS; ASSOCIATION; ENDOSOMES	VPS29 is a key component of the cargo-binding core complex of retromer, a protein assembly with diverse roles in transport of receptors within the endosomal system. VPS29 has a fold related to metal-binding phosphatases and mediates interactions between retromer and other regulatory proteins. In this study we examine the functional interactions of mammalian VPS29, using X-ray crystallography and NMR spectroscopy. We find that although VPS29 can coordinate metal ions Mn2+ and Zn2+ in both the putative active site and at other locations, the affinity for metals is low, and lack of activity in phosphatase assays using a putative peptide substrate support the conclusion that VPS29 is not a functional metalloenzyme. There is evidence that structural elements of VPS29 critical for binding the retromer subunit VPS35 may undergo both metal-dependent and independent conformational changes regulating complex formation, however studies using ITC and NMR residual dipolar coupling (RDC) measurements show that this is not the case. Finally, NMR chemical shift mapping indicates that VPS29 is able to associate with SNX1 via a conserved hydrophobic surface, but with a low affinity that suggests additional interactions will be required to stabilise the complex in vivo. Our conclusion is that VPS29 is a metal ion-independent, rigid scaffolding domain, which is essential but not sufficient for incorporation of retromer into functional endosomal transport assemblies.	[Swarbrick, James D.; Chhabra, Sandeep] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Shaw, Daniel J.; Ghai, Rajesh; Norwood, Suzanne J.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Valkov, Eugene] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Seaman, Matthew N. J.] Univ Cambridge, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge, England	Monash University; University of Queensland; University of Queensland; University of Cambridge	Swarbrick, JD (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	b.collins@imb.uq.edu.au	Valkov, Eugene/C-1554-2010; Collins, Brett/J-1563-2014; Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017; Ghai, Rajesh/D-5903-2012; Valkov, Eugene/AAA-1735-2020	Collins, Brett/0000-0002-6070-3774; Chhabra, Sandeep/0000-0002-5225-1333; Ghai, Rajesh/0000-0002-0919-0934; Valkov, Eugene/0000-0002-3721-1739	Australian Research Council [DP0878608, FT100100027]; NHMRC [511072]; MRC [G0701444] Funding Source: UKRI; Medical Research Council [G0701444] Funding Source: researchfish	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by funds from the Australian Research Council (DP0878608), and NHMRC (511072). BMC is supported by an ARC Future Fellowship (FT100100027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Goddard T. D., SPARKY 3; Gokool S, 2007, BIOCHEM J, V408, P287, DOI 10.1042/BJ20070555; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Homans SW, 2005, CHEMBIOCHEM, V6, P1585, DOI 10.1002/cbic.200500010; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jackson CJ, 2008, ACTA CRYSTALLOGR F, V64, P681, DOI 10.1107/S1744309108017600; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; NORWOOD SJ, 2010, ASSEMBLY SOLUTION ST; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; SEAMAN MN, 2009, J CELL SCI; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	71	47	49	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20420	10.1371/journal.pone.0020420	http://dx.doi.org/10.1371/journal.pone.0020420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629666	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005800050
J	Darisipudi, MN; Allam, R; Rupanagudi, KV; Anders, HJ				Darisipudi, Murthy Narayana; Allam, Ramanjaneyulu; Rupanagudi, Khader Valli; Anders, Hans-Joachim			Polyene Macrolide Antifungal Drugs Trigger Interleukin-1 beta Secretion by Activating the NLRP3 Inflammasome	PLOS ONE			English	Article							NALP3 INFLAMMASOME; IMMUNE-RESPONSES; NYSTATIN; CELLS; RECEPTORS; MECHANISM; CRYSTALS; TOXINS; ALPHA; FORMS	The use of antimycotic drugs in fungal infections is based on the concept that they suppress fungal growth by a direct killing effect. However, amphotericin and nystatin have been reported to also trigger interleukin-1 beta (IL-1 beta) secretion in monocytes but the molecular mechanism is unknown. Here we report that only the polyene macrolides amphotericin B, nystatin, and natamycin but none of the tested azole antimycotic drugs induce significant IL-1 beta secretion in-vitro in dendritic cells isolated from C57BL/6 mouse bone marrow. IL-1 beta release depended on Toll-like receptor-mediated induction of pro-IL-1 beta as well as the NLRP3 inflammasome, its adaptor ASC, and caspase-1 for enzymatic cleavage of proIL-1 beta into its mature form. All three drugs induced potassium efflux from the cells as a known mechanism for NLRP3 activation but the P2X7 receptor was not required for this process. Natamycin-induced IL-1 beta secretion also involved phagocytosis, as cathepsin activation as described for crystal-induced IL-1 beta release. Together, the polyene macrolides amphotericin B, nystatin, and natamycin trigger IL-1 beta secretion by causing potassium efflux from which activates the NLRP3-ASC-caspase-1. We conclude that beyond their effects on fungal growth, these antifungal drugs directly activate the host's innate immunity.	[Darisipudi, Murthy Narayana; Rupanagudi, Khader Valli; Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Allam, Ramanjaneyulu] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Munich; University of Lausanne	Darisipudi, MN (corresponding author), Univ Munich, Med Poliklin, Pettenkoferstr 8A, D-8000 Munich, Germany.	hjanders@med.uni-muenchen.de	Anders, Hans-Joachim/ABD-6247-2021; Allam, Ramanjaneyulu/N-4053-2016	Allam, Ramanjaneyulu/0000-0002-2789-3596; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [GRK 1202]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft GRK 1202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allam R, 2009, J AM SOC NEPHROL, V20, P1986, DOI 10.1681/ASN.2008101067; BOLARD J, 1986, DRUG EXP CLIN RES, V12, P613; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Camacho M, 2004, J INFECT DIS, V190, P1026, DOI 10.1086/423207; Coutinho A, 2004, BIOPHYS J, V87, P3264, DOI 10.1529/biophysj.104.044883; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Ogawa Y, 2006, J INVEST DERMATOL, V126, P349, DOI 10.1038/sj.jid.5700081; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Rogers PD, 2002, ANTIMICROB AGENTS CH, V46, P3412, DOI 10.1128/AAC.46.11.3412-3417.2002; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19588	10.1371/journal.pone.0019588	http://dx.doi.org/10.1371/journal.pone.0019588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625424	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200005
J	Salajegheh, M; Lam, T; Greenberg, SA				Salajegheh, Mohammad; Lam, Theresa; Greenberg, Steven A.			Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis	PLOS ONE			English	Article							CLINICALLY AMYOPATHIC DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; POLYMYOSITIS; PATHOGENESIS; DIAGNOSIS; PROFILES; DISEASE; CELLS	Background: Inclusion body myositis (IBM) is a poorly understood and refractory autoimmune muscle disease. Though widely believed to have no significant humoral autoimmunity, we sought to identify novel autoantibodies with high specificity for this disease. Methodology/Principal Findings: Plasma autoantibodies from 65 people, including 25 with IBM, were analyzed by immunoblots against normal human muscle. Thirteen of 25 (52%) IBM patient samples recognized an approximately 43 kDa muscle protein. No other disease (N = 25) or healthy volunteer (N = 15) samples recognized this protein. Conclusions: Circulating antibodies against a 43-kDa muscle autoantigen may lead to the discovery of a novel biomarker for IBM. Its high specificity for IBM among patients with autoimmune myopathies furthermore suggests a relationship to disease pathogenesis.	[Salajegheh, Mohammad; Greenberg, Steven A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Salajegheh, Mohammad; Lam, Theresa; Greenberg, Steven A.] Childrens Hosp Boston, Childrens Hosp Informat Program, Boston, MA USA; [Salajegheh, Mohammad; Greenberg, Steven A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Salajegheh, M (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	msalajegheh@partners.org			Muscular Dystrophy Association [MDA92561, MDA4353]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This study was sponsored by the Muscular Dystrophy Association (grants MDA92561 to Dr. Salajegheh and MDA4353 to Dr. Greenberg) URL: http://www.mdausa.org/. No additional external funding was received for this study. The named funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Salajegheh, Ms. Lam and Dr. Greenberg report no further financial disclosures in regards to this study.	Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547; Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116; Dalakas MC, 1997, ANN NEUROL, V41, P100, DOI 10.1002/ana.410410116; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Ghirardello A, 2010, RHEUMATOLOGY, V49, P2370, DOI 10.1093/rheumatology/keq281; Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Greenberg SA, 2001, NEUROLOGY, V57, P755, DOI 10.1212/WNL.57.5.755; Greenberg SA, 2007, NEUROLOGY, V69, P2008, DOI 10.1212/01.WNL.0000291619.17160.b8; Gunawardena H, 2008, CURR OPIN RHEUMATOL, V20, P675, DOI 10.1097/BOR.0b013e328313bff4; Hengstman GJD, 2002, J NEUROL, V249, P69, DOI 10.1007/PL00007850; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO;2-G; Limaye V, 2010, RHEUMATOL INT; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Salajegheh M, 2010, MUSCLE NERVE, V42, P576, DOI 10.1002/mus.21739; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sordet C, 2006, JOINT BONE SPINE, V73, P646, DOI 10.1016/j.jbspin.2006.04.005	20	73	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20266	10.1371/journal.pone.0020266	http://dx.doi.org/10.1371/journal.pone.0020266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629782	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200045
J	Hedegaard, CJ; Enevold, C; Sellebjerg, F; Bendtzen, K; Nielsen, CH				Hedegaard, Chris Juul; Enevold, Christian; Sellebjerg, Finn; Bendtzen, Klaus; Nielsen, Claus Henrik			Variation in NOD2 Augments Th2-and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; T-CELLS; CROHNS-DISEASE; INTERLEUKIN-17 PRODUCTION; HEALTHY-INDIVIDUALS; CARD15 MUTATIONS; BLAU-SYNDROME; KAPPA-B; INFLAMMATION; DISTINCT	Variations in the gene for the nucleotide-binding oligomerisation domain (NOD) 2 have been associated with Crohn's disease but not multiple sclerosis (MS). Here we investigate the effect of three polymorphisms in the NOD2 gene (rs5743277, rs2066842 and rs5743291) on cytokine production and CD4+ T cell proliferation elicited by human myelin basic protein (MBP) in blood mononuclear cell (MNC) cultures from 29 patients with MS. No polymorphism was observed at rs5743277. No associations with the rs2066842 polymorphism were found. Concerning rs5743291, none were homozygous for the minor allele. Seven of 29 (24%) patients were heterozygous, and five of these (71%) exhibited increased MBP-induced CD4+ T cell proliferation versus four of 22 (18%), who were homozygous for the major allele (p < 0.04). Interleukin (IL)-5 was induced by MBP in MNC from the same five carriers versus two (9%) homozygotes (p < 0.004); four carriers (57%) versus three non-carriers (14%) exhibited IL-17 responses to MBP (p < 0.04). By contrast, we found no association between the polymorphisms investigated and interferon-gamma-, tumor necrosis factor-alpha-, IL-2, -4- or IL-10 responses to MBP. These results indicate that the rs5743291 polymorphism influences T helper (Th) cell 2- and Th17 cell responses in MNC from MS patients.	[Hedegaard, Chris Juul; Enevold, Christian; Bendtzen, Klaus; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, Copenhagen, Denmark; [Sellebjerg, Finn] Copenhagen Univ Hosp, Dept Neurol, Danish MS Res Ctr, Rigshosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hedegaard, CJ (corresponding author), Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, Copenhagen, Denmark.	claus.henrik.nielsen@rh.regionh.dk		Enevold, Christian/0000-0002-2748-1997; Nielsen, Claus Henrik/0000-0001-7543-9016; Hedegaard, Chris Juul/0000-0003-1333-8687; Sellebjerg, Finn/0000-0002-1333-9623	Warwara Larsen's Foundation [J. 2008-7306]; Aase & Ejnar Danielsen's Foundation [107163]; Research committee of Rigshospitalet; Danish Biotechnology Program	Warwara Larsen's Foundation; Aase & Ejnar Danielsen's Foundation; Research committee of Rigshospitalet; Danish Biotechnology Program	This study was supported by Warwara Larsen's Foundation (J. 2008-7306), Aase & Ejnar Danielsen's Foundation (107163), the Research committee of Rigshospitalet and the Danish Biotechnology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ochi H, 2002, J NEUROL SCI, V201, P45, DOI 10.1016/S0022-510X(02)00189-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Philpott DJ, 2009, NAT IMMUNOL, V10, P455, DOI 10.1038/ni0509-455; Sawcer S, 2003, J NEUROL NEUROSUR PS, V74, P1157, DOI 10.1136/jnnp.74.8.1157; Sorensen TL, 2001, NEUROLOGY, V57, P1371, DOI 10.1212/WNL.57.8.1371; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20253	10.1371/journal.pone.0020253	http://dx.doi.org/10.1371/journal.pone.0020253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625457	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400050
J	Bozoky, Z; Rona, G; Klement, E; Medzihradszky, KF; Merenyi, G; Vertessy, BG; Friedrich, P				Bozoky, Zoltan; Rona, Gergely; Klement, Eva; Medzihradszky, Katalin F.; Merenyi, Gabor; Vertessy, Beata G.; Friedrich, Peter			Calpain-Catalyzed Proteolysis of Human dUTPase Specifically Removes the Nuclear Localization Signal Peptide	PLOS ONE			English	Article							ACTIVE-SITE; ESCHERICHIA-COLI; CELL-CYCLE; IN-VIVO; DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; APOPTOSIS; CLEAVAGE; URACIL; DNA	Background: Calpain proteases drive intracellular signal transduction via specific proteolysis of multiple substrates upon Ca2+-induced activation. Recently, dUTPase, an enzyme essential to maintain genomic integrity, was identified as a physiological calpain substrate in Drosophila cells. Here we investigate the potential structural/functional significance of calpain-activated proteolysis of human dUTPase. Methodology/Principal Findings: Limited proteolysis of human dUTPase by mammalian m-calpain was investigated in the presence and absence of cognate ligands of either calpain or dUTPase. Significant proteolysis was observed only in the presence of Ca(II) ions, inducing calpain action. The presence or absence of the dUTP-analogue alpha,beta-imido-dUTP did not show any effect on Ca2+-calpain-induced cleavage of human dUTPase. The catalytic rate constant of dUTPase was unaffected by calpain cleavage. Gel electrophoretic analysis showed that Ca2+-calpain-induced cleavage of human dUTPase resulted in several distinctly observable dUTPase fragments. Mass spectrometric identification of the calpain-cleaved fragments identified three calpain cleavage sites (between residues (SE5)-S-4; (TP8)-T-7; and (LS32)-L-31). The cleavage between the (LS32)-L-31 peptide bond specifically removes the flexible N-terminal nuclear localization signal, indispensable for cognate localization. Conclusions/Significance: Results argue for a mechanism where Ca2+-calpain may regulate nuclear availability and degradation of dUTPase.	[Bozoky, Zoltan; Rona, Gergely; Merenyi, Gabor; Vertessy, Beata G.; Friedrich, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Klement, Eva; Medzihradszky, Katalin F.] Hungarian Acad Sci, Biol Res Ctr, Prote Res Grp, H-6701 Szeged, Hungary; [Medzihradszky, Katalin F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of California System; University of California San Francisco; Budapest University of Technology & Economics	Bozoky, Z (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	vertessy@enzim.hu; friedric@enzim.hu	Róna, Gergely/AAB-8411-2020; Vertessy, Beata G/H-6202-2012	Róna, Gergely/0000-0003-3222-7261; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund [OTKA NK 60723, OTKA K68229, CK-78646]; Howard Hughes Medical Institutes [55000342]; Alexander von Humboldt Foundation; National Office for Research and Technology, Hungary [TAMOP-4.2.1/B-09/1/KMR-2010-0002];  [ADDMAL09 TET-09-1-2010-001]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Office for Research and Technology, Hungary(National Office for Research and Technology); 	This work was supported by grants from Hungarian Scientific Research Fund (OTKA NK 60723 to PF, OTKA K68229 and CK-78646 to BGV), the Howard Hughes Medical Institutes (#55000342), Alexander von Humboldt Foundation, the ADDMAL09 TET-09-1-2010-001 project and the New Hungary Development Plan (TAMOP-4.2.1/B-09/1/KMR-2010-0002) from the National Office for Research and Technology, Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2004, J BIOL CHEM, V279, P20118, DOI 10.1074/jbc.M311969200; Barabas O, 2003, J BIOL CHEM, V278, P38803, DOI 10.1074/jbc.M306967200; Bekesi A, 2004, J BIOL CHEM, V279, P22362, DOI 10.1074/jbc.M313647200; Bozoky Z, 2009, ARCH BIOCHEM BIOPHYS, V481, P219, DOI 10.1016/j.abb.2008.11.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Cheng ZX, 2008, J ETHNOPHARMACOL, V120, P129, DOI 10.1016/j.jep.2008.07.030; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Gong J, 2010, ARCH VIROL, V155, P1069, DOI 10.1007/s00705-010-0684-2; HORVATH A, 2010, J BACTERIOL, V170, P1069; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Huang CJ, 2010, J BIOL CHEM, V285, P339, DOI 10.1074/jbc.M109.024190; Janossy J, 2004, BIOCHEM PHARMACOL, V67, P1513, DOI 10.1016/j.bcp.2003.12.021; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; Ladner RD, 1997, J BIOL CHEM, V272, P19072, DOI 10.1074/jbc.272.30.19072; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson G, 1996, NAT STRUCT BIOL, V3, P532, DOI 10.1038/nsb0696-532; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; Merenyi G, 2010, FEBS J, V277, P2142, DOI 10.1111/j.1742-4658.2010.07630.x; Muha V, 2009, BIOCHEM BIOPH RES CO, V381, P271, DOI 10.1016/j.bbrc.2009.02.036; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Pineiro D, 2007, EXP CELL RES, V313, P369, DOI 10.1016/j.yexcr.2006.10.020; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; SHERWOOD SW, 1993, P NATL ACAD SCI USA, V90, P3353, DOI 10.1073/pnas.90.8.3353; SHLOMAI J, 1978, J BIOL CHEM, V253, P3305; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Tinkelenberg BA, 2003, EXP CELL RES, V287, P39, DOI 10.1016/S0014-4827(03)00048-X; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Williams D, 2011, BBA-MOL CELL RES, V1813, P315, DOI 10.1016/j.bbamcr.2010.11.021; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19546	10.1371/journal.pone.0019546	http://dx.doi.org/10.1371/journal.pone.0019546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625588	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200009
J	Sugiyama, H; Nakamura, K; Morita, H; Akagi, S; Tani, Y; Katayama, Y; Nishii, N; Miyoshi, T; Nagase, S; Kohno, K; Kusano, KF; Ohe, T; Kurokawa, J; Furukawa, T; Ito, H				Sugiyama, Hiroki; Nakamura, Kazufumi; Morita, Hiroshi; Akagi, Satoshi; Tani, Yoshinori; Katayama, Yusuke; Nishii, Nobuhiro; Miyoshi, Toru; Nagase, Satoshi; Kohno, Kunihisa; Kusano, Kengo Fukushima; Ohe, Tohru; Kurokawa, Junko; Furukawa, Tetsushi; Ito, Hiroshi			Circulating KCNH2 Current-Activating Factor in Patients with Heart Failure and Ventricular Tachyarrhythmia	PLOS ONE			English	Article							RECTIFIER POTASSIUM CURRENT; LONG QT SYNDROME; EXPERIMENTAL-MODEL; CELLULAR BASIS; GUINEA-PIG; ARRHYTHMOGENESIS; FORM	Background: It is estimated that approximately half of the deaths in patients with HF are sudden and that the most likely causes of sudden death are lethal ventricular tachyarrhythmias such as ventricular tachycardia (VT) or fibrillation (VF). However, the precise mechanism of ventricular tachyarrhythmias remains unknown. The KCNH2 channel conducting the delayed rectifier K+ current (I-Kr) is recognized as the most susceptible channel in acquired long QT syndrome. Recent findings have revealed that not only suppression but also enhancement of I-Kr increase vulnerability to major arrhythmic events, as seen in short QT syndrome. Therefore, we investigated the existence of a circulating KCNH2 current-modifying factor in patients with HF. Methodology/Principal Findings: We examined the effects of serum of HF patients on recombinant I-Kr recorded from HEK 293 cells stably expressing KCNH2 by using the whole-cell patch-clamp technique. Study subjects were 14 patients with non-ischemic HF and 6 normal controls. Seven patients had a history of documented ventricular tachyarrhythmias (VT: 7 and VF: 1). Overnight treatment with 2% serum obtained from HF patients with ventricular arrhythmia resulted in a significant enhancement in the peaks of I-Kr tail currents compared to the serum from normal controls and HF patients without ventricular arrhythmia. Conclusions/Significance: Here we provide the first evidence for the presence of a circulating KCNH2 channel activator in patients with HF and ventricular tachyarrhythmias. This factor may be responsible for arhythmogenesis in patients with HF.	[Sugiyama, Hiroki; Nakamura, Kazufumi; Morita, Hiroshi; Akagi, Satoshi; Tani, Yoshinori; Katayama, Yusuke; Nishii, Nobuhiro; Miyoshi, Toru; Nagase, Satoshi; Kohno, Kunihisa; Kusano, Kengo Fukushima; Ohe, Tohru; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan; [Morita, Hiroshi; Miyoshi, Toru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Therapeut, Okayama 7008530, Japan; [Kurokawa, Junko; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan	Okayama University; Okayama University; Tokyo Medical & Dental University (TMDU)	Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan.	ichibun@cc.okayama-u.ac.jp	Kurokawa, Junko/Q-6287-2017; Kurokawa, Junko/ABF-7557-2021; furukawa, tetsushi/ABD-3178-2020; Nishii, Nobuhiro/J-1972-2019	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908; 	Grants-in-Aid for Scientific Research [23136503] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; KJEKSHUS J, 1990, AM J CARDIOL, V65, pI42; Kurokawa J, 2008, J PHYSIOL-LONDON, V586, P2961, DOI 10.1113/jphysiol.2007.150367; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Nakamura K, 2007, J AM COLL CARDIOL, V50, P1808, DOI 10.1016/j.jacc.2007.07.037; Nof E, 2010, HEART RHYTHM, V7, P251, DOI 10.1016/j.hrthm.2009.10.017; Patel C, 2008, HEART RHYTHM, V5, P585, DOI 10.1016/j.hrthm.2008.01.022; Saenen JB, 2008, J MOL CELL CARDIOL, V44, P633, DOI 10.1016/j.yjmcc.2008.01.006; Hansen RS, 2007, J PHARMACOL EXP THER, V321, P996, DOI 10.1124/jpet.106.118448; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tsuji Y, 2000, CARDIOVASC RES, V48, P300, DOI 10.1016/S0008-6363(00)00180-2; Wang YH, 2008, BRIT J PHARMACOL, V154, P429, DOI 10.1038/bjp.2008.95; Watanabe H, 2010, HEART RHYTHM, V7, P647, DOI 10.1016/j.hrthm.2010.01.012; Zhou J, 2005, MOL PHARMACOL, V68, P876, DOI 10.1124/mol.105.014035; Zipes DP, 2005, CAN J CARDIOL, V21, p37A	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19897	10.1371/journal.pone.0019897	http://dx.doi.org/10.1371/journal.pone.0019897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625547	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200030
J	Brouard, O; Le Jeune, AH; Leroy, C; Cereghino, R; Roux, O; Pelozuelo, L; Dejean, A; Corbara, B; Carrias, JF				Brouard, Olivier; Le Jeune, Anne-Helene; Leroy, Celine; Cereghino, Regis; Roux, Olivier; Pelozuelo, Laurent; Dejean, Alain; Corbara, Bruno; Carrias, Jean-Francois			Are Algae Relevant to the Detritus-Based Food Web in Tank-Bromeliads?	PLOS ONE			English	Article							PITCHER-PLANT; COMMUNITY STRUCTURE; MOSQUITO LARVAE; CARBON; PHYTOPLANKTON; POPULATIONS; BACTERIA; GROWTH; FOREST; FRESH	We assessed the occurrence of algae in five species of tank-bromeliads found in contrasting environmental sites in a Neotropical, primary rainforest around the Nouragues Research Station, French Guiana. The distributions of both algal abundance and biomass were examined based on physical parameters, the morphological characteristics of bromeliad species and with regard to the structure of other aquatic microbial communities held in the tanks. Algae were retrieved in all of the bromeliad species with mean densities ranging from similar to 10(2) to 10(4) cells/mL. Their biomass was positively correlated to light exposure and bacterial biomass. Algae represented a tiny component of the detrital food web in shaded bromeliads but accounted for up to 30 percent of the living microbial carbon in the tanks of Catopsis berteroniana, located in a highly exposed area. Thus, while nutrient supplies are believed to originate from wind-borne particles and trapped insects (i.e., allochtonous organic matter), our results indicate that primary producers (i.e., autochtonous organic matter) are present in this insectivorous bromeliad. Using a 24-h incubation of size-fractionated and manipulated samples from this plant, we evaluated the impact of mosquito foraging on algae, other microorganisms and rotifers. The prey assemblages were greatly altered by the predation of mosquito larvae. Grazing losses indicated that the dominant algal taxon, Bumilleriopsis sp., like protozoa and rotifers, is a significant part of the diet of mosquito larvae. We conclude that algae are a relevant functional community of the aquatic food web in C. berteroniana and might form the basis of a complementary non-detrital food web.	[Brouard, Olivier; Le Jeune, Anne-Helene; Corbara, Bruno; Carrias, Jean-Francois] Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, LMGE,UMR 6023, Aubiere, France; [Leroy, Celine; Roux, Olivier; Dejean, Alain] CNRS, UMR 8172, Kourou, France; [Cereghino, Regis; Pelozuelo, Laurent] Univ Toulouse 3, CNRS, EcoLab, Lab Ecol Fonct & Environm,UMR 5245, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Brouard, O (corresponding author), Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, LMGE,UMR 6023, Aubiere, France.	j-francois.carrias@univ-bpclermont.fr	CEREGHINO, Regis/G-9500-2011; Carrias, Jean-François/AAT-2738-2021; Roux, Olivier/A-1181-2011; Carrias, Jean-françois/E-6952-2011; Leroy, Celine/I-4857-2016; Roux, Olivier/I-5675-2016	Carrias, Jean-François/0000-0002-6201-1544; Leroy, Celine/0000-0003-4859-8040; Cereghino, Regis/0000-0003-3981-3159; CORBARA, Bruno/0000-0003-4232-8234; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	Programme Amazonie II of the French Centre National de la Recherche Scientifique [2ID]	Programme Amazonie II of the French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (Project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; ALY C, 1988, ENTOMOL EXP APPL, V46, P55, DOI 10.1007/BF00187000; AMBLARD C, 1991, ANN BIOL-PARIS, V30, P6; BATEMAN LE, 1987, HYDROBIOLOGIA, V147, P129, DOI 10.1007/BF00025735; BENZING DH, 2000, BROMELIACEAE PROFILE; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; Bledzki LA, 1998, HYDROBIOLOGIA, V385, P193, DOI 10.1023/A:1003566729588; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; BRADSHAW WE, 1986, NATL GEOGR RES, V2, P167; BRATBAK G, 1985, MAR ECOL PROG SER, V25, P23, DOI 10.3354/meps025023; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; Carrias JF, 1998, ARCH HYDROBIOL, V143, P227; Carrias JF, 2001, J TROP ECOL, V17, P611, DOI 10.1017/S0266467401001456; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Fish D., 1983, P1; Frank J.H., 1983, P101; Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125; Frazer G.W., 1999, GAP LIGHT ANAL GLA 2, DOI DOI 10.1038/ismej.2015.171; Gebuhr C, 2006, PLANT BIOLOGY, V8, P849, DOI 10.1055/s-2006-924474; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gurung TB, 1999, AQUAT MICROB ECOL, V17, P27, DOI 10.3354/ame017027; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Kalff J, 2002, LIMNOLOGY INLAND WAT; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; KIKKAWA J, 2001, TRENDS ECOL EVOL, V16, P322; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; LAESSLE AM, 1961, ECOLOGY, V42, P499, DOI 10.2307/1932236; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McNeely C, 2007, ECOLOGY, V88, P391, DOI 10.1890/0012-9658(2007)88[391:GTCACS]2.0.CO;2; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; NEILSON AH, 1980, PHYSIOL PLANTARUM, V48, P542, DOI 10.1111/j.1399-3054.1980.tb03302.x; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Richardson BA, 1999, BIOTROPICA, V31, P321, DOI 10.1111/j.1744-7429.1999.tb00144.x; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; Richardson BA, 2000, ECOL ENTOMOL, V25, P348, DOI 10.1046/j.1365-2311.2000.00255.x; Sarthou C, 2003, J VEG SCI, V14, P645, DOI 10.1658/1100-9233(2003)014[0645:SVOTGI]2.0.CO;2; Sigee D. C., 2005, FRESHWATER MICROBIOL; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Trzcinski MK, 2005, OIKOS, V110, P146, DOI 10.1111/j.0030-1299.2005.13633.x; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x	50	50	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20129	10.1371/journal.pone.0020129	http://dx.doi.org/10.1371/journal.pone.0020129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625603	Green Submitted, gold, Green Published			2022-12-27	WOS:000290720200066
J	Bethell, D; Se, Y; Lon, C; Tyner, S; Saunders, D; Sriwichai, S; Darapiseth, S; Teja-Isavadharm, P; Khemawoot, P; Schaecher, K; Ruttvisutinunt, W; Lin, J; Kuntawungin, W; Gosi, P; Timmermans, A; Smith, B; Socheat, D; Fukuda, MM				Bethell, Delia; Se, Youry; Lon, Chanthap; Tyner, Stuart; Saunders, David; Sriwichai, Sabaithip; Darapiseth, Sea; Teja-Isavadharm, Paktiya; Khemawoot, Phisit; Schaecher, Kurt; Ruttvisutinunt, Wiriya; Lin, Jessica; Kuntawungin, Worachet; Gosi, Panita; Timmermans, Ans; Smith, Bryan; Socheat, Duong; Fukuda, Mark M.			Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial	PLOS ONE			English	Article							CAMBODIA	Background: The emergence of artemisinin resistance has raised concerns that the most potent antimalarial drug may be under threat. The currently recommended daily dose of artesunate (AS) is 4 mg/kg, and is administered for 3 days together with a partner antimalarial drug. This study investigated the impact of different AS doses on clinical and parasitological responses in malaria patients from an area of known artemisinin resistance in western Cambodia. Methods: Adult patients with uncomplicated P. falciparum malaria were randomized into one of three 7-day AS monotherapy regimens: 2, 4 or 6 mg/kg/day (total dose 14, 28 and 42 mg/kg). Clinical, parasitological, pharmacokinetic and in vitro drug sensitivity data was collected over a 7-day inpatient period and during weekly follow-up to 42 days. Results: 143 patients were enrolled (n = 75, 40 and 28 to receive AS 2, 4 and 6 mg/kg/day respectively). Cure rates were high in all treatment groups at 42 days despite almost half the patients remaining parasitemic on Day 3. There was no impact of increasing AS dose on median parasite clearance times, median parasite clearance rates or on the proportion of patients remaining parasitemic on Day 3. However at the lowest dose used (2 mg/kg/d) patients with parasitemia > 10,000/mu L had longer median (IQR) parasite clearance times than those with parasitemia < 10,000/mu L (63 (48-75) vs. 84 (66-96) hours, p < 0.0001). 19% of patients in the high-dose arm developed neutropenia (absolute neutrophil count < 1.0 x 10(9)/L) by Day 14 and resulted in the arm being halted early. Conclusion: There is no pharmacodynamic benefit of increasing the daily dose of AS (4mg/kg) currently recommended for short-course combination treatment of uncomplicated malaria, even in regions with emerging artemisinin resistance, as long as the partner drug retains high efficacy.	[Bethell, Delia; Se, Youry; Lon, Chanthap; Tyner, Stuart; Saunders, David; Sriwichai, Sabaithip; Teja-Isavadharm, Paktiya; Khemawoot, Phisit; Schaecher, Kurt; Ruttvisutinunt, Wiriya; Lin, Jessica; Kuntawungin, Worachet; Gosi, Panita; Timmermans, Ans; Smith, Bryan; Fukuda, Mark M.] Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand; [Darapiseth, Sea; Socheat, Duong] Ctr Parasitol Entomol & Malaria Control, Pnom Penh, Cambodia	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Center Parasitology, Entomology & Malaria Control	Bethell, D (corresponding author), Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand.	delia.bethell@afrims.org	Khemawoot, Phisit/ABE-2110-2020; Lin, Jessica/I-2705-2019		Bill and Melinda Gates Foundation through the World Health Organization; U.S. Department of Defense	Bill and Melinda Gates Foundation through the World Health Organization; U.S. Department of Defense(United States Department of Defense)	This study was funded by a Bill and Melinda Gates Foundation Program Grant through the World Health Organization, and the U.S. Department of Defense Global Emerging Infections System (GEIS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bethell D, 2010, CLIN INFECT DIS, V51, pE105, DOI 10.1086/657402; Borrmann S, 2008, ANTIMICROB AGENTS CH, V52, P1799, DOI 10.1128/AAC.00755-07; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Druilhe P, 1998, J CLIN INVEST, V101, P2008, DOI 10.1172/JCI119890; Enserink M, 2010, SCIENCE, V328, P844, DOI 10.1126/science.328.5980.844; Noedl H, 2004, AM J TROP MED HYG, V71, P711, DOI 10.4269/ajtmh.2004.71.711; Noedl H, 2004, ANTIMICROB AGENTS CH, V48, P4485, DOI 10.1128/AAC.48.11.4485-4487.2004; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Snounou G, 1998, PARASITOL TODAY, V14, P462, DOI 10.1016/S0169-4758(98)01340-4; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; TEJAISAVADHARM P, 2010, MOLECULES IN PRESS; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2020, REP ANT DRUG EFF RES; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization, 2009, METHODS SURVEILLANCE; 1998, BRIT PHARMACOPOEIA	24	65	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19283	10.1371/journal.pone.0019283	http://dx.doi.org/10.1371/journal.pone.0019283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603629	Green Submitted, gold, Green Published			2022-12-27	WOS:000290558500006
J	Inoue, D; Wittbrodt, J				Inoue, Daigo; Wittbrodt, Joachim			One for All-A Highly Efficient and Versatile Method for Fluorescent Immunostaining in Fish Embryos	PLOS ONE			English	Article							ANTIGEN RETRIEVAL TECHNIQUES; IN-VIVO; PROTEIN; IMMUNOHISTOCHEMISTRY; NEUROGENESIS; MICROWAVE; SECTIONS; RETINA	Background: For the detection and sub-cellular (co)-localization of proteins in the context of the tissue or organism immunostaining in whole mount preparations or on sections is still the best approach. So far, each antibody required its own fixation and antigen retrieval protocol so that optimizing immunostaining turned out to be tedious and time consuming. Methodology/Principal Finding: Here we present a novel method to efficiently retrieve the antigen in a widely applicable standard protocol, facilitating fluorescent immunostaining of both cryosections and whole mount preparations in zebrafish (Danio rerio) and medaka (Oryzias latipes). Conclusions/Significance: Our method overcomes the loss of sections and damage of tissue and cell morphology, and allows parallel immunostaining in multiple colors, co-immunostaining with fluorescent proteins in transgenic fish lines and in combination with whole mount in situ hybridization.	[Inoue, Daigo; Wittbrodt, Joachim] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany; [Wittbrodt, Joachim] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Inoue, D (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Baden Wurttembe, Germany.	daigo.inoue@cos.uni-heidelberg.de; jochen.wittbrodt@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377	HFSP; Uehara memorial Foundation; Naito Foundation; German Research Foundation [SFB 488]	HFSP(Human Frontier Science Program); Uehara memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); German Research Foundation(German Research Foundation (DFG))	DI was supported by HFSP long-term and Cellular Networks postdoctral fellowships, and by the Uehara memorial and Naito Foundations. This work was supported by the SFB 488 of the German Research Foundation (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanesov A, 2004, METHODS CELL BIOL, V76, P333; Brown KE, 2010, DEV BIOL, V339, P14, DOI 10.1016/j.ydbio.2009.12.003; Buchwalow IB, 2005, ACTA HISTOCHEM, V107, P143, DOI 10.1016/j.acthis.2005.01.003; D'Amico F, 2009, J IMMUNOL METHODS, V341, P1, DOI 10.1016/j.jim.2008.11.007; Del Bene F, 2007, PLOS GENET, V3, P1661, DOI 10.1371/journal.pgen.0030159; Hoetelmans RWM, 2002, BIOTECH HISTOCHEM, V77, P137, DOI 10.1080/714028191; Kim SH, 2004, J MOL HISTOL, V35, P409; Nakamura KC, 2008, J HISTOCHEM CYTOCHEM, V56, P647, DOI 10.1369/jhc.2008.950915; Martinez-Morales JR, 2009, DEVELOPMENT, V136, P2165, DOI 10.1242/dev.033563; ShanRongShi, 1996, BIOTECH HISTOCHEM, V71, P190, DOI 10.3109/10520299609117158; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Souren M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r92; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Taylor CR, 1996, BIOTECH HISTOCHEM, V71, P263, DOI 10.3109/10520299609117171; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	17	98	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19713	10.1371/journal.pone.0019713	http://dx.doi.org/10.1371/journal.pone.0019713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603650	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500026
J	Kuo, CL; Oyler, GA; Shoemaker, CB				Kuo, Chueh-Ling; Oyler, George A.; Shoemaker, Charles B.			Accelerated Neuronal Cell Recovery from Botulinum Neurotoxin Intoxication by Targeted Ubiquitination	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; NEUROTRANSMITTER RELEASE; CHIMERIC MOLECULES; ANTIBODY FRAGMENTS; SEROTYPE-A; SCF; BINDING; PROTEINS; PEPTIDE; DEGRADATION	Botulinum neurotoxin (BoNT), a Category A biodefense agent, delivers a protease to motor neuron cytosol that cleaves one or more soluble NSF attachment protein receptors (SNARE) proteins involved in neurotransmission to cause a flaccid paralysis. No antidotes exist to reverse symptoms of BoNT intoxication so severely affected patients require artificial respiration with prolonged intensive care. Time to recovery depends on toxin serotype because the intraneuronal persistence of the seven known BoNT serotypes varies widely from days to many months. Our therapeutic antidote strategy is to develop 'targeted F-box' (TFB) agents that target the different intraneuronal BoNT proteases for accelerated degradation by the ubiquitin proteasome system (UPS), thus promoting rapid recovery from all serotypes. These agents consist of a camelid heavy chain-only V-H (VHH) domain specific for a BoNT protease fused to an F-box domain recognized by an intraneuronal E3-ligase. A fusion protein containing the 14 kDa anti-BoNT/A protease VHH, ALcB8, joined to a 15 kDa F-box domain region of TrCP (D5) was sufficient to cause increased ubiquitination and accelerate turnover of the targeted BoNT/A protease within neurons. Neuronal cells expressing this TFB, called D5-B8, were also substantially resistant to BoNT/A intoxication and recovered from intoxication at least 2.5 fold quicker than control neurons. Fusion of D5 to a VHH specific for BoNT/B protease (BLcB10) led to accelerated turnover of the targeted protease within neurons, thus demonstrating the modular nature of these therapeutic agents and suggesting that development of similar therapeutic agents specific to all botulinum serotypes should be readily achievable.	[Kuo, Chueh-Ling; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Oyler, George A.] Synapt Res LLC, Baltimore, MD 21218 USA		Kuo, CL (corresponding author), Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu			NIAID; NIH; DHHS [U54 AI057159, R21 AI088489, N01-AI-30050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088489, R29AI030050, U54AI057159] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part with federal funds from the NIAID, NIH, DHHS, under Award Numbers U54 AI057159 and R21 AI088489, and Contract No. N01-AI-30050. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID and NIH. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GO is an employee of Synaptic Research LLC and contributed to the original concept and the data analysis.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Fahrer J, 2010, BIOCONJUGATE CHEM, V21, P130, DOI 10.1021/bc900365b; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gibbs WW, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican0805-78; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KOZAKI S, 1989, INFECT IMMUN, V57, P2634, DOI 10.1128/IAI.57.9.2634-2639.1989; Kuo CL, 2010, TOXICON, V55, P619, DOI 10.1016/j.toxicon.2009.10.019; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Sakamoto KM, 2005, METHOD ENZYMOL, V399, P833, DOI 10.1016/S0076-6879(05)99054-X; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Tsai YC, 2010, P NATL ACAD SCI USA, V107, P16554, DOI 10.1073/pnas.1008302107; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Webb RP, 2009, VACCINE, V27, P4490, DOI 10.1016/j.vaccine.2009.05.030; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zhang Peng, 2009, BMC Pharmacology, V9, P12, DOI 10.1186/1471-2210-9-12; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	41	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20352	10.1371/journal.pone.0020352	http://dx.doi.org/10.1371/journal.pone.0020352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629663	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800044
J	Lee, AP; Brenner, S; Venkatesh, B				Lee, Alison P.; Brenner, Sydney; Venkatesh, Byrappa			Mouse Transgenesis Identifies Conserved Functional Enhancers and cis-Regulatory Motif in the Vertebrate LIM Homeobox Gene Lhx2 Locus	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DNA METHYLATION PATTERNS; IN-VIVO; DENN DOMAIN; HOX GENE; EXPRESSION; PROTEIN; HOMEODOMAIN; ELEMENTS; CONNECDENN	The vertebrate Lhx2 is a member of the LIM homeobox family of transcription factors. It is essential for the normal development of the forebrain, eye, olfactory system and liver as well for the differentiation of lymphoid cells. However, despite the highly restricted spatio-temporal expression pattern of Lhx2, nothing is known about its transcriptional regulation. In mammals and chicken, Crb2, Dennd1a and Lhx2 constitute a conserved linkage block, while the intervening Dennd1a is lost in the fugu Lhx2 locus. To identify functional enhancers of Lhx2, we predicted conserved noncoding elements (CNEs) in the human, mouse and fugu Crb2-Lhx2 loci and assayed their function in transgenic mouse at E11.5. Four of the eight CNE constructs tested functioned as tissue-specific enhancers in specific regions of the central nervous system and the dorsal root ganglia (DRG), recapitulating partial and overlapping expression patterns of Lhx2 and Crb2 genes. There was considerable overlap in the expression domains of the CNEs, which suggests that the CNEs are either redundant enhancers or regulating different genes in the locus. Using a large set of CNEs (810 CNEs) associated with transcription factor-encoding genes that express predominantly in the central nervous system, we predicted four over-represented 8-mer motifs that are likely to be associated with expression in the central nervous system. Mutation of one of them in a CNE that drove reporter expression in the neural tube and DRG abolished expression in both domains indicating that this motif is essential for expression in these domains. The failure of the four functional enhancers to recapitulate the complete expression pattern of Lhx2 at E11.5 indicates that there must be other Lhx2 enhancers that are either located outside the region investigated or divergent in mammals and fishes. Other approaches such as sequence comparison between multiple mammals are required to identify and characterize such enhancers.	[Lee, Alison P.; Brenner, Sydney; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lee, AP (corresponding author), ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore.	mcbbv@imcb.a-star.edu.sg	Lee, Alison/HCH-1286-2022	Lee, Alison/0000-0002-3773-1021; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	The project was funded by the Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; ASP J, 2006, NONRADIOACTIVE SITU, pR11; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Bendall AJ, 1998, DIFFERENTIATION, V63, P151, DOI 10.1046/j.1432-0436.1998.6330151.x; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Guazzi S, 1998, J BIOL CHEM, V273, P11092, DOI 10.1074/jbc.273.18.11092; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Joksimovic M, 2005, GENE EXPR PATTERNS, V5, P792, DOI 10.1016/j.modgep.2005.03.008; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Kolterud A, 2004, GENE EXPR PATTERNS, V4, P521, DOI 10.1016/j.modgep.2004.03.001; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; NAGY A, 2003, MANIPULATING MOUSE E, pR10; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Ovcharenko I, 2008, MOL BIOL EVOL, V25, P1668, DOI 10.1093/molbev/msn116; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Porter FD, 1997, DEVELOPMENT, V124, P2935; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rhee JM, 1998, J BIOL CHEM, V273, P34196, DOI 10.1074/jbc.273.51.34196; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Sironi M, 2005, HUM MOL GENET, V14, P2533, DOI 10.1093/hmg/ddi257; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; van den Hurk JAJM, 2005, MOL VIS, V11, P263; Wandzioch E, 2004, P NATL ACAD SCI USA, V101, P16549, DOI 10.1073/pnas.0404678101; Wang HF, 2001, NEUROSCIENCE, V103, P999, DOI 10.1016/S0306-4522(00)00590-X; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu HK, 1997, BIOCHEM BIOPH RES CO, V234, P742, DOI 10.1006/bbrc.1997.6592; Wu HK, 1996, ONCOGENE, V12, P1205; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhao YG, 2010, DEV BIOL, V337, P313, DOI 10.1016/j.ydbio.2009.11.002; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	68	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20088	10.1371/journal.pone.0020088	http://dx.doi.org/10.1371/journal.pone.0020088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629789	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200034
J	Talman, V; Tuominen, RK; af Gennas, GB; Yli-Kauhaluoma, J; Ekokoski, E				Talman, Virpi; Tuominen, Raimo K.; af Gennas, Gustav Boije; Yli-Kauhaluoma, Jari; Ekokoski, Elina			C1 Domain-Targeted Isophthalate Derivatives Induce Cell Elongation and Cell Cycle Arrest in HeLa Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL; ACTIVATION; ISOZYMES; BINDING; DEATH; IDENTIFICATION; BRYOSTATIN-1; EPSILON; DISEASE	Diacylglycerol (DAG)-mediated signaling pathways, such as those mediated by protein kinase C (PKC), are central in regulating cell proliferation and apoptosis. DAG-responsive C1 domains are therefore considered attractive drug targets. Our group has designed a novel class of compounds targeted to the DAG binding site within the C1 domain of PKC. We have previously shown that these 5-(hydroxymethyl)isophthalates modulate PKC activation in living cells. In this study we investigated their effects on HeLa human cervical cancer cell viability and proliferation by using standard cytotoxicity tests and an automated imaging platform with machine vision technology. Cellular effects and their mechanisms were further characterized with the most potent compound, HMI-1a3. Isophthalate derivatives with high affinity to the PKC C1 domain exhibited antiproliferative and non-necrotic cytotoxic effects on HeLa cells. The anti-proliferative effect was irreversible and accompanied by cell elongation. HMI-1a3 induced down-regulation of retinoblastoma protein and cyclins A, B1, D1, and E. Effects of isophthalates on cell morphology, cell proliferation and expression of cell cycle-related proteins were different from those induced by phorbol 12-myristate-13-acetate (PMA) or bryostatin 1, but correlated closely to binding affinities. Therefore, the results strongly indicate that the effect is C1 domain-mediated.	[Talman, Virpi; Tuominen, Raimo K.; Ekokoski, Elina] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland; [af Gennas, Gustav Boije; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland	University of Helsinki; University of Helsinki	Talman, V (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland.	virpi.talman@helsinki.fi	Talman, Virpi/AAP-5146-2020; Boije af Gennäs, Gustav/N-4545-2015	Boije af Gennäs, Gustav/0000-0002-0099-6085; Talman, Virpi/0000-0002-2702-6505; Yli-Kauhaluoma, Jari/0000-0003-0370-7653	EU [503467]; Finnish Cultural Foundation; Magnus Ehrnrooth Foundation; Finnish Pharmaceutical Society; Alfred Kordelin Foundation	EU(European Commission); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Magnus Ehrnrooth Foundation; Finnish Pharmaceutical Society; Alfred Kordelin Foundation	This work was partially supported by grants from the EU (Pro-Kinase Research project no. 503467), the Finnish Cultural Foundation, the Magnus Ehrnrooth Foundation, the Finnish Pharmaceutical Society, and the Alfred Kordelin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	af Gennas GB, 2009, J MED CHEM, V52, P3969, DOI 10.1021/jm900229p; AFGENNAS GB, 2011, CURR TOP ME IN PRESS; BASU A, 1992, CANCER RES, V52, P3119; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Cameron AJM, 2010, ADV ENZYME REGUL, V50, P169, DOI 10.1016/j.advenzreg.2009.10.004; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Du W, 2009, J BIOL CHEM, V284, P26315, DOI 10.1074/jbc.M109.046904; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; Khan TK, 2009, NEUROBIOL DIS, V34, P332, DOI 10.1016/j.nbd.2009.02.003; Kim H, 2009, TOXICOL LETT, V184, P13, DOI 10.1016/j.toxlet.2008.10.006; Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Kozikowski AP, 1997, J MED CHEM, V40, P1316, DOI 10.1021/jm960875h; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Ling M, 2005, J BIOL CHEM, V280, P17910, DOI 10.1074/jbc.M412036200; Martinez-Ramos I, 2005, J CELL BIOCHEM, V96, P79, DOI 10.1002/jcb.20428; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sun MK, 2010, PHARMACOL THERAPEUT, V127, P66, DOI 10.1016/j.pharmthera.2010.03.001; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Truman JP, 2009, CANCER BIOL THER, V8, P54, DOI 10.4161/cbt.8.1.7119; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	40	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20053	10.1371/journal.pone.0020053	http://dx.doi.org/10.1371/journal.pone.0020053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629792	Green Published, gold			2022-12-27	WOS:000291005200029
J	Wagner, BD; Robertson, CE; Harris, JK				Wagner, Brandie D.; Robertson, Charles E.; Harris, J. Kirk			Application of Two-Part Statistics for Comparison of Sequence Variant Counts	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; MICROARRAY DATA; REGRESSION; INFERENCE; DATABASE; SEARCH; TOOLS	Investigation of microbial communities, particularly human associated communities, is significantly enhanced by the vast amounts of sequence data produced by high throughput sequencing technologies. However, these data create high-dimensional complex data sets that consist of a large proportion of zeros, non-negative skewed counts, and frequently, limited number of samples. These features distinguish sequence data from other forms of high-dimensional data, and are not adequately addressed by statistical approaches in common use. Ultimately, medical studies may identify targeted interventions or treatments, but lack of analytic tools for feature selection and identification of taxa responsible for differences between groups, is hindering advancement. The objective of this paper is to examine the application of a two-part statistic to identify taxa that differ between two groups. The advantages of the two-part statistic over common statistical tests applied to sequence count datasets are discussed. Results from the t-test, the Wilcoxon test, and the two-part test are compared using sequence counts from microbial ecology studies in cystic fibrosis and from cenote samples. We show superior performance of the two-part statistic for analysis of sequence data. The improved performance in microbial ecology studies was independent of study type and sequence technology used.	[Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harris, J. Kirk] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wagner, BD (corresponding author), Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA.	brandie.wagner@ucdenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Wagner, brandie/0000-0002-2745-0103	Cystic Fibrosis Foundation [HARRIS08A0]; National Institutes of Health (NIH) [1U01HL081335-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081335] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Cystic Fibrosis Foundation, number HARRIS08A0 (http://www.cff.org) and the National Institutes of Health (NIH), number 1U01HL081335-01 (http://grants.nih.gov/grants/oer.htm). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 2003, STAT ANAL COMPOSITIO; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bascoul-Mollevi C, 2005, STAT MED, V24, P1435, DOI 10.1002/sim.1979; Berglund EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000481; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eisen JA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000224; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Haas BJ, 2011, GENOME RES; Hallstrom AP, 2010, STAT MED, V29, P391, DOI 10.1002/sim.3785; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; LACHENBRUCH P A, 1976, Biometrische Zeitschrift, V18, P351; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; Lachenbruch PA, 2001, STAT MED, V20, P1215, DOI 10.1002/sim.790; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Neuhauser M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-35; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Relman DA, 2002, J INFECT DIS, V186, pS254, DOI 10.1086/344935; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; SAHL JW, 2010, ENV MICROBIOL; SAHL JW, 2010, ASTROBIOLOGY; Simon, 2004, NATL REV, V68; Taylor S, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1425; Wagner BD, 2008, GENET EPIDEMIOL, V32, P1, DOI 10.1002/gepi.20255; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zuur Alain F., 2009, P1	38	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20296	10.1371/journal.pone.0020296	http://dx.doi.org/10.1371/journal.pone.0020296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629788	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200050
J	Blonder, B; Dornhaus, A				Blonder, Benjamin; Dornhaus, Anna			Time-Ordered Networks Reveal Limitations to Information Flow in Ant Colonies	PLOS ONE			English	Article							SOCIAL NETWORK; BEHAVIOR; ORGANIZATION; DYNAMICS; PATTERNS; MODELS; SIZE	Background: An important function of many complex networks is to inhibit or promote the transmission of disease, resources, or information between individuals. However, little is known about how the temporal dynamics of individual-level interactions affect these networks and constrain their function. Ant colonies are a model comparative system for understanding general principles linking individual-level interactions to network-level functions because interactions among individuals enable integration of multiple sources of information to collectively make decisions, and allocate tasks and resources. Methodology/Findings: Here we show how the temporal and spatial dynamics of such individual interactions provide upper bounds to rates of colony-level information flow in the ant Temnothorax rugatulus. We develop a general framework for analyzing dynamic networks and a mathematical model that predicts how information flow scales with individual mobility and group size. Conclusions/Significance: Using thousands of time-stamped interactions between uniquely marked ants in four colonies of a range of sizes, we demonstrate that observed maximum rates of information flow are always slower than predicted, and are constrained by regulation of individual mobility and contact rate. By accounting for the ordering and timing of interactions, we can resolve important difficulties with network sampling frequency and duration, enabling a broader understanding of interaction network functioning across systems and scales.	[Blonder, Benjamin; Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Blonder, B (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	bblonder@email.arizona.edu			NSF [IOS 0841756]	NSF(National Science Foundation (NSF))	B.B. was supported by a NSF graduate research fellowship. A.D. was supported by NSF grant IOS 0841756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Cao TT, 2008, BIOL LETTERS, V4, P613, DOI 10.1098/rsbl.2008.0381; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cole BJ, 1996, AM NAT, V148, P1, DOI 10.1086/285908; COLE BJ, 1991, AM NAT, V137, P244, DOI 10.1086/285156; Dornhaus A, 2006, INSECT SOC, V53, P420, DOI 10.1007/s00040-006-0887-4; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; HATCHER MJ, 1992, NATURWISSENSCHAFTEN, V79, P32, DOI 10.1007/BF01132279; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Kossinets G., 2008, SIGKDD, P435; Kostakos V, 2009, PHYSICA A, V388, P1007, DOI 10.1016/j.physa.2008.11.021; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Naug D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1023, DOI 10.1007/s00265-009-0721-x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pacala SW, 1996, EVOL ECOL, V10, P127, DOI 10.1007/BF01241782; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PINTERWOLLMAN N, 2011, J R SOC INT IN PRESS; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; ROMANO CM, 2010, PLOS ONE, V5; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Sendova-Franks AB, 2010, ANIM BEHAV, V79, P473, DOI 10.1016/j.anbehav.2009.11.035; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; SOLE RV, 1993, J THEOR BIOL, V161, P343, DOI 10.1006/jtbi.1993.1060; Valverde S, 2006, IEEE INTELL SYST, V21, P36, DOI 10.1109/MIS.2006.34; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	34	74	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20298	10.1371/journal.pone.0020298	http://dx.doi.org/10.1371/journal.pone.0020298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625450	Green Published, gold			2022-12-27	WOS:000290793400053
J	Yepes, A; Rico, S; Rodriguez-Garcia, A; Santamaria, RI; Diaz, M				Yepes, Ana; Rico, Sergio; Rodriguez-Garcia, Antonio; Santamaria, Ramon I.; Diaz, Margarita			Novel Two-Component Systems Implied in Antibiotic Production in Streptomyces coelicolor	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; ATYPICAL RESPONSE REGULATOR; MORPHOLOGICAL-DIFFERENTIATION; SECONDARY METABOLISM; ESCHERICHIA-COLI; HISTIDINE KINASE; HALSTEDII JM8; GROWTH-PHASE; A3(2); GENE	The abundance of two-component systems (TCSs) in Streptomyces coelicolor A3(2) genome indicates their importance in the physiology of this soil bacteria. Currently, several TCSs have been related to antibiotic regulation, and the purpose in this study was the characterization of five TCSs, selected by sequence homology with the well-known absA1A2 system, that could also be associated with this important process. Null mutants of the five TCSs were obtained and two mutants (Delta SCO1744/1745 and Delta SCO4596/4597/4598) showed significant differences in both antibiotic production and morphological differentiation, and have been renamed as abr (antibiotic regulator). No detectable changes in antibiotic production were found in the mutants in the systems that include the ORFs SCO3638/3639, SCO3640/3641 and SCO2165/2166 in any of the culture conditions assayed. The system SCO1744/1745 (AbrA1/A2) was involved in negative regulation of antibiotic production, and acted also as a negative regulator of the morphological differentiation. By contrast, the system SCO4596/4597/4598 (AbrC1/C2/C3), composed of two histidine kinases and one response regulator, had positive effects on both morphological development and antibiotic production. Microarray analyses of the Delta abrC1/C2/C3 and wild-type transcriptomes revealed downregulation of actII-ORF4 and cdaR genes, the actinorhodin and calcium-dependent antibiotic pathway-specific regulators respectively. These results demonstrated the involvement of these new two-component systems in antibiotic production and morphological differentiation by different approaches. One is a pleiotropic negative regulator: abrA1/A2. The other one is a positive regulator composed of three elements, two histidine kinases and one response regulator: abrC1/C2/C3.	[Yepes, Ana; Rico, Sergio; Santamaria, Ramon I.; Diaz, Margarita] Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Rodriguez-Garcia, Antonio] Inst Biotecnol Leon, Leon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Yepes, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Genet & Microbiol, Edificio Dept,Campus Miguel de Unamuno, E-37008 Salamanca, Spain.	mardi@usal.es	Rodríguez-García, Antonio/A-9461-2011; Santamaria, Ramon I/K-2870-2014; Santamaria, Ramon I/M-9069-2019; Martínez, Margarita Díaz/L-3069-2014	Rodríguez-García, Antonio/0000-0001-8118-9762; Santamaria, Ramon I/0000-0002-2181-6776; Santamaria, Ramon I/0000-0002-2181-6776; Martínez, Margarita Díaz/0000-0003-4286-1506	Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon [SA072A07]; Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]; Junta de Castilla y Leon; Consejo Superior de Investigaciones Cientificas (CSIC)	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Consejo Superior de Investigaciones Cientificas (CSIC)	This work has been supported by grants GEN2003-20245-C09-02 from the Comision Interministerial de Ciencia y Tecnologia (CICYT) to R. Santamaria, SA072A07 from the Junta de Castilla y Leon to M. Diaz and BFU2010-17551 from Ministerio de Ciencia e Innovacion (MICINN) to M. Diaz. A. Y. was a holder of a predoctoral grant from the Junta de Castilla y Leon, S.R. has a predoctoral grant from the Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2001, APPL ENVIRON MICROB, V67, P5425, DOI 10.1128/AEM.67.12.5425-5430.2001; Anderson TB, 2001, MOL MICROBIOL, V39, P553, DOI 10.1046/j.1365-2958.2001.02240.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chang HM, 1996, MOL MICROBIOL, V21, P1075; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz M, 2005, MICROBIOL-SGM, V151, P2583, DOI 10.1099/mic.0.27983-0; Fernandez-Abalos JM, 2003, MICROBIOL-SGM, V149, P1623, DOI 10.1099/mic.0.26113-0; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Gadgil M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-66; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hopwood D. A., 1985, GENETIC MANIPULATION; Hosaka T, 2006, MOL MICROBIOL, V61, P883, DOI 10.1111/j.1365-2958.2006.05285.x; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim D, 2001, MICROBIOL-SGM, V147, P1197, DOI 10.1099/00221287-147-5-1197; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; LI L, 2010, J IND MICROBIOL BIOT; Li YH, 2004, PRO BIOMED OPT IMAG, V5, P1, DOI 10.1117/12.533347; Lu YH, 2007, APPL MICROBIOL BIOT, V77, P625, DOI 10.1007/s00253-007-1184-5; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; McKenzie NL, 2010, J ANTIBIOT, V63, P177, DOI 10.1038/ja.2010.13; McKenzie NL, 2009, MICROBIOL-SGM, V155, P1812, DOI 10.1099/mic.0.028431-0; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Ryding NJ, 2002, J BACTERIOL, V184, P794, DOI 10.1128/JB.184.3.794-805.2002; Sambrook J., 2002, MOL CLONING LAB MANU; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; Sheeler NL, 2005, J BACTERIOL, V187, P687, DOI 10.1128/JB.187.2.687-696.2005; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; Tanaka Y, 2009, APPL ENVIRON MICROB, V75, P4919, DOI 10.1128/AEM.00681-09; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Wang G, 2009, ANTIMICROB AGENTS CH, V53, P1019, DOI 10.1128/AAC.00388-08; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; XU D, 2010, APPL ENV MICROBIOL; Xu WJ, 2010, MOL MICROBIOL, V75, P781, DOI 10.1111/j.1365-2958.2009.07023.x	47	36	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19980	10.1371/journal.pone.0019980	http://dx.doi.org/10.1371/journal.pone.0019980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625497	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400027
J	Zhaoping, L; Geisler, WS; May, KA				Zhaoping, Li; Geisler, Wilson S.; May, Keith A.			Human Wavelength Discrimination of Monochromatic Light Explained by Optimal Wavelength Decoding of Light of Unknown Intensity	PLOS ONE			English	Article							VISUAL DISCRIMINATIONS; SPECTRAL SENSITIVITIES; QUANTUM EFFICIENCY; COLOR-VISION; CONES; RETINA	We show that human ability to discriminate the wavelength of monochromatic light can be understood as maximum likelihood decoding of the cone absorptions, with a signal processing efficiency that is independent of the wavelength. This work is built on the framework of ideal observer analysis of visual discrimination used in many previous works. A distinctive aspect of our work is that we highlight a perceptual confound that observers should confuse a change in input light wavelength with a change in input intensity. Hence a simple ideal observer model which assumes that an observer has a full knowledge of input intensity should over-estimate human ability in discriminating wavelengths of two inputs of unequal intensity. This confound also makes it difficult to consistently measure human ability in wavelength discrimination by asking observers to distinguish two input colors while matching their brightness. We argue that the best experimental method for reliable measurement of discrimination thresholds is the one of Pokorny and Smith, in which observers only need to distinguish two inputs, regardless of whether they differ in hue or brightness. We mathematically formulate wavelength discrimination under this wavelength-intensity confound and show a good agreement between our theoretical prediction and the behavioral data. Our analysis explains why the discrimination threshold varies with the input wavelength, and shows how sensitively the threshold depends on the relative densities of the three types of cones in the retina (and in particular predict discriminations in dichromats). Our mathematical formulation and solution can be applied to general problems of sensory discrimination when there is a perceptual confound from other sensory feature dimensions.	[Zhaoping, Li; May, Keith A.] UCL, Dept Comp Sci, London, England; [Geisler, Wilson S.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA	University of London; University College London; University of Texas System; University of Texas Austin	Zhaoping, L (corresponding author), UCL, Dept Comp Sci, London, England.	z.li@ucl.ac.uk	May, Keith/F-8686-2011	May, Keith/0000-0001-8114-5989; Geisler, Wilson/0000-0003-4630-6614	Gatsby Charitable Foundation; BBSRC [GR/E002536/01]	Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Gatsby Charitable Foundation and a Cognitive Science Foresight grant BBSRC #GR/E002536/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; Barlow H. B., 1977, VERTEBRATE PHOTORECE, P337; BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P155, DOI 10.1113/jphysiol.1962.sp006838; BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P169, DOI 10.1113/jphysiol.1962.sp006839; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BEDFORD RE, 1958, J OPT SOC AM, V48, P129, DOI 10.1364/JOSA.48.000129; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; CICERONE CM, 1989, VISION RES, V29, P1587, DOI 10.1016/0042-6989(89)90140-5; Dayan P, 2001, COMPUTATIONAL NEUROS; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; KNOBLAUCH K, 1993, J OPT SOC AM A, V10, P378, DOI 10.1364/JOSAA.10.000378; Li ZP, 2010, PERCEPTION, V39, P1148; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Packer O., 2003, SCI COLOR, P41, DOI 10.1016/B978-044451251-2/50003-9; Pelli D. G., 1990, VISION CODING EFFICI, P3; POKORNY J, 1970, J OPT SOC AM, V60, P562, DOI 10.1364/JOSA.60.000562; Ripamonti C, 2009, J VISION, V9, DOI 10.1167/9.3.10; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; VOS JJ, 1971, VISION RES, V11, P799, DOI 10.1016/0042-6989(71)90003-4; WRIGHT WD, 1952, J OPT SOC AM, V42, P509, DOI 10.1364/JOSA.42.000509; Wright WD, 1934, P PHYS SOC, V46, P459, DOI 10.1088/0959-5309/46/3/317	25	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19248	10.1371/journal.pone.0019248	http://dx.doi.org/10.1371/journal.pone.0019248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625482	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400002
J	Arthaud, L; Ben Rokia-Mille, S; Raad, H; Dombrovsky, A; Prevost, N; Capovilla, M; Robichon, A				Arthaud, Laury; Ben Rokia-Mille, Selim; Raad, Hussein; Dombrovsky, Aviv; Prevost, Nicolas; Capovilla, Maria; Robichon, Alain			Trade-Off between Toxicity and Signal Detection Orchestrated by Frequency- and Density-Dependent Genes	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENE; ARYL-HYDROCARBON RECEPTOR; DROSOPHILA-MELANOGASTER; INTRASPECIFIC COMPETITION; ENVIRONMENT INTERACTIONS; BEHAVIOR POLYMORPHISM; EPIGENETIC REGULATION; OLFACTORY BEHAVIOR; LIPID-PEROXIDATION; LOCUSTA-MIGRATORIA	Behaviors in insects are partly highly efficient Bayesian processes that fulfill exploratory tasks ending with the colonization of new ecological niches. The foraging (for) gene in Drosophila encodes a cGMP-dependent protein kinase (PKG). It has been extensively described as a frequency-dependent gene and its transcripts are differentially expressed between individuals, reflecting the population density context. Some for transcripts, when expressed in a population at high density for many generations, concomitantly trigger strong dispersive behavior associated with foraging activity. Moreover, genotype-by-environment interaction (GEI) analysis has highlighted a dormant role of for in energetic metabolism in a food deprivation context. In our current report, we show that alleles of for encoding different cGMP-dependent kinase isoforms influence the oxidation of aldehyde groups of aromatic molecules emitted by plants via Aldh-III and a phosphorylatable adaptor. The enhanced efficiency of oxidation of aldehyde odorants into carboxyl groups by the action of for lessens their action and toxicity, which should facilitate exploration and guidance in a complex odor environment. Our present data provide evidence that optimal foraging performance requires the fast metabolism of volatile compounds emitted by plants to avoid neurosensory saturation and that the frequency-dependent genes that trigger dispersion influence these processes.	[Arthaud, Laury; Ben Rokia-Mille, Selim; Raad, Hussein; Prevost, Nicolas; Robichon, Alain] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 6243, Sophia Antipolis, France; [Dombrovsky, Aviv] Agr Res Org, Volcani Ctr, IL-50250 Bet Dagan, Israel; [Capovilla, Maria] Univ Ferrara, Dept Biol & Evolut, Dulbecco Telethon Inst, I-44100 Ferrara, Italy	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Ferrara	Arthaud, L (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 6243, Sophia Antipolis, France.	alain.robichon@sophia.inra.fr	Capovilla, Maria/O-8483-2016	robichon, alain/0000-0003-1075-9646; Capovilla, Maria/0000-0002-1308-7964	ANR [blan-0186-01]; CNRS [PEPS 2437]; Maria Capovilla's Telethon [S03021]; Fondazione Telethon Funding Source: Custom	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Maria Capovilla's Telethon; Fondazione Telethon(Fondazione Telethon)	This work was supported by ANR blan-0186-01, a CNRS grant PEPS 2437, and Maria Capovilla's Telethon grant n. S03021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTAD DN, 1983, SCIENCE, V220, P93, DOI 10.1126/science.220.4592.93; ASMAN DC, 1993, J BIOL CHEM, V268, P12530; ASMUSSEN MA, 1983, GENETICS, V103, P335; AYYUB C, 1990, J NEUROGENET, V6, P243, DOI 10.3109/01677069009107114; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Boesch JS, 1999, ARCH BIOCHEM BIOPHYS, V361, P223, DOI 10.1006/abbi.1998.0989; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goldman D, 2010, BIOL PSYCHIAT, V67, P295, DOI 10.1016/j.biopsych.2009.12.005; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; GURU SC, 1990, ALCOHOL, V7, P397, DOI 10.1016/0741-8329(90)90022-5; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; HADDAD GG, 1997, J INSECT PHYSL, V43, P203; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hempel J, 2001, EUR J BIOCHEM, V268, P722, DOI 10.1046/j.1432-1327.2001.01926.x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JORDE PE, 1995, GENETICS, V139, P1077; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Kopp M, 2006, EVOLUTION, V60, P1537; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PENG TX, 1991, GENETICS, V128, P381; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Reisdorph R, 2007, DRUG METAB DISPOS, V35, P386, DOI 10.1124/dmd.106.012393; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; RKHA S, 1991, P NATL ACAD SCI USA, V88, P1835, DOI 10.1073/pnas.88.5.1835; Rokia-Mille SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002395; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schneider KA, 2006, J MATH BIOL, V52, P483, DOI 10.1007/s00285-005-0355-1; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Stagos D, 2010, BRAIN RES BULL, V81, P211, DOI 10.1016/j.brainresbull.2009.08.017; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; TOSIC M, 1981, GENETICS, V97, P679; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Wymore T, 2003, CHEM-BIOL INTERACT, V143, P75, DOI 10.1016/S0009-2797(02)00175-8; Zhang LX, 2002, J CELL BIOCHEM, V85, P392, DOI 10.1002/jcb.10146	61	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19805	10.1371/journal.pone.0019805	http://dx.doi.org/10.1371/journal.pone.0019805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625551	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200024
J	Stewart, JE; Kawabe, M; Abdo, Z; Arie, T; Peever, TL				Stewart, Jane E.; Kawabe, Masato; Abdo, Zaid; Arie, Tsutomu; Peever, Tobin L.			Contrasting Codon Usage Patterns and Purifying Selection at the Mating Locus in Putatively Asexual Alternaria Fungal Species	PLOS ONE			English	Article							AMINO-ACID SITES; PATHOGEN ASPERGILLUS-FUMIGATUS; TRANSFER-RNA GENES; POSITIVE SELECTION; DIVERSIFYING SELECTION; SUBSTITUTION RATES; ESCHERICHIA-COLI; DNA POLYMORPHISM; CRYPTIC SEX; EVOLUTION	Sexual reproduction in heterothallic ascomycete fungi is controlled by a single mating-type locus called MAT1 with two alternate alleles or idiomorphs, MAT1-1 and MAT1-2. These alleles lack sequence similarity and encode different transcriptional regulators. A large number of phytopathogenic fungi including Alternaria spp. are considered asexual, yet still carry expressed MAT1 genes. The molecular evolution of Alternaria MAT1 was explored using nucleotide diversity, nonsynonymous vs. synonymous substitution (dn/ds) ratios and codon usage statistics. Likelihood ratio tests of site-branch models failed to detect positive selection on MAT1-1-1 or MAT1-2-1. Codon-site models demonstrated that both MAT1-1-1 and MAT1-2-1 are under purifying selection and significant differences in codon usage were observed between MAT1-1-1 and MAT1-2-1. Mean GC content at the third position (GC3) and effective codon usage (ENC) were significantly different between MAT1-1-1 and MAT1-2-1 with values of 0.57 and 48 for MAT1-1-1 and 0.62 and 46 for MAT1-2-1, respectively. In contrast, codon usage of Pleospora spp. (anamorph Stemphylium), a closely related Dothideomycete genus, was not significantly different between MAT1-1-1 and MAT1-2-1. The purifying selection and biased codon usage detected at the MAT1 locus in Alternaria spp. suggest a recent sexual past, cryptic sexual present and/or that MAT1 plays important cellular role(s) in addition to mating.	[Stewart, Jane E.; Kawabe, Masato; Peever, Tobin L.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Abdo, Zaid] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Initiat Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Arie, Tsutomu] Tokyo Univ Agr & Technol, Inst Symbiot Sci & Technol, Tokyo, Japan	Washington State University; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Tokyo University of Agriculture & Technology	Stewart, JE (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	jestewart@wsu.edu	Abdo, Zaid/E-5176-2017; ARIE, Tsutomu/C-2831-2013	Abdo, Zaid/0000-0002-8272-7734; ARIE, Tsutomu/0000-0002-4604-6608	NIH [P20RR16448]; ARCS Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; Division Of Environmental Biology [0918668] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [22405018] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	ZA is partially funded by NIH P20RR16448. JS received partial financial support from the ARCS Foundation (www.arcsfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Andersson SGE, 1996, MICROBIOL-UK, V142, P915, DOI 10.1099/00221287-142-4-915; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; BULMER M, 1991, GENETICS, V129, P897; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Civetta A, 2006, MOL BIOL EVOL, V23, P655, DOI 10.1093/molbev/msj074; Debuchy R, 1999, FUNGAL GENET BIOL, V27, P218, DOI 10.1006/fgbi.1999.1142; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; FU Y, 1993, GENETICS, V155, P1405; GENEREUX D, 2002, GENOME BIOL, V3, P58; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Grocock RJ, 2002, GENE, V289, P131, DOI 10.1016/S0378-1119(02)00503-6; Groenewald M, 2006, FUNGAL GENET BIOL, V43, P813, DOI 10.1016/j.fgb.2006.05.008; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Inderbitzin P, 2005, P NATL ACAD SCI USA, V102, P11390, DOI 10.1073/pnas.0501918102; Innan H, 2000, GENETICS, V155, P2015; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; NEUHAUSER C, 2003, HDB STAT GENETICS, P577; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; PEDEN JF, 1999, THESIS U NOTTINGHAM; Peever TL, 1999, PHYTOPATHOLOGY, V89, P851, DOI 10.1094/PHYTO.1999.89.10.851; Rau D, 2007, CURR GENET, V51, P377, DOI 10.1007/s00294-007-0126-1; Rehmeyer CJ, 2009, CURR GENET, V55, P253, DOI 10.1007/s00294-009-0240-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Sharon A, 1996, MOL GEN GENET, V251, P60, DOI 10.1007/BF02174345; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SIMMONS EG, 1986, MYCOTAXON, V25, P287; Staats M, 2007, FUNGAL GENET BIOL, V44, P52, DOI 10.1016/j.fgb.2006.07.003; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yamagishi D, 2006, MOL PLANT MICROBE IN, V19, P1280, DOI 10.1094/MPMI-19-1280; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Zhan JS, 2007, FUNGAL GENET BIOL, V44, P339, DOI 10.1016/j.fgb.2006.10.008	69	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20083	10.1371/journal.pone.0020083	http://dx.doi.org/10.1371/journal.pone.0020083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625561	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200048
J	Trikic, MZ; Monk, P; Roehl, H; Partridge, LJ				Trikic, Michael Z.; Monk, Pete; Roehl, Henry; Partridge, Lynda J.			Regulation of Zebrafish Hatching by Tetraspanin cd63	PLOS ONE			English	Article							CATHEPSIN-L; SECRETORY LYSOSOMES; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN CD63; WILD-TYPE; DIFFERENTIATION; MEMBRANE; VESICLES; BIOSYNTHESIS	Tetraspanins cause the clustering of membrane proteins into a level of organisation essential for cellular function. Given the importance and complicated nature of this mechanism, we attempted a novel approach to identify the function of a single component in a biologically relevant context. A morpholino knockdown strategy was used to investigate the role of cd63, a membrane protein associated with intracellular transport and a melanoma marker, in embryonic zebrafish. By using three separate morpholinos targeting cd63, we were able to identify a specific phenotype. Strikingly, morphant fish failed to hatch due to the lack of secreted proteolytic enzymes required for chorion-softening. The morphology of the hatching gland at both the cellular and intracellular levels was disorganised, suggesting a role for cd63 in the functioning of this organ. This work identifies a specific role for cd63 in the zebrafish embryo and provides evidence for the suitability of zebrafish as a model system for the investigation of tetraspanin enriched microdomains.	[Trikic, Michael Z.; Monk, Pete] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Roehl, Henry] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Trikic, MZ (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.	m.trikic@shef.ac.uk	Monk, Peter/C-6155-2008	Monk, Peter/0000-0003-4637-3059; Trikic, Michael/0000-0001-5580-5402	University of Sheffield, in the department of Molecular Biology and Biotechnology; Medical Research Council [G0700091B] Funding Source: researchfish	University of Sheffield, in the department of Molecular Biology and Biotechnology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a University of Sheffield Krebs Studentship grant, in the department of Molecular Biology and Biotechnology. The funding source no longer exists, however the link to the source of funding follows: http://www.shef.ac.uk/mbb/prospectivepg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; Amano T, 2001, J BIOCHEM-TOKYO, V129, P739, DOI 10.1093/oxfordjournals.jbchem.a002914; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Crosier PS, 2001, DEV DYNAM, V222, P637, DOI 10.1002/dvdy.1218; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gardiner MR, 2005, DEV DYNAM, V234, P992, DOI 10.1002/dvdy.20571; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gritsman K, 2000, DEVELOPMENT, V127, P921; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hiroi J, 2004, DEV GENES EVOL, V214, P176, DOI 10.1007/s00427-004-0397-1; HOTTA H, 1988, CANCER RES, V48, P2955; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kallquist L, 2008, BLOOD, V112, P3444, DOI 10.1182/blood-2007-10-116285; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Leung YF, 2007, INVEST OPHTH VIS SCI, V48, P881, DOI 10.1167/iovs.06-0723; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Mangos S, 2000, MOL CELL BIOCHEM, V215, P93, DOI 10.1023/A:1026598516681; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Muller WEG, 1999, MAR BIOTECHNOL, V1, P569, DOI 10.1007/PL00011812; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rauch GJ, 2003, SUBMISSION CURATION; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Schafer T, 2010, ALLERGY, V65, P1242, DOI 10.1111/j.1398-9995.2010.02350.x; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Thisse B, 2004, ZFIN DIRECT DATA SUB; THISSE C, 1993, DEVELOPMENT, V119, P1203; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Vogel AM, 1997, DEV GENES EVOL, V206, P477, DOI 10.1007/s004270050078; Wu M, 2007, J CELL SCI, V120, P3147, DOI 10.1242/jcs.007260; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Yoshida T, 2008, TRAFFIC, V9, P540, DOI [10.1111/j.1600-0854.2007.00700.x, 10.1111/j.1600-0854.2008.00700.x]	49	35	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19683	10.1371/journal.pone.0019683	http://dx.doi.org/10.1371/journal.pone.0019683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625559	Green Published, Green Accepted, gold			2022-12-27	WOS:000290771200015
J	Finke, C; Ostendorf, F; Braun, M; Ploner, CJ				Finke, Carsten; Ostendorf, Florian; Braun, Mischa; Ploner, Christoph J.			Impaired Representation of Geometric Relationships in Humans with Damage to the Hippocampal Formation	PLOS ONE			English	Article							SPATIAL MEMORY DEFICITS; MEDIAL TEMPORAL-LOBE; SHORT-TERM-MEMORY; PARAHIPPOCAMPAL CORTEX; REORIENTATION; LOCATION; LESIONS; BOUNDARIES; NAVIGATION; INSIGHTS	The pivotal role of the hippocampus for spatial memory is well-established. However, while neurophysiological and imaging studies suggest a specialization of the hippocampus for viewpoint-independent or allocentric memory, results from human lesion studies have been less conclusive. It is currently unclear whether disproportionate impairment in allocentric memory tasks reflects impairment of cognitive functions that are not sufficiently supported by regions outside the medial temporal lobe or whether the deficits observed in some studies are due to experimental factors. Here, we have investigated whether hippocampal contributions to spatial memory depend on the spatial references that are available in a certain behavioral context. Patients with medial temporal lobe lesions affecting systematically the right hippocampal formation performed a series of three oculomotor tasks that required memory of a spatial cue either in retinal coordinates or relative to a single environmental reference across a delay of 5000 ms. Stimulus displays varied the availability of spatial references and contained no complex visuo-spatial associations. Patients showed a selective impairment in a condition that critically depended on memory of the geometric relationship between spatial cue and environmental reference. We infer that regions of the medial temporal lobe, most likely the hippocampal formation, contribute to behavior in conditions that exceed the potential of viewpoint-dependent or egocentric representations. Apparently, this already applies to short-term memory of simple geometric relationships and does not necessarily depend on task difficulty or integration of landmarks into more complex representations. Deficient memory of basic geometric relationships may represent a core deficit that contributes to impaired performance in allocentric spatial memory tasks.	[Finke, Carsten; Ostendorf, Florian; Braun, Mischa; Ploner, Christoph J.] Charite, Neurol Klin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Finke, C (corresponding author), Charite, Neurol Klin, D-13353 Berlin, Germany.	christoph.ploner@charite.de	Ostendorf, Florian/AAE-1348-2019; Finke, Carsten/H-6479-2017; Ostendorf, Florian/E-8342-2013	Ostendorf, Florian/0000-0002-4544-7610; Finke, Carsten/0000-0002-7665-1171; Ostendorf, Florian/0000-0002-4544-7610; Ploner, Christoph Johannes/0000-0003-0983-4530	Deutsche Forschungsgemeinschaft [Pl 248/3-1, Pl 248/4-1]; Bundesministerium fur Bildung und Forschung [01GW0653]; Sonnenfeld-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sonnenfeld-Stiftung	Supported by the Deutsche Forschungsgemeinschaft (grants Pl 248/3-1, Pl 248/4-1), the Bundesministerium fur Bildung und Forschung (grant 01GW0653), and the Sonnenfeld-Stiftung (grant to M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Altman D.G., 1991, PRACTICAL STATISTIC; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bird CM, 2010, J NEUROSCI, V30, P11688, DOI 10.1523/JNEUROSCI.0723-10.2010; Bohbot VD, 2004, NEUROPSYCHOLOGY, V18, P418, DOI 10.1037/0894-4105.18.3.418; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Braun M, 2008, BRAIN, V131, P2742, DOI 10.1093/brain/awn191; Braun M, 2011, HIPPOCAMPUS, V21, P309, DOI 10.1002/hipo.20752; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Finke C, 2008, NEUROPSYCHOLOGIA, V46, P614, DOI 10.1016/j.neuropsychologia.2007.10.004; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Glikmann-Johnston Y, 2008, BRAIN, V131, P3006, DOI 10.1093/brain/awn213; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Hermer L, 1996, COGNITION, V61, P195, DOI 10.1016/S0010-0277(96)00714-7; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Hornak J, 1997, NEUROPSYCHOLOGIA, V35, P1311, DOI 10.1016/S0028-3932(97)00062-6; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lakusta L, 2010, P NATL ACAD SCI USA, V107, P2813, DOI 10.1073/pnas.0909155107; Landau B, 2009, CURR OPIN NEUROBIOL, V19, P12, DOI 10.1016/j.conb.2009.02.001; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Morris R., 2007, HIPPOCAMPUS BOOK, P581; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Parslow DM, 2005, ACTA PSYCHOL, V118, P123, DOI 10.1016/j.actpsy.2004.10.006; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; RAINS GD, 1994, NEUROPSYCHOLOGIA, V32, P1233; Shrager Y, 2007, P NATL ACAD SCI USA, V104, P2961, DOI 10.1073/pnas.0611233104; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Suthana NA, 2009, J NEUROSCI, V29, P10512, DOI 10.1523/JNEUROSCI.0621-09.2009; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19507	10.1371/journal.pone.0019507	http://dx.doi.org/10.1371/journal.pone.0019507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611122	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200009
J	Menkhorst, E; Zhang, JG; Sims, NA; Morgan, PO; Soo, P; Poulton, IJ; Metcalf, D; Alexandrou, E; Gresle, M; Salamonsen, LA; Butzkueven, H; Nicola, NA; Dimitriadis, E				Menkhorst, Ellen; Zhang, Jian-Guo; Sims, Natalie A.; Morgan, Phillip O.; Soo, Priscilla; Poulton, Ingrid J.; Metcalf, Donald; Alexandrou, Estella; Gresle, Melissa; Salamonsen, Lois A.; Butzkueven, Helmut; Nicola, Nicos A.; Dimitriadis, Evdokia			Vaginally Administered PEGylated LIF Antagonist Blocked Embryo Implantation and Eliminated Non-Target Effects on Bone in Mice	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; HUMAN ENDOMETRIUM; INFERTILE WOMEN; BLASTOCYST IMPLANTATION; RECEPTOR; UTERUS; LEVONORGESTREL; INTERLEUKIN-11; PROGESTERONE; EXPRESSION	Female-controlled contraception/HIV prevention is critical to address health issues associated with gender inequality. Therefore, a contraceptive which can be administered in tandem with a microbicide to inhibit sexually transmitted infections, is desirable. Uterine leukemia inhibitory factor (LIF) is obligatory for blastocyst implantation in mice and associated with infertility in women. We aimed to determine whether a PEGylated LIF inhibitor (PEGLA) was an effective contraceptive following vaginal delivery and to identify non-uterine targets of PEGLA in mice. Vaginally-applied (125)I-PEGLA accumulated in blood more slowly (30 min vs 10 min) and showed reduced tissue and blood retention (24 h vs 96 h) compared to intraperitoneal injection in mice. Vaginally-applied PEGLA blocked implantation. PEGLA administered by intraperitoneal injection inhibited bone remodelling whereas vaginally-applied PEGLA had no effect on bone. Further, PEGLA had no effect in an animal model of multiple sclerosis, experimental auto-immune encephalomyelitis, suggesting PEGLA cannot target the central nervous system. Vaginally-administered PEGLA is a promising non-hormonal contraceptive, one which could be delivered alone, or in tandem with a microbicide. Vaginal application reduced the total dose of PEGLA required to block implantation and eliminated the systemic effect on bone, showing the vagina is a promising site of administration for larger drugs which target organs within the reproductive tract.	[Menkhorst, Ellen; Salamonsen, Lois A.; Dimitriadis, Evdokia] Prince Henrys Inst, Clayton, Vic, Australia; [Zhang, Jian-Guo; Morgan, Phillip O.; Soo, Priscilla; Metcalf, Donald; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Sims, Natalie A.; Poulton, Ingrid J.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Alexandrou, Estella; Gresle, Melissa; Butzkueven, Helmut] Howard Florey Inst, Melbourne, Vic, Australia; [Alexandrou, Estella; Butzkueven, Helmut] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Prince Henry's Institute of Medical Research; Walter & Eliza Hall Institute; St. Vincent's Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Menkhorst, E (corresponding author), Prince Henrys Inst, Clayton, Vic, Australia.	ellen.menkhorst@princehenrys.org	Salamonsen, Lois/J-9822-2019; Menkhorst, Ellen/AAU-4329-2021; dimitriadis, e/AAD-7601-2021; Sims, Natalie Ann/A-7192-2012; Menkhorst, Ellen/P-5759-2014; Nicola, Nicos/D-2989-2011	Menkhorst, Ellen/0000-0003-2440-6665; Sims, Natalie Ann/0000-0003-1421-8468; Nicola, Nicos/0000-0003-1054-7889; Dimitriadis, Eva/0000-0001-8698-1927; gresle, melissa/0000-0003-0738-1136; Salamonsen, Lois/0000-0003-0558-7325; Butzkueven, Helmut/0000-0003-3940-8727; dimitriadis, eva/0000-0003-1425-950X	Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School [CIG-07-116]; NHMRC (Australia) [461219, 345401, 516730, 388920]; Lalor Foundation; Victorian Government's (Australia); CASS Foundation; Harold Mitchell Foundation	Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Lalor Foundation; Victorian Government's (Australia); CASS Foundation; Harold Mitchell Foundation	This work was supported by the Consortium for Industrial Collaboration in Contraceptive Research Program (CICCR) of the Contraceptive Research and Development Program (CONRAD) Eastern Virginia Medical School (Sub-project CIG-07-116 [ED]), the NHMRC (Australia) (Program grants: 461219 [NN]; 345401 [NAS]; project grants 516730 [JGZ]; 388920 [ED] and fellowships to LAS, NAS and EM), the Lalor Foundation (Postdoctoral Fellowship [EM]) and the Victorian Government's (Australia) Operational Infrastructure Support Program. EM received travel support from The CASS Foundation and the Harold Mitchell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; [Anonymous], 2009, LANCET, V374, P949; Bahamondes L, 2006, HUM REPROD, V21, P1316, DOI 10.1093/humrep/dei457; Benagiano G, 2008, EXPERT REV MED DEVIC, V5, P639, DOI 10.1586/17434440.5.5.639; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Brache V, 2007, CONTRACEPTION, V76, P111, DOI 10.1016/j.contraception.2007.04.005; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; Cicinelli E, 2004, FERTIL STERIL, V81, P1414, DOI 10.1016/j.fertnstert.2003.12.016; Cicinelli E, 1999, HUM REPROD UPDATE, V5, P365, DOI 10.1093/humupd/5.4.365; Cicinelli E, 2001, FERTIL STERIL, V76, P1108, DOI 10.1016/S0015-0282(01)02905-3; Cicinelli E, 2000, OBSTET GYNECOL, V95, P403, DOI 10.1016/S0029-7844(99)00542-6; CORNISH J, 1993, ENDOCRINOLOGY, V132, P1359, DOI 10.1210/en.132.3.1359; Devoto L, 2005, FERTIL STERIL, V84, P46, DOI 10.1016/j.fertnstert.2005.01.106; deZiegler D, 1997, ANN NY ACAD SCI, V828, P291; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Dimitriadis E, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-44; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Ficicioglu C, 2004, GYNECOL ENDOCRINOL, V18, P240, DOI 10.1080/09513590410001692519; Herrmann M, 2010, CLIN ENDOCRINOL, V72, P571, DOI 10.1111/j.1365-2265.2009.03688.x; HILTON DJ, 1991, J CELL PHYSIOL, V148, P430, DOI 10.1002/jcp.1041480315; Hussain A, 2005, J CONTROL RELEASE, V103, P301, DOI 10.1016/j.jconrel.2004.11.034; Jewkes R, 2010, SCIENCE, V329, P145, DOI 10.1126/science.1193794; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; KOJIMA K, 1994, BIOL REPROD, V50, P882, DOI 10.1095/biolreprod50.4.882; KOPF GS, 2007, SOC REPROD FERTIL S, V63, P21; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; KUROSAWA K, 1985, TOHOKU J EXP MED, V147, P261, DOI 10.1620/tjem.147.261; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Martin TJ, 2007, CLIN SCI, V112, P77, DOI 10.1042/CS20060046; Marwood M, 2009, ENDOCRINOLOGY, V150, P2915, DOI 10.1210/en.2008-1538; Menkhorst E, 2009, BIOL REPROD, V80, P920, DOI 10.1095/biolreprod.108.073601; Mikolajczyk M, 2007, AM J REPROD IMMUNOL, V58, P65, DOI 10.1111/j.1600-0897.2007.00492.x; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tsai HD, 2000, J ASSIST REPROD GEN, V17, P415, DOI 10.1023/A:1009457016871; Vogiagis D, 1996, J ENDOCRINOL, V148, P95, DOI 10.1677/joe.0.1480095; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; WARE CB, 1995, DEVELOPMENT, V121, P1283; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104	48	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19665	10.1371/journal.pone.0019665	http://dx.doi.org/10.1371/journal.pone.0019665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611124	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200024
J	Skennerton, CT; Angly, FE; Breitbart, M; Bragg, L; He, SM; McMahon, KD; Hugenholtz, P; Tyson, GW				Skennerton, Connor T.; Angly, Florent E.; Breitbart, Mya; Bragg, Lauren; He, Shaomei; McMahon, Katherine D.; Hugenholtz, Philip; Tyson, Gene W.			Phage Encoded H-NS: A Potential Achilles Heel in the Bacterial Defence System	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; STREPTOCOCCUS-THERMOPHILUS BACTERIOPHAGES; NUCLEOID-ASSOCIATED PROTEIN; ESCHERICHIA-COLI; GENE-EXPRESSION; DNA; GENOME; VIRUSES; TRANSCRIPTION; COMMUNITY	The relationship between phage and their microbial hosts is difficult to elucidate in complex natural ecosystems. Engineered systems performing enhanced biological phosphorus removal (EBPR), offer stable, lower complexity communities for studying phage-host interactions. Here, metagenomic data from an EBPR reactor dominated by Candidatus Accumulibacter phosphatis (CAP), led to the recovery of three complete and six partial phage genomes. Heat-stable nucleoid structuring (H-NS) protein, a global transcriptional repressor in bacteria, was identified in one of the complete phage genomes (EPV1), and was most similar to a homolog in CAP. We infer that EPV1 is a CAP-specific phage and has the potential to repress up to 6% of host genes based on the presence of putative H-NS binding sites in the CAP genome. These genes include CRISPR associated proteins and a Type III restriction-modification system, which are key host defense mechanisms against phage infection. Further, EPV1 was the only member of the phage community found in an EBPR microbial metagenome collected seven months prior. We propose that EPV1 laterally acquired H-NS from CAP providing it with a means to reduce bacterial defenses, a selective advantage over other phage in the EBPR system. Phage encoded H-NS could constitute a previously unrecognized weapon in the phage-host arms race.	[Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia; [Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Australian Ctr Ecogenom, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Bragg, Lauren] CSIRO Math Informat & Stat, St Lucia, Qld, Australia; [He, Shaomei] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [He, Shaomei] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA	University of Queensland; University of Queensland; University of Queensland; State University System of Florida; University of South Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Skennerton, CT (corresponding author), Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia.	g.tyson@uq.edu.au	Breitbart, Mya/B-1366-2009; Tyson, Gene W/C-6558-2013; Hugenholtz, Philip/AAD-9138-2019; Angly, Florent E/A-7717-2011; Bragg, Lauren/B-8554-2009; McMahon, Katherine D/I-3651-2012	Breitbart, Mya/0000-0003-3210-2899; Tyson, Gene W/0000-0001-8559-9427; Hugenholtz, Philip/0000-0001-5386-7925; Angly, Florent E/0000-0002-8999-0738; Skennerton, Connor/0000-0003-1320-4873; McMahon, Katherine D./0000-0002-7038-026X	Australian Research Council [DP1093175]; US National Science Foundation [BES-0332136]; Directorate For Engineering [0967646] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); US National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Australian Research Council (www.arc.gov.au/), 265 grant DP1093175, and US National Science Foundation (www.nsf.gov/) grant BES-0332136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Barr JJ, 2010, FEMS MICROBIOL ECOL, V74, P631, DOI 10.1111/j.1574-6941.2010.00967.x; Brussow H, 1998, VIRUS GENES, V16, P95, DOI 10.1023/A:1007957911848; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Drummond AJ, 2010, GENEIOUS; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Eppley JM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-398; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; He SM, 2010, APPL ENVIRON MICROB, V76, P5479, DOI 10.1128/AEM.00370-10; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; KRUGER D, 2005, FEMS MICROBIOL REV, V1, P177; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIU QY, 1993, P NATL ACAD SCI USA, V90, P1761, DOI 10.1073/pnas.90.5.1761; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; MEDINAAPARICIO L, 2011, J BACTERIOL, P1410; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Neethling J., 2006, FACTORS INFLUENCING; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Sette M, 2009, J BIOL CHEM, V284, P30453, DOI 10.1074/jbc.M109.044313; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; SUN S, NUCL ACIDS RES; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	36	41	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20095	10.1371/journal.pone.0020095	http://dx.doi.org/10.1371/journal.pone.0020095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625595	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200063
J	Steurer, J; Haller, C; Hauselmann, H; Brunner, F; Bachmann, LM				Steurer, Johann; Haller, Cyrill; Haeuselmann, HansJoerg; Brunner, Florian; Bachmann, Lucas M.			Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review	PLOS ONE			English	Review							BONE-MINERAL DENSITY; HIP FRACTURE; POSTMENOPAUSAL WOMEN; ELDERLY-WOMEN; VERTEBRAL FRACTURE; ASSESSMENT-TOOL; TERM RISK; PREDICTION; VALIDATION; SCORE	Background: With the broad availability of effective medications, identifying individuals bearing a higher risk for osteoporotic fractures has become an issue of major concern in modern medicine. In recent years various prognostic instruments have become available showing conflicting results regarding estimated risks for individual patients. Objective: To provide an overview of current evidence and of opportunities for further research. Methodology/Principal Findings: Systematic Review: We identified studies describing the development of instruments and all subsequent validations in electronic databases and reference lists of included studies. We screened for inclusion, read full papers and extracted data on salient clinical features, performance characteristics and quality in duplicate. Searches retrieved 5,275 records of which full texts of 167 papers were obtained after screening titles and abstract. We included 35 studies enrolling a total of 609,969 patients (median 2546) reporting on 31 derivations and 12 validations after assessing full texts. Median follow-up time was 4.1 years (IQR 3 to 7.7). Only four studies validated an instrument that was developed by another group. None of the existing instruments was validated more than once. The five most frequent included variables in the final model were age, body mass index, bone mass index, past history of falls, and maternal history of fractures. The methodological quality of the studies was moderate. Conclusion: There is a plethora of evidence available studying the association of risk profiles and the development of osteoporotic fractures. The small number of out-of-sample validations, the large variety of study characteristics, outcomes and follow-up periods impedes from deriving robust summaries and from conclusions regarding the clinical performance of many tools. First and foremost, future activity in this field should aim at reaching a consensus among clinical experts in respect to the existing instruments. Then we call for careful validations and expedient adaptations for local circumstances of the most promising candidates.	[Steurer, Johann; Haller, Cyrill; Brunner, Florian; Bachmann, Lucas M.] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland; [Haeuselmann, HansJoerg] Ctr Rheumatol, Zurich, Switzerland; [Haeuselmann, HansJoerg] Bone Dis Clin, Zurich, Switzerland; [Brunner, Florian] Balgrist Univ Hosp, Dept Phys Med & Rheumatol, Zurich, Switzerland	University of Zurich; University of Zurich	Steurer, J (corresponding author), Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland.	Johann.steurer@usz.ch	Bachmann, Lucas M/C-9686-2011	, Lucas/0000-0002-9868-154X	Swiss Association against Osteoporosis	Swiss Association against Osteoporosis	This work was sponsored by an unrestricted grant of the Swiss Association against Osteoporosis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed LA, 2006, EUR J EPIDEMIOL, V21, P815, DOI 10.1007/s10654-006-9072-3; Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; BARRETT CE, 2005, J BONE MINER RES, V20, P185; Bensen R, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-47; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Chen YT, 2007, OSTEOPOROSIS INT, V18, P1287, DOI 10.1007/s00198-007-0380-6; Colon-Emeric CS, 2002, OSTEOPOROSIS INT, V13, P955, DOI 10.1007/s001980200133; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dargent-Molina P, 2002, OSTEOPOROSIS INT, V13, P593, DOI 10.1007/s001980200078; Diez-Perez A, 2007, OSTEOPOROSIS INT, V18, P629, DOI 10.1007/s00198-006-0297-5; ELFFORS L, 1993, BONE, V14, pS45; Ettinger B, 2005, J WOMENS HEALTH, V14, P159, DOI 10.1089/jwh.2005.14.159; Fujiwara S, 2008, OSTEOPOROSIS INT, V19, P429, DOI 10.1007/s00198-007-0544-4; Girman CJ, 2002, J AM GERIATR SOC, V50, P1341, DOI 10.1046/j.1532-5415.2002.50354.x; Guessous I, 2008, RADIOLOGY, V248, P179, DOI 10.1148/radiol.2481070986; Hans D, 2008, J BONE MINER RES, V23, P1045, DOI 10.1359/JBMR.080229; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Krege JH, 2006, OSTEOPOROSIS INT, V17, P379, DOI 10.1007/s00198-005-2005-2; Kung AWC, 2007, J BONE MINER RES, V22, P1080, DOI [10.1359/jbmr.070320, 10.1359/JBMR.070320]; Leslie WD, 2008, BONE, V43, P667, DOI 10.1016/j.bone.2008.06.001; Lippuner K, 2009, OSTEOPOROSIS INT, V20, P1131, DOI 10.1007/s00198-008-0779-8; McGrother CW, 2002, OSTEOPOROSIS INT, V13, P89, DOI 10.1007/s198-002-8343-6; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Nguyen ND, 2005, J BONE MINER RES, V20, P1921, DOI 10.1359/JBMR.050520; Nguyen TV, 2004, OSTEOPOROSIS INT, V15, P49, DOI 10.1007/s00198-003-1511-3; Nguyen TV, 2001, AM J EPIDEMIOL, V153, P587, DOI 10.1093/aje/153.6.587; Porthouse J, 2004, QJM-INT J MED, V97, P569, DOI 10.1093/qjmed/hch097; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Roux C, 2007, ANN RHEUM DIS, V66, P931, DOI 10.1136/ard.2006.064071; Torgerson DJ, 1996, J BONE MINER RES, V11, P293; Turner LW, 1998, J AGING HEALTH, V10, P372, DOI 10.1177/089826439801000306; Turner LW, 1998, SOUTHERN MED J, V91, P533, DOI 10.1097/00007611-199806000-00005; van Staa TP, 2006, QJM-INT J MED, V99, P673, DOI 10.1093/qjmed/hcl094; VANHEMERT AM, 1990, AM J EPIDEMIOL, V132, P123, DOI 10.1093/oxfordjournals.aje.a115624; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568	38	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19994	10.1371/journal.pone.0019994	http://dx.doi.org/10.1371/journal.pone.0019994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625596	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000290720200056
J	Semaan, N; Frenzel, L; Alsaleh, G; Suffert, G; Gottenberg, JE; Sibilia, J; Pfeffer, S; Wachsmann, D				Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Suffert, Guillaume; Gottenberg, Jacques-Eric; Sibilia, Jean; Pfeffer, Sebastien; Wachsmann, Dominique			miR-346 Controls Release of TNF-alpha Protein and Stability of Its mRNA in Rheumatoid Arthritis via Tristetraprolin Stabilization	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; BRUTONS TYROSINE KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MICRORNA; EXPRESSION; CELLS; INFLAMMATION; ACTIVATION; PATHWAYS	TNF-alpha is a major cytokine implicated in rheumatoid arthritis. Its expression is regulated both at the transcriptional and posttranscriptional levels and recent data demonstrated that miRNAs are implicated in TNF-alpha response in macrophages. LPS-activated FLS isolated from RA patients express TNF-alpha mRNA but not the mature protein. This prompted us to look for miRNAs which could be implicated in this anti-inflammatory effect. Using a microarray, we found two miRNAs, miR-125b and miR-939 predicted to target the 3'-UTR of TNF-alpha mRNA, to be up-regulated in RA FLS in response to LPS, but their repression did not restore mature TNF-alpha expression in FLS. We showed previously that miR-346, which is upregulated in LPS-activated FLS, inhibited Btk expression that stabilized TNF-alpha mRNA. Blocking miR-346 reestablished TNF-alpha expression in activated FLS. Interestingly, transfection of miR-346 in LPS-activated THP-1 cells inhibited TNF-alpha secretion. We also demonstrated that TTP, a RNA binding protein which inhibited TNF-alpha synthesis, is overexpressed in activated FLS and that inhibition of miR-346 decreases its expression. Conversely, transfection of miR-346 in LPS-activated THP-1 cells increased TTP mRNA expression and inhibited TNF-alpha release. These results indicate that miR-346 controls TNF-alpha synthesis by regulating TTP expression.	[Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Gottenberg, Jacques-Eric; Sibilia, Jean; Wachsmann, Dominique] Univ Strasbourg, UFR Sci Pharmaceut, Lab Physiopathol Arthrit, EA4438, Illkirch Graffenstaden, France; [Semaan, Noha; Frenzel, Laurent; Alsaleh, Ghada; Gottenberg, Jacques-Eric; Sibilia, Jean; Wachsmann, Dominique] Hop Univ Strasbourg, Dept Rhumatol, Strasbourg Hautepierre, France; [Suffert, Guillaume; Pfeffer, Sebastien] Univ Strasbourg, Architecture & React ARN, Inst Biol Mol & Cellulaire, CNRS, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Semaan, N (corresponding author), Univ Strasbourg, UFR Sci Pharmaceut, Lab Physiopathol Arthrit, EA4438, Illkirch Graffenstaden, France.	s.pfeffer@ibmc-cnrs.unistra.fr; dominique.wachsmann@pharma.u-strasbg.fr	Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019	Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Sibilia, Jean/0000-0002-1601-4795; alsaleh, ghada/0000-0002-4211-3420	CNRS; Bristol Myers Squibb; Roche; Pfizer; Courtin Fundation; CAMPLP	CNRS(Centre National de la Recherche Scientifique (CNRS)); Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Pfizer(Pfizer); Courtin Fundation; CAMPLP	This work was supported by an ATIP starting grant from CNRS to Sebastien Pfeffer and by grants from Bristol Myers Squibb, Roche, Pfizer, Courtin Fundation and CAMPLP to Dominique Wachsmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chatenay-Rivauday C, 1998, MOL MICROBIOL, V29, P39, DOI 10.1046/j.1365-2958.1998.00881.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DECHANET J, 1994, EUR J IMMUNOL, V24, P3222, DOI 10.1002/eji.1830241247; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harashima SI, 2004, RHEUMATOLOGY, V43, P396, DOI 10.1093/rheumatology/keh022; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Neff L, 2001, CELL MICROBIOL, V3, P703, DOI 10.1046/j.1462-5822.2001.00148.x; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; O'Connell RM, NAT REV IMMUNOL, V10, P111; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Semaan N, 2008, J IMMUNOL, V180, P3485, DOI 10.4049/jimmunol.180.5.3485; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Tili Esmerina, 2008, Int J Med Sci, V5, P73; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Zorn CN, 2009, CELL SIGNAL, V21, P79, DOI 10.1016/j.cellsig.2008.09.010	39	80	89	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19827	10.1371/journal.pone.0019827	http://dx.doi.org/10.1371/journal.pone.0019827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611196	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500026
J	Le, LP; Nielsen, GP; Rosenberg, AE; Thomas, D; Batten, JM; Deshpande, V; Schwab, J; Duan, ZF; Xavier, RJ; Hornicek, FJ; Iafrate, AJ				Le, Long Phi; Nielsen, G. Petur; Rosenberg, Andrew Eric; Thomas, Dafydd; Batten, Julie M.; Deshpande, Vikram; Schwab, Joseph; Duan, Zhenfeng; Xavier, Ramnik J.; Hornicek, Francis J.; Iafrate, A. John			Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; FAMILIAL CHORDOMA; SKULL BASE; METHYLATION STATUS; EXPRESSION; CANCER; RECEPTOR; REGIONS; LOCUS	The molecular events in chordoma pathogenesis have not been fully delineated, particularly with respect to copy number changes. Understanding copy number alterations in chordoma may reveal critical disease mechanisms that could be exploited for tumor classification and therapy. We report the copy number analysis of 21 sporadic chordomas using array comparative genomic hybridization (CGH). Recurrent copy changes were further evaluated with immunohistochemistry, methylation specific PCR, and quantitative real-time PCR. Similar to previous findings, large copy number losses, involving chromosomes 1p, 3, 4, 9, 10, 13, 14, and 18, were more common than copy number gains. Loss of CDKN2A with or without loss of CDKN2B on 9p21.3 was observed in 16/20 (80%) unique cases of which six (30%) showed homozygous deletions ranging from 76 kilobases to 4.7 megabases. One copy loss of the 10q23.31 region which encodes PTEN was found in 16/20 (80%) cases. Loss of CDKN2A and PTEN expression in the majority of cases was not attributed to promoter methylation. Our sporadic chordoma cases did not show hotspot point mutations in some common cancer gene targets. Moreover, most of these sporadic tumors are not associated with T (brachyury) duplication or amplification. Deficiency of CDKN2A and PTEN expression, although shared across many other different types of tumors, likely represents a key aspect of chordoma pathogenesis. Sporadic chordomas may rely on mechanisms other than copy number gain if they indeed exploit T/brachyury for proliferation.	[Le, Long Phi; Nielsen, G. Petur; Rosenberg, Andrew Eric; Batten, Julie M.; Deshpande, Vikram; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Thomas, Dafydd] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Schwab, Joseph; Duan, Zhenfeng; Hornicek, Francis J.] Harvard Univ, Orthopaed Oncol Serv, Massachusetts Gen Hosp, Sch Med,Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Le, LP (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	lple@partners.org	Pillay, Nischalan/F-9536-2012		Stephan Harris Chordoma Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Stephan Harris Chordoma Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the Stephan Harris Chordoma Center, Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrakli F, 2007, SURG NEUROL, V68, P425, DOI 10.1016/j.surneu.2006.11.046; Casali PG, 2007, CURR OPIN ONCOL, V19, P367, DOI 10.1097/CCO.0b013e3281214448; CHUANG LSH, 2010, ONCOGENE; Dalpra L, 1999, INT J CANCER, V81, P24, DOI 10.1002/(SICI)1097-0215(19990331)81:1<24::AID-IJC5>3.3.CO;2-F; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Eisenberg MB, 1997, SURG NEUROL, V47, P156, DOI 10.1016/S0090-3019(96)00432-6; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Hallor KH, 2008, BRIT J CANCER, V98, P434, DOI 10.1038/sj.bjc.6604130; Han S, 2009, CLIN CANCER RES, V15, P1940, DOI 10.1158/1078-0432.CCR-08-2364; HEFFELFINGER MJ, 1973, CANCER-AM CANCER SOC, V32, P410, DOI 10.1002/1097-0142(197308)32:2<410::AID-CNCR2820320219>3.0.CO;2-S; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hof H, 2006, ONKOLOGIE, V29, P572, DOI 10.1159/000096283; Kelley MJ, 2001, AM J HUM GENET, V69, P454, DOI 10.1086/321982; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuzniacka A, 2004, CANCER GENET CYTOGEN, V151, P178, DOI 10.1016/j.cancergencyto.2003.09.015; Lee-Jones L, 2004, GENE CHROMOSOME CANC, V41, P80, DOI 10.1002/gcc.20052; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Miozzo M, 2000, INT J CANCER, V87, P68, DOI 10.1002/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V; Naka T, 2005, CANCER-AM CANCER SOC, V104, P1255, DOI 10.1002/cncr.21296; Pallini R, 2003, J NEUROSURG, V98, P812, DOI 10.3171/jns.2003.98.4.0812; PRESNEAU N, 2010, J PATHOL; Riva P, 2003, INT J CANCER, V107, P493, DOI 10.1002/ijc.11421; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Shalaby AAE, 2009, MODERN PATHOL, V22, P996, DOI 10.1038/modpathol.2009.63; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; STACCHIOTTI S, 2009, ANN ONCOL; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tirabosco R, 2008, AM J SURG PATHOL, V32, P572, DOI 10.1097/PAS.0b013e31815b693a; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	31	72	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e18846	10.1371/journal.pone.0018846	http://dx.doi.org/10.1371/journal.pone.0018846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602918	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500002
J	Kotlarchyk, MA; Shreim, SG; Alvarez-Elizondo, MB; Estrada, LC; Singh, R; Valdevit, L; Kniazeva, E; Gratton, E; Putnam, AJ; Botvinick, EL				Kotlarchyk, Maxwell A.; Shreim, Samir G.; Alvarez-Elizondo, Martha B.; Estrada, Laura C.; Singh, Rahul; Valdevit, Lorenzo; Kniazeva, Ekaterina; Gratton, Enrico; Putnam, Andrew J.; Botvinick, Elliot L.			Concentration Independent Modulation of Local Micromechanics in a Fibrin Gel	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX MIMICS; MECHANICAL-PROPERTIES; ENDOTHELIAL-CELLS; PARTICLE TRACKING; STRESS FIBERS; MESH SIZE; HYDROGELS; ELASTICITY; MIGRATION; BEHAVIOR	Methods for tuning extracellular matrix (ECM) mechanics in 3D cell culture that rely on increasing the concentration of either protein or cross-linking molecules fail to control important parameters such as pore size, ligand density, and molecular diffusivity. Alternatively, ECM stiffness can be modulated independently from protein concentration by mechanically loading the ECM. We have developed a novel device for generating stiffness gradients in naturally derived ECMs, where stiffness is tuned by inducing strain, while local mechanical properties are directly determined by laser tweezers based active microrheology (AMR). Hydrogel substrates polymerized within 35 mm diameter Petri dishes are strained non-uniformly by the precise rotation of an embedded cylindrical post, and exhibit a position-dependent stiffness with little to no modulation of local mesh geometry. Here we present the device in the context of fibrin hydrogels. First AMR is used to directly measure local micromechanics in unstrained hydrogels of increasing fibrin concentration. Changes in stiffness are then mapped within our device, where fibrin concentration is held constant. Fluorescence confocal imaging and orbital particle tracking are used to quantify structural changes in fibrin on the micro and nano levels respectively. The micromechanical strain stiffening measured by microrheology is not accompanied by ECM microstructural changes under our applied loads, as measured by confocal microscopy. However, super-resolution orbital tracking reveals nanostructural straightening, lengthening, and reduced movement of fibrin fibers. Furthermore, we show that aortic smooth muscle cells cultured within our device are morphologically sensitive to the induced mechanical gradient. Our results demonstrate a powerful cell culture tool that can be used in the study of mechanical effects on cellular physiology in naturally derived 3D ECM tissues.	[Kotlarchyk, Maxwell A.; Shreim, Samir G.; Alvarez-Elizondo, Martha B.; Estrada, Laura C.; Kniazeva, Ekaterina; Gratton, Enrico; Putnam, Andrew J.; Botvinick, Elliot L.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA; [Alvarez-Elizondo, Martha B.; Botvinick, Elliot L.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Estrada, Laura C.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92715 USA; [Singh, Rahul; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Valdevit, Lorenzo] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Valdevit, Lorenzo] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92717 USA; [Botvinick, Elliot L.] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kotlarchyk, MA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	elliot.botvinick@uci.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377; Valdevit, Lorenzo/0000-0001-9525-7148; Alvarez Elizondo, Martha Beatriz/0000-0002-3632-5224	National Science Foundation [DMR-0805164]; National Institutes of Health [P41-RR001192, R01-HL085339]; UCMEXUS-CONACYT; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCMEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research was provided by the National Science Foundation (DMR-0805164) and the National Institutes of Health (P41-RR001192 and R01-HL085339), and UCMEXUS-CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7; Bereczky Z, 2003, PATHOPHYSIOL HAEMO T, V33, P430, DOI 10.1159/000083841; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; BRAU RR, 2007, J OPT A-PURE APPL OP, pS103; Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333; Hellriegel C, 2009, J R SOC INTERFACE, V6, pS3, DOI 10.1098/rsif.2008.0313.focus; Hudson NE, 2010, BIOPHYS J, V98, P1632, DOI 10.1016/j.bpj.2009.12.4312; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Kim PD, 2009, BIOMATERIALS, V30, P3854, DOI 10.1016/j.biomaterials.2009.04.013; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Kotlarchyk MA, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194121; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Liao HM, 2008, ACTA BIOMATER, V4, P1161, DOI 10.1016/j.actbio.2008.04.013; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; MIZUNO D, 2008, MACROMOLECULES; MOCKROS LF, 1974, BIOPHYS CHEM, V2, P164, DOI 10.1016/0301-4622(74)80037-2; Munoz-Pinto DJ, 2009, J BIOMED MATER RES A, V90A, P303, DOI 10.1002/jbm.a.32492; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040; Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012; Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006; Russell RJ, 2009, BIOPHYS J, V97, P1578, DOI 10.1016/j.bpj.2009.07.017; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Silveira A, 2006, ARTERIOSCL THROM VAS, V26, P2419, DOI 10.1161/01.ATV.0000245798.26855.88; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382	40	66	66	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20201	10.1371/journal.pone.0020201	http://dx.doi.org/10.1371/journal.pone.0020201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629793	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200043
J	Msyamboza, KP; Ngwira, B; Dzowela, T; Mvula, C; Kathyola, D; Harries, AD; Bowie, C				Msyamboza, Kelias P.; Ngwira, Bagrey; Dzowela, Titha; Mvula, Chimwemwe; Kathyola, Damson; Harries, Anthony D.; Bowie, Cameron			The Burden of Selected Chronic Non-Communicable Diseases and Their Risk Factors in Malawi: Nationwide STEPS Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; RESEARCH AGENDA; BLOOD-PRESSURE; AFRICA; TUBERCULOSIS; COUNTRIES; POLICY; CARE	Background: Chronic non-communicable diseases (NCDs) are becoming significant causes of morbidity and mortality, particularly in sub-Saharan African countries, although local, high-quality data to inform evidence-based policies are lacking. Objectives: To determine the magnitude of NCDs and their risk factors in Malawi. Methods: Using the WHO STEPwise approach to chronic disease risk factor surveillance, a population-based, nationwide cross-sectional survey was conducted between July and September 2009 on participants aged 25-64 years. Socio-demographic and behaviour risk factors were collected in Step 1. Physical anthropometric measurements and blood pressure were documented in Step 2. Blood cholesterol and fasting blood glucose were measured in Step 3. Results and Conclusion: A total of 5,206 adults (67% females) were surveyed. Tobacco smoking, alcohol drinking and raised blood pressure (BP) were more frequent in males than females, 25% vs 3%, 30% vs 4% and 37% vs 29%. Overweight, physical inactivity and raised cholesterol were more common in females than males, 28% vs 16%, 13% vs 6% and 11% vs 6%. Tobacco smoking was more common in rural than urban areas 11% vs 7%, and overweight and physical inactivity more common in urban than rural areas 39% vs 22% and 24% vs 9%, all with p < 0.05. Overall (both sexes) prevalence of tobacco smoking, alcohol consumption, overweight and physical inactivity was 14%, 17%, 22%, 10% and prevalence of raised BP, fasting blood sugar and cholesterol was 33%, 6% and 9% respectively. These data could be useful in the formulation and advocacy of NCD policy and action plan in Malawi.	[Msyamboza, Kelias P.] World Hlth Org, Malawi Country Off, Lilongwe, Malawi; [Ngwira, Bagrey; Bowie, Cameron] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Dzowela, Titha; Mvula, Chimwemwe; Kathyola, Damson] Minist Hlth, Lilongwe, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	World Health Organization; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Msyamboza, KP (corresponding author), World Hlth Org, Malawi Country Off, Lilongwe, Malawi.	msyambozak@mw.afro.who.int		Bowie, Cam/0000-0002-6956-3691	Malawi Ministry of Health; World Health Organisation	Malawi Ministry of Health; World Health Organisation(World Health Organization)	The study was co-funded by the Malawi Ministry of Health and World Health Organisation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2010, LANCET; Belghazi J, 2007, VASC HEALTH RISK MAN, V3, P389; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bowie Cameron, 2006, Malawi Med J, V18, P103; Cohen DB, 2010, AM J TROP MED HYG, V83, P575, DOI 10.4269/ajtmh.2010.10-0104; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; Harries AD, 2009, T ROY SOC TROP MED H, V103, P1, DOI 10.1016/j.trstmh.2008.08.008; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Lins Nancy E, 2010, Glob Health Promot, V17, P27, DOI 10.1177/1757975910363927; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; McCarthy M, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-13; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Mufunda J, 2006, ETHNIC DIS, V16, P521; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Organization W. H, 2009, 2008 2013 ACT PLAN G; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; Wan Y, 2010, J HUM HYPERTENS, V24, P431, DOI 10.1038/jhh.2010.37; *WHO DEP CHRON DIS, 2005, PREV CHRON DIS VIT I; *WHO REG OFF S E A, 2009, RES PRIOR NONC DIS; *WHO REG OFF S E A, 2007, REG FRAM PREV CONTR; World Health Organization, 2005, WHO STEPS SURV MAN W; [No title captured]	32	119	122	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20316	10.1371/journal.pone.0020316	http://dx.doi.org/10.1371/journal.pone.0020316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629735	Green Accepted, Green Published, gold			2022-12-27	WOS:000291005200053
J	Tao, R; Li, J; Xin, JJ; Wu, J; Guo, J; Zhang, LY; Jiang, LY; Zhang, W; Yang, Z; Li, LJ				Tao, Ran; Li, Jun; Xin, Jiaojiao; Wu, Jian; Guo, Jing; Zhang, Liyuan; Jiang, Longyan; Zhang, Wu; Yang, Zhe; Li, Lanjuan			Methylation Profile of Single Hepatocytes Derived from Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC INACTIVATION; PROTEOMIC ANALYSIS; CANCER; GENE; LIVER; EXPRESSION; BREAST; CELLS; HYPERMETHYLATION	Background: With the development of high-throughput screening, a variety of genetic alterations has been found in hepatocellular carcinoma (HCC). Although previous studies on HCC methylation profiles have focused on liver tissue, studies using isolated hepatocytes are rare. The heterogeneity of liver composition may impact the genuine methylation status of HCC; therefore, it is important to clarify the methylation profile of hepatocytes to aid in understanding the process of tumorigenesis. Methods and Findings: The global methylation profile of single hepatocytes isolated from liver tissue of hepatitis B virus (HBV) related HCC (HBHC) was analyzed using Illumina Infinium Human Methylation27 BeadChips, and combined bisulfite restriction analysis (COBRA) and bisulfite sequencing were used to validate the 20 significant hypermethylated genes identified. In this study, we found many noteworthy differences in the genome-wide methylation profiles of single hepatocytes of HBHC. Unsupervised hierarchical clustering analysis showed that hepatocyte methylation profiles could be classified according to three cell types: hepatocytes of HCC, adjacent hepatocytes and normal hepatocytes. Among the 20 most hypermethylated genes in the hepatocytes of HBHC, 7 novel genes (WNK2, EMILIN2, TLX3, TM6SF1, TRIM58, HIST1H4F and GRASP) were found to be hypermethylated in HBHC and hypomethylated in paired adjacent liver tissues; these findings have not been reported in previous studies on tissue samples. Conclusion: The genome-wide methylation profile of purified single hepatocytes of HBHC was aided in understanding the process of tumorigenesis, and a series of novel methylated genes found in this study have the potential to be biomarkers for the diagnosis and prognosis of HBHC.	[Tao, Ran; Li, Jun; Xin, Jiaojiao; Guo, Jing; Zhang, Liyuan; Jiang, Longyan; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jian; Zhang, Wu; Yang, Zhe] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Tao, R (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Li, Jun/E-4744-2012	Li, Jun/0000-0002-7236-8088	National ST Major Project [2008ZX10002-005]; National Natural Science Foundation of China [30970747]; Zhejiang Provincial Natural Science Foundation [Y2090010]; Ministry of Health of PRC Science Foundation [WKJ2010-2-006]; Qianjiang Excellent Talent Project [2010R10076]	National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Ministry of Health of PRC Science Foundation; Qianjiang Excellent Talent Project	This work was supported by the National S&T Major Project (2008ZX10002-005), the National Natural Science Foundation of China (30970747), the Zhejiang Provincial Natural Science Foundation (Y2090010), the Ministry of Health of PRC Science Foundation (WKJ2010-2-006) and the Qianjiang Excellent Talent Project (2010R10076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JH, 2006, PROTEOMICS, V6, P538, DOI 10.1002/pmic.200500257; Archer KJ, 2010, MOL GENET GENOMICS, V283, P341, DOI 10.1007/s00438-010-0522-y; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blumberg Baruch S, 2010, Front Biosci (Schol Ed), V2, P756; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Capiod T., 2007, V45, P405; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Galli A, 2010, HEPATOLOGY, V52, P493, DOI 10.1002/hep.23669; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795; Guedj N, 2006, LAB INVEST, V86, P951, DOI 10.1038/labinvest.3700450; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Harrell JC, 2008, CLIN EXP METASTAS, V25, P81, DOI 10.1007/s10585-007-9105-7; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Jeong JS, 2003, EXP MOL PATHOL, V74, P74, DOI 10.1016/S0014-4800(03)80011-4; LAMBERT MP, 2010, J HEPATOLOGY; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Li BK, 2010, ANN SURG ONCOL, V17, P1917, DOI 10.1245/s10434-010-0921-7; Li J, 2006, ASAIO J, V52, P321, DOI 10.1097/01.mat.0000217794.35830.4a; Li J, 2010, DIFFERENTIATION, V80, P166, DOI 10.1016/j.diff.2010.04.002; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Ma XD, 2000, WORLD J GASTROENTERO, V6, P66; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Qiu GH, 2008, J HEPATOL, V48, P433, DOI 10.1016/j.jhep.2007.11.015; RESCAN PY, 1990, AM J PATHOL, V137, P701; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; UM TH, 2010, J HEPATOLOGY; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wu LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014460; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yang ZF, 2008, LIVER INT, V28, P622, DOI 10.1111/j.1478-3231.2008.01687.x; Yuan YF, 2006, CLIN CANCER RES, V12, P6687, DOI 10.1158/1078-0432.CCR-06-0921; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang W, 2000, CANCER RES, V60, P5395; Zhong S, 2002, CLIN CANCER RES, V8, P1087	49	49	53	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19862	10.1371/journal.pone.0019862	http://dx.doi.org/10.1371/journal.pone.0019862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625442	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200017
J	Canesi, L; Negri, A; Barmo, C; Banni, M; Gallo, G; Viarengo, A; Dondero, F				Canesi, Laura; Negri, Alessandro; Barmo, Cristina; Banni, Mohamed; Gallo, Gabriella; Viarengo, Aldo; Dondero, Francesco			The Organophosphate Chlorpyrifos Interferes with the Responses to 17 beta-Estradiol in the Digestive Gland of the Marine Mussel Mytilus galloprovincialis	PLOS ONE			English	Article							DEVELOPMENTAL NEUROTOXICITY; CELL-DEVELOPMENT; GENE-EXPRESSION; IN-VITRO; EXPOSURE; PESTICIDES; POLLUTION; BIVALVE; PROTEIN; MECHANISMS	Background: Many pesticides have been shown to act as endocrine disrupters. Although the potencies of currently used pesticides as hormone agonists/antagonists are low compared with those of natural ligands, their ability to act via multiple mechanisms might enhance the biological effect. The organophosphate Chlorpyrifos (CHP) has been shown to be weakly estrogenic and cause adverse neurodevelopmental effects in mammals. However, no information is available on the endocrine effects of CHP in aquatic organisms. In the digestive gland of the bivalve Mytilus galloprovincialis, a target tissue of both estrogens and pesticides, the possible effects of CHP on the responses to the natural estrogen 17 beta-estradiol (E-2) were investigated. Methodology/Principal Findings: Mussels were exposed to CHP (4.5 mg/l, 72 hrs) and subsequently injected with E-2 (6.75 ng/g dw). Responses were evaluated in CHP, E-2 and CHP/E-2 treatment groups at 24 h p.i. by a biomarker/transcriptomic approach. CHP and E-2 induced additive, synergistic, and antagonistic effects on lysosomal biomarkers (lysosomal membrane stability, lysosome/cytoplasm volume ratio, lipofuscin and neutral lipid accumulation). Additive and synergistic effects were also observed on the expression of estrogen-responsive genes (GST pi, catalase, 5-HTR) evaluated by RT-Q-PCR. The use of a 1.7K cDNA Mytilus microarray showed that CHP, E-2 and CHP/E-2, induced 81, 44, and 65 Differentially Expressed Genes (DEGs), respectively. 24 genes were exclusively shared between CHP and CHP/E-2, only 2 genes between E-2 and CHP/E-2. Moreover, 36 genes were uniquely modulated by CHP/E-2. Gene ontology annotation was used to elucidate the putative mechanisms involved in the responses elicited by different treatments. Conclusions: The results show complex interactions between CHP and E-2 in the digestive gland, indicating that the combination of certain pesticides and hormones may give rise to unexpected effects at the molecular/cellular level. Overall, these data demonstrate that CHP can interfere with the mussel responses to natural estrogens.	[Canesi, Laura; Barmo, Cristina; Gallo, Gabriella] Univ Genoa, Dipartimento Biol, Genoa, Italy; [Negri, Alessandro; Banni, Mohamed; Viarengo, Aldo; Dondero, Francesco] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Ambiente & Vita, Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Sousse, Tunisia	University of Genoa; University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez	Canesi, L (corresponding author), Univ Genoa, Dipartimento Biol, Genoa, Italy.	Laura.Canesi@unige.it	; Dondero, Francesco/J-1528-2012; Banni, Mohamed/M-2144-2014	Viarengo, Aldo/0000-0002-1557-6526; Dondero, Francesco/0000-0001-7945-3712; Banni, Mohamed/0000-0001-9764-0343; Canesi, Laura/0000-0003-2061-3819	Italian Ministry of Research [20079FELYB]; Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia) [2009.0659-42]; UE [FP6-2003-Global-2, 003956]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia)(Fondazione Carige); UE	This work was supported by the Italian Ministry of Research (PRIN2007), prot. 20079FELYB http://prin.miur.it/, Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia)(prot. 2009.0659-42) http://www.fondazionecarige.it, and partly supported by the UE FP6-2003-Global-2 Program, NoMiracle, IP Contract n. 003956 http://nomiracle.jrc.ec.europa.eu/default.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Bagchi D, 1997, TOXICOL LETT, V91, P31, DOI 10.1016/S0378-4274(97)03868-X; Banni M, 2011, PLOSONE IN PRESS; Bejarano AC, 2003, ENVIRON TOXICOL CHEM, V22, P2100, DOI 10.1897/02-293; Bretveld RW, 2006, REPROD BIOL ENDOCRIN, V31, P4; Burlando B, 2002, AM J PHYSIOL-CELL PH, V283, pC1461, DOI 10.1152/ajpcell.00429.2001; Campbell CG, 1997, BRAIN RES BULL, V43, P179, DOI 10.1016/S0361-9230(96)00436-4; Canesi L, 2004, GEN COMP ENDOCR, V136, P58, DOI 10.1016/j.ygcen.2003.12.003; Canesi L, 2008, AQUAT TOXICOL, V87, P272, DOI 10.1016/j.aquatox.2008.02.007; Canesi L, 2007, MOL CELL ENDOCRINOL, V276, P36, DOI 10.1016/j.mce.2007.06.002; Canesi L, 2007, GEN COMP ENDOCR, V153, P40, DOI 10.1016/j.ygcen.2007.02.005; Canesi L, 2006, AM J PHYSIOL-REG I, V291, pR664, DOI 10.1152/ajpregu.00139.2006; Canesi L, 2010, COMP BIOCHEM PHYS C, V152, P399, DOI 10.1016/j.cbpc.2010.06.008; Caughlan A, 2004, TOXICOL SCI, V78, P125, DOI 10.1093/toxsci/kfh038; Choi HJ, 2009, AM J RESP CELL MOL, V40, P168, DOI 10.1165/rcmb.2007-0377OC; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cubero-Leon E, 2010, AQUAT TOXICOL, V98, P178, DOI 10.1016/j.aquatox.2010.02.007; Dam K, 1998, DEV BRAIN RES, V108, P39, DOI 10.1016/S0165-3806(98)00028-5; Degen GH, 2000, INT ARCH OCC ENV HEA, V73, P433, DOI 10.1007/s004200000163; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Doran WJ, 2001, ECOTOX ENVIRON SAFE, V49, P91, DOI 10.1006/eesa.2000.2036; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Gosling E., 1992, DEV AQUACULTURE FISH, V25; Grunfeld HT, 2004, TOXICOL LETT, V151, P467, DOI 10.1016/j.toxlet.2004.03.021; Hagger JA, 2010, ECOTOXICOLOGY, V19, P953, DOI 10.1007/s10646-010-0477-0; Hoarau P, 2006, COMP BIOCHEM PHYS C, V143, P196, DOI 10.1016/j.cbpc.2006.02.007; Iguchi T, 2007, GEN COMP ENDOCR, V153, P25, DOI 10.1016/j.ygcen.2007.01.013; Itziou A, 2009, CHEMOSPHERE, V76, P1315, DOI 10.1016/j.chemosphere.2009.06.032; Janer G, 2005, AQUAT TOXICOL, V75, P32, DOI 10.1016/j.aquatox.2005.01.012; Jones OAH, 2008, MAR ECOL PROG SER, V369, P169, DOI 10.3354/meps07654; Joshi SC, 2007, TOXICOL IND HEALTH, V23, P439, DOI 10.1177/0748233707080908; Kang HG, 2004, TOXICOLOGY, V199, P219, DOI 10.1016/j.tox.2004.02.025; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lluri G, 2008, EXP CELL RES, V314, P11, DOI 10.1016/j.yexcr.2007.06.007; McKinlay R, 2008, ENVIRON INT, V34, P168, DOI 10.1016/j.envint.2007.07.013; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; MOORE MN, 1976, CELL TISSUE RES, V175, P279; MOORE MN, 1988, MAR ECOL PROG SER, V46, P81, DOI 10.3354/meps046081; MOORE MN, 1982, HISTOCHEM J, V14, P713, DOI 10.1007/BF01033620; Odenkirchen E. W., 1988, 85 US FISH WILDL SER; Paszkiewicz-Gadek A, 2003, GYNECOL ENDOCRINOL, V17, P37; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Recchia FM, 2010, INVEST OPHTH VIS SCI, V51, P1098, DOI 10.1167/iovs.09-4006; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419; Serrano R, 1997, ARCH ENV CONTAM TOXI, V29, P284; Sherman JD, 1996, ARCH ENVIRON HEALTH, V51, P5, DOI 10.1080/00039896.1996.9935986; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Slotkin TA, 2009, BRAIN RES, V1263, P23, DOI 10.1016/j.brainres.2009.01.049; Slotkin TA, 2009, ENVIRON HEALTH PERSP, V117, P587, DOI 10.1289/ehp.0800251; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; USEPA, 2000, CHLORPYRIFOS REVISED; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; WHITNEY KD, 1995, TOXICOL APPL PHARM, V134, P53, DOI 10.1006/taap.1995.1168; Wright JP, 2002, J AGR FOOD CHEM, V50, P235, DOI 10.1021/jf0108664	62	45	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19803	10.1371/journal.pone.0019803	http://dx.doi.org/10.1371/journal.pone.0019803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625485	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400012
J	Pavelko, KD; Girtman, MA; Mitsunaga, Y; Mendez-Fernandez, YV; Bell, MP; Hansen, MJ; Allen, KS; Rodriguez, M; Pease, LR				Pavelko, Kevin D.; Girtman, Megan A.; Mitsunaga, Yoshihiro; Mendez-Fernandez, Yanice V.; Bell, Michael P.; Hansen, Michael J.; Allen, Kathleen S.; Rodriguez, Moses; Pease, Larry R.			Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy	PLOS ONE			English	Article							IMMUNE-RESPONSES; LEADER PROTEIN; DANIELS STRAIN; C57BL/6 MICE; SIALIC-ACID; IN-VITRO; T-CELLS; INFECTION; BINDING; EPITOPE	The induction of sterilizing T-cell responses to tumors is a major goal in the development of T-cell vaccines for treating cancer. Although specific components of anti-viral CD8+ immunity are well characterized, we still lack the ability to mimic viral CD8+ T-cell responses in therapeutic settings for treating cancers. Infection with the picornavirus Theiler's murine encephalomyelitis virus (TMEV) induces a strong sterilizing CD8+ T-cell response. In the absence of sterilizing immunity, the virus causes a persistent infection. We capitalized on the ability of TMEV to induce strong cellular immunity even under conditions of immune deficiency by modifying the virus to evaluate its potential as a T-cell vaccine. The introduction of defined CD8+ T-cell epitopes into the leader sequence of the TMEV genome generates an attenuated vaccine strain that can efficiently drive CD8+ T-cell responses to the targeted antigen. This virus activates T-cells in a manner that is capable of inducing targeted tissue damage and glucose dysregulation in an adoptive T-cell transfer model of diabetes mellitus. As a therapeutic vaccine for the treatment of established melanoma, epitope-modified TMEV can induce strong cytotoxic T-cell responses and promote infiltration of the T-cells into established tumors, ultimately leading to a delay in tumor growth and improved survival of vaccinated animals. We propose that epitope-modified TMEV is an excellent candidate for further development as a human T-cell vaccine for use in immunotherapy.	[Pavelko, Kevin D.; Girtman, Megan A.; Mitsunaga, Yoshihiro; Mendez-Fernandez, Yanice V.; Bell, Michael P.; Hansen, Michael J.; Allen, Kathleen S.; Rodriguez, Moses; Pease, Larry R.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	pease.larry@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Rodriguez, Moses/0000-0001-6328-6497	Mayo Clinic, National Institutes of Health (NIH) [5R01CA104996, 5R01NS32129]; Richard M. Schulze Family Foundation; NATIONAL CANCER INSTITUTE [R01CA104996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129] Funding Source: NIH RePORTER	Mayo Clinic, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Schulze Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by Mayo Clinic, National Institutes of Health (NIH) grants 5R01CA104996 and 5R01NS32129, and a generous gift from the Richard M. Schulze Family Foundation. The funders have no role in study design, data collection and anaylsis, decision to publish, or preparation of the manuscript.	Amato RJ, 2010, EXPERT OPIN BIOL TH, V10, P281, DOI 10.1517/14712590903586213; Au GG, 2007, BRIT J HAEMATOL, V137, P133, DOI 10.1111/j.1365-2141.2007.06550.x; Badshah C, 2000, J VIROL, V74, P875, DOI 10.1128/JVI.74.2.875-882.2000; Block MS, 2005, J IMMUNOL, V174, P2756, DOI 10.4049/jimmunol.174.5.2756; BORROW P, 1992, J GEN VIROL, V73, P1861, DOI 10.1099/0022-1317-73-7-1861; Borson ND, 1997, J VIROL, V71, P5244, DOI 10.1128/JVI.71.7.5244-5250.1997; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Delhaye S, 2004, J VIROL, V78, P4357, DOI 10.1128/JVI.78.8.4357-4362.2004; Dethlefs S, 1997, J VIROL, V71, P5361, DOI 10.1128/JVI.71.7.5361-5365.1997; Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1; Gallo P, 2005, GENE THER, V12, pS84, DOI 10.1038/sj.gt.3302619; Goetz C, 2010, CYTOKINE GROWTH F R, V21, P197, DOI 10.1016/j.cytogfr.2010.02.005; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; HEMMI S, 1988, J EXP MED, V168, P2319, DOI 10.1084/jem.168.6.2319; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hwang C, 1999, CURR OPIN MOL THER, V1, P471; Jnaoui K, 2002, J VIROL, V76, P8138, DOI 10.1128/JVI.76.16.8138-8147.2002; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Kang MH, 2008, GLIA, V56, P942, DOI 10.1002/glia.20668; Kumar ASM, 2003, J VIROL, V77, P2709, DOI 10.1128/JVI.77.4.2709-2716.2003; Lin XQ, 1998, J VIROL, V72, P1262, DOI 10.1128/JVI.72.2.1262-1269.1998; LINDSLEY MD, 1991, J VIROL, V65, P6612, DOI 10.1128/JVI.65.12.6612-6620.1991; Lipton HL, 2001, VIRUS RES, V76, P79, DOI 10.1016/S0168-1702(01)00256-8; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; NITAYAPHAN S, 1985, J VIROL, V56, P887, DOI 10.1128/JVI.56.3.887-895.1985; Olson JK, 2002, J IMMUNOL, V169, P2719, DOI 10.4049/jimmunol.169.5.2719; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Reddi HV, 2003, J GEN VIROL, V84, P845, DOI 10.1099/vir.0.18746-0; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; RODRIGUEZ M, 1983, LAB INVEST, V49, P672; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; ROOS RP, 1989, J VIROL, V63, P5492, DOI 10.1128/JVI.63.12.5492-5496.1989; Rossi CP, 1998, J VIROL, V72, P4515; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; van Pesch V, 2001, J VIROL, V75, P7811, DOI 10.1128/JVI.75.17.7811-7817.2001; Zhang G, 1999, J GEN VIROL, V80, P639, DOI 10.1099/0022-1317-80-3-639; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	40	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20217	10.1371/journal.pone.0020217	http://dx.doi.org/10.1371/journal.pone.0020217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625449	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400047
J	McIntyre, KM; Hawkes, I; Waret-Szkuta, A; Morand, S; Baylis, M				McIntyre, K. Marie; Hawkes, Iain; Waret-Szkuta, Agnes; Morand, Serge; Baylis, Matthew			The H-Index as a Quantitative Indicator of the Relative Impact of Human Diseases	PLOS ONE			English	Article								Assessment of the relative impact of diseases and pathogens is important for agencies and other organizations charged with providing disease surveillance, management and control. It also helps funders of disease-related research to identify the most important areas for investment. Decisions as to which pathogens or diseases to target are often made using complex risk assessment approaches; however, these usually involve evaluating a large number of hazards as it is rarely feasible to conduct an in-depth appraisal of each. Here we propose the use of the H-index (or Hirsch index) as an alternative rapid, repeatable and objective means of assessing pathogen impact. H-index scores for 1,414 human pathogens were obtained from the Institute for Scientific Information's Web of Science (WOS) in July/August 2010. Scores were compared for zoonotic/non-zoonotic, and emerging/non-emerging pathogens, and across taxonomic groups. H-indices for a subset of pathogens were compared with Disability Adjusted Life Year (DALY) estimates for the diseases they cause. H-indices ranged from 0 to 456, with a median of 11. Emerging pathogens had higher H-indices than non-emerging pathogens. Zoonotic pathogens tended to have higher H-indices than human-only pathogens, although the opposite was observed for viruses. There was a significant correlation between the DALY of a disease and the H-index of the pathogen(s) that cause it. Therefore, scientific interest, as measured by the H-index, appears to be a reflection of the true impact of pathogens. The H-index method can be utilized to set up an objective, repeatable and readily automated system for assessing pathogen or disease impact.	[McIntyre, K. Marie; Hawkes, Iain; Baylis, Matthew] Univ Liverpool, LUCINDA Grp, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Liverpool, Cheshire, England; [Waret-Szkuta, Agnes; Morand, Serge] Rech Agron Dev Agr Res Dev CIRAD, Unite Rech Anim & Gest Integree Risques, Montpellier, France; [Morand, Serge] Univ Montpellier, Inst Sci Evolut, CNRS, IRD, F-34059 Montpellier, France	University of Liverpool; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	McIntyre, KM (corresponding author), Univ Liverpool, LUCINDA Grp, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Liverpool, Cheshire, England.	k.m.mcintyre@liv.ac.uk	Baylis, Matthew/S-7694-2019; McIntyre, (Kirsty) Marie/B-6907-2013; Morand, Serge/M-5433-2018	Baylis, Matthew/0000-0003-0335-187X; Morand, Serge/0000-0003-3986-7659; Waret-Szkuta, Agnes/0000-0002-6175-4418; McIntyre, Kirsty Marie/0000-0003-1360-122X	NERC [NE/G002827/1]; ANSES; Nuffield Student Bursary; Natural Environment Research Council [NE/G002827/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ANSES; Nuffield Student Bursary; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded under the ERA NET scheme by NERC (grant number NE/G002827/1, URL http://www.nerc.ac.uk/) (KMM and MB) and ANSES (no grant number available, URL http://www.anses.fr/) (AW-S and SM) and via a Nuffield Student Bursary (no grant number available) (IH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GOOGLE SCHOLAR CITAT; [Anonymous], 2008, GLOBAL BURDEN DIS 20; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elsevier, SCIVERSE SCOPUS; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hollander M., 1973, NONPARAMETRIC STAT M; Hunter PR, 2009, LANCET, V373, P630, DOI 10.1016/S0140-6736(09)60397-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; OVERVIEW WEB SCI THO	10	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19558	10.1371/journal.pone.0019558	http://dx.doi.org/10.1371/journal.pone.0019558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625581	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200010
J	Carvajal, A; Ortega, S; Del Olmo, L; Vidal, X; Aguirre, C; Ruiz, B; Conforti, A; Leone, R; Lopez-Vazquez, P; Figueiras, A; Ibanez, L				Carvajal, Alfonso; Ortega, Sara; Del Olmo, Lourdes; Vidal, Xavier; Aguirre, Carmelo; Ruiz, Borja; Conforti, Anita; Leone, Roberto; Lopez-Vazquez, Paula; Figueiras, Adolfo; Ibanez, Luisa			Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLATELET-FUNCTION; RISK; ANTIDEPRESSANTS; ASSOCIATION; POPULATION; HEMORRHAGE; PRESCRIPTION; INCREASE; THERAPY	Background: Selective serotonin reuptake inhibitors (SSRIs) have been associated with upper gastrointestinal (GI) bleeding. Given their worldwide use, even small risks account for a large number of cases. This study has been conducted with carefully collected information to further investigate the relationship between SSRIs and upper GI bleeding. Methods: We conducted a case-control study in hospitals in Spain and in Italy. Cases were patients aged >= 18 years with a primary diagnosis of acute upper GI bleeding diagnosed by endoscopy; three controls were matched by sex, age, date of admission (within 3 months) and hospital among patients who were admitted for elective surgery for non-painful disorders. Exposures to SSRIs, other antidepressants and other drugs were defined as any use of these drugs in the 7 days before the day on which upper gastrointestinal bleeding started (index day). Results: 581 cases of upper GI bleeding and 1358 controls were considered eligible for the study; no differences in age or sex distribution were observed between cases and controls after matching. Overall, 4.0% of the cases and 3.3% of controls used an SSRI antidepressant in the week before the index day. No significant risk of upper GI bleeding was encountered for SSRI antidepressants (adjusted odds ratio, 1.06, 95% CI, 0.57-1.96) or for whichever other grouping of antidepressants. Conclusions: The results of this case-control study showed no significant increase in upper GI bleeding with SSRIs and provide good evidence that the magnitude of any increase in risk is not greater than 2.	[Carvajal, Alfonso; Ortega, Sara; Del Olmo, Lourdes] Univ Valladolid, Inst Farmacoepidemiol, Valladolid, Spain; [Vidal, Xavier; Ibanez, Luisa] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Fundacio Inst Catala Farmacol, WHO Collaborating Ctr Res & Training Pharmacoepid, E-08193 Barcelona, Spain; [Vidal, Xavier; Ibanez, Luisa] Hosp Univ Vall dHebron, Clin Pharmacol Serv, Barcelona, Spain; [Aguirre, Carmelo; Ruiz, Borja] Galdakao Usansolo Hosp, Pharmacovigilance Unit, Bizkaia, Spain; [Conforti, Anita; Leone, Roberto] Univ Verona, Serv Farmacol Med, I-37100 Verona, Italy; [Lopez-Vazquez, Paula; Figueiras, Adolfo] Univ Santiago Compostela, Dept Med Prevent & Salud Publ, Santiago De Compostela, Spain; [Lopez-Vazquez, Paula; Figueiras, Adolfo] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Barcelona, Spain	Universidad de Valladolid; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Galdakao Hospital; University of Verona; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Carvajal, A (corresponding author), Univ Valladolid, Inst Farmacoepidemiol, Valladolid, Spain.	carvajal@ife.uva.es	Vidal, Xavier/I-5958-2019; Figueiras, Adolfo/K-8563-2015; Ibanez, Luisa/M-2986-2013	Vidal, Xavier/0000-0001-6705-4298; Figueiras, Adolfo/0000-0002-5766-8672; Ibanez, Luisa/0000-0002-1175-0574; Lopez-Vazquez, Paula M/0000-0002-6836-2863	Health Research Fund [Fondo de Investigacion Sanitaria] [PI021512, PI021364, PI020661, PI021572]; Ministry of Health & Consumer Affairs, Spain [SAF2002-04057]; Galician Regional Authority, Spain [PGIDIT03PXIC20806PN]; Basque Regional Authority, Spain [02/1572]; Castilla y Leon Regional Authority's General Directorate of Public Health, Research, Development Innovation	Health Research Fund [Fondo de Investigacion Sanitaria]; Ministry of Health & Consumer Affairs, Spain; Galician Regional Authority, Spain; Basque Regional Authority, Spain; Castilla y Leon Regional Authority's General Directorate of Public Health, Research, Development Innovation	This study was supported by grants PI021512, PI021364, PI020661, PI021572 (Health Research Fund [Fondo de Investigacion Sanitaria]), SAF2002-04057 (Ministry of Health & Consumer Affairs, Spain), PGIDIT03PXIC20806PN (Galician Regional Authority, Spain) and 02/1572 (Basque Regional Authority, Spain). Alfonso Carvajal and Sara Ortega had an additional financial support from the Castilla y Leon Regional Authority's General Directorate of Public Health, Research, Development & Innovation.	Ahrens T, 2007, J CLIN PSYCHOPHARM, V27, P602, DOI 10.1097/jcp.0b013e31815abf0e; Bak S, 2002, STROKE, V33, P1465, DOI 10.1161/01.STR.0000018589.56991.BA; Barbui C, 2009, J CLIN PSYCHOPHARM, V29, P33, DOI 10.1097/JCP.0b013e3181929f7a; Bates D. M., 2007, LME4 LINEAR MIXED EF; Brown H, 2006, APPL MIXED MODELS ME, P320; Chen Y, 2008, ANN PHARMACOTHER, V42, P177, DOI 10.1345/aph.1K369; Dall M, 2009, CLIN GASTROENTEROL H, V7, P1314, DOI 10.1016/j.cgh.2009.08.019; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2000, BRIT J CLIN PHARMACO, V50, P43, DOI 10.1046/j.1365-2125.2000.00216.x; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Dickinson T, 2000, BRIT MED J, V320, P1406; Dunn NR, 2000, BRIT MED J, V320, P1405; Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Helin-Salmivaara A, 2007, EUR J CLIN PHARMACOL, V63, P403, DOI 10.1007/s00228-007-0263-y; Hergovich N, 2000, CLIN PHARMACOL THER, V68, P435, DOI 10.1067/mcp.2000.110456; Hougardy DMC, 2008, BRIT J CLIN PHARMACO, V65, P761, DOI 10.1111/j.1365-2125.2008.03098.x; Kharofa J, 2007, STROKE, V38, P3049, DOI 10.1161/STROKEAHA.107.491472; Layton D, 2001, EUR J CLIN PHARMACOL, V57, P167, DOI 10.1007/s002280100263; Lewis JD, 2008, PHARMACOEPIDEM DR S, V17, P328, DOI 10.1002/pds.1546; Arias LHM, 2010, PHARMACOEPIDEM DR S, V19, P895, DOI 10.1002/pds.1944; McCloskey DJ, 2008, TRANSL RES, V151, P168, DOI 10.1016/j.trsl.2007.10.004; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Movig KLL, 2003, ARCH INTERN MED, V163, P2354, DOI 10.1001/archinte.163.19.2354; Ofman JJ, 2002, J RHEUMATOL, V29, P804; Opatrny L, 2008, BRIT J CLIN PHARMACO, V66, P76, DOI 10.1111/j.1365-2125.2008.03154.x; Pinheiro J., 2006, MIXED EFFECTS MODELS; REMALEY AT, 1989, AM J HEMATOL, V31, P188, DOI 10.1002/ajh.2830310308; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P100; Salkeld E, 2008, J CLIN PSYCHOPHARM, V28, P230, DOI 10.1097/JCP.0b013e318166c52e; Skop BP, 1996, PSYCHOSOMATICS, V37, P12, DOI 10.1016/S0033-3182(96)71592-X; Takeuchi K, 2005, GASTROENTEROLOGY, V129, P1108, DOI 10.1053/j.gastro.2005.07.021; Targownik LE, 2009, AM J GASTROENTEROL, V104, P1475, DOI 10.1038/ajg.2009.128; Tata LJ, 2005, ALIMENT PHARM THERAP, V22, P175, DOI 10.1111/j.1365-2036.2005.02543.x; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Vidal X, 2008, DRUG SAFETY, V31, P159, DOI 10.2165/00002018-200831020-00005; Wessinger S, 2006, ALIMENT PHARM THER, V23, P937, DOI 10.1111/j.1365-2036.2006.02859.x	38	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19819	10.1371/journal.pone.0019819	http://dx.doi.org/10.1371/journal.pone.0019819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625637	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200036
J	Grabherr, MG; Pontiller, J; Mauceli, E; Ernst, W; Baumann, M; Biagi, T; Swofford, R; Russell, P; Zody, MC; Di Palma, F; Lindblad-Toh, K; Grabherr, RM				Grabherr, Manfred G.; Pontiller, Jens; Mauceli, Evan; Ernst, Wolfgang; Baumann, Martina; Biagi, Tara; Swofford, Ross; Russell, Pamela; Zody, Michael C.; Di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Reingard M.			Exploiting Nucleotide Composition to Engineer Promoters	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; TRANSCRIPTION; CPG; EVOLUTION; ISLANDS; GENOME	The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue-and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a "proof-of-concept" for custom-designing promoters that are suitable for biotechnological and medical applications.	[Grabherr, Manfred G.; Mauceli, Evan; Biagi, Tara; Swofford, Ross; Russell, Pamela; Zody, Michael C.; Di Palma, Federica; Lindblad-Toh, Kerstin] Broad Inst, Cambridge, MA USA; [Pontiller, Jens; Ernst, Wolfgang; Baumann, Martina; Grabherr, Reingard M.] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Zody, Michael C.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Natural Resources & Life Sciences, Vienna; Uppsala University	Grabherr, MG (corresponding author), Broad Inst, Cambridge, MA USA.	evan@broadinstitute.org		Swofford, Ross/0000-0003-3676-8479; Grabherr, Reingard/0000-0002-4501-927X; Di-Palma, Federica/0000-0002-4394-0102; Russell, Pamela/0000-0003-2997-6392; Ernst, Wolfgang/0000-0003-1625-0103; Grabherr, Manfred/0000-0001-8792-6508	National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes) [NIH 1 U54 HG03067]; Department of Biotechnology, University of Natural Resources and Life Sciences Vienna; ESF EURYI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Biotechnology, University of Natural Resources and Life Sciences Vienna; ESF EURYI(European Science Foundation (ESF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was in part supported by a grant from the National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes, Grant No. NIH 1 U54 HG03067, Lander), and by the Department of Biotechnology, University of Natural Resources and Life Sciences Vienna. KLT is an ESF EURYI award recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Munteanu A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-66; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stegmaier Philip, 2004, Genome Inform, V15, P276; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	31	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20136	10.1371/journal.pone.0020136	http://dx.doi.org/10.1371/journal.pone.0020136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625601	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200068
J	Lehikoinen, A				Lehikoinen, Aleksi			Advanced Autumn Migration of Sparrowhawk Has Increased the Predation Risk of Long-Distance Migrants in Finland	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; PHENOLOGICAL CHANGES; POPULATION DECLINES; HABITAT SELECTION; ACCIPITER-NISUS; SPRING ARRIVAL; BIRDS DEPENDS; PREY; SHIFTS; CONSEQUENCES	Predation affects life history traits of nearly all organisms and the population consequences of predator avoidance are often larger than predation itself. Climate change has been shown to cause phenological changes. These changes are not necessarily similar between species and may cause mismatches between prey and predator. Eurasian sparrowhawk Accipiter nisus, the main predator of passerines, has advanced its autumn phenology by about ten days in 30 years due to climate change. However, we do not know if sparrowhawk migrate earlier in response to earlier migration by its prey or if earlier sparrowhawk migration results in changes to predation risk on its prey. By using the median departure date of 41 passerine species I was able to show that early migrating passerines tend to advance, and late migrating species delay their departure, but none of the species have advanced their departure times as much as the sparrowhawk. This has lead to a situation of increased predation risk on early migrating long-distance migrants (LDM) and decreased the overlap of migration season with later departing short-distance migrants (SDM). Findings highlight the growing list of problems of declining LDM populations caused by climate change. On the other hand it seems that the autumn migration may become safer for SDM whose populations are growing. Results demonstrate that passerines show very conservative response in autumn phenology to climate change, and thus phenological mismatches caused by global warming are not necessarily increasing towards the higher trophic levels.	Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Helsinki	Lehikoinen, A (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland.	aleksi.lehikoinen@helsinki.fi	Lehikoinen, Aleksi/O-5444-2016	Lehikoinen, Aleksi/0000-0002-1989-277X	Finnish Museum of Natural History; Finnish Cultural Foundation	Finnish Museum of Natural History; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The salary of AL comes from the Finnish Museum of Natural History. The observatory received economic support from the Finnish Cultural Foundation to cover the food costs of the observers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CP, 2010, AUK, V127, P411, DOI 10.1525/auk.2009.09108; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brommer JE, 2008, ORNIS FENNICA, V85, P109; Caro Tim, 2005, pXIII; Cramp S., 1988, BIRDS W PALEARCTIC; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Cresswell W, 2010, J ANIM ECOL, V79, P556, DOI 10.1111/j.1365-2656.2010.01671.x; Elewa Ashraf M. T., 2007, P1, DOI 10.1007/978-3-540-46046-6_1; Filippi-Codaccioni O, 2010, J ORNITHOL, V151, P687, DOI 10.1007/s10336-010-0500-5; Forsman JT, 2001, ECOLOGY, V82, P232, DOI 10.1890/0012-9658(2001)082[0232:EOPOCA]2.0.CO;2; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; KJELLEN N, 1992, ORNIS SCAND, V23, P420, DOI 10.2307/3676673; Lehikoinen A., 2008, TRINGA, V35, P146; Lehikoinen A, 1979, TRINGA, V27, P150; Lehikoinen A, 2010, J AVIAN BIOL, V41, P627, DOI 10.1111/j.1600-048X.2010.05080.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; Newson SE, 2010, J APPL ECOL, V47, P244, DOI 10.1111/j.1365-2664.2010.01771.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1998, POPULATION LIMITATIO; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce-Higgins JW, 2009, OECOLOGIA, V159, P649, DOI 10.1007/s00442-008-1242-4; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Saino N, 2009, BIOL LETTERS, V5, P539, DOI 10.1098/rsbl.2009.0312; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Saurola P., 1981, LINTUMIES, V16, P10; SOLONEN T, 1990, HOLARCTIC ECOL, V13, P229; SOLONEN T, 1985, SUOMEN LINNUSTO; Thomson RL, 2006, OIKOS, V113, P325, DOI 10.1111/j.2006.0030-1299.14376.x; Thomson RL, 2006, ECOGRAPHY, V29, P507; Thomson RL, 2010, ECOLOGY, V91, P1832, DOI 10.1890/09-0989.1; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8; Vahatalo AV, 2004, J AVIAN BIOL, V35, P210; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	42	24	24	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20001	10.1371/journal.pone.0020001	http://dx.doi.org/10.1371/journal.pone.0020001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625604	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200057
J	Martinez, G; Forment, J; Llave, C; Pallas, V; Gomez, G				Martinez, German; Forment, Javier; Llave, Cesar; Pallas, Vicente; Gomez, Gustavo			High-Throughput Sequencing, Characterization and Detection of New and Conserved Cucumber miRNAs	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLANT MICRORNAS; MESSENGER-RNA; GENES; IDENTIFICATION; EVOLUTION; TARGETS; ANNOTATION; EXPRESSION; CLEAVAGE	Micro RNAS (miRNAs) are a class of endogenous small non coding RNAs involved in the post-transcriptional regulation of gene expression. In plants, a great number of conserved and specific miRNAs, mainly arising from model species, have been identified to date. However less is known about the diversity of these regulatory RNAs in vegetal species with agricultural and/or horticultural importance. Here we report a combined approach of bioinformatics prediction, high-throughput sequencing data and molecular methods to analyze miRNAs populations in cucumber (Cucumis sativus) plants. A set of 19 conserved and 6 known but non-conserved miRNA families were found in our cucumber small RNA dataset. We also identified 7 (3 with their miRNA* strand) not previously described miRNAs, candidates to be cucumber-specific. To validate their description these new C. sativus miRNAs were detected by northern blot hybridization. Additionally, potential targets for most conserved and new miRNAs were identified in cucumber genome. In summary, in this study we have identified, by first time, conserved, known non-conserved and new miRNAs arising from an agronomically important species such as C. sativus. The detection of this complex population of regulatory small RNAs suggests that similarly to that observe in other plant species, cucumber miRNAs may possibly play an important role in diverse biological and metabolic processes.	[Martinez, German; Forment, Javier; Pallas, Vicente; Gomez, Gustavo] Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain; [Llave, Cesar] CSIC, CIB, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, G (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain.	ggomez@ibmcp.upv.es	Martínez, Germán/ABE-7261-2020; Gomez, Gustavo/E-3663-2012; Llave, Cesar/ABF-5827-2021; Pallas, Vicente/N-1317-2014	Martínez, Germán/0000-0002-5215-0866; Gomez, Gustavo/0000-0003-3715-7792; Pallas, Vicente/0000-0003-4954-989X	Spanish granting agency DGICYT [BIO2008-03528]; Generalitat Valenciana [ACOMP/2010/214]	Spanish granting agency DGICYT; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grant BIO2008-03528 from the Spanish granting agency DGICYT and by grant ACOMP/2010/214 from the Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/J.1364-3703.2009.00608.X, 10.1111/j.1364-3703.2009.00608.x]; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tanurdzic M, 2004, PLANT CELL, V16, pS61, DOI 10.1105/tpc.016667; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang YW, 2009, BIOCHEM BIOPH RES CO, V378, P799, DOI 10.1016/j.bbrc.2008.11.140; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96	34	90	97	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19523	10.1371/journal.pone.0019523	http://dx.doi.org/10.1371/journal.pone.0019523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603611	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300011
J	Ovadia, G; Shifman, S				Ovadia, Galit; Shifman, Sagiv			The Genetic Variation of RELN Expression in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							C-TERMINAL REGION; HUMAN REELIN GENE; COMMON VARIANT; BRAIN; PROMOTER; ASSOCIATION; NEURONS; HYPERMETHYLATION; HIPPOCAMPUS; DECREASE	Reelin plays an important role in the development and function of the brain and has been linked to different neuropsychiatric diseases. To further clarify the connection between reelin and psychiatric disorders, we studied the factors that influence the expression of reelin gene (RELN) and its different isoforms. We examined the total expression of RELN, allelic expression, and two alternative RELN isoforms in postmortem brain samples from patients with schizophrenia and bipolar disorder, as well as unaffected controls. We did not find a significant reduction in the total expression of RELN in schizophrenia or bipolar disorder. However, we did find a significant reduction of the proportion of the short RELN isoform, missing the C-terminal region in bipolar disorder, and imbalance in the allelic expression of RELN in schizophrenia. In addition, we tested the association between variation in RELN expression and rs7341475, an intronic SNP that was found to be associated with schizophrenia in women. We did not find an association between rs7341474 and the total expression of RELN either in women or in the entire sample. However, we observed a nominally significant effect of genotype-by-sex interaction on the variation in microexon skipping. Women with the risk genotype of rs7341475 (GG) had a higher proportion of microexon skipping, which is the isoform predominant in tissues outside the brain, while men had the opposite trend. Finally, we tested 83 SNPs in the gene region for association with expression variation of RELN, but none were significant. Our study further supports the connection between RELN dysfunction and psychiatric disorders, and provides a possible functional role for a schizophrenia associated SNP. Nevertheless, the positive associations observed in this study needs further replication as it may have implications for understanding the biological causes of schizophrenia and bipolar disorder.	[Ovadia, Galit; Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Ovadia, G (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	sagiv@vms.huji.ac.il	Shifman, Sagiv/D-8749-2017	Shifman, Sagiv/0000-0003-4071-5361	National Alliance for Research on Schizophrenia and Depression (NARSAD)	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD)	This work was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Ben-David E, 2010, AM J MED GENET B, V153B, P1244, DOI 10.1002/ajmg.b.31093; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P229, DOI 10.1006/exnr.1999.7019; Eastwood SL, 2006, AM J PSYCHIAT, V163, P540, DOI 10.1176/appi.ajp.163.3.540; Eastwood SL, 2003, MOL PSYCHIATR, V8, P821, DOI 10.1038/sj.mp.4001371; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hamburgh M., 1963, DEV BIOL, V19, P165; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; LEE MT, 2010, MOL PSYCHIAT; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Liu YP, 2010, PSYCHIAT GENET, V20, P184, DOI 10.1097/YPG.0b013e32833a220b; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Pappas GD, 2001, J NEUROCYTOL, V30, P413; Persico AM, 2006, J NEURAL TRANSM, V113, P1373, DOI 10.1007/s00702-006-0441-6; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Tochigi M, 2008, BIOL PSYCHIAT, V63, P530, DOI 10.1016/j.biopsych.2007.07.003; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Tost H, 2010, BIOL PSYCHIAT, V68, P105, DOI 10.1016/j.biopsych.2010.02.023	33	47	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19955	10.1371/journal.pone.0019955	http://dx.doi.org/10.1371/journal.pone.0019955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603580	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300044
J	Rousseau, K; Cardwell, JM; Humphrey, E; Newton, R; Knight, D; Clegg, P; Thornton, DJ				Rousseau, Karine; Cardwell, Jacqueline M.; Humphrey, Emma; Newton, Richard; Knight, David; Clegg, Peter; Thornton, David J.			Muc5b Is the Major Polymeric Mucin in Mucus from Thoroughbred Horses With and Without Airway Mucus Accumulation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; OLIGOMERIC MUCINS; RESPIRATORY-DISEASE; BRONCHOALVEOLAR LAVAGE; UP-REGULATION; GENE MUC5B; GEL-PHASE; EXPRESSION; IDENTIFICATION	Mucus accumulation is a feature of inflammatory airway disease in the horse and has been associated with reduced performance in racehorses. In this study, we have analysed the two major airways gel-forming mucins Muc5b and Muc5ac in respect of their site of synthesis, their biochemical properties, and their amounts in mucus from healthy horses and from horses with signs of airway mucus accumulation. Polyclonal antisera directed against equine Muc5b and Muc5ac were raised and characterised. Immunohistochemical staining of normal equine trachea showed that Muc5ac and Muc5b are produced by cells in the submucosal glands, as well as surface epithelial goblet cells. Western blotting after agarose gel electrophoresis of airway mucus from healthy horses, and horses with mucus accumulation, was used to determine the amounts of these two mucins in tracheal wash samples. The results showed that in healthy horses Muc5b was the predominant mucin with small amounts of Muc5ac. The amounts of Muc5b and Muc5ac were both dramatically increased in samples collected from horses with high mucus scores as determined visually at the time of endoscopy and that this increase also correlated with increase number of bacteria present in the sample. The change in amount of Muc5b and Muc5ac indicates that Muc5b remains the most abundant mucin in mucus. In summary, we have developed mucin specific polyclonal antibodies, which have allowed us to show that there is a significant increase in Muc5b and Muc5ac in mucus accumulated in equine airways and these increases correlated with the numbers of bacteria.	[Rousseau, Karine; Knight, David; Clegg, Peter; Thornton, David J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Cardwell, Jacqueline M.; Newton, Richard] Anim Hlth Trust, Newmarket, Suffolk, England; [Humphrey, Emma; Clegg, Peter] Univ Liverpool, Dept Musculoskeletal Biol, Neston, England	University of Manchester; Animal Health Trust; University of Liverpool	Rousseau, K (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	dave.thornton@manchester.ac.uk	Cardwell, Jacqueline Martina/I-3273-2014	Clegg, Peter/0000-0003-0632-0032; Knight, David/0000-0001-8895-8560; Thornton, David/0000-0001-7148-1970	Horserace Betting Levy Board [VET/PRJ/714, VET/PRJ/74]; Horses Trust	Horserace Betting Levy Board; Horses Trust	The work described here was funded by the Horserace Betting Levy Board grants VET/PRJ/714 and VET/PRJ/74 and by a grant from the Horses Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Equine Veterinary Education, V15, P61; BHASKAR KR, 1985, EXP LUNG RES, V9, P289, DOI 10.3109/01902148509057529; BHASKAR KR, 1991, AM REV RESPIR DIS, V143, P640, DOI 10.1164/ajrccm/143.3.640; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Bullimore SR, 2001, RES VET SCI, V70, P149, DOI 10.1053/rvsc.2001.0455; Burrell MH, 1996, VET REC, V139, P308, DOI 10.1136/vr.139.13.308; BURRELL MH, 1985, EQUINE VET J, V17, P99, DOI 10.1111/j.2042-3306.1985.tb02059.x; Cardwell JM, 2010, EQUINE VET IN PRESS; Cardwell JM, 2007, THESIS OPEN U; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Christley RM, 2001, VET REC, V148, P99, DOI 10.1136/vr.148.4.99; Christley RM, 2001, EQUINE VET J, V33, P256, DOI 10.2746/042516401776249796; COOK WR, 1976, VET REC, V99, P448, DOI 10.1136/vr.99.23.448; DEBOLOS C, 1995, GASTROENTEROLOGY, V109, P723, DOI 10.1016/0016-5085(95)90379-8; DERKSEN FJ, 1985, AM REV RESPIR DIS, V132, P1066; DERKSEN FJ, 1993, EQUINE VET J, V25, P257, DOI 10.1111/j.2042-3306.1993.tb02958.x; Desseyn JL, 1998, J BIOL CHEM, V273, P30157, DOI 10.1074/jbc.273.46.30157; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; Dixon PM, 1995, EQUINE VET J, V27, P416, DOI 10.1111/j.2042-3306.1995.tb04421.x; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Gerber V, 2004, EQUINE VET J, V36, P576, DOI 10.2746/0425164044864525; Gerber V, 2003, EQUINE VET J, V35, P252, DOI 10.2746/042516403776148291; Groneberg DA, 2002, RESP MED, V96, P81, DOI 10.1053/rmed.2001.1221; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kirkham S, 2008, AM J RESP CRIT CARE, V178, P1033, DOI 10.1164/rccm.200803-391OC; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Louahed J, 2000, AM J RESP CELL MOL, V22, P649, DOI 10.1165/ajrcmb.22.6.3927; MACNAMARA B, 1990, J AM VET MED ASSOC, V196, P443; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; MOORE BR, 1995, AM J VET RES, V56, P562; Nordman H, 2002, BIOCHEM J, V364, P191, DOI 10.1042/bj3640191; NUYTTEN J, 1983, ZBL VET MED A, V30, P114; NUYTTEN J, 1981, VLAAMS DIERGEN TIJDS, V50, P417; Oslund KL, 2010, AM J VET RES, V71, P690, DOI 10.2460/ajvr.71.6.690; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; PETTS DN, 1984, J CLIN MICROBIOL, V19, P4, DOI 10.1128/JCM.19.1.4-7.1984; Robinson N E, 1979, Vet Clin North Am Large Anim Pract, V1, P17; Robinson NE, 1997, P AM ASS EQUINE PRAC, V43, P106; ROHRBACH BW, 1990, J AM VET MED ASSOC, V196, P1563; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Ryhner T, 2008, VET IMMUNOL IMMUNOP, V125, P8, DOI 10.1016/j.vetimm.2008.05.011; SCHWAB UE, 2009, IN VITRO CELL DEV BI; Sheehan JK, 2000, METH MOL B, V125, P87; SHEEHAN JK, 1987, BIOCHEM J, V245, P757, DOI 10.1042/bj2450757; Sheehan JK, 1999, BIOCHEM J, V338, P507, DOI 10.1042/0264-6021:3380507; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; THORNTON DJ, 1994, AM J RESP CRIT CARE, V150, P823, DOI 10.1164/ajrccm.150.3.8087358; THORNTON DJ, 1991, BIOCHEM J, V276, P667, DOI 10.1042/bj2760667; THORNTON DJ, 1990, BIOCHEM J, V265, P179, DOI 10.1042/bj2650179; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; VIEL L, 1985, CAN VET J, V26, P33; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; WOODS PSA, 1993, EQUINE VET J, V25, P208, DOI 10.1111/j.2042-3306.1993.tb02945.x; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu L, 2010, AM J RESP C IN PRESS; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19678	10.1371/journal.pone.0019678	http://dx.doi.org/10.1371/journal.pone.0019678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602926	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500021
J	Chen, JM; Sun, YX				Chen, Jiming; Sun, Yingxue			Variation in the Analysis of Positively Selected Sites Using Nonsynonymous/Synonymous Rate Ratios: An Example Using Influenza Virus	PLOS ONE			English	Article							AMINO-ACID SITES; MOLECULAR EVOLUTION; HEMAGGLUTININ; MODELS; TRENDS; GENE	Sites in a gene showing the nonsynonymous/synonymous rate ratio (omega) >1 have been frequently identified to be under positive selection. To examine the performance of such analysis, sites of the omega ratio >1 in the HA1 gene of H3N2 subtype human influenza viruses were identified from seven overlapping sequence data sets in this study. Our results showed that the sites of the omega ratio >1 were of significant variation among the data sets even though they targeted similar clusters, indicating that the analysis is likely to be either of low sensitivity or of low specificity in identifying sites under positive selection. Most (43/45) of the sites showing omega >1 calculated from at least one data set are involved in B-cell epitopes which cover less than a half sites in the protein, suggesting that the analysis is likely to be of low sensitivity rather than of low specificity. It was further found that the analysis sensitivity could not be enhanced by including more sequences or covering longer time intervals. Previously some reports also likely identified only a portion of the sites under positive selection in the viral gene using the omega ratio. Low sensitivity of the analysis may result from that some sites under positive selection in the gene are also under negative (purifying) selection simultaneously for functional constrains, and so their omega ratios could be <1. Theoretically, the sites under the two opposite selection forces at the same time favor only certain nonsynonymous changes, e.g. those changing the antigenicity of the gene and maintaining the gene function. This study also suggested that sometimes we can identify more sites under positive selection using the omega ratio by integrating the positively selected sites estimated from multiple data sets.	[Chen, Jiming; Sun, Yingxue] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China	China Animal Health & Epidemiology Center	Chen, JM (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Agriculture of P. R. China	Ministry of Agriculture of P. R. China	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Crandall KA, 1999, MOL BIOL EVOL, V16, P372, DOI 10.1093/oxfordjournals.molbev.a026118; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Hao DC, 2010, J PLANT RES, V123, P241, DOI 10.1007/s10265-009-0261-5; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li W. H, 1997, MOL EVOLUTION; Nielsen R, 1998, GENETICS, V148, P929; Perry GH, 2006, MOL BIOL EVOL, V23, P644, DOI 10.1093/molbev/msj072; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Van der Merwe MM, 2009, P ROY SOC B-BIOL SCI, V276, P2913, DOI 10.1098/rspb.2009.0328; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	31	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19996	10.1371/journal.pone.0019996	http://dx.doi.org/10.1371/journal.pone.0019996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629696	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005800021
J	Robinson, EJH; Franks, NR; Ellis, S; Okuda, S; Marshall, JAR				Robinson, Elva J. H.; Franks, Nigel R.; Ellis, Samuel; Okuda, Saki; Marshall, James A. R.			A Simple Threshold Rule Is Sufficient to Explain Sophisticated Collective Decision-Making	PLOS ONE			English	Article							NEST-SITE SELECTION; DIVISION-OF-LABOR; COLONIES CHOOSE; ANT COLONIES; MATE CHOICE; HONEY-BEES; EXPERIENCE; ORGANIZATION; EVOLUTION; SWARMS	Decision-making animals can use slow-but-accurate strategies, such as making multiple comparisons, or opt for simpler, faster strategies to find a 'good enough' option. Social animals make collective decisions about many group behaviours including foraging and migration. The key to the collective choice lies with individual behaviour. We present a case study of a collective decision-making process (house-hunting ants, Temnothorax albipennis), in which a previously proposed decision strategy involved both quality-dependent hesitancy and direct comparisons of nests by scouts. An alternative possible decision strategy is that scouting ants use a very simple quality-dependent threshold rule to decide whether to recruit nest-mates to a new site or search for alternatives. We use analytical and simulation modelling to demonstrate that this simple rule is sufficient to explain empirical patterns from three studies of collective decision-making in ants, and can account parsimoniously for apparent comparison by individuals and apparent hesitancy (recruitment latency) effects, when available nests differ strongly in quality. This highlights the need to carefully design experiments to detect individual comparison. We present empirical data strongly suggesting that best-of-n comparison is not used by individual ants, although individual sequential comparisons are not ruled out. However, by using a simple threshold rule, decision-making groups are able to effectively compare options, without relying on any form of direct comparison of alternatives by individuals. This parsimonious mechanism could promote collective rationality in group decision-making.	[Robinson, Elva J. H.; Franks, Nigel R.; Ellis, Samuel; Okuda, Saki] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Robinson, Elva J. H.] Univ York, Dept Biol, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Marshall, James A. R.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England	University of Bristol; University of York - UK; University of Sheffield; University of Sheffield	Robinson, EJH (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Elva.Robinson@yccsa.org	Franks, Nigel/AAG-8207-2019; Robinson, Elva J H/AAC-9785-2019; Ellis, Sam/AGH-4882-2022	Franks, Nigel/0000-0001-8139-9604; Ellis, Samuel/0000-0001-9019-6040; Robinson, Elva/0000-0003-4914-9327; Marshall, James/0000-0002-1506-167X	EPSRC [EP/D076226/1]; Nuffield; University of Bristol; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02166X/2, BB/G02166X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D076226/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Nuffield; University of Bristol; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EJHR and NRF acknowledge support from EPSRC grant EP/D076226/1 http://www.epsrc.ac.uk/Pages/default.aspx. SO was supported by a Nuffield Undergraduate Bursary http://users.ecs.soton.ac.uk/saw/nuffield.html; SE was supported by a University of Bristol Summer Studentship http://www.bristol.ac.uk/biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BURNS JG, 2007, ANIM BEHAV, V70, pE1; CALDERONE NW, 1989, EXPERIENTIA, V45, P765, DOI 10.1007/BF01974583; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; de Biseau J.C., 1992, Psyche (Cambridge), V98, P323, DOI 10.1155/1991/38402; Dhar R, 1997, J CONSUM RES, V24, P215, DOI 10.1086/209506; DOWDS BM, 1983, BEHAVIOUR, V85, P1, DOI 10.1163/156853983X00011; Doyle JR, 1999, PSYCHOL MARKET, V16, P225, DOI 10.1002/(SICI)1520-6793(199905)16:3<225::AID-MAR3>3.0.CO;2-X; Edwards SC, 2009, P ROY SOC B-BIOL SCI, V276, P3655, DOI 10.1098/rspb.2009.0981; FEWELL JH, 1992, OECOLOGIA, V92, P542, DOI 10.1007/BF00317846; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; FREEMAN PR, 1983, INT STAT REV, V51, P189, DOI 10.2307/1402748; Healey CIM, 2008, ANIM BEHAV, V76, P893, DOI 10.1016/j.anbehav.2008.02.016; Hutchinson JMC, 2005, BIOL REV, V80, P73, DOI 10.1017/S1464793104006554; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; Kay LM, 2006, NEURON, V51, P277, DOI 10.1016/j.neuron.2006.07.015; Langen Tom A., 1999, Animal Cognition, V2, P223, DOI 10.1007/s100710050043; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Mabry KE, 2008, AM NAT, V172, P625, DOI 10.1086/591682; Mallon EB, 2000, P ROY SOC B-BIOL SCI, V267, P765, DOI 10.1098/rspb.2000.1069; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Marshall JAR, 2009, CURR BIOL, V19, pR395, DOI 10.1016/j.cub.2009.03.011; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; MOORE AJ, 1988, EVOLUTION, V42, P387, DOI [10.2307/2409241, 10.1111/j.1558-5646.1988.tb04141.x]; *NAT CTR FOR THE R, 2010, RESP US AN BIOSC RES; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P2635, DOI 10.1098/rspb.2009.0350; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; SASAKI T, 2011, BEHAV ECOL IN PRESS; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Seeley TD, 1999, BEHAV ECOL SOCIOBIOL, V45, P19, DOI 10.1007/s002650050536; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Seeley TD, 2001, BEHAV ECOL SOCIOBIOL, V49, P416, DOI 10.1007/s002650000299; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V30, P59, DOI 10.1007/BF00168595; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; SHAFIR S, 1994, ANIM BEHAV, V48, P55, DOI 10.1006/anbe.1994.1211; Stroeymeyt N, 2011, BEHAV ECOL, V22, P535, DOI 10.1093/beheco/arr007; SVENSSON BG, 1989, J INSECT BEHAV, V2, P387, DOI 10.1007/BF01068063; The ABC Research Group, 1999, SIMPLE HEURISTICS MA, P287, DOI DOI 10.1111/.1745-9125.2010.00223.X; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Visscher PK, 1999, NATURE, V397, P400, DOI 10.1038/17047; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0	74	54	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19981	10.1371/journal.pone.0019981	http://dx.doi.org/10.1371/journal.pone.0019981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629645	Green Published, gold, Green Accepted			2022-12-27	WOS:000291005800020
J	Chew, KCM; Matsuda, N; Saisho, K; Lim, GGY; Chai, C; Tan, HM; Tanaka, K; Lim, KL				Chew, Katherine C. M.; Matsuda, Noriyuki; Saisho, Keiko; Lim, Grace G. Y.; Chai, Chou; Tan, Hui-Mei; Tanaka, Keiji; Lim, Kah-Leong			Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; CARRIER PROTEIN; CHAIN SYNTHESIS; DISEASE; PINK1; PHOSPHORYLATION; MITOCHONDRIA; MUTATIONS; DEGRADATION; ACTIVATION	Background: Mutations in the parkin gene, which encodes a ubiquitin ligase (E3), are a major cause of autosomal recessive parkinsonism. Although parkin-mediated ubiquitination was initially linked to protein degradation, accumulating evidence suggests that the enzyme is capable of catalyzing multiple forms of ubiquitin modifications including monoubiquitination, K48- and K63-linked polyubiquitination. In this study, we sought to understand how a single enzyme could exhibit such multifunctional catalytic properties. Methods and Findings: By means of in vitro ubiquitination assays coupled with mass spectrometry analysis, we were surprised to find that parkin is apparently capable of mediating E2-independent protein ubiquitination in vitro, an unprecedented activity exhibited by an E3 member. Interestingly, whereas full length parkin catalyzes solely monoubiquitination regardless of the presence or absence of E2, a truncated parkin mutant containing only the catalytic moiety supports both E2-independent and E2-dependent assembly of ubiquitin chains. Conclusions: Our results here suggest a complex regulation of parkin's activity and may help to explain how a single enzyme like parkin could mediate diverse forms of ubiquitination.	[Chew, Katherine C. M.; Lim, Grace G. Y.; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Matsuda, Noriyuki; Saisho, Keiko; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 113, Japan; [Chai, Chou; Lim, Kah-Leong] A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore; [Tan, Hui-Mei; Lim, Kah-Leong] Natl Inst Neurosci, Singapore, Singapore	National University of Singapore; Tokyo Metropolitan Institute of Medical Science; National Neuroscience Institute (NNI)	Chew, KCM (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	phslkl@nus.edu.sg	Matsuda, Noriyuki/AAI-3156-2020; Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Chew, Katherine C. M./0000-0003-2051-4386; Lim, Kah-Leong/0000-0002-5440-2588	Singapore Biomedical Research Council; Singapore Millennium Foundation; Ministry of Education, Science, Sports, Culture and Technology	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation); Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Singapore Biomedical Research Council (LKL), http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx; the Singapore Millennium Foundation (LKL and GL), http://www.smf-scholar.org/, and the Ministry of Education, Science, Sports, Culture and Technology (NM and KT), http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Huzil JT, 2007, J BIOL CHEM, V282, P37454, DOI 10.1074/jbc.M705242200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; VANNOCKER S, 1991, P NATL ACAD SCI USA, V88, P10297, DOI 10.1073/pnas.88.22.10297; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; YOSHII SR, 2011, J BIOL CHEM; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	35	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19720	10.1371/journal.pone.0019720	http://dx.doi.org/10.1371/journal.pone.0019720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625422	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200009
J	Lai, KM; Bottomley, C; McNerney, R				Lai, Ka-Man; Bottomley, Christian; McNerney, Ruth			Propagation of Respiratory Aerosols by the Vuvuzela	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PULMONARY-FUNCTION; PILGRIMAGE HAJJ; TUBERCULOSIS; INFECTION; INFLUENZA; DISEASE; DISSEMINATION; PARTICLES; CONTAGION	Vuvuzelas, the plastic blowing horns used by sports fans, recently achieved international recognition during the FIFA World Cup soccer tournament in South Africa. We hypothesised that vuvuzelas might facilitate the generation and dissemination of respiratory aerosols. To investigate the quantity and size of aerosols emitted when the instrument is played, eight healthy volunteers were asked to blow a vuvuzela. For each individual the concentration of particles in expelled air was measured using a six channel laser particle counter and the duration of blowing and velocity of air leaving the vuvuzela were recorded. To allow comparison with other activities undertaken at sports events each individual was also asked to shout and the measurements were repeated while using a paper cone to confine the exhaled air. Triplicate measurements were taken for each individual. The mean peak particle counts were 658x10(3) per litre for the vuvuzela and 3.7x10(3) per litre for shouting, representing a mean log(10) difference of 2.20 (95% CI: 2.03,2.36; p<0.001). The majority (>97%) of particles captured from either the vuvuzela or shouting were between 0.5 and 5 microns in diameter. Mean peak airflows recorded for the vuvuzela and shouting were 6.1 and 1.8 litres per second respectively. We conclude that plastic blowing horns (vuvuzelas) have the capacity to propel extremely large numbers of aerosols into the atmosphere of a size able to penetrate the lower lung. Some respiratory pathogens are spread via contaminated aerosols emitted by infected persons. Further investigation is required to assess the potential of the vuvuzela to contribute to the transmission of aerosol borne diseases. We recommend, as a precautionary measure, that people with respiratory infections should be advised not to blow their vuvuzela in enclosed spaces and where there is a risk of infecting others.	[Lai, Ka-Man] UCL, Dept Civil Environm & Geomat Engn, Healthy Infrastruct Res Ctr, London, England; [Bottomley, Christian] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [McNerney, Ruth] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lai, KM (corresponding author), UCL, Dept Civil Environm & Geomat Engn, Healthy Infrastruct Res Ctr, London, England.	ruth.mcnerney@lshtm.ac.uk	Lai, Ka Man/C-3259-2015	Lai, Ka Man/0000-0002-0037-792X; MCNERNEY, Ruth/0000-0002-1957-443X; Bottomley, Christian/0000-0002-5241-8412	Engineering and Physical Science Research Council [EPSRC EP/G029881/1]; Department for International Development, UK; Medical Research Council (UK); Engineering and Physical Sciences Research Council [EP/G029881/1] Funding Source: researchfish; Medical Research Council [G0700837] Funding Source: researchfish; EPSRC [EP/G029881/1] Funding Source: UKRI; MRC [G0700837] Funding Source: UKRI	Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department for International Development, UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Engineering and Physical Science Research Council grant EPSRC EP/G029881/1 (K-ML) and the Department for International Development, UK (RM). CB received salary support from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; Biellik RJ, 1997, B WORLD HEALTH ORGAN, V75, P367; BLUMBERG L, 2010, 2010 FIFA SOCCER WOU, P63; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; DUGUID J P, 1947, Rep Dep Health Scotl, V46, P62; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; DUGUID JP, 1946, BRIT MED J, V1, P265, DOI 10.1136/bmj.1.4442.265; EHRESMANN KR, 1995, J INFECT DIS, V171, P679, DOI 10.1093/infdis/171.3.679; El-Sheikh SM, 1998, TROP MED INT HEALTH, V3, P205; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; HALL WJ, 1980, ANNU REV MED, V31, P233, DOI 10.1146/annurev.me.31.020180.001313; HATCH TF, 1961, BACTERIOL REV, V25, P237, DOI 10.1128/MMBR.25.3.237-240.1961; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Knight V, 1980, Ann N Y Acad Sci, V353, P147, DOI 10.1111/j.1749-6632.1980.tb18917.x; LECLAIR JM, 1980, NEW ENGL J MED, V302, P450, DOI 10.1056/NEJM198002213020807; LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297; Moloney A, 2009, LANCET, V373, P1591, DOI 10.1016/S0140-6736(09)60868-0; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; National Institute for Communicable Diseases, 2011, SEV AC RESP ILLN SAR; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; ROBERTS F, 2000, RESP PHYSL UPDATE AN; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Serisier DJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-63; Swanepoel D, 2010, SAMJ S AFR MED J, V100, P192, DOI 10.7196/SAMJ.4098; Swanepoel DW, 2010, SAMJ S AFR MED J, V100, P99, DOI 10.7196/SAMJ.3697; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179; World Health Organization, 2010, GLOB TUB CONTR WHO R	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20086	10.1371/journal.pone.0020086	http://dx.doi.org/10.1371/journal.pone.0020086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629778	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000291005200033
J	Cimica, V; Chen, HC; Iyer, JK; Reich, NC				Cimica, Velasco; Chen, Hui-Chen; Iyer, Janaki K.; Reich, Nancy C.			Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-beta 1	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; COILED-COIL DOMAIN; NF-KAPPA-B; UNPHOSPHORYLATED STAT3; LIVING CELLS; TYROSINE PHOSPHORYLATION; MITOCHONDRIAL STAT3; SIGNAL TRANSDUCER; CRYSTAL-STRUCTURE; PROTEIN	The signal transducer and activator of transcription-3 (STAT3) induces transcription of genes that control differentiation, inflammation, proliferation, and tumor cell invasion. Cytokines such as interleukin-6 and interferon stimulate the specific tyrosine phosphorylation of STAT3, which confers its ability to bind consensus DNA targets. In addition, unphosphorylated STAT3 has been demonstrated to induce specific gene expression. STAT3 must gain entrance to the nucleus to impact transcription, however access to the nucleus is a tightly regulated process. Because nuclear trafficking is critical to the function of STAT3, we investigated the molecular mechanisms by which STAT3 is imported to the nucleus. Live cell imaging techniques were used with STAT3 tagged with green fluorescence protein (GFP) or photoactivatable GFP to follow the cellular dynamics of both unphosphorylated and tyrosine phosphorylated forms. Cytokine activation did not alter the rate of STAT3 nuclear import or nuclear export. In addition, Forster resonance energy transfer experiments revealed homomeric interaction of unphosphorylated STAT3 dependent on its amino terminus, but this dimerization is not necessary for its nuclear import. Previous work demonstrated the adapter importin-alpha 3 binds to STAT3 and is required for nuclear import. To determine whether STAT3 nuclear import is mediated by the importin-alpha/importin-beta 1 heterodimer, the effects of siRNA to importin-beta 1 were evaluated. Results indicate STAT3 nuclear import is dependent on the function of importin-beta 1. Since the Ran GTPase is necessary to bind importin-beta 1 in the nucleus for release of importin-alpha-cargo, the effect of a GTPase deficient mutant of Ran was tested. Expression of the Ran interfering mutant inhibited STAT3 nuclear import. This study defines importin-alpha/importin-beta 1/Ran as the molecular mechanism by which STAT3 traffics to the nucleus.	[Cimica, Velasco; Chen, Hui-Chen; Iyer, Janaki K.; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cimica, V (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu	Cimica, Velasco/H-2656-2014	Cimica, Velasco/0000-0001-7489-3145	National Institutes of Health [RO1CA122910]; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant RO1CA122910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Dingwall C, 1998, METHOD CELL BIOL, V53, P517; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reich NC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe61; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schroder M, 2004, J LEUKOCYTE BIOL, V75, P792, DOI 10.1189/jlb.1003496; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Wente SR, 2010, COLD SPRING HARB PER; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	69	83	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20188	10.1371/journal.pone.0020188	http://dx.doi.org/10.1371/journal.pone.0020188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625522	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200053
J	Eitel, M; Guidi, L; Hadrys, H; Balsamo, M; Schierwater, B				Eitel, Michael; Guidi, Loretta; Hadrys, Heike; Balsamo, Maria; Schierwater, Bernd			New Insights into Placozoan Sexual Reproduction and Development	PLOS ONE			English	Article							ADHAERENS FE SCHULZE; ANTIGEN 8 SPAG8; TRICHOPLAX-ADHAERENS; CORTICAL GRANULES; CELL-DIFFERENTIATION; ASEXUAL REPRODUCTION; METAZOAN EVOLUTION; HOX GENES; FERTILIZATION; OOGENESIS	Unraveling animal life cycles and embryonic development is basic to understanding animal biology and often sheds light on phylogenetic relationships. A key group for understanding the evolution of the Metazoa is the early branching phylum Placozoa, which has attracted rapidly increasing attention. Despite over a hundred years of placozoan research the life cycle of this enigmatic phylum remains unknown. Placozoa are a unique model system for which the nuclear genome was published before the basic biology (i.e. life cycle and development) has been unraveled. Four organismal studies have reported the development of oocytes and one genetic study has nourished the hypothesis of sexual reproduction in natural populations at least in the past. Here we report new observations on sexual reproduction and embryonic development in the Placozoa and support the hypothesis of current sexual reproduction. The regular observation of oocytes and expressed sperm markers provide support that placozoans reproduce sexually in the field. Using whole genome and EST sequences and additional cDNA cloning we identified five conserved sperm markers, characteristic for different stages in spermatogenesis. We also report details on the embryonic development up to a 128-cell stage and new ultrastructural features occurring during early development. These results suggest that sperm and oocyte generation and maturation occur in different placozoans and that clonal lineages reproduce bisexually in addition to the standard mode of vegetative reproduction. The sum of observations is best congruent with the hypothesis of a simple life cycle with an alternation of reproductive modes between bisexual and vegetative reproduction.	[Eitel, Michael; Hadrys, Heike; Schierwater, Bernd] ITZ, Stiftung Tierarztliche Hsch Hannover, Hannover, Germany; [Guidi, Loretta; Balsamo, Maria] Dept Earth Life & Environm Sci, Urbino, Italy; [Hadrys, Heike; Schierwater, Bernd] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; Yale University	Eitel, M (corresponding author), ITZ, Stiftung Tierarztliche Hsch Hannover, Hannover, Germany.	michael.eitel@ecolevol.de	Balsamo, Maria/AAW-3205-2020	Balsamo, Maria/0000-0002-7947-0632; Eitel, Michael/0000-0002-0531-0732; Guidi, loretta/0000-0002-9009-9520	German Science Foundation (DFG) [Schi-227/20-2, Schi-227/20-3, Schi-227/26-1]; Italian Ministry of Education, University and Research; Evangelische Studienwerk e.V. scholarship; Stiftung Tierarztliche Hochschule Hannover	German Science Foundation (DFG)(German Research Foundation (DFG)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Evangelische Studienwerk e.V. scholarship; Stiftung Tierarztliche Hochschule Hannover	The study was supported by the German Science Foundation (DFG grants Schi-227/20-2, -3 and Schi-227/26-1 to BS) and by the Italian Ministry of Education, University and Research (PRIN 2007 grant to MB). ME acknowledges funding by an Evangelische Studienwerk e.V. scholarship and an "Otto Butschli" scholarship from the Stiftung Tierarztliche Hochschule Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2008, AQUAT BIOL, V1, P291, DOI 10.3354/ab00032; ADIYODI KG, 1994, REPROD BIOL INVERTEB; ANDERSON E, 1968, J CELL BIOL, V37, P514, DOI 10.1083/jcb.37.2.514; Bavestrello G, 2006, CHEM ECOL, V22, P197, DOI 10.1080/02757540600670810; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Blackstone NW, 2009, PLOS BIOL, V7, P29, DOI 10.1371/journal.pbio.1000007; CHEN CLA, 1995, ZOOL STUD, V34, P29; Cheng GY, 2007, ASIAN J ANDROL, V9, P23, DOI 10.1111/j.1745-7262.2007.00247.x; Chiaverano L, 2004, HYDROBIOLOGIA, V530, P373, DOI 10.1007/s10750-004-2666-4; Cran D.G., 1989, Journal of Reproduction and Fertility Supplement, P49; DANDEKAR P, 1992, MOL REPROD DEV, V31, P135, DOI 10.1002/mrd.1080310208; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; DeSalle R, 2008, BIOESSAYS, V30, P1043, DOI 10.1002/bies.20842; Eckelbarger KJ, 2005, INVERTEBR REPROD DEV, V47, P167, DOI 10.1080/07924259.2005.9652157; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Furukawa K, 1994, CHROMOSOME RES, V2, P99, DOI 10.1007/BF01553489; Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P2614, DOI 10.1021/es8024484; Grell K.G., 1984, Advances in Invertebrate Reproduction, V3, P541; GRELL K G, 1971, Naturwissenschaftliche Rundschau, V24, P160; Grell K.G., 1991, P13; GRELL K G, 1971, Cytobiologie, V4, P216; Grell K.G., 1981, TRICHOPLAX ADHAERENS, P107; GRELL KG, 1981, ZOOMORPHOLOGY, V98, P47, DOI 10.1007/BF00310320; GRELL KG, 1971, NATURWISSENSCHAFTEN, V58, P570, DOI 10.1007/BF00598728; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1974, Z MORPHOL TIERE, V79, P295; Guan J, 2010, REPROD DOMEST ANIM, V45, P992, DOI 10.1111/j.1439-0531.2009.01473.x; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Hamel JF, 2007, BIOL BULL-US, V213, P101, DOI 10.2307/25066626; HOTTA Y, 1995, ADV BIOPHYS, V31, P101, DOI 10.1016/0065-227X(95)99386-4; Hwang KC, 2003, BIOCHEM BIOPH RES CO, V306, P198, DOI 10.1016/S0006-291X(03)00916-1; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; JENNISON BL, 1979, CAN J ZOOL, V57, P403, DOI 10.1139/z79-047; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Li R, 2009, CELL BIOCHEM FUNCT, V27, P264, DOI 10.1002/cbf.1574; Liu G, 2004, ACTA BIOCH BIOPH SIN, V36, P93, DOI 10.1093/abbs/36.2.93; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Mei J, 2008, MOL CELL ENDOCRINOL, V289, P67, DOI 10.1016/j.mce.2008.02.016; Mercurio M, 2007, MAR BIOL, V151, P1491, DOI 10.1007/s00227-006-0584-x; MILLER FP, 2009, EVOLUTION SEXUAL REP; NOSEK J, 1984, HISTOCHEM J, V16, P435, DOI 10.1007/BF01002871; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Perovic-Ottstadt S, 2004, INT J DEV BIOL, V48, P293, DOI 10.1387/ijdb.041813sp; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; RUTHMANN A, 1981, Z NATURFORSCH C, V36, P564; RUTHMANN A, 1975, CYTOBIOLOGIE, V10, P421; Salzberg Y, 2010, DEV BIOL, V338, P158, DOI 10.1016/j.ydbio.2009.11.028; Schierwater B, 1998, MOL PHYLOGENET EVOL, V9, P375, DOI 10.1006/mpev.1998.0489; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; SCHIERWATER B, 2009, COMMUNICATIVE INTEGR, V2, P1; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; Schierwater B, 2009, INT J BIOCHEM CELL B, V41, P370, DOI 10.1016/j.biocel.2008.09.023; SCHULSINGER F, 1991, Acta Psychiatrica Scandinavica Supplementum, P1; Schulze FE, 1883, ZOOL ANZ, V6, P92; Schwab K, 2003, KIDNEY INT, V64, P1588, DOI 10.1046/j.1523-1755.2003.00276.x; Shakib K, 2005, PROTEOMICS, V5, P2819, DOI 10.1002/pmic.200401108; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Signorovitch AY, 2005, P NATL ACAD SCI USA, V102, P15518, DOI 10.1073/pnas.0504031102; Simpson T., 1984, CELL BIOL SPONGES; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steiner R, 1999, DEV BIOL, V216, P635, DOI 10.1006/dbio.1999.9520; Swiatek P, 2006, TISSUE CELL, V38, P263, DOI 10.1016/j.tice.2006.06.005; Syed T, 2002, VIE MILIEU, V52, P177; THIEMANN M, 1988, Z NATURFORSCH C, V43, P955; THIEMANN M, 1990, ZOOMORPHOLOGY, V110, P37, DOI 10.1007/BF01632810; THIEMANN M, 1991, ZOOMORPHOLOGY, V110, P165, DOI 10.1007/BF01632872; Velilla E, 2004, MOL REPROD DEV, V68, P507, DOI 10.1002/mrd.20111; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; von der Chevallerie K., 2010, CAH BIOL MAR, V51, P212; Whalan S, 2007, CORAL REEFS, V26, P655, DOI 10.1007/s00338-007-0236-8; WITTE U, 1994, J EXP MAR BIOL ECOL, V183, P41, DOI 10.1016/0022-0981(94)90155-4; Wong Julian L., 2008, V440, P61, DOI 10.1007/978-1-59745-178-9_5; Wu HY, 2010, FEBS LETT, V584, P2807, DOI 10.1016/j.febslet.2010.05.016; Zhang TT, 2010, MICRON, V41, P59, DOI 10.1016/j.micron.2009.08.004; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106	78	46	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19639	10.1371/journal.pone.0019639	http://dx.doi.org/10.1371/journal.pone.0019639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625556	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200012
J	Lorent, N; Sebatunzi, O; Mukeshimana, G; Van den Ende, J; Clerinx, J				Lorent, Natalie; Sebatunzi, Osee; Mukeshimana, Gloria; Van den Ende, Jef; Clerinx, Joannes			Incidence and Risk Factors of Serious Adverse Events during Antituberculous Treatment in Rwanda: A Prospective Cohort Study	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; DRUG-INDUCED HEPATOTOXICITY; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; TUBERCULOSIS PATIENTS; CLINICAL DETERIORATION; PULMONARY TUBERCULOSIS; DISEASE; AFRICA; COUNTRIES	Background: Tuberculosis (TB) and TB-human immunodeficiency virus infection (HIV) coinfection is a major public health concern in resource-limited settings. Although TB treatment is challenging in HIV-infected patients because of treatment interactions, immunopathological reactions, and concurrent infections, few prospective studies have addressed this in sub-Saharan Africa. In this study we aimed to determine incidence, causes of, and risk factors for serious adverse events among patients on first-line antituberculous treatment, as well as its impact on antituberculous treatment outcome. Methods and findings: Prospective observational cohort study of adults treated for TB at the Internal Medicine department of the Kigali University Hospital from May 2008 through August 2009. Of 263 patients enrolled, 253 were retained for analysis: median age 35 (Interquartile range, IQR 28-40), 55% male, 66% HIV-positive with a median CD4 count 104 cells/mm(3) (IQR 44-248 cells/mm(3)). Forty percent had pulmonary TB, 43% extrapulmonary TB and 17% a mixed form. Sixty-four (26%) developed a serious adverse event; 58/167 (35%) HIV-infected vs. 6/86 (7%) HIV-uninfected individuals. Commonest events were concurrent infection (n = 32), drug-induced hepatitis (n = 24) and paradoxical reactions/TB-IRIS (n = 23). HIV-infection (adjusted Hazard Ratio, aHR 3.4, 95% Confidence Interval, CI 1.4-8.7) and extrapulmonary TB (aHR 2, 95% CI 1.1-3.7) were associated with an increased risk of serious adverse events. For TB/HIV co-infected patients, extrapulmonary TB (aHR 2.0, 95% CI 1.1-3.9) and CD4 count <100 cells/mm(3) at TB diagnosis (aHR 1.7, 95% CI 1.0-2.9) were independent predictors. Adverse events were associated with an almost two-fold higher risk of unsuccessful treatment outcome at 6 months (HR 1.89, 95% CI 1.3-3.0). Conclusion: Adverse events frequently complicate the course of antituberculous treatment and worsen treatment outcome, particularly in patients with extrapulmonary TB and advanced immunodeficiency. Concurrent infection accounts for most events. Our data suggest that deterioration in a patient already receiving antituberculous treatment should prompt an aggressive search for additional infections.	[Lorent, Natalie; Sebatunzi, Osee; Mukeshimana, Gloria] Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda; [Lorent, Natalie; Van den Ende, Jef; Clerinx, Joannes] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Lorent, N (corresponding author), Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda.	nlorent@itg.be	Clerinx, Joannes/GLT-1172-2022		Tibotec's REACH Initiative; Belgian Technical Cooperation in Rwanda; Flemisch Research Foundation (FWO), Belgium	Tibotec's REACH Initiative; Belgian Technical Cooperation in Rwanda; Flemisch Research Foundation (FWO), Belgium(FWO)	The study was funded by Tibotec's REACH Initiative grant. NL was supported by the Belgian Technical Cooperation in Rwanda. She received a grant from the Flemisch Research Foundation (FWO), Belgium, in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CHEST; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Colebunders R, 2006, INT J TUBERC LUNG D, V10, P946; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Fernandez-Villar A, 2004, INT J TUBERC LUNG D, V8, P1499; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kumarasamy N, 2004, JAIDS-J ACQ IMM DEF, V37, P1574, DOI 10.1097/00126334-200412150-00007; Lanternier F, 2007, INT J TUBERC LUNG D, V11, P1203; Lawn SD, 2007, AIDS, V21, P2362, DOI 10.1097/QAD.0b013e3282f1be39; Lawn SD, 2007, CURR OPIN HIV AIDS, V2, P339, DOI 10.1097/COH.0b013e3281a3c0a6; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lorent N, 2008, INT J TUBERC LUNG D, V12, P392; LORENT N, 2009, INT J TUBERC LUNG D, V13, pS199; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Tost JR, 2005, INT J TUBERC LUNG D, V9, P534; Tostmann A, 2007, TROP MED INT HEALTH, V12, P852, DOI 10.1111/j.1365-3156.2007.01871.x; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; WHO, 2009, WHOHTMTB2009411; World Health Organization, 2008, WHOHTMTB2008401; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	38	33	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19566	10.1371/journal.pone.0019566	http://dx.doi.org/10.1371/journal.pone.0019566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611117	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200016
J	Gruss, A; Kaplan, DM; Hart, DR				Gruess, Arnaud; Kaplan, David M.; Hart, Deborah R.			Relative Impacts of Adult Movement, Larval Dispersal and Harvester Movement on the Effectiveness of Reserve Networks	PLOS ONE			English	Article							MARINE PROTECTED AREAS; FISHERIES MANAGEMENT; HOME-RANGE; SCIENCE; CONNECTIVITY; MODEL; OCEAN; SUSTAINABILITY; POPULATIONS; PERSISTENCE	Movement of individuals is a critical factor determining the effectiveness of reserve networks. Marine reserves have historically been used for the management of species that are sedentary as adults, and, therefore, larval dispersal has been a major focus of marine-reserve research. The push to use marine reserves for managing pelagic and demersal species poses significant questions regarding their utility for highly-mobile species. Here, a simple conceptual metapopulation model is developed to provide a rigorous comparison of the functioning of reserve networks for populations with different admixtures of larval dispersal and adult movement in a home range. We find that adult movement produces significantly lower persistence than larval dispersal, all other factors being equal. Furthermore, redistribution of harvest effort previously in reserves to remaining fished areas ('fishery squeeze') and fishing along reserve borders ('fishing-the-line') considerably reduce persistence and harvests for populations mobile as adults, while they only marginally changes results for populations with dispersing larvae. Our results also indicate that adult home-range movement and larval dispersal are not simply additive processes, but rather that populations possessing both modes of movement have lower persistence than equivalent populations having the same amount of 'total movement' (sum of larval and adult movement spatial scales) in either larval dispersal or adult movement alone.	[Gruess, Arnaud; Kaplan, David M.] Univ Montpellier 2, IRD, IFREMER, Ctr Rech Halieut Mediterraneenne & Trop,UMR EME 2, Sete, France; [Hart, Deborah R.] NE Fisheries Sci Ctr, Woods Hole, MA USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; National Oceanic Atmospheric Admin (NOAA) - USA	Gruss, A (corresponding author), Univ Montpellier 2, IRD, IFREMER, Ctr Rech Halieut Mediterraneenne & Trop,UMR EME 2, Sete, France.	arnaud.gruss@ird.fr	Kaplan, David/G-5230-2010; Hart, Deborah/E-6917-2016	Kaplan, David/0000-0001-6087-359X; Hart, Deborah/0000-0002-0406-0751	French National Research Agency (ANR) [ANR-08-STRA-03]	French National Research Agency (ANR)(French National Research Agency (ANR))	AG and DMK were supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Program, grant number ANR-08-STRA-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, S AFR SHIPP NEWS FIS; Attwood CG, 1995, S AFR J MARINE SCI, V16, P227; Barrowman NJ, 2000, CAN J FISH AQUAT SCI, V57, P665, DOI 10.1139/cjfas-57-4-665; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Carr MH, 2003, ECOL APPL, V13, pS90; CAVERIVIERE A, 1976, CAH ORSTOM OCEANOGR, V14, P201; Cayre P., 1986, P ICCAT INT SKIPJACK, P252; Cayre P, 1986, P ICCAT C INT SKIPJA, V1, P335; Dawson MN, 2006, SCIENCE, V313, P43; FONTENEAU A, 2005, IOTC2005WPTT21; FONTENEAU A, 1996, 84123 FAO; FONTENEAU A, 1999, COL VOL SCI PAP ICCA, V49, P446; FROESE R, 2006, FISHBASE VERSION; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gascuel D, 1992, AQUAT LIVING RESOUR, V5, P155, DOI 10.1051/alr:1992016; Gerber LR, 2005, CAN J FISH AQUAT SCI, V62, P863, DOI 10.1139/F05-046; Grantham BA, 2003, ECOL APPL, V13, pS108; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; GUNDERSON DR, 1977, FISH B-NOAA, V75, P369; Gurd DB, 2001, CONSERV BIOL, V15, P1355, DOI 10.1046/j.1523-1739.2001.00188.x; Hallier J.-P., 2006, COL VOL SC PAP ICCAT, V59, P411; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Hart DR, 2006, CAN J FISH AQUAT SCI, V63, P1445, DOI 10.1139/F06-071; Harvey CJ, 2006, ECOL APPL, V16, P1502, DOI 10.1890/1051-0761(2006)016[1502:CIBSAA]2.0.CO;2; Hastings A, 2003, ECOL APPL, V13, pS65; Holland D. S., 1996, MAR RESOUR ECON, V11, P157, DOI DOI 10.1086/MRE.11.3.42629158; *ICCAT, 2008, ICCAT MANUAL; Jensen OP, 2010, PROG OCEANOGR, V86, P176, DOI 10.1016/j.pocean.2010.04.020; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Kaplan DM, 2006, ECOL APPL, V16, P2248, DOI 10.1890/1051-0761(2006)016[2248:DPRAEM]2.0.CO;2; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Lubchenco J, 2003, ECOL APPL, V13, pS3; Maury O, 2001, AQUAT LIVING RESOUR, V14, P203, DOI 10.1016/S0990-7440(01)01115-9; Methot RD, 2005, STATUS US CANARY ROC; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Murawski SA, 2000, B MAR SCI, V66, P775; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Nelson J, 2010, MAR POLLUT BULL, V60, P635, DOI 10.1016/j.marpolbul.2010.04.009; Neubert MG, 2003, ECOL LETT, V6, P843, DOI 10.1046/j.1461-0248.2003.00493.x; Norse Elliott A., 2005, P302; O'Farrell MR, 2006, ECOL APPL, V16, P977, DOI 10.1890/1051-0761(2006)016[0977:ETSONR]2.0.CO;2; Pala C, 2009, SCIENCE, V324, P1133, DOI 10.1126/science.324_1133; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pelletier D, 2005, FISH FISH, V6, P307, DOI 10.1111/j.1467-2979.2005.00199.x; PHILLIPS JB, 1964, CALIFORNIA DEP FISH, V127; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; ROBERTS C, 2007, P NATL ACAD SCI USA, V103, P6067; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Shanks AL, 2003, ECOL APPL, V13, pS159; Sibert J, 2003, MAR POLICY, V27, P87, DOI 10.1016/S0308-597X(02)00057-X; Smith MD, 2003, J ENVIRON ECON MANAG, V46, P183, DOI 10.1016/S0095-0696(03)00024-X; Starr R.M., 2007, SPECIES COMPOSITION; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; Stokstad E, 2010, SCIENCE, V327, P1574, DOI 10.1126/science.327.5973.1574; VanKirk RW, 1997, B MATH BIOL, V59, P107, DOI 10.1016/S0092-8240(96)00060-2; Walters CJ, 2007, CAN J FISH AQUAT SCI, V64, P1009, DOI 10.1139/F07-072; White JW, 2010, ECOL APPL, V20, P1523, DOI 10.1890/09-0962.1; Zudaire I, 2010, IOTC 2010	68	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19960	10.1371/journal.pone.0019960	http://dx.doi.org/10.1371/journal.pone.0019960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611148	gold, Green Submitted, Green Published			2022-12-27	WOS:000290657500037
J	Pietropaolo, S; Delage, P; Cayzac, S; Crusio, WE; Cho, YH				Pietropaolo, Susanna; Delage, Pauline; Cayzac, Sebastien; Crusio, Wim E.; Cho, Yoon H.			Sex-Dependent Changes in Social Behaviors in Motor Pre-Symptomatic R6/1 Mice	PLOS ONE			English	Article							DISEASE TRANSGENIC MICE; ACOUSTIC STARTLE REFLEX; PRECLINICAL HUNTINGTONS-DISEASE; ULTRASONIC VOCALIZATIONS; PREPULSE INHIBITION; MOUSE MODEL; MUS-MUSCULUS; FEMALE MICE; PSYCHIATRIC-SYMPTOMS; SYNAPTIC PLASTICITY	Background: The R6/1 mouse line is one of the most widely employed models of Huntington Disease (HD), a complex syndrome characterized by motor and non-motor deficits. Surprisingly, its behavioral phenotype during the early phases of the pathology when the motor impairments are not manifest yet has been poorly investigated. It is also not clear whether the expression of HD-like symptoms at the pre-motor stage in this mouse model differs between the two sexes. Methods: Male and female 12 weeks-old R6/1 mice and their wild-type littermates were tested on a battery of tests modeling some of the major neuropsychiatric non-motor symptoms of HD: alterations in social interest, social interaction and communication, as well as disturbances in prepulse inhibition of the acoustic startle response (PPI) and circadian patterns of activity. The lack of motor symptoms was confirmed during the entire experimental period by means of the tail test for clasping. Results: R6/1 mice displayed marked alterations in all social behaviors which were mainly observed in males. Male R6/1 animals were also the only ones showing reduced body weight. Both male and female transgenic mice displayed mild alterations in the circadian activity patterns, but no deficits in PPI. Conclusions: These results demonstrate the validity of the R6/1 mouse in mimicking selected neuropsychiatric symptoms of HD, the social deficits being the clearest markers of the pre-motor phase of the pathology. Furthermore, our data suggest that male R6/1 mice are more suitable for future studies on the early stages of HD.	[Pietropaolo, Susanna] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France; CNRS, UMR 5287, Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pietropaolo, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France.	y.cho@cnic.u-bordeaux1.fr	Crusio, Wim/A-7070-2008; Crusio, Wim/ABE-1287-2021; Crusio, Wim/ABD-5214-2021	Crusio, Wim/0000-0001-6638-202X; Crusio, Wim/0000-0001-6638-202X; pietropaolo, susanna/0000-0002-8993-1922	March of Dimes [12-FY05-1198]; Conseil Regional d'Aquitaine; CNRS; University of Bordeaux; Hereditary Disease Foundation	March of Dimes(March of Dimes); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Hereditary Disease Foundation	This work was supported by grants from the March of Dimes (12-FY05-1198), Conseil Regional d'Aquitaine, CNRS, and the University of Bordeaux 1 to W. E. Crusio, and from The Hereditary Disease Foundation and the University of Bordeaux 1 to Y. H. Cho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Barquero-Jimenez S, 2001, REV NEUROLOGIA, V32, P1067, DOI 10.33588/rn.3211.2000158; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bolivar VJ, 2004, BRAIN RES, V1005, P29, DOI 10.1016/j.brainres.2004.01.021; CHAMPLIN AK, 1971, J REPROD FERTIL, V27, P233, DOI 10.1530/jrf.0.0270233; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Csomor PA, 2005, BEHAV BRAIN RES, V162, P256, DOI 10.1016/j.bbr.2005.03.020; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; DAmato FR, 1996, NEUROBIOL LEARN MEM, V65, P9, DOI 10.1006/nlme.1996.0002; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dowie MJ, 2009, NEUROSCIENCE, V163, P456, DOI 10.1016/j.neuroscience.2009.06.014; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fattore L, 2010, EXP NEUROL, V224, P23, DOI 10.1016/j.expneurol.2010.03.020; FOLSTEIN SE, 1983, PSYCHIAT DEV, V1, P193; Giralt A, 2009, NEUROSCIENCE, V158, P1234, DOI 10.1016/j.neuroscience.2008.11.024; Graham KL, 2011, AM J PRIMATOL; HANSOTIA P, 1985, NEUROLOGY, V35, P1672, DOI 10.1212/WNL.35.11.1672; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; Hodges A, 2008, GENES BRAIN BEHAV, V7, P288, DOI 10.1111/j.1601-183X.2007.00350.x; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Kieburtz K, 2001, NEUROLOGY, V57, P397; Kloppel S, 2010, NEUROPSYCHOLOGIA, V48, P549, DOI 10.1016/j.neuropsychologia.2009.10.016; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAGGIO JC, 1983, PHYSIOL BEHAV, V31, P269, DOI 10.1016/0031-9384(83)90186-5; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006456.pub2; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; MIRANDA RC, 1994, HORM BEHAV, V28, P367, DOI 10.1006/hbeh.1994.1033; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1983, BEHAV NEURAL BIOL, V38, P32, DOI 10.1016/S0163-1047(83)90354-0; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paradiso S, 2008, PSYCHIAT RES-NEUROIM, V162, P73, DOI 10.1016/j.pscychresns.2007.04.001; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pietropaolo S, 2009, BEHAV GENET; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P505, DOI 10.1037/0735-7044.122.3.505; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Puca F M, 1984, Boll Soc Ital Biol Sper, V60, P989; Rebec GV, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0006.2002; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Snowden JS, 2002, J CLIN EXP NEUROPSYC, V24, P133, DOI 10.1076/jcen.24.2.133.998; SOHRABJI F, 1994, J NEUROSCI, V14, P459; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; WeigellWeber M, 1996, AM J MED GENET, V67, P53, DOI 10.1002/(SICI)1096-8628(19960216)67:1<53::AID-AJMG9>3.0.CO;2-T; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P240, DOI 10.1038/sj.npp.1300323	80	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19965	10.1371/journal.pone.0019965	http://dx.doi.org/10.1371/journal.pone.0019965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603578	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300045
J	Sinauridze, EI; Romanov, AN; Gribkova, IV; Kondakova, OA; Surov, SS; Gorbatenko, AS; Butylin, AA; Monakov, MY; Bogolyubov, AA; Kuznetsov, YV; Sulimov, VB; Ataullakhanov, FI				Sinauridze, Elena I.; Romanov, Alexey N.; Gribkova, Irina V.; Kondakova, Olga A.; Surov, Stepan S.; Gorbatenko, Aleksander S.; Butylin, Andrey A.; Monakov, Mikhail Yu; Bogolyubov, Alexey A.; Kuznetsov, Yuryi V.; Sulimov, Vladimir B.; Ataullakhanov, Fazoyl I.			New Synthetic Thrombin Inhibitors: Molecular Design and Experimental Verification	PLOS ONE			English	Article							DRUG DESIGN; OXYGUANIDINES; HEMODILUTION; COAGULATION; ETEXILATE; PROTEASES; SALINE; MODEL	Background: The development of new anticoagulants is an important goal for the improvement of thromboses treatments. Objectives: The design, synthesis and experimental testing of new safe and effective small molecule direct thrombin inhibitors for intravenous administration. Methods: Computer-aided molecular design of new thrombin inhibitors was performed using our original docking program SOL, which is based on the genetic algorithm of global energy minimization in the framework of a Merck Molecular Force Field. This program takes into account the effects of solvent. The designed molecules with the best scoring functions (calculated binding energies) were synthesized and their thrombin inhibitory activity evaluated experimentally in vitro using a chromogenic substrate in a buffer system and using a thrombin generation test in isolated plasma and in vivo using the newly developed model of hemodilution-induced hypercoagulation in rats. The acute toxicities of the most promising new thrombin inhibitors were evaluated in mice, and their stabilities in aqueous solutions were measured. Results: New compounds that are both effective direct thrombin inhibitors (the best K-1 was <1 nM) and strong anticoagulants in plasma (an IC50 in the thrombin generation assay of approximately 100 nM) were discovered. These compounds contain one of the following new residues as the basic fragment: isothiuronium, 4-aminopyridinium, or 2-aminothiazolinium. LD50 values for the best new inhibitors ranged from 166.7 to >1111.1 mg/kg. A plasma-substituting solution supplemented with one of the new inhibitors prevented hypercoagulation in the rat model of hemodilution-induced hypercoagulation. Activities of the best new inhibitors in physiological saline (1 mu M solutions) were stable after sterilization by autoclaving, and the inhibitors remained stable at long-term storage over more than 1.5 years at room temperature and at 4 degrees C. Conclusions: The high efficacy, stability and low acute toxicity reveal that the inhibitors that were developed may be promising for potential medical applications.	[Sinauridze, Elena I.; Gribkova, Irina V.; Gorbatenko, Aleksander S.; Butylin, Andrey A.; Monakov, Mikhail Yu; Ataullakhanov, Fazoyl I.] Russian Acad Med Sci, Lab Phys Biochem, Natl Res Ctr Hematol, Moscow, Russia; [Romanov, Alexey N.; Kondakova, Olga A.; Sulimov, Vladimir B.] Moscow MV Lomonosov State Univ, Ctr Res Comp, Moscow, Russia; [Sinauridze, Elena I.; Gribkova, Irina V.; Surov, Stepan S.; Ataullakhanov, Fazoyl I.] Russian Acad Sci, Lab Biophys & Physiol Cell, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Butylin, Andrey A.; Ataullakhanov, Fazoyl I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Bogolyubov, Alexey A.; Kuznetsov, Yuryi V.] Russian Acad Sci, Inst Organ Chem, Moscow V71, Russia; [Sulimov, Vladimir B.] Dimonta Ltd, Moscow, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences	Sinauridze, EI (corresponding author), Russian Acad Med Sci, Lab Phys Biochem, Natl Res Ctr Hematol, Moscow, Russia.	sinaurid@list.ru	Ataullakhanov, Fazoil/J-8076-2012; Sinauridze, Elena Ivanovna/E-4058-2014; Kondakova, Olga/H-7930-2017; Sulimov, Vladimir/AAD-6890-2019; Kuznetsov, Yury/AAC-1880-2019; Romanov, Alexey/J-8253-2018	Sinauridze, Elena Ivanovna/0000-0002-5948-3444; Kuznetsov, Yury/0000-0001-6308-4916; Romanov, Alexey/0000-0002-4534-0493	Russian Foundation for Basic Researches [08-04-12060, 09-04-00357-a]; Federal Agency for Science and Innovation (Rosnauka) [02.514.11.4084]	Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Federal Agency for Science and Innovation (Rosnauka)(Federal Agency for Science & Innovations (FASI))	This work was supported in part by grants 08-04-12060 (oriented basic research) and 09-04-00357-a of the Russian Foundation for Basic Researches (http://www.rfbr.ru), and by contract number 02.514.11.4084 of August 08, 2008 from the Federal Agency for Science and Innovation (Rosnauka). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As V. B. Sulimov was employed by Dimonta, Dimonta had a role in analyzing the data and designed the software used in analysis.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Di Nisio M, 2005, NEW ENGL J MED, V353, P1028, DOI 10.1056/NEJMra044440; FILAMOFITSKY MP, 2004, NUMERICAL METHODS PR, V5, P1; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; GRIGORIEV FV, 2006, NUMERICAL METHODS PR, V7, P128; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Illig C, 1998, MED CHEM RES, V8, P244; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Lau A, 2007, THROMB RES, V119, P667, DOI 10.1016/j.thromres.2006.05.008; LOTTENBERG R, 1982, THROMB RES, V28, P313, DOI 10.1016/0049-3848(82)90114-1; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; Lu TB, 2004, BIOORG MED CHEM LETT, V14, P3727, DOI 10.1016/j.bmcl.2004.05.002; Lu TB, 1998, BIOORG MED CHEM LETT, V8, P1595, DOI 10.1016/S0960-894X(98)00290-X; MANO T, 2001, Patent No. 0565897; MATSUO T, 2007, ARGATROBAN ANTITHROM; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; *NAT CANC I, OP REP COLL DIV SET; Ng KFJ, 2002, BRIT J ANAESTH, V88, P475, DOI 10.1093/bja/88.4.475; [Романов А.Н. Romanov A.N.], 2008, [Вычислительные методы и программирование: новые вычислительные технологии, Vychislitel'nye metody i programmirovanie: novye vychislitel'nye tekhnologii], V9, P213; Romanov AN, 2004, J PHYS CHEM A, V108, P9323, DOI 10.1021/jp046721s; Ruttmann TG, 1998, BRIT J ANAESTH, V80, P612, DOI 10.1093/bja/80.5.612; SCHWARZ RP, 1997, ANTICOAGULANTS CARDI, P231; [Синауридзе Елена Ивановна Sinauridze B.I.], 2008, [Технологии живых систем, Technologies of Living Systems, Tekhnologii zhivykh sistem], V5, P3; SINAURIDZE EI, 2005, Patent No. 2005140841; SINAURIDZE EI, 2008, NEW COMPOUNDS ANTITH; SOBOLEV SI, 2008, NUMER METH PART D E, P249; Soll RM, 2000, BIOORG MED CHEM LETT, V10, P1, DOI 10.1016/S0960-894X(99)00632-0; Sorbera LA, 2005, DRUG FUTURE, V30, P877, DOI 10.1358/dof.2005.030.09.938760; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Tomczuk B, 2003, BIOORG MED CHEM LETT, V13, P1495, DOI 10.1016/S0960-894X(03)00125-2; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; ZHABIN SN, 2006, REGISTRATION PROGRAM; GUIDE CARE USE LAB A, P21	37	38	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19969	10.1371/journal.pone.0019969	http://dx.doi.org/10.1371/journal.pone.0019969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603576	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300046
J	Czupryna, J; Tsourkas, A				Czupryna, Julie; Tsourkas, Andrew			Firefly Luciferase and Rluc8 Exhibit Differential Sensitivity to Oxidative Stress in Apoptotic Cells	PLOS ONE			English	Article							CASPASE-INDEPENDENT MECHANISM; HYDROGEN-PEROXIDE; PROTEASOME INHIBITOR; LEUKEMIA-CELLS; CANCER CELLS; AMINO-ACIDS; PROTEIN; DEATH; DEGRADATION; ACTIVATION	Over the past decade, firefly Luciferase (fLuc) has been used in a wide range of biological assays, providing insight into gene regulation, protein-protein interactions, cell proliferation, and cell migration. However, it has also been well established that fLuc activity can be highly sensitive to its surrounding environment. In this study, we found that when various cancer cell lines (HeLa, MCF-7, and 293T) stably expressing fLuc were treated with staurosporine (STS), there was a rapid loss in bioluminescence. In contrast, a stable variant of Renilla luciferase (RLuc), RLuc8, exhibited significantly prolonged functionality under the same conditions. To identify the specific underlying mechanism(s) responsible for the disparate sensitivity of RLuc8 and fLuc to cellular stress, we conducted a series of inhibition studies that targeted known intracellular protein degradation/modification pathways associated with cell death. Interestingly, these studies suggested that reactive oxygen species, particularly hydrogen peroxide (H(2)O(2)), was responsible for the diminution of fLuc activity. Consistent with these findings, the direct application of H(2)O(2) to HeLa cells also led to a reduction in fLuc bioluminescence, while H(2)O(2) scavengers stabilized fLuc activity. Comparatively, RLuc8 was far less sensitive to ROS. These observations suggest that fLuc activity can be substantially altered in studies where ROS levels become elevated and can potentially lead to ambiguous or misleading findings.	[Czupryna, Julie; Tsourkas, Andrew] Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Czupryna, J (corresponding author), Univ Penn, Dept Bioengn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/A-1074-2007; Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Tsourkas, Andrew/0000-0001-7758-1753	American Cancer Society [RSG-07-005-01]; National Science Foundation [0953583]	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the American Cancer Society (RSG-07-005-01) and the National Science Foundation CAREER Award (0953583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; ALTER SC, 1986, BIOCHEMISTRY-US, V25, P1599, DOI 10.1021/bi00355a022; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Branchini BR, 1997, J BIOL CHEM, V272, P19359, DOI 10.1074/jbc.272.31.19359; Branchini BR, 1997, ARCH BIOCHEM BIOPHYS, V340, P52, DOI 10.1006/abbi.1997.9894; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DELIC J, 1993, MOL CELL BIOL, V13, P4875, DOI 10.1128/MCB.13.8.4875; FRANKE JC, BIOCH PHARM, V79, P575; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Han YH, 2008, CHEM-BIOL INTERACT, V171, P67, DOI 10.1016/j.cbi.2007.08.011; Herve-Grepinet V, 2008, FEBS LETT, V582, P1307, DOI 10.1016/j.febslet.2008.03.007; JARVIS WD, 1994, CANCER RES, V54, P1707; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kocha T, 1997, BBA-PROTEIN STRUCT M, V1337, P319, DOI 10.1016/S0167-4838(96)00180-X; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Los M, 1997, BLOOD, V90, P3118, DOI 10.1182/blood.V90.8.3118; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Martinet W, 2004, EUR J CLIN INVEST, V34, P323, DOI 10.1111/j.1365-2362.2004.01343.x; Martinez-Lorenzo MJ, 1998, INT J CANCER, V75, P473, DOI 10.1002/(SICI)1097-0215(19980130)75:3<473::AID-IJC23>3.0.CO;2-8; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Rudolf E, 2008, CELL BIOL TOXICOL, V24, P123, DOI 10.1007/s10565-007-9022-1; SALANEWBY GB, 1994, BBA-PROTEIN STRUCT M, V1206, P155, DOI 10.1016/0167-4838(94)90084-1; SENSIBAR JA, 1990, PROSTATE, V16, P263, DOI 10.1002/pros.2990160310; Simizu S, 1996, CANCER RES, V56, P4978; Sohn JH, 2010, MOL CANCER RES, V8, P246, DOI 10.1158/1541-7786.MCR-09-0141; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Sung D, 1998, PHOTOCHEM PHOTOBIOL, V68, P749, DOI 10.1111/j.1751-1097.1998.tb02540.x; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Wu HM, 2002, FEBS LETT, V526, P101, DOI 10.1016/S0014-5793(02)03151-4; Ye JP, 1999, MOL CELL BIOCHEM, V202, P9, DOI 10.1023/A:1007078915585	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20073	10.1371/journal.pone.0020073	http://dx.doi.org/10.1371/journal.pone.0020073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603648	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500044
J	Pluznick, JL; Rodriguez-Gil, DJ; Hull, M; Mistry, K; Gattone, V; Johnson, CA; Weatherbee, S; Greer, CA; Caplan, MJ				Pluznick, Jennifer L.; Rodriguez-Gil, Diego J.; Hull, Michael; Mistry, Kavita; Gattone, Vincent; Johnson, Colin A.; Weatherbee, Scott; Greer, Charles A.; Caplan, Michael J.			Renal Cystic Disease Proteins Play Critical Roles in the Organization of the Olfactory Epithelium	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MECKEL-GRUBER-SYNDROME; SENSORY NEURONS; MOUSE MODEL; RAT MODEL; WPK RAT; CILIA; EXPRESSION; MUTATIONS; REVEALS	It was reported that some proteins known to cause renal cystic disease (NPHP6; BBS1, and BBS4) also localize to the olfactory epithelium (OE), and that mutations in these proteins can cause anosmia in addition to renal cystic disease. We demonstrate here that a number of other proteins associated with renal cystic diseases - polycystin 1 and 2 (PC1, PC2), and Meckel-Gruber syndrome 1 and 3 (MKS1, MKS3) - localize to the murine OE. PC1, PC2, MKS1 and MKS3 are all detected in the OE by RT-PCR. We find that MKS3 localizes specifically to dendritic knobs of olfactory sensory neurons (OSNs), while PC1 localizes to both dendritic knobs and cilia of mature OSNs. In mice carrying mutations in MKS1, the expression of the olfactory adenylate cyclase (AC3) is substantially reduced. Moreover, in rats with renal cystic disease caused by a mutation in MKS3, the laminar organization of the OE is perturbed and there is a reduced expression of components of the odor transduction cascade (G(olf), AC3) and alpha-acetylated tubulin. Furthermore, we show with electron microscopy that cilia in MKS3 mutant animals do not manifest the proper microtubule architecture. Both MKS1 and MKS3 mutant animals show no obvious alterations in odor receptor expression. These data show that multiple renal cystic proteins localize to the OE, where we speculate that they work together to regulate aspects of the development, maintenance or physiological activities of cilia.	[Pluznick, Jennifer L.; Hull, Michael; Mistry, Kavita; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Rodriguez-Gil, Diego J.; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Rodriguez-Gil, Diego J.; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Gattone, Vincent] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Johnson, Colin A.] Univ Leeds, Leeds Inst Mol Med, Dept Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Weatherbee, Scott] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Leeds; Yale University	Pluznick, JL (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	Michael.caplan@yale.edu		Caplan, Michael/0000-0001-5768-4405; Johnson, Colin/0000-0002-2979-8234; Weatherbee, Scott/0000-0002-0915-1329	NIH [K99-DK081610, DK068581, DC00210, DK57328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068581, R01DK068581, K99DK081610, P50DK057328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Medical Research Council [G0700073] Funding Source: researchfish; MRC [G0700073] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH K99-DK081610 (to JLP), NIH DK068581 (to VG), NIH DC00210 (to CAG), and NIH DK57328 (to MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; FRISCH D, 1967, AM J ANAT, V121, P87, DOI 10.1002/aja.1001210107; Gallagher AR, 2008, AM J PATHOL, V172, P417, DOI 10.2353/ajpath.2008.070381; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Jenkins PM, 2009, CHEM SENSES, V34, P451, DOI 10.1093/chemse/bjp020; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Logan CV, 2011, MOL NEUROBIOL, V43, P12, DOI 10.1007/s12035-010-8154-0; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; MENCO BPM, 1985, J CELL SCI, V78, P283; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Nauta J, 2000, J AM SOC NEPHROL, V11, P2272, DOI 10.1681/ASN.V11122272; Nomura T, 2004, ARCH HISTOL CYTOL, V67, P159, DOI 10.1679/aohc.67.159; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Rodriguez-Gil DJ, 2008, J COMP NEUROL, V511, P301, DOI 10.1002/cne.21834; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tahvanainen E, 2005, ANN MED, V37, P546, DOI 10.1080/07853890500389181; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Treloar HB, 2005, J COMP NEUROL, V482, P201, DOI 10.1002/cne.20431; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Weisz OA, 2000, J BIOL CHEM, V275, P24341, DOI 10.1074/jbc.M000671200; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zaidi AU, 1998, DEV BRAIN RES, V109, P157, DOI 10.1016/S0165-3806(98)00076-5	33	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19694	10.1371/journal.pone.0019694	http://dx.doi.org/10.1371/journal.pone.0019694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21614130	gold, Green Published, Green Submitted			2022-12-27	WOS:000290558500024
J	van der Hoort, B; Guterstam, A; Ehrsson, HH				van der Hoort, Bjorn; Guterstam, Arvid; Ehrsson, H. Henrik			Being Barbie: The Size of One's Own Body Determines the Perceived Size of the World	PLOS ONE			English	Article							RUBBER HAND ILLUSION; SCALED INFORMATION; VISUAL GUIDANCE; PERCEPTION; REPRESENTATION; AFFORDANCES; OWNERSHIP; TOUCH; LIMB	A classical question in philosophy and psychology is if the sense of one's body influences how one visually perceives the world. Several theoreticians have suggested that our own body serves as a fundamental reference in visual perception of sizes and distances, although compelling experimental evidence for this hypothesis is lacking. In contrast, modern textbooks typically explain the perception of object size and distance by the combination of information from different visual cues. Here, we describe full body illusions in which subjects experience the ownership of a doll's body (80 cm or 30 cm) and a giant's body (400 cm) and use these as tools to demonstrate that the size of one's sensed own body directly influences the perception of object size and distance. These effects were quantified in ten separate experiments with complementary verbal, questionnaire, manual, walking, and physiological measures. When participants experienced the tiny body as their own, they perceived objects to be larger and farther away, and when they experienced the large-body illusion, they perceived objects to be smaller and nearer. Importantly, despite identical retinal input, this "body size effect" was greater when the participants experienced a sense of ownership of the artificial bodies compared to a control condition in which ownership was disrupted. These findings are fundamentally important as they suggest a causal relationship between the representations of body space and external space. Thus, our own body size affects how we perceive the world.	[van der Hoort, Bjorn; Guterstam, Arvid; Ehrsson, H. Henrik] Karolinska Inst, Brain Body & Self Lab, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	van der Hoort, B (corresponding author), Karolinska Inst, Brain Body & Self Lab, Dept Neurosci, Stockholm, Sweden.	bvdhoort@gmail.com; henrik.ehrsson@ki.se		Guterstam, Arvid/0000-0002-3694-1318	European Research Council; Swedish Foundation for Strategic Research; Human Frontier Science Programme; James S. McDonnell Foundation; Soderbergska Stiftelsen	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Human Frontier Science Programme(Human Frontier Science Program); James S. McDonnell Foundation; Soderbergska Stiftelsen	This work was supported financially by the European Research Council, the Swedish Foundation for Strategic Research, the Human Frontier Science Programme, the James S. McDonnell Foundation, and the Soderbergska Stiftelsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDITI A, 1986, HDB PERCEPTION HUMAN; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Churchland P., 1994, LARGE SCALE NEURONAL, P23; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; FISHER KS, 1998, PERCEPTION, V17, P609; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Gibson JJ, 1950, PERCEPTION VISUAL WO; GOGEL WC, 1961, J PSYCHOL, V52, P287, DOI 10.1080/00223980.1961.9916529; Goldstein E, 1999, SENSATION PERCEPTION, P215; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; GULICK WL, 1976, HUMAN STEREOPSIS PSY, P292; Haggard P, 2009, PERCEPTION, V38, P1796, DOI 10.1068/p6399; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Linkenauger SA, 2010, PSYCHOL SCI, V21, P1318, DOI 10.1177/0956797610380700; LIPPMAN CW, 1952, J NERV MENT DIS, V116, P346, DOI 10.1097/00005053-195210000-00009; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Marino BFM, 2010, EXP BRAIN RES, V202, P499, DOI 10.1007/s00221-009-2143-4; Mark LS, 1999, J EXP PSYCHOL HUMAN, V25, P287, DOI 10.1037/0096-1523.25.1.287; MARK LS, 1987, J MOTOR BEHAV, V19, P367; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; No? A., 2004, ACTION PERCEPTION; OMURRAY S, 2006, NAT NEUROSCI, V9, P429; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; POINCARE H, 1952, SCI METHOD, P93; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Rosen B, 2009, SCAND J PLAST RECONS, V43, P260, DOI 10.3109/02844310903113107; SALANOVA V, 1995, BRAIN, V118, P607, DOI 10.1093/brain/118.3.607; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; TODD J, 1955, Can Med Assoc J, V73, P701; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	52	206	207	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20195	10.1371/journal.pone.0020195	http://dx.doi.org/10.1371/journal.pone.0020195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21633503	Green Published, gold			2022-12-27	WOS:000291006500040
J	Liang, YJ; Luo, J; Yuan, Q; Zheng, D; Liu, YP; Shi, L; Zhou, Y; Chen, AL; Ren, YY; Sun, KY; Sun, Y; Wang, Y; Zhang, ZS				Liang, Yue-Jin; Luo, Jie; Yuan, Quan; Zheng, Dan; Liu, Ya-Ping; Shi, Lei; Zhou, Ying; Chen, Ai-Ling; Ren, Yong-Ya; Sun, Ke-Yi; Sun, Yan; Wang, Yong; Zhang, Zhao-Song			New Insight into the Antifibrotic Effects of Praziquantel on Mice in Infection with Schistosoma japonicum	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER FIBROSIS; MATRIX METALLOPROTEINASES; TH2 CYTOKINES; RAT-LIVER; ACTIVATION; EXPRESSION; INHIBITORS; BETA; MECHANISMS	Background: Schistosomiasis is a parasitic disease infecting more than 200 million people in the world. Although chemotherapy targeting on killing schistosomes is one of the main strategies in the disease control, there are few effective ways of dealing with liver fibrosis caused by the parasite infection in the chronic and advanced stages of schistosomiasis. For this reason, new strategies and prospective drugs, which exert antifibrotic effects, are urgently required. Methods and Findings: The antifibrotic effects of praziquantel were assessed in the murine models of schistosomiasis japonica. Murine fibrosis models were established by cutaneous infection with 14 +/- 2 Schistosoma japonicum cercariae. Then, the mice of both chronic (8 weeks post-infection) and advanced (15 weeks post-infection) schistosomiasis were treated by gavage of praziquantel (250 mg/kg, once daily for 3 days) to eliminate worms, and followed by praziquantel anti-fibrosis treatment (300 mg/kg, twice daily for 30 days). The fibrosis-related parameters assessed were areas of collagen deposition, content of hydroxyproline and mRNA expressions of Col1 alpha 1, Col3 alpha 1, alpha-SMA, TGF-beta, MMP9, TIMP1, IL-4, IL-10, IL-13 and IFN-gamma of liver. Spleen weight index, alanine aminotransferase activity and liver portal venous pressure were also measured. The results showed that anti-fibrosis treatment improved liver fibrosis, splenomegaly, hepatic function, as well as liver portal hypertension. In order to confirm the anti-fibrotic properties of praziquantel, we established a CCL4-induced model and revealed that CCL4-induced liver fibrosis was inhibited by PZQ treatment for 30 days. Furthermore, we analyzed the effects of praziquantel on mouse primary hepatic stellate cells (HSCs). It is indicated that mRNA expressions of Col1 alpha 1, Col3 alpha 1, alpha-SMA, TGF-beta, MMP9 and TIMP1 of HSCs were all inhibited after praziquantel anti-parasite treatments. Conclusions: The significant amelioration of hepatic fibrosis by praziquantel treatment validates it as a promising drug of anti-fibrosis and offers potential of a new chemotherapy for hepatic fibrosis resulting from schistosomiasis.	[Liang, Yue-Jin; Luo, Jie; Yuan, Quan; Zheng, Dan; Liu, Ya-Ping; Shi, Lei; Zhou, Ying; Chen, Ai-Ling; Sun, Yan; Wang, Yong; Zhang, Zhao-Song] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Ren, Yong-Ya] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Sun, Ke-Yi] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liang, YJ (corresponding author), Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	yongwsh@njmu.edu.cn	Liang, Yuejin/X-5250-2019; yuan, quan/GZM-5597-2022	Liang, Yuejin/0000-0002-9557-1847	National Basic Research Program of China (973 Program) [2007CB513102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) (No. 2007CB513102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani RA, 2010, PARASITOL RES, V107, P1, DOI 10.1007/s00436-010-1855-5; Andersson Karin L, 2007, Curr Treat Options Gastroenterol, V10, P504, DOI 10.1007/s11938-007-0050-y; Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003; Arnaud V, 2008, J INFECT DIS, V198, P418, DOI 10.1086/588826; Arthur MJP, 1998, J GASTROEN HEPATOL, V13, pS33; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Berhe N, 2008, AM J TROP MED HYG, V78, P228, DOI 10.4269/ajtmh.2008.78.228; BIEMPICA L, 1983, AM J TROP MED HYG, V32, P316, DOI 10.4269/ajtmh.1983.32.316; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Cheever AW, 1997, MEM I OSWALDO CRUZ, V92, P689, DOI 10.1590/S0074-02761997000500024; CHRISTIAN J, 2010, GUT, P827; Chu D, 2007, PARASITOLOGY, V134, P1611, DOI 10.1017/S0031182007002946; Constandinou C, 2005, METH MOLEC MED, V117, P237; Cortez-Pinto H, 2001, HEPATO-GASTROENTEROL, V48, P87; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; DUNN MA, 1977, J CLIN INVEST, V59, P666, DOI 10.1172/JCI108685; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Freitas CRL, 1999, MEM I OSWALDO CRUZ, V94, P815, DOI 10.1590/S0074-02761999000600019; Frenzel K, 1999, AM J TROP MED HYG, V60, P927, DOI 10.4269/ajtmh.1999.60.927; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Giannelli G, 2006, J INTERF CYTOK RES, V26, P301, DOI 10.1089/jir.2006.26.301; Gomez DE, 1999, AM J TROP MED HYG, V61, P9, DOI 10.4269/ajtmh.1999.61.9; Gonzalez-Forero D, 2004, J PHYSIOL-LONDON, V557, P991, DOI 10.1113/jphysiol.2003.059972; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HOMEIDA MA, 1991, AM J TROP MED HYG, V45, P360, DOI 10.4269/ajtmh.1991.45.360; Huang XR, 2008, AM J PHYSIOL-RENAL, V295, pF118, DOI 10.1152/ajprenal.00021.2008; Jacobs W, 1998, CELL TISSUE RES, V292, P101, DOI 10.1007/s004410051039; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Maia MD, 2007, ACTA TROP, V101, P183, DOI 10.1016/j.actatropica.2007.01.004; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; MORCOS SH, 1985, AM J TROP MED HYG, V34, P314, DOI 10.4269/ajtmh.1985.34.314; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; Olds G. Richard, 2001, Curr Infect Dis Rep, V3, P59, DOI 10.1007/s11908-001-0060-1; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Peterson TC, 1998, BIOCHEM PHARMACOL, V55, P703, DOI 10.1016/S0006-2952(97)00593-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinlaor S, 2006, INT J CANCER, V119, P1067, DOI 10.1002/ijc.21893; Rakotonirina E J, 2010, Sante, V20, P15, DOI 10.1684/san.2009.0175; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Ross AGP, 1997, PARASITOL TODAY, V13, P152, DOI 10.1016/S0169-4758(97)01026-0; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; STELMA FF, 1995, AM J TROP MED HYG, V53, P167, DOI 10.4269/ajtmh.1995.53.167; Takemura Y, 1998, AM J TROP MED HYG, V59, P551, DOI 10.4269/ajtmh.1998.59.551; Tao FF, 2009, VACCINE, V27, P4110, DOI 10.1016/j.vaccine.2009.04.073; Tomanovic NR, 2009, J GASTROINTEST LIVER, V18, P163; Watson M, 2009, J EXOT PET MED, V18, P229, DOI 10.1053/j.jepm.2009.06.005; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; *WHO, 2002, WHOCDSCPEPVC20024; Wu J, 2008, EXP BIOL MED, V233, P377, DOI 10.3181/0710-RM-269; Xu YongLiang, 2007, Chinese Journal of Schistosomiasis Control, V19, P357; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zhang L, 2008, MICROBES INFECT, V10, P251, DOI 10.1016/j.micinf.2007.11.009	67	46	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20247	10.1371/journal.pone.0020247	http://dx.doi.org/10.1371/journal.pone.0020247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629648	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005800035
J	Coleman, MA; Chambers, J; Knott, NA; Malcolm, HA; Harasti, D; Jordan, A; Kelaher, BP				Coleman, Melinda A.; Chambers, Justine; Knott, Nathan A.; Malcolm, Hamish A.; Harasti, David; Jordan, Alan; Kelaher, Brendan P.			Connectivity within and among a Network of Temperate Marine Reserves	PLOS ONE			English	Article							HABITAT-FORMING ALGA; PHYLLOSPORA-COMOSA PHAEOPHYCEAE; GENETIC-STRUCTURE; MACROCYSTIS-PYRIFERA; POPULATION-STRUCTURE; ECKLONIA-RADIATA; LIFE-HISTORY; GIANT-KELP; DISPERSAL; PATTERNS	Networks of marine reserves are increasingly being promoted as a means of conserving marine biodiversity. One consideration in designing systems of marine reserves is the maintenance of connectivity to ensure the long-term persistence and resilience of populations. Knowledge of connectivity, however, is frequently lacking during marine reserve design and establishment. We characterise patterns of genetic connectivity of 3 key species of habitat-forming macroalgae across an established network of temperate marine reserves on the east coast of Australia and the implications for adaptive management and marine reserve design. Connectivity varied greatly among species. Connectivity was high for the subtidal macroalgae Ecklonia radiata and Phyllospora comosa and neither species showed any clear patterns of genetic structuring with geographic distance within or among marine parks. In contrast, connectivity was low for the intertidal, Hormosira banksii, and there was a strong pattern of isolation by distance. Coastal topography and latitude influenced small scale patterns of genetic structure. These results suggest that some species are well served by the current system of marine reserves in place along this temperate coast but it may be warranted to revisit protection of intertidal habitats to ensure the long-term persistence of important habitat-forming macroalgae. Adaptively managing marine reserve design to maintain connectivity may ensure the long-term persistence and resilience of marine habitats and the biodiversity they support.	[Coleman, Melinda A.; Kelaher, Brendan P.] New S Wales Marine Pk Author, Narooma, Australia; [Coleman, Melinda A.; Knott, Nathan A.; Malcolm, Hamish A.; Harasti, David; Jordan, Alan; Kelaher, Brendan P.] New S Wales Marine Pk Author, Sydney, NSW, Australia; [Chambers, Justine] Australian Genome Res Facil Ltd, Plant Genom Ctr, Glen Osmond, SA, Australia		Coleman, MA (corresponding author), New S Wales Marine Pk Author, Batemans Marine Pk, Narooma, Australia.	Melinda.coleman@environment.nsw.gov.au	Harasti, David/I-1266-2019; Knott, Nathan/AAA-8888-2019; Kelaher, Brendan/P-3647-2017; Coleman, Melinda A/R-5563-2016	Harasti, David/0000-0002-2851-9838; Knott, Nathan/0000-0002-7873-0412; Kelaher, Brendan/0000-0002-7505-4412; Coleman, Melinda A/0000-0003-2623-633X				Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; Andrew NL, 2000, MAR FRESHWATER RES, V51, P255, DOI 10.1071/MF99008; [Anonymous], ALGAE AUSTR INTRO; Araujo MB, 2001, CONSERV BIOL, V15, P1710, DOI 10.1046/j.1523-1739.2001.99450.x; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; BELKHIR K, 2000, GENETIX WINDOWS BASE; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Cai W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024701; Coleman MA, 2009, MAR FRESHWATER RES, V60, P802, DOI 10.1071/MF08268; Coleman MA, 2005, J PHYCOL, V41, P753, DOI 10.1111/j.0022-3646.2005.04136.x; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Coleman MA, 2008, CONSERV GENET, V9, P1015, DOI 10.1007/s10592-007-9437-5; Coleman MA, 2007, MAR FRESHWATER RES, V58, P589, DOI 10.1071/MF06216; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Curley BG, 2009, MAR BIOL, V156, P381, DOI 10.1007/s00227-008-1090-0; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Dolman G, 2009, CONSERV GENET, V10, P657, DOI 10.1007/s10592-008-9603-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goodsell PJ, 2002, MAR ECOL PROG SER, V239, P37, DOI 10.3354/meps239037; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Halpern BS, 2003, ECOL APPL, V13, pS117; HATCHER BG, 1987, MAR BIOL, V95, P63, DOI 10.1007/BF00447486; HUNT A, 1989, MAR BIOL, V102, P537, DOI 10.1007/BF00438356; Irving AD, 2004, MAR BIOL, V144, P361, DOI 10.1007/s00227-003-1202-9; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Keough MJ, 1998, ECOL APPL, V8, P141, DOI 10.1890/1051-0761(1998)008[0141:EOPDFT]2.0.CO;2; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mata MM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003592; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McKenzie PF, 2008, J PHYCOL, V44, P1108, DOI 10.1111/j.1529-8817.2008.00563.x; Millar Alan J. K., 1994, Australian Systematic Botany, V7, P1, DOI 10.1071/SB9940001; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pearson GA, 2006, INTEGR COMP BIOL, V46, P587, DOI 10.1093/icb/icl030; Piggott MP, 2008, MAR ECOL PROG SER, V365, P127, DOI 10.3354/meps07478; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reed DC, 2004, J PHYCOL, V40, P275, DOI 10.1046/j.1529-8817.2004.03119.x; REED DC, 1990, ECOLOGY, V71, P776, DOI 10.2307/1940329; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roughan M, 2011, DEEP-SEA RES PT II, V58, P628, DOI 10.1016/j.dsr2.2010.06.004; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Shanks AL, 2003, ECOL APPL, V13, pS159; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Sherman CDH, 2008, BIOL J LINN SOC, V95, P106, DOI 10.1111/j.1095-8312.2008.01044.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; UNDERWOOD AJ, 1990, HYDROBIOLOGIA, V192, P3, DOI 10.1007/BF00006224; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker DI, 1998, BOT MAR, V41, P105, DOI 10.1515/botm.1998.41.1-6.105; Ward RD, 2001, MAR FRESHWATER RES, V52, P563, DOI 10.1071/MF99184; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WOMERSLEY H.B.S, 1987, MARINE BENTHIC FLO 2; ZIMMERMAN RC, 1985, LIMNOL OCEANOGR, V30, P1298, DOI 10.4319/lo.1985.30.6.1298	68	55	56	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20168	10.1371/journal.pone.0020168	http://dx.doi.org/10.1371/journal.pone.0020168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625388	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200041
J	Mak, IWY; Cowan, RW; Turcotte, RE; Singh, G; Ghert, M				Mak, Isabella W. Y.; Cowan, Robert W.; Turcotte, Robert E.; Singh, Gurmit; Ghert, Michelle			PTHrP Induces Autocrine/Paracrine Proliferation of Bone Tumor Cells through Inhibition of Apoptosis	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; PARATHYROID-HORMONE; IN-VITRO; CANCER; EXPRESSION; CARCINOMA; PEPTIDE; DEATH; DIFFERENTIATION; HYPERCALCEMIA	Giant Cell Tumor of Bone (GCT) is an aggressive skeletal tumor characterized by local bone destruction, high recurrence rates and metastatic potential. Previous work in our lab has shown that the neoplastic cell of GCT is a proliferating pre-osteoblastic stromal cell in which the transcription factor Runx2 plays a role in regulating protein expression. One of the proteins expressed by these cells is parathryroid hormone-related protein (PTHrP). The objectives of this study were to determine the role played by PTHrP in GCT of bone with a focus on cell proliferation and apoptosis. Primary stromal cell cultures from 5 patients with GCT of bone and one lung metastsis were used for cell-based experiments. Control cell lines included a renal cell carcinoma (RCC) cell line and a human fetal osteoblast cell line. Cells were exposed to optimized concentrations of a PTHrP neutralizing antibody and were analyzed with the use of cell proliferation and apoptosis assays including mitochondrial dehydrogenase assays, crystal violet assays, APO-1 ELISAs, caspase activity assays, flow cytometry and immunofluorescent immunohistochemistry. Neutralization of PTHrP in the cell environment inhibited cell proliferation in a consistent manner and induced apoptosis in the GCT stromal cells, with the exception of those obtained from a lung metastasis. Cell cycle progression was not significantly affected by PTHrP neutralization. These findings indicate that PTHrP plays an autocrine/paracrine neoplastic role in GCT by allowing the proliferating stromal cells to evade apoptosis, possibly through non-traditional caspase-independent pathways. Thus PTHrP neutralizing immunotherapy is an intriguing potential therapeutic strategy for this tumor.	[Mak, Isabella W. Y.; Ghert, Michelle] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Cowan, Robert W.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Turcotte, Robert E.] Montreal Gen Hosp, McGill Univ Hlth Ctr, Dept Orthopaed Surg, Montreal, PQ H3G 1A4, Canada; [Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mak, Isabella W. Y.; Cowan, Robert W.; Singh, Gurmit; Ghert, Michelle] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; McGill University; McMaster University; McMaster University	Mak, IWY (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	michelle.ghert@jcc.hhsc.ca	Ghert, Michelle/CAH-4578-2022; Mak, Isabella/E-1777-2012; Ghert, Michelle/AAQ-1745-2021; Singh, Gurmit/C-6744-2014	Ghert, Michelle/0000-0002-4778-4522; Mak, Isabella/0000-0002-7861-4200; Cowan, Robert/0000-0001-7415-7156	Canadian Institutes of Health Research (CIHR); Hamilton Health Science; Juravinski Cancer Centre Foundation; McMaster University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hamilton Health Science; Juravinski Cancer Centre Foundation; McMaster University	The work was funded by Canadian Institutes of Health Research (CIHR) Grant, Hamilton Health Science New Investigator Fund, Juravinski Cancer Centre Foundation Grant, and McMaster University Surgical Associates Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2008, J CANCER RES CLIN, V134, P969, DOI 10.1007/s00432-008-0370-x; Balke M, 2009, J CANCER RES CLIN, V135, P149, DOI 10.1007/s00432-008-0427-x; Betea D, 2004, J CLIN ENDOCR METAB, V89, P3413, DOI 10.1210/jc.2003-031911; Blank M, 2007, CELL CYCLE, V6, P686, DOI 10.4161/cc.6.6.3990; Bradwell AR, 1999, LANCET, V353, P370, DOI 10.1016/S0140-6736(98)06469-1; BURTIS WJ, 1992, CLIN CHEM, V38, P2171; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Cowan RW, 2011, BONE, V48, pS48, DOI 10.1016/j.bone.2010.10.135; Cowan RW, 2009, BONE, V44, P865, DOI 10.1016/j.bone.2009.01.393; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Ghert M, 2007, CLIN ORTHOP RELAT R, P8, DOI 10.1097/BLO.0b013e31804856a1; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Iwamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P6, DOI 10.1053/joca.2002.0860; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kanduc D, 2002, INT J ONCOL, V21, P165; Kartsogiannis V, 1998, BONE, V22, P189, DOI 10.1016/S8756-3282(97)00278-0; Klein G, 2004, CELL DEATH DIFFER, V11, P13, DOI 10.1038/sj.cdd.4401342; Knochentumoren A, 2008, J BONE JOINT SURG AM, V90A, P1060, DOI 10.2106/JBJS.D.02771; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; Luparello C, 2001, J BONE MINER RES, V16, P2173, DOI 10.1359/jbmr.2001.16.12.2173; Mak IWY, 2010, HUM PATHOL, V41, P1320, DOI 10.1016/j.humpath.2010.03.001; Mak IWY, 2009, BONE, V45, P377, DOI 10.1016/j.bone.2009.04.253; Mak IY, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/164197; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Nakashima M, 2003, PATHOL RES PRACT, V199, P85, DOI 10.1078/0344-0338-00359; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; Nishihara M, 2007, ANN NY ACAD SCI, V1117, P385, DOI 10.1196/annals.1402.046; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Talon I, 2006, CARCINOGENESIS, V27, P73, DOI 10.1093/carcin/bgi203; THIEDE MA, 1988, P NATL ACAD SCI USA, V85, P4605, DOI 10.1073/pnas.85.13.4605; Thomas DM, 2009, CURR OPIN ONCOL, V21, P338, DOI 10.1097/CCO.0b013e32832c951d; Tse LF, 2008, BONE, V42, P68, DOI 10.1016/j.bone.2007.08.038; Turcotte RE, 2006, ORTHOP CLIN N AM, V37, P35, DOI 10.1016/j.ocl.2005.08.005; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Yamada T, 2009, MOL CANCER THER, V8, P119, DOI 10.1158/1535-7163.MCT-08-0874	40	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19975	10.1371/journal.pone.0019975	http://dx.doi.org/10.1371/journal.pone.0019975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625386	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200021
J	Sanchez, K; Papelard, A; Nguyen, C; Bendeddouche, I; Jousse, M; Rannou, F; Revel, M; Poiraudeau, S				Sanchez, Katherine; Papelard, Agathe; Nguyen, Christelle; Bendeddouche, Imad; Jousse, Marylene; Rannou, Francois; Revel, Michel; Poiraudeau, Serge			McMaster-Toronto Arthritis Patient Preference Disability Questionnaire Sensitivity to Change in Low Back Pain: Influence of Shifts in Priorities	PLOS ONE			English	Article							COPING STRATEGIES QUESTIONNAIRE; FEAR-AVOIDANCE BELIEFS; CROSS-SECTIONAL SURVEY; RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; CLINICAL-TRIALS; HEALTH; VALIDITY; SCORES; VALIDATION	Objective: To assess the sensitivity to change of the McMaster Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR) in chronic low back pain (CLBP) and shifts in patients' priorities of disabling activities over time. Methods: A prospective longitudinal survey of 100 patients (38 males) with CLBP in a tertiary care teaching hospital. Evaluation at baseline and 6 months by the MACTAR, Quebec Back Pain Disability Questionnaire (QUEBEC), Hospital Anxiety and Depression scale (HAD), Fear-Avoidance Beliefs Questionnaire (FABQ), Coping Strategies Questionnaire (CSQ), and pain and handicap visual analogue scales (VASs). Patients' perceived improvement or worsening of condition was assessed at 6 months. Effect size (ES) and Standardized response mean (SRM) and effect size (ES) were used to evaluate sensitivity to change of the MACTAR. Results: The MACTAR SRM and ES values (SRM = 0.25; ES = 0.37) were among the highest for the instruments evaluated. For patients considering their condition as improved, the SRM was 0.66 and the ES 1. The 3 disability domains, classified by the International Classification of Functioning, Disability and Health (ICF), most often cited as priorities at baseline remained the most cited at follow-up: mobility (40.9% of patients); community, social and civic life (22.7%); and domestic life (22.4%). At 6 months, 48 patients shifted their priorities, for a decrease in MACTAR SRM and ES values for patients considering their condition improved and an increase in these values for those considering their condition deteriorated. Conclusions: Although the MACTAR has similar sensitivity to change as other outcome measures widely used in CLBP, shifts in patient priorities over time are common and influence scores and sensitivity to change.	[Sanchez, Katherine; Papelard, Agathe; Nguyen, Christelle; Bendeddouche, Imad; Jousse, Marylene; Rannou, Francois; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Hop Cochin, AP HP, Serv Med Phys & Readaptat, Paris, France; [Rannou, Francois; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, IFR 25, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sanchez, K (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Serv Med Phys & Readaptat, Paris, France.	serge.poiraudeau@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; Poiraudeau, Serge/0000-0002-1988-9124				ALARCOSCIEZA, 2002, J REHABIL MED, V34, P205; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; CAMELS P, 2005, ANN READAPT MED PHYS, V48, P288; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; CO YY, 1993, J MANIP PHYSIOL THER, V16, P14; DEYO RA, 1986, SPINE, V11, P951, DOI 10.1097/00007632-198611000-00017; Ehrlich GE, 2003, B WORLD HEALTH ORGAN, V81, P671; Fairbank J C, 1980, Physiotherapy, V66, P271; FERMANIAN J, 1984, REV EPIDEMIOL SANTE, V32, P408; FORTIN PR, 1995, ARTHRITIS RHEUM, V38, P1027, DOI 10.1002/art.1780380802; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Hewlett S, 2001, ANN RHEUM DIS, V60, P928, DOI 10.1136/ard.60.10.928; Irachabal S, 2008, ENCEPHALE, V34, P47, DOI 10.1016/j.encep.2006.11.002; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Lester N, 1996, CLIN J PAIN, V12, P291, DOI 10.1097/00002508-199612000-00008; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; MAIN CJ, 1991, PAIN, V46, P287, DOI 10.1016/0304-3959(91)90112-B; Mouthon L, 2008, ARTHRIT RHEUM-ARTHR, V59, P968, DOI 10.1002/art.23819; Nguyen C, 2010, J RHEUMATOL, V37, P359, DOI 10.3899/jrheum.090632; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pfingsten M, 2000, EUR J PAIN-LONDON, V4, P259, DOI 10.1053/eujp.2000.0178; Riley JL, 1997, CLIN J PAIN, V13, P156, DOI 10.1097/00002508-199706000-00010; Robinson ME, 1997, CLIN J PAIN, V13, P43, DOI 10.1097/00002508-199703000-00007; Rocchi M B L, 2005, Eura Medicophys, V41, P275; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Sanchez K, 2009, SPINE, V34, P1052, DOI 10.1097/BRS.0b013e31819c093b; Stratford PW, 1996, PHYS THER, V76, P1109, DOI 10.1093/ptj/76.10.1109; TUGWELL P, 1987, J RHEUMATOL, V14, P446; TUGWELL P, 1990, ARCH INTERN MED, V150, P59, DOI 10.1001/archinte.150.1.59; TULEY MR, 1991, J CLIN EPIDEMIOL, V44, P471; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Verhoeven AC, 2000, J RHEUMATOL, V27, P2801; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; YVANESTHOMAS M, 2002, REV RHUM ED FR, V69, P737; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20274	10.1371/journal.pone.0020274	http://dx.doi.org/10.1371/journal.pone.0020274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629777	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200046
J	Bapat, D; Huang, XM; Gunalan, K; Preiser, PR				Bapat, Devaki; Huang, Ximei; Gunalan, Karthigayan; Preiser, Peter R.			Changes in Parasite Virulence Induced by the Disruption of a Single Member of the 235 kDa Rhoptry Protein Multigene Family of Plasmodium yoelii	PLOS ONE			English	Article							RODENT MALARIA PARASITE; ERYTHROCYTE INVASION PHENOTYPES; HIGH-EFFICIENCY TRANSFECTION; HOST-CELL SELECTION; BINDING-PROTEIN; MEROZOITE PROTEINS; AVIRULENT LINES; IMMUNE EVASION; FALCIPARUM; RECEPTOR	Invasion of the erythrocyte by the merozoites of the malaria parasite is a complex process involving a range of receptor-ligand interactions. Two protein families termed Erythrocyte Binding Like (EBL) proteins and Reticulocyte Binding Protein Homologues (RH) play an important role in host cell recognition by the merozoite. In the rodent malaria parasite, Plasmodium yoelii, the 235 kDa rhoptry proteins (Py235) are coded for by a multigene family and are members of the RH. In P. yoelii Py235 as well as a single member of EBL have been shown to be key mediators of virulence enabling the parasite to invade a wider range of host erythrocytes. One member of Py235, PY01365 is most abundantly transcribed in parasite populations and the protein specifically binds to erythrocytes and is recognized by the protective monoclonal antibody 25.77, suggesting a key role of this particular member in virulence. Recent studies have indicated that overall levels of Py235 expression are essential for parasite virulence. Here we show that disruption of PY01365 in the virulent YM line directly impacts parasite virulence. Furthermore the disruption of PY01365 leads to a reduction in the number of schizonts that express members of Py235 that react specifically with the mcAb 25.77. Erythrocyte binding assays show reduced binding of Py235 to red blood cells in the PY01365 knockout parasite as compared to YM. While our results identify PY01365 as a mediator of parasite virulence, they also confirm that other members of Py235 are able to substitute for PY01365.	[Bapat, Devaki; Huang, Ximei; Gunalan, Karthigayan; Preiser, Peter R.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bapat, D (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	prpreiser@ntu.edu.sg	Gunalan, Karthigayan/AAE-5893-2021; Preiser, Peter R/A-2201-2011	, Peter/0000-0003-4331-7000	Biomedical Research Council of Singapore (BMRC) [08/1/22/19/581]	Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Singapore (BMRC Grant No: 08/1/22/19/581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; FAHEY JR, 1984, INFECT IMMUN, V44, P151, DOI 10.1128/IAI.44.1.151-156.1984; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; Gao X, 2008, PLOS PATHOG IN PRESS; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2006, MOL BIOCHEM PARASIT, V150, P186, DOI 10.1016/j.molbiopara.2006.07.012; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Kappe SHI, 1997, MOL BIOCHEM PARASIT, V89, P137, DOI 10.1016/S0166-6851(97)00113-8; Kappe SHI, 1998, P NATL ACAD SCI USA, V95, P1230, DOI 10.1073/pnas.95.3.1230; KEEN J, 1990, MOL BIOCHEM PARASIT, V42, P241, DOI 10.1016/0166-6851(90)90167-K; Khan SM, 2001, MOL BIOCHEM PARASIT, V114, P197, DOI 10.1016/S0166-6851(01)00253-5; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DC, 2004, P NATL ACAD SCI US; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; Ogun SA, 2006, MOL BIOCH PARASITOL; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Otsuki H, 2009, P NATL ACAD SCI USA, V106, P7167, DOI 10.1073/pnas.0811313106; Pattaradilokrat S, 2009, P NATL ACAD SCI USA, V106, P7161, DOI 10.1073/pnas.0811430106; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Prasad CD, 2003, MOL BIOCHEM PARASIT, V128, P101, DOI 10.1016/S0166-6851(03)00040-9; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1998, EXP PARASITOL, V89, P50, DOI 10.1006/expr.1998.4259; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Ramalingam JK, 2008, J BIOL CHEM, V283, P36386, DOI 10.1074/jbc.M803102200; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998	51	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20170	10.1371/journal.pone.0020170	http://dx.doi.org/10.1371/journal.pone.0020170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625465	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400043
J	Delrieu, I; Yaro, S; Tamekloe, TAS; Njanpop-Lafourcade, BM; Tall, H; Jaillard, P; Ouedraogo, MS; Badziklou, K; Sanou, O; Drabo, A; Gessner, BD; Kambou, JL; Mueller, JE				Delrieu, Isabelle; Yaro, Seydou; Tamekloe, Tsidi A. S.; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Jaillard, Philippe; Ouedraogo, Macaire S.; Badziklou, Kossi; Sanou, Oumarou; Drabo, Aly; Gessner, Bradford D.; Kambou, Jean L.; Mueller, Judith E.			Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; CARRIAGE; IMPACT; NIGER; BELT; W135	Serogroup X meningococci (NmX) historically have caused sporadic and clustered meningitis cases in sub-Saharan Africa. To study recent NmX epidemiology, we analyzed data from population-based, sentinel and passive surveillance, and outbreak investigations of bacterial meningitis in Togo and Burkina Faso during 2006-2010. Cerebrospinal fluid specimens were analyzed by PCR. In Togo during 2006-2009, NmX accounted for 16% of the 702 confirmed bacterial meningitis cases. Kozah district experienced an NmX outbreak in March 2007 with an NmX seasonal cumulative incidence of 33/100,000. In Burkina Faso during 2007-2010, NmX accounted for 7% of the 778 confirmed bacterial meningitis cases, with an increase from 2009 to 2010 (4% to 35% of all confirmed cases, respectively). In 2010, NmX epidemics occurred in northern and central regions of Burkina Faso; the highest district cumulative incidence of NmX was estimated as 130/100,000 during March-April. Although limited to a few districts, we have documented NmX meningitis epidemics occurring with a seasonal incidence previously only reported in the meningitis belt for NmW135 and NmA, which argues for development of an NmX vaccine.	[Delrieu, Isabelle; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Jaillard, Philippe; Sanou, Oumarou; Gessner, Bradford D.; Mueller, Judith E.] Agence Med Prevent, Paris, France; [Yaro, Seydou; Drabo, Aly] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Tamekloe, Tsidi A. S.] Minist Hlth, Lome, Togo; [Ouedraogo, Macaire S.] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Badziklou, Kossi] Natl Inst Hyg, Lome, Togo; [Kambou, Jean L.] Minist Hlth, Ouagadougou, Burkina Faso	Agence de Medecine Preventive; Centre Muraz	Delrieu, I (corresponding author), Agence Med Prevent, Paris, France.	jmueller@aamp.org			Sanofi Pasteur; French Foreign Ministry (Fonds de Solidarite Prioritaire); Institut Pasteur de Paris	Sanofi Pasteur; French Foreign Ministry (Fonds de Solidarite Prioritaire); Institut Pasteur de Paris	The surveillance in Togo and Burkina Faso 2006-09 was supported by Sanofi Pasteur. Surveillance in Burkina Faso 2009-10 was supported by the French Foreign Ministry (Fonds de Solidarite Prioritaire) with the Institut Pasteur de Paris. The Mobile Laboratory has received a donation from Mrs. Claude Lardy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjogble KLS, 2007, VACCINE, V25, pA47, DOI 10.1016/j.vaccine.2007.04.040; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P294; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111/j.1365-3156.2007.01929.x; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Etienne J, 1990, Med Trop (Mars), V50, P227; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lewis R., 2006, WHO HLTH ACTION CRIS, V1, P6; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Materu S, 2007, EMERG INFECT DIS, V13, P944, DOI 10.3201/eid1306.070042; McSweeney C., 2008, CLIMATE CHANGE COUNT; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Mueller JE, 2008, TROP MED INT HEALTH, V13, P1543, DOI 10.1111/j.1365-3156.2008.02165.x; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Ouedraogo RT, 2008, MOBILE LAB IMPROVE R; Traore Y, 2006, CLIN INFECT DIS, V43, P817, DOI 10.1086/507339; WHO-AFRO, 2009, STANDARD OPERATING P	24	97	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19513	10.1371/journal.pone.0019513	http://dx.doi.org/10.1371/journal.pone.0019513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625480	Green Published, gold, Green Submitted			2022-12-27	WOS:000290793400005
J	Ganjavi, H; Lewis, JD; Bellec, P; MacDonald, PA; Waber, DP; Evans, AC; Karama, S				Ganjavi, Hooman; Lewis, John D.; Bellec, Pierre; MacDonald, Penny A.; Waber, Deborah P.; Evans, Alan C.; Karama, Sherif		Brain Dev Cooperative Grp	Negative Associations between Corpus Callosum Midsagittal Area and IQ in a Representative Sample of Healthy Children and Adolescents	PLOS ONE			English	Article							AUTOMATED 3-D EXTRACTION; NORMAL BRAIN-DEVELOPMENT; SEX-DIFFERENCES; GENERAL INTELLIGENCE; NIH MRI; CONNECTIONS; SIZE; PERFORMANCE; THICKNESS; SURFACES	Documented associations between corpus callosum size and cognitive ability have heretofore been inconsistent potentially owing to differences in sample characteristics, differing methodologies in measuring CC size, or the use of absolute versus relative measures. We investigated the relationship between CC size and intelligence quotient (IQ) in the NIH MRI Study of Normal Brain Development sample, a large cohort of healthy children and adolescents (aged six to 18, n = 198) recruited to be representative of the US population. CC midsagittal area was measured using an automated system that partitioned the CC into 25 subregions. IQ was measured using the Wechsler Abbreviated Scale of Intelligence (WASI). After correcting for total brain volume and age, a significant negative correlation was found between total CC midsagittal area and IQ (r=-0.147; p=0.040). Post hoc analyses revealed a significant negative correlation in children (age < 12) (r=-0.279; p=0.004) but not in adolescents (age >= 12) (r=-0.005; p=0.962). Partitioning the subjects by gender revealed a negative correlation in males (r=-0.231; p=0.034) but not in females (r=0.083; p=0.389). Results suggest that the association between CC and intelligence is mostly driven by male children. In children, a significant gender difference was observed for FSIQ and PIQ, and in males, a significant age-group difference was observed for FSIQ and PIQ. These findings suggest that the correlation between CC midsagittal area and IQ may be related to age and gender.	[Ganjavi, Hooman; Karama, Sherif] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Lewis, John D.; Bellec, Pierre; Evans, Alan C.; Karama, Sherif] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [MacDonald, Penny A.; Evans, Alan C.; Karama, Sherif] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Waber, Deborah P.] Harvard Univ, Sch Med, Dept Psychiat, Childrens Hosp, Boston, MA 02115 USA	McGill University; McGill University; McGill University; Harvard University; Boston Children's Hospital; Harvard Medical School	Ganjavi, H (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sherif.karama@mcgill.ca	Pike, Bruce/K-5562-2014; Karama, Sherif/AAT-2683-2021; Evans, Alan C/B-2373-2013; Basser, Peter J/H-5477-2011; Collins, D. Louis/ABD-7708-2021; VanMeter, John W/D-2589-2018	Pike, Bruce/0000-0001-8924-683X; Evans, Alan C/0000-0003-3841-6098; Collins, D. Louis/0000-0002-8432-7021; VanMeter, John W/0000-0002-7012-5197; Freund, Lisa/0000-0003-2095-4023; Gwinn, Katrina/0000-0002-8277-651X; Bellec, Pierre/0000-0002-9111-0699	National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke [N01-HD02-3343, N01-MH9-0002, N01-NS-9-2314, N01-NS-9-2315, N01-NS-9-2316, N01-NS-9-2317, N01-NS-9-2319, N01-NS-9-2320]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS092317, N01NS092319, N01NS092315, N01NS092314, N01NS092316, N01NS092320] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These authors have no support or funding to report. However, data used in the preparation of this article were obtained from the Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development which is funded by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01-HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319 and -2320). With the exception of funding the establishment of the image database, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. A list of participating sites and study investigators can be found at http://www.bic.mni.mcgill.ca/nihpd/info/participating_centers.html.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Ad-Dabbagh Y, 2006, CIVET IMAGE PROCESSI; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Banich MT, 2000, DEV NEUROPSYCHOL, V18, P1, DOI 10.1207/S15326942DN1801_1; Bellec P, 2008, STAT SINICA, V18, P1253; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Colom Roberto, 2010, Dialogues Clin Neurosci, V12, P489; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Doron KW, 2008, CORTEX, V44, P1023, DOI 10.1016/j.cortex.2008.03.007; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; FROST DO, 1990, EXP BRAIN RES, V83, P200; GANJAVI H, 2009, NEGATIVE CORRELATION; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hutchinson AD, 2009, EXP BRAIN RES, V192, P455, DOI 10.1007/s00221-008-1604-5; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jaeger JJ, 1998, NEUROREPORT, V9, P2803, DOI 10.1097/00001756-199808240-00022; Josse G, 2008, J NEUROSCI, V28, P14132, DOI 10.1523/JNEUROSCI.4383-08.2008; Kamphaus R. W., 2005, CLIN ASSESSMENT CHIL, V2nd; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lewis JD, 2009, CEREB CORTEX, V19, P554, DOI 10.1093/cercor/bhn105; Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047; Luders E, 2007, NEUROIMAGE, V37, P1457, DOI 10.1016/j.neuroimage.2007.06.028; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; LUND RD, 1979, BRAIN RES, V167, P172, DOI 10.1016/0006-8993(79)90273-7; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; *MATHW, 2007, MATLAB 7; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Peterson BS, 2001, HUM BRAIN MAPP, V12, P232; SHATZ CJ, 1977, J COMP NEUROL, V173, P497, DOI 10.1002/cne.901730307; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; *SPSS, SPSS STUD VERS 16 0; Tramo MJ, 1998, NEUROLOGY, V50, P1246, DOI 10.1212/WNL.50.5.1246; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Waxman S., 2003, LANGE CLIN NEUROANAT; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wong TT, 2006, CHILD NERV SYST, V22, P999, DOI 10.1007/s00381-006-0133-4; Zufferey PD, 1999, EUR J NEUROSCI, V11, P2669, DOI 10.1046/j.1460-9568.1999.00683.x	47	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19698	10.1371/journal.pone.0019698	http://dx.doi.org/10.1371/journal.pone.0019698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766HI	21625542	Green Published, gold			2022-12-27	WOS:000290771200017
J	Carthy, JM; Garmaroudi, FS; Luo, ZS; McManus, BM				Carthy, Jon M.; Garmaroudi, Farshid S.; Luo, Zongshu; McManus, Bruce M.			Wnt3a Induces Myofibroblast Differentiation by Upregulating TGF-beta Signaling Through SMAD2 in a beta-Catenin-Dependent Manner	PLOS ONE			English	Article							SMOOTH-MUSCLE; TRANSFORMING GROWTH-FACTOR-BETA-1; PATHWAY; CANCER; EXPRESSION; DISEASE; KINASE; STROMA; CELLS	Growing evidence suggests the Wnt family of secreted glycoproteins and their associated signaling pathways, linked to development, are recapitulated during wound repair and regeneration events. However, the role of the Wnt pathway in such settings remains unclear. In the current study, we treated mouse fibroblasts with 250 ng/mL of recombinant Wnt3a for 72 hours and examined its affect on cell morphology and function. Wnt3a induced a spindle-like morphology in fibroblasts characterized by the increased formation of stress fibres. Wnt3a decreased the proliferation of fibroblasts, but significantly increased cell migration as well as fibroblast-mediated contraction of a collagen lattice. Wnt3a significantly increased the expression of TGF-beta and its associated signaling through SMAD2. Consistent with this, we observed significantly increased smooth muscle alpha-actin expression and incorporation of this contractile protein into stress fibres following Wnt3a treatment. Knockdown of beta-catenin using siRNA reversed the Wnt3a-induced smooth muscle alpha-actin expression, suggesting these changes were dependent on canonical Wnt signaling through beta-catenin. Neutralization of TGF-beta with a blocking antibody significantly inhibited the Wnt3a-induced smooth muscle alpha-actin expression, indicating these changes were dependent on the increased TGF-beta signaling. Collectively, this data strongly suggests Wnt3a promotes the formation of a myofibroblast-like phenotype in cultured fibroblasts, in part, by upregulating TGF-beta signaling through SMAD2 in a beta-catenin-dependent mechanism. As myofibroblasts are critical regulators of wound healing responses, these findings may have important implications for our understanding of normal and aberrant injury and repair events.	[Carthy, Jon M.; Garmaroudi, Farshid S.; Luo, Zongshu; McManus, Bruce M.] Univ British Columbia, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Carthy, JM (corresponding author), Univ British Columbia, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	bruce.mcmanus@hli.ubc.ca			Heart and Stroke Foundation of British Columbia; Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" [F08-00086]	Heart and Stroke Foundation of British Columbia; Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling"	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon entitled "Regulation of mesenchymal cell behaviour by versican: Implications for arterial remodeling" F08-00086. (www.heartandstroke.ca) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; CARRE AL, PLAST RECONSTR SURG, V125, P74; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x; LAEREMANS H, CARDIOVASC RES, V87, P514; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MARCHAND A, AGING CELL; Marchant D, 2009, J GEN VIROL, V90, P854, DOI 10.1099/vir.0.005868-0; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rezai N, 2005, LAB INVEST, V85, P982, DOI 10.1038/labinvest.3700302; Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhao JS, 2009, TRENDS BIOTECHNOL, V27, P131, DOI 10.1016/j.tibtech.2008.11.007	32	121	124	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19809	10.1371/journal.pone.0019809	http://dx.doi.org/10.1371/journal.pone.0019809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611174	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200035
J	Corley, M; Hartsuiker, RJ				Corley, Martin; Hartsuiker, Robert J.			Why Um Helps Auditory Word Recognition: The Temporal Delay Hypothesis	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; SPONTANEOUS SPEECH; DISFLUENCIES; INFORMATION; LISTENERS; UH; HESITATIONS; INTEGRATION; SPEAKING; SET	Several studies suggest that speech understanding can sometimes benefit from the presence of filled pauses (uh, um, and the like), and that words following such filled pauses are recognised more quickly. Three experiments examined whether this is because filled pauses serve to delay the onset of upcoming words and these delays facilitate auditory word recognition, or whether the fillers themselves serve to signal upcoming delays in a way which informs listeners' reactions. Participants viewed pairs of images on a computer screen, and followed recorded instructions to press buttons corresponding to either an easy (unmanipulated, with a high-frequency name) or a difficult (visually blurred, low-frequency) image. In all three experiments, participants were faster to respond to easy images. In 50% of trials in each experiment, the name of the image was directly preceded by a delay; in the remaining trials an equivalent delay was included earlier in the instruction. Participants were quicker to respond when a name was directly preceded by a delay, regardless of whether this delay was filled with a spoken um, was silent, or contained an artificial tone. This effect did not interact with the effect of image difficulty, nor did it change over the course of each experiment. Taken together, our consistent finding that delays of any kind help word recognition indicates that natural delays such as fillers need not be seen as 'signals' to explain the benefits they have to listeners' ability to recognise and respond to the words which follow them.	[Corley, Martin] Univ Edinburgh, Sch Philosophy Psychol & Language Sci PPLS, Edinburgh, Midlothian, Scotland; [Hartsuiker, Robert J.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	University of Edinburgh; Ghent University	Corley, M (corresponding author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci PPLS, Edinburgh, Midlothian, Scotland.	Martin.Corley@ed.ac.uk	Hartsuiker, Robert J./N-1668-2019	Hartsuiker, Robert/0000-0002-3680-6765; Corley, Martin/0000-0001-7011-428X	University of Edinburgh	University of Edinburgh	This research was funded internally at the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold JE, 2004, PSYCHOL SCI, V15, P578, DOI 10.1111/j.0956-7976.2004.00723.x; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bailey KGD, 2003, J MEM LANG, V49, P183, DOI 10.1016/S0749-596X(03)00027-5; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; Collard P, 2008, J EXP PSYCHOL LEARN, V34, P696, DOI 10.1037/0278-7393.34.3.696; Corley M, 2007, COGNITION, V105, P658, DOI 10.1016/j.cognition.2006.10.010; Corley M, 2010, LANG COGNITIVE PROC, V25, P706, DOI 10.1080/01690960903512489; Ferreira F, 2004, COGNITIVE SCI, V28, P721, DOI 10.1016/j.cogsci.2003.10.006; HOWELL P, 1991, Q J EXP PSYCHOL-A, V43, P733, DOI 10.1080/14640749108400994; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; MacGregor LJ, 2010, NEUROPSYCHOLOGIA, V48, P3982, DOI 10.1016/j.neuropsychologia.2010.09.024; MARKEL N, 1990, LANG SOC, V19, P81, DOI 10.1017/S0047404500014123; MEHTA G, 1988, LANG SPEECH, V31, P135, DOI 10.1177/002383098803100203; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Tree JEF, 2001, MEM COGNITION, V29, P320, DOI 10.3758/BF03194926; Tree JEF, 1999, J MEM LANG, V40, P280, DOI 10.1006/jmla.1998.2613; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032	27	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19792	10.1371/journal.pone.0019792	http://dx.doi.org/10.1371/journal.pone.0019792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611164	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200033
J	Guan, HY; Song, LB; Cai, JC; Huang, YB; Wu, JH; Yuan, J; Li, J; Li, MF				Guan, Hongyu; Song, Libing; Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Yuan, Jie; Li, Jun; Li, Mengfeng			Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; HUMAN GLIOBLASTOMA CELLS; BCL-2 FAMILY-MEMBERS; BREAST-CANCER; AKT ACTIVATION; UP-REGULATION; LUNG-CANCER; EXPRESSION; SURVIVAL; BIM	The aim of this study was to investigate the mechanism through which Sphingosine kinase-1 (SPHK1) exerts its antiapoptosis activity in glioma cancer cells. We here report that dysregulation of SPHK1 alters the sensitivity of glioma to apoptosis both in vitro and in vivo. Further mechanistic study examined the expression of Bcl-2 family members, including Bcl-2, Mcl-1, Bax and Bim, in SPHK1-overexpressing glioma cells and revealed that only pro-apoptotic Bim was downregulated by SPHK1. Moreover, the transcriptional level of Bim was also altered by SPHK1 in glioma cells. We next confirmed the correlation between SPHK1 and Bim expression in primary glioma specimens. Importantly, increasing SPHK1 expression in glioma cells markedly elevated Akt activity and phosphorylated inactivation of FOXO3a, which led to downregulation of Bim. A pharmacological approach showed that these effects of SPHK1 were dependent on phosphatidylinositol 3-kinase (PI3K). Furthermore, effects of SPHK1 on Akt/FOXO3a/Bim pathway could be reversed by SPHK1 specific RNA interference or SPHK1 inhibitor. Collectively, our results indicate that regulation of the Akt/FOXO3a/Bim pathway may be a novel mechanism by which SPHK1 protects glioma cells from apoptosis, thereby involved in glioma tumorigenesis.	[Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Diabet, Guangzhou 510275, Guangdong, Peoples R China; [Song, Libing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Yuan, Jie; Li, Jun; Li, Mengfeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Jie] Sun Yat Sen Univ, Key Lab Funct Mol Ocean Microorganisms, Dept Educ Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Guan, HY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn	meng, li/GVT-2063-2022; Song, LB/AAL-1968-2020	Huang, Yongbo/0000-0001-6798-0451	Ministry of Science and Technology of China [2005CB724605]; Natural Science Foundation of China [30771110, 30870963, U0632002, 30831160517, 40806059, 81030048, 81001190]; Fundamental Research Funds for the Central Universities [10ykzd03]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006]; Ministry of Education of China [(2008)890, 200805580047]; Guangdong Provincial Natural Science Foundation [06201946]; National High-Tech R&D Program (863 Program) [2007AA09Z431, 2007AA09Z448]; National Science and Technique Major Project [2009ZX09103-041, 201005022-2, 2009ZX10004-213]; Key Science and Technique Research Project of Guangdong Province [2007A03260001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Science and Technique Major Project; Key Science and Technique Research Project of Guangdong Province	The work was funded by the Ministry of Science and Technology of China (973) 2005CB724605; The Natural Science Foundation of China (No. 30771110, 30870963, U0632002, 30831160517, 40806059, 81030048, 81001190); The Fundamental Research Funds for the Central Universities (No. 10ykzd03); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 8251008901000006); Ministry of Education of China [No. (2008)890 and No. 200805580047]; Guangdong Provincial Natural Science Foundation (No. 06201946); National High-Tech R&D Program (863 Program) (2007AA09Z431, 2007AA09Z448); National Science and Technique Major Project (2009ZX09103-041, 201005022-2, 2009ZX10004-213); and The Key Science and Technique Research Project of Guangdong Province (2007A03260001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Andre F, 2008, ANN ONCOL, V19, P315, DOI 10.1093/annonc/mdm429; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dean EJ, 2007, CANCER TREAT REV, V33, P203, DOI 10.1016/j.ctrv.2006.11.002; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; French KJ, 2003, CANCER RES, V63, P5962; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Jiang ZH, 2004, J NEUROCHEM, V89, P168, DOI 10.1111/j.1471-4159.2004.02319.x; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; KLEIHUES P, WHO CLASSIFICATION T; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sonoda Y, 2001, CANCER RES, V61, P6674; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	47	66	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19946	10.1371/journal.pone.0019946	http://dx.doi.org/10.1371/journal.pone.0019946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625639	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200050
J	Sol, D; Griffin, AS; Bartomeus, I; Boyce, H				Sol, Daniel; Griffin, Andrea S.; Bartomeus, Ignasi; Boyce, Hayley			Exploring or Avoiding Novel Food Resources? The Novelty Conflict in an Invasive Bird	PLOS ONE			English	Article							ACRIDOTHERES-TRISTIS; INDIAN MYNAHS; INNOVATION; PREDICTS; PATTERNS; SUCCESS	For an animal invading a novel region, the ability to develop new behaviors should facilitate the use of novel food resources and hence increase its survival in the new environment. However, the need to explore new resources may entail costs such as exposing the animal to unfamiliar predators. These two opposing forces result in an exploration-avoidance conflict, which can be expected to interfere with the acquisition of new resources. However, its consequences should be less dramatic in highly urbanized environments where new food opportunities are common and predation risk is low. We tested this hypothesis experimentally by presenting three foraging tasks to introduced common mynas (Acridotheres tristis) from environments with low and high urbanization levels from Australia. Individuals from the highly urbanized environments, where mynas are both more opportunistic when foraging and less fearful to predators, resolved a technical task faster than those from less urbanized environments. These differences did not reflect innovative 'personalities' and were not confounded by sex, morphology or motivational state. Rather, the principal factors underlying differences in mynas' problem-solving ability were neophobic-neophilic responses, which varied across habitats. Thus, mynas seem to modulate their problem-solving ability according to the benefits and costs of innovating in their particular habitat, which may help us understand the great success of the species in highly urbanized environments.	[Sol, Daniel; Bartomeus, Ignasi] Autonomous Univ Barcelona, Ctr Ecol Res & Forestry Applicat CREAF, Bellaterra, Catalonia, Spain; [Sol, Daniel] CSIC, Spanish Natl Res Council, Ctr Adv Studies Blanes CEAB, Blanes, Spain; [Griffin, Andrea S.; Boyce, Hayley] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Newcastle	Sol, D (corresponding author), Autonomous Univ Barcelona, Ctr Ecol Res & Forestry Applicat CREAF, Bellaterra, Catalonia, Spain.	d.sol@creaf.uab.es	Bartomeus, Ignasi/F-2382-2010; Sol, Daniel/A-5238-2008; Galef, Bennett G/A-5678-2008; Griffin, Andrea S/GWM-8557-2022	Sol, Daniel/0000-0001-6346-6949; Griffin, Andrea S/0000-0003-4624-9904; Bartomeus, Ignasi/0000-0001-7893-4389	Proyecto de Investigacion [CGL2007-66257]; Spanish government [CSD 2008-00040]; Generalitat de Catalunya; Australian Research Council (ARC)	Proyecto de Investigacion; Spanish government(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Australian Research Council (ARC)(Australian Research Council)	Financial support was provided by a Proyecto de Investigacion (CGL2007-66257) and a Consolider project (CSD 2008-00040) from the Spanish government, a DURSI travel grant, a grant from the "Grup de Qualitat en Ecologia evolutiva, comportament i conservacio de la biodiversitat" from Generalitat de Catalunya, and an Australian Research Council (ARC) Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle J. L., 2007, AMOS USERS GUIDE VER; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Blumstein DT., 2010, JWATCHER SOFTWARE; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Boogert NJ, 2006, ANIM BEHAV, V72, P1229, DOI 10.1016/j.anbehav.2006.02.021; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Crawley M. J, 2002, STAT COMPUTING INTRO; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg RS, 2003, ANIMAL INNOVATION; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2010, ANIM BEHAV, V79, P459, DOI 10.1016/j.anbehav.2009.11.029; Griffin AS, 2009, ANIM BEHAV, V78, P79, DOI 10.1016/j.anbehav.2009.03.012; HONE J, 1978, EMU, V78, P227, DOI 10.1071/MU9780227; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lever C., 2006, NATURALISED BIRDS WO; LIKER A, 2009, P NATL ACAD SCI US; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Mayr E., 1965, P29; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Reader S.M., 2003, ANIMAL INNOVATION; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tideman C. R., 2006, INDIAN MYNAH	31	155	157	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19535	10.1371/journal.pone.0019535	http://dx.doi.org/10.1371/journal.pone.0019535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611168	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200012
J	Bottegoni, G; Rocchia, W; Rueda, M; Abagyan, R; Cavalli, A				Bottegoni, Giovanni; Rocchia, Walter; Rueda, Manuel; Abagyan, Ruben; Cavalli, Andrea			Systematic Exploitation of Multiple Receptor Conformations for Virtual Ligand Screening	PLOS ONE			English	Article							PROTEIN FLEXIBILITY; SCORING FUNCTIONS; ENSEMBLE DOCKING; DRUG DISCOVERY; ENRICHMENT; OPTIMIZATION; RECOGNITION; PERFORMANCE; VALIDATION; STRATEGIES	The role of virtual ligand screening in modern drug discovery is to mine large chemical collections and to prioritize for experimental testing a comparatively small and diverse set of compounds with expected activity against a target. Several studies have pointed out that the performance of virtual ligand screening can be improved by taking into account receptor flexibility. Here, we systematically assess how multiple crystallographic receptor conformations, a powerful way of discretely representing protein plasticity, can be exploited in screening protocols to separate binders from non-binders. Our analyses encompass 36 targets of pharmaceutical relevance and are based on actual molecules with reported activity against those targets. The results suggest that an ensemble receptor-based protocol displays a stronger discriminating power between active and inactive molecules as compared to its standard single rigid receptor counterpart. Moreover, such a protocol can be engineered not only to enrich a higher number of active compounds, but also to enhance their chemical diversity. Finally, some clear indications can be gathered on how to select a subset of receptor conformations that is most likely to provide the best performance in a real life scenario.	[Bottegoni, Giovanni; Rocchia, Walter; Cavalli, Andrea] Ist Italiano Tecnol, Dept Drug Discovery & Dev D3, Genoa, Italy; [Rueda, Manuel; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Cavalli, Andrea] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy	Istituto Italiano di Tecnologia - IIT; University of California System; University of California San Diego; University of Bologna	Bottegoni, G (corresponding author), Ist Italiano Tecnol, Dept Drug Discovery & Dev D3, Genoa, Italy.	andrea.cavalli@iit.it	Rocchia, Walter/H-3784-2012	Rocchia, Walter/0000-0003-2480-7151; CAVALLI, ANDREA/0000-0002-6370-1176; Bottegoni, Giovanni/0000-0003-1251-583X; Rueda, Manuel/0000-0001-9280-058X	Fondazione Istituto Italiano di Tecnologia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	Fondazione Istituto Italiano di Tecnologia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by Fondazione Istituto Italiano di Tecnologia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, PROTEINS, V19, P132, DOI 10.1002/prot.340190206; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; Abagyan R., 2010, ICM MANUAL 3 7; Abagyan R, 2009, METHODS MOL BIOL, V575, P249, DOI 10.1007/978-1-60761-274-2_11; Barril X, 2005, J MED CHEM, V48, P4432, DOI 10.1021/jm048972v; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bisson WH, 2007, P NATL ACAD SCI USA, V104, P11927, DOI 10.1073/pnas.0609752104; Bolstad ESD, 2008, PROTEINS, V73, P566, DOI 10.1002/prot.22081; Bottegoni G, 2008, J COMPUT AID MOL DES, V22, P311, DOI 10.1007/s10822-008-9188-5; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Carlson HA, 2000, MOL PHARMACOL, V57, P213; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Corbeil CR, 2007, J CHEM INF MODEL, V47, P435, DOI 10.1021/ci6002637; Craig IR, 2010, J CHEM INF MODEL, V50, P511, DOI 10.1021/ci900407c; Damm KL, 2007, J AM CHEM SOC, V129, P8225, DOI 10.1021/ja0709728; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; FERRARA P, 2007, J MOL MODEL; Good AC, 2008, J COMPUT AID MOL DES, V22, P169, DOI 10.1007/s10822-007-9167-2; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Jahn A, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-14; Jain AN, 2008, J COMPUT AID MOL DES, V22, P133, DOI 10.1007/s10822-008-9196-5; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kirchmair J, 2008, CURR MED CHEM, V15, P2040, DOI 10.2174/092986708785132843; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; McCammon JA, 2005, BBA-PROTEINS PROTEOM, V1754, P221, DOI 10.1016/j.bbapap.2005.07.041; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Park SJ, 2010, J COMPUT AID MOL DES, V24, P459, DOI 10.1007/s10822-010-9362-4; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Rao S, 2008, J COMPUT AID MOL DES, V22, P621, DOI 10.1007/s10822-008-9182-y; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Rueda M, 2009, J CHEM INF MODEL, V49, P716, DOI 10.1021/ci8003732; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Sheridan RP, 2008, J COMPUT AID MOL DES, V22, P257, DOI 10.1007/s10822-008-9168-9; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teodoro ML, 2003, CURR PHARM DESIGN, V9, P1635, DOI 10.2174/1381612033454595; TOTROV M, 1999, DERIVATION SENSITIVE, P37; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Verdonk ML, 2008, J CHEM INF MODEL, V48, P2214, DOI 10.1021/ci8002254; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wei BQ, 2004, J MOL BIOL, V337, P1161, DOI 10.1016/j.jmb.2004.02.015; Zhao Y, 2007, PROTEINS, V68, P726, DOI 10.1002/prot.21423	65	65	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e18845	10.1371/journal.pone.0018845	http://dx.doi.org/10.1371/journal.pone.0018845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21625529	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500002
J	Su, XC; Jin, XG; Min, Y; Mo, LJ; Yang, JG				Su, Xianchuang; Jin, Xiaogang; Min, Yong; Mo, Linjian; Yang, Jiangang			A Curve Shaped Description of Large Networks, with an Application to the Evaluation of Network Models	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; COMMUNITY STRUCTURE; COMPLEX NETWORKS; SCALE-FREE; EVOLUTION; DYNAMICS; INTERNET; GENE	Background: Understanding the structure of complex networks is a continuing challenge, which calls for novel approaches and models to capture their structure and reveal the mechanisms that shape the networks. Although various topological measures, such as degree distributions or clustering coefficients, have been proposed to characterize network structure from many different angles, a comprehensive and intuitive representation of large networks that allows quantitative analysis is still difficult to achieve. Methodology/Principal Findings: Here we propose a mesoscopic description of large networks which associates networks of different structures with a set of particular curves, using breadth-first search. After deriving the expressions of the curves of the random graphs and a small-world-like network, we found that the curves possess a number of network properties together, including the size of the giant component and the local clustering. Besides, the curve can also be used to evaluate the fit of network models to real-world networks. We describe a simple evaluation method based on the curve and apply it to the Drosophila melanogaster protein interaction network. The evaluation method effectively identifies which model better reproduces the topology of the real network among the given models and help infer the underlying growth mechanisms of the Drosophila network. Conclusions/Significance: This curve-shaped description of large networks offers a wealth of possibilities to develop new approaches and applications including network characterization, comparison, classification, modeling and model evaluation, differing from using a large bag of topological measures.	[Su, Xianchuang; Jin, Xiaogang; Min, Yong; Mo, Linjian; Yang, Jiangang] Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Xianchuang; Jin, Xiaogang; Min, Yong; Yang, Jiangang] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Su, XC (corresponding author), Zhejiang Univ, Coll Comp Sci, Inst Artificial Intelligence, Hangzhou 310003, Zhejiang, Peoples R China.	xiaogangj@cise.zju.edu.cn	Jin, Xiaogang/G-6994-2011		National Science Foundation of China [61070069, 60803110]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China grants 61070069 and 60803110 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achlioptas D., 2005, P 37 ANN ACM S THEOR, P694, DOI DOI 10.1145/1060590; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Dall'Asta L, 2006, THEOR COMPUT SCI, V355, P6, DOI 10.1016/j.tcs.2005.12.009; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Eckmann JP, 2002, P NATL ACAD SCI USA, V99, P5825, DOI 10.1073/pnas.032093399; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guclu H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066115; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Knuth D.E., 1997, FUNDAMENTAL ALGORITH, VI; Korniss G, 2003, SCIENCE, V299, P677, DOI 10.1126/science.1079382; Lakhina A, 2003, IEEE INFOCOM SER, P332; Li WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002541; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; Molloy M, 1998, COMB PROBAB COMPUT, V7, P295, DOI 10.1017/S0963548398003526; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2010, TAXONOMY NETWORKS; Petermann T, 2004, EUR PHYS J B, V38, P201, DOI [10.1140/epjb/e2004-00021-5, 10.1140/epjb/e2004-00021-4]; PRICE DJD, 1965, SCIENCE, V149, P510; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061901	40	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19784	10.1371/journal.pone.0019784	http://dx.doi.org/10.1371/journal.pone.0019784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611192	Green Submitted, Green Published, gold			2022-12-27	WOS:000290657500021
J	Anand-Ivell, R; Hiendleder, S; Vinoles, C; Martin, GB; Fitzsimmons, C; Eurich, A; Hafen, B; Ivell, R				Anand-Ivell, Ravinder; Hiendleder, Stefan; Vinoles, Carolina; Martin, Graeme B.; Fitzsimmons, Carolyn; Eurich, Andrea; Hafen, Bettina; Ivell, Richard			INSL3 in the Ruminant: A Powerful Indicator of Gender- and Genetic-Specific Feto-Maternal Dialogue	PLOS ONE			English	Article							RELAXIN-LIKE FACTOR; INSULIN-LIKE FACTOR-3; FETAL GENDER; CIRCULATING HORMONE; BOVINE OVARY; Y-CHROMOSOME; BOS-TAURUS; FACTOR RLF; EXPRESSION; RECEPTOR	The hormone Insulin-like peptide 3 (INSL3) is a major secretory product of the Leydig cells from both fetal and adult testes. Consequently, it is a major gender-specific circulating hormone in the male fetus, where it is responsible for the first phase of testicular descent, and in the adult male. In most female mammals, circulating levels are very low, corresponding to only a small production of INSL3 by the mature ovaries. Female ruminants are exceptional in exhibiting high INSL3 gene expression by the thecal cells of antral follicles and by the corpora lutea. We have developed a specific and sensitive immunoassay to measure ruminant INSL3 and show that, corresponding to the high ovarian gene expression, non-pregnant adult female sheep and cows have up to four times the levels observed in other female mammals. Significantly, this level declines during mid-pregnancy in cows carrying a female fetus, in which INSL3 is undetectable. However, in cows carrying a male fetus, circulating maternal INSL3 becomes elevated further, presumably due to the transplacental transfer of fetal INSL3 into the maternal circulation. Within male fetal blood, INSL3 is high in mid-pregnancy (day 153) corresponding to the first transabdominal phase of testicular descent, and shows a marked dependence on paternal genetics, with pure bred or hybrid male fetuses of Bos taurus (Angus) paternal genome having 30% higher INSL3 levels than those of Bos indicus (Brahman) paternity. Thus INSL3 provides the first example of a gender-specific fetal hormone with the potential to influence both placental and maternal physiology.	[Anand-Ivell, Ravinder] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Anand-Ivell, Ravinder] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Anand-Ivell, Ravinder] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Hiendleder, Stefan; Fitzsimmons, Carolyn; Eurich, Andrea; Hafen, Bettina; Ivell, Richard] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Hiendleder, Stefan; Fitzsimmons, Carolyn] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Vinoles, Carolina; Martin, Graeme B.] Univ Western Australia, Sch Anim Biol M092, Fac Nat & Agr Sci, Crawley, WA, Australia; [Eurich, Andrea; Hafen, Bettina; Ivell, Richard] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of South Australia; University of South Australia; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Western Australia; University of Adelaide	Anand-Ivell, R (corresponding author), FBN Leibniz Inst Farm Anim Biol, Dummerstorf, Germany.	ivell@fbn-dummerstorf.de	Martin, Graeme B/A-2618-2008; Hiendleder, Stefan/J-8008-2012	Martin, Graeme B/0000-0002-1905-7934; Anand-Ivell, Ravinder/0000-0002-4976-4314; Ivell, Richard/0000-0001-6513-2109	JS Davies Bequest; Meat and Livestock Australia [MS. 027]; BioInnovation SA; Australian Research Council	JS Davies Bequest; Meat and Livestock Australia(Meat and Livestock Australia); BioInnovation SA; Australian Research Council(Australian Research Council)	SH is a JS Davies Fellow and part of this study was supported by the JS Davies Bequest. The authors are also grateful to Meat and Livestock Australia (Project MS. 027) for helping fund the sheep studies, and BioInnovation SA and the Australian Research Council for financial support to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Ivell R, 2008, HUM REPROD, V23, P1180, DOI 10.1093/humrep/den038; Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4; Bamberger AM, 1999, INT J GYNECOL PATHOL, V18, P163, DOI 10.1097/00004347-199904000-00011; Bathgate R, 1999, BIOL REPROD, V61, P1090, DOI 10.1095/biolreprod61.4.1090; Bathgate R, 1996, BIOL REPROD, V55, P1452, DOI 10.1095/biolreprod55.6.1452; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bay K, 2005, J CLIN ENDOCR METAB, V90, P3410, DOI 10.1210/jc.2004-2257; Bazzett LB, 1998, AM J MED GENET, V76, P369, DOI 10.1002/(SICI)1096-8628(19980413)76:5<369::AID-AJMG1>3.0.CO;2-I; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Bullesbach EE, 2002, BIOCHEMISTRY-US, V41, P274, DOI 10.1021/bi0117302; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Ferlin A, 2008, J BONE MINER RES, V23, P683, DOI 10.1359/JBMR.080204; Fitzsimmons C, 2008, REPROD FERT DEVELOP, V20, P131, DOI 10.1071/RDv20n1Ab101; Foresta C, 2004, J CLIN ENDOCR METAB, V89, P5952, DOI 10.1210/jc.2004-0575; Gambineri A, 2007, J CLIN ENDOCR METAB, V92, P2066, DOI 10.1210/jc.2006-1678; Goldammer T, 1997, CYTOGENET CELL GENET, V77, P238, DOI 10.1159/000134584; Gray CA, 2000, BIOL REPROD, V62, P448, DOI 10.1095/biolreprod62.2.448; Havelock JC, 2005, FERTIL STERIL, V84, pS3, DOI 10.1016/j.fertnstert.2005.07.019; Heng K, 2008, MOL HUM REPROD, V14, P603, DOI 10.1093/molehr/gan051; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Hiendleder S, 2004, BIOL REPROD, V71, P217, DOI 10.1095/biolreprod.103.026062; Hombach-Klonisch S, 2000, MOL CELL ENDOCRINOL, V159, P147, DOI 10.1016/S0303-7207(99)00190-2; Hombach-Klonisch S, 2001, MOL HUM REPROD, V7, P349, DOI 10.1093/molehr/7.4.349; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Ivell R, 2006, TRENDS ENDOCRIN MET, V17, P123, DOI 10.1016/j.tem.2006.03.004; IVELL R, 1995, BIOL REPROD, V53, P553, DOI 10.1095/biolreprod53.3.553; Ivell R, LEYDIG CELL HLTH DIS, P279; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Kageyama S, 2004, J VET MED SCI, V66, P509, DOI 10.1292/jvms.66.509; Klonisch T, 2001, BIOL REPROD, V64, P442, DOI 10.1095/biolreprod64.2.442; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lowndes K, 2006, PLACENTA, V27, P610, DOI 10.1016/j.placenta.2005.07.011; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Quinones JN, 2005, AM J OBSTET GYNECOL, V193, P1233, DOI 10.1016/j.ajog.2005.05.053; R?sse I., 1991, LEHRBUCH EMBRYOLOGIE; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; STJEAN G, 1992, THERIOGENOLOGY, V38, P951, DOI 10.1016/0093-691X(92)90169-R; van der Westhuizen ET, 2010, MOL PHARMACOL, V77, P759, DOI 10.1124/mol.109.061432; Vodstrcil LA, 2007, REPROD FERT DEVELOP, V19, P530, DOI 10.1071/RD07007; Zarreh-Hoshyari-Khah MR, 1999, BIOL REPROD, V60, P445, DOI 10.1095/biolreprod60.2.445	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19821	10.1371/journal.pone.0019821	http://dx.doi.org/10.1371/journal.pone.0019821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603619	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000290656300030
J	Chen, SC; Frett, E; Marx, J; Bosnakovski, D; Reed, X; Kyba, M; Kennedy, BK				Chen, Steven C.; Frett, Ellie; Marx, Joseph; Bosnakovski, Darko; Reed, Xylena; Kyba, Michael; Kennedy, Brian K.			Decreased Proliferation Kinetics of Mouse Myoblasts Overexpressing FRG1	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; 4Q35 LOCUS; DNA REARRANGEMENTS; RNA PATHOGENESIS; GENE-EXPRESSION; MESSENGER-RNA; CYCLIN-E; FSHD; CELL	Although recent publications have linked the molecular events driving facioscapulohumeral muscular dystrophy (FSHD) to expression of the double homeobox transcription factor DUX4, overexpression of FRG1 has been proposed as one alternative causal agent as mice overexpressing FRG1 present with muscular dystrophy. Here, we characterize proliferative defects in two independent myoblast lines overexpressing FRG1. Myoblasts isolated from thigh muscle of FRG1 transgenic mice, an affected dystrophic muscle, exhibit delayed proliferation as measured by decreased clone size, whereas myoblasts isolated from the unaffected diaphragm muscle proliferated normally. To confirm the observation that overexpression of FRG1 could impair myoblast proliferation, we examined C2C12 myoblasts with inducible overexpression of FRG1, finding increased doubling time and G1-phase cells in mass culture after induction of FRG1 and decreased levels of pRb phosphorylation. We propose that depressed myoblast proliferation may contribute to the pathology of mice overexpressing FRG1 and may play a part in FSHD.	[Chen, Steven C.; Frett, Ellie; Marx, Joseph; Reed, Xylena; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Bosnakovski, Darko; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Bosnakovski, Darko; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Kennedy, Brian K.] Buck Inst Age Res, Novato, CA USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Buck Institute for Research on Aging	Chen, SC (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkennedy@buckinstitute.org	Bosnakovski, Darko/T-8292-2019	Kennedy, Brian/0000-0002-5754-1874; Kyba, Michael/0000-0002-5579-7534; Bosnakovski, Darko/0000-0002-7198-2019	Pacific Northwest Friends of FSHD; NIH [T32 HL007312]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	Pacific Northwest Friends of FSHD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Pacific Northwest Friends of FSHD. S.C.C. is supported by the cardiovascular pathology training grant NIH T32 HL007312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Barro M, 2008, J CELL MOL MED; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; D'Antona G, 2007, J PHYSIOL-LONDON, V584, P997, DOI 10.1113/jphysiol.2007.141481; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Hanel ML, DIFFERENTIATION; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Kudlow BA, 2005, AIDS, V19, P1565, DOI 10.1097/01.aids.0000186827.91408.90; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lemmers RJ, SCIENCE, V329, P1650; Liu Q, J CELL SCI, V1116-1123; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; Masny PS, 2009, EUR J HUM GENET; Melone MAB, 2000, J CELL BIOCHEM, V76, P118; Mittelbronn M, 2008, BRAIN PATHOL, V18, P338, DOI 10.1111/j.1750-3639.2008.00123.x; Mumberg D, 1997, NUCLEIC ACIDS RES, V25, P2098, DOI 10.1093/nar/25.11.2098; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Porter DC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.23.e101; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; SEWING A, 1994, J CELL SCI, V107, P581; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386	59	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19780	10.1371/journal.pone.0019780	http://dx.doi.org/10.1371/journal.pone.0019780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603621	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000290656300027
J	Inacio, AS; Mesquita, KA; Baptista, M; Ramalho-Santos, J; Vaz, WLC; Vieira, OV				Inacio, Angela S.; Mesquita, Katia A.; Baptista, Marta; Ramalho-Santos, Joao; Vaz, Winchil L. C.; Vieira, Otilia V.			In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted Infection Prophylaxis and Contraception	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CATIONIC SURFACTANTS; HIV-INFECTION; CONTROLLED-TRIAL; LIPID-BILAYERS; DOSE-RESPONSE; NONOXYNOL 9; THERMODYNAMICS; MICROBICIDES; CELLS	Background: The need for woman-controlled, cheap, safe, effective, easy-to-use and easy-to-store topical applications for prophylaxis against sexually transmitted infections (STIs) makes surfactant-containing formulations an interesting option that requires a more fundamental knowledge concerning surfactant toxicology and structure-activity relationships. Methodology/Principal Findings: We report in vitro effects of surfactant concentration, exposure time and structure on the viability of mammalian cell types typically encountered in the vagina, namely, fully polarized and confluent epithelial cells, confluent but non-polarized epithelial-like cells, dendritic cells, and human sperm. Representatives of the different families of commercially available surfactants - nonionic (Triton X-100 and monolaurin), zwitterionic (DDPS), anionic (SDS), and cationic (C(n)TAB (n = 10 to 16), C12PB, and C(12)BZK) - were examined. Triton X-100, monolaurin, DDPS and SDS were toxic to all cell types at concentrations around their critical micelle concentration (CMC) suggesting a non-selective mode of action involving cell membrane destabilization and/or destruction. All cationic surfactants were toxic at concentrations far below their CMC and showed significant differences in their toxicity toward polarized as compared with non-polarized cells. Their toxicity was also dependent on the chemical nature of the polar head group. Our results suggest an intracellular locus of action for cationic surfactants and show that their structure-activity relationships could be profitably exploited for STI prophylaxis in vaginal gel formulations. The therapeutic indices comparing polarized epithelial cell toxicity to sperm toxicity for all surfactants examined, except C12PB and C(12)BZK, does not justify their use as contraceptive agents. C12PB and C(12)BZK are shown to have a narrow therapeutic index recommending caution in their use in contraceptive formulations. Conclusions/Significance: Our results contribute to understanding the mechanisms involved in surfactant toxicity, have a predictive value with regard to their safety, and may be used to design more effective and less harmful surfactants for use in topical applications for STI prophylaxis.	[Inacio, Angela S.; Mesquita, Katia A.; Baptista, Marta; Ramalho-Santos, Joao; Vieira, Otilia V.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Hosp Coimbra, Human Reprod Serv, Coimbra, Portugal; [Vaz, Winchil L. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Inacio, AS (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	vieira@cnc.cj.uc.pt	Mesquita, Katia/AAD-1225-2019; Ramalho-Santos, João/F-8641-2012; Santos, João/HHZ-5595-2022; Vieira, Otilia V/O-8660-2017; Vaz, Winchil/N-4320-2013; Inácio, Ângela S./AAE-1653-2020; Vieira, O V/C-4860-2013	Mesquita, Katia/0000-0001-9832-5548; Ramalho-Santos, João/0000-0002-1172-4018; Vieira, Otilia V/0000-0003-4924-1780; Vaz, Winchil/0000-0002-3797-4330; Inácio, Ângela S./0000-0002-5401-8455; 	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT) [PTDC/SAU-MII/66285/2006, PTDC/BIA-BCM/112138/2009]; FCT [SFRH/BD/38397/2007, SFRH/BD/46078/2008]	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the research grants PTDC/SAU-MII/66285/2006 and PTDC/BIA-BCM/112138/2009 from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT). ASI is a holder of a doctoral fellowship (ref. SFRH/BD/38397/2007) from the FCT. MB is a holder of a doctoral fellowship (ref. SFRH/BD/46078/2008) from the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MSC, 2004, BIOPHYS J, V87, P353, DOI [10.1529/biophysj.104.040576, 10.1529/biophysi.104.040576]; Ackermann Leane, 2002, Health Care Women Int, V23, P163, DOI 10.1080/073993302753429031; Ayotte N, 2002, ADV THER, V19, P219, DOI 10.1007/BF02850362; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; BRITO RMM, 1986, ANAL BIOCHEM, V152, P250, DOI 10.1016/0003-2697(86)90406-9; Burns M, 1999, J THROMB THROMBOLYS, V7, P137, DOI 10.1023/A:1008829403320; BUTOR C, 1992, EXP CELL RES, V203, P115, DOI 10.1016/0014-4827(92)90046-B; Carpo Beatriz G, 2007, J Drugs Dermatol, V6, P991; Catalone BJ, 2005, ANTIMICROB AGENTS CH, V49, P1509, DOI 10.1128/AAC.49.4.1509-1520.2005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Dymond MK, 2008, LANGMUIR, V24, P11743, DOI 10.1021/la8017612; Ekelund K, 2005, J PHARM SCI-US, V94, P730, DOI 10.1002/jps.20283; Enomoto R, 2007, ANN NY ACAD SCI, V1095, P1, DOI 10.1196/annals.1397.001; Estronca LMBB, 2007, BIOPHYS J, V93, P4244, DOI 10.1529/biophysj.107.112847; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Finkel R, 2009, PHARMACOLOGY, P33; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GIROLOMONI G, 1995, EUR J IMMUNOL, V25, P2163, DOI 10.1002/eji.1830250807; Hitchcock PJ, 2000, SEXUALLY TRANSMITTED, P149; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Kopecky F, 1996, PHARMAZIE, V51, P135; Krebs FC, 1999, ANTIVIR RES, V43, P157, DOI 10.1016/S0166-3542(99)00044-3; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Masurier C, 1998, J VIROL, V72, P7822, DOI 10.1128/JVI.72.10.7822-7829.1998; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miller V, 1998, ANTIMICROB AGENTS CH, V42, P3123, DOI 10.1128/AAC.42.12.3123; Moreno MJ, 2006, BIOPHYS J, V91, P873, DOI 10.1529/biophysj.106.082115; Neves BM, 2008, TOXICOL LETT, V177, P74, DOI 10.1016/j.toxlet.2007.12.006; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Perani A, 2001, AMINO ACIDS, V21, P185, DOI 10.1007/s007260170025; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Piao J, 2006, COLLOID SURFACE A, V277, P15, DOI 10.1016/j.colsurfa.2005.10.053; Ramalho-Santos J, 2007, MODERN RES ED TOPICS, V1, P394; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; Simoncic B, 1998, ACTA CHIM SLOV, V45, P143; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Spink CH, 1997, J AM CHEM SOC, V119, P10920, DOI 10.1021/ja964324s; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanford C., 1991, HYDROPHOBIC EFFECT F, pix; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS153, DOI 10.1097/01.olq.0000235177.30718.84; VED HS, 1990, LIPIDS, V25, P119, DOI 10.1007/BF02562216; Velarde G, 1999, TOXICOL IN VITRO, V13, P719, DOI 10.1016/S0887-2333(99)00055-7; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105; World Health Organization, 2007, GLOB STRAT PREV CONT; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Zhu DM, 2006, LANGMUIR, V22, P3735, DOI 10.1021/la052161s	64	89	92	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19850	10.1371/journal.pone.0019850	http://dx.doi.org/10.1371/journal.pone.0019850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603626	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300031
J	Vasan, S; Hurley, A; Schlesinger, SJ; Hannaman, D; Gardiner, DF; Dugin, DP; Boente-Carrera, M; Vittorino, R; Caskey, M; Andersen, J; Huang, YX; Cox, JH; Tarragona-Fiol, T; Gill, DK; Cheeseman, H; Clark, L; Dally, L; Smith, C; Schmidt, C; Park, HH; Kopycinski, JT; Gilmour, J; Fast, P; Bernard, R; Ho, DD				Vasan, Sandhya; Hurley, Arlene; Schlesinger, Sarah J.; Hannaman, Drew; Gardiner, David F.; Dugin, Daniel P.; Boente-Carrera, Mar; Vittorino, Roselle; Caskey, Marina; Andersen, Johanne; Huang, Yaoxing; Cox, Josephine H.; Tarragona-Fiol, Tony; Gill, Dilbinder K.; Cheeseman, Hannah; Clark, Lorna; Dally, Len; Smith, Carol; Schmidt, Claudia; Park, Harriet H.; Kopycinski, Jakub T.; Gilmour, Jill; Fast, Patricia; Bernard, Robert; Ho, David D.			In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; RHESUS MACAQUES; PLASMID DNA; VIRUS ANKARA; T-CELLS; NONHUMAN-PRIMATES; PHASE-1 SAFETY; PROTECTS MICE; PRIME; BOOST	Background: DNA-based vaccines have been safe but weakly immunogenic in humans to date. Methods and Findings: We sought to determine the safety, tolerability, and immunogenicity of ADVAX, a multigenic HIV-1 DNA vaccine candidate, injected intramuscularly by in vivo electroporation (EP) in a Phase-1, double-blind, randomized placebo-controlled trial in healthy volunteers. Eight volunteers each received 0.2 mg, 1 mg, or 4 mg ADVAX or saline placebo via EP, or 4 mg ADVAX via standard intramuscular injection at weeks 0 and 8. A third vaccination was administered to eleven volunteers at week 36. EP was safe, well-tolerated and considered acceptable for a prophylactic vaccine. EP delivery of ADVAX increased the magnitude of HIV-1-specific cell mediated immunity by up to 70-fold over IM injection, as measured by gamma interferon ELISpot. The number of antigens to which the response was detected improved with EP and increasing dosage. Intracellular cytokine staining analysis of ELISpot responders revealed both CD4+ and CD8+ T cell responses, with co-secretion of multiple cytokines. Conclusions: This is the first demonstration in healthy volunteers that EP is safe, tolerable, and effective in improving the magnitude, breadth and durability of cellular immune responses to a DNA vaccine candidate.	[Vasan, Sandhya; Hurley, Arlene; Schlesinger, Sarah J.; Gardiner, David F.; Dugin, Daniel P.; Boente-Carrera, Mar; Vittorino, Roselle; Huang, Yaoxing; Ho, David D.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Vasan, Sandhya; Hurley, Arlene; Schlesinger, Sarah J.; Caskey, Marina; Andersen, Johanne; Bernard, Robert] Rockefeller Univ, New York, NY 10021 USA; [Hannaman, Drew; Bernard, Robert] Ichor Med Syst Inc, San Diego, CA USA; [Cox, Josephine H.; Schmidt, Claudia; Park, Harriet H.; Fast, Patricia] Int AIDS Vaccine Initiat, New York, NY USA; [Tarragona-Fiol, Tony; Gill, Dilbinder K.; Cheeseman, Hannah; Clark, Lorna; Kopycinski, Jakub T.; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, Human Immunol Lab, Int AIDS Vaccine Initiat, London, England; [Dally, Len; Smith, Carol] EMMES Corp, Rockville, MD USA	Rockefeller University; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; Emmes Corporation	Vasan, S (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY USA.	svasan@adarc.org		Cox, Josephine/0000-0003-1301-7373; Caskey, Marina/0000-0003-1727-8693; Cheeseman, Hannah/0000-0001-9044-1341	Bill and Melinda Gates Foundation [38648]; International AIDS Vaccine Initiative (IAVI) part by USAID [GPO-A-00-06-00006-00]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI) part by USAID(United States Agency for International Development (USAID))	Funding support for this trial was provided by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, Grant # 38648. Support from the International AIDS Vaccine Initiative (IAVI) was provided in part by USAID Cooperative Agreement Number GPO-A-00-06-00006-00. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of USAID or the US government. Ichor Medical Systems, Inc. provided funding for the TriGrid (TM) device and for personnel. As D. Hannaman and R. Bernard are employees of Ichor Medical Systems, Inc, this funder had a direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The EMMES Corporation provided funding for personnel. Len Dally and Carol Smith are employees of the EMMES Corporation, and had a direct role in database design, data analysis, and manuscript preparation. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.jbiotec.2004.01.015; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chong SY, 2007, VACCINE, V25, P4967, DOI 10.1016/j.vaccine.2006.11.070; Dobano C, 2007, VACCINE, V25, P6635, DOI 10.1016/j.vaccine.2007.06.036; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Hooper JW, 2007, VACCINE, V25, P1814, DOI 10.1016/j.vaccine.2006.11.017; Huang TX, 2008, JAIDS-J ACQ IMM DEF, V47, P403, DOI 10.1097/QAI.0b013e3181651b9d; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li ZM, 2006, VACCINE, V24, P4565, DOI 10.1016/j.vaccine.2005.08.021; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Livingston BD, 2010, VACCINE, V28, P1056, DOI 10.1016/j.vaccine.2009.10.111; Low L, 2009, HUM GENE THER, V20, P1269, DOI 10.1089/hum.2009.067; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Manam S, 2000, INTERVIROLOGY, V43, P273, DOI 10.1159/000053994; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mathiesen I, 1999, GENE THER, V6, P508, DOI 10.1038/sj.gt.3300847; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rottinghaus ST, 2003, VACCINE, V21, P4604, DOI 10.1016/S0264-410X(03)00447-X; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Schalk JAC, 2006, HUM VACCINES, V2, P45, DOI 10.4161/hv.2.2.2620; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Stevenson FK, 2004, P NATL ACAD SCI USA, V101, P14646, DOI 10.1073/pnas.0404896101; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vasan S, 2007, FRONT BIOSCI-LANDMRK, V12, P2330, DOI 10.2741/2235; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635	44	142	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19252	10.1371/journal.pone.0019252	http://dx.doi.org/10.1371/journal.pone.0019252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603651	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300005
J	Ganichkin, OM; Anedchenko, EA; Wahl, MC				Ganichkin, Oleg M.; Anedchenko, Ekaterina A.; Wahl, Markus C.			Crystal Structure Analysis Reveals Functional Flexibility in the Selenocysteine-Specific tRNA from Mouse	PLOS ONE			English	Article							PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; SELENOPROTEIN SYNTHESIS; ELONGATION-FACTOR; WATER; ANTICODON; MECHANISM; SELENIUM; BINDING; KINASE	Background: Selenocysteine tRNAs (tRNA(Sec)) exhibit a number of unique identity elements that are recognized specifically by proteins of the selenocysteine biosynthetic pathways and decoding machineries. Presently, these identity elements and the mechanisms by which they are interpreted by tRNA(Sec)-interacting factors are incompletely understood. Methodology/Principal Findings: We applied rational mutagenesis to obtain well diffracting crystals of murine tRNA(Sec). tRNA(Sec) lacking the single-stranded 3'-acceptor end ((Delta GCCA)RNA(Sec)) yielded a crystal structure at 2.0 angstrom resolution. The global structure of (Delta GCCA)RNA(Sec) resembles the structure of human tRNA(Sec) determined at 3.1 angstrom resolution. Structural comparisons revealed flexible regions in tRNA(Sec) used for induced fit binding to selenophosphate synthetase. Water molecules located in the present structure were involved in the stabilization of two alternative conformations of the anticodon stem-loop. Modeling of a 2'-O-methylated ribose at position U34 of the anticodon loop as found in a sub-population of tRNA(Sec) in vivo showed how this modification favors an anticodon loop conformation that is functional during decoding on the ribosome. Soaking of crystals in Mn2+-containing buffer revealed eight potential divalent metal ion binding sites but the located metal ions did not significantly stabilize specific structural features of tRNA(Sec). Conclusions/Significance: We provide the most highly resolved structure of a tRNA(Sec) molecule to date and assessed the influence of water molecules and metal ions on the molecule's conformation and dynamics. Our results suggest how conformational changes of tRNA(Sec) support its interaction with proteins.	[Ganichkin, Oleg M.; Anedchenko, Ekaterina A.; Wahl, Markus C.] Free Univ Berlin, Abt Strukturbiochem, D-1000 Berlin, Germany	Free University of Berlin	Ganichkin, OM (corresponding author), Free Univ Berlin, Abt Strukturbiochem, D-1000 Berlin, Germany.	mwahl@chemie.fu-berlin.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307	Deutsche Forschungsgemeinschaft [WA 1126/2-3]; Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Supported by a grant from the Deutsche Forschungsgemeinschaft (grant WA 1126/2-3) in the priority program 1087. http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Roger Scherrers, Wyatt Technology Europe GmbH, for analyzing our mouse tRNA<SUP>Sec</SUP> preparation by multi-angle static light scattering. We thank Azat Gabdulkhakov (Freie Universitat Berlin, AG Kristallographie) for help in solving the structure of mouse tRNA<SUP>Sec</SUP>. We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum and the Leibniz-Institut fur Molekulare Pharmakologie. We thank the team of Uwe Muller for support during diffraction data collection.	Alexander RW, 2010, FEBS LETT, V584, P376, DOI 10.1016/j.febslet.2009.11.061; Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; Araiso Y, 2009, P NATL ACAD SCI USA, V106, P16215, DOI 10.1073/pnas.0908861106; BARON C, 1993, J MOL BIOL, V231, P274, DOI 10.1006/jmbi.1993.1282; Biswas R, 1997, J MOL BIOL, V267, P1149, DOI 10.1006/jmbi.1997.0936; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Cabello-Villegas J, 2002, J MOL BIOL, V319, P1015, DOI 10.1016/S0022-2836(02)00382-0; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Correll CC, 1999, J MOL BIOL, V292, P275, DOI 10.1006/jmbi.1999.3072; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GUERON M, 1982, BIOPHYS J, V38, P231, DOI 10.1016/S0006-3495(82)84553-0; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; HOLBROOK SR, 1991, NATURE, V353, P579, DOI 10.1038/353579a0; Hubert N, 1998, RNA, V4, P1029, DOI 10.1017/S1355838298980888; Ioudovitch A, 1998, RNA, V4, P365; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; JOACHIMIAK A, 1994, EMBO J, V13, P367, DOI 10.1002/j.1460-2075.1994.tb06270.x; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; KENNARD O, 1986, J BIOMOL STRUCT DYN, V3, P623, DOI 10.1080/07391102.1986.10508452; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Lodmell JS, 2001, J MOL BIOL, V311, P475, DOI 10.1006/jmbi.2001.4879; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sherlin LD, 2001, RNA, V7, P1671; Sherrer RL, 2011, NUCLEIC ACIDS RES, V39, P1034, DOI 10.1093/nar/gkq845; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Stock T, 2010, MOL MICROBIOL, V75, P149, DOI 10.1111/j.1365-2958.2009.06970.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vendeix FAP, 2008, BIOCHEMISTRY-US, V47, P6117, DOI 10.1021/bi702356j; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Wahl MC, 1996, NAT STRUCT BIOL, V3, P24, DOI 10.1038/nsb0196-24; Walczak R, 1996, RNA, V2, P367; Walter NG, 2007, MOL CELL, V28, P923, DOI 10.1016/j.molcel.2007.12.001; Warner GJ, 2000, J BIOL CHEM, V275, P28110; WESTHOF E, 1988, ANNU REV BIOPHYS BIO, V17, P125; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	65	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20032	10.1371/journal.pone.0020032	http://dx.doi.org/10.1371/journal.pone.0020032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629646	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800023
J	Dobo, J; Major, B; Kekesi, KA; Szabo, I; Megyeri, M; Hajela, K; Juhasz, G; Zavodszky, P; Gal, P				Dobo, Jozsef; Major, Balazs; Kekesi, Katalin A.; Szabo, Istvan; Megyeri, Marton; Hajela, Krishnan; Juhasz, Gabor; Zavodszky, Peter; Gal, Peter			Cleavage of Kininogen and Subsequent Bradykinin Release by the Complement Component: Mannose-Binding Lectin-Associated Serine Protease (MASP)-1	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; HUMAN-PLASMA KALLIKREIN; HEREDITARY ANGIOEDEMA; FACTOR-XII; CATALYTIC REGION; C1 INHIBITOR; ACTIVATION; PATHWAY; MASP-1; IDENTIFICATION	Bradykinin (BK), generated from high-molecular-weight kininogen (HK) is the major mediator of swelling attacks in hereditary angioedema (HAE), a disease associated with C1-inhibitor deficiency. Plasma kallikrein, activated by factor XIIa, is responsible for most of HK cleavage. However other proteases, which activate during episodes of angioedema, might also contribute to BK production. The lectin pathway of the complement system activates after infection and oxidative stress on endothelial cells generating active serine proteases: MASP-1 and MASP-2. Our aim was to study whether activated MASPs are able to digest HK to release BK. Initially we were trying to find potential new substrates of MASP-1 in human plasma by differential gel electrophoresis, and we identified kininogen cleavage products by this proteomic approach. As a control, MASP-2 was included in the study in addition to MASP-1 and kallikrein. The proteolytic cleavage of HK by MASPs was followed by SDS-PAGE, and BK release was detected by HPLC. We showed that MASP-1 was able to cleave HK resulting in BK production. MASP-2 could also cleave HK but could not release BK. The cleavage pattern of MASPs is similar but not strictly identical to that of kallikrein. The catalytic efficiency of HK cleavage by a recombinant version of MASP-1 and MASP-2 was about 4.0 x 10(2) and 2.7 x 10(2) M(-1) s(-1), respectively. C1-inhibitor, the major inhibitor of factor XIIa and kallikrein, also prevented the cleavage of HK by MASPs. In all, a new factor XII- and kallikrein-independent mechanism of bradykinin production by MASP-1 was demonstrated, which may contribute to the pro-inflammatory effect of the lectin pathway of complement and to the elevated bradykinin levels in HAE patients.	[Dobo, Jozsef; Major, Balazs; Szabo, Istvan; Megyeri, Marton; Zavodszky, Peter; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Budapest, Hungary; [Kekesi, Katalin A.; Juhasz, Gabor] Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary; [Hajela, Krishnan] Devi Ahilya Univ, Sch Life Sci, Indore, Madhya Pradesh, India	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Devi Ahilya University	Dobo, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	dobo@enzim.hu; gal@enzim.hu	Juhász, Gábor/I-7781-2017; Gal, Peter/B-5886-2011; Kékesi, Katalin Adrienna A/H-3484-2017; Dobo, Jozsef/C-7331-2014	Juhász, Gábor/0000-0002-0849-6931; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Dobo, Jozsef/0000-0001-9187-8502	Anyos Jedlik [NKFP_07_1-MASPOK07]; Hungarian Scientific Research Fund (OTKA) [NK77978]; NDA [KMOP-1.1.2-07/1-2008 0003]; GVOP-3.2.1; EGIS; TAMOP [4.2.1./B-09/1/KMR-2010 0003]	Anyos Jedlik; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NDA; GVOP-3.2.1; EGIS; TAMOP	This work was funded by the Anyos Jedlik grant NKFP_07_1-MASPOK07, the Hungarian Scientific Research Fund (OTKA) grant NK77978, the NDA grant KMOP-1.1.2-07/1-2008 0003, the GVOP-3.2.1 grant, the EGIS PSYCH grant and the TAMOP 4.2.1./B-09/1/KMR-2010 0003 grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Davis AE, 2005, CLIN IMMUNOL, V114, P3, DOI 10.1016/j.clim.2004.05.007; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; Joseph K, 2008, ANN ALLERG ASTHMA IM, V101, P279, DOI 10.1016/S1081-1206(10)60493-0; Joseph K, 2009, J ALLERGY CLIN IMMUN, V124, P143, DOI 10.1016/j.jaci.2009.02.006; Kaplan AP, 2010, J ALLERGY CLIN IMMUN, V126, P918, DOI 10.1016/j.jaci.2010.08.012; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Keleman Z, 2010, CLIN IMMUNOL, V134, P354, DOI 10.1016/j.clim.2009.11.002; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Montalto MC, 2001, J IMMUNOL, V166, P4148, DOI 10.4049/jimmunol.166.6.4148; MORI K, 1981, J BIOCHEM-TOKYO, V89, P1465, DOI 10.1093/oxfordjournals.jbchem.a133339; NARTIKOVA V F, 1986, Biokhimiya, V51, P463; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; PERKINS SJ, 1990, J MOL BIOL, V214, P751, DOI 10.1016/0022-2836(90)90290-3; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Santos-Gonzalez M, 2007, EXP GERONTOL, V42, P798, DOI 10.1016/j.exger.2007.04.013; SCHIFFMAN S, 1980, J BIOL CHEM, V255, P6433; Szego EM, 2010, EUR NEUROPSYCHOPHARM, V20, P96, DOI 10.1016/j.euroneuro.2009.11.003; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; TANS G, 1987, J BIOL CHEM, V262, P11308; TAYEH MA, 1994, J BIOL CHEM, V269, P16318; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Varga L, 2008, CLIN EXP IMMUNOL, V153, P68, DOI 10.1111/j.1365-2249.2008.03671.x; Wong NKH, 1999, MOL IMMUNOL, V36, P853, DOI 10.1016/S0161-5890(99)00106-6	42	86	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20036	10.1371/journal.pone.0020036	http://dx.doi.org/10.1371/journal.pone.0020036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625439	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200025
J	Floel, A; Warnecke, T; Duning, T; Lating, Y; Uhlenbrock, J; Schneider, A; Vogt, G; Laage, R; Koch, W; Knecht, S; Schabitz, WR				Floel, Agnes; Warnecke, Tobias; Duning, Thomas; Lating, Yvonne; Uhlenbrock, Jan; Schneider, Armin; Vogt, Gerhard; Laage, Rico; Koch, Winfried; Knecht, Stefan; Schaebitz, Wolf-Ruediger			Granulocyte-Colony Stimulating Factor (G-CSF) in Stroke Patients with Concomitant Vascular Disease-A Randomized Controlled Trial	PLOS ONE			English	Article							WHITE-MATTER; CORTICAL STIMULATION; ISCHEMIC-STROKE; MOTOR FUNCTION; RECOVERY; INTEGRITY; SEVERITY; AGE	Background: G-CSF has been shown in animal models of stroke to promote functional and structural regeneration of the central nervous system. It thus might present a therapy to promote recovery in the chronic stage after stroke. Methods: Here, we assessed the safety and tolerability of G-CSF in chronic stroke patients with concomitant vascular disease, and explored efficacy data. 41 patients were studied in a double-blind, randomized approach to either receive 10 days of G-CSF (10 mu g/kg body weight/day), or placebo. Main inclusion criteria were an ischemic infarct > 4 months prior to inclusion, and white matter hyperintensities on MRI. Primary endpoint was number of adverse events. We also explored changes in hand motor function for activities of daily living, motor and verbal learning, and finger tapping speed, over the course of the study. Results: Adverse events (AEs) were more frequent in the G-CSF group, but were generally graded mild or moderate and from the known side-effect spectrum of G-CSF. Leukocyte count rose after day 2 of G-CSF dosing, reached a maximum on day 8 (mean 42/nl), and returned to baseline 1 week after treatment cessation. No significant effect of treatment was detected for the primary efficacy endpoint, the test of hand motor function. Conclusions: These results demonstrate the feasibility, safety and reasonable tolerability of subcutaneous G-CSF in chronic stroke patients. This study thus provides the basis to explore the efficacy of G-CSF in improving chronic stroke-related deficits.	[Floel, Agnes] Charite, Dept Neurol, D-13353 Berlin, Germany; [Floel, Agnes] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Floel, Agnes] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Warnecke, Tobias; Duning, Thomas; Lating, Yvonne; Uhlenbrock, Jan; Knecht, Stefan] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Schneider, Armin; Vogt, Gerhard; Laage, Rico] SYGNIS Biosci, Heidelberg, Germany; [Koch, Winfried] HAAPACS GmbH, Schriesheim, Germany; [Schaebitz, Wolf-Ruediger] Evangel Krankenhaus Bielefeld EVKB, Dept Neurol, Bielefeld, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Evangelical Hospital Bethel (EvKB) - House Gilead I	Floel, A (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	agnes.floeel@charite.de; wolf.schaebitz@evkb.de	Floel, Agnes/A-9426-2017	Schneider, Armin/0000-0003-0296-0059; Knecht, Stefan/0000-0003-1056-9228	Deutsche Forschungsgemeinschaft [Fl 379-4/2, Fl 379-8/1, DFG-Exc 257]; Interdisciplinary Center of Clinical Research Munster [Floe3/004/08]; Bundesministerium fur Bildung und Forschung [FKZ 0315673A, 01EO0801]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research Munster; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to A. F.: Fl 379-4/2, Fl 379-8/1; and by DFG-Exc 257), the Interdisciplinary Center of Clinical Research Munster (Floe3/004/08), and the Bundesministerium fur Bildung und Forschung (FKZ 0315673A and 01EO0801). G-CSF was provided by SYGNIS Bioscience, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon G, 2003, NEUROREHABILITATION, V18, P215; Anderlini P, 2009, CURR OPIN HEMATOL, V16, P35, DOI 10.1097/MOH.0b013e328319913c; Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Berthier ML, 2006, NEUROLOGY, V67, P1687, DOI 10.1212/01.wnl.0000242626.69666.e2; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Breitenstein C, 2007, RESTOR NEUROL NEUROS, V25, P493; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Delano-Wood L, 2008, STROKE, V39, P794, DOI 10.1161/STROKEAHA.107.502534; Diederich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005303; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Endres M, 2008, CEREBROVASC DIS, V25, P268, DOI 10.1159/000118039; Falanga A, 1999, BLOOD, V93, P2506, DOI 10.1182/blood.V93.8.2506.408k31_2506_2514; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Floel A, 2004, ANN NEUROL, V56, P206, DOI 10.1002/ana.20170; Floel A, 2010, NEUROBIOL DIS, V37, P243, DOI 10.1016/j.nbd.2009.05.027; Guerini F, 2004, J AM GERIATR SOC, V52, P252, DOI 10.1111/j.1532-5415.2004.52064.x; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Malloy P, 2007, CLIN NEUROPSYCHOL, V21, P73, DOI 10.1080/13854040500263583; Matsubara H, 2004, LANCET, V363, P746, DOI 10.1016/S0140-6736(04)15713-9; Minnerup J, 2008, STROKE, V39, P1855, DOI 10.1161/STROKEAHA.107.506816; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Sawaki L, 2003, ANN NEUROL, V53, P521, DOI 10.1002/ana.10529; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sevimli S, 2009, EXP NEUROL, V217, P328, DOI 10.1016/j.expneurol.2009.03.018; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Zarei M, 2009, STROKE, V40, P773, DOI 10.1161/STROKEAHA.108.530832	39	30	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19767	10.1371/journal.pone.0019767	http://dx.doi.org/10.1371/journal.pone.0019767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625426	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200012
J	Poirier, C; Boumans, T; Vellema, M; De Groof, G; Charlier, TD; Verhoye, M; Van der Linden, A; Balthazart, J				Poirier, Colline; Boumans, Tiny; Vellema, Michiel; De Groof, Geert; Charlier, Thierry D.; Verhoye, Marleen; Van der Linden, Annemie; Balthazart, Jacques			Own Song Selectivity in the Songbird Auditory Pathway: Suppression by Norepinephrine	PLOS ONE			English	Article							VOCAL CONTROL NUCLEI; MALE ZEBRA FINCHES; NORADRENERGIC NEUROTOXIN; CATECHOLAMINE LEVELS; MONOAMINE LEVELS; SEX-DIFFERENCES; TURNOVER RATES; CONTROL-SYSTEM; BRAIN; DSP-4	Background: Like human speech, birdsong is a learned behavior that supports species and individual recognition. Norepinephrine is a catecholamine suspected to play a role in song learning. The goal of this study was to investigate the role of norepinephrine in bird's own song selectivity, a property thought to be important for auditory feedback processes required for song learning and maintenance. Methodology/Principal Findings: Using functional magnetic resonance imaging, we show that injection of DSP-4, a specific noradrenergic toxin, unmasks own song selectivity in the dorsal part of NCM, a secondary auditory region. Conclusions/Significance: The level of norepinephrine throughout the telencephalon is known to be high in alert birds and low in sleeping birds. Our results suggest that norepinephrine activity can be further decreased, giving rise to a strong own song selective signal in dorsal NCM. This latent own song selective signal, which is only revealed under conditions of very low noradrenergic activity, might play a role in the auditory feedback and/or the integration of this feedback with the motor circuitry for vocal learning and maintenance.	[Poirier, Colline; Boumans, Tiny; Vellema, Michiel; De Groof, Geert; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2020 Antwerp, Belgium; [Vellema, Michiel] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany; [Charlier, Thierry D.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Res Unit Behav Neuroendocrinol, Liege, Belgium	University of Antwerp; Max Planck Society; University of Liege	Poirier, C (corresponding author), Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2020 Antwerp, Belgium.	colline.poirier@ua.ac.be	Charlier, Thierry/J-4668-2015; De Groof, Geert/D-8251-2013; Balthazart, Jacques/H-6865-2019; Van der Linden, Annemie/L-7855-2017	Balthazart, Jacques/0000-0001-9492-2126; Van der Linden, Annemie/0000-0003-2941-6520; Poirier, Colline/0000-0001-9793-4907; Vellema, Michiel/0000-0001-7172-4776; Verhoye, Marleen/0000-0002-6267-0611	University of Antwerp; NINDS [NS035467]; Research Foundation - Flanders (FWO) [G.0420.02]; EC [LSHB-CT-2005-512146, EMIL LSHC-CT-2004-503569]; FRS-FNRS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035467] Funding Source: NIH RePORTER	University of Antwerp; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Foundation - Flanders (FWO)(FWO); EC(European CommissionEuropean Commission Joint Research Centre); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Francqui grant and a BOF-KP grant from the University of Antwerp to C.P., a grant from the NINDS (NS035467) to J.B., and grants from the Research Foundation - Flanders (FWO, project Nr G.0420.02), Concerted Research Actions (GOA funding) from the University of Antwerp, by EC - FP6 project DiMI, LSHB-CT-2005-512146 and EC - FP6 project EMIL LSHC-CT-2004-503569 to A.VdL. T.D.C. was an FRS-FNRS Postdoctoral Researcher and T. B. a doctoral fellow of the Research Foundation - Flanders (FWO). G. D. G. and C. P. are post-doctoral fellows of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; BALL GF, 1994, PSYCHONEUROENDOCRINO, V19, P485, DOI 10.1016/0306-4530(94)90035-3; BALTHAZART J, 1989, BRAIN RES, V492, P163, DOI 10.1016/0006-8993(89)90899-8; BARCLAY SR, 1990, BRAIN RES, V523, P251, DOI 10.1016/0006-8993(90)91494-2; BARCLAY SR, 1988, BRAIN RES, V459, P333, DOI 10.1016/0006-8993(88)90649-X; Barclay SR, 1996, PHARMACOL BIOCHEM BE, V53, P213, DOI 10.1016/0091-3057(95)00183-2; BARCLAY SR, 1992, PHARMACOL BIOCHEM BE, V41, P195, DOI 10.1016/0091-3057(92)90082-Q; BENNETT C, 1984, IRCS MED SCI-BIOCHEM, V12, P181; BERNARD DJ, 1995, J COMP NEUROL, V360, P726, DOI 10.1002/cne.903600415; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Boumans T, 2007, EUR J NEUROSCI, V26, P2613, DOI 10.1111/j.1460-9568.2007.05865.x; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FRITSCHY JM, 1990, J CHEM NEUROANAT, V3, P309; HALLMAN H, 1984, J NEURAL TRANSM, V60, P89, DOI 10.1007/BF01245027; Harding CF, 1998, J NEUROBIOL, V34, P329, DOI 10.1002/(SICI)1097-4695(199803)34:4<329::AID-NEU4>3.0.CO;2-8; Janata P, 1999, J NEUROSCI, V19, P5108; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Lei HM, 2010, NEURON, V65, P122, DOI 10.1016/j.neuron.2009.12.008; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; Margoliash D, 2010, BRAIN LANG, V115, P45, DOI 10.1016/j.bandl.2009.09.005; Mello CV, 1998, J COMP NEUROL, V400, P207; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Poirier C, 2010, NMR BIOMED, V23, P1027, DOI 10.1002/nbm.1525; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Prather JF, 2004, CURR OPIN NEUROBIOL, V14, P496, DOI 10.1016/j.conb.2004.06.004; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Riters LV, 2007, BRAIN RES, V1149, P127, DOI 10.1016/j.brainres.2007.02.059; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Riters LV, 2002, J CHEM NEUROANAT, V23, P269, DOI 10.1016/S0891-0618(02)00005-4; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Vyas A, 2008, BEHAV NEUROSCI, V122, P1148, DOI 10.1037/0735-7044.122.5.1148; Waterman SA, 2008, BEHAV BRAIN RES, V188, P271, DOI 10.1016/j.bbr.2007.11.004	43	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20131	10.1371/journal.pone.0020131	http://dx.doi.org/10.1371/journal.pone.0020131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625389	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200036
J	Mersmann, N; Tkachev, D; Jelinek, R; Roth, PT; Mobius, W; Ruhwedel, T; Ruhle, S; Weber-Fahr, W; Sartorius, A; Klugmann, M				Mersmann, Nadine; Tkachev, Dmitri; Jelinek, Ruth; Roeth, Philipp Thomas; Moebius, Wiebke; Ruhwedel, Torben; Ruehle, Sabine; Weber-Fahr, Wolfgang; Sartorius, Alexander; Klugmann, Matthias			Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACETYL-L-ASPARTATE; SPONGY DEGENERATION; N-ACETYLASPARTYLGLUTAMATE; ELECTRON-MICROSCOPY; TREMOR RAT; BRAIN; CNS; EXPRESSION; MOUSE	Canavan Disease (CD) is a recessive leukodystrophy caused by loss of function mutations in the gene encoding aspartoacylase (ASPA), an oligodendrocyte-enriched enzyme that hydrolyses N-acetylaspartate (NAA) to acetate and aspartate. The neurological phenotypes of different rodent models of CD vary considerably. Here we report on a novel targeted aspa mouse mutant expressing the bacterial beta-Galactosidase (lacZ) gene under the control of the aspa regulatory elements. X-Gal staining in known ASPA expression domains confirms the integrity of the modified locus in heterozygous aspa lacZ-knockin (aspa(lacZ/+)) mice. In addition, abundant ASPA expression was detected in Schwann cells. Homozygous (aspa(lacZ/lacZ)) mutants are ASPA-deficient, show CD-like histopathology and moderate neurological impairment with behavioural deficits that are more pronounced in aspa(lacZ/lacZ) males than females. Non-invasive ultrahigh field proton magnetic resonance spectroscopy revealed increased levels of NAA, myo-inositol and taurine in the aspa(lacZ/lacZ) brain. Spongy degeneration was prominent in hippocampus, thalamus, brain stem, and cerebellum, whereas white matter of optic nerve and corpus callosum was spared. Intracellular vacuolisation in astrocytes coincides with axonal swellings in cerebellum and brain stem of aspa(lacZ/lacZ) mutants indicating that astroglia may act as an osmolyte buffer in the aspa-deficient CNS. In summary, the aspa(lacZ) mouse is an accurate model of CD and an important tool to identify novel aspects of its complex pathology.	[Mersmann, Nadine; Tkachev, Dmitri; Jelinek, Ruth; Roeth, Philipp Thomas; Ruehle, Sabine; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany; [Moebius, Wiebke; Ruhwedel, Torben] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Weber-Fahr, Wolfgang; Sartorius, Alexander] Cent Inst Mental Hlth, Neuroimaging Dept, D-6800 Mannheim, Germany; [Klugmann, Matthias] Univ New S Wales, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia	Johannes Gutenberg University of Mainz; Max Planck Society; Central Institute of Mental Health; University of New South Wales Sydney	Mersmann, N (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany.	m.klugmann@unsw.edu.au	Sartorius, Alexander/E-3061-2012	Ruhwedel, Torben/0000-0002-9535-9395; Sartorius, Alexander/0000-0002-1243-3693; /0000-0002-2902-7165	European Leukodystrophy Association [ELA 2006-032C5]; Mainz University Medical Center [Forschungsfoerderung Stufe 1]	European Leukodystrophy Association; Mainz University Medical Center	This work was supported by the European Leukodystrophy Association (grant number: ELA 2006-032C5), and a grant in aid (Forschungsfoerderung Stufe 1) of the Mainz University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1973, HUM PATHOL, V4, P331, DOI 10.1016/S0046-8177(73)80098-X; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Assadi M, 2010, EUR J PAEDIATR NEURO, V14, P354, DOI 10.1016/j.ejpn.2009.11.006; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Blum S, 1999, J MAGN RESON, V136, P219, DOI 10.1006/jmre.1998.1618; Cakmakci H, 2010, EUR J RADIOL, V74, pE162, DOI 10.1016/j.ejrad.2009.05.048; Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299, DOI 10.1001/archneurpsyc.1931.02230020085005; Cerghet M, 2009, J NEUROL SCI, V286, P76, DOI 10.1016/j.jns.2009.06.039; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Hershfield JR, 2006, FASEB J, V20, P2139, DOI 10.1096/fj.05-5358fje; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; KAMOSHIT.S, 1967, NEUROLOGY, V17, P895, DOI 10.1212/WNL.17.9.895; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kirmani BF, 2003, DEV BRAIN RES, V140, P105, DOI 10.1016/S0165-3806(02)00592-8; Kitada K, 2000, J NEUROCHEM, V74, P2512, DOI 10.1046/j.1471-4159.2000.0742512.x; Klugmann M, 2005, MOL THER, V11, P745, DOI 10.1016/j.ymthe.2005.01.006; Klugmann M, 2003, NEUROREPORT, V14, P1837, DOI 10.1097/00001756-200310060-00016; Klugmann Matthias, 2006, P303, DOI 10.1016/B978-012397632-1/50024-1; KONDO A, 1991, BRAIN, V114, P979, DOI 10.1093/brain/114.2.979; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Matalon R, 2000, J GENE MED, V2, P165; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; Mobius W, 2010, METHOD CELL BIOL, V96, P475, DOI 10.1016/S0091-679X(10)96020-2; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Surendran S, 2004, BRAIN RES, V1016, P268, DOI 10.1016/j.brainres.2004.05.035; Surendran S, 2006, BIOCHEM BIOPH RES CO, V11, P11; SUZUKI K, 1968, ACTA NEUROPATHOL, V10, P95, DOI 10.1007/BF00690515; Tacke U, 2005, NEUROPEDIATRICS, V36, P252, DOI 10.1055/s-2005-865865; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x	44	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20336	10.1371/journal.pone.0020336	http://dx.doi.org/10.1371/journal.pone.0020336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625469	Green Published, gold, Green Submitted			2022-12-27	WOS:000290793400058
J	Luciani, MG; Seok, J; Sayeed, A; Champion, S; Goodson, WH; Jeffrey, SS; Xiao, WZ; Mindrinos, M; Davis, RW; Dairkee, SH				Luciani, Maria Gloria; Seok, Junhee; Sayeed, Aejaz; Champion, Stacey; Goodson, William H.; Jeffrey, Stefanie S.; Xiao, Wenzhong; Mindrinos, Michael; Davis, Ronald W.; Dairkee, Shanaz H.			Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer Cells	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; TUMOR MICROENVIRONMENT; POOR-PROGNOSIS; GROWTH-FACTOR; IN-SITU; EXPRESSION; FIBROBLASTS; CARCINOMA; PROGRESSION; ASSOCIATION	Whether stromal components facilitate growth, invasion, and dissemination of cancer cells or suppress neoplastic lesions from further malignant progression is a continuing conundrum in tumor biology. Conceptualizing a dynamic picture of tumorigenesis is complicated by inter-individual heterogeneity. In the post genomic era, unraveling such complexity remains a challenge for the cancer biologist. Towards establishing a functional association between cellular crosstalk and differential cancer aggressiveness, we identified a signature of malignant breast epithelial response to stromal signaling. Proximity to fibroblasts resulted in gene transcript alterations of > 2-fold for 107 probes, collectively designated as Fibroblast Triggered Gene Expression in Tumor (FTExT). The hazard ratio predicted by the FTExT classifier for distant relapse in patients with intermediate and high grade breast tumors was significant compared to routine clinical variables (dataset 1, n = 258, HR - 2.11, 95% CI 1.17-3.80, p-value 0.01; dataset 2, n = 171, HR - 3.07, 95% CI 1.21-7.83, p-value 0.01). Biofunctions represented by FTExT included inflammatory signaling, free radical scavenging, cell death, and cell proliferation. Unlike genes of the 'proliferation cluster', which are overexpressed in aggressive primary tumors, FTExT genes were uniquely repressed in such cases. As proof of concept for our correlative findings, which link stromal-epithelial crosstalk and tumor behavior, we show a distinctive differential in stromal impact on prognosis-defining functional endpoints of cell cycle progression, and resistance to therapy-induced growth arrest and apoptosis in low vs. high grade cancer cells. Our experimental data thus reveal aspects of 'paracrine cooperativity' that are exclusively contingent upon the histopathologically defined grade of interacting tumor epithelium, and demonstrate that epithelial responsiveness to the tumor microenvironment is a deterministic factor underlying clinical outcome. In this light, early attenuation of epithelial-stromal crosstalk could improve the management of cases prone to be clinically challenging.	[Luciani, Maria Gloria; Sayeed, Aejaz; Champion, Stacey; Goodson, William H.; Dairkee, Shanaz H.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Seok, Junhee; Xiao, Wenzhong; Mindrinos, Michael; Davis, Ronald W.] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Jeffrey, Stefanie S.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; Stanford University; Stanford University	Luciani, MG (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.	dairkes@cpmcri.org	Dairkee, Shanaz Hashmi/D-6743-2012	Dairkee, Shanaz/0000-0002-2073-9684; GOODSON, WILLIAM/0000-0001-7489-3188; Jeffrey, Stefanie/0000-0003-4478-2764; xiao, wenzhong/0000-0003-4944-6380	National Institutes of Health [R01CA109325]; NATIONAL CANCER INSTITUTE [R01CA109325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health under grant R01CA109325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; CAMP JT, 2010, MOL CANC RES    1203; Cardone A, 1997, PANMINERVA MED, V39, P174; CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dairkee SH, 2008, CANCER RES, V68, P2076, DOI 10.1158/0008-5472.CAN-07-6526; Dairkee SH, 2009, CANCER RES, V69, P7826, DOI 10.1158/0008-5472.CAN-09-1564; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Makretsov NA, 2007, MODERN PATHOL, V20, P84, DOI 10.1038/modpathol.3800713; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20016	10.1371/journal.pone.0020016	http://dx.doi.org/10.1371/journal.pone.0020016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625507	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200040
J	Maekawa, T; Takahashi, N; Tabeta, K; Aoki, Y; Miyashita, H; Miyauchi, S; Miyazawa, H; Nakajima, T; Yamazaki, K				Maekawa, Tomoki; Takahashi, Naoki; Tabeta, Koichi; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Nakajima, Takako; Yamazaki, Kazuhisa			Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; CHLAMYDIA-PNEUMONIAE; UP-REGULATION; X-RECEPTOR; ATHEROSCLEROSIS; METABOLISM; RISK; LXR; INFLAMMATION	Background: Recent studies have suggested that periodontal disease increases the risk of atherothrombotic disease. Atherosclerosis has been characterized as a chronic inflammatory response to cholesterol deposition in the arteries. Although several studies have suggested that certain periodontopathic bacteria accelerate atherogenesis in apolipoprotein E-deficient mice, the mechanistic link between cholesterol accumulation and periodontal infection-induced inflammation is largely unknown. Methodology/Principal Findings: We orally infected C57BL/6 and C57BL/6. KOR-Apoe(shl) (B6.Apoeshl) mice with Porphyromonas gingivalis, which is a representative periodontopathic bacterium, and evaluated atherogenesis, gene expression in the aorta and liver and systemic inflammatory and lipid profiles in the blood. Furthermore, the effect of lipopolysaccharide (LPS) from P. gingivalis on cholesterol transport and the related gene expression was examined in peritoneal macrophages. Alveolar bone resorption and elevation of systemic inflammatory responses were induced in both strains. Despite early changes in the expression of key genes involved in cholesterol turnover, such as liver X receptor and ATP-binding cassette A1, serum lipid profiles did not change with short-term infection. Long-term infection was associated with a reduction in serum high-density lipoprotein (HDL) cholesterol but not with the development of atherosclerotic lesions in wild-type mice. In B6.Apoeshl mice, long-term infection resulted in the elevation of very low-density lipoprotein (VLDL), LDL and total cholesterols in addition to the reduction of HDL cholesterol. This shift in the lipid profile was concomitant with a significant increase in atherosclerotic lesions. Stimulation with P. gingivalis LPS induced the change of cholesterol transport via targeting the expression of LDL receptor-related genes and resulted in the disturbance of regulatory mechanisms of the cholesterol level in macrophages. Conclusions/Significance: Periodontal infection itself does not cause atherosclerosis, but it accelerates it by inducing systemic inflammation and deteriorating lipid metabolism, particularly when underlying hyperlidemia or susceptibility to hyperlipidemia exists, and it may contribute to the development of coronary heart disease.	[Maekawa, Tomoki; Takahashi, Naoki; Tabeta, Koichi; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Nakajima, Takako; Yamazaki, Kazuhisa] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Maekawa, Tomoki; Takahashi, Naoki; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Yamazaki, Kazuhisa] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan; [Nakajima, Takako] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan	Niigata University; Niigata University; Niigata University	Maekawa, T (corresponding author), Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan.	kaz@dent.niigata-u.ac.jp	Maekawa, Tomoki/AAA-4673-2020; TABTA, KOICHI/AAG-6481-2020	TABTA, KOICHI/0000-0002-7019-1872; Maekawa, Tomoki/0000-0002-4597-1316	Ministry of Education, Science, Sports and Culture of Japan [19390536, 19592384, 19791610, 20592426]; Promotion of Niigata University Research Project; Grants-in-Aid for Scientific Research [23390476, 21390555] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Niigata University Research Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (19390536, 19592384, 19791610, and 20592426)(http://www.jsps.go.jp/) and the Promotion of Niigata University Research Project (http://www.niigata-u.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Buhlin K, 2009, ATHEROSCLEROSIS, V206, P518, DOI 10.1016/j.atherosclerosis.2009.03.035; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chiu B, 1997, CIRCULATION, V96, P2144; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Domon H, 2008, J LEUKOCYTE BIOL, V83, P672, DOI 10.1189/jlb.0607432; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Feingold KR, 2008, BIOCHEM BIOPH RES CO, V374, P341, DOI 10.1016/j.bbrc.2008.07.023; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Li L, 2008, J LIPID RES, V49, P1782, DOI 10.1194/jlr.M800172-JLR200; Liao HL, 2002, ARTERIOSCL THROM VAS, V22, P127, DOI 10.1161/hq1201.101772; Maekawa T, 2010, J VASC RES, V47, P346, DOI 10.1159/000265568; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; MENDALL MA, 1994, BRIT HEART J, V71, P437; Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x; Norata GD, 2005, INT J MOL MED, V16, P717; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ramirez-Tortosa MC, 2010, NUTR METAB CARDIOVAS, V20, P133, DOI 10.1016/j.numecd.2009.03.003; Rufail ML, 2007, J PERIODONTAL RES, V42, P495, DOI 10.1111/j.1600-0765.2007.00973.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SEYMOUR GJ, 1993, J PERIODONTAL RES, V28, P478, DOI 10.1111/j.1600-0765.1993.tb02108.x; Shimazaki Y, 2007, J DENT RES, V86, P271, DOI 10.1177/154405910708600314; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	40	94	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20240	10.1371/journal.pone.0020240	http://dx.doi.org/10.1371/journal.pone.0020240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625524	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200054
J	Butturini, E; Cavalieri, E; de Prati, AC; Darra, E; Rigo, A; Shoji, K; Murayama, N; Yamazaki, H; Watanabe, Y; Suzuki, H; Mariotto, S				Butturini, Elena; Cavalieri, Elisabetta; de Prati, Alessandra Carcereri; Darra, Elena; Rigo, Antonella; Shoji, Kazuo; Murayama, Norie; Yamazaki, Hiroshi; Watanabe, Yasuo; Suzuki, Hisanori; Mariotto, Sofia			Two Naturally Occurring Terpenes, Dehydrocostuslactone and Costunolide, Decrease Intracellular GSH Content and Inhibit STAT3 Activation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; SERINE PHOSPHORYLATION; SESQUITERPENE LACTONE; S-GLUTATHIONYLATION; MEDIATED APOPTOSIS; OXIDATIVE STRESS; HEME OXYGENASE-1; MEDICINAL-PLANT; CANCER CELLS	The main purpose of the present study is to envisage the molecular mechanism of inhibitory action of dehydrocostuslactone (DCE) andcostunolide (CS), two naturally occurring sesquiterpene lactones, towards the activation of signal transducer and activator of transcription 3 (STAT3). We report that, in human THP-1 cell line, they inhibit IL-6-elicited tyrosine phosphorylation of STAT3 and its DNA binding activity with EC50 of 10 mu M with concomitantdown-regulation of the phosphorylation of the tyrosine Janus kinases JAK1, JAK2 and Tyk2. Furthermore, these compounds that contain an alpha-beta-unsatured carbonyl moiety and function as potent Michael reaction acceptor, induce a rapid drop in intracellular glutathione (GSH) concentration by direct interaction with it, thereby triggering S-glutathionylation of STAT3. Dehydrocostunolide (HCS), the reduced form of CS lacking only the alpha-beta-unsaturated carbonyl group, fails to exert any inhibitory action. Finally, the glutathione ethylene ester (GEE), the cell permeable GSH form, reverts the inhibitory action of DCE and CS on STAT3 tyrosine phosphorylation. We conclude that these two sesquiterpene lactones are able to induce redox-dependent post-translational modification of cysteine residues of STAT3 protein in order to regulate its function.	[Butturini, Elena; Cavalieri, Elisabetta; de Prati, Alessandra Carcereri; Darra, Elena; Shoji, Kazuo; Suzuki, Hisanori; Mariotto, Sofia] Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy; [Butturini, Elena; Shoji, Kazuo; Watanabe, Yasuo] Showa Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan; [Rigo, Antonella] Univ Verona, Dept Med, I-37100 Verona, Italy; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Dept Pharmacokinet, Tokyo, Japan	University of Verona; Showa Pharmaceutical University; University of Verona; Showa Pharmaceutical University	Butturini, E (corresponding author), Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy.	sofiamariotto@hotmail.it	mariotto, sofia/AAH-5473-2019; Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Butturini, Elena/0000-0001-6612-8945; Watanabe, Yasuo/0000-0003-2232-0091; Darra, Elena/0000-0002-4684-4351	University of Verona	University of Verona	This work was partly supported by JointProject (HS). EB was financed by a Ph.D. fellowship (University of Verona). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2008, CURR DRUG TARGETS, V9, P369, DOI 10.2174/138945008784221116; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buettner R, 2002, CLIN CANCER RES, V8, P945; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Paola R, 2005, SHOCK, V24, P255, DOI 10.1097/01.shk.0000175428.57769.34; de Prati AC, 2005, CURR MED CHEM, V12, P1819, DOI 10.2174/0929867054546645; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Jeong GS, 2007, EUR J PHARMACOL, V565, P37, DOI 10.1016/j.ejphar.2007.02.053; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Koo TH, 2001, PLANTA MED, V67, P103, DOI 10.1055/s-2001-11503; KUO PL, 2009, MOL CANC THER; Lee HJ, 1999, PLANTA MED, V65, P104, DOI 10.1055/s-1999-13968; Lee MG, 2001, BIOL PHARM BULL, V24, P303, DOI 10.1248/bpb.24.303; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Mariotto S, 2008, PHARMACOL RES, V57, P110, DOI 10.1016/j.phrs.2007.12.005; Menegazzi M, 2008, INT J BIOCHEM CELL B, V40, P1509, DOI 10.1016/j.biocel.2007.11.019; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pae HO, 2007, INFLAMM RES, V56, P520, DOI 10.1007/s00011-007-7015-4; Pandey MM, 2007, J ETHNOPHARMACOL, V110, P379, DOI 10.1016/j.jep.2006.12.033; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmidt TJ, 1997, BIOORGAN MED CHEM, V5, P645, DOI 10.1016/S0968-0896(97)00003-5; SITIA R, 2004, SCI STKE, pPE27; Townsend PA, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1716fje; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	40	75	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20174	10.1371/journal.pone.0020174	http://dx.doi.org/10.1371/journal.pone.0020174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625597	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200070
J	Olsson, M; Ahlin, S; Olsson, B; Svensson, PA; Stahlman, M; Boren, J; Carlsson, LMS; Sjoholm, K				Olsson, Maja; Ahlin, Sofie; Olsson, Bob; Svensson, Per-Arne; Stahlman, Marcus; Boren, Jan; Carlsson, Lena M. S.; Sjoholm, Kajsa			Establishment of a Transgenic Mouse Model Specifically Expressing Human Serum Amyloid A in Adipose Tissue	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACUTE-PHASE RESPONSE; CHOLESTEROL TRANSPORT; HDL CHOLESTEROL; GENE-EXPRESSION; IN-VIVO; APOA-I; ADIPOCYTE; OBESITY; SIZE	Obesity and obesity co-morbidities are associated with a low grade inflammation and elevated serum levels of acute phase proteins, including serum amyloid A (SAA). In the non-acute phase in humans, adipocytes are major producers of SAA but the function of adipocyte-derived SAA is unknown. To clarify the role of adipocyte-derived SAA, a transgenic mouse model expressing human SAA1 (hSAA) in adipocytes was established. hSAA expression was analysed using real-time PCR analysis. Male animals were challenged with a high fat (HF) diet. Plasma samples were subjected to fast protein liquid chromatography (FPLC) separation. hSAA, cholesterol and triglyceride content were measured in plasma and in FPLC fractions. Real-time PCR analysis confirmed an adipose tissue-specific hSAA gene expression. Moreover, the hSAA gene expression was not influenced by HF diet. However, hSAA plasma levels in HF fed animals (37.7 +/- 4.0 mu g/mL, n = 7) were increased compared to those in normal chow fed animals (4.8 +/- 0.5 mu g/mL, n = 10; p<0.001), and plasma levels in the two groups were in the same ranges as in obese and lean human subjects, respectively. In FPLC separated plasma samples, the concentration of hSAA peaked in high-density lipoprotein (HDL) containing fractions. In addition, cholesterol distribution over the different lipoprotein subfractions as assessed by FPLC analysis was similar within the two experimental groups. The established transgenic mouse model demonstrates that adipose tissue produced hSAA enters the circulation, resulting in elevated plasma levels of hSAA. This new model will enable further studies of metabolic effects of adipose tissue-derived SAA.	[Olsson, Maja; Ahlin, Sofie; Olsson, Bob; Svensson, Per-Arne; Stahlman, Marcus; Boren, Jan; Carlsson, Lena M. S.; Sjoholm, Kajsa] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Olsson, M (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden.	maja.olsson@gu.se	StÃhlman, Marcus/M-4597-2019; Svensson, Per-Arne/R-4626-2019; Carlsson, Lena/F-7570-2018	Carlsson, Lena/0000-0003-4145-6242; Sjoholm, Kajsa/0000-0003-0146-8193; Ahlin, Sofie/0000-0003-0619-2683; Henricsson, Marcus/0000-0002-4202-0339; Olsson, Bob/0000-0002-6368-6172; Svensson, Per-Arne/0000-0002-6731-806X	Swedish Research Council [K2008-65p-20758-01-4, K2010-55X-11285-13]; Swedish Federal Government; Sahlgrenska Academy; VINNOVA-VINNMER program; Jeansson Foundations; Ake Wiberg Foundation; Royal Physiographic Society in Lund (Nilsson-Ehle); Emelle Foundation; Swedish Knowledge Foundation through Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Federal Government; Sahlgrenska Academy; VINNOVA-VINNMER program(Vinnova); Jeansson Foundations; Ake Wiberg Foundation; Royal Physiographic Society in Lund (Nilsson-Ehle); Emelle Foundation; Swedish Knowledge Foundation through Medical Bioinformatics at Corporate Alliances, Karolinska Institutet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Research Council (K2008-65p-20758-01-4 and K2010-55X-11285-13), the Swedish Federal Government under the LUA/ALF agreement, the Sahlgrenska Academy, the VINNOVA-VINNMER program, the Jeansson Foundations, the Ake Wiberg Foundation, the Royal Physiographic Society in Lund (Nilsson-Ehle), the Emelle Foundation and the Swedish Knowledge Foundation through the Industrial PhD programme in Medical Bioinformatics at Corporate Alliances, Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Buyukhatipoglu H, 2007, NEPHROLOGY, V12, P25, DOI 10.1111/j.1440-1797.2006.00742.x; Cabana VG, 2003, J LIPID RES, V44, P780, DOI 10.1194/jlr.M200432-JLR200; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DEBEER MC, 2010, J LIPID RES; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hatanaka E, 2007, IMMUNOL LETT, V108, P160, DOI 10.1016/j.imlet.2006.12.005; Hosoai H, 1999, J LIPID RES, V40, P648; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Jylhava J, 2009, J INTERN MED, V266, P286, DOI 10.1111/j.1365-2796.2009.02120.x; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415; Kindy MS, 2000, ARTERIOSCL THROM VAS, V20, P1543, DOI 10.1161/01.ATV.20.6.1543; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sjoholm K, 2009, CYTOKINE, V48, P260, DOI 10.1016/j.cyto.2009.08.005; Soukas A, 2000, GENE DEV, V14, P963; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Uurtuya S, 2009, J ATHEROSCLER THROMB, V16, P299, DOI 10.5551/jat.E901; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; WANG YC, 2009, J NUTR BIOCH; Wilson PG, 2008, AM J PATHOL, V173, P1902, DOI 10.2353/ajpath.2008.080201; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19609	10.1371/journal.pone.0019609	http://dx.doi.org/10.1371/journal.pone.0019609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611116	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200019
J	Michaelis, M; Geiler, J; Naczk, P; Sithisarn, P; Leutz, A; Doerr, HW; Cinatl, J				Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.			Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression	PLOS ONE			English	Article							OSELTAMIVIR-RESISTANT INFLUENZA; BRONCHIAL EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; IFN REGULATORY FACTOR-3; AVIAN INFLUENZA; PANDEMIC INFLUENZA; ANTIVIRAL THERAPY; SIGNALING PATHWAYS; A(H1N1) VIRUSES; LICORICE ROOTS	Glycyrrhizin is known to exert antiviral and anti-inflammatory effects. Here, the effects of an approved parenteral glycyrrhizin preparation (Stronger Neo-Minophafen C) were investigated on highly pathogenic influenza A H5N1 virus replication, H5N1-induced apoptosis, and H5N1-induced pro-inflammatory responses in lung epithelial (A549) cells. Therapeutic glycyrrhizin concentrations substantially inhibited H5N1-induced expression of the pro-inflammatory molecules CXCL10, interleukin 6, CCL2, and CCL5 (effective glycyrrhizin concentrations 25 to 50 mu g/ml) but interfered with H5N1 replication and H5N1-induced apoptosis to a lesser extent (effective glycyrrhizin concentrations 100 mg/ml or higher). Glycyrrhizin also diminished monocyte migration towards supernatants of H5N1-infected A549 cells. The mechanism by which glycyrrhizin interferes with H5N1 replication and H5N1-induced pro-inflammatory gene expression includes inhibition of H5N1-induced formation of reactive oxygen species and (in turn) reduced activation of NFkB, JNK, and p38, redox-sensitive signalling events known to be relevant for influenza A virus replication. Therefore, glycyrrhizin may complement the arsenal of potential drugs for the treatment of H5N1 disease.	[Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.] Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Michaelis, M (corresponding author), Klinikum JW Goethe Univ, Inst Med Virol, Frankfurt, Germany.	Cinatl@em.uni-frankfurt.de		Michaelis, Martin/0000-0002-5710-5888	EU [512054, 512864, 044512]; Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder	EU(European Commission); Hilfe fur krebskranke Kinder Frankfurt e.V.; Frankfurter Stiftung fur krebskranke Kinder	The work was supported by the EU grants SARS/FLU vaccine (proposal no. 512054), Chimeric Vaccines (proposal no. 512864), and Intranasal H5 vaccine (proposal no. 044512), by the Hilfe fur krebskranke Kinder Frankfurt e.V. and by the Frankfurter Stiftung fur krebskranke Kinder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cinatl J, 2005, ANTIVIR RES, V66, P81, DOI 10.1016/j.antiviral.2005.03.002; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P203, DOI 10.1007/s00430-007-0048-z; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P191, DOI 10.1007/s00430-007-0045-2; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P181, DOI 10.1007/s00430-007-0042-5; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P213, DOI 10.1007/s00430-007-0052-3; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DeFlora S, 1997, EUR RESPIR J, V10, P1535, DOI 10.1183/09031936.97.10071535; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Geiss GK, 2001, J VIROL, V75, P4321, DOI 10.1128/JVI.75.9.4321-4331.2001; Hampson AW, 2008, ANN ACAD MED SINGAP, V37, P510; Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kieny MP, 2008, VACCINE, V26, pD3, DOI 10.1016/j.vaccine.2008.07.046; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Michaelis M, 2010, MED MICROBIOL IMMUN, V199, P291, DOI 10.1007/s00430-010-0155-0; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Michaelis M, 2009, CURR MOL MED, V9, P131, DOI 10.2174/156652409787581565; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; NARDONE LL, 1979, BIOCHIM BIOPHYS ACTA, V573, P276, DOI 10.1016/0005-2760(79)90061-4; Ogbomo H, 2010, BIOCHEM PHARMACOL, V79, P188, DOI 10.1016/j.bcp.2009.07.026; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Saito R, 2008, J INFECT DIS, V197, P630, DOI 10.1086/525055; Saito R, 2007, J MED VIROL, V79, P1569, DOI 10.1002/jmv.20946; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sugrue RJ, 2008, ANN ACAD MED SINGAP, V37, P518; Sumbayev VV, 2006, SCAND J IMMUNOL, V63, P391, DOI 10.1111/j.1365-3083.2006.001764.x; Suzuki Y, 2009, J CLIN MICROBIOL, V47, P623, DOI 10.1128/JCM.01760-08; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; van Rossum TGJ, 1999, CLIN THER, V21, P2080, DOI 10.1016/S0149-2918(00)87239-2; Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang Xiu-qin, 2006, Zhong Yao Cai, V29, P692; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	61	162	170	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19705	10.1371/journal.pone.0019705	http://dx.doi.org/10.1371/journal.pone.0019705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611183	Green Submitted, Green Published, gold			2022-12-27	WOS:000290657500015
J	Smalley-Freed, WG; Efimov, A; Short, SP; Jia, PL; Zhao, ZM; Washington, MK; Robine, S; Coffey, RJ; Reynolds, AB				Smalley-Freed, Whitney G.; Efimov, Andrey; Short, Sarah P.; Jia, Peilin; Zhao, Zhongming; Washington, M. Kay; Robine, Sylvie; Coffey, Robert J.; Reynolds, Albert B.			Adenoma Formation following Limited Ablation of p120-Catenin in the Mouse Intestine	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN COLORECTAL-CANCER; E-CADHERIN; CELL-ADHESION; MOLECULAR-BASIS; ALPHA-CATENIN; F-ACTIN; MICE; EXPRESSION; TUMORS	p120 loss destabilizes E-cadherin and could therefore result in tumor and/or metastasis-promoting activities similar to those caused by E-cadherin downregulation. Previously, we reported that p120 is essential in the intestine for barrier function, epithelial homeostasis and survival. Conditional p120 ablation in the mouse intestine induced severe inflammatory bowel disease, but long-term cancer-related studies were impossible because none of the animals survived longer than 21 days. Here, we used a tamoxifen-inducible mouse model (Vil-Cre-ER(T2); p120(fl/fl)) to limit the extent of p120 ablation and thereby enable long-term studies. Reducing p120 KO to similar to 10% of the intestinal epithelium produced long-lived animals outwardly indistinguishable from controls. Effects of prolonged p120 absence were then evaluated at intervals spanning 2 to 18 months. At all time points, immunostaining revealed microdomains of p120-null epithelium interspersed with normal epithelium. Thus, stochastic p120 ablation is compatible with crypt progenitor cell function and permitted lifelong renewal of the p120-null cells. Consistent with previous observations, a barrier defect and frequent infiltration of neutrophils was observed, suggesting that focal p120 loss generates a microenvironment disposed to chronic inflammation. We report that 45% of these animals developed tumors within 18 months of tamoxifen induction. Interestingly, beta-catenin was upregulated in the majority, but none of the tumors were p120 null. Although further work is required to directly establish mechanism, we conclude that limited p120 ablation can promote tumorigenesis by an indirect non-cell autonomous mechanism. Given that byproducts of inflammation are known to be highly mutagenic, we suggest that tumorigenesis in this model is ultimately driven by the lifelong inability to heal chronic wounds and the substantially increased rates of stochastic gene mutation in tissue microenvironments subjected to chronic inflammation. Indeed, although technical issues precluded direct identification of mutations, beta-catenin upregulation in human colon cancer almost invariably reflects mutations in APC and/or beta-catenin.	[Smalley-Freed, Whitney G.; Efimov, Andrey; Short, Sarah P.; Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Dept Bioinformat, Nashville, TN USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Robine, Sylvie] Inst Curie, CNRS, Dept Morphogenesis & Intracellular Signaling, F-75231 Paris, France; [Coffey, Robert J.] VA Tennessee Valley Healthcare Syst, Med Serv, Nashville, TN USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Smalley-Freed, WG (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA.	al.reynolds@vanderbilt.edu	Jia, Peilin/B-4519-2013	Short, Sarah/0000-0001-9606-7370	Vanderbilt Cancer Center [P30- CA068485]; Research Project Grant [CA111947, CA055724, CA46413]; Vanderbilt GI SPORE [P50 95103]; GI SPORE [P50 95103]; Mouse Models of Human Cancer Consortium [V01 084239]; NATIONAL CANCER INSTITUTE [R29CA055724, P30CA068485, T32CA009592, R01CA111947, R01CA055724, R01CA046413] Funding Source: NIH RePORTER	Vanderbilt Cancer Center; Research Project Grant; Vanderbilt GI SPORE; GI SPORE; Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Vanderbilt Cancer Center Support Grant (P30- CA068485), Research Project Grant CA111947, and the Vanderbilt GI SPORE (P50 95103). Andrey Efimov was supported in part by Research Project Grant CA055724. Robert J. Coffey was supported by Research Project Grant CA46413, GI SPORE (P50 95103), and the Mouse Models of Human Cancer Consortium (V01 084239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berx G, 1996, ONCOGENE, V13, P1919; Brown MV, 2009, EXP CELL RES, V315, P39, DOI 10.1016/j.yexcr.2008.09.025; Campbell RJ, 2002, J CLIN PATHOL-MOL PA, V55, P80, DOI 10.1136/mp.55.2.80; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Deane NG, 2007, MOL CANCER RES, V5, P341, DOI 10.1158/1541-7786.MCR-06-0225; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kim JC, 2008, CANCER SCI, V99, P1348, DOI 10.1111/j.1349-7006.2008.00819.x; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Maltzman T, 1997, CARCINOGENESIS, V18, P2435, DOI 10.1093/carcin/18.12.2435; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Ogawa Y, 1991, Growth Factors, V5, P57, DOI 10.3109/08977199109000271; OKA H, 1992, VIRCHOWS ARCH A, V421, P149, DOI 10.1007/BF01607048; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Skoudy A, 1996, INT J CANCER, V68, P14, DOI 10.1002/(SICI)1097-0215(19960927)68:1<14::AID-IJC3>3.0.CO;2-#; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Vagefi Parsia A, 2005, Clin Colorectal Cancer, V4, P313, DOI 10.3816/CCC.2005.n.003; Valizadeh A, 1997, AM J PATHOL, V150, P1977; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	54	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19880	10.1371/journal.pone.0019880	http://dx.doi.org/10.1371/journal.pone.0019880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611205	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500031
J	Barbier, M; Faille, D; Loriod, B; Textoris, J; Camus, C; Puthier, D; Flori, L; Wassmer, SC; Victorero, G; Alessi, MC; Fusai, T; Nguyen, C; Grau, GE; Rihet, P				Barbier, Mathieu; Faille, Dorothee; Loriod, Beatrice; Textoris, Julien; Camus, Claire; Puthier, Denis; Flori, Laurence; Wassmer, Samuel Crocodile; Victorero, Genevieve; Alessi, Marie-Christine; Fusai, Thierry; Nguyen, Catherine; Grau, Georges E.; Rihet, Pascal			Platelets Alter Gene Expression Profile in Human Brain Endothelial Cells in an In Vitro Model of Cerebral Malaria	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PLASMODIUM-FALCIPARUM; TNF; APOPTOSIS; ERYTHROPOIETIN; INFLAMMATION; MICROARRAYS; ACTIVATION; ADHERENCE; PARASITES	Platelet adhesion to the brain microvasculature has been associated with cerebral malaria (CM) in humans, suggesting that platelets play a role in the pathogenesis of this syndrome. In vitro co-cultures have shown that platelets can act as a bridge between Plasmodium falciparum-infected red blood cells (pRBC) and human brain microvascular endothelial cells (HBEC) and potentiate HBEC apoptosis. Using cDNA microarray technology, we analyzed transcriptional changes of HBEC in response to platelets in the presence or the absence of tumor necrosis factor (TNF) and pRBC, which have been reported to alter gene expression in endothelial cells. Using a rigorous statistical approach with multiple test corrections, we showed a significant effect of platelets on gene expression in HBEC. We also detected a strong effect of TNF, whereas there was no transcriptional change induced specifically by pRBC. Nevertheless, a global ANOVA and a two-way ANOVA suggested that pRBC acted in interaction with platelets and TNF to alter gene expression in HBEC. The expression of selected genes was validated by RT-qPCR. The analysis of gene functional annotation indicated that platelets induce the expression of genes involved in inflammation and apoptosis, such as genes involved in chemokine-, TREM1-, cytokine-, IL10-, TGF beta-, death-receptor-, and apoptosis-signaling. Overall, our results support the hypothesis that platelets play a pathogenic role in CM.	[Barbier, Mathieu; Camus, Claire; Rihet, Pascal] Aix Marseille Univ, Fac Pharm, IFR 48, Lab Pharmacogenet Malad Parasitaires,EA 864, Marseille, France; [Loriod, Beatrice; Textoris, Julien; Camus, Claire; Puthier, Denis; Victorero, Genevieve; Nguyen, Catherine; Rihet, Pascal] Aix Marseille Univ, INSERM U928, TAGC, IFR137, Marseille, France; [Faille, Dorothee; Fusai, Thierry] Inst Rech Biomed Armees Antenne Marseille, URMITE, IMTSSA, Unite Rech Biol & Epidemiol Parasitaires,UMR 6236, Marseille, France; [Faille, Dorothee; Alessi, Marie-Christine] Aix Marseille Univ, Fac Med, INSERM, UMR 626, Marseille, France; [Flori, Laurence] INRA AgroParisTech, Lab Genet Anim & Biol Integrat, Jouy En Josas, France; [Grau, Georges E.] Univ Sydney, Dept Pathol, Vasc Immunol Unit, Camperdown, NSW, Australia; [Wassmer, Samuel Crocodile] NYU, Sch Med, Dept Med Parasitol, New York, NY USA	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; INRAE; University of Sydney; New York University	Barbier, M (corresponding author), Aix Marseille Univ, Fac Pharm, IFR 48, Lab Pharmacogenet Malad Parasitaires,EA 864, Marseille, France.	rihet@tagc.univ-mrs.fr; rihet@tagc.univ-mrs.fr	ALESSI, Marie-christine/AAK-3582-2020; Rihet, Pascal/L-2173-2016; Rihet, Pascal/GQP-1381-2022; Grau, Georges/AGR-7139-2022; puthier, denis/AFV-1973-2022; Faille, Dorothée/AFO-5088-2022; Puthier, Denis/N-5018-2016; loriod, beatrice bl/L-2948-2016; Flori, Laurence/H-3683-2013; Textoris, Julien/H-3317-2019; Nguyen, Catherine/M-4119-2016; Rihet, Pascal/AAD-2018-2022; Wassmer, Samuel/F-8539-2018	ALESSI, Marie-christine/0000-0003-3927-5792; Rihet, Pascal/0000-0002-9459-3905; Rihet, Pascal/0000-0002-9459-3905; Grau, Georges/0000-0002-0442-0462; puthier, denis/0000-0002-7240-5280; Faille, Dorothée/0000-0003-4414-739X; loriod, beatrice bl/0000-0001-5801-2264; Textoris, Julien/0000-0002-3821-9337; Nguyen, Catherine/0000-0001-9376-6360; Rihet, Pascal/0000-0002-9459-3905; Barbier, Mathieu/0000-0002-5154-2163; Wassmer, Samuel/0000-0002-6753-3376	French Ministry of Research and Technology; INSERM; Aix-Marseille University; NHMRC; Australian Research Council; AL Kerr Bequest, Sydney Medical School	French Ministry of Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); AL Kerr Bequest, Sydney Medical School	MB was supported by a studentship from the French Ministry of Research and Technology. The study was supported by INSERM, by Aix-Marseille University, by NHMRC, by Australian Research Council and by the AL Kerr Bequest, Sydney Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715; Bertucci F, 2007, ANTICANCER RES, V27, P3441; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; CHAKRAVORTY SJ, 2007, INT J PARASITOL; Chen LC, 2008, EXP MOL PATHOL, V84, P145, DOI 10.1016/j.yexmp.2007.11.004; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; HEIDRICH HG, 1982, J PARASITOL, V68, P443, DOI 10.2307/3280956; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Lou JN, 1997, AM J PATHOL, V151, P1397; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Susomboon P, 2006, PARASITOL INT, V55, P107, DOI 10.1016/j.parint.2005.11.054; Talby L, 2006, LEUKEMIA RES, V30, P665, DOI 10.1016/j.leukres.2005.10.007; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Viebig NK, 2005, INFECT IMMUN, V73, P3271, DOI 10.1128/IAI.73.6.3271-3277.2005; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761; ZOELLNER H, 1993, THROMB HAEMOSTASIS, V69, P135	44	30	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19651	10.1371/journal.pone.0019651	http://dx.doi.org/10.1371/journal.pone.0019651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603600	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300016
J	Choe, CU; Lardong, K; Gelderblom, M; Ludewig, P; Leypoldt, F; Koch-Nolte, F; Gerloff, C; Magnus, T				Choe, Chi-un; Lardong, Kerstin; Gelderblom, Mathias; Ludewig, Peter; Leypoldt, Frank; Koch-Nolte, Friedrich; Gerloff, Christian; Magnus, Tim			CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; T-CELLS; EXPERIMENTAL STROKE; IMMUNE-RESPONSES; MESSENGER-RNA; EXPRESSION; CHEMOKINES; MICE; RAT; ACTIVATION	Background: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in ischemic stroke. Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophages and microglia. The bifunctional receptor and ectoenzyme CD38 synthesizes calcium-mobilizing second messengers (e.g., cyclic ADP-ribose), which have been shown to be necessary for activation and migration of myeloid immune cells. Therefore, we investigated the dynamics of CD38 in stroke and the impact of CD38-deficiency on cytokine production, inflammation and cerebral damage in a mouse model of cerebral ischemia-reperfusion. Methodology/Principal Findings: We show that the local expression of the chemokine MCP-1 was attenuated in CD38-deficient mice compared with wildtype mice after focal cerebral ischemia and reperfusion. In contrast, no significant induction of MCP-1 expression was observed in peripheral blood after 6 hours. Flow cytometry analysis revealed less infiltrating macrophages and lymphocytes in the ischemic hemisphere of CD38-deficient mice, whereas the amount of resident microglia was unaltered. An up-regulation of CD38 expression was observed in macrophages and CD8(+) cells after focal cerebral ischemia in wildtype mice, whereas CD38 expression was unchanged in microglia. Finally, we demonstrate that CD38-deficiency decreases the cerebral ischemic injury and the persistent neurological deficit after three days of reperfusion in this murine temporary middle cerebral artery occlusion (tMCAO) model. Conclusion/Significance: CD38 is differentially regulated following stroke and its deficiency attenuates the postischemic chemokine production, the immune cell infiltration and the cerebral injury after temporary ischemia and reperfusion. Therefore CD38 might prove a therapeutic target in ischemic stroke.	[Choe, Chi-un; Lardong, Kerstin; Gelderblom, Mathias; Ludewig, Peter; Leypoldt, Frank; Gerloff, Christian; Magnus, Tim] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Koch-Nolte, Friedrich] Univ Hosp Hamburg Eppendorf, Dept Immunol, Hamburg, Germany; [Ludewig, Peter] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Choe, CU (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	cchoe@uke.de; t.magnus@uke.de	Leypoldt, Frank/ABC-3186-2021	Gerloff, Christian/0000-0002-6484-8882; Koch-Nolte, Friedrich/0000-0003-1730-6674; Leypoldt, Frank/0000-0002-8972-515X	Universitatsklinik Hamburg-Eppendorf [NWF-09/02]; Werner-Otto-Foundation; Novartis Foundation; Deutsche Forschungsgemeinschaft [310/6-3]	Universitatsklinik Hamburg-Eppendorf; Werner-Otto-Foundation; Novartis Foundation(Novartis); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Forschungsforderungsfonds NWF-09/02 (C.-u.C.) of the Universitatsklinik Hamburg-Eppendorf, the Werner-Otto-Foundation (C.-u.C., T.M.), the Novartis Foundation (C.-u.C.) and the Deutsche Forschungsgemeinschaft (No 310/6-3 to F.K.-N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KJ, 2010, STROKE, V41, pS75, DOI 10.1161/STROKEAHA.110.592881; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Choe CU, 2009, J NEUROCHEM, V110, P1766, DOI 10.1111/j.1471-4159.2009.06266.x; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Losy J, 2001, STROKE, V32, P2695, DOI 10.1161/hs1101.097380; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; WANG XK, 1995, STROKE, V26, P661, DOI 10.1161/01.STR.26.4.661; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046	28	61	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19046	10.1371/journal.pone.0019046	http://dx.doi.org/10.1371/journal.pone.0019046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21625615	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500003
J	Dong, QF; Nelson, DE; Toh, E; Diao, LX; Gao, X; Fortenberry, JD; Van Der Pol, B				Dong, Qunfeng; Nelson, David E.; Toh, Evelyn; Diao, Lixia; Gao, Xiang; Fortenberry, J. Dennis; Van Der Pol, Barbara			The Microbial Communities in Male First Catch Urine Are Highly Similar to Those in Paired Urethral Swab Specimens	PLOS ONE			English	Article							NONGONOCOCCAL URETHRITIS; ASSOCIATION; INFECTION; CHLAMYDIA; VAGINALIS	Urine is the CDC-recommended specimen for STI testing. It was unknown if the bacterial communities (microbiomes) in urine reflected those in the distal male urethra. We compared microbiomes of 32 paired urine and urethral swab specimens obtained from adult men attending an STD clinic, by 16S rRNA PCR and deep pyrosequencing. Microbiomes of urine and swabs were remarkably similar, regardless of STI status of the subjects. Thus, urine can be used to characterize urethral microbiomes when swabs are undesirable, such as in population-based studies of the urethral microbiome or where multiple sampling of participants is required.	[Dong, Qunfeng; Gao, Xiang] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Nelson, David E.; Toh, Evelyn] Indiana Univ, Dept Biol, Bloomington, IN USA; [Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Dept Pediat, Sect Adolescent Med, Indianapolis, IN USA; [Van Der Pol, Barbara] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dong, QF (corresponding author), Univ N Texas, Dept Biol, Denton, TX 76203 USA.	nelsonde@indiana.edu; bvanderp@indiana.edu		Toh, Evelyn/0000-0003-2932-4060; Van Der Pol, Barbara/0000-0003-3064-8564	Indiana Clinical and Translational Sciences Institute; National Institutes of Health [1UH2DK083980-01, 1RC2HG005806-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083980] Funding Source: NIH RePORTER	Indiana Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Indiana Clinical and Translational Sciences Institute [to B.V. and D.E.N.] and National Institutes of Health [grant number 1UH2DK083980-01 to J.D.F. and 1RC2HG005806-01 to Q.D., D.E.N. and J.D.F.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Centers for Disease Control and Prevention, 2009, LAB DIAGN TEST CHLAM; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Riemersma WA, 2003, J CLIN MICROBIOL, V41, P1977, DOI 10.1128/JCM.41.5.1977-1986.2003; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Torok MR, 2007, J INFECT DIS, V196, P1102, DOI 10.1086/521307; Van Der Pol B, 2006, J CLIN MICROBIOL, V44, P366, DOI 10.1128/JCM.44.2.366-373.2006	14	116	123	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19709	10.1371/journal.pone.0019709	http://dx.doi.org/10.1371/journal.pone.0019709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603636	gold, Green Submitted, Green Published			2022-12-27	WOS:000290558500025
J	Engelmann, I; Griffon, A; Tichit, L; Montanana-Sanchis, F; Wang, GL; Reinke, V; Waterston, RH; Hillier, LW; Ewbank, JJ				Engelmann, Ilka; Griffon, Aurelien; Tichit, Laurent; Montanana-Sanchis, Frederic; Wang, Guilin; Reinke, Valerie; Waterston, Robert H.; Hillier, LaDeana W.; Ewbank, Jonathan J.			A Comprehensive Analysis of Gene Expression Changes Provoked by Bacterial and Fungal Infection in C. elegans	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE EXPRESSION; CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; RNA-SEQ; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; PROTEIN; EVOLUTION; WORMBASE; MODULATE	While Caenorhabditis elegans specifically responds to infection by the up-regulation of certain genes, distinct pathogens trigger the expression of a common set of genes. We applied new methods to conduct a comprehensive and comparative study of the transcriptional response of C. elegans to bacterial and fungal infection. Using tiling arrays and/or RNA-sequencing, we have characterized the genome-wide transcriptional changes that underlie the host's response to infection by three bacterial (Serratia marcescens, Enterococcus faecalis and otorhabdus luminescens) and two fungal pathogens (Drechmeria coniospora and Harposporium sp.). We developed a flexible tool, the WormBase Converter (available at http://wormbasemanager.sourceforge.net/), to allow cross-study comparisons. The new data sets provided more extensive lists of differentially regulated genes than previous studies. Annotation analysis confirmed that genes commonly up-regulated by bacterial infections are related to stress responses. We found substantial overlaps between the genes regulated upon intestinal infection by the bacterial pathogens and Harposporium, and between those regulated by Harposporium and D. coniospora, which infects the epidermis. Among the fungus-regulated genes, there was a significant bias towards genes that are evolving rapidly and potentially encode small proteins. The results obtained using new methods reveal that the response to infection in C. elegans is determined by the nature of the pathogen, the site of infection and the physiological imbalance provoked by infection. They form the basis for future functional dissection of innate immune signaling. Finally, we also propose alternative methods to identify differentially regulated genes that take into account the greater variability in lowly expressed genes.	[Engelmann, Ilka; Griffon, Aurelien; Montanana-Sanchis, Frederic; Ewbank, Jonathan J.] Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France; [Engelmann, Ilka; Griffon, Aurelien; Montanana-Sanchis, Frederic; Ewbank, Jonathan J.] INSERM, U631, F-13258 Marseille, France; [Engelmann, Ilka; Griffon, Aurelien; Montanana-Sanchis, Frederic; Ewbank, Jonathan J.] CNRS, UMR6102, Marseille, France; [Tichit, Laurent] Inst Math Luminy, Marseille, France; [Wang, Guilin; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Waterston, Robert H.; Hillier, LaDeana W.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Yale University; University of Washington; University of Washington Seattle	Engelmann, I (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France.	ewbank@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010	Ewbank, Jonathan J/0000-0002-1257-6862	CNRS; INSERM; ANR; European Community [FP7/2007-2013, PIEF-GA-2008-220008]; National Human Genome Research Institute in the National Institutes of Health (USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); European Community(European Commission); National Human Genome Research Institute in the National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded by institutional grants from the CNRS and INSERM and by the ANR FUNGENOMICS grant. IE received funding from the European Community's FP7/2007-2013 (grant agreement no PIEF-GA-2008-220008). LWH, VR and RWH were supported by funding from the modENCODE Project at the National Human Genome Research Institute in the National Institutes of Health (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Barron GL, 1977, NEMATODE DESTROYING, P1; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; DIJKSTERHUIS J, 1990, MYCOL RES, V94, P1, DOI 10.1016/S0953-7562(09)81257-4; Drace K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006741; Engelmann I, 2010, INVERTEBRATE IMMUNIT, P1; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kim D, 2008, DIS MODEL MECH, V1, P205, DOI 10.1242/dmm.000265; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Liu Tao, 2004, BMC Developmental Biology, V4; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Partridge FA, 2010, DEV DYN; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sleumer MC, 2009, NUCLEIC ACIDS RES, V37, P1323, DOI 10.1093/nar/gkn1041; Thomas JH, 2006, GENETICS, V172, P2269, DOI 10.1534/genetics.105.052746; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	51	118	119	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19055	10.1371/journal.pone.0019055	http://dx.doi.org/10.1371/journal.pone.0019055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602919	gold, Green Submitted, Green Published			2022-12-27	WOS:000290558500004
J	He, L; Whistler, JL				He, Li; Whistler, Jennifer L.			Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis	PLOS ONE			English	Article							ALCOHOL DEPENDENCE; MORPHINE-TOLERANCE; CROSS-TOLERANCE; SPINAL-CORD; INTRATHECAL MORPHINE; NUCLEUS-ACCUMBENS; BETA-ENDORPHIN; KNOCKOUT MICE; BRAIN; DESENSITIZATION	It is well known that the mu-opioid receptor (MOR) plays an important role in the rewarding properties of ethanol. However, it is less clear how chronic ethanol consumption affects MOR signaling. Here, we demonstrate that rats with prolonged voluntary ethanol consumption develop antinociceptive tolerance to opioids. Signaling through the MOR is controlled at many levels, including via the process of endocytosis. Importantly, agonists at the MOR that promote receptor endocytosis, such as the endogenous peptides enkephalin and beta-endorphin, show a reduced propensity to promote antinociceptive tolerance than do agonists, like morphine, which do not promote receptor endocytosis. These observations led us to examine whether chronic ethanol consumption produced opioid tolerance by interfering with MOR endocytosis. Indeed, here we show that chronic ethanol consumption inhibits the endocytosis of MOR in response to opioid peptide. This loss of endocytosis was accompanied by a dramatic decrease in G protein coupled receptor kinase 2 (GRK2) protein levels after chronic drinking, suggesting that loss of this component of the trafficking machinery could be a mechanism by which endocytosis is lost. We also found that MOR coupling to G-protein was decreased in ethanol-drinking rats, providing a functional explanation for loss of opioid antinociception. Together, these results suggest that chronic ethanol drinking alters the ability of MOR to endocytose in response to opioid peptides, and consequently, promotes tolerance to the effects of opioids.	[He, Li; Whistler, Jennifer L.] Univ Calif, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	He, L (corresponding author), Univ Calif, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	jwhistler@gallo.ucsf.edu			ABMRF; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco	ABMRF; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System)	This study was supported by an ABMRF grant (to L.H.) and by funds provided by the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco (to J.L.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2000, J PHARMACOL EXP THER, V295, P1012; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Anton RF, 2004, PSYCHOPHARMACOLOGY, V173, P32, DOI 10.1007/s00213-003-1720-7; Berger AC, 2010, ANN NEUROL, V67, P559, DOI 10.1002/ana.22002; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Campbell VC, 2007, ALCOHOL CLIN EXP RES, V31, P1435, DOI 10.1111/j.1530-0277.2007.00432.x; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; Chen F, 2000, J PHARMACOL EXP THER, V293, P159; deWaele JP, 1997, ALCOHOL CLIN EXP RES, V21, P754, DOI 10.1097/00000374-199706000-00031; DEWAELE JP, 1995, J PHARMACOL EXP THER, V275, P518; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Grecksch G, 2006, PSYCHOPHARMACOLOGY, V186, P177, DOI 10.1007/s00213-006-0365-8; Hall FS, 2001, PSYCHOPHARMACOLOGY, V154, P43, DOI 10.1007/s002130000622; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; He L, 2007, PHARMACOLOGY, V79, P193, DOI 10.1159/000100893; He L, 2009, J PAIN, V10, P369, DOI 10.1016/j.jpain.2008.09.011; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kamdar NK, 2007, PSYCHOPHARMACOLOGY, V192, P207, DOI 10.1007/s00213-007-0711-5; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Koch T, 2004, J NEUROCHEM, V88, P680, DOI 10.1046/j.1471-4159.2003.02189.x; Lam M, 2008, PSYCHOPHARMACOLOGY, V201, P261, DOI 10.1007/s00213-008-1267-8; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Maher CE, 2001, BRAIN RES, V895, P1, DOI 10.1016/S0006-8993(00)03093-6; Marinelli PW, 2003, PSYCHOPHARMACOLOGY, V169, P60, DOI 10.1007/s00213-003-1490-2; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Narita M, 2007, NEUROSCIENCE, V144, P777, DOI 10.1016/j.neuroscience.2006.10.028; Olive MF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0002.2001; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Paxinos G., 2005, STEREOTAXIC COORDINA, V7th; Riba P, 2002, J PHARMACOL EXP THER, V300, P265, DOI 10.1124/jpet.300.1.265; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Saland LC, 2004, ALCOHOL CLIN EXP RES, V28, P98, DOI 10.1097/01.ALC.0000108658.00243.BF; Sanchis-Segura C, 2005, ALCOHOL CLIN EXP RES, V29, P1522, DOI 10.1097/01.alc.0000174913.60384.e8; Shah S, 1997, ALCOHOL, V14, P361, DOI 10.1016/S0741-8329(96)00184-X; SIM LJ, 1995, P NATL ACAD SCI USA, V92, P7242, DOI 10.1073/pnas.92.16.7242; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2002, ALCOHOL CLIN EXP RES, V26, P688, DOI 10.1097/00000374-200205000-00014; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SOSNOWSKI M, 1990, ANESTHESIOLOGY, V73, P1141, DOI 10.1097/00000542-199012000-00012; Trafton JA, 2000, J NEUROSCI, V20, P8578; TSENG LF, 1993, EUR J PHARMACOL, V241, P63, DOI 10.1016/0014-2999(93)90933-9; Ueda H, 2001, J NEUROSCI, V21, P2967, DOI 10.1523/JNEUROSCI.21-09-02967.2001; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Walker EA, 2001, PSYCHOPHARMACOLOGY, V154, P131, DOI 10.1007/s002130000620; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	52	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19372	10.1371/journal.pone.0019372	http://dx.doi.org/10.1371/journal.pone.0019372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602922	gold, Green Published, Green Submitted			2022-12-27	WOS:000290558500008
J	Anderson, I; Scheuner, C; Goker, M; Mavromatis, K; Hooper, SD; Porat, I; Klenk, HP; Ivanova, N; Kyrpides, N				Anderson, Iain; Scheuner, Carmen; Goeker, Markus; Mavromatis, Kostas; Hooper, Sean D.; Porat, Iris; Klenk, Hans-Peter; Ivanova, Natalia; Kyrpides, Nikos			Novel Insights into the Diversity of Catabolic Metabolism from Ten Haloarchaeal Genomes	PLOS ONE			English	Article							ENTNER-DOUDOROFF PATHWAY; UNIVERSAL STRESS-PROTEIN; SP-NOV; GEN. NOV.; HALOQUADRATUM-WALSBYI; HALOPHILIC BACTERIUM; HALOFERAX-VOLCANII; SEQUENCE; HALOBACTERIUM; ARCHAEA	Background: The extremely halophilic archaea are present worldwide in saline environments and have important biotechnological applications. Ten complete genomes of haloarchaea are now available, providing an opportunity for comparative analysis. Methodology/Principal Findings: We report here the comparative analysis of five newly sequenced haloarchaeal genomes with five previously published ones. Whole genome trees based on protein sequences provide strong support for deep relationships between the ten organisms. Using a soft clustering approach, we identified 887 protein clusters present in all halophiles. Of these core clusters, 112 are not found in any other archaea and therefore constitute the haloarchaeal signature. Four of the halophiles were isolated from water, and four were isolated from soil or sediment. Although there are few habitat-specific clusters, the soil/sediment halophiles tend to have greater capacity for polysaccharide degradation, siderophore synthesis, and cell wall modification. Halorhabdus utahensis and Haloterrigena turkmenica encode over forty glycosyl hydrolases each, and may be capable of breaking down naturally occurring complex carbohydrates. H. utahensis is specialized for growth on carbohydrates and has few amino acid degradation pathways. It uses the non-oxidative pentose phosphate pathway instead of the oxidative pathway, giving it more flexibility in the metabolism of pentoses. Conclusions: These new genomes expand our understanding of haloarchaeal catabolic pathways, providing a basis for further experimental analysis, especially with regard to carbohydrate metabolism. Halophilic glycosyl hydrolases for use in biofuel production are more likely to be found in halophiles isolated from soil or sediment.	[Anderson, Iain; Mavromatis, Kostas; Hooper, Sean D.; Ivanova, Natalia; Kyrpides, Nikos] US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA; [Scheuner, Carmen; Goeker, Markus; Klenk, Hans-Peter] Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany; [Porat, Iris] INEOS Bio, Fayetteville, AR USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Anderson, I (corresponding author), US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Göker, Markus/AAX-6258-2021; Kyrpides, Nikos C./A-6305-2014	Göker, Markus/0000-0002-5144-6200; Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of the United States Department of Energy [DE-AC02-05CH112]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Science of the United States Department of Energy (http://www.er.doe.gov/) under Contract No. DE-AC02-05CH112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2009, STAND GENOMIC SCI, V1, P218, DOI 10.4056/sigs.31864; Baker RH, 1998, MOL PHYLOGENET EVOL, V9, P427, DOI 10.1006/mpev.1998.0519; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bardavid RE, 2008, EXTREMOPHILES, V12, P125, DOI 10.1007/s00792-007-0114-x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brewer ML, 2007, J CHEM INF MODEL, V47, P1727, DOI 10.1021/ci600565r; Bucknam J, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-26; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Dadi AP, 2006, BIOTECHNOL BIOENG, V95, P904, DOI 10.1002/bit.21047; DELEY J, 1957, J BIOL CHEM, V227, P745; Di Bonaventura MP, 2010, MOL PHYLOGENET EVOL, V54, P950, DOI 10.1016/j.ympev.2009.08.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; FRANZMANN PD, 1988, SYST APPL MICROBIOL, V11, P20, DOI 10.1016/S0723-2020(88)80044-4; Galtier N, 2007, SYSTEMATIC BIOL, V56, P633, DOI 10.1080/10635150701546231; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Grant W.D., 2001, BERGEYS MANUAL SYSTE, V2nd ed., P294; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Huang JL, 2005, MOL BIOL EVOL, V22, P2142, DOI 10.1093/molbev/msi221; Hugouvieux-Cotte-Pattat N, 2004, MOL MICROBIOL, V51, P1361, DOI 10.1046/j.1365-2958.2003.03908.x; Ihara K, 1997, INT J SYST BACTERIOL, V47, P73, DOI 10.1099/00207713-47-1-73; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Klenk HP, 2010, SYST APPL MICROBIOL, V33, P175, DOI 10.1016/j.syapm.2010.03.003; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIENAU EK, 2009, CLADISTICS, V25, P1; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; Montalvo-Rodriguez R, 1998, INT J SYST BACTERIOL, V48, P1305, DOI 10.1099/00207713-48-4-1305; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OREN A, 1990, INT J SYST BACTERIOL, V40, P209, DOI 10.1099/00207713-40-2-209; OREN A, 1994, FEMS MICROBIOL REV, V13, P415, DOI 10.1111/j.1574-6976.1994.tb00060.x; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; PORTALIER R, 1980, J BACTERIOL, V143, P1095, DOI 10.1128/JB.143.3.1095-1107.1980; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Purdy KJ, 2004, ENVIRON MICROBIOL, V6, P591, DOI 10.1111/j.1462-2920.2004.00592.x; RANGASWAMY V, 1994, J BACTERIOL, V176, P5505, DOI 10.1128/JB.176.17.5505-5512.1994; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sarkar IN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-103; Saunders E, 2010, STAND GENOMIC SCI, V2, P107, DOI 10.4056/sigs.681272; Savage KN, 2007, INT J SYST EVOL MICR, V57, P19, DOI 10.1099/ijs.0.64464-0; Schroder I, 2004, J BACTERIOL, V186, P7680, DOI 10.1128/JB.186.22.7680-7689.2004; Schweikhard ES, 2010, BIOCHEMISTRY-US, V49, P2194, DOI 10.1021/bi9017522; Sisignano M, 2010, MICROBIOL-SGM, V156, P521, DOI 10.1099/mic.0.033449-0; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanaka T, 2004, J BIOL CHEM, V279, P30021, DOI 10.1074/jbc.M314187200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Tsujibo H, 1998, APPL ENVIRON MICROB, V64, P2920; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zvyagintseva IS, 1987, MIKROBIOLOGIYA, V56, P839	90	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20237	10.1371/journal.pone.0020237	http://dx.doi.org/10.1371/journal.pone.0020237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633497	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500046
J	Armstrong, PC; Kirkby, NS; Zain, ZN; Emerson, M; Mitchell, JA; Warner, TD				Armstrong, Paul C.; Kirkby, Nicholas S.; Zain, Zetty N.; Emerson, Michael; Mitchell, Jane A.; Warner, Timothy D.			Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the Mouse	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; CYCLOOXYGENASE SELECTIVITY; GASTROINTESTINAL TOXICITY; PROSTANOID FORMATION; RANDOMIZED-TRIALS; AGGREGATION; ATHEROTHROMBOSIS; PROSTACYCLIN; VIVO	Background: Clinical use of selective inhibitors of cyclooxygenase (COX)-2 appears associated with increased risk of thrombotic events. This is often hypothesised to reflect reduction in anti-thrombotic prostanoids, notably PGI2, formed by COX-2 present within endothelial cells. However, whether COX-2 is actually expressed to any significant extent within endothelial cells is controversial. Here we have tested the effects of acute inhibition of COX on platelet reactivity using a functional in vivo approach in mice. Methodology/Principal Findings: A non-lethal model of platelet-driven thromboembolism in the mouse was used to assess the effects of aspirin (7 days orally as control) diclofenac (1 mg.kg(-1), i.v.) and parecoxib (0.5 mg.kg(-1), i.v.) on thrombus formation induced by collagen or the thromboxane (TX) A(2)-mimetic, U46619. The COX inhibitory profiles of the drugs were confirmed in mouse tissues ex vivo. Collagen and U46619 caused in vivo thrombus formation with the former, but not latter, sensitive to oral dosing with aspirin. Diclofenac inhibited COX-1 and COX-2 ex vivo and reduced thrombus formation in response to collagen, but not U46619. Parecoxib inhibited only COX-2 and had no effect upon thrombus formation caused by either agonist. Conclusions/Significance: Inhibition of COX-1 by diclofenac or aspirin reduced thrombus formation induced by collagen, which is partly dependent upon platelet-derived TXA(2), but not that induced by U46619, which is independent of platelet TXA(2). These results are consistent with the model demonstrating the effects of COX-1 inhibition in platelets, but provide no support for the hypothesis that acute inhibition of COX-2 in the circulation increases thrombosis.	[Armstrong, Paul C.; Kirkby, Nicholas S.; Zain, Zetty N.; Warner, Timothy D.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Emerson, Michael] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Platelet Biol Grp, London, England	University of London; Queen Mary University London; Imperial College London	Armstrong, PC (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.	t.d.warner@qmul.ac.uk	Armstrong, Paul/Z-1408-2019; Warner, Timothy D/A-1980-2009	Warner, Timothy D/0000-0003-3988-4408; MOHD ZAIN, ZETTY NADIA/0000-0002-6299-7796; Armstrong, Paul/0000-0003-0904-677X; Kirkby, Nicholas/0000-0003-3509-8549	European Community [LSHM-CT-2004-0050333]; British Heart Foundation [PG/07/098/23757]; Wellcome Trust [085255/Z/08/Z]; National Institute of Health Research	European Community(European Commission); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR))	This research was supported by European Community FP6 funding ("Eicosanox"; LSHM-CT-2004-0050333), the British Heart Foundation (PG/07/098/23757) and the Wellcome Trust (085255/Z/08/Z). This publication reflects only the authors' views. The European Community is not liable for any use that may be made of information herein. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Armstrong PCJ, 2008, J THROMB HAEMOST, V6, P1933, DOI 10.1111/j.1538-7836.2008.03133.x; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; CRONBERG S, 1984, SCAND J HAEMATOL, V33, P155; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Giuliano F, 1999, BRIT J PHARMACOL, V126, P1824, DOI 10.1038/sj.bjp.0702518; Giuliano F, 2001, EUR J PHARMACOL, V426, P95, DOI 10.1016/S0014-2999(01)01207-9; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; GRYGLEWSKI RJ, 1978, NATURE, V273, P765, DOI 10.1038/273765a0; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jennings LK, 2009, AM J CARDIOL, V103, p4A, DOI 10.1016/j.amjcard.2008.11.017; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KRISHNAMURTHI S, 1984, BIOCHEM PHARMACOL, V33, P3025, DOI 10.1016/0006-2952(84)90604-X; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MONCADA S, 1978, NATURE, V273, P767, DOI 10.1038/273767a0; Moore C, 2010, THROMB HAEMOSTASIS, V104, P342, DOI 10.1160/TH09-11-0764; Niemi TT, 1997, ACTA ANAESTH SCAND, V41, P1353, DOI 10.1111/j.1399-6576.1997.tb04657.x; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Patrono C, 2009, MOL INTERV, V9, P31, DOI 10.1124/mi.9.1.8; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Talley JJ, 2000, J MED CHEM, V43, P1661, DOI 10.1021/jm000069h; Tymvios C, 2008, THROMB HAEMOSTASIS, V99, P435, DOI 10.1160/TH07-07-0479; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; White WB, 2007, HYPERTENSION, V49, P408, DOI 10.1161/01.HYP.0000258106.74139.25; WHITTLE BJR, 1980, PROSTAGLANDINS, V19, P605, DOI 10.1016/S0090-6980(80)80010-4; Zidar N, 2008, J CELL MOL MED	37	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20062	10.1371/journal.pone.0020062	http://dx.doi.org/10.1371/journal.pone.0020062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629780	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200030
J	Kaschner, K; Tittensor, DP; Ready, J; Gerrodette, T; Worm, B				Kaschner, Kristin; Tittensor, Derek P.; Ready, Jonathan; Gerrodette, Tim; Worm, Boris			Current and Future Patterns of Global Marine Mammal Biodiversity	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT SELECTION; SPECIES-DIVERSITY; CETACEAN HABITATS; RIGHT WHALE; CONSERVATION; ECOSYSTEM; IMPACTS; MODELS; OCEAN	Quantifying the spatial distribution of taxa is an important prerequisite for the preservation of biodiversity, and can provide a baseline against which to measure the impacts of climate change. Here we analyse patterns of marine mammal species richness based on predictions of global distributional ranges for 115 species, including all extant pinnipeds and cetaceans. We used an environmental suitability model specifically designed to address the paucity of distributional data for many marine mammal species. We generated richness patterns by overlaying predicted distributions for all species; these were then validated against sightings data from dedicated long-term surveys in the Eastern Tropical Pacific, the Northeast Atlantic and the Southern Ocean. Model outputs correlated well with empirically observed patterns of biodiversity in all three survey regions. Marine mammal richness was predicted to be highest in temperate waters of both hemispheres with distinct hotspots around New Zealand, Japan, Baja California, the Galapagos Islands, the Southeast Pacific, and the Southern Ocean. We then applied our model to explore potential changes in biodiversity under future perturbations of environmental conditions. Forward projections of biodiversity using an intermediate Intergovernmental Panel for Climate Change (IPCC) temperature scenario predicted that projected ocean warming and changes in sea ice cover until 2050 may have moderate effects on the spatial patterns of marine mammal richness. Increases in cetacean richness were predicted above 40 degrees latitude in both hemispheres, while decreases in both pinniped and cetacean richness were expected at lower latitudes. Our results show how species distribution models can be applied to explore broad patterns of marine biodiversity worldwide for taxa for which limited distributional data are available.	[Kaschner, Kristin] Univ Freiburg, Inst Zool, Evolutionary Biol & Ecol Lab, Freiburg, Germany; [Tittensor, Derek P.; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Ready, Jonathan] Fed Univ Para, Inst Estuarine & Coastal Studies, Braganca, Para, Brazil; [Gerrodette, Tim] Natl Marine Fisheries Serv, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA	University of Freiburg; Dalhousie University; Universidade Federal do Para; National Oceanic Atmospheric Admin (NOAA) - USA	Kaschner, K (corresponding author), Univ Freiburg, Inst Zool, Evolutionary Biol & Ecol Lab, Freiburg, Germany.	Kristin.Kaschner@biologie.uni-freiburg.de	Ready, Jonathan S/J-2964-2012; Kaschner, Kristin/GQQ-6475-2022; Tittensor, Derek P./AAV-1117-2021	Ready, Jonathan S/0000-0002-9374-8661; Tittensor, Derek P./0000-0002-9550-3123; Worm, Boris/0000-0002-5742-8716; Kaschner, Kristin/0000-0002-4061-626X	Sloan Foundation; Future Oceans Cluster Project [D 1067/88]; IFM-Geomar Kiel	Sloan Foundation(Alfred P. Sloan Foundation); Future Oceans Cluster Project; IFM-Geomar Kiel	This research was supported by the Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations Project). Partial funding for the main author was provided through the Future Oceans Cluster Project D 1067/88 "Winners and Losers in the Future Oceans'' project, IFM-Geomar Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; AU DWK, 1985, FISH B-NOAA, V83, P623; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; Bivand R., 2009, SPDEP SPATIAL DEPEND; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cotte C, 2007, DEEP-SEA RES PT I, V54, P243, DOI 10.1016/j.dsr.2006.11.001; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Grech A, 2008, CONSERV BIOL, V22, P711, DOI 10.1111/j.1523-1739.2008.00923.x; Greene CH, 2004, FRONT ECOL ENVIRON, V2, P29, DOI 10.1890/1540-9295(2004)002[0029:CATCBO]2.0.CO;2; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; HOYT E, 2005, MARINE PROTECTED ARE, P492; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; *IWC, 2001, IDCR DESS SOWER SURV; JUNGHAUS J, 2006, IPCCAR4 WORLD DAT CT; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K., 2007, SEAMOUNTS ECOLOGY FI, P230; Kaschner K, 2004, MODELLING MAPPING RE; Kaschner K., 2008, AQUAMAPS PREDICTED R; KATONA S, 1988, OCEANOGR MAR BIOL, V26, P553; KINZEY D, 2000, LJ0008 NOAA NMFS SWF; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Krafft BA, 2006, ICES J MAR SCI, V63, P1136, DOI 10.1016/j.icesjms.2006.04.001; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Lunn NJ, 1997, CAN J FISH AQUAT SCI, V54, P914, DOI 10.1139/cjfas-54-4-914; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moore SE, 2000, ARCTIC, V53, P432; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moore Sue E., 1997, Journal of Northwest Atlantic Fishery Science, V22, P55; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; *NAMMCO, 2001, N ATL SIGHT SURV NAS; Nicol S, 2008, MAR FRESHWATER RES, V59, P361, DOI 10.1071/MF07161; *NOAA NODC, 1998, WORLD OC ATL 1998; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; PAYNE PM, 1993, BIOL NO HEMISPHERE P, P51; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; READ J, OBIS SEAMAP MAPPING; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; RIBIC CA, 1991, ANTARCT SCI, V3, P181, DOI 10.1017/S0954102091000214; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P1; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanjit L, 2005, J BIOSCIENCES, V30, P557, DOI 10.1007/BF02703552; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Team RDC, 2009, R LANG ENV STAT COMP; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2; Zacharias Mark A., 2006, Journal of Cetacean Research and Management, V8, P1	76	141	144	5	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19653	10.1371/journal.pone.0019653	http://dx.doi.org/10.1371/journal.pone.0019653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625431	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200008
J	Matz, C; Nouri, B; McCarter, L; Martinez-Urtaza, J				Matz, Carsten; Nouri, Bianka; McCarter, Linda; Martinez-Urtaza, Jaime			Acquired Type III Secretion System Determines Environmental Fitness of Epidemic Vibrio parahaemolyticus in the Interaction with Bacterivorous Protists	PLOS ONE			English	Article							ACANTHAMOEBA-CASTELLANII; INFECTIOUS-DISEASE; GENOMIC ISLANDS; COASTAL WATERS; CHESAPEAKE BAY; CHOLERAE; O3-K6; STRAINS; PATHOGENICITY; EMERGENCE	Genome analyses of marine microbial communities have revealed the widespread occurrence of genomic islands (GIs), many of which encode for protein secretion machineries described in the context of bacteria-eukaryote interactions. Yet experimental support for the specific roles of such GIs in aquatic community interactions remains scarce. Here, we test for the contribution of type III secretion systems (T3SS) to the environmental fitness of epidemic Vibrio parahaemolyticus. Comparisons of V. parahaemolyticus wild types and T3SS-defective mutants demonstrate that the T3SS encoded on genome island VPaI-7 (T3SS-2) promotes survival of V. parahaemolyticus in the interaction with diverse protist taxa. Enhanced persistence was found to be due to T3SS-2 mediated cytotoxicity and facultative parasitism of V. parahaemolyticus on coexisting protists. Growth in the presence of bacterivorous protists and the T3SS-2 genotype showed a strong correlation across environmental and clinical isolates of V. parahaemolyticus. Short-term microcosm experiments provide evidence that protistan hosts facilitate the invasion of T3SS-2 positive V. parahaemolyticus into a coastal plankton community, and that water temperature and productivity further promote enhanced survival of T3SS-2 positive V. parahaemolyticus. This study is the first to describe the fitness advantage of GI-encoded functions in a microbial food web, which may provide a mechanistic explanation for the global spread and the seasonal dynamics of V. parahaemolyticus pathotypes, including the pandemic serotype cluster O3:K6, in aquatic environments.	[Matz, Carsten; Nouri, Bianka] Helmholtz Ctr Infect Res, Braunschweig, Germany; [McCarter, Linda] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Martinez-Urtaza, Jaime] Univ Santiago de Compostela, Inst Acuicultura, Santiago De Compostela, Spain	Helmholtz Association; Helmholtz-Center for Infection Research; University of Iowa; Universidade de Santiago de Compostela	Matz, C (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	jaime.martinez.urtaza@usc.es	Martinez-Urtaza, Jaime/A-5528-2015; Martinez-Urtaza, Jaime/ABG-5429-2020	Martinez-Urtaza, Jaime/0000-0001-6219-0418	University of Iowa Carver College of Medicine Initiative; German Science Foundation (DFG) [Ma 2491/4-1]; Spanish Ministry of Science and Innovation [CGL2009-10488]	University of Iowa Carver College of Medicine Initiative; German Science Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Work supporting the construction of the T3SS-2 mutants in LM5674 was supported by The University of Iowa Carver College of Medicine Initiative Grant (to Linda McCarter). This work was supported by the German Science Foundation (DFG) grant Ma 2491/4-1 (to Carsten Matz) and by the Spanish Ministry of Science and Innovation grant CGL2009-10488 (to Jaime Martinez-Urtaza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers U, 2005, MICROBIOL-SGM, V151, P167, DOI 10.1099/mic.0.27563-0; Baffone W, 2006, ENVIRON MICROBIOL, V8, P1299, DOI 10.1111/j.1462-2920.2006.01011.x; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Boyd EF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-110; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Cabello FC, 2007, EMERG INFECT DIS, V13, P655, DOI 10.3201/eid1304.06-1152; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Han HH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-570; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Jaques S, 2006, J BACTERIOL, V188, P2625, DOI 10.1128/JB.188.7.2625-2635.2006; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Laskowski-Arce MA, 2008, APPL ENVIRON MICROB, V74, P7183, DOI 10.1128/AEM.01332-08; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Martinez-Urtaza J, 2008, EPIDEMIOLOGY, V19, P829, DOI 10.1097/EDE.0b013e3181883d43; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2001, APPL ENVIRON MICROB, V67, P814, DOI 10.1128/AEM.67.2.814-820.2001; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; McCarter Linda, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P51; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Meador CE, 2007, J CLIN MICROBIOL, V45, P1133, DOI 10.1128/JCM.00042-07; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mourino-Perez RR, 2003, APPL ENVIRON MICROB, V69, P6923, DOI 10.1128/AEM.69.11.6923-6931.2003; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Okuda Jun, 1997, Journal of Clinical Microbiology, V35, P3150; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Rodriguez-Castro A, 2010, ENV MICROBIOL REP, V2, P58, DOI 10.1111/j.1758-2229.2009.00064.x; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x; Worden AZ, 2006, ENVIRON MICROBIOL, V8, P21, DOI 10.1111/j.1462-2920.2005.00863.x; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	61	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20275	10.1371/journal.pone.0020275	http://dx.doi.org/10.1371/journal.pone.0020275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629787	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200047
J	Oakland, M; Jeon, B; Sahin, O; Shen, ZQ; Zhang, QJ				Oakland, Mayumi; Jeon, Byeonghwa; Sahin, Orhan; Shen, Zhangqi; Zhang, Qijing			Functional Characterization of a Lipoprotein-Encoding Operon in Campylobacter jejuni	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; STREPTOCOCCUS-MUTANS; EPITHELIAL-CELLS; GENOME SEQUENCE; BINDING PROTEIN; CLONING VECTORS; CMER FUNCTIONS; EFFLUX PUMP; COLONIZATION; ADHERENCE	Background: Bacterial lipoproteins have important functions in bacterial pathogenesis and physiology. In Campylobacter jejuni, a major foodborne pathogen causing gastroenteritis in humans, the majority of lipoproteins have not been functionally characterized. Previously, we showed by DNA microarray that CmeR, a transcriptional regulator repressing the expression of the multidrug efflux pump CmeABC, modulates the expression of a three-gene operon (cj0089, cj0090, and cj0091) encoding a cluster of lipoproteins in C. jejuni. Methodology/Principal Findings: In this work, we characterized the function and regulation of the cj0089-cj0090-cj0091 operon. In contrast to the repression of cmeABC, CmeR activates the expression of the lipoprotein genes and the regulation is confirmed by immunoblotting using anti-Cj0089 and anti-Cj0091 antibodies. Gel mobility shift assay showed that CmeR directly binds to the promoter of the lipoprotein operon, but the binding is much weaker compared with the promoter of cmeABC. Analysis of different cellular fractions indicated that Cj0089 was associated with the inner membrane, while Cj0091 was located on the outer membrane. Inactivation of cj0091, but not cj0089, significantly reduced the adherence of C. jejuni to INT 407 cells in vitro, indicating that Cj0091 has a function in adherence. When inoculated into chickens, the Cj0091 mutant also showed a defect in early colonization of the intestinal tract, suggesting that Cj0091 contributes to Campylobacter colonization in vivo. It was also shown that Cj0091 was produced and immunogenic in chickens that were naturally infected by C. jejuni. Conclusion/Significance: These results indicate that the lipoprotein operon is subject to direct regulation by CmeR and that Cj0091 functions as an adhesion mechanism in C. jejuni and contributes to Campylobacter colonization of the intestinal tract in animal hosts.	[Oakland, Mayumi; Jeon, Byeonghwa; Sahin, Orhan; Shen, Zhangqi; Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA	Iowa State University	Oakland, M (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	zhang123@iastate.edu	Zhang, Qijing/B-7530-2012; Jeon, Byeonghwa/AAB-6806-2020; Shen, Zhangqi/HCI-5736-2022	Jeon, Byeonghwa/0000-0002-6665-5558; Shen, Zhangqi/0000-0003-4789-7540; Sahin, Orhan/0000-0003-0262-4581	United States Department of Agriculture National Research Initiative [RO1DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (www.nih.gov/) grant RO1DK063008 and the Food Safety Research and Response Network (http://www.fsrrn.net/), funded by the United States Department of Agriculture National Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Amako K, 1997, MICROBIOL IMMUNOL, V41, P855, DOI 10.1111/j.1348-0421.1997.tb01940.x; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032; BABAKHANI FK, 1993, INFECT IMMUN, V61, P3466, DOI 10.1128/IAI.61.8.3466-3475.1993; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOLLA JM, 1995, J BACTERIOL, V177, P4266, DOI 10.1128/jb.177.15.4266-4271.1995; CALDWELL MB, 1983, INFECT IMMUN, V42, P1176, DOI 10.1128/IAI.42.3.1176-1182.1983; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Clench MH, 1999, J EXP ZOOL, V283, P441, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;441::AID-JEZ13&gt;3.0.CO;2-8; De E, 2000, FEBS LETT, V469, P93, DOI 10.1016/S0014-5793(00)01244-8; DOUGLAS CWI, 1984, FEMS MICROBIOL LETT, V25, P211; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; FORESTER H, 1983, J GEN MICROBIOL, V129, P2779; Friedman C.R., 2000, CAMPYLOBACTER, P121; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Hu L, 2000, CAMPYLOBACTER, V2nd, P191; HUYER M, 1986, FEMS MICROBIOL LETT, V37, P247, DOI 10.1111/j.1574-6968.1986.tb01803.x; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; JHUANG J, 1997, EUR J BIOCHEM, V224, P575; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Luo N, 2003, ANTIMICROB AGENTS CH, V47, P390, DOI 10.1128/AAC.47.1.390-394.2003; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Petersen L, 2003, J MOL BIOL, V326, P1361, DOI 10.1016/S0022-2836(03)00034-2; Pickett C.L., 2000, CAMPYLOBACTER, P179; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL RG, 1993, J INFECT DIS, V168, P210, DOI 10.1093/infdis/168.1.210; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Vandamme P., 2000, CAMPYLOBACTER, P3; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wosten MMSM, 1998, J BACTERIOL, V180, P594; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	58	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20084	10.1371/journal.pone.0020084	http://dx.doi.org/10.1371/journal.pone.0020084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625391	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200032
J	Ramsgaard, L; Englert, JM; Manni, ML; Milutinovic, PS; Gefter, J; Tobolewski, J; Crum, L; Coudriet, GM; Piganelli, J; Zamora, R; Vodovotz, Y; Enghild, JJ; Oury, TD				Ramsgaard, Lasse; Englert, Judson M.; Manni, Michelle L.; Milutinovic, Pavle S.; Gefter, Julia; Tobolewski, Jacob; Crum, Lauren; Coudriet, Gina M.; Piganelli, Jon; Zamora, Ruben; Vodovotz, Yoram; Enghild, Jan J.; Oury, Tim D.			Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; MOBILITY GROUP BOX-1; PULMONARY-FIBROSIS; NEURITE OUTGROWTH; SOLUBLE RECEPTOR; CELL-SURFACE; HOST-DEFENSE; RAGE; PROTEIN	Background: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. Methodology/Principal Findings: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. Conclusions/Significance: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation.	[Ramsgaard, Lasse; Englert, Judson M.; Manni, Michelle L.; Milutinovic, Pavle S.; Gefter, Julia; Tobolewski, Jacob; Crum, Lauren; Coudriet, Gina M.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Piganelli, Jon] Childrens Hosp Pittsburgh, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; [Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Remodeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Aarhus University	Ramsgaard, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu		Enghild, Jan Johannes/0000-0001-9292-9172	NIH [R21ES013986, F30ES016973, R33-HL-089082]; Lundbeck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295, R33HL089082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013986, F30ES016973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH R21ES013986 to Tim D. Oury; NIH F30ES016973 to Judson M. Englert; NIH R33-HL-089082, The Lundbeck Foundation grant to Lasse Ramsgaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Blackwell TS, 1999, AM J RESP CRIT CARE, V159, P1644, DOI 10.1164/ajrccm.159.5.9806166; BRETT J, 1993, AM J PATHOL, V143, P1699; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; ENGLERT JM, 2011, INT J CLIN EXP PATHO, V4; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Feng YK, 2008, EXP MOL PATHOL, V85, P214, DOI 10.1016/j.yexmp.2008.09.002; FREEMAN B A, 1984, Environmental Health Perspectives, V56, P51, DOI 10.2307/3429835; Gefter JV, 2009, CELL TISSUE RES, V337, P79, DOI 10.1007/s00441-009-0791-0; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu R, 2009, ACTA MED OKAYAMA, V63, P203; Lizotte PP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-15; LONGMUIR IS, 1960, BIOCHEM J, V76, P225, DOI 10.1042/bj0760225; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Pachydaki SI, 2006, EXP EYE RES, V82, P807, DOI 10.1016/j.exer.2005.09.022; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Ramsgaard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009604; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; SU X, 2009, AM J PHYSL LUNG CELL; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	49	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20132	10.1371/journal.pone.0020132	http://dx.doi.org/10.1371/journal.pone.0020132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629785	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200037
J	Shaheen, FS; Znojek, P; Fisher, A; Webster, M; Plummer, R; Gaughan, L; Smith, GCM; Leung, HY; Curtin, NJ; Robson, CN				Shaheen, Fadhel S.; Znojek, Pawel; Fisher, Ann; Webster, Martin; Plummer, Ruth; Gaughan, Luke; Smith, Graeme C. M.; Leung, Hing Y.; Curtin, Nicola J.; Robson, Craig N.			Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer	PLOS ONE			English	Article							CELL-CYCLE; ATM; GAMMA-H2AX; MECHANISMS; INHIBITOR; RADIATION; PATHWAYS	Regardless of the achievable remissions with first line hormone therapy in patients with prostate cancer (CaP), the disease escapes the hormone dependent stage to a more aggressive status where chemotherapy is the only effective treatment and no treatment is curative. This makes it very important to identify new targets that can improve the outcome of treatment. ATM and DNA-PK are the two kinases responsible for signalling and repairing double strand breaks (DSB). Thus, both kinases are pertinent targets in CaP treatment to enhance the activity of the numerous DNA DSB inducing agents used in CaP treatment such as ionizing radiation (IR). Colony formation assay was used to assess the sensitivity of hormone dependent, p53 wt (LNCaP) and hormone independent p53 mutant (PC3) CaP cell lines to the cytotoxic effect of IR and Doxorubicin in the presence or absence of Ku55933 and NU7441 which are small molecule inhibitors of ATM and DNA-PK, respectively. Flow cytometry based methods were used to assess the effect of the two inhibitors on cell cycle, apoptosis and H2AX foci formation. Neutral comet assay was used to assess the induction of DNA DSBs. Ku55933 or NU7441 alone increased the sensitivity of CaP cell lines to the DNA damaging agents, however combining both inhibitors together resulted in further enhancement of sensitivity. The cell cycle profile of both cell lines was altered with increased cell death, DNA DSBs and H2AX foci formation. This study justifies further evaluation of the ATM and DNA-PK inhibitors for clinical application in CaP patients. Additionally, the augmented effect resulting from combining both inhibitors may have a significant implication for the treatment of CaP patients who have a defect in one of the two DSB repair pathways.	[Shaheen, Fadhel S.; Znojek, Pawel; Fisher, Ann; Webster, Martin; Plummer, Ruth; Gaughan, Luke; Curtin, Nicola J.; Robson, Craig N.] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, Graeme C. M.] KuDOS Pharmaceut Ltd, Cambridge, England; [Leung, Hing Y.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Newcastle University - UK; AstraZeneca; Beatson Institute	Shaheen, FS (corresponding author), Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	C.N.Robson@ncl.ac.uk		Leung, Hing Y./0000-0002-3933-3975; Curtin, Nicola/0000-0003-1369-1843	Aga Khan Foundation; CRUK, CancerResearchUK.org; MRC; AICR; MRC [G0900871, G0800889] Funding Source: UKRI; Cancer Research UK [15151] Funding Source: researchfish; Medical Research Council [G0900871, G0800889] Funding Source: researchfish	Aga Khan Foundation; CRUK, CancerResearchUK.org(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Aga Khan Foundation, www.akdn.org/AKF, CRUK, CancerResearchUK.org, MRC, www.mrc.ac.uk, and AICR, www.aicr.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Collis SJ, 2003, CANCER RES, V63, P1550; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Melia J, 2005, BJU INT, V95, P1; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	22	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20311	10.1371/journal.pone.0020311	http://dx.doi.org/10.1371/journal.pone.0020311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629734	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000291005200052
J	Aviello, G; Canadanovic-Brunet, JM; Milic, N; Capasso, R; Fattorusso, E; Taglialatela-Scafati, O; Fasolino, I; Izzo, AA; Borrelli, F				Aviello, Gabriella; Canadanovic-Brunet, Jasna M.; Milic, Natasa; Capasso, Raffaele; Fattorusso, Ernesto; Taglialatela-Scafati, Orazio; Fasolino, Ines; Izzo, Angelo A.; Borrelli, Francesca			Potent Antioxidant and Genoprotective Effects of Boeravinone G, a Rotenoid Isolated from Boerhaavia diffusa	PLOS ONE			English	Article							OXYGEN-FREE-RADICALS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; GASTROINTESTINAL-TRACT; HYDROGEN-PEROXIDE; BOERHAVIA-DIFFUSA; GLUTATHIONE; ISCHEMIA; DAMAGE; ASSAY	Background and Aims: Free radicals are implicated in the aetiology of some gastrointestinal disorders such as gastric ulcer, colorectal cancer and inflammatory bowel disease. In the present study we investigated the antioxidant and genoprotective activity of some rotenoids (i.e. boeravinones) isolated from the roots of Boerhaavia diffusa, a plant used in the Ayurvedic medicine for the treatment of diseases affecting the gastrointestinal tract. Methods/Principal Findings: Antioxidant activity has been evaluated using both chemical (Electron Spin Resonance spectroscopy, ESR) and Caco-2 cells-based (TBARS and ROS) assays. DNA damage was evaluated by Comet assay, while pERK(1/2) and phospho-NF-kB p65 levels were estimated by western blot. Boeravinones G, D and H significantly reduced the signal intensity of ESR induced by hydroxyl radicals, suggesting a scavenging activity. Among rotenoids tested, boeravinone G exerted the most potent effect. Boeravinone G inhibited both TBARS and ROS formation induced by Fenton's reagent, increased SOD activity and reduced H2O2-induced DNA damage. Finally, boeravinone G reduced the levels of pERK(1) and phospho-NF-kB p65 (but not of pERK(2)) increased by Fenton's reagent. Conclusions: It is concluded that boeravinone G exhibits an extraordinary potent antioxidant activity (significant effect in the nanomolar range). The MAP kinase and NF-kB pathways seem to be involved in the antioxidant effect of boeravinone G. Boeravinone G might be considered as lead compound for the development of drugs potentially useful against those pathologies whose aetiology is related to ROS-mediated injuries.	[Aviello, Gabriella; Milic, Natasa; Capasso, Raffaele; Fasolino, Ines; Izzo, Angelo A.; Borrelli, Francesca] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Canadanovic-Brunet, Jasna M.] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia; [Fattorusso, Ernesto; Taglialatela-Scafati, Orazio] Univ Naples Federico II, Dept Nat Prod Chem, Naples, Italy	University of Naples Federico II; University of Novi Sad; University of Naples Federico II	Aviello, G (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	franborr@unina.it	Borrelli, Francesca/AAC-6715-2022	Izzo, Angelo/0000-0002-8557-2133; Borrelli, Francesca/0000-0002-2695-3294; Capasso, Raffaele/0000-0002-3335-1822	Enrico ed Enrica Sovena Foundation	Enrico ed Enrica Sovena Foundation	This work was supported by the Enrico ed Enrica Sovena Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2004, J ENVIRON BIOL, V25, P307; Ahmed-Belkacem A, 2007, J MED CHEM, V50, P1933, DOI 10.1021/jm061450q; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anderson D, 1999, FOOD CHEM TOXICOL, V37, P1015, DOI 10.1016/S0278-6915(99)00089-7; Aviello G, 2010, J CELL MOL MED, V14, P2006, DOI 10.1111/j.1582-4934.2009.00815.x; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Borrelli F, 2005, PLANTA MED, V71, P928, DOI 10.1055/s-2005-871282; Borrelli F, 2006, J NAT PROD, V69, P903, DOI 10.1021/np060073h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canadanovic-Brunet JM, 2005, J SCI FOOD AGR, V85, P265, DOI 10.1002/jsfa.1950; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; CROMBIE L, 1992, BIOORG MED CHEM LETT, V2, P13, DOI 10.1016/S0960-894X(00)80645-9; DHAR ML, 1968, INDIAN J EXP BIOL, V6, P232; Dryden Gerald W Jr, 2005, Curr Gastroenterol Rep, V7, P308, DOI 10.1007/s11894-005-0024-y; Dryden GW, 2006, CURR OPIN GASTROEN, V22, P165, DOI 10.1097/01.mog.0000208463.69266.8c; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Gatof D, 2002, GASTROENTEROL CLIN N, V31, P587, DOI 10.1016/S0889-8553(02)00011-0; Goldstone AB, 2006, FREE RADICAL BIO MED, V41, P1860, DOI 10.1016/j.freeradbiomed.2006.09.015; GUTMAN M, 1970, J BIOL CHEM, V245, P1992; Halliwell B, 2000, FREE RADICAL RES, V33, P819, DOI 10.1080/10715760000301341; Hiruma-Lima CA, 2000, J ETHNOPHARMACOL, V71, P267, DOI 10.1016/S0378-8741(00)00178-1; Holmes EW, 1998, DIGEST DIS SCI, V43, P1088, DOI 10.1023/A:1018899222258; Ishihara T, 2009, J PHARMACOL EXP THER, V328, P152, DOI 10.1124/jpet.108.144451; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Kapoor LD., 1990, HDB AYURVEDIC MED PL; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Karp SM, 2006, DM-DIS MON, V52, P199, DOI 10.1016/j.disamonth.2006.05.005; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim Hyeyoung, 2005, Inflammopharmacology, V13, P63, DOI 10.1163/156856005774423962; Kulich SM, 2003, J BIOSCIENCES, V28, P83, DOI 10.1007/BF02970136; KUPCHAN SM, 1973, J ORG CHEM, V38, P178, DOI 10.1021/jo00941a049; KUTHAN H, 1986, BIOCHEM J, V237, P175, DOI 10.1042/bj2370175; LAMI N, 1991, CHEM PHARM BULL, V39, P1863, DOI 10.1248/cpb.39.1863; Leyon PV, 2005, LIFE SCI, V76, P1339, DOI 10.1016/j.lfs.2004.06.031; Liu LN, 2005, WORLD J GASTROENTERO, V11, P1503, DOI 10.3748/wjg.v11.i10.1503; Mehrotra S, 2002, INT IMMUNOPHARMACOL, V2, P987, DOI 10.1016/S1567-5769(02)00031-0; Miralles-Barrachina O, 1999, CLIN NUTR, V18, P313, DOI 10.1016/S0261-5614(98)80030-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Olaleye MT, 2010, FOOD CHEM TOXICOL, V48, P2200, DOI 10.1016/j.fct.2010.05.047; Opara EC, 2006, DM-DIS MON, V52, P183, DOI 10.1016/j.disamonth.2006.05.003; OTAMIRI T, 1991, DIGEST DIS, V9, P133, DOI 10.1159/000171299; Pari L, 2004, J MED FOOD, V7, P472, DOI 10.1089/jmf.2004.7.472; PARKS DA, 1983, SURGERY, V94, P428; Piquet MA, 2006, GASTROEN CLIN BIOL, V30, P262, DOI 10.1016/S0399-8320(06)73163-3; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Rego AC, 1999, FREE RADICAL BIO MED, V26, P1405, DOI 10.1016/S0891-5849(98)00337-2; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sachidanandam K, 2005, CARDIOVASC DRUG REV, V23, P115; Satheesh M. Amarnath, 2004, Indian Journal of Experimental Biology, V42, P989; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shi MJ, 2004, AM J HYPERTENS, V17, P450, DOI 10.1016/j.amjhyper.2003.12.019; Sido B, 1998, GUT, V42, P485, DOI 10.1136/gut.42.4.485; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Yokomizo A, 2006, BIOSCI BIOTECH BIOCH, V70, P1317, DOI 10.1271/bbb.50604; ZIMMERMAN BJ, 1994, HEPATO-GASTROENTEROL, V41, P337	61	44	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19628	10.1371/journal.pone.0019628	http://dx.doi.org/10.1371/journal.pone.0019628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625488	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400006
J	Natarajan, C; Jiang, XB; Fago, A; Weber, RE; Moriyama, H; Storz, JF				Natarajan, Chandrasekhar; Jiang, Xiaoben; Fago, Angela; Weber, Roy E.; Moriyama, Hideaki; Storz, Jay F.			Expression and Purification of Recombinant Hemoglobin in Escherichia coli	PLOS ONE			English	Article							HUMAN NORMAL ADULT; PROTEIN; ADAPTATION; SUBSTITUTIONS; GLOBIN; INSIGHTS; AFFINITY; ACID; GENE	Background: Recombinant DNA technologies have played a pivotal role in the elucidation of structure-function relationships in hemoglobin (Hb) and other globin proteins. Here we describe the development of a plasmid expression system to synthesize recombinant Hbs in Escherichia coli, and we describe a protocol for expressing Hbs with low intrinsic solubilities. Since the alpha- and beta-chain Hbs of different species span a broad range of solubilities, experimental protocols that have been optimized for expressing recombinant human HbA may often prove unsuitable for the recombinant expression of wildtype and mutant Hbs of other species. Methodology/Principal Findings: As a test case for our expression system, we produced recombinant Hbs of the deer mouse (Peromyscus maniculatus), a species that has been the subject of research on mechanisms of Hb adaptation to hypoxia. By experimentally assessing the combined effects of induction temperature, induction time and E. coli expression strain on the solubility of recombinant deer mouse Hbs, we identified combinations of expression conditions that greatly enhanced the yield of recombinant protein and which also increased the efficiency of post-translational modifications. Conclusion/Significance: Our protocol should prove useful for the experimental study of recombinant Hbs in many non-human animals. One of the chief advantages of our protocol is that we can express soluble recombinant Hb without co-expressing molecular chaperones, and without the need for additional reconstitution or heme-incorporation steps. Moreover, our plasmid construct contains a combination of unique restriction sites that allows us to produce recombinant Hbs with different alpha- and beta-chain subunit combinations by means of cassette mutagenesis.	[Natarajan, Chandrasekhar; Jiang, Xiaoben; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Fago, Angela; Weber, Roy E.] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Natarajan, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Fago, Angela/J-5946-2013; Natarajan, Chandrasekhar/D-3144-2012; Natarajan, Chandrasekar/ABG-5195-2020	Fago, Angela/0000-0001-7315-2628; Natarajan, Chandrasekhar/0000-0002-4841-0426; 	National Science Foundation [DEB-0614342]; National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL087216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Science Foundation Grant DEB-0614342 (http://www.nsf.gov/); and National Institutes of Health/National Heart, Lung, and Blood Institute Grant R01 HL087216 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brittain T, 2002, MOL ASPECTS MED, V23, P293, DOI 10.1016/S0098-2997(02)00004-3; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Chang CK, 2002, BIOCHEMISTRY-US, V41, P5644, DOI 10.1021/bi011919d; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Cheng Y, 2002, BIOCHEMISTRY-US, V41, P11901, DOI 10.1021/bi0202880; Dickerson R.E., 1983, HEMOGLOBIN; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; HERNAN RA, 1992, BIOCHEMISTRY-US, V31, P8619, DOI 10.1021/bi00151a032; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; Ho C, 2000, ENCY LIFE SCI; HOFFMAN SJ, 1990, P NATL ACAD SCI USA, V87, P8521, DOI 10.1073/pnas.87.21.8521; JESSEN TH, 1994, METHOD ENZYMOL, V231, P347; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KIM HW, 1995, J MOL BIOL, V248, P867, DOI 10.1006/jmbi.1995.0267; KIM HW, 1994, P NATL ACAD SCI USA, V91, P11547, DOI 10.1073/pnas.91.24.11547; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; LEE SJ, 1994, MOL MICROBIOL, V11, P833, DOI 10.1111/j.1365-2958.1994.tb00361.x; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; Olins Peter O., 1993, Current Opinion in Biotechnology, V4, P520, DOI 10.1016/0958-1669(93)90071-4; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Pieragostini E, 2005, COMP BIOCHEM PHYS B, V142, P18, DOI 10.1016/j.cbpc.2005.05.005; Sambrook J., 2001, MOL CLONING LAB MANU; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P24, DOI 10.1644/06-MAMM-S-199R1.1; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Tsai CH, 1999, BIOCHEMISTRY-US, V38, P8751, DOI 10.1021/bi990286o; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; WEBER RE, 1981, NATURE, V292, P386, DOI 10.1038/292386a0; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; WEBER RE, 1993, J APPL PHYSIOL, V75, P2646, DOI 10.1152/jappl.1993.75.6.2646; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	40	32	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20176	10.1371/journal.pone.0020176	http://dx.doi.org/10.1371/journal.pone.0020176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625463	Green Submitted, gold, Green Published			2022-12-27	WOS:000290793400044
J	Campo, A; Garnier, S; Dedriche, O; Zekkri, M; Dorigo, M				Campo, Alexandre; Garnier, Simon; Dedriche, Olivier; Zekkri, Mouhcine; Dorigo, Marco			Self-Organized Discrimination of Resources	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; ANTS; SELECTION; ANIMALS; BEES	When selecting a resource to exploit, an insect colony must take into account at least two constraints: the resource must be abundant enough to sustain the whole group, but not too large to limit exploitation costs, and risks of conflicts with other colonies. Following recent results on cockroaches and ants, we introduce here a behavioral mechanism that satisfies these two constraints. Individuals simply modulate their probability to switch to another resource as a function of the local density of conspecifics locally detected. As a result, the individuals gather at the smallest resource that can host the whole group, hence reducing competition and exploitation costs while fulfilling the overall group's needs. Our analysis reveals that the group becomes better at discriminating between similar resources as it grows in size. Also, the discrimination mechanism is flexible and the group readily switches to a better suited resource as it appears in the environment. The collective decision emerges through the self-organization of individuals, that is, in absence of any centralized control. It also requires a minimal individual cognitive investment, making the proposed mechanism likely to occur in other social species and suitable for the development of distributed decision making tools.	[Campo, Alexandre; Dedriche, Olivier; Zekkri, Mouhcine; Dorigo, Marco] Univ Libre Bruxelles, IRIDIA CoDE, Inst Rech Interdisciplinaires & Dev Intelligence, Dept Comp & Decis Engn, Brussels, Belgium; [Garnier, Simon] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Universite Libre de Bruxelles; Princeton University	Campo, A (corresponding author), Univ Libre Bruxelles, IRIDIA CoDE, Inst Rech Interdisciplinaires & Dev Intelligence, Dept Comp & Decis Engn, Brussels, Belgium.	acampo@ulb.ac.be	Garnier, Simon/A-3998-2010; Dorigo, Marco/B-5664-2013; Campo, Alexandre/ABI-1629-2020; Garnier, Simon/N-3814-2019	Dorigo, Marco/0000-0002-3971-0507; Campo, Alexandre/0000-0003-4817-4790; Garnier, Simon/0000-0002-3886-3974	European Union through the ERC [246939]; F.R.S.-FNRS of Belgium; Jules Reyers fund of Belgium; French Ministry of Education, Research and Technology	European Union through the ERC; F.R.S.-FNRS of Belgium(Fonds de la Recherche Scientifique - FNRS); Jules Reyers fund of Belgium; French Ministry of Education, Research and Technology	This work was partially supported by the European Union through the ERC Advanced Grant "E-SWARM: Engineering Swarm Intelligence Systems" (contract 246939). The information provided is the sole responsibility of the authors and does not reflect the European Commission's opinion. The European Commission is not responsible for any use that might be made of data appearing in this publication. AC and MD acknowledge support from the F.R.S.-FNRS of Belgium, of which they are a Research Fellow and a Research Director, respectively. AC gratefully acknowledges support from the Jules Reyers fund of Belgium. SG acknowledges support from the French Ministry of Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; [Anonymous], SWARM INTELLIGENCE; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Blanco S, 2003, EUROPHYS LETT, V61, P168, DOI 10.1209/epl/i2003-00208-x; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; BURY L, 2007, THESIS U LIBRE BRUXE; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Christensen A.L., 2005, 2005014 IRIDIA U LIB; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Dudek G., 2010, COMPUTATIONAL PRINCI, V2nd ed., DOI [10.1017/CBO9780511780929, DOI 10.1017/CBO9780511780929]; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; EGGLESTON DB, 1992, ECOLOGY, V73, P992, DOI 10.2307/1940175; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; GIRGIN S, 2004, P 8 C INT AUT SYST I, P37; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hafner V, 2005, ADAPT BEHAV, V13, P87, DOI 10.1177/105971230501300202; Holway DA, 2001, ANIM BEHAV, V61, P1181, DOI 10.1006/anbe.2000.1698; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; Krause J, 2002, LIVING GROUPS; Lichtenberg EM, 2010, INSECT SOC, V57, P105, DOI 10.1007/s00040-009-0055-8; Lihoreau M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1577, DOI 10.1007/s00265-010-0971-7; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Mallon EB, 2000, P ROY SOC B-BIOL SCI, V267, P765, DOI 10.1098/rspb.2000.1069; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Mondada F., 2009, P 9 C AUT ROB SYST C, V1, P59; Nagamitsu T, 1997, OECOLOGIA, V110, P432, DOI 10.1007/s004420050178; PASTEELS JM, 1987, INDIVIDUAL COLLECTIV, V54, P155; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; RABIN MO, 1963, INFORM CONTROL, V6, P230, DOI 10.1016/S0019-9958(63)90290-0; Sahin E, 2006, AUTON ROBOT, V21, P255, DOI 10.1007/s10514-006-9719-7; Seeley T., 1995, WISDOM HIVE SOCIAL P; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105	41	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19888	10.1371/journal.pone.0019888	http://dx.doi.org/10.1371/journal.pone.0019888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625643	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200043
J	Liu, YF; Zhang, N; Yao, HW; Pan, XM; Ge, M				Liu, Yan-Feng; Zhang, Nan; Yao, Hong-Wei; Pan, Xian-Ming; Ge, Meng			Mth10b, a Unique Member of the Sac10b Family, Does Not Bind Nucleic Acid	PLOS ONE			English	Article							ARCHAEAL CHROMATIN PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; DNA; SSH10B; ALBA; STABILITY; SIR2; MECHANISM	The Sac10b protein family is regarded as a group of nucleic acid-binding proteins that are highly conserved and widely distributed within archaea. All reported members of this family are basic proteins that exist as homodimers in solution and bind to DNA and/or RNA without apparent sequence specificity in vitro. Here, we reported a unique member of the family, Mth10b from Methanobacterium thermoautotrophicum Delta H, whose amino acid sequence shares high homology with other Sac10b family proteins. However, unlike those proteins, Mth10b is an acidic protein; its potential isoelectric point is only 4.56, which is inconsistent with the characteristics of a nucleic acid-binding protein. In this study, Mth10b was expressed in Escherichia coli and purified using a three-column chromatography purification procedure. Biochemical characterization indicated that Mth10b should be similar to typical Sac10b family proteins with respect to its secondary and tertiary structure and in its preferred oligomeric forms. However, an electrophoretic mobility shift analysis (EMSA) showed that neither DNA nor RNA bound to Mth10b in vitro, indicating that either Mth10b likely has a physiological function that is distinct from those of other Sac10b family members or nucleic acid-binding ability may not be a fundamental factor to the actual function of the Sac10b family.	[Liu, Yan-Feng; Zhang, Nan; Yao, Hong-Wei; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ge, Meng] Chinese Acad Sci, Inst Biophys, Ctr Struct & Mol Biol, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Liu, YF (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn; gem@moon.ibp.ac.cn	, 0000-0003-2383-1942/B-1483-2015; Yao, Hongwei/B-1483-2015	, 0000-0003-2383-1942/0000-0003-2383-1942; Yao, Hongwei/0000-0001-8518-7019	Natural Science Foundation of China [30870475]; Ministry of Science and Technology of China [2009CB918801]; China Postdoctoral Science Foundation [20100470567]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants 30870475 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm), 2009CB918801 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), and 20100470567 from China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Biyani K, 2005, BIOCHEMISTRY-US, V44, P14217, DOI 10.1021/bi051266r; BOHRMANN B, 1994, J STRUCT BIOL, V112, P70, DOI 10.1006/jsbi.1994.1008; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Fang XY, 2008, BIOCHEMISTRY-US, V47, P11212, DOI 10.1021/bi8007593; Fang XY, 2009, ARCH BIOCHEM BIOPHYS, V481, P52, DOI 10.1016/j.abb.2008.08.025; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Ge M, 2009, EXTREMOPHILES, V13, P481, DOI 10.1007/s00792-009-0233-7; Ge M, 2009, EXTREMOPHILES, V13, P131, DOI 10.1007/s00792-008-0204-4; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Hada K, 2008, BIOSCI BIOTECH BIOCH, V72, P749, DOI 10.1271/bbb.70639; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Xuan JS, 2009, PROTEIN EXPRES PURIF, V64, P162, DOI 10.1016/j.pep.2008.11.003; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	30	5	5	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19977	10.1371/journal.pone.0019977	http://dx.doi.org/10.1371/journal.pone.0019977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625642	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200053
J	Andersen, S; Donnem, T; Al-Shibli, K; Al-Saad, S; Stenvold, H; Busund, LT; Bremnes, RM				Andersen, Sigve; Donnem, Tom; Al-Shibli, Khalid; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M.			Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; EXPRESSION; ANGIOGENESIS; CARCINOMA; SURVIVAL; TIE-1; METASTASIS; MARKER; SYSTEM	Introduction: Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. Methods: 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and stroma were collected in tissue microarrays (TMAs). Immunohistochemistry (IHC) was used to semiquantitatively evaluate the expression of markers in duplicate tumor and stroma cores. Principal Findings: In univariate analyses, low tumor cell expression of Ang-4 (P = 0.046) and low stromal expressions of Ang-4 (P = 0.009) and Ang-2 (P = 0.017) were individually associated with a poor survival. In the multivariate analysis, low stromal Ang-2 (HR 1.88; CI 95% 1.15-3.08) and Ang-4 (HR 1.47, CI 95% 1.02-2.11, P = 0.04) expressions were independently associated with a poor prognosis. In patients with high tumor cell expression of Ang-2, a concomitantly high tumor VEGF-A expression mediated a dramatic survival reduction (P<0.001). In the multivariate analysis of patients with high Ang-2 expression, high tumor VEGF-A expression appeared an independent poor prognosticator (HR 6.43; CI 95% 2.46-16.8; P<0.001). Conclusions: In tumor cells, only Ang-4 expression has prognostic impact in NSCLC. In tumor stroma, Ang-4 and Ang-2 are independently associated with survival. The prognostic impact of tumor cell VEGF-A in NSCLC appears strongly associated with a concomitantly high tumor cell expression of Ang-2.	[Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Al-Shibli, Khalid; Al-Saad, Samer; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway; [Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp N Norway, Dept Pathol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Andersen, S (corresponding author), Univ Tromso, Inst Clin Med, Tromso, Norway.	sigve.andersen@uit.no		Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The study was solely funded by the Northern Norway Regional Health Authority (Helse Nord RHF), which is responsible for the public hospitals in northern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Chien CY, 2008, J SURG ONCOL, V97, P273, DOI 10.1002/jso.20930; Chung YC, 2006, J SURG ONCOL, V94, P631, DOI 10.1002/jso.20423; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Goldstraw P, 2009, J THORAC ONCOL, V4, P671, DOI 10.1097/JTO.0b013e31819e7814; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holopainen T, 2009, CANCER RES, V69, P4656, DOI 10.1158/0008-5472.CAN-08-4654; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Huang JZ, 2009, INT J ONCOL, V34, P79, DOI 10.3892/ijo_00000131; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Nakayama T, 2004, HISTOPATHOLOGY, V44, P232, DOI 10.1111/j.0309-0167.2004.01817.x; Nakayama T, 2007, WORLD J GASTROENTERO, V13, P4473; Olsen MWB, 2006, NEOPLASIA, V8, P364, DOI 10.1593/neo.06127; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Reinmuth N, 2007, LUNG CANCER, V55, P53, DOI 10.1016/j.lungcan.2006.09.025; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sie M, 2009, J NEUROSURG, V110, P147, DOI 10.3171/2008.6.17612; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Szarvas T, 2008, CLIN CANCER RES, V14, P8253, DOI 10.1158/1078-0432.CCR-08-0677; Tanaka F, 2002, CANCER RES, V62, P7124; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; *WHO, 1999, HIST TYP LUNG PLEUR; Wong MP, 2000, LUNG CANCER-J IASLC, V29, P11, DOI 10.1016/S0169-5002(00)00118-5	33	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19773	10.1371/journal.pone.0019773	http://dx.doi.org/10.1371/journal.pone.0019773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603628	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300026
J	Luk, SU; Lee, TKW; Liu, J; Lee, DTW; Chiu, YT; Ma, S; Ng, IOL; Wong, YC; Chan, FL; Ling, MT				Luk, Sze-Ue; Lee, Terence Kin-Wah; Liu, Ji; Lee, Davy Tak-Wing; Chiu, Yung-Tuen; Ma, Stephanie; Ng, Irene Oi-Lin; Wong, Yong-Chuan; Chan, Franky Leung; Ling, Ming-Tat			Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population	PLOS ONE			English	Article							PROTEIN-BOUND POLYSACCHARIDE; TUMOR-INITIATING CELLS; IN-VITRO; VERSICOLOR; IDENTIFICATION; MODEL; TRIAL; GENE; EXPRESSION; INDUCTION	Recent evidence suggested that prostate cancer stem/progenitor cells (CSC) are responsible for cancer initiation as well as disease progression. Unfortunately, conventional therapies are only effective in targeting the more differentiated cancer cells and spare the CSCs. Here, we report that PSP, an active component extracted from the mushroom Turkey tail (also known as Coriolus versicolor), is effective in targeting prostate CSCs. We found that treatment of the prostate cancer cell line PC-3 with PSP led to the down-regulation of CSC markers (CD133 and CD44) in a time and dose-dependent manner. Meanwhile, PSP treatment not only suppressed the ability of PC-3 cells to form prostaspheres under non-adherent culture conditions, but also inhibited their tumorigenicity in vivo, further proving that PSP can suppress prostate CSC properties. To investigate if the anti-CSC effect of PSP may lead to prostate cancer chemoprevention, transgenic mice (TgMAP) that spontaneously develop prostate tumors were orally fed with PSP for 20 weeks. Whereas 100% of the mice that fed with water only developed prostate tumors at the end of experiment, no tumors could be found in any of the mice fed with PSP, suggesting that PSP treatment can completely inhibit prostate tumor formation. Our results not only demonstrated the intriguing anti-CSC effect of PSP, but also revealed, for the first time, the surprising chemopreventive property of oral PSP consumption against prostate cancer.	[Luk, Sze-Ue; Lee, Davy Tak-Wing; Chiu, Yung-Tuen; Wong, Yong-Chuan] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liu, Ji; Ling, Ming-Tat] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Liu, Ji; Ling, Ming-Tat] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lee, Terence Kin-Wah; Ma, Stephanie; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Franky Leung] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Hong Kong; Chinese University of Hong Kong	Luk, SU (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	mingtat.ling@qut.edu.au	Chan, Franky L./M-1043-2018; Ma, Stephanie Kwai Yee/C-4766-2009	Chan, Franky L./0000-0003-0567-2052; Ma, Stephanie Kwai Yee/0000-0002-2029-7943; Lee, Kin Wah/0000-0003-0682-322X; Ng, Irene Oi-lin/0000-0001-7532-2029	Vice Chancellor Research Fellowship	Vice Chancellor Research Fellowship	Vice Chancellor Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISSON I, 2009, CELL RES; Chow LWC, 2003, AM J CHINESE MED, V31, P1, DOI 10.1142/S0192415X03000758; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dong Y, 1996, RES COMMUN MOL PATH, V92, P140; Duan WM, 2005, ONCOGENE, V24, P1510, DOI 10.1038/sj.onc.1208229; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Gabril MY, 2002, GENE THER, V9, P1589, DOI 10.1038/sj.gt.3301895; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Ho CY, 2005, CANCER BIOL THER, V4, P638, DOI 10.4161/cbt.4.6.1721; Howard EW, 2007, CLIN CANCER RES, V13, P1847, DOI 10.1158/1078-0432.CCR-06-2074; Hsieh TC, 2001, INT J ONCOL, V18, P81; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jimenez-Medina E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-78; Joniau S, 2005, EUR UROL, V48, P379, DOI 10.1016/j.eururo.2005.03.015; Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LEE TK, 2011, HEPATOLOGY; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; LUK SU, 2011, INT J CANC; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Musquera M, 2008, EXPERT REV ANTICANC, V8, P1073, DOI 10.1586/14737140.8.7.1073; Ng TB, 1998, GEN PHARMACOL, V30, P1, DOI 10.1016/S0306-3623(97)00076-1; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pomerantz M, 2007, ANNU REV MED, V58, P205, DOI 10.1146/annurev.med.58.101505.115650; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SAKAGAMI H, 1991, ANTICANCER RES, V11, P993; Sarvis JA, 2008, CURR ONCOL REP, V10, P529, DOI 10.1007/s11912-008-0080-1; Scopelliti A, 2009, EXPERT OPIN BIOL TH, V9, P1005, DOI 10.1517/14712590903066687; Singh RP, 2006, ENDOCR-RELAT CANCER, V13, P751, DOI 10.1677/erc.1.01126; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wan JMF, 2008, INT J ONCOL, V32, P689; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855	38	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19804	10.1371/journal.pone.0019804	http://dx.doi.org/10.1371/journal.pone.0019804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603625	Green Published, gold			2022-12-27	WOS:000290656300028
J	Yan, KK; Gerstein, M				Yan, Koon-Kiu; Gerstein, Mark			The Spread of Scientific Information: Insights from the Web Usage Statistics in PLoS Article-Level Metrics	PLOS ONE			English	Article							CITATIONS	The presence of web-based communities is a distinctive signature of Web 2.0. The web-based feature means that information propagation within each community is highly facilitated, promoting complex collective dynamics in view of information exchange. In this work, we focus on a community of scientists and study, in particular, how the awareness of a scientific paper is spread. Our work is based on the web usage statistics obtained from the PLoS Article Level Metrics dataset compiled by PLoS. The cumulative number of HTML views was found to follow a long tail distribution which is reasonably well-fitted by a lognormal one. We modeled the diffusion of information by a random multiplicative process, and thus extracted the rates of information spread at different stages after the publication of a paper. We found that the spread of information displays two distinct decay regimes: a rapid downfall in the first month after publication, and a gradual power law decay afterwards. We identified these two regimes with two distinct driving processes: a short-term behavior driven by the fame of a paper, and a long-term behavior consistent with citation statistics. The patterns of information spread were found to be remarkably similar in data from different journals, but there are intrinsic differences for different types of web usage (HTML views and PDF downloads versus XML). These similarities and differences shed light on the theoretical understanding of different complex systems, as well as a better design of the corresponding web applications that is of high potential marketing impact.	[Yan, Koon-Kiu; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Yan, Koon-Kiu; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Yan, KK (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	Mark.Gerstein@yale.edu	Yan, Koon-Kiu/A-5940-2009					Adamic L., 2000, Q J ELECT COMMENCE, V1, P5, DOI [10.2139/ssrn.166108, DOI 10.2139/SSRN.166108]; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Crane R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056101; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Kurtz MJ, 2005, J AM SOC INF SCI TEC, V56, P36, DOI 10.1002/asi.20095; Lambiotte R, 2006, PHYSICA A, V362, P485, DOI 10.1016/j.physa.2005.08.047; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Savage N, 2011, COMMUN ACM, V54, P18, DOI 10.1145/1897852.1897860; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Walker D, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06010; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	23	33	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19917	10.1371/journal.pone.0019917	http://dx.doi.org/10.1371/journal.pone.0019917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603617	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300038
J	Forsberg, JA; Eberhardt, J; Boland, PJ; Wedin, R; Healey, JH				Forsberg, Jonathan Agner; Eberhardt, John; Boland, Patrick J.; Wedin, Rikard; Healey, John H.			Estimating Survival in Patients with Operable Skeletal Metastases: An Application of a Bayesian Belief Network	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; BREAST-CANCER; LUNG-CANCER; MODEL; PREDICTION; PROGNOSIS; ONCOLOGY; SURGERY; DISEASE	Background: Accurate estimations of life expectancy are important in the management of patients with metastatic cancer affecting the extremities, and help set patient, family, and physician expectations. Clinically, the decision whether to operate on patients with skeletal metastases, as well as the choice of surgical procedure, are predicated on an individual patient's estimated survival. Currently, there are no reliable methods for estimating survival in this patient population. Bayesian classification, which includes Bayesian belief network (BBN) modeling, is a statistical method that explores conditional, probabilistic relationships between variables to estimate the likelihood of an outcome using observed data. Thus, BBN models are being used with increasing frequency in a variety of diagnoses to codify complex clinical data into prognostic models. The purpose of this study was to determine the feasibility of developing Bayesian classifiers to estimate survival in patients undergoing surgery for metastases of the axial and appendicular skeleton. Methods: We searched an institution-owned patient management database for all patients who underwent surgery for skeletal metastases between 1999 and 2003. We then developed and trained a machine-learned BBN model to estimate survival in months using candidate features based on historical data. Ten-fold cross-validation and receiver operating characteristic (ROC) curve analysis were performed to evaluate the BNN model's accuracy and robustness. Results: A total of 189 consecutive patients were included. First-degree predictors of survival differed between the 3-month and 12-month models. Following cross validation, the area under the ROC curve was 0.85 (95% CI: 0.80-0.93) for 3-month probability of survival and 0.83 (95% CI: 0.77-0.90) for 12-month probability of survival. Conclusions: A robust, accurate, probabilistic naive BBN model was successfully developed using observed clinical data to estimate individualized survival in patients with operable skeletal metastases. This method warrants further development and must be externally validated in other patient populations.	[Forsberg, Jonathan Agner; Boland, Patrick J.; Healey, John H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, New York, NY 10021 USA; [Forsberg, Jonathan Agner; Wedin, Rikard] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Sect Orthopaed & Sports Med, Stockholm, Sweden; [Eberhardt, John] DecisionQ Corp, Bioinformat Div, Washington, DC USA	Memorial Sloan Kettering Cancer Center; Karolinska Institutet; Karolinska University Hospital	Forsberg, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, 1275 York Ave, New York, NY 10021 USA.	jaforsberg@mac.com	Forsberg, Jonathan/K-2116-2012	Wedin, Rikard/0000-0002-2440-1218; Healey, John/0000-0002-0802-1186				Adamina M, 2009, CANCER-AM CANCER SOC, V115, P5371, DOI 10.1002/cncr.24628; Cheng SH, 2006, INT J RADIAT ONCOL, V64, P1401, DOI 10.1016/j.ijrobp.2005.11.015; DAMATO B, 2008, OPHTHALMOLOGY; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Hansen BH, 2004, ACTA ORTHOP SCAND, V75, P11, DOI 10.1080/00016470410001708270; Hartsell WF, 2008, J PALLIAT MED, V11, P723, DOI 10.1089/jpm.2007.0259; Heriot AG, 2006, DIS COLON RECTUM, V49, P816, DOI 10.1007/s10350-006-0523-4; Jerez-Aragones JM, 2003, ARTIF INTELL MED, V27, P45, DOI 10.1016/S0933-3657(02)00086-6; Katagiri H, 2005, J BONE JOINT SURG BR, V87B, P698, DOI 10.1302/0301-620X.87B5.15185; LEVITT SH, 1995, ACTA ONCOL, V34, P839, DOI 10.3109/02841869509127194; Lin PP, 2007, J BONE JOINT SURG AM, V89A, P1794, DOI 10.2106/JBJS.F.00603; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; Muers MF, 1996, THORAX, V51, P894, DOI 10.1136/thx.51.9.894; Narazaki Douglas Kenji, 2006, Clinics, V61, P313, DOI 10.1590/S1807-59322006000400007; Nathan SS, 2005, J CLIN ONCOL, V23, P6072, DOI 10.1200/JCO.2005.08.104; Oken M. M., 1982, AM J CLIN ONCOL; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Saad F, 2007, CANCER-AM CANCER SOC, V110, P1860, DOI 10.1002/cncr.22991; Schneiderbauer MM, 2004, J BONE JOINT SURG AM, V86A, P1684, DOI 10.2106/00004623-200408000-00011; Stojadinovic A, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-12; Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0; Taktak AFG, 2004, PHYS MED BIOL, V49, P87, DOI 10.1088/0031-9155/49/1/006; WEDIN R, 2001, ACTA ORHTOP SCAND  S, V72, pP1	25	115	121	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19956	10.1371/journal.pone.0019956	http://dx.doi.org/10.1371/journal.pone.0019956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603644	gold, Green Submitted, Green Published			2022-12-27	WOS:000290558500039
J	Kim, JH; Lee, SR; Li, LH; Park, HJ; Park, JH; Lee, KY; Kim, MK; Shin, BA; Choi, SY				Kim, Jin Hee; Lee, Sang-Rok; Li, Li-Hua; Park, Hye-Jeong; Park, Jeong-Hoh; Lee, Kwang Youl; Kim, Myeong-Kyu; Shin, Boo Ahn; Choi, Seok-Yong			High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice	PLOS ONE			English	Article							MULTIPLE PROTEINS; POLYPROTEIN; VIRUS; APHTHOVIRUS; EXPRESSION; SEQUENCES; EMBRYOS	When expression of more than one gene is required in cells, bicistronic or multicistronic expression vectors have been used. Among various strategies employed to construct bicistronic or multicistronic vectors, an internal ribosomal entry site (IRES) has been widely used. Due to the large size and difference in expression levels between genes before and after IRES, however, a new strategy was required to replace IRES. A self-cleaving 2A peptide could be a good candidate to replace IRES because of its small size and high cleavage efficiency between genes upstream and downstream ofthe 2A peptide. Despite the advantages of the 2A peptides, its use is not widespread because (i) there are no publicly available cloning vectors harboring a 2A peptide gene and (ii) comprehensive comparison of cleavage efficiency among various 2A peptides reported to date has not been performed in different contexts. Here, we generated four expression plasmids each harboring different 2A peptides derived from the foot-and-mouth disease virus, equine rhinitis A virus, Thoseaasigna virus and porcine teschovirus-1, respectively, and evaluated their cleavage efficiency in three commonly used human cell lines, zebrafish embryos and adult mice. Western blotting and confocal microscopic analyses revealed that among the four 2As, the one derived from porcine teschovirus-1 (P2A) has the highest cleavage efficiency in all the contexts examined. We anticipate that the 2A-harboring cloning vectors we generated and the highest efficiency of the P2A peptide we demonstrated would help biomedical researchers easily adopt the 2A technology when bicistronic or multicistronic expression is required.	[Kim, Jin Hee; Park, Hye-Jeong; Park, Jeong-Hoh; Choi, Seok-Yong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea; [Kim, Jin Hee; Li, Li-Hua; Shin, Boo Ahn] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju, South Korea; [Lee, Sang-Rok] Chosun Univ, Dept Biol, Kwangju, South Korea; [Lee, Sang-Rok] Kim & Jung Co Ltd, Res Inst, Hwasun, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju, South Korea; [Li, Li-Hua] Hainan Med Univ, Dept Pathogen Biol, Haikou, Peoples R China; [Kim, Myeong-Kyu] Chonnam Natl Univ, Dept Neurol, Sch Med, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chosun University; Chonnam National University; Chonnam National University; Hainan Medical University; Chonnam National University	Kim, JH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea.	bashin@chonnam.ac.kr; zebrafish@chonnam.ac.kr		Choi, Seok-Yong/0000-0001-7193-292X	Ministry of Education, Science and Technology [2009-0071597, 2009-0070204]; Korean Health Technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100402]; Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University [R13-2002-013-06002-0]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation at Chonnam National University(Korea Science and Engineering Foundation)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0071597 and 2009-0070204), a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100402) and the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation (R13-2002-013-06002-0) at Chonnam National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramel-Verheije MHG, 2000, VIROLOGY, V278, P380, DOI 10.1006/viro.2000.0525; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P., 2002, Current Gene Therapy, V2, P355, DOI 10.2174/1566523023347742; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957	18	587	681	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18556	10.1371/journal.pone.0018556	http://dx.doi.org/10.1371/journal.pone.0018556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21602908	Green Published, gold			2022-12-27	WOS:000290024700014
J	Goodman, BA; Johnson, PTJ				Goodman, Brett A.; Johnson, Pieter T. J.			Disease and the Extended Phenotype: Parasites Control Host Performance and Survival through Induced Changes in Body Plan	PLOS ONE			English	Article							TROPHICALLY TRANSMITTED PARASITE; RHABDIAS-BUFONIS NEMATODA; TREMATODE INFECTION; WILLAMETTE RIVER; LIMB DEVELOPMENT; LIFE-HISTORY; MANIPULATION; BEHAVIOR; MALFORMATIONS; DEFORMITIES	Background: By definition, parasites harm their hosts. However, some forms of parasite-induced alterations increase parasite transmission between hosts, such that manipulated hosts can be considered extensions of the parasite's phenotype. While well accepted in principle, surprisingly few studies have quantified how parasite manipulations alter host performance and survival under field and laboratory conditions. Methodology/Principal Findings: By interfering with limb development, the trematode Ribeiroia ondatrae causes particularly severe morphological alterations within amphibian hosts that provide an ideal system to evaluate parasite-induced changes in phenotype. Here, we coupled laboratory performance trials with a capture-mark-recapture study of 1388 Pacific chorus frogs (Pseudacris regilla) to quantify the effects of parasite-induced malformations on host locomotion, foraging, and survival. Malformations, which affected similar to 50% of metamorphosing frogs in nature, caused dramatic reductions in all measures of organismal function. Malformed frogs exhibited significantly shorter jumping distances (41% reduction), slower swimming speeds (37% reduction), reduced endurance (66% reduction), and lower foraging success relative to infected hosts without malformations. Furthermore, while normal and malformed individuals had comparable survival within predator-free exclosures, deformed frogs in natural populations had 22% lower biweekly survival than normal frogs and rarely recruited to the adult population over a two-year period. Conclusions/Significance: Our results highlight the ability of parasites to deeply alter multiple dimensions of host phenotype with important consequences for performance and survival. These patterns were best explained by malformation status, rather than infection per se, helping to decouple the direct and indirect effects of parasitism on host fitness.	[Goodman, Brett A.; Johnson, Pieter T. J.] Univ Colorado, Boulder, CO 80309 USA; [Goodman, Brett A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Colorado System; University of Colorado Boulder; University of Adelaide	Goodman, BA (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pieter.johnson@colorado.edu	Goodman, Brett/F-4717-2013	Goodman, Brett/0000-0001-6457-081X; JOHNSON, PIETER/0000-0002-7997-5390	National Science Foundation [DEB-0841758]; David and Lucile Packard Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The work was completed as part of a grant from the National Science Foundation (DEB-0841758) and a fellowship to PJ from the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; BEAVER PAUL C., 1939, JOUR PARASITOL, V25, P383, DOI 10.2307/3272305; Bernot RJ, 2008, FRESHWATER BIOL, V53, P322, DOI 10.1111/j.1365-2427.2007.01896.x; Blanchet S, 2009, TRENDS PARASITOL, V25, P364, DOI 10.1016/j.pt.2009.05.005; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cunningham ME, 2005, ENVIRON BIOL FISH, V73, P9, DOI 10.1007/s10641-004-3153-5; DALY EW, 2011, OECOLOGIA IN PRESS; Dawkins R., 1982, pi; DOBSON AP, 1988, Q REV BIOL, V63, P139, DOI 10.1086/415837; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; FERNER JW, 2009, AMPHIBIAN ECOLOGY CO, pCH8; Fryxell J. M., 2008, SERENGETI; GOATER CP, 1992, PARASITOLOGY, V104, P179, DOI 10.1017/S0031182000060923; GOATER CP, 1992, OECOLOGIA, V89, P161, DOI 10.1007/BF00317213; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; GOODMAN BA, 2011, ECOLOGY IN PRESS; Heemeyer Jennifer L., 2007, Herpetological Review, V38, P425; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Hughes DP, 2008, CURR BIOL, V18, pR294, DOI 10.1016/j.cub.2008.02.001; Jameson D. L., 1956, Copeia, P25; JAMESON DL, 1957, COPEIA, P221; Johnson PTJ, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P511, DOI 10.1201/EBK1420064162-c16; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Johnson PTJ, 2001, HERPETOLOGICA, V57, P336; JOHNSON PTJ, 2011, FUNCT ECOL IN PRESS; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kelehear C, 2009, PARASITOLOGY, V136, P919, DOI 10.1017/S0031182009006325; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Laland KN, 2004, BIOL PHILOS, V19, P313, DOI 10.1023/B:BIPH.0000036113.38737.d8; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; MOORE J, 1984, AM NAT, V123, P572, DOI 10.1086/284224; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2003, OECOLOGIA, V135, P131, DOI 10.1007/s00442-003-1183-x; Nauwelaerts Sandra, 2000, Herpetological Review, V31, P154; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Ouellet M, 2000, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, P617; Parker GA, 2009, EVOLUTION, V63, P448, DOI 10.1111/j.1558-5646.2008.00565.x; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R., 2007, EVOL ECOL, V2; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; ROMANSIC JM, 2011, OECOLOGIA IN PRESS; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C, P478; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Seppala O, 2008, P ROY SOC B-BIOL SCI, V275, P1611, DOI 10.1098/rspb.2008.0152; SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107; Shaw JC, 2009, P ROY SOC B-BIOL SCI, V276, P1137, DOI 10.1098/rspb.2008.1597; Stopper GF, 2002, J EXP ZOOL, V294, P252, DOI 10.1002/jez.10173; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x; Villeneuve DL, 2005, ENVIRON SCI TECHNOL, V39, P3495, DOI 10.1021/es048570c; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; Watkins TB, 2001, EVOLUTION, V55, P1668; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wood CL, 2007, P NATL ACAD SCI USA, V104, P9335, DOI 10.1073/pnas.0700062104; Wright KM., 2001, AMPHIBIAN MED CAPTIV; Yanoviak SP, 2008, AM NAT, V171, P536, DOI 10.1086/528968	70	59	60	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20193	10.1371/journal.pone.0020193	http://dx.doi.org/10.1371/journal.pone.0020193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633498	Green Published, Green Submitted, gold			2022-12-27	WOS:000291006500039
J	Yamakuchi, M; Yagi, S; Ito, T; Lowenstein, CJ				Yamakuchi, Munekazu; Yagi, Shusuke; Ito, Takashi; Lowenstein, Charles J.			MicroRNA-22 Regulates Hypoxia Signaling in Colon Cancer Cells	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GENE-EXPRESSION; VEGF; PREDICTION; MECHANISMS; ORIGINS; HIF-1; RNAS	MicroRNAs (MiRNAs) are short, non-coding RNA that regulate a variety of cellular functions by suppressing target protein expression. We hypothesized that a set of microRNA regulate tumor responses to hypoxia by inhibiting components of the hypoxia signaling pathway. We found that miR-22 expression in human colon cancer is lower than in normal colon tissue. We also found that miR-22 controls hypoxia inducible factor 1 alpha (HIF-1 alpha) expression in the HCT116 colon cancer cell line. Over-expression of miR-22 inhibits HIF-1 alpha expression, repressing vascular endothelial growth factor (VEGF) production during hypoxia. Conversely, knockdown of endogenous miR-22 enhances hypoxia induced expression of HIF-1 alpha and VEGF. The conditioned media from cells over-expressing miR-22 contain less VEGF protein than control cells, and also induce less endothelial cell growth and invasion, suggesting miR-22 in adjacent cells influences endothelial cell function. Taken together, our data suggest that miR-22 might have an anti-angiogenic effect in colon cancer.	[Yamakuchi, Munekazu; Yagi, Shusuke; Ito, Takashi; Lowenstein, Charles J.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University of Rochester	Yamakuchi, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	Munekazu_Yamakuchi@urmc.rochester.edu		Lowenstein, Charles/0000-0003-0485-7514	American Heart Association [0835446N]; NIH	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by American Heart Association grant (0835446N) (MY) and NIH grant (CJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA Y, AM J PATHOL, V176; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cascio S, J CELL PHYSL, V224, P242; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; KROL J, NAT REV GENET; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIU L, TOXICOL IN VITRO, V24, P1168; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rasheed S, 2009, BRIT J CANCER, V100, P1666, DOI 10.1038/sj.bjc.6605026; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; SEMENZA GL, ARTERIOSCLER THROMB, V30, P648; TING Y, BIOCH BIOPHYS RES CO, V394, P606; Xiong J, FEBS J, V277, P1684; XIONG J, ONCOGENE; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	37	108	121	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20291	10.1371/journal.pone.0020291	http://dx.doi.org/10.1371/journal.pone.0020291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629773	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200048
J	Jurjanz, L; Donix, M; Amanatidis, EC; Meyer, S; Poettrich, K; Huebner, T; Baeumler, D; Smolka, MN; Holthoff, VA				Jurjanz, Luisa; Donix, Markus; Amanatidis, Eva C.; Meyer, Shirin; Poettrich, Katrin; Huebner, Thomas; Baeumler, Damaris; Smolka, Michael N.; Holthoff, Vjera A.			Visual Personal Familiarity in Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							EARLY ALZHEIMERS-DISEASE; METABOLIC-CHANGES; FRONTAL-CORTEX; FAMOUS PEOPLE; OLDER-ADULTS; MEMORY; DEMENTIA; FMRI; ACTIVATION; MATTER	Background: Patients with amnestic mild cognitive impairment are at high risk for developing Alzheimer's disease. Besides episodic memory dysfunction they show deficits in accessing contextual knowledge that further specifies a general concept or helps to identify an object or a person. Methodology/Principal Findings: Using functional magnetic resonance imaging, we investigated the neural networks associated with the perception of personal familiar faces and places in patients with amnestic mild cognitive impairment and healthy control subjects. Irrespective of stimulus type, patients compared to control subjects showed lower activity in right prefrontal brain regions when perceiving personally familiar versus unfamiliar faces and places. Both groups did not show different neural activity when perceiving faces or places irrespective of familiarity. Conclusions/Significance: Our data highlight changes in a frontal cortical network associated with knowledge-based personal familiarity among patients with amnestic mild cognitive impairment. These changes could contribute to deficits in social cognition and may reduce the patients' ability to transition from basic to complex situations and tasks.	[Jurjanz, Luisa; Donix, Markus; Amanatidis, Eva C.; Meyer, Shirin; Poettrich, Katrin; Huebner, Thomas; Baeumler, Damaris; Smolka, Michael N.; Holthoff, Vjera A.] Tech Univ Dresden, Div Old Age Psychiat, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Donix, Markus; Holthoff, Vjera A.] German Ctr Neurodegenerat Dis, Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden	Jurjanz, L (corresponding author), Tech Univ Dresden, Div Old Age Psychiat, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, Dresden, Germany.	luisa.jurjanz@uniklinikum-dresden.de; markus.donix@uniklinikum-dresden.de	Smolka, Michael/B-4865-2011	Smolka, Michael/0000-0001-5398-5569; Holthoff, Vjera/0000-0001-7803-1091	Hirnliga eV	Hirnliga eV	This study was funded by Hirnliga eV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ally BA, 2009, BRAIN COGNITION, V69, P504, DOI 10.1016/j.bandc.2008.11.003; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson ND, 2008, NEUROPSYCHOLOGY, V22, P177, DOI 10.1037/0894-4105.22.2.177; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burgener S, 2002, ALZ DIS ASSOC DIS, V16, P88, DOI 10.1097/00002093-200204000-00006; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Clough JS, 2010, SOC NEUROSCI, P1; DAVIS S, 2007, CEREB CORTEX; Delis DC., 2000, CALIFORNIA VERBAL LE; Devanand DP, 2010, J GERIATR PSYCH NEUR, V23, P185, DOI 10.1177/0891988710363715; Donix M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015790; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P22, DOI 10.1093/arclin/acp098; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Estevez-Gonzalez A, 2004, DEMENT GERIATR COGN, V17, P188, DOI 10.1159/000076355; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Giovannetti T, 2006, ARCH CLIN NEUROPSYCH, V21, P607, DOI 10.1016/j.acn.2006.05.005; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hong GRS, 2009, J CLIN NURS, V18, P1365, DOI 10.1111/j.1365-2702.2008.02566.x; Huber W, 1984, Adv Neurol, V42, P291; Hurting C., 2000, WMS R WECHSLER GEDAC; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KESSELS RP, 2010, NEUROPSYCHOL DEV C B, P1; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; LIU L, 1991, AM J OCCUP THER, V45, P67, DOI 10.5014/ajot.45.1.67; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mandzia JL, 2009, NEUROBIOL AGING, V30, P717, DOI 10.1016/j.neurobiolaging.2007.08.024; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; Norton MC, 2009, J GERONTOL B-PSYCHOL, V64, P560, DOI 10.1093/geronb/gbp052; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petrella JR, 2006, RADIOLOGY, V240, P177, DOI 10.1148/radiol.2401050739; Poettrich K, 2009, NEUROBIOL AGING, V30, P284, DOI 10.1016/j.neurobiolaging.2007.05.027; Ries ML, 2006, NEUROIMAGE, V29, P485, DOI 10.1016/j.neuroimage.2005.07.030; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Serra L, 2010, NEUROPSYCHOLOGY, V24, P316, DOI 10.1037/a0017654; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Trivedi MA, 2008, DEMENT GERIATR COGN, V26, P123, DOI 10.1159/000148190; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Werner P, 2009, DEMENT GERIATR COGN, V27, P301, DOI 10.1159/000204915; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193; WESTMAN E, 2010, NEUROIMAGE; Woodard JL, 2009, BRAIN, V132, P2068, DOI 10.1093/brain/awp157	61	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20030	10.1371/journal.pone.0020030	http://dx.doi.org/10.1371/journal.pone.0020030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625502	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400032
J	Christoffels, IK; van de Ven, V; Waldorp, LJ; Formisano, E; Schiller, NO				Christoffels, Ingrid K.; van de Ven, Vincent; Waldorp, Lourens J.; Formisano, Elia; Schiller, Niels O.			The Sensory Consequences of Speaking: Parametric Neural Cancellation during Speech in Auditory Cortex	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; ASSOCIATION CORTEX; NEURONAL-ACTIVITY; FEEDBACK CONTROL; FMRI; ACTIVATIONS; MODULATION; RESPONSES; MODEL	When we speak, we provide ourselves with auditory speech input. Efficient monitoring of speech is often hypothesized to depend on matching the predicted sensory consequences from internal motor commands ( forward model) with actual sensory feedback. In this paper we tested the forward model hypothesis using functional Magnetic Resonance Imaging. We administered an overt picture naming task in which we parametrically reduced the quality of verbal feedback by noise masking. Presentation of the same auditory input in the absence of overt speech served as listening control condition. Our results suggest that a match between predicted and actual sensory feedback results in inhibition of cancellation of auditory activity because speaking with normal unmasked feedback reduced activity in the auditory cortex compared to listening control conditions. Moreover, during self-generated speech, activation in auditory cortex increased as the feedback quality of the self-generated speech decreased. We conclude that during speaking early auditory cortex is involved in matching external signals with an internally generated model or prediction of sensory consequences, the locus of which may reside in auditory or higher order brain areas. Matching at early auditory cortex may provide a very sensitive monitoring mechanism that highlights speech production errors at very early levels of processing and may efficiently determine the self-agency of speech input.	[Christoffels, Ingrid K.; Schiller, Niels O.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Christoffels, Ingrid K.; Schiller, Niels O.] Leiden Univ, Leiden Inst Psychol Res, Leiden, Netherlands; [van de Ven, Vincent; Formisano, Elia] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Waldorp, Lourens J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schiller, Niels O.] Netherlands Inst Adv Study Humanities & Social Sc, Wassenaar, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Maastricht University; University of Amsterdam	Christoffels, IK (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	ichristoffels@fsw.leidenuniv.nl	Schiller, Niels O./A-9481-2008; van de Ven, Vincent/D-3003-2009	Schiller, Niels O./0000-0002-0392-7608; van de Ven, Vincent/0000-0001-8735-3711; Formisano, Elia/0000-0001-5008-2460	Netherlands Organization for Scientific Research (NWO) [451-06-009, 451-07-014, 452-04-337, 453-02-006]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	IKC, VV, EF, and NOS were supported by grants from the Netherlands Organization for Scientific Research (NWO) (respectively 451-06-009, 451-07-014, 452-04-337; and 453-02-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Ford JM, 2005, INT J PSYCHOPHYSIOL, V57, P143, DOI 10.1016/j.ijpsycho.2005.03.002; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Frith C, 2005, CR BIOL, V328, P169, DOI 10.1016/j.crvi.2004.10.012; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Shergill SS, 2001, PSYCHOL MED, V31, P241, DOI 10.1017/S003329170100335X; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Talairach J., 1988, COPLANAR STEREOTAXIC; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Toyomura A, 2007, NEUROSCIENCE, V146, P499, DOI 10.1016/j.neuroscience.2007.02.023; van de Ven VG, 2005, NEUROIMAGE, V27, P644, DOI 10.1016/j.neuroimage.2005.04.041; van de Ven V, 2009, NEUROIMAGE, V47, P1982, DOI 10.1016/j.neuroimage.2009.05.057; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324	38	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e18307	10.1371/journal.pone.0018307	http://dx.doi.org/10.1371/journal.pone.0018307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766HI	21625532	Green Published, gold			2022-12-27	WOS:000290771200003
J	Guckel, E; Frey, S; Zaiss, MM; Schett, G; Ghosh, S; Voll, RE				Gueckel, Eva; Frey, Silke; Zaiss, Mario M.; Schett, Georg; Ghosh, Sankar; Voll, Reinhard E.			Cell-Intrinsic NF-kappa B Activation Is Critical for the Development of Natural Regulatory T Cells in Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; FOXP3 TRANSCRIPTION-FACTOR; GROWTH-FACTOR-BETA; NUCLEAR-FACTOR; C-REL; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; DIFFERENTIAL REQUIREMENT; LYMPHOCYTE-PROLIFERATION; INTESTINAL INFLAMMATION	Background: Naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells develop in the thymus and represent a mature T cell subpopulation critically involved in maintaining peripheral tolerance. The differentiation of Treg cells in the thymus requires T cell receptor (TCR)/CD28 stimulation along with cytokine-promoted Foxp3 induction. TCR-mediated nuclear factor kappa B (NF-kappa B) activation seems to be involved in differentiation of Treg cells because deletion of components of the NF-kappa B signaling pathway, as well as of NF-kB transcription factors, leads to markedly decreased Treg cell numbers in thymus and periphery. Methodology/ Principal Findings: To investigate if Treg cell-intrinsic NF-kappa B activation is required for thymic development and peripheral homeostasis of Treg cells we used transgenic (Tg) mice with thymocyte-specific expression of a stable I kappa B alpha mutant to inhibit NF-kappa B activation solely within the T cell lineage. Here we show that Treg cell-intrinsic NF-kappa B activation is important for the generation of cytokine-responsive Foxp3(-) thymic Treg precursors and their further differentiation into mature Treg cells. Treg cell development could neither be completely rescued by the addition of exogenous Interleukin 2 (IL-2) nor by the presence of wild-type derived cells in adoptive transfer experiments. However, peripheral NF-kappa B activation appears to be required for IL-2 production by conventional T cells, thereby participating in Treg cell homeostasis. Moreover, pharmacological NF-kappa B inhibition via the I kappa B kinase beta (IKK beta) inhibitor AS602868 led to markedly diminished thymic and peripheral Treg cell frequencies. Conclusion/Significance: Our results indicate that Treg cell-intrinsic NF-kappa B activation is essential for thymic Treg cell differentiation, and further suggest pharmacological NF-kappa B inhibition as a potential therapeutic approach for manipulating this process.	[Gueckel, Eva; Frey, Silke; Voll, Reinhard E.] Univ Erlangen Nurnberg, Dept Internal Med, Nikolaus Fiebiger Ctr Mol Med, Clin Res Grp, Erlangen, Germany; [Zaiss, Mario M.; Schett, Georg] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med Rheumatol & Clin Immunol 3, Erlangen, Germany; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Voll, Reinhard E.] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Ctr Chron Immunodeficiency, Freiburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Columbia University; University of Freiburg	Guckel, E (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med, Nikolaus Fiebiger Ctr Mol Med, Clin Res Grp, Erlangen, Germany.	reinhard.voll@uniklinik-freiburg.de	Zaiss, Mario M./ABE-7125-2021	Zaiss, Mario M./0000-0003-3844-1664; Frey, Silke/0000-0001-9411-8357	German Research Society [SFB 643, B3]; Interdisciplinary Center for Clinical Research (IZKF) [N2]; ELAN; German Research Community (DFG) [GK592]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER	German Research Society(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF); ELAN; German Research Community (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the German Research Society (Collaborative Research Centers SFB 643; project B3) and the Interdisciplinary Center for Clinical Research (IZKF, project number N2). Parts of this work were also funded by an intramural grant from the ELAN fund and the Training Grant GK592, from the German Research Community (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frelin C, 2003, ONCOGENE, V22, P8187, DOI 10.1038/sj.onc.1206963; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greve B, 2007, J IMMUNOL, V179, P179, DOI 10.4049/jimmunol.179.1.179; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2008, EUR J IMMUNOL, V38, P928, DOI 10.1002/eji.200838147; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Itoh M, 1999, J IMMUNOL, V162, P5317; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu HY, 2006, CLIN EXP PHARMACOL P, V33, P519, DOI 10.1111/j.1440-1681.2006.04401.x; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lounnas N, 2009, INT J CANCER, V125, P308, DOI 10.1002/ijc.24294; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhao L, 2007, J LEUKOCYTE BIOL, V81, P1386, DOI 10.1189/jlb.0506364; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610; Zhou P, 2005, J IMMUNOL, V174, P3447, DOI 10.4049/jimmunol.174.6.3447	82	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20003	10.1371/journal.pone.0020003	http://dx.doi.org/10.1371/journal.pone.0020003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625598	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200058
J	Nalloor, R; Bunting, K; Vazdarjanova, A				Nalloor, Rebecca; Bunting, Kristopher; Vazdarjanova, Almira			Predicting Impaired Extinction of Traumatic Memory and Elevated Startle	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANIMAL-MODEL; PLUS-MAZE; NEURAL PLASTICITY; PREDATOR STRESS; EXPOSURE; PTSD; ANXIETY; VULNERABILITY; EXPERIENCE	Background: Emotionally traumatic experiences can lead to debilitating anxiety disorders, such as phobias and Post-Traumatic Stress Disorder (PTSD). Exposure to such experiences, however, is not sufficient to induce pathology, as only up to one quarter of people exposed to such events develop PTSD. These statistics, combined with findings that smaller hippocampal size prior to the trauma is associated with higher risk of developing PTSD, suggest that there are pre-disposing factors for such pathology. Because prospective studies in humans are limited and costly, investigating such predispositions, and thus advancing understanding of the genesis of such pathologies, requires the use of animal models where predispositions are identified before the emotional trauma. Most existing animal models are retrospective: they classify subjects as those with or without a PTSD-like phenotype long after experiencing a traumatic event. Attempts to create prospective animal models have been largely unsuccessful. Methodology/Principal Findings: Here we report that individual predispositions to a PTSD-like phenotype, consisting of impaired rate and magnitude of extinction of an emotionally traumatic event coupled with long-lasting elevation of acoustic startle responses, can be revealed following exposure to a mild stressor, but before experiencing emotional trauma. We compare, in rats, the utility of several classification criteria and report that a combination of criteria based on acoustic startle responses and behavior in an anxiogenic environment is a reliable predictor of a PTSD-like phenotype. Conclusions/Significance: There are individual predispositions to developing impaired extinction and elevated acoustic startle that can be identified after exposure to a mildly stressful event, which by itself does not induce such a behavioral phenotype. The model presented here is a valuable tool for studying the etiology and pathophysiology of anxiety disorders and provides a platform for testing behavioral and pharmacological interventions that can reduce the probability of developing pathologic behaviors associated with such disorders.	[Nalloor, Rebecca] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Nalloor, R (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	avazdarjanova@georgiahealth.edu	; Vazdarjanova, Almira/D-8254-2018	Bunting, Kristopher/0000-0002-7252-8598; Vazdarjanova, Almira/0000-0002-3848-8895; Nalloor, Rebecca/0000-0003-1753-8010	National Institute of Mental Health [083188]; Georgia Health Sciences University	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Georgia Health Sciences University	The work was funded by National Institute of Mental Health 083188 (AV), Georgia Health Sciences University Startup (AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, EUR J PHARMACOL, V504, P65, DOI 10.1016/j.ejphar.2004.09.009; Adamec RE, 2006, NEUROSCI BIOBEHAV R, V30, P356, DOI 10.1016/j.neubiorev.2005.04.004; ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Adamec R, 2008, NEUROSCI BIOBEHAV R, V32, P1287, DOI 10.1016/j.neubiorev.2008.05.005; Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; Blanchard D Caroline, 2005, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0819s30; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2006, ANN NY ACAD SCI, V1071, P335, DOI 10.1196/annals.1364.026; Davis M, 2006, J TRAUMA STRESS, V19, P571, DOI 10.1002/jts.20149; DAWSON GR, 1994, PSYCHOPHARMACOLOGY, V113, P570, DOI 10.1007/BF02245242; *DEF HLTH BOARD TA, MENT HLTH TASK FORC; Ehring T, 2007, J NERV MENT DIS, V195, P1004, DOI 10.1097/NMD.0b013e31815c1999; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FILE SE, 1993, PSYCHOPHARMACOLOGY, V111, P491, DOI 10.1007/BF02253541; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Kozlovsky N, 2007, INT J NEUROPSYCHOPH, V10, P741, DOI 10.1017/S1461145707007560; Kozlovsky N, 2008, EUR NEUROPSYCHOPHARM, V18, P107, DOI 10.1016/j.euroneuro.2007.04.009; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Mackenzie L, 2010, NEUROSCIENCE, V169, P733, DOI 10.1016/j.neuroscience.2010.05.005; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; NEUMANN ID, PROGR NEURO IN PRESS; Rasmussen DD, 2008, PSYCHONEUROENDOCRINO, V33, P282, DOI 10.1016/j.psyneuen.2007.11.010; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Roth T.L., J PSYCHIAT IN PRESS; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; US Department of Veterans Affairs, VA DOD CLIN PRACT GU; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	34	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19760	10.1371/journal.pone.0019760	http://dx.doi.org/10.1371/journal.pone.0019760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611173	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200030
J	Severiano, A; Carrico, JA; Robinson, DA; Ramirez, M; Pinto, FR				Severiano, Ana; Carrico, Joao A.; Robinson, D. Ashley; Ramirez, Mario; Pinto, Francisco R.			Evaluation of Jackknife and Bootstrap for Defining Confidence Intervals for Pairwise Agreement Measures	PLOS ONE			English	Article							TYPING METHODS; COEFFICIENT; SIMILARITY; RESISTANT	Several research fields frequently deal with the analysis of diverse classification results of the same entities. This should imply an objective detection of overlaps and divergences between the formed clusters. The congruence between classifications can be quantified by clustering agreement measures, including pairwise agreement measures. Several measures have been proposed and the importance of obtaining confidence intervals for the point estimate in the comparison of these measures has been highlighted. A broad range of methods can be used for the estimation of confidence intervals. However, evidence is lacking about what are the appropriate methods for the calculation of confidence intervals for most clustering agreement measures. Here we evaluate the resampling techniques of bootstrap and jackknife for the calculation of the confidence intervals for clustering agreement measures. Contrary to what has been shown for some statistics, simulations showed that the jackknife performs better than the bootstrap at accurately estimating confidence intervals for pairwise agreement measures, especially when the agreement between partitions is low. The coverage of the jackknife confidence interval is robust to changes in cluster number and cluster size distribution.	[Severiano, Ana; Carrico, Joao A.; Ramirez, Mario] Fac Med Lisbon, Inst Mol Med, Inst Microbiol, Lisbon, Portugal; [Pinto, Francisco R.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Dept Quim & Bioquim, Lisbon, Portugal; [Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA	Universidade de Lisboa; Universidade de Lisboa; University of Mississippi; University of Mississippi Medical Center	Severiano, A (corresponding author), Fac Med Lisbon, Inst Mol Med, Inst Microbiol, Lisbon, Portugal.	jcarrico@fm.ul.pt	Pinto, Francisco/A-7443-2008; Ramirez, Mario/B-4993-2008; Carriço, Joao André/A-7367-2008	Pinto, Francisco/0000-0002-4217-0054; Ramirez, Mario/0000-0002-4084-6233; Carriço, Joao André/0000-0002-5274-2722	Fundacao para a Ciencia e Tecnologia, Portugal [PPTDC/SAU-ESA/71499/2006]; Fundacao Calouste Gulbenkian; American Heart Association; NIH [GM080602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080602] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.S. is supported by a research grant from Fundacao para a Ciencia e Tecnologia, Portugal (PPTDC/SAU-ESA/71499/2006). This work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PPTDC/SAU-ESA/71499/2006) and Fundacao Calouste Gulbenkian. D. A. R. was supported by a grant from the American Heart Association and by NIH grant GM080602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albatineh AN, 2006, J CLASSIF, V23, P301, DOI 10.1007/s00357-006-0017-z; Cagney G, 2005, J PROTEOME RES, V4, P1757, DOI 10.1021/pr0500354; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Hellmann JJ, 1999, ECOL APPL, V9, P824, DOI 10.1890/1051-0761(1999)009[0824:BPAAOF]2.0.CO;2; HELTSHE JF, 1988, BIOMETRICS, V44, P447, DOI 10.2307/2531858; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Mirkin B., 1996, MATH CLASSIFICATION; Newson R, 2006, J STAT SOFTW, V15; Pinto FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003696; Pinto FR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-44; Price GA, 2005, BIOINFORMATICS, V21, P3824, DOI 10.1093/bioinformatics/bti627; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; SMITH EP, 1986, HYDROBIOLOGIA, V139, P237, DOI 10.1007/BF00028294; SMITH W, 1977, BIOMETRICS, V33, P283, DOI 10.2307/2529778; Smyth DS, 2011, INFECT GENET EVOL, V11, P446, DOI 10.1016/j.meegid.2010.12.005; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118; ZAHL S, 1977, ECOLOGY, V58, P907, DOI 10.2307/1936227; Zaiss NH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-6	26	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19539	10.1371/journal.pone.0019539	http://dx.doi.org/10.1371/journal.pone.0019539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611165	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200013
J	Beck, AJ; Vitale, JM; Zhao, QS; Schneider, JS; Chang, C; Altaf, A; Michaels, J; Bhaumik, M; Grange, R; Fraidenraich, D				Beck, Amanda J.; Vitale, Joseph M.; Zhao, Qingshi; Schneider, Joel S.; Chang, Corey; Altaf, Aneela; Michaels, Jennifer; Bhaumik, Mantu; Grange, Robert; Fraidenraich, Diego			Differential Requirement for Utrophin in the Induced Pluripotent Stem Cell Correction of Muscle versus Fat in Muscular Dystrophy Mice	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; RESTORES DYSTROPHIN; SKELETAL-MUSCLE; ALPHA-DYSTROBREVIN; SYSTEMIC DELIVERY; FULL-LENGTH; MDX; EXPRESSION; INJECTION; PROTEIN	Duchenne muscular dystrophy (DMD) is an incurable degenerative muscle disorder. We injected WT mouse induced pluripotent stem cells (iPSCs) into mdx and mdx: utrophin mutant blastocysts, which are predisposed to develop DMD with an increasing degree of severity (mdx <<< mdx: utrophin). In mdx chimeras, iPSC-dystrophin was supplied to the muscle sarcolemma to effect corrections at morphological and functional levels. Dystrobrevin was observed in dystrophin-positive and, at a lesser extent, utrophin-positive areas. In the mdx: utrophin mutant chimeras, although iPSC-dystrophin was also supplied to the muscle sarcolemma, mice still displayed poor skeletal muscle histopathology, and negligible levels of dystrobrevin in dystrophin-and utrophin-negative areas. Not only dystrophin-expressing tissues are affected by iPSCs. Mdx and mdx: utrophin mice have reduced fat/body weight ratio, but iPSC injection normalized this parameter in both mdx and mdx: utrophin chimeras, despite the fact that utrophin was compromised in the mdx: utrophin chimeric fat. The results suggest that the presence of utrophin is required for the iPSC-corrections in skeletal muscle. Furthermore, the results highlight a potential (utrophin-independent) non-cell autonomous role for iPSC-dystrophin in the corrections of non-muscle tissue like fat, which is intimately related to the muscle.	[Beck, Amanda J.; Vitale, Joseph M.; Zhao, Qingshi; Schneider, Joel S.; Chang, Corey; Altaf, Aneela; Fraidenraich, Diego] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Michaels, Jennifer] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Newark, NJ 07103 USA; [Bhaumik, Mantu] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; [Grange, Robert] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Polytechnic Institute & State University	Beck, AJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, 185 S Orange Ave, Newark, NJ 07103 USA.	fraidedi@umdnj.edu	Zhao, Qingshi/H-9839-2013		NIH [HL094905]; Muscular Dystrophy Association [68648]; Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the NIH (HL094905), the Muscular Dystrophy Association (68648) and the Hispanic Center of Excellence-New Jersey Medical School (HCoE-NJMS) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, J CELL SCI, V121, P48, DOI 10.1242/jcs.020701; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nawrotzki R, 1998, J CELL SCI, V111, P2595; Odom GL, 2010, MOL THER; Odom GL, 2008, MOL THER, V16, P1539, DOI 10.1038/mt.2008.149; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Schneider JS, 2009, STEM CELL REV REP; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Stillwell E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004759; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wolff AV, 2006, MUSCLE NERVE, V34, P304, DOI 10.1002/mus.20588; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2010, NATURE, V467, P280, DOI 10.1038/467280a	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20065	10.1371/journal.pone.0020065	http://dx.doi.org/10.1371/journal.pone.0020065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603573	Green Submitted, gold, Green Published			2022-12-27	WOS:000290656300050
J	Crespo, MD; Rubini, M				Crespo, Maria D.; Rubini, Marina			Rational Design of Protein Stability: Effect of (2S,4R)-4-Fluoroproline on the Stability and Folding Pathway of Ubiquitin	PLOS ONE			English	Article							COLLAGEN TRIPLE-HELIX; PROLINE RESIDUES; CONFORMATIONAL STABILITY; SYNTHETIC BIOLOGY; IN-VIVO; PEPTIDES; 4-FLUOROPROLINE; INSIGHTS; MODEL; STABILIZATION	Background: Many strategies have been employed to increase the conformational stability of proteins. The use of 4-substituted proline analogs capable to induce pre-organization in target proteins is an attractive tool to deliver an additional conformational stability without perturbing the overall protein structure. Both, peptides and proteins containing 4-fluorinated proline derivatives can be stabilized by forcing the pyrrolidine ring in its favored puckering conformation. The fluorinated pyrrolidine rings of proline can preferably stabilize either a C-gamma-exo or a C-gamma-endo ring pucker in dependence of proline chirality (4R/4S) in a complex protein structure. To examine whether this rational strategy can be generally used for protein stabilization, we have chosen human ubiquitin as a model protein which contains three proline residues displaying C-gamma-exo puckering. Methodology/Principal Findings: While (2S, 4R)-4-fluoroproline ((4R)-FPro) containing ubiquitinin can be expressed in related auxotrophic Escherichia coli strain, all attempts to incorporate (2S, 4S)-4-fluoroproline ((4S)-FPro) failed. Our results indicate that (4R)-FPro is favoring the C-gamma-exo conformation present in the wild type structure and stabilizes the protein structure due to a pre-organization effect. This was confirmed by thermal and guanidinium chloride-induced denaturation profile analyses, where we observed an increase in stability of -4.71 kJ.mol(-1) in the case of (4R)-FPro containing ubiquitin ((4R)-FPro-ub) compared to wild type ubiquitin (wt-ub). Expectedly, activity assays revealed that (4R)-FPro-ub retained the full biological activity compared to wt-ub. Conclusions/Significance: The results fully confirm the general applicability of incorporating fluoroproline derivatives for improving protein stability. In general, a rational design strategy that enforces the natural occurring proline puckering conformation can be used to stabilize the desired target protein.	[Crespo, Maria D.] ETH Honggerberg, Inst Mol Biol & Biophys, Zurich, Switzerland; [Rubini, Marina] Univ Konstanz, Dept Organ Chem, Constance, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Konstanz	Crespo, MD (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, Zurich, Switzerland.	marina.rubini@uni-konstanz.de		Rubini, Marina/0000-0002-3102-2558	University of Konstanz	University of Konstanz	This work was supported by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth D, 2004, CHEMBIOCHEM, V5, P79, DOI 10.1002/cbic.200300702; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; BRIGGS MS, 1992, P NATL ACAD SCI USA, V89, P2017, DOI 10.1073/pnas.89.6.2017; Crespo MD, 2006, J MOL BIOL, V360, P1053, DOI 10.1016/j.jmb.2006.05.061; Crespo MD, 2004, EUR J BIOCHEM, V271, P4474, DOI 10.1111/j.1432-1033.2004.04392.x; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v; Gladwin ST, 1996, FOLD DES, V1, P407, DOI 10.1016/S1359-0278(96)00057-0; Golbik R, 2005, BIOCHEMISTRY-US, V44, P16026, DOI 10.1021/bi051442w; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Jackson SE, 2006, ORG BIOMOL CHEM, V4, P1845, DOI 10.1039/b600829c; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; KIEFHABER T, 2005, PROTEIN FOLDING HDB, V1; Kim W, 2005, J AM CHEM SOC, V127, P18121, DOI 10.1021/ja054105j; Kim W, 2006, ANGEW CHEM INT EDIT, V45, P8141, DOI 10.1002/anie.200603227; Kim WY, 2004, CHEMBIOCHEM, V5, P928, DOI 10.1002/cbic.200400052; Lee HY, 2006, J AM CHEM SOC, V128, P337, DOI 10.1021/ja0563410; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; Marsh ENG, 2000, CHEM BIOL, V7, pR153, DOI 10.1016/S1074-5521(00)00139-3; Montclare JK, 2009, CHEMBIOCHEM, V10, P84, DOI 10.1002/cbic.200800164; Moroder L, 2010, CHEMPHYSCHEM, V11, P1181, DOI 10.1002/cphc.201000035; Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; PANASIK N, 1994, INT J PEPT PROT RES, V44, P262; Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115; Son S, 2006, CHEMBIOCHEM, V7, P1251, DOI 10.1002/cbic.200500420; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588; Tang Y, 2001, ANGEW CHEM INT EDIT, V40, P1494, DOI 10.1002/1521-3773(20010417)40:8<1494::AID-ANIE1494>3.0.CO;2-X; Vallee-Belisle A, 2007, J MOL BIOL, V374, P791, DOI 10.1016/j.jmb.2007.09.018; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang P, 2003, J AM CHEM SOC, V125, P6900, DOI 10.1021/ja0298287; Went HM, 2004, FEBS LETT, V567, P333, DOI 10.1016/j.febslet.2004.04.089; WINTRODE PL, 1994, PROTEINS, V18, P246, DOI 10.1002/prot.340180305; WOOLFSON DN, 1993, J MOL BIOL, V229, P502, DOI 10.1006/jmbi.1993.1049	51	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19425	10.1371/journal.pone.0019425	http://dx.doi.org/10.1371/journal.pone.0019425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21625626	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300008
J	Melichar, H; Li, O; Ross, J; Haber, H; Cado, D; Nolla, H; Robey, EA; Winoto, A				Melichar, Heather; Li, Ou; Ross, Jenny; Haber, Hilary; Cado, Dragana; Nolla, Hector; Robey, Ellen A.; Winoto, Astar			Comparative Study of Hematopoietic Differentiation between Human Embryonic Stem Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; DELTA-LIKE-1 IN-VITRO; RED-BLOOD-CELLS; CORD BLOOD; HUMAN BLASTOCYSTS; PROGENITOR CELLS; STROMAL CELLS; GENERATION; INDUCTION; VIVO	Directed differentiation of human embryonic stem cells (hESCs) into any desired cell type has been hailed as a therapeutic promise to cure many human diseases. However, substantial roadblocks still exist for in vitro differentiation of hESCs into distinct cell types, including T lymphocytes. Here we examined the hematopoietic differentiation potential of six different hESC lines. We compare their ability to develop into CD34(+) or CD34(+) CD45(+) hematopoietic precursor populations under several differentiation conditions. Comparison of lymphoid potential of hESC derived- and fetal tissue derived-hematopoietic precursors was also made. We found diverse hematopoietic potential between hESC lines depending on the culture or passage conditions. In contrast to fetal-derived hematopoietic precursors, none of the CD34(+) precursors differentiated from hESCs were able to develop further into T cells. These data underscore the difficulties in the current strategy of hESC forward differentiation and highlight distinct differences between CD34(+) hematopoietic precursors generated in vitro versus in vivo.	[Melichar, Heather; Li, Ou; Ross, Jenny; Haber, Hilary; Cado, Dragana; Nolla, Hector; Robey, Ellen A.; Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Melichar, H (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu		Haber, Hilary/0000-0003-3895-5980	California Institute for Regenerative Medicine (CIRM) [RS1-00295, T1-00007, TG2-01164]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by a California Institute for Regenerative Medicine (CIRM) SEED Grant (RS1-00295) to A. W. and E. R., a CIRM post-doctoral fellowship (Training Grant Number T1-00007) (to H.J.M.) and a CIRM graduate student fellowship (Training Grant Number TG2-01164) (to J.R.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Chang KH, 2008, EXP CELL RES, V314, P2930, DOI 10.1016/j.yexcr.2008.07.019; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DRAVID G, 2010, MOL THER        1221; FENG Q, STEM CELLS, V28, P704; Galic Z, 2006, P NATL ACAD SCI USA, V103, P11742, DOI 10.1073/pnas.0604244103; Galic Z, 2009, STEM CELLS, V27, P100, DOI 10.1634/stemcells.2008-0813; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; GRIGORIADIS AE, BLOOD, V115, P2769; HANNA J, P NATL ACAD SCI US, V107, P9222; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Kim SE, 2007, MOL CELLS, V23, P49; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; LENGNER CJ, CELL, V141, P872; Lu SJ, 2004, BLOOD, V103, P4134, DOI 10.1182/blood-2003-10-3575; Martin CH, 2008, BLOOD, V112, P2730, DOI 10.1182/blood-2008-01-133801; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Patel E, 2009, IMMUNOLOGY, V128, pe497, DOI 10.1111/j.1365-2567.2008.03013.x; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Salvagiotto G, 2008, EXP HEMATOL, V36, P1377, DOI 10.1016/j.exphem.2008.06.015; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yokoyama Y, 2009, BLOOD, V113, P6584, DOI 10.1182/blood-2008-06-160838	37	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19854	10.1371/journal.pone.0019854	http://dx.doi.org/10.1371/journal.pone.0019854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603627	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300033
J	He, W; Zhu, F; Ma, XG; Zhao, XY; Zheng, M; Chen, Z; Heymsfield, SB; Zhu, SK				He, Wei; Zhu, Fei; Ma, Xiaoguang; Zhao, Xinyu; Zheng, Min; Chen, Zhao; Heymsfield, Steven B.; Zhu, Shankuan			Actinic Skin Damage and Mortality - the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study	PLOS ONE			English	Article							VITAMIN-D; SUN PROTECTION; EXPOSURE; SUNLIGHT; PREVENTION; DETERMINANTS; PREVALENCE; RADIATION; VALIDITY; SMOKING	Background: Exposure to sunlight may decrease the risk of several diseases through the synthesis of vitamin D, whereas solar radiation is the main cause of some skin and eye diseases. However, to the best of our knowledge, the association of sun-induced skin damage with mortality remains unknown. Methodology/Principal Findings: Subjects were 8472 white participants aged 25-74 years in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cardiovascular disease mortality, cancer mortality, and all-cause mortality were obtained by either a death certificate or a proxy interview, or both. Actinic skin damage was examined and recorded by the presence and severity (absent, minimal, moderate, or severe) of overall actinic skin damage and its components (i.e., fine telangiectasia, solar elastosis, and actinic keratoses). Cox regression and Kaplan-Meier methods were applied to explore the associations. A total of 672 cancer deaths, 1500 cardiovascular disease deaths, and 2969 deaths from all causes were documented through the follow-up between 1971 and 1992. After controlling for potential confounding variables, severe overall actinic skin damage was associated with a 45% higher risk for all-cause mortality (95% CI: 1.22, 1.72; P<0.001), moderate overall skin damage with a 20% higher risk (95% CI: 1.08., 1.32; P<0.001), and minimal overall skin damage with no significant mortality difference, when compared to those with no skin damage. Similar results were obtained for all-cause mortality with fine telangiectasia, solar elastosis, and actinic keratoses. The results were similar for cancer and cardiovascular disease mortality. Conclusions: The present study gives an indication of an association of actinic skin damage with cardiovascular disease, cancer and all-cause mortality in white subjects. Given the lack of support in the scientific literature and potential unmeasured confounding factors, this finding should be interpreted with caution. More independent studies are needed before any practical recommendations can be made.	[He, Wei; Zhu, Fei; Zhao, Xinyu; Zhu, Shankuan] Zhejiang Univ, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Xiaoguang; Zhu, Shankuan] Med Coll Wisconsin, Injury Res Ctr, Milwaukee, WI 53226 USA; [Ma, Xiaoguang] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC USA; [Zheng, Min] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhao] Univ Arizona, Div Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Zhejiang University; Medical College of Wisconsin; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Zhejiang University; University of Arizona; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	He, W (corresponding author), Zhejiang Univ, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	zsk@zju.edu.cn	Ma, Xiaoguang/AAS-6923-2020; MA, XIAO/HHN-5611-2022; Heymsfield, Steven B/N-1968-2017; He, Wei/C-8441-2015	Heymsfield, Steven B/0000-0003-1127-9425; He, Wei/0000-0003-0161-3274	Zhejiang University, Hangzhou, China	Zhejiang University, Hangzhou, China	This study was supported in part by the "985" development initiative from Zhejiang University, Hangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM AC DERM, 2009, AM AC DERM ISS UPD P; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; ARTHEY S, 1995, SOC SCI MED, V40, P265, DOI 10.1016/0277-9536(94)E0063-X; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Brown TT, 2006, J AM ACAD DERMATOL, V55, P577, DOI 10.1016/j.jaad.2006.05.029; CALDERONE DC, 1995, J AM ACAD DERMATOL, V32, P1016, DOI 10.1016/0190-9622(95)91342-4; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Cox C S, 1997, Vital Health Stat 1, P1; COX DR, 1972, J R STAT SOC B, V34, P187; Davis KJ, 2002, PEDIATRICS, V110, P27, DOI 10.1542/peds.110.1.27; Engel A, 1978, Vital Health Stat 1, P1; ENGEL A, 1988, ARCH DERMATOL, V124, P72, DOI 10.1001/archderm.124.1.72; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FRANCES C, 1991, BRIT J DERMATOL, V125, P43, DOI 10.1111/j.1365-2133.1991.tb06037.x; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Gillie O, 2006, BRIT J DERMATOL, V154, P1052, DOI 10.1111/j.1365-2133.2006.07261.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2008, ADV EXP MED BIOL, V624, P1, DOI 10.1007/978-0-387-77574-6_1; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOLMAN CDJ, 1984, AM J EPIDEMIOL, V120, P414, DOI 10.1093/oxfordjournals.aje.a113906; Ingram D D, 1994, Vital Health Stat 2, P1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koh HK, 1997, AM J PUBLIC HEALTH, V87, P1214, DOI 10.2105/AJPH.87.7.1214; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lucas RM, 2006, B WORLD HEALTH ORGAN, V84, P485, DOI 10.2471/BLT.05.026559; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARKS R, 1994, PIGM CELL RES, V7, P104, DOI 10.1111/j.1600-0749.1994.tb00029.x; Matts PJ, 2010, PHOTOCH PHOTOBIO SCI, V9, P421, DOI 10.1039/b9pp00166b; Miller H W, 1973, Vital Health Stat 1, P1; Moller P, 2002, FASEB J, V16, P45, DOI 10.1096/fj.01-0386com; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Narbutt J, 2009, ARCH DERMATOL, V145, P133, DOI 10.1001/archdermatol.2008.574; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ness AR, 1999, BRIT MED J, V319, P114, DOI 10.1136/bmj.319.7202.114; Purba MB, 2001, AGE AGEING, V30, P227, DOI 10.1093/ageing/30.3.227; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Robinson JK, 2000, J AM ACAD DERMATOL, V42, P746, DOI 10.1067/mjd.2000.103984; SAFAVI K, 1994, J INVEST DERMATOL, V102, pS51, DOI 10.1111/1523-1747.ep12388611; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; *US BUR CENS, 1971, 1970 CENS POP ALPH I; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vural P, 1999, J EUR ACAD DERMATOL, V13, P96, DOI 10.1111/j.1468-3083.1999.tb00860.x; World Health Organization, 2003, INTERSUN GLOB UV PRO; Wulf HC, 2004, MICRON, V35, P185, DOI 10.1016/j.micron.2003.11.005; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x	50	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19907	10.1371/journal.pone.0019907	http://dx.doi.org/10.1371/journal.pone.0019907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21603643	gold, Green Published, Green Submitted			2022-12-27	WOS:000290558500036
J	Olsson, M; Andersson, S; Wapstra, E				Olsson, Mats; Andersson, Staffan; Wapstra, Erik			UV-Deprived Coloration Reduces Success in Mate Acquisition in Male Sand Lizards (Lacerta agilis)	PLOS ONE			English	Article							NUPTIAL COLORATION; SELECTION; SIGNALS; PREFERENCES; PATERNITY; ABILITY	Background: Recent work on animal signals has revealed a wide occurrence of UV signals in tetrapods, in particular birds, but also in lizards (and perhaps other Squamate reptiles). Our previous work on the Swedish sand lizard (Lacerta agilis) has verified, both in correlative selection analyses in the wild and with laboratory and field experiments, the importance of the green 'badge' on the body sides of adult males for securing mating opportunities, probably mostly through deterring rival males rather than attracting females. The role of UV in communication has, however, never been examined. Methodology/Principal Findings: Here we show that when measured immediately after spring skin shedding, there is also signaling in the UV. By UV-depriving the signal (reflectance) with sun block chemicals fixated with permeable, harmless spray dressing, we show that males in the control group (spray dressing only) had significantly higher success in mate acquisition than UV-deprived males. Conclusions/Significance: These results suggest that at least two colour traits in sand lizards, badge area and UV, contribute to rival deterrence and/or female choice on UV characters, which elevates success in mate acquisition in UV intact male sand lizards.	[Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Olsson, Mats; Andersson, Staffan] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia	University of Sydney; University of Gothenburg; University of Tasmania	Olsson, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	mats.olsson@sydney.edu.au	Wapstra, Erik/J-7482-2014; Andersson, Staffan/B-1534-2010; Olsson, Mats/AAK-5565-2021	Wapstra, Erik/0000-0002-2050-8026; Andersson, Staffan/0000-0003-1474-3596; Olsson, Mats/0000-0002-4130-1323	Australian Research Council (ARC) [DP0453116]	Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Australian Research Council (ARC) with grant DP0453116. The ARC can be found at www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderholm S, 2004, BIOL LETT, V271, P142; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; [Anonymous], 2005, MG BEH ECOL; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; de Lanuza GPI, 2007, AMPHIBIA-REPTILIA, V28, P438, DOI 10.1163/156853807781374764; Delhey K, 2003, P ROY SOC B-BIOL SCI, V270, P2057, DOI 10.1098/rspb.2003.2460; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gullberg A, 1997, MOL ECOL, V6, P105, DOI 10.1046/j.1365-294X.1997.t01-1-00156.x; Hasson O, 1997, J THEOR BIOL, V185, P139, DOI 10.1006/jtbi.1996.0258; Li DQ, 2005, ANIM BEHAV, V70, P771, DOI 10.1016/j.anbehav.2004.12.021; Losey GS, 2003, ANIM BEHAV, V66, P299, DOI 10.1006/anbe.2003.2214; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P249, DOI 10.1007/s002650050095; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P169, DOI 10.1007/s002650050084; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Olsson M, 2000, P ROY SOC LOND B BIO, V267, P1; Pryke SR, 2003, ANIM BEHAV, V66, P217, DOI 10.1006/anbe.2003.2193; ROHWER S, 1982, AM ZOOL, V22, P531; Stapley J, 2006, BIOL LETTERS, V2, P169, DOI 10.1098/rsbl.2005.0419; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	26	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19360	10.1371/journal.pone.0019360	http://dx.doi.org/10.1371/journal.pone.0019360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602928	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500007
J	Dimayuga, PC; Chyu, KY; Kirzner, J; Yano, J; Zhao, XN; Zhou, JC; Shah, PK; Cercek, B				Dimayuga, Paul C.; Chyu, Kuang-Yuh; Kirzner, Jonathan; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Shah, Prediman K.; Cercek, Bojan			Enhanced Neointima Formation Following Arterial Injury in Immune Deficient Rag-1-/- Mice Is Attenuated by Adoptive Transfer of CD8(+) T cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; DRUG-ELUTING STENTS; VASCULAR INJURY; APOLIPOPROTEIN-E; KNOCKOUT MICE; FACTOR 1-ALPHA; LYMPHOCYTES; CD4(+); INFLAMMATION	T cells modulate neointima formation after arterial injury but the specific T cell population that is activated in response to arterial injury remains unknown. The objective of the study was to identify the T cell populations that are activated and modulate neointimal thickening after arterial injury in mice. Arterial injury in wild type C57Bl6 mice resulted in T cell activation characterized by increased CD4(+) CD44(hi) and CD8(+) CD44(hi) T cells in the lymph nodes and spleens. Splenic CD8(+) CD25(+) T cells and CD8(+) CD28(+) T cells, but not CD4(+) CD25(+) and CD4(+) CD28(+) T cells, were also significantly increased. Adoptive cell transfer of CD4(+) or CD8(+) T cells from donor CD8-/- or CD4-/- mice, respectively, to immune-deficient Rag-1-/- mice was performed to determine the T cell subtype that inhibits neointima formation after arterial injury. Rag-1-/- mice that received CD8(+) T cells had significantly reduced neointima formation compared with Rag-1-/- mice without cell transfer. CD4(+) T cell transfer did not reduce neointima formation. CD8(+) T cells from CD4-/- mice had cytotoxic activity against syngeneic smooth muscle cells in vitro. The study shows that although both CD8(+) T cells and CD4(+) T cells are activated in response to arterial injury, adoptive cell transfer identifies CD8(+) T cells as the specific and selective cell type involved in inhibiting neointima formation.	[Dimayuga, Paul C.; Chyu, Kuang-Yuh; Kirzner, Jonathan; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Shah, Prediman K.; Cercek, Bojan] Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Dimayuga, PC (corresponding author), Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA.	DimayugaP@cshs.org			Spielberg Family Cardiovascular Research Fund; Heart Foundation, Cedars-Sinai Medical Center	Spielberg Family Cardiovascular Research Fund; Heart Foundation, Cedars-Sinai Medical Center	This work was supported by the Spielberg Family Cardiovascular Research Fund and the Heart Foundation, Cedars-Sinai Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunetti ND, 2008, CORONARY ARTERY DIS, V19, P133, DOI 10.1097/MCA.0b013e3282f3fbcb; Chyu KY, 1999, CIRC RES, V85, P1192; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2010, CURR OPIN LIPIDOL, V21, P416, DOI 10.1097/MOL.0b013e32833cacbe; Dimayuga PC, 2009, AM J PHYSIOL-REG I, V297, pR1593, DOI 10.1152/ajpregu.00114.2009; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; HART MN, 1985, AM J PATHOL, V119, P448; Karshovska E, 2007, ARTERIOSCL THROM VAS, V27, P2540, DOI 10.1161/ATVBAHA.107.151050; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kurobe H, 2010, ARTERIOSCL THROM VAS, V30, P210, DOI 10.1161/ATVBAHA.109.192666; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Lukashev D, 2001, J BIOL CHEM, V276, P48754, DOI 10.1074/jbc.M104782200; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakazawa G, 2007, HERZ, V32, P274, DOI 10.1007/s00059-007-2997-9; Navarro-Lopez F, 2003, REV ESP CARDIOL, V56, P465, DOI 10.1157/13047011; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Remskar M, 2001, CIRC RES, V88, P390; Richard DE, 2000, J BIOL CHEM, V275, P26765; Sardella G, 2005, IMMUNOL LETT, V96, P85, DOI 10.1016/j.imlet.2004.08.001; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Shishido T, 2006, BIOCHEM BIOPH RES CO, V345, P1446, DOI 10.1016/j.bbrc.2006.05.056; Steffel J, 2007, HERZ, V32, P268, DOI 10.1007/s00059-007-3000-5; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Tanaka T, 2004, AM J CARDIOL, V93, P1547, DOI 10.1016/j.amjcard.2004.02.070; TURKA LA, 1990, J IMMUNOL, V144, P1646; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhu BH, 2002, ARTERIOSCL THROM VAS, V22, P450, DOI 10.1161/hq0302.105377	41	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20214	10.1371/journal.pone.0020214	http://dx.doi.org/10.1371/journal.pone.0020214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629656	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005800034
J	Donati, C; Marseglia, G; Magi, A; Serrati, S; Cencetti, F; Bernacchioni, C; Nannetti, G; Benelli, M; Brunelli, S; Torricelli, F; Cossu, G; Bruni, P				Donati, Chiara; Marseglia, Giuseppina; Magi, Alberto; Serrati, Simona; Cencetti, Francesca; Bernacchioni, Caterina; Nannetti, Genni; Benelli, Matteo; Brunelli, Silvia; Torricelli, Francesca; Cossu, Giulio; Bruni, Paola			Sphingosine 1-Phosphate Induces Differentiation of Mesoangioblasts towards Smooth Muscle. A Role for GATA6	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TGF-BETA; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; PROLIFERATION; MULTIPOTENT; APOPTOSIS	Different cells can contribute to repair following vascular injury by differentiating into smooth muscle (SM) cells; however the extracellular signals involved are presently poorly characterized. Mesoangioblasts are progenitor cells capable of differentiating into various mesoderm cell types including SM cells. In this study the biological action exerted by the pleiotropic sphingolipid sphingosine 1-phosphate (S1P) in human mesoangioblasts has been initially investigated by cDNA microarray analysis. Obtained data confirmed the anti-apoptotic action of this sphingolipid and identified for the first time a strong differentiating action toward SM cells. Quantitative mRNA and protein analysis corroborated the microarray results demonstrating enhanced expression of myogenic marker proteins and regulation of the expression of transcription factor GATA6 and its co-regulator, LMCD1. Importantly, GATA6 up-regulation induced by S1P was responsible for the enhanced expression of SM-specific contractile proteins. Moreover, by specific gene silencing experiments GATA6 was critical in the pro-differentiating activity of the cytokine TGF beta. Finally, the pharmacological inhibition of endogenous S1P formation in response to TGFb abrogated GATA6 up-regulation, supporting the view that the S1P pathway plays a physiological role in mediating the pro-myogenic effect of TGFb. This study individuates GATA6 as novel player in the complex transcriptional regulation of mesoangioblast differentiation into SM cells and highlights a role for S1P to favour vascular regeneration.	[Donati, Chiara; Cencetti, Francesca; Bernacchioni, Caterina; Bruni, Paola] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Donati, Chiara; Cencetti, Francesca; Bernacchioni, Caterina; Bruni, Paola] IIM, Rome, Italy; [Marseglia, Giuseppina; Magi, Alberto; Nannetti, Genni; Benelli, Matteo; Torricelli, Francesca] Azienda Osped Univ, SOD Diagnost Genet, Florence, Italy; [Serrati, Simona] Univ Florence, Dipartimento Oncol & Patol Sperimentali, Florence, Italy; [Brunelli, Silvia; Cossu, Giulio] Ist Sci H San Raffaele, Div Med Rigenerat, Milan, Italy; [Brunelli, Silvia] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy; [Cossu, Giulio] Univ Milan, Dipartimento Biol, Milan, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; University of Milan	Donati, C (corresponding author), Univ Florence, Dipartimento Sci Biochim, Florence, Italy.		Brunelli, Silvia/P-3853-2019; Bruni, Paola/A-1151-2008; Serrati, Simona/B-2520-2013; Magi, Alberto/M-6773-2015; cencetti, francesca/J-8372-2018; Benelli, Matteo/I-2497-2018; Brunelli, Silvia/J-3248-2014; donati, chiara/AAN-2682-2021	Brunelli, Silvia/0000-0003-1753-5346; Serrati, Simona/0000-0002-4015-5205; Magi, Alberto/0000-0001-7393-4283; Benelli, Matteo/0000-0003-1227-356X; Brunelli, Silvia/0000-0003-1753-5346; donati, chiara/0000-0003-2224-4199; Cencetti, Francesca/0000-0003-4351-2965; Bruni, Paola/0000-0002-1151-3413; Bernacchioni, Caterina/0000-0002-1023-0067; Cossu, Giulio/0000-0001-5863-9593	University of Florence; Ente Cassa di Risparmio di Firenze; Fondazione Cassa di Risparmio di Lucca	University of Florence; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Fondazione Cassa di Risparmio di Lucca	This work was supported by funds from University of Florence (ex-60%) to P. Bruni and C. Donati, www.unifi.it, Ente Cassa di Risparmio di Firenze to F. Torricelli, www.crf.it, Fondazione Cassa di Risparmio di Lucca to P. Bruni, www.fondazionecarilucca.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbuti A, 2010, J MOL CELL CARDIOL, V48, P415, DOI 10.1016/j.yjmcc.2009.10.006; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Brunelli S, 2005, TRENDS CARDIOVAS MED, V15, P96, DOI 10.1016/j.tcm.2005.04.004; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; Donati C, 2009, CELL SIGNAL, V21, P228, DOI 10.1016/j.cellsig.2008.10.007; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grabski AD, 2009, ARTERIOSCL THROM VAS, V29, P1644, DOI 10.1161/ATVBAHA.109.191965; Han CL, 2001, J VASC RES, V38, P113, DOI 10.1159/000051038; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Krenning G, 2008, TRENDS CARDIOVAS MED, V18, P312, DOI 10.1016/j.tcm.2009.01.004; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Narita N, 1996, GENOMICS, V36, P345, DOI 10.1006/geno.1996.0472; Nincheri P, 2009, CELL MOL LIFE SCI, V66, P1741, DOI 10.1007/s00018-009-9181-8; Nincheri P, 2010, CELL SIGNAL, V22, P1688, DOI 10.1016/j.cellsig.2010.06.009; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Radeke HH, 2005, J IMMUNOL, V174, P2778, DOI 10.4049/jimmunol.174.5.2778; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Sachinidis A, 2003, CELL PHYSIOL BIOCHEM, V13, P423, DOI 10.1159/000075130; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Tagliafico E, 2004, J CELL SCI, V117, P4377, DOI 10.1242/jcs.01291; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wamhoff BR, 2008, ARTERIOSCL THROM VAS, V28, P1454, DOI 10.1161/ATVBAHA.107.159392; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200	47	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20389	10.1371/journal.pone.0020389	http://dx.doi.org/10.1371/journal.pone.0020389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629665	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800047
J	Greene, TA; Alarcon, S; Thomas, A; Berdougo, E; Doranz, BJ; Breslin, PAS; Rucker, JB				Greene, Tiffani A.; Alarcon, Suzanne; Thomas, Anu; Berdougo, Eli; Doranz, Benjamin J.; Breslin, Paul A. S.; Rucker, Joseph B.			Probenecid Inhibits the Human Bitter Taste Receptor TAS2R16 and Suppresses Bitter Perception of Salicin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MULTIDRUG-RESISTANCE PROTEINS; CELLS; FAMILY; PHENYLTHIOCARBAMIDE; SENSITIVITY; SENSATIONS; DIVERSITY; SACCHARIN; TRANSPORT	Bitter taste stimuli are detected by a diverse family of G protein-coupled receptors (GPCRs) expressed in gustatory cells. Each bitter taste receptor (TAS2R) responds to an array of compounds, many of which are toxic and can be found in nature. For example, human TAS2R16 (hTAS2R16) responds to beta-glucosides such as salicin, and hTAS2R38 responds to thiourea-containing molecules such as glucosinolates and phenylthiocarbamide (PTC). While many substances are known to activate TAS2Rs, only one inhibitor that specifically blocks bitter receptor activation has been described. Here, we describe a new inhibitor of bitter taste receptors, p-(dipropylsulfamoyl) benzoic acid (probenecid), that acts on a subset of TAS2Rs and inhibits through a novel, allosteric mechanism of action. Probenecid is an FDA-approved inhibitor of the Multidrug Resistance Protein 1 (MRP1) transporter and is clinically used to treat gout in humans. Probenecid is also commonly used to enhance cellular signals in GPCR calcium mobilization assays. We show that probenecid specifically inhibits the cellular response mediated by the bitter taste receptor hTAS2R16 and provide molecular and pharmacological evidence for direct interaction with this GPCR using a non-competitive (allosteric) mechanism. Through a comprehensive analysis of hTAS2R16 point mutants, we define amino acid residues involved in the probenecid interaction that result in decreased sensitivity to probenecid while maintaining normal responses to salicin. Probenecid inhibits hTAS2R16, hTAS2R38, and hTAS2R43, but does not inhibit the bitter receptor hTAS2R31 or non-TAS2R GPCRs. Additionally, structurally unrelated MRP1 inhibitors, such as indomethacin, fail to inhibit hTAS2R16 function. Finally, we demonstrate that the inhibitory activity of probenecid in cellular experiments translates to inhibition of bitter taste perception of salicin in humans. This work identifies probenecid as a pharmacological tool for understanding the cell biology of bitter taste and as a lead for the development of broad specificity bitter blockers to improve nutrition and medical compliance.	[Greene, Tiffani A.; Thomas, Anu; Berdougo, Eli; Doranz, Benjamin J.; Rucker, Joseph B.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Alarcon, Suzanne; Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Monell Chemical Senses Center	Greene, TA (corresponding author), Integral Mol Inc, Philadelphia, PA 19104 USA.	jrucker@integralmolecular.com		Breslin, Paul/0000-0001-5988-8401	National Institutes of Health [DC002995, DC010105, GM072379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM072379, R44GM072379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002995, R44DC010105, R01DC002995, R43DC010105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health: DC002995 to P.A.S.B., DC010105 to J.B.R., and GM072379 to B.J.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DAYTON PG, 1966, J MED CHEM, V9, P941, DOI 10.1021/jm00324a034; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Egan JM, 2008, MOL INTERV, V8, P78, DOI 10.1124/mi.8.2.5; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; JANSSEN S, 2011, P NATL ACAD SCI US; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; SIROTNAK FM, 1991, CANCER RES, V51, P1412; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stocker SL, 2008, CLIN PHARMACOKINET, V47, P111, DOI 10.2165/00003088-200847020-00004; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x	52	91	97	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20123	10.1371/journal.pone.0020123	http://dx.doi.org/10.1371/journal.pone.0020123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629661	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005800028
J	Nazer, E; Verdun, RE; Sanchez, DO				Nazer, Ezequiel; Verdun, Ramiro E.; Sanchez, Daniel O.			Nucleolar Localization of RNA Binding Proteins Induced by Actinomycin D and Heat Shock in Trypanosoma cruzi	PLOS ONE			English	Article							SR SPLICING FACTORS; STRESS GRANULES; LIFE-CYCLE; POLY(A)-BINDING PROTEIN; NUCLEAR-ORGANIZATION; DOMAIN PROTEINS; GENE-EXPRESSION; MESSENGER-RNAS; BRUCEI; PHOSPHORYLATION	In this work we show that under Actinomycin D (ActD) treatment, several RNA Binding Proteins (RBPs) involved in mRNA metabolism are relocalized into the nucleolus in Trypanosoma cruzi as a specific stress response. ATP depletion as well as kinase inhibition markedly reduced the nucleolar localization response, suggesting that an energy-dependent transport modulated by the phosphorylation status of the parasite might be required. Deletion analyses in one of such proteins, TcSR62, showed that a domain bearing basic amino acids located in the COOH terminal region was sufficient to promote its nucleolar relocalization. Interestingly, we showed that in addition to RBPs, poly(A)+ RNA is also accumulated into the nucleolus in response to ActD treatment. Finally, we found out that nucleolar relocalization of RBPs is also triggered by severe heat shock in a reversible way. Together, these results suggest that the nucleolus of an early divergent eukaryote is either able to sequester key factors related to mRNA metabolism in response to transcriptional stress or behaves as a RBP processing center, arguing in favour to the hypothesis that the non-traditional features of the nucleolus could be acquired early during evolution.	[Nazer, Ezequiel; Sanchez, Daniel O.] UNSAM CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, San Martin, Buenos Aires, Argentina; [Verdun, Ramiro E.] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Miami	Nazer, E (corresponding author), UNSAM CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, San Martin, Buenos Aires, Argentina.	dsanchez@unsam.edu.ar		sanchez, daniel/0000-0002-5427-7764	National Agency for promotion of Science and Technology, (ANPCyT, Argentina) [PICT 2007-624]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)	National Agency for promotion of Science and Technology, (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Agency for promotion of Science and Technology, (ANPCyT, Argentina, PICT 2007-624 to D.O.S.) and by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2003, PLANT J, V36, P883, DOI 10.1046/j.1365-313X.2003.01932.x; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Avila ML, 2007, BIOCHEM BIOPH RES CO, V364, P26, DOI 10.1016/j.bbrc.2007.09.090; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Bercovich N, 2009, BIOCHEM BIOPH RES CO, V380, P850, DOI 10.1016/j.bbrc.2009.01.182; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brown JWS, 2005, NUCLEIC ACIDS RES, V33, pD633, DOI 10.1093/nar/gki052; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; De Carvalho Elizeu F., 1994, Biological Research, V27, P225; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Foldynova-Trantirkova S, 2005, INT J PARASITOL, V35, P359, DOI 10.1016/j.ijpara.2004.12.012; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gluenz E, 2007, INT J PARASITOL, V37, P617, DOI 10.1016/j.ijpara.2006.11.016; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Karni-Schmidt O, 2008, J CELL SCI, V121, P4098, DOI 10.1242/jcs.030098; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; LAIRD PW, 1987, NUCLEIC ACIDS RES, V15, P10087, DOI 10.1093/nar/15.24.10087; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Lee MGS, 1997, ANNU REV MICROBIOL, V51, P463, DOI 10.1146/annurev.micro.51.1.463; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lopez-Velazquez G, 2005, MICROSC MICROANAL, V11, P293, DOI 10.1017/S1431927605050233; Marchetti MA, 2000, J CELL SCI, V113, P899; MARTIN F, 1993, BIOCHEM BIOPH RES CO, V196, P1155, DOI 10.1006/bbrc.1993.2372; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Nepomuceno-Mejia T, 2010, FEMS MICROBIOL LETT, V313, P41, DOI 10.1111/j.1574-6968.2010.02117.x; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Tillemans V, 2006, PLANT CELL, V18, P3218, DOI 10.1105/tpc.106.044529; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Weighardt F, 1999, J CELL SCI, V112, P1465; Weingartner M, 2001, PLANT CELL, V13, P1929, DOI 10.1105/tpc.13.8.1929; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	65	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19920	10.1371/journal.pone.0019920	http://dx.doi.org/10.1371/journal.pone.0019920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629693	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005800016
J	Udelnow, A; Kreyes, A; Ellinger, S; Landfester, K; Walther, P; Klapperstueck, T; Wohlrab, J; Henne-Bruns, D; Knippschild, U; Wurl, P				Udelnow, Andrej; Kreyes, Andreas; Ellinger, Stefan; Landfester, Katharina; Walther, Paul; Klapperstueck, Thomas; Wohlrab, Johannes; Henne-Bruns, Doris; Knippschild, Uwe; Wuerl, Peter			Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; CHOLINE PHOSPHOLIPID-METABOLISM; MAGNETIC-RESONANCE-SPECTROSCOPY; BREAST-CANCER; IN-VITRO; MALIGNANT-TRANSFORMATION; EPITHELIAL-CELLS; TUMOR RESISTANCE; APOPTOTIC DEATH; DOSE-RESPONSES	Background: Omeprazole has recently been described as a modulator of tumour chemoresistance, although its underlying molecular mechanisms remain controversial. Since pancreatic tumours are highly chemoresistant, a logical step would be to investigate the pharmacodynamic, morphological and biochemical effects of omeprazole on pancreatic cancer cell lines. Methodology/Principal Findings: Dose-effect curves of omeprazole, pantoprazole, gemcitabine, 5-fluorouracil and the combinations of omeprazole and 5-fluorouracil or gemcitabine were generated for the pancreatic cancer cell lines MiaPaCa-2, ASPC-1, Colo357, PancTu-1, Panc1 and Panc89. They revealed that omeprazole inhibited proliferation at probably nontoxic concentrations and reversed the hormesis phenomena of 5-fluorouracil. Electron microscopy showed that omeprazole led to accumulation of phagophores and early autophagosomes in ASPC-1 and MiaPaCa-2 cells. Signal changes indicating inhibited proliferation and programmed cell death were found by proton NMR spectroscopy of both cell lines when treated with omeprazole which was identified intracellularly. Omeprazole modulates the lysosomal transport pathway as shown by Western blot analysis of the expression of LAMP-1, Cathepsin-D and beta-COP in lysosome-and Golgi complex containing cell fractions. Acridine orange staining revealed that the pump function of the vATPase was not specifically inhibited by omeprazole. Gene expression of the autophagy-related LC3 gene as well as of Bad, Mdr-1, Atg12 and the vATPase was analysed after treatment of cells with 5-fluorouracil and omeprazole and confirmed the above mentioned results. Conclusions: We hypothesise that omeprazole interacts with the regulatory functions of the vATPase without inhibiting its pump function. A modulation of the lysosomal transport pathway and autophagy is caused in pancreatic cancer cells leading to programmed cell death. This may circumvent common resistance mechanisms of pancreatic cancer. Since omeprazole use has already been established in clinical practice these results could lead to new clinical applications.	[Udelnow, Andrej; Henne-Bruns, Doris; Knippschild, Uwe; Wuerl, Peter] Univ Hosp Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany; [Kreyes, Andreas; Ellinger, Stefan] Univ Ulm, Inst Organ Chem Macromol Chem & Organ Mat, Ulm, Germany; [Landfester, Katharina] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Walther, Paul] Univ Ulm, Dept Elect Microscopy, Ulm, Germany; [Klapperstueck, Thomas; Wohlrab, Johannes] Univ Halle Wittenberg, Dept Dermatol & Venereol, Halle, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Martin Luther University Halle Wittenberg	Udelnow, A (corresponding author), St Franziskus Hosp, Dept Surg, Flensburg, Germany.	oberiu2@googlemail.com	Landfester, Katharina/F-9449-2011	Landfester, Katharina/0000-0001-9591-4638				Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aboagye EO, 1999, CANCER RES, V59, P80; Ackerstaff E, 2001, CANCER RES, V61, P3599; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Breedveld P, 2004, CANCER RES, V64, P5804, DOI 10.1158/0008-5472.CAN-03-4062; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2010, DOSE-RESPONSE, V8, P80, DOI 10.2203/dose-response.09-063.Calabrese; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Chinni SR, 1999, BIOCHEM J, V339, P599, DOI 10.1042/0264-6021:3390599; Chou T C, 1994, Contrib Gynecol Obstet, V19, P91; COWIE FJ, 1995, BRIT J CANCER, V71, P877, DOI 10.1038/bjc.1995.169; De Milito A, 2005, EXPERT OPIN PHARMACO, V6, P1049, DOI 10.1517/14656566.6.7.1049; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; ESPINA V, 2010, ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0010240; Fischbach W, 2004, GUT, V53, P34, DOI 10.1136/gut.53.1.34; FRUCHT H, 1991, DIGEST DIS SCI, V36, P394, DOI 10.1007/BF01298865; Garcea G, 2008, J PANCREAS, V9, P99; GENTRY J, 2004, R NEWS, V4, P14; Gjoen T, 1997, SUBCELLULAR FRACTION, P169; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; GRECO WR, 1990, CANCER RES, V50, P5318; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Griffin JL, 2003, CANCER RES, V63, P3195; Grochola LF, 2010, PANCREAS, V39, P76, DOI 10.1097/MPA.0b013e3181b9f105; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hettiarachchi KD, 2006, FOOD CHEM TOXICOL, V44, P1966, DOI 10.1016/j.fct.2006.06.023; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katagiri F, 2005, BIOL PHARM BULL, V28, P370, DOI 10.1248/bpb.28.370; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KLIONSKY DJ, 2003, AUTOPHAGY AUTOPHAGY, P1; Klotz U, 2004, BASIC CLIN PHARMACOL, V95, P2, DOI 10.1111/j.1600-0773.2004.pto950102.x; Kohler T, 2002, LEUKEMIA, V16, P22, DOI 10.1038/sj.leu.2402340; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Liu F, 2007, BIOL PHARM BULL, V30, P2279, DOI 10.1248/bpb.30.2279; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; MATTSSON JP, 1991, BIOCHIM BIOPHYS ACTA, V1065, P261, DOI 10.1016/0005-2736(91)90238-4; Mirossay L, 1999, PHYSIOL RES, V48, P135; Moka D, 1998, J PHARMACEUT BIOMED, V17, P125, DOI 10.1016/S0731-7085(97)00176-3; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Mori N, 2007, CANCER RES, V67, P11284, DOI 10.1158/0008-5472.CAN-07-2728; Nascarella MA, 2009, DOSE-RESPONSE, V7, P160, DOI 10.2203/dose-response.08-025.Nascarella; OKABE T, 1983, CANCER, V51, P662, DOI 10.1002/1097-0142(19830215)51:4<662::AID-CNCR2820510419>3.0.CO;2-X; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Pauli-Magnus C, 2001, N-S ARCH PHARMACOL, V364, P551, DOI 10.1007/s00210-001-0489-7; R Core Team, 2020, R LANG ENV STAT COMP; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; RENBERG L, 1989, DRUG METAB DISPOS, V17, P69; Ritz C, 2005, J STAT SOFTWARE, V12; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Trauzold A, 2003, BRIT J CANCER, V89, P1714, DOI 10.1038/sj.bjc.6601330; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yeo M, 2004, CLIN CANCER RES, V10, P8687, DOI 10.1158/1078-0432.CCR-04-1065; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118	70	82	85	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20143	10.1371/journal.pone.0020143	http://dx.doi.org/10.1371/journal.pone.0020143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629657	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800029
J	Si, YH; Liu, XY; Cheng, M; Wang, MR; Gong, QL; Yang, Y; Wang, TY; Yang, W				Si, Youhui; Liu, Xiuying; Cheng, Min; Wang, Maorong; Gong, Qiaoling; Yang, Yang; Wang, Tianyi; Yang, Wei			Growth Differentiation Factor 15 Is Induced by Hepatitis C Virus Infection and Regulates Hepatocellular Carcinoma-Related Genes	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; ACUTE CORONARY SYNDROME; TGF-BETA SUPERFAMILY; MESSENGER-RNA; CANCER; EXPRESSION; CELLS; LIVER; SEVERITY; PATHWAYS	Liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) are commonly induced by chronic hepatitis C virus (HCV) infection. We aimed to identify and characterize the involvement of previously screened cytokine GDF15 in HCV pathogenesis. We examined the GDF15 expression after HCV infection both in vitro and in vivo. Cultured JFH-1 HCV was used to determine the GDF15 function on virus propagation. GDF15 overexpression and RNA interference were employed to profile the GDF15-regulated genes, signaling pathways and cell biology phenotypes. The mRNA expression and protein secretion of GDF15 was dramatically increased in HCV-infected hepatoma cells, which maybe a host response to viral proteins or infection-induced cell stress. Patients infected with HCV had an average 15-fold higher blood GDF15 level than that of healthy volunteers. Three HCC individuals in the HCV cohort showed extremely high GDF15 concentrations. Transfection or exogenously supplied GDF15 enhanced HCV propagation, whereas knockdown of endogenous GDF15 resulted in inhibition of virus replication. Overexpressed GDF15 led to Akt activation and the phosphorylation of Akt downstream targeted GSK-3 beta and Raf. Several HCC-related molecules, such as E-cadherin, beta-catenin, Cyclin A2/B1/D1, were up-regulated by GDF15 stimulation in vitro. Overexpression of GDF15 in hepatoma cells resulted in increased DNA synthesis, promoted cell proliferation, and importantly enhanced invasiveness of the cells. In conclusion, these results suggest that an elevated serum GDF15 level is a potential diagnostic marker for viral hepatitis, and GDF15 may contribute to HCV pathogenesis by altering the signaling and growth of host cells.	[Si, Youhui; Liu, Xiuying; Cheng, Min; Gong, Qiaoling; Yang, Yang; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China; [Si, Youhui; Liu, Xiuying; Cheng, Min; Gong, Qiaoling; Yang, Yang; Yang, Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Maorong] 81st Hosp PLA, Liver Dis Ctr PLA, Nanjing, Peoples R China; [Wang, Tianyi] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Si, YH (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China.	wyang@ipb.pumc.edu.cn	Si, Youhui/O-6274-2017	Si, Youhui/0000-0001-8909-221X	Chinese Science and Technology Key Project [2008ZX10002-014, 2009ZX10004-303]; National Basic Research Program of China [2011CB504804]; National Natural Science Foundation of China [30970156]; Institute of Pathogen Biology [2010IPB102]	Chinese Science and Technology Key Project; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology	This work was supported by grants from the Chinese Science and Technology Key Project (2008ZX10002-014, 2009ZX10004-303), the National Basic Research Program of China (2011CB504804), National Natural Science Foundation of China (30970156) and an intramural grant from the Institute of Pathogen Biology (2010IPB102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Komurian-Pradel F, 2001, J VIROL METHODS, V95, P111, DOI 10.1016/S0166-0934(01)00300-7; Lee DH, 2003, CANCER RES, V63, P4648; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; ROULOT D, 1995, HEPATOLOGY, V21, P298, DOI 10.1002/hep.1840210206; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tsai JF, 1997, HEPATOLOGY, V25, P1141, DOI 10.1002/hep.510250516; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; von Wichert T, 2005, ONCOGENE, V24, P1284, DOI 10.1038/sj.onc.1208264; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Welsh JB, 2001, CANCER RES, V61, P5974; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200	33	36	38	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19967	10.1371/journal.pone.0019967	http://dx.doi.org/10.1371/journal.pone.0019967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625435	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000291005200020
J	Yu, J; Li, X; Wang, Y; Li, B; Li, HY; Li, YP; Zhou, WH; Zhang, CZ; Wang, YY; Rao, ZH; Bartlam, M; Cao, YJ				Yu, Jia; Li, Xin; Wang, Yu; Li, Bo; Li, Hongyue; Li, Yapeng; Zhou, Weihong; Zhang, Cuizhu; Wang, Yingying; Rao, Zihe; Bartlam, Mark; Cao, Youjia			PDlim2 Selectively Interacts with the PDZ Binding Motif of Highly Pathogenic Avian H5N1 Influenza A Virus NS1	PLOS ONE			English	Article							NF-KAPPA-B; STRUCTURAL BASIS; INFECTED-CELLS; PROTEIN; DOMAIN; GENE; DETERMINANTS; RECOGNITION; ACTIVATION; SEQUENCE	The multi-functional NS1 protein of influenza A virus is a viral virulence determining factor. The last four residues at the C-terminus of NS1 constitute a type I PDZ domain binding motif (PBM). Avian influenza viruses currently in circulation carry an NS1 PBM with consensus sequence ESEV, whereas human influenza viruses bear an NS1 PBM with consensus sequence RSKV or RSEV. The PBM sequence of the influenza A virus NS1 is reported to contribute to high viral pathogenicity in animal studies. Here, we report the identification of PDlim2 as a novel binding target of the highly pathogenic avian influenza virus H5N1 strain with an NS1 PBM of ESEV (A/Chicken/Henan/12/2004/H5N1, HN12-NS1) by yeast two-hybrid screening. The interaction was confirmed by in vitro GST pull-down assays, as well as by in vivo mammalian two-hybrid assays and bimolecular fluorescence complementation assays. The binding was also confirmed to be mediated by the interaction of the PDlim2 PDZ domain with the NS1 PBM motif. Interestingly, our assays showed that PDlim2 bound specifically with HN12-NS1, but exhibited no binding to NS1 from a human influenza H1N1 virus bearing an RSEV PBM (A/Puerto Rico/8/34/H1N1, PR8-NS1). A crystal structure of the PDlim2 PDZ domain fused with the C-terminal hexapeptide from HN12-NS1, together with GST pull-down assays on PDlim2 mutants, reveals that residues Arg16 and Lys31 of PDlim2 are critical for the binding between PDlim2 and HN12-NS1. The identification of a selective binding target of HN12-NS1 (ESEV), but not PR8-NS1 (RSEV), enables us to propose a structural mechanism for the interaction between NS1 PBM and PDlim2 or other PDZ-containing proteins.	[Yu, Jia; Li, Xin; Wang, Yu; Li, Bo; Li, Hongyue; Li, Yapeng; Zhou, Weihong; Zhang, Cuizhu; Rao, Zihe; Bartlam, Mark; Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yu, J (corresponding author), Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China.	bartlam@nankai.edu.cn; caoyj@nankai.edu.cn	Rao, Zihe/HCH-6944-2022; wang, yingying/GRS-3058-2022	Bartlam, Mark/0000-0001-5173-5080	National Natural Science Foundation of China [30599432, 31000345, 30870128]; National S&T Major Project on Major Infectious Diseases [2008ZX10001-010]; Ministry of Science and Technology 973 Project [2007CB914301, 2007CB914800, 2010CB530304]; Tianjin Municipal Science and Technology Commission [08SYSYTC00200, 08QTPTJC28200]; 111 Project [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project on Major Infectious Diseases; Ministry of Science and Technology 973 Project(National Basic Research Program of China); Tianjin Municipal Science and Technology Commission; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (grant numbers 30599432, 31000345 and 30870128) to Y. C., the National S&T Major Project on Major Infectious Diseases (grant numbers 2008ZX10001-010), the Ministry of Science and Technology 973 Project (grant numbers 2007CB914301, 2007CB914800, 2010CB530304), and the Tianjin Municipal Science and Technology Commission (grant numbers 08SYSYTC00200, 08QTPTJC28200). This work is also supported by the 111 Project, B08011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Healy NC, 2009, J LEUKOCYTE BIOL, V85, P481, DOI 10.1189/jlb.0408238; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; [Li Bo 李博], 2010, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V43, P29; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Thomas M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-25; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Tomarev SL, 2004, INVEST OPHTH VIS SCI, V45, pU314; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; Wakita K, 2001, CANCER RES, V61, P854; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	38	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19511	10.1371/journal.pone.0019511	http://dx.doi.org/10.1371/journal.pone.0019511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625420	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200003
J	Kim, J; Park, S; Blake, R				Kim, Jejoong; Park, Sohee; Blake, Randolph			Perception of Biological Motion in Schizophrenia and Healthy Individuals: A Behavioral and fMRI Study	PLOS ONE			English	Article							VISUAL-PERCEPTION; PROCESSING DEFICITS; IMPAIRED DETECTION; FROM-MOTION; MASKING; ATTENTION; DENSITY; DISCRIMINATION; REPRESENTATION; ORGANIZATION	Background: Anomalous visual perception is a common feature of schizophrenia plausibly associated with impaired social cognition that, in turn, could affect social behavior. Past research suggests impairment in biological motion perception in schizophrenia. Behavioral and functional magnetic resonance imaging (fMRI) experiments were conducted to verify the existence of this impairment, to clarify its perceptual basis, and to identify accompanying neural concomitants of those deficits. Methodology/Findings: In Experiment 1, we measured ability to detect biological motion portrayed by point-light animations embedded within masking noise. Experiment 2 measured discrimination accuracy for pairs of point-light biological motion sequences differing in the degree of perturbation of the kinematics portrayed in those sequences. Experiment 3 measured BOLD signals using event-related fMRI during a biological motion categorization task. Compared to healthy individuals, schizophrenia patients performed significantly worse on both the detection (Experiment 1) and discrimination (Experiment 2) tasks. Consistent with the behavioral results, the fMRI study revealed that healthy individuals exhibited strong activation to biological motion, but not to scrambled motion in the posterior portion of the superior temporal sulcus (STSp). Interestingly, strong STSp activation was also observed for scrambled or partially scrambled motion when the healthy participants perceived it as normal biological motion. On the other hand, STSp activation in schizophrenia patients was not selective to biological or scrambled motion. Conclusion: Schizophrenia is accompanied by difficulties discriminating biological from non-biological motion, and associated with those difficulties are altered patterns of neural responses within brain area STSp. The perceptual deficits exhibited by schizophrenia patients may be an exaggerated manifestation of neural events within STSp associated with perceptual errors made by healthy observers on these same tasks. The present findings fit within the context of theories of delusion involving perceptual and cognitive processes.	[Kim, Jejoong; Park, Sohee; Blake, Randolph] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Kim, Jejoong; Park, Sohee; Blake, Randolph] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Blake, Randolph] Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN USA	Seoul National University (SNU); Vanderbilt University; Vanderbilt University	Kim, J (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	Jejoong3@snu.ac.kr		Park, Sohee/0000-0003-3797-4776	NARSAD; Ministry of Education, Science and Technology, Korea [R31-10089]	NARSAD(NARSAD); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by NARSAD, and WCU program (R31-10089) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Bandettini PA, 2000, MAGNET RESON MED, V43, P540, DOI 10.1002/(SICI)1522-2594(200004)43:4<540::AID-MRM8>3.0.CO;2-R; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Blackwood NJ, 2001, AM J PSYCHIAT, V158, P527, DOI 10.1176/appi.ajp.158.4.527; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brugger P, 1997, Cogn Neuropsychiatry, V2, P251, DOI 10.1080/135468097396270; BRUGGER P, 1993, PSYCHOPATHOLOGY, V26, P261, DOI 10.1159/000284831; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Cadenhead KS, 1998, BIOL PSYCHIAT, V43, P132, DOI 10.1016/S0006-3223(97)00316-8; Cavanagh P, 1991, Spat Vis, V5, P303, DOI 10.1163/156856891X00065; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Clementz BA, 1996, PSYCHOPHYSIOLOGY, V33, P650, DOI 10.1111/j.1469-8986.1996.tb02360.x; Collerton D, 2005, BEHAV BRAIN SCI, V28, P737; CUTTING JE, 1988, PERCEPT PSYCHOPHYS, V44, P339, DOI 10.3758/BF03210415; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Doniger GM, 2001, NEUROIMAGE, V13, P305, DOI 10.1006/nimg.2000.0684; First MB, 2002, STRUCTURED CLIN INTE; Foxe JJ, 2001, NEUROREPORT, V12, P3815, DOI 10.1097/00001756-200112040-00043; Gale HJ, 2000, SCHIZOPHR RES, V46, P149, DOI 10.1016/S0920-9964(00)00006-2; Green MF, 1997, ARCH GEN PSYCHIAT, V54, P465; Green MF, 2010, CURR DIR PSYCHOL SCI, V19, P243, DOI 10.1177/0963721410377600; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grossman ED, 2004, J COGNITIVE NEUROSCI, V16, P1669, DOI 10.1162/0898929042568569; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Herzog MH, 2004, PSYCHIAT RES, V129, P55, DOI 10.1016/j.psychres.2004.06.008; Hiris E, 2005, PERCEPT PSYCHOPHYS, V67, P435, DOI 10.3758/BF03193322; Ishai A, 2000, NEURON, V22, P189; Izawa R, 2002, SCHIZOPHR RES, V53, P67, DOI 10.1016/S0920-9964(00)00116-X; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jung WH, 2009, EUR ARCH PSY CLIN N, V259, P46, DOI 10.1007/s00406-008-0833-8; Kantrowitz JT, 2009, SCHIZOPHRENIA BULL, V35, P1085, DOI 10.1093/schbul/sbp100; Karlsgodt KH, 2010, CURR DIR PSYCHOL SCI, V19, P226, DOI 10.1177/0963721410377601; Kelemen O, 2005, NEUROPSYCHOLOGY, V19, P494, DOI 10.1037/0894-4105.19.4.494; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim JJ, 2005, SCHIZOPHR RES, V77, P299, DOI 10.1016/j.schres.2005.04.006; Knight RA, 2000, J ABNORM PSYCHOL, V109, P575, DOI 10.1037//0021-843X.109.4.575; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Langdon R, 2000, MIND LANG, V15, P184, DOI 10.1111/1468-0017.00129; Li CSR, 2002, PROG NEURO-PSYCHOPH, V26, P929, DOI 10.1016/S0278-5846(02)00207-5; Lou HC, 2011, J VISION, V11, DOI 10.1167/11.2.15; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Maher BA, 2002, DELUSIONS COMPREHE 2, P309; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McLeod P, 1996, VIS COGN, V3, P363, DOI 10.1080/135062896395634; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; O'Donnell BF, 2002, J ABNORM PSYCHOL, V111, P620, DOI 10.1037//0021-843X.111.4.620; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1299, DOI 10.1016/S0028-3932(97)00005-5; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1289, DOI 10.1016/S0028-3932(97)00004-3; SCHWARTZ BD, 1983, BIOL PSYCHIAT, V18, P1311; Sekuler R, 2002, STEVENS HDB EXPT PSY, V1; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Silverstein SM, 1996, J ABNORM PSYCHOL, V105, P410, DOI 10.1037/0021-843X.105.3.410; Silverstein Steven M, 2006, Cogn Neuropsychiatry, V11, P112, DOI 10.1080/13546800444000209; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stuve TA, 1997, PSYCHOL MED, V27, P143, DOI 10.1017/S0033291796004230; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Talairach J., 1988, COPLANAR STEREOTAXIC; Thakkar KN, 2011, BIOL PSYCHIAT, V69, P55, DOI 10.1016/j.biopsych.2010.08.016; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; VAINA LM, 1990, VISUAL NEUROSCI, V5, P353, DOI 10.1017/S0952523800000444; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	86	60	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19971	10.1371/journal.pone.0019971	http://dx.doi.org/10.1371/journal.pone.0019971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625492	gold, Green Published, Green Submitted			2022-12-27	WOS:000290793400026
J	Szabo, NE; Zhao, TY; Cankaya, M; Stoykova, A; Zhou, XL; Alvarez-Bolado, G				Szabo, Nora-Emoeke; Zhao, Tianyu; Cankaya, Murat; Stoykova, Anastassia; Zhou, Xunlei; Alvarez-Bolado, Gonzalo			Interaction between Axons and Specific Populations of Surrounding Cells Is Indispensable for Collateral Formation in the Mammillary System	PLOS ONE			English	Article							EMBRYONIC MOUSE FOREBRAIN; IN-SITU HYBRIDIZATION; MILK-EJECTION REFLEX; WINGED HELIX GENE; PAX6 MUTANT MICE; TARGET RECOGNITION; MAMMILLOTHALAMIC TRACT; BOUNDARY FORMATION; ADHESION MOLECULE; RAT HYPOTHALAMUS	Background: An essential phenomenon during brain development is the extension of long collateral branches by axons. How the local cellular environment contributes to the initial sprouting of these branches in specific points of an axonal shaft remains unclear. Methodology/Principal Findings: The principal mammillary tract (pm) is a landmark axonal bundle connecting ventral diencephalon to brainstem (through the mammillotegmental tract, mtg). Late in development, the axons of the principal mammillary tract sprout collateral branches at a very specific point forming a large bundle whose target is the thalamus. Inspection of this model showed a number of distinct, identified cell populations originated in the dorsal and the ventral diencephalon and migrating during development to arrange themselves into several discrete groups around the branching point. Further analysis of this system in several mouse lines carrying mutant alleles of genes expressed in defined subpopulations (including Pax6, Foxb1, Lrp6 and Gbx2) together with the use of an unambiguous genetic marker of mammillary axons revealed: 1) a specific group of Pax6-expressing cells in close apposition with the prospective branching point is indispensable to elicit axonal branching in this system; and 2) cooperation of transcription factors Foxb1 and Pax6 to differentially regulate navigation and fasciculation of distinct branches of the principal mammillary tract. Conclusions/Significance: Our results define for the first time a model system where interaction of the axonal shaft with a specific group of surrounding cells is essential to promote branching. Additionally, we provide insight on the cooperative transcriptional regulation necessary to promote and organize an intricate axonal tree.	[Szabo, Nora-Emoeke; Zhao, Tianyu; Zhou, Xunlei; Alvarez-Bolado, Gonzalo] Max Planck Inst Biophys Chem, Brain Dev Grp, D-37077 Gottingen, Germany; [Cankaya, Murat] Erzincan Univ, Fac Sci & Art, Dept Biol, Erzincan, Turkey; [Stoykova, Anastassia] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society; Erzincan Binali Yildirim University; Max Planck Society	Szabo, NE (corresponding author), IRCM, Montreal, PQ, Canada.	alvarez@ana.uni-heidelberg.de		Alvarez-Bolado, Gonzalo/0000-0002-3044-1603	Max Planck Society; Deutsche Forschungsgemeinschaft [AL 603]; NICHD [IA 52242]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work was supported by the Max Planck Society and by the Deutsche Forschungsgemeinschaft Grant AL 603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Andrea Wizenmann (University of Tubingen) and Herbert Hildebrandt (University of Hannover) made valuable comments on the text. Michael Heide (University of Heidelberg) assisted with the confocal microscopy. The anti-Pax6 antibody, developed by A. Kawakami, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Alpeeva EV, 2009, BRAIN RES, V1248, P1, DOI 10.1016/j.brainres.2008.10.060; ALTMAN J, 1986, ADV ANAT EMBRYOL CEL, V100, P1; Alvarez-Bolado G, 2000, DEV NEUROSCI-BASEL, V22, P197, DOI 10.1159/000017442; Alvarez-Bolado G, 2000, DEVELOPMENT, V127, P1029; Andrews GL, 2003, J NEUROSCI, V23, P9873; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bayer Shirley A., 1995, P1041; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CANTERAS NS, 1992, P NATL ACAD SCI USA, V89, P10089, DOI 10.1073/pnas.89.21.10089; Daston MM, 1996, J NEUROSCI, V16, P5488; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duncan MK, 2000, J CELL SCI, V113, P3173; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; EASTER SS, 1993, J NEUROSCI, V13, P285; Gallo G, 1999, J NEUROSCI, V19, P3860; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Grinchuk O, 2005, J BIOL CHEM, V280, P35228, DOI 10.1074/jbc.M506195200; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HAYAKAWA T, 1989, J COMP NEUROL, V284, P1, DOI 10.1002/cne.902840102; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JEANNETEAU F, 2010, NAT NEUROSCI, DOI DOI 10.1242/DEV.046441; Jelsing J, 2008, NEUROSCIENCE, V154, P641, DOI 10.1016/j.neuroscience.2008.03.051; Jones L, 2002, DEVELOPMENT, V129, P5041; Kaestner KH, 1996, MECH DEVELOP, V55, P221, DOI 10.1016/0925-4773(96)00507-2; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kloetzli JM, 2001, GENESIS, V29, P60, DOI 10.1002/1526-968X(200102)29:2<60::AID-GENE1006>3.0.CO;2-L; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Mastick GS, 1997, DEVELOPMENT, V124, P1985; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Meech R, 1999, P NATL ACAD SCI USA, V96, P2420, DOI 10.1073/pnas.96.5.2420; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nural HF, 2004, J COMP NEUROL, V479, P399, DOI 10.1002/cne.20317; OLEARY DDM, 1990, COLD SH Q B, V55, P453; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Pinon MC, 2008, J NEUROSCI, V28, P8724, DOI 10.1523/JNEUROSCI.2565-08.2008; Pratt T, 2000, DEVELOPMENT, V127, P5167; Puelles L., 2004, RAT NERVOUS SYSTEM, P3, DOI [10.1016/b978-012547638-6/50002-x, DOI 10.1016/B978-012547638-6/50002-X]; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; Scholpp S, 2010, TRENDS NEUROSCI, V33, P373, DOI 10.1016/j.tins.2010.05.003; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Tsuchiya R, 2009, J NEUROSCI RES, V87, P1620, DOI 10.1002/jnr.21966; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Valverde F, 2000, J COMP NEUROL, V419, P485; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Wehr R, 1997, DEVELOPMENT, V124, P4447; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhao TY, 2008, EUR J NEUROSCI, V28, P1941, DOI 10.1111/j.1460-9568.2008.06503.x; Zhao TY, 2007, GENESIS, V45, P781, DOI 10.1002/dvg.20356; Zhou CJ, 2004, J NEUROSCI, V24, P7632, DOI 10.1523/JNEUROSCI.2123-04.2004; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	69	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20315	10.1371/journal.pone.0020315	http://dx.doi.org/10.1371/journal.pone.0020315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625468	gold, Green Published			2022-12-27	WOS:000290793400055
J	Bai, QF; Shen, YL; Yao, XJ; Wang, F; Du, YP; Wang, Q; Jin, NZ; Hai, J; Hu, TJ; Yang, JB				Bai, Qifeng; Shen, Yulin; Yao, Xiaojun; Wang, Fang; Du, Yuping; Wang, Qin; Jin, Nengzhi; Hai, Jun; Hu, Tiejun; Yang, Jinbo			Modeling a New Water Channel That Allows SET9 to Dimethylate p53	PLOS ONE			English	Article							LYSINE METHYLTRANSFERASE SET7/9; COVALENT HISTONE MODIFICATIONS; MOLECULAR-DYNAMICS SIMULATION; FULL-LENGTH INTEGRASE; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; ACTIVE-SITE; DNA COMPLEX; METHYLATION; TRANSCRIPTION	SET9, a protein lysine methyltransferase, has been thought to be capable of transferring only one methyl group to target lysine residues. However, some reports have pointed out that SET9 can dimethylate Lys372 of p53 (p53-K372) and Lys4 of histone H3 (H3-K4). In order to understand how p53 can be dimethylated by SET9, we measured the radius of the channel that surrounds p53-K372, first on the basis of the crystal structure of SET9, and we show that the channel is not suitable for water movement. Second, molecular dynamic (MD) simulations were carried out for 204 ns on the crystal structure of SET9. The results show that water leaves the active site of SET9 through a new channel, which is made of G292, A295, Y305 and Y335. In addition, the results of molecular docking and MD simulations indicate that the new water channel continues to remain open when S-adenosyl-L-methionine (AdoMet) or S-adenosyl-L-homocysteine (AdoHcy) is bound to SET9. The changes in the radii of these two channels were measured in the equilibrium phase at the constant temperature of 300 K. The results indicate that the first channel still does not allow water to get into or out of the active site, but the new channel is large enough to allow this water to circulate. Our results indicate that water can be removed from the active site, an essential process for allowing the dimethylation reaction to occur.	[Bai, Qifeng; Wang, Fang; Du, Yuping; Wang, Qin; Hai, Jun; Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Shen, Yulin; Jin, Nengzhi; Hu, Tiejun] Gansu Comp Ctr, Lanzhou, Gansu, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Sch Chem, Lanzhou 730000, Gansu, Peoples R China; [Yang, Jinbo] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA	Lanzhou University; Lanzhou University; Cleveland Clinic Foundation	Bai, QF (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	htj@mail.gspcc.com; yangjb@lzu.edu.cn	Yang, Jinbo/AAM-9580-2020; Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187	Ministry of Education [NCET-08-0260]; Ministry of Science and Technology of the People's Republic of China [2009DFA30990]; Gansu Provincial Science and Technology [0708WCGA149]; China's Ministry of Science; Innovative Team-Building Program of Gansu Province [098TTCA007]	Ministry of Education; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Gansu Provincial Science and Technology; China's Ministry of Science; Innovative Team-Building Program of Gansu Province	This work was supported by grants NCET-08-0260 from Ministry of Education and 2009DFA30990 from Ministry of Science and Technology of the People's Republic of China; 0708WCGA149 from the Gansu Provincial Science and Technology to J.Y.; 2009AA01A130 from China's Ministry of Science 863 and 098TTCA007 from Innovative Team-Building Program of Gansu Province to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Chakrabarti SK, 2003, J BIOL CHEM, V278, P23617, DOI 10.1074/jbc.M303423200; *CHEMAXON, 2009, MARV WAS US DRAW DIS; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; De Luca L, 2003, BIOCHEM BIOPH RES CO, V310, P1083, DOI 10.1016/j.bbrc.2003.09.120; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; FRISCH MJ, 1998, GAUSSIAN98 REVISION; Garcia-Fandino R, 2009, J AM CHEM SOC, V131, P15678, DOI 10.1021/ja903400n; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nicholls P, 2000, CELL MOL LIFE SCI, V57, P987, DOI 10.1007/PL00000751; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ruiz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003230; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang SL, 2007, J PHYS CHEM B, V111, P3758, DOI 10.1021/jp067147i; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107	39	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19856	10.1371/journal.pone.0019856	http://dx.doi.org/10.1371/journal.pone.0019856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625555	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200027
J	Kang, YS; Kim, W; Huh, YH; Bae, J; Kim, JS; Song, WK				Kang, Yong Seok; Kim, Wook; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun			P130Cas Attenuates Epidermal Growth Factor (EGF) Receptor Internalization by Modulating EGF-Triggered Dynamin Phosphorylation	PLOS ONE			English	Article							ADAPTER PROTEIN CAS; TYROSINE PHOSPHORYLATION; C-SRC; SIGNAL-TRANSDUCTION; ERBB RECEPTORS; ENDOCYTOSIS; CELLS; ACTIVATION; KINASE; CANCER	Background: Endocytosis controls localization-specific signal transduction via epidermal growth factor receptor (EGFR), as well as downregulation of that receptor. Extracellular matrix (ECM)-integrin coupling induces formation of macromolecular complexes that include EGFR, integrin, Src kinase and p130Cas, resulting in EGFR activation. In addition, cell adhesion to ECM increases EGFR localization at the cell surface and reduces EGFR internalization. The molecular mechanisms involved are not yet well understood. Methodology/Principal Findings: We investigated the molecular mechanism by which p130Cas affects the endocytic regulation of EGFR. Biochemical quantification revealed that cell adhesion to fibronectin (FN) increases total EGFR levels and its phosphorylation, and that p130Cas is required for this process. Measurements of Texas Red-labeled EGF uptake and cell surface EGFR revealed that p130Cas overexpression reduces EGF-induced EGFR internalization, while p130Cas depletion enhances it. In addition, both FN-mediated cell adhesion and p130Cas overexpression reduce EGF-stimulated dynamin phosphorylation, which is necessary for EGF-induced EGFR internalization. Coimmunoprecipitation and GST pull-down assays confirmed the interaction between p130Cas and dynamin. Moreover, a SH3-domain-deleted form of p130Cas, which shows diminished binding to dynamin, inhibits dynamin phosphorylation and EGF uptake less effectively than wild-type p130Cas. Conclusions/Significance: Our results show that p130Cas plays an inhibitory role in EGFR internalization via its interaction with dynamin. Given that the EGFR internalization process determines signaling density and specificity in the EGFR pathway, these findings suggest that the interaction between p130Cas and dynamin may regulate EGFR trafficking and signaling in the same manner as other endocytic regulatory proteins related to EGFR endocytosis.	[Kang, Yong Seok; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Kang, Yong Seok; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun] Gwangju Inst Sci & Technol, Bio Imaging & Cell Dynam Res Ctr, Kwangju, South Korea; [Kim, Wook] NIA, Diabet Sect, NIH, Baltimore, MD 21224 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kang, YS (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Bio Imaging Research Center at GIST; Cell Dynamic Research Center [20100001616]; Korea Foundation for Cancer Research [KFCR-2009-001]; Mid-career Researcher Program [20100000344]; Korean Government (MEST) [2010K001181]	Bio Imaging Research Center at GIST; Cell Dynamic Research Center; Korea Foundation for Cancer Research; Mid-career Researcher Program; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Bio Imaging Research Center at GIST, the Cell Dynamic Research Center (20100001616), the Korea Foundation for Cancer Research (KFCR-2009-001), the Mid-career Researcher Program (20100000344), and the Converging Research Center Program (2010K001181) funded by the Korean Government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee JW, 2004, MOL CELLS, V17, P188; Lie PPY, 2006, J ENDOCRINOL, V191, P571, DOI 10.1677/joe.1.06996; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97	45	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20125	10.1371/journal.pone.0020125	http://dx.doi.org/10.1371/journal.pone.0020125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625594	Green Submitted, gold, Green Published			2022-12-27	WOS:000290720200065
J	Patel, SJ; Jindal, R; King, KR; Tilles, AW; Yarmush, ML				Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.			The Inflammatory Response to Double Stranded DNA in Endothelial Cells Is Mediated by NF kappa B and TNF alpha	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; INTRACELLULAR DNA; BACTERIAL-DNA; RECOGNITION; EXPRESSION; INFECTION; DISEASE; VIRUS; AIM2; ACTIVATION	Endothelial cells represent an important barrier between the intravascular compartment and extravascular tissues, and therefore serve as key sensors, communicators, and amplifiers of danger signals in innate immunity and inflammation. Double stranded DNA (dsDNA) released from damaged host cells during injury or introduced by pathogens during infection, has emerged as a potent danger signal. While the dsDNA-mediated immune response has been extensively studied in immune cells, little is known about the direct and indirect effects of dsDNA on the vascular endothelium. In this study we show that direct dsDNA stimulation of endothelial cells induces a potent proinflammatory response as demonstrated by increased expression of ICAM1, E-selectin and VCAM1, and enhanced leukocyte adhesion. This response was dependent on the stress kinases JNK and p38 MAPK, required the activation of proinflammatory transcription factors NF kappa B and IRF3, and triggered the robust secretion of TNF alpha for sustained secondary activation of the endothelium. DNA-induced TNF alpha secretion proved to be essential in vivo, as mice deficient in the TNF receptor were unable to mount an acute inflammatory response to dsDNA. Our findings suggest that the endothelium plays an active role in mediating dsDNA-induced inflammatory responses, and implicate its importance in establishing an acute inflammatory response to sterile injury or systemic infection, where host or pathogen derived dsDNA may serve as a danger signal.	[Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; [Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Patel, Suraj J.; Jindal, Rohit; King, Kevin R.; Tilles, Arno W.; Yarmush, Martin L.] Shriners Burns Hosp, Boston, MA USA; [Patel, Suraj J.; Yarmush, Martin L.] Harvard Univ, MIT, Sch Med, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jindal, Rohit; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick	Patel, SJ (corresponding author), Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA.	ireis@sbi.org		Yarmush, Martin/0000-0003-4986-8444	Department of Defense CDMRP; NIH BioMEMS Resource Center [P41 EB-002503]; NIH [RO1AI063795]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	Department of Defense CDMRP(United States Department of Defense); NIH BioMEMS Resource Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	SJP was supported in part by a Department of Defense CDMRP Predoctoral Training Award. The work was supported by NIH BioMEMS Resource Center Grant P41 EB-002503, NIH Grant RO1AI063795, and a grant from the Shriners Hospital for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; GERSON SL, 1985, J CLIN INVEST, V76, P1382, DOI 10.1172/JCI112114; Grundy JE, 1998, J INFECT DIS, V177, P1465, DOI 10.1086/515300; Heidemann J, 2006, INFECT IMMUN, V74, P5425, DOI 10.1128/IAI.00248-06; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jindal R, 2011, TISSUE ENG PART C-ME, V17, P113, DOI [10.1089/ten.tec.2009.0782, 10.1089/ten.TEC.2009.0782]; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; JONES K, 1995, J EXP MED, V182, P1213, DOI 10.1084/jem.182.5.1213; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuvin JT, 2003, CIRCULATION, V107, P3243, DOI 10.1161/01.CIR.0000075928.54461.33; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Rafii S, 2001, CIRC RES, V88, P903, DOI 10.1161/hh0901.089884; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; VANE JR, 1990, NEW ENGL J MED, V323, P27; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wieder KJ, 2005, BIOMED MICRODEVICES, V7, P213, DOI 10.1007/s10544-005-3028-3; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19910	10.1371/journal.pone.0019910	http://dx.doi.org/10.1371/journal.pone.0019910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611132	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200046
J	Da Lage, JL; Maczkowiak, F; Cariou, ML				Da Lage, Jean-Luc; Maczkowiak, Frederique; Cariou, Marie-Louise			Phylogenetic Distribution of Intron Positions in AlphaAmylase Genes of Bilateria Suggests Numerous Gains and Losses	PLOS ONE			English	Article							AMYLASE MULTIGENE FAMILY; SPLICEOSOMAL INTRONS; MOLECULAR PHYLOGENY; DIVERGENCE TIMES; AMYREL GENE; RICH GENES; EVOLUTION; EXON; SEQUENCE; GENOME	Most eukaryotes have at least some genes interrupted by introns. While it is well accepted that introns were already present at moderate density in the last eukaryote common ancestor, the conspicuous diversity of intron density among genomes suggests a complex evolutionary history, with marked differences between phyla. The question of the rates of intron gains and loss in the course of evolution and factors influencing them remains controversial. We have investigated a single gene family, alpha-amylase, in 55 species covering a variety of animal phyla. Comparison of intron positions across phyla suggests a complex history, with a likely ancestral intronless gene undergoing frequent intron loss and gain, leading to extant intron/exon structures that are highly variable, even among species from the same phylum. Because introns are known to play no regulatory role in this gene and there is no alternative splicing, the structural differences may be interpreted more easily: intron positions, sizes, losses or gains may be more likely related to factors linked to splicing mechanisms and requirements, and to recognition of introns and exons, or to more extrinsic factors, such as life cycle and population size. We have shown that intron losses outnumbered gains in recent periods, but that "resets'' of intron positions occurred at the origin of several phyla, including vertebrates. Rates of gain and loss appear to be positively correlated. No phase preference was found. We also found evidence for parallel gains and for intron sliding. Presence of introns at given positions was correlated to a strong protosplice consensus sequence AG/G, which was much weaker in the absence of intron. In contrast, recent intron insertions were not associated with a specific sequence. In animal Amy genes, population size and generation time seem to have played only minor roles in shaping gene structures.	[Da Lage, Jean-Luc; Maczkowiak, Frederique; Cariou, Marie-Louise] CNRS, UPR 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Maczkowiak, Frederique] Univ Paris 11, Inst Curie, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Da Lage, JL (corresponding author), CNRS, UPR 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France.	jldl@legs.cnrs-gif.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was funded by regular annual funding from the CNRS (www.cnrs.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Ahmadinejad N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-57; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; BASU MK, 2007, MOL BIOL EV IN PRESS; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BREATHNACH R, 1977, NATURE, V270, P314, DOI 10.1038/270314a0; BROWN CJ, 1990, GENETICS, V126, P131; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CAVALIERSMITH T, 2006, PHILOS T ROYAL SOC, V361; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Coulombe-Huntington J, 2008, INTRON LOSS GAIN EUK; Coulombe-Huntington J, 2007, MOL BIOL EVOL, V24, P2842, DOI 10.1093/molbev/msm235; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Da Lage JL, 2007, FEBS LETT, V581, P3927, DOI 10.1016/j.febslet.2007.07.019; Da Lage JL, 2002, BIOLOGIA, V57, P181; Da Lage JL, 2003, J MOL EVOL, V57, P355, DOI 10.1007/s00239-003-2488-4; DaLage JL, 1996, J MOL EVOL, V43, P334, DOI 10.1007/PL00006093; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; DENOEUD F, 2010, SCIENCE; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Doddapaneni H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-92; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drouin G, 1997, J MOL EVOL, V45, P509, DOI 10.1007/PL00006255; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Edvardsen RB, 2004, J MOL EVOL, V59, P448, DOI 10.1007/s00239-004-2636-5; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Feiber AL, 2002, J MOL EVOL, V55, P401, DOI 10.1007/s00239-002-2336-y; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Frugoli JA, 1998, GENETICS, V149, P355; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Grimaldi David, 2005, pi; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; Hager KP, 1996, FEBS LETT, V387, P94, DOI 10.1016/0014-5793(96)00477-2; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HUANG N, 1992, P NATL ACAD SCI USA, V89, P7526, DOI 10.1073/pnas.89.16.7526; JANECEK S, 1994, EUR J BIOCHEM, V224, P519, DOI 10.1111/j.1432-1033.1994.00519.x; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Knowles DG, 2006, MOL BIOL EVOL, V23, P1548, DOI 10.1093/molbev/msl017; KOONIN EV, 2006, BIOL DIRECT, V1, DOI DOI 10.1186/1745-6150-1181-1122; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Krzywinski J, 2002, MOL BIOL EVOL, V19, P362, DOI 10.1093/oxfordjournals.molbev.a004091; Kvist AP, 1999, MATRIX BIOL, V18, P261, DOI 10.1016/S0945-053X(99)00018-9; Lecointre G., 2017, CLASSIFICATION PHYLO; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; LOH TH, 2008, MOL BIOL EVOL, V25, P526; Long MY, 2000, MOL BIOL EVOL, V17, P1789, DOI 10.1093/oxfordjournals.molbev.a026279; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Lynch M, 2007, ORIGINS GENOME ARCHI; Maczkowiak F, 2006, GENETICA, V128, P145, DOI 10.1007/s10709-005-5578-y; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Matthews CM, 1998, J MOL EVOL, V47, P763, DOI 10.1007/PL00006435; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; RAGG H, 2010, CELLULAR MOL LIFE SC; RAGG H, 2009, BMC EVOLUTIONARY BIO, V9, DOI DOI 10.1186/1471-2148/1189/1208; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; Roy SW, 2006, TRENDS GENET, V22, P468, DOI 10.1016/j.tig.2006.07.002; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schmitt DM, 2001, J MOL EVOL, V53, P703, DOI 10.1007/s002390010257; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stoltzfus A, 2004, CURR BIOL, V14, pR351, DOI 10.1016/j.cub.2004.04.024; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Sullivan James C, 2006, Genome Inform, V17, P219; SUTLIFF TD, 1991, PLANT MOL BIOL, V16, P579, DOI 10.1007/BF00023423; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Sverdlov AV, 2004, GENE, V338, P85, DOI 10.1016/j.gene.2004.05.027; Sverdlov AV, 2004, CURR BIOL, V14, P1505, DOI 10.1016/j.cub.2004.08.027; Sverdlov AV, 2003, CURR BIOL, V13, P2170, DOI 10.1016/j.cub.2003.12.003; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinogradov AE, 2001, J MOL EVOL, V52, P2, DOI 10.1007/s002390010128; Wada H, 2002, J MOL EVOL, V54, P118, DOI 10.1007/s00239-001-0024-y; WALCHLI C, 1992, EUR J BIOCHEM, V205, P583, DOI 10.1111/j.1432-1033.1992.tb16816.x; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Zhang Z, 2003, J MOL EVOL, V56, P121, DOI 10.1007/s00239-002-2384-3	116	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19673	10.1371/journal.pone.0019673	http://dx.doi.org/10.1371/journal.pone.0019673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611157	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500011
J	Moura-Alves, P; Neves-Costa, A; Raquel, H; Pacheco, TR; D'Almeida, B; Rodrigues, R; Cadima-Couto, I; Chora, A; Oliveira, M; Gama-Carvalho, M; Hacohen, N; Moita, LF				Moura-Alves, Pedro; Neves-Costa, Ana; Raquel, Helena; Pacheco, Teresa Raquel; D'Almeida, Bruno; Rodrigues, Raquel; Cadima-Couto, Iris; Chora, Angelo; Oliveira, Mariana; Gama-Carvalho, Margarida; Hacohen, Nir; Moita, Luis F.			An shRNA-Based Screen of Splicing Regulators Identifies SFRS3 as a Negative Regulator of IL-1 beta Secretion	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; SIGNALING PATHWAY; IMMUNE-RESPONSES; INFLAMMASOME; ACTIVATION; RECEPTOR; RIBONUCLEOPROTEIN; TRANSCRIPTION; CONSEQUENCES; SPLICEOSOME	The generation of diversity and plasticity of transcriptional programs are key components of effective vertebrate immune responses. The role of Alternative Splicing has been recognized, but it is underappreciated and poorly understood as a critical mechanism for the regulation and fine-tuning of physiological immune responses. Here we report the generation of loss-of-function phenotypes for a large collection of genes known or predicted to be involved in the splicing reaction and the identification of 19 novel regulators of IL-1 beta secretion in response to E. coli challenge of THP-1 cells. Twelve of these genes are required for IL-1 beta secretion, while seven are negative regulators of this process. Silencing of SFRS3 increased IL-1 beta secretion due to elevation of IL-1 beta and caspase-1 mRNA in addition to active caspase-1 levels. This study points to the relevance of splicing in the regulation of auto-inflammatory diseases.	[Moura-Alves, Pedro; Neves-Costa, Ana; Raquel, Helena; Pacheco, Teresa Raquel; D'Almeida, Bruno; Rodrigues, Raquel; Cadima-Couto, Iris; Chora, Angelo; Moita, Luis F.] Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal; [Oliveira, Mariana; Gama-Carvalho, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biodiversidade Genom Func & Integrat BioFIG, Lisbon, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA USA; [Hacohen, Nir] MIT & Harvard, Broad Inst, Cambridge, MA USA	Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Moura-Alves, P (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.	lmoita@fm.ul.pt	Moura-Alves, Pedro/R-7727-2016; Ferreira Chora, Angelo/AAZ-6503-2021; Moita, Luis F./L-1296-2013; Gama-Carvalho, Margarida/E-6180-2012; Carvalho, Margarida/GZA-4406-2022; Alves, Pedro Moura/AAX-6854-2020; Rodrigues, Raquel/GZM-7677-2022; Moita, Luis/HCI-2793-2022; Neves-Costa, Ana/AAJ-7066-2021	Moura-Alves, Pedro/0000-0003-4337-9113; Ferreira Chora, Angelo/0000-0002-7941-7196; Moita, Luis F./0000-0003-0707-315X; Gama-Carvalho, Margarida/0000-0002-0365-6916; Moita, Luis/0000-0003-0707-315X; Neves-Costa, Ana/0000-0001-6506-7829; Rodrigues, Raquel/0000-0002-7557-1815; Pacheco, Teresa/0000-0002-5506-0233; Raquel, Helena/0000-0001-6008-6852	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/100780/2008, PIC/IC/82991/2007]	Fundacao Luso-Americana para o Desenvolvimento; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	L.F.M. is a Young Investigator from the Human Frontier Science Program (www.hfsp.org) and receives support from Fundacao Luso-Americana para o Desenvolvimento (http://www.flad.pt/) and Fundacao para a Ciencia e a Tecnologia (http://alfa.fct.mctes.pt/); (PTDC/SAU-MII/100780/2008 and PIC/IC/82991/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraldi PG, 2003, J MED CHEM, V46, P1318, DOI 10.1021/jm021049d; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MISHRA BB, CELL MICROBIOL; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; NETEA MG, PLOS PATHOG, V6; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; SIMS GP, ANN REV IMMUNOL, V28, P367; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Swiggard WJ., 2001, CURR PROTOC IMMUNOL, V86, P1, DOI [DOI 10.1002/0471142735.IM0307S25, 10.1002/0471142735.im0307s25]; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WEINTZ G, MOL SYST BIOL, V6, P371; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19829	10.1371/journal.pone.0019829	http://dx.doi.org/10.1371/journal.pone.0019829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611201	Green Submitted, Green Published, gold			2022-12-27	WOS:000290657500027
J	Tian, LC; Yang, PZ; Lei, B; Shao, J; Wang, CK; Xiang, Q; Wei, L; Peng, ZG; Kijlstra, A				Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui; Kijlstra, Aize			AAV2-Mediated Subretinal Gene Transfer of hIFN-alpha Attenuates Experimental Autoimmune Uveoretinitis in Mice	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; LEBERS CONGENITAL AMAUROSIS; REDUCES LYSOSOMAL STORAGE; IMPROVES RETINAL FUNCTION; INTERFERON-ALPHA; VII MICE; IN-VIVO; THERAPY; UVEITIS; SAFETY	Background: Recent reports show that gene therapy may provide a long-term, safe and effective intervention for human diseases. In this study, we investigated the effectiveness of adeno-associated virus 2 (AAV2) based human interferon-alpha (hIFN-alpha) gene therapy in experimental autoimmune uveoretinitis (EAU), a classic model for human uveitis. Methodology/Principal Findings: An AAV2 vector harboring the hIFN-alpha gene (AAV2.hIFN-alpha) was subretinally injected into B10RIII mice at two doses (1.5x10(6) vg, 1.5x10(8) vg). AAV2 vector encoding green fluorescent protein (AAV2.GFP) was used as a control (5x10(8) vg). The expression of hIFN-alpha in homogenized eyes and serum was detected by ELISA three weeks after injection. The biodistribution of vector DNA in the injected eyes, contralateral eyes and distant organs was determined by PCR. EAU was induced by immunization with IRBP(161-180) three weeks following vector injections, and evaluated clinically and pathologically. IRBP-specific proliferation and IL-17 expression of lymphocytes from the spleen and lymph nodes were assayed to test the influence of the subretinal delivery of AAV2. hIFN-alpha on the systemic immune response. hIFN-alpha was effectively expressed in the eyes from three weeks to three months following subretinal injection of AAV2. hIFN-alpha vector. DNA of AAV2.GFP was observed only in the injected eyes, but not in the distant organs or contralateral eyes. Subretinal injection of both doses significantly attenuated EAU activity clinically and histologically. For the lower dose, there was no difference concerning lymphocyte proliferation and IL-17 production among the AAV2.hIFN-alpha, AAV2.GFP and PBS injected mice. However, the higher dose of AAV2.hIFN-alpha significantly suppressed lymphocyte proliferation and IL-17 production. Conclusions/Significance: Subretinal delivery of AAV2.hIFN-alpha lead to an effective expression within the eye for at least three months and significantly attenuated EAU activity. AAV2.hIFN-alpha was shown to inhibit the systemic IRBP-specific immune response.	[Tian, Lichun] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Tian, Lichun; Yang, Peizeng; Lei, Bo; Shao, Ju; Wang, Chaokui; Xiang, Qin; Wei, Lin; Peng, Zhougui] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Sun Yat Sen University; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013	Lei, Bo/0000-0002-5497-0905	Natural Science Foundation [30910103912]; National Basic Research Program of China (973 Program) [2011CB510200]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC)	This work was funded by Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), http://159.226.244.15/portal/Proj_List.asp; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000; PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml; National Basic Research Program of China (973 Program) (2011CB510200), http://www.most.gov.cn/tztg/201010/W020101021511061090978.pdf; Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037) http://www. ctin.ac.cn/Class.aspx?clsId = 226; Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), http://www.ctin.ac.cn/View.aspx?id = 14380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barker SE, 2009, J GENE MED, V11, P486, DOI 10.1002/jgm.1327; Broderick CA, 2005, MOL THER, V12, P369, DOI 10.1016/j.ymthe.2005.03.018; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; CASPI RR, 2003, EXPT AUTOIMMUNE UVEO, pCH15; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Goldstein H, 1980, Adv Ophthalmol, V40, P1; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hennig AK, 2004, MOL THER, V10, P106, DOI 10.1016/j.ymthe.2004.03.018; Hennig AK, 2003, J NEUROSCI, V23, P3302; Imrie FR, 2007, CURR OPIN OPHTHALMOL, V18, P481, DOI 10.1097/ICU.0b013e3282f03d42; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Lai YKY, 2002, GENE THER, V9, P804, DOI 10.1038/sj.gt.3301695; Lei B, 2009, MOL VIS, V15, P1374; Li QH, 2008, MOL VIS, V14, P1760; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Rolling F, 2004, GENE THER, V11, pS26, DOI 10.1038/sj.gt.3302366; Smith JR, 2005, HUM GENE THER, V16, P1037, DOI 10.1089/hum.2005.16.1037; Sobaci G, 2010, OPHTHALMOLOGY, V117, P1430, DOI 10.1016/j.ophtha.2009.11.022; Srivastava A, 2010, CLIN CHIM ACTA, V411, P1165, DOI 10.1016/j.cca.2010.04.017; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; UCHIO E, 1994, INVEST OPHTH VIS SCI, V35, P2626; Wang W, 2008, CLIN CANCER RES, V14, P8314, DOI 10.1158/1078-0432.CCR-08-0705; Yang DSF, 2008, BRIT J HOSP MED, V69, P575, DOI 10.12968/hmed.2008.69.10.31317; Yeh Steven, 2007, Expert Rev Clin Immunol, V3, P781, DOI 10.1586/1744666X.3.5.781	33	26	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19542	10.1371/journal.pone.0019542	http://dx.doi.org/10.1371/journal.pone.0019542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611186	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500007
J	Premji, A; Rai, N; Nelson, A				Premji, Azra; Rai, Navjot; Nelson, Aimee			Area 5 Influences Excitability within the Primary Motor Cortex in Humans	PLOS ONE			English	Article							THETA-BURST-STIMULATION; POSTERIOR PARIETAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED POTENTIALS; INTERVAL INTRACORTICAL INHIBITION; FUNCTIONAL-ANATOMY; FRONTAL-CORTEX; RHESUS-MONKEY; MOVEMENT; CIRCUITS	In non-human primates, Brodmann's area 5 (BA 5) has direct connectivity with primary motor cortex (M1), is largely dedicated to the representation of the hand and may have evolved with the ability to perform skilled hand movement. Less is known about human BA 5 and its interaction with M1 neural circuits related to hand control. The present study examines the influence of BA 5 on excitatory and inhibitory neural circuitry within M1 bilaterally before and after continuous (cTBS), intermittent (iTBS), and sham theta-burst stimulation (sham TBS) over left hemisphere BA 5. Using single and paired-pulse TMS, measurements of motor evoked potentials (MEPs), short interval intracortical inhibition (SICI), and intracortical facilitation (ICF) were quantified for the representation of the first dorsal interosseous muscle. Results indicate that cTBS over BA 5 influences M1 excitability such that MEP amplitudes are increased bilaterally for up to one hour. ITBS over BA 5 results in an increase in MEP amplitude contralateral to stimulation with a delayed onset that persists up to one hour. SICI and ICF were unaltered following TBS over BA 5. Similarly, F-wave amplitude and latency were unaltered following cTBS over BA 5. The data suggest that BA 5 alters M1 output directed to the hand by influencing corticospinal neurons and not interneurons that mediate SICI or ICF circuitry. Targeting BA 5 via cTBS and iTBS is a novel mechanism to powerfully modulate activity within M1 and may provide an avenue for investigating hand control in healthy populations and modifying impaired hand function in clinical populations.	[Premji, Azra; Rai, Navjot; Nelson, Aimee] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Premji, A (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	ajnelson@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research is funded by the Natural Sciences and Engineering Research Council of Canada operating grant to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astafiev SV, 2003, J NEUROSCI, V23, P4689; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; CARDENASMORALES L, 2008, MECH APPL THETA BURS, P1; Chen R, 1997, NEUROLOGY, V49, P1054, DOI 10.1212/WNL.49.4.1054; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; COULTER JD, 1977, BRAIN RES, V129, P335, DOI 10.1016/0006-8993(77)90012-9; DI LV, 2006, J NEUROPHYSIOL, V96, P1765; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gardner EP, 2007, J NEUROPHYSIOL, V97, P387, DOI 10.1152/jn.00558.2006; Garey LJ, 1994, LOCALISATION CEREBRA; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Huang YZ, 2010, MOVEMENT DISORD, V25, P696, DOI 10.1002/mds.22814; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel FC, 2009, NEUROLOGY, V72, P1766, DOI 10.1212/WNL.0b013e3181a609c5; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Katayama T, 2007, CLIN NEUROPHYSIOL, V118, P2506, DOI 10.1016/j.clinph.2007.08.011; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Ni Z, 2007, J PHYSIOL-LONDON, V583, P971, DOI 10.1113/jphysiol.2007.135749; Orth M, 2009, J NEUROL NEUROSUR PS, V80, P29, DOI 10.1136/jnnp.2008.149484; Padberg J, 2005, CEREB CORTEX, V15, P1938, DOI 10.1093/cercor/bhi071; Padberg J, 2007, J NEUROSCI, V27, P10106, DOI 10.1523/JNEUROSCI.2632-07.2007; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Poreisz C, 2008, EXP BRAIN RES, V185, P611, DOI 10.1007/s00221-007-1188-5; Premji A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-91; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; Stoeckel MC, 2004, EUR J NEUROSCI, V19, P1067, DOI 10.1111/j.0953-816X.2004.03185.x; STRICK PL, 1978, BRAIN RES, V157, P325, DOI 10.1016/0006-8993(78)90035-5; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Talairach J., 1988, COPLANAR STEREOTAXIC; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P1815, DOI 10.1016/j.clinph.2007.05.062; Taoka M, 2000, EXP BRAIN RES, V134, P139, DOI 10.1007/s002210000464; Voller B, 2005, J NEUROPHYSIOL, V94, P1115, DOI 10.1152/jn.00333.2005; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006; ZARZECKI P, 1978, BRAIN RES, V157, P331, DOI 10.1016/0006-8993(78)90036-7; Zhang HQ, 2001, J NEUROPHYSIOL, V85, P1823, DOI 10.1152/jn.2001.85.5.1823	53	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20023	10.1371/journal.pone.0020023	http://dx.doi.org/10.1371/journal.pone.0020023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603571	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300048
J	Richter, F; Leaver-Fay, A; Khare, SD; Bjelic, S; Baker, D				Richter, Florian; Leaver-Fay, Andrew; Khare, Sagar D.; Bjelic, Sinisa; Baker, David			De Novo Enzyme Design Using Rosetta3	PLOS ONE			English	Article							TRIOSEPHOSPHATE ISOMERASE; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION	The Rosetta de novo enzyme design protocol has been used to design enzyme catalysts for a variety of chemical reactions, and in principle can be applied to any arbitrary chemical reaction of interest, The process has four stages: 1) choice of a catalytic mechanism and corresponding minimal model active site, 2) identification of sites in a set of scaffold proteins where this minimal active site can be realized, 3) optimization of the identities of the surrounding residues for stabilizing interactions with the transition state and primary catalytic residues, and 4) evaluation and ranking the resulting designed sequences. Stages two through four of this process can be carried out with the Rosetta package, while stage one needs to be done externally. Here, we demonstrate how to carry out the Rosetta enzyme design protocol from start to end in detail using for illustration the triosephosphate isomerase reaction.	[Richter, Florian; Khare, Sagar D.; Bjelic, Sinisa; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Richter, Florian; Baker, David] Univ Washington, Interdisciplinary Program Biomol Struct & Design, Seattle, WA 98195 USA; [Leaver-Fay, Andrew] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Richter, F (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	floric@u.washington.edu		Bjelic, Sinisa/0000-0002-9300-614X	Defense Advanced Reasearch Projects Agency (DARPA); Howard Hughes Medical Institute (HHMI)	Defense Advanced Reasearch Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	Defense Advanced Reasearch Projects Agency (DARPA), Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM J, 2008, J AM CHEM SOC, V130, P15361; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Guallar V, 2004, J MOL BIOL, V337, P227, DOI 10.1016/j.jmb.2003.11.016; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Khersonsky O, 2010, J MOL BIOL, V396, P1025, DOI 10.1016/j.jmb.2009.12.031; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang X, 2008, J ORG CHEM, V73, P889, DOI 10.1021/jo701974n	17	185	196	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19230	10.1371/journal.pone.0019230	http://dx.doi.org/10.1371/journal.pone.0019230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603656	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300004
J	Jacobsen, ID; Grosse, K; Berndt, A; Hube, B				Jacobsen, Ilse D.; Grosse, Katharina; Berndt, Angela; Hube, Bernhard			Pathogenesis of Candida albicans Infections in the Alternative Chorio-Allantoic Membrane Chicken Embryo Model Resembles Systemic Murine Infections	PLOS ONE			English	Article							GALLERIA-MELLONELLA LARVAE; INNATE IMMUNE-RESPONSE; OROPHARYNGEAL CANDIDIASIS; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; ANIMAL-MODELS; IN-VIVO; VIRULENCE; MICE; HOST	Alternative models of microbial infections are increasingly used to screen virulence determinants of pathogens. In this study, we investigated the pathogenesis of Candida albicans and C. glabrata infections in chicken embryos infected via the chorio-allantoic membrane (CAM) and analyzed the virulence of deletion mutants. The developing immune system of the host significantly influenced susceptibility: With increasing age, embryos became more resistant and mounted a more balanced immune response, characterized by lower induction of proinflammatory cytokines and increased transcription of regulatory cytokines, suggesting that immunopathology contributes to pathogenesis. While many aspects of the chicken embryo response resembled murine infections, we also observed significant differences: In contrast to systemic infections in mice, IL-10 had a beneficial effect in chicken embryos. IL-22 and IL-17A were only upregulated after the peak mortality in the chicken embryo model occurred; thus, the role of the Th17 response in this model remains unclear. Abscess formation occurs frequently in murine models, whereas the avian response was dominated by granuloma formation. Pathogenicity of the majority of 15 tested C. albicans deletion strains was comparable to the virulence in mouse models and reduced virulence was associated with significantly lower transcription of proinflammatory cytokines. However, fungal burden did not correlate with virulence and for few mutants like bcr1 Delta and tec1 Delta different outcomes in survival compared to murine infections were observed. C. albicans strains locked in the yeast stage disseminated significantly more often from the CAM into the embryo, supporting the hypothesis that the yeast morphology is responsible for dissemination in systemic infections. These data suggest that the pathogenesis of C. albicans infections in the chicken embryo model resembles systemic murine infections but also differs in some aspects. Despite its limitations, it presents a useful alternative tool to pre-screen C. albicans strains to select strains for subsequent testing in murine models.	[Jacobsen, Ilse D.; Grosse, Katharina; Hube, Bernhard] Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Berndt, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Schiller University of Jena	Jacobsen, ID (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	ilse.jacobsen@hki-jena.de	Jacobsen, Ilse/B-3155-2011	Jacobsen, Ilse/0000-0002-6033-9984; Hube, Bernhard/0000-0002-6028-0425	Federal Ministry of Education and Health (BMBF) [0314108]; European Commission [PITN-GA-2008-214004]	Federal Ministry of Education and Health (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was partially supported by grant no. 0314108 from the Federal Ministry of Education and Health (BMBF) and the European Commission (PITN-GA-2008-214004, FINSysB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Argimon S, 2007, EUKARYOT CELL; Beeckman DSA, 2010, DEV COMP IMMUNOL, V34, P812, DOI 10.1016/j.dci.2010.03.001; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; BUDDINGH CJ, 1970, J INFECT DIS, V121, P660; Carvajal BG, 2008, VACCINE, V26, P5423, DOI 10.1016/j.vaccine.2008.07.088; CAWSON RA, 1973, BRIT J DERMATOL, V89, P497, DOI 10.1111/j.1365-2133.1973.tb03011.x; Chamilos G, 2006, J INFECT DIS, V193, P1014, DOI 10.1086/500950; Chiang LY, 2007, CELL MICROBIOL, V9, P233, DOI 10.1111/j.1462-5822.2006.00784.x; De Boever S, 2008, AVIAN PATHOL, V37, P39, DOI 10.1080/03079450701784875; de Repentigny L, 2004, CURR OPIN MICROBIOL, V7, P324, DOI 10.1016/j.mib.2004.06.001; Gow NAR, 2003, MED MYCOL, V41, P331, DOI 10.1080/13693780310001600859; Harmon BG, 1998, POULTRY SCI, V77, P972, DOI 10.1093/ps/77.7.972; HARTL A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P926; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; KOBAYASHI I, 1989, MICROBIOL IMMUNOL, V33, P709, DOI 10.1111/j.1348-0421.1989.tb00958.x; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MacCallum DM, 2009, FEMS YEAST RES, V9, P1111, DOI 10.1111/j.1567-1364.2009.00576.x; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; McKenzie CG, INFECT IMMUN, V78, P1650; Meade KG, 2009, DEV COMP IMMUNOL, V33, P516, DOI 10.1016/j.dci.2008.10.003; Moore M, 1939, SCIENCE, V89, P514, DOI 10.1126/science.89.2318.514; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Naglik JR, 2008, FEMS MICROBIOL LETT, V283, P129, DOI 10.1111/j.1574-6968.2008.01160.x; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; NORRIS RF, 1948, ARCH PATHOL, V45, P506; Odds FC, 2000, MICROBIOL-SGM, V146, P1881, DOI 10.1099/00221287-146-8-1881; Odds FC., 1988, CANDIDA CANDIDOSIS; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; PARTRIDGE BM, 1971, J CLIN PATHOL, V24, P645, DOI 10.1136/jcp.24.7.645; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pieper J, 2008, VET IMMUNOL IMMUNOP, V124, P241, DOI 10.1016/j.vetimm.2008.03.008; Rowan R, 2009, BIOMETALS, V22, P461, DOI 10.1007/s10534-008-9182-3; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; SHIMIZU K, 1987, MICROBIOL IMMUNOL, V31, P1045, DOI 10.1111/j.1348-0421.1987.tb01337.x; SMITH RT, 1956, J EXP MED, V104, P217, DOI 10.1084/jem.104.2.217; Sonneborn A, 2000, MOL MICROBIOL, V35, P386, DOI 10.1046/j.1365-2958.2000.01705.x; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Vazquez-Torres A, 1999, INFECT IMMUN, V67, P670, DOI 10.1128/IAI.67.2.670-674.1999	52	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19741	10.1371/journal.pone.0019741	http://dx.doi.org/10.1371/journal.pone.0019741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603634	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500027
J	Pahl, M; Zhu, H; Tautz, J; Zhang, SW				Pahl, Mario; Zhu, Hong; Tautz, Juergen; Zhang, Shaowu			Large Scale Homing in Honeybees	PLOS ONE			English	Article							INITIAL ORIENTATION; OUTDOOR SCENES; L HYMENOPTERA; ANTS USE; BEES; PERFORMANCE; NAVIGATION; LANDMARKS; FLIGHTS; ABILITY	Honeybee foragers frequently fly several kilometres to and from vital resources, and communicate those locations to their nest mates by a symbolic dance language. Research has shown that they achieve this feat by memorizing landmarks and the skyline panorama, using the sun and polarized skylight as compasses and by integrating their outbound flight paths. In order to investigate the capacity of the honeybees' homing abilities, we artificially displaced foragers to novel release spots at various distances up to 13 km in the four cardinal directions. Returning bees were individually registered by a radio frequency identification (RFID) system at the hive entrance. We found that homing rate, homing speed and the maximum homing distance depend on the release direction. Bees released in the east were more likely to find their way back home, and returned faster than bees released in any other direction, due to the familiarity of global landmarks seen from the hive. Our findings suggest that such large scale homing is facilitated by global landmarks acting as beacons, and possibly the entire skyline panorama.	[Pahl, Mario; Tautz, Juergen] Univ Wurzburg, Bioctr, BEEgrp, Wurzburg, Germany; [Pahl, Mario; Zhu, Hong; Zhang, Shaowu] Australian Natl Univ, Res Sch Biol, Ctr Excellence Vis Sci, Canberra, ACT, Australia	University of Wurzburg; Australian National University	Pahl, M (corresponding author), Univ Wurzburg, Bioctr, BEEgrp, Wurzburg, Germany.	mario.pahl@uni-wuerzburg.de		Zhang, Shaowu/0000-0002-3551-5587	ARC COE in Vision Sciences [CE0561903]; ARC [DP-0450535]; German Excellence Initiative; German Research Foundation (DFG); University of Wuerzburg	ARC COE in Vision Sciences(Australian Research Council); ARC(Australian Research Council); German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was supported by the ARC COE in Vision Sciences (CE0561903), ARC DP-0450535 to SWZ, MP, and HZ (http://www.vision.edu.au/). MP was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, Wurzburg University (http://www.graduateschools.uniwuerzburg.de/life_sciences). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrol D.P., 1994, Mysore Journal of Agricultural Sciences, V28, P249; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Capaldi EA, 1999, J EXP BIOL, V202, P1655; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; CHITTKA L, 1995, ANIM BEHAV, V50, P23, DOI 10.1006/anbe.1995.0217; Chmurzynski JA, 1998, ETHOLOGY, V104, P421, DOI 10.1111/j.1439-0310.1998.tb00080.x; Collett M, 2002, J EXP BIOL, V205, P807; Collett TS, 2007, J EXP BIOL, V210, P2025, DOI 10.1242/jeb.000315; DYER FC, 1981, SCIENCE, V214, P1041, DOI 10.1126/science.214.4524.1041; Eckert JE, 1933, J AGRIC RES, V47, P0257; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fabre J. H, 1879, SOUVENIRS ENTOMOLOGI, V1; FABRE JH, 1882, SOUVENIRS ENTOMOLOGI, V2; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Guedot C, 2009, ECOL ENTOMOL, V34, P158, DOI 10.1111/j.1365-2311.2008.01054.x; HanauerThieser U, 1995, J COMP PHYSIOL B, V165, P471, DOI 10.1007/BF00261302; HERAN H, 1963, Z VERGL PHYSIOL, V47, P39, DOI 10.1007/BF00342890; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; LABHART T, 1980, J COMP PHYSIOL, V141, P19, DOI 10.1007/BF00611874; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2000, P ROY SOC B-BIOL SCI, V267, P961, DOI 10.1098/rspb.2000.1097; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; SOUTHWICK EE, 1995, AM NAT, V146, P748, DOI 10.1086/285823; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Tautz J, 2004, PLOS BIOL, V2, P915, DOI 10.1371/journal.pbio.0020211; Towne WF, 2008, J EXP BIOL, V211, P3729, DOI 10.1242/jeb.022970; Tsuneki K., 1965, Etizenia Fukui, Vno. 9, P1; UCHIDA TOHRU, 1951, JOUR FAC SCI HOKKAIDO UNIV SER VI ZOOL, V10, P87; UGOLINI A, 1985, Z TIERPSYCHOL, V69, P133; UGOLINI A, 1987, MONIT ZOOL ITAL, V21, P157; vanNieuwstadt MGL, 1996, APIDOLOGIE, V27, P219, DOI 10.1051/apido:19960404; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Zeil J, 1996, J EXP BIOL, V199, P245; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450	40	64	67	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19669	10.1371/journal.pone.0019669	http://dx.doi.org/10.1371/journal.pone.0019669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602920	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500019
J	Kolluru, B; Hawizy, L; Murray-Rust, P; Tsujii, J; Ananiadou, S				Kolluru, BalaKrishna; Hawizy, Lezan; Murray-Rust, Peter; Tsujii, Junichi; Ananiadou, Sophia			Using Workflows to Explore and Optimise Named Entity Recognition for Chemistry	PLOS ONE			English	Article							BIOINFORMATICS; TOOLS; WEB	Chemistry text mining tools should be interoperable and adaptable regardless of system-level implementation, installation or even programming issues. We aim to abstract the functionality of these tools from the underlying implementation via reconfigurable workflows for automatically identifying chemical names. To achieve this, we refactored an established named entity recogniser (in the chemistry domain), OSCAR and studied the impact of each component on the net performance. We developed two reconfigurable workflows from OSCAR using an interoperable text mining framework, U-Compare. These workflows can be altered using the drag-&-drop mechanism of the graphical user interface of U-Compare. These workflows also provide a platform to study the relationship between text mining components such as tokenisation and named entity recognition (using maximum entropy Markov model (MEMM) and pattern recognition based classifiers). Results indicate that, for chemistry in particular, eliminating noise generated by tokenisation techniques lead to a slightly better performance than others, in terms of named entity recognition (NER) accuracy. Poor tokenisation translates into poorer input to the classifier components which in turn leads to an increase in Type I or Type II errors, thus, lowering the overall performance. On the Sciborg corpus, the workflow based system, which uses a new tokeniser whilst retaining the same MEMM component, increases the F-score from 82.35% to 84.44%. On the PubMed corpus, it recorded an F-score of 84.84% as against 84.23% by OSCAR.	[Kolluru, BalaKrishna; Tsujii, Junichi; Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Hawizy, Lezan; Murray-Rust, Peter] Univ Cambridge, Unilever Ctr Mol Informat, Cambridge, England	University of Manchester; University of Cambridge	Kolluru, B (corresponding author), Univ Manchester, Natl Ctr Text Min, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	balakrishna.kolluru@manchester.ac.uk		Hawizy, Lezan/0000-0002-0932-3135; Murray-Rust, Peter/0000-0003-3386-3972	UK Joint Information Systems Committee (JISC); Biotechnology and Biological Sciences Research Council [BB/F006039/1]; BBSRC [BB/G53025X/1, BB/F006012/1, BB/F006039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G53025X/1, BB/F006012/1] Funding Source: researchfish	UK Joint Information Systems Committee (JISC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research has been supported by the UK Joint Information Systems Committee (JISC) (CheTA project) and the Biotechnology and Biological Sciences Research Council (ONDEX project, BB/F006039/1). The National Centre for Text Mining is supported by JISC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, 2010, PIP PIL; Banville DL, 2006, DRUG DISCOV TODAY, V11, P35, DOI 10.1016/S1359-6446(05)03682-2; COPESTAKE A, 2010, EXTRACTING SCI SCI P; Corbett P, 2006, LECT NOTES COMPUT SC, V4216, P107; Corbett P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S4; *EBI, 2010, CHEM ENT BIOL INT CH; FERRUCCI D, 2006, INTEROPERABILITYSTAN; FLORIAN B, 2008, CICLING, P334; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; Hettne KM, 2010, J CHEMINFORMATICS, V2, DOI [10.1186/1758-2946-2-3, 10.1186/1758-2946-2-4]; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jiao DZ, 2009, J CHEM INF MODEL, V49, P263, DOI 10.1021/ci800332w; KANO Y, 2010, BIOINFORMATICS; KANO Y, 2008, P 1 INT C GLOB INT L, P122; KANO Y, 2009, SETQA NLP 09, P22; Kano Y, 2009, BIOINFORMATICS, V25, P1997, DOI 10.1093/bioinformatics/btp289; Kemp N, 1998, J CHEM INF COMP SCI, V38, P544, DOI 10.1021/ci980324v; KLINGER R, 2009, CHEM NAMES TERMINOLO; Klinger R, 2008, BIOINFORMATICS, V24, pI268, DOI 10.1093/bioinformatics/btn181; Kolarik C., 2008, WORKSH BUILD EV RES; KOLRIK C, 2007, BIOINFORMATICS, V13, P264; KUHN T, 2009, CHEM CENTRAL J, V3, P42; Kuhn T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-159; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; MELLEBEEK B, 2009, NATURE PRECEDINGS; MIYAO Y, 2005, ACL 05 P 43 ANN M AS, P83; Muller B, 2010, LECT NOTES COMPUT SC, V6107, P152, DOI 10.1007/978-3-642-13084-7_12; Murray-Rust P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-141; Murray-Rust P, 1999, J CHEM INF COMP SCI, V39, P928, DOI 10.1021/ci990052b; *NIH, 2010, PUBM; NOBATA C, 2009, INT C DIG LIB SEM WE; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; RUPP CJ, 2006, P 4 UK E SCI ALL HAN; RUPP CJ, 2007, INTEGRATING GEN PURP; Shon J, 2008, CURR OPIN DRUG DISC, V11, P381; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; TAYLOR I, 2007, WORKFLOWS E SCI WORK; TIWARI A, 2008, COMPUTATIONAL BIOL C, V31, P306; Townsend Joseph A., 2009, Proceedings of the 2009 5th IEEE International Conference on e-Science (e-Science 2009), P337, DOI 10.1109/e-Science.2009.54; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y., 2009, P 12 C EUR CHAPT ACL, P790; Vellay S. G. P., 2009, Infectious Disorders - Drug Targets, V9, P366; WILBUR W, 1999, AMIA S 1999, P176; Wren JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S3; 2010, OPENNLP; 2010, MEDLINE	46	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20181	10.1371/journal.pone.0020181	http://dx.doi.org/10.1371/journal.pone.0020181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633495	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500036
J	Zhang, FB; Shang, DH; Zhang, YH; Tian, Y				Zhang, Fengbo; Shang, Donghao; Zhang, Yuhai; Tian, Ye			Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; INTERFERON-ALPHA; INDUCIBLE FACTOR; CANCER; IL-22; EXPRESSION; CYTOKINE; SURVIVAL; IL-10; COLON	Background: Renal cell carcinoma (RCC) is one of the most common kidney cancers and is highly resistant to chemotherapy. Accumulating evidence suggests that interleukin-22 (IL-22) may mediate host defense against varietal pathogens as a proinflammatory and anti-inflammatory cytokine. The purpose of this study is to assess the inhibitory effects of IL-22 on human RCC cell line A498 and to investigate the possible mechanisms underlying the anti-tumor effects of this cytokine. Methodology: A498 cells, a RCC cell line, were used to assess the inhibitory growth effects of IL-22 using the MTT assay and flow cytometric analysis in vitro. BALB/C nude mice bearing A498 cell xenografts were used to examine the antitumor efficacy of IL-22 in vivo. Western blotting assay was performed to detect the regulation of the intracellular signaling pathway of IL-22. Principal Findings: We found that IL-22 suppressed the growth of A498 cells in a dose-dependent manner and inhibited the growth of A498 xenografts. We also observed that IL-22 produced a dose-dependent inhibitory effect on A498 cells that involved the induction of G2/M cell cycle arrest without cell apoptosis. Moreover, we showed that the phosphorylation of STAT1 was increased and the phosphorylation of ERK1/2 was attenuated in A498 cells exposed to IL-22. The growth inhibition of A498 cells was partially revised after IL-22 treatment as the expression of STAT1 was knocked down. And inflammatory cytokines, interferon-alpha and tumor necrosis factor-alpha (TNF-alpha) were barely involved in the suppression of A498 cell xenografts treated with IL-22. Conclusions: IL-22 dose-dependently suppresses RCC cell line A498 cells in vitro and induces growth inhibition of A498 cell-bearing mouse xenografts. These results suggest that the anti-RCC effects of IL-22 are at least partially mediated through regulation of STAT1 signaling pathways and G2/M cell cycle arrest, rather than by inducing apoptosis and inflammatory cytokines.	[Zhang, Fengbo; Shang, Donghao; Zhang, Yuhai; Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol Surg, Beijing, Peoples R China	Capital Medical University	Zhang, FB (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Urol Surg, Beijing, Peoples R China.	Fengbo_zhang@hotmail.com						Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Anderson GM, 2004, CURR OPIN PHARMACOL, V4, P314, DOI 10.1016/j.coph.2004.04.004; Arias JF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-15; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; DeCastro GJ, 2008, UROL CLIN N AM, V35, P581, DOI 10.1016/j.ucl.2008.07.005; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Hartmann JT, 1999, ANTICANCER RES, V19, P1541; Hernberg M, 1999, J IMMUNOTHER, V22, P145, DOI 10.1097/00002371-199903000-00006; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Krop I, 2005, CANCER RES, V65, P9659, DOI 10.1158/0008-5472.CAN-05-1663; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Nagakawa H, 2004, SCAND J IMMUNOL, V60, P449, DOI 10.1111/j.0300-9475.2004.01504.x; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Nanus DM, 2004, CANCER-AM CANCER SOC, V101, P1545, DOI 10.1002/cncr.20541; O'Brien MF, 2004, EUR UROL, V45, P613, DOI 10.1016/j.eururo.2003.11.002; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roos FC, 2009, CURR OPIN UROL, V19, P459, DOI 10.1097/MOU.0b013e32832f0c7d; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Thompson CL, 2010, CANCER CAUSE CONTROL, V21, P1165, DOI 10.1007/s10552-010-9542-5; Veiga-Fernandes H, 2010, J EXP MED, V207, P269, DOI 10.1084/jem.20100105; Vuky J, 2000, UROL ONCOL, V5, P249, DOI 10.1016/S1078-1439(00)00068-5; Weber GF, 2006, J IMMUNOL, V177, P8266, DOI 10.4049/jimmunol.177.11.8266; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yao SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000789; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zhu ZZ, 2010, ONCOLOGY-BASEL, V78, P382, DOI 10.1159/000320521; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	43	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20382	10.1371/journal.pone.0020382	http://dx.doi.org/10.1371/journal.pone.0020382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625390	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200057
J	Alexandrov, BS; Valtchinov, VI; Alexandrov, LB; Gelev, V; Dagon, Y; Bock, J; Kohane, IS; Rasmussen, KO; Bishop, AR; Usheva, A				Alexandrov, Boian S.; Valtchinov, Vlad I.; Alexandrov, Ludmil B.; Gelev, Vladimir; Dagon, Yossi; Bock, Jonathan; Kohane, Isaac S.; Rasmussen, Kim O.; Bishop, Alan R.; Usheva, Anny			DNA Dynamics Is Likely to Be a Factor in the Genomic Nucleotide Repeats Expansions Related to Diseases	PLOS ONE			English	Article							BASAL TRANSCRIPTION; INSTABILITY; GENE; MECHANISMS; ATAXIA; REPLICATION; PROMOTER; SEQUENCE; BINDING; COMMON	Trinucleotide repeats sequences (TRS) represent a common type of genomic DNA motif whose expansion is associated with a large number of human diseases. The driving molecular mechanisms of the TRS ongoing dynamic expansion across generations and within tissues and its influence on genomic DNA functions are not well understood. Here we report results for a novel and notable collective breathing behavior of genomic DNA of tandem TRS, leading to propensity for large local DNA transient openings at physiological temperature. Our Langevin molecular dynamics (LMD) and Markov Chain Monte Carlo (MCMC) simulations demonstrate that the patterns of openings of various TRSs depend specifically on their length. The collective propensity for DNA strand separation of repeated sequences serves as a precursor for outsized intermediate bubble states independently of the G/C-content. We report that repeats have the potential to interfere with the binding of transcription factors to their consensus sequence by altered DNA breathing dynamics in proximity of the binding sites. These observations might influence ongoing attempts to use LMD and MCMC simulations for TRS-related modeling of genomic DNA functionality in elucidating the common denominators of the dynamic TRS expansion mutation with potential therapeutic applications.	[Alexandrov, Boian S.; Rasmussen, Kim O.; Bishop, Alan R.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Valtchinov, Vlad I.; Kohane, Isaac S.] Natl Ctr Biomed Comp Informat Integrating Biol &, Boston, MA USA; [Alexandrov, Ludmil B.; Gelev, Vladimir; Dagon, Yossi; Bock, Jonathan; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Alexandrov, BS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA.	ausheva@bidmc.harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Dagon, Yossi/AAI-5882-2020; Alexandrov, Ludmil/AAS-1454-2021; Alexandrov, Boian/D-2488-2010; Rasmussen, Kim O/B-5464-2009; Alexandrov, Ludmil/B-6582-2014	Kohane, Isaac Kohane/0000-0003-2192-5160; Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Boian/0000-0001-8636-4603; Rasmussen, Kim O/0000-0002-4029-4723; Alexandrov, Ludmil/0000-0003-3596-4515	New Atlantic Technology Group, LLC, Newton, MA [0246, 02468]; National Institute of Health [GM073911]; ARRA supplement [GM073911-04S]; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010125] Funding Source: NIH RePORTER	New Atlantic Technology Group, LLC, Newton, MA; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA supplement; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory(National Nuclear Security Administration); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank New Atlantic Technology Group, LLC, Newton, MA 0246 for support.; This research was supported by grants from the National Institute of Health Grant GM073911, ARRA supplement GM073911-04S to AU, Contract DE-AC52-06NA25396 National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory, New Atlantic Technology Group, LLC, Newton, MA 02468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Alexandrov BS, 2009, NUCLEIC ACIDS RES, V37, P2405, DOI 10.1093/nar/gkp016; Ares S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.035504; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Cannella M, 2005, AM J MED GENET B, V133B, P127, DOI 10.1002/ajmg.b.30125; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cheli Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008743; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kornberg A, 2005, DNA REPLICATION, P41; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pandolfo M., 2006, GENETIC INSTABILITIE, P277; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Potaman VN, 2003, J MOL BIOL, V326, P1095, DOI 10.1016/S0022-2836(03)00037-8; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rindler PM, 2011, NUCLEIC ACIDS RES, V39, P526, DOI 10.1093/nar/gkq788; Schmid R, 1995, N ENGL J MED, V333, P1217; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Zeng Y, 2004, J MOL BIOL, V339, P67, DOI 10.1016/j.jmb.2004.02.072	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19800	10.1371/journal.pone.0019800	http://dx.doi.org/10.1371/journal.pone.0019800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625483	Green Published, gold, Green Submitted			2022-12-27	WOS:000290793400011
J	Glendorf, T; Stidsen, CE; Norrman, M; Nishimura, E; Sorensen, AR; Kjeldsen, T				Glendorf, Tine; Stidsen, Carsten E.; Norrman, Mathias; Nishimura, Erica; Sorensen, Anders R.; Kjeldsen, Thomas			Engineering of Insulin Receptor Isoform-Selective Insulin Analogues	PLOS ONE			English	Article							IGF-II; STRUCTURAL SWITCH; HYBRID RECEPTORS; BINDING EPITOPES; LIGAND-BINDING; ALPHA-SUBUNIT; B-ISOFORM; A-ISOFORM; CHAIN; RESIDUES	Background: The insulin receptor (IR) exists in two isoforms, A and B, and the isoform expression pattern is tissue-specific. The C-terminus of the insulin B chain is important for receptor binding and has been shown to contact the IR just adjacent to the region where the A and B isoforms differ. The aim of this study was to investigate the importance of the C-terminus of the B chain in IR isoform binding in order to explore the possibility of engineering tissue-specific/liver-specific insulin analogues. Methodology/Principal Findings: Insulin analogue libraries were constructed by total amino acid scanning mutagenesis. The relative binding affinities for the A and B isoform of the IR were determined by competition assays using scintillation proximity assay technology. Structural information was obtained by X-ray crystallography. Introduction of B25A or B25N mutations resulted in analogues with a 2-fold preference for the B compared to the A isoform, whereas the opposite was observed with a B25Y substitution. An acidic amino acid residue at position B27 caused an additional 2-fold selective increase in affinity for the receptor B isoform for analogues bearing a B25N mutation. Furthermore, the combination of B25H with either B27D or B27E also resulted in B isoform-preferential analogues (2-fold preference) even though the corresponding single mutation analogues displayed no differences in relative isoform binding affinity. Conclusions/Significance: We have discovered a new class of IR isoform-selective insulin analogues with 2-4-fold differences in relative binding affinities for either the A or the B isoform of the IR compared to human insulin. Our results demonstrate that a mutation at position B25 alone or in combination with a mutation at position B27 in the insulin molecule confers IR isoform selectivity. Isoform-preferential analogues may provide new opportunities for developing insulin analogues with improved clinical benefits.	[Glendorf, Tine; Stidsen, Carsten E.; Norrman, Mathias; Nishimura, Erica; Sorensen, Anders R.; Kjeldsen, Thomas] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark	Novo Nordisk	Glendorf, T (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	tgle@novonordisk.com		Nishimura, Erica/0000-0001-5741-3648; Kjeldsen, Thomas/0000-0003-0094-9286	Danish Ministry of Science, Technology and Innovation; Novo Nordisk; Novo Nordisk A/S	Danish Ministry of Science, Technology and Innovation; Novo Nordisk(Novo Nordisk); Novo Nordisk A/S(Novo Nordisk)	This work was supported by the Danish Ministry of Science, Technology and Innovation, the Novo Nordisk CORA Training and Research Program, and Novo Nordisk A/S. Novo Nordisk A/S had a role in the decision to publish. The work was carried out as part of T.G.'s Ph.D. studies and was funded by the Danish Ministry of Science, Technology and Innovation and Novo Nordisk A/S (the ministry paid part of T. G.'s salary and Novo Nordisk paid the rest of T.G.'s salary and for the experimental work T.G. performed in the laboratories. T.G. is a Novo Nordisk employee now and designed the study, collected the data, analyzed it and wrote the manuscript so T.G. definitely had a role in decision to publish. Novo Nordisk also paid the publication fee.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; DEMEYTS P, 1978, NATURE, V273, P504; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frayn K. N., 2010, METABOLIC REGULATION; Giudice J, 2011, J CELL SCI, V124, P801, DOI 10.1242/jcs.076869; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Serrano R, 2005, J MOL ENDOCRINOL, V34, P153, DOI 10.1677/jme.1.01635; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w	50	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20288	10.1371/journal.pone.0020288	http://dx.doi.org/10.1371/journal.pone.0020288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625452	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400052
J	Hagita, S; Osaka, M; Shimokado, K; Yoshida, M				Hagita, Sumihiko; Osaka, Mizuko; Shimokado, Kentaro; Yoshida, Masayuki			Adipose Inflammation Initiates Recruitment of Leukocytes to Mouse Femoral Artery: Role of Adipo-Vascular Axis in Chronic Inflammation	PLOS ONE			English	Article							HIGH-FAT-DIET; MACROPHAGE POLARIZATION; DENDRITIC CELLS; TISSUE INFLAMMATION; INSULIN-RESISTANCE; INDUCED OBESITY; MICE; EXPRESSION; ACTIVATION; ACCUMULATION	Background: Although inflammation within adipose tissues is known to play a role in metabolic syndrome, the causative connection between inflamed adipose tissue and atherosclerosis is not fully understood. In the present study, we examined the direct effects of adipose tissue on macro-vascular inflammation using intravital microscopic analysis of the femoral artery after adipose tissue transplantation. Methods and Results: We obtained subcutaneous (SQ) and visceral (VIS) adipose tissues from C57BL/6 mice fed normal chow (NC) or a high fat diet (HF), then transplanted the tissues into the perivascular area of the femoral artery of recipient C57/BL6 mice. Quantitative intravital microscopic analysis revealed an increase in adherent leukocytes after adipose tissue transplantation, with VIS found to induce significantly more leukocyte accumulation as compared to SQ. Moreover, adipose tissues from HF fed mice showed significantly more adhesion to the femoral artery. Simultaneous flow cytometry demonstrated upregulation of CD11b on peripheral granulocyte and monocytes after adipose tissue transplantation. We also observed dominant expressions of the inflammatory cytokine IL-6, and chemokines MCP-1 and MIP-1 beta in the stromal vascular fraction (SVF) of these adipose tissues as well as sera of recipient mice after transplantation. Finally, massive accumulations of pro-inflammatory and dendritic cells were detected in mice with VIS transplantation as compared to SQ, as well as in HF mice as compared to those fed NC. Conclusion: Our in vivo findings indicate that adipose tissue stimulates leukocyte accumulation in the femoral artery. The underlying mechanisms involve upregulation of CD11b in leukocytes, induction of cytokines and chemokines, and accumulation of pro-inflammatory cells in the SVF.	[Hagita, Sumihiko; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Life Sci & Bioeth Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hagita, Sumihiko; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Vasc Med, Bunkyo Ku, Tokyo, Japan; [Hagita, Sumihiko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science	Hagita, S (corresponding author), Tokyo Med & Dent Univ, Life Sci & Bioeth Res Ctr, Bunkyo Ku, Tokyo, Japan.	masa.vasc@tmd.ac.jp	王, 强/F-4212-2011		Mitsubishi Pharma Research Foundation;  [18590805]	Mitsubishi Pharma Research Foundation; 	This study was supported in part by a Grant-in-Aid for Scientific Research (no. 18590805) and a research grant from the Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Cui J, 2009, CELL IMMUNOL, V260, P44, DOI 10.1016/j.cellimm.2009.08.001; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI 10.1002/jcp.22241; Hagita S, 2008, HYPERTENSION, V51, P797, DOI 10.1161/HYPERTENSIONAHA.107.098855; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jabs A, 2007, ATHEROSCLEROSIS, V192, P75, DOI 10.1016/j.atherosclerosis.2006.05.050; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kim CS, 2008, OBESITY, V16, P1261, DOI 10.1038/oby.2008.55; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; KURAHARA H, 2009, J SURG RES; Lazarus AH, 1998, CYTOMETRY, V32, P206, DOI 10.1002/(SICI)1097-0320(19980701)32:3<206::AID-CYTO7>3.0.CO;2-H; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MARTINEZNUNEZ RT, 2010, J BIOL CHEM; Mullerad J, 2000, CYTOKINE, V12, P1683, DOI 10.1006/cyto.2000.0775; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ohman MK, 2010, ARTERIOSCL THROM VAS, V30, P1151, DOI 10.1161/ATVBAHA.110.205914; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Upham JW, 2000, CYTOMETRY, V40, P50, DOI 10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; WEBSTER GA, 1995, CLIN EXP IMMUNOL, V100, P536; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044	37	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19871	10.1371/journal.pone.0019871	http://dx.doi.org/10.1371/journal.pone.0019871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625491	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400017
J	Espinosa, O; Hancock, JM				Espinosa, Octavio; Hancock, John M.			A Gene-Phenotype Network for the Laboratory Mouse and Its Implications for Systematic Phenotyping	PLOS ONE			English	Article							R-PACKAGE; DATABASE; ONTOLOGIES; REPOSITORY; DISCOVERY; MODELS; TOOL	The laboratory mouse is the pre-eminent model organism for the dissection of human disease pathways. With the advent of a comprehensive panel of gene knockouts, projects to characterise the phenotypes of all knockout lines are being initiated. The range of genotype-phenotype associations can be represented using the Mammalian Phenotype ontology. Using publicly available data annotated with this ontology we have constructed gene and phenotype networks representing these associations. These networks show a scale-free, hierarchical and modular character and community structure. They also exhibit enrichment for gene coexpression, protein-protein interactions and Gene Ontology annotation similarity. Close association between gene communities and some high-level ontology terms suggests that systematic phenotyping can provide a direct insight into underlying pathways. However some phenotypes are distributed more diffusely across gene networks, likely reflecting the pleiotropic roles of many genes. Phenotype communities show a many-to-many relationship to human disease communities, but stronger overlap at more granular levels of description. This may suggest that systematic phenotyping projects should aim for high granularity annotations to maximise their relevance to human disease.	[Espinosa, Octavio; Hancock, John M.] MRC Mammalian Genet Unit, Bioinformat Grp, Harwell, Oxon, England; [Espinosa, Octavio] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	MRC Harwell; University of Oxford	Espinosa, O (corresponding author), Inst Canc Res, Chester Beattie Labs, London SW3 6JB, England.	j.hancock@har.mrc.ac.uk	Hancock, John/A-2442-2009	Hancock, John/0000-0003-2991-2217	UK Medical Research Council; MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beck T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S2; Brown SDM, 2009, ANNU REV GENET, V43, P305, DOI 10.1146/annurev-genet-102108-134143; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Groth P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-136; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hancock JM, 2009, MAMM GENOME, V20, P457, DOI 10.1007/s00335-009-9208-3; Hancock John M., 2007, Briefings in Functional Genomics & Proteomics, V6, P292, DOI 10.1093/bfgp/elm033; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; JIANG JQ, 2010, J INTEGR BIOINFORM, V7, DOI DOI 10.2390/BIECOLL-JIB-2010-2149; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Morgan H, 2010, NUCLEIC ACIDS RES, V38, pD577, DOI 10.1093/nar/gkp1007; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Ringwald M, 2000, NUCLEIC ACIDS RES, V28, P115, DOI 10.1093/nar/28.1.115; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SCHAEFER E, 2010, EUR J MED GENET; Schofield PN, 2010, DIS MODEL MECH, V3, P281, DOI 10.1242/dmm.002790; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19693	10.1371/journal.pone.0019693	http://dx.doi.org/10.1371/journal.pone.0019693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625554	gold, Green Submitted, Green Published			2022-12-27	WOS:000290771200016
J	Huang, JQ; Zheng, ZL; Andersson, AF; Engstrand, L; Ye, WM				Huang, Jiaqi; Zheng, Zongli; Andersson, Anders F.; Engstrand, Lars; Ye, Weimin			Rapid Screening of Complex DNA Samples by Single-Molecule Amplification and Sequencing	PLOS ONE			English	Article								Microbial cloning makes Sanger sequencing of complex DNA samples possible but is labor intensive. We present a simple, rapid and robust method that enables laboratories without special equipment to perform single-molecule amplicon sequencing, although in a low-throughput manner, from sub-picogram quantities of DNA. The method can also be used for quick quality control of next-generation sequencing libraries, as was demonstrated for a metagenomic sample.	[Huang, Jiaqi; Zheng, Zongli; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zheng, Zongli; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Engstrand, Lars] Swedish Inst Communicable Infect Dis Control, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Swedish Institute for Infectious Disease Control	Huang, JQ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	zhengzongli@gmail.com	Huang, Jiaqi/AGG-3698-2022; Andersson, Anders/J-9310-2019; Huang, Jiaqi/AAK-8658-2020; zheng, zongli/C-7309-2008; huang, jiaqi/HCI-2563-2022; zheng, zongli/B-2917-2011	Huang, Jiaqi/0000-0002-7808-9477; Andersson, Anders/0000-0002-3627-6899; Huang, Jiaqi/0000-0002-7808-9477; zheng, zongli/0000-0003-4849-4903	European Union [LSHC-CT-2005-018704]; Swedish Cancer Society; Karolinska Institutet (KID); Swedish Research Council FORMAS	European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet (KID); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Sixth Research Framework Program of the European Union, project INCA (LSHC-CT-2005-018704) to Olof Nyren and LE, and Swedish Cancer Society to Olof Nyren, WY, and LE. JH and ZZ were also supported by scholarships from the Karolinska Institutet (KID). AA was funded by a grant from the Swedish Research Council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Fredlake CP, 2008, P NATL ACAD SCI USA, V105, P476, DOI 10.1073/pnas.0705093105; *ILL INC, 2007, PREP SAMPL SEQ GEN D; Karger BL, 2009, ELECTROPHORESIS, V30, pS196, DOI 10.1002/elps.200900218; Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	6	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19723	10.1371/journal.pone.0019723	http://dx.doi.org/10.1371/journal.pone.0019723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625543	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200019
J	Shulse, CN; Allen, EE				Shulse, Christine N.; Allen, Eric E.			Widespread Occurrence of Secondary Lipid Biosynthesis Potential in Microbial Lineages	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; III POLYKETIDE SYNTHASES; TO-HEAD HYDROCARBON; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ESCHERICHIA-COLI; GENOME SEQUENCE; PSYCHROMONAS-INGRAHAMII; HETEROCYST GLYCOLIPIDS; FACULTATIVE ANAEROBE	Bacterial production of long-chain omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), is constrained to a narrow subset of marine gamma-proteobacteria. The genes responsible for de novo bacterial PUFA biosynthesis, designated pfaEABCD, encode large, multi-domain protein complexes akin to type I iterative fatty acid and polyketide synthases, herein referred to as "Pfa synthases". In addition to the archetypal Pfa synthase gene products from marine bacteria, we have identified homologous type I FAS/PKS gene clusters in diverse microbial lineages spanning 45 genera representing 10 phyla, presumed to be involved in long-chain fatty acid biosynthesis. In total, 20 distinct types of gene clusters were identified. Collectively, we propose the designation of "secondary lipids" to describe these biosynthetic pathways and products, a proposition consistent with the "secondary metabolite" vernacular. Phylogenomic analysis reveals a high degree of functional conservation within distinct biosynthetic pathways. Incongruence between secondary lipid synthase functional clades and taxonomic group membership combined with the lack of orthologous gene clusters in closely related strains suggests horizontal gene transfer has contributed to the dissemination of specialized lipid biosynthetic activities across disparate microbial lineages.	[Shulse, Christine N.; Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Allen, Eric E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Shulse, CN (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eallen@ucsd.edu	PONNERASSERY, Sudheesh/C-4589-2014	Shulse, Christine/0000-0001-9320-4384				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auman AJ, 2006, INT J SYST EVOL MICR, V56, P1001, DOI 10.1099/ijs.0.64068-0; Bauersachs T, 2009, PHYTOCHEMISTRY, V70, P2034, DOI 10.1016/j.phytochem.2009.08.014; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bowman JP, 1998, MICROBIOL-UK, V144, P1601, DOI 10.1099/00221287-144-6-1601; Campbell EL, 1997, ARCH MICROBIOL, V167, P251, DOI 10.1007/s002030050440; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARKE K, 2001, PLYMOUTH PRIMER E; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hantash FM, 1997, MICROBIOL-UK, V143, P147, DOI 10.1099/00221287-143-1-147; Herlemann DPR, 2009, APPL ENVIRON MICROB, V75, P2841, DOI 10.1128/AEM.02698-08; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lippmeier JC, 2009, LIPIDS, V44, P621, DOI 10.1007/s11745-009-3311-9; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miller M. A., 2010, CIPRES PORTALS; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Moser DP, 1996, APPL ENVIRON MICROB, V62, P2100, DOI 10.1128/AEM.62.6.2100-2105.1996; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; Nichols DS, 2002, J MICROBIOL METH, V48, P161, DOI 10.1016/S0167-7012(01)00320-7; Nishida T, 2006, FEBS LETT, V580, P2731, DOI 10.1016/j.febslet.2006.04.032; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; PERRY KA, 1993, SCIENCE, V259, P801, DOI 10.1126/science.259.5096.801; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; Riley M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-210; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANGKHOBOL V, 1981, INT J SYST BACTERIOL, V31, P285, DOI 10.1099/00207713-31-3-285; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Singh A, 1996, J IND MICROBIOL, V16, P370, DOI 10.1007/BF01570118; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Starkey RL, 1939, SOIL SCI, V47, P329, DOI 10.1097/00010694-193904000-00007; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wiens GD, 2008, J BACTERIOL, V190, P6970, DOI 10.1128/JB.00721-08; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Yokochi T, 1998, APPL MICROBIOL BIOT, V49, P72, DOI 10.1007/s002530051139; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	62	60	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20146	10.1371/journal.pone.0020146	http://dx.doi.org/10.1371/journal.pone.0020146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21629834	gold, Green Published			2022-12-27	WOS:000290771200050
J	Chang, CK; Hayes, RD; Perera, G; Broadbent, MTM; Fernandes, AC; Lee, WE; Hotopf, M; Stewart, R				Chang, Chin-Kuo; Hayes, Richard D.; Perera, Gayan; Broadbent, Mathew T. M.; Fernandes, Andrea C.; Lee, William E.; Hotopf, Mathew; Stewart, Robert			Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; ALL-CAUSE MORTALITY; PHYSICAL HEALTH; PREMATURE MORTALITY; MEDICAL ILLNESSES; BIPOLAR DISORDER; EXCESS MORTALITY; SCHIZOPHRENIA; SUICIDE; COHORT	Objective: Despite improving healthcare, the gap in mortality between people with serious mental illness (SMI) and general population persists, especially for younger age groups. The electronic database from a large and comprehensive secondary mental healthcare provider in London was utilized to assess the impact of SMI diagnoses on life expectancy at birth. Method: People who were diagnosed with SMI (schizophrenia, schizoaffective disorder, bipolar disorder), substance use disorder, and depressive episode/disorder before the end of 2009 and under active review by the South London and Maudsley NHS Foundation Trust (SLAM) in southeast London during 2007-09 comprised the sample, retrieved by the SLAM Case Register Interactive Search (CRIS) system. We estimated life expectancy at birth for people with SMI and each diagnosis, from national mortality returns between 2007-09, using a life table method. Results: A total of 31,719 eligible people, aged 15 years or older, with SMI were analyzed. Among them, 1,370 died during 2007-09. Compared to national figures, all disorders were associated with substantially lower life expectancy: 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women. Highest reductions were found for men with schizophrenia (14.6 years lost) and women with schizoaffective disorders (17.5 years lost). Conclusion: The impact of serious mental illness on life expectancy is marked and generally higher than similarly calculated impacts of well-recognised adverse exposures such as smoking, diabetes and obesity. Strategies to identify and prevent causes of premature death are urgently required.	[Chang, Chin-Kuo; Lee, William E.; Hotopf, Mathew] Kings Coll London, Inst Psychiat, Acad Dept Psychol Med, London WC2R 2LS, England; [Broadbent, Mathew T. M.] S London & Maudsley NHS Fdn Trust, London, England	University of London; King's College London; South London & Maudsley NHS Trust	Chang, CK (corresponding author), Kings Coll London, Inst Psychiat, Acad Dept Psychol Med, London WC2R 2LS, England.	chin-kuo.chang@kcl.ac.uk	Lee, William E/B-5836-2011; Stewart, Robert/B-1667-2010; Hotopf, Matthew/E-4971-2010; Hayes, Richard/D-2382-2010; Chang, Chin-Kuo/E-4991-2010	Lee, William E/0000-0002-0607-038X; Stewart, Robert/0000-0002-4435-6397; Hotopf, Matthew/0000-0002-3980-4466; Hayes, Richard/0000-0003-4453-244X; Chang, Chin-Kuo/0000-0002-8338-7196; Perera, Gayan/0000-0002-3414-303X	UK National Institute for Health Research; Guy's Trust; St Thomas' Trust; South London Special Trust; Maudsley Special Trust; National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; UK Medical Research Council; MRC [G0601720] Funding Source: UKRI; Medical Research Council [G0601720] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Guy's Trust; St Thomas' Trust; South London Special Trust; Maudsley Special Trust; National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The development of the SLAM BRC Case Register was funded by two Capital Awards from the UK National Institute for Health Research and is further supported through the BRC Nucleus funded jointly by the Guy's and St Thomas' Trustees and South London and Maudsley Special Trustees. C-KC, RH, AF, MB, MH and RS are funded by the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. WL is funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier P, 2006, PHARMACOEPIDEM DR S, V15, P873, DOI 10.1002/pds.1325; Baxter DN, 1996, BRIT J PSYCHIAT, V168, P772, DOI 10.1192/bjp.168.6.772; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; CALDWELL CB, 1990, SCHIZOPHRENIA BULL, V16, P571, DOI 10.1093/schbul/16.4.571; Carter KN, 2010, NEW ZEAL MED J, V123, P13; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Chiang CL, 1984, LIFE TABLE ITS APPL; Chwastiak LA, 2009, LANCET, V374, P590, DOI 10.1016/S0140-6736(09)61072-2; Clarke CA, 2010, SOC SCI MED, V70, P1373, DOI 10.1016/j.socscimed.2010.01.003; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Connolly M., 2005, ADV PSYCHIAT TREAT, V11, P125, DOI [10.1192/APT.11.2.125, DOI 10.1192/APT.11.2.125, 10.1192/apt.11.2.125]; Danaei G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000248; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; Dembling BP, 1999, PSYCHIATR SERV, V50, P1036, DOI 10.1176/ps.50.8.1036; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dutta R, 2007, PSYCHOL MED, V37, P839, DOI 10.1017/S0033291707000347; Fagiolini A, 2009, J CLIN PSYCHIAT, V70, P22, DOI 10.4088/JCP.7075su1c.04; Gray R, 2009, INT J MENT HEALTH NU, V18, P299, DOI 10.1111/j.1447-0349.2009.00640.x; *GREAT LOND AUTH I, 2010, LIF EXP BIRTH 2007 0; Hannerz H, 2001, PUBLIC HEALTH, V115, P328; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; McGirr A, 2008, SCHIZOPHR RES, V98, P217, DOI 10.1016/j.schres.2007.09.009; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; *METH GROUP OFF NA, 2003, NAT STAT METH SER, V33; Montejo AL, 2010, EUR PSYCHIAT, V25, pS3, DOI 10.1016/S0924-9338(10)71699-0; Newcomer JW, 2007, JAMA-J AM MED ASSOC, V298, P1794, DOI 10.1001/jama.298.15.1794; Office for National Statistics, 2009, MORT STAT DEATHS REG; Office of National Statistics, 2009, LIF EXP BIRTH REM HI; Osborn D, 2008, SCHIZOPHR RES, V99, P134, DOI 10.1016/j.schres.2007.11.025; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Osby U, 2000, BRIT MED J, V321, P483, DOI 10.1136/bmj.321.7259.483; Ozasa K, 2008, J EPIDEMIOL, V18, P111, DOI 10.2188/jea.JE2007416; Piatt EE, 2010, PSYCHIAT SERV, V61, P663, DOI 10.1176/ps.2010.61.7.663; POL LG, 2010, DEMOGRAPHY HLTH HLTH; Robson D, 2007, INT J NURS STUD, V44, P457, DOI 10.1016/j.ijnurstu.2006.07.013; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5; Smith S, 2007, EUR PSYCHIAT, V22, P413, DOI 10.1016/j.eurpsy.2007.07.002; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Tamakoshi A, 2010, J EPIDEMIOL, V20, P370, DOI 10.2188/jea.JE20100017; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	43	383	385	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19590	10.1371/journal.pone.0019590	http://dx.doi.org/10.1371/journal.pone.0019590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611123	gold, Green Published			2022-12-27	WOS:000290720200017
J	Hansen, LH; Bentzon-Tilia, M; Bentzon-Tilia, S; Norman, A; Rafty, L; Sorensen, SJ				Hansen, Lars H.; Bentzon-Tilia, Mikkel; Bentzon-Tilia, Sara; Norman, Anders; Rafty, Louise; Sorensen, Soren J.			Design and Synthesis of a Quintessential Self-Transmissible IncX1 Plasmid, pX1.0	PLOS ONE			English	Article							ESCHERICHIA-COLI; CONFERRING RESISTANCE; VIRULENCE PLASMID; BIOFILM FORMATION; MULTIDRUG EFFLUX; DNA SEGMENTS; GENE; GENOME; CONSTRUCTION; REPLICATION	DNA exchange in bacteria via conjugative plasmids is believed to be among the most important contributing factors to the rapid evolution- and diversification rates observed in bacterial species. The IncX1 plasmids are particularly interesting in relation to enteric bacteria, and typically carry genetic loads like antibiotic resistance genes and virulence factors. So far, however, a "pure" version of these molecular parasites, without genetic loads, has yet to be isolated from the environment. Here we report the construction of pX1.0, a fully synthesized IncX1 plasmid capable of horizontal transfer between different enteric bacteria. The designed pX1.0 sequence was derived from the consensus gene content of five IncX1 plasmids and three other, more divergent, members of the same phylogenetic group. The pX1.0 plasmid was shown to replicate stably in E. coli with a plasmid DNA per total DNA ratio corresponding to approximately 3-9 plasmids per chromosome depending on the growth phase of the host. Through conjugation, pX1.0 was able to self-transfer horizontally into an isogenic strain of E. coli as well as into two additional species belonging to the family Enterobacteriaceae. Our results demonstrate the immediate applicability of recent advances made within the field of synthetic biology for designing and constructing DNA systems, previously existing only in silica.	[Hansen, Lars H.; Bentzon-Tilia, Mikkel; Bentzon-Tilia, Sara; Norman, Anders; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Rafty, Louise] DNA2 0, Menlo Pk, CA USA	University of Copenhagen	Hansen, LH (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	hestbjerg@bio.ku.dk	Hansen, Lars/G-3236-2011; Norman, Anders/E-2515-2011; Bentzon-Tilia, Mikkel/C-4319-2013; Bentzon-Tilia, Mikkel/AAW-2341-2021; Sørensen, Søren Johannes/N-2120-2019; Sørensen, Søren J/J-5015-2014	Norman, Anders/0000-0002-1282-394X; Bentzon-Tilia, Mikkel/0000-0002-7888-9845; Sørensen, Søren Johannes/0000-0001-6227-9906; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Danish Research Council for Independent Research; Natural Sciences (FNU) [09-065940]	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Sciences (FNU)(Danish Natural Science Research Council)	The project was partly funded by The Danish Research Council for Independent Research vertical bar Natural Sciences (FNU). FNU homepage: http://fi.dk, grant number: 09-065940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAHL MI, 2007, MULTIPLE ANTIBIOTIC; BRADLEY DE, 1978, PLASMID, V1, P376, DOI 10.1016/0147-619X(78)90053-7; Burian J, 1997, PLASMID, V37, P2, DOI 10.1006/plas.1996.1273; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; DILLON PJ, 1991, J VIROL, V65, P4490, DOI 10.1128/JVI.65.8.4490-4493.1991; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Harada KM, 2006, PLASMID, V56, P11, DOI 10.1016/j.plasmid.2005.12.002; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Kamachi K, 2006, MICROBIOL-SGM, V152, P3477, DOI 10.1099/mic.0.29056-0; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Olsen JE, 2004, MICROB PATHOGENESIS, V36, P337, DOI 10.1016/j.micpath.2004.02.005; RYAN MJ, 1979, J BIOL CHEM, V254, P5817; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; STALKER DM, 1985, PLASMID, V14, P245, DOI 10.1016/0147-619X(85)90008-3; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19912	10.1371/journal.pone.0019912	http://dx.doi.org/10.1371/journal.pone.0019912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625636	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200047
J	Krauss, J; Gallenberger, I; Steffan-Dewenter, I				Krauss, Jochen; Gallenberger, Iris; Steffan-Dewenter, Ingolf			Decreased Functional Diversity and Biological Pest Control in Conventional Compared to Organic Crop Fields	PLOS ONE			English	Article							LANDSCAPE CONTEXT; NATURAL ENEMIES; CEREAL APHIDS; POLLINATOR DIVERSITY; ECOSYSTEM SERVICES; PLANT DIVERSITY; LAND-USE; BIODIVERSITY; PREDATORS; WHEAT	Organic farming is one of the most successful agri-environmental schemes, as humans benefit from high quality food, farmers from higher prices for their products and it often successfully protects biodiversity. However there is little knowledge if organic farming also increases ecosystem services like pest control. We assessed 30 triticale fields (15 organic vs. 15 conventional) and recorded vascular plants, pollinators, aphids and their predators. Further, five conventional fields which were treated with insecticides were compared with 10 non-treated conventional fields. Organic fields had five times higher plant species richness and about twenty times higher pollinator species richness compared to conventional fields. Abundance of pollinators was even more than one-hundred times higher on organic fields. In contrast, the abundance of cereal aphids was five times lower in organic fields, while predator abundances were three times higher and predator-prey ratios twenty times higher in organic fields, indicating a significantly higher potential for biological pest control in organic fields. Insecticide treatment in conventional fields had only a short-term effect on aphid densities while later in the season aphid abundances were even higher and predator abundances lower in treated compared to untreated conventional fields. Our data indicate that insecticide treatment kept aphid predators at low abundances throughout the season, thereby significantly reducing top-down control of aphid populations. Plant and pollinator species richness as well as predator abundances and predator-prey ratios were higher at field edges compared to field centres, highlighting the importance of field edges for ecosystem services. In conclusion organic farming increases biodiversity, including important functional groups like plants, pollinators and predators which enhance natural pest control. Preventative insecticide application in conventional fields has only short-term effects on aphid densities but long-term negative effects on biological pest control. Therefore conventional farmers should restrict insecticide applications to situations where thresholds for pest densities are reached.	[Krauss, Jochen; Steffan-Dewenter, Ingolf] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Krauss, Jochen; Gallenberger, Iris; Steffan-Dewenter, Ingolf] Univ Bayreuth, Dept Anim Ecol 1, Populat Ecol Grp, Bayreuth, Germany	University of Wurzburg; University of Bayreuth	Krauss, J (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Wurzburg, Germany.	j.krauss@uni-wuerzburg.de	Krauss, Jochen/C-6216-2014	Krauss, Jochen/0000-0003-2304-9117; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	European Community [226852]; German Research Foundation (DFG); University of Wuerzburg	European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	I.S.-D. and J.K. acknowledge project funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 226852, Scales Project (http://www.scales-project.net). The publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Banks JE, 2004, AGR ECOSYST ENVIRON, V103, P595, DOI 10.1016/j.agee.2003.11.005; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Boutin C, 2008, AGR ECOSYST ENVIRON, V123, P185, DOI 10.1016/j.agee.2007.05.010; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; Dallimer M, 2010, BIOL LETTERS, V6, P643, DOI 10.1098/rsbl.2010.0228; Devlaeminck R, 2005, AGR ECOSYST ENVIRON, V107, P57, DOI 10.1016/j.agee.2004.10.003; Freier B, 2007, BIOCONTROL, V52, P775, DOI 10.1007/s10526-007-9081-5; Fuller RJ, 2005, BIOL LETTERS, V1, P431, DOI 10.1098/rsbl.2005.0357; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gibson RH, 2007, J APPL ECOL, V44, P792, DOI 10.1111/j.1365-2664.2007.01292.x; Harri SA, 2008, J ANIM ECOL, V77, P605, DOI 10.1111/j.1365-2656.2008.01373.x; Hald AB, 1999, ANN APPL BIOL, V134, P307, DOI 10.1111/j.1744-7348.1999.tb05269.x; Hiltbrunner J, 2008, WEED RES, V48, P360, DOI 10.1111/j.1365-3180.2008.00639.x; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Holland JM, 1997, ANN APPL BIOL, V131, P375, DOI 10.1111/j.1744-7348.1997.tb05167.x; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Hradetzky R, 1997, BIOL AGRIC HORTIC, V15, P353, DOI 10.1080/01448765.1997.9755209; Jorgensen JR, 2007, BIOMASS BIOENERG, V31, P308, DOI 10.1016/j.biombioe.2007.01.001; KIECKHEFER RW, 1995, AGRON J, V87, P785, DOI 10.2134/agronj1995.00021962008700050001x; Kiss J, 1997, AGR ECOSYST ENVIRON, V63, P227, DOI 10.1016/S0167-8809(97)00018-2; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Letourneau DK, 2008, FRONT ECOL ENVIRON, V6, P430, DOI 10.1890/070081; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Oberg S, 2007, AGR ECOSYST ENVIRON, V122, P211, DOI 10.1016/j.agee.2006.12.034; Oettler G, 2005, J AGR SCI-CAMBRIDGE, V143, P329, DOI 10.1017/S0021859605005290; Ostman O, 2003, ECOL ECON, V45, P149, DOI 10.1016/S0921-8009(03)00007-7; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Purtauf T, 2005, AGR ECOSYST ENVIRON, V108, P165, DOI 10.1016/j.agee.2005.01.005; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Romero A, 2008, AGR ECOSYST ENVIRON, V124, P97, DOI 10.1016/j.agee.2007.08.002; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Roschewitz I, 2005, AGR ECOSYST ENVIRON, V108, P218, DOI 10.1016/j.agee.2005.02.005; Rundlof M, 2006, J APPL ECOL, V43, P1121, DOI 10.1111/j.1365-2664.2006.01233.x; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; Snyder WE, 2003, ECOLOGY, V84, P91, DOI 10.1890/0012-9658(2003)084[0091:IBSAGN]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; WHARE DM, 2004, PESTICIDE BOOK MEIST; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Zehnder G, 2007, ANNU REV ENTOMOL, V52, P57, DOI 10.1146/annurev.ento.52.110405.091337	50	73	78	9	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19502	10.1371/journal.pone.0019502	http://dx.doi.org/10.1371/journal.pone.0019502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611171	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200008
J	Dugue, L; Marque, P; VanRullen, R				Dugue, Laura; Marque, Philippe; VanRullen, Rufin			Transcranial Magnetic Stimulation Reveals Attentional Feedback to Area V1 during Serial Visual Search	PLOS ONE			English	Article							FRONTAL EYE FIELDS; PARIETAL CORTEX; TIME-COURSE; SET-SIZE; CONJUNCTION; PERCEPTION; BRAIN; MODEL	Visual search tasks have been used to understand how, where and when attention influences visual processing. Current theories suggest the involvement of a high-level "saliency map'' that selects a candidate location to focus attentional resources. For a parallel (or "pop-out'') task, the first chosen location is systematically the target, but for a serial (or "difficult'') task, the system may cycle on a few distractors before finally focusing on the target. This implies that attentional effects upon early visual areas, involving feedback from higher areas, should be visible at longer latencies during serial search. A previous study from Juan & Walsh (2003) had used Transcranial Magnetic Stimulation (TMS) to support this conclusion; however, only a few post-stimulus delays were compared, and no control TMS location was used. Here we applied TMS double-pulses (sub-threshold) to induce a transient inhibition of area V1 at every post-stimulus delay between 100 ms and 500 ms (50 ms steps). The search array was presented either at the location affected by the TMS pulses (previously identified by applying several pulses at supra-threshold intensity to induce phosphene perception), or in the opposite hemifield, which served as a retinotopically-defined control location. Two search tasks were used: a parallel (+ among Ls) and a serial one (T among Ls). TMS specifically impaired the serial, but not the parallel search. We highlight an involvement of V1 in serial search 300 ms after the onset; conversely, V1 did not contribute to parallel search at delays beyond 100 ms. This study supports the idea that serial search differs from parallel search by the presence of additional cycles of a select-and-focus iterative loop between V1 and higher-level areas.	[Dugue, Laura; VanRullen, Rufin] Univ Toulouse 3, F-31062 Toulouse, France; [Dugue, Laura; VanRullen, Rufin] CNRS, Ctr Rech Cerveau & Cognit, UMR5549, Fac Med Purpan, Toulouse, France; [Marque, Philippe] CHU Rangueil, F-31054 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Dugue, L (corresponding author), Univ Toulouse 3, F-31062 Toulouse, France.	laura.dugue@cerco.ups-tlse.fr	MARQUE, Philippe/AAC-4798-2019; MARQUE, PHILIPPE/F-9303-2013; VanRullen, Rufin/B-2150-2008	VanRullen, Rufin/0000-0002-3611-7716; Dugue, Laura/0000-0003-3085-1458	EURYI Award; ANR [06JCJC-0154]	EURYI Award(European Science Foundation (ESF)); ANR(French National Research Agency (ANR))	This research was funded by a EURYI Award and an ANR grant 06JCJC-0154 to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Barker AT, 1999, HIST BASIC PRINCIPLE; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; Deco G, 2002, VISION RES, V42, P2925, DOI 10.1016/S0042-6989(02)00358-9; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Green DM, 1966, SIGNAL DETECTION THE; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kalla R, 2008, NEUROREPORT, V19, P1067, DOI 10.1097/WNR.0b013e328304d9c4; Muggleton NG, 2008, NEUROPSYCHOLOGIA, V46, P2198, DOI 10.1016/j.neuropsychologia.2008.02.016; Muggleton NG, 2010, CORTEX, V46, P178, DOI 10.1016/j.cortex.2009.01.011; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; PALMER J, 1993, J EXP PSYCHOL HUMAN, V19, P108, DOI 10.1037/0096-1523.19.1.108; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; Sommer M, 2008, TMS WAVEFORM CURRENT; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2010, CURR BIOL, V20, pR346, DOI 10.1016/j.cub.2010.02.016; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	29	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19712	10.1371/journal.pone.0019712	http://dx.doi.org/10.1371/journal.pone.0019712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611188	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500016
J	Jeffery, NW; Elias-Gutierrez, M; Adamowicz, SJ				Jeffery, Nicholas W.; Elias-Gutierrez, Manuel; Adamowicz, Sarah J.			Species Diversity and Phylogeographical Affinities of the Branchiopoda (Crustacea) of Churchill, Manitoba, Canada	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; CLADOCERA; COLONIZATION; PATTERNS; BARCODE; LIFE	The region of Churchill, Manitoba, contains a wide variety of habitats representative of both the boreal forest and arctic tundra and has been used as a model site for biodiversity studies for nearly seven decades within Canada. Much previous work has been done in Churchill to study the Daphnia pulex species complex in particular, but no study has completed a wide-scale survey on the crustacean species that inhabit Churchill's aquatic ecosystems using molecular markers. We have employed DNA barcoding to study the diversity of the Branchiopoda (Crustacea) in a wide variety of freshwater habitats and to determine the likely origins of the Churchill fauna following the last glaciation. The standard animal barcode marker (COI) was sequenced for 327 specimens, and a 3% divergence threshold was used to delineate potential species. We found 42 provisional and valid branchiopod species from this survey alone, including several cryptic lineages, in comparison with the 25 previously recorded from previous ecological works. Using published sequence data, we explored the phylogeographic affinities of Churchill's branchiopods, finding that the Churchill fauna apparently originated from all directions from multiple glacial refugia (including southern, Beringian, and high arctic regions). Overall, these microcrustaceans are very diverse in Churchill and contain multiple species complexes. The present study introduces among the first sequences for some understudied genera, for which further work is required to delineate species boundaries and develop a more complete understanding of branchiopod diversity over a larger spatial scale.	[Jeffery, Nicholas W.; Adamowicz, Sarah J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Jeffery, Nicholas W.; Adamowicz, Sarah J.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Elias-Gutierrez, Manuel] Colegio Frontera Sur, Dept Systemat & Aquat Ecol, Chetumal Unit, Quintana Roo, Mexico	University of Guelph; University of Guelph; El Colegio de la Frontera Sur (ECOSUR)	Jeffery, NW (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	njeffery@uoguelph.ca	Elias-Gutierrez, Manuel/A-8952-2013; Jeffery, Nicholas W/J-5859-2019	Elias-Gutierrez, Manuel/0000-0003-2562-4584; Jeffery, Nicholas W/0000-0003-4242-5712	Natural Sciences and Engineering Research Council of Canada (NSERC); Genome Canada; Northern Scientific Training Program; Northern Research Fund award; Ontario Genomics Institute [2008-OGI-ICI-03]; Mexican Barcode of Life (MEXBOL) project	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Northern Scientific Training Program; Northern Research Fund award; Ontario Genomics Institute; Mexican Barcode of Life (MEXBOL) project	This project was supported by an International Polar Year (IPY) grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and a Genome Canada grant to Paul Hebert. This work was also funded by the Northern Scientific Training Program to NWJ (http://www.ainc-inac.gc.ca/nth/st/nstp/index-eng.asp), and a Northern Research Fund award to SJA (http://www.churchillscience.ca/index.php?page = re_funding). This project was funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03). The work conducted by ME-G was supported in part by the Mexican Barcode of Life (MEXBOL) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P455, DOI 10.1111/j.1466-822x.2005.00164.x; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BERNER DB, 1986, EPA600486032, P1; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; HANN BJ, 1995, HYDROBIOLOGIA, V307, P9, DOI 10.1007/BF00031992; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEBERT PDN, 1986, CAN J FISH AQUAT SCI, V43, P1416, DOI 10.1139/f86-175; HEBERT PDN, 1987, HYDROBIOLOGIA, V145, P183, DOI 10.1007/BF02530279; HEBERT PDN, 1982, ANN ZOOL FENN, V19, P349; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; McClure H. Elliot, 1943, ECOL MONOGR, V13, P1, DOI 10.2307/1943588; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Quiroz-Vazquez P, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2236.1.4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rowe Chad L., 2007, Zootaxa, V1656, P1; Shelford VE, 1941, ECOLOGY, V22, P47, DOI 10.2307/1930008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THORP JH, 2001, ECOLOGY CLASSIFICATI; Weider LJ, 2010, P ROY SOC B-BIOL SCI, V277, P139, DOI 10.1098/rspb.2009.1326; WEIDER LJ, 1987, ECOLOGY, V68, P188, DOI 10.2307/1938819; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x	40	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e18364	10.1371/journal.pone.0018364	http://dx.doi.org/10.1371/journal.pone.0018364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21610864	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500001
J	Lammer, AB; Beck, A; Grummich, B; Forschler, A; Krugel, T; Kahn, T; Schneider, D; Illes, P; Franke, H; Krugel, U				Laemmer, Alexandra B.; Beck, Alexander; Grummich, Benjamin; Foerschler, Annette; Kruegel, Thomas; Kahn, Thomas; Schneider, Dietmar; Illes, Peter; Franke, Heike; Kruegel, Ute			The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; TUMOR-NECROSIS-FACTOR; FOCAL BRAIN ISCHEMIA; EXTRACELLULAR ATP; MICROGLIAL ACTIVATION; PURINERGIC MODULATION; NUCLEUS-ACCUMBENS; P2X(7) RECEPTORS; INDUCED INJURY; UP-REGULATION	Background: After ischemia of the CNS, extracellular adenosine 5'-triphosphate (ATP) can reach high concentrations due to cell damage and subsequent increase of membrane permeability. ATP may cause cellular degeneration and death, mediated by P2X and P2Y receptors. Methodology/Principal Findings: The effects of inhibition of P2 receptors by pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) on electrophysiological, functional and morphological alterations in an ischemia model with permanent middle cerebral artery occlusion (MCAO) were investigated up to day 28. Spontaneously hypertensive rats received PPADS or vehicle intracerebroventricularly 15 minutes prior MCAO for up to 7 days. The functional recovery monitored by qEEG was improved by PPADS indicated by an accelerated recovery of ischemia-induced qEEG changes in the delta and alpha frequency bands along with a faster and sustained recovery of motor impairments. Whereas the functional improvements by PPADS were persistent at day 28, the infarct volume measured by magnetic resonance imaging and the amount of TUNEL-positive cells were significantly reduced by PPADS only until day 7. Further, by immunohistochemistry and confocal laser scanning microscopy, we identified both neurons and astrocytes as TUNEL-positive after MCAO. Conclusion: The persistent beneficial effect of PPADS on the functional parameters without differences in the late (day 28) infarct size and apoptosis suggests that the early inhibition of P2 receptors might be favourable for the maintenance or early reconstruction of neuronal connectivity in the periinfarct area after ischemic incidents.	[Laemmer, Alexandra B.; Beck, Alexander] Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany; [Laemmer, Alexandra B.; Schneider, Dietmar] Univ Leipzig, Dept Neurol, Leipzig, Germany; [Grummich, Benjamin; Kruegel, Thomas; Illes, Peter; Franke, Heike; Kruegel, Ute] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Foerschler, Annette; Kahn, Thomas] Univ Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany	University of Erlangen Nuremberg; Leipzig University; Leipzig University; Leipzig University	Lammer, AB (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany.	ute.kruegel@medizin.uni-leipzig.de	Forschler, Annette/O-9390-2015	Forschler, Annette/0000-0001-9665-5228; Krugel, Ute/0000-0002-2317-2302	Deutsche Forschungsgemeinschaft (DFG) [KI677, KR3614]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de; KI677, KR3614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Beaumont E, 2004, MUSCLE NERVE, V29, P234, DOI 10.1002/mus.10539; Boltze J, 2006, ARTIF ORGANS, V30, P756, DOI 10.1111/j.1525-1594.2006.00297.x; Braun N, 1998, J NEUROSCI, V18, P4891; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Burnstock G, 2011, CURR TOP ME IN PRESS; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Cavaliere F, 2004, EXP CELL RES, V300, P149, DOI 10.1016/j.yexcr.2004.07.009; Cavaliere F, 2003, NEUROSCIENCE, V120, P85, DOI 10.1016/S0306-4522(03)00228-8; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Dijkhuizen RM, 2003, J CEREBR BLOOD F MET, V23, P1383, DOI 10.1097/01.WCB.0000100341.78607.EB; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Ferrari D, 1997, J IMMUNOL, V159, P1451; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Finnigan SP, 2006, CLIN NEUROPHYSIOL, V117, P2338, DOI 10.1016/j.clinph.2006.06.718; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Franke H, 2004, NEUROSCIENCE, V127, P431, DOI 10.1016/j.neuroscience.2004.05.003; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Jacobson KA, 1998, J MED CHEM, V41, P2201, DOI 10.1021/jm980183o; Juranyi Z, 1999, BRAIN RES, V823, P183, DOI 10.1016/S0006-8993(99)01169-5; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Krugel U, 2004, INT J DEV NEUROSCI, V22, P565, DOI 10.1016/j.ijdevneu.2004.07.009; Krugel U, 2003, SYNAPSE, V47, P134, DOI 10.1002/syn.10162; Krugel U, 2001, EUR J PHARMACOL, V420, pR3, DOI 10.1016/S0014-2999(01)01001-9; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Le Feuvre RA, 2003, J CEREBR BLOOD F MET, V23, P381, DOI 10.1097/01.WCB.0000048519.34839.97; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Moyanova S, 1998, ARCH PHYSIOL BIOCHEM, V106, P384, DOI 10.1076/apab.106.5.384.4362; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Noto T, 2004, MOL BRAIN RES, V128, P30, DOI 10.1016/j.molbrainres.2004.06.003; NUWER MR, 1987, NEUROLOGY, V37, P1153, DOI 10.1212/WNL.37.7.1153; Paxinos P., 1986, RAT BRAIN STEREOTAXI; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Taoufik E, 2008, CURR PHARM DESIGN, V14, P3565, DOI 10.2174/138161208786848748; Thomalla G, 2006, STROKE, V37, P852, DOI 10.1161/01.STR.0000204120.79399.72; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Zhang L, 2000, J NEUROL SCI, V174, P141, DOI 10.1016/S0022-510X(00)00268-9; Zhang YC, 2006, J NEUROPHYSIOL, V95, P1537, DOI 10.1152/jn.01166.2005	68	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19983	10.1371/journal.pone.0019983	http://dx.doi.org/10.1371/journal.pone.0019983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611146	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500038
J	Meissner, B; Rogalski, T; Viveiros, R; Warner, A; Plastino, L; Lorch, A; Granger, L; Segalat, L; Moerman, DG				Meissner, Barbara; Rogalski, Teresa; Viveiros, Ryan; Warner, Adam; Plastino, Lorena; Lorch, Adam; Granger, Laure; Segalat, Laurent; Moerman, Donald G.			Determining the Sub-Cellular Localization of Proteins within Caenorhabditis elegans Body Wall Muscle	PLOS ONE			English	Article							INTEGRIN ADHESION COMPLEXES; OPEN READING FRAMES; C-ELEGANS; FOCAL ADHESIONS; MECHANOSENSORY FUNCTION; FUNCTIONAL GENOMICS; FLUORESCENT PROTEIN; CELL-ADHESION; LINKED KINASE; GENE	Determining the sub-cellular localization of a protein within a cell is often an essential step towards understanding its function. In Caenorhabditis elegans, the relatively large size of the body wall muscle cells and the exquisite organization of their sarcomeres offer an opportunity to identify the precise position of proteins within cell substructures. Our goal in this study is to generate a comprehensive "localizome'' for C. elegans body wall muscle by GFP-tagging proteins expressed in muscle and determining their location within the cell. For this project, we focused on proteins that we know are expressed in muscle and are orthologs or at least homologs of human proteins. To date we have analyzed the expression of about 227 GFP-tagged proteins that show localized expression in the body wall muscle of this nematode (e.g. dense bodies, M-lines, myofilaments, mitochondria, cell membrane, nucleus or nucleolus). For most proteins analyzed in this study no prior data on sub-cellular localization was available. In addition to discrete sub-cellular localization we observe overlapping patterns of localization including the presence of a protein in the dense body and the nucleus, or the dense body and the M-lines. In total we discern more than 14 sub-cellular localization patterns within nematode body wall muscle. The localization of this large set of proteins within a muscle cell will serve as an invaluable resource in our investigation of muscle sarcomere assembly and function.	[Meissner, Barbara; Rogalski, Teresa; Viveiros, Ryan; Warner, Adam; Plastino, Lorena; Lorch, Adam; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Moerman, Donald G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Granger, Laure; Segalat, Laurent] Univ Lyon 1, CNRS, CGMC, F-69622 Villeurbanne, France	University of British Columbia; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Meissner, B (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	moerman@zoology.ubc.ca			Canadian Institute for Health Research; National Science and Engineering Research Council	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Canadian Institute for Health Research and the National Science and Engineering Research Council to DGM. RV is a research trainee of the Michael Smith Foundation for Health Research. DGM is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; GHOSH SR, 2010, EUR J CELL BIOL, DOI DOI 10.1016/JEJCB.2009.11.027; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heyman JA, 1999, GENOME RES, V9, P383; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Labouesse M, 2003, CURR BIOL, V13, pR528, DOI 10.1016/S0960-9822(03)00448-2; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Lin XY, 2003, CURR BIOL, V13, P922, DOI 10.1016/S0960-9822(03)00372-5; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; MELLO C, 1995, CAENORHABDITIS ELEGA, P452; MOERMAN DG, 1997, MUSCLE STRUCTURE FUN, P417; MOERMAN DG, 2006, SARCOMERE ASSEMBLY C, DOI DOI 10.1895/WORMBOOK.1.81.1; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moulder GL, 1996, MOL BIOL CELL, V7, P1181, DOI 10.1091/mbc.7.8.1181; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; POOT YZ, 1996, J HISTOCHEM CYTOCHEM, V44, P1363; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Ruksana R, 2005, GENES CELLS, V10, P261, DOI 10.1111/j.1365-2443.2005.00829.x; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Waterston R., 1988, NEMATODE C ELEGANS, P281; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Zervas CG, 2002, CURR BIOL, V12, pR350, DOI 10.1016/S0960-9822(02)00856-4; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zwaal RR, 2001, J BIOL CHEM, V276, P43557, DOI 10.1074/jbc.M104693200	58	31	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19937	10.1371/journal.pone.0019937	http://dx.doi.org/10.1371/journal.pone.0019937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611156	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500035
J	Wu, B; Benrashid, E; Lu, PJ; Cloer, C; Zillmer, A; Shaban, M; Lu, QL				Wu, Bo; Benrashid, Ehsan; Lu, Peijuan; Cloer, Caryn; Zillmer, Allen; Shaban, Mona; Lu, Qi Long			Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development	PLOS ONE			English	Article							MUSCLE-CELLS; EXPRESSION; RESTORATION; DELIVERY; DELETION; GENE; MICE	Antisense therapy has recently been demonstrated with great potential for targeted exon skipping and restoration of dystrophin production in cultured muscle cells and in muscles of Duchenne Muscular Dystrophy (DMD) patients. Therapeutic values of exon skipping critically depend on efficacy of the drugs, antisense oligomers (AOs). However, no animal model has been established to test AO targeting human dystrophin exon in vivo systemically. In this study, we applied Vivo-Morpholino to the hDMD mouse, a transgenic model carrying the full-length human dystrophin gene, and achieved for the first time more than 70% efficiency of targeted human dystrophin exon skipping in vivo systemically. We also established a GFP-reporter myoblast culture to screen AOs targeting human dystrophin exon 50. Antisense efficiency for most AOs is consistent between the reporter cells, human myoblasts and in the hDMD mice in vivo. However, variation in efficiency was also clearly observed. A combination of in vitro cell culture and a Vivo-Morpholino based evaluation in vivo systemically in the hDMD mice therefore may represent a prudent approach for selecting AO drug and to meet the regulatory requirement.	[Wu, Bo; Benrashid, Ehsan; Lu, Peijuan; Cloer, Caryn; Zillmer, Allen; Shaban, Mona; Lu, Qi Long] Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Dept Neurol, Charlotte, NC 28203 USA	Carolinas Medical Center	Wu, B (corresponding author), Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Dept Neurol, Charlotte, NC 28203 USA.	bo.wu@carolinashealthcare.org; qi.lu@carolinashealthcare.org	lu, qi/HHS-2115-2022	Benrashid, Ehsan/0000-0003-4216-6095	Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation; Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA; U.S. Army Medical Research, Department of Defense [W81XWH-05-1-0616]	Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation; Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA; U.S. Army Medical Research, Department of Defense(United States Department of Defense)	This work was supported by the Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation and Carolinas Medical Center, Charlotte, NC; Charley's Fund, MA USA and by U.S. Army Medical Research, Department of Defense (W81XWH-05-1-0616). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HU Y, 2010, MOL THER JAN, P19; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Mirabella M, 1998, NEUROLOGY, V51, P592, DOI 10.1212/WNL.51.2.592; Sazani P, 2001, NUCLEIC ACIDS RES, V29, P3965, DOI 10.1093/nar/29.19.3965; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; Takeshima Y, 2001, BRAIN DEV-JPN, V23, P788, DOI 10.1016/S0387-7604(01)00326-6; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	24	11	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19906	10.1371/journal.pone.0019906	http://dx.doi.org/10.1371/journal.pone.0019906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611204	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500032
J	Carnes, LM; Nunn, CL; Lewis, RJ				Carnes, Laurel Mariah; Nunn, Charles L.; Lewis, Rebecca J.			Effects of the Distribution of Female Primates on the Number of Males	PLOS ONE			English	Article							EXAGGERATED SEXUAL SWELLINGS; MALE REPRODUCTIVE SUCCESS; EXTRA-PAIR COPULATIONS; MALE MATING STRATEGIES; MALE VERREAUXS SIFAKA; MALE RHESUS MACAQUES; INTER-TROOP TRANSFER; SOCIAL-ORGANIZATION; JAPANESE MACAQUES; ANIMAL SOCIETIES	The spatiotemporal distribution of females is thought to drive variation in mating systems, and hence plays a central role in understanding animal behavior, ecology and evolution. Previous research has focused on investigating the links between female spatiotemporal distribution and the number of males in haplorhine primates. However, important questions remain concerning the importance of spatial cohesion, the generality of the pattern across haplorhine and strepsirrhine primates, and the consistency of previous findings given phylogenetic uncertainty. To address these issues, we examined how the spatiotemporal distribution of females influences the number of males in primate groups using an expanded comparative dataset and recent advances in Bayesian phylogenetic and statistical methods. Specifically, we investigated the effect of female distributional factors (female number, spatial cohesion, estrous synchrony, breeding season duration and breeding seasonality) on the number of males in primate groups. Using Bayesian approaches to control for uncertainty in phylogeny and the model of trait evolution, we found that the number of females exerted a strong influence on the number of males in primate groups. In a multiple regression model that controlled for female number, we found support for temporal effects, particularly involving female estrous synchrony: the number of males increases when females are more synchronously receptive. Similarly, the number of males increases in species with shorter birth seasons, suggesting that greater breeding seasonality makes defense of females more difficult for male primates. When comparing primate suborders, we found only weak evidence for differences in traits between haplorhines and strepsirrhines, and including suborder in the statistical models did not affect our conclusions or give compelling evidence for different effects in haplorhines and strepsirrhines. Collectively, these results demonstrate that male monopolization is driven primarily by the number of females in groups, and secondarily by synchrony of female reproduction within groups.	[Carnes, Laurel Mariah] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Nunn, Charles L.] Harvard Univ, Peabody Museum, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Lewis, Rebecca J.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	University of Chicago; Harvard University; University of Texas System; University of Texas Austin	Carnes, LM (corresponding author), Univ Chicago, Sch Law, Chicago, IL 60637 USA.	rjlewis@mail.utexas.edu	Lewis, Rebecca/M-9205-2019	Lewis, Rebecca/0000-0003-3533-6105	Harvard University; National Science Foundation [BCS-0923791]; Rapaport-King Thesis Scholarship	Harvard University; National Science Foundation(National Science Foundation (NSF)); Rapaport-King Thesis Scholarship	CLN was supported by Harvard University and the National Science Foundation (BCS-0923791). RJL was supported by a Rapaport-King Thesis Scholarship (http://www.utexas.edu/cola/progs/lahonors/scholarships/lah/rapoport-king-thesis.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; ALTMANN J, 1990, ANIM BEHAV, V39, P193, DOI 10.1016/S0003-3472(05)80740-7; Andelman S.J, 1986, P201; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BERARD JD, 1994, BEHAVIOUR, V129, P177, DOI 10.1163/156853994X00604; BOINSKI S, 1987, BEHAV ECOL SOCIOBIOL, V21, P13, DOI 10.1007/BF00324430; Boinski S, 2005, BEHAVIOUR, V142, P525, DOI 10.1163/1568539054352888; Borries C, 2000, PRIMATE MALES, P146; Brauch K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1453, DOI 10.1007/s00265-008-0575-7; Brown GP, 1999, BEHAV ECOL SOCIOBIOL, V47, P9, DOI 10.1007/s002650050644; Campbell CJ., 2010, PRIMATES PERSPECTIVE; Cant MA, 1998, ANIM BEHAV, V55, P163, DOI 10.1006/anbe.1997.0589; Cappozzo HL, 2008, NATURWISSENSCHAFTEN, V95, P625, DOI 10.1007/s00114-008-0363-2; Carlson AA, 2001, ANIM BEHAV, V62, P1047, DOI 10.1006/anbe.2001.1849; Chapman CA, 2009, PRIMATES, V50, P12, DOI 10.1007/s10329-008-0123-0; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; CHENEY DL, 1983, AM NAT, V122, P392, DOI 10.1086/284142; Clarke MR, 2010, PRIMATES, V51, P241, DOI 10.1007/s10329-010-0195-5; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; CLUTTONB.TH, 1974, NATURE, V250, P539, DOI 10.1038/250539a0; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; Cords M, 2000, PRIMATE MALES, P84; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; Dixson A, 2002, EVOL ANTHROPOL, V11, P195, DOI 10.1002/evan.10090; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Dunbar RIM, 1999, PRIMATE MALES; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberle M, 2004, BEHAV ECOL SOCIOBIOL, V57, P77, DOI 10.1007/s00265-004-0826-1; EISENBER.JF, 1972, SCIENCE, V176, P863, DOI 10.1126/science.176.4037.863; Eisenberg J.F., 1981, MAMMALIAN RAD; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Engelhardt A, 2006, BEHAV ECOL SOCIOBIOL, V59, P740, DOI 10.1007/s00265-005-0104-x; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GLANDER KE, 1992, INT J PRIMATOL, V13, P415, DOI 10.1007/BF02547826; GRANT JWA, 1995, ANIM BEHAV, V49, P367, DOI 10.1006/anbe.1995.9998; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hayakawa S, 2007, INT J PRIMATOL, V28, P73, DOI 10.1007/s10764-006-9109-1; HEWS DK, 1993, ANIM BEHAV, V46, P279, DOI 10.1006/anbe.1993.1189; Heymann EW, 2000, PRIMATE MALES, P64; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Ims, 1988, NATURE, V335, P541; IMS RA, 1987, AM NAT, V130, P475, DOI 10.1086/284725; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Isaac JL, 2003, BEHAV ECOL, V14, P818, DOI 10.1093/beheco/arg076; Janson C, 2005, CAM S BIO EVOL ANTHR, V44, P307, DOI 10.1017/CBO9780511542343.012; Janson Charles H., 1992, P95; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Johnson DDP, 2000, MAMMAL REV, V30, P171, DOI 10.1046/j.1365-2907.2000.00066.x; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; JONES KC, 1983, FOLIA PRIMATOL, V40, P145, DOI 10.1159/000156096; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 2000, PRIMATE MALES, P55; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; KEDDYHECTOR AC, 1992, AM ZOOL, V32, P62; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kraus C, 2003, ANIM BEHAV, V66, P225, DOI 10.1006/anbe.2003.2192; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Kutsukake N, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P165, DOI 10.1017/CBO9780511641954.009; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis RJ, 2008, INT J PRIMATOL, V29, P1249, DOI 10.1007/s10764-008-9304-3; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lindenfors P, 2004, P ROY SOC B-BIOL SCI, V271, pS101, DOI 10.1098/rsbl.2003.0114; Martin JK, 2007, OECOLOGIA, V154, P227, DOI 10.1007/s00442-007-0823-y; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; Meade A., 2007, BAYESTRAITS; Mitani JC, 1996, AM J PRIMATOL, V38, P315, DOI 10.1002/(SICI)1098-2345(1996)38:4<315::AID-AJP3>3.0.CO;2-1; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Muller AE, 2000, BIOL REV, V75, P405, DOI 10.1017/S0006323100005533; Muller AE, 2005, AM J PHYS ANTHROPOL, V128, P399, DOI 10.1002/ajpa.20086; NELSON J, 1995, BEHAV ECOL SOCIOBIOL, V37, P217, DOI 10.1007/s002650050184; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Ostner J, 2008, BEHAV ECOL SOCIOBIOL, V62, P627, DOI 10.1007/s00265-007-0487-y; PACKER C, 1979, ANIM BEHAV, V27, P1, DOI 10.1016/0003-3472(79)90126-X; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 2002, BIOL EVOLUTION STAT, P148; PALOMBIT RA, 1994, ANIM BEHAV, V47, P721, DOI 10.1006/anbe.1994.1097; PEREIRA ME, 1991, PHYSIOL BEHAV, V49, P47, DOI 10.1016/0031-9384(91)90228-G; Perrin WF, 2003, MAR MAMMAL SCI, V19, P462, DOI 10.1111/j.1748-7692.2003.tb01315.x; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; REICHARD U, 1995, ETHOLOGY, V100, P99; RIDLEY M, 1986, ANIM BEHAV, V34, P1848, DOI 10.1016/S0003-3472(86)80271-8; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; ROWELL TE, 1975, J REPROD FERTIL, V43, P419; Say L, 2001, P ROY SOC B-BIOL SCI, V268, P1049, DOI 10.1098/rspb.2001.1583; Setchell JM, 2005, ANIM BEHAV, V70, P1105, DOI 10.1016/j.anbehav.2005.02.021; SMALL MF, 1989, YEARB PHYS ANTHROPOL, V32, P103; Smuts B. B., 1987, PRIMATE SOC; Sokal RR, 1995, BIOMETRY; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Soltis J, 1997, ANIM BEHAV, V54, P737, DOI 10.1006/anbe.1997.0568; SPRAGUE DS, 1991, FOLIA PRIMATOL, V57, P156, DOI 10.1159/000156577; Strier KB, 2003, YEARB PHYS ANTHROPOL, V46, P2, DOI 10.1002/ajpa.10383; Strier KB, 1996, HUM NATURE-INT BIOS, V7, P105, DOI 10.1007/BF02692107; Struhsaker TT, 2008, INT J PRIMATOL, V29, P19, DOI 10.1007/s10764-007-9146-4; TERBORGH J, 1986, ANNU REV ECOL SYST, V17, P111; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Treatman-Clark K, 2006, THESIS STONY BROOK U; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Noordwijk MA, 1985, J COMP ETHOL, V70, P277; van Schaik CP., 1989, COMP SOCIOECOLOGY BE, P195; VANHOOFF JARAM, 1994, BEHAVIOUR, V130, P309, DOI 10.1163/156853994X00587; vanSchaik CP, 1996, ETHOLOGY, V102, P915; VEHRENCAMP SL, 1983, AM ZOOL, V23, P327; Verdolin JL, 2007, BEHAVIOUR, V144, P1361, DOI 10.1163/156853907782418231; WEBSTER MS, 1994, CONDOR, V96, P722, DOI 10.2307/1369475; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; ZABEL CJ, 1989, ANIM BEHAV, V38, P830, DOI 10.1016/S0003-3472(89)80114-9	128	25	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19853	10.1371/journal.pone.0019853	http://dx.doi.org/10.1371/journal.pone.0019853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603570	Green Submitted, Green Published, gold			2022-12-27	WOS:000290656300032
J	Krumm, SA; Ndungu, JM; Yoon, JJ; Dochow, M; Sun, AM; Natchus, M; Snyder, JP; Plemper, RK				Krumm, Stefanie A.; Ndungu, J. Maina; Yoon, Jeong-Joong; Dochow, Melanie; Sun, Aiming; Natchus, Michael; Snyder, James P.; Plemper, Richard K.			Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PERIPHERAL-BLOOD LYMPHOCYTES; INFLUENZA-A VIRUSES; NF-KAPPA-B; MEASLES-VIRUS; IN-VITRO; TYPE-1 REPLICATION; YOUNG-CHILDREN; CELL-LINE; PROTEIN	Therapeutic targeting of host cell factors required for virus replication rather than of pathogen components opens new perspectives to counteract virus infections. Anticipated advantages of this approach include a heightened barrier against the development of viral resistance and a broadened pathogen target spectrum. Myxoviruses are predominantly associated with acute disease and thus are particularly attractive for this approach since treatment time can be kept limited. To identify inhibitor candidates, we have analyzed hit compounds that emerged from a large-scale high-throughput screen for their ability to block replication of members of both the orthomyxovirus and paramyxovirus families. This has returned a compound class with broad anti-viral activity including potent inhibition of different influenza virus and paramyxovirus strains. After hit-to-lead chemistry, inhibitory concentrations are in the nanomolar range in the context of immortalized cell lines and human PBMCs. The compound shows high metabolic stability when exposed to human S-9 hepatocyte subcellular fractions. Antiviral activity is host-cell species specific and most pronounced in cells of higher mammalian origin, supporting a host-cell target. While the compound induces a temporary cell cycle arrest, host mRNA and protein biosynthesis are largely unaffected and treated cells maintain full metabolic activity. Viral replication is blocked at a post-entry step and resembles the inhibition profile of a known inhibitor of viral RNA-dependent RNA-polymerase (RdRp) activity. Direct assessment of RdRp activity in the presence of the reagent reveals strong inhibition both in the context of viral infection and in reporter-based minireplicon assays. In toto, we have identified a compound class with broad viral target range that blocks host factors required for viral RdRp activity. Viral adaptation attempts did not induce resistance after prolonged exposure, in contrast to rapid adaptation to a pathogen-directed inhibitor of RdRp activity.	[Krumm, Stefanie A.; Yoon, Jeong-Joong; Dochow, Melanie; Plemper, Richard K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Krumm, Stefanie A.; Yoon, Jeong-Joong; Dochow, Melanie; Plemper, Richard K.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Ndungu, J. Maina; Sun, Aiming; Natchus, Michael; Snyder, James P.] Emory Univ, Emory Inst Drug Discovery, Atlanta, GA 30322 USA; [Snyder, James P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Plemper, Richard K.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University	Krumm, SA (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	rplempe@emory.edu			NIH/NIAID [AI071002, AI085328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085328, R01AI071002] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by Public Health Service Grants AI071002 and AI085328 (to R. K. P.) from the NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvesalo J, 2008, J INFECT DIS, V197, P156, DOI 10.1086/524142; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Borghouts C, 2008, COMB CHEM HIGH T SCR, V11, P135; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boyd DR, 2004, ORG BIOMOL CHEM, V2, P2530, DOI 10.1039/b409149c; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Carsillo M, 2010, J VIROL, V84, P2180, DOI 10.1128/JVI.01316-09; Coiras M, 2008, PROTEOMICS, V8, P852, DOI 10.1002/pmic.200700664; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Ding XR, 2008, PHARMACOGENOMICS J, V8, P61, DOI 10.1038/sj.tpj.6500459; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Engelking O, 1999, J GEN VIROL, V80, P1599, DOI 10.1099/0022-1317-80-7-1599; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fisher MB, 1997, TETRAHEDRON-ASYMMETR, V8, P613, DOI 10.1016/S0957-4166(97)00033-5; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Fry AM, 2006, CLIN INFECT DIS, V43, P1016, DOI 10.1086/507638; GAO WY, 1993, P NATL ACAD SCI USA, V90, P8925, DOI 10.1073/pnas.90.19.8925; Garcia M, 2005, J VIROL, V79, P9197, DOI 10.1128/JVI.79.14.9197-9205.2005; Garcia M, 2008, J GEN VIROL, V89, P984, DOI 10.1099/vir.0.83601-0; GRANT DM, 1991, J INHERIT METAB DIS, V14, P421, DOI 10.1007/BF01797915; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Hilpert K, 2007, NAT PROTOC, V2, P1652, DOI 10.1038/nprot.2007.203; Honda A, 2008, J BIOTECHNOL, V133, P208, DOI 10.1016/j.jbiotec.2007.08.019; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; KAGAN HB, 2000, CATALYTIC ASYMMETRIC, P327; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kaur G, 2008, EXPERT OPIN INV DRUG, V17, P43, DOI 10.1517/13543784.17.1.43; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Koch-Weser J, 1974, Cardiovasc Clin, V6, P63; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; LAMB RA, 2007, FIELDS VIROLOGY, V5, P1449; Lee JK, 2007, J VIROL, V81, P8821, DOI 10.1128/JVI.00754-07; Leung Alexander K C, 2004, J Pediatr Health Care, V18, P297, DOI 10.1016/S0891-5245(04)00268-8; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Luthra P, 2008, J VIROL, V82, P10887, DOI 10.1128/JVI.00806-08; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Moyle G, 2008, 48 ANN ICAAC IDSA 46; Moyle Graeme, 2010, Antimicrob Agents Chemother, V54, P3170, DOI 10.1128/AAC.00268-10; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Plemper RK, 2005, ANTIMICROB AGENTS CH, V49, P3755, DOI 10.1128/AAC.49.9.3755-3761.2005; Plemper RK, 2004, P NATL ACAD SCI USA, V101, P5628, DOI 10.1073/pnas.0308520101; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Salerno D, 2007, GENE, V405, P65, DOI 10.1016/j.gene.2007.09.010; Schang Luis M, 2006, Expert Rev Anti Infect Ther, V4, P953, DOI 10.1586/14787210.4.6.953; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stiver G, 2003, CAN MED ASSOC J, V168, P49; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sun A, 2008, J MED CHEM, V51, P3731, DOI 10.1021/jm701239a; Sun M, 2008, J VIROL, V82, P105, DOI 10.1128/JVI.01520-07; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; White LK, 2007, ANTIMICROB AGENTS CH, V51, P2293, DOI 10.1128/AAC.00289-07; WHO, 2009, CONC FRAM INT CLASS, P1; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yoon JJ, 2008, J BIOMOL SCREEN, V13, P591, DOI 10.1177/1087057108321089; Yoon JJ, 2009, ANTIMICROB AGENTS CH, V53, P3860, DOI 10.1128/AAC.00503-09; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	80	38	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e20069	10.1371/journal.pone.0020069	http://dx.doi.org/10.1371/journal.pone.0020069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603574	gold, Green Submitted, Green Published			2022-12-27	WOS:000290656300051
J	Dhorda, M; Nyehangane, D; Renia, L; Piola, P; Guerin, PJ; Snounou, G				Dhorda, Mehul; Nyehangane, Dan; Renia, Laurent; Piola, Patrice; Guerin, Philippe J.; Snounou, Georges			Transmission of Plasmodium vivax in South-Western Uganda: Report of Three Cases in Pregnant Women	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN MALARIA PARASITES; INFECTION; PCR; POPULATION; AFRICA; REGION; OVALE	Plasmodium vivax is considered to be rare in the predominantly Duffy negative populations of Sub-Saharan Africa, as this red blood cell surface antigen is essential for invasion by the parasite. However, despite only very few reports of molecularly confirmed P. vivax from tropical Africa, serological evidence indicated that 13% of the persons sampled in Congo had been exposed to P. vivax. We identified P. vivax by microscopy in 8 smears from Ugandan pregnant women who had been enrolled in a longitudinal study of malaria in pregnancy. A nested polymerase chain reaction (PCR) protocol was used to detect and identify the Plasmodium parasites present. PCR analysis confirmed the presence of P. vivax for three of the women and analysis of all available samples from these women revealed clinically silent chronic low-grade vivax infections for two of them. The parasites in one woman carried pyrimethamine resistance-associated double non-synonymous mutations in the P. vivax dihydrofolate reductase gene. The three women found infected with P. vivax were Duffy positive as were nine of 68 women randomly selected from the cohort. The data presented from these three case reports is consistent with stable transmission of malaria in a predominantly Duffy negative African population. Given the substantial morbidity associated with vivax infection in non-African endemic areas, it will be important to investigate whether the distribution and prevalence of P. vivax have been underestimated in Sub-Saharan Africa. This is particularly important in the context of the drive to eliminate malaria and its morbidity.	[Dhorda, Mehul; Nyehangane, Dan; Piola, Patrice] Epictr, Mbarara, Uganda; [Dhorda, Mehul; Snounou, Georges] INSERM, UMR S 945, Paris, France; [Dhorda, Mehul; Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Renia, Laurent; Snounou, Georges] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Piola, Patrice; Guerin, Philippe J.] Epictr, Paris, France; [Piola, Patrice; Guerin, Philippe J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Oxford	Dhorda, M (corresponding author), Epictr, Mbarara, Uganda.	georges.snounou@upmc.fr	Guerin, Philippe/AAH-8873-2021; Snounou, Georges/F-3352-2011; Renia, Laurent/E-2117-2011	Snounou, Georges/0000-0002-6133-6398; Renia, Laurent/0000-0003-0349-1557; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres (MSF); European Commission; AEDES Foundation; Agency for Science, Technology and Research (A*STAR) (Singapore)	Medecins Sans Frontieres (MSF); European Commission(European CommissionEuropean Commission Joint Research Centre); AEDES Foundation; Agency for Science, Technology and Research (A*STAR) (Singapore)(Agency for Science Technology & Research (A*STAR))	This study was sponsored by Medecins Sans Frontieres (MSF) and received additional financial support from the European Commission, the AEDES Foundation and the Agency for Science, Technology and Research (A*STAR) (Singapore). LR and GS are currently part of an official collaboration between SIgN/A*-STAR and INSERM (Laboratoire International Associe, INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blossom DB, 2005, AM J TROP MED HYG, V73, P188, DOI 10.4269/ajtmh.2005.73.188; BRAY RS, 1958, J PARASITOL, V44, P371, DOI 10.2307/3274317; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; GARNHAM PCC, 1966, MALARIA PARASITES OT, P216; Gautret P, 2001, ACTA TROP, V78, P177, DOI 10.1016/S0001-706X(00)00181-9; Green MD, 2007, J INFECT DIS, V196, P1403, DOI 10.1086/522632; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Imwong M, 2003, ANTIMICROB AGENTS CH, V47, P1514, DOI 10.1128/AAC.47.5.1514-1521.2003; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; MAYNE Bruce, 1932, Public Health Reports, V47, P1771, DOI 10.2307/4580535; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Rosenberg R, 2007, TRENDS PARASITOL, V23, P193, DOI 10.1016/j.pt.2007.02.009; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Rubio JM, 1999, J CLIN MICROBIOL, V37, P3260, DOI 10.1128/JCM.37.10.3260-3264.1999; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou G, 1998, ACTA TROP, V70, P197, DOI 10.1016/S0001-706X(98)00021-7; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Stephens J. W., 1922, Annals of Tropical Medicine and Parasitology, V16, P383; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19801	10.1371/journal.pone.0019801	http://dx.doi.org/10.1371/journal.pone.0019801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603649	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500031
J	Dugatkin, LA; Dugatkin, AD				Dugatkin, Lee Alan; Dugatkin, Aaron David			Overestimating Resource Value and Its Effects on Fighting Decisions	PLOS ONE			English	Article							EVOLUTION; STRATEGY	Much work in behavioral ecology has shown that animals fight over resources such as food, and that they make strategic decisions about when to engage in such fights. Here, we examine the evolution of one, heretofore unexamined, component of that strategic decision about whether to fight for a resource. We present the results of a computer simulation that examined the evolution of over-or underestimating the value of a resource ( food) as a function of an individual's current hunger level. In our model, animals fought for food when they perceived their current food level to be below the mean for the environment. We considered seven strategies for estimating food value: 1) always underestimate food value, 2) always overestimate food value, 3) never over-or underestimate food value, 4) overestimate food value when hungry, 5) underestimate food value when hungry, 6) overestimate food value when relatively satiated, and 7) underestimate food value when relatively satiated. We first competed all seven strategies against each other when they began at approximately equal frequencies. In such a competition, two strategies-"always overestimate food value,'' and "overestimate food value when hungry''-were very successful. We next competed each of these strategies against the default strategy of "never overor underestimate,'' when the default strategy was set at 99% of the population. Again, the strategies of "always overestimate food value'' and "overestimate food value when hungry'' fared well. Our results suggest that overestimating food value when deciding whether to fight should be favored by natural selection.	[Dugatkin, Lee Alan] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Dugatkin, Aaron David] Murray Hill Acad, Louisville, KY USA	University of Louisville	Dugatkin, LA (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	lee.dugatkin@louisville.edu						Dugatkin L. A., 2009, PRINCIPLES ANIMAL BE; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; Houston AI, 1999, MODELS ADAPTIVE BEHA; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Mangel M., 1988, DYNAMIC MODELING BEH; Maynard Smith J., 1982, pi; Mesterton-Gibbons M, 2009, J THEOR BIOL, V256, P263, DOI 10.1016/j.jtbi.2008.10.004; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Wilensky U., 1999, NET LOGO	12	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19924	10.1371/journal.pone.0019924	http://dx.doi.org/10.1371/journal.pone.0019924			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603640	gold, Green Published, Green Submitted			2022-12-27	WOS:000290558500037
J	Hopkins, R; Bridgeman, A; Joseph, J; Gilbert, SC; McShane, H; Hanke, T				Hopkins, Richard; Bridgeman, Anne; Joseph, Joan; Gilbert, Sarah C.; McShane, Helen; Hanke, Tomas			Dual Neonate Vaccine Platform against HIV-1 and M-tuberculosis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIME-BOOST IMMUNIZATION; BACILLUS-CALMETTE-GUERIN; CYTOTOXIC T-LYMPHOCYTES; MHC CLASS-II; ANTIGEN PRESENTATION; PROTECTIVE EFFICACY; RECOMBINANT BCG; ENHANCED IMMUNOGENICITY; CHILD TRANSMISSION	Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guerin (BCG) as a prevention against TB. BCG protects against disseminated disease in the first 10 years of life, but provides a variable protection against pulmonary TB and enhancing boost delivered by recombinant modified vaccinia virus Ankara (rMVA) expressing antigen 85A (Ag85A) of M. tuberculosis is currently in phase IIb evaluation in African neonates. If the newborn's mother is positive for human immunodeficiency virus type 1 (HIV-1), the baby is at high risk of acquiring HIV-1 through breastfeeding. We suggested that a vaccination consisting of recombinant BCG expressing HIV-1 immunogen administered at birth followed by a boost with rMVA sharing the same immunogen could serve as a strategy for prevention of mother-to-child transmission of HIV-1 and rMVA expressing an African HIV-1-derived immunogen HIVA is currently in phase I trials in African neonates. Here, we aim to develop a dual neonate vaccine platform against HIV-1 and TB consisting of BCG. HIVA administered at birth followed by a boost with MVA.HIVA.85A. Thus, mMVA.HIVA.85A and sMVA.HIVA.85A vaccines were constructed, in which the transgene transcription is driven by either modified H5 or short synthetic promoters, respectively, and tested for immunogenicity alone and in combination with BCG. HIVA(222). mMVA.HIVA.85A was produced markerless and thus suitable for clinical manufacture. While sMVA.HIVA.85A expressed higher levels of the immunogens, it was less immunogenic than mMVA.HIVA.85A in BALB/cmice. A BCG. HIVA(222)-mMVA.HIVA.85A prime-boost regimen induced robust T cell responses to both HIV-1 and M. tuberculosis. Therefore, proof-of-principle for a dual anti-HIV-1/M. tuberculosis infant vaccine platform is established. Induction of immune responses against these pathogens soon after birth is highly desirable and may provide a basis for lifetime protection maintained by boosts later in life.	[Hopkins, Richard; Bridgeman, Anne; Hanke, Tomas] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Joseph, Joan] Univ Barcelona, Sch Med, AIDS Res Unit, Hosp Clin,IDIBAPS,HIVACAT, Barcelona, Spain; [Gilbert, Sarah C.; McShane, Helen; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; Jenner Institute	Hopkins, R (corresponding author), Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	tomas.hanke@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Hopkins, Richard/AAI-5007-2020	Gilbert, Sarah C./0000-0002-6823-9750; Bridgeman, Anne/0000-0002-9478-6125; McShane, Helen/0000-0002-2126-5142	Medical Research Council of UK; HIVACAT; Foundation for Research and Prevention of AIDS in Spain [FIPSE 36338/02]; Medical Research Council [G1000800d] Funding Source: researchfish	Medical Research Council of UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HIVACAT; Foundation for Research and Prevention of AIDS in Spain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council of UK and HIVACAT, the Foundation for Research and Prevention of AIDS in Spain (FIPSE 36338/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami Y, 2005, J VIROL, V79, P12871, DOI 10.1128/JVI.79.20.12871-12879.2005; Bridgeman A, 2009, VACCINE, V28, P474, DOI 10.1016/j.vaccine.2009.09.136; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Chege GK, 2009, VACCINE, V27, P4857, DOI 10.1016/j.vaccine.2009.05.064; Chen ZW, 2008, JAIDS-J ACQ IMM DEF, V47, P412, DOI 10.1097/QAI.0b013e3181651bb2; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dasgupta A, 2007, J IMMUNOL, V178, P1654, DOI 10.4049/jimmunol.178.3.1654; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Im Eung-Jun, 2004, Expert Rev Vaccines, V3, pS89, DOI 10.1586/14760584.3.4.S89; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li P, 2005, J IMMUNOL, V175, P6481, DOI 10.4049/jimmunol.175.10.6481; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Lugosi L, 1989, Acta Leprol, V7 Suppl 1, P256; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Nkolola JP, 2004, GENE THER, V11, P1068, DOI 10.1038/sj.gt.3302241; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Safrit JT, 2004, JAIDS-J ACQ IMM DEF, V35, P169, DOI 10.1097/00126334-200402010-00012; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Uhlig U, 2009, AM J RESP CRIT CARE, V179; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Wang ZB, 2010, IMAGE VISION COMPUT, V28, P5, DOI 10.1016/j.imavis.2009.06.007; Wang ZD, 2007, VACCINE, V25, P1132, DOI 10.1016/j.vaccine.2006.09.067; Webb TJR, 2006, EUR J IMMUNOL, V36, P2595, DOI 10.1002/eji.200636024; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; World Health Organization, 2009, 2008 2013 ACT PLAN G, V416, P1; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; YASUTOMI Y, 1993, J IMMUNOL, V150, P3101	54	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20067	10.1371/journal.pone.0020067	http://dx.doi.org/10.1371/journal.pone.0020067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603645	gold, Green Published, Green Submitted			2022-12-27	WOS:000290558500043
J	Moore, RA; Warren, RL; Freeman, JD; Gustavsen, JA; Chenard, C; Friedman, JM; Suttle, CA; Zhao, YJ; Holt, RA				Moore, Richard A.; Warren, Rene L.; Freeman, J. Douglas; Gustavsen, Julia A.; Chenard, Caroline; Friedman, Jan M.; Suttle, Curtis A.; Zhao, Yongjun; Holt, Robert A.			The Sensitivity of Massively Parallel Sequencing for Detecting Candidate Infectious Agents Associated with Human Tissue	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO; SYNECHOCOCCUS; CYANOPHAGES; HARNAV	Massively parallel sequencing technology now provides the opportunity to sample the transcriptome of a given tissue comprehensively. Transcripts at only a few copies per cell are readily detectable, allowing the discovery of low abundance viral and bacterial transcripts in human tissue samples. Here we describe an approach for mining large sequence data sets for the presence of microbial sequences. Further, we demonstrate the sensitivity of this approach by sequencing human RNA-seq libraries spiked with decreasing amounts of an RNA-virus. At a modest depth of sequencing, viral transcripts can be detected at frequencies less than 1 in 1,000,000. With current sequencing platforms approaching outputs of one billion reads per run, this is a highly sensitive method for detecting putative infectious agents associated with human tissues.	[Moore, Richard A.; Warren, Rene L.; Freeman, J. Douglas; Zhao, Yongjun; Holt, Robert A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Gustavsen, Julia A.; Chenard, Caroline] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Vancouver, BC, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Moore, RA (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada.	rmoore@bcgsc.ca	Holt, Robert A/C-3303-2009; suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008; Gustavsen, Julia/AAR-9433-2020; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Gustavsen, Julia/0000-0002-4764-4802; Warren, Rene/0000-0002-9890-2293; Friedman, Jan/0000-0002-7482-9570	British Columbia Clinical Genomics Network	British Columbia Clinical Genomics Network	Funding for this study was provided by the British Columbia Clinical Genomics Network (http://www.bccgn.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Garza DR, 1998, MICROB ECOL, V36, P281, DOI 10.1007/s002489900115; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x	16	46	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19838	10.1371/journal.pone.0019838	http://dx.doi.org/10.1371/journal.pone.0019838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603639	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500032
J	Xu, WM; Chen, J; Chen, H; Diao, RY; Fok, KL; Dong, JD; Sun, TT; Chen, WY; Yu, MK; Zhang, XH; Tsang, LL; Lau, A; Shi, QX; Shi, QH; Huang, PB; Chan, HC				Xu, Wen Ming; Chen, Jing; Chen, Hui; Diao, Rui Ying; Fok, Kin Lam; Dong, Jian Da; Sun, Ting Ting; Chen, Wen Ying; Yu, Mei Kuen; Zhang, Xiao Hu; Tsang, Lai Ling; Lau, Ann; Shi, Qi Xian; Shi, Qing Hua; Huang, Ping Bo; Chan, Hsiao Chang			Defective CFTR-Dependent CREB Activation Results in Impaired Spermatogenesis and Azoospermia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SOLUBLE ADENYLYL-CYCLASE; CYSTIC-FIBROSIS GENE; TRANSCRIPTION FACTORS; CONGENITAL ABSENCE; INFERTILE MEN; SPERM QUALITY; VAS-DEFERENS; HEALTHY-MEN; GERM-CELLS	Cystic fibrosis (CF) is the most common life-limiting recessive genetic disease among Caucasians caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) with over 95% male patients infertile. However, whether CFTR mutations could affect spermatogenesis and result in azoospermia remains an open question. Here we report compromised spermatogenesis, with significantly reduced testicular weight and sperm count, and decreased cAMP-responsive element binding protein (CREB) expression in the testes of CFTR knockout mice. The involvement of CFTR in HCO3- transport and the expression of the HCO3- sensor, soluble adenylyl cyclase (sAC), are demonstrated for the first time in the primary culture of rat Sertoli cells. Inhibition of CFTR or depletion of HCO3- could reduce FSH-stimulated, sAC-dependent cAMP production and phosphorylation of CREB, the key transcription factor in spermatogenesis. Decreased CFTR and CREB expression are also observed in human testes with azoospermia. The present study reveals a previously undefined role of CFTR and sAC in regulating the cAMP-CREB signaling pathway in Sertoli cells, defect of which may result in impaired spermatogenesis and azoospermia. Altered CFTR-sAC-cAMP-CREB functional loop may also underline the pathogenesis of various CF-related diseases.	[Xu, Wen Ming; Chan, Hsiao Chang] Sichuan Univ, Chinese Univ Hong Kong, W China Inst Women & Childrens Hlth, Joint Lab Reprod Med,W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Xu, Wen Ming; Chen, Jing; Chen, Hui; Diao, Rui Ying; Fok, Kin Lam; Dong, Jian Da; Sun, Ting Ting; Chen, Wen Ying; Yu, Mei Kuen; Zhang, Xiao Hu; Tsang, Lai Ling; Lau, Ann; Chan, Hsiao Chang] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Diao, Rui Ying] Peking Univ, Shenzhen Key Lab Male Reprod & Genet, Shenzhen Hosp, Shenzhen, Peoples R China; [Chen, Wen Ying; Shi, Qi Xian] Zhejiang Acad Med Sci, Dept Reprod Physiol, Hangzhou, Zhejiang, Peoples R China; [Shi, Qing Hua] Univ Sci & Technol China, Lab Mol & Cell Genet, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Peoples R China; [Huang, Ping Bo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Sichuan University; Chinese University of Hong Kong; Peking University; Zhejiang Academy of Medical Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Hong Kong University of Science & Technology	Xu, WM (corresponding author), Sichuan Univ, Chinese Univ Hong Kong, W China Inst Women & Childrens Hlth, Joint Lab Reprod Med,W China Univ Hosp 2, Chengdu 610064, Peoples R China.	hsiaocchan@cuhk.edu.hk	Fok, Kin Lam/G-2757-2017; Chan, Hsiao Chang/E-1507-2016; Fok, Ellis/M-2784-2019; Dong, Jianda/C-3338-2018; Huang, Pingbo/I-1127-2019; Shi, Qinghua/N-2950-2013	Fok, Kin Lam/0000-0003-3038-1337; Fok, Ellis/0000-0003-3038-1337; Dong, Jianda/0000-0001-5583-0210; Huang, Pingbo/0000-0002-4560-8760; 	National Natural Science Foundation of China [30770817]; South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 projects [2006CB504002]; Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong; Morningside Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 projects(National Basic Research Program of China); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong(Chinese University of Hong Kong); Morningside Foundation	The work was supported by the National Natural Science Foundation of China (No. 30770817), the South China National Research Center for Integrated Biosciences in collaboration with Sun Yat-sen University, the National 973 projects (2006CB504002), the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong, and the Morningside Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093; Boockfor FR, 1998, AM J PHYSIOL-CELL PH, V274, pC922, DOI 10.1152/ajpcell.1998.274.4.C922; BUNDEY RA, 2004, SCI STKE, pPE19; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Jakubiczka S, 1999, HUM REPROD, V14, P1833, DOI 10.1093/humrep/14.7.1833; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Larriba S, 2005, INT J ANDROL, V28, P284, DOI 10.1111/j.1365-2605.2005.00544.x; Larriba S, 1998, HUM MOL GENET, V7, P1739, DOI 10.1093/hmg/7.11.1739; Mak JCW, 2002, EUR J PHARMACOL, V436, P165, DOI 10.1016/S0014-2999(01)01625-9; Mak V, 2000, HUM REPROD, V15, P436, DOI 10.1093/humrep/15.2.436; Marquez B, 2008, REPROD FERT DEVELOP, V20, P247, DOI 10.1071/RD07146; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mruk DD, 1999, J BIOL CHEM, V274, P27056, DOI 10.1074/jbc.274.38.27056; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Pallares-Ruiz N, 1999, HUM REPROD, V14, P3035, DOI 10.1093/humrep/14.12.3035; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Ravnik-Glavac M, 2001, GENET TEST, V5, P243, DOI 10.1089/10906570152742308; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schulz S, 2006, FERTIL STERIL, V85, P135, DOI 10.1016/j.fertnstert.2005.07.1282; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Song GJ, 2000, FERTIL STERIL, V73, P1104, DOI 10.1016/S0015-0282(00)00520-3; TINDALL DJ, 1981, ENVIRON HEALTH PERSP, V38, P5, DOI 10.2307/3429353; TIZZANO EF, 1994, AM J PATHOL, V144, P906; Tuerlings JHAM, 1998, FERTIL STERIL, V69, P899, DOI 10.1016/S0015-0282(98)00050-8; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Walker WH, 1996, TRENDS ENDOCRIN MET, V7, P133, DOI 10.1016/1043-2760(96)00035-5; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104	44	94	101	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19120	10.1371/journal.pone.0019120	http://dx.doi.org/10.1371/journal.pone.0019120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21625623	Green Submitted, Green Published, gold			2022-12-27	WOS:000290386800008
J	Rezaei-Ghaleh, N; Andreetto, E; Yan, LM; Kapurniotu, A; Zweckstetter, M				Rezaei-Ghaleh, Nasrollah; Andreetto, Erika; Yan, Li-Mei; Kapurniotu, Aphrodite; Zweckstetter, Markus			Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; DIABETES-MELLITUS; CHEMICAL-EXCHANGE; AQUEOUS-SOLUTION; STATE NMR; IN-VITRO; PROTEIN; IAPP; OLIGOMERS	Assembly of amyloid-beta peptide (A beta) into cytotoxic oligomeric and fibrillar aggregates is believed to be a major pathologic event in Alzheimer's disease (AD) and interfering with A beta aggregation is an important strategy in the development of novel therapeutic approaches. Prior studies have shown that the double N-methylated analogue of islet amyloid polypeptide (IAPP) IAPP-GI, which is a conformationally constrained IAPP analogue mimicking a non-amyloidogenic IAPP conformation, is capable of blocking cytotoxic self-assembly of A beta. Here we investigate the interaction of IAPP-GI with A beta 40 and A beta 42 using NMR spectroscopy. The most pronounced NMR chemical shift changes were observed for residues 13-20, while residues 7-9, 15-16 as well as the C-terminal half of A beta - that is both regions of the A beta sequence that are converted into beta-strands in amyloid fibrils - were less accessible to solvent in the presence of IAPP-GI. At the same time, interaction of IAPP-GI with A beta resulted in a concentration-dependent co-aggregation of A beta and IAPP-GI that was enhanced for the more aggregation prone A beta 42 peptide. On the basis of the reduced toxicity of the A beta peptide in the presence of IAPP-GI, our data are consistent with the suggestion that IAPP-GI redirects A beta into nontoxic "off-pathway'' aggregates.	[Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Andreetto, Erika; Yan, Li-Mei; Kapurniotu, Aphrodite] Tech Univ Munich, Div Peptide Biochem, D-8050 Freising Weihenstephan, Germany; [Zweckstetter, Markus] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	Max Planck Society; Technical University of Munich; German Research Foundation (DFG)	Rezaei-Ghaleh, N (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	mzwecks@gwdg.de	Rezaei-Ghaleh, Nasrollah/B-9443-2008	Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Zweckstetter, Markus/0000-0002-2536-6581	Max Planck Society; DFG [ZW 71/2-2, 3-2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the DFG through a Heisenberg scholarship (ZW 71/2-2 and 3-2) to M.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BLOMBERG F, 1977, J AM CHEM SOC, V99, P8149, DOI 10.1021/ja00467a005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Narayanan S, 2005, BIOCHEMISTRY-US, V44, P1444, DOI 10.1021/bi048264b; Nicolls MR, 2004, CURR ALZHEIMER RES, V1, P47, DOI 10.2174/1567205043480555; PELTON JG, 1993, PROTEIN SCI, V2, P543; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Rhoades E, 2000, BBA-PROTEIN STRUCT M, V1476, P230, DOI 10.1016/S0167-4838(99)00248-4; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Schmitz O, 2004, DIABETES, V53, pS233, DOI 10.2337/diabetes.53.suppl_3.S233; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Vaiana SM, 2008, BIOPHYS J, V94, pL45, DOI 10.1529/biophysj.107.125146; Velkova A, 2008, ANGEW CHEM INT EDIT, V47, P7114, DOI 10.1002/anie.200801499; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	40	39	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20289	10.1371/journal.pone.0020289	http://dx.doi.org/10.1371/journal.pone.0020289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633500	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500052
J	Baumann, O; Skilleter, AJ; Mattingley, JB				Baumann, Oliver; Skilleter, Ashley J.; Mattingley, Jason B.			Short-Term Memory Maintenance of Object Locations during Active Navigation: Which Working Memory Subsystem Is Essential?	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ROUTE DIRECTIONS; INTERFERENCE; LANDMARKS; SYSTEMS	The goal of the present study was to examine the extent to which working memory supports the maintenance of object locations during active spatial navigation. Participants were required to navigate a virtual environment and to encode the location of a target object. In the subsequent maintenance period they performed one of three secondary tasks that were designed to selectively load visual, verbal or spatial working memory subsystems. Thereafter participants re-entered the environment and navigated back to the remembered location of the target. We found that while navigation performance in participants with high navigational ability was impaired only by the spatial secondary task, navigation performance in participants with poor navigational ability was impaired equally by spatial and verbal secondary tasks. The visual secondary task had no effect on navigation performance. Our results extend current knowledge by showing that the differential engagement of working memory subsystems is determined by navigational ability.	[Baumann, Oliver] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Baumann, O (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	o.baumann@uq.edu.au	Mattingley, Jason/J-1537-2014; Baumann, Oliver/C-8296-2009; Skilleter, Ashley/D-4176-2011	Mattingley, Jason/0000-0003-0929-9216; Baumann, Oliver/0000-0003-3976-5855	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Thinking Systems Team	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Thinking Systems Team	This research project was supported by an Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) Thinking Systems Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Thinking Systems Team for their support, and in particular Mark Wakabayashi and Daniel Clark for programming the virtual environment used in the study. We further thank Edgar Chan and David Painter for useful discussions and comments on the manuscript, and Amy Collins for collecting data for an earlier version of the present study.	Avraamides MN, 2004, J EXP PSYCHOL LEARN, V30, P801, DOI 10.1037/0278-7393.30.4.804; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A.D., 1990, NEUROPSYCHOLOGICAL I, P54; Baumann O, 2010, NEUROIMAGE, V49, P2816, DOI 10.1016/j.neuroimage.2009.10.021; Bryant DJ, 1997, MIND LANG, V12, P239, DOI 10.1111/1468-0017.00047; COLLE HA, 1976, J VERB LEARN VERB BE, V15, P17, DOI 10.1016/S0022-5371(76)90003-7; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Daniel MP, 2004, APPL COGNITIVE PSYCH, V18, P57, DOI 10.1002/acp.941; Denis M, 1999, APPL COGNITIVE PSYCH, V13, P145, DOI 10.1002/(SICI)1099-0720(199904)13:2<145::AID-ACP550>3.0.CO;2-4; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Garden S, 2002, APPL COGNITIVE PSYCH, V16, P35, DOI 10.1002/acp.746; Hecker R, 1997, NEUROPSYCHOLOGIA, V35, P599, DOI 10.1016/S0028-3932(96)00106-6; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Ishikawa T, 2006, COGNITIVE PSYCHOL, V52, P93, DOI 10.1016/j.cogpsych.2005.08.003; Janzen G, 2008, HIPPOCAMPUS, V18, P40, DOI 10.1002/hipo.20364; Kessels RPC, 1999, NEUROREPORT, V10, P3765, DOI 10.1097/00001756-199912160-00008; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; Logie R. H., 1995, VISUOSPATIAL WORKING; Mallot HA, 2000, PERCEPTION, V29, P43, DOI 10.1068/p2865; McConnell J, 2000, Q J EXP PSYCHOL-A, V53, P53, DOI 10.1080/027249800390664; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Quinn JG, 1996, Q J EXP PSYCHOL-A, V49, P200, DOI 10.1080/027249896392865; SALAME P, 1982, J VERB LEARN VERB BE, V21, P150, DOI 10.1016/S0022-5371(82)90521-7; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001	28	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19707	10.1371/journal.pone.0019707	http://dx.doi.org/10.1371/journal.pone.0019707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IJ	21629686	gold, Green Published			2022-12-27	WOS:000291005800006
J	Nair, D; Dayyat, EA; Zhang, SX; Wang, Y; Gozal, D				Nair, Deepti; Dayyat, Ehab A.; Zhang, Shelley X.; Wang, Yang; Gozal, David			Intermittent Hypoxia-Induced Cognitive Deficits Are Mediated by NADPH Oxidase Activity in a Murine Model of Sleep Apnea	PLOS ONE			English	Article							SPATIAL-LEARNING DEFICITS; CHRONIC GRANULOMATOUS-DISEASE; OXIDATIVE STRESS; CORTICAL-NEURONS; NITRIC-OXIDE; MOUSE MODEL; ACTIVATION; MICE; MAZE; RATS	Background: In rodents, exposure to intermittent hypoxia (IH), a hallmark of obstructive sleep apnea (OSA), is associated with neurobehavioral impairments, increased apoptosis in the hippocampus and cortex, as well as increased oxidant stress and inflammation. Excessive NADPH oxidase activity may play a role in IH-induced CNS dysfunction. Methods and Findings: The effect of IH during light period on two forms of spatial learning in the water maze and well as markers of oxidative stress was assessed in mice lacking NADPH oxidase activity (gp91phox(_/Y)) and wild-type littermates. On a standard place training task, gp91phox(_/Y) displayed normal learning, and were protected from the spatial learning deficits observed in wild-type littermates exposed to IH. Moreover, anxiety levels were increased in wild-type mice exposed to IH as compared to room air (RA) controls, while no changes emerged in gp91phox(_/Y) mice. Additionally, wild-type mice, but not gp91phox(_/Y) mice had significantly elevated levels of NADPH oxidase expression and activity, as well as MDA and 8-OHDG in cortical and hippocampal lysates following IH exposures. Conclusions: The oxidative stress responses and neurobehavioral impairments induced by IH during sleep are mediated, at least in part, by excessive NADPH oxidase activity, and thus pharmacological agents targeting NADPH oxidase may provide a therapeutic strategy in sleep-disordered breathing.	[Nair, Deepti; Dayyat, Ehab A.; Zhang, Shelley X.; Wang, Yang; Gozal, David] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Nair, D (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA.	dgozal@uchicago.edu	Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	Nair, Deepti/0000-0002-0491-717X	National Institutes of Health [HL-086662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grant HL-086662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005; Akashiba T, 2002, CHEST, V122, P861, DOI 10.1378/chest.122.3.861; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Angermuller S, 2009, HISTOCHEM CELL BIOL, V131, P459, DOI 10.1007/s00418-009-0563-7; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baran AS, 2003, CNS SPECTR, V8, P128, DOI 10.1017/S1092852900018356; Bardwell WA, 2001, SLEEP, V24, P905, DOI 10.1093/sleep/24.8.905; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Borak J, 1996, J SLEEP RES, V5, P123, DOI 10.1046/j.1365-2869.1996.d01-60.x; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Bruce-Keller AJ, 2010, ANTIOXID REDOX SIGN, V12, P1371, DOI 10.1089/ars.2009.2823; Burckhardt IC, 2008, AM J RESP CRIT CARE, V177, P1135, DOI 10.1164/rccm.200701-110OC; Carpagnano GE, 2002, CHEST, V122, P1162, DOI 10.1378/chest.122.4.1162; Chen H, 2009, J CEREB BLOOD FLOW M; Day R, 1999, PROG CARDIOVASC DIS, V41, P341, DOI 10.1053/pcad.1999.0410341; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Droge W, 2002, AGEING RES REV, V1, P257, DOI 10.1016/S1568-1637(01)00008-3; Eckeli AL, 2000, NEUROREPORT, V11, P1839, DOI 10.1097/00001756-200006260-00008; El-Sheikh M, 2010, CHILD DEV, V81, P870, DOI 10.1111/j.1467-8624.2010.01439.x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FILE SE, 1992, BIOL COUN S, P25; FUKUI T, 1995, BBA-BIOENERGETICS, V1231, P215, DOI 10.1016/0005-2728(95)00098-4; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Goldbart AD, 2006, BRAIN RES, V1090, P190, DOI 10.1016/j.brainres.2006.03.046; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal D, 2007, AM J RESP CRIT CARE, V176, P188, DOI 10.1164/rccm.200610-1519OC; Gozal D, 2010, AM J RESP CRIT CARE, V182, P104, DOI 10.1164/rccm.201001-0108OC; Gozal D, 2008, CURR OPIN PEDIATR, V20, P654, DOI 10.1097/MOP.0b013e328316ec2d; Gozal E, 2002, SLEEP, V25, pA333; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Ha JS, 2010, EXP CELL RES, V316, P1651, DOI 10.1016/j.yexcr.2010.03.021; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jang HJ, 2008, NEUROSCI LETT, V443, P17, DOI 10.1016/j.neulet.2008.07.049; Jun J, 2008, AM J PHYSIOL-REG I, V295, pR1274, DOI 10.1152/ajpregu.90346.2008; KAPLAN R, 1992, AUST NZ J PSYCHIAT, V26, P586, DOI 10.3109/00048679209072093; Kaster MP, 2007, EUR J PHARMACOL, V565, P119, DOI 10.1016/j.ejphar.2007.03.003; Kheirandish L, 2005, SLEEP, V28, P1412, DOI 10.1093/sleep/28.11.1412; Kishida KT, 2005, J NEUROCHEM, V94, P299, DOI 10.1111/j.1471-4159.2005.03189.x; Kubota H, 2010, ANN THORAC SURG, V90, P1692, DOI 10.1016/j.athoracsur.2010.04.097; Li JG, 2007, J APPL PHYSIOL, V102, P557, DOI 10.1152/japplphysiol.01081.2006; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; Li RC, 2003, AM J RESP CRIT CARE, V168, P469, DOI 10.1164/rccm.200211-1264OC; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Maneen MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1042, DOI 10.1152/ajpheart.00800.2006; Miller FJ, 2002, METHOD ENZYMOL, V353, P220; MONTPLAISIR J, 1992, SLEEP, V15, pS17, DOI 10.1093/sleep/15.suppl_6.S17; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURALIKRISHNA AR, 2006, FREE RADIC BIOL MED, V40, P376, DOI DOI 10.1016/J.FREERADBIOMED.2005.08.044; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Noh KM, 2000, J NEUROSCI, V20; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Row BW, 2007, BEHAV BRAIN RES, V177, P308, DOI 10.1016/j.bbr.2006.11.028; Row BW, 2004, J NEUROCHEM, V89, P189, DOI 10.1111/j.1471-4159.2004.02352.x; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Row BW, 2002, PEDIATR RES, V52, P449, DOI 10.1203/01.PDR.0000030718.77598.A4; ROYERPOKORA B, 1987, DIS MARKERS, V5, P57; Sanchez AI, 2001, PSYCHIAT CLIN NEUROS, V55, P641, DOI 10.1046/j.1440-1819.2001.00918.x; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Sumimoto H, 2004, JPN J INFECT DIS, V57, pS24; Tammariello SP, 2000, J NEUROSCI, V20; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yasui Hiroyuki, 2005, Drug Metab Pharmacokinet, V20, P1, DOI 10.2133/dmpk.20.1; Zhan GX, 2005, AM J RESP CRIT CARE, V172, P921, DOI 10.1164/rccm.200504-581OC; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zomkowski ADE, 2004, BRAIN RES, V1023, P253, DOI 10.1016/j.brainres.2004.07.041	90	124	131	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19847	10.1371/journal.pone.0019847	http://dx.doi.org/10.1371/journal.pone.0019847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625437	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200016
J	Fong, MY; McDunn, J; Kakar, SS				Fong, Miranda Y.; McDunn, Jonathan; Kakar, Sham S.			Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer	PLOS ONE			English	Article							N-ACETYLASPARTATE; BREAST-CANCER; PROSTATE-CANCER; AEROBIC GLYCOLYSIS; VITAMIN-E; TAURINE; ACID; RESONANCE; GROWTH; PROFILES	In this study, we characterized the metabolome of the human ovary and identified metabolic alternations that coincide with primary epithelial ovarian cancer (EOC) and metastatic tumors resulting from primary ovarian cancer (MOC) using three analytical platforms: gas chromatography mass spectrometry (GC/MS) and liquid chromatography tandem mass spectrometry (LC/MS/MS) using buffer systems and instrument settings to catalog positive or negative ions. The human ovarian metabolome was found to contain 364 biochemicals and upon transformation of the ovary caused changes in energy utilization, altering metabolites associated with glycolysis and beta-oxidation of fatty acids-such as carnitine (1.79 fold in EOC, p < 0.001; 1.88 fold in MOC, p < 0.001), acetylcarnitine (1.75 fold in EOC, p < 0.001; 2.39 fold in MOC, p < 0.001), and butyrylcarnitine (3.62 fold, p < 0.0094 in EOC; 7.88 fold, p < 0.001 in MOC). There were also significant changes in phenylalanine catabolism marked by increases in phenylpyruvate (4.21 fold; p = 0.0098) and phenyllactate (195.45 fold; p < 0.0023) in EOC. Ovarian cancer also displayed an enhanced oxidative stress response as indicated by increases in 2-aminobutyrate in EOC (1.46 fold, p = 0.0316) and in MOC (2.25 fold, p < 0.001) and several isoforms of tocopherols. We have also identified novel metabolites in the ovary, specifically N-acetylasparate and N-acetyl-aspartyl-glutamate, whose role in ovarian physiology has yet to be determined. These data enhance our understanding of the diverse biochemistry of the human ovary and demonstrate metabolic alterations upon transformation. Furthermore, metabolites with significant changes between groups provide insight into biochemical consequences of transformation and are candidate biomarkers of ovarian oncogenesis. Validation studies are warranted to determine whether these compounds have clinical utility in the diagnosis or clinical management of ovarian cancer patients.	[Fong, Miranda Y.; Kakar, Sham S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Kakar, Sham S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [McDunn, Jonathan] Metabolon Inc, Durham, NC USA	University of Louisville; University of Louisville; Metabolon	Fong, MY (corresponding author), Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA.	sskaka01@louisville.edu		McDunn, Jonathan/0000-0001-8792-828X	NIH/NCI [CA124630]; Metabolon, Inc.; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Metabolon, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funds used to perform this work were supported by a NIH/NCI CA124630 research Grant to SSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon was paid for the service peformed in metabolites profiling according to signed contract.; JM is an employee of Metabolon, Inc. and was responsible for preliminary analysis of the data and final editing of the manuscript. However, as part of the University of Louisville's contract with Metabolon, Inc., he does not have any financial benefit or retention of invention or ownership rights, patentable or not. This does not affect adherence to PLoS ONE policies on sharing data and material.	ATEN RF, 1994, ENDOCRINOLOGY, V135, P533, DOI 10.1210/en.135.2.533; Baslow MH, 2010, AMINO ACIDS, V38, P51, DOI 10.1007/s00726-009-0232-0; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; BHOSALE P, INT J GYNECOL CANC, V20, P936; CASSLEN BG, 1987, J REPROD MED, V32, P181; CESARIO S, NURS WOMENS HLTH, V14, P222; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chen JL, 2010, WORLD J GASTROENTERO, V16, P5874, DOI 10.3748/wjg.v16.i46.5874; CHEN X, J SEP SCI; Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; Clark JF, 2006, MED HYPOTHESES, V67, P506, DOI 10.1016/j.mehy.2006.02.047; COLLIER VU, 1980, AM J PHYSIOL, V238, pE450, DOI 10.1152/ajpendo.1980.238.5.E450; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Debier C, 2005, BRIT J NUTR, V93, P153, DOI 10.1079/BJN20041308; DELRIO RM, 1990, PROG CLIN BIOL RES, V351, P357; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fernandes CG, 2010, CELL MOL NEUROBIOL, V30, P317, DOI 10.1007/s10571-009-9455-6; Frickenschmidt A, 2008, BIOMARKERS, V13, P435, DOI [10.1080/13547500802012858, 10.1080/13547500802012858 ]; Galarreta M, 1996, ADV EXP MED BIOL, V403, P463; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; GUERIN P, 1995, HUM REPROD, V10, P866, DOI 10.1093/oxfordjournals.humrep.a136052; HAM EA, 1963, BIOCHIM BIOPHYS ACTA, V71, P208, DOI 10.1016/0006-3002(63)91008-4; Hascalik S, 2006, INT J GYNECOL CANCER, V16, P423, DOI 10.1111/j.1525-1438.2006.00200.x; Hellstrom I, 2008, ADV EXP MED BIOL, V622, P15, DOI 10.1007/978-0-387-68969-2_2; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; JHIANG SM, 1993, FEBS LETT, V318, P139, DOI 10.1016/0014-5793(93)80008-I; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolwijck E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010293; Kondoh H, 2005, CANCER RES, V65, P177; KOTHANDARAMAN N, BMC CANC, V10, P64; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin BY, 2009, PROTEOM CLIN APPL, V3, P853, DOI 10.1002/prca.200800141; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2003, ANTICANCER RES, V23, P1149; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Melichar B, 1998, CLIN CANCER RES, V4, P3069; MEYDANI SN, 1992, VITAMIN E HLTH DIS, P549; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; *NAT CANC I, STAT FACT SHEET; Neesham D, 2007, AUST FAM PHYSICIAN, V36, P126; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Odin AP, 1997, MUTAT RES-REV MUTAT, V386, P39, DOI 10.1016/S1383-5742(96)00044-0; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; OPPENHEIMER L, 1979, J BIOL CHEM, V254, P5184; ORENSANZ LM, 1986, ADV BIOCHEM PSYCHOPH, V42, P265; Osl M, 2008, BIOINFORMATICS, V24, P2908, DOI 10.1093/bioinformatics/btn506; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; PHOENIX J, 1994, EXP PHYSIOL, V79, P601, DOI 10.1113/expphysiol.1994.sp003794; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rimpi S, 2007, BIOCHEM SOC T, V35, P305, DOI 10.1042/BST0350305; ROBINSON MB, 1986, EUR J PHARMACOL, V130, P345, DOI 10.1016/0014-2999(86)90291-8; Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sager TN, 1997, J NEUROCHEM, V68, P675; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; SLUPSKY CM, CLIN CANC RES, V16, P5835; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; SOLIS JM, 1988, NEUROSCI LETT, V91, P53, DOI 10.1016/0304-3940(88)90248-0; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STRUYS EA, ANN CLIN BIOCH, V47, P282; Szelag Adam, 2002, Ginekol Pol, V73, P627; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; VANDERHEIDEN MG, SCIENCE, V329, P1492; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEI J, INT J CANC; Wong DA, 2004, J BIOL CHEM, V279, P41302, DOI 10.1074/jbc.M406766200; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Yang CS, 1997, BIOCHEM PHARMACOL, V53, P357, DOI 10.1016/S0006-2952(96)00729-0; Zagouri F, 2010, EUR J GYNAECOL ONCOL, V31, P268; ZHEN H, INT J GYNECOL CANC, V20, P316	94	115	119	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19963	10.1371/journal.pone.0019963	http://dx.doi.org/10.1371/journal.pone.0019963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625518	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200034
J	Li, GT; Zhou, XY; Kong, LG; Wang, YL; Zhang, H; Zhu, H; Mitchell, TK; Dean, RA; Xu, JR				Li, Guotian; Zhou, Xiaoying; Kong, Lingan; Wang, Yuling; Zhang, Haifeng; Zhu, Heng; Mitchell, Thomas K.; Dean, Ralph A.; Xu, Jin-Rong			MoSfl1 Is Important for Virulence and Heat Tolerance in Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; INFECTION-RELATED MORPHOGENESIS; CANDIDA-ALBICANS SFL1; TRANSCRIPTION FACTOR; ZINC-FINGER; APPRESSORIUM FORMATION; USTILAGO-MAYDIS; MAP KINASE; SACCHAROMYCES-CEREVISIAE; TURGOR GENERATION	The formation of appressoria, specialized plant penetration structures of Magnaporthe oryzae, is regulated by the MST11-MST7-PMK1 MAP kinase cascade. One of its downstream transcription factor, MST12, is important for penetration and invasive growth but dispensable for appressorium formation. To identify additional downstream targets that are regulated by Pmk1, in this study we performed phosphorylation assays with a protein microarray composed of 573 M. oryzae transcription factor (TF) genes. Three of the TF genes phosphorylated by Pmk1 in vitro were further analyzed by coimmunoprecipitation assays. One of them, MoSFL1, was found to interact with Pmk1 in vivo. Like other Sfl1 orthologs, the MoSfl1 protein has the HSF-like domain. When expressed in yeast, MoSFL1 functionally complemented the flocculation defects of the sfl1 mutant. In M. oryzae, deletion of MoSFl1 resulted in a significant reduction in virulence on rice and barley seedlings. Consistent with this observation, the Mosfl1 mutant was defective in invasive growth in penetration assays with rice leaf sheaths. In comparison with that of vegetative hyphae, the expression level of MoSFL1 was increased in appressoria and infected rice leaves. The Mosfl1 mutant also had increased sensitivity to elevated temperatures. In CM cultures of the Mosfl1 and pmk1 mutants grown at 30 degrees C, the production of aerial hyphae and melanization were reduced but their growth rate was not altered. When assayed by qRT-PCR, the transcription levels of the MoHSP30 and MoHSP98 genes were reduced 10- and 3-fold, respectively, in the Mosfl1 mutant. SFL1 orthologs are conserved in filamentous ascomycetes but none of them have been functionally characterized in non-Saccharomycetales fungi. MoSfl1 has one putative MAPK docking site and three putative MAPK phosphorylation sites. Therefore, it may be functionally related to Pmk1 in the regulation of invasive growth and stress responses in M. oryzae.	[Li, Guotian; Zhou, Xiaoying; Kong, Lingan; Zhang, Haifeng; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Wang, Yuling] NW A&F Univ, Coll Plant Protect, Yangling, Shanxi, Peoples R China; [Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Mitchell, Thomas K.] Ohio State Univ, Dept Plant Pathol, Columbia, OH USA; [Dean, Ralph A.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwest A&F University - China; Johns Hopkins University; University System of Ohio; Ohio State University; University of North Carolina; North Carolina State University	Li, GT (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu			USDA [2007-35319-102681]; China Scholarship Council via Northwest A F University [2008630021]	USDA(United States Department of Agriculture (USDA)); China Scholarship Council via Northwest A F University(China Scholarship Council)	This work was supported by a grant from the USDA Integrated Research Program (#2007-35319-102681). Guotian Li was partially supported by a China Scholarship Council fellowship, #2008630021, via Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Bourett TM, 2002, FUNGAL GENET BIOL, V37, P211, DOI 10.1016/S1087-1845(02)00524-8; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; FUJITA A, 1989, GENE, V85, P321; Galeote VA, 2007, CURR GENET, V52, P55, DOI 10.1007/s00294-007-0136-z; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grunler A, 2010, FUNGAL GENET BIOL, V47, P619, DOI 10.1016/j.fgb.2010.04.001; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hartmann HA, 1999, PLANT CELL, V11, P1293, DOI 10.1105/tpc.11.7.1293; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Kaffarnik F, 2003, EMBO J, V22, P5817, DOI 10.1093/emboj/cdg554; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kim TS, 2004, MOL CELL BIOL, V24, P7695, DOI 10.1128/MCB.24.17.7695-7706.2004; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masloff S, 1999, GENETICS, V152, P191; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Mitchell TK, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P73, DOI 10.1007/978-1-4020-9500-9_8; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Mok J, 2009, NAT PROTOC, V4, P1820, DOI 10.1038/nprot.2009.194; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Nishimura M, 2009, BIOSCI BIOTECH BIOCH, V73, P1779, DOI 10.1271/bbb.90146; Odenbach D, 2007, MOL MICROBIOL, V64, P293, DOI 10.1111/j.1365-2958.2007.05643.x; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; Patzold AJ, 2001, FEBS LETT, V494, P64, DOI 10.1016/S0014-5793(01)02312-2; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Shi ZX, 1995, MOL PLANT MICROBE IN, V8, P949, DOI 10.1094/MPMI-8-0949; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; TABA MRM, 1991, GENE DEV, V5, P2000, DOI 10.1101/gad.5.11.2000; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; VALENT B, 1991, GENETICS, V127, P87; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang TT, 2008, CHINESE SCI BULL, V53, P2624, DOI 10.1007/s11434-008-0302-9; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	71	37	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19951	10.1371/journal.pone.0019951	http://dx.doi.org/10.1371/journal.pone.0019951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625508	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200033
J	Xue, XL; Sztajer, H; Buddruhs, N; Petersen, J; Rohde, M; Talay, SR; Wagner-Dobler, I				Xue, Xiaoli; Sztajer, Helena; Buddruhs, Nora; Petersen, Joern; Rohde, Manfred; Talay, Susanne R.; Wagner-Doebler, Irene			Lack of the Delta Subunit of RNA Polymerase Increases Virulence Related Traits of Streptococcus mutans	PLOS ONE			English	Article							WALL-ASSOCIATED PROTEIN; BIOFILM FORMATION; DENTAL BIOFILM; BACTERIAL INTERACTIONS; MICROARRAY ANALYSIS; ORAL STREPTOCOCCI; STRESS TOLERANCE; MATRIX MOLECULES; HEART-VALVE; SURFACE	The delta subunit of the RNA polymerase, RpoE, maintains the transcriptional specificity in Gram-positive bacteria. Lack of RpoE results in massive changes in the transcriptome of the human dental caries pathogen Streptococcus mutans. In this study, we analyzed traits of the Delta rpoE mutant which are important for biofilm formation and interaction with oral microorganisms and human cells and performed a global phenotypic analysis of its physiological functions. The Delta rpoE mutant showed higher self-aggregation compared to the wild type and coaggregated with other oral bacteria and Candida albicans. It formed a biofilm with a different matrix structure and an altered surface attachment. The amount of the cell surface antigens I/II SpaP and the glucosyltransferase GtfB was reduced. The Delta rpoE mutant displayed significantly stronger adhesion to human extracellular matrix components, especially to fibronectin, than the wild type. Its adhesion to human epithelial cells HEp-2 was reduced, probably due to the highly aggregated cell mass. The analysis of 1248 physiological traits using phenotype microarrays showed that the Delta rpoE mutant metabolized a wider spectrum of carbon sources than the wild type and had acquired resistance to antibiotics and inhibitory compounds with various modes of action. The reduced antigenicity, increased aggregation, adherence to fibronection, broader substrate spectrum and increased resistance to antibiotics of the Delta rpoE mutant reveal the physiological potential of S. mutans and show that some of its virulence related traits are increased.	[Xue, Xiaoli; Sztajer, Helena; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res GmbH, Div Cell Biol, Res Grp Microbial Commun, Braunschweig, Germany; [Buddruhs, Nora; Petersen, Joern] German Collect Microorganisms & Cell Cultures Gmb, Res Grp Roseobacter Mol Systemat, Braunschweig, Germany; [Rohde, Manfred; Talay, Susanne R.] Helmholtz Ctr Infect Res GmbH, Dept Med Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research	Xue, XL (corresponding author), Helmholtz Ctr Infect Res GmbH, Div Cell Biol, Res Grp Microbial Commun, Braunschweig, Germany.	iwd@gbf.de	Wagner-Döbler, Irene/Y-1685-2019	Wagner-Dobler, Irene/0000-0001-5883-2502	Chinese Academy of Science (CSC); German State Ministry for Research and Education (BMBF) [FK 0315411A]; German Research Organisation (DFG) [DFG TRR 51]; European Community [FP7/2007-2013, 222886-2]; Helmholtz-Centre for Infection Research (HZI) GmbH; German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH	Chinese Academy of Science (CSC)(Chinese Academy of Sciences); German State Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Organisation (DFG)(German Research Foundation (DFG)); European Community(European Commission); Helmholtz-Centre for Infection Research (HZI) GmbH; German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH	Xiaoli Xue was supported by a Chinese Academy of Science (CSC)-Helmholtz Joint Fellowship. IWD acknowledges the support of the German State Ministry for Research and Education (BMBF), grant FK 0315411A, and the support of the German Research Organisation (DFG) for the Special Research Program (SFB), grant DFG TRR 51. The research leading to the Phenotype Microarray (PM) results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 222886-2 (Microme project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HSZ, MR, ST and IWD are employees of the Helmholtz-Centre for Infection Research (HZI) GmbH. NB and JP are employees of the German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH. Both institutions are govenment funded research organizations. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abranches J, 2009, ORAL MICROBIOL IMMUN, V24, P141, DOI 10.1111/j.1399-302X.2008.00487.x; ACHBERGER EC, 1981, J BIOL CHEM, V256, P7424; Ahn SJ, 2009, APPL ENVIRON MICROB, V75, P2517, DOI 10.1128/AEM.02367-08; Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Beg AM, 2002, BIOCHEM BIOPH RES CO, V298, P75, DOI 10.1016/S0006-291X(02)02390-2; Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Burne RA, 1996, J DENT RES, V75, P1572, DOI 10.1177/00220345960750080801; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; CROWLEY PJ, 1987, INFECT IMMUN, V55, P2695, DOI 10.1128/IAI.55.11.2695-2700.1987; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Garcia-Godoy F, 2008, J AM DENT ASSOC, V139, p25S, DOI 10.14219/jada.archive.2008.0352; Han TK, 2006, BIOCHEM BIOPH RES CO, V343, P787, DOI 10.1016/j.bbrc.2006.03.025; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; HONDA O, 1990, J GEN MICROBIOL, V136, P2099, DOI 10.1099/00221287-136-10-2099; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jarosz LM, 2009, EUKARYOT CELL, V8, P1658, DOI 10.1128/EC.00070-09; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; Jiang YL, 2002, J ENDODONT, V28, P279, DOI 10.1097/00004770-200204000-00005; Jones AL, 2003, INFECT IMMUN, V71, P4011, DOI 10.1128/IAI.71.7.4011-4017.2003; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kaur SJ, 2010, J BIOL CHEM, V285, P27798, DOI 10.1074/jbc.M109.098053; Kelemen L, 2004, FEBS LETT, V566, P190, DOI 10.1016/j.febslet.2004.04.029; Kinney KK, 2010, AM J MED SCI, V340, P209, DOI 10.1097/MAJ.0b013e3181e99aa4; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nakano K, 2006, MICROBES INFECT, V8, P114, DOI 10.1016/j.micinf.2005.06.005; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Ogawa A, 2011, APPL ENVIRON MICROB, V77, P1572, DOI 10.1128/AEM.02066-10; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; RIIHINEN K, 2010, PHYTOTHER RES; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; SKLAVOUNOU A, 1980, INFECT IMMUN, V27, P686, DOI 10.1128/IAI.27.2.686-689.1980; TAKAHASHI N, 2010, J DENT RES; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; Vilchez R, 2010, CHEMBIOCHEM, V11, P1552, DOI 10.1002/cbic.201000086; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang W, 2003, BIOTECHNOL BIOENG, V83, P525, DOI 10.1002/bit.10701; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Zhang JQ, 2009, MICROBIOL-SGM, V155, P61, DOI 10.1099/mic.0.023077-0; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zhu L, 2006, MICROBIOL-SGM, V152, P2395, DOI 10.1099/mic.0.28883-0; Zhu M, 2009, APPL ENVIRON MICROB, V75, P7037, DOI 10.1128/AEM.01015-09; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	69	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20075	10.1371/journal.pone.0020075	http://dx.doi.org/10.1371/journal.pone.0020075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625504	Green Submitted, Green Published, gold			2022-12-27	WOS:000290771200045
J	Zhang, JZ; Zhang, X; Arakane, Y; Muthukrishnan, S; Kramer, KJ; Ma, EB; Zhu, KY				Zhang, Jianzhen; Zhang, Xin; Arakane, Yasuyuki; Muthukrishnan, Subbaratnam; Kramer, Karl J.; Ma, Enbo; Zhu, Kun Yan			Comparative Genomic Analysis of Chitinase and Chitinase-Like Genes in the African Malaria Mosquito (Anopheles gambiae)	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; PROTEINS; EXPRESSION; CLONING; CDNA; INSECT; FAMILY; IDENTIFICATION	Chitinase is an important enzyme responsible for chitin metabolism in a wide range of organisms including bacteria, yeasts and other fungi, nematodes and arthropods. However, current knowledge on chitinolytic enzymes, especially their structures, functions and regulation is very limited. In this study we have identified 20 chitinase and chitinase-like genes in the African malaria mosquito, Anopheles gambiae, through genome-wide searching and transcript profiling. We assigned these genes into eight different chitinase groupings (groups I-VIII). Domain analysis of their predicted proteins showed that all contained at least one catalytic domain. However, only seven (AgCht4, AgCht5-1, AgCht6, AgCht7, AgCht8, AgCht10 and AgCht23) displayed one or more chitin-binding domains. Analyses of stage-and tissue-specific gene expression revealed that most of these genes were expressed in larval stages. However, AgCht8 was mainly expressed in the pupal and adult stages. AgCht2 and AgCht12 were specifically expressed in the foregut, whereas AgCht13 was only expressed in the midgut. The high diversity and complexity of An. gambiae chitinase and chitinase-like genes suggest their diverse functions during different developmental stages and in different tissues of the insect. A comparative genomic analysis of these genes along with those present in Drosophila melanogaster, Tribolium castaneum and several other insect species led to a uniform classification and nomenclature of these genes. Our investigation also provided important information for conducting future studies on the functions of chitinase and chitinase-like genes in this important malaria vector and other species of arthropods.	[Zhang, Jianzhen; Ma, Enbo] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhang, Jianzhen; Zhang, Xin; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Arakane, Yasuyuki; Muthukrishnan, Subbaratnam; Kramer, Karl J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Arakane, Yasuyuki] Chonnam Natl Univ, Div Plant Biotechnol, Coll Agr & Life Sci, Kwangju, South Korea	Shanxi University; Kansas State University; Kansas State University; Chonnam National University	Zhang, JZ (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China.	kzhu@ksu.edu		Zhu, Kun Yan/0000-0001-9372-8030	Kansas Agricultural Experiment Station; Kansas State University; Direct For Biological Sciences [1022227] Funding Source: National Science Foundation	Kansas Agricultural Experiment Station; Kansas State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Kansas Agricultural Experiment Station and the K-State Arthropod Genomics Center funded by the K-State Targeted Excellence Program at Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2003, BIOCHEM BIOPH RES CO, V310, P188, DOI 10.1016/j.bbrc.2003.08.136; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Bolognesi R, 2005, INSECT BIOCHEM MOLEC, V35, P1249, DOI 10.1016/j.ibmb.2005.06.006; Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; de la Vega H, 1998, INSECT MOL BIOL, V7, P233, DOI 10.1111/j.1365-2583.1998.00065.x; Fitches E, 2004, INSECT BIOCHEM MOLEC, V34, P1037, DOI 10.1016/j.ibmb.2004.06.012; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Genta FA, 2006, INSECT BIOCHEM MOLEC, V36, P789, DOI 10.1016/j.ibmb.2006.07.007; Khajuria C, 2010, INSECT BIOCHEM MOLEC, V40, P621, DOI 10.1016/j.ibmb.2010.06.003; Kim MG, 1998, INSECT BIOCHEM MOLEC, V28, P163, DOI 10.1016/S0965-1748(97)00112-4; KIRKPATRICK RB, 1995, GENE, V153, P147, DOI 10.1016/0378-1119(94)00756-I; KRAMER KJ, 1993, INSECT BIOCHEM MOLEC, V23, P691, DOI 10.1016/0965-1748(93)90043-R; Kramer KJ, 2005, COMPREHENSIVE MOL IN, V4, P111; KRISHNAN A, 1994, J BIOL CHEM, V269, P20971; Matsumiya M, 2006, BIOSCI BIOTECH BIOCH, V70, P971, DOI 10.1271/bbb.70.971; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017; Nakabachi A, 2010, INSECT MOL BIOL, V19, P175, DOI 10.1111/j.1365-2583.2009.00985.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Royer W, 2002, BIOCHEM J, V366, P921, DOI 10.1042/bj20011764; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; Shen ZC, 1997, J BIOL CHEM, V272, P28895, DOI 10.1074/jbc.272.46.28895; Shi L, 2004, INSECT MOL BIOL, V13, P387, DOI 10.1111/j.0962-1075.2004.00496.x; Shinoda T, 2001, INSECT BIOCHEM MOLEC, V31, P521, DOI 10.1016/S0965-1748(00)00133-8; Shuhui L, 2009, INT ARCH ALLERGY IMM, V149, P369, DOI 10.1159/000205583; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Wei Y, 2010, MICRON, V41, P953, DOI 10.1016/j.micron.2010.07.005; ZHANG J, 2011, INSECT BIOC IN PRESS; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zheng Y, 2002, INSECT BIOCHEM MOLEC, V32, P1813, DOI 10.1016/S0965-1748(02)00166-2; Zhu Q, 2008, INSECT BIOCHEM MOLEC, V38, P467, DOI 10.1016/j.ibmb.2007.06.011; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zhu QS, 2004, BIOINFORMATICS, V20, P161, DOI 10.1093/bioinformatics/bth020	38	71	92	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19899	10.1371/journal.pone.0019899	http://dx.doi.org/10.1371/journal.pone.0019899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611131	gold, Green Published			2022-12-27	WOS:000290720200045
J	Hasegawa, Y; Ikeno, H				Hasegawa, Yuji; Ikeno, Hidetoshi			How Do Honeybees Attract Nestmates Using Waggle Dances in Dark and Noisy Hives?	PLOS ONE			English	Article							APIS-MELLIFERA; HEARING; BEES; COMMUNICATION; HYMENOPTERA; DROSOPHILA; COURTSHIP; DIRECTION; LANGUAGE; BEHAVIOR	It is well known that honeybees share information related to food sources with nestmates using a dance language that is representative of symbolic communication among non-primates. Some honeybee species engage in visually apparent behavior, walking in a figure-eight pattern inside their dark hives. It has been suggested that sounds play an important role in this dance language, even though a variety of wing vibration sounds are produced by honeybee behaviors in hives. It has been shown that dances emit sounds primarily at about 250-300 Hz, which is in the same frequency range as honeybees' flight sounds. Thus the exact mechanism whereby honeybees attract nestmates using waggle dances in such a dark and noisy hive is as yet unclear. In this study, we used a flight simulator in which honeybees were attached to a torque meter in order to analyze the component of bees' orienting response caused only by sounds, and not by odor or by vibrations sensed by their legs. We showed using single sound localization that honeybees preferred sounds around 265 Hz. Furthermore, according to sound discrimination tests using sounds of the same frequency, honeybees preferred rhythmic sounds. Our results demonstrate that frequency and rhythmic components play a complementary role in localizing dance sounds. Dance sounds were presumably developed to share information in a dark and noisy environment.	[Hasegawa, Yuji] Honda Res Inst Japan Co Ltd, Wako, Saitama, Japan; [Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo, Japan	Honda Motor Company; University of Hyogo	Hasegawa, Y (corresponding author), Honda Res Inst Japan Co Ltd, Wako, Saitama, Japan.	yuji.hasegawa@jp.honda-ri.com	Ikeno, Hidetoshi/O-3034-2018	Ikeno, Hidetoshi/0000-0002-5134-5485				ALEXANDER BA, 1991, ANN ENTOMOL SOC AM, V84, P137, DOI 10.1093/aesa/84.2.137; BASTIAN J, 1972, J COMP PHYSIOL, V77, P126, DOI 10.1007/BF00693602; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; DRELLER C, 1993, J COMP PHYSIOL A, V173, P275, DOI 10.1007/BF00212691; DRELLER C, 1994, INSECT SOC, V41, P291, DOI 10.1007/BF01242300; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Engel MS, 1997, ANN ENTOMOL SOC AM, V90, P43, DOI 10.1093/aesa/90.1.43; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HEDWING T, 2006, J COMP PHYSIOL A, V192, P677; HEISENBERG M, 1993, VISUAL MOTION ITS RO, P265; IKENO H, 2005, IEICE T INF SYST, V88, P2144; Kilpinen O, 1997, J COMP PHYSIOL A, V181, P309, DOI 10.1007/s003590050117; Kirchner WH, 1996, APIDOLOGIE, V27, P331, DOI 10.1051/apido:19960501; KIRCHNER WH, 1988, NATURWISSENSCHAFTEN, V75, P629, DOI 10.1007/BF00366482; KIRCHNER WH, 1991, J COMP PHYSIOL A, V168, P85, DOI 10.1007/BF00217106; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; MICHELSEN A, 1987, J COMP PHYSIOL A, V161, P633, DOI 10.1007/BF00605005; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Nieh JC, 2000, J EXP BIOL, V203, P1573; PRINGLE JWS, 1968, ADV INSECT PHYSL; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; SEELEY TD, 1995, WISDOM HIVE SOCIAL P, P69; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Tautz J, 2001, J EXP BIOL, V204, P3737; TOWNE WF, 1989, SCIENCE, V244, P686, DOI 10.1126/science.244.4905.686; Tsujiuchi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000234; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; von Frisch K., 1967, DANCE LANGUAGE ORIEN	28	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19619	10.1371/journal.pone.0019619	http://dx.doi.org/10.1371/journal.pone.0019619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603608	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300014
J	Almberg, ES; Cross, PC; Johnson, CJ; Heisey, DM; Richards, BJ				Almberg, Emily S.; Cross, Paul C.; Johnson, Christopher J.; Heisey, Dennis M.; Richards, Bryan J.			Modeling Routes of Chronic Wasting Disease Transmission: Environmental Prion Persistence Promotes Deer Population Decline and Extinction	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; WILDLIFE EPIDEMIC; INFECTIOUS PRIONS; GROWTH-RATES; DYNAMICS; ELK; PATTERNS; COLORADO; SCRAPIE	Chronic wasting disease (CWD) is a fatal disease of deer, elk, and moose transmitted through direct, animal-to-animal contact, and indirectly, via environmental contamination. Considerable attention has been paid to modeling direct transmission, but despite the fact that CWD prions can remain infectious in the environment for years, relatively little information exists about the potential effects of indirect transmission on CWD dynamics. In the present study, we use simulation models to demonstrate how indirect transmission and the duration of environmental prion persistence may affect epidemics of CWD and populations of North American deer. Existing data from Colorado, Wyoming, and Wisconsin's CWD epidemics were used to define plausible short-term outcomes and associated parameter spaces. Resulting long-term outcomes range from relatively low disease prevalence and limited host-population decline to host-population collapse and extinction. Our models suggest that disease prevalence and the severity of population decline is driven by the duration that prions remain infectious in the environment. Despite relatively low epidemic growth rates, the basic reproductive number, R-0, may be much larger than expected under the direct-transmission paradigm because the infectious period can vastly exceed the host's life span. High prion persistence is expected to lead to an increasing environmental pool of prions during the early phases (i.e. approximately during the first 50 years) of the epidemic. As a consequence, over this period of time, disease dynamics will become more heavily influenced by indirect transmission, which may explain some of the observed regional differences in age and sex-specific disease patterns. This suggests management interventions, such as culling or vaccination, will become increasingly less effective as CWD epidemics progress.	[Almberg, Emily S.; Cross, Paul C.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Almberg, Emily S.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Johnson, Christopher J.; Heisey, Dennis M.] US Geol Survey, Prion Res Lab, Natl Wildlife Hlth Ctr, Madison, WI USA	United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Almberg, ES (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA.	esa5046@psu.edu	Johnson, Christopher/B-1436-2009; Cross, Paul/K-6987-2012	Johnson, Christopher/0000-0003-4539-2581; Cross, Paul/0000-0001-8045-5213	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	This work was funded by the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; ANDERSON R M, 1991; Barlow ND, 2000, J ANIM ECOL, V69, P703, DOI 10.1046/j.1365-2656.2000.00428.x; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; BINFET J, 2009, JOB COMPLETION REPOR, P177; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; David Walter W, 2011, Nat Commun, V2, P200, DOI 10.1038/ncomms1203; DUSEK GL, 1989, WILDLIFE MONOGR, P1; EDMUNDS D, 2010, VECTOR NEWSLETTER WI; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; GILL RB, 1999, DECLINING MULE DEER, P1; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; HALEY NJ, 2009, PLOS ONE, V4; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2011, J TOXICOL ENV HEAL A, V74, P161, DOI 10.1080/15287394.2011.529066; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; KEELING MJ, 2008, MODELING INFECT DIS, V366; Keyser PD, 2005, WILDLIFE SOC B, V33, P222, DOI 10.2193/0091-7648(2005)33[222:DRPIWD]2.0.CO;2; KREEGER TJ, 2008, CHRON WAST DIS WORKS, P8; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McCaffery Keith R., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P249; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; RILEY SJ, 1984, J WILDLIFE MANAGE, V48, P1302, DOI 10.2307/3801790; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Schauber EM, 2003, WILDLIFE SOC B, V31, P610; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; SMITH W P, 1991, Mammalian Species, P1, DOI 10.2307/3504281; Swihart RK, 1998, CAN J ZOOL, V76, P1932, DOI 10.1139/cjz-76-10-1932; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TANNER JT, 1975, ECOLOGY, V56, P855, DOI 10.2307/1936296; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; *WI DEP NAT RES, 2009, FALL DEER POP DENS 2; *WI DEP NAT RES, 2010, WISC CHRON WAST DIS; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123	62	103	104	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19896	10.1371/journal.pone.0019896	http://dx.doi.org/10.1371/journal.pone.0019896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603638	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500035
J	Takahashi, J; Misawa, M; Iwahashi, H				Takahashi, Junko; Misawa, Masaki; Iwahashi, Hitoshi			Oligonucleotide Microarray Analysis of Age-Related Gene Expression Profiles in Miniature Pigs	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; ANIMAL-MODEL; WHOLE-BLOOD; CORD-BLOOD; GENOME; TOXICOGENOMICS; HLA	Miniature pigs are useful model animals for humans because they have similar anatomy and digestive physiology to humans and are easy to breed and handle. In this study, whole blood microarray analyses were conducted to evaluate variations of correlation among individuals and ages using specific pathogen-free (SPF) Clawn miniature pigs. Whole blood RNA is easy to handle compared to isolated white blood cell RNA and can be used for health and disease monitoring and animal control. In addition, whole blood is a heterogeneous mixture of subpopulation cells. Once a great change occurs in composition and expressing condition of subpopulations, their associated change will be reflected on whole blood RNA. From 12 to 30 weeks of age, fractions of lymphocytes, monocytes, neutrophils, eosinophils, and basophils in white blood cells showed insignificant differences with age as a result of ANOVA analysis. This study attempted to identify characteristics of age-related gene expression by taking into account the change in the number of expressed genes by age and similarities of gene expression intensity between individuals. As a result, the number of expressed genes was less in fetal stage and infancy period but increased with age, reaching a steady state of gene expression after 20 weeks of age. Variation in gene expression intensity within the same age was great in fetal stage and infancy period, but converged with age. The variation between 20 and 30 weeks of age was comparable to that among 30 weeks individuals. These results indicate that uniformity of laboratory animals is expected for miniature pigs after 20 weeks of age. Furthermore, a possibility was shown that whole blood RNA analysis is applicable to evaluation of physiological state.	[Takahashi, Junko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Misawa, Masaki] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Iwahashi, Hitoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Kagawa, Japan; [Iwahashi, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Takahashi, J (corresponding author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan.	junko-takahashi@aist.go.jp	Iwahashi, Hitoshi/S-1360-2019; Misawa, Masaki/M-8235-2018; Takahashi, Junko/L-6921-2018	Misawa, Masaki/0000-0002-3685-5612; Takahashi, Junko/0000-0002-1941-0136				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Beijar ECE, 2006, PLACENTA, V27, P322, DOI 10.1016/j.placenta.2004.12.012; Canaday DH, 2006, CELL IMMUNOL, V243, P96, DOI 10.1016/j.cellimm.2007.01.003; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Forster-Waldl E, 2005, PEDIATR RES, V58, P121, DOI 10.1203/01.PDR.0000163397.53466.0F; Frei R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008808; Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; HUNT DWC, 1994, BLOOD, V84, P4333, DOI 10.1182/blood.V84.12.4333.bloodjournal84124333; Komatsu T, 1998, HUM REPROD, V13, P2246, DOI 10.1093/humrep/13.8.2246; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Pennie W, 2004, ENVIRON HEALTH PERSP, V112, P417, DOI 10.1289/ehp.6674; PURI S, 1993, TISSUE ANTIGENS, V42, P67, DOI 10.1111/j.1399-0039.1993.tb02169.x; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Williams-Devane CR, 2009, TOXICOL SCI, V109, P358, DOI 10.1093/toxsci/kfp061; IMMUNOPOLYMORPHISM D	29	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19761	10.1371/journal.pone.0019761	http://dx.doi.org/10.1371/journal.pone.0019761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603646	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500029
J	Fernandes, HL; Albert, MV; Kording, KP				Fernandes, Hugo Liberal; Albert, Mark Vincent; Kording, Konrad Paul			Measuring Generalization of Visuomotor Perturbations in Wrist Movements Using Mobile Phones	PLOS ONE			English	Article							UNIVERSAL LAW; MOTOR CONTROL; RECOGNITION; ADAPTATION; STATISTICS; DYNAMICS; ERRORS	Recent studies in motor control have shown that visuomotor rotations for reaching have narrow generalization functions: what we learn during movements in one direction only affects subsequent movements into close directions. Here we wanted to measure the generalization functions for wrist movement. To do so we had 7 subjects performing an experiment holding a mobile phone in their dominant hand. The mobile phone's built in acceleration sensor provided a convenient way to measure wrist movements and to run the behavioral protocol. Subjects moved a cursor on the screen by tilting the phone. Movements on the screen toward the training target were rotated and we then measured how learning of the rotation in the training direction affected subsequent movements in other directions. We find that generalization is local and similar to generalization patterns of visuomotor rotation for reaching.	[Fernandes, Hugo Liberal; Albert, Mark Vincent; Kording, Konrad Paul] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Fernandes, Hugo Liberal; Albert, Mark Vincent; Kording, Konrad Paul] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Fernandes, Hugo Liberal] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oerias, Portugal; [Kording, Konrad Paul] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad Paul] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Universidade Nova de Lisboa; Northwestern University; Northwestern University	Fernandes, HL (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	hugoguh@gmail.com	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	Fundacao Calouste Gulbenkian, Siemens SA; Fundacao para a Ciencia e Tecnologia [SFRH/BD/33525/2008]; NIH [1R01NS063399, 2P01NS044393]; Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian, Siemens SA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HLF was supported by the Ph.D. Program in Computational Biology of the Instituto Gulbenkian de Ciencia, Portugal (sponsored by Fundacao Calouste Gulbenkian, Siemens SA, and Fundacao para a Ciencia e Tecnologia; SFRH/BD/33525/2008). This work was supported by NIH 1R01NS063399 and 2P01NS044393 and the Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; Calinon S, 2007, IEEE T SYST MAN CY B, V37, P286, DOI 10.1109/TSMCB.2006.886952; Chater N, 2003, J MATH PSYCHOL, V47, P346, DOI 10.1016/S0022-2496(03)00013-0; Coltz JD, 1999, J NEUROSCI, V19, P1782; Donchin O, 2003, J NEUROSCI, V23, P9032; Gfeller B., 2004, ADV PERVASIVE COMPUT, P265; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Mathews AG, 2005, COMP MED SY, P425, DOI 10.1109/CBMS.2005.21; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Quinn PC, 2007, MEM COGNITION, V35, P1422, DOI 10.3758/BF03193612; Shadmehr R, 2000, J NEUROSCI, V20, P7807; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Slijper H, 2009, J MOTOR BEHAV, V41, P3, DOI 10.1080/00222895.2009.10125922; SMITH LB, 1979, CHILD DEV, V50, P705, DOI 10.1111/j.1467-8624.1979.tb02418.x; SPIVEY J, 2007, CONTINUITY MIND; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20290	10.1371/journal.pone.0020290	http://dx.doi.org/10.1371/journal.pone.0020290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629659	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800041
J	Polakof, S; Panserat, S; Craig, PM; Martyres, DJ; Plagnes-Juan, E; Savari, S; Aris-Brosou, S; Moon, TW				Polakof, Sergio; Panserat, Stephane; Craig, Paul M.; Martyres, David J.; Plagnes-Juan, Elisabeth; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.			The Metabolic Consequences of Hepatic AMP-Kinase Phosphorylation in Rainbow Trout	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; SKELETAL-MUSCLE; METFORMIN; INSULIN; EXPRESSION; LIVER; MODEL; GLUCONEOGENESIS	AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine protein kinase, is proposed to function as a "fuel gauge'' to monitor cellular energy status in response to nutritional environmental variations. However, in fish, few studies have addressed the metabolic consequences related to the activation of this kinase. This study demonstrates that the rainbow trout (Oncorhynchus mykiss) possesses paralogs of the three known AMPK subunits that co-diversified, that the AMPK protein is present in the liver and in isolated hepatocytes, and it does change in response to physiological (fasting-re-feeding cycle) and pharmacological (AICAR and metformin administration and incubations) manipulations. Moreover, the phosphorylation of AMPK results in the phosphorylation of acetyl-CoA carboxylase, a main downstream target of AMPK in mammals. Other findings include changes in hepatic glycogen levels and several molecular actors involved in hepatic glucose and lipid metabolism, including mRNA transcript levels for glucokinase, glucose-6-phosphatase and fatty acid synthase both in vivo and in vitro. The fact that most results presented in this study are consistent with the recognized role of AMPK as a master regulator of energy homeostasis in living organisms supports the idea that these functions are conserved in this piscine model.	[Polakof, Sergio; Panserat, Stephane; Plagnes-Juan, Elisabeth] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France; [Polakof, Sergio] Univ Vigo, Lab Fisiol Anim, Dept Biol Func & Ciencias Saude, Fac Biol, Vigo 36310, Spain; [Craig, Paul M.; Martyres, David J.; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Craig, Paul M.; Martyres, David J.; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	INRAE; Universite de Pau et des Pays de l'Adour; Universidade de Vigo; University of Ottawa; University of Ottawa	Polakof, S (corresponding author), CRNH Auvergne, INRA, UMR 1019, UNH, Clermont Ferrand, France.	spolakof@st-pee.inra.fr	Craig, Paul/G-4248-2011; Craig, Paul/J-4058-2015; Polakof, Sergio/V-1132-2017	Polakof, Sergio/0000-0002-0976-8732; Panserat, Stephane/0000-0002-4479-9868; Aris-Brosou, Stephane/0000-0003-4987-0296	Xunta de Galicia; NSERC Canada; France-Canada Research Fund; Natural Sciences & Engineering Research Council (NSERC) of Canada	Xunta de Galicia(Xunta de GaliciaEuropean Commission); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); France-Canada Research Fund; Natural Sciences & Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	S. Polakof was the recipient of a postdoctoral fellowship from the Xunta de Galicia (Program Angeles Alvarino), P. Craig was supported by a postdoctoral fellowship from NSERC Canada, and D.J. Martyres by an undergraduate scholarship from NSERC Canada. This study was supported by research grants from a France-Canada Research Fund grant to T.W. Moon and S. Panserat, and Natural Sciences & Engineering Research Council (NSERC) of Canada grants to S. Aris-Brosou and T.W. Moon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; Aris-Brosou S., 2008, INT J PLANT GENOMICS, V2008; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Diamanti-Kandarakis E, 2010, EUR J ENDOCRINOL, V162, P193, DOI 10.1530/EJE-09-0733; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; HERTZ Y, 1989, AQUACULTURE, V80, P175, DOI 10.1016/0044-8486(89)90283-4; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jibb LA, 2008, J EXP BIOL, V211, P3111, DOI 10.1242/jeb.019117; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Magallon S., 2009, TIMETREE LIFE, P133; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Mommsen Thomas P., 1994, Biochemistry and Molecular Biology of Fishes, V3, P355; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Navarro I., 1995, BIOCH MOL BIOL FISHE, p394 ; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; PANSERAT S, 2009, AM J PHYSIOL-REG I, V293, P707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagnes-Juan E, 2008, J EXP BIOL, V211, P2510, DOI 10.1242/jeb.018374; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2009, AM J PHYSIOL-REG I, V297, pR1769, DOI 10.1152/ajpregu.00369.2009; Polakof S, 2010, J EXP BIOL, V213, P1443, DOI 10.1242/jeb.037689; Posada D., 2003, CURRENT PROTOCOLS BI; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Tomita K, 2005, ALCOHOL CLIN EXP RES, V29, p240S, DOI 10.1097/01.alc.0000191126.11479.69; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1	49	54	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20228	10.1371/journal.pone.0020228	http://dx.doi.org/10.1371/journal.pone.0020228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625448	Green Published, gold			2022-12-27	WOS:000290793400048
J	Prabhu, VS; Farnham, PG; Hutchinson, AB; Soorapanth, S; Heffelfinger, JD; Golden, MR; Brooks, JT; Rimland, D; Sansom, SL				Prabhu, Vimalanand S.; Farnham, Paul G.; Hutchinson, Angela B.; Soorapanth, Sada; Heffelfinger, James D.; Golden, Matthew R.; Brooks, John T.; Rimland, David; Sansom, Stephanie L.			Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PERSONS; MEDICAL-CARE; STATES; TRANSMISSION; PREVENTION; DIAGNOSIS; LIFE; GUIDELINES	Background: Identifying and treating persons with human immunodeficiency virus (HIV) infection early in their disease stage is considered an effective means of reducing the impact of the disease. We compared the cost-effectiveness of HIV screening in three settings, sexually transmitted disease (STD) clinics serving men who have sex with men, hospital emergency departments (EDs), settings where patients are likely to be diagnosed early, and inpatient diagnosis based on clinical manifestations. Methods and Findings: We developed the Progression and Transmission of HIV/AIDS model, a health state transition model that tracks index patients and their infected partners from HIV infection to death. We used program characteristics for each setting to compare the incremental cost per quality-adjusted life year gained from early versus late diagnosis and treatment. We ran the model for 10,000 index patients for each setting, examining alternative scenarios, excluding and including transmission to partners, and assuming HAART was initiated at a CD4 count of either 350 or 500 cells/mu L. Screening in STD clinics and EDs was cost-effective compared with diagnosing inpatients, even when including only the benefits to the index patients. Screening patients in STD clinics, who have less-advanced disease, was cost-effective compared with ED screening when treatment with HAART was initiated at a CD4 count of 500 cells/mu L. When the benefits of reduced transmission to partners from early diagnosis were included, screening in settings with less-advanced disease stages was cost-saving compared with screening later in the course of infection. The study was limited by a small number of observations on CD4 count at diagnosis and by including transmission only to first generation partners of the index patients. Conclusions: HIV prevention efforts can be advanced by screening in settings where patients present with less-advanced stages of HIV infection and by initiating treatment with HAART earlier in the course of infection.	[Prabhu, Vimalanand S.] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Farnham, Paul G.; Hutchinson, Angela B.; Heffelfinger, James D.; Brooks, John T.; Sansom, Stephanie L.] Ctr Dis Control & Prevent CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA; [Soorapanth, Sada] San Francisco State Univ, San Francisco, CA 94132 USA; [Golden, Matthew R.] Univ Washington, Publ Health Seattle & King Cty STD Clin, Seattle, WA 98195 USA; [Golden, Matthew R.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Rimland, David] Vet Affairs Med Ctr, Med Specialty Serv Line RIM 111, Decatur, GA 30033 USA; [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California State University System; San Francisco State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University	Prabhu, VS (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA.	pgf1@cdc.gov	Golden, Matthew/AAE-4314-2020	Soorapanth, Sada/0000-0002-0644-9082				Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; CDC, 2003, MMWR-MORBID MORTAL W, V52, P329; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Freeman HP, 1995, NATL VITAL STAT REPO, V3, P19; Gold MR, 1996, COST EFFECTIVENESS H; Golden MR, 2009, MONTR CAN 16 C RETR; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Helms DJ, 2009, JAIDS-J ACQ IMM DEF, V50, P320, DOI 10.1097/QAI.0b013e3181945f03; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holtgrave DR, 2010, PUBLIC HEALTH REP, V125, P372, DOI 10.1177/003335491012500305; Jean-Jacques M, 2008, AIDS CARE, V20, P977, DOI 10.1080/09540120701767257; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lyons MS, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-220; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mauskopf J, 2005, JAIDS-J ACQ IMM DEF, V39, P562; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Merito Monica, 2006, Eur J Health Econ, V7, P30, DOI 10.1007/s10198-005-0327-9; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Sabin CA, 2008, AIDS, V22, P1943, DOI 10.1097/QAD.0b013e32830e4cf3; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sculpher Mark, 2006, DECISION MODELLING H; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17	53	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19936	10.1371/journal.pone.0019936	http://dx.doi.org/10.1371/journal.pone.0019936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625489	Green Published, gold			2022-12-27	WOS:000290793400020
J	Sorci, M; Silkworth, W; Gehan, T; Belfort, G				Sorci, Mirco; Silkworth, Whitney; Gehan, Timothy; Belfort, Georges			Evaluating Nuclei Concentration in Amyloid Fibrillation Reactions Using Back-Calculation Approach	PLOS ONE			English	Article							PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; MOLECULAR-BASIS; EARLY EVENTS; INSULIN; MECHANISM; OLIGOMERS; PATHWAYS; KINETICS; STATES	Background: In spite of our extensive knowledge of the more than 20 proteins associated with different amyloid diseases, we do not know how amyloid toxicity occurs or how to block its action. Recent contradictory reports suggest that the fibrils and/or the oligomer precursors cause toxicity. An estimate of their temporal concentration may broaden understanding of the amyloid aggregation process. Methodology/Principal Findings: Assuming that conversion of folded protein to fibril is initiated by a nucleation event, we back-calculate the distribution of nuclei concentration. The temporal in vitro concentration of nuclei for the model hormone, recombinant human insulin, is estimated to be in the picomolar range. This is a conservative estimate since the back-calculation method is likely to overestimate the nuclei concentration because it does not take into consideration fibril fragmentation, which would lower the amount of nuclei Conclusions: Because of their propensity to form aggregates (non-ordered) and fibrils (ordered), this very low concentration could explain the difficulty in isolating and blocking oligomers or nuclei toxicity and the long onset time for amyloid diseases.	[Sorci, Mirco] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Sorci, M (corresponding author), Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.	belfog@rpi.edu	Gehan, Timothy/U-6630-2018	Gehan, Timothy/0000-0003-0143-791X	NSF [CTS-94-00610]; DOE [DE-FE02-90ER14114, DE-FE02001ER46429]	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	This work was supported by NSF (CTS-94-00610) and DOE (DE-FE02-90ER14114 and DE-FE02001ER46429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; [Anonymous], 2001, NATURE STRUCTURAL BI, V8, P281; [Anonymous], GOODNESS FIT TESTS; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Heldt CL, 2011, PROTEINS, V79, P92, DOI 10.1002/prot.22861; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nayak A, 2009, PROTEINS, V74, P556, DOI 10.1002/prot.22169; Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Oosawa F., 1975, THERMODYNAMICS POLYM; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pease LF, 2010, BIOPHYS J, V99, P3979, DOI 10.1016/j.bpj.2010.10.010; Podesta A, 2006, BIOPHYS J, V90, P589, DOI 10.1529/biophysj.105.068833; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Sipe JD, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P1, DOI 10.1002/9783527619344; Sorci M, 2009, PROTEINS, V77, P62, DOI 10.1002/prot.22417; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; WAUGH DAVID F., 1957, J CELL AND COMP PHYSIOL, V49, P145, DOI 10.1002/jcp.1030490415; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20072	10.1371/journal.pone.0020072	http://dx.doi.org/10.1371/journal.pone.0020072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625464	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400038
J	Zhang, YZ; Handley, D; Kaplan, T; Yu, HY; Bais, AS; Richards, T; Pandit, KV; Zeng, QL; Benos, PV; Friedman, N; Eickelberg, O; Kaminski, N				Zhang, Yingze; Handley, Daniel; Kaplan, Tommy; Yu, Haiying; Bais, Abha S.; Richards, Thomas; Pandit, Kusum V.; Zeng, Qilu; Benos, Panayiotis V.; Friedman, Nir; Eickelberg, Oliver; Kaminski, Naftali			High Throughput Determination of TGF beta 1/SMAD3 Targets in A549 Lung Epithelial Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SURFACTANT PROTEIN-B; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR-I; GENE-EXPRESSION DATA; TGF-BETA; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; CONFERS RESISTANCE	Background: Transforming growth factor beta 1 (TGF beta 1) plays a major role in many lung diseases including lung cancer, pulmonary hypertension, and pulmonary fibrosis. TGF beta 1 activates a signal transduction cascade that results in the transcriptional regulation of genes in the nucleus, primarily through the DNA-binding transcription factor SMAD3. The objective of this study is to identify genome-wide scale map of SMAD3 binding targets and the molecular pathways and networks affected by the TGF beta 1/SMAD3 signaling in lung epithelial cells. Methodology: We combined chromatin immunoprecipitation with human promoter region microarrays (ChIP-on-chip) along with gene expression microarrays to study global transcriptional regulation of the TGF beta 1/SMAD3 pathway in human A549 alveolar epithelial cells. The molecular pathways and networks associated with TGF beta 1/SMAD3 signaling were identified using computational approaches. Validation of selected target gene expression and direct binding of SMAD3 to promoters were performed by quantitative real time RT-PCR and electrophoretic mobility shift assay on A549 and human primary lung epithelial cells. Results and Conclusions: Known TGF beta 1 target genes such as SERPINE1, SMAD6, SMAD7, TGFB1 and LTBP3, were found in both ChIP-on-chip and gene expression analyses as well as some previously unrecognized targets such as FOXA2. SMAD3 binding of FOXA2 promoter and changed expression were confirmed. Computational approaches combining ChIP-on-chip and gene expression microarray revealed multiple target molecular pathways affected by the TGF beta 1/SMAD3 signaling. Identification of global targets and molecular pathways and networks associated with TGF beta 1/SMAD3 signaling allow for a better understanding of the mechanisms that determine epithelial cell phenotypes in fibrogenesis and carcinogenesis as does the discovery of the direct effect of TGF beta 1 on FOXA2.	[Zhang, Yingze; Handley, Daniel; Richards, Thomas; Pandit, Kusum V.; Zeng, Qilu; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Richard P & Dorothy P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Kaplan, Tommy] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Sch Comp Sci & Engn, Jerusalem, Israel; [Yu, Haiying; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Asklepios Hosp Gauting, Munich, Germany; [Yu, Haiying; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Bais, Abha S.; Benos, Panayiotis V.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; Hebrew University of Jerusalem; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, YZ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Richard P & Dorothy P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.	zhangy@upmc.edu	Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012; Eickelberg, Oliver/A-5461-2013; Pandit, Kusum/E-7265-2018	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550; Eickelberg, Oliver/0000-0001-7170-0360; Kaminski, Naftali/0000-0001-5917-4601; Pandit, Kusum/0000-0001-7458-4705; Benos, Panayiotis/0000-0003-3172-3132	Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; National Institutes of Health [HL0894932, HL095397, LM009657]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008949, R01HL095397] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009657] Funding Source: NIH RePORTER	Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research and National Institutes of Health grants HL0894932, HL095397, and LM009657 (to Dr. Kaminski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Bonewald LF, 1999, CRIT REV EUKAR GENE, V9, P33, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.30; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Dave NB, 2005, METH MOLEC MED, V117, P333; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Ekins S, 2006, XENOBIOTICA, V36, P877, DOI 10.1080/00498250600861660; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; *GENEGO M, 2008, GENEGO IS LEAD PROV; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; *ING SYST, 2008, ING PATHW AN; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kaminski N, 2003, AM J RESP CELL MOL, V29, pS32; Khoor A, 2004, HUM PATHOL, V35, P560, DOI 10.1016/j.humpath.2004.01.017; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Latella G, 2009, LIVER INT, V29, P997, DOI 10.1111/j.1478-3231.2009.02011.x; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Maitra M, 2010, J BIOL CHEM, V285, P22103, DOI 10.1074/jbc.M110.121467; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; RAHMANN S, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1032; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; WINGENDER E, 2004, IN SILICO BIOL, V4, P55; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yoshimi T, 2005, EUR J CELL BIOL, V84, P555, DOI 10.1016/j.ejcb.2004.12.026; YU H, 2008, FASEB J; Yu HY, 2008, FASEB J, V22, P1778, DOI 10.1096/fj.07-083857; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; ZHONG Q, 2010, AM J RESP CELL MOL B; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	72	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20319	10.1371/journal.pone.0020319	http://dx.doi.org/10.1371/journal.pone.0020319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625455	Green Published, Green Accepted, gold			2022-12-27	WOS:000290793400056
J	Liu, PC; Wang, JX; Song, QS; Zhao, XF				Liu, Peng-Cheng; Wang, Jin-Xing; Song, Qi-Sheng; Zhao, Xiao-Fan			The Participation of Calponin in the Cross Talk between 20-Hydroxyecdysone and Juvenile Hormone Signaling Pathways by Phosphorylation Variation	PLOS ONE			English	Article							PROTEIN-KINASE-C; DROSOPHILA-MELANOGASTER; HELICOVERPA-ARMIGERA; ECDYSONE RECEPTOR; METHOPRENE-TOLERANT; BROAD-COMPLEX; INSECT DEVELOPMENT; VAV PROTOONCOGENE; NUCLEAR RECEPTOR; GENE-EXPRESSION	20-hydroxyecdysone (20E) and juvenile hormone (JH) signaling pathways interact to mediate insect development, but the mechanism of this interaction is poorly understood. Here, a calponin homologue domain (Chd) containing protein (HaCal) is reported to play a key role in the cross talk between 20E and JH signaling by varying its phosphorylation. Chd is known as an actin binding domain present in many proteins including some signaling proteins. Using an epidermal cell line (HaEpi), HaCal was found to be up-regulated by either 20E or the JH analog methoprene (JHA). 20E induced rapid phosphorylation of HaCal whereas no phosphorylation occurred with JHA. HaCal could be quickly translocated into the nuclei through 20E or JH signaling but interacted with USP1 only under the mediation of JHA. Knockdown of HaCal by RNAi blocked the 20E inducibility of USP1, PKC and HR3, and also blocked the JHA inducibility of USP1, PKC and JHi. After gene silencing of HaCal by ingestion of dsHaCal expressed by Escherichia coli, the larval development was arrested and the gene expression of USP1, PKC, HR3 and JHi were blocked. These composite data suggest that HaCal plays roles in hormonal signaling by quickly transferring into nucleus to function as a phosphorylated form in the 20E pathway and as a non-phosphorylated form interacting with USP1 in the JH pathway to facilitate 20E or JH signaling cascade, in short, by switching its phosphorylation status to regulate insect development.	[Liu, Peng-Cheng; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China; [Song, Qi-Sheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Shandong University; University of Missouri System; University of Missouri Columbia	Liu, PC (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021	Liu, Pengcheng/0000-0003-1179-2296; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [30710103901, 30970404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No: 30710103901 and 30970404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; Dekel I, 2000, FEBS LETT, V472, P99, DOI 10.1016/S0014-5793(00)01413-7; DIANA E, 2003, BIOESSAYS, V25, P994; DONG DJ, 2010, AMINO ACIDS; Dong DJ, 2012, AMINO ACIDS, V42, P1297, DOI 10.1007/s00726-010-0824-8; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Ferjani I, 2010, BBA-PROTEINS PROTEOM, V1804, P1760, DOI 10.1016/j.bbapap.2010.05.012; Fu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-600; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Henrich VC, 1999, VITAM HORM, V55, P73; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; Hou L, 2011, AMINO ACIDS, V40, P953, DOI 10.1007/s00726-010-0720-2; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KOELLE MR, 1992, P NATL ACAD SCI USA, V89, P6167, DOI 10.1073/pnas.89.13.6167; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; ORO AE, 1992, DEVELOPMENT, V115, P449; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Sasorith Souphatta, 2002, Journal of Insect Science (Tucson), V2, pUnpaginated; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Soin T, 2008, J INSECT PHYSIOL, V54, P429, DOI 10.1016/j.jinsphys.2007.11.001; Song Q, 2003, INSECT BIOCHEM MOLEC, V33, P1211, DOI 10.1016/j.ibmb.2003.06.005; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Sui YP, 2009, INSECT MOL BIOL, V18, P353, DOI 10.1111/j.1365-2583.2009.00879.x; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; WILLIAMS CM, 1961, TRENDS ENDOCRIN MET, V16, P6; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; XU Y, 2002, EUR J BIOCH; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhao XF, 2004, INSECT MOL BIOL, V13, P407, DOI 10.1111/j.0962-1075.2004.00499.x; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259	59	30	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19776	10.1371/journal.pone.0019776	http://dx.doi.org/10.1371/journal.pone.0019776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625546	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200021
J	Tayebi, M; Jones, DR; Taylor, WA; Stileman, BF; Chapman, C; Zhao, DM; David, M				Tayebi, Mourad; Jones, Daryl Rhys; Taylor, William Alexander; Stileman, Benjamin Frederick; Chapman, Charlotte; Zhao, Deming; David, Monique			PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; TRANSMISSIBLE MINK ENCEPHALOPATHY; MONOCLONAL-ANTIBODIES; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; COMMON MECHANISM; PROTEIN PRPSC; HUMAN PLASMA; CELL-LINES; IN-VIVO	The development of antibodies with binding capacity towards soluble oligomeric forms of PrPSc recognised in the aggregation process in early stage of the disease would be of paramount importance in diagnosing prion diseases before extensive neuropathology has ensued. As blood transfusion appears to be efficient in the transmission of the infectious prion agent, there is an urgent need to develop reagents that would specifically recognize oligomeric forms of the abnormally folded prion protein, PrPSc. To that end, we show that anti-PrP monoclonal antibodies (called PRIOC mAbs) derived from mice immunised with native PrP-coated microbeads are able to immunodetect oligomers/multimers of PrPSc. Oligomer-specific immunoreactivity displayed by these PRIOC mAbs was demonstrated as large aggregates of immunoreactive deposits in prion-permissive neuroblastoma cell lines but not in equivalent non-infected or prn-p(0/0) cell lines. In contrast, an anti-monomer PrP antibody displayed diffuse immunoreactivity restricted to the cell membrane. Furthermore, our PRIOC mAbs did not display any binding with monomeric recombinant and cellular prion proteins but strongly detected PrPSc oligomers as shown by a newly developed sensitive and specific ELISA. Finally, PrioC antibodies were also able to bind soluble oligomers formed of Ab and a-synuclein. These findings demonstrate the potential use of anti-prion antibodies that bind PrPSc oligomers, recognised in early stage of the disease, for the diagnosis of prion diseases in blood and other body fluids.	[Tayebi, Mourad; Jones, Daryl Rhys; Taylor, William Alexander; Stileman, Benjamin Frederick; Chapman, Charlotte; David, Monique] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim TSE Lab, Beijing 100094, Peoples R China	University of London; University of London Royal Veterinary College; China Agricultural University	Tayebi, M (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England.	mtayebi@rvc.ac.uk		TAYEBI, MOURAD/0000-0001-8664-6918	United Kingdom Royal Society; Royal Veterinary College	United Kingdom Royal Society(Royal Society of London); Royal Veterinary College	This work was supported by the United Kingdom Royal Society and The Royal Veterinary College Internal Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; CURIN S, 2004, J BIOL CHEM, V279, P3694; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Jones DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009804; Jones M, 2009, BRAIN PATHOL, V19, P293, DOI 10.1111/j.1750-3639.2008.00181.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kim JI, 2003, J NEUROIMMUNOL, V140, P137, DOI 10.1016/S0165-5728(03)00181-4; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nakamura N, 2003, HYBRIDOMA HYBRIDOM, V22, P263, DOI 10.1089/153685903322328992; Nishimura T, 2008, BIOCHEM BIOPH RES CO, V377, P1047, DOI 10.1016/j.bbrc.2008.10.087; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PORTER DD, 1973, J IMMUNOL, V111, P1407; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Rubenstein R, 1999, J NEUROVIROL, V5, P401, DOI 10.3109/13550289909029481; Soto C, 1999, J MOL MED-JMM, V77, P412, DOI 10.1007/s001090050371; SPINNER DS, J LEUKOC BIOL, V81, P1374; Tayebi M, 2004, MOL MED, V10, P104, DOI 10.2119/2004-00027.Tayebi; Tayebi M, 2009, J GEN VIROL, V90, P777, DOI 10.1099/vir.0.005041-0; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 1996, ARCH VIROL, V141, P763, DOI 10.1007/BF01718334; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19998	10.1371/journal.pone.0019998	http://dx.doi.org/10.1371/journal.pone.0019998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625515	Green Published, gold			2022-12-27	WOS:000290771200038
J	Bolbecker, AR; Hong, SL; Kent, JS; Klaunig, MJ; O'Donnell, BF; Hetrick, WP				Bolbecker, Amanda R.; Hong, S. Lee; Kent, Jerillyn S.; Klaunig, Mallory J.; O'Donnell, Brian F.; Hetrick, William P.			Postural Control in Bipolar Disorder: Increased Sway Area and Decreased Dynamical Complexity	PLOS ONE			English	Article							SOFT NEUROLOGICAL SIGNS; GRAY-MATTER LOSS; PARKINSONS-DISEASE; CHRONIC LITHIUM; HUNTINGTONS-DISEASE; CEREBELLAR VERMIS; EUTHYMIC PATIENTS; MOOD DISORDERS; FRONTAL-LOBE; MRI ANALYSIS	Structural, neurochemical, and functional abnormalities have been identified in the brains of individuals with bipolar disorder, including in key brain structures implicated in postural control, i.e. the cerebellum, brainstem, and basal ganglia. Given these findings, we tested the hypothesis that postural control deficits are present in individuals with bipolar disorder. Sixteen participants with bipolar disorder (BD) and 16 age-matched non-psychiatric healthy controls were asked to stand as still as possible on a force platform for 2 minutes under 4 conditions: (1) eyes open-open base; (2) eyes closed-open base; (3) eyes open-closed base; and (4) eyes closed-closed base. Postural sway data were submitted to conventional quantitative analyses of the magnitude of sway area using the center of pressure measurement. In addition, data were submitted to detrended fluctuation analysis, a nonlinear dynamical systems analytic technique that measures complexity of a time-series, on both the anterior-posterior and medio-lateral directions. The bipolar disorder group had increased sway area, indicative of reduced postural control. Decreased complexity in the medio-lateral direction was also observed for the bipolar disorder group, suggesting both a reduction in dynamic range available to them for postural control, and that their postural corrections were primarily dominated by longer time-scales. On both of these measures, significant interactions between diagnostic group and visual condition were also observed, suggesting that the BD participants were impaired in their ability to make corrections to their sway pattern when no visual information was available. Greater sway magnitude and reduced complexity suggest that individuals with bipolar disorder have deficits in sensorimotor integration and a reduced range of timescales available on which to make postural corrections.	[Bolbecker, Amanda R.; Kent, Jerillyn S.; O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bolbecker, Amanda R.; Klaunig, Mallory J.; O'Donnell, Brian F.; Hetrick, William P.] Larue D Carter Mem Hosp, Indianapolis, IN USA; [Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [O'Donnell, Brian F.; Hetrick, William P.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bolbecker, AR (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	whetrick@indiana.edu	Hong, S./B-2390-2008	Hong, S./0000-0001-6044-2482	National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute of Mental Health [R01 MH074983]; clinical research team at Larue D. Carter Memorial Hospital; Indiana University Neuroscience Clinical Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074983] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); clinical research team at Larue D. Carter Memorial Hospital; Indiana University Neuroscience Clinical Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a 2007 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant awarded to Amanda R. Bolbecker and National Institute of Mental Health grant R01 MH074983 to William P. Hetrick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jennifer Forsyth, Colleen Merrill, Ashley Steffen, and Sam Kaiser for their assistance in collecting postural sway data. We also thank the clinical research team at Larue D. Carter Memorial Hospital and the Indiana University Neuroscience Clinical Research Center for their support.	Adler CM, 2007, BIOL PSYCHIAT, V61, P776, DOI 10.1016/j.biopsych.2006.05.042; Baumann B, 1999, J AFFECT DISORDERS, V54, P217, DOI 10.1016/S0165-0327(98)00168-2; Bolbecker AR, 2009, BIPOLAR DISORD, V11, P19, DOI 10.1111/j.1399-5618.2008.00642.x; Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020; Brambilla P, 2001, PSYCHIAT RES-NEUROIM, V106, P65, DOI 10.1016/S0925-4927(01)00073-7; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cecil KM, 2003, J CHILD ADOL PSYCHOP, V13, P545, DOI 10.1089/104454603322724931; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chang TT, 2010, BIPOLAR DISORD, V12, P102, DOI 10.1111/j.1399-5618.2009.00771.x; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; CUTTING JC, 1976, PSYCHOL MED, V6, P635; DelBello MP, 1999, NEUROPSYCHOPHARMACOL, V21, P63, DOI 10.1016/S0893-133X(99)00026-3; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; First M.B., 2016, STRUCTURED CLIN INTE; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; Forssberg H, 1999, CURR OPIN NEUROBIOL, V9, P676, DOI 10.1016/S0959-4388(99)00037-9; Friedrich M, 2008, EXP BRAIN RES, V186, P305, DOI 10.1007/s00221-007-1233-4; Goswami U, 2006, BRIT J PSYCHIAT, V188, P366, DOI 10.1192/bjp.188.4.366; Goswami U, 2007, J AFFECT DISORDERS, V103, P99, DOI 10.1016/j.jad.2007.01.009; Green MJ, 2007, J AFFECT DISORDERS, V103, P29, DOI 10.1016/j.jad.2007.01.024; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guy W., 1976, ECDEU ASSESSMENT MAN; Hong SL, 2007, NEUROSCI LETT, V423, P104, DOI 10.1016/j.neulet.2007.06.043; Katz Donald B, 2002, Behav Cogn Neurosci Rev, V1, P229, DOI 10.1177/1534582302001003004; Keshavan MS, 1999, J PSYCHIATR RES, V33, P513, DOI 10.1016/S0022-3956(99)00033-3; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; LEINER HC, 1991, BEHAV BRAIN RES, V44, P113, DOI 10.1016/S0166-4328(05)80016-6; LIPPMANN S, 1982, AM J PSYCHIAT, V139, P667; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lohr JB, 2006, J NEUROPSYCH CLIN N, V18, P342, DOI 10.1176/appi.neuropsych.18.3.342; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Manji HK, 2000, J CLIN PSYCHIAT, V61, P82; Marvel CL, 2004, PSYCHIAT CLIN N AM, V27, P19, DOI 10.1016/S0193-953X(03)00106-0; MAYBERG HS, 1992, NEUROLOGY, V42, P1791, DOI 10.1212/WNL.42.9.1791; MENDEZ MF, 1994, INT J PSYCHIAT MED, V24, P189, DOI 10.2190/HU6W-3K7Q-NAEL-XU6K; Mills NP, 2005, AM J PSYCHIAT, V162, P1530, DOI 10.1176/appi.ajp.162.8.1530; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moorhead TWJ, 2007, BIOL PSYCHIAT, V62, P894, DOI 10.1016/j.biopsych.2007.03.005; NAKAGAWA H, 1993, ACTA OTO-LARYNGOL, P112; NASRALLAH HA, 1982, J CLIN PSYCHIAT, V43, P439; NASRALLAH HA, 1981, LANCET, V1, P1102; Negash A, 2004, J AFFECT DISORDERS, V80, P221, DOI 10.1016/S0165-0327(03)00116-2; Newell KM, 2002, AM J MENT RETARD, V107, P270, DOI 10.1352/0895-8017(2002)107<0270:OODACI>2.0.CO;2; NEWELL KM, 1998, DEGREES FREEDOM DEV; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Nonaka S, 1998, NEUROREPORT, V9, P2081, DOI 10.1097/00001756-199806220-00031; Ogendahl BK, 2006, PSYCHOL MED, V36, P1219, DOI 10.1017/S0033291706008269; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Ruocco HH, 2008, J NEUROL NEUROSUR PS, V79, P130, DOI 10.1136/jnnp.2007.116244; Sanches M, 2005, BIPOLAR DISORD, V7, P153, DOI 10.1111/j.1399-5618.2004.00178.x; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Tandberg E, 1996, ARCH NEUROL-CHICAGO, V53, P175, DOI 10.1001/archneur.1996.00550020087019; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; VANEMMERIK REA, 1993, MOVEMENT DISORD, V8, P305, DOI 10.1002/mds.870080309; Venault P, 2001, NEUROREPORT, V12, P3091, DOI 10.1097/00001756-200110080-00022; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Wei HF, 2000, EUR J PHARMACOL, V392, P117, DOI 10.1016/S0014-2999(00)00127-8; Williams LM, 2008, SCHIZOPHR RES, V99, P182, DOI 10.1016/j.schres.2007.10.019; Wiste AK, 2008, BIPOLAR DISORD, V10, P349, DOI 10.1111/j.1399-5618.2007.00528.x; Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; YADALAM KG, 1985, AM J PSYCHIAT, V142, P1067; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zheng J, 2009, J HUAZHONG U SCI-MED, V29, P725, DOI 10.1007/s11596-009-0610-6; Zimbelman JL, 2007, J INT NEUROPSYCH SOC, V13, P758, DOI 10.1017/S1355617707071214	80	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19824	10.1371/journal.pone.0019824	http://dx.doi.org/10.1371/journal.pone.0019824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611126	gold, Green Submitted, Green Published			2022-12-27	WOS:000290720200037
J	Carrier, DR				Carrier, David R.			The Advantage of Standing Up to Fight and the Evolution of Habitual Bipedalism in Hominins	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; REPRODUCTIVE SUCCESS; FUNCTIONAL-ANATOMY; NATIONAL-PARK; INTERGROUP AGGRESSION; PHYSICAL HEIGHT; PELVIC LIMB; CHIMPANZEES; BEHAVIOR; ORIGIN	Background: Many quadrupedal species stand bipedally on their hindlimbs to fight. This posture may provide a performance advantage by allowing the forelimbs to strike an opponent with the range of motion that is intrinsic to high-speed running, jumping, rapid braking and turning; the range of motion over which peak force and power can be produced. Methodology/Principal Findings: To test the hypothesis that bipedal (i.e., orthograde) posture provides a performance advantage when striking with the forelimbs, I measured the force and energy produced when human subjects struck from "quadrupedal' (i.e., pronograde) and bipedal postures. Downward and upward directed striking energy was measured with a custom designed pendulum transducer. Side and forward strikes were measured with a punching bag instrumented with an accelerometer. When subjects struck downward from a bipedal posture the work was 43.70 +/- 12.59% (mean +/- S. E.) greater than when they struck from a quadrupedal posture. Similarly, 47.49 +/- 17.95% more work was produced when subjects struck upward from a bipedal stance compared to a quadrupedal stance. Importantly, subjects did 229.69 +/- 44.19% more work in downward than upward directed strikes. During side and forward strikes the force impulses were 30.12 +/- 3.68 and 43.04 +/- 9.00% greater from a bipedal posture than a quadrupedal posture, respectively. Conclusions/Significance: These results indicate that bipedal posture does provide a performance advantage for striking with the forelimbs. The mating systems of great apes are characterized by intense male-male competition in which conflict is resolved through force or the threat of force. Great apes often fight from bipedal posture, striking with both the fore-and hindlimbs. These observations, plus the findings of this study, suggest that sexual selection contributed to the evolution of habitual bipedalism in hominins.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Carrier, DR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	carrier@biology.utah.edu			National Science Foundation [IOS-0817782]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from The National Science Foundation (IOS-0817782). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Brewer G, 2009, EVOL PSYCHOL-US, V7, P477; Buunk AP, 2008, EVOL HUM BEHAV, V29, P133, DOI 10.1016/j.evolhumbehav.2007.11.006; Carrier D, 2004, FROM BIPED TO STRIDER, P135; Carrier DR, 2008, J EXP BIOL, V211, P150, DOI 10.1242/jeb.010678; Carrier DR, 2007, EVOLUTION, V61, P596, DOI 10.1111/j.1558-5646.2007.00061.x; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; CASE A, 2006, NBER WORKING PAPER S, V1246; Chagnon N.A., 1979, EVOLUTIONARY BIOL HU, P86; Daly M, 2001, CAN J CRIMINOL, V43, P219; Darwin Charles, 1871, DESCENT MAN; DEWAAL F, 1982, CHIMPANZEE POLITICS; DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8; ENQUIST M, 1985, ANIM BEHAV, V33, P1152, DOI 10.1016/S0003-3472(85)80175-5; ETKIN W, 1954, AM NAT, V88, P129, DOI 10.1086/281823; FEINGOLD A, 1982, PSYCHOL REP, V50, P810, DOI 10.2466/pr0.1982.50.3.810; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; GALDIKAS BMF, 1985, FOLIA PRIMATOL, V45, P9, DOI 10.1159/000156188; Garner BA, 2003, ANN BIOMED ENG, V31, P207, DOI 10.1114/1.1540105; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; Goodall J., 1986, CHIMPANZEES GOMBE PA; Guthrie, 1970, EVOLUTIONARY BIOL, V4, P257; HARCOURT AH, 1978, Z TIERPSYCHOL, V48, P401; Hohmann G, 2003, BEHAVIOUR, V140, P1389, DOI 10.1163/156853903771980648; Hunt KD, 1996, S AFR J SCI, V92, P77; Iwamoto M., 1985, P251; JABLONSKI NG, 1993, J HUM EVOL, V24, P259, DOI 10.1006/jhev.1993.1021; JENKINS FA, 1979, J ZOOL, V188, P379; Johnson GR, 1996, J BIOMECH, V29, P1039, DOI 10.1016/0021-9290(95)00176-X; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Jurmain R, 1997, PRIMATES, V38, P1, DOI 10.1007/BF02385918; Kano T., 1992, LAST APE PYGMY CHIMP; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KORTLANDT A, 1963, P 16 INT C ZOOL, V3, P64; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; LIVINGSTONE FB, 1962, AM ANTHROPOL, V64, P301, DOI 10.1525/aa.1962.64.2.02a00050; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; LYNN M, 1984, PERS SOC PSYCHOL B, V10, P349, DOI 10.1177/0146167284103002; MANNING JT, 1995, ETHOL SOCIOBIOL, V16, P145, DOI 10.1016/0162-3095(94)00074-H; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; Mueller U, 2001, BEHAV ECOL SOCIOBIOL, V50, P302, DOI 10.1007/s002650100370; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; Nishida T., 1990, P63; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pawlowski B, 2002, EVOL HUM BEHAV, V23, P139, DOI 10.1016/S1090-5138(01)00092-7; Plavcan J. Michael, 1999, P241, DOI 10.1017/CBO9780511542466.012; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Plavcan JM, 2000, J HUM EVOL, V39, P327, DOI 10.1006/jhev.2000.0423; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; SHEPPERD JA, 1989, PERS SOC PSYCHOL B, V15, P617, DOI 10.1177/0146167289154014; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Szalai F, 2009, ANIM BEHAV, V78, P949, DOI 10.1016/j.anbehav.2009.06.025; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; THORNHILL R, 1983, ETHOL SOCIOBIOL, V4, P137, DOI 10.1016/0162-3095(83)90027-4; THORNHILL R, 2003, PSYCHOL EVOL GENDER, V4, P283; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Thorpe S.K.S., 2002, P231; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Walter M., 2004, Human Evolution, V19, P19, DOI 10.1007/BF02438907; Walther F.R., 1984, COMMUNICATION EXPRES; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; WESCOTT RW, 1967, MAN, V2, P630; WHEELER PE, 1984, J HUM EVOL, V13, P91, DOI 10.1016/S0047-2484(84)80079-2; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P491, DOI 10.1111/j.1469-7580.2007.00703.x; WILSON M, 1995, CAN J CRIMINOL, V37, P331; Wilson M, 1993, Violence Vict, V8, P271; Wilson M., 1998, THEORETICAL CRIMINOL, V2, P291, DOI DOI 10.1177/1362480698002003001; Witte TH, 2006, J EXP BIOL, V209, P4389, DOI 10.1242/jeb.02518; Wrangham Richard, 1996, DEMONIC MALES APES O; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; [No title captured]	86	45	45	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19630	10.1371/journal.pone.0019630	http://dx.doi.org/10.1371/journal.pone.0019630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21611167	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200021
J	Schmidt, FA; Goktas, O; Harms, L; Bohner, G; Erb, K; Dahlslett, B; Fleiner, F				Schmidt, Felix Alexander; Goktas, Onder; Harms, Lutz; Bohner, Georg; Erb, Katharina; Dahlslett, Bettina; Fleiner, Franca			Structural Correlates of Taste and Smell Loss in Encephalitis Disseminatae	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; ODOR IDENTIFICATION; DIAGNOSTIC-CRITERIA; TEMPORAL-LOBES; DYSFUNCTION; TESTS; DISCRIMINATION; SCHIZOPHRENIA	Background: Olfactory dysfunction in MS patients is reported in the literature. MRI of the olfactory bulb (OB) is discussed as a promising new testing method for measuring olfactory function (OF). Aim of this study was to explore reasons for and optimize the detection of olfactory dysfunction in MS patients with MRI. Materials and Methods: OB and olfactory brain volume was assessed within 34 MS patients by manual segmentation. Olfactory function was tested using the Threshold-Discrimination-Identification-Test (TDI), gustatory function was tested using Taste Strips (TST). Results: 41% of the MS patients displayed olfactory dysfunction (8% of the control group), 16% displayed gustatory dysfunction (5% of the control group). There was a correlation between the OB volume and the number and volume of MS lesions in the olfactory brain. Olfactory brain volume correlated with the volume of lesions in the olfactory brain and the EDSS score. The TST score correlated with the number and volume of lesions in the olfactory brain. Conclusion: The correlation between a higher number and volume of MS lesions with a decreased OB and olfactory brain volume could help to explain olfactory dysfunction.	[Schmidt, Felix Alexander; Goktas, Onder; Dahlslett, Bettina; Fleiner, Franca] Univ Berlin, Dept Otolaryngol Head & Neck Surg, Charite Campus Mitte, Smell & Taste Consultat Serv, Berlin, Germany; [Schmidt, Felix Alexander; Harms, Lutz] Univ Berlin, Dept Neurol, Charite Campus Mitte, Consultat Serv Multiple Sclerosis, Berlin, Germany; [Bohner, Georg; Erb, Katharina] Univ Berlin, Dept Radiol, Charite Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, FA (corresponding author), Univ Berlin, Dept Otolaryngol Head & Neck Surg, Charite Campus Mitte, Smell & Taste Consultat Serv, Berlin, Germany.	oender.goektas@charite.de		Bohner, Georg/0000-0002-1919-092X				Abolmaali N, 2009, LARYNGO RHINO OTOL, V88, P10, DOI 10.1055/s-2008-1077630; Abolmaali N, 2008, NEUROIMAG CLIN N AM, V18, P233, DOI 10.1016/j.nic.2007.10.002; BAUKNECHT, 2010, RO FO, V182, P163; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Doty RL, 1998, ANN NY ACAD SCI, V855, P781, DOI 10.1111/j.1749-6632.1998.tb10658.x; FOLEY FW, 1992, ARCH NEUROL-CHICAGO, V49, P238, DOI 10.1001/archneur.1992.00530270052018; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; Heilmann S, 2004, LARYNGO RHINO OTOL, V83, P729, DOI 10.1055/s-2004-825676; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; HUMMEL T, 2009, RIECH SCHMECKSTORUNG, P20; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Mueller C, 2003, RHINOLOGY, V41, P2; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Rombaux P, 2006, LARYNGOSCOPE, V116, P436, DOI 10.1097/01.MLG.0000195291.36641.1E; Rombaux P, 2009, RHINOLOGY, V47, P3; Thomann PA, 2009, NEUROBIOL AGING, V30, P838, DOI 10.1016/j.neurobiolaging.2007.08.001; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Wattendorf E, 2009, J NEUROSCI, V29, P15410, DOI 10.1523/JNEUROSCI.1909-09.2009; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Zorzon M, 2000, MULT SCLER J, V6, P386, DOI 10.1191/135245800701566368	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19702	10.1371/journal.pone.0019702	http://dx.doi.org/10.1371/journal.pone.0019702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611177	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500014
J	Grosberg, LE; Radosevich, AJ; Asfaha, S; Wang, TC; Hillman, EMC				Grosberg, Lauren E.; Radosevich, Andrew J.; Asfaha, Samuel; Wang, Timothy C.; Hillman, Elizabeth M. C.			Spectral Characterization and Unmixing of Intrinsic Contrast in Intact Normal and Diseased Gastric Tissues Using Hyperspectral Two-Photon Microscopy	PLOS ONE			English	Article							IN-VIVO; FLUORESCENCE SPECTROSCOPY; MULTIPHOTON MICROSCOPY; EXTRACELLULAR-MATRIX; HUMAN SKIN; CANCER; RESOLUTION; NAD(P)H; SYSTEM	Background: Living tissues contain a range of intrinsic fluorophores and sources of second harmonic generation which provide contrast that can be exploited for fresh tissue imaging. Microscopic imaging of fresh tissue samples can circumvent the cost and time associated with conventional histology. Further, intrinsic contrast can provide rich information about a tissue's composition, structure and function, and opens the potential for in-vivo imaging without the need for contrast agents. Methodology/Principal Findings: In this study, we used hyperspectral two-photon microscopy to explore the characteristics of both normal and diseased gastrointestinal (GI) tissues, relying only on their endogenous fluorescence and second harmonic generation to provide contrast. We obtained hyperspectral data at subcellular resolution by acquiring images over a range of two-photon excitation wavelengths, and found excitation spectral signatures of specific tissue types based on our ability to clearly visualize morphology. We present the two-photon excitation spectral properties of four major tissue types that are present throughout the GI tract: epithelium, lamina propria, collagen, and lymphatic tissue. Using these four excitation signatures as basis spectra, linear unmixing strategies were applied to hyperspectral data sets of both normal and neoplastic tissue acquired in the colon and small intestine. Our results show that hyperspectral unmixing with excitation spectra allows segmentation, showing promise for blind identification of tissue types within a field of view, analogous to specific staining in conventional histology. The intrinsic spectral signatures of these tissue types provide information relating to their biochemical composition. Conclusions/Significance: These results suggest hyperspectral two-photon microscopy could provide an alternative to conventional histology either for in-situ imaging, or intraoperative 'instant histology' of fresh tissue biopsies.	[Grosberg, Lauren E.; Radosevich, Andrew J.; Hillman, Elizabeth M. C.] Columbia Univ, Lab Funct Opt Imaging, Dept Biomed Engn, New York, NY 10027 USA; [Grosberg, Lauren E.; Radosevich, Andrew J.; Hillman, Elizabeth M. C.] Columbia Univ, Lab Funct Opt Imaging, Dept Radiol, New York, NY USA; [Asfaha, Samuel; Wang, Timothy C.] Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY USA	Columbia University; Columbia University; Columbia University	Grosberg, LE (corresponding author), Columbia Univ, Lab Funct Opt Imaging, Dept Biomed Engn, New York, NY 10027 USA.	leg2137@columbia.edu	Asfaha, Samuel/I-8245-2015; Hillman, Elizabeth M C/B-9854-2009	Asfaha, Samuel/0000-0001-6972-0338; Wang, Timothy/0000-0001-5730-3019; Hillman, Elizabeth M. C./0000-0001-5511-1451	National Institutes of Health [R21NS053684, R01NS063226, U54CA126513]; National Science Foundation [0954796]; Human Frontier Science Program; Wallace H. Coulter Foundation; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063226, R21NS053684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); Wallace H. Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (R21NS053684, R01NS063226, and U54CA126513), the National Science Foundation (0954796), the Human Frontier Science Program and the Wallace H. Coulter Foundation. L. Grosberg receives National Science Foundation graduate fellowship funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohorfoush AG, 1996, ENDOSCOPY, V28, P372, DOI 10.1055/s-2007-1005484; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Chen J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/289; COTHREN RM, 1990, GASTROINTEST ENDOSC, V36, P105, DOI 10.1016/S0016-5107(90)70961-3; Dela Cruz JM, 2010, BIOMED OPT EXPRESS, V1, P1320, DOI 10.1364/BOE.1.001320; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Georgakoudi I, 2002, CANCER RES, V62, P682; Grosberg LE, 2009, ADV OPTICS BIOTECHNO; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Laiho LH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891370; LIOTTA LA, 1985, ANN NY ACAD SCI, V460, P333, DOI 10.1111/j.1749-6632.1985.tb51180.x; Liu JTC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363363; McCaslin AFH, 2010, J CEREB BLOOD FLOW M; Molitoris BA, 2005, AM J PHYSIOL-RENAL, V288, pF1084, DOI 10.1152/ajprenal.00473.2004; Mukherjee S, 2009, P SOC PHOTO OPT INST, V7161; OHTSUKA A, 1992, CELL TISSUE RES, V269, P403, DOI 10.1007/BF00353895; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Paoli J, 2008, J INVEST DERMATOL, V128, P1248, DOI 10.1038/sj.jid.5701139; Pavlova I, 2010, PROC SPIE, V7569, DOI 10.1117/12.841017; Radosevich AJ, 2008, OPT LETT, V33, P2164, DOI 10.1364/OL.33.002164; Ramanujam N, 2000, NEOPLASIA, V2, P89, DOI 10.1038/sj.neo.7900077; Rogart JN, 2008, CLIN GASTROENTEROL H, V6, P95, DOI 10.1016/j.cgh.2007.10.008; Ross M. H., 2006, HISTOLOGY TEXT ATLAS; SAYER P, 1974, BIOCHEM MED METAB B, V10, P24, DOI 10.1016/0006-2944(74)90005-2; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Tang S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127203; Wallace MB, 2010, GASTROENTEROLOGY, V138, P2140, DOI 10.1053/j.gastro.2009.12.067; Williams RM, 2010, TRANSL ONCOL, V3, P181, DOI 10.1593/tlo.09310; Wu YC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2362741; Wu YC, 2009, OPT EXPRESS, V17, P7907, DOI 10.1364/OE.17.007907; Zakaryan A, 2001, INT IMMUNOL, V13, P1141, DOI 10.1093/intimm/13.9.1141; Zhao YB, 2010, BIOMED OPT EXPRESS, V1, P1159, DOI 10.1364/BOE.1.001159; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	37	34	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19925	10.1371/journal.pone.0019925	http://dx.doi.org/10.1371/journal.pone.0019925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603623	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300039
J	Hlavova, M; Cizkova, M; Vitova, M; Bisova, K; Zachleder, V				Hlavova, Monika; Cizkova, Maria; Vitova, Milada; Bisova, Katerina; Zachleder, Vilem			DNA Damage during G2 Phase Does Not Affect Cell Cycle Progression of the Green Alga Scenedesmus quadricauda	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; P53-DEPENDENT G(1) ARREST; HISTONE H1 KINASE; FISSION YEAST; CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; MIDBLASTULA TRANSITION; REPRODUCTIVE EVENTS; IONIZING-RADIATION; DIVISION PROCESSES	DNA damage is a threat to genomic integrity in all living organisms. Plants and green algae are particularly susceptible to DNA damage especially that caused by UV light, due to their light dependency for photosynthesis. For survival of a plant, and other eukaryotic cells, it is essential for an organism to continuously check the integrity of its genetic material and, when damaged, to repair it immediately. Cells therefore utilize a DNA damage response pathway that is responsible for sensing, reacting to and repairing damaged DNA. We have studied the effect of 5-fluorodeoxyuridine, zeocin, caffeine and combinations of these on the cell cycle of the green alga Scenedesmus quadricauda. The cells delayed S phase and underwent a permanent G2 phase block if DNA metabolism was affected prior to S phase; the G2 phase block imposed by zeocin was partially abolished by caffeine. No cell cycle block was observed if the treatment with zeocin occurred in G2 phase and the cells divided normally. CDKA and CDKB kinases regulate mitosis in S. quadricauda; their kinase activities were inhibited by Wee1. CDKA, CDKB protein levels were stabilized in the presence of zeocin. In contrast, the protein level of Wee1 was unaffected by DNA perturbing treatments. Wee1 therefore does not appear to be involved in the DNA damage response in S. quadricauda. Our results imply a specific reaction to DNA damage in S. quadricauda, with no cell cycle arrest, after experiencing DNA damage during G2 phase.	[Hlavova, Monika; Cizkova, Maria; Vitova, Milada; Bisova, Katerina; Zachleder, Vilem] ASCR, Inst Microbiol, Lab Cell Cycles Algae, Trebon, Czech Republic; [Hlavova, Monika] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Hlavova, M (corresponding author), ASCR, Inst Microbiol, Lab Cell Cycles Algae, Trebon, Czech Republic.	bisova@alga.cz	Hlavova, Monika/J-9800-2014; Bišová, Kateřina/H-2625-2014; Vítová, Milada/H-3953-2014; Cizkova, Maria/T-9121-2018	Bišová, Kateřina/0000-0003-1997-0894; Vítová, Milada/0000-0002-0552-3295; Cizkova, Maria/0000-0002-2328-8583	Grant Agency of the Academy of Sciences of the Czech Republic [A500200614, M200200904]; Grant Agency of the Czech Republic [204/09/0111, 525/09/0102]; Academy of Sciences of the Czech Republic [AV0Z50200510]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was financially supported by the Grant Agency of the Academy of Sciences of the Czech Republic (grant numbers A500200614, M200200904); the Grant Agency of the Czech Republic (grant numbers 204/09/0111, and 525/09/0102), and the Institutional Research Concept (number AV0Z50200510) funded by the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; Bennett RAO, 1996, INT J RADIAT BIOL, V70, P623; Bisova K, 2000, PLANT PHYSIOL BIOCH, V38, P755, DOI 10.1016/S0981-9428(00)01179-7; Bisova K, 2003, FOLIA MICROBIOL, V48, P805, DOI 10.1007/BF02931518; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Calonge TM, 2008, DNA REPAIR, V7, P136, DOI 10.1016/j.dnarep.2007.07.017; Chankova SG, 2007, RADIAT ENVIRON BIOPH, V46, P409, DOI 10.1007/s00411-007-0123-2; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; DECALLONNE JR, 1976, ANAL BIOCHEM, V74, P448, DOI 10.1016/0003-2697(76)90225-6; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; EHRENFELD GM, 1987, BIOCHEMISTRY-US, V26, P931, DOI 10.1021/bi00377a038; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; GATIGNOL A, 1988, FEBS LETT, V230, P17; Hanawalt PC, 1996, ENVIRON HEALTH PERSP, V104, P547, DOI 10.2307/3432821; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Howard A, 1953, HEREDITY           S, V6, P261; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Janke R, 2010, NUCLEIC ACIDS RES, V38, P2302, DOI 10.1093/nar/gkp1222; JOHN PCL, 1984, MICROBIOL SCI, V1, P96; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KOSTRUB CF, 1997, MOL GEN GENET, V254, P38999; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU CC, 1982, P NATL ACAD SCI-BIOL, V79, P2942, DOI 10.1073/pnas.79.9.2942; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee MW, 2007, YEAST, V24, P145, DOI 10.1002/yea.1446; Lukavsky J., 1973, ARCH HYDROBIOL SUPPL, V9, P416; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pelayo HR, 2001, PLANTA, V212, P444, DOI 10.1007/s004250000415; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; PICKETTHEAPS JD, 1975, J PHYCOL, V11, P186, DOI 10.1111/j.0022-3646.1975.00186.x; Poon RYC, 1997, CANCER RES, V57, P5168; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Rohr J, 2004, PLANT J, V40, P611, DOI 10.1111/j.1365-313X.2004.02227.x; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sarkaria JN, 1999, CANCER RES, V59, P4375; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SETLIK I, 1972, Algological Studies, V7, P172; Setlik I., 1984, MICROBIAL CELL CYCLE, P253; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Siede W, 1996, GENETICS, V142, P91; Slaninova M, 2003, DNA REPAIR, V2, P737, DOI 10.1016/S1568-7864(03)00047-8; Tao Y, 2010, CHEMOSPHERE, V78, P541, DOI 10.1016/j.chemosphere.2009.11.016; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vitova M, 2005, FOLIA MICROBIOL, V50, P333, DOI 10.1007/BF02931414; Vitova M, 2005, FOLIA MICROBIOL, V50, P141, DOI 10.1007/BF02931463; Vitova M, 2008, PLANT CELL PHYSIOL, V49, P1805, DOI 10.1093/pcp/pcn162; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; WANKA F, 1962, PLANTA, V58, P594, DOI 10.1007/BF01914751; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1993, GENETICS, V134, P63; Weingartner M, 2003, J CELL SCI, V116, P487, DOI 10.1242/jcs.00250; WOOLLARD A, 1995, BIOESSAYS, V17, P481, DOI 10.1002/bies.950170604; ZACHLEDER, 1990, J CELL SCI, V97, P631; ZACHLEDER, 1988, J CELL SCI, V91, P531; ZACHLEDER V, 1982, BIOL PLANTARUM, V24, P341, DOI 10.1007/BF02909100; ZACHLEDER V, 1994, J PHYCOL, V30, P274, DOI 10.1111/j.0022-3646.1994.00274.x; Zachleder V, 2002, EUR J PHYCOL, V37, P361, DOI 10.1017/S0967026202003815; Zachleder V, 1997, J PHYCOL, V33, P673, DOI 10.1111/j.0022-3646.1997.00673.x; Zachleder V, 1996, PROTOPLASMA, V192, P228, DOI 10.1007/BF01273894; ZACHLEDER V, 1989, PROTOPLASMA, V150, P160, DOI 10.1007/BF01403672; ZACHLEDER V, 1995, J PHYCOL, V30, P941; Zachleder V., 1984, ARCH HYDROBIOL SUPPL, V67, P313, DOI [10.1127/algol_stud/67/1984/313, DOI 10.1127/ALGOL_STUD/67/1984/313]; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	88	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19626	10.1371/journal.pone.0019626	http://dx.doi.org/10.1371/journal.pone.0019626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603605	Green Submitted, Green Published, gold			2022-12-27	WOS:000290656300015
J	Khan, SH; Arnott, JA; Kumar, R				Khan, Shagufta H.; Arnott, John A.; Kumar, Raj			Naturally Occurring Osmolyte, Trehalose Induces Functional Conformation in an Intrinsically Disordered Activation Domain of Glucocorticoid Receptor	PLOS ONE			English	Article							IN-VITRO; PROTEINS	Intrinsically disordered (ID) regions are frequently found in the activation domains of many transcription factors including nuclear hormone receptors. It is believed that these ID regions promote molecular recognition by creating large surfaces suitable for interactions with their specific protein binding partners, which is a critical component of gene regulation by transcription factors. It has been hypothesized that conditional folding of these activation domains may be a prerequisite for their efficient interaction with specific coregulatory proteins, and subsequent transcriptional activity leading to the regulation of target gene(s). In this study, we tested whether a naturally occurring osmolyte, trehalose can promote functionally ordered conformation in glucocorticoid receptor's major activation function domain, AF1, which is found to exist as an ID protein, and requires an efficient interaction with coregulatory proteins for optimal activity. Our data show that trehalose induces an ordered conformation in AF1 such that its interaction with steroid receptor coactivator-1 (SRC-1), a critical coregulator of glucocorticoid receptor's activity, is greatly enhanced.	[Khan, Shagufta H.; Arnott, John A.; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Khan, SH (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	rkumar@tcmedc.org			National Institutes of Health [RO1DK058829, 1R03AR057193-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants, RO1DK058829 (RK) and 1R03AR057193-01 (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19689	10.1371/journal.pone.0019689	http://dx.doi.org/10.1371/journal.pone.0019689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603604	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300018
J	Brandt, R; Navas, CA				Brandt, Renata; Navas, Carlos A.			Life-History Evolution on Tropidurinae Lizards: Influence of Lineage, Body Size and Climate	PLOS ONE			English	Article							RELATIVE CLUTCH MASS; LOWLAND RAIN-FOREST; PHYLOGENETIC SIGNAL; EGG SIZE; LOCOMOTOR PERFORMANCE; REPRODUCTIVE ECOLOGY; SOUTHEASTERN BRAZIL; IGUANID LIZARDS; EASTERN BRAZIL; SQUAMATA	The study of life history variation is central to the evolutionary theory. In many ectothermic lineages, including lizards, life history traits are plastic and relate to several sources of variation including body size, which is both a factor and a life history trait likely to modulate reproductive parameters. Larger species within a lineage, for example tend to be more fecund and have larger clutch size, but clutch size may also be influenced by climate, independently of body size. Thus, the study of climatic effects on lizard fecundity is mandatory on the current scenario of global climatic change. We asked how body and clutch size have responded to climate through time in a group of tropical lizards, the Tropidurinae, and how these two variables relate to each other. We used both traditional and phylogenetic comparative methods. Body and clutch size are variable within Tropidurinae, and both traits are influenced by phylogenetic position. Across the lineage, species which evolved larger size produce more eggs and neither trait is influenced by temperature components. A climatic component of precipitation, however, relates to larger female body size, and therefore seems to exert an indirect relationship on clutch size. This effect of precipitation on body size is likely a correlate of primary production. A decrease in fecundity is expected for Tropidurinae species on continental landmasses, which are predicted to undergo a decrease in summer rainfall.	[Brandt, Renata; Navas, Carlos A.] Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo	Brandt, R (corresponding author), Univ Sao Paulo, Dept Fisiol, Inst Biociencias, Sao Paulo, Brazil.	rbrandt@ib.usp.br	Navas, Carlos/B-2138-2013; Brandt, Renata/H-4112-2013	Navas, Carlos/0000-0002-9859-0568; Brandt, Renata/0000-0002-8725-2360	FAPESP [03/13235-4, 2003/01577-8, 2008/57687-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	R. B. was supported by a doctoral fellowship of FAPESP (03/13235-4). C.A.N. was funded by FAPESP (2003/01577-8 and 2008/57687-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton KG, 2004, J EVOLUTION BIOL, V17, P1157, DOI 10.1111/j.1420-9101.2004.00764.x; BARBAULT R, 1975, B SOC ZOOL FR, V100, P153; Bauwens D, 1997, AM NAT, V149, P91, DOI 10.1086/285980; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bock BC, 2009, REV BIOL TROP, V57, P1253; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; Cruz FB, 1998, HERPETOL J, V8, P107; Cruz FB, 1997, STUD NEOTROP FAUNA E, V32, P28, DOI 10.1076/snfe.32.1.28.13465; Cruz FB, 1997, J HERPETOL, V31, P444, DOI 10.2307/1565679; Du WG, 2005, BIOL LETTERS, V1, P98, DOI 10.1098/rsbl.2004.0268; Dunham A.E., 1988, Biology of Reptilia, V16, P441; Dunham A. E., 1981, MISC PUBL MUS ZOOL, V158, P1; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Ellinger N, 2001, J HERPETOL, V35, P395, DOI 10.2307/1565957; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitch H. S., 1985, U KANSAS MUS NAT HIS, V76, P1; Fitch H. S., 1970, U KANSAS MUS NAT HIS, V52, P1; FITCH HS, 1982, OCCAS PAPERS MUS NAT, V96, P1; FROST D R, 1992, American Museum Novitates, P1; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Galdino CAB, 2003, J HERPETOL, V37, P687, DOI 10.1670/114-02A; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grizante MB, 2010, J EVOLUTION BIOL, V23, P98, DOI 10.1111/j.1420-9101.2009.01868.x; Harvey MB, 2000, ZOOL J LINN SOC-LOND, V128, P189; Heins DC, 2004, ECOL FRESHW FISH, V13, P258, DOI 10.1111/j.1600-0633.2004.00064.x; HOWLAND JM, 1990, CAN J ZOOL, V68, P1366, DOI 10.1139/z90-204; IPCC, 2007, CONTR WORK GROUP 1 2; JAMES C, 1988, OECOLOGIA, V75, P307, DOI 10.1007/BF00378615; Kiefer MC, 2008, CAN J ZOOL, V86, P1376, DOI 10.1139/Z08-106; Kohlsdorf T, 2008, J EVOLUTION BIOL, V21, P781, DOI 10.1111/j.1420-9101.2008.01516.x; Kohlsdorf T, 2006, EVOL ECOL, V20, P549, DOI 10.1007/s10682-006-9116-x; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison W.P., MESQUITE MODULAR SYS; MARENGO JA, 2010, NOVA ACTA LEOPOLDINA, V112, P1; Martori Ricardo, 1994, Amphibia-Reptilia, V15, P317, DOI 10.1163/156853894X00092; Midford PE, 2010, PDAP PACKAGE MESQUIT; Miles DB, 2000, EVOLUTION, V54, P1386; MILES DB, 1992, AM NAT, V139, P848, DOI 10.1086/285361; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; POPP J L, 1983, Primates, V24, P198, DOI 10.1007/BF02381082; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RAND AS, 1982, HERPETOLOGICA, V38, P171; Rochet MJ, 2000, ICES J MAR SCI, V57, P228, DOI 10.1006/jmsc.2000.0641; Shine R, 2003, OECOLOGIA, V136, P450, DOI 10.1007/s00442-003-1281-9; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Taylor HL, 2003, SOUTHWEST NAT, V48, P680, DOI 10.1894/0038-4909(2003)048<0680:PPARRO>2.0.CO;2; TINKLE DW, 1970, EVOLUTION, V24, P55, DOI 10.1111/j.1558-5646.1970.tb01740.x; Van Sluys M, 2002, HERPETOL J, V12, P89; Van Sluys M, 2010, AMPHIBIA-REPTILIA, V31, P117, DOI 10.1163/156853810790457920; VANSLUYS M, 1993, J HERPETOL, V27, P28; Vitt L.J., 1992, P135; VITT LJ, 1982, HERPETOLOGICA, V38, P237; VITT LJ, 1981, AM NAT, V117, P506, DOI 10.1086/283731; Vitt LJ, 1996, HERPETOLOGICA, V52, P121; VITT LJ, 1991, CAN J ZOOL, V69, P504, DOI 10.1139/z91-077; Vitt LJ, 1997, CAN J ZOOL, V75, P1876, DOI 10.1139/z97-817; VITT LJ, 1978, AM NAT, V112, P595, DOI 10.1086/283300; VITT LJ, 1993, CAN J ZOOL, V71, P2370, DOI 10.1139/z93-333; VITT LJ, 1983, COPEIA, P131; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wiederhecker HC, 2002, J HERPETOL, V36, P82, DOI 10.1670/0022-1511(2002)036[0082:REOTTS]2.0.CO;2; Yom-Tov Y, 2006, OECOLOGIA, V148, P213, DOI 10.1007/s00442-006-0364-9; YOMTOV Y, 1986, BIOL J LINN SOC, V29, P245, DOI 10.1111/j.1095-8312.1986.tb00278.x	72	36	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20040	10.1371/journal.pone.0020040	http://dx.doi.org/10.1371/journal.pone.0020040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603641	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500042
J	Rudick, RA; Rani, MRS; Xu, YM; Lee, JC; Na, J; Shrock, J; Josyula, A; Fisher, E; Ransohoff, RM				Rudick, Richard A.; Rani, M. R. Sandhya; Xu, Yaomin; Lee, Jar-Chi; Na, Jie; Shrock, Jennifer; Josyula, Anupama; Fisher, Elizabeth; Ransohoff, Richard M.			Excessive Biologic Response to IFN beta Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA; NEUTRALIZING ANTIBODIES; I INTERFERON; THERAPY; MARKER; GAMMA; IDENTIFICATION; EXACERBATIONS; IFN-BETA-1A; EXPRESSION	Background: Interferon-beta (IFN beta) is used to inhibit disease activity in multiple sclerosis (MS), but its mechanisms of action are incompletely understood, individual treatment response varies, and biological markers predicting response to treatment have yet to be identified. Methods: The relationship between the molecular response to IFN beta and treatment response was determined in 85 patients using a longitudinal design in which treatment effect was categorized by brain magnetic resonance imaging as good (n = 70) or poor response (n = 15). Molecular response was quantified using a customized cDNA macroarray assay for 166 IFN-regulated genes (IRGs). Results: The molecular response to IFNb differed significantly between patients in the pattern and number of regulated genes. The molecular response was strikingly stable for individuals for as long as 24 months, however, suggesting an individual 'IFN response fingerprint'. Unexpectedly, patients with poor response showed an exaggerated molecular response. IRG induction ratios demonstrated an exaggerated molecular response at both the first and 6-month IFN beta injections. Conclusion: MS patients exhibit individually unique but temporally stable biological responses to IFN beta. Poor treatment response is not explained by the duration of biological effects or the specific genes induced. Rather, individuals with poor treatment response have a generally exaggerated biological response to type 1 IFN injections. We hypothesize that the molecular response to type 1 IFN identifies a pathogenetically distinct subset of MS patients whose disease is driven in part by innate immunity. The findings suggest a strategy for biologically based, rational use of IFN beta for individual MS patients.	[Rudick, Richard A.; Ransohoff, Richard M.] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA; [Rani, M. R. Sandhya; Shrock, Jennifer; Josyula, Anupama; Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Fisher, Elizabeth] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rudick, RA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA.	rudickr@ccf.org			National Institutes of Health [P50NS38667, UL1 RR024989]; NIH-NINDS [P50 NS 38667, 4 P01NS38667]; Biogen Idec; Novartis; Teva; Millennium; Genzyme-Bayer; Wyeth; Bayhill; Pfizer; Merck Serono; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biogen Idec(Biogen); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Millennium(Takeda Pharmaceutical Company Ltd); Genzyme-Bayer; Wyeth(Wyeth); Bayhill; Pfizer(Pfizer); Merck Serono(Merck & Company); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the National Institutes of Health (P50NS38667 and UL1 RR024989). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Without charge, Biogen Idec tested serum from the study subjects for neutralizing antibodies at 6 months and provided the data to the investigators. Biogen Idec had no role in study design, data analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and wish to declare the following conflicts: All authors received support (paid to institution) for this project via NIH-NINDS grant P50 NS 38667 (2004-2009), Project 4 P01NS38667. [Rudick Richard] RMR was PI for the P50 and PO1; RAR was director for Project 4. RAR: Consulting fees or honoraria: Biogen Idec, Novartis, Teva [Rudick, Richard], Millennium [Rudick, Richard], Genzyme-Bayer [Rudick, Richard],; Wyeth, Bayhill [Rudick, Richard], Pfizer Royalties: Informa Healthcare Travel expenses paid: Novartis [Rudick, Richard], Millenium [Rudick, Richard], Genzyme-Bayer [Rudick, Richard], Merck Serono [Rudick, Richard], Wyeth [Rudick, Richard], Pfizer. RMR: Consultancies (within 12 mos): Abbott, Biogen, Johnson & Johnson, Merck, Novartis, Pfizer, Teva Paid lectures (not speakers bureaus): Biogen Idec, grand rounds only, not promotional Grants/grants pending (paid to institution): NIH; NMSS; Biogen Idec; Chemocentryx EF: Consultancies: Biogen Idec, Genzyme, Millenium, Pfizer, Wyeth Grants/grants pending (paid to institution): Biogen, Genzyme, Millenium, Wyeth; NIH-NINDS. Honoraria: Biogen, Teva Travel expenses: Biogen, Genzyme, Millenium, Wyeth, Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bertolotto A, 2008, NEUROL SCI, V29, pS216, DOI 10.1007/s10072-008-0941-2; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Buttmann M, 2007, J NEUROIMMUNOL, V190, P170, DOI 10.1016/j.jneuroim.2007.08.009; Carrieri PB, 2008, IMMUNOPHARM IMMUNOT, V30, P1, DOI 10.1080/08923970802302753; Cohen JA, 2008, MULT SCLER, V14, P370, DOI 10.1177/1352458507083189; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Drulovic J, 2009, J NEUROIMMUNOL, V215, P90, DOI 10.1016/j.jneuroim.2009.07.010; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Durelli L, 2008, J NEUROL NEUROSUR PS, V79, P646, DOI 10.1136/jnnp.2007.130229; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Gandhi KS, 2008, J INTERF CYTOK RES, V28, P529, DOI 10.1089/jir.2008.0007; Garcia-Merino A, 2009, CLIN IMMUNOL, V132, P195, DOI 10.1016/j.clim.2009.04.006; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kantor AB, 2007, J NEUROIMMUNOL, V188, P103, DOI 10.1016/j.jneuroim.2007.05.009; Kauffman MA, 2009, INT J CLIN PHARM TH, V47, P328; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Naundorf S, 2009, EUR J IMMUNOL, V39, P1066, DOI 10.1002/eji.200838773; PANITCH HS, 1987, LANCET, V1, P893; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Prosperini L, 2009, EUR J NEUROL, V16, P1202, DOI 10.1111/j.1468-1331.2009.02708.x; Prync AES, 2008, INT J CLIN PHARM TH, V46, P64; Rani MRS, 2009, ANN NY ACAD SCI, V1182, P58, DOI 10.1111/j.1749-6632.2009.05068.x; Reder AT, 2008, J INTERF CYTOK RES, V28, P317, DOI 10.1089/jir.2007.0131; Rio J, 2008, MULT SCLER J, V14, P479, DOI 10.1177/1352458507085555; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Rudick RA, 1999, J NEUROIMMUNOL, V93, P8, DOI 10.1016/S0165-5728(98)00174-X; Rudick RA, 2002, MULT SCLER, V8, P359, DOI 10.1191/1352458502ms845oa; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sbardella E, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-54; Schlaak JF, 2002, J BIOL CHEM, V277, P49428, DOI 10.1074/jbc.M205571200; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Sturzebecher S, 1999, J INTERF CYTOK RES, V19, P1257, DOI 10.1089/107999099312920; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wandinger KP, 2001, ANN NEUROL, V50, P349, DOI 10.1002/ana.1096; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Wiesemann E, 2008, CLIN IMMUNOL, V128, P306, DOI 10.1016/j.clim.2008.04.007; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	49	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19262	10.1371/journal.pone.0019262	http://dx.doi.org/10.1371/journal.pone.0019262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602934	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500005
J	Seligman, BJ; Cullen, MR; Horwitz, RI				Seligman, Benjamin J.; Cullen, Mark R.; Horwitz, Ralph I.			Aging, Transition, and Estimating the Global Burden of Disease	PLOS ONE			English	Article								Background: The World Health Organization's Global Burden of Disease (GBD) reports are an important tool for global health policy makers, however the accuracy of estimates for countries undergoing an epidemiologic transition is unclear. We attempted to validate the life table model used to generate estimates for all-cause mortality in developing countries. Methods and Results: Data were obtained for males and females from the Human Mortality Database for all countries with available data every ten years from 1900 to 2000. These provided inputs for the GBD life table model and served as comparison observed data. Above age sixty model estimates of survival for both sexes differed substantially from those observed. Prior to the year 1960 for males and 1930 for females, estimated survival tended to be greater than observed; following 1960 for both males and females estimated survival tended to be less than observed. Viewing observed and estimated survival separately, observed survival past sixty increased over the years considered. For males, the increase was from a mean (sd) probability of 0.22 (0.06) to 0.46 (0.1). For females, the increase was from 0.26 (0.06) to 0.65 (0.08). By contrast, estimated survival past sixty decreased over the same period. Among males, estimated survival probability declined from 0.54 (0.2) to 0.09 (0.06). Among females, the decline was from 0.36 (0.12) to 0.15 (0.08). Conclusions: These results show that the GBD mortality model did not accurately estimate survival at older ages as developed countries transitioned in the twentieth century and may be similarly flawed in developing countries now undergoing transition. Estimates of the size of older-age populations and their attributable disease burden should be reconsidered.	[Seligman, Benjamin J.; Cullen, Mark R.] Stanford Univ Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Horwitz, Ralph I.] GlaxoSmithKline, Philadelphia, PA USA	Stanford University; GlaxoSmithKline	Seligman, BJ (corresponding author), Stanford Univ Sch Med, Dept Med, Palo Alto, CA 94304 USA.	bensel1@stanford.edu		cullen, mark/0000-0001-7996-1864; Seligman, Benjamin/0000-0002-8223-5924	Stanford Medical Scholars Program; Stanford NIH/NCCR [TLI RR025742]	Stanford Medical Scholars Program; Stanford NIH/NCCR(Swiss National Science Foundation (SNSF))	This publication was supported by the Stanford Medical Scholars Program and by the Stanford NIH/NCCR CTSA grant number TLI RR025742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], HUM MORT DAT; [Anonymous], PLOS MED; [Anonymous], POPULATION STUDIES; [Anonymous], GLOBAL BURDEN DIS RI; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; R Core Team, 2018, R LANG ENV STAT COMP; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; World Health Organization, 2008, The global burden of disease: 2004 update	10	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20264	10.1371/journal.pone.0020264	http://dx.doi.org/10.1371/journal.pone.0020264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629652	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800039
J	Duan, YK; Zhu, Z; Cai, K; Tan, XM; Lu, XF				Duan, Yangkai; Zhu, Zhi; Cai, Ke; Tan, Xiaoming; Lu, Xuefeng			De novo Biosynthesis of Biodiesel by Escherichia coli in Optimized Fed-Batch Cultivation	PLOS ONE			English	Article							BIOMASS; OVERPRODUCTION; BIOFUELS; ALKANES	Biodiesel is a renewable alternative to petroleum diesel fuel that can contribute to carbon dioxide emission reduction and energy supply. Biodiesel is composed of fatty acid alkyl esters, including fatty acid methyl esters (FAMEs) and fatty acid ethyl esters (FAEEs), and is currently produced through the transesterification reaction of methanol (or ethanol) and triacylglycerols (TAGs). TAGs are mainly obtained from oilseed plants and microalgae. A sustainable supply of TAGs is a major bottleneck for current biodiesel production. Here we report the de novo biosynthesis of FAEEs from glucose, which can be derived from lignocellulosic biomass, in genetically engineered Escherichia coli by introduction of the ethanol-producing pathway from Zymomonas mobilis, genetic manipulation to increase the pool of fatty acyl-CoA, and heterologous expression of acyl-coenzyme A: diacylglycerol acyltransferase from Acinetobacter baylyi. An optimized fed-batch microbial fermentation of the modified E. coli strain yielded a titer of 922 mg L(-1) FAEEs that consisted primarily of ethyl palmitate, -oleate, -myristate and -palmitoleate.	[Duan, Yangkai; Zhu, Zhi; Cai, Ke; Tan, Xiaoming; Lu, Xuefeng] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Duan, YK (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China.	lvxf@qibebt.ac.cn	zheng, yonghong/H-3700-2012; Duan, Yangkai/C-4166-2018; Tan, Xiaoming/E-6571-2013	Duan, Yangkai/0000-0002-0995-333X; Tan, Xiaoming/0000-0002-7375-3674	Chinese Academy of Sciences foundation [O91001110A]	Chinese Academy of Sciences foundation	This study was supported by the "100-Talent Program of the Chinese Academy of Sciences" foundation (Grant O91001110A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	14	50	66	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20265	10.1371/journal.pone.0020265	http://dx.doi.org/10.1371/journal.pone.0020265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629774	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200044
J	Yu, H; He, YH; Zhang, X; Peng, ZH; Yang, YT; Zhu, R; Bai, JY; Tian, Y; Li, XH; Chen, WS; Fang, DC; Wang, RQ				Yu, Hao; He, Yonghong; Zhang, Xin; Peng, Zhihong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Tian, Yin; Li, Xiaohuan; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan			The Rat IgGFc gamma BP and Muc2 C-Terminal Domains and TFF3 in Two Intestinal Mucus Layers Bind Together by Covalent Interaction	PLOS ONE			English	Article							DIMER FORMATION; PROTEIN; BARRIER; THICKNESS; CLEAVAGE; COLITIS; CELLS; COLON	Background: The secreted proteins from goblet cells compose the intestinal mucus. The aims of this study were to determine how they exist in two intestinal mucus layers. Methodology/Principal Findings: The intestinal mucosa was fixed with Carnoy solution and immunostained. Mucus from the loose layer, the firm layer was gently suctioned or scraped, respectively, lysed in SDS sample buffer with or without DTT, then subjected to the western blotting of rTFF3, rIgGFc gamma BP or rMuc2. The non-reduced or reduced soluble mucus samples in RIPA buffer were co-immunoprecipitated to investigate their possible interactions. Polyclonal antibodies for rTFF3, the rIgGFc gamma BP C-terminal domain and the rMuc2 C-terminal domain confirmed their localization in the mucus layer and in the mucus collected from the rat intestinal loose layer or firm layer in both western blot and immunoprecipitation experiments. A complex of rTFF3, which was approximately 250 kDa, and a monomer of 6 kDa were present in both layers of the intestinal mucus; rIgGFc gamma BP was present in the complex (250-280 kDa) under non-reducing conditions, but shifted to 164 kDa under reducing conditions in both of the layers. rMuc2 was found mainly in a complex of 214-270 kDa under non-reducing conditions, but it shifted to 140 kDa under reducing conditions. The co-immunoprecipitation experiments showed that binding occurs among rTFF3, rIgGFc gamma BP and rMuc2 in the RIPA buffer soluble intestinal mucus. Blocking the covalent interaction by 100 mM DTT in the RIPA buffer soluble intestinal mucus disassociated their binding. Conclusions/Significance: Rat goblet cell-secreted TFF3, IgGFc gamma BP and Muc2, existing in the two intestinal mucus layers, are bound together by covalent interactions in the soluble fraction of intestinal mucus and form heteropolymers to be one of the biochemical mechanisms of composing the net-like structure of mucus.	[Yu, Hao; He, Yonghong; Zhang, Xin; Peng, Zhihong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Tian, Yin; Li, Xiaohuan; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University	Yu, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	rongquanw@hotmail.com		Wang, Rongquan/0000-0001-5307-0086	NSFC; Natural Science Foundation of CQ CSTC [2008BA5034]	NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by a NSFC grant (Y.H.) and the Natural Science Foundation Project of CQ CSTC 2008BA5034 (R. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bell SL, 1998, EUR J BIOCHEM, V253, P123, DOI 10.1046/j.1432-1327.1998.2530123.x; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Feng ZM, 2007, DIGEST DIS SCI, V52, P2104, DOI 10.1007/s10620-006-9711-2; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gindzienski A, 2003, J Physiol Pharmacol, V54 Suppl 3, P127; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hoffmann W, 2009, J MED CHEM, V52, P6505, DOI 10.1021/jm9008136; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Khatri IA, 1998, BIOCHEM J, V331, P323, DOI 10.1042/bj3310323; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Kobayashi K, 2001, IMMUNOL LETT, V79, P229, DOI 10.1016/S0165-2478(01)00288-7; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; MCCORMICK DA, 1990, J CLIN PATHOL, V43, P143, DOI 10.1136/jcp.43.2.143; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P963, DOI 10.1002/ibd.20163; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Xu GQ, 2000, EUR J BIOCHEM, V267, P2998, DOI 10.1046/j.1432-1327.2000.01319.x; XU GQ, 1992, J BIOL CHEM, V267, P5401	31	24	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20334	10.1371/journal.pone.0020334	http://dx.doi.org/10.1371/journal.pone.0020334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629776	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005200055
J	Ohashi, E; Tanabe, K; Henmi, Y; Mesaki, K; Kobayashi, Y; Takei, K				Ohashi, Emiko; Tanabe, Kenji; Henmi, Yuji; Mesaki, Kumi; Kobayashi, Yuka; Takei, Kohji			Receptor Sorting within Endosomal Trafficking Pathway Is Facilitated by Dynamic Actin Filaments	PLOS ONE			English	Article							ENDOCYTIC RECYCLING COMPARTMENT; PLASMA-MEMBRANE; IN-VIVO; F-ACTIN; PROTEIN; TRANSPORT; MYOSIN; CLATHRIN; POLYMERIZATION; LYSOSOMES	Early endosomes (EEs) are known to be a sorting station for internalized molecules destined for degradation, recycling, or other intracellular organelles. Segregation is an essential step in such sorting, but the molecular mechanism of this process remains to be elucidated. Here, we show that actin is required for efficient recycling and endosomal maturation by producing a motile force. Perturbation of actin dynamics by drugs induced a few enlarged EEs containing several degradative vacuoles and also interfered with their transporting ability. Actin repolymerization induced by washout of the drug caused the vacuoles to dissociate and individually translocate toward the perinuclear region. We further elucidated that cortactin, an actin-nucleating factor, was required for transporting contents from within EEs. Actin filaments regulated by cortactin may provide a motile force for efficient sorting within early endosomes. These data suggest that actin filaments coordinate with microtubules to mediate segregation in EEs.	[Ohashi, Emiko; Tanabe, Kenji; Henmi, Yuji; Mesaki, Kumi; Kobayashi, Yuka; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Okayama, Japan	Okayama University	Ohashi, E (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Okayama, Japan.	kt0911@gmail.com	TANABE, Kenji/B-2319-2011	Tanabe, Kenji/0000-0003-2645-9429; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Science, Sports, Culture and Technology of Japan [23113721, 15079206]; Okayama Medical Foundation; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okayama Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan, (23113721) http://kaken.nii.ac.jp/en/p/23113721, (15079206) http://kaken.nii.ac.jp/en/p/15079206; and by the Okayama Medical Foundation, http://omf.umin.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Semenova I, 2008, CURR BIOL, V18, P1581, DOI 10.1016/j.cub.2008.08.070; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Shinozaki-Narikawa N, 2006, TRAFFIC, V7, P1539, DOI 10.1111/j.1600-0854.2006.00480.x; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	49	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19942	10.1371/journal.pone.0019942	http://dx.doi.org/10.1371/journal.pone.0019942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625493	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400021
J	Teismann, IK; Warnecke, T; Suntrup, S; Steinstrater, O; Kronenberg, L; Ringelstein, EB; Dengler, R; Petri, S; Pantev, C; Dziewas, R				Teismann, Inga K.; Warnecke, Tobias; Suntrup, Sonja; Steinstraeter, Olaf; Kronenberg, Linda; Ringelstein, E. Bernd; Dengler, Reinhard; Petri, Susanne; Pantev, Christo; Dziewas, Rainer			Cortical Processing of Swallowing in ALS Patients with Progressive Dysphagia - A Magnetoencephalographic Study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR CORTEX; CEREBRAL-CORTEX; REORGANIZATION; COMPENSATION; STIMULATION; ACTIVATION; POWER; MRI; PET	Amyotrophic lateral sclerosis (ALS) is a rare disease causing degeneration of the upper and lower motor neuron. Involvement of the bulbar motor neurons often results in fast progressive dysphagia. While cortical compensation of dysphagia has been previously shown in stroke patients, this topic has not been addressed in patients suffering from ALS. In the present study, we investigated cortical activation during deglutition in two groups of ALS patients with either moderate or severe dysphagia. Whole-head MEG was employed on fourteen patients with sporadic ALS using a self-paced swallowing paradigm. Data were analyzed by means of time-frequency analysis and synthetic aperture magnetometry (SAM). Group analysis of individual SAM data was performed using a permutation test. We found a reduction of cortical swallowing related activation in ALS patients compared to healthy controls. Additionally a disease-related shift of hemispheric lateralization was observed. While healthy subjects showed bilateral cortical activation, the right sensorimotor cortex was predominantly involved in ALS patients. Both effects were even stronger in the group of patients with severe dysphagia. Our results suggest that bilateral degeneration of the upper motor neuron in the primary motor areas also impairs further adjusted motor areas, which leads to a strong reduction of 'swallowing related' cortical activation. While both hemispheres are affected by the degeneration a relatively stronger activation is seen in the right hemisphere. This right hemispheric lateralization of volitional swallowing observed in this study may be the only sign of cortical plasticity in dysphagic ALS patients. It may demonstrate compensational mechanisms in the right hemisphere which is known to predominantly coordinate the pharyngeal phase of deglutition. These results add new aspects to our understanding of the pathophysiology of dysphagia in ALS patients and beyond. The compensational mechanisms observed could be relevant for future research in swallowing therapies.	[Teismann, Inga K.; Warnecke, Tobias; Suntrup, Sonja; Ringelstein, E. Bernd; Dziewas, Rainer] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Teismann, Inga K.; Suntrup, Sonja; Steinstraeter, Olaf; Kronenberg, Linda; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany	University of Munster; University of Munster; Hannover Medical School	Teismann, IK (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	i.teismann@uni-muenster.de	Dziewas, Rainer/AAX-9505-2020; Petri, Susanne/AID-7665-2022	Dziewas, Rainer/0000-0003-1592-8461; 	DFG [PA-392/9-2]	DFG(German Research Foundation (DFG))	This study was supported by DFG (PA-392/9-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 1996, NEUROL CLIN, V14, P399, DOI 10.1016/S0733-8619(05)70264-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Butman JA, 2007, AM J NEURORADIOL, V28, P87; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Daniels S K, 1996, J Stroke Cerebrovasc Dis, V6, P30, DOI 10.1016/S1052-3057(96)80023-1; Daniels SK, 2006, DYSPHAGIA, V21, P21, DOI 10.1007/s00455-005-9007-2; Dziewas R, 2003, NEUROIMAGE, V20, P135, DOI 10.1016/S1053-8119(03)00285-4; Dziewas R, 2007, DYSPHAGIA, V22, P63, DOI 10.1007/s00455-006-9032-9; Dziewas R, 2009, HUM BRAIN MAPP, V30, P1352, DOI 10.1002/hbm.20603; Ertekin C, 2000, BRAIN, V123, P125, DOI 10.1093/brain/123.1.125; Furlong PL, 2004, NEUROIMAGE, V22, P1447, DOI 10.1016/j.neuroimage.2004.02.041; Hamalainen Matti S., 1992, Brain Topography, V5, P95, DOI 10.1007/BF01129036; Hamdy S, 1999, J NEUROPHYSIOL, V81, P1917, DOI 10.1152/jn.1999.81.4.1917; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Higo R, 2004, AURIS NASUS LARYNX, V31, P247, DOI 10.1016/j.anl.2004.05.009; Hillel A, 1999, NEUROLOGY, V53, pS22; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Hughes TAT, 1996, QJM-MON J ASSOC PHYS, V89, P109; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; KEW JJM, 1994, NEUROLOGY, V44, P1101, DOI 10.1212/WNL.44.6.1101; Konrad C, 2006, EXP BRAIN RES, V172, P361, DOI 10.1007/s00221-006-0352-7; Konrad C, 2002, EXP BRAIN RES, V143, P51, DOI 10.1007/s00221-001-0981-9; Kuipers-Upmeijer J, 2001, J NEUROL NEUROSUR PS, V71, P615, DOI 10.1136/jnnp.71.5.615; LANGMORE SE, 1991, ANN OTO RHINOL LARYN, V100, P678; Le Forestier N, 2001, J NEUROL SCI, V185, P95, DOI 10.1016/S0022-510X(01)00469-5; Leder SB, 2004, DYSPHAGIA, V19, P177, DOI 10.1007/s00455-004-0009-2; Li SS, 2009, AMYOTROPH LATERAL SC, V10, P280, DOI 10.3109/17482960902893342; LUIS MLS, 1990, J NEUROL, V237, P471; Mohammadi B, 2009, J NEUROL, V256, P1263, DOI 10.1007/s00415-009-5112-8; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Robbins J, 1988, Dysphagia, V3, P11, DOI 10.1007/BF02406275; ROBBINS JA, 1993, ARCH PHYS MED REHAB, V74, P1295, DOI 10.1016/0003-9993(93)90082-L; ROBINSON S, 1999, SENDAI RECENT ADV BI, P232; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Smith CD, 2002, NEUROLOGY, V58, P647, DOI 10.1212/WNL.58.4.647; Steinstraeter O, 2009, EXP BRAIN RES, V193, P387, DOI 10.1007/s00221-008-1634-z; Tanaka M, 2003, NEUROL RES, V25, P351, DOI 10.1179/016164103101201670; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Teismann IK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-62; Teismann IK, 2010, NEUROBIOL AGING, V31, P1044, DOI 10.1016/j.neurobiolaging.2008.07.001; Teismann IK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-71; Teismann IK, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-13; Teismann IK, 2009, HUM BRAIN MAPP, V30, P92, DOI 10.1002/hbm.20488; Vaiman M, 2004, OTOLARYNG HEAD NECK, V131, P548, DOI 10.1016/j.otohns.2004.03.013; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; YETKIN FZ, 1995, AM J NEURORADIOL, V16, P1087	51	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19987	10.1371/journal.pone.0019987	http://dx.doi.org/10.1371/journal.pone.0019987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625445	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400028
J	Weber, E; Gruetzner, R; Werner, S; Engler, C; Marillonnet, S				Weber, Ernst; Gruetzner, Ramona; Werner, Stefan; Engler, Carola; Marillonnet, Sylvestre			Assembly of Designer TAL Effectors by Golden Gate Cloning	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; III EFFECTORS; ONE-POT; GENE; RECOGNITION; EXPRESSION; NUCLEASES; PATHOGEN; AVRBS3	Generation of customized DNA binding domains targeting unique sequences in complex genomes is crucial for many biotechnological applications. The recently described DNA binding domain of the transcription activator-like effectors (TALEs) from Xanthomonas consists of a series of repeats arranged in tandem, each repeat binding a nucleotide of the target sequence. We present here a strategy for engineering of TALE proteins with novel DNA binding specificities based on the 17.5 repeat-containing AvrBs3 TALE as a scaffold. For each of the 17 full repeats, four module types were generated, each with a distinct base preference. Using this set of 68 repeat modules, recognition domains for any 17 nucleotide DNA target sequence of choice can be constructed by assembling selected modules in a defined linear order. Assembly is performed in two successive one-pot cloning steps using the Golden Gate cloning method that allows seamless fusion of multiple DNA fragments. Applying this strategy, we assembled designer TALEs with new target specificities and tested their function in vivo.	[Weber, Ernst; Gruetzner, Ramona; Werner, Stefan; Engler, Carola; Marillonnet, Sylvestre] Icon Genet GmbH, Halle, Saale, Germany	ICON plc	Weber, E (corresponding author), Icon Genet GmbH, Halle, Saale, Germany.	marillonnet@icongenetics.de		Werner, Stefan/0000-0002-4932-1441	Icon Gentics GmbH	Icon Gentics GmbH	This work was funded by Icon Gentics GmbH. As all authors are employed by the funder, the funder played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; FELENBOK B, 1991, J BIOTECHNOL, V17, P11, DOI 10.1016/0168-1656(91)90023-O; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LI T, 2010, NUCL ACIDS RES; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; MILLER JC, 2010, NAT BIOTECHNOL; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WEBER E, 2011, PLOS ONE; ZHANG F, 2011, NAT BIOTECHNOL	24	146	241	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19722	10.1371/journal.pone.0019722	http://dx.doi.org/10.1371/journal.pone.0019722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625552	Green Submitted, Green Published, gold			2022-12-27	WOS:000290771200018
J	Ingels, J; Tchesunov, AV; Vanreusel, A				Ingels, Jeroen; Tchesunov, Alexei V.; Vanreusel, Ann			Meiofauna in the Gollum Channels and the Whittard Canyon, Celtic Margin-How Local Environmental Conditions Shape Nematode Structure and Function	PLOS ONE			English	Article							NEAR-BOTTOM FLOW; DEEP-SEA; CONTINENTAL-SLOPE; METAZOAN MEIOFAUNA; SPECIES-DIVERSITY; MARINE NEMATODES; SHELF BREAK; ASTOMONEMA-SOUTHWARDORUM; SEDIMENT TRANSPORT; PORCUPINE-SEABIGHT	The Gollum Channels and Whittard Canyon (NE Atlantic) are two areas that receive high input of organic matter and phytodetritus from euphotic layers, but they are typified by different trophic and hydrodynamic conditions. Sediment biogeochemistry was analysed in conjunction with structure and diversity of the nematode community and differences were tested between study areas, water depths (700 m vs 1000 m), stations, and sediment layers. The Gollum Channels and Whittard Canyon harboured high meiofauna abundances (1054-1426 ind. 10 cm(-2)) and high nematode diversity (total of 181 genera). Next to enhanced meiofauna abundance and nematode biomass, there were signs of high levels of organic matter deposition leading to reduced sedimentary conditions, which in turn structured the nematode community. Striking in this respect was the presence of large numbers of 'chemosynthetic' Astomonema nematodes (Astomonema southwardorum, Order Monhysterida, Family Siphonolaimidae). This genus lacks a mouth, buccal cavity and pharynx and possesses a rudimentary gut containing internal, symbiotic prokaryotes which have been recognised as sulphur-oxidising bacteria. Dominance of Astomonema may indicate the presence of reduced environments in the study areas, which is partially confirmed by the local biogeochemical environment. The nematode communities were mostly affected by sediment layer differences and concomitant trophic conditions rather than other spatial gradients related to study area, water depth or station differences, pointing to small-scale heterogeneity as the main source of variation in nematode structure and function. Furthermore, the positive relation between nematode standing stocks, and quantity and quality of the organic matter was stronger when hydrodynamic disturbance was greater. Analogically, this study also suggests that structural diversity can be positively correlated with trophic conditions and that this relation is tighter when hydrodynamic disturbance is greater.	[Ingels, Jeroen; Vanreusel, Ann] Univ Ghent, Dept Marine Biol, B-9000 Ghent, Belgium; [Tchesunov, Alexei V.] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Fac Biol, Moscow, Russia	Ghent University; Lomonosov Moscow State University	Ingels, J (corresponding author), Univ Ghent, Dept Marine Biol, B-9000 Ghent, Belgium.	jeroen.ingels@ugent.be	Ingels, Jeroen/A-1691-2008	Ingels, Jeroen/0000-0001-8342-2222; Tchesunov, Alexei/0000-0003-2365-910X	European Commission [GOCE511234, 2263541]; Russian Fund for Basic Research [09-04-01212]	European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the European Commission's Sixth Framework Programme HERMES project (http://www.eu-hermes.net, EC contract GOCE511234) and the European Commission's Seventh Framework Programme HERMIONE project (http://www.eu-hermione.net, grant agreement number 2263541). Participation of AVT in this research was supported by the Russian Fund for Basic Research (grant number 09-04-01212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero A, 2003, CONT SHELF RES, V23, P79, DOI 10.1016/S0278-4343(02)00168-1; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; AUSTEN MC, 1993, J MAR BIOL ASSOC UK, V73, P627, DOI 10.1017/S0025315400033166; Bianchelli S, 2008, CHEM ECOL, V24, P101, DOI 10.1080/02757540801963386; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cunningham MJ, 2005, SEDIMENT GEOL, V179, P99, DOI 10.1016/j.sedgeo.2005.04.014; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Deprez T, 2005, NEMYS WORLD WIDE WEB; Duineveld G, 2001, OCEANOL ACTA, V24, P69, DOI 10.1016/S0399-1784(00)01129-4; Duros P, 2011, DEEP-SEA RES PT I, V58, P128, DOI 10.1016/j.dsr.2010.11.008; Gage J.D., 1992, DEEP SEA BIOL NATURA; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Garcia R, 2007, MAR ECOL PROG SER, V340, P207, DOI 10.3354/meps340207; GIERE O, 1995, J MAR BIOL ASSOC UK, V75, P153, DOI 10.1017/S0025315400015265; Gorley C.K., 2006, GETTING STARTED PRIM; HEIP C, 1990, NETH J SEA RES, V26, P333, DOI 10.1016/0077-7579(90)90095-X; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip Carlo H. R., 1998, Oceanis, V24, P61; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Hill AE, 1998, J MAR RES, V56, P87, DOI 10.1357/002224098321836127; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hope WD, 1977, Mikrofauna Meeresbodens, VNo. 61, P307; HOSTE E, 2006, TEMPORAL SPATIAL VAR; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUSTON MA, 1994, BIOLOGICAL DIVERSITY; INGELS J, DEEP SEA 2 IN PRESS; Ingels J., 2006, HERMES RV BELGICA 20; Ingels J, 2009, DEEP-SEA RES PT I, V56, P1521, DOI 10.1016/j.dsr.2009.04.010; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Joint I, 2001, DEEP-SEA RES PT II, V48, P3049, DOI 10.1016/S0967-0645(01)00032-7; Jorissen FJ, 1995, MAR MICROPALEONTOL, V26, P3, DOI 10.1016/0377-8398(95)00047-X; KENYON NH, 1978, OCEANOL ACTA, V1, P369; KENYON NH, 1987, MAR GEOL, V74, P57, DOI 10.1016/0025-3227(87)90005-3; Kito K, 2006, ZOOTAXA, P39; Lampitt RS, 1997, DEEP-SEA RES PT I, V44, P1377, DOI 10.1016/S0967-0637(97)00020-4; Lampitt RS, 1995, DEEP-SEA RES PT I, V42, P1865, DOI 10.1016/0967-0637(95)00084-4; Lee HJ, 2001, POLAR BIOL, V24, P926; Levin LA, 2003, ECOSY WORLD, V28, P111; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MCLAREN P, 1985, J SEDIMENT PETROL, V55, P457; Mokievskii VO, 2007, OCEANOLOGY+, V47, P797, DOI 10.1134/S0001437007060057; Musat N, 2007, ENVIRON MICROBIOL, V9, P1345, DOI 10.1111/j.1462-2920.2006.01232.x; Oliveira A, 2007, MAR GEOL, V246, P105, DOI 10.1016/j.margeo.2007.04.017; Ott J, 2004, SYMBIOSIS, V36, P103; Pfannkuche O, 2000, DEEP-SEA RES PT II, V47, P2805, DOI 10.1016/S0967-0645(00)00050-3; PFANNKUCHE O, 1985, OCEANOL ACTA, V8, P343; PINGREE RD, 1989, PROG OCEANOGR, V23, P303, DOI 10.1016/0079-6611(89)90003-7; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; REID GS, 1990, MAR GEOL, V92, P69, DOI 10.1016/0025-3227(90)90027-H; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schmidt S, 2001, MAR GEOL, V173, P55, DOI 10.1016/S0025-3227(00)00163-8; Schratzberger M, 1998, MAR BIOL, V130, P643, DOI 10.1007/s002270050286; Schratzberger M, 2009, MAR BIOL, V156, P709, DOI 10.1007/s00227-008-1122-9; SHERMAN KM, 1981, AM ZOOL, V21, P1035; Smith C. R., 2010, P ROYAL SOC B; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Soltwedel T, 2003, VIE MILIEU, V53, P1; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Thiel H, 1983, DEEP SEA BIOL, P167; Thiel H., 1978, UPWELLING ECOSYSTEMS, p124?138; Thistle D, 1998, DEEP-SEA RES PT I, V45, P625, DOI 10.1016/S0967-0637(97)00101-5; Thistle D, 1998, DEEP-SEA RES PT II, V45, P13, DOI 10.1016/S0967-0645(97)00044-1; Thistle D, 1999, DEEP-SEA RES PT I, V46, P2041, DOI 10.1016/S0967-0637(99)00040-0; Thomsen L, 2002, PROG OCEANOGR, V52, P315, DOI 10.1016/S0079-6611(02)00013-7; Tyler P, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.05; Van Rooij D., 2004, INTEGRATED STUDY QUA; Vanaverbeke J, 1997, J SEA RES, V38, P93, DOI 10.1016/S1385-1101(97)00038-5; VANREUSEL A, 1995, INT REV GES HYDROBIO, V80, P313, DOI 10.1002/iroh.19950800218; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; VIDAKOVIC J, 1987, CAH BIOL MAR, V28, P111; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9; Vincx M., 1996, METHODS EXAMINATION, P214; Warwick R.M., 1998, FREE LIVING MARINE N; WHITE M, 2008, HERMES DELIVERABLE 1; White M, 2006, HERMES DELIVERABLE 4; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327	87	62	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20094	10.1371/journal.pone.0020094	http://dx.doi.org/10.1371/journal.pone.0020094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21629829	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200062
J	Hu, JH; Xie, F; Li, C; Jiang, JP				Hu, Junhua; Xie, Feng; Li, Cheng; Jiang, Jianping			Elevational Patterns of Species Richness, Range and Body Size for Spiny Frogs	PLOS ONE			English	Article							SMALL MAMMAL DIVERSITY; TRIBE PAINI AMPHIBIA; BERGMANNS RULE; RAPOPORTS RULE; SUBGENUS-PAA; GENUS-RANA; PHYLOGENETIC-RELATIONSHIPS; LATITUDINAL GRADIENTS; HENGDUAN MOUNTAINS; ENDEMIC RICHNESS	Quantifying spatial patterns of species richness is a core problem in biodiversity theory. Spiny frogs of the subfamily Painae (Anura: Dicroglossidae) are widespread, but endemic to Asia. Using spiny frog distribution and body size data, and a digital elevation model data set we explored altitudinal patterns of spiny frog richness and quantified the effect of area on the richness pattern over a large altitudinal gradient from 0-5000 m a.s.l. We also tested two hypotheses: (i) the Rapoport's altitudinal effect is valid for the Painae, and (ii) Bergmann's clines are present in spiny frogs. The species richness of Painae across four different altitudinal band widths (100 m, 200 m, 300 m and 400 m) all showed hump-shaped patterns along altitudinal gradient. The altitudinal changes in species richness of the Paini and Quasipaini tribes further confirmed this finding, while the peak of Quasipaini species richness occurred at lower elevations than the maxima of Paini. The area did not explain a significant amount of variation in total, nor Paini species richness, but it did explain variation in Quasipaini. Five distinct groups across altitudinal gradient were found. Species altitudinal ranges did not expand with an increase in the midpoints of altitudinal ranges. A significant negative correlation between body size and elevation was exhibited. Our findings demonstrate that Rapoport's altitudinal rule is not a compulsory attribute of spiny frogs and also suggest that Bergmann's rule is not generally applicable to amphibians. The study highlights a need to explore the underlying mechanisms of species richness patterns, particularly for amphibians in macroecology.	[Hu, Junhua; Xie, Feng; Li, Cheng; Jiang, Jianping] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Hu, JH (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	jiangjp@cib.ac.cn	hu, jh/B-4853-2010	hu, jh/0000-0002-6669-8443	National Natural Sciences Foundation of China [31071906, 30730029]; Chinese Academy of Sciences [GJHZ0954, Y0B3021, Y1B3021, KSCX2-EW-J-22]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Natural Sciences Foundation of China (31071906, 30730029), the International Collaborate Project of the Chinese Academy of Sciences (GJHZ0954), and the Field Front Project of the Knowledge Innovation Program of the Chinese Academy of Sciences (Y0B3021, Y1B3021, KSCX2-EW-J-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2008, EVOLUTION, V62, P413, DOI 10.1111/j.1558-5646.2007.00297.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Ashton KG, 2002, CAN J ZOOL, V80, P708, DOI 10.1139/Z02-049; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Beck J, 2008, J BIOGEOGR, V35, P1452, DOI 10.1111/j.1365-2699.2008.01886.x; Beketov MA, 2009, GLOBAL ECOL BIOGEOGR, V18, P498, DOI 10.1111/j.1466-8238.2009.00466.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Blackburn TM, 2001, GLOBAL ECOL BIOGEOGR, V10, P245, DOI 10.1046/j.1466-822X.2001.00237.x; Bordoloi S, 2001, CURR SCI INDIA, V80, P1219; Brehm G, 2004, GLOBAL ECOL BIOGEOGR, V13, P7, DOI 10.1111/j.1466-882X.2004.00069.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; BROWN WALTER C., 1961, ECOLOGY, V42, P628; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; DUBOIS A, 1983, COPEIA, P895; DUBOIS A, 1979, J HERPETOL, V13, P403, DOI 10.2307/1563474; Dubois Alain, 1992, Bulletin Mensuel de la Societe Linneenne de Lyon, V61, P305; FAUTH JE, 1989, BIOTROPICA, V21, P178, DOI 10.2307/2388708; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Fischer J, 2005, DIVERS DISTRIB, V11, P225, DOI 10.1111/j.1366-9516.2005.00139.x; Freckleton RP, 2003, AM NAT, V161, P821, DOI 10.1086/374346; Frost DR, 2010, AMPHIBIAN SPECIES WO; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes J.A., 2007, ENCY BIODIVERSITY, V2, P1, DOI DOI 10.1016/B978-012226865-6/00503-1; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hausdorf B, 2003, GLOBAL ECOL BIOGEOGR, V12, P389, DOI 10.1046/j.1466-822X.2003.00050.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; Hu Junhua, 2007, Chinese Journal of Applied and Environmental Biology, V13, P731; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jiang J, 2010, HERPETOLOGICA SINICA, V12, P1; Jiang JP, 2005, ZOOL SCI, V22, P353, DOI 10.2108/zsj.22.353; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; KHAN MS, 1989, J HERPETOL, V23, P419, DOI 10.2307/1564055; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Krizmanic I, 2005, HERPETOL J, V15, P205; Laugen AT, 2005, EVOL ECOL RES, V7, P717; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; LINDSEY CC, 1966, EVOLUTION, V20, P456, DOI 10.1111/j.1558-5646.1966.tb03380.x; Lomolino M.V., 2004, FDN BIOGEOGRAPHY CLA; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MAC ARTHUR ROBERT H., 1967; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; Measey GJ, 2006, EVOL ECOL RES, V8, P1049; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nathan R, 1999, ISRAEL J ZOOL, V45, P1; Ohler A, 2006, ZOOSYSTEMA, V28, P769; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olalla-Tarraga MA, 2007, GLOBAL ECOL BIOGEOGR, V16, P606, DOI 10.1111/j.1466-8238.2007.00309.x; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Qian H, 1998, J BIOGEOGR, V25, P829, DOI 10.1046/j.1365-2699.1998.00247.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ribas CR, 2006, GLOBAL ECOL BIOGEOGR, V15, P614, DOI 10.1111/j.1466-8238.2006.00265.x; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Ruggiero A, 1998, BIOL J LINN SOC, V63, P283, DOI 10.1111/j.1095-8312.1998.tb01518.x; Ruggiero A, 2007, GLOBAL ECOL BIOGEOGR, V16, P401, DOI 10.1111/j.1466-8238.2006.00303.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Williams C. B., 1964, PATTERNS BALANCE NAT; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5	90	39	45	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19817	10.1371/journal.pone.0019817	http://dx.doi.org/10.1371/journal.pone.0019817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611199	Green Submitted, gold, Green Published			2022-12-27	WOS:000290657500024
J	Worner, CH; Olguin, A; Ruiz-Garcia, JL; Garzon-Jimenez, N				Woerner, Carlos H.; Olguin, Alicia; Ruiz-Garcia, Jose L.; Garzon-Jimenez, Nuria			Cell Pattern in Adult Human Corneal Endothelium	PLOS ONE			English	Article							NORMAL GRAIN-GROWTH; SURFACE MECHANICS; DENSITY; AGE; POLYMEGETHISM; POPULATION; MORPHOLOGY; MOTION; MODEL; EYES	A review of the current data on the cell density of normal adult human endothelial cells was carried out in order to establish some common parameters appearing in the different considered populations. From the analysis of cell growth patterns, it is inferred that the cell aging rate is similar for each of the different considered populations. Also, the morphology, the cell distribution and the tendency to hexagonallity are studied. The results are consistent with the hypothesis that this phenomenon is analogous with cell behavior in other structures such as dry foams and grains in polycrystalline materials. Therefore, its driving force may be controlled by the surface tension and the mobility of the boundaries.	[Woerner, Carlos H.; Olguin, Alicia] Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile; [Ruiz-Garcia, Jose L.] Univ Complutense Madrid, Escuela Univ Opt, Madrid, Spain; [Garzon-Jimenez, Nuria] Inst Oftalmol Avanzada, Madrid, Spain	Pontificia Universidad Catolica de Valparaiso; Complutense University of Madrid	Worner, CH (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Fis, Valparaiso, Chile.	cworner@ucv.cl	Garzón, Nuria/ABF-5087-2021; Wörner, Carlos/J-7242-2012; Garzón, Nuria/H-1838-2019	Garzón, Nuria/0000-0002-6162-0081; Garzón, Nuria/0000-0002-6162-0081; Worner, Carlos H./0000-0003-3680-0723				Amann J, 2003, AM J OPHTHALMOL, V135, P584, DOI 10.1016/S0002-9394(02)02237-7; [Anonymous], 2010, J EMMETROPIA; Armitage WJ, 2003, INVEST OPHTH VIS SCI, V44, P3326, DOI 10.1167/iovs.02-1255; Ashraf KM, 2006, EYE, V20, P116, DOI 10.1038/sj.eye.6701798; ATKINSON HV, 1988, ACTA METALL MATER, V36, P469, DOI 10.1016/0001-6160(88)90079-X; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; FELTHAM P, 1957, ACTA METALL MATER, V5, P97, DOI 10.1016/0001-6160(57)90136-0; Fischer FD, 2008, ACTA MATER, V56, P5395, DOI 10.1016/j.actamat.2008.07.021; FRADKOV VE, 1994, ADV PHYS, V43, P739, DOI 10.1080/00018739400101559; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GLAZIER JA, 1992, J PHYS-CONDENS MAT, V4, P1867, DOI 10.1088/0953-8984/4/8/004; Gonzalez-Meijome JM, 2010, GRAEF ARCH CLIN EXP, V248, P1159, DOI 10.1007/s00417-010-1337-6; Hashemian MN, 2006, BMC OPHTHALMOLOGY, V6, P1; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Humphreys FJ, 1995, RECRYSTALLIZATION RE, P628; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Jun AS, 2006, EXP EYE RES, V83, P890, DOI 10.1016/j.exer.2006.03.025; Kim HS, 2010, COMP MATER SCI, V50, P600, DOI 10.1016/j.commatsci.2010.09.023; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; MATSUDA M, 1985, ARCH OPHTHALMOL-CHIC, V103, P68; MollerPedersen T, 1997, CORNEA, V16, P333; Muller A, 2002, OPTOMETRY VISION SCI, V79, P762, DOI 10.1097/00006324-200212000-00008; MULLINS WW, 1956, J APPL PHYS, V27, P900, DOI 10.1063/1.1722511; MULLINS WW, 1958, ACTA METALL MATER, V6, P414, DOI 10.1016/0001-6160(58)90020-8; Oliveira C, 2007, BRIT J OPHTHALMOL, V91, P37, DOI 10.1136/bjo.2006.102061; Padilla MDB, 2004, CORNEA, V23, P129, DOI 10.1097/00003226-200403000-00005; Parade CS, 2008, ACTA MATER, V56, P4200, DOI 10.1016/j.actamat.2008.04.054; Pomeau Y, 2006, PHYS TODAY, V59, P39, DOI 10.1063/1.2195314; Rao SK, 2000, CORNEA, V19, P820, DOI 10.1097/00003226-200011000-00012; Rios PR, 2008, ACTA MATER, V56, P1165, DOI 10.1016/j.actamat.2007.11.010; Roszkowska Anna M., 2004, International Ophthalmology, V25, P163, DOI 10.1007/s10792-004-1957-0; SCHIMMELPFENNIG BH, 1984, INVEST OPHTH VIS SCI, V25, P223; SCHOESSLER JP, 1987, CURR EYE RES, V6, P301, DOI 10.3109/02713688709025182; Semes L, 2006, OPTOMETRY VISION SCI, V83, P512, DOI 10.1097/01.opx.0000225117.55813.e9; Shao YL, 2007, CORNEA, V26, P130, DOI 10.1097/ICO.0b013e31802be63e; Snellingen T, 2001, CORNEA, V20, P55, DOI 10.1097/00003226-200101000-00011; STOCKER EG, 1985, INVEST OPHTH VIS SCI, V26, P857; SUDA T, 1984, JPN J OPHTHALMOL, V28, P331; THOMPSON CV, 1990, ANNU REV MATER SCI, V20, P245, DOI 10.1146/annurev.ms.20.080190.001333; VAZ MF, 1988, SCRIPTA METALL MATER, V22, P35, DOI 10.1016/S0036-9748(88)80302-8; Weaire D., 1999, PHYS FOAMS; Worner CH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021404; Worner CH, 2003, ACTA MATER, V51, P6263, DOI 10.1016/S1359-6454(03)00449-X; YEE RW, 1985, CURR EYE RES, V4, P671, DOI 10.3109/02713688509017661	46	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19483	10.1371/journal.pone.0019483	http://dx.doi.org/10.1371/journal.pone.0019483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602935	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000290558500012
J	Thaler, L; Arnott, SR; Goodale, MA				Thaler, Lore; Arnott, Stephen R.; Goodale, Melvyn A.			Neural Correlates of Natural Human Echolocation in Early and Late Blind Echolocation Experts	PLOS ONE			English	Article							SENSORY SUBSTITUTION; HUMAN CEREBELLUM; AUDITORY MOTION; CORTEX ACTIVITY; VISUAL-CORTEX; PLASTICITY; PERCEPTION; CONNECTIVITY; RESPONDS; VISION	Background: A small number of blind people are adept at echolocating silent objects simply by producing mouth clicks and listening to the returning echoes. Yet the neural architecture underlying this type of aid-free human echolocation has not been investigated. To tackle this question, we recruited echolocation experts, one early-and one late-blind, and measured functional brain activity in each of them while they listened to their own echolocation sounds. Results: When we compared brain activity for sounds that contained both clicks and the returning echoes with brain activity for control sounds that did not contain the echoes, but were otherwise acoustically matched, we found activity in calcarine cortex in both individuals. Importantly, for the same comparison, we did not observe a difference in activity in auditory cortex. In the early-blind, but not the late-blind participant, we also found that the calcarine activity was greater for echoes reflected from surfaces located in contralateral space. Finally, in both individuals, we found activation in middle temporal and nearby cortical regions when they listened to echoes reflected from moving targets. Conclusions: These findings suggest that processing of click-echoes recruits brain regions typically devoted to vision rather than audition in both early and late blind echolocation experts.	[Thaler, Lore; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Arnott, Stephen R.] Rotman Res Inst, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Baycrest	Thaler, L (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	mgoodale@uwo.ca	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561	Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by the Canadian Institutes of Health Research (MAG) and the Ontario Ministry of Research and Innovation (LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2010, J NEUROSCI, V30, P4489, DOI 10.1523/JNEUROSCI.5661-09.2010; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Burton H, 2003, J NEUROSCI, V23, P4005; CISELET V, 1982, ARCH INT PHYSIOL BIO, V90, pP47; De Volder AG, 1999, BRAIN RES, V826, P128, DOI 10.1016/S0006-8993(99)01275-5; Dufour A, 2005, EXP BRAIN RES, V165, P515, DOI 10.1007/s00221-005-2329-3; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glickstein M, 2009, NEUROSCIENCE, V162, P549, DOI 10.1016/j.neuroscience.2009.02.054; Glickstein M, 2011, CORTEX, V47, P59, DOI 10.1016/j.cortex.2009.09.001; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HEYES T, 1984, ELECTRON WIRELESS W, V90, P26; Hughes B, 2001, HUM MOVEMENT SCI, V20, P371, DOI 10.1016/S0167-9457(01)00059-8; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; Kay L., 1964, ULTRASONICS, V2, P53, DOI 10.1016/0041-624X(64)90382-8; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; KISH D, 1995, THESIS CALIFORNIA ST; Langers DRM, 2005, NEUROIMAGE, V28, P490, DOI 10.1016/j.neuroimage.2005.06.024; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Rojas JAM, 2009, ACTA ACUST UNITED AC, V95, P325, DOI 10.3813/AAA.918155; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; SAMUELS ML, 1992, AM STAT, V46, P228, DOI 10.2307/2685222; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Talairach J., 1988, COPLANAR STEREOTAXIC; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	49	145	145	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20162	10.1371/journal.pone.0020162	http://dx.doi.org/10.1371/journal.pone.0020162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21633496	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000291006500033
J	Luedeling, E; Girvetz, EH; Semenov, MA; Brown, PH				Luedeling, Eike; Girvetz, Evan H.; Semenov, Mikhail A.; Brown, Patrick H.			Climate Change Affects Winter Chill for Temperate Fruit and Nut Trees	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; HYDROGEN CYANAMIDE; DORMANCY BREAKING; DEPENDENCE; RELEASE; PLANTS; LEAF	Background: Temperate fruit and nut trees require adequate winter chill to produce economically viable yields. Global warming has the potential to reduce available winter chill and greatly impact crop yields. Methodology/Principal Findings: We estimated winter chill for two past (1975 and 2000) and 18 future scenarios (mid and end 21st century; 3 Global Climate Models [GCMs]; 3 greenhouse gas emissions [GHG] scenarios). For 4,293 weather stations around the world and GCM projections, Safe Winter Chill (SWC), the amount of winter chill that is exceeded in 90% of all years, was estimated for all scenarios using the "Dynamic Model" and interpolated globally. We found that SWC ranged between 0 and about 170 Chill Portions (CP) for all climate scenarios, but that the global distribution varied across scenarios. Warm regions are likely to experience severe reductions in available winter chill, potentially threatening production there. In contrast, SWC in most temperate growing regions is likely to remain relatively unchanged, and cold regions may even see an increase in SWC. Climate change impacts on SWC differed quantitatively among GCMs and GHG scenarios, with the highest GHG leading to losses up to 40 CP in warm regions, compared to 20 CP for the lowest GHG. Conclusions/Significance: The extent of projected changes in winter chill in many major growing regions of fruits and nuts indicates that growers of these commodities will likely experience problems in the future. Mitigation of climate change through reductions in greenhouse gas emissions can help reduce the impacts, however, adaption to changes will have to occur. To better prepare for likely impacts of climate change, efforts should be undertaken to breed tree cultivars for lower chilling requirements, to develop tools to cope with insufficient winter chill, and to better understand the temperature responses of tree crops.	[Luedeling, Eike] World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Girvetz, Evan H.] Nature Conservancy, Seattle, WA USA; [Semenov, Mikhail A.] Rothamsted Res, Harpenden, Herts, England; [Brown, Patrick H.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	CGIAR; World Agroforestry (ICRAF); Nature Conservancy; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Davis	Luedeling, E (corresponding author), World Agroforestry Ctr ICRAF, Nairobi, Kenya.	e.luedeling@cgiar.org	Luedeling, Eike/I-3269-2019; Luedeling, Eike/A-5662-2012; Brown, Patrick/E-4085-2012; Semenov, Mikhail/HCI-8667-2022; Semenov, Mikhail/W-8060-2019	Luedeling, Eike/0000-0002-7316-3631; Luedeling, Eike/0000-0002-7316-3631; Brown, Patrick/0000-0001-6857-8608; Semenov, Mikhail/0000-0002-1561-7113; 	Biotechnology and Biological Sciences Research Council of the UK (BBSRC); BBSRC [BBS/E/C/00004938] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004938] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan P, 1997, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.1997.444.2; Almorox J, 2005, ENERG CONVERS MANAGE, V46, P1465, DOI 10.1016/j.enconman.2004.07.007; BALANDIER P, 1993, AGR FOREST METEOROL, V67, P95, DOI 10.1016/0168-1923(93)90052-J; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; Chandler WH, 1942, DECIDUOUS ORCHARDS; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; *CIA, 2006, CIA WORLD FACTB; DOZIER WA, 1990, HORTSCIENCE, V25, P1573, DOI 10.21273/HORTSCI.25.12.1573; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Erez A, 2000, TEMPERATE FRUIT CROPS IN WARM CLIMATES, P17; EREZ A, 1966, PHYSIOL PLANTARUM, V19, P650, DOI 10.1111/j.1399-3054.1966.tb07049.x; Evans N, 2010, FOOD SECUR, V2, P143, DOI 10.1007/s12571-010-0058-3; FAOSTAT, 2009, STAT DAT FOOD AGR OR; FISHMAN S, 1987, J THEOR BIOL, V126, P309, DOI 10.1016/S0022-5193(87)80237-0; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; GEORGE AP, 1992, AUST J EXP AGR, V32, P89, DOI 10.1071/EA9920089; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; GRIESBACH J., 2007, GROWING TEMPERATE FR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; Lazzarotto P, 2010, CLIM RES, V41, P221, DOI 10.3354/cr00847; LINVILL DE, 1990, HORTSCIENCE, V25, P14, DOI 10.21273/HORTSCI.25.1.14; Luedeling E, 2011, INT J BIOMETEOROL, V55, P411, DOI 10.1007/s00484-010-0352-y; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; Luedeling E, 2009, AGR FOREST METEOROL, V149, P1854, DOI 10.1016/j.agrformet.2009.06.013; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Luedeling E, 2009, CLIMATIC CHANGE, V96, P219, DOI 10.1007/s10584-009-9581-7; Luedeling E, 2009, AGR ECOSYST ENVIRON, V133, P23, DOI 10.1016/j.agee.2009.04.016; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; *NCDC, 2008, DAT NAT CLIM DAT CTR; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Petri JL, 2004, ACTA HORTIC, P53, DOI 10.17660/ActaHortic.2004.662.4; RICHARDSON E A, 1974, Hortscience, V9, P331; Ruiz D, 2007, ENVIRON EXP BOT, V61, P254, DOI 10.1016/j.envexpbot.2007.06.008; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; SEMENOV MA, CLIMATE RES IN PRESS; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Semenov MA, 2009, J EXP BOT, V60, P2791, DOI 10.1093/jxb/erp164; Semenov MA, 2009, J R SOC INTERFACE, V6, P343, DOI 10.1098/rsif.2008.0285; Spencer J.W., 1971, SEARCH, V2, P172; Vegis A., 1961, HDB PFLANZENPHYSIOLO, V16, P168; Vennetier M, 2009, FOREST ECOL MANAG, V258, pS56, DOI 10.1016/j.foreco.2009.09.015; Wilks DS, 1999, PROG PHYS GEOG, V23, P329, DOI 10.1177/030913339902300302; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107	48	196	204	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20155	10.1371/journal.pone.0020155	http://dx.doi.org/10.1371/journal.pone.0020155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629649	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800030
J	Siarkou, VI; Stamatakis, A; Kappas, I; Hadweh, P; Laroucau, K				Siarkou, Victoria I.; Stamatakis, Alexandros; Kappas, Ilias; Hadweh, Paul; Laroucau, Karine			Evolutionary Relationships among Chlamydophila abortus Variant Strains Inferred by rRNA Secondary Structure-Based Phylogeny	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; MEMBRANE PROTEIN GENE; ET-AL. 1989; CHLAMYDIA-PSITTACI; BINDING-SITE; INCLUSION MORPHOLOGY; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; PROVIDES EVIDENCE; STRUCTURE MODEL	The evolutionary relationships among known Chlamydophila abortus variant strains including the LLG and POS, previously identified as being highly distinct, were investigated based on rRNA secondary structure information. PCR-amplified overlapping fragments of the 16S, 16S-23S intergenic spacer (IS), and 23S domain I rRNAs were subjected to cloning and sequencing. Secondary structure analysis revealed the presence of transitional single nucleotide variations (SNVs), two of which occurred in loops, while seven in stem regions that did not result in compensatory substitutions. Notably, only two SNVs, in 16S and 23S, occurred within evolutionary variable regions. Maximum likelihood and Bayesian phylogeny reconstructions revealed that C. abortus strains could be regarded as representing two distinct lineages, one including the "classical'' C. abortus strains and the other the "LLG/POS variant'', with the type strain B577(T) possibly representing an intermediate of the two lineages. The two C. abortus lineages shared three unique (apomorphic) characters in the 23S domain I and 16S-23S IS, but interestingly lacked synapomorphies in the 16S rRNA. The two lineages could be distinguished on the basis of eight positions; four of these comprised residues that appeared to be signature or unique for the "classical'' lineage, while three were unique for the "LLG/POS variant''. The U277 (E. coli numbering) signature character, corresponding to a highly conserved residue of the 16S molecule, and the unique G681 residue, conserved in a functionally strategic region also of 16S, are the most pronounced attributes (autapomorphies) of the "classical'' and the "LLG/POS variant'' lineages, respectively. Both lineages were found to be descendants of a common ancestor with the Prk/Daruma C. psittaci variant. Compared with the "classical'', the "LLG/POS variant'' lineage has retained more ancestral features. The current rRNA secondary structure-based analysis and phylogenetic inference reveal new insights into how these two C. abortus lineages have differentiated during their evolution.	[Siarkou, Victoria I.] Aristotle Univ Thessaloniki, Lab Microbiol & Infect Dis, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Exelixis Lab, Sci Comp Grp, Heidelberg, Germany; [Kappas, Ilias; Hadweh, Paul] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, Sch Biol, GR-54006 Thessaloniki, Greece; [Laroucau, Karine] French Agcy Food Environm & Occupat Hlth & Safety, Bacterial Zoonoses Unit, Maisons Alfort, France	Aristotle University of Thessaloniki; Heidelberg Institute for Theoretical Studies; Aristotle University of Thessaloniki; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Siarkou, VI (corresponding author), Aristotle Univ Thessaloniki, Lab Microbiol & Infect Dis, Fac Vet Med, GR-54006 Thessaloniki, Greece.	vickysi@vet.auth.gr	Stamatakis, Alexandros/B-8740-2009; Laroucau, Karine/GSO-1980-2022; Kappas, Ilias/AAB-5286-2021; Kappas, Ilias/H-9973-2013	Stamatakis, Alexandros/0000-0003-0353-0691; Laroucau, Karine/0000-0001-7605-8602; Kappas, Ilias/0000-0002-8564-7035; Hadweh, Paul/0000-0001-8418-9987				Aitken I. D., 2000, Diseases of sheep, P81; ALLMANG C, 1994, NUCLEIC ACIDS RES, V22, P3708, DOI 10.1093/nar/22.18.3708; Anton AI, 1999, J BACTERIOL, V181, P2703; Bouakane A, 2005, VET REC, V157, P771, DOI 10.1136/vr.157.24.771; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Boumedine KS, 1998, RES MICROBIOL, V149, P735, DOI 10.1016/S0923-2508(99)80020-5; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Bush RM, 2001, INT J SYST EVOL MICR, V51, P203, DOI 10.1099/00207713-51-1-203; Cannone Jamie J., 2002, BMC Bioinformatics, V3, P1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CORMACK RS, 1991, J BIOL CHEM, V266, P18525; DAMMEL CS, 1993, GENE DEV, V7, P660, DOI 10.1101/gad.7.4.660; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; ENGEL JN, 1987, J BACTERIOL, V169, P5678, DOI 10.1128/jb.169.12.5678-5685.1987; Everett KDE, 2000, VET MICROBIOL, V75, P109, DOI 10.1016/S0378-1135(00)00213-3; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Everett KDE, 1997, INT J SYST BACTERIOL, V47, P461, DOI 10.1099/00207713-47-2-461; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P803, DOI 10.1099/00207713-49-2-803; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; GAUTHERET D, 1995, RNA, V1, P807; GRIFFITHS PC, 1992, VET MICROBIOL, V30, P165, DOI 10.1016/0378-1135(92)90111-6; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; HOPFL P, 1989, EUR J BIOCHEM, V185, P355, DOI 10.1111/j.1432-1033.1989.tb15123.x; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kerr K, 2005, RES VET SCI, V78, P1, DOI 10.1016/j.rvsc.2004.08.004; Laroucau K, 2010, VACCINE, V28, P5653, DOI 10.1016/j.vaccine.2010.06.064; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; MARKEY BK, 1993, VET MICROBIOL, V35, P141, DOI 10.1016/0378-1135(93)90122-N; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; MOUGEL M, 1988, NUCLEIC ACIDS RES, V16, P2825, DOI 10.1093/nar/16.7.2825; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; OLSEN GJ, 1993, FASEB J, V7, P113, DOI 10.1096/fasebj.7.1.8422957; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003; Pettersson B, 1997, J BACTERIOL, V179, P4195, DOI 10.1128/jb.179.13.4195-4205.1997; Pettersson B, 2001, INT J SYST EVOL MICR, V51, P633, DOI 10.1099/00207713-51-2-633; Pettersson B, 2000, INT J SYST EVOL MICR, V50, P291, DOI 10.1099/00207713-50-1-291; POWERS T, 1995, RNA, V1, P194; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Ramaswamy P, 2009, J MOL BIOL, V392, P666, DOI 10.1016/j.jmb.2009.07.032; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALINAS J, 1995, VET MICROBIOL, V43, P219, DOI 10.1016/0378-1135(94)00100-B; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Siarkou V, 2002, VET MICROBIOL, V85, P145, DOI 10.1016/S0378-1135(01)00506-5; Smit S, 2007, NUCLEIC ACIDS RES, V35, P3339, DOI 10.1093/nar/gkm101; Smith TF, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-16; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; STERN S, 1988, J MOL BIOL, V200, P291, DOI 10.1016/0022-2836(88)90241-0; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Van Loock M, 2003, INT J SYST EVOL MICR, V53, P761, DOI 10.1099/ijs.0.02329-0; VANCAMP G, 1993, CURR MICROBIOL, V27, P147, DOI 10.1007/BF01576012; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Young JM, 2000, INT J SYST EVOL MICR, V50, P1687, DOI 10.1099/00207713-50-4-1687; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	78	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19813	10.1371/journal.pone.0019813	http://dx.doi.org/10.1371/journal.pone.0019813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629695	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005800011
J	Andonian, K; Hierro, JL; Khetsuriani, L; Becerra, P; Janoyan, G; Villarreal, D; Cavieres, L; Fox, LR; Callaway, RM				Andonian, Krikor; Hierro, Jose L.; Khetsuriani, Liana; Becerra, Pablo; Janoyan, Grigor; Villarreal, Diego; Cavieres, Lohengrin; Fox, Laurel R.; Callaway, Ragan M.			Range-Expanding Populations of a Globally Introduced Weed Experience Negative Plant-Soil Feedbacks	PLOS ONE			English	Article							STARTHISTLE CENTAUREA-SOLSTITIALIS; INVASIVE TREE; RELEASE; BIOTA; PATHOGENS; EXPLAIN; ACCUMULATION; DIVERSITY; SUCCESS; FITNESS	Background: Biological invasions are fundamentally biogeographic processes that occur over large spatial scales. Interactions with soil microbes can have strong impacts on plant invasions, but how these interactions vary among areas where introduced species are highly invasive vs. naturalized is still unknown. In this study, we examined biogeographic variation in plant-soil microbe interactions of a globally invasive weed, Centaurea solstitialis (yellow starthistle). We addressed the following questions (1) Is Centaurea released from natural enemy pressure from soil microbes in introduced regions? and (2) Is variation in plant-soil feedbacks associated with variation in Centaurea's invasive success? Methodology/Principal Findings: We conducted greenhouse experiments using soils and seeds collected from native Eurasian populations and introduced populations spanning North and South America where Centaurea is highly invasive and noninvasive. Soil microbes had pervasive negative effects in all regions, although the magnitude of their effect varied among regions. These patterns were not unequivocally congruent with the enemy release hypothesis. Surprisingly, we also found that Centaurea generated strong negative feedbacks in regions where it is the most invasive, while it generated neutral plant-soil feedbacks where it is noninvasive. Conclusions/Significance: Recent studies have found reduced below-ground enemy attack and more positive plant-soil feedbacks in range-expanding plant populations, but we found increased negative effects of soil microbes in range-expanding Centaurea populations. While such negative feedbacks may limit the long-term persistence of invasive plants, such feedbacks may also contribute to the success of invasions, either by having disproportionately negative impacts on competing species, or by yielding relatively better growth in uncolonized areas that would encourage lateral spread. Enemy release from soil-borne pathogens is not sufficient to explain the success of this weed in such different regions. The biogeographic variation in soil-microbe effects indicates that different mechanisms may operate on this species in different regions, thus establishing geographic mosaics of species interactions that contribute to variation in invasion success.	[Andonian, Krikor; Fox, Laurel R.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hierro, Jose L.; Villarreal, Diego] Univ Nacl La Pampa, Fac Ciencias Exactas & Nat, Santa Rosa, Argentina; [Hierro, Jose L.] Consejo Nacl Invest Cient & Tecn, La Pampa, Santa Rosa, Argentina; [Khetsuriani, Liana] Georgian Acad Sci, Inst Bot, GE-380060 Tbilisi, Georgia; [Becerra, Pablo] Catholic Univ Chile, Fac Agron & Ingn Forestal, Dept Ecosistemas & Medio Ambiente, Santiago, Chile; [Janoyan, Grigor] Amer Univ Armenia, Acopian Ctr Environm, Yerevan, Armenia; [Cavieres, Lohengrin] Univ Concepcion, Dept Bot, Concepcion, Chile; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of California System; University of California Santa Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Academy of Sciences of Georgia; Pontificia Universidad Catolica de Chile; American University of Armenia; Universidad de Concepcion; University of Montana System; University of Montana	Andonian, K (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	andonian@biology.ucsc.edu	Cavieres, Lohengrin/A-9542-2010	Cavieres, Lohengrin/0000-0001-9122-3020	U.S. Fulbright Student Fellowship; STEPS; Langenheim Plant Ecology Fellowship; CRDF [GEB1-2833]; NSF; Andrew W. Mellon Foundation; DoD SERDP; University of Montana; Rocky Mountain Research Station; CONICET; Institute of Ecology and Biodiversity [ICM P05-002]	U.S. Fulbright Student Fellowship; STEPS; Langenheim Plant Ecology Fellowship; CRDF; NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation; DoD SERDP; University of Montana; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute of Ecology and Biodiversity	This research was funded by a U.S. Fulbright Student Fellowship, a STEPS Institute Graduate Student Fellowship, and a Langenheim Plant Ecology Fellowship to K.A., CRDF grant #GEB1-2833 to R.M.C. and J.L.H. Additional support was provided from NSF, the Andrew W. Mellon Foundation, DoD SERDP, the University of Montana Sponsored Research Office, and the Rocky Mountain Research Station to R. M. C., from CONICET to J.L.H., and from the Institute of Ecology and Biodiversity (ICM P05-002) to P.B. and L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2009, J PLANT ECOL, V2, P77, DOI 10.1093/jpe/rtp008; Andonian K, 2011, BIOL INVASIONS, V13, P2957, DOI 10.1007/s10530-011-9978-x; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beckstead J, 2003, ECOLOGY, V84, P2824, DOI 10.1890/02-0517; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Brandt AJ, 2009, ECOLOGY, V90, P1063, DOI 10.1890/08-0054.1; Callaway RM, 2006, BIOL INVASIONS, V8, P1389, DOI 10.1007/s10530-006-0003-8; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; ELTON CS, 1958, ECOLOGY INVASIONS PL; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Eppinga MB, 2006, OIKOS, V114, P168, DOI 10.1111/j.2006.0030-1299.14625.x; Gerlach JD, 1997, P CALIF WEED SCI SOC, V49, P136; Grosholz ED, 2003, ECOL LETT, V6, P700, DOI 10.1046/j.1461-0248.2003.00495.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Hierro JL, 2009, OIKOS, V118, P529, DOI [10.1111/j.1600-0706.2009.17283.x, 10.1111/j.1600-0706.2008.17283.x]; Hijano E., 1995, ALFALFA ARGENTINA; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; KULMATISKI A, 2008, ECOL LETT, P980; Lambrinos JG, 2002, ECOLOGY, V83, P518, DOI 10.1890/0012-9658(2002)083[0518:TVISOC]2.0.CO;2; MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357; MADDOX MD, 1981, ARRW20 USDA ARS; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Nijjer S, 2007, P ROY SOC B-BIOL SCI, V274, P2621, DOI 10.1098/rspb.2007.0804; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pitcairn M. J., 2006, California Agriculture, V60, P83, DOI 10.3733/ca.v060n02p83; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Shea K, 2005, ECOLOGY, V86, P3174, DOI 10.1890/05-0195; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Springer YP, 2009, ECOLOGY, V90, P1852, DOI 10.1890/08-0740.1; Swope SM, 2010, ECOLOGY, V91, P2284, DOI 10.1890/09-0855.1; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Thompson J. N., 2005, INTERSPEC INTERACT; Uygur S, 2004, WEED SCI, V52, P746, DOI 10.1614/WS-03-150R1; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Kleunen M, 2009, J ECOL, V97, P385, DOI 10.1111/j.1365-2745.2009.01483.x; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	52	37	37	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20117	10.1371/journal.pone.0020117	http://dx.doi.org/10.1371/journal.pone.0020117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629781	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200035
J	Bryan, SJ; Burroughs, NJ; Evered, C; Sacharz, J; Nenninger, A; Mullineaux, CW; Spence, EM				Bryan, Samantha J.; Burroughs, Nigel J.; Evered, Carol; Sacharz, Joanna; Nenninger, Anja; Mullineaux, Conrad W.; Spence, Edward M.			Loss of the SPHF Homologue Slr1768 Leads to a Catastrophic Failure in the Maintenance of Thylakoid Membranes in Synechocystis sp PCC 6803	PLOS ONE			English	Article							ESCHERICHIA-COLI; SP PCC-6803; ARABIDOPSIS-THALIANA; DELETION MUTANT; PLASMA-MEMBRANE; NUCLEAR GENE; BIOGENESIS; PROTEINS; CYANOBACTERIA; ALBINO3	Background: In cyanobacteria the photosystems are localised to, and maintained in, specialist membranes called the thylakoids. The mechanism driving the biogenesis of the thylakoid membranes is still an open question, with only two potential biogenesis factors, Vipp1 and Alb3 currently identified. Methodology/Principal Findings: We generated a slr1768 knockout using the pGEM T-easy vector and REDIRECT. By comparing growth and pigment content (chlorophyll a fluoresence) of the Delta slr1768 mutant with the wild-type, we found that Dslr1768 has a conditional phenotype; specifically under high light conditions (130 mu mol m(-2) s(-1)) thylakoid biogenesis is disrupted leading to cell death on a scale of days. The thylakoids show considerable disruption, with loss of both structure and density, while chlorophyll a density decreases with the loss of thylakoids, although photosynthetic efficiency is unaffected. Under low light (30 mu mol m(-2) s(-1)) the phenotype is significantly reduced, with a growth rate similar to the wildtype and only a low frequency of cells with evident thylakoid disruption. Conclusions/Significance: This is the first example of a gene that affects the maintenance of the thylakoid membranes specifically under high light, and which displays a phenotype dependent on light intensity. Our results demonstrate that Slr1768 has a leading role in acclimatisation, linking light damage with maintenance of the thylakoids.	[Bryan, Samantha J.; Sacharz, Joanna; Nenninger, Anja; Mullineaux, Conrad W.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Burroughs, Nigel J.] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Evered, Carol] Warwick HRI, Wellesbourne, Warwick, England; [Spence, Edward M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of London; Queen Mary University London; University of Warwick; University of Warwick	Bryan, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	edward.spence@kcl.ac.uk			University of Warwick; BBSRC [BB/G021856/1]; Biotechnology and Biological Sciences Research Council [BB/G021856/1] Funding Source: researchfish	University of Warwick; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	University of Warwick (www2.warwick.ac.uk), BBSRC grant no. BB/G021856/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; BELFORT M, 1973, J BACTERIOL, V115, P299, DOI 10.1128/JB.115.1.299-306.1973; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; CHENG HH, 1988, P NATL ACAD SCI USA, V85, P7882, DOI 10.1073/pnas.85.21.7882; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; GAUTSCH JW, 1974, GENETICS, V77, P435; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; GOLDEN SS, 1988, METHOD ENZYMOL, V167, P714; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2002, STREPTOMYCES COELICO; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; HINTERSTOISSER B, 1993, J PLANT PHYSIOL, V142, P407, DOI 10.1016/S0176-1617(11)81245-9; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; MacKinney G, 1941, J BIOL CHEM, V140, P315; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; Nickelsen J, 2011, FEMS MICROBIOL LETT, V315, P1, DOI 10.1111/j.1574-6968.2010.02096.x; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	39	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19625	10.1371/journal.pone.0019625	http://dx.doi.org/10.1371/journal.pone.0019625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625427	Green Published, gold			2022-12-27	WOS:000291005200006
J	Malhotra, S; Lapointe, J; Salari, K; Higgins, JP; Ferrari, M; Montgomery, K; van de Rijn, M; Brooks, JD; Pollack, JR				Malhotra, Sameer; Lapointe, Jacques; Salari, Keyan; Higgins, John P.; Ferrari, Michelle; Montgomery, Kelli; van de Rijn, Matt; Brooks, James D.; Pollack, Jonathan R.			A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; TOPOISOMERASE-II-ALPHA; BREAST-CANCER; RADICAL PROSTATECTOMY; RB/E2F PATHWAY; CELL-CYCLE; BIOMARKERS; SURVIVAL; KI-67; KI67	Prostate cancer exhibits tremendous variability in clinical behavior, ranging from indolent to lethal disease. Better prognostic markers are needed to stratify patients for appropriately aggressive therapy. By expression profiling, we can identify a proliferation signature variably expressed in prostate cancers. Here, we asked whether one or more tissue biomarkers might capture that information, and provide prognostic utility. We assayed three proliferation signature genes: MKI67 (Ki-67; also a classic proliferation biomarker), TOP2A (DNA topoisomerase II, alpha), and E2F1 (E2F transcription factor 1). Immunohistochemical staining was evaluable on 139 radical prostatectomy cases (in tissue microarray format), with a median clinical follow-up of eight years. Each of the three proliferation markers was by itself prognostic. Notably, combining the three markers together as a "proliferation index" (0 or 1, vs. 2 or 3 positive markers) provided superior prognostic performance (hazard ratio = 2.6 (95% CI: 1.4-4.9); P = 0.001). In a multivariate analysis that included preoperative serum prostate specific antigen (PSA) levels, Gleason grade and pathologic tumor stage, the composite proliferation index remained a significant predictor (P = 0.005). Analysis of receiver-operating characteristic (ROC) curves confirmed the improved prognostication afforded by incorporating the proliferation index (compared to the clinicopathologic data alone). Our findings highlight the potential value of a multi-gene signature-based diagnostic, and define a tri-marker proliferation index with possible utility for improved prognostication and treatment stratification in prostate cancer.	[Malhotra, Sameer; Ferrari, Michelle; Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Lapointe, Jacques] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada; [Salari, Keyan; Higgins, John P.; Montgomery, Kelli; van de Rijn, Matt; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Salari, Keyan] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; McGill University; Stanford University; Stanford University	Malhotra, S (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu; pollack1@stanford.edu		van de Rijn, Matt/0000-0002-1909-9739	National Institutes of Health [CA111782, CA122246]; CTSA [UL1 RR025744]; Burroughs Wellcome Fund [1007519]; NATIONAL CANCER INSTITUTE [R01CA111782, R01CA122246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health: CA111782 (JDB), CA122246 (JRP), CTSA grant UL1 RR025744 (Stanford Spectrum); and from the Burroughs Wellcome Fund: #1007519 (JRP, JDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brustmann H, 2004, GYNECOL ONCOL, V95, P16, DOI 10.1016/j.ygyno.2004.07.040; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Cowen D, 2002, CLIN CANCER RES, V8, P1148; D'Amico AV, 2005, J CLIN ONCOL, V23, P4975, DOI 10.1200/JCO.2005.08.904; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Gerdes J, 1990, Semin Cancer Biol, V1, P199; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Gunia S, 2008, WORLD J UROL, V26, P243, DOI 10.1007/s00345-008-0257-0; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Hartmann EM, 2009, FUTURE ONCOL, V5, P63, DOI 10.2217/14796694.5.1.63; Inoue T, 2005, UROLOGY, V66, P332, DOI 10.1016/j.urology.2005.02.028; Jamali M, 2008, ENDOCR PATHOL, V19, P282, DOI 10.1007/s12022-008-9044-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; Keshgegian AA, 1998, AM J CLIN PATHOL, V110, P443; Kosari F, 2008, CLIN CANCER RES, V14, P1734, DOI 10.1158/1078-0432.CCR-07-1494; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lowrance William T, 2009, Rev Urol, V11, P117; Mazhar D, 2008, NAT CLIN PRACT UROL, V5, P486, DOI 10.1038/ncpuro1204; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; O'Connor JK, 2006, INT J RADIAT ONCOL, V65, P1411, DOI 10.1016/j.ijrobp.2006.02.045; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Shariat SF, 2008, CURR OPIN UROL, V18, P279, DOI 10.1097/MOU.0b013e3282f9b3e5; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WATT PM, 1994, BIOCHEM J, V303, P681, DOI 10.1042/bj3030681; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174	51	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20293	10.1371/journal.pone.0020293	http://dx.doi.org/10.1371/journal.pone.0020293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629784	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200049
J	Pignatelli, M; Moya, A				Pignatelli, Miguel; Moya, Andres			Evaluating the Fidelity of De Novo Short Read Metagenomic Assembly Using Simulated Data	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; PHYLOGENETIC CLASSIFICATION; TAXONOMIC CLASSIFICATION; DATA SETS; COMMUNITY; GENOMES; RESOURCE; MILLIONS; ARACHNE	A frequent step in metagenomic data analysis comprises the assembly of the sequenced reads. Many assembly tools have been published in the last years targeting data coming from next-generation sequencing (NGS) technologies but these assemblers have not been designed for or tested in multi-genome scenarios that characterize metagenomic studies. Here we provide a critical assessment of current de novo short reads assembly tools in multi-genome scenarios using complex simulated metagenomic data. With this approach we tested the fidelity of different assemblers in metagenomic studies demonstrating that even under the simplest compositions the number of chimeric contigs involving different species is noticeable. We further showed that the assembly process reduces the accuracy of the functional classification of the metagenomic data and that these errors can be overcome raising the coverage of the studied metagenome. The results presented here highlight the particular difficulties that de novo genome assemblers face in multi-genome scenarios demonstrating that these difficulties, that often compromise the functional classification of the analyzed data, can be overcome with a high sequencing effort.	[Pignatelli, Miguel; Moya, Andres] UVEG Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain; [Pignatelli, Miguel; Moya, Andres] CIBERESP, Barcelona, Spain; [Pignatelli, Miguel] European Bioinformat Inst, Hinxton, England	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; European Molecular Biology Laboratory (EMBL)	Pignatelli, M (corresponding author), UVEG Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain.	mp@ebi.ac.uk	Moya, Andrés/A-8190-2008	Moya, Andrés/0000-0002-2867-1119	Ministerio de Ciencia y Educacion, Spain [SAF2009-13032-C02-01]; Generalitat Valenciana, Spain [Prometeo/2009/092]; CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain)	Ministerio de Ciencia y Educacion, Spain(Spanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by grants SAF2009-13032-C02-01 from Ministerio de Ciencia y Educacion, Spain, as well as Prometeo/2009/092 from Generalitat Valenciana, Spain. M.P. is the recipient of a contract from the CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHARUVAKA A, 2010, EVALUATION SHORT REA; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; HUANG X, 2005, CURR PROTOC BIOINFOR, pCH11; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; SUTTON GG, 1995, GENOME SCI TECHNOLOG, V1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Ye Yuzhen, 2009, Journal of Bioinformatics and Computational Biology, V7, P455, DOI 10.1142/S0219720009004151; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19984	10.1371/journal.pone.0019984	http://dx.doi.org/10.1371/journal.pone.0019984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625384	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200022
J	Yang, QS; He, H; Li, HY; Tian, H; Zhang, JJ; Zhai, LG; Chen, JD; Wu, H; Yi, GJ; He, ZH; Peng, XX				Yang, Qiaosong; He, Han; Li, Heying; Tian, Hua; Zhang, Jianjun; Zhai, Liguang; Chen, Jiandong; Wu, Hong; Yi, Ganjun; He, Zheng-Hui; Peng, Xinxiang			NOA1 Functions in a Temperature-Dependent Manner to Regulate Chlorophyll Biosynthesis and Rubisco Formation in Rice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ARABIDOPSIS-THALIANA; ORYZA-SATIVA; RNA-BINDING; MUTANT; IDENTIFICATION; LIGHT; PORB; PROTOCHLOROPHYLLIDE; TRANSCRIPTION	NITRIC OXIDE-ASSOCIATED1 (NOA1) encodes a circularly permuted GTPase (cGTPase) known to be essential for ribosome assembly in plants. While the reduced chlorophyll and Rubisco phenotypes were formerly noticed in both NOA1-supressed rice and Arabidopsis, a detailed insight is still necessary. In this study, by using RNAi transgenic rice, we further demonstrate that NOA1 functions in a temperature-dependent manner to regulate chlorophyll and Rubisco levels. When plants were grown at 30 degrees C, the chlorophyll and Rubisco levels in OsNOA1-silenced plants were only slightly lower than those in WT. However, at 22 degrees C, the silenced plants accumulated far less chlorophyll and Rubisco than WT. It was further revealed that the regulation of chlorophyll and Rubisco occurs at the anabolic level. Etiolated WT seedlings restored chlorophyll and Rubisco accumulations readily once returned to light, at either 30 degrees C or 15 degrees C. Etiolated OsNOA1-silenced plants accumulated chlorophyll and Rubisco to normal levels only at 30 degrees C, and lost this ability at low temperature. On the other hand, de-etiolated OsNOA1-silenced seedlings maintained similar levels of chlorophyll and Rubisco as WT, even after being shifted to 15 degrees C for various times. Further expression analyses identified several candidate genes, including OsPorA (NADPH: protochlorophyllide oxidoreductase A), OsrbcL (Rubisco large subunit), OsRALyase (Ribosomal RNA apurinic site specific lyase) and OsPuf4 (RNA-binding protein of the Puf family), which may be involved in OsNOA1-regulated chlorophyll biosynthesis and Rubisco formation. Overall, our results suggest OsNOA1 functions in a temperature-dependent manner to regulate chlorophyll biosynthesis, Rubisco formation and plastid development in rice.	[Yang, Qiaosong; He, Han; Li, Heying; Zhang, Jianjun; Zhai, Liguang; Chen, Jiandong; Wu, Hong; Peng, Xinxiang] S China Agr Univ, Educ Dept Guangdong Prov, Key Lab Plant Funct Genom & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Yang, Qiaosong; Yi, Ganjun] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China; [Tian, Hua] S China Agr Univ, Coll Agr, Guangzhou, Guangdong, Peoples R China; [He, Zheng-Hui] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	South China Agricultural University; Guangdong Academy of Agricultural Sciences; South China Agricultural University; California State University System; San Francisco State University	Peng, XX (corresponding author), S China Agr Univ, Educ Dept Guangdong Prov, Key Lab Plant Funct Genom & Biotechnol, Guangzhou, Guangdong, Peoples R China.	xpeng@scau.edu.cn	Yang, Qiaosong/AAX-4986-2020	He, Zheng-Hui/0000-0002-0075-4983	National Natural Science Foundation of China [30870184, 30971710]; Post-doctoral Science Foundation of China [200801256]; National Basic Research Program of China [2009CB118504]; National Institutes of Health [S06 GM52588]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM052588] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral Science Foundation of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (30870184, 30971710, http://www.nsfc.gov.cn), Post-doctoral Science Foundation of China (200801256, http://www.chinapostdoctor.org.cn) and National Basic Research Program of China (2009CB118504, http://www.973.gov.cn). This work was also partially supported by the National Institutes of Health (SCORE award no. S06 GM52588) to Z.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; An SJ, 2011, THEOR APPL GENET, V122, P459, DOI 10.1007/s00122-010-1460-0; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Araki N, 2000, PHYSIOL PLANTARUM, V108, P19, DOI 10.1034/j.1399-3054.2000.108001019x./; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; BEVINS MA, 1993, PLANT PHYSIOL, V103, P1123, DOI 10.1104/pp.103.4.1123; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Cui JX, 2011, PLANT CELL ENVIRON, V34, P347, DOI 10.1111/j.1365-3040.2010.02248.x; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Ito Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2727, DOI 10.1271/bbb.66.2727; Koeda S, 2009, J PLANT RES, V122, P623, DOI 10.1007/s10265-009-0250-8; Kolbert Z, 2008, J PLANT PHYSIOL, V165, P967, DOI 10.1016/j.jplph.2007.07.019; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu HJ, 2010, NEW PHYTOL, V187, P83, DOI 10.1111/j.1469-8137.2010.03264.x; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Nakano R, 2006, PLANT CELL PHYSIOL, V47, P270, DOI 10.1093/pcp/pci245; Nishiyama I., 1977, Agriculture and Horticulture (Nogyo oyobi Engei), V52, P1480; NISHIYAMA I, 1977, AGR HORTIC, V53, P30; NISHIYAMA I, 1977, AGR HORTIC, V52, P1353; NISHIYAMA I, 1977, AGR HORTIC, V53, P263; Ogasawara T, 1999, EMBO J, V18, P6522, DOI 10.1093/emboj/18.22.6522; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Philippar K, 2007, P NATL ACAD SCI USA, V104, P678, DOI 10.1073/pnas.0610062104; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Samuelsen AI, 1997, PLANTA, V201, P303, DOI 10.1007/s004250050071; Schoefs B, 1999, PHOTOSYNTHETICA, V36, P481, DOI 10.1023/A:1007002101856; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tamaki H, 2009, PLANT J, V57, P1027, DOI 10.1111/j.1365-313X.2008.03750.x; Tun NN, 2008, NEW PHYTOL, V178, P515, DOI 10.1111/j.1469-8137.2008.02383.x; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; Zhou YH, 2007, ANN BOT-LONDON, V100, P839, DOI 10.1093/aob/mcm181; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	49	24	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20015	10.1371/journal.pone.0020015	http://dx.doi.org/10.1371/journal.pone.0020015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625436	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200024
J	Zhou, GF; Afrane, YA; Vardo-Zalik, AM; Atieli, H; Zhong, DB; Wamae, P; Himeidan, YE; Minakawa, N; Githeko, AK; Yan, GY				Zhou, Guofa; Afrane, Yaw A.; Vardo-Zalik, Anne M.; Atieli, Harrysone; Zhong, Daibin; Wamae, Peter; Himeidan, Yousif E.; Minakawa, Noboru; Githeko, Andrew K.; Yan, Guiyun			Changing Patterns of Malaria Epidemiology between 2002 and 2010 in Western Kenya: The Fall and Rise of Malaria	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; TRANSMISSION; COVERAGE; ELIMINATION; IMPACT; VARIABILITY; ARABIENSIS; MANAGEMENT; MORTALITY	Background: The impact of insecticide treated nets (ITNs) on reducing malaria incidence is shown mainly through data collection from health facilities. Routine evaluation of long-term epidemiological and entomological dynamics is currently unavailable. In Kenya, new policies supporting the provision of free ITNs were implemented nationwide in June 2006. To evaluate the impacts of ITNs on malaria transmission, we conducted monthly surveys in three sentinel sites with different transmission intensities in western Kenya from 2002 to 2010. Methods and Findings: Longitudinal samplings of malaria parasite prevalence in asymptomatic school children and vector abundance in randomly selected houses were undertaken monthly from February 2002. ITN ownership and usage surveys were conducted annually from 2004 to 2010. Asymptomatic malaria parasite prevalence and vector abundances gradually decreased in all three sites from 2002 to 2006, and parasite prevalence reached its lowest level from late 2006 to early 2007. The abundance of the major malaria vectors, Anopheles funestus and An. gambiae, increased about 5-10 folds in all study sites after 2007. However, the resurgence of vectors was highly variable between sites and species. By 2010, asymptomatic parasite prevalence in Kombewa had resurged to levels recorded in 2004/2005, but the resurgence was smaller in magnitude in the other sites. Household ITN ownership was at 50-70% in 2009, but the functional and effective bed net coverage in the population was estimated at 40.3%, 49.4% and 28.2% in 2010 in Iguhu, Kombewa, and Marani, respectively. Conclusion: The resurgence in parasite prevalence and malaria vectors has been observed in two out of three sentinel sites in western Kenya despite a high ownership of ITNs. The likely factors contributing to malaria resurgence include reduced efficacy of ITNs, insecticide resistance in mosquitoes and lack of proper use of ITNs. These factors should be targeted to avoid further resurgence of malaria transmission.	[Zhou, Guofa; Vardo-Zalik, Anne M.; Zhong, Daibin; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA; [Afrane, Yaw A.; Atieli, Harrysone; Wamae, Peter; Himeidan, Yousif E.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Minakawa, Noboru] Nagasaki Univ, Inst Trop Med, Dept Med Entomol, Nagasaki 852, Japan	University of California System; University of California Irvine; Kenya Medical Research Institute; Nagasaki University	Zhou, GF (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.	zhoug@uci.edu	Zhong, Daibin/GRF-0564-2022	, Noboru/0000-0003-3664-9605	National Institute of Health [D43 TW01505, R01 A1050243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was funded by the National Institute of Health (D43 TW01505 and R01 A1050243). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2009, AM J TROP MED HYG, V81, P195; [Anonymous], 2009, LANCET, V374, P266, DOI 10.1016/S0140-6736(09)61346-5; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, GUIDELINES LAB FIELD; [Anonymous], 2008, WORLD MAL REP 2008; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chaves LF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-100; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; GILLIES MT, 1987, 55 S AFR I MED RES; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; GREENWOOD B, 2009, T ROY SOC TROP MED H, V103, P2; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Hsiang MS, 2010, LANCET, V375, P1586, DOI 10.1016/S0140-6736(10)60350-9; Kamau L, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1101; Knols BGJ, 2010, AM J TROP MED HYG, V82, P174, DOI 10.4269/ajtmh.2010.09-0787; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Muller O, 2009, LANCET, V373, P122, DOI 10.1016/S0140-6736(09)60033-7; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Shah NK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000312; Slutsker L, 2009, LANCET, V373, P11, DOI 10.1016/S0140-6736(08)61597-4; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; *WHO, 1975, 13 WHO; WHO, 2009, WHOHTMNTDWHOPES20095; WHO, 2008, GLOB MAL CONTR EL RE; *WHO, 2009, RBMEXD2009STATE2 WHO; WHO GMP, 2005, INS TREAT MOSQ NETS; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	60	88	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20318	10.1371/journal.pone.0020318	http://dx.doi.org/10.1371/journal.pone.0020318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629783	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200054
J	Monsey, MS; Ota, KT; Akingbade, IF; Hong, ES; Schafe, GE				Monsey, Melissa S.; Ota, Kristie T.; Akingbade, Irene F.; Hong, Ellie S.; Schafe, Glenn E.			Epigenetic Alterations Are Critical for Fear Memory Consolidation and Synaptic Plasticity in the Lateral Amygdala	PLOS ONE			English	Article							LONG-TERM-MEMORY; DNA METHYLATION; HISTONE ACETYLATION; CONDITIONED FEAR; ERK/MAP KINASE; MECHANISMS; ACQUISITION; ACTIVATION; TRANSCRIPTION; POTENTIATION	Epigenetic mechanisms, including histone acetylation and DNA methylation, have been widely implicated in hippocampal-dependent learning paradigms. Here, we have examined the role of epigenetic alterations in amygdala-dependent auditory Pavlovian fear conditioning and associated synaptic plasticity in the lateral nucleus of the amygdala (LA) in the rat. Using Western blotting, we first show that auditory fear conditioning is associated with an increase in histone H3 acetylation and DNMT3A expression in the LA, and that training-related alterations in histone acetylation and DNMT3A expression in the LA are downstream of ERK/MAPK signaling. Next, we show that intra-LA infusion of the histone deacetylase (HDAC) inhibitor TSA increases H3 acetylation and enhances fear memory consolidation; that is, long-term memory (LTM) is enhanced, while short-term memory (STM) is unaffected. Conversely, intra-LA infusion of the DNA methyltransferase (DNMT) inhibitor 5-AZA impairs fear memory consolidation. Further, intra-LA infusion of 5-AZA was observed to impair training-related increases in H3 acetylation, and pre-treatment with TSA was observed to rescue the memory consolidation deficit induced by 5-AZA. In our final series of experiments, we show that bath application of either 5-AZA or TSA to amygdala slices results in significant impairment or enhancement, respectively, of long-term potentiation (LTP) at both thalamic and cortical inputs to the LA. Further, the deficit in LTP following treatment with 5-AZA was observed to be rescued at both inputs by co-application of TSA. Collectively, these findings provide strong support that histone acetylation and DNA methylation work in concert to regulate memory consolidation of auditory fear conditioning and associated synaptic plasticity in the LA.	[Monsey, Melissa S.; Ota, Kristie T.; Akingbade, Irene F.; Hong, Ellie S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University	Monsey, MS (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu			National Institutes of Health [MH 073949]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to GES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; PAUL S, 2006, BIOL PSYCHIAT; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Ploski JE, 2010, J NEUROCHEM, V112, P636, DOI 10.1111/j.1471-4159.2009.06491.x; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 1999, LEARN MEMORY, V6, P97; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286	40	150	157	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19958	10.1371/journal.pone.0019958	http://dx.doi.org/10.1371/journal.pone.0019958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625500	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400023
J	Nekouzadeh, A; Rudy, Y				Nekouzadeh, Ali; Rudy, Yoram			Continuum Molecular Simulation of Large Conformational Changes during Ion-Channel Gating	PLOS ONE			English	Article							DIELECTRIC-CONSTANT; DYNAMICS SIMULATION; PROTEIN; COOPERATIVITY; LINKING; ENERGY; MOTION; MODEL; STATE; GO	A modeling framework was developed to simulate large and gradual conformational changes within a macromolecule (protein) when its low amplitude high frequency vibrations are not concerned. Governing equations were derived as alternative to Langevin and Smoluchowski equations and used to simulate gating conformational changes of the Kv7.1 ion-channel over the time scale of its gating process (tens of milliseconds). The alternative equations predict the statistical properties of the motion trajectories with good accuracy and do not require the force field to be constant over the diffusion length, as assumed in Langevin equation. The open probability of the ion-channel was determined considering cooperativity of four subunits and solving their concerted transition to the open state analytically. The simulated open probabilities for a series of voltage clamp tests produced current traces that were similar to experimentally recorded currents.	[Nekouzadeh, Ali] Washington Univ, Cardiac Bioelect & Arrhythmia Ctr, St Louis, MO 63130 USA; Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Nekouzadeh, A (corresponding author), Washington Univ, Cardiac Bioelect & Arrhythmia Ctr, St Louis, MO 63130 USA.	nekouzadeh@wustl.edu; rudy@wustl.edu	nekouzadeh, ali/E-1290-2011		National Institutes of Health-National Heart, Lung and Blood Institute [R01-HL 049054-18, R01-HL 033343-26]; Children's Discovery Institute Fellowship [CH-F-2008-121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033343, R01HL049054] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Discovery Institute Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health-National Heart, Lung and Blood Institute grants R01-HL 049054-18 and R01-HL 033343-26 (to Y.R.) and a Children's Discovery Institute Fellowship No. CH-F-2008-121 (to A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CF, 2010, P NATL ACAD SCI US; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Chen A, 2000, BIOPHYS J, V78, P2814, DOI 10.1016/S0006-3495(00)76824-X; Coffey W.T., 2004, LANGEVIN EQUATION AP, DOI 10.1142/5343; DILGER JP, 1979, SCIENCE, V206, P1196, DOI 10.1126/science.228394; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Koehorst RBM, 2004, BIOPHYS J, V87, P1445, DOI 10.1529/biophysj.104.043208; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Lange OF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2199530; Lecar H, 2003, BIOPHYS J, V85, P2854, DOI 10.1016/S0006-3495(03)74708-0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; NAKAMURA H, 1988, PROTEIN ENG, V2, P177, DOI 10.1093/protein/2.3.177; Nekouzadeh A, 2011, 3 RESIDUE LOOP CLOSU; Nekouzadeh A, 2008, BIOPHYS J, V95, P3510, DOI 10.1529/biophysj.108.136721; Paci E, 2002, BIOPHYS J, V83, P3032, DOI 10.1016/S0006-3495(02)75308-3; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; RAUDINO A, 1986, BIOPHYS J, V50, P441, DOI 10.1016/S0006-3495(86)83480-4; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Silva JR, 2010, J GEN PHYSIOL, V135, P575, DOI 10.1085/jgp.200910358; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Sprik M, 1998, J CHEM PHYS, V109, P7737, DOI 10.1063/1.477419; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20186	10.1371/journal.pone.0020186	http://dx.doi.org/10.1371/journal.pone.0020186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625456	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400045
J	Strange, A; Li, P; Lister, C; Anderson, J; Warthmann, N; Shindo, C; Irwin, J; Nordborg, M; Dean, C				Strange, Amy; Li, Peijin; Lister, Clare; Anderson, Jillian; Warthmann, Norman; Shindo, Chikako; Irwin, Judith; Nordborg, Magnus; Dean, Caroline			Major-Effect Alleles at Relatively Few Loci Underlie Distinct Vernalization and Flowering Variation in Arabidopsis Accessions	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED LINE POPULATIONS; NATURAL VARIATION; FT PROTEIN; FLORAL INDUCTION; TIME-VARIATION; THALIANA; RECOMBINANT; FRIGIDA; GENE	We have explored the genetic basis of variation in vernalization requirement and response in Arabidopsis accessions, selected on the basis of their phenotypic distinctiveness. Phenotyping of F2 populations in different environments, plus fine mapping, indicated possible causative genes. Our data support the identification of FRI and FLC as candidates for the major-effect QTL underlying variation in vernalization response, and identify a weak FLC allele, caused by a Mutator-like transposon, contributing to flowering time variation in two N. American accessions. They also reveal a number of additional QTL that contribute to flowering time variation after saturating vernalization. One of these was the result of expression variation at the FT locus. Overall, our data suggest that distinct phenotypic variation in the vernalization and flowering response of Arabidopsis accessions is accounted for by variation that has arisen independently at relatively few major-effect loci.	[Strange, Amy; Li, Peijin; Lister, Clare; Anderson, Jillian; Shindo, Chikako; Irwin, Judith; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Warthmann, Norman] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Nordborg, Magnus] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; University of Southern California	Strange, A (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	caroline.dean@bbsrc.ac.uk	Li, Peijin/D-5764-2016; Warthmann, Norman/E-1069-2011; Li, Peijin/AAT-6978-2021	Warthmann, Norman/0000-0002-1178-8409; Li, Peijin/0000-0003-1579-7553; Dean, Caroline/0000-0002-6555-3525; Nordborg, Magnus/0000-0001-7178-9748	BBSRC [BB/E009662/1]; DuPont; BBSRC [BB/I007857/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009662/1, BB/I007857/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DuPont; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a BBSRC CASE studentship (partnered with DuPont), BBSRC grant BB/E009662/1 and BBSRC Strategic Grant to The John Innes Centre. We thank Detlef Weigel for funding the verification by Genaissance of unpublished data, on all the markers used for the genetic mapping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jorgensen S, 2004, MOL ECOL, V13, P3403, DOI 10.1111/j.1365-294X.2004.02329.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Larsson AS, 1998, GENETICS, V149, P597; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; LI Y, 2010, P NATL ACAD SCI US; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2004, P NATL ACAD SCI USA, V101, P3281, DOI 10.1073/pnas.0306778101; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Osterberg MK, 2002, GENETICS, V161, P299; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rouse DT, 2002, PLANT J, V29, P183, DOI 10.1046/j.0960-7412.2001.01210.x; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Schlappi MR, 2006, PLANT PHYSIOL, V142, P1728, DOI 10.1104/pp.106.085571; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Ungerer MC, 2002, GENETICS, V160, P1133; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102	49	63	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19949	10.1371/journal.pone.0019949	http://dx.doi.org/10.1371/journal.pone.0019949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625501	Green Published, gold			2022-12-27	WOS:000290793400022
J	Andrecut, M; Halley, JD; Winkler, DA; Huang, S				Andrecut, Mircea; Halley, Julianne D.; Winkler, David A.; Huang, Sui			A General Model for Binary Cell Fate Decision Gene Circuits with Degeneracy: Indeterminacy and Switch Behavior in the Absence of Cooperativity	PLOS ONE			English	Article							TRANSCRIPTION FACTORS GATA-1; STEM-CELL; C/EBP-ALPHA; LINEAGE-COMMITMENT; PU.1; EXPRESSION; MOUSE; TROPHECTODERM; LANDSCAPE; STATE	Background: The gene regulatory circuit motif in which two opposing fate-determining transcription factors inhibit each other but activate themselves has been used in mathematical models of binary cell fate decisions in multipotent stem or progenitor cells. This simple circuit can generate multistability and explains the symmetric "poised" precursor state in which both factors are present in the cell at equal amounts as well as the resolution of this indeterminate state as the cell commits to either cell fate characterized by an asymmetric expression pattern of the two factors. This establishes the two alternative stable attractors that represent the two fate options. It has been debated whether cooperativity of molecular interactions is necessary to produce such multistability. Principal Findings: Here we take a general modeling approach and argue that this question is not relevant. We show that non-linearity can arise in two distinct models in which no explicit interaction between the two factors is assumed and that distinct chemical reaction kinetic formalisms can lead to the same (generic) dynamical system form. Moreover, we describe a novel type of bifurcation that produces a degenerate steady state that can explain the metastable state of indeterminacy prior to cell fate decision-making and is consistent with biological observations. Conclusion: The general model presented here thus offers a novel principle for linking regulatory circuits with the state of indeterminacy characteristic of multipotent (stem) cells.	[Andrecut, Mircea; Halley, Julianne D.; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Winkler, David A.] CSIRO, Clayton, Vic 3168, Australia; [Winkler, David A.] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	University of Calgary; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Andrecut, M (corresponding author), Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada.	Dave.Winkler@csiro.au; sui.huang@ucalgary.ca	Winkler, David A/A-3774-2008	Winkler, David A/0000-0002-7301-6076; Winkler, David Alan/0000-0003-2423-674X	Alberta Innovates/iCore; National Sciences and Engineering Research Council of Canada [372012-2009]; Victoria Fellowship; CSIRO	Alberta Innovates/iCore; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Victoria Fellowship; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Alberta Innovates/iCore (M.A., S.H.); National Sciences and Engineering Research Council of Canada (S.H.), grant number: 372012-2009; Victoria Fellowship (J.D.H.); CSIRO Newton Turner Award (D.A.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrecut M, 2008, J THEOR BIOL, V250, P468, DOI 10.1016/j.jtbi.2007.10.035; Andrecut M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/148; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bar-Yam Y, 1997, STUDIES NONLINEARITY; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHEN HM, 1995, ONCOGENE, V11, P1549; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; DELBRUCK M, 1949, C INT CTR NAT RECH S; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; HALLEY JD, 2009, STEM CELL RES; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; HUANG S, 2009, ENCY COMPLEXITY SYST; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000380; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Lipshtat A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188101; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; NICOLIS G, 1986, REP PROG PHYS, V49, P873, DOI 10.1088/0034-4885/49/8/002; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Rangatia J, 2002, MOL CELL BIOL, V22, P8681, DOI 10.1128/MCB.22.24.8681-8694.2002; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Sneppen K., 2005, PHYS MOL BIOL; Sternman J., 2000, BUSINESS DYNAMICS SY; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; WANG J, BIOPHYS J IN PRESS; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; ZHOU JX, 2010, TRENDS GENE IN PRESS; ZHOU JX, 2010, TRANDS GENE IN PRESS	59	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19358	10.1371/journal.pone.0019358	http://dx.doi.org/10.1371/journal.pone.0019358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625586	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200006
J	Dahlin, JS; Ivarsson, MA; Heyman, B; Hallgren, J				Dahlin, Joakim S.; Ivarsson, Martin A.; Heyman, Birgitta; Hallgren, Jenny			IgE Immune Complexes Stimulate an Increase in Lung Mast Cell Progenitors in a Mouse Model of Allergic Airway Inflammation	PLOS ONE			English	Article							FC-GAMMA-RIV; IMMUNOGLOBULIN-E; IN-VIVO; ASTHMA; ANTIBODY; RECEPTOR; MICE; RECRUITMENT; RESPONSES; ANTIGEN	Mast cell numbers and allergen specific IgE are increased in the lungs of patients with allergic asthma and this can be reproduced in mouse models. The increased number of mast cells is likely due to recruitment of mast cell progenitors that mature in situ. We hypothesized that formation of IgE immune complexes in the lungs of sensitized mice increase the migration of mast cell progenitors to this organ. To study this, a model of allergic airway inflammation where mice were immunized with ovalbumin (OVA) in alum twice followed by three daily intranasal challenges of either OVA coupled to trinitrophenyl (TNP) alone or as immune complexes with IgE-anti-TNP, was used. Mast cell progenitors were quantified by a limiting dilution assay. IgE immune complex challenge of sensitized mice elicited three times more mast cell progenitors per lung than challenge with the same dose of antigen alone. This dose of antigen challenge alone did not increase the levels of mast cell progenitors compared to unchallenged mice. IgE immune complex challenge of sensitized mice also enhanced the frequency of mast cell progenitors per 10 6 mononuclear cells by 2.1-fold. The enhancement of lung mast cell progenitors by IgE immune complex challenge was lost in FcR gamma deficient mice but not in CD23 deficient mice. Our data show that IgE immune complex challenge enhances the number of mast cell progenitors in the lung through activation of an Fc receptor associated with the FcR gamma chain. This most likely takes place via activation of Fc epsilon RI, although activation via Fc gamma RIV or a combination of the two receptors cannot be excluded. IgE immune complex-mediated enhancement of lung MCp numbers is a new reason to target IgE in therapies against allergic asthma.	[Dahlin, Joakim S.; Ivarsson, Martin A.; Heyman, Birgitta; Hallgren, Jenny] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Dahlin, JS (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	jenny.hallgren@imbim.uu.se	Ivarsson, Martin/AAE-2406-2020; Dahlin, Joakim/J-1057-2019; Hallgren Martinsson, Jenny/AAZ-5937-2021; Hallgren Martinsson, Jenny/AAZ-6356-2021	Ivarsson, Martin/0000-0002-7745-1331; Dahlin, Joakim/0000-0003-3007-9875; Hallgren Martinsson, Jenny/0000-0002-3685-5364; Heyman, Birgitta/0000-0003-0869-0483	Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Swedish Research Council; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation	Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation	This work was supported by grants to J. Hallgren from the Linne Foundation, Ake Wiberg Foundation (www.ake-wiberg.com/), Magnus Bergvall Foundation (www.magnbergvallsstiftelse.nu/) and the Swedish Research Council (www.vr.se/) and grants to B. Heyman from the Swedish Research Council, Ellen, Walter and Lennart Hesselman's Foundation, Hans von Kantzow's Foundation, King Gustaf V:s 80 Years Foundation (ams.orbelon.com/gv80/), Ollie and Elof Ericsson's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chvatchko Y, 1996, J EXP MED, V184, P2353, DOI 10.1084/jem.184.6.2353; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; CRAPPER RM, 1983, J IMMUNOL, V131, P923; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Getahun A, 2006, IMMUNOL LETT, V104, P38, DOI 10.1016/j.imlet.2005.11.005; GOOD A, 1980, PREPARATIONS HAPTEN; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Heyman B, 2002, ALLERGY, V57, P577, DOI 10.1034/j.1398-9995.2002.02159.x; Hirano M, 2007, NAT IMMUNOL, V8, P762, DOI 10.1038/ni1477; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Holgate S, 2009, ALLERGY, V64, P1728, DOI 10.1111/j.1398-9995.2009.02201.x; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Karasuyama H, 1988, Tanpakushitsu Kakusan Koso, V33, P2527; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; STERK AR, 1982, J IMMUNOL, V128, P838; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; TEUSCHER C, 1985, INFECT IMMUN, V48, P474, DOI 10.1128/IAI.48.2.474-479.1985; VANHERWERDEN L, 1995, LANCET, V346, P1262, DOI 10.1016/S0140-6736(95)91863-9; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zuberi RI, 2000, J IMMUNOL, V164, P2667, DOI 10.4049/jimmunol.164.5.2667	32	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20261	10.1371/journal.pone.0020261	http://dx.doi.org/10.1371/journal.pone.0020261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625525	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200055
J	Donati, G; Kesch, K; Ndremifidy, K; Schmidt, SL; Ramanamanjato, JB; Borgognini-Tarli, SM; Ganzhorn, JU				Donati, Giuseppe; Kesch, Kristina; Ndremifidy, Kelard; Schmidt, Stacey L.; Ramanamanjato, Jean-Baptiste; Borgognini-Tarli, Silvana M.; Ganzhorn, Joerg U.			Better Few than Hungry: Flexible Feeding Ecology of Collared Lemurs Eulemur collaris in Littoral Forest Fragments	PLOS ONE			English	Article							RANOMAFANA-NATIONAL-PARK; BEHAVIORAL ECOLOGY; ALOUATTA-PALLIATA; ACTIVITY PATTERNS; FULVUS-RUFUS; PRIMATE POPULATIONS; PROPITHECUS-DIADEMA; EASTERN MADAGASCAR; SOCIAL-STRUCTURE; HABITAT QUALITY	Background: Frugivorous primates are known to encounter many problems to cope with habitat degradation, due to the fluctuating spatial and temporal distribution of their food resources. Since lemur communities evolved strategies to deal with periods of food scarcity, these primates are expected to be naturally adapted to fluctuating ecological conditions and to tolerate a certain degree of habitat changes. However, behavioral and ecological strategies adopted by frugivorous lemurs to survive in secondary habitats have been little investigated. Here, we compared the behavioral ecology of collared lemurs (Eulemur collaris) in a degraded fragment of littoral forest of south-east Madagascar, Mandena, with that of their conspecifics in a more intact habitat, Sainte Luce. Methodology/Principal Findings: Lemur groups in Mandena and in Sainte Luce were censused in 2004/2007 and in 2000, respectively. Data were collected via instantaneous sampling on five lemur groups totaling 1,698 observation hours. The Shannon index was used to determine dietary diversity and nutritional analyses were conducted to assess food quality. All feeding trees were identified and measured, and ranging areas determined via the minimum convex polygon. In the degraded area lemurs were able to modify several aspects of their feeding strategies by decreasing group size and by increasing feeding time, ranging areas, and number of feeding trees. The above strategies were apparently able to counteract a clear reduction in both food quality and size of feeding trees. Conclusions/Significance: Our findings indicate that collared lemurs in littoral forest fragments modified their behavior to cope with the pressures of fluctuating resource availability. The observed flexibility is likely to be an adaptation to Malagasy rainforests, which are known to undergo periods of fruit scarcity and low productivity. These results should be carefully considered when relocating lemurs or when selecting suitable areas for their conservation.	[Donati, Giuseppe] Oxford Brookes Univ, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Donati, Giuseppe; Borgognini-Tarli, Silvana M.] Univ Pisa, Dept Biol, Pisa, Italy; [Kesch, Kristina; Ganzhorn, Joerg U.] Univ Hamburg, Dept Anim Ecol & Conservat, Hamburg, Germany; [Ndremifidy, Kelard] Univ Antananarivo, Dept Anim Biol, Antananarivo, Madagascar; [Schmidt, Stacey L.] Univ Colorado, Colorado Div Wildlife, Ft Collins, CO USA; [Ramanamanjato, Jean-Baptiste] QIT Madagascar Minerals, Rio Tinto, Tolagnaro, Madagascar	Oxford Brookes University; University of Pisa; University of Hamburg; University Antananarivo; Rio Tinto	Donati, G (corresponding author), Oxford Brookes Univ, Dept Geog & Anthropol, Oxford OX3 0BP, England.	gdonati@brookes.ac.uk	Ganzhorn, Joerg/AAO-6955-2020	Ganzhorn, Joerg/0000-0003-1395-9758; Donati, Giuseppe/0000-0002-4803-0642	Rufford Small Grant for Nature Conservation; Qit Madagascar Minerals; Department of Biology, University of Pisa; Department of Anthropology and Geography, Oxford Brookes University; Department of Animal Ecology and Conservation, University of Hamburg	Rufford Small Grant for Nature Conservation; Qit Madagascar Minerals; Department of Biology, University of Pisa; Department of Anthropology and Geography, Oxford Brookes University; Department of Animal Ecology and Conservation, University of Hamburg	The work was funded by Rufford Small Grant for Nature Conservation (http://www.ruffordsmallgrants.org/rsg/Projects/GiuseppeDonati); Qit Madagascar Minerals; Department of Biology, University of Pisa; Department of Anthropology and Geography, Oxford Brookes University; and Department of Animal Ecology and Conservation, University of Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; BALKO EA, 1998, THESIS SUNY COLL ENV; Barton RA, 1996, BEHAV ECOL SOCIOBIOL, V38, P321, DOI 10.1007/s002650050248; Bicca-Marques JC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P283; Bollen A, 2006, ORYX, V40, P57, DOI 10.1017/S0030605306000111; Bollen A, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P93, DOI 10.1007/1-4020-3833-X_6; Bollen A, 2005, BIOTROPICA, V37, P32, DOI 10.1111/j.1744-7429.2005.04094.x; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Clarke MR, 2002, INT J PRIMATOL, V23, P365, DOI 10.1023/A:1013839713223; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cowlishaw G., 2000, PRIMATE CONSERVATION; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Curtis DJ, 1999, AM J PRIMATOL, V47, P279, DOI 10.1002/(SICI)1098-2345(1999)47:4<279::AID-AJP2>3.0.CO;2-U; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Donati G, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P119; DONATI G, 2002, THESIS U PISA; Donati G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1237, DOI 10.1007/s00265-007-0354-x; Donati Giuseppe, 2007, P237; Donati G, 2009, ANIM BEHAV, V77, P317, DOI 10.1016/j.anbehav.2008.09.033; Dunn JC, 2010, INT J PRIMATOL, V31, P887, DOI 10.1007/s10764-010-9436-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Erhart EM, 2008, AM J PHYS ANTHROPOL, V136, P183, DOI 10.1002/ajpa.20793; Estrada A, 1996, INT J PRIMATOL, V17, P759, DOI 10.1007/BF02735263; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Ganzhorn J. U., 2007, BIODIVERSITY ECOLOGY, V11; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; Ganzhorn Joerg U., 2007, P223; Ganzhorn Jorg U., 1999, P75, DOI 10.1017/CBO9780511542381.005; GANZHORN JU, 1988, OECOLOGIA, V75, P436, DOI 10.1007/BF00376949; GANZHORN JU, 1995, ECOLOGY, V76, P2084, DOI 10.2307/1941683; GARDNER CJ, 2009, MALAGASY NATURE, V2, P2; Glander K.E., 1981, P231; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Holloway Louise, 1999, Lemur News, V4, P29; Irwin MT, 2008, INT J PRIMATOL, V29, P95, DOI 10.1007/s10764-007-9222-9; Irwin MT, 2007, AM J PRIMATOL, V69, P434, DOI 10.1002/ajp.20360; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IWAMOTO T, 1983, J ANIM ECOL, V52, P357, DOI 10.2307/4559; KURLAND JA, 1987, PRIMATES, V28, P71, DOI 10.1007/BF02382184; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; LEIGHTON M, 1982, BIOTROPICA, V14, P81, DOI 10.2307/2387735; Lovejoy T.E., 1986, P257; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; MARSH CW, 1981, FOLIA PRIMATOL, V35, P30, DOI 10.1159/000155964; Marsh L.K., 2003, PARKS RES FOR ONT P; MEDLEY KE, 1993, ECON BOT, V47, P171, DOI 10.1007/BF02862020; Menon S, 1996, INT J PRIMATOL, V17, P969, DOI 10.1007/BF02735297; MERENLENDER A, 1998, CONSERV ECOL, V2; NAGY KA, 1979, ECOLOGY, V60, P475, DOI 10.2307/1936066; Oates J.F., 1977, PRIMATE ECOLOGY, P276; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; Ortmann Sylvia, 2006, P397; Overdorff DJ, 1999, AM J PHYS ANTHROPOL, V108, P295, DOI 10.1002/(SICI)1096-8644(199903)108:3<295::AID-AJPA5>3.3.CO;2-H; OVERDORFF DJ, 1993, INT J PRIMATOL, V14, P721, DOI 10.1007/BF02192188; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; Pereira ME, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P93; PLUMPTRE AJ, 1994, J APPL ECOL, V31, P631, DOI 10.2307/2404154; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rabenantoandro J., 2007, BIODIVERSITY ECOLOGY, P65; RASMUSSEN MA, 1999, THESIS DUKE U DURHAM; Ratsimbazafy Jonah H., 2002, Lemur News, V7, P7; Reich PB, 2001, TRENDS ECOL EVOL, V16, P674, DOI 10.1016/S0169-5347(01)02306-0; RICHARD AF, 1991, ANNU REV ECOL SYST, V22, P145, DOI 10.1146/annurev.es.22.110191.001045; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Rode KD, 2006, BIOTROPICA, V38, P625, DOI 10.1111/j.1744-7429.2006.00183.x; Ross Caroline, 2003, P90; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Schwitzer Nora, 2007, Endangered Species Research, V3, P239; Stevenson PR, 1998, INT J PRIMATOL, V19, P313, DOI 10.1023/A:1020387700923; STRIER KB, 1989, FOLIA PRIMATOL, V52, P70, DOI 10.1159/000156383; Sussman R.W., 1974, P75; Tutin CEG, 1999, PRIMATES, V40, P249, DOI 10.1007/BF02557714; van Hooff J.A.R.A.M., 1992, P357; Vasey N., 2003, NAT HIST MADAG, P1332; VASEY N, 1997, THESIS WASHINGTON U; WHITE FJ, 1995, FOLIA PRIMATOL, V64, P124, DOI 10.1159/000156842; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; Wright PC, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P121, DOI 10.1007/1-4020-3833-X_7; Zinner D, 1999, ZOO BIOL, V18, P495, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;495::AID-ZOO4&gt;3.0.CO;2-U	87	38	38	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19807	10.1371/journal.pone.0019807	http://dx.doi.org/10.1371/journal.pone.0019807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766HI	21625557	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200025
J	Gao, Y; Chung, T; Zou, X; Pike, HM; Brown, RE				Gao, Yongguang; Chung, Taeowan; Zou, Xianqiong; Pike, Helen M.; Brown, Rhoderick E.			Human Glycolipid Transfer Protein (GLTP) Expression Modulates Cell Shape	PLOS ONE			English	Article							DELTA-CATENIN; DOWN-REGULATION; GROWTH; GLYCOSPHINGOLIPIDS; ADHESION; PROLIFERATION; MOTILITY; PATHWAY; GENE	Glycolipid transfer protein (GLTP) accelerates glycosphingolipid (GSL) intermembrane transfer via a unique lipid transfer/binding fold (GLTP-fold) that defines the GLTP superfamily and is the prototype for GLTP-like domains in larger proteins, i.e. phosphoinositol 4-phosphate adaptor protein-2 (FAPP2). Although GLTP-folds are known to play roles in the nonvesicular intracellular trafficking of glycolipids, their ability to alter cell phenotype remains unexplored. In the present study, overexpression of human glycolipid transfer protein (GLTP) was found to dramatically alter cell phenotype, with cells becoming round between 24 and 48 h after transfection. By 48 h post transfection, similar to 70% conversion to the markedly round shape was evident in HeLa and HEK-293 cells, but not in A549 cells. In contrast, overexpression of W96A-GLTP, a liganding-site point mutant with abrogated ability to transfer glycolipid, did not alter cell shape. The round adherent cells exhibited diminished motility in wound healing assays and an inability to endocytose cholera toxin but remained viable and showed little increase in apoptosis as assessed by poly(ADP-ribose) polymerase cleavage. A round cell phenotype also was induced by overexpression of FAPP2, which binds/transfers glycolipid via its C-terminal GLTP-like fold, but not by a plant GLTP ortholog (ACD11), which is incapable of glycolipid binding/transfer. Screening for human protein partners of GLTP by yeast two hybrid screening and by immuno-pulldown analyses revealed regulation of the GLTP-induced cell rounding response by interaction with delta-catenin. Remarkably, while delta-catenin overexpression alone induced dendritic outgrowths, coexpression of GLTP along with delta-catenin accelerated transition to the rounded phenotype. The findings represent the first known phenotypic changes triggered by GLTP overexpression and regulated by direct interaction with a p120-catenin protein family member.	[Gao, Yongguang; Zou, Xianqiong; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Chung, Taeowan] Yeungnam Univ, Sch Biotechnol, Kyeongsan, South Korea	University of Minnesota System; Yeungnam University	Gao, Y (corresponding author), Univ Calif Meced, Sch Nat Sci, Merced, CA USA.	reb@umn.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252; Brown, Rhoderick/0000-0002-7337-3604	Hormel Foundation;  [NIH GM45928];  [NIH CA121493]; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	Hormel Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We express our gratitude for financial support by NIH GM45928, NIH CA121493, and The Hormel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bektas M, 2003, GLYCOCONJUGATE J, V20, P39, DOI 10.1023/B:GLYC.0000016741.88476.8b; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Neumann S, 2008, BIOL CHEM, V389, P1349, DOI 10.1515/BC.2008.154; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Reynolds AB, 2010, CELL, V141, P20, DOI 10.1016/j.cell.2010.03.022; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang T, 2009, ONCOGENE, V28, P555, DOI 10.1038/onc.2008.399; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19990	10.1371/journal.pone.0019990	http://dx.doi.org/10.1371/journal.pone.0019990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625605	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200055
J	Miller, KJ; Rowden, AA; Williams, A; Haussermann, V				Miller, Karen J.; Rowden, Ashley A.; Williams, Alan; Hauessermann, Vreni			Out of Their Depth? Isolated Deep Populations of the Cosmopolitan Coral Desmophyllum dianthus May Be Highly Vulnerable to Environmental Change	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SCLERACTINIAN CORALS; INTEGRATED SOFTWARE; SECONDARY STRUCTURE; MARINE ECOSYSTEMS; SEA; CONNECTIVITY; DIVERSITY; SEQUENCES; SEAMOUNTS	Deep sea scleractinian corals will be particularly vulnerable to the effects of climate change, facing loss of up to70% of their habitat as the Aragonite Saturation Horizon (below which corals are unable to form calcium carbonate skeletons) rises. Persistence of deep sea scleractinian corals will therefore rely on the ability of larvae to disperse to, and colonise, suitable shallow-water habitat. We used DNA sequence data of the internal transcribed spacer (ITS), the mitochondrial ribosomal subunit (16S) and mitochondrial control region (MtC) to determine levels of gene flow both within and among populations of the deep sea coral Desmophyllum dianthus in SE Australia, New Zealand and Chile to assess the ability of corals to disperse into different regions and habitats. We found significant genetic subdivision among the three widely separated geographic regions consistent with isolation and limited contemporary gene flow. Furthermore, corals from different depth strata (shallow <600 m, mid 1000-1500 m, deep >1500 m) even on the same or nearby seamounts were strongly differentiated, indicating limited vertical larval dispersal. Genetic differentiation with depth is consistent with the stratification of the Subantarctic Mode Water, Antarctic Intermediate Water, the Circumpolar Deep and North Pacific Deep Waters in the Southern Ocean, and we propose that coral larvae will be retained within, and rarely migrate among, these water masses. The apparent absence of vertical larval dispersal suggests deep populations of D. dianthus are unlikely to colonise shallow water as the aragonite saturation horizon rises and deep waters become uninhabitable. Similarly, assumptions that deep populations will act as refuges for shallow populations that are impacted by activities such as fishing or mining are also unlikely to hold true. Clearly future environmental management strategies must consider both regional and depth-related isolation of deep-sea coral populations.	[Miller, Karen J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Rowden, Ashley A.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Williams, Alan] Commonwealth Sci & Ind Res Org, Hobart, Tas, Australia; [Hauessermann, Vreni] Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Fac Recursos Nat, Valparaiso, Chile; [Hauessermann, Vreni] Huinay Sci Field Stn, Puerto Montt, Chile	University of Tasmania; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Pontificia Universidad Catolica de Valparaiso	Miller, KJ (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Karen.Miller@utas.edu.au	Williams, Alan/C-6999-2012; Miller, Karen/A-7902-2011; Rowden, Ashley/ABG-6010-2020; Miller, Karen/V-4098-2019; Rowden, Ashley/O-9358-2019	Williams, Alan/0000-0002-2867-7713; Rowden, Ashley/0000-0003-2975-2524	New Zealand Foundation for Research, Science and Technology; Ministry of Fisheries; Australian Government Department of Environment and Heritage; CSIRO Wealth; Global Census of Marine Life on Seamounts (CenSeam)	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Ministry of Fisheries; Australian Government Department of Environment and Heritage(Australian Government); CSIRO Wealth; Global Census of Marine Life on Seamounts (CenSeam)	This research was supported by the Global Census of Marine Life on Seamounts (CenSeam), the NIWA project 'Seamounts: their importance for fisheries and marine ecosystems' funded by the New Zealand Foundation for Research, Science and Technology and the Ministry of Fisheries, the Australian Government Department of Environment and Heritage and the CSIRO Wealth from Oceans Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Arantes RCM, 2009, MAR ECOL PROG SER, V397, P71, DOI 10.3354/meps08230; Audzijonyte A, 2010, EVOLUTION, V64, P2369, DOI 10.1111/j.1558-5646.2010.00987.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Cairns S.D., 1995, NZ OCEANOGRAPHIC I M, V103; Cairns S.D, 1994, SMITHSONIAN CONTRIBU, V557, P150; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Chen CA, 2004, ZOOL STUD, V43, P759; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; CLARK MR, 2007, IMPACTS FISHERIES SE, P413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coleman AW, 2008, J MOL EVOL, V67, P389, DOI 10.1007/s00239-008-9160-y; Costantini F, 2010, MAR ECOL-EVOL PERSP, V31, P261, DOI 10.1111/j.1439-0485.2009.00333.x; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Duenas LF, 2009, MAR ECOL PROG SER, V397, P11, DOI 10.3354/meps08307; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Forsterra G., 2003, ZOOL VERH, V345, P117; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P304; GRANGE KR, 1981, NEW ZEAL J ZOOL, V8, P209, DOI 10.1080/03014223.1981.10427963; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Haussermann V, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P195; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; MCCULLOCH M, 2005, 3 INT S DEEP SEA COR, V3; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; SCHMITZ WJ, 1996, WORLD OCEAN CIRCULAT, V1, P141; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Smith PJ, 2004, MAR BIOL, V144, P253, DOI 10.1007/s00227-003-1206-5; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Swofford DL, 1998, PHYLOGENETIC ANAL US; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Vezina AF, 2008, MAR ECOL PROG SER, V373, P199, DOI 10.3354/meps07868; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; Wright S, 1931, GENETICS, V16, P0097; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x	55	32	33	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19004	10.1371/journal.pone.0019004	http://dx.doi.org/10.1371/journal.pone.0019004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611159	Green Published, gold			2022-12-27	WOS:000290720200004
J	Benson, RW; Norton, MD; Lin, I; Du Comb, WS; Godoy, VG				Benson, Ryan W.; Norton, Matthew D.; Lin, Ida; Du Comb, William S.; Godoy, Veronica G.			An Active Site Aromatic Triad in Escherichia coli DNA Pol IV Coordinates Cell Survival and Mutagenesis in Different DNA Damaging Agents	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; POLYMERASE-III HOLOENZYME; Y-FAMILY; IN-VITRO; BETA-CLAMP; REPLICATION; BYPASS; ROLES; LESIONS; METHYL	DinB (DNA Pol IV) is a translesion (TLS) DNA polymerase, which inserts a nucleotide opposite an otherwise replication-stalling N-2-dG lesion in vitro, and confers resistance to nitrofurazone (NFZ), a compound that forms these lesions in vivo. DinB is also known to be part of the cellular response to alkylation DNA damage. Yet it is not known if DinB active site residues, in addition to aminoacids involved in DNA synthesis, are critical in alkylation lesion bypass. It is also unclear which active site aminoacids, if any, might modulate DinB's bypass fidelity of distinct lesions. Here we report that along with the classical catalytic residues, an active site "aromatic triad'', namely residues F12, F13, and Y79, is critical for cell survival in the presence of the alkylating agent methyl methanesulfonate (MMS). Strains expressing dinB alleles with single point mutations in the aromatic triad survive poorly in MMS. Remarkably, these strains show fewer MMS-than NFZ-induced mutants, suggesting that the aromatic triad, in addition to its role in TLS, modulates DinB's accuracy in bypassing distinct lesions. The high bypass fidelity of prevalent alkylation lesions is evident even when the DinB active site performs error-prone NFZ-induced lesion bypass. The analyses carried out with the active site aromatic triad suggest that the DinB active site residues are poised to proficiently bypass distinctive DNA lesions, yet they are also malleable so that the accuracy of the bypass is lesion-dependent.	[Benson, Ryan W.; Norton, Matthew D.; Lin, Ida; Du Comb, William S.; Godoy, Veronica G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Benson, RW (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	v.godoycarter@neu.edu			NIGMS [1RO1GM088230-01A1]; RSFD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088230] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); RSFD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the 1RO1GM088230-01A1 award from NIGMS to V. G. Godoy and in part by an RSFD award to V. G. Godoy by the office of the Provost of Northeastern University (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson DI, 2010, MOL MICROBIOL, V77, P540, DOI 10.1111/j.1365-2958.2010.07260.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becherel OJ, 2002, DNA REPAIR, V1, P703, DOI 10.1016/S1568-7864(02)00106-4; Benson RW, 2011, J MICROBIOL METH, V84, P479, DOI 10.1016/j.mimet.2010.12.020; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; Bjedov I, 2003, DNA REPAIR, V2, P417, DOI 10.1016/S1568-7864(02)00241-0; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURCH LH, 2011, CELL CYCLE, P10; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Foti JJ, 2010, J BIOL CHEM, V285, P23084, DOI 10.1074/jbc.M110.115774; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Godoy VG, 2000, GENETICS, V154, P49; GODOY VG, 2005, ENCY BIOL CHEM, P546; Grzesiuk E, 2001, MUTAT RES-FUND MOL M, V480, P77, DOI 10.1016/S0027-5107(01)00171-3; Jarosz DF, 2009, P NATL ACAD SCI USA, V106, P21137, DOI 10.1073/pnas.0907257106; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Johnson RE, 2007, MOL CELL BIOL, V27, P7198, DOI 10.1128/MCB.01079-07; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; KIM HS, 1994, P NATL ACAD SCI USA, V91, P3725, DOI 10.1073/pnas.91.9.3725; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KWONSHIN O, 1987, J BIOL CHEM, V262, P2121; Kyrtopoulos SA, 1998, MUTAT RES-FUND MOL M, V405, P135, DOI 10.1016/S0027-5107(98)00130-4; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lawley P D, 1966, Prog Nucleic Acid Res Mol Biol, V5, P89, DOI 10.1016/S0079-6603(08)60232-9; LENGELER J, 1980, ARCH MICROBIOL, V128, P196, DOI 10.1007/BF00406158; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MAGUIN E, 1986, J BACTERIOL, V166, P733, DOI 10.1128/jb.166.3.733-738.1986; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monti P, 2004, BIOCHEMISTRY-US, V43, P5592, DOI 10.1021/bi035968x; MURRAYLY.IM, 1968, LANCET, V2, P895; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ona KR, 2009, J BACTERIOL, V191, P4959, DOI 10.1128/JB.00495-09; PANIGRAHI GB, 1990, BIOCHEMISTRY-US, V29, P2122, DOI 10.1021/bi00460a023; Pillaire MJ, 2010, ONCOGENE, V29, P876, DOI 10.1038/onc.2009.378; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; REBECK GW, 1991, J BACTERIOL, V173, P2068, DOI 10.1128/jb.173.6.2068-2076.1991; Rodgers G. L., 1997, Journal of Burn Care and Rehabilitation, V18, P406, DOI 10.1097/00004630-199709000-00006; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SENGUPTA S, 1990, MUTAT RES, V244, P55, DOI 10.1016/0165-7992(90)90108-V; Shah D, 2001, BIOCHEMISTRY-US, V40, P1796, DOI 10.1021/bi0024658; SHAVITT O, 1989, J BIOL CHEM, V264, P11275; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; SINGER B, 1982, ANNU REV BIOCHEM, V51, P655, DOI 10.1146/annurev.bi.51.070182.003255; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; WANG H, 2010, NEURO ONCOL; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	76	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19944	10.1371/journal.pone.0019944	http://dx.doi.org/10.1371/journal.pone.0019944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21614131	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500036
J	Franklin, BS; Vitorino, BLF; Coelho, HC; Menezes-Neto, A; Santos, MLS; Campos, FMF; Brito, CF; Fontes, CJ; Lacerda, MV; Carvalho, LH				Franklin, Bernardo S.; Vitorino, Barbara L. F.; Coelho, Helena C.; Menezes-Neto, Armando; Santos, Marina L. S.; Campos, Fernanda M. F.; Brito, Cristiana F.; Fontes, Cor J.; Lacerda, Marcus V.; Carvalho, Luzia H.			Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; CELL-FREE DNA; CANCER-PATIENTS; MYOCARDIAL-INFARCTION; MICROARRAY ANALYSIS; FALCIPARUM MALARIA; NORTHWESTERN INDIA; PROGNOSTIC MARKER; BRAZILIAN AMAZON	Background: Given the increasing evidence of Plasmodium vivax infections associated with severe and fatal disease, the identification of sensitive and reliable markers for vivax severity is crucial to improve patient care. Circulating nucleic acids (CNAs) have been increasingly recognized as powerful diagnostic and prognostic tools for various inflammatory diseases and tumors as their plasma concentrations increase according to malignancy. Given the marked inflammatory status of P. vivax infection, we investigated here the usefulness of CNAs as biomarkers for malaria morbidity. Methods and Findings: CNAs levels in plasma from twenty-one acute P. vivax malaria patients from the Brazilian Amazon and 14 malaria non-exposed healthy donors were quantified by two different methodologies: amplification of the human telomerase reverse transcriptase (hTERT) genomic sequence by quantitative real time PCR (qPCR), and the fluorometric dsDNA quantification by Pico Green. CNAs levels were significantly increased in plasma from P. vivax patients as compared to healthy donors (p<0.0001). Importantly, plasma CNAs levels were strongly associated with vivax morbidity (p<0.0001), including a drop in platelet counts (p = 0.0021). These findings were further sustained when we assessed CNAS levels in plasma samples from 14 additional P. vivax patients of a different endemic area in Brazil, in which CNAS levels strongly correlated with thrombocytopenia (p = 0.0072). We further show that plasma CNAs levels decrease and reach physiological levels after antimalarial treatment. Although we found both host and parasite specific genomic sequences circulating in plasma, only host CNAs clearly reflected the clinical spectrum of P. vivax malaria. Conclusions: Here, we provide the first evidence of increased plasma CNAs levels in malaria patients and reveal their potential as sensitive biomarkers for vivax malaria morbidity.	[Franklin, Bernardo S.; Vitorino, Barbara L. F.; Menezes-Neto, Armando; Santos, Marina L. S.; Campos, Fernanda M. F.; Brito, Cristiana F.; Carvalho, Luzia H.] Fundacao Oswaldo Cruz, Lab Malaria, Ctr Pesquisa Rene, Belo Horizonte, MG, Brazil; [Coelho, Helena C.; Lacerda, Marcus V.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Fontes, Cor J.] Univ Fed Mato Grosso, Dept Clin Med, Cuiaba, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso	Franklin, BS (corresponding author), Fundacao Oswaldo Cruz, Lab Malaria, Ctr Pesquisa Rene, Belo Horizonte, MG, Brazil.	bernardo@cpqrr.fiocruz.br; lhcarvalho@cpqrr.fiocruz.br	Fontes, Cor JF/G-7331-2018; carvalho, luzia H/C-4087-2013; Franklin, Bernardo S/G-8186-2012; Campos, Fernanda/GRR-6776-2022; Carvalho, Luzia H/AAW-3461-2021	Fontes, Cor JF/0000-0003-2756-0588; Franklin, Bernardo S/0000-0003-2591-9833; Menezes-Neto, Armando/0000-0002-2003-908X	Research Foundation of Minas Gerais State (FAPEMIG); Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Pronex Malaria; CNPq/DECIT/MS; FAPEMIG; CNPq-FIOCRUZ; CNPq; Helixis Young Investigator Award	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Pronex Malaria; CNPq/DECIT/MS(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Helixis Young Investigator Award	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), The Brazilian National Research Council (CNPq), and Oswaldo Cruz Foundation (FIOCRUZ, PAPES V), Pronex Malaria, CNPq/DECIT/MS; scholarships from FAPEMIG (FMFC), CNPq-FIOCRUZ (BSF), and CNPq (LHC, ATC, and CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Program for Technological Development in Tools for Health - PDTIS - FIOCRUZ for use of its facilities; Belisa Maria Lopes Magalhaes and Raimunda Ericilda da Silva for their help with patients in the endemic area. The authors would also like to thank the Helixis Incorporation (currently Illumina) for the PIXO Real Time PCR Instrumet awarded to BSF as the 2009 winner of the Helixis Young Investigator Award.	Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Anker P, 2002, CLIN CHEM, V48, P1210; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001; Atamaniuk J, 2006, CLIN CHEM, V52, P523, DOI 10.1373/clinchem.2005.058883; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Chen JA, 2007, AUTOIMMUNITY, V40, P307, DOI 10.1080/08916930701356317; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; ELLINGER J, 2009, UROL ONCOL; Ellinger J, 2008, CANCER LETT, V264, P274, DOI 10.1016/j.canlet.2008.01.038; Ellinger J, 2009, J UROLOGY, V181, P363, DOI 10.1016/j.juro.2008.08.118; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang ZH, 2006, CANCER LETT, V243, P64, DOI 10.1016/j.canlet.2005.11.027; Jahr S, 2001, CANCER RES, V61, P1659; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jung K, 2004, CANCER LETT, V205, P173, DOI 10.1016/j.canlet.2003.11.023; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Karunaweera ND, 1998, AM J TROP MED HYG, V58, P204, DOI 10.4269/ajtmh.1998.58.204; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, PLATELETS, V21, P623, DOI 10.3109/09537104.2010.505308; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KOFFLER D, 1973, J CLIN INVEST, V52, P198, DOI 10.1172/JCI107165; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Mandel P., 1948, CR HEBD ACAD SCI, P142; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miu J, 2008, INFECT IMMUN, V76, P1812, DOI 10.1128/IAI.01650-07; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ombrello C, 2010, J CARDIOVASC TRANSL, V3, P538, DOI 10.1007/s12265-010-9213-7; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Rani S, 2007, CLIN CHEM, V53, P1936, DOI 10.1373/clinchem.2007.087973; Shaikh Qurban Hussain, 2009, J Coll Physicians Surg Pak, V19, P708, DOI 11.2009/JCPSP.708710; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sozzi G, 2001, CANCER RES, V61, P4675; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trejo-Becerril C, 2003, INT J CANCER, V104, P663, DOI 10.1002/ijc.11003; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; World Health Organization, 2000, SEV FALC MAL	59	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19842	10.1371/journal.pone.0019842	http://dx.doi.org/10.1371/journal.pone.0019842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611202	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500028
J	Arndt, PG; Strahan, B; Wang, Y; Long, CM; Horiuchi, K; Walcheck, B				Arndt, Patrick G.; Strahan, Brian; Wang, Yue; Long, Chunmei; Horiuchi, Keisuke; Walcheck, Bruce			Leukocyte ADAM17 Regulates Acute Pulmonary Inflammation	PLOS ONE			English	Article							ACUTE LUNG INJURY; NECROSIS-FACTOR-ALPHA; IN-VIVO; TNF-ALPHA; FUNCTIONAL-CHARACTERIZATION; NEUTROPHIL ACCUMULATION; CHEMOKINE KC; CELLS; LIPOPOLYSACCHARIDE; EXPRESSION	The transmembrane protease ADAM17 regulates the release and density of various leukocyte cell surface proteins that modulate inflammation, including L-selectin, TNF-alpha, and IL-6R. At this time, its in vivo substrates and role in pulmonary inflammation have not been directly examined. Using conditional ADAM17 knock-out mice, we investigated leukocyte ADAM17 in acute lung inflammation. Alveolar TNF-a levels were significantly reduced (>95%) in ADAM17-null mice following LPS administration, as was the shedding of L-selectin, a neutrophil-expressed adhesion molecule. Alveolar IL-6R levels, however, were reduced by only approximate to 25% in ADAM17-null mice, indicating that ADAM17 is not its primary sheddase in our model. Neutrophil infiltration into the alveolar compartment is a key event in the pathophysiology of acute airway inflammation. Following LPS inhalation, alveolar neutrophil levels and lung inflammation in ADAM17-null mice were overall reduced when compared to control mice. Interestingly, however, neutrophil recruitment to the alveolar compartment occurred earlier in ADAM17-null mice after exposure to LPS. This decrease in alveolar neutrophil recruitment in ADAM17-null mice was accompanied by significantly diminished alveolar levels of the neutrophil-tropic chemokines CXCL1 and CXCL5. Altogether, our study suggests that leukocyte ADAM17 promotes inflammation in the lung, and thus this sheddase may be a potential target in the design of pharmacologic therapies for acute lung injury.	[Arndt, Patrick G.; Strahan, Brian] Univ Minnesota, Dept Internal Med, Div Pulm Allergy & Crit Care Med, St Paul, MN 55108 USA; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan	University of Minnesota System; University of Minnesota Twin Cities; Keio University	Arndt, PG (corresponding author), Univ Minnesota, Dept Internal Med, Div Pulm Allergy & Crit Care Med, St Paul, MN 55108 USA.	walch003@umn.edu	Horiuchi, Keisuke/L-2277-2013	Horiuchi, Keisuke/0000-0001-7063-9609	National Institutes of Health [HL61613, AI083521, HL84201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084201, R01HL061613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by research funding HL61613, AI083521 (BW) and HL84201 (PGA) from the National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Arndt PG, 2005, J IMMUNOL, V175, P4049, DOI 10.4049/jimmunol.175.6.4049; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Calkins CM, 2001, J SURG RES, V101, P232, DOI 10.1006/jsre.2001.6274; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; Elizur A, 2008, AM J RESP CELL MOL, V38, P8, DOI 10.1165/rcmb.2007-0203OC; FREVERT CW, 1995, J IMMUNOL, V154, P335; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McColl SR, 1999, J IMMUNOL, V163, P2829; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Neumann B, 1996, J IMMUNOL, V156, P1587; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zhang XW, 2001, EUR J PHARMACOL, V427, P277, DOI 10.1016/S0014-2999(01)01235-3	43	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19938	10.1371/journal.pone.0019938	http://dx.doi.org/10.1371/journal.pone.0019938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603616	Green Submitted, gold, Green Published			2022-12-27	WOS:000290656300041
J	Hagen, M; Wikelski, M; Kissling, WD				Hagen, Melanie; Wikelski, Martin; Kissling, W. Daniel			Space Use of Bumblebees (Bombus spp.) Revealed by Radio-Tracking	PLOS ONE			English	Article							FORAGING RANGE; TERRESTRIS HYMENOPTERA; LANDSCAPE-SCALE; BEES; DISTANCES; POLLINATORS; CONSERVATION; PATTERNS; DENSITY; APIDAE	Background: Accurate estimates of movement behavior and distances travelled by animals are difficult to obtain, especially for small-bodied insects where transmitter weights have prevented the use of radio-tracking. Methodology/Principal Findings: Here, we report the first successful use of micro radio telemetry to track flight distances and space use of bumblebees. Using ground surveys and Cessna overflights in a Central European rural landscape mosaic we obtained maximum flight distances of 2.5 km, 1.9 km and 1.3 km for Bombus terrestris (workers), Bombus ruderatus (worker), and Bombus hortorum (young queens), respectively. Bumblebee individuals used large areas (0.25-43.53 ha) within one or a few days. Habitat analyses of one B. hortorum queen at the landscape scale indicated that gardens within villages were used more often than expected from habitat availability. Detailed movement trajectories of this individual revealed that prominent landscape structures (e. g. trees) and flower patches were repeatedly visited. However, we also observed long (i.e. >45 min) resting periods between flights (B. hortorum) and differences in flower-handling between bumblebees with and without transmitters (B. terrestris) suggesting that the current weight of transmitters (200 mg) may still impose significant energetic costs on the insects. Conclusions/Significance: Spatio-temporal movements of bumblebees can now be tracked with telemetry methods. Our measured flight distances exceed many previous estimates of bumblebee foraging ranges and suggest that travelling long distances to food resources may be common. However, even the smallest currently available transmitters still appear to compromise flower handling performance and cause an increase in resting behavior of bees. Future reductions of transmitter mass and size could open up new avenues for quantifying landscape-scale space use of insect pollinators and could provide novel insights into the behavior and requirements of bumblebees during critical life stages, e. g. when searching for mates, nest locations or hibernation sites.	[Hagen, Melanie] Univ Bielefeld, Bielefeld, Germany; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Kissling, W. Daniel] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, Aarhus, Denmark	University of Bielefeld; Max Planck Society; Aarhus University	Hagen, M (corresponding author), Univ Bielefeld, Bielefeld, Germany.	melanie.hagen@web.de	Kissling, W. Daniel/B-1749-2009; Hagen, Melanie/I-7939-2013		Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MR, 2007, J APPL ENTOMOL, V131, P537, DOI 10.1111/j.1439-0418.2007.01162.x; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Carvell C, 2006, APIDOLOGIE, V37, P326, DOI 10.1051/apido:2006002; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Comba L, 1999, ETHOL ECOL EVOL, V11, P243, DOI 10.1080/08927014.1999.9522826; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Dramstad WE, 1996, J INSECT BEHAV, V9, P163, DOI 10.1007/BF02213863; Eddy W. F., 1977, ACM Transactions on Mathematical Software, V3, P398, DOI 10.1145/355759.355766; Elliott SE, 2009, ENVIRON ENTOMOL, V38, P748, DOI 10.1603/022.038.0327; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Heinrich B., 1979, BUMBLEBEE EC; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Jenness J, 2008, ARCVIEW 3 X EXTENSIO; Kenward R., 1987, WILDLIFE RADIO TAGGI; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2004, J ANIM ECOL, V73, P517, DOI 10.1111/j.0021-8790.2004.00826.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; PFLUMM W, 1977, APIDOLOGIE, V8, P401, DOI 10.1051/apido:19770410; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Riley JR, 1998, J INSECT BEHAV, V11, P287, DOI 10.1023/A:1021004209198; Saure Christoph, 1996, Linnean Society Symposium Series, V18, P47; Saville NM, 1997, AGR ECOSYST ENVIRON, V61, P145, DOI 10.1016/S0167-8809(96)01100-0; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; Tommasi D, 2004, CAN ENTOMOL, V136, P851; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; White G.C., 1990, ANAL WILDLIFE RADIO; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Williams P, 2000, BRITAIN PRELIMINARY; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Williams P, 2009, CONSERV BIOL, V23, P931, DOI 10.1111/j.1523-1739.2009.01176.x; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; WILLMER PG, 1994, ECOL ENTOMOL, V19, P271, DOI 10.1111/j.1365-2311.1994.tb00419.x; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	60	135	141	3	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19997	10.1371/journal.pone.0019997	http://dx.doi.org/10.1371/journal.pone.0019997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603569	Green Submitted, gold, Green Published			2022-12-27	WOS:000290656300047
J	Oelkers, JM; Vinzenz, M; Nemethova, M; Jacob, S; Lai, FPL; Block, J; Szczodrak, M; Kerkhoff, E; Backert, S; Schluter, K; Stradal, TEB; Small, JV; Koestler, SA; Rottner, K				Oelkers, J. Margit; Vinzenz, Marlene; Nemethova, Maria; Jacob, Sonja; Lai, Frank P. L.; Block, Jennifer; Szczodrak, Malgorzata; Kerkhoff, Eugen; Backert, Steffen; Schlueter, Kai; Stradal, Theresia E. B.; Small, J. Victor; Koestler, Stefan A.; Rottner, Klemens			Microtubules as Platforms for Assaying Actin Polymerization In Vivo	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; FILOPODIA FORMATION; WASP/SCAR PROTEINS; NUCLEATION FACTOR; CELL-ADHESION; LEADING-EDGE; CORDON-BLEU	The actin cytoskeleton is continuously remodeled through cycles of actin filament assembly and disassembly. Filaments are born through nucleation and shaped into supramolecular structures with various essential functions. These range from contractile and protrusive assemblies in muscle and non-muscle cells to actin filament comets propelling vesicles or pathogens through the cytosol. Although nucleation has been extensively studied using purified proteins in vitro, dissection of the process in cells is complicated by the abundance and molecular complexity of actin filament arrays. We here describe the ectopic nucleation of actin filaments on the surface of microtubules, free of endogenous actin and interfering membrane or lipid. All major mechanisms of actin filament nucleation were recapitulated, including filament assembly induced by Arp2/3 complex, formin and Spir. This novel approach allows systematic dissection of actin nucleation in the cytosol of live cells, its genetic re-engineering as well as screening for new modifiers of the process.	[Oelkers, J. Margit; Lai, Frank P. L.; Block, Jennifer; Szczodrak, Malgorzata; Schlueter, Kai; Stradal, Theresia E. B.; Koestler, Stefan A.; Rottner, Klemens] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Vinzenz, Marlene; Nemethova, Maria; Jacob, Sonja; Small, J. Victor] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Lai, Frank P. L.] Inst Med Biol, Dept Dev & Regenerat Biol, Singapore, Singapore; [Kerkhoff, Eugen] Univ Hosp Regensburg, Mol Cell Biol Lab, Dept Neurol, Bavarian Genome Res Network, Regensburg, Germany; [Backert, Steffen] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Schlueter, Kai; Stradal, Theresia E. B.] Univ Munster, Inst Mol Cell Biol, Munster, Germany; [Oelkers, J. Margit; Block, Jennifer; Koestler, Stefan A.; Rottner, Klemens] Univ Bonn, Inst Genet, D-5300 Bonn, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Regensburg; University College Dublin; University of Munster; University of Bonn	Oelkers, JM (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	krottner@uni-bonn.de	Rottner, Klemens/AAE-5030-2020	Koestler, Stefan/0000-0002-7223-8291; Rottner, Klemens/0000-0003-4244-4198; Stradal, Theresia/0000-0002-0352-9474	Deutsche Forschungsgemeinschaft; European Community [MEST-2004-504990]; Austrian Science Foundation [FWF 1516-B09, FWF P21292-B09]; Austrian Science Fund (FWF) [I 516, P 21292] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (to KR and TEBS). MS was supported through a Marie Curie Early stage Training (contract MEST-2004-504990) of the European Community's Sixth Framework Programme. JVS acknowledges grants from the Austrian Science Foundation (projects FWF 1516-B09 and FWF P21292-B09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; AIZAWA H, 1991, J BIOL CHEM, V266, P9841; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; KERKHOFF E, 2010, EUROPEAN J CELL BIOL; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; ROTTNER K, 2006, CELL BIOL LAB HDB, P111; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Schmauch C, 2009, EUR J CELL BIOL, V88, P385, DOI 10.1016/j.ejcb.2009.02.185; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Tanaka S, 2009, GENESIS, V47, P638, DOI 10.1002/dvg.20544; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	68	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19931	10.1371/journal.pone.0019931	http://dx.doi.org/10.1371/journal.pone.0019931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603613	Green Submitted, Green Published, gold			2022-12-27	WOS:000290656300040
J	Mavros, MN; Athanasiou, S; Gkegkes, ID; Polyzos, KA; Peppas, G; Falagas, ME				Mavros, Michael N.; Athanasiou, Stavros; Gkegkes, Ioannis D.; Polyzos, Konstantinos A.; Peppas, George; Falagas, Matthew E.			Do Psychological Variables Affect Early Surgical Recovery?	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; DEPRESSIVE SYMPTOMS; CARDIAC-SURGERY; STRESS; OUTCOMES; INTERVENTION; RELAXATION; ANXIETY; IMPACT; STAY	Background: Numerous studies have examined the effect of psychological variables on surgical recovery, but no definite conclusion has been reached yet. We sought to examine whether psychological factors influence early surgical recovery. Methods: We performed a systematic search in PubMed, Scopus and PsycINFO databases to identify studies examining the association of preoperative psychological variables or interventions with objectively measured, early surgical outcomes. Results: We identified 16 eligible studies, 15 of which reported a significant association between at least one psychological variable or intervention and an early postoperative outcome. However, most studies also reported psychological factors not influencing surgical recovery and there was significant heterogeneity across the studies. Overall, trait and state anxiety, state anger, active coping, subclinical depression, and intramarital hostility appeared to complicate recovery, while dispositional optimism, religiousness, anger control, low pain expectations, and external locus of control seemed to promote healing. Psychological interventions (guided relaxation, couple support visit, and psychiatric interview) also appeared to favor recovery. Psychological factors unrelated to surgical outcomes included loneliness, perceived social support, anger expression, and trait anger. Conclusion: Although the heterogeneity of the available evidence precludes any safe conclusions, psychological variables appear to be associated with early surgical recovery; this association could bear important implications for clinical practice. Large clinical trials and further analyses are needed to precisely evaluate the contribution of psychology in surgical recovery.	[Mavros, Michael N.; Athanasiou, Stavros; Gkegkes, Ioannis D.; Polyzos, Konstantinos A.; Peppas, George; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Athanasiou, Stavros] Univ Athens, Sch Med, Dept Obstet & Gynecol, GR-11527 Athens, Greece; [Peppas, George] Henry Dunant Hosp, Dept Surg, Athens, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Athens Medical School; National & Kapodistrian University of Athens; Henry Dunant Hospital; Henry Dunant Hospital; Tufts University	Mavros, MN (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	foster, kylie a/A-9248-2012; Mavros, M/AAS-3154-2020	Polyzos, Konstantinos/0000-0003-4720-5604; ATHANASIOU, STAVROS/0000-0003-0005-0369				ANDERSON KO, 1983, J BEHAV MED, V6, P1, DOI 10.1007/BF00845274; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bosch JA, 2007, PSYCHOSOM MED, V69, P597, DOI 10.1097/PSY.0B013E318148C682; Broadbent E, 2003, PSYCHOSOM MED, V65, P865, DOI 10.1097/01.PSY.0000088589.92699.30; COHEN F, 1973, PSYCHOSOM MED, V35, P375, DOI 10.1097/00006842-197309000-00002; Colella Tracey J F, 2004, Eur J Cardiovasc Nurs, V3, P211; Contrada RJ, 2004, HEALTH PSYCHOL, V23, P227, DOI 10.1037/0278-6133.23.3.227; Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; Davis MC, 2009, AM J LIFESTYLE MED, V3, p60S, DOI 10.1177/1559827609335152; DEVINE EC, 1992, PATIENT EDUC COUNS, V19, P129, DOI 10.1016/0738-3991(92)90193-M; EVANS C, 1988, LANCET, V2, P491, DOI 10.1016/S0140-6736(88)90131-6; Falagas ME, 2010, INT J TUBERC LUNG D, V14, P141; Falagas ME, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1744; GEORGE J M, 1980, Journal of Behavioral Medicine, V3, P291, DOI 10.1007/BF00845053; Gouin JP, 2008, BRAIN BEHAV IMMUN, V22, P699, DOI 10.1016/j.bbi.2007.10.013; Halpin LS, 2005, J NURS CARE QUAL, V20, P73, DOI 10.1097/00001786-200501000-00012; HOLDENLUND C, 1988, RES NURS HEALTH, V11, P235, DOI 10.1002/nur.4770110405; Johnston Marie, 1993, Annals of Behavioral Medicine, V15, P245; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; LESERMAN J, 1989, BEHAV MED, V15, P111, DOI 10.1080/08964289.1989.9934573; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; LINN BS, 1988, PSYCHOSOM MED, V50, P230, DOI 10.1097/00006842-198805000-00002; LUDWICKROSENTHAL R, 1988, PSYCHOL BULL, V104, P326, DOI 10.1037/0033-2909.104.3.326; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; MATHEWS A, 1981, BRIT J CLIN PSYCHOL, V20, P243, DOI 10.1111/j.2044-8260.1981.tb00525.x; MUMFORD E, 1982, AM J PUBLIC HEALTH, V72, P141, DOI 10.2105/AJPH.72.2.141; Munafo MR, 2001, J PSYCHOSOM RES, V51, P589, DOI 10.1016/S0022-3999(01)00258-6; Pignay-Demaria V, 2003, ANN THORAC SURG, V75, P314, DOI 10.1016/S0003-4975(02)04391-6; Rosenberger PH, 2006, J AM ACAD ORTHOP SUR, V14, P397, DOI 10.5435/00124635-200607000-00002; Rosmarakis ES, 2005, FASEB J, V19, P673, DOI 10.1096/fj.04-3140lfe; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; SCHINDLER BA, 1989, GEN HOSP PSYCHIAT, V11, P358, DOI 10.1016/0163-8343(89)90124-2; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Shuldham C, 1999, INT J NURS STUD, V36, P171, DOI 10.1016/S0020-7489(99)00010-3; Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548; Stengrevics S, 1996, PSYCHOL HEALTH, V11, P471, DOI 10.1080/08870449608401983; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Vollmer-Conna U, 2009, ACTA NEUROPSYCHIATR, V21, P169, DOI 10.1111/j.1601-5215.2009.00398.x	40	107	117	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20306	10.1371/journal.pone.0020306	http://dx.doi.org/10.1371/journal.pone.0020306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21633506	gold, Green Published, Green Submitted			2022-12-27	WOS:000291006500053
J	Nadendla, SK; Hazan, A; Ward, M; Harper, LJ; Moutasim, K; Bianchi, LS; Naase, M; Ghali, L; Thomas, GJ; Prowse, DM; Philpott, MP; Neill, GW				Nadendla, Sandeep K.; Hazan, Allon; Ward, Matt; Harper, Lisa J.; Moutasim, Karwan; Bianchi, Lucia S.; Naase, Mahmoud; Ghali, Lucy; Thomas, Gareth J.; Prowse, David M.; Philpott, Michael P.; Neill, Graham W.			GLI1 Confers Profound Phenotypic Changes upon LNCaP Prostate Cancer Cells That Include the Acquisition of a Hormone Independent State	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; STEM-CELLS; TRANSCRIPTIONAL ACTIVITY; CLAUDIN EXPRESSION; DRUG-RESISTANCE; LIPOCALIN NGAL; BREAST-CANCER; NUDE-MICE; IN-VITRO	The GLI (GLI1/GLI2) transcription factors have been implicated in the development and progression of prostate cancer although our understanding of how they actually contribute to the biology of these common tumours is limited. We observed that GLI reporter activity was higher in normal (PNT-2) and tumourigenic (DU145 and PC-3) androgen-independent cells compared to androgen-dependent LNCaP prostate cancer cells and, accordingly, GLI mRNA levels were also elevated. Ectopic expression of GLI1 or the constitutively active Delta NGLI2 mutant induced a distinct cobblestone-like morphology in LNCaP cells that, regarding the former, correlated with increased GLI2 as well as expression of the basal/stem-like markers CD44, beta 1-integrin, Delta Np63 and BMI1, and decreased expression of the luminal marker AR (androgen receptor). LNCaP-GLI1 cells were viable in the presence of the AR inhibitor bicalutamide and gene expression profiling revealed that the transcriptome of LNCaP-GLI1 cells was significantly closer to DU145 and PC-3 cells than to control LNCaP-pBP (empty vector) cells, as well as identifying LCN2/NGAL as a highly induced transcript which is associated with hormone independence in breast and prostate cancer. Functionally, LNCaP-GLI1 cells displayed greater clonal growth and were more invasive than control cells but they did not form colonies in soft agar or prostaspheres in suspension suggesting that they do not possess inherent stem cell properties. Moreover, targeted suppression of GLI1 or GLI2 with siRNA did not reverse the transformed phenotype of LNCaP-GLI1 cells nor did double GLI1/GLI2 knockdowns activate AR expression in DU145 or PC-3 cells. As such, early targeting of the GLI oncoproteins may hinder progression to a hormone independent state but a more detailed understanding of the mechanisms that maintain this phenotype is required to determine if their inhibition will enhance the efficacy of anti-hormonal therapy through the induction of a luminal phenotype and increased dependency upon AR function.	[Nadendla, Sandeep K.; Hazan, Allon; Ward, Matt; Harper, Lisa J.; Bianchi, Lucia S.; Philpott, Michael P.; Neill, Graham W.] Queen Mary Univ London, Ctr Cutaneous Res, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Nadendla, Sandeep K.; Naase, Mahmoud; Ghali, Lucy] Middlesex Univ, Dept Biomed Sci, Sch Hlth & Social Sci, Enfield, Middx, England; [Moutasim, Karwan; Thomas, Gareth J.] Univ Southampton, Canc Sci Div, Sch Med, Southampton, Hants, England; [Prowse, David M.] Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London; Middlesex University; University of Southampton; University of London; Queen Mary University London	Nadendla, SK (corresponding author), Queen Mary Univ London, Ctr Cutaneous Res, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England.	g.w.neill@qmul.ac.uk	Neill, Graham/C-9008-2012	Philpott, Michael/0000-0002-1255-4612	Middlesex University; Prostate Action [G2007/55, G2008/07, G2009/30]; Barts; The London Charity	Middlesex University; Prostate Action; Barts; The London Charity	This work was principally (and generously) supported by the Middlesex University Matched Funding Scheme (SKN), Prostate Action http://www.prostateaction.org.uk/ (SKN and AH: Grant codes G2007/55, G2008/07 and G2009/30) and Barts and The London Charity http://www.bartsandthelondoncharity.org.uk/ (GWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay S, 2008, J PATHOL, V216, P460, DOI 10.1002/path.2427; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Chen BY, 2007, BIOCHEM BIOPH RES CO, V357, P1084, DOI 10.1016/j.bbrc.2007.04.091; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Creighton CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-199; Datta S, 2006, CELL MOL LIFE SCI, V63, P435, DOI 10.1007/s00018-005-5389-4; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gruvberger S, 2001, CANCER RES, V61, P5979; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jarrard DF, 1998, CANCER RES, V58, P5310; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kinoshita H, 2000, CANCER RES, V60, P3623; Kise Y, 2006, BIOCHEM BIOPH RES CO, V351, P78, DOI 10.1016/j.bbrc.2006.10.036; KLARMANN GJ, 2009, CLIN EXP METASTASIS; Krajewska M, 2007, PROSTATE, V67, P907, DOI 10.1002/pros.20578; Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; LEE EK, 2010, J PROTEOME RES; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu AY, 1999, PROSTATE, V40, P192; Liu AY, 2002, PROSTATE, V50, P92, DOI 10.1002/pros.10036; Lu S, 2007, CLIN CANCER RES, V13, P5692, DOI 10.1158/1078-0432.CCR-07-1078; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Moses MA, 1998, CANCER RES, V58, P1395; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Nadiminty N, 2010, PROSTATE, V70, P276, DOI 10.1002/pros.21062; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Neill GW, 2003, CANCER RES, V63, P4692; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Prasad PD, 2010, CELL TISSUE RES, V339, P337, DOI 10.1007/s00441-009-0902-y; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shaw G, 2008, EUR UROL, V54, P1333, DOI 10.1016/j.eururo.2008.01.070; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Sikand K, 2010, INT J CANC; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; SINGH A, 2010, ONCOGENE; Speek M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-13; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Sun RP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-93; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Szasz AM, 2010, BJU INT, V105, P716, DOI 10.1111/j.1464-410X.2009.08808.x; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tessel MA, 2010, CURR OPIN ONCOL, V22, P592, DOI 10.1097/CCO.0b013e32833ea80c; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; Vare P, 2008, ONCOL REP, V19, P25; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang FH, 2005, CLIN CANCER RES, V11, P4512, DOI 10.1158/1078-0432.CCR-04-2571; Zhang YM, 2009, NEOPLASIA, V11, P96, DOI 10.1593/neo.81264; ZHAO J, 2009, BREAST CANC RES TREA	88	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20271	10.1371/journal.pone.0020271	http://dx.doi.org/10.1371/journal.pone.0020271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633508	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000291006500050
J	Laffray, S; Pages, S; Dufour, H; De Koninck, P; De Koninck, Y; Cote, D				Laffray, Sophie; Pages, Stephane; Dufour, Hugues; De Koninck, Paul; De Koninck, Yves; Cote, Daniel			Adaptive Movement Compensation for In Vivo Imaging of Fast Cellular Dynamics within a Moving Tissue	PLOS ONE			English	Article							MOUSE SPINAL-CORD; LONG-TERM; MICROSCOPY; BRAIN; RESOLUTION; AXONS; MICE	In vivo non-linear optical microscopy has been essential to advance our knowledge of how intact biological systems work. It has been particularly enabling to decipher fast spatiotemporal cellular dynamics in neural networks. The power of the technique stems from its optical sectioning capability that in turn also limits its application to essentially immobile tissue. Only tissue not affected by movement or in which movement can be physically constrained can be imaged fast enough to conduct functional studies at high temporal resolution. Here, we show dynamic two-photon Ca(2+) imaging in the spinal cord of a living rat at millisecond time scale, free of motion artifacts using an optical stabilization system. We describe a fast, non-contact adaptive movement compensation approach, applicable to rough and weakly reflective surfaces, allowing real-time functional imaging from intrinsically moving tissue in live animals. The strategy involves enslaving the position of the microscope objective to that of the tissue surface in real-time through optical monitoring and a closed feedback loop. The performance of the system allows for efficient image locking even in conditions of random or irregular movements.	[Laffray, Sophie; Pages, Stephane; Dufour, Hugues; De Koninck, Paul; De Koninck, Yves; Cote, Daniel] Univ Laval, CRULRG, Quebec City, PQ, Canada; [De Koninck, Yves; Cote, Daniel] Univ Laval, Ctr Opt Photon & Laser, Quebec City, PQ G1K 7P4, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada; [De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Cote, Daniel] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Laffray, S (corresponding author), Univ Laval, CRULRG, Quebec City, PQ, Canada.	Yves.Dekoninck@crulrg.ulaval.ca	Côté, Daniel/D-5185-2011; De Koninck, Yves/C-2659-2008; Laffray, Sophie/AAA-4792-2019	De Koninck, Yves/0000-0002-5779-9330; Laffray, Sophie/0000-0002-1562-0304	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec; CIPI TEN	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); CIPI TEN	Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html), The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml), CIPI TEN (http://www.cipi.ulaval.ca/programs/ten_program/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatryan K, 2010, OPT EXPRESS, V18, P13981, DOI 10.1364/OE.18.013981; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; JOHANNSSEN HC, 2010, J PHYSL; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kreft M, 2005, ANN NY ACAD SCI, V1048, P321, DOI 10.1196/annals.1342.029; LEWIS CE, 1986, RADIOLOGY, V160, P803, DOI 10.1148/radiology.160.3.3737921; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Rajadhyaksha M, 1999, APPL OPTICS, V38, P2105, DOI 10.1364/AO.38.002105; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751	21	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19928	10.1371/journal.pone.0019928	http://dx.doi.org/10.1371/journal.pone.0019928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629702	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005800017
J	Nauwelaers, D; Van Houtte, M; Winters, B; Steegen, K; Van Baelen, K; Chi, E; Zhou, MM; Steiner, D; Bonesteel, R; Aston, C; Stuyver, LJ				Nauwelaers, David; Van Houtte, Margriet; Winters, Bart; Steegen, Kim; Van Baelen, Kurt; Chi, Ellen; Zhou, Mimi; Steiner, Derek; Bonesteel, Rachelle; Aston, Colin; Stuyver, Lieven J.			A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; GENETIC SUBTYPES; IN-VITRO; TYPE-1; INHIBITORS; SELECTION	In order to determine phenotypic protease and reverse transcriptase inhibitor-associated resistance in HIV subtype C virus, we have synthetically constructed an HIV-1 subtype C (HIV-1-C) viral backbone for use in a recombinant virus assay. The in silico designed viral genome was divided into 4 fragments, which were chemically synthesized and joined together by conventional subcloning. Subsequently, gag-protease-reverse-transcriptase (GPRT) fragments from 8 HIV-1 subtype C-infected patient samples were RT-PCR-amplified and cloned into the HIV-1-C backbone (deleted for GPRT) using In-Fusion reagents. Recombinant viruses (1 to 5 per patient sample) were produced in MT4-eGFP cells where cyto-pathogenic effect (CPE), p24 and Viral Load (VL) were monitored. The resulting HIV-1-C recombinant virus stocks (RVS) were added to MT4-eGFP cells in the presence of serial dilutions of antiretroviral drugs (PI, NNRTI, NRTI) to determine the fold-change in IC50 compared to the IC50 of wild-type HIV-1 virus. Additionally, viral RNA was extracted from the HIV-1-C RVS and the amplified GPRT products were used to generate recombinant virus in a subtype B backbone. Phenotypic resistance profiles in a subtype B and subtype C backbone were compared. The following observations were made: i) functional, infectious HIV-1 subtype C viruses were generated, confirmed by VL and p24 measurements; ii) their rate of infection was slower than viruses generated in the subtype B backbone; iii) they did not produce clear CPE in MT4 cells; and iv) drug resistance profiles generated in both backbones were very similar, including re-sensitizing effects like M184V on AZT.	[Nauwelaers, David; Van Houtte, Margriet; Winters, Bart; Steegen, Kim; Van Baelen, Kurt; Stuyver, Lieven J.] Virco BVBA, Beerse, Belgium; [Chi, Ellen; Zhou, Mimi; Steiner, Derek; Bonesteel, Rachelle; Aston, Colin] Centocor Inc, Centocor Res & Discovery, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Nauwelaers, D (corresponding author), Biocartis NV, Generaal De Wittelaan L11 B3, Mechelen, Belgium.	lstuyver@its.jnj.com	Steegen, K/AAF-6512-2020; Steegen, Kim/ABH-4471-2020	Steegen, Kim/0000-0003-3226-7685	Virco BVBA; Centocor	Virco BVBA; Centocor	The following commercial companies are funders for this study: Virco BVBA (employees DN, MVH, KS, BW, KVB, LJS) and its affiliate Centocor (employees EC, MZ, DS, RB, CA). There were no external funding sources for this study. This research was conducted in the course of the authors' employment. The funders had no direct or indirect influence on the results of the research or on the presentation of the results in the paper.	Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; BORROTOESODA K, 2001, ANTIVIR THER, V6; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Cello J, 2002, NATURE, V418, P915, DOI 10.1038/418915a; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Church G, 2005, NATURE, V438, P423, DOI 10.1038/438423a; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; EVANS GA, 2001, Patent No. 6670127; EVANS GA, 1998, Patent No. 6521427; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; GIBSON DG, SCIENCE; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Iordanskiy S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-85; Jackson JH, 2008, BMC SYST BIOL, V2, DOI [10.1186/1752-0509-2-62, 10.1007/s11693-008-9018-z]; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KUSUMI K, 1992, J VIROL, V66, P875, DOI 10.1128/JVI.66.2.875-885.1992; Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Quinones-Mateu ME, 1999, AIDS RES HUM RETROV, V15, P85, DOI 10.1089/088922299311763; Rabinow Paul, 2009, Syst Synth Biol, V3, P99, DOI 10.1007/s11693-009-9042-7; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Wainberg MA, 2005, ANTIMICROB AGENTS CH, V49, P1671, DOI 10.1128/AAC.49.5.1671-1678.2005; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19643	10.1371/journal.pone.0019643	http://dx.doi.org/10.1371/journal.pone.0019643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629677	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005800004
J	Popa, I; Therville, N; Carpentier, S; Levade, T; Cuvillier, O; Portoukalian, J				Popa, Iuliana; Therville, Nicole; Carpentier, Stephane; Levade, Thierry; Cuvillier, Olivier; Portoukalian, Jacques			Production of Multiple Brain-Like Ganglioside Species Is Dispensable for Fas-Induced Apoptosis of Lymphoid Cells	PLOS ONE			English	Article							ACIDIC SPHINGOMYELINASE; MEDIATED APOPTOSIS; GD3 GANGLIOSIDE; LYSOSOMAL SPHINGOMYELINASE; T-LYMPHOCYTES; CERAMIDE; DEATH; MICE; MITOCHONDRIA; SPHINGOSINE	Activation of an acid sphingomyelinase (aSMase) leading to a biosynthesis of GD3 disialoganglioside has been associated with Fas-induced apoptosis of lymphoid cells. The present study was undertaken to clarify the role of this enzyme in the generation of gangliosides during apoptosis triggered by Fas ligation. The issue was addressed by using aSMase-deficient and aSMase-corrected cell lines derived from Niemann-Pick disease (NPD) patients. Fas cross-linking elicited a rapid production of large amounts of complex a-and b-series species of gangliosides with a pattern and a chromatographic behavior as single bands reminiscent of brain gangliosides. The gangliosides were synthesized within the first ten minutes and completely disappeared within thirty minutes after stimulation. Noteworthy is the observation that GD3 was not the only ganglioside produced. The production of gangliosides and the onset of apoptotic hallmarks occurred similarly in both aSMase-deficient and aSMase-corrected NPD lymphoid cells, indicating that aSMase activation is not accountable for ganglioside generation. Hampering ganglioside production by inhibiting the key enzyme glucosylceramide synthase did not abrogate the apoptotic process. In addition, GM3 synthase-deficient lymphoid cells underwent Fas-induced apoptosis, suggesting that gangliosides are unlikely to play an indispensable role in transducing Fas-induced apoptosis of lymphoid cells.	[Popa, Iuliana; Portoukalian, Jacques] Univ Lyon 1, Hop Edouard Herriot, Lab Rech Dermatol, EA4169, F-69365 Lyon, France; [Therville, Nicole; Carpentier, Stephane; Levade, Thierry] Fac Med Toulouse, INSERM, UMR1037, F-31073 Toulouse, France; [Therville, Nicole; Carpentier, Stephane; Levade, Thierry] Univ Toulouse, Ctr Rech Cancerol Toulouse, Toulouse, France; [Levade, Thierry] CHU Purpan, Inst Federatif Biol, Lab Biochim Metab, Toulouse, France; [Cuvillier, Olivier] CNRS, IPBS, Toulouse, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Popa, I (corresponding author), Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France.	thierry.levade@inserm.fr; olivier.cuvillier@ipbs.fr; jacques.portoukalian@univ-lyon1.fr	Levade, Thierry/O-8948-2014; CUVILLIER, Olivier/B-2567-2009; CUVILLIER, Olivier/S-1631-2019; Therville, Nicole/P-2371-2014	CUVILLIER, Olivier/0000-0003-3346-375X; CUVILLIER, Olivier/0000-0003-3346-375X; Therville, Nicole/0000-0002-7068-1361; portoukalian, jacques/0000-0001-6584-3234	INSERM; Vaincre les Maladies Lysosomales Foundation; Universite Paul Sabatier	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Vaincre les Maladies Lysosomales Foundation; Universite Paul Sabatier	This work was supported by INSERM, Universite Paul Sabatier, and Vaincre les Maladies Lysosomales Foundation (to OC and TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezombes C, 2001, FASEB J, V15, P297; Bodennec J, 2000, J LIPID RES, V41, P1524; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; BOUCHON B, 1990, BIOCHIM BIOPHYS ACTA, V1051, P1, DOI 10.1016/0167-4889(90)90166-B; Chen HY, 2002, J EXP MED, V196, P1529, DOI 10.1084/jem.20021915; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; GILL BM, 1994, IMMUNOL REV, V142, P113, DOI 10.1111/j.1600-065X.1994.tb00885.x; GRABER D, 1994, J NEUROCHEM, V63, P1060; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KISIC A, 1974, J LIPID RES, V15, P179; Lin T, 2000, J BIOL CHEM, V275, P8657, DOI 10.1074/jbc.275.12.8657; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; OKADA Y, 1988, FEBS LETT, V235, P25, DOI 10.1016/0014-5793(88)81227-4; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Popa I, 2002, J LIPID RES, V43, P1335, DOI 10.1194/jlr.D20005-JLR200; PORTOUKALIAN J, 1986, J CHROMATOGR, V380, P386, DOI 10.1016/S0378-4347(00)83668-3; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Shimizu M, 1999, J IMMUNOL, V162, P7350; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19974	10.1371/journal.pone.0019974	http://dx.doi.org/10.1371/journal.pone.0019974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629700	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800019
J	Mausberg, TB; Wess, G; Simak, J; Keller, L; Drogemuller, M; Drogemuller, C; Webster, MT; Stephenson, H; Dukes-McEwan, J; Leeb, T				Mausberg, Theresa-Bernadette; Wess, Gerhard; Simak, Julia; Keller, Lisa; Droegemueller, Michaela; Droegemueller, Cord; Webster, Matthew T.; Stephenson, Hannah; Dukes-McEwan, Joanna; Leeb, Tosso			A Locus on Chromosome 5 Is Associated with Dilated Cardiomyopathy in Doberman Pinschers	PLOS ONE			English	Article							CANDIDATE GENE; DOGS	Dilated cardiomyopathy (DCM) is a heterogeneous group of heart diseases with a strong genetic background. Currently, many human DCM cases exist where no causative mutation can be identified. DCM also occurs with high prevalence in several large dog breeds. In the Doberman Pinscher a specific DCM form characterized by arrhythmias and/or echocardiographic changes has been intensively studied by veterinary cardiologists. We performed a genome-wide association study in Doberman Pinschers. Using 71 cases and 70 controls collected in Germany we identified a genome-wide significant association to DCM on chromosome 5. We validated the association in an independent cohort collected in the United Kingdom. There is no known DCM candidate gene under the association signal. Therefore, DCM in Doberman Pinschers offers the chance of identifying a novel DCM gene that might also be relevant for human health.	[Mausberg, Theresa-Bernadette; Droegemueller, Michaela; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Wess, Gerhard; Simak, Julia; Keller, Lisa] LMU Univ, Clin Small Anim Med, Munich, Germany; [Webster, Matthew T.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Stephenson, Hannah; Dukes-McEwan, Joanna] Univ Liverpool, Small Anim Teaching Hosp, Liverpool L69 3BX, Merseyside, England	University of Bern; University of Munich; Uppsala University; University of Liverpool	Mausberg, TB (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014	Leeb, Tosso/0000-0003-0553-4880; Dukes-McEwan, Joanna/0000-0002-0326-8251; Webster, Matthew/0000-0003-1141-2863; Wess, Gerhard/0000-0002-6634-8072; Drogemuller, Cord/0000-0001-9773-522X	European Commission [LUPA-GA.201270]; Albert-Heim Foundation; Boehringer Ingelheim Vetemedica	European Commission(European CommissionEuropean Commission Joint Research Centre); Albert-Heim Foundation; Boehringer Ingelheim Vetemedica(Boehringer Ingelheim)	This work was funded thanks to grants from the European Commission (LUPA-GA.201270), the Albert-Heim Foundation, and Boehringer Ingelheim Vetemedica (PROTECT study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Calvert CA, 2000, J AM VET MED ASSOC, V217, P1328, DOI 10.2460/javma.2000.217.1328; Calvert CA, 2004, J AM ANIM HOSP ASSOC, V40, P24, DOI 10.5326/0400024; CALVERT CA, 1982, J AM VET MED ASSOC, V181, P598; Calvert CA, 1997, J AM VET MED ASSOC, V210, P505; CALVERT CA, 2000, CURRENT VET THERAPY, V13, P756; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Meurs KM, 2008, AM J VET RES, V69, P1050, DOI 10.2460/ajvr.69.8.1050; Meurs KM, 2007, J VET INTERN MED, V21, P1016, DOI 10.1892/0891-6640(2007)21[1016:APGEOF]2.0.CO;2; Meurs KM, 2001, AM J VET RES, V62, P33, DOI 10.2460/ajvr.2001.62.33; Minors SL, 1998, J VET INTERN MED, V12, P369, DOI 10.1111/j.1939-1676.1998.tb02137.x; O'Grady MR, 2008, J VET INTERN MED, V22, P897, DOI 10.1111/j.1939-1676.2008.0116.x; O'Grady MR, 2004, VET CLIN N AM-SMALL, V34, P1187, DOI 10.1016/j.cvsm.2004.05.009; RABER H, 1993, ENZYKLOPADIE HUNDERA, V1, P467; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Stabej P, 2005, CYTOGENET GENOME RES, V111, P140, DOI 10.1159/000086383; Stabej P, 2005, AM J VET RES, V66, P432, DOI 10.2460/ajvr.2005.66.432; Stabej P, 2004, GENE, V340, P241, DOI 10.1016/j.gene.2004.06.050; Stark K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001167; Tidholm A, 1997, J AM ANIM HOSP ASSOC, V33, P544, DOI 10.5326/15473317-33-6-544; Wess G, 2010, J VET INTERN MED, V24, P533, DOI 10.1111/j.1939-1676.2010.0479.x; WIERSMA AC, 2007, BMC VET RES, V3; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525	29	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20042	10.1371/journal.pone.0020042	http://dx.doi.org/10.1371/journal.pone.0020042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625443	gold, Green Published, Green Submitted			2022-12-27	WOS:000290793400035
J	Opitz, CA; Litzenburger, UM; Opitz, U; Sahm, F; Ochs, K; Lutz, C; Wick, W; Platten, M				Opitz, Christiane A.; Litzenburger, Ulrike M.; Opitz, Uta; Sahm, Felix; Ochs, Katharina; Lutz, Christian; Wick, Wolfgang; Platten, Michael			The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; TRYPTOPHAN DEGRADATION; INTERFERON-GAMMA; DENDRITIC CELLS; OVARIAN-CANCER; PROTEIN-KINASE; HEPATOCELLULAR-CARCINOMA; ENDOMETRIAL CANCER; MECHANISM; SURVIVAL	1-methyl-D-tryptophan (1-D-MT) is currently being used in clinical trials in patients with relapsed or refractory solid tumors with the aim of inhibiting indoleamine-2,3-dioxygenase (IDO)-mediated tumor immune escape. IDO is expressed in tumors and tumor-draining lymph nodes and degrades tryptophan (trp) to create an immunsuppressive micromilieu both by depleting trp and by accumulating immunosuppressive metabolites of the kynurenine (kyn) pathway. Here we show that proliferation of alloreactive T-cells cocultured with IDO1-positive human cancer cells paradoxically was inhibited by 1-D-MT. Surprisingly incubation with 1-D-MT increased kyn production of human cancer cells. Cell-free assays revealed that 1-D-MT did not alter IDO1 enzymatic activity. Instead, 1-D-MT induced IDO1 mRNA and protein expression through pathways involving p38 MAPK and JNK signalling. Treatment of cancer patients with 1-D-MT has transcriptional effects that may promote rather than suppress anti-tumor immune escape by increasing IDO1 in the cancer cells. These off-target effects should be carefully analyzed in the ongoing clinical trials with 1-D-MT.	[Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, Neurol Clin, Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-6900 Heidelberg, Germany; [Opitz, Uta; Lutz, Christian] Heidelberg Pharma AG, Ladenburg, Germany; [Sahm, Felix] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Sahm, Felix] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-6900 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Opitz, CA (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, Neurol Clin, Heidelberg, Germany.	m.platten@dkfz-heidelberg.de	Wick, Wolfgang/AAA-2545-2020; Sahm, Felix/GQY-8202-2022; Opitz, Christiane A/I-9507-2012; Platten, Michael/F-2902-2013	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Opitz, Christiane A/0000-0001-5575-9821; Platten, Michael/0000-0002-4746-887X	Helmholtz Association [VH-NG-306]; Hertie Foundation; Heidelberg University	Helmholtz Association(Helmholtz Association); Hertie Foundation; Heidelberg University	This work was supported by a grant from the Helmholtz Association (VH-NG-306) to MP and the Hertie Foundation to WW. CAO is supported by a Heidelberg University Medical Faculty Postdoctoral Fellowship. As Uta Opitz and Christian Lutz are employees of Heidelberg Pharma, Heidelberg Pharma had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Corrigall VM, 2009, IMMUNOLOGY, V128, P218, DOI 10.1111/j.1365-2567.2009.03103.x; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; Giannopoulos A, 2003, CLIN CANCER RES, V9, P5550; Herve C, 1996, J CHROMATOGR B, V675, P157, DOI 10.1016/0378-4347(95)00341-X; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Ino K, 2006, BRIT J CANCER, V95, P1555, DOI 10.1038/sj.bjc.6603477; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Ishio T, 2004, J GASTROEN HEPATOL, V19, P319, DOI 10.1111/j.1440-1746.2003.03259.x; LANZ T, 2009, STEM CELLS DEV; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Marth C, 2006, INT J GYNECOL CANCER, V16, P1522, DOI 10.1111/j.1525-1438.2006.00622.x; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Okamoto T, 2007, CYTOTECHNOLOGY, V54, P107, DOI 10.1007/s10616-007-9081-4; Opitz CA, 2007, CELL MOL LIFE SCI, V64, P2542, DOI 10.1007/s00018-007-7140-9; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; OZAKI Y, 1988, P NATL ACAD SCI USA, V85, P1242, DOI 10.1073/pnas.85.4.1242; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Takao M, 2007, ONCOL REP, V17, P1333; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang Y, 2009, BRAIN BEHAV IMMUN; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; YOSHIDA R, 1988, J IMMUNOL, V141, P2819; Yu WG, 1996, INT IMMUNOL, V8, P855, DOI 10.1093/intimm/8.6.855; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	41	107	115	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19823	10.1371/journal.pone.0019823	http://dx.doi.org/10.1371/journal.pone.0019823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625531	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400013
J	Neiber, MT; Hartke, TR; Stemme, T; Bergmann, A; Rust, J; Iliffe, TM; Koenemann, S				Neiber, Marco T.; Hartke, Tamara R.; Stemme, Torben; Bergmann, Alexandra; Rust, Jes; Iliffe, Thomas M.; Koenemann, Stefan			Global Biodiversity and Phylogenetic Evaluation of Remipedia (Crustacea)	PLOS ONE			English	Article							NEW-SPECIES REMIPEDIA; SAN-SALVADOR ISLAND; ANCHIALINE CAVES; GODZILLIOGNOMUS-FRONDOSUS; NUCLEOTIDE SUBSTITUTION; SURFACE-WATER; FAUNA; SPELEONECTIDAE; BAHAMAS; MODEL	Remipedia is one of the most recently discovered classes of crustaceans, first described in 1981 from anchialine caves in the Bahamas Archipelago. The class is divided into the order Enantiopoda, represented by two fossil species, and Nectiopoda, which contains all known extant remipedes. Since their discovery, the number of nectiopodan species has increased to 24, half of which were described during the last decade. Nectiopoda exhibit a disjunct global distribution pattern, with the highest abundance and diversity in the Caribbean region, and isolated species in the Canary Islands and in Western Australia. Our review of Remipedia provides an overview of their ecological characteristics, including a detailed list of all anchialine marine caves, from which species have been recorded. We discuss alternative hypotheses of the phylogenetic position of Remipedia within Arthropoda, and present first results of an ongoing molecular-phylogenetic analysis that do not support the monophyly of several nectiopodan taxa. We believe that a taxonomic revision of Remipedia is absolutely essential, and that a comprehensive revision should include a reappraisal of the fossil record.	[Neiber, Marco T.; Hartke, Tamara R.] Univ Vet Med Hannover, Inst Anim Ecol & Cell Biol, Hannover, Germany; [Stemme, Torben] Univ Vet Med Hannover, Inst Physiol, Div Cell Biol, Hannover, Germany; [Bergmann, Alexandra; Rust, Jes] Univ Bonn, Steinmann Inst, Dept Palaeontol, D-5300 Bonn, Germany; [Iliffe, Thomas M.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Koenemann, Stefan] Univ Siegen, Sect Biol Sci & Technol, Siegen, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Bonn; Texas A&M University System; Universitat Siegen	Neiber, MT (corresponding author), Univ Vet Med Hannover, Inst Anim Ecol & Cell Biol, Hannover, Germany.	marco.neiber@tiho-hannover.de; koenemann@biologie.uni-siegen.de	Stemme, Torben/X-3748-2019; Illife, Thomas/R-2252-2017; Hartke, Tamara/I-2579-2013	Stemme, Torben/0000-0003-2751-2690; Illife, Thomas/0000-0002-4342-5960; Hartke, Tamara/0000-0002-5422-5251	German Science Foundation [DFG KO 3483/1-1]; National Science Foundation [DEB-9870219, 0315903]; NOAA Caribbean Marine Research Center	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); NOAA Caribbean Marine Research Center(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was supported by a grant from the German Science Foundation to S. Koenemann (DFG KO 3483/1-1). Biological collections from caves in the Bahamas were carried out under the terms of a Marine Resource Collecting Permit issued by the Bahamas Department of Fisheries to T. M. Iliffe, while cave investigations in the Bahamas, Mexico and Canary Islands were funded by grants from the National Science Foundation (DEB-9870219, 0315903) and NOAA Caribbean Marine Research Center to T. M. Iliffe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez F, 2005, J CRUSTACEAN BIOL, V25, P81, DOI 10.1651/C-2516; BATE CS, 1888, REPORT CRUSTACEA MAC; BIRSHTEIN YA, 1960, OSNOVY PALEONTOLOGII, P421; Black S., 2001, CAPE RANGE REMIPEDE; Boxshall GA, 2000, ZOOL ANZ, V239, P1; Briggs D.E.G., 1976, GEOL SURV CAN BULL, V264, P1; Brnnich M.T, 1772, ZOOLOGIAE FUNDAMENTA; BROOKS HK, 1955, J PALEONTOL, V29, P852; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Carpenter JH, 1999, CRUSTACEANA, V72, P979, DOI 10.1163/156854099503889; Chace F.A. Jr., 1972, Smithsonian Contributions to Zoology, VNo. 131, P1; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; CREASER EP, 1936, PUBL CARNEGIE I WASH, V47, P117; Daenekas J, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2016.1.3; Dakin WJ, 1914, P ZOOL SOC LOND, V1914, P293; Danielopol DL, 2000, ZOOL SCR, V29, P1, DOI 10.1046/j.1463-6409.2000.00027.x; De Haan W., 1833, FAUNA JAPONICA SIVE; DEBLAINVILLE MHD, 1816, B SOC PHILOMATHIQUE, V8, P113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson M. J., 1998, Arthropod relationships., P67; EMERSON MJ, 1991, P SAN DIEGO SOC NATU, V7, P1; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Fabricius JC., 1798, ENTOMOLOGIAE SYSTE S; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Fanenbruck M, 2004, P NATL ACAD SCI USA, V101, P3868, DOI 10.1073/pnas.0306212101; Felgenhauer B.E., 1992, P225; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fosshagen A., 1973, Sarsia, V52, P145; GIBSON R, 1989, J ZOOL, V219, P517, DOI 10.1111/j.1469-7998.1989.tb02597.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HART CW, 1985, P BIOL SOC WASH, V98, P288; Hazerli Dennis, 2010, Marine Biodiversity, V40, P71, DOI 10.1007/s12526-009-0033-4; HOLSINGER JR, 1988, AM SCI, V76, P146; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys WF, 2005, CRUSTACEANA, V78, P1339, DOI 10.1163/156854005776759861; Humphreys W. F., 1999, Journal of the Royal Society of Western Australia, V82, P99; HUMPHREYS WF, 2000, ECOSYSTEMS WORLD, V30, P59; Huys R, 1996, SCI MAR, V60, P497; ILIFFE T M, 1990, Memoires de Biospeologie, V17, P93; Iliffe Thomas M., 2010, Zootaxa, V2491, P61; Iliffe TM, 2000, ECOSY WORLD, V30, P59; ILIFFE TM, 1984, SCIENCE, V225, P309, DOI 10.1126/science.225.4659.309; Jaume D, 1996, J NAT HIST, V30, P1583, DOI 10.1080/00222939600770921; Jaume D, 2001, ZOOL J LINN SOC-LOND, V133, P1, DOI 10.1006/zjls.2000.0288; Jenner RA, 2010, ARTHROPOD STRUCT DEV, V39, P143, DOI 10.1016/j.asd.2009.11.001; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; KIEFER FRIEDRICH, 1927, ZOOL ANZ, V73, P302; Koenemann S, 2003, CONTRIB ZOOL, V72, P227, DOI 10.1163/18759866-07204004; KOENEMANN S, TREATISE ZO IN PRESS, V5; Koenemann S, 2007, J CRUSTACEAN BIOL, V27, P534, DOI 10.1651/S-2809A.1; Koenemann S, 2006, CRUSTACEANA, V79, P607, DOI 10.1163/156854006777584296; Koenemann S, 2010, ARTHROPOD STRUCT DEV, V39, P88, DOI 10.1016/j.asd.2009.10.003; Koenemann S, 2007, ORG DIVERS EVOL, V7, DOI 10.1016/j.ode.2006.07.002; Koenemann Stefan, 2004, Zootaxa, V618, P1; Koenemann Stefan, 2009, Marine Biodiversity, V39, P215, DOI 10.1007/s12526-009-0021-8; Koenemann S, 2009, DEV GENES EVOL, V219, P131, DOI 10.1007/s00427-009-0273-0; Koenernann S, 2008, J CRUSTACEAN BIOL, V28, P128, DOI 10.1651/07-2865R.1; Kornicker LS, 2007, ZOOTAXA, P1; Kornicker LS., 1976, SMITHSON CONTR ZOOL, V219, P1, DOI [10.5479/si.00810282.219, DOI 10.5479/SI.00810282.219]; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Latreille P.A., 1802, HIST NATURELLE GEN P, V3; LATREILLE PA, 1817, REGNE ANIMAL DISTRIB, V3, P1; Lavrov DV, 2004, P ROY SOC B-BIOL SCI, V271, P537, DOI 10.1098/rspb.2003.2631; Lorentzen Doerte, 2007, Zootaxa, V1543, P61; Moura Gisela, 1996, Journal of Comparative Biology, V1, P95; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nylander JAA., 2004, BIOINFORMATICS; RAFINESQUE C. S., 1815, ANAL NATURE TABLEAU, P1, DOI DOI 10.5962/BHL.TITLE.106607; Rambaut A., 2007, TRACER V1 4; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; RESSER CHARLES E., 1929, PROC U S NATION MUS, V76, P1; ROUCH R, 1987, STYGOLOGIA, V3, P345; SANDERS HL, 1955, P NATL ACAD SCI USA, V41, P61, DOI 10.1073/pnas.41.1.61; SCHRAM F R, 1974, Fieldiana Geology, V33, P95; Schram F.R., 1986, CRUSTACEA; Schram FR, 2004, ASSEMBLING THE TREE OF LIFE, P319; Schram FR, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P233; SCHRAM FR, 1986, SAN DIEGO SOC NATURA, V15, P1; SCHRAM FR, 1986, ENV SW, V515, P16; Scott T., 1894, Report of the Fishery Board for Scotland, V12, P231; Shimomura M, 2009, ZOOTAXA, P55, DOI 10.11646/zootaxa.1990.1.4; SILVESTRI F., 1931, BOLL LAB ZOOL GEN E AGRARIA [PORTICI], V25, P275; Spears T., 1997, ARTHROPOD RELATIONSH, P169; STOCK JH, 1981, BIJDR DIERKD, V51, P345; STOCK JH, 1994, HYDROBIOLOGIA, V287, P105, DOI 10.1007/BF00006900; STOCK JH, 1993, J NAT HIST, V27, P807, DOI 10.1080/00222939300770491; STOCK JH, 1986, STYGOLOGIA, V2, P105; STOCK JH, 1980, BIJDR DIERKD, V50, P105; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Valdecasas A.G., 1985, Eos-Revista Espanola de Entomologia, V60, P329; Wheeler WC, 2004, ASSEMBLING THE TREE OF LIFE, P281; Wilkens Horst, 2009, Marine Biodiversity, V39, P155, DOI 10.1007/s12526-009-0019-2; Wills M. A., 1998, Arthropod relationships., P189; WILSON MILDRED STRATTON, 1958, PROC U S NATL MUS, V108, P137; Wollermann U, 2007, J CRUSTACEAN BIOL, V27, P10, DOI 10.1651/S-2763.1; YAGER J, 1994, J CRUSTACEAN BIOL, V14, P752, DOI 10.2307/1548869; YAGER J, 1981, Journal of Crustacean Biology, V1, P328, DOI 10.2307/1547965; Yager J, 1996, INVERTEBR TAXON, V10, P171, DOI 10.1071/IT9960171; YAGER J, 1986, P BIOL SOC WASH, V99, P65; YAGER J, 1989, B MAR SCI, V44, P1195; YAGER J, 1987, Stygologia, V3, P160; YAGER J, 1987, P BIOL SOC WASH, V100, P302; Yager J, 1999, CRUSTACEANA, V72, P965, DOI 10.1163/156854099503861; YAGER J, 1991, VERH DTSCH ZOOL GES, V84, P261; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	109	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19627	10.1371/journal.pone.0019627	http://dx.doi.org/10.1371/journal.pone.0019627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625553	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200011
J	Heron-Delaney, M; Anzures, G; Herbert, JS; Quinn, PC; Slater, AM; Tanaka, JW; Lee, K; Pascalis, O				Heron-Delaney, Michelle; Anzures, Gizelle; Herbert, Jane S.; Quinn, Paul C.; Slater, Alan M.; Tanaka, James W.; Lee, Kang; Pascalis, Olivier			Perceptual Training Prevents the Emergence of the Other Race Effect during Infancy	PLOS ONE			English	Article							FACE RECOGNITION; OWN-RACE; 3-MONTH-OLD INFANTS; PLASTICITY; EXPERIENCE; CHILDHOOD; MEMORY; BIAS	Experience plays a crucial role in the development of the face processing system. At 6 months of age infants can discriminate individual faces from their own and other races. By 9 months of age this ability to process other-race faces is typically lost, due to minimal experience with other-race faces, and vast exposure to own-race faces, for which infants come to manifest expertise [1]. This is known as the Other Race Effect. In the current study, we demonstrate that exposing Caucasian infants to Chinese faces through perceptual training via picture books for a total of one hour between 6 and 9 months allows Caucasian infants to maintain the ability to discriminate Chinese faces at 9 months of age. The development of the processing of face race can be modified by training, highlighting the importance of early experience in shaping the face representation.	[Heron-Delaney, Michelle; Herbert, Jane S.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Anzures, Gizelle] Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; [Quinn, Paul C.] Univ Delaware, Dept Psychol, Newark, DE USA; [Slater, Alan M.] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England; [Tanaka, James W.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Lee, Kang] Univ Toronto, Inst Child Study, Toronto, ON, Canada; [Pascalis, Olivier] Univ Pierre Mendes France, Lab Psychol & Neurocognit, Grenoble, France	University of Sheffield; University of Toronto; University of Delaware; University of Exeter; University of Victoria; University of Toronto; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Heron-Delaney, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	michelle.delaney@uq.edu.au	Herbert, Jane/GNP-3396-2022; Heron-Delaney, Michelle/M-7540-2014	Herbert, Jane/0000-0002-8762-4531; pascalis, olivier/0000-0003-4609-3233; Heron-Delaney, Michelle/0000-0003-1332-9385	Economic and Social Research Council [RES-000-22-3246]; National Institutes of Health [R01 HD046526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/G027188/1] Funding Source: researchfish; ESRC [ES/G027188/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an Economic and Social Research Council grant (RES-000-22-3246)(http://www.esrc.ac.uk/funding-and-guidance/funding-opportunities/) awarded to MH-D, JSH, and OP, and by National Institutes of Health grant R01 HD046526 (http://grants.nih.gov/grants/oer.htm) awarded to PCQ, AMS, JWT, KL, and OP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; de Heering A, 2010, DEVELOPMENTAL SCI, V13, P181, DOI 10.1111/j.1467-7687.2009.00876.x; ELLIOTT ES, 1973, B PSYCHONOMIC SOC, V2, P71, DOI 10.3758/BF03327717; FAGAN JF, 1974, CHILD DEV, V45, P351; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Ferguson KT, 2009, INFANCY, V14, P263, DOI 10.1080/15250000902839369; GOLDSTEIN AG, 1985, B PSYCHONOMIC SOC, V23, P211; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; MALPASS RS, 1973, PERCEPT PSYCHOPHYS, V14, P285, DOI 10.3758/BF03212392; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; SLATER AM, 1975, J EXP CHILD PSYCHOL, V20, P240, DOI 10.1016/0022-0965(75)90101-0; Tanaka JW, 2009, COGN AFFECT BEHAV NE, V9, P122, DOI 10.3758/CABN.9.1.122	23	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19858	10.1371/journal.pone.0019858	http://dx.doi.org/10.1371/journal.pone.0019858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21625638	gold, Green Published, Green Accepted			2022-12-27	WOS:000290720200040
J	Park, J; Lee, HJ; Cheon, CI; Kim, SH; Hur, YS; Auh, CK; Im, KH; Yun, DJ; Lee, S; Davis, KR				Park, Jungan; Lee, Hyun-Ju; Cheon, Choong-Ill; Kim, Sung-Han; Hur, Yoon-Sun; Auh, Chung-Kyun; Im, Kyung-Hwan; Yun, Dae-Jin; Lee, Sukchan; Davis, Keith R.			The Arabidopsis thaliana Homeobox Gene ATHB12 Is Involved in Symptom Development Caused by Geminivirus Infection	PLOS ONE			English	Article							CURLY-TOP-VIRUS; HD-ZIP PROTEIN; VIRION-SENSE GENES; TRANSCRIPTIONAL ANALYSIS; WATER-DEFICIT; EXPRESSION; INTERACTS; MOVEMENT; GROWTH; CELLS	Background: Geminiviruses are single-stranded DNA viruses that infect a number of monocotyledonous and dicotyledonous plants. Arabidopsis is susceptible to infection with the Curtovirus, Beet severe curly top virus (BSCTV). Infection of Arabidopsis with BSCTV causes severe symptoms characterized by stunting, leaf curling, and the development of abnormal inflorescence and root structures. BSCTV-induced symptom development requires the virus-encoded C4 protein which is thought to interact with specific plant-host proteins and disrupt signaling pathways important for controlling cell division and development. Very little is known about the specific plant regulatory factors that participate in BSCTV-induced symptom development. This study was conducted to identify specific transcription factors that are induced by BSCTV infection. Methodology/Principal Findings: Arabidopsis plants were inoculated with BSCTV and the induction of specific transcription factors was monitored using quantitative real-time polymerase chain reaction assays. We found that the ATHB12 and ATHB7 genes, members of the homeodomain-leucine zipper family of transcription factors previously shown to be induced by abscisic acid and water stress, are induced in symptomatic tissues of Arabidopsis inoculated with BSCTV. ATHB12 expression is correlated with an array of morphological abnormalities including leaf curling, stunting, and callus-like structures in infected Arabidopsis. Inoculation of plants with a BSCTV mutant with a defective c4 gene failed to induce ATHB12. Transgenic plants expressing the BSCTV C4 gene exhibited increased ATHB12 expression whereas BSCTV-infected ATHB12 knock-down plants developed milder symptoms and had lower ATHB12 expression compared to the wild-type plants. Reporter gene studies demonstrated that the ATHB12 promoter was responsive to BSCTV infection and the highest expression levels were observed in symptomatic tissues where cell cycle genes also were induced. Conclusions/Significance: These results suggest that ATHB7 and ATHB12 may play an important role in the activation of the abnormal cell division associated with symptom development during geminivirus infection.	[Park, Jungan; Lee, Hyun-Ju; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Cheon, Choong-Ill; Kim, Sung-Han; Hur, Yoon-Sun] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Auh, Chung-Kyun] Mokpo Natl Univ, Div Life Sci, Muan, South Korea; [Im, Kyung-Hwan] Univ Incheon, Dept Biol, Inchon, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju, South Korea; [Davis, Keith R.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Owensboro Canc Res Program,James Graham Brown Can, Louisville, KY 40292 USA	Sungkyunkwan University (SKKU); Sookmyung Women's University; Mokpo National University; Incheon National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; University of Louisville	Park, J (corresponding author), Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea.	sukchan@skku.ac.kr; keith.davis@omhs.org	Davis, Keith/H-3242-2019; Kim, Sunghan/ABH-3874-2020; Davis, Keith R/C-5623-2009	Davis, Keith/0000-0002-7432-8610; Davis, Keith R/0000-0002-7432-8610; Yun, Dae-Jin/0000-0002-3638-6043; Kim, Sunghan/0000-0002-4955-8780	Rural Development Administration (RDA) in Korea [PJ006325]	Rural Development Administration (RDA) in Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by a grant of the BioGreen21 Agenda program (No. PJ006325) from the Rural Development Administration (RDA) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Baliji S, 2007, MOL PLANT MICROBE IN, V20, P194, DOI 10.1094/MPMI-20-2-0194; Baliji S, 2010, VIROLOGY, V402, P238, DOI 10.1016/j.virol.2010.03.023; BRIDDON RW, 1989, VIROLOGY, V172, P628, DOI 10.1016/0042-6822(89)90205-5; CARABELLI M, 1993, PLANT J, V4, P469, DOI 10.1046/j.1365-313X.1993.04030469.x; CHAN RL, 1994, PLANT PHYSIOL, V106, P1687, DOI 10.1104/pp.106.4.1687; DAVIS KR, 1989, MOL PLANT MICROBE IN, V2, P363, DOI 10.1094/MPMI-2-363; Desvoyes B, 2002, PLANT PHYSIOL, V129, P1521, DOI 10.1104/pp.004754; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Egelkrout EM, 2001, PLANT CELL, V13, P1437, DOI 10.1105/tpc.13.6.1437; Egelkrout EM, 2002, PLANT CELL, V14, P3225, DOI 10.1105/tpc.006403; Engler JD, 1999, PLANT CELL, V11, P793, DOI 10.1105/tpc.11.5.793; FRISCHMUTH S, 1993, VIROLOGY, V197, P312, DOI 10.1006/viro.1993.1592; Gutierrez C, 2000, PLANT MOL BIOL, V43, P763, DOI 10.1023/A:1006462028363; Hao LH, 2003, PLANT CELL, V15, P1034, DOI 10.1105/tpc.009530; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; HORMUZDI SG, 1995, VIROLOGY, V206, P1044, DOI 10.1006/viro.1995.1027; HORMUZDI SG, 1993, VIROLOGY, V193, P900, DOI 10.1006/viro.1993.1199; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; JEFFERSON RA, 1987, EMBO J, V6, P3901; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; KAWAHARA R, 1995, PLANT MOL BIOL, V27, P155, DOI 10.1007/BF00019187; Lai JB, 2009, PLANT J, V57, P905, DOI 10.1111/j.1365-313X.2008.03737.x; Latham JR, 1997, PLANT J, V11, P1273, DOI 10.1046/j.1365-313X.1997.11061273.x; LEE S, 1994, PLANT J, V6, P525, DOI 10.1046/j.1365-313X.1994.6040525.x; Lee Sukchan, 1996, Journal of Plant Biology, V39, P249; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Lee YH, 1998, PLANT MOL BIOL, V37, P377, DOI 10.1023/A:1006084305012; Lucas WJ, 1996, J EXP BOT, V47, P1119, DOI 10.1093/jxb/47.Special_Issue.1119; MATTHEWS R, 2001, PLANT VIROLOGY; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; MEISSNER R, 1995, PLANTA, V195, P541, DOI 10.1007/BF00195713; Mills-Lujan K, 2010, PROTOPLASMA, V239, P95, DOI 10.1007/s00709-009-0086-z; Moon YH, 1996, MOL CELLS, V6, P366; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Park J, 2004, MOL CELLS, V17, P117; Park J, 2010, PLANT CELL REP, V29, P1377, DOI 10.1007/s00299-010-0923-8; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SCHENA M, 1994, P NATL ACAD SCI USA, V91, P8393, DOI 10.1073/pnas.91.18.8393; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shin D, 2004, BIOCHEM BIOPH RES CO, V323, P534, DOI 10.1016/j.bbrc.2004.08.127; SMITH SH, 1968, PHYTOPATHOLOGY, V58, P1669; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Son O, 2010, PLANT CELL PHYSIOL, V51, P1537, DOI 10.1093/pcp/pcq108; STANLEY J, 1992, VIROLOGY, V191, P396, DOI 10.1016/0042-6822(92)90201-Y; Steindler C, 1999, DEVELOPMENT, V126, P4235; STENGER DC, 1992, J GEN VIROL, V73, P237, DOI 10.1099/0022-1317-73-2-237; STENGER DC, 1990, J GEN VIROL, V71, P2211, DOI 10.1099/0022-1317-71-10-2211; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Ware DH, 1997, PLANT PHYSIOL, V114, P1163; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang JY, 2008, GENE DEV, V22, P2564, DOI 10.1101/gad.1682208	60	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20054	10.1371/journal.pone.0020054	http://dx.doi.org/10.1371/journal.pone.0020054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625602	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200059
J	Shatnyeva, OM; Kubarenko, AV; Weber, CEM; Pappa, A; Schwartz-Albiez, R; Weber, ANR; Krammer, PH; Lavrik, IN				Shatnyeva, Olga M.; Kubarenko, Andriy V.; Weber, Claudia E. M.; Pappa, Alexander; Schwartz-Albiez, Reinhard; Weber, Alexander N. R.; Krammer, Peter H.; Lavrik, Inna N.			Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation	PLOS ONE			English	Article							SIGNALING COMPLEX; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; DEATH; RECEPTOR; FAS; LIGAND; DOMAIN; SIALYLATION; REQUIREMENT	Protein modifications of death receptor pathways play a central role in the regulation of apoptosis. It has been demonstrated that O-glycosylation of TRAIL-receptor (R) is essential for sensitivity and resistance towards TRAIL-mediated apoptosis. In this study we ask whether and how glycosylation of CD95 (Fas/APO-1), another death receptor, influences DISC formation and procaspase-8 activation at the CD95 DISC and thereby the onset of apoptosis. We concentrated on N-glycostructure since O-glycosylation of CD95 was not found. We applied different approaches to analyze the role of CD95 N-glycosylation on the signal transduction: in silico modeling of CD95 DISC, generation of CD95 glycosylation mutants (at N136 and N118), modulation of N-glycosylation by deoxymannojirimycin (DMM) and sialidase from Vibrio cholerae (VCN). We demonstrate that N-deglycosylation of CD95 does not block DISC formation and results only in the reduction of the procaspase-8 activation at the DISC. These findings are important for the better understanding of CD95 apoptosis regulation and reveal differences between apoptotic signaling pathways of the TRAIL and CD95 systems.	[Shatnyeva, Olga M.; Weber, Claudia E. M.; Pappa, Alexander; Krammer, Peter H.; Lavrik, Inna N.] German Canc Res Ctr, Div Immunogenet, D-6900 Heidelberg, Germany; [Kubarenko, Andriy V.; Weber, Alexander N. R.] German Canc Res Ctr, Jr Res Grp Toll Like Receptors & Canc, D-6900 Heidelberg, Germany; [Schwartz-Albiez, Reinhard] German Canc Res Ctr, Div Translat Immunol, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Shatnyeva, OM (corresponding author), German Canc Res Ctr, Div Immunogenet, D-6900 Heidelberg, Germany.	i.lavrik@dkfz.de	Lavrik, Inna N/C-1700-2009	Lavrik, Inna N/0000-0002-9324-309X; Weber, Alexander/0000-0002-8627-7056	Helmholtz Alliance on Systems Biology (SBCancer); Wilhelm Sander Stiftung; Helmholtz-Russia Joint Research Groups [2008-2 SFB 405]; Tumorzentrum Heidelberg/Mannheim	Helmholtz Alliance on Systems Biology (SBCancer); Wilhelm Sander Stiftung; Helmholtz-Russia Joint Research Groups; Tumorzentrum Heidelberg/Mannheim	Funding was provided by Helmholtz Alliance on Systems Biology (SBCancer), Wilhelm Sander Stiftung, Helmholtz-Russia Joint Research Groups-2008-2 SFB 405 and the Tumorzentrum Heidelberg/Mannheim. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AERTS JMFG, 1986, BIOCHEM BIOPH RES CO, V141, P452, DOI 10.1016/S0006-291X(86)80194-2; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; OEHM A, 1992, J BIOL CHEM, V267, P10709; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Powell LD., 2001, CURR PROTOC MOL BIOL; RALPH P, 1983, IMMUNOL LETT, V7, P17, DOI 10.1016/0165-2478(83)90049-4; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 2000, METHOD ENZYMOL, V322, P363; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schmitz I, 2002, BIOCHEM BIOPH RES CO, V297, P459, DOI 10.1016/S0006-291X(02)02242-8; Schneider U, 1977, Haematol Blood Transfus, V20, P265; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920	56	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19927	10.1371/journal.pone.0019927	http://dx.doi.org/10.1371/journal.pone.0019927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625644	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200049
J	Swietnicki, W; Carmany, D; Retford, M; Guelta, M; Dorsey, R; Bozue, J; Lee, MS; Olson, MA				Swietnicki, Wieslaw; Carmany, Daniel; Retford, Michael; Guelta, Mark; Dorsey, Russell; Bozue, Joel; Lee, Michael S.; Olson, Mark A.			Identification of Small-Molecule Inhibitors of Yersinia pestis Type III Secretion System YscN ATPase	PLOS ONE			English	Article							INFECTIOUS-DISEASES; YOP TRANSLOCATION; VIRULENCE; PLAGUE; ENERGY; ENTEROCOLITICA; GUADINOMINES; EFFICIENT; PROTEINS; PORE	Yersinia pestis is a Gram negative zoonotic pathogen responsible for causing bubonic and pneumonic plague in humans. The pathogen uses a type III secretion system (T3SS) to deliver virulence factors directly from bacterium into host mammalian cells. The system contains a single ATPase, YscN, necessary for delivery of virulence factors. In this work, we show that deletion of the catalytic domain of the yscN gene in Y. pestis CO92 attenuated the strain over three million-fold in the Swiss-Webster mouse model of bubonic plague. The result validates the YscN protein as a therapeutic target for plague. The catalytic domain of the YscN protein was made using recombinant methods and its ATPase activity was characterized in vitro. To identify candidate therapeutics, we tested computationally selected small molecules for inhibition of YscN ATPase activity. The best inhibitors had measured IC50 values below 20 mu M in an in vitro ATPase assay and were also found to inhibit the homologous BsaS protein from Burkholderia mallei animal-like T3SS at similar concentrations. Moreover, the compounds fully inhibited YopE secretion by attenuated Y. pestis in a bacterial cell culture and mammalian cells at mM concentrations. The data demonstrate the feasibility of targeting and inhibiting a critical protein transport ATPase of a bacterial virulence system. It is likely the same strategy could be applied to many other common human pathogens using type III secretion system, including enteropathogenic E. coli, Shigella flexneri, Salmonella typhimurium, and Burkholderia mallei/pseudomallei species.	[Swietnicki, Wieslaw] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Carmany, Daniel] Battelle Eastern Sci & Technol Ctr, Battelle Mem Inst, Aberdeen, MD USA; [Retford, Michael; Guelta, Mark; Dorsey, Russell] Edgewood Chem & Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD USA; [Bozue, Joel] USA, Med Res Inst Infect Dis, Div Bacteriol, Ft Detrick, MD 21702 USA; [Lee, Michael S.; Olson, Mark A.] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Ft Detrick, MD 21702 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Swietnicki, W (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD USA.	wieslaw.swietnicki@usuhs.mil	Bozue, Joel/AAE-4363-2022; Swietnicki, Wieslaw/AAU-1536-2020; Bozue, Joel/AAE-4357-2022; Swietnicki, Wieslaw/AAL-2452-2021; Swietnicki, Wieslaw/GOP-2576-2022	Bozue, Joel/0000-0001-6959-8176; Swietnicki, Wieslaw/0000-0002-9354-8184; Bozue, Joel/0000-0001-6959-8176; 	Defense Threat Reduction Agency [2.10019_08_RD_B]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency project 2.10019_08_RD_B (W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello D, 2010, ANTIMICROB AGENTS CH, V54, P1988, DOI 10.1128/AAC.01598-09; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Chen ZW, 2010, VET RES, V41, DOI 10.1051/vetres/2009053; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; De Marcos Lousa Carine, 2009, Commun Integr Biol, V2, P97; Ding C, 2002, J VIROL, V76, P338, DOI 10.1128/JVI.76.1.338-345.2002; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Felise HB, 2008, CELL HOST MICROBE, V4, P325, DOI 10.1016/j.chom.2008.08.001; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Harmon DE, 2010, ANTIMICROB AGENTS CH, V54, P3241, DOI 10.1128/AAC.00364-10; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Iwatsuki M, 2008, J ANTIBIOT, V61, P230, DOI 10.1038/ja.2008.33; Jiang XH, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-18; Journet L, 2005, MOL MEMBR BIOL, V22, P41, DOI 10.1080/09687860500041858; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keyser P, 2008, J INTERN MED, V264, P17, DOI 10.1111/j.1365-2796.2008.01941.x; Kim OK, 2009, J MED CHEM, V52, P5626, DOI 10.1021/jm9006577; Kline T, 2008, J MED CHEM, V51, P7065, DOI 10.1021/jm8004515; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Martin CA, 2008, EUR J CLIN MICROBIOL, V27, P635, DOI 10.1007/s10096-008-0489-3; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Motre A, 2008, GENE, V420, P17, DOI 10.1016/j.gene.2008.04.017; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Pan NJ, 2009, ANTIMICROB AGENTS CH, V53, P385, DOI 10.1128/AAC.00670-08; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; PITT ML, 2004, AN MOD CORR PROT PLA; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Ritchie JM, 2005, INFECT IMMUN, V73, P1466, DOI 10.1128/IAI.73.3.1466-1474.2005; Rocke TE, 2008, J WILDLIFE DIS, V44, P930, DOI 10.7589/0090-3558-44.4.930; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Tautz L, 2005, J BIOL CHEM, V280, P9400, DOI 10.1074/jbc.M413122200; Tree JJ, 2009, INFECT IMMUN, V77, P4209, DOI 10.1128/IAI.00562-09; Ulrich RL, 2004, INFECT IMMUN, V72, P6589, DOI 10.1128/IAI.72.11.6589-6596.2004; Veenendaal AKJ, 2009, J BACTERIOL, V191, P563, DOI 10.1128/JB.01004-08; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; WORSHAM P, 1998, MEDISCHE MICROBIOLOG, V6, pS34; Worsham PL, 1995, CONTRIB TO MICROBIOL, V13, P325; Yin Jia-Xiang, 2008, BMC Ecology, V8, P18, DOI 10.1186/1472-6785-8-18; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	65	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19716	10.1371/journal.pone.0019716	http://dx.doi.org/10.1371/journal.pone.0019716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611119	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200028
J	Suzuki, S; Ono, N; Furusawa, C; Ying, BW; Yomo, T				Suzuki, Shingo; Ono, Naoaki; Furusawa, Chikara; Ying, Bei-Wen; Yomo, Tetsuya			Comparison of Sequence Reads Obtained from Three Next-Generation Sequencing Platforms	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOME	Next-generation sequencing technologies enable the rapid cost-effective production of sequence data. To evaluate the performance of these sequencing technologies, investigation of the quality of sequence reads obtained from these methods is important. In this study, we analyzed the quality of sequence reads and SNP detection performance using three commercially available next-generation sequencers, i.e., Roche Genome Sequencer FLX System (FLX), Illumina Genome Analyzer (GA), and Applied Biosystems SOLiD system (SOLiD). A common genomic DNA sample obtained from Escherichia coli strain DH1 was applied to these sequencers. The obtained sequence reads were aligned to the complete genome sequence of E. coli DH1, to evaluate the accuracy and sequence bias of these sequence methods. We found that the fraction of "junk'' data, which could not be aligned to the reference genome, was largest in the data set of SOLiD, in which about half of reads could not be aligned. Among data sets after alignment to the reference, sequence accuracy was poorest in GA data sets, suggesting relatively low fidelity of the elongation reaction in the GA method. Furthermore, by aligning the sequence reads to the E. coli strain W3110, we screened sequence differences between two E. coli strains using data sets of three different next-generation platforms. The results revealed that the detected sequence differences were similar among these three methods, while the sequence coverage required for the detection was significantly small in the FLX data set. These results provided valuable information on the quality of short sequence reads and the performance of SNP detection in three next-generation sequencing platforms.	[Suzuki, Shingo; Ono, Naoaki; Furusawa, Chikara; Ying, Bei-Wen; Yomo, Tetsuya] Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Japan Science & Technology Agency (JST); Osaka University	Suzuki, S (corresponding author), Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Furusawa, Chikara/ABB-6516-2021; Furusawa, Chikara/N-6103-2015; Suzuki, Shingo/O-3651-2014; Ying, Bei-Wen/Q-9750-2019	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975; Suzuki, Shingo/0000-0003-1332-3194; Ying, Bei-Wen/0000-0003-2517-5686; ONO, Naoaki/0000-0002-7722-055X	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by the Global COE (Centers of Excellence) program and Special Coordination Funds for Promoting Science and Technology: Yuragi Project of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Kashiwagi A, 2009, METAB ENG, V11, P56, DOI 10.1016/j.ymben.2008.08.002; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Walter NAR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-379	13	62	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19534	10.1371/journal.pone.0019534	http://dx.doi.org/10.1371/journal.pone.0019534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611185	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500006
J	Trian, T; Burgess, JK; Niimi, K; Moir, LM; Ge, Q; Berger, P; Liggett, SB; Black, JL; Oliver, BG				Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Berger, Patrick; Liggett, Stephen B.; Black, Judith L.; Oliver, Brian G.			beta(2)-Agonist Induced cAMP Is Decreased in Asthmatic Airway Smooth Muscle Due to Increased PDE4D	PLOS ONE			English	Article							BETA-ADRENOCEPTOR RESPONSIVENESS; CELL-PROLIFERATION; PHOSPHODIESTERASE-4 INHIBITOR; ROFLUMILAST; EXPRESSION; RECEPTOR; DESENSITIZATION; MECHANISM; ALPHA	Background and Objective: Asthma is associated with airway narrowing in response to bronchoconstricting stimuli and increased airway smooth muscle (ASM) mass. In addition, some studies have suggested impaired beta-agonist induced ASM relaxation in asthmatics, but the mechanism is not known. Objective: To characterize the potential defect in beta-agonist induced cAMP in ASM derived from asthmatic in comparison to non-asthmatic subjects and to investigate its mechanism. Methods: We examined beta(2)-adrenergic (beta(2)AR) receptor expression and basal beta-agonist and forskolin (direct activator of adenylyl cyclase) stimulated cAMP production in asthmatic cultured ASM (n = 15) and non-asthmatic ASM (n = 22). Based on these results, PDE activity, PDE4D expression and cell proliferation were determined. Results: In the presence of IBMX, a pan PDE inhibitor, asthmatic ASM had similar to 50% lower cAMP production in response to isoproterenol, albuterol, formoterol, and forskolin compared to non-asthmatic ASM. However when PDE4 was specifically inhibited, cAMP production by the agonists and forskolin was normalized in asthmatic ASM. We then measured the amount and activity of PDE4, and found similar to 2-fold greater expression and activity in asthmatic ASM compared to non-asthmatic ASM. Furthermore, inhibition of PDE4 reduced asthmatic ASM proliferation but not that of non-asthmatic ASM. Conclusion: Decreased beta-agonist induced cAMP in ASM from asthmatics results from enhanced degradation due to increased PDE4D expression. Clinical manifestations of this dysregulation would be suboptimal beta-agonist-mediated bronchodilation and possibly reduced control over increasing ASM mass. These phenotypes appear to be "hard-wired'' into ASM from asthmatics, as they do not require an inflammatory environment in culture to be observed.	[Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Black, Judith L.; Oliver, Brian G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Trian, Thomas; Burgess, Janette K.; Niimi, Kyoko; Moir, Lyn M.; Ge, Qi; Black, Judith L.; Oliver, Brian G.] Univ Sydney, Discipline Pharmacol, Sch Med Sci, Sydney, NSW 2006, Australia; [Berger, Patrick] Univ Bordeaux Segalen, Ctr Rech Cardiothorac Bordeaux, INSERM, Bordeaux, France; [Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University System of Maryland; University of Maryland Baltimore	Trian, T (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brian.oliver@sydney.edu.au	Black, Judith L/C-6559-2008; Burgess, Janette/M-7117-2019; Berger, Patrick/D-8779-2012; Moir, Lyn/A-8967-2011; Ge, Qi/D-3988-2013; Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010; liggett, stephen b/E-7453-2012	Berger, Patrick/0000-0003-4702-0343; Oliver, Brian/0000-0002-7122-9262; Burgess, Janette/0000-0001-9868-9966; Liggett, Stephen B./0000-0002-0128-3669; trian, thomas/0000-0002-2567-4867	National Health and Medical Research Council Australia [464815, 402835]; Asthma Foundation of NSW; NHMRC [571098]; US National Institutes of Health [HL071609, HL065899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899, R01HL071609] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of NSW; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support funding: National Health and Medical Research Council Australia #464815 (http://www.nhmrc.gov.au/), The Asthma Foundation of NSW (http://www.asthmafoundation.org.au); J. K. Burgess is supported by a National Health and Medical Research Council Australia R. Douglas Wright Fellowship #402835 (http://www.nhmrc.gov.au/), and J. L. Black by an NHMRC Senior Principal Research Fellowship #571098 (http://www.nhmrc.gov.au/). S. B. Liggett is supported by the US National Institutes of Health grants HL071609 and HL065899 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; BRODDE OE, 1985, J CLIN INVEST, V76, P1096, DOI 10.1172/JCI112063; Burgess JK, 2006, J ALLERGY CLIN IMMUN, V118, P649, DOI 10.1016/j.jaci.2006.05.019; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Cone J, 1999, J CARDIOVASC PHARM, V34, P497, DOI 10.1097/00005344-199910000-00004; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Deshpande DA, 2010, NATURE MED IN PRESS; Diab-Assef M, 2002, SCAND J GASTROENTERO, V37, P206, DOI 10.1080/003655202753416894; FRASER CM, 1981, NEW ENGL J MED, V305, P1165, DOI 10.1056/NEJM198111123052001; GINA, 2010, GLOB STRAT ASTHM MAN; GOLDIE RG, 1986, BRIT J CLIN PHARMACO, V22, P669, DOI 10.1111/j.1365-2125.1986.tb02956.x; Goto M, 2009, CELL IMMUNOL, V258, P147, DOI 10.1016/j.cellimm.2009.04.005; Growcott EJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-9; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Laporte JD, 1998, AM J PHYSIOL-LUNG C, V275, pL491, DOI 10.1152/ajplung.1998.275.3.L491; Louw C, 2007, RESPIRATION, V74, P411, DOI 10.1159/000095677; Mahn K, 2010, THORAX, V65, P547, DOI 10.1136/thx.2009.129296; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Moore PE, 2001, J APPL PHYSIOL, V91, P1467, DOI 10.1152/jappl.2001.91.3.1467; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; SPINA D, 1989, AM REV RESPIR DIS, V140, P1410, DOI 10.1164/ajrccm/140.5.1410; Stewart AG, 1997, BRIT J PHARMACOL, V121, P361, DOI 10.1038/sj.bjp.0701128; Togo S, 2009, AM J PHYSIOL-LUNG C, V296, pL959, DOI 10.1152/ajplung.00508.2007; TOMLINSON PR, 1995, BIOCHEM PHARMACOL, V49, P1809, DOI 10.1016/0006-2952(94)00532-Q; Trian T, 2009, AM J RESPIR CELL MOL; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709	35	75	75	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20000	10.1371/journal.pone.0020000	http://dx.doi.org/10.1371/journal.pone.0020000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611147	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500039
J	Banai, K; Yifat, R				Banai, Karen; Yifat, Rachel			Perceptual Anchoring in Preschool Children: Not Adultlike, but There	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; AUDITORY-DISCRIMINATION; DECISION-MAKING; DYSLEXIA; CORTEX; MEMORY; PITCH	Background: Recent studies suggest that human auditory perception follows a prolonged developmental trajectory, sometimes continuing well into adolescence. Whereas both sensory and cognitive accounts have been proposed, the development of the ability to base current perceptual decisions on prior information, an ability that strongly benefits adult perception, has not been directly explored. Here we ask whether the auditory frequency discrimination of preschool children also improves when given the opportunity to use previously presented standard stimuli as perceptual anchors, and whether the magnitude of this anchoring effect undergoes developmental changes. Methodology/Principal Findings: Frequency discrimination was tested using two adaptive same/different protocols. In one protocol (with-reference), a repeated 1-kHz standard tone was presented repeatedly across trials. In the other (no-reference), no such repetitions occurred. Verbal memory and early reading skills were also evaluated to determine if the pattern of correlations between frequency discrimination, memory and literacy is similar to that previously reported in older children and adults. Preschool children were significantly more sensitive in the with-reference than in the no-reference condition, but the magnitude of this anchoring effect was smaller than that observed in adults. The pattern of correlations among discrimination thresholds, memory and literacy replicated previous reports in older children. Conclusions/Significance: The processes allowing the use of context to form perceptual anchors are already functional among preschool children, albeit to a lesser extent than in adults. Nevertheless, immature anchoring cannot fully account for the poorer frequency discrimination abilities of young children. That anchoring is present among the majority of typically developing preschool children suggests that the anchoring deficits observed among individuals with dyslexia represent a true deficit rather than a developmental delay.	[Banai, Karen; Yifat, Rachel] Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel	University of Haifa	Banai, K (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel.	kbanai@research.haifa.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470	Israel Science Foundation [LHSI 1842/07]; Marie Curie grants [IRG 224763]	Israel Science Foundation(Israel Science Foundation); Marie Curie grants(European Commission)	This study was supported by Israel Science Foundation (LHSI 1842/07) and Marie Curie (IRG 224763) grants to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Baddeley A. D, 1986, WORKING MEMORY; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Banai K, 2010, DYSLEXIA, V16, P240, DOI 10.1002/dys.407; Ceponiene R, 2002, COGNITIVE BRAIN RES, V13, P101, DOI 10.1016/S0926-6410(01)00093-3; CREELMAN CD, 1979, J EXP PSYCHOL HUMAN, V5, P146, DOI 10.1037/0096-1523.5.1.146; Dawes P, 2008, J SPEECH LANG HEAR R, V51, P1002, DOI 10.1044/1092-4388(2008/073); Halliday LF, 2008, J ACOUST SOC AM, V123, P4393, DOI 10.1121/1.2890749; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; Harris JA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000100; He C, 2007, J COGNITIVE NEUROSCI, V19, P878, DOI 10.1162/jocn.2007.19.5.878; JENSEN JK, 1993, PSYCHOL SCI, V4, P104, DOI 10.1111/j.1467-9280.1993.tb00469.x; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; MAXON AB, 1982, EAR HEARING, V3, P301, DOI 10.1097/00003446-198211000-00003; Moore DR, 2008, HEARING RES, V238, P147, DOI 10.1016/j.heares.2007.11.013; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Moore JK, 2007, INT J AUDIOL, V46, P460, DOI 10.1080/14992020701383019; Nachmias J, 2006, VISION RES, V46, P2456, DOI 10.1016/j.visres.2006.01.029; Nahum M, 2010, J NEUROSCI, V30, P1128, DOI 10.1523/JNEUROSCI.1781-09.2010; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; SHANY M, 2000, TEST ASSESSMENT EARL; Sutcliffe P, 2005, J EXP CHILD PSYCHOL, V91, P249, DOI 10.1016/j.jecp.2005.03.004; Thompson NC, 1999, J SPEECH LANG HEAR R, V42, P1061, DOI 10.1044/jslhr.4205.1061; Trainor L, 2003, INT J PSYCHOPHYSIOL, V51, P5, DOI 10.1016/S0167-8760(03)00148-X; Tsaliach Inbal, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P221; Tubul G., 1995, TEST PHONOLOGICAL AW; Werner LA, 2007, J COMMUN DISORD, V40, P275, DOI 10.1016/j.jcomdis.2007.03.004; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	31	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19769	10.1371/journal.pone.0019769	http://dx.doi.org/10.1371/journal.pone.0019769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603614	Green Submitted, Green Published, gold			2022-12-27	WOS:000290656300025
J	Paulay, G; Starmer, J				Paulay, Gustav; Starmer, John			Evolution, Insular Restriction, and Extinction of Oceanic Land Crabs, Exemplified by the Loss of an Endemic Geograpsus in the Hawaiian Islands	PLOS ONE			English	Article							TERRESTRIAL DECAPOD CRUSTACEANS; RAIN-FOREST; CHRISTMAS ISLAND; RED CRABS; FRESH-WATER; BRACHYURA; TAXONOMY; MARINE; GENUS; DIVERSIFICATION	Most oceanic islands harbor unusual and vulnerable biotas as a result of isolation. As many groups, including dominant competitors and predators, have not naturally reached remote islands, others were less constrained to evolve novel adaptations and invade adaptive zones occupied by other taxa on continents. Land crabs are an excellent example of such ecological release, and some crab lineages made the macro-evolutionary transition from sea to land on islands. Numerous land crabs are restricted to, although widespread among, oceanic islands, where they can be keystone species in coastal forests, occupying guilds filled by vertebrates on continents. In the remote Hawaiian Islands, land crabs are strikingly absent. Here we show that absence of land crabs in the Hawaiian Islands is the result of extinction, rather than dispersal limitation. Analysis of fossil remains from all major islands show that an endemic Geograpsus was abundant before human colonization, grew larger than any congener, and extended further inland and to higher elevation than other land crabs in Oceania. Land crabs are major predators of nesting sea birds, invertebrates and plants, affect seed dispersal, control litter decomposition, and are important in nutrient cycling; their removal can lead to large-scale shifts in ecological communities. Although the importance of land crabs is obvious on remote and relatively undisturbed islands, it is less apparent on others, likely because they are decimated by humans and introduced biota. The loss of Geograpsus and potentially other land crabs likely had profound consequences for Hawaiian ecosystems.	[Paulay, Gustav; Starmer, John] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Paulay, G (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	paulay@flmnh.ufl.edu; eucidaris@gmail.com		Starmer, John/0000-0003-2926-5048	US National Science Foundation (NSF) [DEB-0529724]; Leila & William Brayfield Scholarship; Southwest Florida Fossil Club	US National Science Foundation (NSF)(National Science Foundation (NSF)); Leila & William Brayfield Scholarship; Southwest Florida Fossil Club	Partially supported with funding from the US National Science Foundation (NSF DEB-0529724), Leila & William Brayfield Scholarship, and the Southwest Florida Fossil Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT R. TUCKER, 1960, INDO PACIFIC MOLLUSCA, V1, P33; Abele L.G., 1974, Bulletin of Zoological Nomenclature, V31, P49; ALEXANDER HGL, 1979, PHILOS T ROY SOC B, V286, P241, DOI 10.1098/rstb.1979.0031; Amesbury SS, 1980, 66 U GUAM MAR LAB; Anger K, 1995, J EXP MAR BIOL ECOL, V193, P119, DOI 10.1016/0022-0981(95)00114-X; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Banerjee S. K., 1960, Temminckia, V10, P132; Burney DA, 2001, ECOL MONOGR, V71, P615, DOI 10.1890/0012-9615(2001)071[0615:FEFADB]2.0.CO;2; Burney DA, 2006, HUM ECOL, V34, P219, DOI 10.1007/s10745-006-9015-3; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; CARSON HL, 1983, GENETICS, V103, P465; Dai A-Y., 1991, CRABS CHINA SEAS; Dana J. D., 1852, CRUSTACEA 1; Dana JD, 1851, P ACAD NAT SCI PHILA, V5, P247; De Man J. G., 1889, Zoologische Jahrbuecher Abteilungen f Systematik, Viv, P409; Diesel R, 2000, J ZOOL, V250, P141, DOI 10.1111/j.1469-7998.2000.tb01066.x; Edmondson C.H., 1946, REEF SHORE FAUNA HAW; EDMONDSON CHARLES HOWARD, 1962, OCCAS PAPERS BERNICE PAUAHI BISHOP MUS, V23, P1; EDMONDSON CHARLES HOWARD, 1959, OCCAS PAPERS BERNICE P BISHOP MUS, V22, P153; Ehrhardt J. P, 1970, Bull. Soc. zool. Fr., V95, P41; Eldredge Lucius G., 2003, Bishop Museum Occasional Papers, V76, P1; Etpison MT, 2004, PALAU NATURAL HIST; Foale Simon, 1999, Pacific Science, V53, P37; GARTH J S, 1973, Proceedings of the California Academy of Sciences, V39, P311; GEORGE RW, 1974, P 2 INT COR REEF S, V1, P321; Giffin JG, 2003, PUU WAA WAA BIOL ASS; Godwin S., 2006, INVENTORY INTERTIDAL; Grant P.R., 2007, WHY SPECIES MULTIPLY; Green PT, 1997, ECOLOGY, V78, P2474, DOI 10.1890/0012-9658(1997)078[2474:COSRBL]2.0.CO;2; Green PT, 1997, J TROP ECOL, V13, P17, DOI 10.1017/S0266467400010221; Green PT, 1999, OECOLOGIA, V119, P435, DOI 10.1007/s004420050805; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P411, DOI 10.1098/rstb.1971.0020; HADFIELD MG, 1986, MALACOLOGIA, V27, P67; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; Hartnoll RG, 2009, J CRUSTACEAN BIOL, V29, P57, DOI [10.1651/08-2992.1, 10.1561/08-2992.1]; Hedges SB, 1996, ANNU REV ECOL SYST, V27, P163, DOI 10.1146/annurev.ecolsys.27.1.163; Hicks J, 1990, CHRISTMAS CRABS; Holthuis B. V., 1995, EVOLUTION MARINE FRE; Holthuis L. B., 1954, Atoll Research Bulletin, VNo. 24, P1; HOWARTH F G, 1990, Bishop Museum Occasional Papers, V30, P4; *ICZN, 1979, B ZOOL NOMENCLATURE, V36, P119; Innocenti G, 2007, CRUSTACEANA, V80, P635, DOI 10.1163/156854007780765632; JAMES HF, 1987, P NATL ACAD SCI USA, V84, P2350, DOI 10.1073/pnas.84.8.2350; James HF, 1991, ORNITHOLOGICAL MONOG, V45, P1, DOI DOI 10.2307/40166713; Jordan S, 2003, SYST BIOL, V52, P89, DOI 10.1080/10635150390132803; Kay E.A., 1984, Bernice P. Bishop Museum Special Publication, V72, P15; Kessler C, 2005, CRUSTACEANA, V78, P761, DOI 10.1163/156854005774353485; Kingsley JS, 1880, P ACAD NAT SCI PHILA, V1880, P187; KIRCH PV, 1982, PAC SCI, V36, P1; Kirch PV, 1986, BISHOP MUSEUM OCCASI, V26, P52; Kolinski Steven P., 1994, Herpetological Review, V25, P120; LEE MAB, 1985, OIKOS, V45, P169, DOI 10.2307/3565702; Liu HC, 2005, J CRUSTACEAN BIOL, V25, P135, DOI 10.1651/C-2499; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MARQUET G, 1991, CRUSTACEANA, V61, P125, DOI 10.1163/156854091X00632; McCormack G., 2007, COOK ISLANDS BIODIVE; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; MURRAY J, 1988, Pacific Science, V42, P150; Naruse T, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.1987.1.3; Naruse Tohru, 2008, Species Diversity, V13, P117; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Ng PKL, 1999, ZOOL STUD, V38, P228; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; ODOWD DJ, 1989, J TROP ECOL, V5, P337, DOI 10.1017/S0266467400003746; ODOWD DJ, 1991, J TROP ECOL, V7, P113, DOI 10.1017/S0266467400005162; ODOWD DJ, 1990, OIKOS, V58, P289, DOI 10.2307/3545219; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Olson SL, 1991, ORNITHOL MONOGR, V45, P1, DOI DOI 10.2307/40166794; PAULAY G, 1994, AM ZOOL, V34, P134; Paulay G, 2002, INTEGR COMP BIOL, V42, P922, DOI 10.1093/icb/42.5.922; Paulay Gustav, 1997, P298; Paulay Gustav, 2003, Micronesica, V35-36, P456; Paulson Dennis R., 2003, International Journal of Odonatology, V6, P39; Pitman Robert L., 2005, Marine Ornithology, V33, P193; POUPIN J, 1998, ATOLL RES B, V451, P1, DOI DOI 10.5479/SI.00775630.451.1; Rathbun M.J., 1906, B US FISH COMM, V23, P829; Rosenberg G, 1996, EVOLUTION, V50, P682, DOI 10.1111/j.1558-5646.1996.tb03878.x; Sachet M. H., 1962, Atoll Research Bulletin, VNo. 86, P1; Sakai T, 1976, CRABS JAPAN ADJACENT; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Schubart CD, 2000, MOL PHYLOGENET EVOL, V15, P179, DOI 10.1006/mpev.1999.0754; Solem A., 1979, HIST BIOGEOGRAPHY PL, P277; Sorbini L., 1988, SMITHSONIAN CONTRIBU, V14, P1; Steadman David W., 2006, P1; Tesch J. J., 1917, Zoologische Mededeelingen Leiden, V3; TITCOMB M, 1978, PAC SCI, V32, P325; Turkay M., 1974, Senckenbergiana Biologica, V55, P223; Vermeij G.J, 1987, EVOLUTION ESCALATION; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wetterer JK, 2006, PAC SCI, V60, P413, DOI 10.1353/psc.2006.0022; Whitelegge T., 1897, MEMOIRS AUSTR MUSEUM, V3, P127, DOI DOI 10.3853/0067-1967.3.1897.492; Williams ST, 2004, EVOLUTION, V58, P2227; WILSON EDWARD O., 1967, PAC INSECTS MONOGR, V14, P1; Wolcott TG, 1988, ECOLOGY, P55; Yaldwyn J.C., 1979, ATOLL RES B, V235, P1; Yeo DCJ, 2008, HYDROBIOLOGIA, V595, P275, DOI 10.1007/s10750-007-9023-3; Zimmerman EC, 1948, INSECT HAWAII, V1	98	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19916	10.1371/journal.pone.0019916	http://dx.doi.org/10.1371/journal.pone.0019916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603620	gold, Green Submitted, Green Published			2022-12-27	WOS:000290656300037
J	Xavier, MJ; Williams, MJ				Xavier, Miguel J.; Williams, Michael J.			The Rho-Family GTPase Rac1 Regulates Integrin Localization Drosophila Immunosurveillance Cells	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; LEPTOPILINA-BOULARDI; ALPHA-V-BETA-3 INTEGRIN; BLOOD-CELLS; PROTEIN; MELANOGASTER; HEMATOPOIESIS; TRAFFICKING; ACTIVATION; INSIGHTS	Background: When the parasitoid wasp Leptopilina boulardi lays an egg in a Drosophila larva, phagocytic cells called plasmatocytes and specialized cells known as lamellocytes encapsulate the egg. The Drosophila beta-integrin Myospheroid (Mys) is necessary for lamellocytes to adhere to the cellular capsule surrounding L. boulardi eggs. Integrins are heterodimeric adhesion receptors consisting of alpha and beta subunits, and similar to other plasma membrane receptors undergo ligand-dependent endocytosis. In mammalian cells it is known that integrin binding to the extracellular matrix induces the activation of Rac GTPases, and we have previously shown that Rac1 and Rac2 are necessary for a proper encapsulation response in Drosophila larvae. We wanted to test the possibility that Myospheroid and Rac GTPases interact during the Drosophila anti-parasitoid immune response. Results: In the current study we demonstrate that Rac1 is required for the proper localization of Myospheroid to the cell periphery of haemocytes after parasitization. Interestingly, the mislocalization of Myospheroid in Rac1 mutants is rescued by hyperthermia, involving the heat shock protein Hsp83. From these results we conclude that Rac1 and Hsp83 are required for the proper localization of Mys after parasitization. Significance: We show for the first time that the small GTPase Rac1 is required for Mysopheroid localization. Interestingly, the necessity of Rac1 in Mys localization was negated by hyperthermia. This presents a problem, in Drosophila we quite often raise larvae at 29 degrees C when using the GAL4/UAS misexpression system. If hyperthermia rescues receptor endosomal recycling defects, raising larvae in hyperthermic conditions may mask potentially interesting phenotypes.	[Xavier, Miguel J.; Williams, Michael J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen	Xavier, MJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	m.j.williams@abdn.ac.uk	Xavier, Miguel/AAD-4576-2022	Xavier, Miguel/0000-0003-0709-7223	Swedish Research Council; Swedish Cancer Society; Royal Society; College of Life Sciences and Medicine, University of Aberdeen; NICHD	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Royal Society(Royal Society of London); College of Life Sciences and Medicine, University of Aberdeen; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society, the Royal Society and the College of Life Sciences and Medicine, University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Ueda, NIG, Japan, for his kind gift of UAS-Rac<SUP>IR</SUP> flies, and Dr. Ando, Hungarian Academy of Sciences, Hungary, for the Nimrod and L1a antibodies. The Myospheroid antibody developed by Dr. D. Brower was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; BREHELIN M, 1982, CELL TISSUE RES, V221, P607; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; di Blasio L, 2010, TRAFFIC, V11, P1107, DOI 10.1111/j.1600-0854.2010.01077.x; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Mathieu J, 2007, GENETICS, V176, P1579, DOI 10.1534/genetics.107.071282; Meister M, 2004, CURR OPIN IMMUNOL, V16, P10, DOI 10.1016/j.coi.2003.11.002; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pinon P, 2011, PIGM CELL MELANOMA R, V24, P282, DOI 10.1111/j.1755-148X.2010.00806.x; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	43	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19504	10.1371/journal.pone.0019504	http://dx.doi.org/10.1371/journal.pone.0019504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603603	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300010
J	Montemurro, MA; Zanette, DH				Montemurro, Marcelo A.; Zanette, Damian H.			Universal Entropy of Word Ordering Across Linguistic Families	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DATA-COMPRESSION; ENGLISH; SEQUENCES; LANGUAGE; TEXTS	Background: The language faculty is probably the most distinctive feature of our species, and endows us with a unique ability to exchange highly structured information. In written language, information is encoded by the concatenation of basic symbols under grammatical and semantic constraints. As is also the case in other natural information carriers, the resulting symbolic sequences show a delicate balance between order and disorder. That balance is determined by the interplay between the diversity of symbols and by their specific ordering in the sequences. Here we used entropy to quantify the contribution of different organizational levels to the overall statistical structure of language. Methodology/Principal Findings: We computed a relative entropy measure to quantify the degree of ordering in word sequences from languages belonging to several linguistic families. While a direct estimation of the overall entropy of language yielded values that varied for the different families considered, the relative entropy quantifying word ordering presented an almost constant value for all those families. Conclusions/Significance: Our results indicate that despite the differences in the structure and vocabulary of the languages analyzed, the impact of word ordering in the structure of language is a statistical linguistic universal.	[Montemurro, Marcelo A.] Univ Manchester, Manchester, Lancs, England; [Zanette, Damian H.] Ctr Atom Bariloche, Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Zanette, Damian H.] Inst Balseiro, San Carlos De Bariloche, Rio Negro, Argentina	University of Manchester; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Montemurro, MA (corresponding author), Univ Manchester, Manchester, Lancs, England.	M.Montemurro@manchester.ac.uk		Zanette, Damian/0000-0003-0681-0592; Breakspear, Michael/0000-0003-4943-3969; Montemurro, Marcelo/0000-0003-0893-8530	UK Medical Research Council (MRC); Royal Society; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/C010841/1]; Agencia Nacional de Promocion Cientifica y Tecnologica; Universidad Nacional de Cuyo of Argentina (SECTyP-UNCuyo); Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Cuyo of Argentina (SECTyP-UNCuyo); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Marcelo A. Montemurro was supported by the UK Medical Research Council (MRC), the Royal Society, and UK Engineering and Physical Sciences Research Council (EPSRC) grant EP/C010841/1. Damian H. Zanette was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica and Universidad Nacional de Cuyo of Argentina (SECTyP-UNCuyo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F, Vxiv; Alvarez-Lacalle E, 2006, P NATL ACAD SCI USA, V103, P7956, DOI 10.1073/pnas.0510673103; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Chomsky N, 1965, ASPECTS THEOR SYNTAX; Cover T.M., 2006, ELEMENTS INFORM THEO, Vxxiii; COVER TM, 1978, IEEE T INFORM THEORY, V24, P413, DOI 10.1109/TIT.1978.1055912; Darwin C, 1859, ORIGIN SPECIES MEANS; EBELING W, 1995, PHYSICA A, V215, P233, DOI 10.1016/0378-4371(95)00025-3; EBELING W, 1994, EUROPHYS LETT, V26, P241, DOI 10.1209/0295-5075/26/4/001; Gao Y, 2008, ENTROPY-SWITZ, V10, P71, DOI 10.3390/entropy-e10020071; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; GREENBERG JH, 1969, SCIENCE, V166, P473, DOI 10.1126/science.166.3904.473; GREENBERG JH, 1963, C HELD DOBBS FERR NE; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; HOLLANDER M, 1999, NONPARAMETRIC STAT M, V14; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kontoyiannis I, 1998, IEEE T INFORM THEORY, V44, P1319, DOI 10.1109/18.669425; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Miestamo Matti, 2008, LANGUAGE COMPLEXITY; Montemurro MA, 2002, FRACTALS, V10, P451, DOI 10.1142/S0218348X02001257; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; RUHLEN M, 1994, ORIGIN LANGUAGE TRAC, V11; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SMITH JM, 1995, MAJOR TRANSITIONS EV, V14; TEAHAN WJ, 1996, DAT COMPR C, P53; WYNER AD, 1989, IEEE T INFORM THEORY, V35, P1250, DOI 10.1109/18.45281; Zanette D, 2008, NATURE, V453, P988, DOI 10.1038/453988a; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zipf George, 1935, PSYCHOBIOLOGY LANGUA; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714; ZIV J, 1978, IEEE T INFORM THEORY, V24, P530, DOI 10.1109/TIT.1978.1055934	35	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19875	10.1371/journal.pone.0019875	http://dx.doi.org/10.1371/journal.pone.0019875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603637	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500033
J	Onomoto, K; Morimoto, S; Kawaguchi, T; Toyoda, H; Tanaka, M; Kuroda, M; Uno, K; Kumada, T; Matsuda, F; Shimotohno, K; Fujita, T; Murakami, Y				Onomoto, Koji; Morimoto, Shiho; Kawaguchi, Takahisa; Toyoda, Hidenori; Tanaka, Masami; Kuroda, Masahiko; Uno, Kazuko; Kumada, Takashi; Matsuda, Fumihiko; Shimotohno, Kunitada; Fujita, Takashi; Murakami, Yoshiki			Dysregulation of IFN System Can Lead to Poor Response to Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis C	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; PLUS RIBAVIRIN; COMBINATION THERAPY; VIRUS; LIVER; PEGINTERFERON; ALPHA; INFECTION; IL28B; 1B	Background: Despite being expensive, the standard combination of pegylated interferon (Peg-IFN)-alpha and ribavirin used to treat chronic hepatitis C (CH) results in a moderate clearance rate and a plethora of side effects. This makes it necessary to predict patient outcome so as to improve the accuracy of treatment. Although the antiviral mechanism of genetically altered IL28B is unknown, IL28B polymorphism is considered a good predictor of IFN combination treatment outcome. Methodology: Using microarray, we quantified the expression profile of 237 IFN related genes in 87 CH liver biopsy specimens to clarify the relationship between IFN pathway and viral elimination, and to predict patients' clinical outcome. In 72 out of 87 patients we also analyzed IL28B polymorphism (rs8099917). Principal Findings: Five IFN related-genes (IFI27, IFI 44, ISG15, MX1, and OAS1) had expression levels significantly higher in nonresponders (NR) than in normal liver (NL) and sustained virological responders (SVR); this high expression was also frequently seen in cases with the minor (TG or GG) IL28B genotype. The expression pattern of 31 IFN related-genes also differed significantly between NR and NL. We predicted drug response in NR with 86.1% accuracy by diagonal linear discriminant analysis (DLDA). Conclusion: IFN system dysregulation before treatment was associated with poor IFN therapy response. Determining IFN related-gene expression pattern based on patients' response to combination therapy, allowed us to predict drug response with high accuracy. This method can be applied to establishing novel antiviral therapies and strategies for patients using a more individual approach.	[Onomoto, Koji; Morimoto, Shiho; Fujita, Takashi] Kyoto Univ, Inst Viral Res, Kyoto, Japan; [Onomoto, Koji; Morimoto, Shiho; Fujita, Takashi] Kyoto Univ, Grad Sch Biosci, Kyoto, Japan; [Kawaguchi, Takahisa; Matsuda, Fumihiko; Murakami, Yoshiki] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Tanaka, Masami; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Kyoto, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan; [Onomoto, Koji] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Ogaki Municipal Hospital; Tokyo Medical University; Chiba Institute of Technology; Waseda University	Onomoto, K (corresponding author), Chiba Univ, Div Mol Immunol, Med Mycol Res Ctr, Chiba, Japan.	ymurakami@genome.med.kyoto-u.ac.jp			Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Y.M. was financially supported by the Japanese Ministry of Health, Labour and Welfare. Grants-in-Aid for scientific research were received from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bondini S, 2006, Minerva Gastroenterol Dietol, V52, P135; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chen TY, 2007, TRANSL RES, V150, P116, DOI 10.1016/j.trsl.2007.01.007; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Dill MT, 2011, GASTROENTEROLOGY; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Ikeda Kenji, 2006, Intervirology, V49, P82, DOI 10.1159/000087268; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mengshol JA, 2009, GUT, V58, P964, DOI 10.1136/gut.2008.168948; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Patzwahl R, 2001, J VIROL, V75, P1332, DOI 10.1128/JVI.75.3.1332-1338.2001; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2010, SWISS MED WKLY, V140, P3, DOI smw-12670; Sharma P, 2007, LIVER TRANSPLANT, V13, P1100, DOI 10.1002/lt.21121; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Uno K, 2005, WORLD J GASTROENTERO, V11, P7330, DOI 10.3748/wjg.v11.i46.7391; Wertheimer AM, 2004, HEPATOLOGY, V40, P335, DOI 10.1002/hep.20306; Younossi ZM, 2009, HEPATOLOGY, V49, P763, DOI 10.1002/hep.22729	33	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19799	10.1371/journal.pone.0019799	http://dx.doi.org/10.1371/journal.pone.0019799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603632	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500030
J	Filali, H; Martin-Burriel, I; Harders, F; Varona, L; Lyahyai, J; Zaragoza, P; Pumarola, M; Badiola, JJ; Bossers, A; Bolea, R				Filali, Hicham; Martin-Burriel, Inmaculada; Harders, Frank; Varona, Luis; Lyahyai, Jaber; Zaragoza, Pilar; Pumarola, Marti; Badiola, Juan J.; Bossers, Alex; Bolea, Rosa			Gene Expression Profiling and Association with Prion-Related Lesions in the Medulla Oblongata of Symptomatic Natural Scrapie Animals	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PANCREATITIS-ASSOCIATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN SUBSTANTIA-NIGRA; GLUTATHIONE-PEROXIDASE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; APOLIPOPROTEIN-E; PEYERS-PATCHES	The pathogenesis of natural scrapie and other prion diseases remains unclear. Examining transcriptome variations in infected versus control animals may highlight new genes potentially involved in some of the molecular mechanisms of prion-induced pathology. The aim of this work was to identify disease-associated alterations in the gene expression profiles of the caudal medulla oblongata (MO) in sheep presenting the symptomatic phase of natural scrapie. The gene expression patterns in the MO from 7 sheep that had been naturally infected with scrapie were compared with 6 controls using a Central Veterinary Institute (CVI) custom designed 4 x 44K microarray. The microarray consisted of a probe set on the previously sequenced ovine tissue library by CVI and was supplemented with all of the Ovis aries transcripts that are currently publicly available. Over 350 probe sets displayed greater than 2-fold changes in expression. We identified 148 genes from these probes, many of which encode proteins that are involved in the immune response, ion transport, cell adhesion, and transcription. Our results confirm previously published gene expression changes that were observed in murine models with induced scrapie. Moreover, we have identified new genes that exhibit differential expression in scrapie and could be involved in prion neuropathology. Finally, we have investigated the relationship between gene expression profiles and the appearance of the main scrapie-related lesions, including prion protein deposition, gliosis and spongiosis. In this context, the potential impacts of these gene expression changes in the MO on scrapie development are discussed.	[Filali, Hicham; Badiola, Juan J.; Bolea, Rosa] Univ Zaragoza, Ctr Invest Encefalopatias & Enfermedades Transmis, Fac Vet, Zaragoza, Spain; [Martin-Burriel, Inmaculada; Lyahyai, Jaber; Zaragoza, Pilar] Univ Zaragoza, Lab Genet Bioquim LAGENBIO, Fac Vet, Zaragoza, Spain; [Harders, Frank; Bossers, Alex] Cent Inst Anim Dis Control CIDC Lelystad, Lelystad, Netherlands; [Varona, Luis] Univ Zaragoza, Unidad Genet Cuantitat & Mejora Anim, Fac Vet, Zaragoza, Spain; [Pumarola, Marti] UAB IRTA, PRIOCAT Lab, CReSA, Barcelona, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; IRTA	Filali, H (corresponding author), Univ Zaragoza, Ctr Invest Encefalopatias & Enfermedades Transmis, Fac Vet, Zaragoza, Spain.	rbolea@unizar.es	zaragoza, pilar/AAN-9479-2021; Bossers, Alex/AAA-6025-2021; Martin-Burriel, Inmaculada/K-3724-2014; Lyahyai, Jaber/C-4341-2011; Bossers, Alex/F-7757-2019; Varona Aguado, Luis/C-2744-2012; Filali, Hicham/D-1279-2014	Bossers, Alex/0000-0002-6586-717X; Martin-Burriel, Inmaculada/0000-0001-6016-4726; Bossers, Alex/0000-0002-6586-717X; Varona Aguado, Luis/0000-0001-6256-5478; Filali, Hicham/0000-0003-3352-740X; Pumarola Batlle, Marti/0000-0002-0935-7941	Spanish MCIIN [AGL2008-0256]; Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID); Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV)	Spanish MCIIN; Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID); Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV)	This work was performed as part of the AGL2008-0256 project, financed by the Spanish MCIIN. Hicham Filali was supported by doctoral grants from the Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID). Arrays and sequenced libraries were made available from projects at CVI supported by grants from the Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin C, 2004, J GEN VIROL, V85, P2103, DOI 10.1099/vir.0.80047-0; ARUSHANIAN EB, ZH NEVROL PSIKHIATR, V110, P100; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bertipaglia I., 2007, V45, P29; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Bolea R, 2005, J VET DIAGN INVEST, V17, P467, DOI 10.1177/104063870501700511; BOLEA R, NEUROPATHOL APPL NEU, V36, P300; Bons N, 1999, P NATL ACAD SCI USA, V96, P4046, DOI 10.1073/pnas.96.7.4046; Booth S, 2004, BIOCHEM BIOPH RES CO, V325, P1339, DOI 10.1016/j.bbrc.2004.10.150; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brown AR, 2004, NEUROPATH APPL NEURO, V30, P555, DOI 10.1111/j.1365-2990.2004.00565.x; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Brown DR, 2001, MED HYPOTHESES, V57, P555, DOI 10.1054/mehy.2001.1388; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Casellas J, 2008, ANIM GENET, V39, P89, DOI 10.1111/j.1365-2052.2007.01670.x; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chesebro B, 1997, NAT MED, V3, P491, DOI 10.1038/nm0597-491; Choe LH, 2002, ELECTROPHORESIS, V23, P2242, DOI 10.1002/1522-2683(200207)23:14<2242::AID-ELPS2242>3.0.CO;2-F; Cosseddu GM, 2007, BRAIN RES, V1142, P217, DOI 10.1016/j.brainres.2007.01.033; Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006; Counts SE, 2008, CELL MOL LIFE SCI, V65, P1842, DOI 10.1007/s00018-008-8159-2; Counts SE, 2008, NEURODEGENER DIS, V5, P228, DOI 10.1159/000113710; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; Crawley JN, 2008, CELL MOL LIFE SCI, V65, P1836, DOI 10.1007/s00018-008-8158-3; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; DUGUID JR, 1990, NUCLEIC ACIDS RES, V18, P2789, DOI 10.1093/nar/18.9.2789; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fukuhara R, 2003, ZOOL SCI, V20, P861, DOI 10.2108/zsj.20.861; Garcia-Crespo David, 2005, BMC Vet Res, V1, P3, DOI 10.1186/1746-6148-1-3; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GEORGSSON G, 1993, J COMP PATHOL, V108, P229, DOI 10.1016/S0021-9975(08)80287-3; Giese A, 2001, CURR TOP MICROBIOL, V253, P203; Giese A, 1998, BRAIN PATHOL, V8, P449; Goldmann W, 1999, J GEN VIROL, V80, P2275, DOI 10.1099/0022-1317-80-8-2275; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hanlon J, 2002, J COMP PATHOL, V127, P280, DOI 10.1053/jcpa.2002.0595; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hochstrasser DF, 1997, FEBS LETT, V416, P161, DOI 10.1016/S0014-5793(97)01191-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG Y, TRENDS MOL MED, V16, P287; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hur K, 2002, MECH AGEING DEV, V123, P1637, DOI 10.1016/S0047-6374(02)00099-4; Ishisaka R, 1999, CELL STRUCT FUNCT, V24, P465, DOI 10.1247/csf.24.465; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jones V, 1996, VET REC, V139, P360, DOI 10.1136/vr.139.15.360; Khaniya B, 2009, J TOXICOL ENV HEAL A, V72, P1008, DOI 10.1080/15287390903084199; Kim HC, 1999, BRAIN RES, V851, P76, DOI 10.1016/S0006-8993(99)02122-8; Kim JI, 2001, ANN NY ACAD SCI, V928, P182, DOI 10.1111/j.1749-6632.2001.tb05648.x; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; LAPLANCHE JL, 1993, MAMM GENOME, V4, P463, DOI 10.1007/BF00296824; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li XM, 2004, PROTEIN SCI, V13, P2845, DOI 10.1110/ps.04937304; Liang Y, 2008, J NEURO-ONCOL, V86, P133, DOI 10.1007/s11060-007-9457-5; Ligios C, 2002, J COMP PATHOL, V127, P45, DOI 10.1053/jcpa.2002.0589; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Lyahyai J, 2010, ANIM BIOTECHNOL, V21, P1, DOI 10.1080/10495390903323851; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; ORELLE B, 1992, J CLIN INVEST, V90, P2284, DOI 10.1172/JCI116115; Palmiter R D, 1987, Experientia Suppl, V52, P63; Pappolla MA, 2002, J PINEAL RES, V32, P135, DOI 10.1034/j.1600-079x.2002.1o838.x; Parveen I, 2005, VET RES, V36, P665, DOI 10.1051/vetres:2005028; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Serrano C, 2009, VET RES, V40, DOI 10.1051/vetres/2009024; Siso S, 2002, ACTA NEUROPATHOL, V103, P615, DOI 10.1007/s00401-001-0512-6; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Skretting G, 2004, BIOCHEM BIOPH RES CO, V316, P272, DOI 10.1016/j.bbrc.2004.02.040; Skretting G, 2006, GENE, V376, P116, DOI 10.1016/j.gene.2006.02.021; Spiropoulos J, 2007, NEUROPATH APPL NEURO, V33, P398, DOI 10.1111/j.1365-2990.2007.00800.x; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Umehara F, 2004, NEUROLOGY, V62, P1604, DOI 10.1212/01.WNL.0000123116.96441.34; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas F, 2006, J VET INTERN MED, V20, P187, DOI 10.1892/0891-6640(2006)20[187:DACEOS]2.0.CO;2; Vidal E, 2009, J COMP PATHOL, V141, P135, DOI 10.1016/j.jcpa.2009.04.002; Vidal E, 2006, J VIROL METHODS, V136, P137, DOI 10.1016/j.jviromet.2006.05.008; WELLS GAH, 1995, VET REC, V136, P211, DOI 10.1136/vr.136.9.211; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; WOLLMER MA, BIOCH BIOPHYS ACTA, V1801, P762; Xiang W, 2005, ANN NEUROL, V58, P242, DOI 10.1002/ana.20551; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; YANG X, J PSYCHOPHARMACOL; Zetzsche T, 2010, EXPERT REV MOL DIAGN, V10, P667, DOI 10.1586/ERM.10.48	104	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19909	10.1371/journal.pone.0019909	http://dx.doi.org/10.1371/journal.pone.0019909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629698	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800015
J	Skalamera, D; Ranall, MV; Wilson, BM; Leo, P; Purdon, AS; Hyde, C; Nourbakhsh, E; Grimmond, SM; Barry, SC; Gabrielli, B; Gonda, TJ				Skalamera, Dubravka; Ranall, Max V.; Wilson, Benjamin M.; Leo, Paul; Purdon, Amy S.; Hyde, Carolyn; Nourbakhsh, Ehsan; Grimmond, Sean M.; Barry, Simon C.; Gabrielli, Brian; Gonda, Thomas J.			A High-Throughput Platform for Lentiviral Overexpression Screening of the Human ORFeome	PLOS ONE			English	Article							OPEN READING FRAMES; CELL-CYCLE ARREST; FUNCTIONAL GENOMICS; UBIQUITIN CHAINS; PROTEIN-KINASES; GENE-EXPRESSION; IDENTIFICATION; NEK6; CLONING; VECTORS	In response to the growing need for functional analysis of the human genome, we have developed a platform for high-throughput functional screening of genes overexpressed from lentiviral vectors. Protein-coding human open reading frames (ORFs) from the Mammalian Gene Collection were transferred into lentiviral expression vector using the highly efficient Gateway recombination cloning. Target ORFs were inserted into the vector downstream of a constitutive promoter and upstream of an IRES controlled GFP reporter, so that their transfection, transduction and expression could be monitored by fluorescence. The expression plasmids and viral packaging plasmids were combined and transfected into 293T cells to produce virus, which was then used to transduce the screening cell line. We have optimised the transfection and transduction procedures so that they can be performed using robotic liquid handling systems in arrayed 96-well microplate, one-gene-per-well format, without the need to concentrate the viral supernatant. Since lentiviruses can infect both dividing and non-dividing cells, this system can be used to overexpress human ORFs in a broad spectrum of experimental contexts. We tested the platform in a 1990 gene pilot screen for genes that can increase proliferation of the non-tumorigenic mammary epithelial cell line MCF-10A after removal of growth factors. Transduced cells were labelled with the nucleoside analogue 5-ethynyl-2'-deoxyuridine (EdU) to detect cells progressing through S phase. Hits were identified using high-content imaging and statistical analysis and confirmed with vectors using two different promoters (CMV and EF1 alpha). The screen demonstrates the reliability, versatility and utility of our screening platform, and identifies novel cell cycle/proliferative activities for a number of genes.	[Skalamera, Dubravka; Ranall, Max V.; Wilson, Benjamin M.; Leo, Paul; Purdon, Amy S.; Hyde, Carolyn; Gabrielli, Brian; Gonda, Thomas J.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Nourbakhsh, Ehsan; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Barry, Simon C.] Univ Adelaide, Mol Immunol Lab, Discipline Paediat, Adelaide, SA, Australia; [Barry, Simon C.] Womens & Childrens Hosp, Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia	University of Queensland; University of Queensland; University of Adelaide; Womens & Childrens Hospital Australia	Skalamera, D (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia.	d.skalamera@uq.edu.au	Grimmond, Sean/K-3246-2019; Gonda, Thomas J/A-3620-2012; Grimmond, Sean M/J-5304-2016; Leo, Paul J/B-3470-2011; barry, simon/Y-4529-2019; Gabrielli, Brian G/B-3655-2011; Leo, Paul/R-4464-2019	Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Leo, Paul J/0000-0001-8325-4134; barry, simon/0000-0002-0597-7609; Gabrielli, Brian G/0000-0003-3933-1651; Skalamera, Dubravka/0000-0002-5301-302X; Gonda, Thomas/0000-0002-8792-3021	National Health and Medical Research Council of Australia (NHMRC) [ID401608]; Australia Research Council (ARC) [LE0668241]; Australian Cancer Research Foundation (ACRF)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF)	This work was supported by funding from the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au/; grant ID401608), the Australia Research Council (ARC, http://www.arc.gov.au/; grant LE0668241) and the Australian Cancer Research Foundation (ACRF, http://www.acrf.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres DA, 2006, METHOD ENZYMOL, V407, P499, DOI 10.1016/S0076-6879(05)07040-0; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Blesch A, 2004, METHODS, V33, P164, DOI 10.1016/j.ymeth.2003.11.005; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Brown AL, 2006, J LEUKOCYTE BIOL, V80, P433, DOI 10.1189/jlb.0206112; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chilov D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng115; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Crawford DF, 2001, J BIOL CHEM, V276, P37166, DOI 10.1074/jbc.M103414200; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011940; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIRKS W, 1993, GENE, V128, P247, DOI 10.1016/0378-1119(93)90569-O; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Forrest ARR, 2003, GENOME RES, V13, P1366, DOI 10.1101/gr.1012403; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Koenig-Hoffmann K, 2005, INT J CANCER, V113, P434, DOI 10.1002/ijc.20601; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Ranall MV, 2010, BIOTECHNIQUES, V48, P379, DOI 10.2144/000113410; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Temple G, 2006, HUM MOL GENET, V15, pR31, DOI 10.1093/hmg/ddl048; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiemann S, 2004, GENOME RES, V14, P2136, DOI 10.1101/gr.2576704; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	60	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20057	10.1371/journal.pone.0020057	http://dx.doi.org/10.1371/journal.pone.0020057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629697	Green Published, gold			2022-12-27	WOS:000291005800025
J	Su, WW; Chen, PYF; Hsiao, CH; Chen, HSL				Su, Wei-Wen; Chen, Phil Yeong-Fung; Hsiao, Ching-Hsi; Chen, Henry Shen-Lih			Primary Phacoemulsification and Intraocular Lens Implantation for Acute Primary Angle-Closure	PLOS ONE			English	Article							CATARACT-SURGERY; OCULAR BIOMETRY; LASER IRIDOTOMY; ASIAN EYES; GLAUCOMA; EXTRACTION; CONFIGURATION; RISE	Background: To investigate the effect of primary phacoemulsification on intraocular pressure (IOP) in patients with acute primary angle-closure (PAC) and coexisting cataract. Methodology: Sixteen eyes of 14 patients with acute PAC received phacoemulsification and intraocular lens implantation as initial management for medically uncontrolled IOP in a retrospective chart review. The effects on IOP, vision, anterior chamber depth (ACD), and number of antiglaucoma medications were evaluated. Principal Findings: The postoperative IOP was reduced in 16 eyes (100%). The mean +/- standard deviation preoperative IOP was 48.81 +/- 16.83 mm Hg, which decreased postoperatively to 16.46 +/- 10.67 mm Hg at 1 day, 9.43 +/- 3.03 mm Hg at 1 week, 9.49 +/- 2.14 mm Hg at 2 weeks, 10.78 +/- 3.56 mm Hg at 1 month, and 10.70 +/- 2.80 mm Hg at 3 months(p<0.001). The mean number of antiglaucoma medications decreased from 3.56 +/- 1.14 to 0.13 +/- 0.34 (p<0.001). The average preoperative ACD was 2.08 +/- 0.35 mm, which increased to 3.59 +/- 0.33 mm after surgery (p<0.001). Visual acuity (converted into logarithm of the minimum angle of resolution [logMAR]) improved from 1.14 +/- 0.71 to 0.73 +/- 0.53 (p=0.001). Conclusions: Primary phacoemulsification plus intraocular lens implantation lowered IOP, reduced the use of antiglaucoma medications, and improved vision in patients with acute PAC. This is a safe and effective method of IOP control and can be considered a first treatment option in managing patients with acute PAC and coexisting cataract.	[Su, Wei-Wen; Chen, Phil Yeong-Fung; Hsiao, Ching-Hsi; Chen, Henry Shen-Lih] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Su, WW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan.	hslchen@yahoo.com.tw		Su, Wei-Wen/0000-0001-9682-9152				ALSBIRK PH, 1975, ACTA OPHTHALMOL, V53, P89; Aung T, 2001, AM J OPHTHALMOL, V131, P7, DOI 10.1016/S0002-9394(00)00621-8; Choong YF, 1999, EYE, V13, P613, DOI 10.1038/eye.1999.168; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Gunning FP, 1998, J CATARACT REFR SURG, V24, P1347, DOI 10.1016/S0886-3350(98)80227-7; Hu CC, 2008, ACTA OPHTHALMOL, V86, P440, DOI 10.1111/j.1600-0420.2007.01066.x; Imaizumi M, 2006, J CATARACT REFR SURG, V32, P85, DOI 10.1016/j.jcrs.2005.11.014; Jacobi PC, 2002, OPHTHALMOLOGY, V109, P1597, DOI 10.1016/S0161-6420(02)01123-5; Keenan TDL, 2009, J GLAUCOMA, V18, P201, DOI 10.1097/IJG.0b013e318181540a; Kurimoto Y, 1997, AM J OPHTHALMOL, V124, P775, DOI 10.1016/S0002-9394(14)71694-0; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Lan YW, 2007, OPHTHALMOLOGICA, V221, P388, DOI 10.1159/000107498; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; MARKOWITZ SN, 1985, AM J OPHTHALMOL, V99, P400, DOI 10.1016/0002-9394(85)90005-4; Nolan W, 2006, BRIT J OPHTHALMOL, V90, P1, DOI 10.1136/bjo.2005.082040; Nolan WP, 2000, BRIT J OPHTHALMOL, V84, P1255, DOI 10.1136/bjo.84.11.1255; Nonaka A, 2006, OPHTHALMOLOGY, V113, P437, DOI 10.1016/j.ophtha.2005.11.018; PANEK WC, 1990, AM J OPHTHALMOL, V110, P185, DOI 10.1016/S0002-9394(14)76989-2; Ritch R, 1989, GLAUCOMAS, V1; Roberts TV, 2000, J CATARACT REFR SURG, V26, P1012, DOI 10.1016/S0886-3350(00)00358-8; Rosman M, 2002, OPHTHALMOLOGY, V109, P2227, DOI 10.1016/S0161-6420(02)01275-7; Tham CCY, 2009, OPHTHALMOLOGY, V116, P725, DOI 10.1016/j.ophtha.2008.12.054; TORNQUIST RAGNAR, 1953, ACTA OPHTHALMOL SUPPL, V39, P1; Yang CH, 1997, J CATARACT REFR SURG, V23, P1109, DOI 10.1016/S0886-3350(97)80089-2; Zhi ZM, 2003, AM J OPHTHALMOL, V135, P534, DOI 10.1016/S0002-9394(02)02108-6; Zhuo YH, 2009, J GLAUCOMA, V18, P646, DOI 10.1097/IJG.0b013e31819c4322	26	16	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20056	10.1371/journal.pone.0020056	http://dx.doi.org/10.1371/journal.pone.0020056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629644	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800024
J	Wang, HM; Pan, YL; Xue, B; Wang, XH; Zhao, F; Jia, J; Liang, XB; Wang, XM				Wang, Haomin; Pan, Yanli; Xue, Bing; Wang, Xinhong; Zhao, Feng; Jia, Jun; Liang, Xibin; Wang, Xiaomin			The Antioxidative Effect of Electro-Acupuncture in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; SUBSTANTIA-NIGRA; GLUTATHIONE-PEROXIDASE; BASAL GANGLIA; DOPAMINERGIC-NEURONS; TRANSECTED RATS; MESSENGER-RNA; ANIMAL-MODELS; MPTP; STIMULATION	Accumulating evidence indicates that oxidative stress plays a critical role in Parkinson's disease (PD). Our previous work has shown that 100 Hz electro-acupuncture (EA) stimulation at ZUSANLI (ST36) and SANYINJIAO (SP6) protects neurons in the substantia nigra pars compacta from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in male C57BL/6 mice, a model of PD. In the present study we administered 100 Hz EA stimulation at the two acupoints to MPTP-lesioned mice for 12 sessions starting from the day prior to the first MPTP injection. We found that in the striatum of MPTP treated mice 100 Hz EA stimulation effectively inhibited the production of hydrogen peroxide and malonaldehyde, and increased glutathione concentration and total superoxide dismutase activity through biochemical methods. However, it decreased glutathione peroxidase activity via biochemical analysis and did not affect the level of 1-methyl-4-phenylpyridinium in the striatum revealed by high performance liquid chromatography with ultraviolet detection. These data suggest that 100 Hz EA stimulation at ST36 and SP6 has antioxidative effects in the MPTP model of PD. This data, along with our previous work, indicates that 100 Hz EA stimulation at ST36 and SP6 protects the nigrostriatal system by multiple mechanisms including antioxidation and antiapoptosis, and suggests that EA stimulation is a promising therapy for treating PD.	[Wang, Haomin; Wang, Xinhong; Wang, Xiaomin] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Pan, Yanli] Beijing An Ding Hosp, Sci & Educ Off, Beijing, Peoples R China; [Xue, Bing] Capital Med Univ, Med Expt & Test Ctr, Beijing, Peoples R China; [Zhao, Feng] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Jia, Jun; Wang, Xiaomin] Capital Med Univ, Key Lab Neurodegenerat Disorders, Dept Physiol, Minist Educ, Beijing, Peoples R China; [Liang, Xibin] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Peking University; Capital Medical University; Capital Medical University; Capital Medical University; Stanford University	Wang, HM (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [30472245]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2011CB504100) and the National Natural Science Foundation of China (30472245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; BRADBURY AJ, 1986, NEUROPHARMACOLOGY, V25, P939, DOI 10.1016/0028-3908(86)90025-0; Chen L, 1998, J Tradit Chin Med, V18, P23; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DOS SJG, 2008, PHYSIOL BEHAV, V93, P155; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Floor E, 1998, J NEUROCHEM, V70, P268; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; HERKENHAM M, 1991, NEUROSCIENCE, V40, P133, DOI 10.1016/0306-4522(91)90180-V; Hirsch EC, 2003, J NEURAL TRANSM-SUPP, P89, DOI 10.1007/978-3-7091-0643-3_6; Huang C, 2000, NEUROSCI LETT, V294, P159, DOI 10.1016/S0304-3940(00)01572-X; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kim ST, 2010, J PHYSIOL SCI, V60, P27, DOI 10.1007/s12576-009-0061-7; KISH SJ, 1985, NEUROSCI LETT, V58, P343, DOI 10.1016/0304-3940(85)90078-3; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Kung YY, 2006, AM J CHINESE MED, V34, P47, DOI 10.1142/S0192415X0600362X; Lee SH, 2002, NEUROSCI LETT, V332, P17, DOI 10.1016/S0304-3940(02)00900-X; Liang LP, 2007, J NEUROSCI, V27, P4326, DOI 10.1523/JNEUROSCI.0019-07.2007; Liang XB, 2003, NEUROREPORT, V14, P1177, DOI 10.1097/00001756-200306110-00015; Liang XB, 2002, MOL BRAIN RES, V108, P51, DOI 10.1016/S0169-328X(02)00513-2; Liu XY, 2004, EXP NEUROL, V189, P189, DOI 10.1016/j.expneurol.2004.05.028; Luo DZ, 2009, EUR J PHARMACOL, V617, P33, DOI 10.1016/j.ejphar.2009.06.015; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Orth M, 2003, MOVEMENT DISORD, V18, P729, DOI 10.1002/mds.10447; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Rabinovic AD, 1998, J NEUROCHEM, V71, P2071; Ren Xiao-ming, 2008, J Tradit Chin Med, V28, P255; Rho SW, 2008, MOL CELLS, V25, P178; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H; Shulman LM, 2002, MOVEMENT DISORD, V17, P799, DOI 10.1002/mds.10134; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zhao LC, 2009, COMP BIOCHEM PHYS B, V152, P339, DOI 10.1016/j.cbpb.2008.12.014; Zhuang X, 2000, J Tradit Chin Med, V20, P265	53	59	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19790	10.1371/journal.pone.0019790	http://dx.doi.org/10.1371/journal.pone.0019790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625423	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200013
J	Lee, YJ; Savtchenko, R; Ostapchenko, VG; Makarava, N; Baskakov, IV				Lee, Young Jin; Savtchenko, Regina; Ostapchenko, Valeriy G.; Makarava, Natallia; Baskakov, Ilia V.			Molecular Structure of Amyloid Fibrils Controls the Relationship between Fibrillar Size and Toxicity	PLOS ONE			English	Article							PRION PROTEIN; PHYSICAL-PROPERTIES; DISEASE; PRP; NEURODEGENERATION; CLASSIFICATION; DEGENERATION; IMPAIRMENT; MECHANISMS; INSIGHTS	Background: According to the prevailing view, soluble oligomers or small fibrillar fragments are considered to be the most toxic species in prion diseases. To test this hypothesis, two conformationally different amyloid states were produced from the same highly pure recombinant full-length prion protein (rPrP). The cytotoxic potential of intact fibrils and fibrillar fragments generated by sonication from these two states was tested using cultured cells. Methodology/Principal Findings: For one amyloid state, fibril fragmentation was found to enhance its cytotoxic potential, whereas for another amyloid state formed within the same amino acid sequence, the fragmented fibrils were found to be substantially less toxic than the intact fibrils. Consistent with the previous studies, the toxic effects were more pronounced for cell cultures expressing normal isoform of the prion protein (PrPC) at high levels confirming that cytotoxicity was in part PrPC-dependent. Silencing of PrPC expression by small hairpin RNAs designed to silence expression of human PrPC (shRNA-PrPC) deminished the deleterious effects of the two amyloid states to a different extent, suggesting that the role of PrPC mediated and PrPC-independent mechanisms depends on the structure of the aggregates. Conclusions/Significance: This work provides a direct illustration that the relationship between an amyloid's physical dimension and its toxic potential is not unidirectional but is controlled by the molecular structure of prion protein (PrP) molecules within aggregated states. Depending on the structure, a decrease in size of amyloid fibrils can either enhance or abolish their cytotoxic effect. Regardless of the molecular structure or size of PrP aggregates, silencing of PrPC expression can be exploited to reduce their deleterious effects.	[Lee, Young Jin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Lee, YJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Lee, Young Jin/AAF-6189-2019; Lee, Young Jin/K-9635-2019	Lee, Young Jin/0000-0002-2325-5271; Ostapchenko, Valeriy/0000-0002-3629-7702	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS045585 to I.V.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BITAN G, 2002, P NATL ACAD SCI USA, P330; Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Ermolayev V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000558; Ermolayev V, 2009, BIOPHYS J, V96, P3390, DOI 10.1016/j.bpj.2009.01.032; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krasemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013906; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Mabbott N, 2005, HAEMATOLOGICA, V90, P542; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Novitskaya V, 2007, J NEUROCHEM, V102, P398, DOI 10.1111/j.1471-4159.2007.04537.x; Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PARK JH, 2010, HIPPOCAMPUS IN PRESS; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Radford HE, 2010, CURR ISSUES MOL BIOL, V12, P119; RESENBERGER UK, 2011, EMBO J IN PRESS; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	50	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20244	10.1371/journal.pone.0020244	http://dx.doi.org/10.1371/journal.pone.0020244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625461	Green Published, gold, Green Submitted			2022-12-27	WOS:000290793400049
J	Tippett, E; Cheng, WJ; Westhorpe, C; Cameron, PU; Brew, BJ; Lewin, SR; Jaworowski, A; Crowe, SM				Tippett, Emma; Cheng, Wan-Jung; Westhorpe, Clare; Cameron, Paul U.; Brew, Bruce J.; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.			Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; ANTIINFLAMMATORY TYPE-2 MACROPHAGES; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; CYSTEINE-RICH FAMILY; TOLL-LIKE RECEPTORS; SOLUBLE CD163; ENDOTHELIAL-CELLS; MICROBIAL TRANSLOCATION; ACTIVATION MARKERS	CD163, a haptoglobin-hemoglobin (Hp-Hb) scavenger receptor, expressed by monocytes and macrophages, is important in resolution of inflammation. Age-related non-AIDS co-morbidities in HIV-infected individuals, particularly dementia and cardiovascular disease, result in part from effects of HIV-1 infection on monocyte and macrophage biology. CD163 coexpression on CD14+CD16++ monocytes has been proposed as a useful biomarker for HIV-1 disease progression and the presence of HIV associated dementia. Here we investigated CD163 expression on monocyte subsets ex vivo, on cultured macrophages, and soluble in plasma, in the setting of HIV-1 infection. Whole blood immunophenotyping revealed CD163 expression on CD14++CD16- monocytes but not on CD14+CD16++ monocytes (P = 0.004), supported by CD163 mRNA levels. Incubation with M-CSF induced CD163 protein expression on CD14+ CD16++ monocytes to the same extent as CD14++CD16- monocytes. CD163 expression on CD14++CD16- monocytes from HIV-infected subjects was significantly higher than from uninfected individuals, with a trend towards increased expression on CD14++CD16- monocytes (P = 0.019 and 0.069 respectively), which is accounted for by HIV-1 therapy including protease inhibitors. Shedding of CD163 was shown to predominantly occur from the CD14++CD16- subset after Ficoll isolation and LPS stimulation. Soluble CD163 concentration in plasma from HIV-1 infected donors was similar to HIV-1 uninfected donors. Monocyte CD163 expression in HIV-1 infected patients showed a complicated relationship with classical measures of disease progression. Our findings clarify technical issues regarding CD163 expression on monocyte subsets and further elucidates its role in HIV-associated inflammation by demonstrating that CD163 is readily lost from CD14++CD16- monocytes and induced in pro-inflammatory CD14+ CD16++ monocytes by M-CSF. Our data show that all monocyte subsets are potentially capable of differentiating into CD163-expressing anti-inflammatory macrophages given appropriate stimuli. Levels of CD163 expression on monocytes may be a potential biomarker reflecting efforts by the immune system to resolve immune activation and inflammation in HIV-infected individuals.	[Tippett, Emma; Cheng, Wan-Jung; Westhorpe, Clare; Cameron, Paul U.; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia; [Tippett, Emma; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cameron, Paul U.; Jaworowski, Anthony] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia	Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; St Vincents Hospital Sydney	Tippett, E (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia.	crowe@burnet.edu.au	Lewin, Sharon/Z-3297-2019; Brew, Bruce/J-6513-2012	brew, bruce/0000-0003-0622-1392; Lewin, Sharon Ruth/0000-0002-0330-8241; Westhorpe, Clare/0000-0002-5789-0425; jaworowski, anthony/0000-0002-3844-805X; Cameron, Paul Urquhart/0000-0002-1906-6945	National Health and Medical Research Council [358399]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by National Health and Medical Research Council Program Grant 358399 to SRL and SMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bissel SJ, 2006, J NEUROIMMUNOL, V177, P85, DOI 10.1016/j.jneuroim.2006.04.017; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Clerici M, 2000, ANN NY ACAD SCI, V917, P956; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Daly A, 2006, ALIMENT PHARM THER, V24, P553, DOI 10.1111/j.1365-2036.2006.03012.x; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Droste A, 1999, BIOCHEM BIOPH RES CO, V256, P110, DOI 10.1006/bbrc.1999.0294; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Goldstein JI, 2003, ATHEROSCLEROSIS, V170, P325, DOI 10.1016/S0021-9150(03)00297-1; Goodale D, 2009, CYTOM PART B-CLIN CY, V76B, P107, DOI 10.1002/cyto.b.20449; Hamann W, 1995, INFLAMM RES, V44, P535, DOI 10.1007/BF01757358; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Hogger P, 1998, J IMMUNOL, V161, P1883; Jaworowski A, 2006, J INFECT DIS, V193, P693, DOI 10.1086/500367; Knudsen TB, 2007, SCAND J INFECT DIS, V39, P542, DOI 10.1080/00365540601113685; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kruger M, 1996, IMMUNOLOGY, V87, P162; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Maniecki MB, 2011, IMMUNOBIOLO IN PRESS; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Moniuszko M, 2006, CLIN VACCINE IMMUNOL, V13, P704, DOI 10.1128/CVI.00417-05; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; MORGANELLI PM, 1988, J IMMUNOL, V140, P2296; MUSSON RA, 1984, SURV IMMUNOL RES, V3, P138; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Richens J, 2007, IMMUNOBIOLOGY, V212, P29, DOI 10.1016/j.imbio.2006.06.012; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Sanchez C, 1999, J IMMUNOL, V162, P5230; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2005, EUR J HAEMATOL, V74, P6, DOI 10.1111/j.1600-0609.2004.00318.x; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Souques F, 1997, J IMMUNOL METHODS, V204, P153, DOI 10.1016/S0022-1759(97)00039-2; Stec M, 2007, J LEUKOCYTE BIOL, V82, P594, DOI 10.1189/jlb.0207117; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Sulahian TH, 2004, J LEUKOCYTE BIOL, V76, P271, DOI 10.1189/jlb.1003523; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; Wenzel I, 1996, EUR J IMMUNOL, V26, P2758, DOI 10.1002/eji.1830261131; Williams L, 2002, J LEUKOCYTE BIOL, V72, P800; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Yearley JH, 2007, AIDS RES HUM RETROV, V23, P515, DOI 10.1089/aid.2006.0211; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZWADLOKLARWASSER G, 1990, INT ARCH ALLER A IMM, V91, P175, DOI 10.1159/000235111	73	73	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19968	10.1371/journal.pone.0019968	http://dx.doi.org/10.1371/journal.pone.0019968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625498	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400025
J	Chen, JH; Lu, ZJ; Cheng, D; Peng, S; Wang, HY				Chen, Jiahuan; Lu, Zhijuan; Cheng, De; Peng, Sha; Wang, Huayan			Isolation and Characterization of Porcine Amniotic Fluid-Derived Multipotent Stem Cells	PLOS ONE			English	Article							BONE-MARROW; DIFFERENTIATION; LINES; ISCHEMIA	The aim of this study was to isolate and characterize porcine amniotic fluid-derived multipotent stem cells (pAF-MSC). The porcine amniotic fluid (AF) from the amniotic cavity of pregnant gilts in the early stages of gestation (at E35) was collected and centrifuged for 5-10 min at 400 g to pellet cells. The primary culture of AF showed the multiple cell types, including the epithelial-like cells and fibroblast-like cells. By culturing in AMM medium for 6 to 8 days, the epithelial-like cells disappeared and the remaining cells presented the fibroblastoid morphology. The doubling time of pAF-MSCs was about 34.6 h, and the cells had been continually cultured over 60 passages in vitro. The flow cytometry results showed that pAF-MSCs were positive for CD44, CD117 and CD166, but negative for CD34, CD45 and CD54. Meanwhile, pAF-MSCs expressed ES cell markers, such as Oct4, Nanog, SSEA4, Tra-1-60 and Tra-1-81. The ratio of CD117(+)CD44(+) cells accounted for 98% of pAF-MSCs population. Three germ layer markers, including FGF5 (ectodermal marker), AFP (endodermal marker) and Bra (mesodermal marker), were detected in embryoid bodies derived from pAF-MSCs. Under the different induction conditions, the pAF-MSCs were capable of differentiating into neurocytes, adipocytes and beating cardiomyocytes. Furthermore, the pAF-MSCs didn't form teratoma when injected into immunodeficiency mice. These optimal features of pAF-MSCs provide an excellent alternative stem cell resource for potential cell therapy in regenerative medicine and transgenic animals.	[Chen, Jiahuan; Lu, Zhijuan; Cheng, De; Peng, Sha; Wang, Huayan] NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Lu, Zhijuan] Zhengzhou Senior High Sch, Zhemgzhou, Henan, Peoples R China	Northwest A&F University - China	Chen, JH (corresponding author), NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	pengsha123@yahoo.com.cn; hhwang101@163.com			Chinese National Programs for Fundamental Research and Development ("973" Plan) [2009CB941002]	Chinese National Programs for Fundamental Research and Development ("973" Plan)(National Basic Research Program of China)	This work was supported by the Major Project of Chinese National Programs for Fundamental Research and Development ("973" Plan, 2009CB941002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Gemmis P, 2006, STEM CELLS DEV, V15, P719; EZASHI T, 2009, PNAS, P1; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; HOLM F, 2010, DRUG DISCOV TODAY TE, V5, P131; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Phermthai T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-79; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; STEELE MW, 1974, LANCET, V2, P1210; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003	29	57	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19964	10.1371/journal.pone.0019964	http://dx.doi.org/10.1371/journal.pone.0019964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625520	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200035
J	Dingle, KE; Griffiths, D; Didelot, X; Evans, J; Vaughan, A; Kachrimanidou, M; Stoesser, N; Jolley, KA; Golubchik, T; Harding, RM; Peto, TE; Fawley, W; Walker, AS; Wilcox, M; Crook, DW				Dingle, Kate E.; Griffiths, David; Didelot, Xavier; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Jolley, Keith A.; Golubchik, Tanya; Harding, Rosalind M.; Peto, Tim E.; Fawley, Warren; Walker, A. Sarah; Wilcox, Mark; Crook, Derrick W.			Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; HYPERVIRULENT STRAIN; SEQUENCE-ANALYSIS; PCR; EPIDEMIC; INFECTION; TCDC; MICROEVOLUTION; TRANSCRIPTION	Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.	[Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Dingle, Kate E.; Griffiths, David; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Peto, Tim E.; Walker, A. Sarah; Crook, Derrick W.] John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England; [Griffiths, David; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Peto, Tim E.; Walker, A. Sarah; Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Didelot, Xavier; Golubchik, Tanya] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Jolley, Keith A.; Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Fawley, Warren; Wilcox, Mark] Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS1 3EX, W Yorkshire, England; [Wilcox, Mark] Univ Leeds, Dept Microbiol, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Leeds General Infirmary; University of Leeds; University of Leeds	Dingle, KE (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	kate.dingle@ndcls.ox.ac.uk	Walker, Sarah/HDM-8717-2022; Stoesser, Nicole/H-3421-2019; Jolley, Keith/ABE-8587-2020; Didelot, Xavier/P-4282-2019; Golubchik, Tanya/B-4226-2018; Didelot, Xavier/H-1608-2013	Stoesser, Nicole/0000-0002-4508-7969; Jolley, Keith/0000-0002-0751-0287; Didelot, Xavier/0000-0003-1885-500X; Golubchik, Tanya/0000-0003-2765-9828; Didelot, Xavier/0000-0003-1885-500X; Kachrimanidou, Melina/0000-0001-9524-0047; peto, tim/0000-0003-3477-8307; Dingle, Kate/0000-0002-2303-5957	NIHR Biomedical Research Centre, Oxford, United Kingdom; Wellcome Trust; Medical Research Council [G0600719B, G0800778] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10279] Funding Source: researchfish; MRC [G0800778] Funding Source: UKRI	NIHR Biomedical Research Centre, Oxford, United Kingdom(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the NIHR Biomedical Research Centre, Oxford, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Clinical Microbiology Laboratory and Infection Control, John Radcliffe Hospital, Oxford, and Infection Control Laboratory staff, Leeds General Infirmary, for their assistance throughout this work. This publication made use of the Clostridium difficile Multilocus Sequence Typing website, http://pubmlst.org/cdifficile/ which uses the Bacterial Isolate Genome Sequence Database system developed by Keith Jolley and sited at the Department of Zoology, University of Oxford [61]. The development of this site has been funded by the Wellcome Trust.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belmares J, 2009, CLIN INFECT DIS, V49, P1141, DOI 10.1086/605638; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burns K, 2010, J HOSP INFECT, V75, P287, DOI 10.1016/j.jhin.2010.03.025; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; Govind R, 2006, J BACTERIOL, V188, P3716, DOI 10.1128/JB.188.10.3716-3720.2006; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammond GA, 1997, MICROB PATHOGENESIS, V22, P143, DOI 10.1006/mpat.1996.0100; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hensgens MP, 2009, EUROSURVEILLANCE, V14, P7; *HLTH PROT AG, 2009, CLOSTR DIFF RIB NETW; *HLTH PROT AG, 2005, COMMUN DIS REP CDR W, V15, P2; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2006, EMERG INFECT DIS, V12, P827; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marsh JW, 2010, J CLIN MICROBIOL, V48, P412, DOI 10.1128/JCM.01315-09; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Pasanen T, 2011, CLIN MICROBIOL INFEC, V17, P166, DOI 10.1111/j.1469-0691.2010.03221.x; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pituch H, 2006, J MED MICROBIOL, V55, P207, DOI 10.1099/jmm.0.46213-0; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Soehn F, 1998, MOL GEN GENET, V258, P222, DOI 10.1007/s004380050726; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012	61	130	131	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19993	10.1371/journal.pone.0019993	http://dx.doi.org/10.1371/journal.pone.0019993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625511	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200037
J	Marais, S; Pepper, DJ; Schutz, C; Wilkinson, RJ; Meintjes, G				Marais, Suzaan; Pepper, Dominique J.; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme			Presentation and Outcome of Tuberculous Meningitis in a High HIV Prevalence Setting	PLOS ONE			English	Article							INFECTED PATIENTS; CRYPTOCOCCAL MENINGITIS; CEREBROSPINAL-FLUID; ADULTS	Background: Mycobacterium tuberculosis is a common, devastating cause of meningitis in HIV-infected persons. Due to international rollout programs, access to antiretroviral therapy (ART) is increasing globally. Starting patients with HIV-associated tuberculous meningitis (TBM) on ART during tuberculosis (TB) treatment may increase survival in these patients. We undertook this study to describe causes of meningitis at a secondary-level hospital in a high HIV/TB co-infection setting and to determine predictors of mortality in patients with TBM. Methods: A retrospective review of cerebrospinal fluid findings and clinical records over a six-month period (March 2009-August 2009). Definite, probable and possible TBM were diagnosed according to published case definitions. Results: TBM was diagnosed in 120/211 patients (57%) with meningitis. In 106 HIV-infected patients with TBM, six-month all-cause mortality was lower in those who received antiretroviral therapy (ART) during TB treatment; hazard ratio = 0.30 (95% CI = 0.08-0.82). Factors associated with inpatient mortality in HIV-infected patients were 1) low CD4(+) count at presentation; adjusted odds ratio (AOR) = 1.4 (95% confidence interval [CI] = 1.03-1.96) per 50 cells/mu L drop in CD4(+) count and, 2) higher British Medical Research Council TBM disease grade (2 or 3 versus 1); AOR = 4.8 (95% CI = 1.4515.87). Interpretation: Starting ART prior to or during TB treatment may be associated with lower mortality in patients with HIV-associated TBM. Advanced HIV and worse stage of TBM disease predict in-hospital mortality in patients presenting with TBM.	[Marais, Suzaan; Pepper, Dominique J.; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Marais, Suzaan; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Cape Town, South Africa; [Marais, Suzaan; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Pepper, Dominique J.] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Cape Town; University of Cape Town; University of Mississippi; University of Mississippi Medical Center; Imperial College London; MRC National Institute for Medical Research	Marais, S (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	suzaanmarais@gmail.com	Marais, Suzaan/AAG-2750-2019; Schutz, Charlotte/G-6864-2016	Marais, Suzaan/0000-0002-8050-9610; Schutz, Charlotte/0000-0001-8329-6158; Meintjes, Graeme/0000-0003-1196-4414; Wilkinson, Robert/0000-0002-2753-1800	Perinatal HIV Research Unit, the US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [WT 081667, 084323, 088316]; Fogarty International Center South Africa TB/AIDS [NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370, U2RTW007373 ICORTA]; European Union [SANTE/2005/105-061-102]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [U2RTW007373, U2RTW007370] Funding Source: NIH RePORTER	Perinatal HIV Research Unit, the US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa TB/AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (DJP, SM and CS); Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316); a Fogarty International Center South Africa TB/AIDS Training Award (GM and DJP and CS, NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370, U2RTW007373 ICORTA); a European Union Grant (RJW, SANTE/2005/105-061-102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Bogaerts J, 1999, J INFECTION, V39, P32, DOI 10.1016/S0163-4453(99)90099-3; Cecchini D, 2007, AIDS, V21, P373, DOI 10.1097/QAD.0b013e328012b84d; Croda MG, 2010, INT J INFECT DIS, V14, pE586, DOI 10.1016/j.ijid.2009.08.012; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Gibbon CJ, 2008, S AFRICAN MED FORMUL, P301; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Heyderman RS, 1998, CLIN INFECT DIS, V26, P284, DOI 10.1086/516298; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Karande Sunil, 2005, Indian Journal of Pediatrics, V72, P755, DOI 10.1007/BF02734147; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Marais S, 2010, TUBERCULOSIS, V90, P367, DOI 10.1016/j.tube.2010.08.006; MARSHALL G, 1948, LANCET, V254, P582; Medecins Sans Frontieres Western Cape Province Department of Health City of Cape Town Department of Health University of Cape Town Infectious Disease Epidemiology Unit, 2008, COMPR TB HIV SERV PR; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, CLIN INFECT DIS, V48, pE96, DOI 10.1086/598988; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Puccioni-Sohler M, 2007, ARQ NEURO-PSIQUIAT, V65, P48, DOI 10.1590/S0004-282X2007000100011; *S AFR DEP HLTH HI, 2007, S AFR DEP HLTH HIV 1; Schutte CM, 2001, INFECTION, V29, P213, DOI 10.1007/s15010-001-1198-3; Subsai K, 2004, EUR J NEUROL, V11, P755, DOI 10.1111/j.1468-1331.2004.00879.x; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Torok ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001772; TOROK ME, 2010, CLIN INFECT IN PRESS; van der Weert EM, 2006, PEDIATR INFECT DIS J, V25, P65, DOI 10.1097/01.inf.0000183751.75880.f8; van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353; *WHO, 2010, WHO UN ACC SCAL PRIO	33	64	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20077	10.1371/journal.pone.0020077	http://dx.doi.org/10.1371/journal.pone.0020077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625509	Green Published, gold			2022-12-27	WOS:000290771200046
J	Gutenkunst, RN; Coombs, D; Starr, T; Dustin, ML; Goldstein, B				Gutenkunst, Ryan N.; Coombs, Daniel; Starr, Toby; Dustin, Michael L.; Goldstein, Byron			A Biophysical Model of Cell Adhesion Mediated by Immunoadhesin Drugs and Antibodies	PLOS ONE			English	Article							2-DIMENSIONAL DISSOCIATION-CONSTANT; FC-GAMMA-RIII; T-CELLS; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-G; SHEAR-FLOW; RECEPTORS; CD2; AFFINITY; CYTOTOXICITY	A promising direction in drug development is to exploit the ability of natural killer cells to kill antibody-labeled target cells. Monoclonal antibodies and drugs designed to elicit this effect typically bind cell-surface epitopes that are overexpressed on target cells but also present on other cells. Thus it is important to understand adhesion of cells by antibodies and similar molecules. We present an equilibrium model of such adhesion, incorporating heterogeneity in target cell epitope density, nonspecific adhesion forces, and epitope immobility. We compare with experiments on the adhesion of Jurkat T cells to bilayers containing the relevant natural killer cell receptor, with adhesion mediated by the drug alefacept. We show that a model in which all target cell epitopes are mobile and available is inconsistent with the data, suggesting that more complex mechanisms are at work. We hypothesize that the immobile epitope fraction may change with cell adhesion, and we find that such a model is more consistent with the data, although discrepancies remain. We also quantitatively describe the parameter space in which binding occurs. Our model elaborates substantially on previous work, and our results offer guidance for the refinement of therapeutic immunoadhesins. Furthermore, our comparison with data from Jurkat T cells also points toward mechanisms relating epitope immobility to cell adhesion.	[Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V5Z 1M9, Canada; [Starr, Toby; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Starr, Toby; Dustin, Michael L.] Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY USA; [Goldstein, Byron] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA	University of Arizona; University of British Columbia; University of British Columbia; New York University; United States Department of Energy (DOE); Los Alamos National Laboratory	Gutenkunst, RN (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	ryan.gutenkunst@arizona.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Coombs, Daniel/0000-0002-8038-6278	Department of Energy [W-7405-ENG-36]; National Institutes of Health [R37-GM035556, R56-AI44931, P30-6M092391]; National Science and Engineering Research Council; Mathematics of Information Technology and Complex Systems National Centre of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems National Centre of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Energy through contract W-7405-ENG-36 and the National Institutes of Health through grants R37-GM035556 and R56-AI44931 and P30-6M092391. Further support was provided by the National Science and Engineering Research Council and the Mathematics of Information Technology and Complex Systems National Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CL, 1990, J IMMUNOL, V145, P196; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Ashkenazi Avi, 1995, Methods (Orlando), V8, P104, DOI 10.1006/meth.1995.9996; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1981, CELL BIOPHYS, V3, P289, DOI 10.1007/BF02782629; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cooper JC, 2003, EUR J IMMUNOL, V33, P666, DOI 10.1002/eji.200323586; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; FEWTRELL C, 1980, J IMMUNOL, V125, P701; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Ghetie MA, 1997, P NATL ACAD SCI USA, V94, P7509, DOI 10.1073/pnas.94.14.7509; HAMMER DA, 1989, CELL BIOPHYS, V14, P139, DOI 10.1007/BF02797131; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Koon HB, 2006, LEUKEMIA RES, V30, P190, DOI 10.1016/j.leukres.2005.06.007; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; MAJEAU GR, 1994, J IMMUNOL, V152, P2753; Preithner S, 2006, MOL IMMUNOL, V43, P1183, DOI 10.1016/j.molimm.2005.07.010; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; SCALLON BJ, 1989, P NATL ACAD SCI USA, V86, P5079, DOI 10.1073/pnas.86.13.5079; Shao JY, 2005, ANN BIOMED ENG, V33, P483, DOI 10.1007/s10439-005-2504-5; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; WELLS AF, 1966, APPL MICROBIOL, V14, P271, DOI 10.1128/AEM.14.2.271-275.1966; WOFSY C, 1992, MATH BIOSCI, V112, P115, DOI 10.1016/0025-5564(92)90090-J; Zhu DM, 2006, ACS CHEM BIOL, V1, P649, DOI 10.1021/cb6002515; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19701	10.1371/journal.pone.0019701	http://dx.doi.org/10.1371/journal.pone.0019701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21629715	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200027
J	Trappetti, C; Ogunniyi, AD; Oggioni, MR; Paton, JC				Trappetti, Claudia; Ogunniyi, Abiodun D.; Oggioni, Marco R.; Paton, James C.			Extracellular Matrix Formation Enhances the Ability of Streptococcus pneumoniae to Cause Invasive Disease	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; NASOPHARYNGEAL COLONIZATION; BIOFILM FORMATION; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; OTITIS-MEDIA; MIDDLE-EAR; CHINCHILLA MODEL; EPITHELIAL-CELLS; GENE-EXPRESSION	During infection, pneumococci exist mainly in sessile biofilms rather than in planktonic form, except during sepsis. However, relatively little is known about how biofilms contribute to pneumococcal pathogenesis. Here, we carried out a biofilm assay on opaque and transparent variants of a clinical serotype 19F strain WCH159. After 4 days incubation, scanning electron microscopy revealed that opaque biofilm bacteria produced an extracellular matrix, whereas the transparent variant did not. The opaque biofilm-derived bacteria translocated from the nasopharynx to the lungs and brain of mice, and showed 100-fold greater in vitro adherence to A549 cells than transparent bacteria. Microarray analysis of planktonic and sessile bacteria from transparent and opaque variants showed differential gene expression in two operons: the lic operon, which is involved in choline uptake, and in the two-component system, ciaRH. Mutants of these genes did not form an extracellular matrix, could not translocate from the nasopharynx to the lungs or the brain, and adhered poorly to A549 cells. We conclude that only the opaque phenotype is able to form extracellular matrix, and that the lic operon and ciaRH contribute to this process. We propose that during infection, extracellular matrix formation enhances the ability of pneumococci to cause invasive disease.	[Trappetti, Claudia; Ogunniyi, Abiodun D.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia; [Oggioni, Marco R.] Univ Siena, Lab Microbiol Mol & Biotecnol, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Adelaide; University of Siena	Trappetti, C (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	david.ogunniyi@adelaide.edu.au	Oggioni, Marco Rinaldo/K-3839-2016; Paton, James C/A-9920-2008	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Ogunniyi, Abiodun/0000-0001-9308-5629; Trappetti, Claudia/0000-0001-8272-0068	National Health and Medical Research Council of Australia (NHMRC) [565526, 627142]; Wellcome Trust	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) program grant 565526 and Project Grant 627142 (www.nhmrc.gov.au). J.C.P. is a NHMRC Australia Fellow (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr Layla Mahdi for advice and assistance with microarray work and animal experiments, Mark van der Hoek for help with statistical analysis of microarray data, and Ursula Talbot for assistance with tissue culture experiments. We thank Prof. David Briles (UAB, Birmingham, AL, USA, for the supply of the serotype 6B strain L82016), and Prof. Michael Jennings (Griffith University, Gold Coast, Queensland, Australia), for the kind gift of TEPC-15 monoclonal antibody. We acknowledge BmG@S (the Bacterial Microarray Group at St George's, University of London) for supply of the microarray and advice and The Wellcome Trust for funding the multi-collaborative microbial pathogen microarray facility under its Functional Genomics Resources Initiative.	ALLISON DG, 1984, J MICROBIOL METH, V2, P93, DOI 10.1016/0167-7012(84)90034-4; Arce FT, 2009, J BACTERIOL, V191, P2512, DOI 10.1128/JB.01596-08; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; CORNFORD EM, 1978, J NEUROCHEM, V30, P299, DOI 10.1111/j.1471-4159.1978.tb06530.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUNDELL DR, 1995, INFECT IMMUN, V63, P757, DOI 10.1128/IAI.63.3.757-761.1995; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dagan R, 2009, ADV EXP MED BIOL, V634, P69, DOI 10.1007/978-0-387-79838-7_7; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; Dawid S, 2009, J BACTERIOL, V191, P1509, DOI 10.1128/JB.01213-08; Domenech M, 2009, ENVIRON MICROBIOL, V11, P2542, DOI 10.1111/j.1462-2920.2009.01979.x; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; GUENZI E, 1994, MOL MICROBIOL, V12, P505, DOI 10.1111/j.1365-2958.1994.tb01038.x; HAKENBECK R, 1978, ANTIMICROB AGENTS CH, V13, P302, DOI 10.1128/AAC.13.2.302; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoa M, 2009, INT J PEDIATR OTORHI, V73, P1242, DOI 10.1016/j.ijporl.2009.05.016; HONE D, 1988, MICROB PATHOGENESIS, V5, P407, DOI 10.1016/0882-4010(88)90002-2; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kobayashi H, 2009, J INFECT CHEMOTHER, V15, P125, DOI 10.1007/s10156-008-0691-3; Konradsen HB, 2002, CLIN DIAGN LAB IMMUN, V9, P358, DOI 10.1128/CDLI.9.2.358-365.2002; Kos MI, 2009, INFECTION, V37, P450, DOI 10.1007/s15010-008-8335-1; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; LOFFELHOLZ K, 1993, PROG BRAIN RES, V98, P197; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; McDaniel LS, 1997, GENE THER, V4, P375, DOI 10.1038/sj.gt.3300401; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, DNA RES, V16, P177, DOI 10.1093/dnares/dsp007; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Serino L, 2000, MOL MICROBIOL, V35, P1550, DOI 10.1046/j.1365-2958.2000.01825.x; Serino L, 2002, MOL MICROBIOL, V43, P437, DOI 10.1046/j.1365-2958.2002.02755.x; Serruto D, 2009, VACCINE, V27, P3245, DOI 10.1016/j.vaccine.2009.01.072; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thurnheer T, 2006, CARIES RES, V40, P163, DOI 10.1159/000091065; Tong HH, 2000, INFECT IMMUN, V68, P4593, DOI 10.1128/IAI.68.8.4593-4597.2000; Tong HH, 2001, INFECT IMMUN, V69, P602, DOI 10.1128/IAI.69.1.602-606.2001; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	77	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19844	10.1371/journal.pone.0019844	http://dx.doi.org/10.1371/journal.pone.0019844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611130	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200039
J	Troupin, C; Schnuriger, A; Duponchel, S; Deback, C; Schnepf, N; Dehee, A; Garbarg-Chenon, A				Troupin, Cecile; Schnuriger, Aurelie; Duponchel, Sarah; Deback, Claire; Schnepf, Nathalie; Dehee, Axelle; Garbarg-Chenon, Antoine			Rotavirus Rearranged Genomic RNA Segments Are Preferentially Packaged into Viruses Despite Not Conferring Selective Growth Advantage to Viruses	PLOS ONE			English	Article							BOVINE ROTAVIRUS; SEQUENCE-ANALYSIS; ENGINEERED SSRNA; STRANDED-RNA; VP6 GENE; STRAIN; MECHANISM; INFECTION; NSP1; REASSORTMENT	The rotavirus (RV) genome consists of 11 double-stranded RNA segments. Sometimes, partial sequence duplication of an RNA segment leads to a rearranged RNA segment. To specify the impact of rearrangement, the replication efficiencies of human RV with rearranged segments 7, 11 or both were compared to these of the homologous human wild-type RV (wt-RV) and of the bovine wt-RV strain RF. As judged by viral growth curves, rotaviruses with a rearranged genome (r-RV) had no selective growth advantage over the homologous wt-RV. In contrast, r-RV were selected over wt-RV during competitive experiments (i.e mixed infections between r-RV and wt-RV followed by serial passages in cell culture). Moreover, when competitive experiments were performed between a human r-RV and the bovine wt-RV strain RF, which had a clear growth advantage, rearranged segments 7, 11 or both always segregated in viral progenies even when performing mixed infections at an MOI ratio of 1 r-RV to 100 wt-RV. Lastly, bovine reassortant viruses that had inherited a rearranged segment 7 from human r-RV were generated. Although substitution of wt by rearranged segment 7 did not result in any growth advantage, the rearranged segment was selected in the viral progenies resulting from mixed infections by bovine reassortant r-RV and wt-RV, even for an MOI ratio of 1 r-RV to 10(7) wt-RV. Lack of selective growth advantage of r-RV over wt-RV in cell culture suggests a mechanism of preferential packaging of the rearranged segments over their standard counterparts in the viral progeny.	[Troupin, Cecile; Schnuriger, Aurelie; Duponchel, Sarah; Deback, Claire; Schnepf, Nathalie; Dehee, Axelle; Garbarg-Chenon, Antoine] Univ Paris 06, Paris, France; [Schnuriger, Aurelie; Duponchel, Sarah; Garbarg-Chenon, Antoine] Inst Natl Sante & Rech Med, ERL U1057, UMR 7203, Paris, France; [Schnuriger, Aurelie; Dehee, Axelle; Garbarg-Chenon, Antoine] Hop Armand Trousseau, AP HP, Lab Virol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Troupin, C (corresponding author), Univ Paris 06, Paris, France.	a.chenon@trs.aphp.fr	Deback, Claire/T-3054-2019; DEBACK, Claire/GQP-1189-2022; DEBACK, Claire/GRE-8739-2022; Troupin, Cécile/AAE-9428-2021; schnuriger, aurelie/A-6628-2011; Deback, Claire/B-2787-2014; Garbarg- Chenon, antoine/B-3397-2010	Deback, Claire/0000-0001-9465-2381; DEBACK, Claire/0000-0001-9465-2381; schnuriger, aurelie/0000-0003-0931-8720; Deback, Claire/0000-0001-9465-2381; Garbarg- Chenon, antoine/0000-0003-2940-6672	MRT; UPMC; ACI microbiologie fondamentale; ADVM	MRT; UPMC; ACI microbiologie fondamentale; ADVM	Cecile Troupin and Sarah Duponchel were supported by PhD fellowships funded by an MRT grant. This work was supported in part by UPMC funds and by grants from the ACI microbiologie fondamentale and ADVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2008, ARCH VIROL, V153, P555, DOI 10.1007/s00705-007-0004-7; ALLEN AM, 1985, J GEN VIROL, V66, P2703, DOI 10.1099/0022-1317-66-12-2703; APONTE C, 1993, ARCH VIROL, V133, P85, DOI 10.1007/BF01309746; BALLARD A, 1992, J GEN VIROL, V73, P633, DOI 10.1099/0022-1317-73-3-633; BELLINZONI RC, 1987, J CLIN MICROBIOL, V25, P952, DOI 10.1128/JCM.25.5.952-954.1987; Chnaiderman J, 1998, ARCH VIROL, V143, P1711, DOI 10.1007/s007050050411; Desselberger U, 1996, ADV VIRUS RES, V46, P69, DOI 10.1016/S0065-3527(08)60070-6; EATON BT, 1987, VIRUS RES, V6, P363, DOI 10.1016/0168-1702(87)90067-0; Estes MK, 2007, FIELDS VIROLOGY, P1917; Gault E, 2001, J VIROL, V75, P7305, DOI 10.1128/JVI.75.16.7305-7314.2001; GIAMBIAGI S, 1994, ARCH VIROL, V136, P415, DOI 10.1007/BF01321070; GRAHAM A, 1987, J GEN VIROL, V68, P115, DOI 10.1099/0022-1317-68-1-115; GUSMAO RHP, 1994, J DIARRHOEAL DIS RES, V12, P129; HUA J, 1994, VIROLOGY, V198, P567, DOI 10.1006/viro.1994.1068; HUNDLEY F, 1987, J VIROL, V61, P3365, DOI 10.1128/JVI.61.11.3365-3372.1987; HUNDLEY F, 1985, VIROLOGY, V143, P88, DOI 10.1016/0042-6822(85)90099-6; Kojima K, 1996, VIROLOGY, V224, P446, DOI 10.1006/viro.1996.0551; Kojima K, 2000, VIRUS RES, V67, P163, DOI 10.1016/S0168-1702(00)00139-8; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; MATSUI SM, 1990, J VIROL, V64, P120, DOI 10.1128/JVI.64.1.120-124.1990; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006; Matthijnssens J, 2006, BIOCHEM BIOPH RES CO, V340, P140, DOI 10.1016/j.bbrc.2005.11.165; MATTION NM, 1990, J GEN VIROL, V71, P355, DOI 10.1099/0022-1317-71-2-355; MCINTYRE M, 1987, J GEN VIROL, V68, P2961, DOI 10.1099/0022-1317-68-11-2961; MENDEZ E, 1992, ARCH VIROL, V125, P331, DOI 10.1007/BF01309651; Nakagomi T, 1999, J CLIN MICROBIOL, V37, P1213, DOI 10.1128/JCM.37.4.1213-1216.1999; OISHI I, 1991, MICROBIOL IMMUNOL, V35, P953, DOI 10.1111/j.1348-0421.1991.tb01617.x; Palombo EA, 1998, ACTA VIROL, V42, P55; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patton JT, 1999, VIROLOGY, V264, P167, DOI 10.1006/viro.1999.9989; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; PEDLEY S, 1984, J GEN VIROL, V65, P1141, DOI 10.1099/0022-1317-65-7-1141; POCOCK DH, 1987, VET MICROBIOL, V13, P27, DOI 10.1016/0378-1135(87)90095-2; Roner MR, 2007, J GEN VIROL, V88, P3401, DOI 10.1099/vir.0.83209-0; Roner MR, 2007, VIROLOGY, V358, P89, DOI 10.1016/j.virol.2006.08.017; Roner MR, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-1; Roner MR, 2004, VIROLOGY, V329, P348, DOI 10.1016/j.virol.2004.08.026; Schnepf N, 2008, J VIROL, V82, P3689, DOI 10.1128/JVI.01770-07; SHEN S, 1994, J VIROL, V68, P1682, DOI 10.1128/JVI.68.3.1682-1688.1994; THOULESS ME, 1986, ARCH VIROL, V89, P161, DOI 10.1007/BF01309886; TIAN Y, 1993, J VIROL, V67, P6625, DOI 10.1128/JVI.67.11.6625-6632.1993; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Xu ZC, 1996, VET MICROBIOL, V52, P235, DOI 10.1016/S0378-1135(96)00069-7	44	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20080	10.1371/journal.pone.0020080	http://dx.doi.org/10.1371/journal.pone.0020080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611152	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500041
J	Herman-Roloff, A; Otieno, N; Agot, K; Ndinya-Achola, J; Bailey, RC				Herman-Roloff, Amy; Otieno, Nixon; Agot, Kawango; Ndinya-Achola, Jeckoniah; Bailey, Robert C.			Acceptability of Medical Male Circumcision Among Uncircumcised Men in Kenya One Year After the Launch of the National Male Circumcision Program	PLOS ONE			English	Article							NYANZA PROVINCE; PREVENTION	Background: Numerous studies have demonstrated that male circumcision (MC) reduces the incidence of the Type-1 human immunodeficiency virus (HIV) among heterosexual men by at least half. Methods: One year after the launch of a national Voluntary Medical Male Circumcision program in Kenya, this study conducted 12 focus group discussions among uncircumcised men in Nyanza Province to assess the revealed, non-hypothetical, facilitators and barriers to the uptake of MC. Results: The primary barriers to MC uptake included time away from work; culture and religion; possible adverse events; and the post-surgical abstinence period. The primary facilitators of MC uptake included hygiene; social pressure; protection against HIV and other sexually transmitted infections; and improved sexual performance and satisfaction. Conclusions: Some activities which might increase MC uptake include dispelling MC misconceptions; increasing involvement of religious leaders, women's groups, and peer mobilizers for MC promotion; and increasing the relevance of MC among men who are already practicing an HIV prevention method.	[Herman-Roloff, Amy; Bailey, Robert C.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60680 USA; [Herman-Roloff, Amy; Otieno, Nixon; Bailey, Robert C.] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Ndinya-Achola, Jeckoniah] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Herman-Roloff, A (corresponding author), Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60680 USA.	amykateherman@hotmail.com			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for this study was provided by a grant to FHI from the Bill and Melinda Gates Foundation to support the Male Circumcision Consortium, a partnership between FHI, University of Illinois at Chicago working closely with the Nyanza Reproductive Health Society, and EngenderHealth. The views expressed in this publication do not necessarily reflect those of the Bill and Melinda Gates Foundation or the MCC partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2010, MED MALE CIRCUMCISIO; Kenya National Bureau of Statistics, 2009, POP HOUS CENS RES; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ngalande RC, 2006, AIDS BEHAV, V10, P377, DOI 10.1007/s10461-006-9076-8; [Republic of Kenya Ministry of Public Health & Sanitation], 2009, KEN NAT STRAT VOL ME; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Westercamp N, 2010, FACTORS ASS CIRCUMCI; Wilcken A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-209	19	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19814	10.1371/journal.pone.0019814	http://dx.doi.org/10.1371/journal.pone.0019814			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603622	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300029
J	Ruetz, T; Cornick, S; Guttman, JA				Ruetz, Tyson; Cornick, Steve; Guttman, Julian Andrew			The Spectrin Cytoskeleton Is Crucial for Adherent and Invasive Bacterial Pathogenesis	PLOS ONE			English	Article							III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; LISTERIA-MONOCYTOGENES; PEDESTAL FORMATION; MEMBRANE-SKELETON; EPITHELIAL-CELLS; MAMMALIAN-CELLS; EUKARYOTIC CELLS; PROTEIN; ACTIN	Various enteric bacterial pathogens target the host cell cytoskeletal machinery as a crucial event in their pathogenesis. Despite thorough studies detailing strategies microbes use to exploit these components of the host cell, the role of the spectrin-based cytoskeleton has been largely overlooked. Here we show that the spectrin cytoskeleton is a host system that is hijacked by adherent (Entropathogenic Escherichia coli [EPEC]), invasive triggering (Salmonella enterica serovar Typhimurium [S. Typhimurium]) and invasive zippering (Listeria monocytogenes) bacteria. We demonstrate that spectrin cytoskeletal proteins are recruited to EPEC pedestals, S. Typhimurium membrane ruffles and Salmonella containing vacuoles (SCVs), as well as sites of invasion and comet tail initiation by L. monocytogenes. Spectrin was often seen co-localizing with actin filaments at the cell periphery, however a disconnect between the actin and spectrin cytoskeletons was also observed. During infections with S. Typhimurium Delta sipA, actin-rich membrane ruffles at characteristic sites of bacterial invasion often occurred in the absence of spectrin cytoskeletal proteins. Additionally, early in the formation of L. monocytogenes comet tails, spectrin cytoskeletal elements were recruited to the surface of the internalized bacteria independent of actin filaments. Further studies revealed the presence of the spectrin cytoskeleton during SCV and Listeria comet tail formation, highlighting novel cytoplasmic roles for the spectrin cytoskeleton. SiRNA targeted against spectrin and the spectrin-associated proteins severely diminished EPEC pedestal formation as well as S. Typhimurium and L. monocytogenes invasion. Ultimately, these findings identify the spectrin cytoskeleton as a ubiquitous target of enteric bacterial pathogens and indicate that this cytoskeletal system is critical for these infections to progress.	[Ruetz, Tyson; Cornick, Steve; Guttman, Julian Andrew] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Ruetz, T (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jguttman@sfu.ca		Ruetz, Tyson/0000-0002-3568-7717; Cornick, Steve/0000-0003-3883-6033	Canadian Institute for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Baumann O, 1998, CELL MOTIL CYTOSKEL, V41, P74, DOI 10.1002/(SICI)1097-0169(1998)41:1<74::AID-CM7>3.0.CO;2-F; Beck KA, 1996, AM J PHYSIOL-CELL PH, V270, pC1263, DOI 10.1152/ajpcell.1996.270.5.C1263; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; DeVinney R, 2001, MOL MICROBIOL, V41, P1445, DOI 10.1046/j.1365-2958.2001.02617.x; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; Figueiredo JF, 2009, MICROBES INFECT, V11, P850, DOI 10.1016/j.micinf.2009.05.003; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Guttman JA, 2010, INFECT IMMUN, V78, P3316, DOI 10.1128/IAI.00161-10; Guttman JA, 2007, ANAT REC, V290, P199, DOI 10.1002/ar.20414; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KOCKS C, 1993, J CELL SCI, V105, P699; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; MARSHALL LM, 1984, J CELL BIOL, V98, P2055, DOI 10.1083/jcb.98.6.2055; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; Park JU, 2000, APMIS, V108, P45, DOI 10.1034/j.1600-0463.2000.d01-4.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; TAKEUCHI A, 1967, AM J PATHOL, V51, P137; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19940	10.1371/journal.pone.0019940	http://dx.doi.org/10.1371/journal.pone.0019940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603579	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300042
J	Walter, D; Satheesha, S; Albrecht, P; Bornhauser, BC; D'Alessandro, V; Oesch, SM; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, FK; Schafer, BW				Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Rehrauer, Hubert; Leuschner, Ivo; Koscielniak, Ewa; Gengler, Carole; Moch, Holger; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.		CWS Study Grp	CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres	PLOS ONE			English	Article							CARCINOMA-CELLS; INITIATING CELLS; DRUG-RESISTANCE; TUMOR-FORMATION; NEURAL-TUBE; CANCER; IDENTIFICATION; EXPRESSION; GROWTH; DIFFERENTIATION	Cancer stem cells (CSCs) have been identified in a number of solid tumors, but not yet in rhabdomyosarcoma (RMS), the most frequently occurring soft tissue tumor in childhood. Hence, the aim of this study was to identify and characterize a CSC population in RMS using a functional approach. We found that embryonal rhabdomyosarcoma (eRMS) cell lines can form rhabdomyosarcoma spheres (short rhabdospheres) in stem cell medium containing defined growth factors over several passages. Using an orthotopic xenograft model, we demonstrate that a 100 fold less sphere cells result in faster tumor growth compared to the adherent population suggesting that CSCs were enriched in the sphere population. Furthermore, stem cell genes such as oct4, nanog, c-myc, pax3 and sox2 are significantly upregulated in rhabdospheres which can be differentiated into multiple lineages such as adipocytes, myocytes and neuronal cells. Surprisingly, gene expression profiles indicate that rhabdospheres show more similarities with neuronal than with hematopoietic or mesenchymal stem cells. Analysis of these profiles identified the known CSC marker CD133 as one of the genes upregulated in rhabdospheres, both on RNA and protein levels. CD133(+) sorted cells were subsequently shown to be more tumorigenic and more resistant to commonly used chemotherapeutics. Using a tissue microarray (TMA) of eRMS patients, we found that high expression of CD133 correlates with poor overall survival. Hence, CD133 could be a prognostic marker for eRMS. These experiments indicate that a CD133(+) CSC population can be enriched from eRMS which might help to develop novel targeted therapies against this pediatric tumor.	[Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland; [Walter, Dagmar; Satheesha, Sampoorna; Albrecht, Patrick; Bornhauser, Beat C.; D'Alessandro, Valentina; Oesch, Susanne M.; Bernasconi, Michele; Niggli, Felix K.; Schaefer, Beat W.] Univ Childrens Hosp, Childrens Res Ctr, Zurich, Switzerland; [Oesch, Susanne M.] Roche Pharma Schweiz, Basel, Switzerland; [Rehrauer, Hubert] Univ Zurich, Funct Genom Ctr, Zurich, Switzerland; [Leuschner, Ivo] Univ Kiel, Dept Pathol, D-2300 Kiel, Germany; [Koscielniak, Ewa] Klinikum Stuttgart, Olgahosp, Stuttgart, Germany; [Gengler, Carole; Moch, Holger] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; Roche Holding; University of Zurich; University of Kiel; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Zurich; University Zurich Hospital	Walter, D (corresponding author), Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch	Bornhauser, Beat/M-4437-2014; Bernasconi, Michele/CAG-2492-2022; Bernasconi, Michele/C-6734-2008; Niggli, Felix/L-6547-2017; Rappaz, Sampoorna/ABD-6160-2021; Bernasconi, Michele/GOH-1815-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Niggli, Felix/0000-0002-7553-3712; Rappaz, Sampoorna/0000-0002-7330-7586; Bernasconi, Michele/0000-0002-5746-8806; Bornhauser, Beat/0000-0003-2890-3191; Schafer, Beat/0000-0001-5988-2915	Swiss National Science Foundation [3100-122562]; Swiss Research Foundation Child and Cancer	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Research Foundation Child and Cancer	This study was supported by grants (3100-122562) from the Swiss National Science Foundation and the Swiss Research Foundation Child and Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Angello JC, 1997, DEV BIOL, V192, P93, DOI 10.1006/dbio.1997.8722; Astolfi A, 2001, GENE, V274, P139, DOI 10.1016/S0378-1119(01)00619-9; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouchard F, 2009, STEM CELLS DEV, V18, P1023, DOI 10.1089/scd.2008.0288; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Dantonello TM, 2008, J CLIN ONCOL, V26, P406, DOI 10.1200/JCO.2007.12.2382; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDowell HP, 2003, ARCH DIS CHILD, V88, P354, DOI 10.1136/adc.88.4.354; Merlino G, 2007, GENE DEV, V21, P1275, DOI 10.1101/gad.1563707; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; *SCI T, 2009, HUM MES STEM CELL PR; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh S, 2007, NEUROSURG CLIN N AM, V18, P31, DOI 10.1016/j.nec.2006.10.014; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; TAJBAKHSH S, 1994, NEURON, V13, P813, DOI 10.1016/0896-6273(94)90248-8; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Wachtel M, 2006, J CLIN ONCOL, V24, P816, DOI 10.1200/JCO.2005.03.4934; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606	50	84	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19506	10.1371/journal.pone.0019506	http://dx.doi.org/10.1371/journal.pone.0019506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602936	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500013
J	Maxwell, SM; Breed, GA; Nickel, BA; Makanga-Bahouna, J; Pemo-Makaya, E; Parnell, RJ; Formia, A; Ngouessono, S; Godley, BJ; Costa, DP; Witt, MJ; Coyne, MS				Maxwell, Sara M.; Breed, Greg A.; Nickel, Barry A.; Makanga-Bahouna, Junior; Pemo-Makaya, Edgard; Parnell, Richard J.; Formia, Angela; Ngouessono, Solange; Godley, Brendan J.; Costa, Daniel P.; Witt, Matthew J.; Coyne, Michael S.			Using Satellite Tracking to Optimize Protection of Long-Lived Marine Species: Olive Ridley Sea Turtle Conservation in Central Africa	PLOS ONE			English	Article							LEATHERBACK TURTLES; LEPIDOCHELYS-OLIVACEA; DERMOCHELYS-CORIACEA; BODY-SIZE; FORAGING STRATEGIES; NESTING MIGRATIONS; GREEN TURTLES; MOVEMENT; BEHAVIOR; AREAS	Tractable conservation measures for long-lived species require the intersection between protection of biologically relevant life history stages and a socioeconomically feasible setting. To protect breeding adults, we require knowledge of animal movements, how movement relates to political boundaries, and our confidence in spatial analyses of movement. We used satellite tracking and a switching state-space model to determine the internesting movements of olive ridley sea turtles (Lepidochelys olivacea) (n = 18) in Central Africa during two breeding seasons (2007-08, 2008-09). These movements were analyzed in relation to current park boundaries and a proposed transboundary park between Gabon and the Republic of Congo, both created to reduce unintentional bycatch of sea turtles in marine fisheries. We additionally determined confidence intervals surrounding home range calculations. Turtles remained largely within a 30 km radius from the original nesting site before departing for distant foraging grounds. Only 44.6 percent of high-density areas were found within the current park but the proposed transboundary park would incorporate 97.6 percent of high-density areas. Though tagged individuals originated in Gabon, turtles were found in Congolese waters during greater than half of the internesting period (53.7 percent), highlighting the need for international cooperation and offering scientific support for a proposed transboundary park. This is the first comprehensive study on the internesting movements of solitary nesting olive ridley sea turtles, and it suggests the opportunity for tractable conservation measures for female nesting olive ridleys at this and other solitary nesting sites around the world. We draw from our results a framework for cost-effective protection of long-lived species using satellite telemetry as a primary tool.	[Maxwell, Sara M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Breed, Greg A.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Nickel, Barry A.] Univ Calif Santa Cruz, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Makanga-Bahouna, Junior; Pemo-Makaya, Edgard; Parnell, Richard J.] Parc Natl Mayumba, Wildlife Conservat Soc, Mayumba, Gabon; [Formia, Angela] Global Conservat Program, Wildlife Conservat Soc, New York, NY USA; [Ngouessono, Solange] Agence Natl Parcs Nationaux, Libreville, Gabon; [Godley, Brendan J.; Witt, Matthew J.; Coyne, Michael S.] Univ Exeter, Ctr Ecol & Conservat, Marine Turtle Res Grp, Penyrn, Cornwall, England; [Coyne, Michael S.] SEATURTLE Org, Durham, NC USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Wildlife Conservation Society; University of Exeter	Maxwell, SM (corresponding author), Marine Conservat Inst, Long Marine Lab, Santa Cruz, CA USA.	smaxwell@ucsc.edu	godley, brendan j/A-6139-2009; Witt, Matthew/V-3318-2018; godley, brendan/O-1959-2019; Costa, Daniel/E-2616-2013	godley, brendan j/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan/0000-0003-3845-0034; Maxwell, Sara/0000-0002-4425-9378; Costa, Daniel/0000-0002-0233-5782	Disney Worldwide Conservation Fund [STO-08-01]; Tagging of Pacific Predators Project; Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface; Friends of Long Marine Laboratory; Society for the Study of Amphibians and Reptiles; Marilyn Davis Memorial Scholarship; UCSC Graduate Student Association; Square's Landscaping and Kitchen Gardens, Inc.; National Science Foundation; University of California; United States Fish and Wildlife Service, U.S. Department of the Interior	Disney Worldwide Conservation Fund; Tagging of Pacific Predators Project; Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface; Friends of Long Marine Laboratory; Society for the Study of Amphibians and Reptiles; Marilyn Davis Memorial Scholarship; UCSC Graduate Student Association; Square's Landscaping and Kitchen Gardens, Inc.; National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); United States Fish and Wildlife Service, U.S. Department of the Interior(US Fish & Wildlife Service)	This work was supported by the Disney Worldwide Conservation Fund (STO-08-01) and the Tagging of Pacific Predators Project, with additional support from the Darwin Initiative, Center for the Dynamics and Evolution of the Land-Sea Interface, Friends of Long Marine Laboratory, Society for the Study of Amphibians and Reptiles, the Marilyn Davis Memorial Scholarship, the UCSC Graduate Student Association, Square's Landscaping and Kitchen Gardens, Inc. SMM was supported by fellowships from the National Science Foundation, University of California Santa Cruz, Achievement Awards for College Scientists and Steve Blank. Sea turtle nest monitoring in Gabon was coordinated through the Gabon Sea Turtle Partnership, with funding from the Marine Turtle Conservation Fund (United States Fish and Wildlife Service, U.S. Department of the Interior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2000, B MAR SCI, V66, P875; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; BALAZS G, 1999, PUBLICATION IUCN SSC, V4; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bernardo J., 2007, BIOL CONSERVATION RI, P59; Blumenthal Janice M., 2006, Endangered Species Research, V7, P1; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; *CLS SERV AGR, 2008, US MAN; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Craig MP, 1999, MAR MAMMAL SCI, V15, P786, DOI 10.1111/j.1748-7692.1999.tb00843.x; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; ECKERT KL, 1989, HERPETOLOGICA, V45, P190; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Ehrenfeld D, 2000, CONSERV BIOL, V14, P105, DOI 10.1046/j.1523-1739.2000.99325.x; Finkelstein ME, 2010, ANIM CONSERV, V13, P148, DOI 10.1111/j.1469-1795.2009.00311.x; Fossette S, 2007, MAR ECOL PROG SER, V338, P233, DOI 10.3354/meps338233; Fretey J, 2001, BIOGEOGRAPHY CONSERV; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Godgenger MC, 2009, ORYX, V43, P556, DOI 10.1017/S0030605309990329; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamel MA, 2008, J EXP MAR BIOL ECOL, V359, P47, DOI 10.1016/j.jembe.2008.02.019; Hays GC, 2001, MAR BIOL, V139, P395; Hays GC, 1999, MAR ECOL PROG SER, V189, P263, DOI 10.3354/meps189263; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Heppell SS, 1999, AM FISH S S, V23, P137; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalb H., 1999, BEHAV PHYSL SOLITARY; Kenward R., 1987, WILDLIFE RADIO TAGGI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; *MAY NAT PARK, UNPUB; Meylan Anne, 1995, P67; Miller Jeffrey D., 1997, P51; Moser BW, 2007, J WILDLIFE MANAGE, V71, P2421, DOI 10.2193/2007-003; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Parnell Richard, 2007, Marine Turtle Newsletter, P12; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; Plotkin PT, 1996, HERPETOLOGICA, V52, P1; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Powell R., 2000, RES TECHNIQUES ANIMA, P64; PRITCHARD PCH, 1980, AM ZOOL, V20, P609; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Roberts CM, 2000, B MAR SCI, V66, P581; Root TL, 2006, CONSERV BIOL, V20, P706, DOI 10.1111/j.1523-1739.2006.00465.x; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Schultz JP, 1975, ZOOL VERH-LEIDEN, V143, P3; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Tucker AD, 2010, J EXP MAR BIOL ECOL, V383, P48, DOI 10.1016/j.jembe.2009.11.009; VANBUSKIRK J, 1994, COPEIA, P66; VANLEEUWE H, 2008, MARINE TURDE SEASON; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Walker JS, 2008, COMPUT ENVIRON URBAN, V32, P19, DOI 10.1016/j.compenvurbsys.2007.02.001; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whiting S. D., 2007, Endangered Species Research, V3, P1, DOI 10.3354/esr003001; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Zbinden JA, 2007, BIOL CONSERV, V137, P157, DOI 10.1016/j.biocon.2007.01.022	82	107	108	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19905	10.1371/journal.pone.0019905	http://dx.doi.org/10.1371/journal.pone.0019905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589942	Green Submitted, Green Published, gold			2022-12-27	WOS:000290483600035
J	Friberg, IM; Lowe, A; Ralli, C; Bradley, JE; Jackson, JA				Friberg, Ida M.; Lowe, Ann; Ralli, Catriona; Bradley, Janette E.; Jackson, Joseph A.			Temporal Anomalies in Immunological Gene Expression in a Time Series of Wild Mice: Signature of an Epidemic?	PLOS ONE			English	Article							COWPOX VIRUS-INFECTION; WOOD MICE; HANTAVIRUS INFECTION; IMMUNE-RESPONSES; HOST IMMUNE; FIELD VOLE; POPULATION; PARASITES; DISEASE; DYNAMICS	Although the ecological importance of coinfection is increasingly recognized, analyses of microbial pathogen dynamics in wildlife usually focus on an ad hoc subset of the species present due to technological limitations on detection. Here we demonstrate the use of expression profiles for immunological genes (pattern recognition receptors, cytokines and transcription factors) as a means to identify, without preconception, the likelihood of important acute microbial infections in wildlife. Using a wood mouse population in the UK as a model we identified significant temporal clusters of individuals with extreme expression of immunological mediators across multiple loci, typical of an acute microbial infection. These clusters were circumstantially associated with demographic perturbation in the summertime wood mouse population. Animals in one cluster also had significantly higher individual macroparasite burdens than contemporaries with "normal" expression patterns. If the extreme transcriptional profiles observed are induced by an infectious agent then this implicates macroparasites as a possible player in mediating individual susceptibility or resilience to infection. The form of survey described here, combined with next generation nucleic acids sequencing methods for the broad detection of microbial infectious agents in individuals with anomalous immunological transcriptional profiles, could be a powerful tool for revealing unrecognized, ecologically important infectious agents circulating in wildlife populations.	[Friberg, Ida M.; Lowe, Ann; Ralli, Catriona; Bradley, Janette E.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Friberg, Ida M.; Jackson, Joseph A.] Aberystwyth Univ, IBERS, Aberystwyth, Ceredigion, Wales	University of Nottingham; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Friberg, IM (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	plximf@Nottingham.ac.uk		Jackson, Ida/0000-0002-3139-7384; Bradley, Janette/0000-0003-3973-7977	Natural Environment Research Council [NE/E015131/1]; European Commission; NERC [NE/E015131/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding from the Natural Environment Research Council to JEB (NE/E015131/1) and the European Commission to IMF ( Marie Curie Early Stage Research Training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Alzhanova D, 2010, MICROBES INFECT, V12, P900, DOI 10.1016/j.micinf.2010.07.007; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Carslake D, 2005, J ANIM ECOL, V74, P647, DOI 10.1111/j.1365-2656.2005.00966.x; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; FLOWERDEW JR, 1972, J ANIM ECOL, V41, P553, DOI 10.2307/3195; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Guivier E, 2010, INFECT GENET EVOL, V10, P1208, DOI 10.1016/j.meegid.2010.07.022; GURNELL J, 1978, J ANIM ECOL, V47, P741, DOI 10.2307/3668; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Jackson JA, 2011, MOL ECOL, V20, P893, DOI 10.1111/j.1365-294X.2010.04907.x; Jackson JA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-16; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lonergan M, 2010, DIS AQUAT ORGAN, V88, P183, DOI 10.3354/dao02153; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; McKimmie CS, 2005, BIOCHEM BIOPH RES CO, V336, P925, DOI 10.1016/j.bbrc.2005.08.209; Montgomery WI, 1997, J ANIM ECOL, V66, P755, DOI 10.2307/5926; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Redpath SM, 2006, ECOL LETT, V9, P410, DOI 10.1111/j.1461-0248.2006.00895.x; ROWE FP, 1985, J APPL ECOL, V22, P55, DOI 10.2307/2403326; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stephan K, 2007, EUR J IMMUNOL, V37, P212, DOI 10.1002/eji.200636156; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Telfer S, 2005, OIKOS, V109, P317, DOI 10.1111/j.0030-1299.2005.13734.x; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thiriot A, 2009, MOL IMMUNOL, V46, P601, DOI 10.1016/j.molimm.2008.07.027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILSON WL, 1993, MAMMAL REV, V23, P73, DOI 10.1111/j.1365-2907.1993.tb00418.x; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20070	10.1371/journal.pone.0020070	http://dx.doi.org/10.1371/journal.pone.0020070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629775	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200031
J	Chowdhury, P; Pore, D; Mahata, N; Karmakar, P; Pal, A; Chakrabarti, MK				Chowdhury, Pinki; Pore, Debasis; Mahata, Nibedita; Karmakar, Poulomee; Pal, Amit; Chakrabarti, Manoj K.			Thermostable Direct Hemolysin Downregulates Human Colon Carcinoma Cell Proliferation with the Involvement of E-Cadherin, and beta-Catenin/Tcf-4 Signaling	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; HEAT-STABLE ENTEROTOXIN; PROTEIN-KINASE-C; VIBRIO-PARAHAEMOLYTICUS; EXTRACELLULAR CALCIUM; ESCHERICHIA-COLI; CACO-2 CELLS; IN-VITRO; CANCER; EXPRESSION	Background: Colon cancers are the frequent causes of cancer mortality worldwide. Recently bacterial toxins have received marked attention as promising approaches in the treatment of colon cancer. Thermostable direct hemolysin (TDH) secreted by Vibrio parahaemolyticus causes influx of extracellular calcium with the subsequent rise in intracellular calcium level in intestinal epithelial cells and it is known that calcium has antiproliferative activity against colon cancer. Key Results: In the present study it has been shown that TDH, a well-known traditional virulent factor inhibits proliferation of human colon carcinoma cells through the involvement of CaSR in its mechanism. TDH treatment does not induce DNA fragmentation, nor causes the release of lactate dehydrogenase. Therefore, apoptosis and cytotoxicity are not contributing to the TDH-mediated reduction of proliferation rate, and hence the reduction appears to be caused by decrease in cell proliferation. The elevation of E-cadherin, a cell adhesion molecule and suppression of beta-catenin, a proto-oncogene have been observed in presence of CaSR agonists whereas reverse effect has been seen in presence of CaSR antagonist as well as si-RNA in TDH treated cells. TDH also triggers a significant reduction of Cyclin-D and cdk2, two important cell cycle regulatory proteins along with an up regulation of cell cycle inhibitory protein p27(Kip1) in presence of CaSR agonists. Conclusion: Therefore TDH can downregulate colonic carcinoma cell proliferation and involves CaSR in its mechanism of action. The downregulation occurs mainly through the involvement of E-cadherin-beta-catenin mediated pathway and the inhibition of cell cycle regulators as well as upregulation of cell cycle inhibitors.	[Chowdhury, Pinki; Pore, Debasis; Mahata, Nibedita; Karmakar, Poulomee; Pal, Amit; Chakrabarti, Manoj K.] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chowdhury, P (corresponding author), Baylor Coll Med, Dept Med, Div Hematol & Oncol, Houston, TX 77030 USA.	mkc_niced@yahoo.co.in		/0000-0002-6026-1187; Chowdhury, Pinki/0000-0003-4100-0333	University Grants Commission, Government of India; Indian Council of Medical Research	University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The first author (PC) and fourth author (PK) are the recipients of the Senior Research Fellowship and Junior Research Fellowship of the University Grants Commission, Government of India, respectively. The second (DP) and third (NM) authors are the recipients of the Senior Research Fellowship of the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhattacharya J, 1998, BBA-MOL CELL RES, V1403, P1, DOI 10.1016/S0167-4889(98)00026-3; BOYNTON AL, 1988, MINER ELECTROL METAB, V14, P86; BURAS RR, 1995, CELL PROLIFERAT, V28, P245, DOI 10.1111/j.1365-2184.1995.tb00067.x; Chakrabarty AM, 2003, J BACTERIOL, V185, P2683, DOI 10.1128/JB.185.9.2683-2686.2003; Chakrabarty S, 2003, CANCER RES, V63, P67; Chou TC, 1998, P NATL ACAD SCI USA, V95, P9642, DOI 10.1073/pnas.95.16.9642; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; DOUET JP, 1992, RES MICROBIOL, V143, P569, DOI 10.1016/0923-2508(92)90114-4; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; Ferlay J, 2001, CANC INCIDENCE MORTA; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gupta DD, 2005, TOXICOL APPL PHARM, V206, P9, DOI 10.1016/j.taap.2004.11.001; Hawk ET, 2002, SURG CLIN N AM, V82, P905, DOI 10.1016/S0039-6109(02)00046-4; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; HONDA T, 1992, CAN J MICROBIOL, V38, P1175, DOI 10.1139/m92-192; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HULLA W, 1995, INT J CANCER, V62, P711, DOI 10.1002/ijc.2910620611; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kallay E, 1997, BIOCHEM BIOPH RES CO, V232, P80, DOI 10.1006/bbrc.1997.6225; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lipkin M, 1999, ANN NY ACAD SCI, V889, P120, DOI 10.1111/j.1749-6632.1999.tb08729.x; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Punj V, 2004, ONCOGENE, V23, P2367, DOI 10.1038/sj.onc.1207376; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; Saha S, 2008, J APPL TOXICOL, V28, P475, DOI 10.1002/jat.1297; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sinha G, 2003, NAT MED, V9, P1229, DOI 10.1038/nm1003-1229a; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Wang HM, 2001, J CELL PHYSIOL, V187, P188, DOI 10.1002/jcp.1068; Wargovich MJ, 2000, CARCINOGENESIS, V21, P1149, DOI 10.1093/carcin/21.6.1149; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Yamada T, 2002, P NATL ACAD SCI USA, V99, P14098, DOI 10.1073/pnas.222539699	41	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20098	10.1371/journal.pone.0020098	http://dx.doi.org/10.1371/journal.pone.0020098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625458	Green Submitted, gold, Green Published			2022-12-27	WOS:000290793400039
J	Koettgen, M; Hofherr, A; Li, WZ; Chu, K; Cook, S; Montell, C; Watnick, T				Koettgen, Michael; Hofherr, Alexis; Li, Weizhe; Chu, Kristy; Cook, Stacey; Montell, Craig; Watnick, Terry			Drosophila Sperm Swim Backwards in the Female Reproductive Tract and Are Activated via TRPP2 Ion Channels	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MALE-FERTILITY; CATION CHANNEL; MELANOGASTER; GENE; PROTEIN; PKD2; ACP36DE; STORAGE; MECHANISMS	Background: Sperm have but one purpose, to fertilize an egg. In various species including Drosophila melanogaster female sperm storage is a necessary step in the reproductive process. Amo is a homolog of the human transient receptor potential channel TRPP2 (also known as PKD2), which is mutated in autosomal dominant polycystic kidney disease. In flies Amo is required for sperm storage. Drosophila males with Amo mutations produce motile sperm that are transferred to the uterus but they do not reach the female storage organs. Therefore Amo appears to be a mediator of directed sperm motility in the female reproductive tract but the underlying mechanism is unknown. Methodology/Principal Findings: Amo exhibits a unique expression pattern during spermatogenesis. In spermatocytes, Amo is restricted to the endoplasmic reticulum (ER) whereas in mature sperm, Amo clusters at the distal tip of the sperm tail. Here we show that flagellar localization of Amo is required for sperm storage. This raised the question of how Amo at the rear end of sperm regulates forward movement into the storage organs. In order to address this question, we used in vivo imaging of dual labelled sperm to demonstrate that Drosophila sperm navigate backwards in the female reproductive tract. In addition, we show that sperm exhibit hyperactivation upon transfer to the uterus. Amo mutant sperm remain capable of reverse motility but fail to display hyperactivation and directed movement, suggesting that these functions are required for sperm storage in flies. Conclusions/Significance: Amo is part of a signalling complex at the leading edge of the sperm tail that modulates flagellar beating and that guides a backwards path into the storage organs. Our data support an evolutionarily conserved role for TRPP2 channels in cilia.	[Koettgen, Michael; Li, Weizhe; Chu, Kristy; Cook, Stacey; Watnick, Terry] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Koettgen, Michael; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Koettgen, Michael; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Koettgen, M (corresponding author), Univ Med Ctr Freiburg, Div Nephrol, Freiburg, Germany.	michael.koettgen@uniklinik-freiburg.de; twatnick@jhmi.edu	Li, Weizhe/G-6960-2012; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Kottgen, Michael/0000-0003-2406-5039; , Alexis/0000-0003-2842-6161	NIH [R01GM073704, RO1-EY08117, R01-EY10852]; PKD Foundation; DFG [KFO201]; German Federal and State Governments, Spemann Graduate School [GSC-4]; NATIONAL EYE INSTITUTE [R01EY008117, R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; DFG(German Research Foundation (DFG)); German Federal and State Governments, Spemann Graduate School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01GM073704 to TW, PKD Foundation Young Investigator Award and DFG KFO201 to MK, NIH RO1-EY08117 and NIH R01-EY10852 to CM. This study was supported in part by the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2009, P NATL ACAD SCI USA, V106, P15796, DOI 10.1073/pnas.0904029106; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Fraser LR, 2010, MOL REPROD DEV, V77, P197, DOI 10.1002/mrd.21124; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Neubaum DM, 1999, GENETICS, V153, P845; Neubaum DM, 1999, CURR TOP DEV BIOL, V41, P67; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Qazi MCB, 2003, J EXP BIOL, V206, P3521, DOI 10.1242/jeb.00585; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Venglarik CJ, 2004, J AM SOC NEPHROL, V15, P1168, DOI 10.1097/01.ASN.0000125616.42669.51; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8	36	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20031	10.1371/journal.pone.0020031	http://dx.doi.org/10.1371/journal.pone.0020031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625494	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400033
J	Meng, S; Liu, ZH; Xu, LL; Li, L; Mei, S; Bao, LL; Deng, W; Li, L; Lei, RY; Xie, LZ; Qin, C; Zhang, LQ				Meng, Shu; Liu, Zhonghua; Xu, Lili; Li, Li; Mei, Shan; Bao, Linlin; Deng, Wei; Li, Lina; Lei, Rongyue; Xie, Liangzhi; Qin, Chuan; Zhang, Linqi			Intranasal Immunization with Recombinant HA and Mast Cell Activator C48/80 Elicits Protective Immunity against 2009 Pandemic H1N1 Influenza in Mice	PLOS ONE			English	Article							ANTIBODY-RESPONSES; MUCOSAL IMMUNITY; CHOLERA-TOXIN; VACCINE; ADJUVANT; VIRUS; MUTANT; INFECTION; ENTEROTOXINS; HUMANS	Background: Pandemic influenza represents a major threat to global health. Vaccination is the most economic and effective strategy to control influenza pandemic. Conventional vaccine approach, despite being effective, has a number of major deficiencies including limited range of protection, total dependence on embryonated eggs for production, and time consuming for vaccine production. There is an urgent need to develop novel vaccine strategies to overcome these deficiencies. Methodology/Principal Findings: The major objective of this work was to develop a novel vaccine strategy combining recombinant haemagglutinin (HA) protein and a master cell (MC) activator C48/80 for intranasal immunization. We demonstrated in BALB/c mice that MC activator C48/80 had strong adjuvant activity when co-administered with recombinant HA protein intranasally. Vaccination with C48/80 significantly increased the serum IgG and mucosal surface IgA antibody responses against HA protein. Such increases correlated with stronger and durable neutralizing antibody activities, offering protection to vaccinated animals from disease progression after challenge with lethal dose of A/California/04/2009 live virus. Furthermore, protected animals demonstrated significant reduction in lung virus titers, minimal structural alteration in lung tissues as well as higher and balanced production of Th1 and Th2 cytokines in the stimulated splenocytes when compared to those without C48/80. Conclusions/Significance: The present study demonstrates that the novel vaccine approach of combining recombinant HA and mucosal adjuvant C48/80 is safe and effective in eliciting protective immunity in mice. Future studies on the mechanism of action of C48/80 and potential combination with other vaccine strategies such as prime and boost approach may help to induce even more potent and broad immune responses against viruses from various clades.	[Meng, Shu; Liu, Zhonghua; Li, Li; Mei, Shan; Li, Lina; Lei, Rongyue; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100037, Peoples R China; [Xu, Lili; Bao, Linlin; Deng, Wei; Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100037, Peoples R China; [Xu, Lili; Bao, Linlin; Deng, Wei; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Xie, Liangzhi] Sino Biol Inc, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Meng, S (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100037, Peoples R China.	zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; Deng, Wei/GWC-9207-2022		National Science and Technology Major Project [2009ZX10004-016, 2008ZX10001-011]; Chinese Natural Science Foundation [30825035]; Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund; US National Institute of Health [U19 AI51915]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National Science and Technology Major Project; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Science and Technology Major Project (2009ZX10004-016, and 2008ZX10001-011), the National Outstanding Youth Award of the Chinese Natural Science Foundation (30825035), Tsinghua University Initiative Scientific Research Program and Tsinghua Yue-Yuen Medical Sciences Fund. This work is also partially funded by US National Institute of Health CIPRA Grant (U19 AI51915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1100; Bao LL, 2010, VIRUS RES, V151, P60, DOI 10.1016/j.virusres.2010.03.019; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; CROFT M, 1991, J IMMUNOL, V146, P4055; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fisman DN, 2009, NEW ENGL J MED, V361, P2000, DOI 10.1056/NEJMc0907256; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glezen W Paul, 2004, Expert Rev Vaccines, V3, P131, DOI 10.1586/14760584.3.2.131; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Marshall JS, 2003, CURR PHARM DESIGN, V9, P11, DOI 10.2174/1381612033392413; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Peter Z, 2008, IMMUNOL LETT, V115, P144, DOI 10.1016/j.imlet.2007.11.001; Pizza M, 2001, VACCINE, V19, P2534, DOI 10.1016/S0264-410X(00)00137-7; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Pulendran B, 2008, NAT MED, V14, P489, DOI 10.1038/nm0508-489; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ren SR, 2010, CELL IMMUNOL, V263, P204, DOI 10.1016/j.cellimm.2010.03.017; ROTHSCHILD AM, 1970, BRIT J PHARMACOL, V38, P253, DOI 10.1111/j.1476-5381.1970.tb10354.x; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Tamura S, 2010, JPN J INFECT DIS, V63, P8; Tempesta M, 2007, VACCINE, V25, P7927, DOI 10.1016/j.vaccine.2007.09.004; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Tritto E, 2007, J IMMUNOL, V179, P5346, DOI 10.4049/jimmunol.179.8.5346; Watanabe I, 2002, VACCINE, V20, P3443, DOI 10.1016/S0264-410X(02)00351-1; Williams NA, 1999, IMMUNOL TODAY, V20, P95, DOI 10.1016/S0167-5699(98)01397-8; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	46	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19863	10.1371/journal.pone.0019863	http://dx.doi.org/10.1371/journal.pone.0019863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625486	gold, Green Published, Green Submitted			2022-12-27	WOS:000290793400016
J	Pan, QM; Bai, YF; Wu, JG; Han, XG				Pan, Qingmin; Bai, Yongfei; Wu, Jianguo; Han, Xingguo			Hierarchical Plant Responses and Diversity Loss after Nitrogen Addition: Testing Three Functionally-Based Hypotheses in the Inner Mongolia Grassland	PLOS ONE			English	Article							SPECIES RICHNESS; SUCCESSIONAL GRASSLAND; COMPETITION; BIODIVERSITY; ALLOCATION; DEPOSITION; BIOMASS; AVAILABILITY; RESOURCES; LIGHT	Background: Numerous studies have shown that nitrogen (N) deposition decreases biodiversity in terrestrial ecosystems. To explain the N-induced species loss, three functionally based hypotheses have been proposed: the aboveground competition hypothesis, the belowground competition hypothesis, and the total competition hypothesis. However, none of them is supported sufficiently by field experiments. A main challenge to testing these hypotheses is to ascertain the role of shoot and root competition in controlling plant responses to N enrichment. Simultaneously examining both aboveground and belowground responses in natural ecosystems is logistically complex, and has rarely been done. Methodology/Principal Findings: In a two-year N addition experiment conducted in a natural grassland ecosystem, we investigated both above-and belowground responses of plants at the individual, species, and community levels. Plants differed significantly in their responses to N addition across the different organizational levels. The community-level species loss was mainly due to the loss of perennial grasses and forbs, while the relative abundance of plant species was dependent mainly on individual-level responses. Plasticity in biomass allocation was much smaller within a species than between species, providing a biological basis for explaining the functionally based species loss. All species increased biomass allocation to aboveground parts, but species with high belowground allocations were replaced by those with high aboveground allocations, indicating that the increased aboveground competition was the key process responsible for the observed diversity loss after N addition in this grassland ecosystem. Conclusions/Significance: Our findings shed new light on the validity of the three competing hypotheses concerning species loss in response to N enrichment. They also have important implications for predicting the future impacts of N deposition on the structure and functioning of terrestrial ecosystems. In addition, we have developed a new technique for ascertaining the roles of aboveground and belowground competition in determining plant responses to N fertilization.	[Pan, Qingmin; Bai, Yongfei; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil SUCCES, Hohhot, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University	Pan, QM (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	pqm@ibcas.ac.cn	Wu, Jianguo/G-6267-2010; Han, Xingguo/K-7552-2016	Wu, Jianguo/0000-0002-1182-3024; Han, Xingguo/0000-0002-1836-975X	State Key Basic Research Development Program of China [2007CB106803]; Natural Science Foundation of China [30170670]; National Science Foundation [DEB-0618193]	State Key Basic Research Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the State Key Basic Research Development Program of China (2007CB106803), Natural Science Foundation of China (30170670) and supported by National Science Foundation under grant no. DEB-0618193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; BAZZAZ FA, PLANT RESOURCE ALLOC; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Callaway JC, 2003, ECOL APPL, V13, P1626, DOI 10.1890/02-5144; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Fortunel C, 2009, PERSPECT PLANT ECOL, V11, P267, DOI 10.1016/j.ppees.2009.04.003; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; OLFF H, 1992, OECOLOGIA, V89, P412, DOI 10.1007/BF00317420; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Robinson D, 1988, FUNCT ECOL, V2, P249, DOI 10.2307/2389701; Rubio G, 1999, NEW PHYTOL, V143, P539, DOI 10.1046/j.1469-8137.1999.00482.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 1999, ECOLOGY, V80, P455, DOI 10.1890/0012-9658(1999)080[0455:PDDSRA]2.0.CO;2; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; SULTAN SE, 1987, EVOL BIOL, V21, P127; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; TILMAN D, 1988; Tilman David, 1993, P13; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x	36	27	39	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20078	10.1371/journal.pone.0020078	http://dx.doi.org/10.1371/journal.pone.0020078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625503	Green Published, gold			2022-12-27	WOS:000290771200047
J	Cigognini, D; Satta, A; Colleoni, B; Silva, D; Donega, M; Antonini, S; Gelain, F				Cigognini, Daniela; Satta, Alessandro; Colleoni, Bianca; Silva, Diego; Donega, Matteo; Antonini, Stefania; Gelain, Fabrizio			Evaluation of Early and Late Effects into the Acute Spinal Cord Injury of an Injectable Functionalized Self-Assembling Scaffold	PLOS ONE			English	Article							NEURAL STEM-CELLS; PEPTIDE NANOFIBER SCAFFOLD; MATRIX METALLOPROTEINASES; ADULT-RAT; AXONAL GROWTH; SCHWANN-CELLS; BRAIN-TISSUE; TRACT AXONS; REGENERATION; REPAIR	The complex physiopathological events occurring after spinal cord injury (SCI) make this devastating trauma still incurable. Self-assembling peptides (SAPs) are nanomaterials displaying some appealing properties for application in regenerative medicine because they mimic the structure of the extra-cellular matrix (ECM), are reabsorbable, allow biofunctionalizations and can be injected directly into the lesion. In this study we evaluated the putative neurorigenerative properties of RADA16-4G-BMHP1 SAP, proved to enhance in vitro neural stem cells survival and differentiation. This SAP (RADA16-I) has been functionalized with a bone marrow homing motif (BMHP1) and optimized via the insertion of a 4-glycine-spacer that ameliorates scaffold stability and exposure of the biomotifs. We injected the scaffold immediately after contusion in the rat spinal cord, then we evaluated the early effects by semi-quantitative RT-PCR and the late effects by histological analysis. Locomotor recovery over 8 weeks was assessed using Basso, Beattie, Bresnahan (BBB) test. Gene expression analysis showed that at 7 days after lesion the functionalized SAP induced a general upregulation of GAP-43, trophic factors and ECM remodelling proteins, whereas 3 days after SCI no remarkable changes were observed. Hystological analysis revealed that 8 weeks after SCI our scaffold increased cellular infiltration, basement membrane deposition and axon regeneration/sprouting within the cyst. Moreover the functionalized SAP showed to be compatible with the surrounding nervous tissue and to at least partially fill the cavities. Finally SAP injection resulted in a statistically significant improvement of both hindlimbs' motor performance and forelimbs-hindlimbs coordination. Altogether, these results indicate that RADA16-4G-BMHP1 induced favourable reparative processes, such as matrix remodelling, and provided a physical and trophic support to nervous tissue ingrowth. Thus this biomaterial, eventually combined with cells and growth factors, may constitute a promising biomimetic scaffold for regenerative applications in the injured central nervous system.	[Cigognini, Daniela; Satta, Alessandro; Colleoni, Bianca; Silva, Diego; Donega, Matteo; Antonini, Stefania; Gelain, Fabrizio] Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy; [Cigognini, Daniela; Silva, Diego; Antonini, Stefania; Gelain, Fabrizio] Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, Milan, Italy; [Gelain, Fabrizio] Casa Sollievo della Sofferenza Hosp, San Giovanni Rotondo, Italy	University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Casa Sollievo Della Sofferenza	Cigognini, D (corresponding author), Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy.	fabrizio.gelain@unimib.it	Gelain, Fabrizio G/K-5069-2012; Satta, Alessandro/Q-3504-2019	Gelain, Fabrizio G/0000-0002-2624-5853; Satta, Alessandro/0000-0002-3717-9337	CARIPLO Foundation; Regione Lombardia (Local Government)	CARIPLO Foundation(Fondazione Cariplo); Regione Lombardia (Local Government)(Regione Lombardia)	This work was supported by CARIPLO Foundation and Regione Lombardia (Local Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Arcaute K, 2010, ACTA BIOMATER, V6, P1047, DOI 10.1016/j.actbio.2009.08.017; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Fernandes KJL, 1999, J COMP NEUROL, V414, P495, DOI 10.1002/(SICI)1096-9861(19991129)414:4<495::AID-CNE6>3.0.CO;2-S; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3; Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; *ICCP, 2007, EXP TREATM SPIN CORD; JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018; King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lu HZ, 2009, ACTA NEUROBIOL EXP, V69, P441; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003; Andrade MSR, 2010, BRAIN RES, V1346, P266, DOI 10.1016/j.brainres.2010.05.070; Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009; Ringhoffer M, 2001, INT J ONCOL, V19, P983; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004; Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Sinescu Crina, 2010, J Med Life, V3, P254; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsiper MV, 2002, J CELL SCI, V115, P1005; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Yao L, 2010, J BIOMED MATER RES A, V92A, P484, DOI 10.1002/jbm.a.32359; Ye JL, 2004, BRAIN RES, V997, P30, DOI 10.1016/j.brainres.2003.10.036; Ye ZY, 2008, J PEPT SCI, V14, P152, DOI 10.1002/psc.988; Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	66	94	107	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19782	10.1371/journal.pone.0019782	http://dx.doi.org/10.1371/journal.pone.0019782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611127	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200032
J	Martins, AS; Ordonez, JL; Amaral, AT; Prins, F; Floris, G; Debiec-Rychter, M; Hogendoorn, PCW; de Alava, E				Sofia Martins, Ana; Luis Ordonez, Jose; Teresa Amaral, Ana; Prins, Frans; Floris, Giuseppe; Debiec-Rychter, Maria; Hogendoorn, Pancras C. W.; de Alava, Enrique			IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR-I; INSULIN-RECEPTOR SUBSTRATE-1; ADENOCARCINOMA A549 CELLS; MEDIATED ENDOCYTOSIS; INTERNALIZATION; PATHWAY; SENSITIVITY; MECHANISMS; EXPRESSION; CAVEOLAE	Receptor endocytosis is critical for cell signaling. IGF1R mediates an autocrine loop that is de-regulated in Ewing Sarcoma (ES) cells. Here we study the impact of IGF1R internalization, mediated by clathrin and caveolin-1 (CAV1), in ES signaling. We used clathrin and CAV1-siRNA to interfere in clathrin-and caveolin-dependent endocytosis. Chlorpromazine (CPMZ) and methyl-beta-cyclo-dextrin (MCD) were also used in order to inhibit clathrin-and caveolin-dependent endocytosis, respectively. We analyzed IGF1R internalization and co-localization with clathrin and CAV1 upon ligand binding, as well as the status of the IGF1R pathway, cellular proliferation, and the apoptosis of interfered and inhibited ES cells. We performed a high-throughput tyrosine kinase phosphorylation assay to analyze the effects of combining the IGF1R tyrosine kinase inhibitor AEW541 (AEW) with CPMZ or MCD on the intracellular phospho-proteome. We observed that IGF1R is internalized upon ligand binding in ES cells and that this process is dependent on clathrin or CAV1. The blockage of receptor internalization inhibited AKT and MAPK phosphorylation, reducing the proliferative rate of ES cells and increasing the levels of apoptosis. Combination of AEW with CPMZ or MCD largely enhanced these effects. CAV1 and clathrin endocytosis controls IGF1R internalization and signaling and has a profound impact on ES IGF1R-promoted survival signaling. We propose the combination of tyrosine-kinase inhibitors with endocytosis inhibitors as a new therapeutic approach to achieve a stronger degree of receptor inhibition in this, or other neoplasms dependent on IGF1R signaling.	[Sofia Martins, Ana; Luis Ordonez, Jose; Teresa Amaral, Ana; de Alava, Enrique] Univ Salamanca, Lab Mol Pathol 20, Sarcomas Lab, Ctr Invest Canc IBMCC,CSIC, E-37008 Salamanca, Spain; [Prins, Frans; Hogendoorn, Pancras C. W.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Floris, Giuseppe] Catholic Univ Louvain, Expt Oncol Lab, B-3000 Louvain, Belgium; [Debiec-Rychter, Maria] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite Catholique Louvain; Universite Catholique Louvain	Martins, AS (corresponding author), Univ Salamanca, Lab Mol Pathol 20, Sarcomas Lab, Ctr Invest Canc IBMCC,CSIC, E-37008 Salamanca, Spain.	edealava@usal.es	IBIS, SARCOMAS/O-1893-2015; de Alava, Enrique/GOH-0368-2022; Hogendoorn, Pancras/O-6494-2019; Ordóñez, José Luis/B-6069-2017; Hogendoorn, Pancras C.W./H-5859-2015; Floris, Giuseppe/AAG-6754-2022; Floris, Giuseppe/AFL-6620-2022	de Alava, Enrique/0000-0001-8400-046X; Hogendoorn, Pancras/0000-0002-1513-8104; Ordóñez, José Luis/0000-0002-3791-4215; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Floris, Giuseppe/0000-0003-2391-5425; Floris, Giuseppe/0000-0003-2391-5425; Amaral, Ana/0000-0001-7887-4814	EuroBoNet; European research network, European Commission [018814]; Instituto de Salud Carlos Tercero [PI081828]; ISCIII [CD6/00001]	EuroBoNet(European CommissionEuropean Commission Joint Research Centre); European research network, European Commission(European CommissionEuropean Commission Joint Research Centre); Instituto de Salud Carlos Tercero; ISCIII(Instituto de Salud Carlos III)	Funding provided by EuroBoNet, the European research network on bone tumors (FP6-2004-Lifescihealth-5, proposal number 018814)-European Commission and the Instituto de Salud Carlos Tercero, FIS- project PI081828. J.L. Ordonez is supported by the ISCIII (Contratos Perfeccionamiento CD6/00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carelli S, 2006, J CELL PHYSIOL, V208, P354, DOI 10.1002/jcp.20670; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chen J, 2008, J CELL PHYSIOL, V217, P281, DOI 10.1002/jcp.21498; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CHUANG LM, 1993, P NATL ACAD SCI USA, V90, P5172, DOI 10.1073/pnas.90.11.5172; Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dong AQ, 2008, ACTA BIOCH BIOPH SIN, V40, P497, DOI 10.1111/j.1745-7270.2008.00429.x; FURLANETTO RW, 1988, ENDOCRINOLOGY, V122, P2044, DOI 10.1210/endo-122-5-2044; Furukawa M, 2005, CLIN CANCER RES, V11, P3233, DOI 10.1158/1078-0432.CCR-04-1915; GIORGETTI S, 1994, EUR J BIOCHEM, V223, P195, DOI 10.1111/j.1432-1033.1994.tb18983.x; HSU D, 1994, ENDOCRINOLOGY, V134, P744, DOI 10.1210/en.134.2.744; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Ma ZY, 2007, CELL MOL BIOL LETT, V12, P556, DOI 10.2478/s11658-007-0022-1; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Martins AS, 2008, CANCER RES, V68, P6260, DOI 10.1158/0008-5472.CAN-07-3074; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Strammiello R, 2003, HORM METAB RES, V35, P675; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; VANDERVEN LTM, 1994, INT J CANCER, V59, P427, DOI 10.1002/ijc.2910590323; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yang JL, 2007, J SURG ONCOL, V95, P183, DOI 10.1002/jso.20636; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	37	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19846	10.1371/journal.pone.0019846	http://dx.doi.org/10.1371/journal.pone.0019846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611203	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500030
J	Xu, ZF; Yue, M; Zhou, R; Jin, Q; Fan, Y; Bei, WC; Chen, HC				Xu, Zhuofei; Yue, Min; Zhou, Rui; Jin, Qi; Fan, Yang; Bei, Weicheng; Chen, Huanchun			Genomic Characterization of Haemophilus parasuis SH0165, a Highly Virulent Strain of Serovar 5 Prevalent in China	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; ACTINOBACILLUS-PLEUROPNEUMONIAE; MOLECULAR CHARACTERIZATION; MANNHEIMIA-HAEMOLYTICA; IRON ACQUISITION; GENE-CLUSTER; DNA UPTAKE; IDENTIFICATION; SEQUENCE; EXPRESSION	Haemophilus parasuis can be either a commensal bacterium of the porcine respiratory tract or an opportunistic pathogen causing Glasser's disease, a severe systemic disease that has led to significant economical losses in the pig industry worldwide. We determined the complete genomic sequence of H. parasuis SH0165, a highly virulent strain of serovar 5, which was isolated from a hog pen in North China. The single circular chromosome was 2,269,156 base pairs in length and contained 2,031 protein-coding genes. Together with the full spectrum of genes detected by the analysis of metabolic pathways, we confirmed that H. parasuis generates ATP via both fermentation and respiration, and possesses an intact TCA cycle for anabolism. In addition to possessing the complete pathway essential for the biosynthesis of heme, this pathogen was also found to be well-equipped with different iron acquisition systems, such as the TonB system and ABC-type transport complexes, to overcome iron limitation during infection and persistence. We identified a number of genes encoding potential virulence factors, such as type IV fimbriae and surface polysaccharides. Analysis of the genome confirmed that H. parasuis is naturally competent, as genes related to DNA uptake are present. A nine-mer DNA uptake signal sequence (ACAAGCGGT), identical to that found in Actinobacillus pleuropneumoniae and Mannheimia haemolytica, followed by similar downstream motifs, was identified in the SH0165 genome. Genomic and phylogenetic comparisons with other Pasteurellaceae species further indicated that H. parasuis was closely related to another swine pathogenic bacteria A. pleuropneumoniae. The comprehensive genetic analysis presented here provides a foundation for future research on the metabolism, natural competence and virulence of H. parasuis.	[Xu, Zhuofei; Yue, Min; Zhou, Rui; Bei, Weicheng; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Jin, Qi; Fan, Yang] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China	Huazhong Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Xu, ZF (corresponding author), Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	beiwc@mail.hzau.edu.cn; chenhch@mail.hzau.edu.cn	Yue, Min/H-2760-2019	Yue, Min/0000-0002-6787-0794	National Natural Science Foundation of China [30901075, 30970109]; National Programs for High Technology Research [2010AA10A202]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Programs for High Technology Research; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (30901075, 30970109), National Programs for High Technology Research (No. 2010AA10A202) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amano H, 1997, J VET MED SCI, V59, P451, DOI 10.1292/jvms.59.451; Banks KE, 2008, J INFECT DIS, V197, P1531, DOI 10.1086/588001; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BIBERSTEIN EL, 1969, J MED MICROBIOL, V2, P75, DOI 10.1099/00222615-2-1-75; Bigas A, 2005, VET MICROBIOL, V105, P223, DOI 10.1016/j.vetmic.2004.10.015; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bozue JA, 1999, J BIOL CHEM, V274, P4106, DOI 10.1074/jbc.274.7.4106; Brondijk THC, 2002, MOL MICROBIOL, V44, P245, DOI 10.1046/j.1365-2958.2002.02875.x; Buettner FFR, 2008, INFECT IMMUN, V76, P2284, DOI 10.1128/IAI.01540-07; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Challacombe JF, 2007, J BACTERIOL, V189, P1890, DOI 10.1128/JB.01422-06; CHARLAND N, 1995, CAN J MICROBIOL, V41, P70, DOI 10.1139/m95-009; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Del Rio ML, 2006, VET RES, V37, P49, DOI 10.1051/vetres:2005039; del Rio ML, 2005, FEMS IMMUNOL MED MIC, V45, P75, DOI 10.1016/j.femsim.2005.02.008; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erbel PJA, 2003, J BACTERIOL, V185, P1995, DOI 10.1128/JB.185.6.1995-2004.2003; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FINK DL, 2006, PROKARYOTES, V6, P1034; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frase H, 2007, BIOCHEMISTRY-US, V46, P6647, DOI 10.1021/bi7002789; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; GRAYOWEN SD, 1995, INFECT IMMUN, V63, P1201, DOI 10.1128/IAI.63.4.1201-1210.1995; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jahreis K, 2002, J BACTERIOL, V184, P5307, DOI 10.1128/JB.184.19.5307-5316.2002; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lagergard Teresa, 1995, Trends in Microbiology, V3, P87, DOI 10.1016/S0966-842X(00)88888-5; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lichtensteiger CA, 2003, VET MICROBIOL, V93, P79, DOI 10.1016/S0378-1135(02)00443-1; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; MUNCH S, 1992, J VET MED B, V39, P59, DOI 10.1111/j.1439-0450.1992.tb01138.x; Nedbalcova K, 2006, VET MED-CZECH, V51, P168, DOI 10.17221/5537-VETMED; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Oliveira S, 2003, AM J VET RES, V64, P435, DOI 10.2460/ajvr.2003.64.435; Olvera A, 2006, APPL ENVIRON MICROB, V72, P3984, DOI 10.1128/AEM.02834-05; Olvera A, 2010, VET RES, V41, DOI 10.1051/vetres/2009074; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pina S, 2009, J BACTERIOL, V191, P576, DOI 10.1128/JB.00703-08; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; REID G, 1987, REV INFECT DIS, V9, P470; Rhodes ER, 2005, INFECT IMMUN, V73, P3758, DOI 10.1128/IAI.73.6.3758-3763.2005; Roehrig SC, 2007, VET MICROBIOL, V121, P316, DOI 10.1016/j.vetmic.2006.12.013; Ruiz A, 2001, J CLIN MICROBIOL, V39, P1757, DOI 10.1128/JCM.39.5.1757-1762.2001; Sack M, 2009, VET MICROBIOL, V136, P382, DOI 10.1016/j.vetmic.2008.11.008; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; SIDIBE M, 1993, CAN J VET RES, V57, P204; Stevenson A, 2003, VET MICROBIOL, V92, P121, DOI 10.1016/S0378-1135(02)00351-6; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tullius MV, 1996, J BIOL CHEM, V271, P15373, DOI 10.1074/jbc.271.26.15373; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Watson AA, 1996, GENE, V180, P49, DOI 10.1016/S0378-1119(96)00403-9; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08; Zhou HZ, 2010, VET MICROBIOL, V144, P377, DOI 10.1016/j.vetmic.2010.01.023; Zucker BA, 1996, AM J VET RES, V57, P63	85	39	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19631	10.1371/journal.pone.0019631	http://dx.doi.org/10.1371/journal.pone.0019631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611187	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500009
J	Codoner, FM; Pou, C; Thielen, A; Garcia, F; Delgado, R; Dalmau, D; Alvarez-Tejado, M; Ruiz, L; Clotet, B; Paredes, R				Codoner, Francisco M.; Pou, Christian; Thielen, Alexander; Garcia, Federico; Delgado, Rafael; Dalmau, David; Alvarez-Tejado, Miguel; Ruiz, Lidia; Clotet, Bonaventura; Paredes, Roger			Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects	PLOS ONE			English	Article							RESISTANT VIRAL VARIANTS; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; TREATMENT-NAIVE; VIROLOGICAL RESPONSES; MINORITY VARIANTS; HIV-1; PROTEASE; TRANSMISSION; MUTATIONS	Objective: To explore the potential of deep HIV-1 sequencing for adding clinically relevant information relative to viral population sequencing in heavily pre-treated HIV-1-infected subjects. Methods: In a proof-of-concept study, deep sequencing was compared to population sequencing in HIV-1-infected individuals with previous triple-class virological failure who also developed virologic failure to deep salvage therapy including, at least, darunavir, tipranavir, etravirine or raltegravir. Viral susceptibility was inferred before salvage therapy initiation and at virological failure using deep and population sequencing genotypes interpreted with the HIVdb, Rega and ANRS algorithms. The threshold level for mutant detection with deep sequencing was 1%. Results: 7 subjects with previous exposure to a median of 15 antiretrovirals during a median of 13 years were included. Deep salvage therapy included darunavir, tipranavir, etravirine or raltegravir in 4, 2, 2 and 5 subjects, respectively. Self-reported treatment adherence was adequate in 4 and partial in 2; one individual underwent treatment interruption during follow-up. Deep sequencing detected all mutations found by population sequencing and identified additional resistance mutations in all but one individual, predominantly after virological failure to deep salvage therapy. Additional genotypic information led to consistent decreases in predicted susceptibility to etravirine, efavirenz, nucleoside reverse transcriptase inhibitors and indinavir in 2, 1, 2 and 1 subject, respectively. Deep sequencing data did not consistently modify the susceptibility predictions achieved with population sequencing for darunavir, tipranavir or raltegravir. Conclusions: In this subset of heavily pre-treated individuals, deep sequencing improved the assessment of genotypic resistance to etravirine, but did not consistently provide additional information on darunavir, tipranavir or raltegravir susceptibility. These data may inform the design of future studies addressing the clinical value of minority drug-resistant variants in treatment-experienced subjects.	[Codoner, Francisco M.; Pou, Christian; Ruiz, Lidia; Clotet, Bonaventura; Paredes, Roger] SIDA irsiCaixa HIVACAT, Inst Recerca, Badalona, Spain; [Clotet, Bonaventura; Paredes, Roger] Hosp Badalona Germans Trias & Pujol, Unitat VIH, Badalona, Spain; [Thielen, Alexander] Max Planck Inst Informat, Saarbrucken, Germany; [Garcia, Federico] Hosp San Cecilio, Granada, Spain; [Delgado, Rafael] Hosp 12 Octubre, E-28041 Madrid, Spain; [Dalmau, David] Hosp Univ Mutua Terrassa, Terrassa, Spain; [Alvarez-Tejado, Miguel] Roche Diagnost SL, Sant Cugat Del Valles, Spain	Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Max Planck Society; Hospital Universitario San Cecilio; Hospital Universitario 12 de Octubre; Hospital Universitario Mutua Terrassa; Roche Holding	Codoner, FM (corresponding author), Lifesequencing SL, Valencia, Spain.	fcodoner@gmail.com; rparedes@irsicaixa.es	Ruiz, Lidia/ABF-9720-2021; Delgado, Rafael/C-4910-2016; Pou, Christian/B-2932-2015; Garcia, Federico/AAA-3175-2020; DELGADO, RAFAEL/A-2938-2012	Delgado, Rafael/0000-0002-6912-4736; Pou, Christian/0000-0003-3932-788X; Garcia, Federico/0000-0001-7611-781X; 	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Science and Innovation [IDI-20080843]; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, European Commission [223131]; Marie Curie European Reintegration Grant [238885]; European Commission; Abbott; BMS; Gilead; Roche; Pfizer; Siemens; Merck; Boehringer Ingelheim	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie European Reintegration Grant(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Roche(Roche Holding); Pfizer(Pfizer); Siemens(Siemens AG); Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim)	This study was supported by the CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Science and Innovation (IDI-20080843) and 'CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network', Integrated Project no. 223131, funded by the European Commission Framework 7 Program. FMC was supported by Marie Curie European Reintegration Grant number 238885, 'HIV Coevolution', funded by the European Commission Framework 7 Program. Miguel Alvarez-Tejado works for Roche Diagnostics, S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; F. Garcia has been a consultant on advisory boards, or has participated in speakers' bureaus, with Roche, Boehringer-Ingelheim, BMS, GSK, Gilead, Janssen, Merck and Pfizer. R. Delgado has received consulting fees and grant support from Abbott, BMS, Gilead and Roche. D. Dalmau has been a consultant on advisory boards, has participated in speakers' bureaus, or has conducted clinical trials with Roche, Boehringer-Ingelheim, Abbott, BMS, GSK, Gilead, Tibotec, Janssen, Merck and Pfizer. M. Alvarez-Tejado works for Roche Diagnostics S.L., Spain, which commercializes the 454 sequencing technology in Spain. B. Clotet has been a consultant on advisory boards, has participated in speakers' bureaus, or has conducted clinical trials with Roche, Boehringer-Ingelheim, Abbott, BMS, GSK, Gilead, Tibotec, Janssen, Merck, Pfizer, Siemens, Monogram Biosciences, and Panacos. R. Paredes has received consulting fees from Pfizer and grant support from Pfizer, Siemens, Merck and Boehringer Ingelheim. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. F.M. Codoner, C. Pou, A. Thielen, and L. Ruiz report no conflicts of interest relevant to this article. No other potential conflict of interest relevant to this article was reported.	Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; D'Aquila RT, 2011, AIDS RES HUM RETROV, V27, P201, DOI 10.1089/aid.2010.0077; de Meyer S, 2008, AIDS RES HUM RETROV, V24, P379, DOI 10.1089/aid.2007.0173; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Marcelin AG, 2008, ANTIMICROB AGENTS CH, V52, P3237, DOI 10.1128/AAC.00133-08; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Pellegrin I, 2006, ANTIVIR THER, V11, P421; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Rhee SY, 2005, J INFECT DIS, V192, P456, DOI 10.1086/431601; Shao W, 2009, ANTIVIR THER, V14, pA123; Shikuma CM, 2007, JAIDS-J ACQ IMM DEF, V44, P540, DOI 10.1097/QAI.0b013e318031d5a0; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Toni TA, 2009, ANTIMICROB AGENTS CH, V53, P1670, DOI 10.1128/AAC.01494-08; Van Laethem K, 2009, ALGORITHM USE GENOTY; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Yates PJ, 2006, ANTIMICROB AGENTS CH, V50, P1092, DOI 10.1128/AAC.50.3.1092-1095.2006	25	41	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19461	10.1371/journal.pone.0019461	http://dx.doi.org/10.1371/journal.pone.0019461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602929	gold, Green Submitted, Green Published			2022-12-27	WOS:000290558500011
J	Galian, C; Manon, F; Dezi, M; Torres, C; Ebel, C; Levy, D; Jault, JM				Galian, Carmen; Manon, Florence; Dezi, Manuela; Torres, Cristina; Ebel, Christine; Levy, Daniel; Jault, Jean-Michel			Optimized Purification of a Heterodimeric ABC Transporter in a Highly Stable Form Amenable to 2-D Crystallization	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ANTIGEN-PROCESSING TAP; BINDING CASSETTE TRANSPORTER; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MULTIDRUG-RESISTANCE PROTEIN-1; ATP-BINDING; MEMBRANE-PROTEINS; P-GLYCOPROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI	Optimized protocols for achieving high-yield expression, purification and reconstitution of membrane proteins are required to study their structure and function. We previously reported high-level expression in Escherichia coli of active BmrC and BmrD proteins from Bacillus subtilis, previously named YheI and YheH. These proteins are half-transporters which belong to the ABC (ATP-Binding Cassette) superfamily and associate in vivo to form a functional transporter able to efflux drugs. In this report, high-yield purification and functional reconstitution were achieved for the heterodimer BmrC/BmrD. In contrast to other detergents more efficient for solubilizing the transporter, dodecyl-beta-D-maltoside (DDM) maintained it in a drug-sensitive and vanadate-sensitive ATPase-competent state after purification by affinity chromatography. High amounts of pure proteins were obtained which were shown either by analytical ultracentrifugation or gel filtration to form a monodisperse heterodimer in solution, which was notably stable for more than one month at 4 degrees C. Functional reconstitution using different lipid compositions induced an 8-fold increase of the ATPase activity (k(cat)similar to 5 s(-1)). We further validated that the quality of the purified BmrC/BmrD heterodimer is suitable for structural analyses, as its reconstitution at high protein densities led to the formation of 2-D crystals. Electron microscopy of negatively stained crystals allowed the calculation of a projection map at 20 angstrom resolution revealing that BmrC/BmrD might assemble into oligomers in a lipidic environment.	[Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] CNRS, UMR 5075, Grenoble, France; [Galian, Carmen; Manon, Florence; Torres, Cristina; Ebel, Christine; Jault, Jean-Michel] CEA, Grenoble, France; [Dezi, Manuela; Levy, Daniel] Inst Curie, Ctr Rech, Paris, France; [Dezi, Manuela; Levy, Daniel] CNRS, UMR 168, Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Galian, C (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden.	jean-michel.jault@ibs.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Dezi, Manuela/0000-0001-8727-9910; levy, daniel/0000-0002-8949-4072; Ebel, Christine/0000-0002-6912-500X	Agence Nationale de la Recherche [ANR-06-Blan-0420, ANR-PCV06-135269]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the 'Agence Nationale de la Recherche', grant No: ANR-06-Blan-0420 (to D.L. & J.-M.J.) and ANR-PCV06-135269 (to J.-M.J.), and initial funding from the CNRS as an ATIP program to J.-M.J. is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bourdineaud JP, 2004, INT J FOOD MICROBIOL, V92, P1, DOI 10.1016/S0168-1605(03)00162-4; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dalmas O, 2005, BIOCHEMISTRY-US, V44, P4312, DOI 10.1021/bi0482809; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Ferreira-Pereira A, 2003, J BIOL CHEM, V278, P11995, DOI 10.1074/jbc.M212198200; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lee EW, 2003, ANTIMICROB AGENTS CH, V47, P3733, DOI 10.1128/AAC.47.12.3733-3738.2003; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Margolles A, 2006, MICROBIOL-SGM, V152, P3497, DOI 10.1099/mic.0.29097-0; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Newby ZER, 2009, NAT PROTOC, V4, P619, DOI 10.1038/nprot.2009.27; Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Robertson GT, 2005, ANTIMICROB AGENTS CH, V49, P4781, DOI 10.1128/AAC.49.11.4781-4783.2005; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Salvay AG, 2006, PROG COLL POL SCI S, V131, P74, DOI 10.1007/2882_006; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Uebel S, 1997, FEBS LETT, V416, P359, DOI 10.1016/S0014-5793(97)01222-2; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Wang J, 2008, BIOCHEMISTRY-US, V47, P5194, DOI 10.1021/bi800292v; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward A, 2009, J STRUCT BIOL, V165, P169, DOI 10.1016/j.jsb.2008.11.006; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	84	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19677	10.1371/journal.pone.0019677	http://dx.doi.org/10.1371/journal.pone.0019677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602923	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500020
J	Li, L; Xiao, XS; Li, SQ; Jia, XY; Wang, PF; Guo, XM; Jiao, XD; Zhang, QJ; Hejtmancik, JF				Li, Lin; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Wang, Panfeng; Guo, Xiangming; Jiao, Xiaodong; Zhang, Qingjiong; Hejtmancik, J. Fielding			Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis	PLOS ONE			English	Article							GENOTYPING MICROARRAY; RETINITIS-PIGMENTOSA; RETINAL DYSTROPHIES; MOLECULAR-GENETICS; MISSENSE MUTATIONS; ALLELES; SPECTRUM; PROTEIN; CRX	Background: Leber congenital amaurosis (LCA) is the earliest onset and most severe form of hereditary retinal dystrophy. So far, full spectrum of variations in the 15 genes known to cause LCA has not been systemically evaluated in East Asians. Therefore, we performed comprehensive detection of variants in these 15 genes in 87 unrelated Han Chinese patients with LCA. Methodology/Principal Findings: The 51 most frequently mutated exons and introns in the 15 genes were selected for an initial scan using cycle sequencing. All the remaining exons in 11 of the 15 genes were subsequently sequenced. Fifty-three different variants were identified in 44 of the 87 patients (50.6%), involving 78 of the 88 alleles (11 homozygous and 56 heterozygous variants). Of the 53 variants, 35 (66%) were novel pathogenic mutations. In these Chinese patients, variants in GUCY2D are the most common cause of LCA (16.1% cases), followed by CRB1 (11.5%), RPGRIP1 (8%), RPE65 (5.7%), SPATA7 (4.6%), CEP290 (4.6%), CRX (3.4%), LCA5 (2.3%), MERTK (2.3%), AIPL1 (1.1%), and RDH12 (1.1%). This differs from the variation spectrum described in other populations. An initial scan of 55 of 215 PCR amplicons, including 214 exons and 1 intron, detected 83.3% (65/78) of the mutant alleles ultimately found in these 87 patients. In addition, sequencing only 9 exons would detect over 50% of the identified variants and require less than 5% of the labor and cost of comprehensive sequencing for all exons. Conclusions/Significance: Our results suggest that specific difference in the variation spectrum found in LCA patients from the Han Chinese and other populations are related by ethnicity. Sequencing exons in order of decreasing risk is a cost-effective way to identify causative mutations responsible for LCA, especially in the context of genetic counseling for individual patients in a clinical setting.	[Li, Lin; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Wang, Panfeng; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Lin; Jiao, Xiaodong; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Li, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	qingjiongzhang@yahoo.com	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Science Fund for Distinguished Young Scholars [30725044]; National 973 Plan of China [2010CB529904]; NATIONAL EYE INSTITUTE [ZIAEY000272] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National 973 Plan of China(National Basic Research Program of China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Science Fund for Distinguished Young Scholars (30725044, http://www.nsfc.gov.cn/Portal0/default124.htm) and National 973 Plan of China (2010CB529904, http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Cremers FPM, 2002, HUM MOL GENET, V11, P1169, DOI 10.1093/hmg/11.10.1169; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Leber T., 1869, ALBRECHT GRAEFES ARC, V15, P1, DOI [DOI 10.1007/BF02721213, 10.1007/BF02721213]; Li YM, 2009, INVEST OPHTH VIS SCI, V50, P1336, DOI 10.1167/iovs.08-2589; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 2004, AM J HUM GENET, V75, P639, DOI 10.1086/424889; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Rozet JM, 2000, INVEST OPHTH VIS SCI, V41, pS533; Seong MW, 2008, MOL VIS, V14, P1429; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Sundaresan P, 2009, MOL VIS, V15, P1781; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; Wang PF, 2007, GRAEF ARCH CLIN EXP, V245, P1401, DOI 10.1007/s00417-007-0554-0; Yoshida S, 2006, MOL VIS, V12, P1558; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111; Zhang Q, 2001, Ophthalmic Genet, V22, P89, DOI 10.1076/opge.22.2.89.2227	36	78	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19458	10.1371/journal.pone.0019458	http://dx.doi.org/10.1371/journal.pone.0019458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602930	Green Published, gold, Green Submitted			2022-12-27	WOS:000290558500010
J	Valenzuela, MS; Chen, YD; Davis, S; Yang, F; Walker, RL; Bilke, S; Lueders, J; Martin, MM; Aladjem, MI; Massion, PP; Meltzer, PS				Valenzuela, Manuel S.; Chen, Yidong; Davis, Sean; Yang, Fan; Walker, Robert L.; Bilke, Sven; Lueders, John; Martin, Melvenia M.; Aladjem, Mirit I.; Massion, Pierre P.; Meltzer, Paul S.			Preferential Localization of Human Origins of DNA Replication at the 5 '-Ends of Expressed Genes and at Evolutionarily Conserved DNA Sequences	PLOS ONE			English	Article							HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; INITIATION; GENOME; SITES; CHROMATIN; ELEMENTS; IDENTIFICATION; ORGANIZATION; METAZOANS	Background: Replication of mammalian genomes requires the activation of thousands of origins which are both spatially and temporally regulated by as yet unknown mechanisms. At the most fundamental level, our knowledge about the distribution pattern of origins in each of the chromosomes, among different cell types, and whether the physiological state of the cells alters this distribution is at present very limited. Methodology/Principal Findings: We have used standard lambda-exonuclease resistant nascent DNA preparations in the size range of 0.7-1.5 kb obtained from the breast cancer cell line MCF-7 hybridized to a custom tiling array containing 50-60 nt probes evenly distributed among genic and non-genic regions covering about 1% of the human genome. A similar DNA preparation was used for high-throughput DNA sequencing. Array experiments were also performed with DNA obtained from BT-474 and H520 cell lines. By determining the sites showing nascent DNA enrichment, we have localized several thousand origins of DNA replication. Our major findings are: (a) both array and DNA sequencing assay methods produced essentially the same origin distribution profile; (b) origin distribution is largely conserved (> 70%) in all cell lines tested; (c) origins are enriched at the 5' ends of expressed genes and at evolutionarily conserved intergenic sequences; and (d) ChIP on chip experiments in MCF-7 showed an enrichment of H3K4Me3 and RNA Polymerase II chromatin binding sites at origins of DNA replication. Conclusions/Significance: Our results suggest that the program for origin activation is largely conserved among different cell types. Also, our work supports recent studies connecting transcription initiation with replication, and in addition suggests that evolutionarily conserved intergenic sequences have the potential to participate in origin selection. Overall, our observations suggest that replication origin selection is a stochastic process significantly dependent upon local accessibility to replication factors.	[Valenzuela, Manuel S.; Chen, Yidong; Davis, Sean; Yang, Fan; Walker, Robert L.; Bilke, Sven; Lueders, John; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Valenzuela, Manuel S.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Martin, Melvenia M.; Aladjem, Mirit I.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Massion, Pierre P.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Meharry Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Valenzuela, MS (corresponding author), NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mvalenzuela@mmc.edu; pmeltzer@mail.nih.gov	Davis, Sean/AAD-1801-2021; Aladjem, Mirit/G-2169-2010	Davis, Sean/0000-0002-8991-6458; Aladjem, Mirit/0000-0002-1875-3110; Walker, Robert/0000-0001-8235-4686	NIH [CA138180, CA102353]; NATIONAL CANCER INSTITUTE [ZIABC011091, SC1CA138180, R01CA102353, ZIABC010411] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by NIH intramural funding and by NIH grants [CA138180 to MSV, and CA102353 to PPM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; DePamphilis ML, 1997, METHODS, V13, P211, DOI 10.1006/meth.1997.0521; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; DOBBS DL, 1994, NUCLEIC ACIDS RES, V22, P2479, DOI 10.1093/nar/22.13.2479; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gerbi SA, 1997, METHODS, V13, P271, DOI 10.1006/meth.1997.0526; Gomez M, 2008, GENE DEV, V22, P375, DOI 10.1101/gad.445608; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hamlin JL, 2008, J CELL BIOCHEM, V105, P321, DOI 10.1002/jcb.21828; Hu L, 2004, BIOCHEM BIOPH RES CO, V320, P648, DOI 10.1016/j.bbrc.2004.06.018; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kornberg A., 1992, DNA REPLICATION; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Price GB, 2003, J BIOL CHEM, V278, P19649, DOI 10.1074/jbc.M207002200; Rhind N, 2010, CHROMOSOME RES, V18, P35, DOI 10.1007/s10577-009-9093-3; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; TODOROVIC V, 1999, FRONT BIOSCI, V4, P859; VALENZUELA MS, 1990, MOL GEN GENET, V220, P361, DOI 10.1007/BF00391739; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276	35	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e17308	10.1371/journal.pone.0017308	http://dx.doi.org/10.1371/journal.pone.0017308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602917	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500001
J	Ferreira, RBR; Gill, N; Willing, BP; Antunes, LCM; Russell, SL; Croxen, MA; Finlay, BB				Ferreira, Rosana B. R.; Gill, Navkiran; Willing, Benjamin P.; Antunes, L. Caetano M.; Russell, Shannon L.; Croxen, Matthew A.; Finlay, B. Brett			The Intestinal Microbiota Plays a Role in Salmonella-Induced Colitis Independent of Pathogen Colonization	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; 16S RIBOSOMAL-RNA; CROHNS-DISEASE; GUT MICROBIOTA; DOUBLE-BLIND; TYPHIMURIUM INFECTION; CANDIDA-ALBICANS; GENETIC-CONTROL; MICE; METRONIDAZOLE	The intestinal microbiota is composed of hundreds of species of bacteria, fungi and protozoa and is critical for numerous biological processes, such as nutrient acquisition, vitamin production, and colonization resistance against bacterial pathogens. We studied the role of the intestinal microbiota on host resistance to Salmonella enterica serovar Typhimurium-induced colitis. Using multiple antibiotic treatments in 129S1/SvImJ mice, we showed that disruption of the intestinal microbiota alters host susceptibility to infection. Although all antibiotic treatments caused similar increases in pathogen colonization, the development of enterocolitis was seen only when streptomycin or vancomycin was used; no significant pathology was observed with the use of metronidazole. Interestingly, metronidazole-treated and infected C57BL/6 mice developed severe pathology. We hypothesized that the intestinal microbiota confers resistance to infectious colitis without affecting the ability of S. Typhimurium to colonize the intestine. Indeed, different antibiotic treatments caused distinct shifts in the intestinal microbiota prior to infection. Through fluorescence in situ hybridization, terminal restriction fragment length polymorphism, and real-time PCR, we showed that there is a strong correlation between the intestinal microbiota composition before infection and susceptibility to Salmonella-induced colitis. Members of the Bacteroidetes phylum were present at significantly higher levels in mice resistant to colitis. Further analysis revealed that Porphyromonadaceae levels were also increased in these mice. Conversely, there was a positive correlation between the abundance of Lactobacillus sp. and predisposition to colitis. Our data suggests that different members of the microbiota might be associated with S. Typhimurium colonization and colitis. Dissecting the mechanisms involved in resistance to infection and inflammation will be critical for the development of therapeutic and preventative measures against enteric pathogens.	[Ferreira, Rosana B. R.; Gill, Navkiran; Willing, Benjamin P.; Antunes, L. Caetano M.; Russell, Shannon L.; Croxen, Matthew A.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Russell, Shannon L.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Ferreira, RBR (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca	Martha Antunes, Luis Caetano/B-6864-2012; Willing, Benjamin/AAA-9650-2019; Ferreira, Rosana BR/A-3682-2019; Ferreira, Rosana/E-5169-2013; Antunes, Luis Caetano Martha/P-4988-2019	Martha Antunes, Luis Caetano/0000-0002-4933-2570; Ferreira, Rosana BR/0000-0002-7162-0026; Croxen, Matthew/0000-0002-9564-7952	Canadian Institutes of Health Research (CIHR); Canadian Crohn's and Colitis Foundation; Michael Smith Foundation for Heath Research; Michael Smith Foundation; National Science and Engineering Research Council (NSERC); Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Crohn's and Colitis Foundation; Michael Smith Foundation for Heath Research(Michael Smith Foundation for Health Research); Michael Smith Foundation(Michael Smith Foundation for Health Research); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Crohn's and Colitis Foundation. R. B. R. Ferreira, N. Gill and L. C. M. Antunes are supported by postdoctoral fellowships from the CIHR. N. Gill is also supported by the Michael Smith Foundation for Heath Research. S. Russell is supported by a junior graduate studentship from the Michael Smith Foundation and a Canada Graduate Scholarship (CGS) from the National Science and Engineering Research Council (NSERC). M. A. Croxen is supported by a Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals postdoctoral fellowship. B. B. Finlay is the University of British Columbia Peter Wall Distinguished Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMBROSE NS, 1985, DIS COLON RECTUM, V28, P81, DOI 10.1007/BF02552649; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Begon M., 1996, ECOLOGY; BLICHFELDT P, 1978, SCAND J GASTROENTERO, V13, P123, DOI 10.3109/00365527809179816; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Damaskos D, 2008, BRIT J CLIN PHARMACO, V65, P453, DOI 10.1111/j.1365-2125.2008.03096.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gionchetti P, 2006, WORLD J GASTROENTERO, V12, P3306, DOI 10.3748/wjg.v12.i21.3306; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kibe R, 2007, MICROBIOL IMMUNOL, V51, P349, DOI 10.1111/j.1348-0421.2007.tb03916.x; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marteau P, 2006, GUT, V55, P842, DOI 10.1136/gut.2005.076604; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Pelissier MA, 2010, FEMS MICROBIOL ECOL, V73, P601, DOI 10.1111/j.1574-6941.2010.00916.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Petersen A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-245; Prantera C, 2002, GUT, V51, P405, DOI 10.1136/gut.51.3.405; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; URSING B, 1982, GASTROENTEROLOGY, V83, P550; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	45	113	119	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20338	10.1371/journal.pone.0020338	http://dx.doi.org/10.1371/journal.pone.0020338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633507	gold, Green Submitted, Green Published			2022-12-27	WOS:000291006500058
J	Dyce, PW; Liu, JH; Tayade, C; Kidder, GM; Betts, DH; Li, JL				Dyce, Paul W.; Liu, Jinghe; Tayade, Chandrakant; Kidder, Gerald M.; Betts, Dean H.; Li, Julang			In Vitro and In Vivo Germ Line Potential of Stem Cells Derived from Newborn Mouse Skin	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; GENE-EXPRESSION; PORCINE SKIN; OVARIAN STRUCTURES; FIG-ALPHA; DIFFERENTIATION; MEIOSIS; MICE; POPULATION; FOLLICLES	We previously reported that fetal porcine skin-derived stem cells were capable of differentiation into oocyte-like cells (OLCs). Here we report that newborn mice skin-derived stem cells are also capable of differentiating into early OLCs. Using stem cells from mice that are transgenic for Oct4 germline distal enhancer-GFP, germ cells resulting from their differentiation are expected to be GFP(+). After differentiation, some GFP(+) OLCs reached 40-45 mu M and expressed oocyte markers. Flow cytometric analysis revealed that similar to 0.3% of the freshly isolated skin cells were GFP(+). The GFP-positive cells increased to similar to 7% after differentiation, suggesting that the GFP(+) cells could be of in vivo origin, but are more likely induced upon being cultured in vitro. To study the in vivo germ cell potential of skin-derived cells, they were aggregated with newborn ovarian cells, and transplanted under the kidney capsule of ovariectomized mice. GFP(+) oocytes were identified within a subpopulation of follicles in the resulting growth. Our finding that early oocytes can be differentiated from mice skin-derived cells in defined medium may offer a new in vitro model to study germ cell formation and oogenesis.	[Dyce, Paul W.; Liu, Jinghe; Li, Julang] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Dyce, Paul W.; Kidder, Gerald M.; Betts, Dean H.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada; [Dyce, Paul W.; Kidder, Gerald M.; Betts, Dean H.] Childrens Hlth Res Inst, London, ON, Canada; [Tayade, Chandrakant] Queens Univ, Dept Anat & Cell Biol, Kingston, ON, Canada	University of Guelph; Western University (University of Western Ontario); Queens University - Canada	Dyce, PW (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	jli@uoguelph.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142; Dyce, Paul/0000-0002-4574-3321	Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes for Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC), and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA). Paul W. Dyce was supported by a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and subsequently by a Postdoctoral Fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL M, 2009, J MOL ENDOCRINOL; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Epifano O, 2002, TRENDS ENDOCRIN MET, V13, P169, DOI 10.1016/S1043-2760(02)00576-3; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Guo W, 2009, CELL PROLIFERAT, V42, P49, DOI 10.1111/j.1365-2184.2008.00573.x; HEYTING C, 1988, CHROMOSOMA, V96, P325, DOI 10.1007/BF00286921; Klink A, 1997, MAMM GENOME, V8, P376, DOI 10.1007/s003359900638; KROEZE KL, 2009, J INVEST DERMATOL; KUES WA, 2004, BIOL REPROD; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Liang LF, 1997, DEVELOPMENT, V124, P4939; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Molyneaux KA, 2004, GENE EXPR PATTERNS, V4, P167, DOI 10.1016/j.modgep.2003.09.002; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pesce M, 1996, Int J Dev Biol, VSuppl 1, p229S; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Ratajczak MZ, 2007, LEUKEMIA, V21, P860, DOI 10.1038/sj.leu.2404630; Ratajczak MZ, 2008, J AUTOIMMUN, V30, P151, DOI 10.1016/j.jaut.2007.12.003; Redvers RP, 2006, P NATL ACAD SCI USA, V103, P13168, DOI 10.1073/pnas.0602579103; Sato S, 1995, DNA Res, V2, P89, DOI 10.1093/dnares/2.2.89; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Weinbauer GF, 1997, ADV EXP MED BIOL, V424, P51; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	44	59	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20339	10.1371/journal.pone.0020339	http://dx.doi.org/10.1371/journal.pone.0020339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629667	Green Published, gold			2022-12-27	WOS:000291005800043
J	Ding, Y; Zou, J; Li, ZL; Tian, JJ; Abdelalim, S; Du, F; She, RP; Wang, DS; Tan, C; Wang, HJ; Chen, WJ; Lv, DQ; Chang, LL				Ding, Ye; Zou, Jun; Li, Zhili; Tian, Jijing; Abdelalim, Saed; Du, Fang; She, Ruiping; Wang, Desheng; Tan, Cheng; Wang, Huijuan; Chen, Wenjuan; Lv, Dongqiang; Chang, Lingling			Study of Histopathological and Molecular Changes of Rat Kidney under Simulated Weightlessness and Resistance Training Protective Effect	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; HINDLIMB SUSPENSION; OXIDATIVE STRESS; PROTEIN-METABOLISM; SKELETAL RESPONSE; INDUCED APOPTOSIS; CYTOSOLIC CA2+; RENAL-FUNCTION; MODEL	To explore the effects of long-term weightlessness on the renal tissue, we used the two months tail suspension model to simulate microgravity and investigated the simulated microgravity on the renal morphological damages and related molecular mechanisms. The microscopic examination of tissue structure and ultrastructure was carried out for histopathological changes of renal tissue morphology. The immunohistochemistry, real-time PCR and Western blot were performed to explore the molecular mechanisms associated the observations. Hematoxylin and eosin (HE) staining showed severe pathological kidney lesions including glomerular atrophy, degeneration and necrosis of renal tubular epithelial cells in two months tail-suspended rats. Ultrastructural studies of the renal tubular epithelial cells demonstrated that basal laminas of renal tubules were rough and incrassate with mitochondria swelling and vacuolation. Cell apoptosis in kidney monitored by the expression of Bax/Bcl-2 and caspase-3 accompanied these pathological damages caused by long-term microgravity. Analysis of the HSP70 protein expression illustrated that overexpression of HSP70 might play a crucial role in inducing those pathological damages. Glucose regulated protein 78 (GRP78), one of the endoplasmic reticulum (ER) chaperones, was up-regulated significantly in the kidney of tail suspension rat, which implied that ER-stress was associated with apoptosis. Furthermore, CHOP and caspase-12 pathways were activated in ER-stress induced apoptosis. Resistance training not only reduced kidney cell apoptosis and expression of HSP70 protein, it also can attenuate the kidney impairment imposed by weightlessness. The appropriate optimization might be needed for the long term application for space exploration.	[Ding, Ye; Tian, Jijing; Du, Fang; She, Ruiping; Lv, Dongqiang; Chang, Lingling] China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China; [Zou, Jun; Abdelalim, Saed] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [Li, Zhili; Wang, Desheng; Tan, Cheng; Wang, Huijuan; Chen, Wenjuan] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Ding, Y (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China.	sheruiping@126.com	wang, huimin/HDM-8421-2022; El-Ashram, Saeed/AAC-6060-2021; wang, hui/GRS-4730-2022	El-Ashram, Saeed/0000-0003-0389-1980; 	Advanced Space Medico-Engineering Research Project of China [SJ200802]; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities [IRT0866]	Advanced Space Medico-Engineering Research Project of China; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities	This work was supported by Advanced Space Medico-Engineering Research Project of China, grant (NO. SJ200802), and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin KM, 1996, MED SCI SPORT EXER, V28, P1247, DOI 10.1097/00005768-199610000-00007; Brooks DP, 2000, J APPL PHYSIOL, V88, P1316, DOI 10.1152/jappl.2000.88.4.1316; CAMPBELL WW, 1995, AM J PHYSIOL-ENDOC M, V268, pE1143, DOI 10.1152/ajpendo.1995.268.6.E1143; Castaneda C, 2001, ANN INTERN MED, V135, P965, DOI 10.7326/0003-4819-135-11-200112040-00008; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Convertino VA, 2000, J APPL PHYSIOL, V89, P1737, DOI 10.1152/jappl.2000.89.5.1737; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; De Santo NG, 2005, J RENAL NUTR, V15, P183, DOI 10.1053/j.jrn.2004.09.011; Fluckey JD, 2002, ACTA PHYSIOL SCAND, V176, P293, DOI 10.1046/j.1365-201X.2002.01040.x; Gazenko O G, 1986, Probl Kosm Biol, V54, P1; GLOBUS RK, 1986, J BONE MINER RES, V1, P191; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; Halet G, 1999, AM J PHYSIOL-HEART C, V276, pH1131, DOI 10.1152/ajpheart.1999.276.4.H1131; Inagi R, 2005, KIDNEY INT, V68, P2639, DOI 10.1111/j.1523-1755.2005.00736.x; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; LINDERMAN JK, 1994, AM J PHYSIOL, V267, pR365, DOI 10.1152/ajpregu.1994.267.2.R365; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu T, 2008, POULTRY SCI, V87, P250, DOI 10.3382/ps.2007-00353; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyake Masao, 2003, Biol Sci Space, V17, P173; Morel JL, 1997, AM J PHYSIOL-HEART C, V273, pH2867, DOI 10.1152/ajpheart.1997.273.6.H2867; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NATOCHIN YV, 1991, AVIAT SPACE ENVIR MD, V62, P1037; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028; Rall LC, 1996, ARTHRITIS RHEUM, V39, P1115, DOI 10.1002/art.1780390707; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; ROYLAND JE, 1994, LIFE SCI, V54, P545, DOI 10.1016/0024-3205(94)90005-1; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tesch PA, 1997, INT J SPORTS MED, V18, pS322, DOI 10.1055/s-2007-972744; Thomas GL, 1998, NEPHROL DIAL TRANSPL, V13, P2216, DOI 10.1093/ndt/13.9.2216; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner R T, 1979, Physiologist, V22, pS73; Wade CE, 1998, AM J PHYSIOL-REG I, V275, pR1058; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Wimalawansa SM, 1999, J APPL PHYSIOL, V86, P1841, DOI 10.1152/jappl.1999.86.6.1841; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zorbas Yan G., 2001, International Urology and Nephrology, V33, P423, DOI 10.1023/A:1019519403233	55	27	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20008	10.1371/journal.pone.0020008	http://dx.doi.org/10.1371/journal.pone.0020008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625440	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200023
J	Eggermont, JJ; Munguia, R; Pienkowski, M; Shaw, G				Eggermont, Jos J.; Munguia, Raymundo; Pienkowski, Martin; Shaw, Greg			Comparison of LFP-Based and Spike-Based Spectro-Temporal Receptive Fields and Cross-Correlation in Cat Primary Auditory Cortex	PLOS ONE			English	Article							CEREBRAL-CORTEX; NEURAL ACTIVITY; IN-VIVO; POTENTIALS; FREQUENCY; NEURONS; ORGANIZATION; DEPENDENCE; AWAKE	Multi-electrode array recordings of spike and local field potential (LFP) activity were made from primary auditory cortex of 12 normal hearing, ketamine-anesthetized cats. We evaluated 259 spectro-temporal receptive fields (STRFs) and 492 frequency-tuning curves (FTCs) based on LFPs and spikes simultaneously recorded on the same electrode. We compared their characteristic frequency (CF) gradients and their cross-correlation distances. The CF gradient for spike-based FTCs was about twice that for 2-40 Hz-filtered LFP-based FTCs, indicating greatly reduced frequency selectivity for LFPs. We also present comparisons for LFPs band-pass filtered between 4-8 Hz, 8-16 Hz and 16-40 Hz, with spike-based STRFs, on the basis of their marginal frequency distributions. We find on average a significantly larger correlation between the spike based marginal frequency distributions and those based on the 16-40 Hz filtered LFP, compared to those based on the 4-8 Hz, 816 Hz and 2-40 Hz filtered LFP. This suggests greater frequency specificity for the 16-40 Hz LFPs compared to those of lower frequency content. For spontaneous LFP and spike activity we evaluated 1373 pair correlations for pairs with > 200 spikes in 900 s per electrode. Peak correlation-coefficient space constants were similar for the 2-40 Hz filtered LFP (5.5 mm) and the 16-40 Hz LFP (7.4 mm), whereas for spike-pair correlations it was about half that, at 3.2 mm. Comparing spike-pairs with 2-40 Hz (and 16-40 Hz) LFP-pair correlations showed that about 16% (9%) of the variance in the spike-pair correlations could be explained from LFP-pair correlations recorded on the same electrodes within the same electrode array. This larger correlation distance combined with the reduced CF gradient and much broader frequency selectivity suggests that LFPs are not a substitute for spike activity in primary auditory cortex.	[Eggermont, Jos J.; Pienkowski, Martin; Shaw, Greg] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Eggermont, Jos J.; Munguia, Raymundo] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Eggermont, Jos J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary	Eggermont, JJ (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.	eggermon@ucalgary.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [NSERC 1206-2010]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada under Grant number NSERC 1206-2010. NSERC's URL is http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU, P1; ABELES M, 1988, FORMATION PROCESSING, P225; Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Cottaris NP, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026007; David S.V., 2010, COMPUT INTEL NEUROSC, DOI DOI 10.1155/2010/393019; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; DICKSON JW, 1974, J NEUROPHYSIOL, V37, P1239, DOI 10.1152/jn.1974.37.6.1239; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2121, DOI 10.1097/00001756-199511000-00006; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; EGGERMONT JJ, 1992, J NEUROPHYSIOL, V68, P1216, DOI 10.1152/jn.1992.68.4.1216; Eggermont JJ, 2006, J NEUROPHYSIOL, V96, P746, DOI 10.1152/jn.00059.2006; Elhilali M, 2007, J NEUROSCI, V27, P10372, DOI 10.1523/JNEUROSCI.1462-07.2007; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Gourevitch B, 2007, J NEUROSCI METH, V163, P181, DOI 10.1016/j.jneumeth.2007.02.021; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kayser C, 2007, J NEUROPHYSIOL, V98, P1806, DOI 10.1152/jn.00358.2007; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MARMARELIS PZ, 1978, ANAL PHYSL SYSTEMS W, P1; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Norena A, 2002, HEARING RES, V166, P202, DOI 10.1016/S0378-5955(02)00329-5; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2008, J NEUROSCI, V28, P8885, DOI 10.1523/JNEUROSCI.2693-08.2008; Qin L, 2003, NEUROSCI RES, V46, P145, DOI 10.1016/S0168-0102(03)00034-8; Qin L, 2008, J NEUROPHYSIOL, V99, P2305, DOI 10.1152/jn.01125.2007; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; Valentine PA, 2004, HEARING RES, V196, P119, DOI 10.1016/j.heares.2004.05.011; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Young CK, 2009, PROG NEUROBIOL, V89, P61, DOI 10.1016/j.pneurobio.2009.06.002; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	49	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20046	10.1371/journal.pone.0020046	http://dx.doi.org/10.1371/journal.pone.0020046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625385	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200028
J	Andiappan, AK; Wang, DY; Anantharaman, R; Parate, PN; Suri, BK; Low, HQ; Li, Y; Zhao, W; Castagnoli, P; Liu, JJ; Chew, FT				Andiappan, Anand Kumar; Wang, De Yun; Anantharaman, Ramani; Parate, Pallavi Nilkanth; Suri, Bani Kaur; Low, Hui Qi; Li, Yi; Zhao, Wanting; Castagnoli, Paola; Liu, Jianjun; Chew, Fook Tim			Genome-Wide Association Study for Atopy and Allergic Rhinitis in a Singapore Chinese Population	PLOS ONE			English	Article							B-CELL DEVELOPMENT; BRONCHIAL HYPERRESPONSIVENESS; SUSCEPTIBILITY GENES; RISK-FACTORS; ASTHMA; GENETICS; BCAP; EXPRESSION; INTERMITTENT; PREVALENCE	Allergic rhinitis (AR) is an atopic disease which affects about 600 million people worldwide and results from a complex interplay between genetic and environmental factors. However genetic association studies on known candidate genes yielded variable results. The aim of this study is to identify the genetic variants that influence predisposition towards allergic rhinitis in an ethnic Chinese population in Singapore using a genome-wide association study (GWAS) approach. A total of 4461 ethnic Chinese volunteers were recruited in Singapore and classified according to their allergic disease status. The GWAS included a discovery stage comparing 515 atopic cases (including 456 AR cases) and 486 non-allergic non-rhinitis (NANR) controls. The top SNPs were then validated in a replication cohort consisting of a separate 2323 atopic cases (including 676 AR cases) and 511 NANR controls. Two SNPs showed consistent association in both discovery and replication phases; MRPL4 SNP rs8111930 on 19q13.2 (OR = 0.69, P-combined = 4.46 x 10(-05)) and BCAP SNP rs505010 on chromosome 10q24.1 (OR = 0.64, P-combined = 1.10 x 10(-04)). In addition, we also replicated multiple associations within known candidates regions such as HLA-DQ and NPSR1 locus in the discovery phase. Our study suggests that MRPL4 and BCAP, key components of the HIF-1 alpha and PI3K/Akt signaling pathways respectively, are two novel candidate genes for atopy and allergic rhinitis. Further study on these molecules and their signaling pathways would help in understanding of the pathogenesis of allergic rhinitis and identification of targets for new therapeutic intervention.	[Andiappan, Anand Kumar; Anantharaman, Ramani; Parate, Pallavi Nilkanth; Suri, Bani Kaur; Chew, Fook Tim] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wang, De Yun] Natl Univ Singapore, Dept Otolaryngol, Singapore 117548, Singapore; [Low, Hui Qi; Li, Yi; Zhao, Wanting; Liu, Jianjun] Genome Inst Singapore GIS, Singapore, Singapore; [Castagnoli, Paola] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Andiappan, AK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	liuj3@gis.a-star.edu.sg; dbscft@nus.edu.sg	zhao, wanting/D-5019-2011; Chew, Fook Tim/E-7259-2010; Liu, Jianjun/AAK-4989-2020	Chew, Fook Tim/0000-0003-1337-5146; Liu, Jianjun/0000-0002-3255-3019; Andiappan, Anand Kumar/0000-0002-8442-1544	Singapore Immunology Network [SIgN-06-006, SIgN-08-020]; National Medical Research Council, Singapore [NMRC/1150/2008]; National University of Singapore (NUS); MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: researchfish	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University of Singapore (NUS)(National University of Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from the Singapore Immunology Network (SIgN-06-006 and SIgN-08-020); National Medical Research Council (NMRC/1150/2008), Singapore; and National University of Singapore (NUS) for the Graduate Research Scholarship for students involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Anantharaman R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-82; Andiappan AK, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-36; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Blumenthal MN, 2004, HUM GENET, V114, P157, DOI 10.1007/s00439-003-1030-5; Blumenthal MN, 2005, CURR OPIN ALLERGY CL, V5, P141, DOI 10.1097/01.all.0000162306.12728.c2; BLUMENTHAL MN, 1986, J ALLERGY CLIN IMMUN, V78, P962, DOI 10.1016/0091-6749(86)90286-1; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2005, CLIN EXP ALLERGY, V35, P728, DOI 10.1111/j.1365-2222.2005.02274.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bouzigon E, 2007, GENET EPIDEMIOL, V31, P618; Campbell A, 1997, ALLERGY, V52, P1022, DOI 10.1111/j.1398-9995.1997.tb02425.x; Chang HC, 2009, J IMMUNOL, V183, P4887, DOI 10.4049/jimmunol.0900363; Choi SH, 2007, ALLERGY, V62, P1051, DOI 10.1111/j.1398-9995.2007.01403.x; Clarke JR, 2000, AM J RESP CRIT CARE, V162, P2188, DOI 10.1164/ajrccm.162.6.9904057; Cousins DJ, 2008, J ALLERGY CLIN IMMUN, V121, P803, DOI 10.1016/j.jaci.2008.02.008; Denham S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-38; Duffy DL, 1998, AM J RESP CRIT CARE, V157, P840, DOI 10.1164/ajrccm.157.3.9702070; Falade AG, 2009, J NATL MED ASSOC, V101, P414, DOI 10.1016/S0027-9684(15)30925-1; Hakonarson H, 2002, AM J HUM GENET, V71, P191; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Held W, 2008, BLOOD, V112, P8, DOI 10.1182/blood-2008-03-147165; Hurme M, 2003, ANN MED, V35, P256, DOI 10.1080/07853890310000682; Ikeda K, 1998, MOL CELL BIOL, V18, P10, DOI 10.1128/MCB.18.1.10; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Juuti-Uusitalo KM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-279; Kabesch M, 2010, CURR OPIN ALLERGY CL, V10, P407, DOI 10.1097/ACI.0b013e32833dc779; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JS, 2008, J ALLERGY CLIN IMMUN, V122, P929, DOI 10.1016/j.jaci.2008.08.009; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Lee KS, 2008, AM J RESP CRIT CARE, V178, P787, DOI 10.1164/rccm.200801-008OC; Lennartsson A, 2005, GENE, V356, P193, DOI 10.1016/j.gene.2005.05.004; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; MacFarlane AW, 2008, BLOOD, V112, P131, DOI 10.1182/blood-2007-08-107847; MacLean JA, 2001, ARCH DERMATOL, V137, P1474; Maksimovic N, 2010, HEALTHMED, V4, P63; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mosges R, 2007, ALLERGY, V62, P969, DOI 10.1111/j.1398-9995.2007.01440.x; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moon H, 2008, ALLERGY, V63, P116; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; Ober C, 1999, CLIN EXP ALLERGY, V29, P11; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Olson N, 2010, AM J RESP CRIT CARE, V181; PARE G, 2008, PLOS GENETICS, V4; Park SJ, 2009, DRUG FUTURE, V34, P673, DOI 10.1358/dof.2009.034.08.1394327; Postma DS, 2000, AM J RESP CRIT CARE, V162, pS118, DOI 10.1164/ajrccm.162.supplement_2.ras-13; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reed SD, 2004, PHARMACOECONOMICS, V22, P345, DOI 10.2165/00019053-200422060-00002; Sih T, 2010, PEDIAT ALLERG IMM-UK, V21, pE107, DOI 10.1111/j.1399-3038.2009.00933.x; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Voelkel NF, 2009, IMMUNOL CELL BIOL, V87, P601, DOI 10.1038/icb.2009.45; Vogtel M, 2010, CURR OPIN ALLERGY CL, V10, P206, DOI 10.1097/ACI.0b013e32833903a6; Wen RR, 2001, FASEB J, V15, pA320; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Willis-Owen SAG, 2009, CURR ALLERGY ASTHM R, V9, P3, DOI 10.1007/s11882-009-0001-x; Yamazaki T, 2003, NAT IMMUNOL, V4, P780, DOI 10.1038/ni949; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Zhang GC, 2009, J HUM GENET, V54, P624, DOI 10.1038/jhg.2009.97	62	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19719	10.1371/journal.pone.0019719	http://dx.doi.org/10.1371/journal.pone.0019719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625490	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400008
J	Marconi, VC; Grandits, G; Okulicz, JF; Wortmann, G; Ganesan, A; Crum-Cianflone, N; Polis, M; Landrum, M; Dolan, MJ; Ahuja, SK; Agan, B; Kulkarni, H				Marconi, Vincent C.; Grandits, Greg; Okulicz, Jason F.; Wortmann, Glenn; Ganesan, Anuradha; Crum-Cianflone, Nancy; Polis, Michael; Landrum, Michael; Dolan, Matthew J.; Ahuja, Sunil K.; Agan, Brian; Kulkarni, Hemant		Infect Dis Clinical Res Program	Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS	PLOS ONE			English	Article							PROTEASE INHIBITOR THERAPY; TERM-FOLLOW-UP; HIV-1-INFECTED PATIENTS; CELL COUNT; RNA LEVEL; INTERMITTENT VIREMIA; DISEASE PROGRESSION; CLINICAL-OUTCOMES; LYMPHOCYTE COUNTS; PREDICTIVE VALUE	Background: The impact of viral load (VL) decay and cumulative VL on CD4 recovery and AIDS after highly-active antiretroviral therapy (HAART) is unknown. Methods and Findings: Three virologic kinetic parameters (first year and overall exponential VL decay constants, and first year VL slope) and cumulative VL during HAART were estimated for 2,278 patients who initiated HAART in the U. S. Military HIV Natural History Study. CD4 and VL trajectories were computed using linear and nonlinear Generalized Estimating Equations models. Multivariate Poisson and linear regression models were used to determine associations of VL parameters with CD4 recovery, adjusted for factors known to correlate with immune recovery. Cumulative VL higher than the sample median was independently associated with an increased risk of AIDS (relative risk 2.38, 95% confidence interval 1.56-3.62, p < 0.001). Among patients with VL suppression, first year VL decay and slope were independent predictors of early CD4 recovery (p = 0.001) and overall gain (p < 0.05). Despite VL suppression, those with slow decay during the first year of HAART as well as during the entire therapy period (overall), in general, gained less CD4 cells compared to the other subjects (133 vs. 195.4 cells/mu L; p = 0.001) even after adjusting for potential confounders. Conclusions: In a cohort with free access to healthcare, independent of established predictors of AIDS and CD4 recovery during HAART, cumulative VL and virologic decay patterns were associated with AIDS and distinct aspects of CD4 reconstitution.	[Marconi, Vincent C.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Marconi, Vincent C.; Grandits, Greg; Okulicz, Jason F.; Wortmann, Glenn; Ganesan, Anuradha; Crum-Cianflone, Nancy; Polis, Michael; Landrum, Michael; Agan, Brian] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Grandits, Greg] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Okulicz, Jason F.; Landrum, Michael] Brooke Army Med Ctr, San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX 78234 USA; [Wortmann, Glenn] Walter Reed Army Med Ctr, Infect Dis Serv, Washington, DC 20307 USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Crum-Cianflone, Nancy] USN, Infect Dis Clin, San Diego Med Ctr, San Diego, CA 92152 USA; [Polis, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Dolan, Matthew J.] Wilford Hall USAF Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX 78236 USA; [Ahuja, Sunil K.; Kulkarni, Hemant] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Ahuja, Sunil K.; Kulkarni, Hemant] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	Emory University; Uniformed Services University of the Health Sciences - USA; University of Minnesota System; University of Minnesota Twin Cities; San Antonio Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Air Force; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Marconi, VC (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	vcmarco@emory.edu; kulkarnih@uthscsa.edu	Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Kulkarni, Hemant/AEM-5750-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Polis, Michael/0000-0002-9151-2268; Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program [IDCRP-000-03]; Department of Defense through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-5072]; Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System; NIH [R37046326]; VA; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award; Doris Duke Distinguished Clinical Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072, R37AI046326] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program; Department of Defense through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award(Burroughs Wellcome Fund); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-03) was provided by the Infectious Disease Clinical Research Program, a Department of Defense program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Inter-Agency Agreement Y1-AI-5072. This work was also supported by the Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) award from the NIH to SKA. SKA is also supported by a VA MERIT award and is a recipient of the Elizabeth Glaser Scientist Award, the Burroughs Wellcome Clinical Scientist Award in Translational Research, and the Doris Duke Distinguished Clinical Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Anastos K, 2004, ANN INTERN MED, V140, P256, DOI 10.7326/0003-4819-140-4-200402170-00007; Anastos K, 2002, ARCH INTERN MED, V162, P1973, DOI 10.1001/archinte.162.17.1973; [Anonymous], 1993, JAMA, V269, P729; [Anonymous], [No title captured]; Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Breban R, 2006, LANCET, V367, P1285, DOI 10.1016/S0140-6736(06)68543-7; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; Choi AI, 2009, AIDS, V23, P2143, DOI 10.1097/QAD.0b013e3283313c91; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Ghani AC, 2002, J ACQ IMMUN DEF SYND, V30, P167, DOI 10.1097/00042560-200206010-00005; Ghani AC, 2001, J ACQ IMMUN DEF SYND, V28, P226, DOI 10.1097/00042560-200111010-00004; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hulgan T, 2007, J INFECT DIS, V195, P425, DOI 10.1086/510536; Jacobson LP, 2002, AM J EPIDEMIOL, V155, P760, DOI 10.1093/aje/155.8.760; Journot V, 2001, CONTROL CLIN TRIALS, V22, P639, DOI 10.1016/S0197-2456(01)00158-1; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873; Kitchen CM, 2001, CLIN INFECT DIS, V33, P466, DOI 10.1086/321900; Kousignian I, 2003, JAIDS-J ACQ IMM DEF, V34, P50, DOI 10.1097/00126334-200309010-00007; Kravcik S, 2001, HIV Clin Trials, V2, P160, DOI 10.1310/F45L-FDKK-Y48N-N2BT; Kuritzkes DR, 2007, J INFECT DIS, V195, P1169, DOI 10.1086/512619; Kuritzkes DR, 2000, J INFECT DIS, V181, P491, DOI 10.1086/315244; Le Moing V, 2002, J INFECT DIS, V185, P471, DOI 10.1086/338929; Lewden C, 2002, J INFECT DIS, V186, P710, DOI 10.1086/342047; LOVEDAY C, 1995, LANCET, V345, P820, DOI 10.1016/S0140-6736(95)92963-0; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maggiolo F, 2000, J ACQ IMMUN DEF SYND, V25, P36, DOI 10.1097/00126334-200009010-00005; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Notermans DW, 1998, AIDS, V12, P1483, DOI 10.1097/00002030-199812000-00010; PHILLIPS AN, 1994, BRIT MED J, V309, P309, DOI 10.1136/bmj.309.6950.309; Polis MA, 2001, LANCET, V358, P1760, DOI 10.1016/S0140-6736(01)06802-7; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sprout M, 2005, ANTIVIR THER, V10, P357; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Tomasoni LR, 2003, HIV CLIN TRIALS, V4, P311, DOI 10.1310/FGMF-Y0LY-DMX8-371V; Torti C, 2004, VIRAL IMMUNOL, V17, P279, DOI 10.1089/0882824041310630; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Weintrob AC, 2008, JAIDS-J ACQ IMM DEF, V49, P40, DOI 10.1097/QAI.0b013e31817bec05; Weintrob AC, 2009, JAIDS-J ACQ IMM DEF, V52, P574, DOI 10.1097/QAI.0b013e3181b98537; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Wu HL, 2005, JAIDS-J ACQ IMM DEF, V39, P272, DOI 10.1097/01.qai.0000165907.04710.da; Wu HL, 1999, J INFECT DIS, V179, P799, DOI 10.1086/314670; Zoufaly A, 2009, J INFECT DIS, V200, P79, DOI 10.1086/599313	63	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e17956	10.1371/journal.pone.0017956	http://dx.doi.org/10.1371/journal.pone.0017956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625477	Green Published, gold, Green Submitted			2022-12-27	WOS:000290793400001
J	Grenz, A; Dalton, JH; Bauerle, JD; Badulak, A; Ridyard, D; Gandjeva, A; Aherne, CM; Brodsky, KS; Kim, JH; Tuder, RM; Eltzschig, HK				Grenz, Almut; Dalton, Julee H.; Bauerle, Jessica D.; Badulak, Alexander; Ridyard, Douglas; Gandjeva, Aneta; Aherne, Carol M.; Brodsky, Kelley S.; Kim, Jae-Hwan; Tuder, Rubin M.; Eltzschig, Holger K.			Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; INDUCED VASCULAR LEAK; INDUCIBLE FACTOR-I; ACUTE LUNG INJURY; ADENOSINE RECEPTOR; ECTO-5'-NUCLEOTIDASE CD73; NUCLEOTIDE PHOSPHOHYDROLYSIS; ISCHEMIA/REPERFUSION INJURY; HIF-1-DEPENDENT REPRESSION	The netrin family of secreted proteins provides migrational cues in the developing central nervous system. Recently, netrins have also been shown to regulate diverse processes beyond their functions in the brain, incluing the ochrestration of inflammatory events. Particularly netrin-1 has been implicated in dampening hypoxia-induced inflammation. Here, we hypothesized an anti-inflammatory role of endogenous netrin-1 in acute kidney injury (AKI). As homozygous deletion of netrin-1 is lethal, we studied mice with partial netrin-1 deletion (Ntn-1(+/-) mice) as a genetic model. In fact, Ntn-1(+/-) mice showed attenuated Ntn-1 levels at baseline and following ischemic AKI. Functional studies of AKI induced by 30 min of renal ischemia and reperfusion revealed enhanced kidney dysfunction in Ntn-1(+/-) mice as assessed by measurements of glomerular filtration, urine flow rate, urine electrolytes, serum creatinine and creatinine clearance. Consistent with these findings, histological studies indicated a more severe degree kidney injury. Similarly, elevations of renal and systemic inflammatory markers were enhanced in mice with partial netrin-1 deficiency. Finally, treatment of Ntn-1(+/-) mice with exogenous netrin-1 restored a normal phenotype during AKI. Taking together, these studies implicate endogenous netrin-1 in attenuating renal inflammation during AKI.	[Grenz, Almut; Dalton, Julee H.; Bauerle, Jessica D.; Badulak, Alexander; Ridyard, Douglas; Aherne, Carol M.; Brodsky, Kelley S.; Kim, Jae-Hwan; Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA; [Gandjeva, Aneta; Tuder, Rubin M.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Kim, Jae-Hwan] Korea Univ, Coll Med, Dept Anesthesiol, Seoul 136705, South Korea	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University; Korea University Medicine (KU Medicine)	Grenz, A (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Anschutz Med Campus, Aurora, CO USA.	Almut.Grenz@ucdenver.edu; holger.eltzschig@ucdenver.edu		Aherne, Carol/0000-0001-5653-9003	United States National Institutes of Health [R01-HL0921, R01-DK083385, R01HL098294]; Foundation for Anesthesia Education and Research (FAER); American Society of Nephrology; DFG (Deutsche Forschungsgemeinschaft) [GR2121/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Anesthesia Education and Research (FAER); American Society of Nephrology; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present studies were supported by United States National Institutes of Health grant R01-HL0921, R01-DK083385 and R01HL098294 and Foundation for Anesthesia Education and Research (FAER) Grants to HKE, an American Society of Nephrology Medical Student Scholar grant and FAER grant to JDB, JHD and AB, and a DFG (Deutsche Forschungsgemeinschaft) Research Fellowship Grant (GR2121/1-1) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bove T, 2005, CIRCULATION, V111, P3230, DOI 10.1161/CIRCULATIONAHA.104.509141; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2009, EXPERT OPIN THER TAR, V13, P1267, DOI 10.1517/14728220903241666; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006; Guckelberger O, 2004, THROMB HAEMOSTASIS, V91, P576, DOI 10.1160/TH03-06-0373; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Lu B, 2008, TRANSPLANTATION, V86, P1707, DOI 10.1097/TP.0b013e31819022bc; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mehta RL, 2005, J AM SOC NEPHROL, V16, P12, DOI 10.1681/ASN.2004110954; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; PARK SW, 2010, J PHARM EXP THER; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Reeves WB, 2008, AM J PHYSIOL-RENAL, V294, pF731, DOI 10.1152/ajprenal.00507.2007; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Wang WW, 2009, AM J PHYSIOL-RENAL, V296, pF723, DOI 10.1152/ajprenal.90686.2008; WEN J, FASEB J, V24, P740	61	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e14812	10.1371/journal.pone.0014812	http://dx.doi.org/10.1371/journal.pone.0014812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625583	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200001
J	Shan, XY; Margulies, KB				Shan, Xiaoyin; Margulies, Kenneth B.			Differential Regulation of PDE5 Expression in Left and Right Ventricles of Feline Hypertrophy Models	PLOS ONE			English	Article							PRESSURE-OVERLOAD; PULMONARY-HYPERTENSION; CYCLIC-GMP; PHOSPHODIESTERASE TYPE-5; CARDIAC-HYPERTROPHY; CHRONIC INHIBITION; HEART-FAILURE; IN-VIVO; SILDENAFIL; MYOCARDIUM	Background: Though long known to affect smooth muscle biology, recent studies indicate that phosphodiesterase 5 (PDE5) is also expressed in myocardium. Recognizing that the regulation of PDE5 in hypertrophy is not well understood, we assessed the response of PDE5 expression and the level of cGMP-dependent kinase I (cGKI) in the left and right ventricles of feline hypertrophy models. Methodology/Principal Findings: Using a cDNA library of feline aortic smooth muscle cells, we identified and cloned PDE5 cDNA for the first time in this species. The sequence shares 98% identity with its human orthologue at the amino acid level. E. coli expression of the cloned allele allowed selection of antibodies with appropriate specificity, facilitating the analysis of PDE5 expression in feline models created by selective proximal aortic (Ao) or pulmonary artery (PA) banding that resulted in hypertrophy of the left ventricle (LV) and right ventricle (RV), respectively. We demonstrated that PDE5 expression responded differentially with a decreased expression in the LV and an increased expression in the RV in the Ao-banded model. Similarly, in the PA-banded model, LV showed reduced expression while the RV expression was unaltered. In addition, the expression of cGKI was significantly decreased in the RV of Ao-banded group, correlating inversely with the increase in PDE5 expression. Conclusions/Significance: The differential regulation of PDE5 and cGKI expression suggests that the mechanisms involved in hypertrophy could be different in RV vs. LV. Reciprocal PDE5 and cGKI expression in the RV of Ao-banded model suggests functional significance for PDE5 up-regulation.	[Shan, Xiaoyin; Margulies, Kenneth B.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Shan, XY (corresponding author), Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	ken.margulies@uphs.upenn.edu			U. S. National Institutes of Health [R01 AG 17022]; NATIONAL INSTITUTE ON AGING [R01AG017022] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported through funds from the U. S. National Institutes of Health (R01 AG 17022). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen A, 2008, EUR J HEART FAIL, V10, P1158, DOI 10.1016/j.ejheart.2008.09.016; BAILEY BA, 1992, J MOL CELL CARDIOL, V24, P365, DOI 10.1016/0022-2828(92)93191-L; Bessay EP, 2008, J PHARMACOL EXP THER, V325, P62, DOI 10.1124/jpet.107.133405; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Corbin JD, 2004, INT J IMPOT RES, V16, pS4, DOI 10.1038/sj.ijir.3901205; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Furukawa T, 2006, J MOL CELL CARDIOL, V41, P753, DOI 10.1016/j.yjmcc.2006.07.021; Geng Y, 1998, J BIOL CHEM, V273, P27484, DOI 10.1074/jbc.273.42.27484; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Ito M, 1996, CELL SIGNAL, V8, P575, DOI 10.1016/S0898-6568(96)00112-X; Itoh T, 2004, AM J RESP CRIT CARE, V169, P34, DOI 10.1164/rccm.200303-346OC; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Kuhn M, 2009, CARDIOVASC RES, V82, P4, DOI 10.1093/cvr/cvp057; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin CS, 2004, INT J IMPOT RES, V16, pS8, DOI 10.1038/sj.ijir.3901207; LOISELLE DS, 1979, AM J PHYSIOL, V237, pH90, DOI 10.1152/ajpheart.1979.237.1.H90; Lusche DF, 2005, EUR J PHARMACOL, V513, P9, DOI 10.1016/j.ejphar.2005.01.047; MOLLER G, PLOS ONE, V5; Murata T, 2010, ANTICANCER RES, V30, P355; Nagayama T, 2009, J MOL CELL CARDIOL, V46, P560, DOI 10.1016/j.yjmcc.2008.12.008; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Quaile MP, 2007, J MOL CELL CARDIOL, V43, P552, DOI 10.1016/j.yjmcc.2007.08.013; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Sanchez LS, 1998, PEDIATR RES, V43, P163, DOI 10.1203/00006450-199802000-00002; Schafer S, 2009, CARDIOVASC RES, V82, P30, DOI 10.1093/cvr/cvp002; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; Shan XY, 2008, BIOCHEMISTRY-US, V47, P10041, DOI 10.1021/bi800972z; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto Eiki, 2009, Expert Rev Clin Pharmacol, V2, P323, DOI 10.1586/ecp.09.20; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; WILLIAMS JF, 1982, J CLIN INVEST, V69, P309, DOI 10.1172/JCI110454; Xu HL, 2004, AM J PHYSIOL-HEART C, V287, pH2501, DOI 10.1152/ajpheart.00319.2004	40	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19922	10.1371/journal.pone.0019922	http://dx.doi.org/10.1371/journal.pone.0019922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625548	Green Submitted, Green Published, gold			2022-12-27	WOS:000290771200031
J	Sopko, N; Qin, YL; Finan, A; Dadabayev, A; Chigurupati, S; Qin, J; Penn, MS; Gupta, S				Sopko, Nikolai; Qin, Yilu; Finan, Amanda; Dadabayev, Alisher; Chigurupati, Sravanthi; Qin, Jun; Penn, Marc S.; Gupta, Sudhiranjan			Significance of Thymosin beta 4 and Implication of PINCH-1-ILK-alpha-Parvin (PIP) Complex in Human Dilated Cardiomyopathy	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; NF-KAPPA-B; CARDIAC-HYPERTROPHY; HEART-FAILURE; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; TARGETED ABLATION; PROTEIN-KINASE	Myocardial remodeling is a major contributor in the development of heart failure (HF) after myocardial infarction (MI). Integrin-linked kinase (ILK), LIM-only adaptor PINCH-1, and alpha-parvin are essential components of focal adhesions (FAs), which are highly expressed in the heart. ILK binds tightly to PINCH-1 and alpha-parvin, which regulates FA assembly and promotes cell survival via the activation of the kinase Akt. Mice lacking ILK, PINCH or alpha-parvin have been shown to develop severe defects in the heart, suggesting that these proteins play a critical role in heart function. Utilizing failing human heart tissues (dilated cardiomyopathy, DCM), we found a 2.27-fold (p < 0.001) enhanced expression of PINCH, 4 fold for alpha-parvin, and 10.5 fold (p < 0.001) for ILK as compared to non-failing (NF) counterparts. No significant enhancements were found for the PINCH isoform PINCH-2 and parvin isoform beta-parvin. Using a co-immunoprecipitation method, we also found that the PINCH-1-ILK-alpha-parvin (PIP) complex and Akt activation were significantly up-regulated. These observations were further corroborated with the mouse myocardial infarction (MI) and transaortic constriction (TAC) model. Thymosin beta4 (T beta 4), an effective cell penetrating peptide for treating MI, was found to further enhance the level of PIP components and Akt activation, while substantially suppressing NF-kappa B activation and collagen expression-the hallmarks of cardiac fibrosis. In the presence of an Akt inhibitor, wortmannin, we show that T beta 4 had a decreased effect in protecting the heart from MI. These data suggest that the PIP complex and activation of Akt play critical roles in HF development. T beta 4 treatment likely improves cardiac function by enhancing PIP mediated Akt activation and suppressing NF-kappa B activation and collagen-mediated fibrosis. These data provide significant insight into the role of the PIP-Akt pathway and its regulation by T beta 4 treatment in post-MI.	[Sopko, Nikolai; Finan, Amanda; Dadabayev, Alisher; Penn, Marc S.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Chigurupati, Sravanthi; Gupta, Sudhiranjan] Texas A&M Hlth Sci Ctr, Coll Med, Cardiovasc Res Inst, Div Cardiol,Dept Internal Med, Temple, TX USA; [Qin, Yilu; Qin, Jun; Gupta, Sudhiranjan] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cleveland Clinic Foundation	Sopko, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA.	sgupta@medicine.tamhsc.edu	Sopko, Nikolai/AAL-2036-2020	Sopko, Nikolai/0000-0003-4913-0570; Qin, Jun/0000-0002-2647-9270	American Heart Association [0835227N]; Texas A & M Health Science Center [R8000 R3536]; National Institutes of Health [R01HL58758]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Texas A & M Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by American Heart Association (National Scientist Development Grant (0835227N) and a start up fund from Texas A & M Health Science Center, Scott & White RGP Award (R8000 R3536) to Dr. S. Gupta, and National Institutes of Health grant to Dr. J. Qin (R01HL58758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI M, 2011, EFFECT AMINOGUANIDIN; Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Eke I, 2010, J CLIN INVEST, V120, P2516, DOI 10.1172/JCI41078; Fujiwara M, 2008, CIRC J, V72, P127, DOI 10.1253/circj.72.127; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Gao J, 2007, J MOL CELL CARDIOL, V43, P601, DOI 10.1016/j.yjmcc.2007.08.009; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Gupta S, 2005, J MOL MED, V83, P993, DOI 10.1007/s00109-005-0691-z; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Haq S, 2001, CIRCULATION, V103, P670; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YW, 2007, AM J PHYSIOL-HEART C, V292, pH946, DOI 10.1152/ajpheart.00361.2006; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Sasaki T, 2007, PEDIATR INT, V49, P966, DOI 10.1111/j.1442-200X.2007.02491.x; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Sosne G, 2005, INVEST OPHTH VIS SCI, V46, P2388, DOI 10.1167/iovs.04-1368; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wu CY, 1999, J CELL SCI, V112, P4485; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076	48	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20184	10.1371/journal.pone.0020184	http://dx.doi.org/10.1371/journal.pone.0020184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625516	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200052
J	Di Fonzo, MMI; Pelletier, F; Clutton-Brock, TH; Pemberton, JM; Coulson, T				Di Fonzo, Martina M. I.; Pelletier, Fanie; Clutton-Brock, T. H.; Pemberton, Josephine M.; Coulson, Tim			The Population Growth Consequences of Variation in Individual Heterozygosity	PLOS ONE			English	Article							SOAY SHEEP; SELECTION; RELATEDNESS; INSTABILITY; STABILITY; SURVIVAL; FITNESS; TRAITS; RESCUE; AGE	Heterozygosity has been associated with components of fitness in numerous studies across a wide range of taxa. Because heterozygosity is associated with individual performance it is also expected to be associated with population dynamics. However, investigations into the association between heterozygosity and population dynamics have been rare because of difficulties in linking evolutionary and ecological processes. The choice of heterozygosity measure is a further issue confounding such studies as it can be biased by individual differences in the frequencies of the alleles studied, the number of alleles at each locus as well as the total number of loci typed. In this study, we first examine the differences between the principal metrics used to calculate heterozygosity using long-term data from a marked population of Soay sheep (Ovis aries). Next, by means of statistical transformation of the homozygosity weighted by loci index, we determine how heterozygosity contributes to population growth in Soay sheep by modelling individual contributions to population growth (p(t(i))) as a function of several covariates, including sex, weight and faecal egg count - a surrogate of parasitic nematode burden in the gut. We demonstrate that although heterozygosity is associated with some components of fitness, most notably adult male reproductive success, in general it is only weakly associated with population growth.	[Di Fonzo, Martina M. I.; Pelletier, Fanie; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Di Fonzo, Martina M. I.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Clutton-Brock, T. H.] Univ Cambridge, Dept Zool, Cambridge, England; [Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Imperial College London; Zoological Society of London; University of Cambridge; University of Edinburgh	Di Fonzo, MMI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	martina.di-fonzo06@imperial.ac.uk	Di Fonzo, Martina/G-3463-2013; Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021	Di Fonzo, Martina/0000-0002-2033-0598; Coulson, Tim/0000-0001-9371-9003	NERC [NE/G004854/1] Funding Source: UKRI; Natural Environment Research Council [NE/G004854/1, NE/B504314/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACEVEDOWHITEHOU.K, 2003, NATURE, V422; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; BANCROFT DR, 1995, PHILOS T R SOC B, V347, P263, DOI 10.1098/rstb.1995.0026; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Clutton-Brock TH, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P276; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; CLUTTONBROCK TH, 1992, J ANIM ECOL, V61, P381, DOI 10.2307/5330; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Jewell P.A., 1974, ISLAND SURVIVORS ECO; KOEHN RK, 1984, MAR BIOL, V82, P1, DOI 10.1007/BF00392757; LEARY RF, 1985, EVOLUTION, V39, P308, DOI [10.2307/2408364, 10.1111/j.1558-5646.1985.tb05668.x]; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Milner JM, 1999, J ANIM ECOL, V68, P472, DOI 10.1046/j.1365-2656.1999.00299.x; Ministry of Agriculture Fisheries and Food, 1971, MAN VET PAR LAB TECH; Overall ADJ, 2005, MOL ECOL, V14, P3383, DOI 10.1111/j.1365-294X.2005.02682.x; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pemberton JM, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P217; Pemberton JM, 1996, PHILOS T R SOC B, V351, P745, DOI 10.1098/rstb.1996.0069; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SLATE J, 2000, P ROY SOC LOND B BIO, V267, P1656; SNEDDON N, 2004, P ROY SOC LOND B BIO, V271, P1823; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184	39	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19667	10.1371/journal.pone.0019667	http://dx.doi.org/10.1371/journal.pone.0019667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611172	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200025
J	Israeli, E; Yakunin, E; Zarbiv, Y; Hacohen-Solovich, A; Kisos, H; Loeb, V; Lichtenstein, M; Ben-Gedalya, T; Sabag, O; Pikarsky, E; Lorberboum-Galski, H; Sharon, R				Israeli, Eitan; Yakunin, Eugenia; Zarbiv, Yonaton; Hacohen-Solovich, Amir; Kisos, Haya; Loeb, Virginie; Lichtenstein, Michal; Ben-Gedalya, Tziona; Sabag, Ofra; Pikarsky, Eli; Lorberboum-Galski, Haya; Sharon, Ronit			alpha-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease	PLOS ONE			English	Article							BETA-SYNUCLEIN; GAMMA-SYNUCLEIN; CELL-DEATH; IN-VIVO; CANCER; RELEASE; GENE; OVEREXPRESSION; PROGRESSION; MECHANISMS	Alpha Synuclein (alpha-Syn) is a protein implicated in mechanisms of neuronal degeneration in Parkinson's disease (PD). alpha-Syn is primarily a neuronal protein, however, its expression is found in various tumors including ovarian, colorectal and melanoma tumors. It has been hypothesized that neurodegeneration may share common mechanisms with oncogenesis. We tested whether alpha-Syn expression affects tumorigenesis of three types of tumors. Specifically, B16 melanoma, E0771 mammary gland adenocarcinoma and D122 Lewis lung carcinoma. For this aim, we utilized transgenic mice expression the human A53T alpha-Syn form. We found that the in vivo growth of B16 and E0771 but not D122 was enhanced in the A53T alpha-Syn mice. The effect on tumorigenesis was not detected in age-matched APP/PS1 mice, modeling Alzheimer's disease (AD), suggesting a specific effect for alpha-Syn-dependent neurodegeneration. Importantly, transgenic alpha-Syn expression was detected within the three tumor types. We further show uptake of exogenously added, purified alpha-Syn, by the cultured tumor cells. In accord, with the affected tumorigenesis in the young A53T alpha-Syn mice, over-expression of alpha-Syn in cultured B16 and E0771 cells enhanced proliferation, however, had no effect on the proliferation of D122 cells. Based on these results, we suggest that certain forms of alpha-Syn may selectively accelerate cellular mechanisms leading to cancer.	[Israeli, Eitan; Yakunin, Eugenia; Zarbiv, Yonaton; Hacohen-Solovich, Amir; Kisos, Haya; Loeb, Virginie; Lichtenstein, Michal; Sabag, Ofra; Lorberboum-Galski, Haya; Sharon, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Israeli, E (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	ronitsh@ekmd.huji.ac.il	pikarsky, eli/GXV-7099-2022; Lorberboum-Galski, Haya/K-8839-2019	Zarbiv, Yonaton/0000-0002-7040-1913; pikarsky, eli/0000-0003-4186-7105	National Institutes of Health [R01 NS051318]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grant R01 NS051318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bajaj A, 2010, CANCER CAUSE CONTROL, V21, P697, DOI 10.1007/s10552-009-9497-6; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; BYSTRYN JC, 1976, J IMMUNOL, V116, P1302; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; D'Amelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; GARBER K, J NATL CANC I, V102, P371; Garber K, 2010, J NATL CANCER I, V102, P371, DOI 10.1093/jnci/djq081; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Irony-Tur-Sinai M, 2009, INT IMMUNOPHARMACOL, V9, P1236, DOI 10.1016/j.intimp.2009.07.006; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Ji HJ, 1997, CANCER RES, V57, P759; Kawashima M, 2000, ACTA NEUROPATHOL, V99, P154, DOI 10.1007/PL00007419; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morgan J, 2009, GYNECOL ONCOL, V114, P293, DOI 10.1016/j.ygyno.2009.04.036; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Poewe W, 2007, MOVEMENT DISORD, V22, pS374, DOI 10.1002/mds.21681; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POULOGIANNIS G, 2010, P NATL ACAD SCI US; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Staropoli JF, 2008, BIOESSAYS, V30, P719, DOI 10.1002/bies.20784; TAY SP, 2010, J BIOL CHEM; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Ye Q, 2010, ONCOL REP, V23, P429, DOI 10.3892/or_00000652; Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377	66	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19622	10.1371/journal.pone.0019622	http://dx.doi.org/10.1371/journal.pone.0019622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611169	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200020
J	Mouttet, R; Bearez, P; Thomas, C; Desneux, N				Mouttet, Raphaelle; Bearez, Philippe; Thomas, Cecile; Desneux, Nicolas			Phytophagous Arthropods and a Pathogen Sharing a Host Plant: Evidence for Indirect Plant-Mediated Interactions	PLOS ONE			English	Article							INDUCED RESISTANCE; BOTRYTIS-CINEREA; PEST-MANAGEMENT; SOYBEAN APHID; TRADE-OFFS; CROSS-TALK; HERBIVORES; RESPONSES; DEFENSE; FUNGUS	In ecological systems, indirect interactions between plant pathogens and phytophagous arthropods can arise when infestation by a first attacker alters the common host plant so that although a second attacker could be spatially or temporally separated from the first one, the former could be affected. The induction of plant defense reactions leading to the production of secondary metabolites is thought to have an important role since it involves antagonistic and/or synergistic cross-talks that may determine the outcome of such interactions. We carried out experiments under controlled conditions on young rose plants in order to assess the impact of these indirect interactions on life history traits of three pests: the necrotrophic fungus Botrytis cinerea Pers.: Fr. (Helotiales: Sclerotiniaceae), the aphid Rhodobium porosum Sanderson (Hemiptera: Aphididae) and the thrips Frankliniella occidentalis Pergande (Thysanoptera: Thripidae). Our results indicated (i) a bi-directional negative interaction between B. cinerea and R. porosum, which is conveyed by decreased aphid growth rate and reduced fungal lesion area, as well as (ii) an indirect negative effect of B. cinerea on insect behavior. No indirect effect was observed between thrips and aphids. This research highlights several complex interactions that may be involved in structuring herbivore and plant pathogen communities within natural and managed ecosystems.	[Mouttet, Raphaelle; Bearez, Philippe; Thomas, Cecile; Desneux, Nicolas] French Natl Inst Agr Res INRA, UR 880, Sophia Antipolis, France	INRAE	Mouttet, R (corresponding author), French Natl Inst Agr Res INRA, UR 880, Sophia Antipolis, France.	nicolas.desneux@sophia.inra.fr	Desneux, Nicolas/J-6262-2013		French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy)	French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy)	This work was supported by an "Innovative project" grant from the French National Institute for Agricultural Research (INRA, Department of Environment and Agronomy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; AJLAN AM, 1991, ENTOMOL EXP APPL, V58, P83, DOI 10.1007/BF00163317; ALTIERI MA, 1983, ENVIRON MANAGE, V7, P91, DOI 10.1007/BF01867047; Barbosa P, 1991, MICROBIAL MEDIATION; BARFIELD CS, 1984, FLA ENTOMOL, V67, P42, DOI 10.2307/3494103; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRUN R, 2003, ROSE SERRE FLEUR COU; Cardoza YJ, 2003, ENVIRON ENTOMOL, V32, P220, DOI 10.1603/0046-225X-32.1.220; Chaman ME, 2003, J AGR FOOD CHEM, V51, P2227, DOI 10.1021/jf020953b; De Vos M, 2006, PLANT PHYSIOL, V142, P352, DOI 10.1104/pp.106.083907; Derckel JP, 1999, PHYTOPATHOLOGY, V89, P197, DOI 10.1094/PHYTO.1999.89.3.197; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Fournier V, 2006, ECOL APPL, V16, P2382, DOI 10.1890/1051-0761(2006)016[2382:MPEOAS]2.0.CO;2; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hatcher PE, 2000, NEW PHYTOL, V146, P325, DOI 10.1046/j.1469-8137.2000.00646.x; HATCHER PE, 1994, FUNCT ECOL, V8, P265, DOI 10.2307/2389910; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Hatcher PE, 2004, ECOLOGY, V85, P59, DOI 10.1890/02-0724; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Janssen A, 1998, EXP APPL ACAROL, V22, P497, DOI 10.1023/A:1006089924336; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; KARBAN R, 1987, SCIENCE, V235, P678, DOI 10.1126/science.235.4789.678; Klepzig KD, 1997, GREAT LAKES ENTOMOL, V30, P99; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kruess A, 2002, OECOLOGIA, V130, P563, DOI 10.1007/s00442-001-0829-9; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Moran PJ, 1998, OECOLOGIA, V115, P523, DOI 10.1007/s004420050550; Moran PJ, 1998, ENVIRON ENTOMOL, V27, P39, DOI 10.1093/ee/27.1.39; Morin P., 1999, COMMUNITY ECOL; MOUND LA, 1971, B ENTOMOL RES, V60, P547, DOI 10.1017/S0007485300042309; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Paul ND, 2000, TRENDS PLANT SCI, V5, P220, DOI 10.1016/S1360-1385(00)01603-4; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ramirez-Romero R, 2008, PESTIC BIOCHEM PHYS, V91, P110, DOI 10.1016/j.pestbp.2008.01.010; RAVEN JA, 1983, ADV ECOL RES, V13, P135, DOI 10.1016/S0065-2504(08)60109-9; Rayapuram C, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-109; Rodriguez-Saona C, 2005, OECOLOGIA, V143, P566, DOI 10.1007/s00442-005-0006-7; Roder G, 2007, OIKOS, V116, P1514, DOI [10.1111/j.2007.0030-1299.16057.x, 10.1111/j.0030-1299.2007.16057.x]; Rostas M, 2003, BASIC APPL ECOL, V4, P43, DOI 10.1078/1439-1791-00132; ROSTAS M, 2002, AGR FOREST ENTOMOL, V4, P1; Russo VM, 1997, CROP PROT, V16, P581, DOI 10.1016/S0261-2194(97)00024-0; Villada ES, 2009, J EXP BOT, V60, P3269, DOI 10.1093/jxb/erp163; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Simon M, 2003, AGR FOREST ENTOMOL, V5, P275, DOI 10.1046/j.1461-9563.2003.00189.x; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Stout MJ, 1996, BIOCHEM SYST ECOL, V24, P611, DOI 10.1016/S0305-1978(97)81205-7; Taylor JE, 2004, J EXP BOT, V55, P159, DOI 10.1093/jxb/erh053; Viswanathan DV, 2008, ECOL ENTOMOL, V33, P86, DOI 10.1111/j.1365-2311.2007.00943.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	68	50	52	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18840	10.1371/journal.pone.0018840	http://dx.doi.org/10.1371/journal.pone.0018840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611161	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200003
J	Planche, A; Bacac, M; Provero, P; Fusco, C; Delorenzi, M; Stehle, JC; Stamenkovic, I				Planche, Anne; Bacac, Marina; Provero, Paolo; Fusco, Carlo; Delorenzi, Mauro; Stehle, Jean-Christophe; Stamenkovic, Ivan			Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR MICROENVIRONMENT; TGF-BETA; PERIOSTIN; CELL; SIGNATURE; GROWTH; FIBROBLASTS; PROGRESSION; SURVIVAL	Primary tumor growth induces host tissue responses that are believed to support and promote tumor progression. Identification of the molecular characteristics of the tumor microenvironment and elucidation of its crosstalk with tumor cells may therefore be crucial for improving our understanding of the processes implicated in cancer progression, identifying potential therapeutic targets, and uncovering stromal gene expression signatures that may predict clinical outcome. A key issue to resolve, therefore, is whether the stromal response to tumor growth is largely a generic phenomenon, irrespective of the tumor type or whether the response reflects tumor-specific properties. To address similarity or distinction of stromal gene expression changes during cancer progression, oligonucleotide-based Affymetrix microarray technology was used to compare the transcriptomes of laser-microdissected stromal cells derived from invasive human breast and prostate carcinoma. Invasive breast and prostate cancer-associated stroma was observed to display distinct transcriptomes, with a limited number of shared genes. Interestingly, both breast and prostate tumor-specific dysregulated stromal genes were observed to cluster breast and prostate cancer patients, respectively, into two distinct groups with statistically different clinical outcomes. By contrast, a gene signature that was common to the reactive stroma of both tumor types did not have survival predictive value. Univariate Cox analysis identified genes whose expression level was most strongly associated with patient survival. Taken together, these observations suggest that the tumor microenvironment displays distinct features according to the tumor type that provides survival-predictive value.	[Planche, Anne; Bacac, Marina; Fusco, Carlo; Stehle, Jean-Christophe; Stamenkovic, Ivan] Univ Lausanne, CHUV, Inst Pathol, Lausanne, Switzerland; [Planche, Anne; Bacac, Marina; Fusco, Carlo; Stehle, Jean-Christophe; Stamenkovic, Ivan] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Delorenzi, Mauro] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Turin; Swiss Institute of Bioinformatics	Planche, A (corresponding author), Univ Lausanne, CHUV, Inst Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Fusco, Carlo/AAC-7332-2022; Provero, Paolo/AAC-1930-2019		Swiss Fonds National pour la Recherche Scientifique (FNRS) [310030-130350]; NCCR Molecular Oncology; Italian Association for Cancer Research [IG9408]	Swiss Fonds National pour la Recherche Scientifique (FNRS)(Swiss National Science Foundation (SNSF)); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Swiss Fonds National pour la Recherche Scientifique (FNRS) grant No. 310030-130350 and the NCCR Molecular Oncology. P. P. gratefully acknowledges support from the Italian Association for Cancer Research under grant IG9408. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; BAUER M, ONCOGENE, V29, P1732; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gillan L, 2002, CANCER RES, V62, P5358; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Ismail RS, 2000, CANCER RES, V60, P6744; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; MICHAYLIRA CZ, CANC RES, V70, P5281; Olumi AF, 1999, CANCER RES, V59, P5002; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Saranac L, 2007, THESCIENTIFICWORLDJO, V7, P1263, DOI 10.1100/tsw.2007.218; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yoshioka N, 2002, EXP CELL RES, V279, P91, DOI 10.1006/excr.2002.5590	35	105	105	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e18640	10.1371/journal.pone.0018640	http://dx.doi.org/10.1371/journal.pone.0018640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611158	Green Published, gold, Green Submitted			2022-12-27	WOS:000290720200001
J	Stemberger, S; Jamnig, A; Stefanova, N; Lepperdinger, G; Reindl, M; Wenning, GK				Stemberger, Sylvia; Jamnig, Angelika; Stefanova, Nadia; Lepperdinger, Guenter; Reindl, Markus; Wenning, Gregor K.			Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; MARROW STROMAL CELLS; ADULT BONE-MARROW; PARKINSONS-DISEASE; STRIATONIGRAL DEGENERATION; MICROGLIAL ACTIVATION; RAT MODEL; TARGETED OVEREXPRESSION; IN-VITRO; TRANSPLANTATION	Background: Mesenchymal stem cells (MSC) are currently strong candidates for cell-based therapies. They are well known for their differentiation potential and immunoregulatory properties and have been proven to be potentially effective in the treatment of a large variety of diseases, including neurodegenerative disorders. Currently there is no treatment that provides consistent long-term benefits for patients with multiple system atrophy (MSA), a fatal late onset alpha-synucleinopathy. Principally neuroprotective or regenerative strategies, including cell-based therapies, represent a powerful approach for treating MSA. In this study we investigated the efficacy of intravenously applied MSCs in terms of behavioural improvement, neuroprotection and modulation of neuroinflammation in the (PLP)-alpha synuclein (alpha SYN) MSA model. Methodology/Principal Findings: MSCs were intravenously applied in aged (PLP)-alpha SYN transgenic mice. Behavioural analyses, defining fine motor coordination and balance capabilities as well as stride length analysis, were performed to measure behavioural outcome. Neuroprotection was assessed by quantifying TH neurons in the substantia nigra pars compacta (SNc). MSC treatment on neuroinflammation was analysed by cytokine measurements (IL-1 alpha, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, GM-CSF, INF gamma, MCP-1, TGF-beta 1, TNF-alpha) in brain lysates together with immunohistochemistry for T-cells and microglia. Four weeks post MSC treatment we observed neuroprotection in the SNc, as well as downregulation of cytokines involved in neuroinflammation. However, there was no behavioural improvement after MSC application. Conclusions/Significance: To our knowledge this is the first experimental approach of MSC treatment in a transgenic MSA mouse model. Our data suggest that intravenously infused MSCs have a potent effect on immunomodulation and neuroprotection. Our data warrant further studies to elucidate the efficacy of systemically administered MSCs in transgenic MSA models.	[Stemberger, Sylvia; Stefanova, Nadia; Wenning, Gregor K.] Innsbruck Med Univ, Div Clin Neurobiol, Dept Neurol, Innsbruck, Austria; [Stemberger, Sylvia; Stefanova, Nadia; Reindl, Markus; Wenning, Gregor K.] Innsbruck Med Univ, Clin Dept Neurol, Innsbruck, Austria; [Jamnig, Angelika; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Austrian Academy of Sciences	Stemberger, S (corresponding author), Innsbruck Med Univ, Div Clin Neurobiol, Dept Neurol, Innsbruck, Austria.	sylvia.stemberger@i-med.ac.at	Stefanova, Nadia/ABF-5664-2020; Reindl, Markus/ABE-5880-2020	Stefanova, Nadia/0000-0001-8188-639X; Lepperdinger, Gunter/0000-0002-4265-4489; Reindl, Markus/0000-0003-2817-1402; Wenning, Gregor/0000-0001-9077-1666	Austrian Research Foundation [FWF W1206]	Austrian Research Foundation(Austrian Science Fund (FWF))	This study was supported by the Austrian Research Foundation graduate program SPIN (FWF W1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carter RJ, 1999, J NEUROSCI, V19, P3248; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Darlington PJ, 2010, ANN NEUROL, V68, P540, DOI 10.1002/ana.22065; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Koellensperger M, 2009, J NEUROSCI RES, V87, P1679, DOI 10.1002/jnr.21972; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Mayhew TM, 1996, J ANAT, V188, P1; Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745; Offen D, 2007, J NEURAL TRANSM-SUPP, P133; Ozawa T, 2006, ACTA NEUROPATHOL, V112, P531, DOI 10.1007/s00401-006-0109-1; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Park HJ, 2011, CELL TRANSPLANT, V20, P827, DOI 10.3727/096368910X540630; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Puschban Z, 2005, BRAIN RES BULL, V68, P54, DOI 10.1016/j.brainresbull.2005.08.025; Puschban Z, 2000, NEUROSCIENCE, V95, P377; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stefanova N, 2010, MOVEMENT DISORD, V25, pS625; Stefanova N, 2008, EXP NEUROL, V210, P421, DOI 10.1016/j.expneurol.2007.11.022; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Stefanova N, 2009, EXP NEUROL, V219, P368, DOI 10.1016/j.expneurol.2009.05.016; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; Wenning GK, 1996, MOVEMENT DISORD, V11, P522, DOI 10.1002/mds.870110507; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zhao H, 2004, CYTOKINE, V28, P1, DOI 10.1016/j.cyto.2004.05.004	58	67	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19808	10.1371/journal.pone.0019808	http://dx.doi.org/10.1371/journal.pone.0019808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625635	gold, Green Submitted, Green Published			2022-12-27	WOS:000290720200034
J	Zhou, TB; Qin, YH; Su, LN; Lei, FY; Huang, WF; Zhao, YJ				Zhou, Tian-Biao; Qin, Yuan-Han; Su, Li-Na; Lei, Feng-Ying; Huang, Wei-Fang; Zhao, Yan-Jun			ACE I/D Gene Polymorphism Can't Predict the Steroid Responsiveness in Asian Children with Idiopathic Nephrotic Syndrome: A Meta-Analysis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; INSERTION/DELETION POLYMORPHISM; EARLY-DIAGNOSIS; EGYPTIAN CHILDREN; IGA NEPHROPATHY; ASSOCIATION; SYSTEM; METHYLATION; DISEASE; RISK	Background: The results from the published studies on the association between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and the treatment response to steroid in Asian children with idiopathic nephrotic syndrome (INS) is still conflicting. This meta-analysis was performed to evaluate the relation between ACE I/D gene polymorphism and treatment response to steroid in Asian children and to explore whether ACE D allele or DD genotype could become a predictive marker for steroid responsiveness. Methodology/Principal Findings: Association studies were identified from the databases of PubMed, Embase, Cochrane Library and CBM-disc (China Biological Medicine Database) as of September 1, 2010, and eligible investigations were synthesized using meta-analysis method. Five investigations were identified for the analysis of association between ACE I/D gene polymorphism and steroid-resistant nephrotic syndrome (SRNS) risk in Asian children and seven studies were included to explore the relationship between ACE I/D gene polymorphism and steroid-sensitive nephrotic syndrome (SSNS) susceptibility. Five investigations were recruited to explore the difference of ACE I/D gene distribution between SRNS and SSNS. There was no a markedly association between D allele or DD genotype and SRNS susceptibility or SSNS risk, and the gene distribution differences of ACE between SRNS and SSNS were not statistically significant. II genotype might play a positive role against SRNS onset but not for SSNS (OR = 0.51, P = 0.02; OR = 0.95, P = 0.85; respectively), however, the result for the association of II genotype with SRNS risk was not stable. Conclusions/Significance: Our results indicate that D allele or DD homozygous can't become a significant genetic molecular marker to predict the treatment response to steroid in Asian children with INS.	[Zhou, Tian-Biao; Qin, Yuan-Han; Su, Li-Na; Lei, Feng-Ying; Huang, Wei-Fang; Zhao, Yan-Jun] GuangXi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China	Guangxi Medical University	Qin, YH (corresponding author), GuangXi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China.	yuanhanqin@yahoo.cn	zhou, tian-biao/B-8201-2012	Li, Weijia/0000-0002-7546-6388				Al-Eisa A, 2001, SCAND J UROL NEPHROL, V35, P239; Correa SAA, 2009, J RENIN-ANGIO-ALDO S, V10, P51, DOI 10.1177/1470320309102317; Arfa Imen, 2010, Tunis Med, V88, P38; Bukreeva L, 2009, J RENIN-ANGIO-ALDO S, V10, P237, DOI 10.1177/1470320309343813; Burns WC, 2011, CELLS TISSUES ORGANS, V193, P74, DOI 10.1159/000320359; Butani L, 2009, PEDIATR NEPHROL, V24, P1517, DOI 10.1007/s00467-009-1220-z; Celik US, 2006, RENAL FAILURE, V28, P401, DOI 10.1080/08860220600599084; Chang JW, 2009, EUR J PEDIATR, V168, P1189, DOI 10.1007/s00431-008-0902-z; Costa AM, 2009, EUR J APPL PHYSIOL, V106, P785, DOI 10.1007/s00421-009-1080-z; DANG XQ, 2000, CHIN J PEDIAT, V38, P288; Fahmy ME, 2008, BRATISL MED J, V109, P298; Fedor R, 2010, TRANSPL P, V42, P2304, DOI 10.1016/j.transproceed.2010.05.020; Goodman C, 2009, AM J REPROD IMMUNOL, V62, P365, DOI 10.1111/j.1600-0897.2009.00744.x; Huang HD, 2010, CHINESE MED J-PEKING, V123, P3238, DOI 10.3760/cma.j.issn.0366-6999.2010.22.012; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Jung S, 2010, ONCOL REP, V23, P1675, DOI 10.3892/or_00000811; Khurana M, 2006, PEDIATR NEPHROL, V21, P1257, DOI 10.1007/s00467-006-0165-8; Lambert DW, 2010, CELL MOL LIFE SCI, V67, P89, DOI 10.1007/s00018-009-0152-x; Lubel JS, 2008, J GASTROEN HEPATOL, V23, P1327, DOI 10.1111/j.1440-1746.2008.05461.x; Madani A, 2010, IRAN J KIDNEY DIS, V4, P292; Manrique-Rodriguez S, 2010, PHARM WORLD SCI, V32, P314, DOI 10.1007/s11096-010-9380-2; Moribe T, 2008, INT J ONCOL, V33, P949, DOI 10.3892/ijo_00000082; Oktem F, 2004, PEDIATR NEPHROL, V19, P384, DOI 10.1007/s00467-003-1398-4; Patil S J, 2005, Indian J Med Sci, V59, P431; QIN YH, 2011, J RENIN ANGIOTENSIN; Ribeiro-Oliveira A, 2008, VASC HEALTH RISK MAN, V4, P787; Saber-Ayad M, 2010, J RENIN-ANGIO-ALDO S, V11, P111, DOI 10.1177/1470320309359021; Sasse B, 2006, NEPHROLOGY, V11, P538, DOI 10.1111/j.1440-1797.2006.00669.x; Schena FP, 2001, KIDNEY INT, V60, P732, DOI 10.1046/j.1523-1755.2001.060002732.x; Serdaroglu E, 2005, PEDIATR NEPHROL, V20, P1738, DOI 10.1007/s00467-005-2010-x; Settin A, 2009, J RENIN-ANGIO-ALDO S, V10, P96, DOI 10.1177/1470320309105198; Sun QP, 2010, J MOL DIAGN, V12, P718, DOI 10.2353/jmoldx.2010.100002; Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a; Tronvik E, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-4; Tsai IJ, 2006, AM J NEPHROL, V26, P157, DOI 10.1159/000092982; Woroniecki RP, 2006, AM J NEPHROL, V26, P258, DOI 10.1159/000093814; [杨方 Yang Fang], 2005, [暨南大学学报. 自然科学与医学版, Journal of Jinan University], V26, P246; Yong D, 2006, AM J NEPHROL, V26, P511, DOI 10.1159/000097367; Zhang YG, 2011, ALLERGY, V66, P197, DOI 10.1111/j.1398-9995.2010.02438.x	39	51	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19599	10.1371/journal.pone.0019599	http://dx.doi.org/10.1371/journal.pone.0019599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611163	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200018
J	Hou, LP; Phillips, C; Azaro, M; Brzustowicz, LM; Bartlett, CW				Hou, Liping; Phillips, Christopher; Azaro, Marco; Brzustowicz, Linda M.; Bartlett, Christopher W.			Validation of a Cost-Efficient Multi-Purpose SNP Panel for Disease Based Research	PLOS ONE			English	Article							HUMAN GENOME; IDENTIFICATION; ASSOCIATION; ASSAY; STRATIFICATION; PROJECT; PROGRAM	Background: Here we present convergent methodologies using theoretical calculations, empirical assessment on in-house and publicly available datasets as well as in silico simulations, that validate a panel of SNPs for a variety of necessary tasks in human genetics disease research before resources are committed to larger-scale genotyping studies on those samples. While large-scale well-funded human genetic studies routinely have up to a million SNP genotypes, samples in a human genetics laboratory that are not yet part of such studies may be productively utilized in pilot projects or as part of targeted follow-up work though such smaller scale applications require at least some genome-wide genotype data for quality control purposes such as DNA "barcoding'' to detect swaps or contamination issues, determining familial relationships between samples and correcting biases due to population effects such as population stratification in pilot studies. Principal Findings: Empirical performance in classification of relative types for any two given DNA samples (e. g., full siblings, parental, etc) indicated that for outbred populations the panel performs sufficiently to classify relationship in extended families and therefore also for smaller structures such as trios and for twin zygosity testing. Additionally, familial relationships do not significantly diminish the (mean match) probability of sharing SNP genotypes in pedigrees, further indicating the uniqueness of the "barcode.'' Simulation using these SNPs for an African American case-control disease association study demonstrated that population stratification, even in complex admixed samples, can be adequately corrected under a range of disease models using the SNP panel. Conclusion: The panel has been validated for use in a variety of human disease genetics research tasks including sample barcoding, relationship verification, population substructure detection and statistical correction. Given the ease of genotyping our specific assay contained herein, this panel represents a useful and economical panel for human geneticists.	[Hou, Liping; Bartlett, Christopher W.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH USA; [Phillips, Christopher] Univ Santiago de Compostela, Genom Med Grp, Forens Genet Dept, Galicia, Spain; [Phillips, Christopher] Hosp Clin Univ, Genom Med Grp, Ctr Nacl Genotipado CeGen, Galicia, Spain; [Azaro, Marco; Brzustowicz, Linda M.] Rutgers State Univ, Dept Genet, New Brunswick, NJ 08903 USA; [Bartlett, Christopher W.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Universidade de Santiago de Compostela; Rutgers State University New Brunswick; University System of Ohio; Ohio State University	Hou, LP (corresponding author), Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH USA.	Christopher.Bartlett@nationwidechildrens.org	Bartlett, Christopher/B-4958-2009; Hou, Liping/G-1648-2011; Phillips, Christopher/E-4005-2012; Bartlett, Christopher/AAD-8813-2022	Bartlett, Christopher/0000-0001-7837-6348; Hou, Liping/0000-0003-3972-245X; Phillips, Christopher/0000-0002-9601-0128; Bartlett, Christopher/0000-0001-7837-6348	NIH [R01 DC009453]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for this research came from NIH R01 DC009453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo J, 2008, INT J LEGAL MED, V122, P435, DOI 10.1007/s00414-008-0233-7; Bartlett CW, 2002, AM J HUM GENET, V71, P45, DOI 10.1086/341095; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Borsting C, 2008, FORENSIC SCI INT-GEN, V2, P292, DOI 10.1016/j.fsigen.2008.03.007; Bruse SE, 2008, BIOTECHNIQUES, V45, P559, DOI 10.2144/000112960; BUTLER JM, 2008, GENETICS S, V1, P471; CARTWRIGHT P, 1994, MAKE PEDFILES; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Musgrave-Brown E, 2007, FORENSIC SCI INT-GEN, V1, P186, DOI 10.1016/j.fsigen.2007.01.004; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P180, DOI 10.1016/j.fsigen.2007.02.007; Porras L, 2009, FORENSIC SCI INT-GEN, V4, pE9, DOI 10.1016/j.fsigen.2008.12.003; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Santos C, 2011, FORENSIC SCI INT-GEN, V5, pE25, DOI 10.1016/j.fsigen.2010.03.006; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wright FA, 2007, BIOINFORMATICS, V23, P2581, DOI 10.1093/bioinformatics/btm386	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19699	10.1371/journal.pone.0019699	http://dx.doi.org/10.1371/journal.pone.0019699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611176	Green Submitted, Green Published, gold			2022-12-27	WOS:000290657500013
J	Symoens, S; Malfait, F; Vlummens, P; Hermanns-Le, T; Syx, D; De Paepe, A				Symoens, Sofie; Malfait, Fransiska; Vlummens, Philip; Hermanns-Le, Trinh; Syx, Delfien; De Paepe, Anne			A Novel Splice Variant in the N-propeptide of COL5A1 Causes an EDS Phenotype with Severe Kyphoscoliosis and Eye Involvement	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; SYNDROME TYPE-I; HEREDITARY SPHEROCYTOSIS; SITE; MUTATIONS; COLLAGEN; GENE; EXON; CHAIN; ACTIVATE	Background: The Ehlers-Danlos Syndrome (EDS) is a heritable connective tissue disorder characterized by hyperextensible skin, joint hypermobility and soft tissue fragility. The classic subtype of EDS is caused by mutations in one of the type V collagen genes (COL5A1 and COL5A2). Most mutations affect the type V collagen helical domain and lead to a diminished or structurally abnormal type V collagen protein. Remarkably, only two mutations were reported to affect the extended, highly conserved N-propeptide domain, which plays an important role in the regulation of the heterotypic collagen fibril diameter. We identified a novel COL5A1 N-propeptide mutation, resulting in an unusual but severe classic EDS phenotype and a remarkable splicing outcome. Methodology/Principal Findings: We identified a novel COL5A1 N-propeptide acceptor-splice site mutation (IVS6-2A>G, NM_000093.3_c.925-2A>G) in a patient with cutaneous features of EDS, severe progressive scoliosis and eye involvement. Two mutant transcripts were identified, one with an exon 7 skip and one in which exon 7 and the upstream exon 6 are deleted. Both transcripts are expressed and secreted into the extracellular matrix, where they can participate in and perturb collagen fibrillogenesis, as illustrated by the presence of dermal collagen cauliflowers. Determination of the order of intron removal and computational analysis showed that simultaneous skipping of exons 6 and 7 is due to the combined effect of delayed splicing of intron 7, altered pre-mRNA secondary structure, low splice site strength and possibly disturbed binding of splicing factors. Conclusions/Significance: We report a novel COL5A1 N-propeptide acceptor-splice site mutation in intron 6, which not only affects splicing of the adjacent exon 7, but also causes a splicing error of the upstream exon 6. Our findings add further insights into the COL5A1 splicing order and show for the first time that a single COL5A1 acceptor-splice site mutation can perturb splicing of the upstream exon.	[Symoens, Sofie; Malfait, Fransiska; Vlummens, Philip; Syx, Delfien; De Paepe, Anne] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Hermanns-Le, Trinh] Univ Hosp Sart Tilman, Dept Dermatopathol, Liege, Belgium	Ghent University; Ghent University Hospital; University of Liege	Symoens, S (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	Sofie.Symoens@UGent.be	Malfait, Fransiska/K-7897-2014	Malfait, Fransiska/0000-0002-5010-0304; Syx, Delfien/0000-0001-9421-4496; Vlummens, Philip/0000-0001-8275-2887	Fund for Scientific Research-Flanders; GOA grant; European Commission; Methusalem grant; FWO [G.0171.05, 12051203, 512117, 08/01M01108]; Fund for Scientific Research (FWO), Flanders (Belgium)	Fund for Scientific Research-Flanders(FWO); GOA grant; European Commission(European CommissionEuropean Commission Joint Research Centre); Methusalem grant; FWO(FWO); Fund for Scientific Research (FWO), Flanders (Belgium)(FWO)	Funding for this work was provided by the following: Contract grant sponsor: Fund for Scientific Research-Flanders; GOA grant; "Geneskin'' consortium within the sixth framework program of the European Commission; Methusalem grant. Contract grant number: FWO grant number G.0171.05, GOA grant number 12051203, Geneskin grant number 512117, Methusalem grant number 08/01M01108. FM is a post-doctoral fellow of the Fund for Scientific Research (FWO), Flanders (Belgium). PV and DS are fellows of the Fund for Scientific Research (FWO), Flanders (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bonod-Bidaud C, 2007, BIOCHEM J, V405, P299, DOI 10.1042/BJ20070051; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; DePaepe A, 1997, AM J HUM GENET, V60, P547; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Edelman EJ, 2007, BLOOD, V109, P5491, DOI 10.1182/blood-2006-09-046573; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Fang LJ, 2001, J MOL BIOL, V307, P1261, DOI 10.1006/jmbi.2001.4561; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; Giunta C, 2005, MOL GENET METAB, V86, P269, DOI 10.1016/j.ymgme.2005.04.014; Giunta C, 2002, AM J MED GENET, V109, P284, DOI 10.1002/ajmg.10373; Haire RN, 1997, AM J HUM GENET, V60, P798; HAUSSER I, 1994, HUM GENET, V93, P394; Malfait F, 2005, HUM MUTAT, V25, P28, DOI 10.1002/humu.20107; McAlinden A, 2005, J BIOL CHEM, V280, P32700, DOI 10.1074/jbc.M505940200; Mitchell AL, 2009, HUM MUTAT, V30, P995, DOI 10.1002/humu.21000; Natalizio BJ, 2009, J BIOL CHEM, V284, P8683, DOI 10.1074/jbc.M806919200; Perrotta S, 2009, HAEMATOL-HEMATOL J, V94, P1753, DOI 10.3324/haematol.2009.010124; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schwartz S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000300; Schwarze U, 2004, AM J HUM GENET, V74, P917, DOI 10.1086/420794; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Symoens S, 2009, HUM MUTAT, V30, pE395, DOI 10.1002/humu.20887; Takahara K, 2002, AM J HUM GENET, V71, P451, DOI 10.1086/342099; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20121	10.1371/journal.pone.0020121	http://dx.doi.org/10.1371/journal.pone.0020121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611149	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500045
J	Wang, SH; Martin, SM; Harris, PS; Knudson, CM				Wang, Sih-han; Martin, Sean M.; Harris, Peter S.; Knudson, C. Michael			Caspase Inhibition Blocks Cell Death and Enhances Mitophagy but Fails to Promote T-Cell Lymphoma	PLOS ONE			English	Article							SOMATIC FRAMESHIFT MUTATIONS; TUMOR-SUPPRESSOR; CHROMOSOMAL INSTABILITY; PROGNOSTIC-SIGNIFICANCE; TRANSGENIC MICE; AUTOPHAGY GENE; APOPTOSIS; APAF-1; BAX; CANCER	Caspase-9 is a component of the apoptosome that mediates cell death following release of cytochrome c from mitochondria. Inhibition of Caspase-9 with a dominant negative construct (Casp9DN) blocks apoptosome function, promotes viability and has been implicated in carcinogenesis. Inhibition of the apoptosome in vitro impairs mitochondrial function and promotes mitophagy. To examine whether inhibition of the apoptosome would enhance mitophagy and promote oncogenesis in vivo, transgenic mice were generated that express Casp9DN in the T cell lineage. The effects of Casp9DN on thymocyte viability, mitophagy and thymic tumor formation were examined. In primary thymocytes, Casp9DN delayed dexamethasone (Dex)-induced cell death, altered mitochondrial structure, and decreased oxidant production. Transmission electron microscopy (TEM) revealed that inhibition of the apoptosome resulted in structurally abnormal mitochondria that in some cases were engulfed by double-membrane structures resembling autophagosomes. Consistent with mitochondria being engulfed by autophagosomes (mitophagy), confocal microscopy showed colocalization of LC3-GFP and mitochondria. However, Casp9DN did not significantly accelerate T-cell lymphoma alone, or in combination with Lck-Bax38/1, or with Beclin 1+/2 mice, two tumor-prone strains in which altered mitochondrial function has been implicated in promoting tumor development. In addition, heterozygous disruption of Beclin 1 had no effect on T-cell lymphoma formation in Lck-Bax38/1 mice. Further studies showed that Beclin 1 levels had no effect on Casp9DN-induced loss of mitochondrial function. These results demonstrate that neither inhibition of apoptosome function nor Beclin 1 haploinsufficiency accelerate T-cell lymphoma development in mice.	[Wang, Sih-han; Martin, Sean M.; Harris, Peter S.; Knudson, C. Michael] Univ Iowa, Dept Pathol, Roy J & Lucille P Carver Coll Med, Iowa City, IA 52242 USA; [Wang, Sih-han; Knudson, C. Michael] Univ Iowa, Free Radical & Radiat Biol Program, Roy J & Lucille P Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa	Wang, SH (corresponding author), Univ Iowa, Dept Pathol, Roy J & Lucille P Carver Coll Med, Iowa City, IA 52242 USA.	c-knudson@uiowa.edu	Wang, Sih-han/M-6523-2013	Wang, Sih-han/0000-0002-9870-3761; Knudson, Charles Michael/0000-0003-3964-5466	National Cancer Institute [CA104695]; National Institutes of Health; Roy J. and Lucille A. Carver College of Medicine; NATIONAL CANCER INSTITUTE [R01CA104695] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. and Lucille A. Carver College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute RO1 #CA104695 (CMK). Lck-Casp9DN transgenic mice were generated at the University of Iowa Transgenic Animal Facility, directed by Curt D. Sigmund, Ph.D. and supported in part by grants from the National Institutes of Health and from the Roy J. and Lucille A. Carver College of Medicine. The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Brown NM, 2007, J BIOL CHEM, V282, P2144, DOI 10.1074/jbc.M607961200; Catchpoole DR, 2001, EUR J CANCER, V37, P2217, DOI 10.1016/S0959-8049(01)00273-8; Cheng N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001911; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; de Wetering CIV, 2008, FREE RADICAL BIO MED, V44, P1677, DOI 10.1016/j.freeradbiomed.2008.01.022; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim MS, 2008, DIGEST LIVER DIS, V40, P599, DOI 10.1016/j.dld.2008.02.008; Knudson CM, 2001, CANCER RES, V61, P659; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Luke JJ, 2003, CELL DEATH DIFFER, V10, P740, DOI 10.1038/sj.cdd.4401233; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Soung YH, 2006, APMIS, V114, P292, DOI 10.1111/j.1600-0463.2006.apm_364.x; Strater J, 2010, INT J CANCER, V127, P873, DOI 10.1002/ijc.25111; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Werth JL, 2000, EXP NEUROL, V161, P203, DOI 10.1006/exnr.1999.7241; Yamamoto H, 1998, CANCER RES, V58, P997; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19786	10.1371/journal.pone.0019786	http://dx.doi.org/10.1371/journal.pone.0019786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611191	gold, Green Submitted, Green Published			2022-12-27	WOS:000290657500022
J	Le, CF; Palanisamy, NK; Yusof, MYM; Sekaran, SD				Le, Cheng-Foh; Palanisamy, Navindra Kumari; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi			Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE; CHILDREN; SUSCEPTIBILITIES; MENINGITIS	Background: Streptococcus pneumoniae is a major causative agent of severe infections, including sepsis, pneumonia, meningitis, and otitis media, that has since become a major public health concern. In this study, the serotypes distribution of pneumococcal isolates was investigated to predict the efficacy of the 7-valent pneumococcal conjugate vaccine (PCV7) among the Malaysian populations. Methodology/Principal Findings: A total of 151 clinical isolates were serotyped using multiplex PCR assays. Out of them, there were 21.2% penicillin-resistant, 29.1% penicillin-intermediate, and 49.7% penicillin-susceptible S. pneumoniae strains. Serotypes detected among the Malaysian isolates were 1, 3, 10A, 11A/11D, 12F/12A, 14, 15A, 15B/15C, 16F, 18C/18B/18A/18F, 19A, 19F, 23F, 35B, 35F/47F, 6A/6B, 7C/7B/40, 7F/7A, 9V/9A, and 34. Serotype 19F and 23F were the two most prevalent serotypes detected. Serotypes are highly associated with invasiveness of isolates (p = 0.001) and penicillin susceptibility (p<0.001). Serotype 19F was observed to have increased resistance against penicillin while serotype 19A has high invasive tendency. Age of patients was an important factor underlying the pneumococcal serotypes (p = 0.03) and clinical sites of infections (p<0.001). High prevalence of pneumococcal isolates were detected among children <5 years old at nasopharyngeal sites while elderly adults >= 60 years old were at increased risk for pneumococcal bacteremia. Conclusion/Significance: Current study revealed that a number of serotypes, especially those associated with high penicillin resistance, have been formulated in the PCV7. Therefore, the protections expected from the routine use of PCV7 would be encouraging for the Malaysian. However, it is not possible to predict serotypes that might become predominant in the future and hence continued surveillance of circulating serotypes will be needed.	[Le, Cheng-Foh; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Palanisamy, Navindra Kumari] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia	Universiti Malaya; Universiti Teknologi MARA	Le, CF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	MD YUSOF, MOHD YASIM/B-9133-2010; Sekaran, Shamala Devi/B-8482-2008; Devi, Shamala Devi/B-9735-2010	Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; Le, Cheng Foh/0000-0002-2295-6690	Ministry of Science and Technology, Malaysia [36-02-03-6027]	Ministry of Science and Technology, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was supported by a grant provided by the Ministry of Science and Technology, Malaysia: 36-02-03-6027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arai S, 2001, MICROBIOL IMMUNOL, V45, P159, DOI 10.1111/j.1348-0421.2001.tb01284.x; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; Catterall JR, 1999, THORAX, V54, P929, DOI 10.1136/thx.54.10.929; CHEONG YM, 1988, J TROP PEDIATRICS, V34, P182, DOI 10.1093/tropej/34.4.182; CHOO KE, 1990, ANN TROP PAEDIATR, V10, P89, DOI 10.1080/02724936.1990.11747415; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI; Desa Mohd Nasir Mohd, 2003, International Journal of Infectious Diseases, V7, P190, DOI 10.1016/S1201-9712(03)90051-8; Dobay O, 2003, J ANTIMICROB CHEMOTH, V51, P887, DOI 10.1093/jac/dkg171; Hussain IHMI, 1998, PEDIATR INFECT DIS J, V17, pS189, DOI 10.1097/00006454-199809001-00021; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jacobs MR, 1999, ANTIMICROB AGENTS CH, V43, P1901, DOI 10.1128/AAC.43.8.1901; JAMAL F, 1987, J TROP MED PUBLIC HL, V18, P79; Lim LH, 2007, J PAEDIATR CHILD H, V43, P366, DOI 10.1111/j.1440-1754.2007.01081.x; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pankuch GA, 2003, J ANTIMICROB CHEMOTH, V51, P443, DOI 10.1093/jac/dkg091; Rohani MY, 1999, EPIDEMIOL INFECT, V122, P77, DOI 10.1017/S0950268898001605; Rohani MY, 1999, J ANTIMICROB CHEMOTH, V44, P852, DOI 10.1093/jac/44.6.852; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; SNIADACK DH, 1995, PEDIATR INFECT DIS J, V14, P503, DOI 10.1097/00006454-199506000-00007; TEE AC, 1993, THESIS U MALAYA; UNAL S, 1992, J CLIN MICROBIOL, V30, P1685, DOI 10.1128/JCM.30.7.1685-1691.1992	23	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19547	10.1371/journal.pone.0019547	http://dx.doi.org/10.1371/journal.pone.0019547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603602	gold, Green Submitted, Green Published			2022-12-27	WOS:000290656300012
J	Chou, SW; Hwang, PS; Gomez, G; Fernando, CA; West, MC; Pollock, LM; Lin-Jones, J; Burnside, B; McDermott, BM				Chou, Shih-Wei; Hwang, Philsang; Gomez, Gustavo; Fernando, Carol A.; West, Megan C.; Pollock, Lana M.; Lin-Jones, Jennifer; Burnside, Beth; McDermott, Brian M., Jr.			Fascin 2b Is a Component of Stereocilia that Lengthens Actin-Based Protrusions	PLOS ONE			English	Article							HAIR CELL STEREOCILIA; BUNDLING PROTEIN; MOLECULAR TREADMILL; BIRD COCHLEA; INNER-EAR; IN-VIVO; ESPIN; EXPRESSION; FILAMENTS; BINDING	Stereocilia are actin-filled protrusions that permit mechanotransduction in the internal ear. To identify proteins that organize the cytoskeleton of stereocilia, we scrutinized the hair-cell transcriptome of zebrafish. One promising candidate encodes fascin 2b, a filamentous actin-bundling protein found in retinal photoreceptors. Immunolabeling of zebrafish hair cells and the use of transgenic zebrafish that expressed fascin 2b fused to green fluorescent protein demonstrated that fascin 2b localized to stereocilia specifically. When filamentous actin and recombinant fusion protein containing fascin 2b were combined in vitro to determine their dissociation constant, a K(d)approximate to 0.37 mu M was observed. Electron microscopy showed that fascin 2b-actin filament complexes formed parallel actin bundles in vitro. We demonstrated that expression of fascin 2b or espin, another actin-bundling protein, in COS-7 cells induced the formation of long filopodia. Coexpression showed synergism between these proteins through the formation of extra-long protrusions. Using phosphomutant fascin 2b proteins, which mimicked either a phosphorylated or a nonphosphorylated state, in COS-7 cells and in transgenic hair cells, we showed that both formation of long filopodia and localization of fascin 2b to stereocilia were dependent on serine 38. Overexpression of wild-type fascin 2b in hair cells was correlated with increased stereociliary length relative to controls. These findings indicate that fascin 2b plays a key role in shaping stereocilia.	[Chou, Shih-Wei; Hwang, Philsang; Gomez, Gustavo; Fernando, Carol A.; West, Megan C.; Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Chou, Shih-Wei; Hwang, Philsang; West, Megan C.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Lin-Jones, Jennifer; Burnside, Beth] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Berkeley	Chou, SW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.	bmm30@case.edu			March of Dimes Foundation [5-FY07-663]; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health [DC009437, GM-08613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613, T32GM008056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009437] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-663 from the March of Dimes Foundation (B. M. M.), the Center for Clinical Research and Technology at University Hospitals Case Medical Center (B. M. M.), and National Institutes of Health Grant DC009437 (B. M. M.). National Institutes of Health (NIH) Training Grant GM-08613 supports L. M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Belyantseva IA, 2003, TRENDS MOL MED, V9, P458, DOI 10.1016/j.molmed.2003.09.008; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Chen B, 1999, MOL BIOL CELL, V10, P4327, DOI 10.1091/mbc.10.12.4327; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; Daudet N, 2002, CELL MOTIL CYTOSKEL, V53, P326, DOI 10.1002/cm.10092; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Eatock RA, 2003, CURR TOP DEV BIOL, V57, P389, DOI 10.1016/S0070-2153(03)57013-2; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Leong DT, 2007, BIOMATERIALS, V28, P203, DOI 10.1016/j.biomaterials.2006.09.011; Li HW, 2004, J COMP NEUROL, V468, P125, DOI 10.1002/cne.10944; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; McDermott BM, 2010, GENE EXPR PATTERNS, V10, P113, DOI 10.1016/j.gep.2010.01.001; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ono S, 1997, J BIOL CHEM, V272, P2527; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sambrook J, 2001, MOL CLONING LAB MANU; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Sekerkova G, 2006, CELL MOL LIFE SCI, V63, P2329, DOI 10.1007/s00018-006-6148-x; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; TILNEY LG, 1992, DEVELOPMENT, V116, P213; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	52	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e14807	10.1371/journal.pone.0014807	http://dx.doi.org/10.1371/journal.pone.0014807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21625653	Green Submitted, Green Published, gold			2022-12-27	WOS:000290018400002
J	Das, R				Das, Rhiju			Four Small Puzzles That Rosetta Doesn't Solve	PLOS ONE			English	Article							ALL-ATOM REFINEMENT; DE-NOVO PREDICTION; HIGH-RESOLUTION; PROTEIN STRUCTURES; RNA STRUCTURE; 3-DIMENSIONAL STRUCTURE; COMPUTATIONAL DESIGN; ANGSTROM RESOLUTION; TERTIARY STRUCTURES; RIBOSOMAL-RNA	A complete macromolecule modeling package must be able to solve the simplest structure prediction problems. Despite recent successes in high resolution structure modeling and design, the Rosetta software suite fares poorly on small protein and RNA puzzles, some as small as four residues. To illustrate these problems, this manuscript presents Rosetta results for four well-defined test cases: the 20-residue mini-protein Trp cage, an even smaller disulfide-stabilized conotoxin, the reactive loop of a serine protease inhibitor, and a UUCG RNA tetraloop. In contrast to previous Rosetta studies, several lines of evidence indicate that conformational sampling is not the major bottleneck in modeling these small systems. Instead, approximations and omissions in the Rosetta all-atom energy function currently preclude discriminating experimentally observed conformations from de novo models at atomic resolution. These molecular "puzzles'' should serve as useful model systems for developers wishing to make foundational improvements to this powerful modeling suite.	[Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Das, R (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	rhiju@stanford.edu		Das, Rhiju/0000-0001-7497-0972	Burroughs-Wellcome Career Award; National Science Foundation [CNS-0619926]	Burroughs-Wellcome Career Award(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF))	This work was supported by a Burroughs-Wellcome Career Award at the Scientific Interface: http://www.bwfund.org/pages/129/Career-Awards-at-the-Scientific-Interface/. Computations were carried out on the BioX2 cluster (National Science Foundation award CNS-0619926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Auffinger P, 2003, CHEM BIOL, V10, P551, DOI 10.1016/S1074-5521(03)00121-2; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Blose JM, 2009, J AM CHEM SOC, V131, P8474, DOI 10.1021/ja900065e; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Correll CC, 2003, NUCLEIC ACIDS RES, V31, P6806, DOI 10.1093/nar/gkg908; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Dast R, 2008, P NATL ACAD SCI USA, V105, P4144, DOI 10.1073/pnas.0709032105; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Eastman P, 2010, J COMPUT CHEM, V31, P1268, DOI 10.1002/jcc.21413; Guddat LW, 1996, BIOCHEMISTRY-US, V35, P11329, DOI 10.1021/bi960820h; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kladwang W, 2011, RNA, V17, P522, DOI 10.1261/rna.2516311; Kortemme T, 2004, SCI STKE, V2004; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lassila JK, 2010, P NATL ACAD SCI USA, V107, P4937, DOI 10.1073/pnas.0913638107; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McKnight CJ, 1996, J MOL BIOL, V260, P126; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467	50	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20044	10.1371/journal.pone.0020044	http://dx.doi.org/10.1371/journal.pone.0020044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625446	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400036
J	Montero-Pau, J; Serra, M				Montero-Pau, Javier; Serra, Manuel			Life-Cycle Switching and Coexistence of Species with No Niche Differentiation	PLOS ONE			English	Article							SEXUAL REPRODUCTION; INDUCTION; ALLOCATION; DIAPAUSE; SIMILARITY; DIVERGENCE; ROTIFERS; COMPLEX; GROWTH	The increasing evidence of coexistence of cryptic species with no recognized niche differentiation has called attention to mechanisms reducing competition that are not based on niche-differentiation. Only sex-based mechanisms have been shown to create the negative feedback needed for stable coexistence of competitors with completely overlapping niches. Here we show that density-dependent sexual and diapause investment can mediate coexistence of facultative sexual species having identical niches. We modelled the dynamics of two competing cyclical parthenogens with species-specific density-dependent sexual and diapause investment and either equal or different competitive abilities. We show that investment in sexual reproduction creates an opportunity for other species to invade and become established. This may happen even if the invading species is an inferior competitor. Our results suggests a previously unnoticed mechanism for species coexistence and can be extended to other facultative sexual species and species investing in diapause where similar density-dependent life-history switches could act to promote coexistence.	[Montero-Pau, Javier; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat Biol Evolutiva, Valencia, Spain	University of Valencia	Montero-Pau, J (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat Biol Evolutiva, Valencia, Spain.	javier.montero@uv.es	Montero-Pau, Javier/H-6711-2015; Serra, Manuel/H-7817-2015	Montero-Pau, Javier/0000-0002-0864-8157; Serra, Manuel/0000-0003-1731-1529	USA National Science Foundation [EF-0412674]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07364]; Spanish Ministerio de Ciencia y Tecnologia [BES2004-5248]	USA National Science Foundation(National Science Foundation (NSF)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the USA National Science Foundation (EF-0412674) (http://www.nsf.gov), the Spanish Ministerio de Ciencia e Innovacion (CGL2009-07364) (http://www.micinn.es), and by a fellowship to JMP by the Spanish Ministerio de Ciencia y Tecnologia (BES2004-5248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAN S, 1994, HYDROBIOLOGIA, V293, P185, DOI 10.1007/BF00229940; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2002, OECOLOGIA, V131, P35, DOI 10.1007/s00442-001-0856-6; Coelho FF, 2005, REV BIOL TROP, V53, P369; DEMEESTER L, 2004, EVOLUTION MOL ECOSYS; Garcia-Roger EM, 2009, LIMNOL OCEANOGR, V54, P1845, DOI 10.4319/lo.2009.54.6.1845; Gomez A, 2002, EVOLUTION, V56, P1431; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Kubanek J, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P453; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Roff Derek A., 1992; Schroder T, 2005, HYDROBIOLOGIA, V546, P291, DOI 10.1007/s10750-005-4235-x; Serra M, 1999, J EVOLUTION BIOL, V12, P263; Serra M, 2005, J PLANKTON RES, V27, P37, DOI 10.1093/plankt/fbh148; Serra M, 2004, EVOLUTION MOL ECOSYS; Serra M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P281, DOI 10.1007/978-90-481-2770-2_14; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; SNELL TW, 1988, J EXP MAR BIOL ECOL, V124, P73, DOI 10.1016/0022-0981(88)90112-8; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Takada T, 1996, J THEOR BIOL, V182, P179, DOI 10.1006/jtbi.1996.0153; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Zadereev E, 2007, AQUAT ECOL, V41, P255, DOI 10.1007/s10452-006-9062-2; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712	30	29	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20314	10.1371/journal.pone.0020314	http://dx.doi.org/10.1371/journal.pone.0020314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625466	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400054
J	Hu, CX; Wei, H; van den Hoek, AM; Wang, M; van der Heijden, R; Spijksma, G; Reijmers, TH; Bouwman, J; Wopereis, S; Havekes, LM; Verheij, E; Hankemeier, T; Xu, GW; van der Greef, J				Hu, Chunxiu; Wei, Heng; van den Hoek, Anita M.; Wang, Mei; van der Heijden, Rob; Spijksma, Gerwin; Reijmers, Theo H.; Bouwman, Jildau; Wopereis, Suzan; Havekes, Louis M.; Verheij, Elwin; Hankemeier, Thomas; Xu, Guowang; van der Greef, Jan			Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; CARDIOVASCULAR RISK-FACTORS; INCREASES HDL-CHOLESTEROL; CB1 RECEPTOR ANTAGONIST; FREE FATTY-ACIDS; TRANSFER PROTEIN; AGGRAVATES ATHEROSCLEROSIS; OVERWEIGHT PATIENTS; METABOLIC SYNDROME; HEPATIC STEATOSIS	Background: Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes. The first selective cannabinoid-1 receptor blocker rimonabant, an anorectic anti-obesity drug, was frequently used in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m(2) with associated risk factors such as type II diabetes and dyslipidaemia in the past. Less is known about the impact of this drug on the regulation of lipid metabolism in plasma and liver in the early stage of obesity. Methodology/Principal Findings: We designed a four-week parallel controlled intervention on apolipoprotein E3 Leiden cholesteryl ester transfer protein (ApoE*3Leiden. CETP) transgenic mice with mild overweight and hypercholesterolemia. A liquid chromatography-linear ion trap-Fourier transform ion cyclotron resonance-mass spectrometric approach was employed to investigate plasma and liver lipid responses to the rimonabant intervention. Rimonabant was found to induce a significant body weight loss (9.4%, p<0.05) and a significant plasma total cholesterol reduction (24%, p<0.05). Six plasma and three liver lipids in ApoE*3Leiden. CETP transgenic mice were detected to most significantly respond to rimonabant treatment. Distinct lipid patterns between the mice were observed for both plasma and liver samples in rimonabant treatment vs. non-treated controls. This study successfully applied, for the first time, systems biology based lipidomics approaches to evaluate treatment effects of rimonabant in the early stage of obesity. Conclusion: The effects of rimonabant on lipid metabolism and body weight reduction in the early stage obesity were shown to be moderate in ApoE*3Leiden. CETP mice on high-fat diet.	[Hu, Chunxiu; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hu, Chunxiu; van der Heijden, Rob; Spijksma, Gerwin; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Wei, Heng; Wang, Mei; Xu, Guowang; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Wang, Mei; van der Greef, Jan] SU BioMed, Zeist, Netherlands; [van den Hoek, Anita M.; Havekes, Louis M.] TNO, Gaubius Lab, Leiden, Netherlands; [Wei, Heng; Bouwman, Jildau; Wopereis, Suzan; Verheij, Elwin; van der Greef, Jan] TNO, Dept Earth Environm & Life Sci, NL-3700 AJ Zeist, Netherlands; [Bouwman, Jildau; Hankemeier, Thomas] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Netherlands Metab Ctr, Leiden, Netherlands	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; jan.vandergreef@tno.nl	Xu, Guowang/L-6910-2014; van der Heijden, Rob/D-1403-2013; Hankemeier, Thomas/V-5407-2019	Xu, Guowang/0000-0003-4298-3554; Hankemeier, Thomas/0000-0001-7871-2073	Royal Netherlands Academy of Arts and Sciences (KNAW) [05-PhD-07]; Chinese Academy of Sciences (CAS) [05-PhD-07]; Ministry of Science and Technology of China, the Key Foundation [2009DFA41250]; National Natural Science Foundation of China [21021004, 20835006]; SU Biomedicine (SUB) [031.13097]; Netherlands Genomics Initiative	Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Ministry of Science and Technology of China, the Key Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SU Biomedicine (SUB); Netherlands Genomics Initiative	This study was supported by a Joint Ph.D. training grant (number 05-PhD-07) within the China Exchange Program between the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Chinese Academy of Sciences (CAS), by the Sino-Dutch Joint Program supported by the China International Science and Technology Cooperation Program (2009DFA41250) from the Ministry of Science and Technology of China, the Key Foundation (No. 20835006), and the Creative Research Group Project (No. 21021004) from National Natural Science Foundation of China and the Netherlands Genomics Initiative. In addition, the work presented is part of a larger project with Project No. of 031.13097 financially supported by SU Biomedicine (SUB). Authors employed by SUB contributed to experimental conceiving and design, guidance and discussion of the project. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bergheanu SC, 2008, CURR MED RES OPIN, V24, P2477, DOI [10.1185/03007990802321709, 10.1185/03007990802321709 ]; Bijland S, 2010, J LIPID RES, V51, P97, DOI 10.1194/jlr.M900186-JLR200; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; de Haan W, 2008, ATHEROSCLEROSIS, V197, P57, DOI 10.1016/j.atherosclerosis.2007.08.001; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; Despres JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dullaart RPF, 1999, EUR J CLIN INVEST, V29, P663; ENGELI S, 2006, CLIN CORNERSTONE S, V4, pS24; Epstein LH, 1998, PEDIATRICS, V101, P554; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; GRASS DS, 1995, J LIPID RES, V36, P1082; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Jong MC, 1996, ARTERIOSCL THROM VAS, V16, P934, DOI 10.1161/01.ATV.16.8.934; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lafontan M, 2007, DIABETES METAB, V33, P85, DOI 10.1016/j.diabet.2007.02.001; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Mathur P, 2007, INDIAN J PEDIATR, V74, P401, DOI 10.1007/s12098-007-0068-0; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miller Wendy M, 2005, Curr Cardiol Rep, V7, P465, DOI 10.1007/s11886-005-0065-8; Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12; Neuschwander-Tetri BA, 2007, HEPATOLOGY, V46, P12, DOI 10.1002/hep.21821; NISHINA PM, 1990, J LIPID RES, V31, P859; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pagotto U, 2005, ANN MED, V37, P270, DOI 10.1080/07853890510037419; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Papandreou D, 2007, CLIN NUTR, V26, P409, DOI 10.1016/j.clnu.2007.02.002; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Schwarz E, 2008, J PROTEOME RES, V7, P4266, DOI 10.1021/pr800188y; SOTHERN MS, 1993, ANN NY ACAD SCI, V699, P292, DOI 10.1111/j.1749-6632.1993.tb18870.x; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Westerbacka J, 2010, GASTROENTEROLOGY, V139, P1961, DOI 10.1053/j.gastro.2010.06.064; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	56	14	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19423	10.1371/journal.pone.0019423	http://dx.doi.org/10.1371/journal.pone.0019423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611179	Green Published, gold			2022-12-27	WOS:000290657500004
J	Xin, XR; Fan, B; Flammer, J; Miller, NR; Jaggi, GP; Killer, HE; Meyer, P; Neutzner, A				Xin, Xiaorong; Fan, Bin; Flammer, Josef; Miller, Neil R.; Jaggi, Gregor P.; Killer, Hanspeter E.; Meyer, Peter; Neutzner, Albert			Meningothelial Cells React to Elevated Pressure and Oxidative Stress	PLOS ONE			English	Article							NERVE HEAD ASTROCYTES; OPTIC-NERVE; SUBARACHNOID SPACE; PATHOGENESIS; MENINGIOMAS; ACTIVATION; MENINGES; GLAUCOMA; JUNCTION; IMMUNE	Background: Meningothelial cells (MECs) are the cellular components of the meninges enveloping the brain. Although MECs are not fully understood, several functions of these cells have been described. The presence of desmosomes and tight junctions between MECs hints towards a barrier function protecting the brain. In addition, MECs perform endocytosis and, by the secretion of cytokines, are involved in immunological processes in the brain. However, little is known about the influence of pathological conditions on MEC function; e. g., during diseases associated with elevated intracranial pressure, hypoxia or increased oxidative stress. Methods: We studied the effect of elevated pressure, hypoxia, and oxidative stress on immortalized human as well as primary porcine MECs. We used MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) bioreduction assays to assess the proliferation of MECs in response to treatment and compared to untreated control cells. To assess endocytotic activity, the uptake of fluorescently labeled latex beads was analyzed by fluorescence microscopy. Results: We found that exposure of MECs to elevated pressure caused significant cellular proliferation and a dramatic decrease in endocytotic activity. In addition, mild oxidative stress severely inhibited endocytosis. Conclusion: Elevated pressure and oxidative stress impact MEC physiology and might therefore influence the microenvironment of the subarachnoid space and thus the cerebrospinal fluid within this compartment with potential negative impact on neuronal function.	[Xin, Xiaorong; Fan, Bin; Flammer, Josef; Meyer, Peter; Neutzner, Albert] Univ Basel Hosp, Dept Biomed Ocular Pharmacol & Physiol, CH-4031 Basel, Switzerland; [Xin, Xiaorong; Fan, Bin; Flammer, Josef; Meyer, Peter; Neutzner, Albert] Univ Basel Hosp, Dept Ophthalmol, CH-4031 Basel, Switzerland; [Miller, Neil R.] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA; [Jaggi, Gregor P.; Killer, Hanspeter E.] Kantonsspital, Dept Ophthalmol, Aarau, Switzerland	University of Basel; University of Basel; Johns Hopkins University; Johns Hopkins Medicine; Kantonsspital Aarau AG (KSA)	Xin, XR (corresponding author), Univ Basel Hosp, Dept Biomed Ocular Pharmacol & Physiol, CH-4031 Basel, Switzerland.	albert.neutzner@unibas.ch	Neutzner, Albert/ABC-4368-2020	Jaggi, Gregor/0000-0002-5925-238X; Neutzner, Albert/0000-0001-9254-5558	Messerli Foundation; Zurich; Grieshaber Foundation for Eye Research	Messerli Foundation; Zurich; Grieshaber Foundation for Eye Research	Financial support was provided by the Messerli Foundation, Zurich and the Grieshaber Foundation for Eye Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat K, 2008, CELL TISSUE RES, V331, P401, DOI 10.1007/s00441-007-0512-5; Alomar SA, 2010, SEMIN DIAGN PATHOL, V27, P97, DOI 10.1053/j.semdp.2010.06.001; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x; Hashimoto K, 2005, BRAIN RES, V1054, P103, DOI 10.1016/j.brainres.2005.06.050; Kastenbauer S, 2002, NEUROLOGY, V58, P186, DOI 10.1212/WNL.58.2.186; Killer HE, 2007, BRAIN, V130, P514, DOI 10.1093/brain/awl324; Killer HE, 2008, CLIN EXP OPHTHALMOL, V36, P308, DOI 10.1111/j.1442-9071.2008.01735.x; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Malone P, 2007, GLIA, V55, P1085, DOI 10.1002/glia.20527; Mandal A, 2009, AM J PHYSIOL-CELL PH, V297, pC111, DOI 10.1152/ajpcell.00539.2008; Mattsson N, 2009, ANN NY ACAD SCI, V1180, P28, DOI 10.1111/j.1749-6632.2009.04944.x; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; Pache M, 2006, OPHTHALMOLOGICA, V220, P393, DOI 10.1159/000095867; Puttmann S, 2005, LAB INVEST, V85, P1163, DOI 10.1038/labinvest.3700307; Robinson K, 2004, CELL MICROBIOL, V6, P927, DOI 10.1111/j.1462-5822.2004.00410.x; Sinclair AJ, 2008, J NEUROIMMUNOL, V201, P212, DOI 10.1016/j.jneuroim.2008.06.029; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; XIN X, 2010, GRAEFES ARC IN PRESS	20	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20142	10.1371/journal.pone.0020142	http://dx.doi.org/10.1371/journal.pone.0020142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611150	Green Published, Green Submitted, gold			2022-12-27	WOS:000290657500046
J	Enjuanes, A; Fernandez, V; Hernandez, L; Navarro, A; Bea, S; Pinyol, M; Lopez-Guillermo, A; Rosenwald, A; Ott, G; Campo, E; Jares, P				Enjuanes, Anna; Fernandez, Veronica; Hernandez, Luis; Navarro, Alba; Bea, Silvia; Pinyol, Magda; Lopez-Guillermo, Armando; Rosenwald, Andreas; Ott, German; Campo, Elias; Jares, Pedro			Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; GENOME-WIDE ANALYSIS; DNA HYPERMETHYLATION; CANCER; EXPRESSION; BREAST; DEMETHYLATION; EPIGENETICS; PATTERNS; FREQUENT	Background: Mantle cell lymphoma (MCL) is genetically characterized by the t(11; 14)(q13; q32) translocation and a high number of secondary chromosomal alterations. The contribution of DNA methylation to MCL lymphomagenesis is not well known. We sought to identify epigenetically silenced genes in these tumours that might have clinical relevance. Methodology/Principal Findings: To identify potential methylated genes in MCL we initially investigated seven MCL cell lines treated with epigenetic drugs and gene expression microarray profiling. The methylation status of selected candidate genes was validated by a quantitative assay and subsequently analyzed in a series of primary MCL (n = 38). After pharmacological reversion we identified 252 potentially methylated genes. The methylation analysis of a subset of these genes (n = 25) in the MCL cell lines and normal B lymphocytes confirmed that 80% of them were methylated in the cell lines but not in normal lymphocytes. The subsequent analysis in primary MCL identified five genes (SOX9, HOXA9, AHR, NR2F2, and ROBO1) frequently methylated in these tumours. The gene methylation events tended to occur in the same primary neoplasms and correlated with higher proliferation, increased number of chromosomal abnormalities, and shorter survival of the patients. Conclusions: We have identified a set of genes whose methylation degree and gene expression levels correlate with aggressive clinicopathological features of MCL. Our findings also suggest that a subset of MCL might show a CpG island methylator phenotype (CIMP) that may influence the behaviour of the tumours.	[Enjuanes, Anna; Fernandez, Veronica; Hernandez, Luis; Navarro, Alba; Bea, Silvia; Campo, Elias; Jares, Pedro] Univ Barcelona, Hematopathol Sect, Dept Anat Pathol, Hosp Clin,Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Pinyol, Magda; Jares, Pedro] Univ Barcelona, Genom Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Lopez-Guillermo, Armando] Univ Barcelona, Hosp Clin, Dept Hematol, Barcelona, Spain; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Enjuanes, A (corresponding author), Univ Barcelona, Hematopathol Sect, Dept Anat Pathol, Hosp Clin,Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.	pjares@clinic.ub.es	Hernandez, Luis/D-4684-2018; Lopez-Guillermo, Armando/Z-5684-2019; bea, silvia/K-7699-2014; ENJUANES, Anna/H-3245-2015; Navarro, Alba/H-2611-2015; Jares, Pedro/T-3778-2019; Campo, Elias/AAC-5593-2019	Hernandez, Luis/0000-0002-4854-3069; bea, silvia/0000-0001-7192-2385; ENJUANES, Anna/0000-0002-4679-6687; Navarro, Alba/0000-0002-4041-0974; Campo, Elias/0000-0001-9850-9793; JARES, PEDRO/0000-0002-8401-579X	Lymphoma Research Foundation [LRF07168]; Spanish Ministry of Science and Innovation [CICYT SAF 08/3869]; Asociacion Espanola Contra el Cancer (AECC) of Barcelona; Instituto de Salud Carlos III-RETIC [RD07/0020/2004]; Spanish Ministry of Education and Science (MEC); FIS; Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany; Robert-Bosch-Stiftung	Lymphoma Research Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Asociacion Espanola Contra el Cancer (AECC) of Barcelona; Instituto de Salud Carlos III-RETIC(Instituto de Salud Carlos III); Spanish Ministry of Education and Science (MEC)(Spanish Government); FIS(Instituto de Salud Carlos III); Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany; Robert-Bosch-Stiftung	This study was supported by grants from Lymphoma Research Foundation LRF07168 (PJ), the CICYT SAF 08/3869 from the Spanish Ministry of Science and Innovation, the Asociacion Espanola Contra el Cancer (AECC) of Barcelona 2008, and the Instituto de Salud Carlos III-RETIC (RD07/0020/2004). VF was a recipient of a predoctoral fellowship from Spanish Ministry of Education and Science (MEC). LH is a researcher from IDIBAPS and supported by FIS and "Programa d'estabilitzacio d'investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut (Generalitat de Catalunya)". AR was, in part, supported by the Interdisciplinary Center for Clinical Research (IZKF), University of Wurzburg, Germany. GO is supported by the Robert-Bosch-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CLAUS R, 2007, ONCOGENE, V21, P2114; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Drivdahl R, 2004, ONCOGENE, V23, P4584, DOI 10.1038/sj.onc.1207603; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Ripperger T, 2007, HAEMATOLOGICA, V92, P460, DOI 10.3324/haematol.10337; Salaverria I, 2006, HAEMATOLOGICA, V91, P11; Sato N, 2003, CANCER RES, V63, P3735; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sundaresan V, 1998, ONCOGENE, V17, P1723, DOI 10.1038/sj.onc.1202103; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Swerdlow SH, 2008, WHO CLASSIFICATION T; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561	38	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19736	10.1371/journal.pone.0019736	http://dx.doi.org/10.1371/journal.pone.0019736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603610	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300022
J	Zappia, MP; Brocco, MA; Billi, SC; Frasch, AC; Ceriani, MF				Paula Zappia, Maria; Adriana Brocco, Marcela; Billi, Silvia C.; Frasch, Alberto C.; Fernanda Ceriani, Maria			M6 Membrane Protein Plays an Essential Role in Drosophila Oogenesis	PLOS ONE			English	Article							FEMALE-STERILE MUTATION; PROTEOLIPID PROTEIN; FOLLICULAR-EPITHELIUM; VITELLINE MEMBRANE; GENE-EXPRESSION; OVARIAN FOLLICLES; NUDEL PROTEASE; STEM-CELLS; MELANOGASTER; MORPHOGENESIS	We had previously shown that the transmembrane glycoprotein M6a, a member of the proteolipid protein (PLP) family, regulates neurite/filopodium outgrowth, hence, M6a might be involved in neuronal remodeling and differentiation. In this work we focused on M6, the only PLP family member present in Drosophila, and ortholog to M6a. Unexpectedly, we found that decreased expression of M6 leads to female sterility. M6 is expressed in the membrane of the follicular epithelium in ovarioles throughout oogenesis. Phenotypes triggered by M6 downregulation in hypomorphic mutants included egg collapse and egg permeability, thus suggesting M6 involvement in eggshell biosynthesis. In addition, RNAi-mediated M6 knockdown targeted specifically to follicle cells induced an arrest of egg chamber development, revealing that M6 is essential in oogenesis. Interestingly, M6-associated phenotypes evidenced abnormal changes of the follicle cell shape and disrupted follicular epithelium in mid-and late-stage egg chambers. Therefore, we propose that M6 plays a role in follicular epithelium maintenance involving membrane cell remodeling during oogenesis in Drosophila.	[Paula Zappia, Maria; Adriana Brocco, Marcela; Billi, Silvia C.; Frasch, Alberto C.] Univ Nacl Gen San Martin, Consejo Nacl Invest Cientif & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, Buenos Aires, DF, Argentina; [Paula Zappia, Maria; Fernanda Ceriani, Maria] CABA, Lab Genet Comportamiento, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Paula Zappia, Maria; Fernanda Ceriani, Maria] CABA, Inst Invest Bioquim Buenos Aires IIB BA, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zappia, MP (corresponding author), Univ Nacl Gen San Martin, Consejo Nacl Invest Cientif & Tecn, Inst Tecnol Chascomus, Inst Invest Biotecnol, Buenos Aires, DF, Argentina.	mpzappia@iib.unsam.edu.ar; fceriani@leloir.org.ar		Frasch, Alberto Carlos/0000-0001-7532-653X; Ceriani, Maria/0000-0001-8945-3070	HHMI; Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2007-678, PICT 2005-38204]; National Council for Research in Science and Technology (CONICET)	HHMI(Howard Hughes Medical Institute); Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); National Council for Research in Science and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by the International Research Scholar from the HHMI to ACF, and grants from the Agencia Nacional para la Promocion Cientifica y Tecnologica (ANPCyT, PICT 2007-678 to MFC and PICT 2005-38204 to ACF). MPZ is supported by a graduate fellowship from the National Council for Research in Science and Technology (CONICET), SCB is also supported by CONICET, and MFC, MAB and ACF are members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, J NEUROSCI RES, V78, P702, DOI 10.1002/jnr.20328; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Biosystems A., 2004, GUIDE PERFORMING REL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DIMARIO PJ, 1987, J CELL BIOL, V105, P199, DOI 10.1083/jcb.105.1.199; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; Dobens LL, 2000, DEV DYNAM, V218, P80, DOI 10.1002/(SICI)1097-0177(200005)218:1<80::AID-DVDY7>3.0.CO;2-8; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Elalayli M, 2008, DEV BIOL, V319, P359, DOI 10.1016/j.ydbio.2008.04.035; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gudz TI, 2002, J NEUROSCI, V22, P7398; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Kalwy SA, 1997, J NEUROSCI RES, V48, P201; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LeMosy EK, 2000, DEV BIOL, V217, P352, DOI 10.1006/dbio.1999.9562; LeMosy EK, 1998, DEVELOPMENT, V125, P4045; Manogaran A, 2004, DEV BIOL, V270, P261, DOI 10.1016/j.ydbio.2004.02.009; MCGUIRE SE, 2004, SCI STKE, P16; Michibata H, 2009, STEM CELLS DEV, V18, P629, DOI 10.1089/scd.2008.0215; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; NEWMAN SM, 1981, DEV BIOL, V86, P393, DOI 10.1016/0012-1606(81)90197-4; Pascucci T, 1996, DEV BIOL, V177, P590, DOI 10.1006/dbio.1996.0188; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAVANT SS, 1989, DEV BIOL, V135, P43, DOI 10.1016/0012-1606(89)90156-5; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Schotman H, 2009, J CELL SCI, V122, P2662, DOI 10.1242/jcs.039347; SCHUPBACH T, 1991, GENETICS, V129, P1119; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; Stecca B, 2000, J NEUROSCI, V20, P4002; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; WILLIAMS JL, 1987, MOL GEN GENET, V209, P360, DOI 10.1007/BF00329666; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19715	10.1371/journal.pone.0019715	http://dx.doi.org/10.1371/journal.pone.0019715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603606	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300020
J	Ma, L; Dong, JL; Jin, YS; Chen, ML; Shen, XY; Wang, T				Ma, Lei; Dong, Jiangli; Jin, Yongsheng; Chen, Mingliang; Shen, Xiaoye; Wang, Tao			RMDAP: A Versatile, Ready-To-Use Toolbox for Multigene Genetic Transformation	PLOS ONE			English	Article							RECOMBINANT-DNA; RAPID CONSTRUCTION; MULTIPLE GENES; BINARY VECTORS; IN-VITRO; EFFICIENT; SYSTEM; MARKER; PLANTS; EXPRESSION	Background: The use of transgenes to improve complex traits in crops has challenged current genetic transformation technology for multigene transfer. Therefore, a multigene transformation strategy for use in plant molecular biology and plant genetic breeding is thus needed. Methodology/Principal Findings: Here we describe a versatile, ready-to-use multigene genetic transformation method, named the Recombination-assisted Multifunctional DNA Assembly Platform (RMDAP), which combines many of the useful features of existing plant transformation systems. This platform incorporates three widely-used recombination systems, namely, Gateway technology, in vivo Cre/loxP and recombineering into a highly efficient and reliable approach for gene assembly. RMDAP proposes a strategy for gene stacking and contains a wide range of flexible, modular vectors offering a series of functionally validated genetic elements to manipulate transgene overexpression or gene silencing involved in a metabolic pathway. In particular, the ability to construct a multigene marker-free vector is another attractive feature. The built-in flexibility of original vectors has greatly increased the expansibility and applicability of the system. A proof-of-principle experiment was confirmed by successfully transferring several heterologous genes into the plant genome. Conclusions/Significance: This platform is a ready-to-use toolbox for full exploitation of the potential for coordinate regulation of metabolic pathways and molecular breeding, and will eventually achieve the aim of what we call "one-stop breeding.''	[Ma, Lei; Dong, Jiangli; Jin, Yongsheng; Chen, Mingliang; Shen, Xiaoye; Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University	Ma, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	wangt@cau.edu.cn			Hi-Tech Research and Development (863) Program of China [2007AA10Z176, 2009AA102108]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by the Hi-Tech Research and Development (863) Program of China (2007AA10Z176, 2009AA102108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmert K, 2000, PLANTA, V211, P841, DOI 10.1007/s004250000350; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chen QJ, 2006, PLANT MOL BIOL, V62, P927, DOI 10.1007/s11103-006-9065-3; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dafhnis-Calas F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni192; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Daniell H, 2002, CURR OPIN BIOTECH, V13, P136, DOI 10.1016/S0958-1669(02)00297-5; Deavours BE, 2005, PLANT PHYSIOL, V138, P2245, DOI 10.1104/pp.105.062539; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Komori T, 2007, PLANT PHYSIOL, V145, P1155, DOI 10.1104/pp.107.105734; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Liang Z, 1997, Chin J Biotechnol, V13, P153; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Sambrook J., 2001, MOL CLONING LAB MANU; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Small I, 2007, CURR OPIN BIOTECH, V18, P148, DOI 10.1016/j.copbio.2007.01.012; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Verweire D, 2007, PLANT PHYSIOL, V145, P1220, DOI 10.1104/pp.107.106526; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yuan Y, 2004, ACTA BOT SIN, V46, P862; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	41	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19883	10.1371/journal.pone.0019883	http://dx.doi.org/10.1371/journal.pone.0019883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603635	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500034
J	Watkins, RL; Pallister, KB; Voyich, JM				Watkins, Robert L.; Pallister, Kyler B.; Voyich, Jovanka M.			The SaeR/S Gene Regulatory System Induces a Pro-Inflammatory Cytokine Response during Staphylococcus aureus Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; IN-VITRO; AGR; GAMMA; EXPRESSION; MUTANT; NEUTROPHILS; INTERFERON	Community-associated methicillin-resistant Staphylococcus aureus accounts for a large portion of the increased staphylococcal disease incidence and can cause illness ranging from mild skin infections to rapidly fatal sepsis syndromes. Currently, we have limited understanding of S. aureus-derived mechanisms contributing to bacterial pathogenesis and host inflammation during staphylococcal disease. Herein, we characterize an influential role for the saeR/S two-component gene regulatory system in mediating cytokine induction using mouse models of S. aureus pathogenesis. Invasive S. aureus infection induced the production of localized and systemic pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), interleukin (IL)-6 and IL-2. In contrast, mice infected with an isogenic saeR/S deletion mutant demonstrated significantly reduced pro-inflammatory cytokine levels. Additionally, secreted factors influenced by saeR/S elicited pro-inflammatory cytokines in human blood ex vivo. Our study further demonstrated robust saeR/S-mediated IFN-gamma production during both invasive and subcutaneous skin infections. Results also indicated a critical role for saeR/S in promoting bacterial survival and enhancing host mortality during S. aureus peritonitis. Taken together, this study provides insight into specific mechanisms used by S. aureus during staphylococcal disease and characterizes a relationship between a bacterial global regulator of virulence and the production of pro-inflammatory mediators.	[Watkins, Robert L.; Pallister, Kyler B.; Voyich, Jovanka M.] Montana State Univ, Dept Immunol Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Watkins, RL (corresponding author), Montana State Univ, Dept Immunol Infect Dis, Bozeman, MT 59717 USA.	jovanka@montana.edu			National Institutes of Health (NIH) [PAR98-072, NIH-RR020185]; Montana State University-Bozeman; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana State University-Bozeman; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH)-PAR98-072, NIH-RR020185 and a Molecular Biosciences Fellowship-Montana State University-Bozeman (to RLW). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Giraudo AT, 1996, CAN J MICROBIOL, V42, P120, DOI 10.1139/m96-019; GIRAUDO AT, 1994, J BASIC MICROB, V34, P317, DOI 10.1002/jobm.3620340507; Grundmeier M, 2010, J INFECT DIS, V201, P871, DOI 10.1086/651023; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; LIANG X, 2006, INFECT IMMUN, V268, P98; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MATIN GS, 2003, NEW ENGL J MED, V348, P1546; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Pantrangi M, 2010, FEMS MICROBIOL LETT, V308, P175, DOI 10.1111/j.1574-6968.2010.02012.x; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; ROZALSKA B, 1993, FEMS IMMUNOL MED MIC, V7, P145; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; Schlievert PM, 2010, J ALLERGY CLIN IMMUN, V125, P39, DOI 10.1016/j.jaci.2009.10.039; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210; Zhao YX, 1998, IMMUNOLOGY, V93, P80	52	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19939	10.1371/journal.pone.0019939	http://dx.doi.org/10.1371/journal.pone.0019939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603642	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500038
J	Cheng, L; Yang, ZH; Wang, XH; Jiao, YY; Xie, XY; Lin, J; Zhang, H; Han, JQ; Jiang, K; Ye, QN				Cheng, Long; Yang, Zhihong; Wang, Xiaohui; Jiao, Yuanyuan; Xie, Xiangyang; Lin, Jing; Zhang, Hao; Han, Juqiang; Jiang, Kai; Ye, Qinong			Suppression of Estrogen Receptor Transcriptional Activity by Connective Tissue Growth Factor	PLOS ONE			English	Article							ALPHA-ASSOCIATED PROTEIN; BREAST-CANCER CELLS; CCN FAMILY; CROSS-TALK; EXPRESSION; CYR61; CTGF; MEMBRANE; ACTS; BETA	Secreted growth factors have been shown to stimulate the transcriptional activity of estrogen receptors (ER) that are responsible for many biological processes. However, whether these growth factors physically interact with ER remains unclear. Here, we show for the first time that connective tissue growth factor (CTGF) physically and functionally associates with ER. CTGF interacted with ER both in vitro and in vivo. CTGF interacted with ER DNA-binding domain. ER interaction region in CTGF was mapped to the thrombospondin type I repeat, a cell attachment motif. Overexpression of CTGF inhibited ER transcriptional activity as well as the expression of estrogen-responsive genes, including pS2 and cathepsin D. Reduction of endogenous CTGF with CTGF small interfering RNA enhanced ER transcriptional activity. The interaction between CTGF and ER is required for the repression of estrogen-responsive transcription by CTGF. Moreover, CTGF reduced ER protein expression, whereas the CTGF mutant that did not repress ER transcriptional activity also did not alter ER protein levels. The results suggested the transcriptional regulation of estrogen signaling through interaction between CTGF and ER, and thus may provide a novel mechanism by which cross-talk between secreted growth factor and ER signaling pathways occurs.	[Cheng, Long; Yang, Zhihong; Wang, Xiaohui; Jiao, Yuanyuan; Xie, Xiangyang; Zhang, Hao; Han, Juqiang; Jiang, Kai; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China; [Lin, Jing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Clin Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Cheng, L (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	yeqn66@yahoo.com	jiao, jen/L-2076-2013	Cheng, Long/0000-0002-4752-1298; Jiang, Kai/0000-0002-8507-1945	Major State Basic Research Development Program [2011CB504202, 2007CB914603]; National Natural Science Foundation [30972594, 30800205, 81072173, 30625035]; National Key Technologies RD Program [2009ZX09301-002]; Medicine and Health Research Foundation [06J021]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Medicine and Health Research Foundation	This work was supported by Major State Basic Research Development Program (2011CB504202 and 2007CB914603), National Natural Science Foundation (30972594, 30800205, 81072173 and 30625035), the National Key Technologies R&D Program for New Drugs (2009ZX09301-002), and Medicine and Health Research Foundation of PLA People's Liberation Army (06J021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chang CC, 2006, JNCI-J NATL CANCER I, V98, P984, DOI 10.1093/jnci/djj242; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Farooqui M, 2006, MOL CANCER THER, V5, P611, DOI 10.1158/1535-7163.MCT-05-0016; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; Jacob J, 2006, MOL CELL ENDOCRINOL, V246, P34, DOI 10.1016/j.mce.2005.11.015; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lichtner RB, 2003, BIOMED PHARMACOTHER, V57, P447, DOI 10.1016/j.biopha.2003.09.006; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; Loven MA, 2004, MOL ENDOCRINOL, V18, P2649, DOI 10.1210/me.2003-0195; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; PIETRAS RJ, 1980, BIOCHEM J, V191, P743, DOI 10.1042/bj1910743; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, CANCER RES, V61, P8917; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	48	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20028	10.1371/journal.pone.0020028	http://dx.doi.org/10.1371/journal.pone.0020028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629692	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005800022
J	Gupta, N; Singh, S; Maturu, VN; Sharma, YP; Gill, KD				Gupta, Nidhi; Singh, Surjit; Maturu, V. Nagarjuna; Sharma, Yash Paul; Gill, Kiran Dip			Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HUMAN-SERUM PARAOXONASE; DEPENDENT DIABETES-MELLITUS; ARTERY-DISEASE; GLN-ARG192 POLYMORPHISM; PROMOTER POLYMORPHISMS; GENETIC-POLYMORPHISM; PESTICIDE EXPOSURE; VASCULAR-DISEASE; ATHEROSCLEROSIS	Background: Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore preventing the development of atherosclerosis. The polymorphisms of PON1 gene are known to affect the PON1 activity and thereby coronary artery disease (CAD) risk. As studies are lacking in North-West Indian Punjabi's, a distinct ethnic group with high incidence of CAD, we determined PON1 activity, genotypes and haplotypes in this population and correlated them with the risk of CAD. Methodology/Principal Findings: 350 angiographically proven (>= 70% stenosis) CAD patients and 300 healthy controls were investigated. PON1 activity was determined towards paraoxon (Paraoxonase; PONase) and phenylacetate (Arylesterase; AREase) substrates. In addition, genotyping was carried out by using multiplex PCR, allele specific oligonucleotide -PCR and PCR-RFLP methods and haplotyping was determined by PHASE software. The serum PONase and AREase activities were significantly lower in CAD patients as compared to the controls. All studied polymorphisms except L55M had significant effect on PONase activity. However AREase activity was not affected by them. In a logistic regression model, after adjustment for the conventional risk factors for CAD, QR (OR: 2.73 (1.57-4.72)) and RR (OR, 16.24 (6.41-41.14)) genotypes of Q192R polymorphism and GG (OR: 2.07 (1.02-4.21)) genotype of -162A/G polymorphism had significantly higher CAD risk. Haplotypes L-T-G-Q-C (OR: 3.25 (1.72-6.16)) and L-T-G-R-G (OR: 2.82 (1.01-7.80)) were also significantly associated with CAD. Conclusions: In conclusion this study shows that CAD patients had lower PONase and AREase activities as compared to the controls. The coding Q192R polymorphism, promoter -162A/G polymorphism and L-T-G-Q-C and L-T-G-R-G haplotypes are all independently associated with CAD.	[Gupta, Nidhi; Gill, Kiran Dip] PGIMER, Dept Biochem, Chandigarh, India; [Singh, Surjit; Maturu, V. Nagarjuna] PGIMER, Dept Internal Med, Chandigarh, India; [Sharma, Yash Paul] PGIMER, Dept Cardiol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, N (corresponding author), PGIMER, Dept Biochem, Chandigarh, India.	kdgill2002@yahoo.co.in		Maturu, Venkata Nagarjuna/0000-0002-3679-9497	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC)	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC)(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC), provided research fellowship to NG. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Antikainen M, 1996, J CLIN INVEST, V98, P883, DOI 10.1172/JCI118869; Arca M, 2002, EUR J CLIN INVEST, V32, P9, DOI 10.1046/j.1365-2362.2002.00935.x; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P1673, DOI 10.1289/ehp.7005; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; CAMBIEN F, 2001, GENOTYPE PHENOTYPE, P31; Cao HB, 1999, J LIPID RES, V40, P133; Daly AK, 1996, METHOD ENZYMOL, V272, P199, DOI 10.1016/S0076-6879(96)72024-4; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Deakin S, 2003, BIOCHEM J, V372, P643, DOI 10.1042/BJ20021670; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Enas E A, 1998, Indian Heart J, V50, P105; Enas E A, 1996, Indian Heart J, V48, P343; FURLONG CE, 1991, BIOCHEMISTRY-US, V30, P10133, DOI 10.1021/bi00106a009; Furlong CE, 2006, PHARMACOGENET GENOM, V16, P183; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; GARIN MCB, 1994, BIOCHEM J, V304, P549, DOI 10.1042/bj3040549; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gouedard C, 2003, MOL PHARMACOL, V63, P945, DOI 10.1124/mol.63.4.945; HEGELE RA, 1995, ARTERIOSCL THROM VAS, V15, P89, DOI 10.1161/01.ATV.15.1.89; Hernandez AF, 2003, HUM EXP TOXICOL, V22, P565, DOI 10.1191/0960327103ht400oa; James RW, 2000, DIABETES, V49, P1390, DOI 10.2337/diabetes.49.8.1390; Janus ED, 1996, CIRCULATION, V94, P2671, DOI 10.1161/01.CIR.94.11.2671; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Jarvik GP, 2003, ARTERIOSCL THROM VAS, V23, P1465, DOI 10.1161/01.ATV.0000081635.96290.D3; Ko YL, 1998, ATHEROSCLEROSIS, V141, P259, DOI 10.1016/S0021-9150(98)00179-8; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev N, 2001, J MOL MED, V79, P457, DOI 10.1007/s001090100240; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 1998, ATHEROSCLEROSIS, V139, P341, DOI 10.1016/S0021-9150(98)00095-1; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 2002, CURR OPIN LIPIDOL, V13, P357, DOI 10.1097/00041433-200208000-00002; Mackness B, 1997, BRIT J PHARMACOL, V122, P265, DOI 10.1038/sj.bjp.0701390; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; Mackness MI, 2000, CURR OPIN LIPIDOL, V11, P383, DOI 10.1097/00041433-200008000-00007; MCELVEEN J, 1986, CLIN CHEM, V32, P671; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; Najafi M, 2009, THROMB RES, V123, P503, DOI 10.1016/j.thromres.2008.03.004; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nevin DN, 1996, ARTERIOSCL THROM VAS, V16, P1243, DOI 10.1161/01.ATV.16.10.1243; Ombres D, 1998, ARTERIOSCL THROM VAS, V18, P1611, DOI 10.1161/01.ATV.18.10.1611; Richter RJ, 2010, ADV EXP MED BIOL, V660, P29, DOI 10.1007/978-1-60761-350-3_4; Richter RJ, 2008, CIRC-CARDIOVASC GENE, V1, P147, DOI 10.1161/CIRCGENETICS.108.811638; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; ROSE HA, 1970, CENSUS REPORT, V1, P55; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; SAIKAWA Y, 1995, BIOCHEMISTRY-US, V34, P9951, DOI 10.1021/bi00031a018; Sanghera DK, 1997, ARTERIOSCL THROM VAS, V17, P1067, DOI 10.1161/01.ATV.17.6.1067; Schmidt H, 1998, STROKE, V29, P2043, DOI 10.1161/01.STR.29.10.2043; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Singh S, 1999, INDIAN J MED RES, V110, P133; Singh S, 2007, INDIAN J MED RES, V125, P783; SORENSON RC, 1995, P NATL ACAD SCI USA, V92, P7187, DOI 10.1073/pnas.92.16.7187; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; Suehiro T, 1996, INT J CARDIOL, V57, P69, DOI 10.1016/S0167-5273(96)02779-9; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Zama T, 1997, ARTERIOSCL THROM VAS, V17, P3565, DOI 10.1161/01.ATV.17.12.3565	62	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e17805	10.1371/journal.pone.0017805	http://dx.doi.org/10.1371/journal.pone.0017805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629682	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800001
J	Kolligs, FT; Crispin, A; Munte, A; Wagner, A; Mansmann, U; Goke, B				Kolligs, Frank T.; Crispin, Alexander; Munte, Axel; Wagner, Andreas; Mansmann, Ulrich; Goeke, Burkhard			Risk of Advanced Colorectal Neoplasia According to Age and Gender	PLOS ONE			English	Article							FECAL OCCULT-BLOOD; SOCIETY-TASK-FORCE; ASYMPTOMATIC ADULTS; CANCER STATISTICS; COLONIC NEOPLASIA; ADVANCED ADENOMAS; AMERICAN-COLLEGE; COLONOSCOPY; PREVENTION; SURVEILLANCE	Background: Colorectal cancer (CRC) is one of the leading causes of cancer related morbidity and death. Despite the fact that the mean age at diagnosis of CRC is lower in men, screening by colonoscopy or fecal occult blood test (FOBT) is initiated at same age in both genders. The prevalence of the common CRC precursor lesion, advanced adenoma, is well documented only in the screening population. The purpose of this study was to assess the risk of advanced adenoma at ages below screening age. Methods and Findings: We analyzed data from a census of 625,918 outpatient colonoscopies performed in adults in Bavaria between 2006 and 2008. A logistic regression model to determine gender-and age-specific risk of advanced neoplasia was developed. Advanced neoplasia was found in 16,740 women (4.6%) and 22,684 men (8.6%). Male sex was associated with an overall increased risk of advanced neoplasia (odds ratio 1.95; 95% confidence interval, CI, 1.91 to 2.00). At any age and in any indication group, more colonoscopies were needed in women than in men to detect advanced adenoma or cancer. At age 75 14.8 (95% CI, 14.4-15.2) screening, 18.2 (95% CI, 17.7-18.7) diagnostic, and 7.9 (95% CI, 7.6-8.2) colonoscopies to follow up on a positive FOBT (FOBT colonoscopies) were needed to find advanced adenoma in women. At age 50 39.0 (95% CI, 38.0-40.0) diagnostic, and 16.3 (95% CI, 15.7-16.9) FOBT colonoscopies were needed. Comparable numbers were reached 20 and 10 years earlier in men than in women, respectively. Conclusions: At any age and independent of the indication for colonoscopy, men are at higher risk of having advanced neoplasia diagnosed upon colonoscopy than women. This suggests that starting screening earlier in life in men than in women might result in a relevant increase in the detection of asymptomatic preneoplastic and neoplastic colonic lesions.	[Kolligs, Frank T.; Wagner, Andreas; Goeke, Burkhard] Univ Munich, Dept Med 2, Munich, Germany; [Crispin, Alexander; Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Munte, Axel] Bavarian Assoc Compulsory Hlth Insurance Phys, Munich, Germany	University of Munich; University of Munich	Kolligs, FT (corresponding author), Univ Munich, Dept Med 2, Munich, Germany.	fkolligs@med.uni-muenchen.de			Munich Center of Health Sciences	Munich Center of Health Sciences	The support by the LMUinnovativ project Munich Center of Health Sciences, subproject II (evidence-based prevention and modeling of chronic diseases) is gratefully acknowledged.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; Gellad ZF, 2010, AM J GASTROENTEROL, V105, P1746, DOI 10.1038/ajg.2010.107; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones RM, 2010, CANCER EPIDEM BIOMAR, V19, P2821, DOI 10.1158/1055-9965.EPI-10-0695; Kahi CJ, 2008, GASTROENTEROLOGY, V135, P380, DOI 10.1053/j.gastro.2008.06.026; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman D, 2005, AM J GASTROENTEROL, V100, P2756, DOI 10.1111/j.1572-0241.2005.00352.x; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansmann U, 2008, DTSCH ARZTEBL INT, V105, P434, DOI 10.3238/arztebl.2008.0434; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	31	63	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20076	10.1371/journal.pone.0020076	http://dx.doi.org/10.1371/journal.pone.0020076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629650	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800026
J	Verdino, P; Witherden, DA; Podshivalova, K; Rieder, SE; Havran, WL; Wilson, IA				Verdino, Petra; Witherden, Deborah A.; Podshivalova, Katie; Rieder, Stephanie E.; Havran, Wendy L.; Wilson, Ian A.			cDNA Sequence and Fab Crystal Structure of HL4E10, a Hamster IgG Lambda Light Chain Antibody Stimulatory for gamma delta T Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; ANTIGEN RECOGNITION; SIGNAL PEPTIDES; PREDICTION; JAML; GENE; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISM; EXPRESSION	Hamsters are widely used to generate monoclonal antibodies against mouse, rat, and human antigens, but sequence and structural information for hamster immunoglobulins is sparse. To our knowledge, only three hamster IgG sequences have been published, all of which use kappa light chains, and no three-dimensional structure of a hamster antibody has been reported. We generated antibody HL4E10 as a probe to identify novel costimulatory molecules on the surface of gamma delta T cells which lack the traditional alpha beta T cell co-receptors CD4, CD8, and the costimulatory molecule CD28. HL4E10 binding to gamma delta T cell, surface-expressed, Junctional Adhesion Molecule-Like (JAML) protein leads to potent costimulation via activation of MAP kinase pathways and cytokine production, resulting in cell proliferation. The cDNA sequence of HL4E10 is the first example of a hamster lambda light chain and only the second known complete hamster heavy chain sequence. The crystal structure of the HL4E10 Fab at 2.95 angstrom resolution reveals a rigid combining site with pockets faceted by solvent-exposed tyrosine residues, which are structurally optimized for JAML binding. The characterization of HL4E10 thus comprises a valuable addition to the spartan database of hamster immunoglobulin genes and structures. As the HL4E10 antibody is uniquely costimulatory for gamma delta T cells, humanized versions thereof may be of clinical relevance in treating gamma delta T cell dysfunction-associated diseases, such as chronic non-healing wounds and cancer.	[Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Witherden, Deborah A.; Podshivalova, Katie; Rieder, Stephanie E.; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Verdino, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Podshivalova, Katie/K-7401-2019		NIH [AI042266, CA58896, AI064811]; Skaggs Institute; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R01AI064811, R37AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Erwin-Schrodinger Fellowship J2313 of the Austrian Science Fund (P.V.), by NIH grants AI042266 and CA58896 (I.A.W.), AI064811 (W.L.H.) and the Skaggs Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEGRE ML, 1995, J IMMUNOL, V155, P1544; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boismenu R, 1998, CLIN IMMUNOL IMMUNOP, V86, P121, DOI 10.1006/clin.1997.4468; Born WK, 2006, CURR OPIN IMMUNOL, V18, P31, DOI 10.1016/j.coi.2005.11.007; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; COLLINS M, 1995, IMMUNOGENETICS, V42, P225, DOI 10.1007/BF00191230; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez A, 2008, J CLASSIF, V25, P43, DOI 10.1007/s00357-008-9004-x; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jameson J, 2003, CURR OPIN IMMUNOL, V15, P349, DOI 10.1016/S0952-7915(03)00045-1; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kabelitz D, 2000, INT ARCH ALLERGY IMM, V122, P1, DOI 10.1159/000024353; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEGENDRE NM, 1993, PRACTICAL GUIDE PROT; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mallender WD, 1995, MOL IMMUNOL, V32, P1093, DOI 10.1016/0161-5890(95)00082-8; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCGUIRE KL, 1985, NUCLEIC ACIDS RES, V13, P5611, DOI 10.1093/nar/13.15.5611; Mozdzanowski J, 1998, ANAL BIOCHEM, V260, P183, DOI 10.1006/abio.1998.2690; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; SANCHEZMADRID F, 1983, J IMMUNOL, V130, P309; Sharp LL, 2005, CRIT REV IMMUNOL, V25, P1, DOI 10.1615/CritRevImmunol.v25.i1.10; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tsunasawa S, 1998, J BIOCHEM, V124, P778, DOI 10.1093/oxfordjournals.jbchem.a022179; Verdino P, 2011, STRUCTURE, V19, P80, DOI 10.1016/j.str.2010.10.007; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Werner WE, 2005, ANAL BIOCHEM, V342, P120, DOI 10.1016/j.ab.2005.04.012; WHITTERS MJ, 1995, IMMUNOGENETICS, V42, P227, DOI 10.1007/BF00191231; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	63	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19828	10.1371/journal.pone.0019828	http://dx.doi.org/10.1371/journal.pone.0019828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629689	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800012
J	Balk, L; Hylland, K; Hansson, T; Berntssen, MHG; Beyer, J; Jonsson, G; Melbye, A; Grung, M; Torstensen, BE; Borseth, JF; Skarphedinsdottir, H; Klungsoyr, J				Balk, Lennart; Hylland, Ketil; Hansson, Tomas; Berntssen, Marc H. G.; Beyer, Jonny; Jonsson, Grete; Melbye, Alf; Grung, Merete; Torstensen, Bente E.; Borseth, Jan Fredrik; Skarphedinsdottir, Halldora; Klungsoyr, Jarle			Biomarkers in Natural Fish Populations Indicate Adverse Biological Effects of Offshore Oil Production	PLOS ONE			English	Article							COD GADUS-MORHUA; PIKE ESOX-LUCIUS; PERCH PERCA-FLUVIATILIS; DNA ADDUCT FORMATION; SALMON SALMO-SALAR; NORTH-SEA-OIL; ATLANTIC COD; VITAMIN-E; LIPID-COMPOSITION; FUNDULUS-HETEROCLITUS	Background: Despite the growing awareness of the necessity of a sustainable development, the global economy continues to depend largely on the consumption of non-renewable energy resources. One such energy resource is fossil oil extracted from the seabed at offshore oil platforms. This type of oil production causes continuous environmental pollution from drilling waste, discharge of large amounts of produced water, and accidental spills. Methods and principal findings: Samples from natural populations of haddock (Melanogrammus aeglefinus) and Atlantic cod (Gadus morhua) in two North Sea areas with extensive oil production were investigated. Exposure to and uptake of polycyclic aromatic hydrocarbons (PAHs) were demonstrated, and biomarker analyses revealed adverse biological effects, including induction of biotransformation enzymes, oxidative stress, altered fatty acid composition, and genotoxicity. Genotoxicity was reflected by a hepatic DNA adduct pattern typical for exposure to a mixture of PAHs. Control material was collected from a North Sea area without oil production and from remote Icelandic waters. The difference between the two control areas indicates significant background pollution in the North Sea. Conclusion: It is most remarkable to obtain biomarker responses in natural fish populations in the open sea that are similar to the biomarker responses in fish from highly polluted areas close to a point source. Risk assessment of various threats to the marine fish populations in the North Sea, such as overfishing, global warming, and eutrophication, should also take into account the ecologically relevant impact of offshore oil production.	[Balk, Lennart; Hansson, Tomas; Skarphedinsdottir, Halldora] Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden; [Hylland, Ketil] Univ Oslo, Dept Biol, Oslo, Norway; [Hylland, Ketil; Grung, Merete] Norwegian Inst Water Res NIVA, Oslo, Norway; [Berntssen, Marc H. G.; Torstensen, Bente E.] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Beyer, Jonny; Borseth, Jan Fredrik] Int Res Inst Stavanger IRIS, Stavanger, Norway; [Beyer, Jonny] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Jonsson, Grete] Stavanger Univ Hosp, Dept Med Biochem, Stavanger, Norway; [Melbye, Alf] SINTEF Mat & Chem, Trondheim, Norway; [Klungsoyr, Jarle] Inst Marine Res IMR, Bergen, Norway	Stockholm University; University of Oslo; Norwegian Institute for Water Research (NIVA); Universitetet i Stavanger; Stavanger University Hospital; SINTEF; Institute of Marine Research - Norway	Balk, L (corresponding author), Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden.	lennart.balk@itm.su.se; tomas.hansson@itm.su.se	Berntssen, Marc/O-9406-2018; Beyer, Jonny/E-8001-2011	Beyer, Jonny/0000-0003-2229-3185	Norwegian Research Council; Norwegian Ministry of Fisheries; Norwegian Oil Industry Association	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Ministry of Fisheries; Norwegian Oil Industry Association	The study was supported by the Norwegian Research Council, the Norwegian Ministry of Fisheries, and the Norwegian Oil Industry Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 2000, AQUAT TOXICOL, V51, P241, DOI 10.1016/S0166-445X(00)00108-9; Aas E, 2000, BIOMARKERS, V5, P9, DOI 10.1080/135475000230505; Aas E, 2003, BIOMARKERS, V8, P445, DOI 10.1080/1354750032000158439; BALK L, 1984, TOXICOL APPL PHARM, V74, P430, DOI 10.1016/0041-008X(84)90296-5; BEACH AC, 1992, CARCINOGENESIS, V13, P1053, DOI 10.1093/carcin/13.7.1053; BELL JG, 1985, BRIT J NUTR, V53, P149, DOI 10.1079/BJN19850019; Beyer J, 2010, ENVIRON TOXICOL PHAR, V30, P224, DOI 10.1016/j.etap.2010.08.004; Bohne-Kjersem A, 2009, MAR ENVIRON RES, V68, P268, DOI 10.1016/j.marenvres.2009.06.016; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; BRIDGES B A, 1990, Mutation Research, V239, P143, DOI 10.1016/0165-1110(90)90002-S; Brigelius-Flohe R, 2010, MOL NUTR FOOD RES, V54, P583, DOI 10.1002/mnfr.201000091; Brigelius-Flohe R, 2010, MOL NUTR FOOD RES, V54, P581, DOI [10.1002/mnfr.201090018, 10.1002/mnfr.201000091]; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DUNN BP, 1987, CANCER RES, V47, P6543; Ericson G, 1999, AQUAT TOXICOL, V45, P181, DOI 10.1016/S0166-445X(98)00100-3; Ericson G, 2000, MUTAT RES-FUND MOL M, V454, P11, DOI 10.1016/S0027-5107(00)00092-0; Ericson G, 1999, MUTAT RES-FUND MOL M, V427, P135, DOI 10.1016/S0027-5107(99)00088-3; Ericson G, 1998, CAN J FISH AQUAT SCI, V55, P815, DOI 10.1139/cjfas-55-4-815; EXLER J, 1975, J AM OIL CHEM SOC, V52, P154, DOI 10.1007/BF02557948; Falch E, 2006, J FOOD COMPOS ANAL, V19, P727, DOI 10.1016/j.jfca.2005.12.004; Falch E, 2006, PROCESS BIOCHEM, V41, P666, DOI 10.1016/j.procbio.2005.08.015; Farkas T, 2001, AQUAC RES, V32, P645, DOI 10.1046/j.1365-2109.2001.00600.x; Farmen E, 2010, MAR POLLUT BULL, V60, P1092, DOI 10.1016/j.marpolbul.2010.01.015; Farmer PB, 1999, MUTAT RES-FUND MOL M, V424, P275, DOI 10.1016/S0027-5107(99)00025-1; French BL, 1996, AQUAT TOXICOL, V36, P1, DOI 10.1016/S0166-445X(96)00812-0; Gamble SC, 1997, J CHEM TECHNOL BIOT, V68, P123; GOKSOYR A, 1991, COMP BIOCHEM PHYS C, V100, P157, DOI 10.1016/0742-8413(91)90144-I; Grim JM, 2010, J EXP BIOL, V213, P445, DOI 10.1242/jeb.036939; Grung M, 2009, J TOXICOL ENV HEAL A, V72, P254, DOI 10.1080/15287390802539210; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Holth TF, 2009, ENVIRON SCI TECHNOL, V43, P3329, DOI 10.1021/es803479p; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P125, DOI 10.1080/15287390500259392; Jonsson G, 2003, J ENVIRON MONITOR, V5, P513, DOI 10.1039/b300903n; JOSEPHY PD, 1997, MOL TOXICOLOGY, P97; KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0; Knijn R.J., 1993, ICES COOP RES REP, V194, P268; KURELEC B, 1993, MAR ENVIRON RES, V35, P341, DOI 10.1016/0141-1136(93)90101-5; LEACH JJ, 1973, TOXICOL APPL PHARM, V25, P430; LIE O, 1986, AQUACULTURE, V59, P187, DOI 10.1016/0044-8486(86)90003-7; LIE O, 1994, FISH PHYSIOL BIOCHEM, V13, P241, DOI 10.1007/BF00004362; LIEHR JG, 1986, P NATL ACAD SCI USA, V83, P5301, DOI 10.1073/pnas.83.14.5301; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKEE MJ, 1983, AQUAT TOXICOL, V3, P103, DOI 10.1016/0166-445X(83)90032-2; Meier S, 2007, COMP BIOCHEM PHYS C, V145, P420, DOI 10.1016/j.cbpc.2007.01.012; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Neff J.M., 2002, BIOACCUMULATION MARI, P241; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; REICHERT WL, 1994, NMFSNWFSC14 NOAA NTI; Rilfors L, 2002, COLLOID SURFACE B, V26, P112, DOI 10.1016/S0927-7765(01)00310-1; RUUS A, 2003, 86903 SFT NIVA; SANTOS J, 1993, AQUACULTURE, V110, P173; Shugart L. R., 1995, AQUATIC TOXICOLOGY E, P405; STAGG RM, 1996, PRODUCED WATER, V2, P195; STEIN JE, 1993, MAR ENVIRON RES, V35, P95, DOI 10.1016/0141-1136(93)90020-Z; Sturve J, 2006, AQUAT TOXICOL, V78, pS73, DOI 10.1016/j.aquatox.2006.02.019; Sundt RC, 2009, MAR POLLUT BULL, V58, P1382, DOI 10.1016/j.marpolbul.2009.04.016; The National Academy Press, 2003, OIL SEA; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; VARANASI U, 1989, CANCER RES, V49, P1171; VARANASI U, 1989, CRC UNISCIENCE SERIE, P93; Willett KL, 2001, TOXICOL APPL PHARM, V177, P264, DOI 10.1006/taap.2001.9296; WURGLER FE, 1992, MUTAGENESIS, V7, P321, DOI 10.1093/mutage/7.5.321; 2001, SURVEY INFORM CUTTIN, P54	70	54	56	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19735	10.1371/journal.pone.0019735	http://dx.doi.org/10.1371/journal.pone.0019735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625421	gold, Green Published, Green Submitted			2022-12-27	WOS:000291005200011
J	Buckthought, A; Jessula, S; Mendola, JD				Buckthought, Athena; Jessula, Samuel; Mendola, Janine D.			Bistable Percepts in the Brain: fMRI Contrasts Monocular Pattern Rivalry and Binocular Rivalry	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; HUMAN OCCIPITAL CORTEX; AMBIGUOUS FIGURES; SPATIAL-FREQUENCY; NEURONAL-ACTIVITY; DEPTH; ATTENTION; MODEL; V1	The neural correlates of binocular rivalry have been actively debated in recent years, and are of considerable interest as they may shed light on mechanisms of conscious awareness. In a related phenomenon, monocular rivalry, a composite image is shown to both eyes. The subject experiences perceptual alternations in which the two stimulus components alternate in clarity or salience. The experience is similar to perceptual alternations in binocular rivalry, although the reduction in visibility of the suppressed component is greater for binocular rivalry, especially at higher stimulus contrasts. We used fMRI at 3T to image activity in visual cortex while subjects perceived either monocular or binocular rivalry, or a matched non-rivalrous control condition. The stimulus patterns were left/right oblique gratings with the luminance contrast set at 9%, 18% or 36%. Compared to a blank screen, both binocular and monocular rivalry showed a U-shaped function of activation as a function of stimulus contrast, i.e. higher activity for most areas at 9% and 36%. The sites of cortical activation for monocular rivalry included occipital pole (V1, V2, V3), ventral temporal, and superior parietal cortex. The additional areas for binocular rivalry included lateral occipital regions, as well as inferior parietal cortex close to the temporoparietal junction (TPJ). In particular, higher-tier areas MT+ and V3A were more active for binocular than monocular rivalry for all contrasts. In comparison, activation in V2 and V3 was reduced for binocular compared to monocular rivalry at the higher contrasts that evoked stronger binocular perceptual suppression, indicating that the effects of suppression are not limited to interocular suppression in V1.	[Buckthought, Athena; Jessula, Samuel; Mendola, Janine D.] McGill Univ, Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ H3A 2T5, Canada	McGill University	Buckthought, A (corresponding author), McGill Univ, Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ H3A 2T5, Canada.	athenabuck1@gmail.com			NSERC; National Institutes of Health (NIH) [R01 EY015219]; Canadian Foundation for Innovation; NATIONAL EYE INSTITUTE [R01EY015219] Funding Source: NIH RePORTER	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NSERC (www.nserc.ca) and National Institutes of Health (NIH) R01 EY015219 grants, as well as a LOF grant from the Canadian Foundation for Innovation (http://www.innovation.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON J, 1973, PERCEPTION, V2, P127, DOI 10.1068/p020127; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Boutet I, 2001, PERCEPTION, V30, P743, DOI 10.1068/p3183; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; Brouwer GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005056; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; CAMPBELL FW, 1972, J PHYSIOL-LONDON, V225, pP19; CAMPBELL FW, 1973, PERCEPTION, V2, P123, DOI 10.1068/p020123; CAVANAGH P, 1984, J OPT SOC AM A, V1, P893, DOI 10.1364/JOSAA.1.000893; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dayan P, 1998, NEURAL COMPUT, V10, P1119, DOI 10.1162/089976698300017377; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Freeman A., 2005, BINOCULAR RIVALRY, P47; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; Inui T, 2000, NEUROSCI LETT, V282, P145, DOI 10.1016/S0304-3940(00)00899-5; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; KITTERLE FL, 1980, B PSYCHONOMIC SOC, V16, P405; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Likova LT, 2007, NEUROIMAGE, V38, P293, DOI 10.1016/j.neuroimage.2007.06.039; LIU L, 1992, VISION RES, V32, P1471, DOI 10.1016/0042-6989(92)90203-U; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lumer ED, 1998, CEREB CORTEX, V8, P553, DOI 10.1093/cercor/8.6.553; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marois R, 2004, J NEUROPHYSIOL, V92, P2985, DOI 10.1152/jn.01061.2003; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; METELLI F, 1970, Ergonomics, V13, P59, DOI 10.1080/00140137008931118; Moradi F, 2009, J VISION, V9, DOI 10.1167/9.3.13; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; O'Shea RP, 2009, VISION RES, V49, P671, DOI 10.1016/j.visres.2009.01.020; Pearson J, 2005, PSYCHOL SCI, V16, P516, DOI 10.1111/j.0956-7976.2005.01566.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Raemaekers M, 2009, BRAIN RES, V1252, P161, DOI 10.1016/j.brainres.2008.11.078; RAMACHANDRAN VS, 1985, PERCEPTION, V14, P135, DOI 10.1068/p140135; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rubin E., 1921, VISUELL WAHRGENOMMEN; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Slotnick SD, 2005, COGNITIVE BRAIN RES, V24, P97, DOI 10.1016/j.cogbrainres.2004.12.008; Sterzer P, 2002, NEUROIMAGE, V15, P908, DOI 10.1006/nimg.2001.1030; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson B, 2008, J NEUROSCI METH, V168, P71, DOI 10.1016/j.jneumeth.2007.09.020; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tyler CW, 2006, NEUROIMAGE, V30, P228, DOI 10.1016/j.neuroimage.2005.09.067; van Boxtel JJA, 2008, J VISION, V8, DOI 10.1167/8.15.13; WADE NJ, 1975, PERCEPTION, V4, P85, DOI 10.1068/p040085; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461; Wilcke JC, 2009, BRAIN RES, V1305, P96, DOI 10.1016/j.brainres.2009.09.080; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Wilson HR, 2007, VISION RES, V47, P2741, DOI 10.1016/j.visres.2007.07.007; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	71	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20367	10.1371/journal.pone.0020367	http://dx.doi.org/10.1371/journal.pone.0020367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629791	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200056
J	Tamura, R; Nishida, H; Eifuku, S; Nagao, K; Fushiki, H; Watanabe, Y; Ono, T				Tamura, Ryoi; Nishida, Hiroshi; Eifuku, Satoshi; Nagao, Kaoru; Fushiki, Hiroaki; Watanabe, Yukio; Ono, Taketoshi			Short-Term Synaptic Plasticity in the Dentate Gyrus of Monkeys	PLOS ONE			English	Article							URETHANE-ANESTHETIZED RATS; PAIRED-PULSE DEPRESSION; FREELY MOVING RATS; HIPPOCAMPAL-FORMATION; MEMORY; POTENTIATION; INHIBITION; FACILITATION; CELLS	The hippocampus plays an important role in learning and memory. Synaptic plasticity in the hippocampus, short-term and long-term, is postulated to be a neural substrate of memory trace. Paired-pulse stimulation is a standard technique for evaluating a form of short-term synaptic plasticity in rodents. However, evidence is lacking for paired-pulse responses in the primate hippocampus. In the present study, we recorded paired-pulse responses in the dentate gyrus of monkeys while stimulating to the medial part of the perforant path at several inter-pulse intervals (IPIs) using low and high stimulus intensities. When the stimulus intensity was low, the first pulse produced early strong depression (at IPIs of 10-30 ms) and late slight depression (at IPIs of 100-1000 ms) of field excitatory postsynaptic potentials (fEPSPs) generated by the second pulse, interposing no depression IPIs (50-70 ms). When the stimulus intensity was high, fEPSPs generated by the second pulse were depressed by the first pulse at all IPIs except for the longest one (2000 ms). Population spikes (PSs) generated by the second pulse were completely blocked or strongly depressed at shorter IPIs (10-100 or 200 ms, respectively), while no depression or slight facilitation occurred at longer IPIs (500-2000 ms). Administration of diazepam slightly increased fEPSPs, while it decreased PSs produced by the first pulse. It also enhanced the facilitation of PSs produced by the second stimulation at longer IPIs. The present results, in comparison with previous studies using rodents, indicate that paired-pulse responses of fEPSPs in the monkey are basically similar to those of rodents, although paired-pulse responses of PSs in the monkey are more delayed than those in rodents and have a different sensitivity to diazepam.	[Tamura, Ryoi; Nishida, Hiroshi; Eifuku, Satoshi; Nagao, Kaoru] Toyama Univ, Dept Integrat Neurosci, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan	University of Toyama	Tamura, R (corresponding author), Toyama Univ, Dept Integrat Neurosci, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan.	rtamura@med.u-toyama.ac.jp			Japan Society for the Promotion of Science [20500356]; Japan Chemical Industry Association, Long-range Research Initiative [2004NT01]; Grants-in-Aid for Scientific Research [23500465] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Chemical Industry Association, Long-range Research Initiative; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (C); Grant number: 20500356, and Japan Chemical Industry Association, Long-range Research Initiative; Grant number: 2004NT01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMEC RE, 1981, EPILEPSIA, V22, P205; ALBERTSON TE, 1989, EXP NEUROL, V106, P142, DOI 10.1016/0014-4886(89)90087-3; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; BAKST I, 1985, J COMP NEUROL, V236, P423, DOI 10.1002/cne.902360402; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bliss TVP, 2007, HIPPOCAMPUS BOOK, P343; Bronzino JD, 1997, ANN BIOMED ENG, V25, P870, DOI 10.1007/BF02684171; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; Krug M, 1998, EUR J PHARMACOL, V356, P179, DOI 10.1016/S0014-2999(98)00544-5; Kusama T., 1970, STEREOTAXIC ATLAS BR; LOMO T, 1971, EXP BRAIN RES, V12, P18; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; PITKANEN A, 1993, J COMP NEUROL, V331, P37, DOI 10.1002/cne.903310104; RALL T W, 1990, P345; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tamura R, 2011, HIPPOCAMPUS, V21, P565, DOI 10.1002/hipo.20773; TUFF LP, 1983, BRAIN RES, V277, P79, DOI 10.1016/0006-8993(83)90909-5; URUNO K, 1995, BRAIN RES, V695, P163, DOI 10.1016/0006-8993(95)00652-7; Wilson CL, 1998, EPILEPSY RES, V31, P211, DOI 10.1016/S0920-1211(98)00063-1; Yamaguchi H, 2001, J PHARMACOL EXP THER, V298, P354; Zappone CA, 2004, J NEUROSCI, V24, P853, DOI 10.1523/JNEUROSCI.1619-03.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20006	10.1371/journal.pone.0020006	http://dx.doi.org/10.1371/journal.pone.0020006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625444	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400029
J	Beaudrot, L; Du, YJ; Kassim, AR; Rejmanek, M; Harrison, RD				Beaudrot, Lydia; Du, Yanjun; Kassim, Abdul Rahman; Rejmanek, Marcel; Harrison, Rhett D.			Do Epigeal Termite Mounds Increase the Diversity of Plant Habitats in a Tropical Rain Forest in Peninsular Malaysia?	PLOS ONE			English	Article							BUILDING TERMITES; BETA-DIVERSITY; TRADE-OFFS; HETEROGENEITY; MECHANISMS; ASSOCIATIONS; PERFORMANCE; NUTRIENTS; COMMUNITY; ISOPTERA	The extent to which environmental heterogeneity can account for tree species coexistence in diverse ecosystems, such as tropical rainforests, is hotly debated, although the importance of spatial variability in contributing to species co-existence is well recognized. Termites contribute to the micro-topographical and nutrient spatial heterogeneity of tropical forests. We therefore investigated whether epigeal termite mounds could contribute to the coexistence of plant species within a 50 ha plot at Pasoh Forest Reserve, Malaysia. Overall, stem density was significantly higher on mounds than in their immediate surroundings, but tree species diversity was significantly lower. Canonical correspondence analysis showed that location on or off mounds significantly influenced species distribution when stems were characterized by basal area. Like studies of termite mounds in other ecosystems, our results suggest that epigeal termite mounds provide a specific microhabitat for the enhanced growth and survival of certain species in these species-rich tropical forests. However, the extent to which epigeal termite mounds facilitate species coexistence warrants further investigation.	[Beaudrot, Lydia; Rejmanek, Marcel] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Beaudrot, Lydia; Du, Yanjun; Kassim, Abdul Rahman; Harrison, Rhett D.] Ctr Trop Forest Sci, Int Field Biol Course 2008, Pasoh Forest Reserve, Malaysia; [Du, Yanjun] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Kassim, Abdul Rahman] Forest Res Inst Malaysia, Selangor, Malaysia; [Rejmanek, Marcel] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Harrison, Rhett D.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China	University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Botany, CAS; Institute Penyelidikan Perhutanan Malaysia; University of California System; University of California Davis; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Beaudrot, L (corresponding author), Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA.	rharrison@xtbg.org.cn	; Beaudrot, L./M-6936-2017	Harrison, Rhett/0000-0001-9055-3546; Beaudrot, L./0000-0001-8135-7519	Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course; Forest Research Institute of Malaysia; Center for Tropical Forest Science; Arnold Arboretum	Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course; Forest Research Institute of Malaysia; Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Arnold Arboretum	The Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Forest Research Institute of Malaysia, the Center for Tropical Forest Science, and the Arnold Arboretum for supporting the 2008 International CTFS-AA Field Biology Course and providing the opportunity to study in the Pasoh Forest Reserve. We thank Shawn Cheng, Mark Grote, and John Harting for their help on the project and Alison Marklein for assistance with R code. We thank Cori Boyko, Ryan Boyko, John Chau, Katie Feilen, Ben Janes, Andrew Latimer, Andy Marshall, Casey Peters, and Jens Stevens for discussion and feedback on earlier drafts. We would also like to thank Gary Paoli and three anonymous reviewers whose comments on earlier versions greatly improved the manuscript.	ABE T, 1979, Japanese Journal of Ecology, V29, P337; ABE T, 1978, Kontyu, V46, P273; ABE T, 1978, MALAYSIAN NATURALIST, V30, P235; Adzmi Y, 2010, J TROP FOR SCI, V22, P21; Baillie IC, 2006, J TROP ECOL, V22, P543, DOI 10.1017/S026646740600352X; Baltzer JL, 2007, J BIOGEOGR, V34, P1916, DOI 10.1111/j.1365-2699.2007.01739.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Baraloto C, 2010, BIOTROPICA, V42, P420, DOI 10.1111/j.1744-7429.2009.00620.x; BIGNELL DE, 1995, INSECT SOC, V42, P57, DOI 10.1007/BF01245699; Blomqvist MM, 2000, OIKOS, V90, P582, DOI 10.1034/j.1600-0706.2000.900316.x; BURSLEM D.F.R.P., 1996, ECOLOGY TROPICAL FOR, P211; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; COVENTRY RJ, 1988, AUST J SOIL RES, V26, P375, DOI 10.1071/SR9880375; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HOBBS RJ, 1985, OECOLOGIA, V67, P342, DOI 10.1007/BF00384939; Holt JA, 2000, TERMITES EVOLUTION S; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KANG BT, 1978, PLANT SOIL, V50, P241, DOI 10.1007/BF02107175; Kitajima K., 2008, TROPICAL FOREST COMM, P160; KOCHUMMEN K M, 1990, Journal of Tropical Forest Science, V3, P1; Lee K. E., 1971, TERMITES AND SOILS; Leps J, 2003, MULTIVARIATE ANAL EC; MCCOMIE LD, 1993, J SOIL SCI, V44, P427, DOI 10.1111/j.1365-2389.1993.tb00465.x; Moe SR, 2009, PLANT ECOL, V202, P31, DOI 10.1007/s11258-009-9575-6; NYE PH, 1955, J SOIL SCI, V6, P73, DOI 10.1111/j.1365-2389.1955.tb00831.x; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; PENDLETON ROBERT L., 1942, JOUR AMER SOC AGRON, V34, P340; Potts MD, 2002, ECOLOGY, V83, P2782, DOI 10.1890/0012-9658(2002)083[2782:HPITRF]2.0.CO;2; R Core Team, 2020, R LANG ENV STAT COMP; Rogers LKR, 1999, INSECT SOC, V46, P366, DOI 10.1007/s000400050158; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; SALICK J, 1983, BIOTROPICA, V15, P1, DOI 10.2307/2387990; Sileshi GW, 2010, J VEG SCI, V21, P923, DOI 10.1111/j.1654-1103.2010.01197.x; SPAIN AV, 1988, J ECOL, V76, P181, DOI 10.2307/2260462; Takamura K, 2001, J TROP ECOL, V17, P541, DOI 10.1017/S0266467401001407; THO YP, 1982, STUDIES TAXONOMY BIO; Tilman D., 1982, Monographs in Population Biology, pi; Traore S, 2008, PLANT ECOL, V198, P285, DOI 10.1007/s11258-008-9404-3; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Veenendaal EM, 1996, J ECOL, V84, P83, DOI 10.2307/2261702; WATSON JP, 1977, J SOIL SCI, V28, P664, DOI 10.1111/j.1365-2389.1977.tb02273.x; Wood T.G., 1978, International Biological Programme, P245; WOOD TG, 1996, AGR ZOOLOGY REV, P117; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zimmermann JK, 2008, TROPICAL FOREST COMM, P98	48	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19777	10.1371/journal.pone.0019777	http://dx.doi.org/10.1371/journal.pone.0019777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625558	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200022
J	Lichtner, M; Mastroianni, CM; Rossi, R; Russo, G; Belvisi, V; Marocco, R; Mascia, C; Del Borgo, C; Mengoni, F; Sauzullo, I; d'Ettorre, G; D'Agostino, C; Massetti, AP; Vullo, V				Lichtner, Miriam; Mastroianni, Claudio M.; Rossi, Raffaella; Russo, Gianluca; Belvisi, Valeria; Marocco, Raffaella; Mascia, Claudia; Del Borgo, Cosmo; Mengoni, Fabio; Sauzullo, Ilaria; d'Ettorre, Gabriella; D'Agostino, Claudia; Massetti, Anna P.; Vullo, Vincenzo			Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection	PLOS ONE			English	Article							INFLUENZA A(H1N1) INFECTION; CRITICALLY-ILL PATIENTS; CLINICAL-ASPECTS; VIRUS; ACTIVATION; INTERFERON; SUBSETS; LOAD	Background: Dysregulation of host immune responses plays a critical role in the pathogenesis of severe 2009 pandemic H1N1 infection. Whether H1N1 virus could escape innate immune defense in vivo remains to be investigated. The aim of this study was to evaluate the pattern of innate immune response during human 2009 H1N1 infection. We performed the enumeration of circulating myeloid dendritic cells (mDC) and plasmacytoid DC (pDC) in blood from patients with H1N1 pneumonia shortly after the onset of symptoms and during follow-up at different intervals of time. The analysis of CD4 and CD8 count, CD38 T-cell activation marker and serum cytokine/chemokine plasma levels was also done. Methodology/Principal Findings: Blood samples were collected from 13 hospitalized patients with confirmed H1N1-related pneumonia at time of admission and at weeks 1, 4, and 16 of follow-up. 13 healthy donors were enrolled as controls. In the acute phase of the disease, H1N1-infected patients exhibited a significant depletion in both circulating pDC and mDC in conjunction with a decrease of CD4 and CD8 T cell count. In addition, we found plasmatic hyperproduction of IP-10 and RANTES, whereas increase in T-cell immune activation was found at all time points. When we assessed the changes in DC count over time, we observed a progressive normalization of mDC number. On the contrary, H1N1-infected patients did not achieve a complete recovery of pDC count as values remained lower than healthy controls even after 16 weeks of follow-up. Conclusions: H1N1 disease is associated with a profound depletion of DC subsets. The persistence of pDC deficit for several weeks after disease recovery could be due to H1N1 virus itself or to a preexisting impairment of innate immunity.	[Lichtner, Miriam; Mastroianni, Claudio M.; Belvisi, Valeria; Marocco, Raffaella; Mascia, Claudia; Del Borgo, Cosmo] Univ La Sapienza, Infect Dis Unit, SM Goretti Hosp, Latina, Italy; [Lichtner, Miriam; Mastroianni, Claudio M.; Rossi, Raffaella; Russo, Gianluca; Mengoni, Fabio; Sauzullo, Ilaria; d'Ettorre, Gabriella; D'Agostino, Claudia; Massetti, Anna P.; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Lichtner, M (corresponding author), Univ La Sapienza, Infect Dis Unit, SM Goretti Hosp, Latina, Italy.	claudio.mastroianni@uniroma1.it	Russo, Gianluca/H-5128-2017; MASTROIANNI, Claudio Maria/O-9741-2019; d'Ettorre, Gabriella/K-4511-2016; Russo, Gianluca/N-4362-2019	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Massetti, Anna Paola/0000-0003-0520-8743; Russo, Gianluca/0000-0002-8764-7389; D'Agostino, Caudia/0000-0002-4399-8785; d'Ettorre, Gabriella/0000-0002-3571-5677; Belvisi, Valeria/0000-0002-5835-1597; Sauzullo, Ilaria/0000-0002-0060-0749	Sapienza University of Rome	Sapienza University of Rome	The study was supported by grants from the Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Arankalle VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013099; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hosmalin Anne, 2008, V415, P273, DOI 10.1007/978-1-59745-570-1_16; Jiang TJ, 2010, CLIN IMMUNOL, V137, P303, DOI 10.1016/j.clim.2010.07.010; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lichtner M, 2008, CURR HIV RES, V6, P19, DOI 10.2174/157016208783571937; Liu WC, 2010, J VIROL, V84, P12011, DOI 10.1128/JVI.01316-10; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; WOLF AI, 2010, J INFECT DIS, V182, P871	25	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19872	10.1371/journal.pone.0019872	http://dx.doi.org/10.1371/journal.pone.0019872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625541	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200028
J	Alba, R; Cots, D; Ostapchuk, P; Bosch, A; Hearing, P; Chillon, M				Alba, Raul; Cots, Dan; Ostapchuk, Philomena; Bosch, Assumpcio; Hearing, Patrick; Chillon, Miguel			Altering the Ad5 Packaging Domain Affects the Maturation of the Ad Particles	PLOS ONE			English	Article							DEPENDENT ADENOVIRAL VECTORS; 55-KILODALTON PROTEINS; L1 52-KILODALTON; GENE-TRANSFER; IVA2 PROTEIN; HELPER-VIRUS; SEQUENCES; SYSTEM; DNA; TYPE-5	We have previously described a new family of mutant adenoviruses carrying different combinations of attB/attP sequences from bacteriophage PhiC31 flanking the Ad5 packaging domain. These novel helper viruses have a significantly delayed viral life cycle and a severe packaging impairment, regardless of the presence of PhiC31 recombinase. Their infectious viral titers are significantly lower (100-1000 fold) than those of control adenovirus at 36 hours post-infection, but allow for efficient packaging of helper-dependent adenovirus. In the present work, we have analyzed which steps of the adenovirus life cycle are altered in attB-helper adenoviruses and investigated whether these viruses can provide the necessary viral proteins in trans. The entry of attB-adenoviral genomes into the cell nucleus early at early timepoints post-infection was not impaired and viral protein expression levels were found to be similar to those of control adenovirus. However, electron microscopy and capsid protein composition analyses revealed that attB-adenoviruses remain at an intermediate state of maturation 36 hours post-infection in comparison to control adenovirus which were fully mature and infective at this time point. Therefore, an additional 20-24 hours were found to be required for the appearance of mature attB-adenovirus. Interestingly, attB-adenovirus assembly and infectivity was restored by inserting a second packaging signal close to the right-end ITR, thus discarding the possibility that the attB-adenovirus genome was retained in a nuclear compartment deleterious for virus assembly. The present study may have substantive implications for helper-dependent adenovirus technology since helper attB-adenovirus allows for preferential packaging of helper-dependent adenovirus genomes.	[Alba, Raul; Cots, Dan; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain; [Alba, Raul; Cots, Dan; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Ostapchuk, Philomena; Hearing, Patrick] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; ICREA	Alba, R (corresponding author), Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	miguel.chillon@uab.es	Alba, Raul/B-5859-2012; Bosch, Assumpcio/C-7593-2015; Chillon, Miguel/A-2466-2009	Bosch, Assumpcio/0000-0002-7205-2796; Chillon, Miguel/0000-0003-0840-2111	Instituto Salud Carlos III [PI081162]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR-2009-1300]; Association Francaise contre les Myopathies (AFM) [12277]; EC [FP7-222992]; CAV-4-MPS an E-Rare project [ISCIII PS09/02674]; NIH [AI041636]; FI-Generalitat [2003-0367]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041636] Funding Source: NIH RePORTER	Instituto Salud Carlos III(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); EC(European CommissionEuropean Commission Joint Research Centre); CAV-4-MPS an E-Rare project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FI-Generalitat; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Instituto Salud Carlos III (PI081162)(MC); Agencia de Gestio d'Ajuts Universitaris i de Recerca (SGR-2009-1300)(MC); the Association Francaise contre les Myopathies (AFM#12277) (MC); BrainCAV an EC-FP7 project (FP7-222992)(AB); CAV-4-MPS an E-Rare project (ISCIII PS09/02674)(AB); and NIH AI041636 (PH). RA was a recipient of a FI-Generalitat fellowship # 2003-0367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, GENE THER, V12, pS18, DOI 10.1038/sj.gt.3302612; Alba R, 2007, VIROLOGY, V367, P51, DOI 10.1016/j.virol.2007.05.014; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; CHARDONN.Y, 1970, VIROLOGY, V40, P462, DOI 10.1016/0042-6822(70)90189-3; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HASSON TB, 1989, J VIROL, V63, P3612, DOI 10.1128/JVI.63.9.3612-3621.1989; HASSON TB, 1992, J VIROL, V66, P6133, DOI 10.1128/JVI.66.10.6133-6142.1992; HEARING P, 1987, J VIROL, V61, P2555, DOI 10.1128/JVI.61.8.2555-2558.1987; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Morsy MA, 1998, P NATL ACAD SCI USA, V95, P7866, DOI 10.1073/pnas.95.14.7866; Ng P, 2002, J VIROL, V76, P4181, DOI 10.1128/JVI.76.9.4181-4189.2002; Ng P, 2001, MOL THER, V3, P809, DOI 10.1006/mthe.2001.0323; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Ostapchuk P, 2005, J VIROL, V79, P2831, DOI 10.1128/JVI.79.5.2831-2838.2005; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palmer Donna J., 2008, V433, P33, DOI 10.1007/978-1-59745-237-3_3; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Sandalon Z, 2000, J VIROL, V74, P10381, DOI 10.1128/JVI.74.22.10381-10389.2000; SARNOW P, 1982, J MOL BIOL, V162, P565, DOI 10.1016/0022-2836(82)90389-8; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; STOW ND, 1981, J VIROL, V37, P171, DOI 10.1128/JVI.37.1.171-180.1981; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weber Joseph M., 2003, Acta Microbiologica et Immunologica Hungarica, V50, P95, DOI 10.1556/AMicr.50.2003.1.9; Xue YM, 2005, J VIROL, V79, P2474, DOI 10.1128/JVI.79.4.2474-2483.2005; Zhang W, 2003, J VIROL, V77, P3586, DOI 10.1128/JVI.77.6.3586-3594.2003	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19564	10.1371/journal.pone.0019564	http://dx.doi.org/10.1371/journal.pone.0019564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611162	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000290720200015
J	Del Porto, P; Cifani, N; Guarnieri, S; Di Domenico, EG; Mariggio, MA; Spadaro, F; Guglietta, S; Anile, M; Venuta, F; Quattrucci, S; Ascenzioni, F				Del Porto, Paola; Cifani, Noemi; Guarnieri, Simone; Di Domenico, Enea Gino; Mariggio, Maria A.; Spadaro, Francesca; Guglietta, Silvia; Anile, Marco; Venuta, Federico; Quattrucci, Serena; Ascenzioni, Fiorentina			Dysfunctional CFTR Alters the Bactericidal Activity of Human Macrophages against Pseudomonas aeruginosa	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SUSCEPTIBILITY; IDENTIFICATION; LOCALIZATION; INFLAMMATION; NEUTROPHILS; INFECTION; CELLS	Chronic inflammation of the lung, as a consequence of persistent bacterial infections by several opportunistic pathogens represents the main cause of mortality and morbidity in cystic fibrosis (CF) patients. Mechanisms leading to increased susceptibility to bacterial infections in CF are not completely known, although the involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in microbicidal functions of macrophages is emerging. Tissue macrophages differentiate in situ from infiltrating monocytes, additionally, mature macrophages from different tissues, although having a number of common activities, exhibit variation in some molecular and cellular functions. In order to highlight possible intrinsic macrophage defects due to CFTR dysfunction, we have focused our attention on in vitro differentiated macrophages from human peripheral blood monocytes. Here we report on the contribution of CFTR in the bactericidal activity against Pseudomonas aeruginosa of monocyte derived human macrophages. At first, by real time PCR, immunofluorescence and patch clamp recordings we demonstrated that CFTR is expressed and is mainly localized to surface plasma membranes of human monocyte derived macrophages (MDM) where it acts as a cAMP-dependent chloride channel. Next, we evaluated the bactericidal activity of P. aeruginosa infected macrophages from healthy donors and CF patients by antibiotic protection assays. Our results demonstrate that control and CF macrophages do not differ in the phagocytic activity when infected with P. aeruginosa. Rather, although a reduction of intracellular live bacteria was detected in both non-CF and CF cells, the percentage of surviving bacteria was significantly higher in CF cells. These findings further support the role of CFTR in the fundamental functions of innate immune cells including eradication of bacterial infections by macrophages.	[Del Porto, Paola; Cifani, Noemi; Di Domenico, Enea Gino; Guglietta, Silvia; Ascenzioni, Fiorentina] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Guarnieri, Simone; Mariggio, Maria A.] Univ Gabriele Annunzio, Dept Neurosci & Imaging, Ctr Excellence Ageing CeSI, Chieti, Italy; [Spadaro, Francesca] Ist Super Sanita, Dept Cell Biol & Neurosci, Unit Expt Immunotherapy, I-00161 Rome, Italy; [Anile, Marco; Venuta, Federico] Univ Roma La Sapienza, Policlin Umberto I, Dept Thorac Surg, Rome, Italy; [Quattrucci, Serena] Univ Roma La Sapienza, Dept Pediat, Ctr Riferimento Fibrosi Cist Reg Lazio, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome	Del Porto, P (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	delporto@uniroma1.it	Spadaro, Francesca/M-7512-2017; Di Domenico, Enea Gino/I-2542-2019; Del Porto, Paola/AAU-2550-2020; Mariggiò, Maria Addolorata/T-9047-2017; Guarnieri, Simone/AAA-5921-2020; Guglietta, Silvia/A-3918-2012	Spadaro, Francesca/0000-0002-6610-350X; Di Domenico, Enea Gino/0000-0001-6295-6006; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Mariggio, Maria Addolorata/0000-0002-3508-8706; Del Porto, Paola/0000-0003-4802-8910; Guarnieri, Simone/0000-0002-2916-2965; Venuta, Federico/0000-0001-9296-877X; Guglietta, Silvia/0000-0001-9998-5716	Italian Foundation for Cystic Fibrosis Research [FFC 14/2007, FFC 21/2009]; Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza'	Italian Foundation for Cystic Fibrosis Research; Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza'(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the Italian Foundation for Cystic Fibrosis Research (grants FFC 14/2007 and FFC 21/2009 adopted by Delegazione FFC di Latina e Lega Italiana Fibrosi Cistica Onlus-Associazione Laziale Onlus'') to P. D. P and by the Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza' to F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriche C, 2010, GENE THER, V17, P1341, DOI 10.1038/gt.2010.89; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Dormer RL, 2001, PFLUG ARCH EUR J PHY, V443, pS117; Haggie PM, 2009, AM J PHYSIOL-LUNG C, V296, pL859, DOI 10.1152/ajplung.00018.2009; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; MATSUI H, 1998, SCIENCE, V95, P1005; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Nixon GM, 2002, ARCH DIS CHILD, V87, P306, DOI 10.1136/adc.87.4.306; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; RIORDAN JR, 1989, SCIENCE, V245, P1066; Saiman L, 1999, J CLIN MICROBIOL, V37, P2987, DOI 10.1128/JCM.37.9.2987-2991.1999; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Swanson J, 2006, NAT CELL BIOL, V8, P908, DOI 10.1038/ncb0906-908; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	33	113	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19970	10.1371/journal.pone.0019970	http://dx.doi.org/10.1371/journal.pone.0019970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625641	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200051
J	dos Santos, SS; Ferreira, KS; Almeida, SR				dos Santos, Suelen Silvana; Ferreira, Karen Spadari; Almeida, Sandro Rogerio			Paracoccidioides brasilinsis-Induced Migration of Dendritic Cells and Subsequent T-Cell Activation in the Lung-Draining Lymph Nodes	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; CRYPTOCOCCUS-NEOFORMANS INFECTION; ANTIGEN PRESENTATION; MURINE MODEL; IN-VIVO; BRASILIENSIS; EXPRESSION; INTERLEUKIN-10; MACROPHAGES; RECEPTOR	Paracoccidioidomycosis is a mycotic disease caused by a dimorphic fungus, Paracoccidioides brasiliensis (Pb), that starts with inhalation of the fungus; thus, lung cells such as DC are part of the first line of defense against this microorganism. Migration of DC to the lymph nodes is the first step in initiating T cell responses. The mechanisms involved in resistance to Pb infection are poorly understood, but it is likely that DC play a pivotal role in the induction of effector T cells that control Pb infection. In this study, we showed that after Pb Infection, an important modification of lung DC receptor expression occurred. We observed an increased expression of CCR7 and CD103 on lung DC after infection, as well as MHC-II. After Pb infection, bone marrow-derived DC as well lung DC, migrate to lymph nodes. Migration of lung DC could represent an important mechanism of pathogenesis during PCM infection. In resume our data showed that Pb induced DC migration. Furthermore, we demonstrated that bone marrow-derived DC stimulated by Pb migrate to the lymph nodes and activate a T helper (Th) response. To the best of our knowledge, this is the first reported data showing that Pb induces migration of DC and activate a T helper (Th) response.	[dos Santos, Suelen Silvana; Almeida, Sandro Rogerio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil; [Ferreira, Karen Spadari] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	dos Santos, SS (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil.	sandroal@usp.br	almeida, sandro r/F-5816-2012; Ferreira/Spadari, Karen SF/D-4437-2013; Ferreira, Karen/AAA-4363-2022; Santos, Suelen/F-3048-2014	almeida, sandro r/0000-0002-0562-1610; Spadari, Karen/0000-0003-2832-5942	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo [07/57594-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (research fellowships to SRA) and Fundacao de de Amparo a Pesquisa do Estado de Sao Paulo (proc. no. 07/57594-9) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Beauchamp NM, 2010, J VIROL, V84, P10191, DOI 10.1128/JVI.00892-10; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; Dan JM, 2008, INFECT IMMUN, V76, P2362, DOI 10.1128/IAI.00095-08; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; Ferreira KS, 2004, IMMUNOL LETT, V94, P107, DOI 10.1016/j.imlet.2004.04.005; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Lukens MV, 2009, J VIROL, V83, P7235, DOI 10.1128/JVI.00452-09; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Romano CC, 2005, CLIN IMMUNOL, V114, P86, DOI 10.1016/j.clim.2004.09.005; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; WATANABE K, 1991, INFECT IMMUN, V59, P521, DOI 10.1128/IAI.59.2.521-528.1991; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19690	10.1371/journal.pone.0019690	http://dx.doi.org/10.1371/journal.pone.0019690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611175	gold, Green Submitted, Green Published			2022-12-27	WOS:000290720200026
J	Pursall, ER; Rolff, J				Pursall, E. Rhiannon; Rolff, Jens			Immune Responses Accelerate Ageing: Proof-of-Principle in an Insect Model	PLOS ONE			English	Article							LIFE-SPAN; INNATE IMMUNITY; INFLAMMATION; DISEASES; ACTIVATION; RESISTANCE; LONGEVITY; MORTALITY; ORIGINS; PROTEIN	The pathology of many of the world's most important infectious diseases is caused by the immune response. Additionally age-related disease is often attributed to inflammatory responses. Consequently a reduction in infections and hence inflammation early in life has been hypothesized to explain the rise in lifespan in industrialized societies. Here we demonstrate experimentally for the first time that eliciting an immune response early in life accelerates ageing. We use the beetle Tenebrio molitor as an inflammation model. We provide a proof of principle for the effects of early infection on morbidity late in life and demonstrate a long-lasting cost of immunopathology. Along with presenting a proof-of-principle study, we discuss a mechanism for the apparently counter-adaptive persistence of immunopathology in natural populations. If immunopathology from early immune response only becomes costly later in life, natural selection on reducing self-harm would be relaxed, which could explain the presence of immune self-harm in nature.	[Pursall, E. Rhiannon] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Birmingham; University of Sheffield	Pursall, ER (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	r.pursall@bham.ac.uk; jor@sheffield.ac.uk		Rolff, Jens/0000-0002-1529-5409	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council (BBSRC) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armitage SAO, 2003, J EVOLUTION BIOL, V16, P1038, DOI 10.1046/j.1420-9101.2003.00551.x; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bengtsson T, 2003, INT J EPIDEMIOL, V32, P286, DOI 10.1093/ije/dyg061; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; BRODERICK N, INSECT INFECT IMMUNI; Catalano R, 2006, INT J EPIDEMIOL, V35, P1264, DOI 10.1093/ije/dyl108; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Licastro Federico, 2005, Immun Ageing, V2, P8; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 1997, NEW ENGL J MED, V337, P423; RYERSE JS, 1979, TISSUE CELL, V11, P533, DOI 10.1016/0040-8166(79)90061-2; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sherratt TN, 2010, J ANIM ECOL, V79, P1034, DOI 10.1111/j.1365-2656.2010.01719.x; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; THOMPSON JJW, 2002, THESIS U SHEFFIELD S; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH	42	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19972	10.1371/journal.pone.0019972	http://dx.doi.org/10.1371/journal.pone.0019972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625631	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200052
J	Yan, HQ; Chang, SH; Tian, ZX; Zhang, L; Sun, YC; Li, Y; Wang, J; Wang, YP				Yan, Hai-Qin; Chang, Su-Hua; Tian, Zhe-Xian; Zhang, Le; Sun, Yi-Cheng; Li, Yan; Wang, Jing; Wang, Yi-Ping			Novel AroA from Pseudomonas putida Confers Tobacco Plant with High Tolerance to Glyphosate	PLOS ONE			English	Article							RAPESEED BRASSICA-NAPUS; ESCHERICHIA-COLI K12; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; TRANSGENIC PLANTS; CODON USAGE; DNA; TRANSFORMATION; SUBSTITUTION	Glyphosate is a non-selective broad-spectrum herbicide that inhibits 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS, also designated as AroA), a key enzyme in the aromatic amino acid biosynthesis pathway in microorganisms and plants. Previously, we reported that a novel AroA (PpAroA1) from Pseudomonas putida had high tolerance to glyphosate, with little homology to class I or class II glyphosate-tolerant AroA. In this study, the coding sequence of PpAroA1 was optimized for tobacco. For maturation of the enzyme in chloroplast, a chloroplast transit peptide coding sequence was fused in frame with the optimized aroA gene (PparoA1(optimized)) at the 59 end. The PparoA1(optimized) gene was introduced into the tobacco (Nicotiana tabacum L. cv. W38) genome via Agrobacterium-mediated transformation. The transformed explants were first screened in shoot induction medium containing kanamycin. Then glyphosate tolerance was assayed in putative transgenic plants and its T-1 progeny. Our results show that the PpAroA1 from Pseudomonas putida can efficiently confer tobacco plants with high glyphosate tolerance. Transgenic tobacco overexpressing the PparoA1(optimized) gene exhibit high tolerance to glyphosate, which suggest that the novel PpAroA1 is a new and good candidate applied in transgenic crops with glyphosate tolerance in future.	[Yan, Hai-Qin; Tian, Zhe-Xian; Zhang, Le; Sun, Yi-Cheng; Li, Yan; Wang, Yi-Ping] Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Hai-Qin] Bengbu Med Coll, Dept Histol & Embryol, Bengbu Anhui, Peoples R China; [Chang, Su-Hua; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Sun, Yi-Cheng] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Sun, Yi-Cheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Bengbu Medical College; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, HQ (corresponding author), Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	wangyp@pku.edu.cn	Chang, Suhua/AGZ-1921-2022	Wang, Yiping/0000-0002-1995-8521	National Transgenic Research and Industrialization Special Foundation of China [2009ZX08009-057B, 2008ZX08009-003-002]; Ministry of Science and Technology of China [2007AA021307]	National Transgenic Research and Industrialization Special Foundation of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants from the National Transgenic Research and Industrialization Special Foundation of China No. 2009ZX08009-057B, No. 2008ZX08009-003-002, and the Hi-Tech Research and Development "863" Program No. 2007AA021307 from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry G.F., 1992, World Patent, Patent No. [9204449, WO 9. 204: 449]; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; CERA, 2010, GM CROP DAT; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; COMAI L, 1985, NATURE, V317, P741, DOI 10.1038/317741a0; DELLACIOPPA G, 1987, BIO-TECHNOL, V5, P579, DOI 10.1038/nbt0687-579; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Kahrizi D, 2005, FEBS J, V272, P513; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1986, FASEB J, V45, P1506; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Sun YC, 2006, FEBS LETT, V580, P1521, DOI 10.1016/j.febslet.2006.01.075; Sun YC, 2005, APPL ENVIRON MICROB, V71, P4771, DOI 10.1128/AEM.71.8.4771-4776.2005; SUN YC, 2007, Patent No. 7214535; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x	28	19	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19732	10.1371/journal.pone.0019732	http://dx.doi.org/10.1371/journal.pone.0019732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611121	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200029
J	Jones, MR; Chua, A; Chen, YDI; Li, XH; Krauss, RM; Rotter, JI; Legro, RS; Azziz, R; Goodarzi, MO				Jones, Michelle R.; Chua, Angela; Chen, Yii-Der I.; Li, Xiaohui; Krauss, Ronald M.; Rotter, Jerome I.; Legro, Richard S.; Azziz, Ricardo; Goodarzi, Mark O.			Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome	PLOS ONE			English	Article							MICROARRAY ANALYSIS; WOMEN; TESTOSTERONE; DICKKOPF-1; FEATURES; HSD17B6; CELLS	Novel pathways in polycystic ovary syndrome (PCOS) are being identified in gene expression studies in PCOS tissues; such pathways may contain key genes in disease etiology. Previous expression studies identified both dickkopf homolog 1 (DKK1) and DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1) as differentially expressed in PCOS tissue, implicating them as candidates for PCOS susceptibility. To test this, we genotyped a discovery cohort of 335 PCOS cases and 198 healthy controls for three DKK1 single nucleotide polymorphisms (SNPs) and four DNAJB1 SNPs and a replication cohort of 396 PCOS cases and 306 healthy controls for 1 DKK1 SNP and 1 DNAJB1 SNP. SNPs and haplotypes were determined and tested for association with PCOS and component phenotypes. We found that no single nucleotide polymorphisms were associated with PCOS risk; however, the major allele of rs1569198 from DKK1 was associated with increased total testosterone (discovery cohort P = 0.0035) and dehydroepiandrosterone sulfate (replication cohort P = 0.05). Minor allele carriers at rs3962158 from DNAJB1 had increased fasting insulin (discovery cohort P = 0.003), increased HOMA-IR (discovery cohort P = 0.006; replication cohort P = 0.036), and increased HOMA-%B (discovery cohort P = 0.004). Carriers of haplotype 2 at DNAJB1 also had increased fasting insulin, HOMA-IR, and HOMA-%B. These findings suggest that genetic variation in DKK1 and DNAJB1 may have a role in the hyperandrogenic and metabolic dysfunction of PCOS, respectively. Our results also demonstrate the utility of gene expression data as a source of novel candidate genes in PCOS, a complex and still incompletely defined disease, for which alternative methods of gene identification are needed.	[Jones, Michelle R.; Chua, Angela; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Chen, Yii-Der I.; Azziz, Ricardo; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Chen, Yii-Der I.; Li, Xiaohui; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rotter, Jerome I.; Azziz, Ricardo; Goodarzi, Mark O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Azziz, Ricardo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Jones, MR (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Azziz, Ricardo/N-7229-2014	Goodarzi, Mark/0000-0001-6364-5103; Azziz, Ricardo/0000-0002-3917-0483; Legro, Richard/0000-0001-9927-7584	National Institutes of Health [R01-HD29364, K24-HD01346, R01-DK79888, U54-HD034449, R01-HL069757]; National Center for Research Resources [M01-RR00425]; Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056510, U54HD034449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001346, R01HD029364] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Winnick Clinical Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [R01-HD29364, K24-HD01346 to R. A., R01-DK79888 to M.O.G., U54-HD034449 to R. S. L., R01-HL069757 to R. M. K.]; National Center for Research Resources [M01-RR00425 to the Cedars-Sinai General Clinical Research Center]; Winnick Clinical Scholars Award [to M.O.G.]; and an endowment from the Helping Hand of Los Angeles, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Borro M, 2007, CLIN EXP IMMUNOL, V150, P494, DOI 10.1111/j.1365-2249.2007.03498.x; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1092, P175, DOI 10.1196/annals.1365.015; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Jee S, 2007, INT J MOL MED, V20, P829; Jones MR, 2006, FERTIL STERIL, V86, P1438, DOI 10.1016/j.fertnstert.2006.04.027; Jones MR, 2009, J CLIN ENDOCR METAB, V94, P5034, DOI 10.1210/jc.2009-0931; Ke L, 2010, J WOMENS HEALTH, V19, P2227, DOI 10.1089/jwh.2009.1902; Kwack MH, 2008, J INVEST DERMATOL, V128, P262, DOI 10.1038/sj.jid.5700999; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Mohamed-Hussein ZA, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-18; Piters E, 2010, CALCIFIED TISSUE INT, V86, P271, DOI 10.1007/s00223-010-9334-7; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	25	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20120	10.1371/journal.pone.0020120	http://dx.doi.org/10.1371/journal.pone.0020120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611153	Green Published, gold			2022-12-27	WOS:000290657500044
J	Zhu, DX; Mackenzie, NCW; Millan, JL; Farquharson, C; MacRae, VE				Zhu, Dongxing; Mackenzie, Neil Charles Wallace; Millan, Jose Luis; Farquharson, Colin; MacRae, Vicky Elizabeth			The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							INFANTILE ARTERIAL CALCIFICATION; DENTIN MATRIX PROTEIN-1; IN-VITRO; ALKALINE-PHOSPHATASE; CHONDROCYTE DIFFERENTIATION; BONE MINERALIZATION; UP-REGULATION; OSTEOBLASTS; REGULATORS; MICE	Background: Vascular calcification is an indicator of elevated cardiovascular risk. Vascular smooth muscle cells (VSMCs), the predominant cell type involved in medial vascular calcification, can undergo phenotypic transition to both osteoblastic and chondrocytic cells within a calcifying environment. Methodology/Principal Findings: In the present study, using in vitro VSMC calcification studies in conjunction with ex vivo analyses of a mouse model of medial calcification, we show that vascular calcification is also associated with the expression of osteocyte phenotype markers. As controls, the terminal differentiation of murine calvarial osteoblasts into osteocytes was induced in vitro in the presence of calcifying medium (containing beta-glycerophosphate and ascorbic acid), as determined by increased expression of the osteocyte markers DMP-1, E11 and sclerostin. Culture of murine aortic VSMCs under identical conditions confirmed that the calcification of these cells can also be induced in similar calcifying medium. Calcified VSMCs had increased alkaline phosphatase activity and PiT-1 expression, which are recognized markers of vascular calcification. Expression of DMP-1, E11 and sclerostin was up-regulated during VSMC calcification in vitro. Increased protein expression of E11, an early osteocyte marker, and sclerostin, expressed by more mature osteocytes was also observed in the calcified media of Enpp1 2/2 mouse aortic tissue. Conclusions/Significance: This study has demonstrated the up-regulation of key osteocytic molecules during the vascular calcification process. A fuller understanding of the functional role of osteocyte formation and specifically sclerostin and E11 expression in the vascular calcification process may identify novel potential therapeutic strategies for clinical intervention.	[Zhu, Dongxing; Mackenzie, Neil Charles Wallace; Farquharson, Colin; MacRae, Vicky Elizabeth] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Sanford Burnham Prebys Medical Discovery Institute	Zhu, DX (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	vicky.macrae@roslin.ed.ac.uk	zhu, dongxing/AAM-4330-2020; Zhu, Dongxing/N-5059-2014; farquharson, colin/C-2956-2011	zhu, dongxing/0000-0001-5419-438X; farquharson, colin/0000-0002-4970-4039; MacRae, Vicky/0000-0001-6306-7040	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F023928/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023928/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an Institute Strategic Programme Grant and Institute Career Path Fellowship funding from the Biotechnology and Biological Sciences Research Council (BBSRC) www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarden EM, 1996, BONE, V18, P305, DOI 10.1016/8756-3282(96)00010-5; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Balemans W, 2005, BONE, V36, P943, DOI 10.1016/j.bone.2005.02.019; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Burger E H, 1999, Adv Dent Res, V13, P93; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Dallas SL, 2009, CELLS TISSUES ORGANS, V189, P6, DOI 10.1159/000151745; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Farquharson C, 1999, BONE, V25, P405, DOI 10.1016/S8756-3282(99)00187-8; FARQUHARSON C, 1995, BONE, V17, P279, DOI 10.1016/8756-3282(95)00220-8; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Hadjiargyrou M, 2001, BONE, V29, P149, DOI 10.1016/S8756-3282(01)00489-6; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Irie K, 2008, J HISTOCHEM CYTOCHEM, V56, P561, DOI 10.1369/jhc.2008.950527; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Karsdal MA, 2004, DNA CELL BIOL, V23, P155, DOI 10.1089/104454904322964751; Kneissel M, 2009, IBMS BONEKEY, V6, P259; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; LOMRI A, 1988, BONE, V9, P165, DOI 10.1016/8756-3282(88)90006-3; MacRae VE, 2006, J ENDOCRINOL, V189, P319, DOI 10.1677/joe.1.06609; Macrae VE, 2009, J CELL PHYSIOL, V218, P276, DOI 10.1002/jcp.21593; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Martin-Villar E, 2009, INT J BIOCHEM CELL B, V41, P1421, DOI 10.1016/j.biocel.2008.12.010; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Speer MY, 2005, CARDIOVASC RES, V66, P324, DOI 10.1016/j.cardiores.2005.01.023; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen R L, 2005, J Endocrinol Invest, V28, P15; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	46	175	191	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19595	10.1371/journal.pone.0019595	http://dx.doi.org/10.1371/journal.pone.0019595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611184	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500008
J	Racape, M; Van Huyen, JPD; Danger, R; Giral, M; Bleicher, F; Foucher, Y; Pallier, A; Pilet, P; Tafelmeyer, P; Ashton-Chess, J; Dugast, E; Pettre, S; Charreau, B; Soulillou, JP; Brouard, S				Racape, Maud; Van Huyen, Jean-Paul Duong; Danger, Richard; Giral, Magali; Bleicher, Francoise; Foucher, Yohann; Pallier, Annaick; Pilet, Paul; Tafelmeyer, Petra; Ashton-Chess, Joanna; Dugast, Emilie; Pettre, Segolene; Charreau, Beatrice; Soulillou, Jean-Paul; Brouard, Sophie			The Involvement of SMILE/TMTC3 in Endoplasmic Reticulum Stress Response	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PLASMA-CELL DIFFERENTIATION; RENAL-TRANSPLANT TOLERANCE; TRANSCRIPTION FACTOR XBP-1; OPERATIONAL TOLERANCE; ER STRESS; MAINTENANCE IMMUNOSUPPRESSION; ORGAN-TRANSPLANTATION; HUMANS; KIDNEY	Background: Thestate of operational tolerance has been detected sporadically in some renal transplanted patients that stopped immunosuppressive drugs, demonstrating that allograft tolerance might exist in humans. Several years ago, a study by Brouard et al. identified a molecular signature of several genes that were significantly differentially expressed in the blood of such patients compared with patients with other clinical situations. The aim of the present study is to analyze the role of one of these molecules over-expressed in the blood of operationally tolerant patients, SMILE or TMTC3, a protein whose function is still unknown. Methodology/Principal Findings: We first confirmed that SMILE mRNA is differentially expressed in the blood of operationally tolerant patients with drug-free long term graft function compared to stable and rejecting patients. Using a yeast two-hybrid approach and a colocalization study by confocal microscopy we furthermore report an interaction of SMILE with PDIA3, a molecule resident in the endoplasmic reticulum (ER). In accordance with this observation, SMILE silencing in HeLa cells correlated with the modulation of several transcripts involved in proteolysis and a decrease in proteasome activity. Finally, SMILE silencing increased HeLa cell sensitivity to the proteasome inhibitor Bortezomib, a drug that induces ER stress via protein overload, and increased transcript expression of a stress response protein, XBP-1, in HeLa cells and keratinocytes. Conclusion/Significance: In this study we showed that SMILE is involved in the endoplasmic reticulum stress response, by modulating proteasome activity and XBP-1 transcript expression. This function of SMILE may influence immune cell behavior in the context of transplantation, and the analysis of endoplasmic reticulum stress in transplantation may reveal new pathways of regulation in long-term graft acceptance thereby increasing our understanding of tolerance.	[Racape, Maud; Danger, Richard; Giral, Magali; Pallier, Annaick; Ashton-Chess, Joanna; Dugast, Emilie; Pettre, Segolene; Charreau, Beatrice; Soulillou, Jean-Paul; Brouard, Sophie] Inst Natl Sante & Rech Med, Unite Mixte Rech 643, Nantes, France; [Racape, Maud; Danger, Richard; Giral, Magali; Pallier, Annaick; Ashton-Chess, Joanna; Dugast, Emilie; Pettre, Segolene; Charreau, Beatrice; Soulillou, Jean-Paul; Brouard, Sophie] Inst Transplantat Urol Nephrol, Nantes, France; [Racape, Maud; Danger, Richard; Foucher, Yohann; Ashton-Chess, Joanna; Dugast, Emilie; Pettre, Segolene; Charreau, Beatrice; Soulillou, Jean-Paul] Univ Nantes, Nantes, France; [Giral, Magali; Charreau, Beatrice; Soulillou, Jean-Paul] Ctr Hosp Univ Hotel Dieu, Nantes, France; [Van Huyen, Jean-Paul Duong] Univ Paris 05, Hop Europeen Georges Pompidou, PARCC, Inst Natl Sante & Rech Med,U970, Paris, France; [Bleicher, Francoise] Univ Lyon 1, Inst Genom Fonct Lyon, Unite Mixte Rech 5242, F-69365 Lyon, France; [Bleicher, Francoise] Ecole Normale Super, CNRS, Paris, France; [Pilet, Paul] Inst Natl Sante & Rech Med, EMI 9903, Fac Odontol, Nantes, France; [Tafelmeyer, Petra] Hybrigen Serv SAS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Racape, M (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech 643, Nantes, France.	sophie.brouard@univ-nantes.fr	brouard, sophie c/Q-1285-2016; Foucher, Yohann/ABB-6362-2021; CHARREAU, Beatrice/AAK-8186-2020; Foucher, Yohann/G-2714-2013; Paul, Pilet/A-3755-2015; Foucher, Yohann/L-8995-2015	Foucher, Yohann/0000-0003-0330-7457; CHARREAU, Beatrice/0000-0001-5870-4615; Foucher, Yohann/0000-0003-0330-7457; Danger, Richard/0000-0002-5058-795X	Agence de la Biomedecine	Agence de la Biomedecine	This work was supported by a grant from the Agence de la Biomedecine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kingsley CI, 2007, TRANSPL INT, V20, P828, DOI 10.1111/j.1432-2277.2007.00533.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Louis S, 2006, TRANSPLANTATION, V81, P398, DOI 10.1097/01.tp.0000203166.44968.86; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Mao WK, 2008, J MOL CELL CARDIOL, V45, P250, DOI 10.1016/j.yjmcc.2008.05.010; Moraes-Vieira PMM, 2010, HUM IMMUNOL, V71, P442, DOI 10.1016/j.humimm.2010.01.022; Nakamichi N, 2009, LAB INVEST, V89, P327, DOI 10.1038/labinvest.2008.157; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Orlando G, 2009, J HEPATOL, V50, P1247, DOI 10.1016/j.jhep.2009.03.006; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2009, TRANSPLANTATION, V88, P605, DOI 10.1097/TP.0b013e3181b22cec; PALLIER A, 2010, KIDNEY INT; Porcheray F, 2009, AM J TRANSPLANT, V9, P2126, DOI 10.1111/j.1600-6143.2009.02738.x; Roussey-Kesler G, 2006, AM J TRANSPLANT, V6, P736, DOI 10.1111/j.1600-6143.2006.01280.x; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Santos SG, 2007, J BIOL CHEM, V282, P17587, DOI 10.1074/jbc.M702212200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sis B, 2010, AM J TRANSPLANT; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Trivedi HL, 2010, TRANSPLANTATION, V90, P221, DOI 10.1097/TP.0b013e3181dde912; Trivedi HL, 2009, TRANSPLANTATION, V87, P1555, DOI 10.1097/TP.0b013e3181a4b91b; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	45	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19321	10.1371/journal.pone.0019321	http://dx.doi.org/10.1371/journal.pone.0019321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603654	gold, Green Submitted, Green Published			2022-12-27	WOS:000290656300006
J	Robbins, CM; Hooker, S; Kittles, RA; Carpten, JD				Robbins, Christiane M.; Hooker, Stanley; Kittles, Rick A.; Carpten, John D.			EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men	PLOS ONE			English	Article							8Q24; ASSOCIATIONS; VARIANTS; SINGLE; ELAC2; LOCI; MSR1	The EphB2 gene has been implicated as a tumor suppressor gene somatically altered in both prostate cancer (PC) and colorectal cancer. We have previously shown an association between an EphB2 germline nonsense variant and risk of familial prostate cancer among African American Men (AAM). Here we set out to test the hypothesis that common variation within the EphB2 locus is associated with increased risk of sporadic PC in AAM. We genotyped a set of 341 single nucleotide polymorphisms (SNPs) encompassing the EphB2 locus, including known and novel coding and noncoding variants, in 490 AA sporadic PC cases and 567 matched controls. Single marker-based logistical regression analyses revealed seven EphB2 SNPs showing statistically significant association with prostate cancer risk in our population. The most significant association was achieved for a novel synonymous coding SNP, TGen-624, (Odds Ratio (OR) = 0.22; 95% Confidence Interval (CI) 0.08-0.66, p = 1x10(-5)). Two other SNPs also show significant associations toward a protective effect rs10465543 and rs12090415 (p = 1x10(-4)), OR = 0.49 and 0.7, respectively. Two additional SNPs revealed trends towards an increase in risk of prostate cancer, rs4612601 and rs4263970 (p = 0.001), OR = 1.35 and 1.31, respectively. Furthermore, haplotype analysis revealed low levels of linkage disequilibrium within the region, with two blocks being associated with prostate cancer risk among our population. These data suggest that genetic variation at the EphB2 locus may increase risk of sporadic PC among AAM.	[Robbins, Christiane M.; Carpten, John D.] Translat Genom Res Inst, Div Integrated Canc Gen, Phoenix, AZ USA; [Hooker, Stanley] Univ Chicago, Pritzker Sch Med, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Kittles, Rick A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Kittles, Rick A.] Univ Chicago, Inst Human Genet, Chicago, IL 60637 USA	Translational Genomics Research Institute; University of Chicago; University of Chicago; University of Chicago	Robbins, CM (corresponding author), Translat Genom Res Inst, Div Integrated Canc Gen, Phoenix, AZ USA.	jcarpten@tgen.org		Kittles, Rick/0000-0002-5004-4437	National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities [R01CA122009]; Department of Defense [DAMD W81XWH-07-1-0203]; NATIONAL CANCER INSTITUTE [R01CA122009] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, Center to Reduce Cancer Health Disparities Grant (R01CA122009) and the Department of Defense (DAMD W81XWH-07-1-0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benford ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-334; Beuten J, 2010, CANCER EPIDEM BIOMAR, V19, P588, DOI 10.1158/1055-9965.EPI-09-0864; Bock CH, 2009, HUM GENET, V126, P637, DOI 10.1007/s00439-009-0712-z; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; GANN PH, 2002, REV UROL S, V5, pS3; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kieffer Nelly, 2006, Bull Soc Sci Med Grand Duche Luxemb, P21; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Oba SM, 2001, CANCER LETT, V164, P97, DOI 10.1016/S0304-3835(00)00716-3; Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Xu B, 2010, PROSTATE CANCER P D, V13, P270, DOI 10.1038/pcan.2010.6; Xu JF, 2009, CANCER EPIDEM BIOMAR, V18, P2145, DOI 10.1158/1055-9965.EPI-09-0091	23	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19494	10.1371/journal.pone.0019494	http://dx.doi.org/10.1371/journal.pone.0019494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603658	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300009
J	Costanzo, MS; Brown, KM; Hartl, DL				Costanzo, Marna S.; Brown, Kyle M.; Hartl, Daniel L.			Fitness Trade-Offs in the Evolution of Dihydrofolate Reductase and Drug Resistance in Plasmodium falciparum	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; CHLORPROGUANIL-DAPSONE; SULFADOXINE-PYRIMETHAMINE; AFRICAN CHILDREN; MALARIA; CYCLOGUANIL; MUTATIONS; ALLELES; CHLORCYCLOGUANIL; WR99210	Background: Patterns of emerging drug resistance reflect the underlying adaptive landscapes for specific drugs. In Plasmodium falciparum, the parasite that causes the most serious form of malaria, antifolate drugs inhibit the function of essential enzymes in the folate pathway. However, a handful of mutations in the gene coding for one such enzyme, dihydrofolate reductase, confer drug resistance. Understanding how evolution proceeds from drug susceptibility to drug resistance is critical if new antifolate treatments are to have sustained usefulness. Methodology/Principal Findings: We use a transgenic yeast expression system to build on previous studies that described the adaptive landscape for the antifolate drug pyrimethamine, and we describe the most likely evolutionary trajectories for the evolution of drug resistance to the antifolate chlorcycloguanil. We find that the adaptive landscape for chlorcycloguanil is multi-peaked, not all highly resistant alleles are equally accessible by evolution, and there are both commonalities and differences in adaptive landscapes for chlorcycloguanil and pyrimethamine. Conclusions/Significance: Our findings suggest that cross-resistance between drugs targeting the same enzyme reflect the fitness landscapes associated with each particular drug and the position of the genotype on both landscapes. The possible public health implications of these findings are discussed.	[Costanzo, Marna S.; Brown, Kyle M.; Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Costanzo, MS (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	marna.costanzo@gmail.com			NIH [GM079536]; Harvey Fellowship; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grant GM079536 to DLH, a Harvey Fellowship to MSC, and a National Science Foundation graduate research fellowship to KMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 2010, R LANG ENV STAT COMP; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Chusacultanachai S, 2002, MOL BIOCHEM PARASIT, V120, P61, DOI 10.1016/S0166-6851(01)00440-6; CLYDE D. F., 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene, V54, P597, DOI 10.1016/0035-9203(60)90038-9; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; DePristo MA, 2007, MOL BIOL EVOL, V24, P1608, DOI 10.1093/molbev/msm118; Ferlan JT, 2001, MOL BIOCHEM PARASIT, V113, P139, DOI 10.1016/S0166-6851(01)00207-9; FERONE R, 1969, MOL PHARMACOL, V5, P49; FERONE R, 1977, B WORLD HEALTH ORGAN, V55, P291; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hankins EG, 2001, MOL BIOCHEM PARASIT, V117, P91, DOI 10.1016/S0166-6851(01)00335-8; Hastings MD, 2002, P NATL ACAD SCI USA, V99, P13137, DOI 10.1073/pnas.182295999; Hunt SY, 2005, MOL BIOCHEM PARASIT, V139, P25, DOI 10.1016/j.molbiopara.2004.09.005; Kompis IM, 2005, CHEM REV, V105, P593, DOI 10.1021/cr0301144; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Malisa AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-190; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Nzila A, 2006, J ANTIMICROB CHEMOTH, V57, P1043, DOI 10.1093/jac/dkl104; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila-Mounda A, 1998, ANTIMICROB AGENTS CH, V42, P164, DOI 10.1128/AAC.42.1.164; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1117, DOI 10.1016/S0968-0896(00)00022-5; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; THOMPSON PE, 1968, J PARASITOL, V54, P588, DOI 10.2307/3277088; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilairatana P, 1997, ANN TROP MED PARASIT, V91, P125, DOI 10.1080/00034989761454; Wooden JM, 1997, MOL BIOCHEM PARASIT, V85, P25, DOI 10.1016/S0166-6851(96)02808-3; [No title captured]; [No title captured]	36	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19636	10.1371/journal.pone.0019636	http://dx.doi.org/10.1371/journal.pone.0019636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625425	gold, Green Submitted, Green Published			2022-12-27	WOS:000291005200007
J	Obeidat, M; Wain, LV; Shrine, N; Kalsheker, N; Artigas, MS; Repapi, E; Burton, PR; Johnson, T; Ramasamy, A; Zhao, JH; Zhai, GJ; Huffman, JE; Vitart, V; Albrecht, E; Igl, W; Hartikainen, AL; Pouta, A; Cadby, G; Hui, J; Palmer, LJ; Hadley, D; McArdle, WL; Rudnicka, AR; Barroso, I; Loos, RJF; Wareham, NJ; Mangino, M; Soranzo, N; Spector, TD; Glaeser, S; Homuth, G; Volzke, H; Deloukas, P; Granell, R; Henderson, J; Grkovic, I; Jankovic, S; Zgaga, L; Polasek, O; Rudan, I; Wright, AF; Campbell, H; Wild, SH; Wilson, JF; Heinrich, J; Imboden, M; Probst-Hensch, NM; Gyllensten, U; Johansson, A; Zaboli, G; Mustelin, L; Rantanen, T; Surakka, I; Kaprio, J; Jarvelin, MR; Hayward, C; Evans, DM; Koch, B; Musk, AW; Elliott, P; Strachan, DP; Tobin, MD; Sayers, I; Hall, IP				Obeidat, Ma'en; Wain, Louise V.; Shrine, Nick; Kalsheker, Noor; Artigas, Maria Soler; Repapi, Emmanouela; Burton, Paul R.; Johnson, Toby; Ramasamy, Adaikalavan; Zhao, Jing Hua; Zhai, Guangju; Huffman, Jennifer E.; Vitart, Veronique; Albrecht, Eva; Igl, Wilmar; Hartikainen, Anna-Liisa; Pouta, Anneli; Cadby, Gemma; Hui, Jennie; Palmer, Lyle J.; Hadley, David; McArdle, Wendy L.; Rudnicka, Alicja R.; Barroso, Ines; Loos, Ruth J. F.; Wareham, Nicholas J.; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.; Glaeser, Sven; Homuth, Georg; Voelzke, Henry; Deloukas, Panos; Granell, Raquel; Henderson, John; Grkovic, Ivica; Jankovic, Stipan; Zgaga, Lina; Polasek, Ozren; Rudan, Igor; Wright, Alan F.; Campbell, Harry; Wild, Sarah H.; Wilson, James F.; Heinrich, Joachim; Imboden, Medea; Probst-Hensch, Nicole M.; Gyllensten, Ulf; Johansson, Asa; Zaboli, Ghazal; Mustelin, Linda; Rantanen, Taina; Surakka, Ida; Kaprio, Jaakko; Jarvelin, Marjo-Riitta; Hayward, Caroline; Evans, David M.; Koch, Beate; Musk, Arthur William; Elliott, Paul; Strachan, David P.; Tobin, Martin D.; Sayers, Ian; Hall, Ian P.		SpiroMeta Consortium	A Comprehensive Evaluation of Potential Lung Function Associated Genes in the SpiroMeta General Population Sample	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PHOSPHODIESTERASE 4D GENE; ALPHA(1)-ANTITRYPSIN DEFICIENCY; HEALTH; PDE4D; RISK	Rationale: Lung function measures are heritable traits that predict population morbidity and mortality and are essential for the diagnosis of chronic obstructive pulmonary disease (COPD). Variations in many genes have been reported to affect these traits, but attempts at replication have provided conflicting results. Recently, we undertook a meta-analysis of Genome Wide Association Study (GWAS) results for lung function measures in 20,288 individuals from the general population (the SpiroMeta consortium). Objectives: To comprehensively analyse previously reported genetic associations with lung function measures, and to investigate whether single nucleotide polymorphisms (SNPs) in these genomic regions are associated with lung function in a large population sample. Methods: We analysed association for SNPs tagging 130 genes and 48 intergenic regions (+/-10 kb), after conducting a systematic review of the literature in the PubMed database for genetic association studies reporting lung function associations. Results: The analysis included 16,936 genotyped and imputed SNPs. No loci showed overall significant association for FEV(1) or FEV(1)/FVC traits using a carefully defined significance threshold of 1.3 x 10(-5). The most significant loci associated with FEV1 include SNPs tagging MACROD2 (P = 6.81 x 10(-5)), CNTN5 (P = 4.37 x 10(-4)), and TRPV4 (P = 1.58 x 10(-3)). Among ever-smokers, SERPINA1 showed the most significant association with FEV1 (P = 8.41 x 10(-5)), followed by PDE4D (P = 1.22 x 10(-4)). The strongest association with FEV1/FVC ratio was observed with ABCC1 (P = 4.38 x 10(-4)), and ESR1 (P = 5.42 x 10(-4)) among ever-smokers. Conclusions: Polymorphisms spanning previously associated lung function genes did not show strong evidence for association with lung function measures in the SpiroMeta consortium population. Common SERPINA1 polymorphisms may affect FEV1 among smokers in the general population.	[Obeidat, Ma'en; Sayers, Ian; Hall, Ian P.] Univ Nottingham Hosp, Div Therapeut & Mol Med, Nottingham Resp Biomed Res Unit, Nottingham NG7 2UH, England; [Wain, Louise V.; Shrine, Nick; Artigas, Maria Soler; Repapi, Emmanouela; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Wain, Louise V.; Shrine, Nick; Artigas, Maria Soler; Repapi, Emmanouela; Burton, Paul R.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Kalsheker, Noor] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Kalsheker, Noor] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England; [Repapi, Emmanouela] Univ Oxford, Ludwig Inst Canc Res, Oxford, England; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Ramasamy, Adaikalavan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Zhai, Guangju; Mangino, Massimo; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Huffman, Jennifer E.; Vitart, Veronique; Wright, Alan F.; Hayward, Caroline] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Albrecht, Eva] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Igl, Wilmar; Zaboli, Ghazal] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Cadby, Gemma; Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Hui, Jennie] PathWest Lab Med WA, Nedlands, WA, Australia; [Hui, Jennie; Musk, Arthur William] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Hui, Jennie] Univ Western Australia, Sch Populat Hlth, Crawley, Australia; [Hui, Jennie] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia; [Hadley, David; Rudnicka, Alicja R.; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England; [Hadley, David] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [McArdle, Wendy L.] Univ Bristol, Sch Social & Community Med, ALSPAC Lab, Bristol, Avon, England; [Barroso, Ines; Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp Cambridge, Cambridge, England; [Glaeser, Sven; Koch, Beate] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, SHIP Clin Epidemiol Res, Inst Community Med, Greifswald, Germany; [Grkovic, Ivica; Jankovic, Stipan; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Zgaga, Lina] Univ Zagreb, Fac Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Polasek, Ozren] Univ Split, Dept Publ Hlth, Split, Croatia; [Rudan, Igor; Campbell, Harry; Wild, Sarah H.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Imboden, Medea; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gyllensten, Ulf; Johansson, Asa] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Mustelin, Linda; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Rantanen, Taina] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Rantanen, Taina] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [Surakka, Ida; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida; Kaprio, Jaakko] Natl Inst Hlth & Welf, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Evans, David M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Musk, Arthur William] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Musk, Arthur William] Univ Western Australia, Sch Med, Crawley, Australia; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London, England; [SpiroMeta Consortium] SpiroMeta Consortium, Leicester, Leics, England; [Musk, Arthur William] Univ Western Australia, Sch Pharmacol, Crawley, Australia; [Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	University of Nottingham; University of Leicester; University of Leicester; University of Nottingham; University of Nottingham; Ludwig Institute for Cancer Research; University of Oxford; University of London; Queen Mary University London; Imperial College London; Imperial College London; University of Cambridge; University of London; King's College London; University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; University of Oulu; Finland National Institute for Health & Welfare; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; University of Western Australia; University of Western Australia; St Georges University London; State University System of Florida; University of South Florida; University of Bristol; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Split; University of Zagreb; University of Split; University of Edinburgh; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Uppsala University; University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Bristol; University of Western Australia; University of Western Australia; Imperial College London; University of Leicester; University of Western Australia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Obeidat, M (corresponding author), Univ Nottingham Hosp, Div Therapeut & Mol Med, Nottingham Resp Biomed Res Unit, Nottingham NG7 2UH, England.	mt47@le.ac.uk; Ian.hall@nottingham.ac.uk	Hayward, Caroline/M-8818-2016; Wilson, James F/A-5704-2009; Hadley, David/I-6902-2012; Rudan, Igor/I-1467-2012; Rantanen, Taina/O-6579-2016; Hui, Jennie/A-9543-2013; Loos, Ruth J F/Q-2862-2016; Janković, Stipan/E-3315-2017; Johansson, Åsa/G-5270-2011; Loos, Ruth/GON-5877-2022; Heinrich, Joachim/N-1720-2013; Cadby, Gemma/AAE-3849-2022; Palmer, Lyle John/N-1948-2019; Burton, Paul R/H-7527-2016; Ramasamy, Adaikalavan/G-2632-2010; Johansson, Åsa/AAG-6799-2021; Granell, Raquel/AAB-5256-2022; Granell, Raquel/AAY-4846-2020; Mangino, Massimo/F-5134-2011; Evans, David M/H-6325-2013; Artigas, María Soler/L-6529-2013; Deloukas, Panos/B-2922-2013; Polasek, Ozren/B-6002-2011; Kaprio, Jaakko/A-1820-2008; Grković, Ivica/D-8728-2017; Campbell, Harry/E-2959-2010; Zgaga, Lina/Q-9415-2018; Palmer, Lyle John/K-3196-2014	Hayward, Caroline/0000-0002-9405-9550; Wilson, James F/0000-0001-5751-9178; Rudan, Igor/0000-0001-6993-6884; Rantanen, Taina/0000-0002-1604-1945; Hui, Jennie/0000-0002-1653-2496; Loos, Ruth J F/0000-0002-8532-5087; Johansson, Åsa/0000-0002-2915-4498; Heinrich, Joachim/0000-0002-9620-1629; Palmer, Lyle John/0000-0002-1628-3055; Ramasamy, Adaikalavan/0000-0002-7598-2892; Johansson, Åsa/0000-0002-2915-4498; Granell, Raquel/0000-0002-4890-4012; Mangino, Massimo/0000-0002-2167-7470; Evans, David M/0000-0003-0663-4621; Artigas, María Soler/0000-0002-3213-1107; Deloukas, Panos/0000-0001-9251-070X; Polasek, Ozren/0000-0002-5765-1862; Kaprio, Jaakko/0000-0002-3716-2455; Grković, Ivica/0000-0001-9010-2091; Campbell, Harry/0000-0002-6169-6262; Zgaga, Lina/0000-0003-4089-9703; Palmer, Lyle John/0000-0002-1628-3055; Surakka, Ida/0000-0002-6669-5541; Shrine, Nick/0000-0003-3641-4371; Tobin, Martin/0000-0002-3596-7874; Hall, Ian/0000-0001-9933-3216; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; /0000-0001-8085-0731; Johnson, Toby/0000-0002-5998-3270; Soranzo, Nicole/0000-0003-1095-3852; Elliott, Paul/0000-0002-7511-5684; Rudnicka, Alicja R/0000-0003-0369-8574; Wain, Louise/0000-0003-4951-1867; Sayers, Ian/0000-0001-5601-5410	Medical Research Council [G0500539]; Wellcome Trust [068545/Z/02, 076113/B/04/Z, 079895, 077016/Z/05/Z]; UK Medical Research Council [G990146, G0000934]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF); Juvenile Diabetes Research Foundation International; National Institute for Health Research Cambridge Biomedical Research Centre; Cancer Research United Kingdom; United Kingdom NIHR Cambridge Biomedical Research Centre; Academy of Finland; Finnish Ministry of Education; ENGAGE [HEALTH-F4-2007-201413]; European Union [QLG2-CT-2002-01254]; Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF), German National Genome Research Network; Munich Center of Health Sciences (MC Health); UBS Wealth Foundation [BA29s8Q7-DZZ]; Medical Research Council (UK); Republic of Coatia Ministry of Science, Education and Sports [108-1080315-0302]; Academy of Finland [104781, 1114194, 120315]; Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; Biocentrum Helsinki; European Commission [01947 (LSHG-CT-2006-01947), LSHG-CT-2006-018947]; European Community [018996, LSH-2004-1.2.5-1, FP7/2007-2013, HEALTH-F2-2008-201865-GEFOS]; Swedish Medical Research Council [K2007-66X-20270-01-3]; Chief Scientist Office of the Scottish Government; Royal Society; MRC Human Genetics Unit; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; German Asthma and COPD Network (COSYCONET; BMBF) [01GI0883]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Arthritis Research Campaign; National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Biotechnology and biological Sciences Research Council (BBSRC);  [U01 DK062418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; Medical Research Council [G0801056B, G0401540, MC_U106179471, MC_qA137934, G9815508, G0000934, MC_U106188470, G0902125, G0600705, G0902313, G1001799, G0800582, G0801056, G0701863] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [G0000934, G0401540, G0701863, G0600705, MC_U106188470, G0902125, MC_qA137934, G0800582, G0801056, G0902313, G1001799] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research United Kingdom(Cancer Research UK); United Kingdom NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Academy of Finland(Academy of Finland); Finnish Ministry of Education; ENGAGE; European Union(European Commission); Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF), German National Genome Research Network(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MC Health); UBS Wealth Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Republic of Coatia Ministry of Science, Education and Sports; Academy of Finland(Academy of Finland); Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biocentrum Helsinki; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community(European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Chief Scientist Office of the Scottish Government; Royal Society(Royal Society of London); MRC Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Asthma and COPD Network (COSYCONET; BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; Arthritis Research Campaign(Versus Arthritis); National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge use of the DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council and Wellcome Trust. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. P. Strachan and P. Burton for preparing and providing the control DNA samples.; Cohort funding: ALSPAC: The UK Medical Research Council (Grant number: G990146), the Wellcome Trust and the University of Bristol provide core support for ALSPAC. B58C - WTCCC: The British 1958 Birth Cohort DNA collection was funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Genotyping for the Wellcome Trust Case Control Consortium was funded by the Wellcome Trust grant 076113/B/04/Z. B58C - T1DGC: This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. T1DGC GWAS data were deposited by the Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge (John Todd, Helen Stevens and Neil Walker), which is funded by Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Research Centre; the CIMR is in receipt of a Wellcome Trust Strategic Award (079895). EPIC: The EPIC Norfolk Study is funded by Cancer Research United Kingdom and the Medical Research Council.. I. B. received funding from the Wellcome Trust (077016/Z/05/Z) and from the United Kingdom NIHR Cambridge Biomedical Research Centre. FTC: Academy of Finland Centre of Excellence in Complex Disease Genetics. Finnish Twin Study on Aging was funded by Academy of Finland and Finnish Ministry of Education. ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). KORA S3: The KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The authors research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Genotyping for the KORA F3/500K Study which included the lung function characterized KORA C sample was partly funded by UBS Wealth Foundation Grant BA29s8Q7-DZZ. Korcula: The Korcula study (Croatia) was funded by grants from the Medical Research Council (UK) and Republic of Coatia Ministry of Science, Education and Sports research grants to I. R. (Vis) (108-1080315-0302). NFBC1966: Financial support was received from the Academy of Finland (project grants 104781, 1114194, 120315 and Cernter of Excellence in Complex Disease Genetics), Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council (studentship grant G0500539). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Institute for Health and Welfare, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. A. R.; was supported by the European Commission as part of GABRIEL (a multidisciplinary study to identify the genetic andenvironmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1 Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control. NSPHS: EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 01947 (LSHG-CT-2006-01947). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (project number K2007-66X-20270-01-3). The computations were performed on UPPMAX (http://www.uppmax.uu.se) resources under Project p2008027. ORCADES: The ORCADES study was funded by the Chief Scientist Office of the Scottish Government, the Royal Society and the MRC Human Genetics Unit. DNA extraction was performed at the Wellcome Trust Clinical Research Facility in Edinburgh. Genotyping was funded by the European Union Framework Programme 6 EUROSPAN project. SHIP: SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the German Asthma and COPD Network (COSYCONET; BMBF grant 01GI0883), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG. TwinsUK: TwinsUK is funded by the Wellcome Trust; the Arthritis Research Campaign; European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and Seventh Framework Programme (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and biological Sciences Research Council (BBSRC) project grant. Vis: The Vis study (Croatia) was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants to I. R. (108-1080315-0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chappell S, 2006, HUM MUTAT, V27, P103, DOI 10.1002/humu.20275; DeMeo DL, 2004, THORAX, V59, P259, DOI 10.1136/thx.2003.006502; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Hersh CP, 2005, AM J RESP CELL MOL, V33, P71, DOI 10.1165/rcmb.2005-0073OC; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Homma S, 2006, INT J MOL MED, V18, P933; HUBERT HB, 1982, AM REV RESPIR DIS, V125, P409; Kalsheker NA, 2009, J CLIN PATHOL, V62, P865, DOI 10.1136/jcp.2008.063495; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Reneland RH, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-9; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429	23	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19382	10.1371/journal.pone.0019382	http://dx.doi.org/10.1371/journal.pone.0019382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625484	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000290793400003
J	Bettus, G; Ranjeva, JP; Wendling, F; Benar, CG; Confort-Gouny, S; Regis, J; Chauvel, P; Cozzone, PJ; Lemieux, L; Bartolomei, F; Guye, M				Bettus, Gaelle; Ranjeva, Jean-Philippe; Wendling, Fabrice; Benar, Christian G.; Confort-Gouny, Sylviane; Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Lemieux, Louis; Bartolomei, Fabrice; Guye, Maxime			Interictal Functional Connectivity of Human Epileptic Networks Assessed by Intracerebral EEG and BOLD Signal Fluctuations	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MONKEY VISUAL-CORTEX; EPILEPTOGENIC NETWORKS; FIELD POTENTIALS; FMRI; MRI; ABNORMALITIES; OSCILLATIONS; CORRELATE; SPIKES	In this study, we aimed to demonstrate whether spontaneous fluctuations in the blood oxygen level dependent (BOLD) signal derived from resting state functional magnetic resonance imaging (fMRI) reflect spontaneous neuronal activity in pathological brain regions as well as in regions spared by epileptiform discharges. This is a crucial issue as coherent fluctuations of fMRI signals between remote brain areas are now widely used to define functional connectivity in physiology and in pathophysiology. We quantified functional connectivity using non-linear measures of cross-correlation between signals obtained from intracerebral EEG (iEEG) and resting-state functional MRI (fMRI) in 5 patients suffering from intractable temporal lobe epilepsy (TLE). Functional connectivity was quantified with both modalities in areas exhibiting different electrophysiological states (epileptic and non affected regions) during the interictal period. Functional connectivity as measured from the iEEG signal was higher in regions affected by electrical epileptiform abnormalities relative to non-affected areas, whereas an opposite pattern was found for functional connectivity measured from the BOLD signal. Significant negative correlations were found between the functional connectivities of iEEG and BOLD signal when considering all pairs of signals (theta, alpha, beta and broadband) and when considering pairs of signals in regions spared by epileptiform discharges (in broadband signal). This suggests differential effects of epileptic phenomena on electrophysiological and hemodynamic signals and/or an alteration of the neurovascular coupling secondary to pathological plasticity in TLE even in regions spared by epileptiform discharges. In addition, indices of directionality calculated from both modalities were consistent showing that the epileptogenic regions exert a significant influence onto the non epileptic areas during the interictal period. This study shows that functional connectivity measured by iEEG and BOLD signals give complementary but sometimes inconsistent information in TLE.	[Bettus, Gaelle; Ranjeva, Jean-Philippe; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Guye, Maxime] CNRS, UMR 6612, CRMBM, Marseille, France; [Bettus, Gaelle; Benar, Christian G.; Regis, Jean; Chauvel, Patrick; Bartolomei, Fabrice] INSERM, U751, Lab Neurophysiol & Neuropsychol, F-13258 Marseille, France; [Bettus, Gaelle; Ranjeva, Jean-Philippe; Benar, Christian G.; Confort-Gouny, Sylviane; Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Bartolomei, Fabrice; Guye, Maxime] Univ Mediterranee Aix Marseille II, Fac Med, Marseille, France; [Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Bartolomei, Fabrice; Guye, Maxime] Assistance Publ Hop Marseille, Marseille, France; [Wendling, Fabrice] INSERM, U642, Rennes, France; [Lemieux, Louis] UCL, Dept Clin & Expt Epilepsy, UCL Inst Neurol, London, England; [Lemieux, Louis] Natl Soc Epilepsy, MRI Unit, Bucksburn, Aberdeen, Scotland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Bettus, G (corresponding author), CNRS, UMR 6612, CRMBM, Marseille, France.	fabrice.bartolomei@mail.ap-hm.fr	WENDLING, Fabrice/P-9574-2019; Wendling, Fabrice/F-8924-2013	WENDLING, Fabrice/0000-0003-2428-9665; Lemieux, Louis/0000-0003-3036-7412; Chauvel, Patrick/0000-0003-2161-6077; Ranjeva, Jean-Philippe/0000-0001-8073-102X	CNRS; INSERM; Agence Nationale de la Recherche (ANR, CONNECTEPI); ADEREM; Region 'Provence Alpes-Cote d'Azur' and Deltamed; Medical Research Council (MRC) [G0301067]; Medical Research Council [G0301067] Funding Source: researchfish; MRC [G0301067] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (ANR, CONNECTEPI)(French National Research Agency (ANR)); ADEREM; Region 'Provence Alpes-Cote d'Azur' and Deltamed(Region Provence-Alpes-Cote d'Azur); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by CNRS, INSERM, Agence Nationale de la Recherche (ANR, CONNECTEPI) and ADEREM. GB is funded by a PhD research grant delivered by the Region 'Provence Alpes-Cote d'Azur' and Deltamed. This work was also partly funded through a grant from the Medical Research Council (MRC grant number G0301067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; BANCAUD JTJ, 1965, STEREOELECTOENCEPHAL; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2002, EPILEPSIA, V43, P1001, DOI 10.1046/j.1528-1157.2002.48501.x; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Benar CG, 2006, NEUROIMAGE, V30, P1161, DOI 10.1016/j.neuroimage.2005.11.008; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bourien J, 2005, CLIN NEUROPHYSIOL, V116, P443, DOI 10.1016/j.clinph.2004.08.010; Carmichael DW, 2010, NEUROIMAGE, V49, P379, DOI 10.1016/j.neuroimage.2009.07.062; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; CHAUVEL P, 1987, REV NEUROL, V143, P443; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Ekstrom A, 2009, J NEUROPHYSIOL, V101, P2668, DOI 10.1152/jn.91252.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Guye M, 2005, NEUROIMAGE, V26, P1174, DOI 10.1016/j.neuroimage.2005.03.023; Guye M, 2002, EPILEPSIA, V43, P1197, DOI 10.1046/j.1528-1157.2002.05102.x; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Lemieux L, 2008, HUM BRAIN MAPP, V29, P329, DOI 10.1002/hbm.20389; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LIAO W, 2010, HUM BRAIN MAPP; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Ojemann GA, 2010, BRAIN, V133, P46, DOI 10.1093/brain/awp227; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Rodrigo S, 2008, EPILEPSIA, V49, P1367, DOI 10.1111/j.1528-1167.2008.01607.x; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; TALAIRACH J, 1974, NEUROCHIRURGIE, V20, P1; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Vulliemoz S, 2011, NEUROIMAGE, V54, P182, DOI 10.1016/j.neuroimage.2010.08.004; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Wendling F, 2001, NEUROPHYSIOL CLIN, V31, P139, DOI 10.1016/S0987-7053(01)00255-6; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Yogarajah M, 2008, NEUROIMAGE, V40, P1755, DOI 10.1016/j.neuroimage.2007.12.046; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	60	82	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20071	10.1371/journal.pone.0020071	http://dx.doi.org/10.1371/journal.pone.0020071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625517	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200044
J	Kumar, S; Pioszak, A; Zhang, CH; Swaminathan, K; Xu, HE				Kumar, Shiva; Pioszak, Augen; Zhang, Chenghai; Swaminathan, Kunchithapadam; Xu, H. Eric			Crystal Structure of the PAC1R Extracellular Domain Unifies a Consensus Fold for Hormone Recognition by Class B G-Protein Coupled Receptors	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; HYPOTHALAMIC POLYPEPTIDE; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; PITUITARY-GLAND; BINDING-SITES; PACAP; PEPTIDE; VIP	Pituitary adenylate cyclase activating polypeptide (PACAP) is a member of the PACAP/glucagon family of peptide hormones, which controls many physiological functions in the immune, nervous, endocrine, and muscular systems. It activates adenylate cyclase by binding to its receptor, PAC1R, a member of class B G-protein coupled receptors (GPCR). Crystal structures of a number of Class B GPCR extracellular domains (ECD) bound to their respective peptide hormones have revealed a consensus mechanism of hormone binding. However, the mechanism of how PACAP binds to its receptor remains controversial as an NMR structure of the PAC1R ECD/PACAP complex reveals a different topology of the ECD and a distinct mode of ligand recognition. Here we report a 1.9 angstrom crystal structure of the PAC1R ECD, which adopts the same fold as commonly observed for other members of Class B GPCR. Binding studies and cell-based assays with alanine-scanned peptides and mutated receptor support a model that PAC1R uses the same conserved fold of Class B GPCR ECD for PACAP binding, thus unifying the consensus mechanism of hormone binding for this family of receptors.	[Kumar, Shiva; Pioszak, Augen; Zhang, Chenghai; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA; [Kumar, Shiva; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Van Andel Institute; National University of Singapore	Kumar, S (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA.	dbsks@nus.edu.sg; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	Jay and Betty Van Andel foundation; National Institute of Health [GM08743]; Ministry of Education, Singapore and Biomedical Research Council; National University of Singapore; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the U. S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM008743] Funding Source: NIH RePORTER	Jay and Betty Van Andel foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Singapore and Biomedical Research Council(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the Jay and Betty Van Andel foundation (HEX, AP and KS), National Institute of Health grant GM08743 (HEX and AP), grants from Ministry of Education, Singapore and Biomedical Research Council (KS) and a research scholarship from National University of Singapore (KS). We thank J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (LS-CAT), which is partly funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of the Advanced Photon Source was supported by the Office of Science of the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2008, ANN NY ACAD SCI, V1144, P28, DOI 10.1196/annals.1418.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BUSCAIL L, 1990, FEBS LETT, V262, P77, DOI 10.1016/0014-5793(90)80158-F; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; CAUVIN A, 1990, PEPTIDES, V11, P773, DOI 10.1016/0196-9781(90)90194-A; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Dickinson T, 1999, TRENDS PHARMACOL SCI, V20, P324, DOI 10.1016/S0165-6147(99)01340-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOTTSCHALL PE, 1990, ENDOCRINOLOGY, V127, P272, DOI 10.1210/endo-127-1-272; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; LAM HC, 1990, EUR J BIOCHEM, V193, P725, DOI 10.1111/j.1432-1033.1990.tb19392.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Martinez C, 2006, ANN NY ACAD SCI, V1070, P405, DOI 10.1196/annals.1317.053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rawlings SR, 1996, ENDOCR REV, V17, P4, DOI 10.1210/er.17.1.4; Reglodi D, 2006, ANN NY ACAD SCI, V1070, P518, DOI 10.1196/annals.1317.072; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROBBERECHT P, 1984, FEBS LETT, V166, P277, DOI 10.1016/0014-5793(84)80095-2; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; STOFFEL M, 1994, GENOMICS, V23, P697, DOI 10.1006/geno.1994.1560; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	43	48	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19682	10.1371/journal.pone.0019682	http://dx.doi.org/10.1371/journal.pone.0019682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625560	Green Submitted, Green Published, gold			2022-12-27	WOS:000290771200014
J	Lu, Y; Malmhall, C; Sjostrand, M; Radinger, M; O'Neil, SE; Lotvall, J; Bossios, A				Lu, You; Malmhall, Carina; Sjostrand, Margareta; Radinger, Madeleine; O'Neil, Serena E.; Lotvall, Jan; Bossios, Apostolos			Expansion of CD4(+)CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and ROR gamma t Cells in Allergic Inflammation, Local Lung Distribution and Chemokine Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TOLERANCE INDUCTION; TGF-BETA; DIFFERENTIATION; TREG; RECRUITMENT; MECHANISMS; DEPLETION; RESPONSES; CONTAINS	Allergic asthma is associated with airway eosinophilia, which is regulated by different T-effector cells. T cells express transcription factors T-bet, GATA-3, ROR gamma t and Foxp3, representing Th1, Th2, Th17 and Treg cells respectively. No study has directly determined the relative presence of each of these T cell subsets concomitantly in a model of allergic airway inflammation. In this study we determined the degree of expansion of these T cell subsets, in the lungs of allergen challenged mice. Cell proliferation was determined by incorporation of 5-bromo-2'-deoxyuridine (BrdU) together with 7-aminoactnomycin (7-AAD). The immunohistochemical localisation of T cells in the lung microenvironments was also quantified. Local expression of cytokines, chemokines and receptor genes was measured using real-time RT-PCR array analysis in tissue sections isolated by laser microdissection and pressure catapulting technology. Allergen exposure increased the numbers of T-bet(+), GATA-3(+), ROR gamma t(+) and Foxp3(+) cells in CD4(+)CD25(+) and CD4(+)CD25(-) T cells, with the greatest expansion of GATA-3(+) cells. The majority of CD4(+)CD25(+) T-bet(+), GATA-3(+), ROR gamma t(+) and Foxp3(+) cells had incorporated BrdU and underwent proliferation during allergen exposure. Allergen exposure led to the accumulation of T-bet(+), GATA-3(+) and Foxp3(+) cells in peribronchial and alveolar tissue, GATA-3(+) and Foxp3(+) cells in perivascular tissue, and ROR gamma t(+) cells in alveolar tissue. A total of 28 cytokines, chemokines and receptor genes were altered more than 3 fold upon allergen exposure, with expression of half of the genes claimed in all three microenvironments. Our study shows that allergen exposure affects all T effector cells in lung, with a dominant of Th2 cells, but with different local cell distribution, probably due to a distinguished local inflammatory milieu.	[Lu, You; Malmhall, Carina; Sjostrand, Margareta; Radinger, Madeleine; O'Neil, Serena E.; Lotvall, Jan; Bossios, Apostolos] Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Lu, Y (corresponding author), Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	apostolos.bossios@gu.se	Bossios, Apostolos/ABH-8262-2020	Bossios, Apostolos/0000-0002-0494-2690; Radinger, Madeleine/0000-0002-0652-7378; Lotvall, Jan/0000-0001-9195-9249	Swedish Heart-Lung Foundation [20070575]; Sahlgrenska University Hospital Foundation, Gothenburg, Sweden; Herman Krefting Foundation Against Asthma/Allergy	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska University Hospital Foundation, Gothenburg, Sweden; Herman Krefting Foundation Against Asthma/Allergy	The work was supported by a grant from the Swedish Heart-Lung Foundation (project no. 20070575) and Sahlgrenska University Hospital Foundation, Gothenburg, Sweden. Prof. Jan Lotvall is funded by the Herman Krefting Foundation Against Asthma/Allergy. The sponsors played no role in the study design, conduct, collection, analysis, interpretation, review, or approval of the manuscript.	Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brusko TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007980; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Herve MGD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011784; Eriksson U, 2005, J IMMUNOL, V175, P2715, DOI 10.4049/jimmunol.175.4.2715; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Laan M, 1999, J IMMUNOL, V162, P2347; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lu Y, 2010, SCAND J IMMUNOL, V71, P176, DOI 10.1111/j.1365-3083.2009.02363.x; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Radinger M, 2011, IMMUNOLOGY, V132, P144, DOI 10.1111/j.1365-2567.2010.03349.x; ROSSETTI CA, 2010, RES VET SCI; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samitas K, 2011, EUR RESPIR J, V37, P331, DOI 10.1183/09031936.00017810; Saoudi A, 1996, J EXP MED, V184, P2393, DOI 10.1084/jem.184.6.2393; Schmidt-Weber C. B., 2008, V94, P1, DOI 10.1159/000154844; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Sun JB, 2006, J IMMUNOL, V177, P7634, DOI 10.4049/jimmunol.177.11.7634; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P4, DOI 10.1111/j.1365-2222.2005.02139.x; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Yamashita N, 2006, J ALLERGY CLIN IMMUN, V117, P1040, DOI 10.1016/j.jaci.2006.01.009; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhao LL, 2008, SCAND J IMMUNOL, V67, P480, DOI 10.1111/j.1365-3083.2008.02098.x; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	47	11	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19889	10.1371/journal.pone.0019889	http://dx.doi.org/10.1371/journal.pone.0019889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625544	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200029
J	Rhodin, MHJ; Dinman, JD				Rhodin, Michael H. J.; Dinman, Jonathan D.			An Extensive Network of Information Flow through the B1b/c Intersubunit Bridge of the Yeast Ribosome	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DIAMOND-BLACKFAN ANEMIA; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PEPTIDYL TRANSFERASE CENTER; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; PROTEIN L11; EUKARYOTIC RIBOSOME; VIRUS PROPAGATION	Yeast ribosomal proteins L11 and S18 form a dynamic intersubunit interaction called the B1b/c bridge. Recent high resolution images of the ribosome have enabled targeting of specific residues in this bridge to address how distantly separated regions within the large and small subunits of the ribosome communicate with each other. Mutations were generated in the L11 side of the B1b/c bridge with a particular focus on disrupting the opposing charge motifs that have previously been proposed to be involved in subunit ratcheting. Mutants had wide-ranging effects on cellular viability and translational fidelity, with the most pronounced phenotypes corresponding to amino acid changes resulting in alterations of local charge properties. Chemical protection studies of selected mutants revealed rRNA structural changes in both the large and small subunits. In the large subunit rRNA, structural changes mapped to Helices 39, 80, 82, 83, 84, and the peptidyltransferase center. In the small subunit rRNA, structural changes were identified in helices 30 and 42, located between S18 and the decoding center. The rRNA structural changes correlated with charge-specific alterations to the L11 side of the B1b/c bridge. These analyses underscore the importance of the opposing charge mechanism in mediating B1b/c bridge interactions and suggest an extensive network of information exchange between distinct regions of the large and small subunits.	[Rhodin, Michael H. J.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Rhodin, MHJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [R01 GM058859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant to JDD from the National Institutes of Health (R01 GM058859). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Besseova I, 2010, NUCLEIC ACIDS RES, V38, P6247, DOI 10.1093/nar/gkq414; Breinig F, 2002, CELL, V108, P395, DOI 10.1016/S0092-8674(02)00634-7; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CLARE J, 1985, P NATL ACAD SCI USA, V82, P2829, DOI 10.1073/pnas.82.9.2829; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; DeLano W., 2006, PYMOL MOL GRAPHICS S; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1995, YEAST, V11, P1115, DOI 10.1002/yea.320111202; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman Jonathan D, 2005, Int J Biomed Sci, V1, P2; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; ICHO T, 1988, J BIOL CHEM, V263, P1467; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P6175, DOI 10.1093/nar/gkn642; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; OHTAKE Y, 1995, MOL CELL BIOL, V15, P2772; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Rakauskaite R, 2008, NUCLEIC ACIDS RES, V36, P1497, DOI 10.1093/nar/gkm1179; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Shasmal M, 2010, BIOCHEM BIOPH RES CO, V399, P192, DOI 10.1016/j.bbrc.2010.07.053; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	53	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20048	10.1371/journal.pone.0020048	http://dx.doi.org/10.1371/journal.pone.0020048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625514	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200043
J	Srivastava, A; Gangnard, S; Dechavanne, S; Amirat, F; Bentley, AL; Bentley, GA; Gamain, B				Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.; Gamain, Benoit			Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; FALCIPARUM-INFECTED ERYTHROCYTES; CROSS-REACTIVE ANTIBODIES; PLASMODIUM-FALCIPARUM; VAR GENE; MEMBRANE PROTEIN-1; PARASITE ADHESION; PLACENTAL MALARIA; IMMUNOGLOBULIN-G; HIGH-LEVEL	Var2CSA, a key molecule linked with pregnancy-associated malaria (PAM), causes sequestration of Plasmodium falciparum infected erythrocytes (PEs) in the placenta by adhesion to chondroitin sulfate A (CSA). Var2CSA possesses a 300 kDa extracellular region composed of six Duffy-binding like (DBL) domains and a cysteine-rich interdomain region (CIDRpam) module. Although initial studies implicated several individual var2CSA DBL domains as important for adhesion of PEs to CSA, new studies revealed that these individual domains lack both the affinity and specificity displayed by the full-length extracellular region. Indeed, recent evidence suggests the presence of a single CSA-binding site formed by a higher-order domain organization rather than several independent binding sites located on the different domains. Here, we search for the minimal binding region within var2CSA that maintains high affinity and specificity for CSA binding, a characteristic feature of the full-length extracellular region. Accordingly, truncated recombinant var2CSA proteins comprising different domain combinations were expressed and their binding characteristics assessed against different sulfated glycosaminoglycans (GAGs). Our results indicate that the smallest region within var2CSA with similar binding properties to those of the full-length var2CSA is DBL1X-3X. We also demonstrate that inhibitory antibodies raised in rabbit against the full-length DBL1X-6e target principally DBL3X and, to a lesser extent, DBL5e. Taken together, our results indicate that efforts should focus on the DBL1X-3X region for developing vaccine and therapeutic strategies aimed at combating PAM.	[Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, F-75015 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.] CNRS, URA2185, F-75015 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] INSERM, U665, F-75739 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] Univ Paris Diderot, UMR S665, F-75739 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Srivastava, A (corresponding author), Inst Pasteur, Unite Immunol Struct, F-75015 Paris, France.	benoit.gamain@inserm.fr	SRIVASTAVA, ANAND/C-9609-2012; Gamain, Benoit/N-9985-2017; Dechavanne, Sebastien/AAL-8108-2021; Srivastava, Anand/AFY-2073-2022; Srivastava, Anand/AAD-2166-2019	SRIVASTAVA, ANAND/0000-0002-2031-4643; Gamain, Benoit/0000-0002-8255-2145; Srivastava, Anand/0000-0002-2031-4643; Dechavanne, Sebastien/0000-0001-9400-1976	Institut National de la Sante et de la Recherche Medicale; Sanofi-Aventis; European Community [201222]; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Sanofi-Aventis(Sanofi-Aventis); European Community(European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by an ATIP-AVENIR grant from the Institut National de la Sante et de la Recherche Medicale and Sanofi-Aventis (BG). The research leading to these results has received funding from the European Community's Seventh Framework Programme Grant ([FP7/2007-2013]) ( to GAB and BG) under Grant agreement 201222. AS was supported by a grant from the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Badaut C, 2007, MOL BIOCHEM PARASIT, V151, P89, DOI 10.1016/j.molbiopara.2006.10.010; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gangnard S, 2010, MOL BIOCHEM PARASIT, V173, P115, DOI 10.1016/j.molbiopara.2010.05.014; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	45	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20270	10.1371/journal.pone.0020270	http://dx.doi.org/10.1371/journal.pone.0020270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625526	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200056
J	Re, VE; Culasso, ACA; Mengarelli, S; Farias, AA; Fay, F; Pisano, MB; Elbarcha, O; Contigiani, MS; Campos, RH				Re, Viviana E.; Culasso, Andres C. A.; Mengarelli, Silvia; Farias, Adrian A.; Fay, Fabian; Pisano, Maria B.; Elbarcha, Osvaldo; Contigiani, Marta S.; Campos, Rodolfo H.			Phylodynamics of Hepatitis C Virus Subtype 2c in the Province of Cordoba, Argentina	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH PREVALENCE; GENOTYPE 1B; INFECTION	The Hepatitis C Virus Genotype 2 subtype 2c (HCV-2c) is detected as a low prevalence subtype in many countries, except in Southern Europe and Western Africa. The current epidemiology of HCV in Argentina, a low-prevalence country, shows the expected low prevalence for this subtype. However, this subtype is the most prevalent in the central province of Cordoba. Cruz del Eje (CdE), a small rural city of this province, shows a prevalence for HCV infections of 5%, being 90% of the samples classified as HCV-2c. In other locations of Cordoba Province (OLC) with lower prevalence for HCV, HCV-2c was recorded in about 50% of the samples. The phylogenetic analysis of samples from Cordoba Province consistently conformed a monophyletic group with HCV-2c sequences from all the countries where HCV-2c has been sequenced. The phylogeographic analysis showed an overall association between geographical traits and phylogeny, being these associations significant (alpha = 0.05) for Italy, France, Argentina (places other than Cordoba), Martinique, CdE and OLC. The coalescence analysis for samples from CdE, OLC and France yielded a Time for the Most Common Recent Ancestor of about 140 years, whereas its demographic reconstruction showed a "lag" phase in the viral population until 1880 and then an exponential growth until 1940. These results were also obtained when each geographical area was analyzed separately, suggesting that HCV-2c came into Cordoba province during the migration process, mainly from Europe, which is compatible with the history of Argentina of the early 20th century. This also suggests that the spread of HCV-2c occurred in Europe and South America almost simultaneously, possibly as a result of the advances in medicine technology of the first half of the 20th century.	[Re, Viviana E.; Farias, Adrian A.; Pisano, Maria B.; Contigiani, Marta S.] Univ Cordoba, Inst Virol, Fac Ciencias Med, Cordoba, Argentina; [Re, Viviana E.; Elbarcha, Osvaldo] Univ Catolica Cordoba, Fac Ciencias Quim, Catedra Virol, Cordoba, Argentina; [Culasso, Andres C. A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Mengarelli, Silvia] Hosp San Roque, Serv Gastroenterol, Cordoba, Argentina; [Fay, Fabian] Ctr Diag Mol, Lab CIBIC, Rosario, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba; Catholic University of Cordoba; University of Buenos Aires	Re, VE (corresponding author), Univ Cordoba, Inst Virol, Fac Ciencias Med, Cordoba, Argentina.	rcampos@ffyb.uba.ar			Secyt-Universidad Nacional de Cordoba [Secyt UNC- 69/08]; Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT) [PICT2008, 1229]; Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba [MINCyT-Cba 86/09]; SIP-Universidad Catolica de Cordoba; Universidad de Buenos Aires [SECyT-UBA2008 B037]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112-200801-01169]; CONICET; CONICET, Argentina; Fundacion Roemmers	Secyt-Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); SIP-Universidad Catolica de Cordoba; Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Roemmers	This project was supported by grants from: Fundacion Roemmers, Secyt-Universidad Nacional de Cordoba (Secyt UNC- 69/08), Agencia Nacional de Promocion Cientifica Tecnologica (ANPCyT; PICT2008, 1229), Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba (MINCyT-Cba 86/09), SIP-Universidad Catolica de Cordoba, Universidad de Buenos Aires (SECyT-UBA2008 B037) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP 112-200801-01169). M. B. P. and A. C. A. C. are recipients of CONICET doctoral fellowships. V. E. R. and R. C. are members of the researcher career from CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dal Molin G, 2002, J MED VIROL, V68, P352, DOI 10.1002/jmv.10210; Di Lello F, 2008, J MED VIROL, V80, P619, DOI 10.1002/jmv.21112; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Golemba MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008751; Goloboff P, 2008, CLADISTICS, V24, P91; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Mengarelli S, 2006, ACTA GASTROENTEROL L, V36, pS68; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Nakao H, 1996, ARCH VIROL, V141, P701, DOI 10.1007/BF01718327; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Quarleri JF, 2000, J CLIN MICROBIOL, V38, P4560, DOI 10.1128/JCM.38.12.4560-4568.2000; Re V, 2003, MEDICINA-BUENOS AIRE, V63, P205; Re V, 2007, MEM I OSWALDO CRUZ, V102, P995, DOI 10.1590/S0074-02762007000800016; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19471	10.1371/journal.pone.0019471	http://dx.doi.org/10.1371/journal.pone.0019471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611129	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200007
J	Serbecic, N; Aboul-Enein, F; Beutelspacher, SC; Vass, C; Kristoferitsch, W; Lassmann, H; Reitner, A; Schmidt-Erfurth, U				Serbecic, Nermin; Aboul-Enein, Fahmy; Beutelspacher, Sven C.; Vass, Clemens; Kristoferitsch, Wolfgang; Lassmann, Hans; Reitner, Andreas; Schmidt-Erfurth, Ursula			High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years	PLOS ONE			English	Article							NERVE-FIBER LAYER; NEUROMYELITIS-OPTICA; DISABILITY; THICKNESS; LESIONS; INFLAMMATION; PROGRESSION; DISEASE; ATROPHY; WINDOW	Background: "Non-invasive, faster and less expensive than MRI'' and "the eye is a window to the brain'' are recent slogans promoting optical coherence tomography (OCT) as a new surrogate marker in multiple sclerosis (MS). Indeed, OCT allows for the first time a non-invasive visualization of axons of the central nervous system (CNS). Reduction of retina nerve fibre layer (RNFL) thickness was suggested to correlate with disease activity and duration. However, several issues are unclear: Do a few million axons, which build up both optic nerves, really resemble billions of CNS neurons? Does global CNS damage really result in global RNFL reduction? And if so, does global RNFL reduction really exist in all MS patients, and follow a slowly but steadily ongoing pattern? How can these (hypothesized) subtle global RNFL changes be reliably measured and separated from the rather gross RNFL changes caused by optic neuritis? Before generally being accepted, this interpretation needs further critical and objective validation. Methodology: We prospectively studied 37 MS patients with relapsing remitting (n = 27) and secondary progressive (n = 10) course on two occasions with a median interval of 22.4 +/- 0.5 months [range 19-27]. We used the high resolution spectral domain (SD-)OCT with the Spectralis 3.5 mm circle scan protocol with locked reference images and eye tracking mode. Patients with an attack of optic neuritis within 12 months prior to the onset of the study were excluded. Principal Findings: Although the disease was highly active over the observation period in more than half of the included relapsing remitting MS patients (19 patients/32 relapses) and the initial RNFL pattern showed a broad range, from normal to markedly reduced thickness, no significant changes between baseline and follow-up examinations could be detected. Conclusions: These results show that caution is required when using OCT for monitoring disease activity and global axonal injury in MS.	[Serbecic, Nermin; Vass, Clemens; Reitner, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Beutelspacher, Sven C.] Univ Heidelberg, Dept Ophthalmol, Fac Med Mannheim, D-6800 Mannheim, Germany; [Lassmann, Hans] Med Univ Vienna, Brain Res Ctr, Vienna, Austria	Medical University of Vienna; Donauspital; Ruprecht Karls University Heidelberg; Medical University of Vienna	Serbecic, N (corresponding author), Med Univ Vienna, Dept Ophthalmol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Lassmann, Hans/Z-2269-2019; Vass, Clemens/AAZ-2564-2020	Lassmann, Hans/0000-0001-8617-5052; Vass, Clemens/0000-0003-4756-9088; Schmidt-Erfurth, Ursula/0000-0002-7788-7311	Medical Research Society Vienna, DC	Medical Research Society Vienna, DC	This study was funded by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Ban M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002891; Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Feigin V, 2009, NEUROEPIDEMIOLOGY, V33, P296, DOI 10.1159/000252942; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Ge YL, 2000, RADIOLOGY, V214, P665, DOI 10.1148/radiology.214.3.r00mr30665; Gilmore CP, 2010, MULT SCLER J, V16, P756, DOI 10.1177/1352458510366014; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Haarmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013568; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Henderson APD, 2010, J NEUROL, V257, P1083, DOI 10.1007/s00415-010-5467-x; Khanifar AA, 2010, CLIN OPHTHALMOL, V4, P1007, DOI 10.2147/OPTH.S13278; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Mostert JP, 2010, EUR J NEUROL, V17, P1471, DOI 10.1111/j.1468-1331.2010.03093.x; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Serbecic N, 2011, BRIT J OPHTHALMOL, V95, P804, DOI 10.1136/bjo.2010.186221; Serbecic N, 2012, ACTA OPHTHALMOL, V90, P540, DOI 10.1111/j.1755-3768.2010.02013.x; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970	35	47	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19843	10.1371/journal.pone.0019843	http://dx.doi.org/10.1371/journal.pone.0019843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611198	Green Submitted, Green Published, gold			2022-12-27	WOS:000290657500029
J	Vuataz, L; Sartori, M; Wagner, A; Monaghan, MT				Vuataz, Laurent; Sartori, Michel; Wagner, Andre; Monaghan, Michael T.			Toward a DNA Taxonomy of Alpine Rhithrogena (Ephemeroptera: Heptageniidae) Using a Mixed Yule-Coalescent Analysis of Mitochondrial and Nuclear DNA	PLOS ONE			English	Article							PARTITIONED BAYESIAN ANALYSES; SPECIES DELIMITATION; DIVERSITY; SYSTEMATICS; DISPERSAL; PHYLOGENY; ALIGNMENT; MAYFLIES; BARCODES; EXAMPLE	Aquatic larvae of many Rhithrogena mayflies (Ephemeroptera) inhabit sensitive Alpine environments. A number of species are on the IUCN Red List and many recognized species have restricted distributions and are of conservation interest. Despite their ecological and conservation importance, ambiguous morphological differences among closely related species suggest that the current taxonomy may not accurately reflect the evolutionary diversity of the group. Here we examined the species status of nearly 50% of European Rhithrogena diversity using a widespread sampling scheme of Alpine species that included 22 type localities, general mixed Yule-coalescent (GMYC) model analysis of one standard mtDNA marker and one newly developed nDNA marker, and morphological identification where possible. Using sequences from 533 individuals from 144 sampling localities, we observed significant clustering of the mitochondrial (cox1) marker into 31 GMYC species. Twenty-one of these could be identified based on the presence of topotypes (expertly identified specimens from the species' type locality) or unambiguous morphology. These results strongly suggest the presence of both cryptic diversity and taxonomic oversplitting in Rhithrogena. Significant clustering was not detected with protein-coding nuclear PEPCK, although nine GMYC species were congruent with well supported terminal clusters of nDNA. Lack of greater congruence in the two data sets may be the result of incomplete sorting of ancestral polymorphism. Bayesian phylogenetic analyses of both gene regions recovered four of the six recognized Rhithrogena species groups in our samples as monophyletic. Future development of more nuclear markers would facilitate multi-locus analysis of unresolved, closely related species pairs. The DNA taxonomy developed here lays the groundwork for a future revision of the important but cryptic Rhithrogena genus in Europe.	[Vuataz, Laurent; Sartori, Michel; Wagner, Andre] Musee Cantonal Zool, Lausanne, Switzerland; [Vuataz, Laurent] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Monaghan, Michael T.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	University of Lausanne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Vuataz, L (corresponding author), Musee Cantonal Zool, Lausanne, Switzerland.	laurent.vuataz@vd.ch	Monaghan, Michael T/A-2589-2009; Vuataz, Laurent/AAD-7486-2022; Sartori, Michel/AAT-9599-2020	Monaghan, Michael T/0000-0001-6200-2376; Sartori, Michel/0000-0003-3397-3397	Swiss National Science Foundation (FNS) [31003A-116049]; European Union	Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF)); European Union(European Commission)	Research was funded by the Swiss National Science Foundation (FNS nr. 31003A-116049; www.snf.ch) and by the European Union FP7 Project BioFresh (freshwaterbiodiversity.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson S, 2010, EVOLUTION, V64, P986, DOI 10.1111/j.1558-5646.2009.00872.x; Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Belfiore C., 1992, FRAGMENTA ENTOMOLOGI, V23, P235; Bode SNS, 2010, MOL PHYLOGENET EVOL, V54, P542, DOI 10.1016/j.ympev.2009.08.022; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brittain JE., 2008, INT ADV ECOLOGY ZOOG, P1, DOI DOI 10.1525/CALIFORNIA/9780520098688.003.0001; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Espeland M, 2010, J EVOLUTION BIOL, V23, P2112, DOI 10.1111/j.1420-9101.2010.02072.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Friedlander TP, 1996, MOL BIOL EVOL, V13, P594, DOI 10.1093/oxfordjournals.molbev.a025619; Gattolliat JL, 2010, J N AM BENTHOL SOC, V29, P1042, DOI 10.1899/09-119.1; Hauer FR, 1997, HYDROL PROCESS, V11, P903; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacob U., 1974, ENTOMOLOGISCHE NACHR, V11, P167; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Jousselin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-295; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Knispel S, 2006, J N AM BENTHOL SOC, V25, P430, DOI 10.1899/0887-3593(2006)25[430:EDITMO]2.0.CO;2; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; MALZACHER P, 1998, ROTE LISTE GEFAHRDET, P264; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nekola JC, 2009, MOL PHYLOGENET EVOL, V53, P1010, DOI 10.1016/j.ympev.2009.09.012; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pinzon-Navarro S, 2010, MOL PHYLOGENET EVOL, V56, P281, DOI 10.1016/j.ympev.2010.02.022; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, COLLAPSE DESCRIBING; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Renoult JP, 2009, MOL ECOL, V18, P4298, DOI 10.1111/j.1365-294X.2009.04351.x; Robinson CT, 2010, HANDB ENVIRON CHEM, V6, P193, DOI 10.1007/978-3-540-88275-6_10; SARTORI M, 1988, Annales de Limnologie, V24, P261; SARTORI M, 1994, LISTE ROUGE ESPECES, P72; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Soldan Tomas, 1999, Klapalekiana, V35, P25; Sowa R., 1984, P 4 INT C EPH BECH C, P37; STUDEMANN D, 1992, EPHEMEROPTERA; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomka I., 1993, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V66, P255; Weichselbaumer Peter, 1995, Limnologica, V25, P157; Wiens JJ, 2008, BIOSCIENCE, V58, P297, DOI 10.1641/B580405; Yassin A, 2009, MOL PHYLOGENET EVOL, V53, P404, DOI 10.1016/j.ympev.2009.06.012; ZURWERRA A, 1987, ARCH HYDROBIOL, V109, P481	66	77	81	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19728	10.1371/journal.pone.0019728	http://dx.doi.org/10.1371/journal.pone.0019728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611178	gold, Green Published			2022-12-27	WOS:000290657500017
J	Ramsay, SE; Whincup, PH; Hardoon, SL; Lennon, LT; Morris, RW; Wannamethee, SG				Ramsay, Sheena E.; Whincup, Peter H.; Hardoon, Sarah L.; Lennon, Lucy T.; Morris, Richard W.; Wannamethee, S. G.			Social Class Differences in Secular Trends in Established Coronary Risk Factors over 20 Years: A Cohort Study of British Men from 1978-80 to 1998-2000	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEALTH INEQUALITIES; EUROPEAN COUNTRIES; BLOOD-PRESSURE; HEART-DISEASE; POPULATION; CHOLESTEROL; MORTALITY; SMOKING	Background: Coronary heart disease (CHD) mortality in the UK since the late 1970s has declined more markedly among higher socioeconomic groups. However, little is known about changes in coronary risk factors in different socioeconomic groups. This study examined whether changes in established coronary risk factors in Britain over 20 years between 1978-80 and 1998-2000 differed between socioeconomic groups. Methods and Findings: A socioeconomically representative cohort of 7735 British men aged 40-59 years was followed-up from 1978-80 to 1998-2000; data on blood pressure (BP), cholesterol, body mass index (BMI) and cigarette smoking were collected at both points in 4252 survivors. Social class was based on longest-held occupation in middle-age. Compared with men in non-manual occupations, men in manual occupations experienced a greater increase in BMI (mean difference=0.33 kg/m(2); 95%CI 0.14-0.53; p for interaction=0.001), a smaller decline in non-HDL cholesterol (difference in mean change=0.18 mmol/l; 95%CI 0.11-0.25, p for interaction <= 0.0001) and a smaller increase in HDL cholesterol (difference in mean change=0.04 mmol/l; 95%CI 0.02-0.06, p for interaction <= 0.0001). However, mean systolic BP declined more in manual than non-manual groups (difference in mean change=3.6; 95%CI 2.1-5.1, p for interaction <= 0.0001). The odds of being a current smoker in 1978-80 and 1998-2000 did not differ between non-manual and manual social classes (p for interaction = 0.51). Conclusion: Several key risk factors for CHD and type 2 diabetes showed less favourable changes in men in manual occupations. Continuing priority is needed to improve adverse cardiovascular risk profiles in socially disadvantaged groups in the UK.	[Ramsay, Sheena E.; Hardoon, Sarah L.; Lennon, Lucy T.; Morris, Richard W.; Wannamethee, S. G.] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter H.] St Georges Univ London, Div Community Hlth Sci, London, England	University of London; University College London; St Georges University London	Ramsay, SE (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	s.ramsay@ucl.ac.uk	Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Morris, Richard/0000-0001-7240-4563; Whincup, Peter/0000-0002-5589-4107; Wannamethee, Sasiwarang/0000-0001-9484-9977; Ramsay, Sheena/0000-0002-0391-9704	British Heart Foundation; MRC [G0701739, G0501859] Funding Source: UKRI; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [G0701739, G0501859] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Allender S., 2008, CORONARY HEART DIS S; Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; BRUCE NG, 1990, J HYPERTENS        S, V4, pS11; *DEP HLTH, 2005, TACKL HLTH IN STAT R; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P922, DOI 10.1136/jech.56.12.922; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hardoon SL, 2010, EUR J CARDIOV PREV R, V17, P502, DOI 10.1097/HJR.0b013e3283378865; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Lampe FC, 2005, BMJ-BRIT MED J, V330, P1046, DOI 10.1136/bmj.330.7499.1046; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Peltonen M, 1998, J INTERN MED, V244, P1, DOI 10.1046/j.1365-2796.1998.00289.x; Ramsay SE, 2008, J EPIDEMIOL COMMUN H, V62, P75, DOI 10.1136/jech.2006.053207; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; THELLE DS, 1983, BRIT HEART J, V49, P205, DOI 10.1136/hrt.49.3.205; Thomas MC, 2002, J PUBLIC HEALTH MED, V24, P285, DOI 10.1093/pubmed/24.4.285; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295; WHINCUP PH, 1992, J EPIDEMIOL COMMUN H, V46, P164, DOI 10.1136/jech.46.2.164	28	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19742	10.1371/journal.pone.0019742	http://dx.doi.org/10.1371/journal.pone.0019742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21603647	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000290558500028
J	Maus, GW; Fischer, J; Whitney, D				Maus, Gerrit W.; Fischer, Jason; Whitney, David			Perceived Positions Determine Crowding	PLOS ONE			English	Article							FLASH-LAG; PSYCHOMETRIC FUNCTION; MOTION SIGNALS; PERCEPTION; SHIFT	Crowding is a fundamental bottleneck in object recognition. In crowding, an object in the periphery becomes unrecognizable when surrounded by clutter or distractor objects. Crowding depends on the positions of target and distractors, both their eccentricity and their relative spacing. In all previous studies, position has been expressed in terms of retinal position. However, in a number of situations retinal and perceived positions can be dissociated. Does retinal or perceived position determine the magnitude of crowding? Here observers performed an orientation judgment on a target Gabor patch surrounded by distractors that drifted toward or away from the target, causing an illusory motion-induced position shift. Distractors in identical physical positions led to worse performance when they drifted towards the target (appearing closer) versus away from the target (appearing further). This difference in crowding corresponded to the difference in perceived positions. Further, the perceptual mislocalization was necessary for the change in crowding, and both the mislocalization and crowding scaled with drift speed. The results show that crowding occurs after perceived positions have been assigned by the visual system. Crowding does not operate in a purely retinal coordinate system; perceived positions need to be taken into account.	[Maus, Gerrit W.; Fischer, Jason; Whitney, David] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Maus, Gerrit W.; Fischer, Jason; Whitney, David] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Davis	Maus, GW (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	maus@berkeley.edu	Maus, Gerrit W/A-7542-2011	Maus, Gerrit W/0000-0003-4843-3748	NIH [EY018216]; NSF [0748689]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants NIH EY018216 (http://www.nei.nih.gov) and NSF 0748689 (http://nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTIS S, 1989, P RET RES F, V2, P247; Arnold DH, 2007, VISION RES, V47, P2403, DOI 10.1016/j.visres.2007.04.025; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; Cavanagh P., 2007, J VISION, V7, P338, DOI [DOI 10.1167/7.9.338, 10.1167/7.9.338.]; Chappell M, 2007, J VISION, V7, DOI 10.1167/7.10.8; Chung STL, 2007, VISION RES, V47, P231, DOI 10.1016/j.visres.2006.10.008; Dakin SC, 2008, PERCEPTION, V37, P81; DAKIN SC, J VIS UNPUB; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Erlhagen W, 2003, BIOL CYBERN, V88, P409, DOI 10.1007/s00422-002-0387-1; Farzin F, 2009, J VISION, V9, DOI 10.1167/9.6.18; Fischer J, 2011, J COGNITIVE NEUROSCI, V23, P119, DOI 10.1162/jocn.2010.21417; Fu YX, 2004, J NEUROSCI, V24, P2165, DOI 10.1523/JNEUROSCI.5145-03.2004; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kirschfeld K, 2006, VISION RES, V46, P1547, DOI 10.1016/j.visres.2005.07.010; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Livne T, 2007, J VISION, V7, DOI 10.1167/7.2.4; Livne T, 2010, J VISION, V10, DOI 10.1167/10.3.1; Louie EG, 2007, J VISION, V7, DOI 10.1167/7.2.24; Maiche A, 2007, VISION RES, V47, P1655, DOI 10.1016/j.visres.2007.02.008; Maus GW, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00186; Maus GW, 2009, J EXP PSYCHOL HUMAN, V35, P611, DOI 10.1037/a0012317; McGraw PV, 2004, CURR BIOL, V14, P1090, DOI 10.1016/j.cub.2004.06.028; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Rider AT, 2009, J VISION, V9, DOI 10.1167/9.13.8; Saarela TP, 2009, J VISION, V9, DOI 10.1167/9.2.5; Tsui SY, 2007, VISION RES, V47, P402, DOI 10.1016/j.visres.2006.11.003; Wallis TSA, 2011, CURR BIOL, V21, P254, DOI 10.1016/j.cub.2011.01.011; Whitney D, 2003, SCIENCE, V302, P878, DOI 10.1126/science.1087839; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K	47	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19796	10.1371/journal.pone.0019796	http://dx.doi.org/10.1371/journal.pone.0019796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IJ	21629690	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800010
J	Stevenson, L; Allen, WL; Proutski, I; Stewart, G; Johnston, L; McCloskey, K; Wilson, PM; Longley, DB; Johnston, PG				Stevenson, Leanne; Allen, Wendy L.; Proutski, Irina; Stewart, Gail; Johnston, Louise; McCloskey, Karen; Wilson, Peter M.; Longley, Daniel B.; Johnston, Patrick G.			Calbindin 2 (CALB2) Regulates 5-Fluorouracil Sensitivity in Colorectal Cancer by Modulating the Intrinsic Apoptotic Pathway	PLOS ONE			English	Article							MULTICENTER RANDOMIZED-TRIAL; CELL-DEATH; 1ST-LINE TREATMENT; GENE-EXPRESSION; CALRETININ; FLUOROURACIL; IRINOTECAN; LOCALIZATION; MESOTHELIOMA; CHEMOTHERAPY	The role of the calcium binding protein, Calbindin 2 (CALB2), in regulating the response of colorectal cancer (CRC) cells to 5-Fluorouracil (5-FU) was investigated. Real-time RT-PCR and Western blot analysis revealed that CALB2 mRNA and protein expression were down-regulated in p53 wild-type and p53 null isogenic HCT116 CRC cell lines following 48 h and 72 h 5-FU treatment. Moreover, 5-FU-induced apoptosis was significantly reduced in HCT116 and LS174T CRC cell lines in which CALB2 expression had been silenced. Further investigation revealed that CALB2 translocated to the mitochondria following 5-FU treatment and that 5-FU-induced loss of mitochondrial membrane potential (Delta psi(m)) was abrogated in CALB2-silenced cells. Furthermore, CALB2 silencing decreased 5-FU-induced cytochrome c and smac release from the mitochondria and also decreased 5-FU-induced activation of caspases 9 and 3/7. Of note, co-silencing of XIAP overcame 5-FU resistance in CALB2-silenced cells. Collectively, these results suggest that following 5-FU treatment in CRC cell lines, CALB2 is involved in apoptosis induction through the intrinsic mitochondrial pathway. This indicates that CALB2 may be an important mediator of 5-FU-induced cell death. Moreover, down-regulation of CALB2 in response to 5-FU may represent an intrinsic mechanism of resistance to this anti-cancer drug.	[Stevenson, Leanne; Allen, Wendy L.; Proutski, Irina; Stewart, Gail; Johnston, Louise; McCloskey, Karen; Wilson, Peter M.; Longley, Daniel B.; Johnston, Patrick G.] Queens Univ Belfast, Drug Resistance Grp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Stevenson, L (corresponding author), Queens Univ Belfast, Drug Resistance Grp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	s.stevenson@qub.ac.uk		Moore, Wendy/0000-0003-0732-4123; McCloskey, Karen/0000-0002-9135-9013	Cancer Research UK [C212/A7402]; Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety [RRG/3261/05, RRG 6.42]	Cancer Research UK(Cancer Research UK); Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety	Funding was received from Cancer Research UK (C212/A7402); and Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety (RRG/3261/05, RRG 6.42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertschy S, 1998, HISTOCHEM CELL BIOL, V109, P59; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Caponigro F, 2005, CURR OPIN ONCOL, V17, P212, DOI 10.1097/01.cco.0000159623.68506.cf; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; D'Orlando C, 2002, BRAIN RES, V945, P181, DOI 10.1016/S0006-8993(02)02753-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gotzos V, 1996, ANTICANCER RES, V16, P3491; Gotzos V, 1999, AM J SURG PATHOL, V23, P701, DOI 10.1097/00000478-199906000-00010; Hack NJ, 2000, J NEUROSCI, V20; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Johnston PG, 2001, ANTI-CANCER DRUG, V12, P639, DOI 10.1097/00001813-200109000-00001; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuznicki J, 1996, BBA-MOL CELL RES, V1313, P194, DOI 10.1016/0167-4889(96)00089-4; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Longley DB, 2002, CANCER RES, V62, P2644; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Schurmans S, 1997, P NATL ACAD SCI USA, V94, P10415, DOI 10.1073/pnas.94.19.10415; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wu Y, 2009, CANCER BIOL THER, V8, P146, DOI 10.4161/cbt.8.2.7087; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20276	10.1371/journal.pone.0020276	http://dx.doi.org/10.1371/journal.pone.0020276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629658	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800040
J	Gentilucci, M; Campione, GC				Gentilucci, Maurizio; Campione, Giovanna Cristina			Do Postures of Distal Effectors Affect the Control of Actions of Other Distal Effectors? Evidence for a System of Interactions between Hand and Mouth	PLOS ONE			English	Article							AREA F5; LANGUAGE; REPRESENTATION; GESTURE; SPEECH; COMMUNICATION; PREMOTOR; CORTEX; MONKEY	The present study aimed at determining whether, in healthy humans, postures assumed by distal effectors affect the control of the successive grasp executed with other distal effectors. In experiments 1 and 2, participants reached different objects with their head and grasped them with their mouth, after assuming different hand postures. The postures could be implicitly associated with interactions with large or small objects. The kinematics of lip shaping during grasp varied congruently with the hand posture, i.e. it was larger or smaller when it could be associated with the grasping of large or small objects, respectively. In experiments 3 and 4, participants reached and grasped different objects with their hand, after assuming the postures of mouth aperture or closure (experiment 3) and the postures of toe extension or flexion (experiment 4). The mouth postures affected the kinematics of finger shaping during grasp, that is larger finger shaping corresponded with opened mouth and smaller finger shaping with closed mouth. In contrast, the foot postures did not influence the hand grasp kinematics. Finally, in experiment 5 participants reached-grasped different objects with their hand while pronouncing opened and closed vowels, as verified by the analysis of their vocal spectra. Open and closed vowels induced larger and smaller finger shaping, respectively. In all experiments postures of the distal effectors induced no effect, or only unspecific effects on the kinematics of the reach proximal/axial component. The data from the present study support the hypothesis that there exists a system involved in establishing interactions between movements and postures of hand and mouth. This system might have been used to transfer a repertoire of hand gestures to mouth articulation postures during language evolution and, in modern humans, it may have evolved a system controlling the interactions existing between speech and gestures.	[Gentilucci, Maurizio; Campione, Giovanna Cristina] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Gentilucci, M (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	maurizio.gentilucci@unipr.it		Campione, Giovanna Cristina/0000-0003-0410-5400	MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca); IIT ( Istituto Italiano di Tecnologia)	MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca)(Ministry of Education, Universities and Research (MIUR)); IIT ( Istituto Italiano di Tecnologia)	The study was supported by grants MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca) and IIT ( Istituto Italiano di Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Armstrong D. F., 1999, ORIGINAL SIGNS GESTU; Armstrong D. F., 1995, GESTURE NATURE LANGU; Baldissera FG, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-70; Barbieri F, 2007, EXP BRAIN RES, V180, P421, DOI 10.1007/s00221-007-0869-4; Barbieri F, 2009, BRAIN LANG, V110, P1, DOI 10.1016/j.bandl.2009.01.002; Bernardis P, 2006, NEUROPSYCHOLOGIA, V44, P178, DOI 10.1016/j.neuropsychologia.2005.05.007; Browman C., 1995, MIND MOTION EXPLORAT, P175; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Corballis MC, 2002, HAND MOUTH ORIGINS L; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Donald M., 1991, ORIGINS MODERN MIND; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Gentilucci M, 2002, NEUROPSYCHOLOGIA, V40, P1139, DOI 10.1016/S0028-3932(01)00233-0; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gentilucci M, 2006, J COGNITIVE NEUROSCI, V18, P1059, DOI 10.1162/jocn.2006.18.7.1059; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; GIVON Talmy, 1995, FUNCTIONALISM GRAMMA; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; LEONI FA, 2002, MANUALE FONETICA; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paget R, 1930, HUMAN SPEECH; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Ruben RJ, 2005, ACTA OTO-LARYNGOL, V125, P464, DOI 10.1080/00016480510026287; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	34	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19793	10.1371/journal.pone.0019793	http://dx.doi.org/10.1371/journal.pone.0019793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625428	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200014
J	Stewart, JL; Maloof, JN; Nemhauser, JL				Stewart, Jodi L.; Maloof, Julin N.; Nemhauser, Jennifer L.			PIF Genes Mediate the Effect of Sucrose on Seedling Growth Dynamics	PLOS ONE			English	Article							LIGHT-SIGNAL-TRANSDUCTION; HYPOCOTYL ELONGATION; TRANSCRIPTION FACTOR; BLUE-LIGHT; ARABIDOPSIS; PHYTOCHROME; GIBBERELLIN; DEGRADATION; GERMINATION; PROTEIN	As photoautotrophs, plants can use both the form and amount of fixed carbon as a measure of the light environment. In this study, we used a variety of approaches to elucidate the role of exogenous sucrose in modifying seedling growth dynamics. In addition to its known effects on germination, high-resolution temporal analysis revealed that sucrose could extend the number of days plants exhibited rapid hypocotyl elongation, leading to dramatic increases in ultimate seedling height. In addition, sucrose changed the timing of daily growth maxima, demonstrating that diel growth dynamics are more plastic than previously suspected. Sucrose-dependent growth promotion required function of multiple phytochrome-interacting factors (PIFs), and overexpression of PIF5 led to growth dynamics similar to plants exposed to sucrose. Consistent with this result, sucrose was found to increase levels of PIF5 protein. PIFs have well-established roles as integrators of response to light levels, time of day and phytohormone signaling. Our findings strongly suggest that carbon availability can modify the known photomorphogenetic signaling network.	[Stewart, Jodi L.; Nemhauser, Jennifer L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Maloof, Julin N.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis	Stewart, JL (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jn7@uw.edu		Maloof, Julin/0000-0002-9623-2599	National Science Foundation [IOS-0820854, IOS-0919021]; Seattle Chapter of the Achievement Rewards for College Scientists Foundation; University of Washington	National Science Foundation(National Science Foundation (NSF)); Seattle Chapter of the Achievement Rewards for College Scientists Foundation; University of Washington(University of Washington)	JLS is supported by the National Science Foundation Graduate Research Fellowship Program and the Seattle Chapter of the Achievement Rewards for College Scientists Foundation. Funding for the Maloof Lab was provided by National Science Foundation grant IOS-0820854. Funding for the Nemhauser Lab was provided by the University of Washington Royalty Research Fund and National Science Foundation grant IOS-0919021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Chory J, 2010, PLANT J, V61, P982, DOI 10.1111/j.1365-313X.2009.04105.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Dijkwel PP, 1996, PLANT PHYSIOL, V110, P455, DOI 10.1104/pp.110.2.455; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; KAZAMA H, 1973, PLANT CELL PHYSIOL, V14, P449; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kurata T, 1998, PLANT PHYSIOL, V118, P793, DOI 10.1104/pp.118.3.793; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Monte E, 2007, J EXP BOT, V58, P3125, DOI 10.1093/jxb/erm186; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Oh E, 2004, PLANT CELL, V16, P3045, DOI 10.1105/tpc.104.025163; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Parks BM, 1998, PLANT PHYSIOL, V118, P609, DOI 10.1104/pp.118.2.609; Parks BM, 2001, CURR OPIN PLANT BIOL, V4, P436, DOI 10.1016/S1369-5266(00)00197-7; Penfield S, 2010, PLANT MOL BIOL, V73, P89, DOI 10.1007/s11103-009-9571-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piskurewicz U, 2009, EMBO J, V28, P2259, DOI 10.1038/emboj.2009.170; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078; Zhang YQ, 2010, J PLANT PHYSIOL, V167, P1130, DOI 10.1016/j.jplph.2010.03.007; [No title captured]	51	82	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19894	10.1371/journal.pone.0019894	http://dx.doi.org/10.1371/journal.pone.0019894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625438	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200019
J	Chang, CH; Chang, TY; Chang, YJ; Huang, KL; Chin, SC; Ryu, SJ; Yang, TC; Lee, TH				Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Chin, Shy Chyi; Ryu, Shan Jin; Yang, Tao Chieh; Lee, Tsong Hai			The Role of Perfusion Computed Tomography in the Prediction of Cerebral Hyperperfusion Syndrome	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CAROTID-ARTERY STENOSIS; CT PERFUSION; ACUTE STROKE; BLOOD-FLOW; INTRACRANIAL HEMORRHAGE; QUANTITATIVE ASSESSMENT; ISCHEMIC-STROKE; DYNAMIC CT; ENDARTERECTOMY	Background: Hyperperfusion syndrome (HPS) following carotid angioplasty with stenting (CAS) is associated with significant morbidity and mortality. At present, there are no reliable parameters to predict HPS. The aim of this study was to clarify whether perfusion computed tomography (CT) is a feasible and reliable tool in predicting HPS after CAS. Methodology/Principal Findings: We performed a retrospective case-control study of 54 patients (11 HPS patients and 43 non-HPS) with unilateral severe stenosis of the carotid artery who underwent CAS. We compared the prevalence of vascular risk factors and perfusion CT parameters including regional cerebral blood volume (rCBV), regional cerebral blood flow (rCBF), and time to peak (TTP) within seven days prior to CAS. Demographic information, risk factors for atherosclerosis, and perfusion CT parameters were evaluated by multivariable logistic regression analysis. The rCBV index was calculated as [(ipsilateral rCBV - contralateral rCBV)/contralateral rCBV], and indices of rCBF and TTP were similarly calculated. We found that eleven patients had HPS, including five with intracranial hemorrhages (ICHs) of whom three died. After a comparison with non-HPS control subjects, independent predictors of HPS included the severity of ipsilateral carotid artery stenosis, 3-hour mean systolic blood pressure (3 h SBP) after CAS, pre-stenting rCBV index > 0.15 and TTP index > 0.22. Conclusions/Significance: The combination of severe ipsilateral carotid stenosis, 3 h SBP after CAS, rCBV index and TTP index provides a potential screening tool for predicting HPS in patients with unilateral carotid stenosis receiving CAS. In addition, adequate management of post-stenting blood pressure is the most important treatable factor in preventing HPS in these high risk patients.	[Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Stroke Ctr, Tao Yuan, Taiwan; [Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Linkou Med Ctr, Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chin, Shy Chyi] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan; [Yang, Tao Chieh] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, CH (corresponding author), Chang Gung Univ, Stroke Ctr, Tao Yuan, Taiwan.	thlee@adm.cgmh.org.tw	Lee, Tsong Hai/C-1235-2011	Chang, Ting-Yu/0000-0003-4642-7352	Chang Gung Memorial Hospital [CMRPG 35073]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant from the Medical Research Project, Chang Gung Memorial Hospital (CMRPG 35073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Chebl A, 2004, J AM COLL CARDIOL, V43, P1596, DOI 10.1016/j.jacc.2003.12.039; BERNSTEIN M, 1984, NEUROSURGERY, V15, P50, DOI 10.1227/00006123-198407000-00010; CAPLAN LR, 1978, STROKE, V9, P457, DOI 10.1161/01.STR.9.5.457; Ernst T, 1999, MAGN RESON IMAGING, V17, P349, DOI 10.1016/S0730-725X(98)00171-4; Ferguson GG, 1999, STROKE, V30, P1751, DOI 10.1161/01.STR.30.9.1751; Firlik AD, 1997, STROKE, V28, P2208, DOI 10.1161/01.STR.28.11.2208; GIBBS JM, 1984, LANCET, V1, P310; Gillard JH, 2000, NEUROL RES, V22, P457; Golledge J, 2000, STROKE, V31, P1439, DOI 10.1161/01.STR.31.6.1439; Hobson R W 2nd, 1997, Cardiovasc Surg, V5, P457, DOI 10.1016/S0967-2109(97)00048-3; Howell M, 2002, J ENDOVASC THER, V9, P810, DOI 10.1583/1545-1550(2002)009<0810:COPSBP>2.0.CO;2; Jain R, 2004, RADIOLOGY, V231, P906, DOI 10.1148/radiol.2313030093; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Kluytmans M, 1998, RADIOLOGY, V209, P675, DOI 10.1148/radiology.209.3.9844658; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lu J, 2005, CHINESE MED J-PEKING, V118, P1812; Malek AM, 2000, STROKE, V31, P3029, DOI 10.1161/01.STR.31.12.3029; Markus HS, 2004, J NEUROL NEUROSUR PS, V75, P353, DOI 10.1136/jnnp.2003.025825; McCabe DJH, 1999, STROKE, V30, P2483, DOI 10.1161/01.STR.30.11.2483; Meyers PM, 2000, NEUROSURGERY, V47, P335, DOI 10.1097/00006123-200008000-00013; Morrish W, 2000, AM J NEURORADIOL, V21, P1911; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; NORRVING B, 1982, STROKE, V13, P155, DOI 10.1161/01.STR.13.2.155; Ouriel K, 1999, J VASC SURG, V29, P82, DOI 10.1016/S0741-5214(99)70362-9; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Qureshi AI, 2002, STROKE, V33, P1916, DOI 10.1161/01.STR.0000019423.08947.43; Reichenbach JR, 1999, AM J NEURORADIOL, V20, P1842; Roberts HC, 2000, AM J NEURORADIOL, V21, P421; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Sanelli PC, 2004, ACAD RADIOL, V11, P1085, DOI 10.1016/j.acra.2004.07.002; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Tomandl BF, 2003, RADIOGRAPHICS, V23, P565, DOI 10.1148/rg.233025036; Trojanowska A, 2006, J NEURORADIOLOGY, V33, P169, DOI 10.1016/S0150-9861(06)77255-8; Tseng YC, 2009, J COMPUT ASSIST TOMO, V33, P540, DOI 10.1097/RCT.0b013e318188ad99; Waaijer A, 2007, RADIOLOGY, V245, P541, DOI 10.1148/radiol.2451061493	37	13	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19886	10.1371/journal.pone.0019886	http://dx.doi.org/10.1371/journal.pone.0019886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625479	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400018
J	Laoong-u-thai, Y; Zhao, BP; Phongdara, A; Yang, JZ				Laoong-u-thai, Yanisa; Zhao, Baoping; Phongdara, Amornrat; Yang, Jinzeng			Molecular Characterizations of a Novel Putative DNA-Binding Protein LvDBP23 in Marine Shrimp L. vannamei Tissues and Molting Stages	PLOS ONE			English	Article							EXPRESSION PATTERNS; GLYCINE-RICH; MUSCLE; REGION	Background: Litopenaeus Vannamei, well known as pacific white shrimp, is the most popular shrimp in the world shrimp market. Identification and characterization of shrimp muscle regulatory genes are not only important for shrimp genetic improvement, but also facilitate comparative genomic tools for understanding of muscle development and regeneration. Methodology/Principal Findings: A novel mRNA encoding for a putative DNA-binding protein LvDBP23 was identified from Litopenaeus vannamei abdominal muscle cDNA library. The LvDBP23 cDNA contains 639 nucleotides of protein-coding sequence with deduced 212 amino acids of predicted molecular mass 23.32 kDa with glycine-rich domain at amino acid position 94-130. The mRNA sequence is successfully used for producing LvDBP23 recombinant protein in sf9 insect cell expression system. The expression of LvDBP23 mRNA is presented in abdominal muscle and swimming leg muscle, as well as other tissues including intestine, lymphoid and gill. The mRNA expression has the highest level in abdominal muscle in all tested tissues. LVDBP23 transcript during the molt cycle is highly expressed in the intermolt stage. In vitro nucleic acid-binding assays reveal that LvDBP23 protein can bind to both ssDNA and dsDNA, indicating its possible role of regulation of gene transcription. Conclusions/Significance: We are the first to report a DNA-binding protein identified from the abdominal muscle tissue of marine shrimp L. Vannamei. Its high-level specific expression during the intermot stage suggests its role in the regulation of muscle buildup during the growth phase of shrimp molt cycle.	[Laoong-u-thai, Yanisa; Zhao, Baoping; Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Laoong-u-thai, Yanisa] Burapha Univ, Fac Engn, Dept Chem Engn, Chon Buri, Thailand; [Phongdara, Amornrat] Prince Songkla Univ, Ctr Genom & Bioinformat Res, Hat Yai, Thailand; [Yang, Jinzeng] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Burapha University; Prince of Songkla University; Huazhong Agricultural University	Laoong-u-thai, Y (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	pamornra@yahoo.com; Jinzeng@hawaii.edu			USDA-CSREES-TSTAR [2008-34135-19343]; National Research Council of Thailand; National Research University Project of Thailand; Office of the Higher Education Commission [SCI540527M]	USDA-CSREES-TSTAR(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Research University Project of Thailand; Office of the Higher Education Commission	The USDA-CSREES-TSTAR programs (Award # 2008-34135-19343), National Research Council of Thailand, The National Research University Project of Thailand and Office of the Higher Education Commission (Grant # SCI540527M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Cesar JRO, 2007, MOL REPROD DEV, V74, P554, DOI 10.1002/mrd.20605; Cesar JRO, 2008, ANIMAL, P1; Cesar JRD, 2006, AQUACULTURE, V261, P688, DOI 10.1016/j.aquaculture.2006.08.003; ELHAJ AJ, 1987, J EXP BIOL, V127, P413; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Laoong-U-Thai Y, 2009, INT J BIOL SCI, V5, P205; Li F, 2005, MOL CELL BIOL, V25, P8913, DOI 10.1128/MCB.25.20.8913-8924.2005; Li ZC, 2010, MOL REPROD DEV, V77, P990, DOI 10.1002/mrd.21252; Li ZC, 2010, MOL REPROD DEV, V77, P76, DOI 10.1002/mrd.21111; Lin L, 1996, MOL CELL BIOL, V16, P2248; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mykles D.L., 1985, Progress in Clinical and Biological Research, V180, P141; MYKLES DL, 1990, J CRUSTACEAN BIOL, V10, P577, DOI 10.2307/1548402; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; Wyban J, 2009, P SPEC SESS SUST SHR, P12; Zhang Shuli, 2009, Weishengwu Xuebao, V49, P453	21	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19959	10.1371/journal.pone.0019959	http://dx.doi.org/10.1371/journal.pone.0019959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625495	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400024
J	Lugt, BV; Beck, ZT; Fuhlbrigge, RC; Hacohen, N; Campbell, JJ; Boes, M				Lugt, Bryan Vander; Beck, Zachary T.; Fuhlbrigge, Robert C.; Hacohen, Nir; Campbell, James J.; Boes, Marianne			TGF-beta Suppresses beta-Catenin-Dependent Tolerogenic Activation Program in Dendritic Cells	PLOS ONE			English	Article							LANGERHANS CELLS; MATURATION; RESPONSES; ADHESION; DISRUPTION; RECEPTORS; TOLERANCE; IMMATURE; IMMUNITY	The mechanisms that underlie the critical dendritic cell (DC) function in maintainance of peripheral immune tolerance are incompletely understood, although the beta-catenin signaling pathway is critical for this role. The molecular details by which beta-catenin signaling is regulated in DCs are unknown. Mechanical disruption of murine bone marrow-derived DC (BMDC) clusters activates DCs while maintaining their tolerogenic potential and this activation is associated with beta-catenin signaling, providing a useful model with which to explore tolerance-associated beta-catenin signaling in DCs. In this report, we demonstrate novel molecular features of the signaling events that control DC activation in response to mechanical stimulation. Non-canonical beta-catenin signaling is an essential component of this tolerogenic activation and is modulated by adhesion molecules, including integrins. This unique beta-catenin-dependent signaling pathway is constitutively active at low levels, suggesting that mechanical stimulation is not necessarily required for induction of this unique activation program. We additionally find that the immunomodulatory cytokine TGF-beta antagonizes beta-catenin in DCs, thereby selectively suppressing signaling associated with tolerogenic DC activation while having no impact on LPS-induced, beta-cateninin-dependent immunogenic activation. These findings provide new molecular insight into the regulation of a critical signaling pathway for DC function in peripheral immune tolerance.	[Lugt, Bryan Vander; Beck, Zachary T.; Fuhlbrigge, Robert C.; Campbell, James J.; Boes, Marianne] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Hacohen, Nir] Broad Inst Harvard & MIT, Cambridge, MA USA; [Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat Immunol, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Lugt, BV (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jcampbell@rics.bwh.harvard.edu; mboes@umcutrecht.nl		Boes, Marianne/0000-0003-2590-1692	National Institutes of Health (NIH) [RO1-AR052810, R01-AI046784, R03-AI083796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046784, R03AI083796, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052810] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors received funding from the National Institutes of Health, NIH RO1-AR052810 (to MB and RF) and R01-AI046784 & R03-AI083796 (to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Fu CM, 2010, IMMUNOL RES, V46, P72, DOI 10.1007/s12026-009-8126-5; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Geissmann F, 1999, J IMMUNOL, V162, P4567; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; van den Broek M, 2007, IMMUNITY, V27, P544, DOI 10.1016/j.immuni.2007.10.004	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20099	10.1371/journal.pone.0020099	http://dx.doi.org/10.1371/journal.pone.0020099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625453	gold, Green Published, Green Submitted			2022-12-27	WOS:000290793400040
J	Chan, AK; van Lettow, M; Tenthani, L; Kumwenda, M; Gawa, L; Kadzanja, A; Mnthambala, A; Kambanji, M				Chan, Adrienne K.; van Lettow, Monique; Tenthani, Lyson; Kumwenda, Moses; Gawa, Lucy; Kadzanja, Alice; Mnthambala, Austin; Kambanji, Marion			Outcome Assessment of a Dedicated HIV Positive Health Care Worker Clinic at a Central Hospital in Malawi: A Retrospective Observational Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTHERN AFRICA; PROVISION; HIV/AIDS; IMPACT	Background: Malawi has one of the world's lowest densities of Health Care Workers (HCW) per capita. This study evaluates outcomes of a dedicated HCW HIV clinic in Malawi, created at Zomba Central Hospital in January 2007. Methods and Findings: Retrospective cohort data was analyzed comparing HCW clinic patient baseline characteristics and treatment outcomes at 18 months after inception, against those attending the general HIV clinic. In-depth interviews and focus group discussions were conducted to explore perceptions of patients and caregivers regarding program value, level of awareness and barriers for uptake amongst HCW. 306 patients were enrolled on antiretroviral therapy (ART) in the HCW HIV clinic, 6784 in the general clinic. Significantly (p < 0.01) more HCW clients were initiated on ART on the basis of CD4 as opposed to WHO Stage 3/4 (36% vs. 23%). Significantly fewer HCW clients defaulted (6% vs. 17%), and died (4% vs. 12%). The dedicated HCW HIV clinic was perceived as important and convenient in terms of reduced waiting times, and prompt and high quality care. Improved confidentiality was an appreciated quality of the HCW clinic however barriers included fear of being recognized. Conclusions/Significance: Outcomes at the HCW clinic appear better compared to the general HIV clinic. The strategy of dedicated clinics to care for health providers is a means of HIV impact mitigation within human resource constrained health systems in high prevalence settings.	[Chan, Adrienne K.; van Lettow, Monique; Kumwenda, Moses; Gawa, Lucy; Kadzanja, Alice; Kambanji, Marion] Dignitas Int, Zomba, Malawi; [Chan, Adrienne K.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Tenthani, Lyson; Mnthambala, Austin] Malawi Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [van Lettow, Monique] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Chan, AK (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org		Kumwenda, Moses Kelly/0000-0003-3091-7330				Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; *DEP HUM RES MAN D, 2007, MAL MIN HLTH PAYR DA; Dieleman M, 2007, HEALTH POLICY PLANN, V22, P139, DOI 10.1093/heapol/czm006; *DIGN INT, 2008, Q STAT REP; GALVIN S, 2008, HIV CARE HLTH WORKER; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; JOSHUA M, 2010, COMMUNICATION; Kiragu K, 2008, CARING CAREGIVERS HI; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Makombe SD, 2007, B WORLD HEALTH ORGAN, V85, P851; *MAL MIN HLTH, 2009, GUID ART PROV; *MAL MIN HLTH, 2008, Q REP ANT TREATM PRO; *MAL MIN HLTH, 2008, HIV SYPH SER NAT HIV; Malawi Ministry of Health, 2007, HUM RES HLTH CENS; Medecins sans Frontieres, 2007, HELP WANT CONFR HLTH; MUGANZI AM, 2009, HIV MED C; MUULA AS, 2007, HUMAN RESOURCES REQU, P7; Uebel K, 2004, SAMJ S AFR MED J, V94, P423; Uebel KE, 2007, J INFECT DIS, V196, pS500, DOI 10.1086/521113; WHO, 2006, WORK TOG HLTH WORLD	20	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19789	10.1371/journal.pone.0019789	http://dx.doi.org/10.1371/journal.pone.0019789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625545	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200023
J	Kupakuwana, GV; Crill, JE; McPike, MP; Borer, PN				Kupakuwana, Gillian V.; Crill, James E., II; McPike, Mark P.; Borer, Philip N.			Acyclic Identification of Aptamers for Human alpha-Thrombin Using Over-Represented Libraries and Deep Sequencing	PLOS ONE			English	Article							IN-VITRO SELECTION; BINDING DNA APTAMERS; CAPILLARY-ELECTROPHORESIS; EQUILIBRIUM MIXTURES; AUTOMATED SELECTION; RNA APTAMERS; NON-SELEX; LIGANDS; MOLECULES; DIAGNOSTICS	Background: Aptamers are oligonucleotides that bind proteins and other targets with high affinity and selectivity. Twenty years ago elements of natural selection were adapted to in vitro selection in order to distinguish aptamers among randomized sequence libraries. The primary bottleneck in traditional aptamer discovery is multiple cycles of in vitro evolution. Methodology/Principal Findings: We show that over-representation of sequences in aptamer libraries and deep sequencing enables acyclic identification of aptamers. We demonstrated this by isolating a known family of aptamers for human alpha-thrombin. Aptamers were found within a library containing an average of 56,000 copies of each possible randomized 15mer segment. The high affinity sequences were counted many times above the background in 2-6 million reads. Clustering analysis of sequences with more than 10 counts distinguished two sequence motifs with candidates at high abundance. Motif I contained the previously observed consensus 15mer, Thb1 (46,000 counts), and related variants with mostly G/T substitutions; secondary analysis showed that affinity for thrombin correlated with abundance (K-d=12 nM for Thb1). The signal-to-noise ratio for this experiment was roughly 10,000: 1 for Thb1. Motif II was unrelated to Thb1 with the leading candidate (29,000 counts) being a novel aptamer against hexose sugars in the storage and elution buffers for Concanavilin A (K-d = 0.5 mM for alpha-methyl-mannoside); ConA was used to immobilize alpha-thrombin. Conclusions/Significance: Over-representation together with deep sequencing can dramatically shorten the discovery process, distinguish aptamers having a wide range of affinity for the target, allow an exhaustive search of the sequence space within a simplified library, reduce the quantity of the target required, eliminate cycling artifacts, and should allow multiplexing of sequencing experiments and targets.	[Kupakuwana, Gillian V.; Borer, Philip N.] Syracuse Univ, Grad Program Struct Biol Biochem & Biophys, Syracuse, NY 13244 USA; [Crill, James E., II; McPike, Mark P.; Borer, Philip N.] AptaMatrix Inc, Syracuse, NY USA; [Borer, Philip N.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA	Syracuse University; Syracuse University	Kupakuwana, GV (corresponding author), Syracuse Univ, Grad Program Struct Biol Biochem & Biophys, Syracuse, NY 13244 USA.	pnborer@syr.edu			National Institutes of Health [R43, R44 AI075739, F31 GM086129]; New York State Office of Science, Technology and Academic Research [TTIP C060056]; Syracuse Center of Excellence in Environmental and Energy Systems [EPA X-83232501]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI075739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Science, Technology and Academic Research; Syracuse Center of Excellence in Environmental and Energy Systems; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (R43, R44 AI075739) to AptaMatrix, Inc., an NIH pre-doctoral fellowship (F31 GM086129) to GVK, a grant from the New York State Office of Science, Technology and Academic Research to Syracuse University (TTIP C060056), and from the Syracuse Center of Excellence in Environmental and Energy Systems to SU (EPA X-83232501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNIE JG, 2008, T ROY SOC TROP MED H, V102, pS55; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Berezovski MV, 2006, NAT PROTOC, V1, P1359, DOI 10.1038/nprot.2006.200; Biesecker G, 1999, IMMUNOPHARMACOLOGY, V42, P219, DOI 10.1016/S0162-3109(99)00020-X; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Boese BJ, 2007, NUCLEIC ACIDS RES, V35, P6378, DOI 10.1093/nar/gkm708; BORER PN, 2009, Patent No. 2009151688; BORER PN, 2010, PITTCON M PITTSB C A, P1430; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Cox JC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf107; Cox JC, 2002, COMB CHEM HIGH T SCR, V5, P289; Davis JP, 1996, METHOD ENZYMOL, V267, P302; Deterding RR, 2010, AM J RESP CRIT CARE, V181, pA6722; Drabovich A, 2005, J AM CHEM SOC, V127, P11224, DOI 10.1021/ja0530016; Eaton BE, 1997, BIOORGAN MED CHEM, V5, P1087, DOI 10.1016/S0968-0896(97)00044-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Golden MC, 2000, J BIOTECHNOL, V81, P167, DOI 10.1016/S0168-1656(00)00290-X; Hicke BJ, 2006, J NUCL MED, V47, P668; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kelly JA, 1996, J MOL BIOL, V256, P417, DOI 10.1006/jmbi.1996.0097; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; KUPAKUWANA GV, THESIS SYRACUSE U; KUPAKUWANA GV, 2010, BIOPHYS SOC M, pB276; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Marshall KA, 2000, METHOD ENZYMOL, V318, P193; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Niles JC, 2006, ACS CHEM BIOL, V1, P515, DOI 10.1021/cb6002527; Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48; Padmanabhan K, 1996, ACTA CRYSTALLOGR D, V52, P272, DOI 10.1107/S0907444995013977; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pandana H, 2008, IEEE SENS J, V8, P661, DOI 10.1109/JSEN.2008.922725; Platt M, 2009, INTEGR BIOL-UK, V1, P116, DOI 10.1039/b814892a; Potyrailo RA, 1998, ANAL CHEM, V70, P3419, DOI 10.1021/ac9802325; SILVERMAN SK, 2007, FUNCTIONAL NUCL ACID; Stojanovic MN, 2001, J AM CHEM SOC, V123, P4928, DOI 10.1021/ja0038171; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xu Y, 2009, ANAL CHEM, V81, P7436, DOI 10.1021/ac9012072; Yang Q, 1998, P NATL ACAD SCI USA, V95, P5462, DOI 10.1073/pnas.95.10.5462; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169	47	40	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19395	10.1371/journal.pone.0019395	http://dx.doi.org/10.1371/journal.pone.0019395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625587	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200007
J	Cioaca, D; Ghenea, S; Spiridon, LN; Marin, M; Petrescu, AJ; Petrescu, SM				Cioaca, Daniela; Ghenea, Simona; Spiridon, Laurentiu N.; Marin, Marioara; Petrescu, Andrei-Jose; Petrescu, Stefana M.			C-Terminus Glycans with Critical Functional Role in the Maturation of Secretory Glycoproteins	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; N-GLYCOSYLATION SITES; NEGATIVE OCULOCUTANEOUS ALBINISM; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LINKED OLIGOSACCHARIDES; TYROSINASE ACTIVITY; SERVER; TRANSPORT	The N-glycans of membrane glycoproteins are mainly exposed to the extracellular space. Human tyrosinase is a transmembrane glycoprotein with six or seven bulky N-glycans exposed towards the lumen of subcellular organelles. The central active site region of human tyrosinase is modeled here within less than 2.5 angstrom accuracy starting from Streptomyces castaneoglobisporus tyrosinase. The model accounts for the last five C-terminus glycosylation sites of which four are occupied and indicates that these cluster in two pairs - one in close vicinity to the active site and the other on the opposite side. We have analyzed and compared the roles of all tyrosinase N-glycans during tyrosinase processing with a special focus on the proximal to the active site N-glycans, s6:N337 and s7:N371, versus s3:N161 and s4:N230 which decorate the opposite side of the domain. To this end, we have constructed mutants of human tyrosinase in which its seven N-glycosylation sites were deleted. Ablation of the s6:N337 and s7:N371 sites arrests the post-translational productive folding process resulting in terminally misfolded mutants subjected to degradation through the mannosidase driven ERAD pathway. In contrast, single mutants of the other five N-glycans located either opposite to the active site or into the N-terminus Cys1 extension of tyrosinase are temperature-sensitive mutants and recover enzymatic activity at the permissive temperature of 31 degrees C. Sites s3 and s4 display selective calreticulin binding properties. The C-terminus sites s7 and s6 are critical for the endoplasmic reticulum retention and intracellular disposal. Results herein suggest that individual N-glycan location is critical for the stability, regional folding control and secretion of human tyrosinase and explains some tyrosinase gene missense mutations associated with oculocutaneous albinism type I.	[Cioaca, Daniela; Ghenea, Simona; Spiridon, Laurentiu N.; Marin, Marioara; Petrescu, Andrei-Jose; Petrescu, Stefana M.] Acad Romana, Dept Mol Cell Biol, Inst Biochem, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology	Cioaca, D (corresponding author), Acad Romana, Dept Mol Cell Biol, Inst Biochem, Bucharest, Romania.	ap@biochim.ro; Stefana.Petrescu@biochim.ro	Spiridon, Laurentiu N/A-3352-2017; Chiritoiu, Mari/Q-3983-2017; Petrescu, Stefana M/I-9240-2012; Petrescu, Stefana/AAJ-9505-2021; Petrescu, Andrei-Jose J/G-4576-2016	Spiridon, Laurentiu N/0000-0003-3080-1610; Chiritoiu, Mari/0000-0003-2064-2003; Petrescu, Stefana M/0000-0002-4047-0811; Petrescu, Stefana/0000-0002-4047-0811; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Ghenea, Simona/0000-0002-5566-0335	Institute of Biochemistry; CNCSIS [ID 1171 - 1018/2008, ID 249 - 168/2007]; European Social Fund [POSDRU/89/1.5/S/60746]	Institute of Biochemistry; CNCSIS(Consiliul National al Cercetarii Stiintifice (CNCS)); European Social Fund(European Social Fund (ESF))	This work was supported by the Romanian Academy projects 1 and 3 of the Institute of Biochemistry and CNCSIS Grants ID 1171 - 1018/2008 and ID 249 - 168/2007. Simona Ghenea also acknowledges the postdoctoral program POSDRU/89/1.5/S/60746, from European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Branza-Nichita N, 1999, BIOCHEM BIOPH RES CO, V261, P720, DOI 10.1006/bbrc.1999.1030; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Furumura M, 1998, BIOCHEM BIOPH RES CO, V242, P579, DOI 10.1006/bbrc.1997.8007; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gupta G, 2009, GLYCOCONJUGATE J, V26, P691, DOI 10.1007/s10719-008-9213-x; Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; JACOBSON SG, 1984, DOC OPHTHALMOL, V56, P337, DOI 10.1007/BF00155678; Kamada A, 2004, J BIOL CHEM, V279, P21533, DOI 10.1074/jbc.M401403200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Miyazaki Satoshi, 2002, Journal of Structural and Functional Genomics, V2, P37, DOI 10.1023/A:1014418700858; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Negroiu G, 1999, CELL MOL BIOL, V45, P1001; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808; Olivares C, 2003, J BIOL CHEM, V278, P15735, DOI 10.1074/jbc.M300658200; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Petrescu SM, 1997, J BIOL CHEM, V272, P15796, DOI 10.1074/jbc.272.25.15796; Petrescu SM, 2000, BIOCHEMISTRY-US, V39, P5229, DOI 10.1021/bi000107z; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Popescu CI, 2005, J BIOL CHEM, V280, P13833, DOI 10.1074/jbc.M413087200; Popescu CI, 2006, J BIOL CHEM, V281, P21682, DOI 10.1074/jbc.M603841200; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rogers KA, 2006, IMMUNOLOGY, V118, P88, DOI 10.1111/j.1365-2567.2006.02345.x; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Tang BL, 1995, EUR J CELL BIOL, V68, P398; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	59	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19979	10.1371/journal.pone.0019979	http://dx.doi.org/10.1371/journal.pone.0019979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625599	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200054
J	Sanders, J; Haag, JD; Samuelson, DJ				Sanders, Jennifer; Haag, Jill D.; Samuelson, David J.			Physical Confirmation and Mapping of Overlapping Rat Mammary Carcinoma Susceptibility QTLs, Mcs2 and Mcs6	PLOS ONE			English	Article							BREAST-CANCER RISK; GROWTH-FACTOR-I; CIRCULATING LEVELS; IGF-I; BINDING-PROTEIN; POLYMORPHISMS; SUPPRESSOR; EXPRESSION; GENES; LOCI	Only a portion of the estimated heritability of breast cancer susceptibility has been explained by individual loci. Comparative genetic approaches that first use an experimental organism to map susceptibility QTLs are unbiased methods to identify human orthologs to target in human population-based genetic association studies. Here, overlapping rat mammary carcinoma susceptibility (Mcs) predicted QTLs, Mcs6 and Mcs2, were physically confirmed and mapped to identify the human orthologous region. To physically confirm Mcs6 and Mcs2, congenic lines were established using the Wistar-Furth (WF) rat strain, which is susceptible to developing mammary carcinomas, as the recipient (genetic background) and either Wistar-Kyoto (WKy, Mcs6) or Copenhagen (COP, Mcs2), which are resistant, as donor strains. By comparing Mcs phenotypes of WF. WKy congenic lines with distinct segments of WKy chromosome 7 we physically confirmed and mapped Mcs6 to similar to 33 Mb between markers D7Rat171 and gUwm64-3. The predicted Mcs2 QTL was also physically confirmed using segments of COP chromosome 7 introgressed into a susceptible WF background. The Mcs6 and Mcs2 overlapping genomic regions contain multiple annotated genes, but none have a clear or well established link to breast cancer susceptibility. Igf1 and Socs2 are two of multiple potential candidate genes in Mcs6. The human genomic region orthologous to rat Mcs6 is on chromosome 12 from base positions 71,270,266 to 105,502,699. This region has not shown a genome-wide significant association to breast cancer risk in pun studies of breast cancer susceptibility.	[Sanders, Jennifer; Samuelson, David J.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Haag, Jill D.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Samuelson, David J.] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Samuelson, David J.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [Samuelson, David J.] Univ Louisville, Sch Med, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA	University of Louisville; University of Wisconsin System; University of Wisconsin Madison; University of Louisville; University of Louisville; University of Louisville	Sanders, J (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	david.samuelson@louisville.edu			National Institutes of Health [CA137052, CA077494, ES014443]; University of Louisville; NATIONAL CANCER INSTITUTE [R01CA077494, R01CA137052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants CA137052, CA077494, and ES014443. J.S. was supported by the University of Louisville Integrated Programs in Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Aldave AJ, 2010, INVEST OPHTH VIS SCI, V51, P4006, DOI 10.1167/iovs.09-4067; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Cleveland RJ, 2006, CARCINOGENESIS, V27, P758, DOI 10.1093/carcin/bgi294; Datta B, 2009, BBA-REV CANCER, V1796, P281, DOI 10.1016/j.bbcan.2009.08.002; Farabegoli F, 2005, J CLIN PATHOL, V58, P1046, DOI 10.1136/jcp.2004.024919; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gu FY, 2010, CANCER EPIDEM BIOMAR, V19, P2877, DOI 10.1158/1055-9965.EPI-10-0507; Haffner MC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-136; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Lan H, 2001, GENETICS, V157, P331; Leung KC, 2003, P NATL ACAD SCI USA, V100, P1016, DOI 10.1073/pnas.0337600100; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Neuhausen SL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2414; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; PEYRAT JP, 1990, J STEROID BIOCHEM, V37, P823, DOI 10.1016/0960-0760(90)90426-L; Quan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014727; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Samuelson DJ, 2003, CARCINOGENESIS, V24, P1455, DOI 10.1093/carcin/bgg112; Sasi W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-178; Shepel LA, 1998, GENETICS, V149, P289; Shull James D, 2007, Breast Dis, V28, P69; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thompson TC, 2010, YONSEI MED J, V51, P479, DOI 10.3349/ymj.2010.51.4.479; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Valladares A, 2006, CANCER GENET CYTOGEN, V170, P147, DOI 10.1016/j.cancergencyto.2006.06.002	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19891	10.1371/journal.pone.0019891	http://dx.doi.org/10.1371/journal.pone.0019891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625632	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200044
J	Stuken, A; Orr, RJS; Kellmann, R; Murray, SA; Neilan, BA; Jakobsen, KS				Stuken, Anke; Orr, Russell J. S.; Kellmann, Ralf; Murray, Shauna A.; Neilan, Brett A.; Jakobsen, Kjetill S.			Discovery of Nuclear-Encoded Genes for the Neurotoxin Saxitoxin in Dinoflagellates	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXIN; GYMNODINIUM-CATENATUM DINOPHYCEAE; ALEXANDRIUM-TAMARENSE; PHYLOGENETIC ANALYSES; SIGNAL PEPTIDES; PURIFICATION; BACTERIA; PROTEIN; CYANOBACTERIA; BIOSYNTHESIS	Saxitoxin is a potent neurotoxin that occurs in aquatic environments worldwide. Ingestion of vector species can lead to paralytic shellfish poisoning, a severe human illness that may lead to paralysis and death. In freshwaters, the toxin is produced by prokaryotic cyanobacteria; in marine waters, it is associated with eukaryotic dinoflagellates. However, several studies suggest that saxitoxin is not produced by dinoflagellates themselves, but by co-cultured bacteria. Here, we show that genes required for saxitoxin synthesis are encoded in the nuclear genomes of dinoflagellates. We sequenced >1.2x10(6) mRNA transcripts from the two saxitoxin-producing dinoflagellate strains Alexandrium fundyense CCMP1719 and A. minutum CCMP113 using high-throughput sequencing technology. In addition, we used in silico transcriptome analyses, RACE, qPCR and conventional PCR coupled with Sanger sequencing. These approaches successfully identified genes required for saxitoxin-synthesis in the two transcriptomes. We focused on sxtA, the unique starting gene of saxitoxin synthesis, and show that the dinoflagellate transcripts of sxtA have the same domain structure as the cyanobacterial sxtA genes. But, in contrast to the bacterial homologs, the dinoflagellate transcripts are monocistronic, have a higher GC content, occur in multiple copies, contain typical dinoflagellate spliced-leader sequences and eukaryotic polyA-tails. Further, we investigated 28 saxitoxin-producing and non-producing dinoflagellate strains from six different genera for the presence of genomic sxtA homologs. Our results show very good agreement between the presence of sxtA and saxitoxin-synthesis, except in three strains of A. tamarense, for which we amplified sxtA, but did not detect the toxin. Our work opens for possibilities to develop molecular tools to detect saxitoxin-producing dinoflagellates in the environment.	[Stuken, Anke; Orr, Russell J. S.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway; [Kellmann, Ralf] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Murray, Shauna A.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Murray, Shauna A.; Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia; [Murray, Shauna A.; Neilan, Brett A.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo; University of Bergen; University of New South Wales Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of Oslo	Stuken, A (corresponding author), Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway.	k.s.jakobsen@bio.uio.no	Murray, Shauna/K-5781-2015; Neilan, Brett A/I-5767-2012	Murray, Shauna/0000-0001-7096-1307; Neilan, Brett A/0000-0001-6113-772X; Stuken, Anke/0000-0002-7553-9524	ARC [LP0776759]; Research Council of Norway [186292/V40]	ARC(Australian Research Council); Research Council of Norway(Research Council of Norway)	SM and BAN are fellows of the Australian Research Council and were supported by ARC project LP0776759. This project was supported by a grant (186292/V40) from the Research Council of Norway to KSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALAM M, 1973, TOXICON, V11, P65, DOI 10.1016/0041-0101(73)90154-2; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baker TR, 2003, TOXICON, V41, P339, DOI 10.1016/S0041-0101(02)00314-8; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CAVALIERE R, 2008, THESIS U NEW S WALES; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Doblin MA, 1999, J EXP MAR BIOL ECOL, V236, P33, DOI 10.1016/S0022-0981(98)00193-2; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Hallegraeff G. M., 1995, MANUAL HARMFUL MARIN, V33, P1; Harlow LD, 2007, PHYCOLOGIA, V46, P46, DOI 10.2216/06-28.1; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Ho AYT, 2006, AQUAT MICROB ECOL, V42, P41, DOI 10.3354/ame042041; Hoagland P, 2006, ECOLOGY HARMFUL ALGA; Hold GL, 2001, FEMS MICROBIOL ECOL, V36, P223, DOI 10.1111/j.1574-6941.2001.tb00843.x; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Hsiao YY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/138538; Prol MJ, 2009, CAN J MICROBIOL, V55, P943, DOI [10.1139/W09-047, 10.1139/w09-047]; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KELLMANN R, 2005, THESIS U NEW S WALES; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2010, MAR DRUGS, V8, P1011, DOI 10.3390/md8041011; KUMAR S, BIOINFORMAT IN PRESS; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LE QH, 1997, MOL GEN GENET, V225, P10; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; LIN S, 2006, J PHYCOL, V42, P3; Maddison WP, 1992, MACCLADE; Martins CA, 2003, APPL ENVIRON MICROB, V69, P5693, DOI 10.1128/AEM.69.9.5693-5698.2003; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Negri A, 2003, J PHYCOL, V39, P663, DOI 10.1046/j.1529-8817.2003.02131.x; ORR RJS, HARMFUL ALG IN PRESS; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Plumley FG, 2001, J PHYCOL, V37, P926; Sako Y, 2001, J PHYCOL, V37, P1044, DOI 10.1046/j.1529-8817.2001.00119.x; SATO S, 1998, PURIFICATION FLUORES, P465; SCHANTZ EJ, 1966, BIOCHEMISTRY-US, V5, P1191, DOI 10.1021/bi00868a011; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shimizu Y, 1996, ANNU REV MICROBIOL, V50, P431, DOI 10.1146/annurev.micro.50.1.431; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein LD, 2004, NATURE, V431, P915, DOI 10.1038/431915a; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Stuken A, 2010, MICROBIOL-SGM, V156, P2438, DOI 10.1099/mic.0.036988-0; Taroncher-Oldenburg G, 1999, NAT TOXINS, V7, P207, DOI 10.1002/1522-7189(200009/10)7:5<207::AID-NT61>3.0.CO;2-Q; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Worden AZ, 2010, CURR OPIN MICROBIOL, V13, P652, DOI 10.1016/j.mib.2010.08.001; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248; Yoshida T, 2002, FISHERIES SCI, V68, P634, DOI 10.1046/j.1444-2906.2002.00471.x; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003	65	141	146	9	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20096	10.1371/journal.pone.0020096	http://dx.doi.org/10.1371/journal.pone.0020096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625593	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200064
J	Meade, J; Nam, KB; Lee, JW; Hatchwell, BJ				Meade, Jessica; Nam, Ki-Baek; Lee, Jin-Won; Hatchwell, Ben J.			An Experimental Test of the Information Model for Negotiation of Biparental Care	PLOS ONE			English	Article							MALE PARENTAL CARE; LONG-TAILED TITS; SEX-DIFFERENCES; REPRODUCTIVE SUCCESS; PARTNER CONTRIBUTION; FICEDULA-HYPOLEUCA; OFFSPRING CARE; HOUSE SPARROWS; BROOD SIZE; TESTOSTERONE	Background: Theoretical modelling of biparental care suggests that it can be a stable strategy if parents partially compensate for changes in behaviour by their partners. In empirical studies, however, parents occasionally match rather than compensate for the actions of their partners. The recently proposed "information model'' adds to the earlier theory by factoring in information on brood value and/or need into parental decision-making. This leads to a variety of predicted parental responses following a change in partner work-rate depending on the information available to parents. Methodology/Principal Findings: We experimentally test predictions of the information model using a population of long-tailed tits. We show that parental information on brood need varies systematically through the nestling period and use this variation to predict parental responses to an experimental increase in partner work-rate via playback of extra chick begging calls. When parental information is relatively high, partial compensation is predicted, whereas when parental information is low, a matching response is predicted. Conclusions/Significance: We find that although some responses are consistent with predictions, parents match a change in their partner's work-rate more often than expected and we discuss possible explanations for our findings.	[Meade, Jessica; Nam, Ki-Baek; Hatchwell, Ben J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Lee, Jin-Won] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	University of Sheffield; Seoul National University (SNU)	Meade, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	J.Meade@sheffield.ac.uk	Hatchwell, Ben J/C-5433-2016; Meade, Jessica/A-6411-2013; Meade, Jessica/O-7771-2019	Hatchwell, Ben J/0000-0002-1039-4782; Lee, Jinwon/0000-0003-4153-0609	Natural Environment Research Council; Nuffield Foundation; Association for the Study of Animal Behaviour; University of Sheffield; NERC [NE/E006655/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006655/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nuffield Foundation; Association for the Study of Animal Behaviour; University of Sheffield; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the Natural Environment Research Council, Nuffield Foundation, Association for the Study of Animal Behaviour, and the University of Sheffield, to whom the authors are most grateful. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CHASE I, 1980, AM NAT, V115, P27; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hatchwell BJ, 2006, ADV STUD BEHAV, V36, P355, DOI 10.1016/S0065-3454(06)36008-1; Hatchwell BJ, 1999, AUK, V116, P355, DOI 10.2307/4089370; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Houston A.I., 1985, P471; Hunt KE, 1999, BEHAV ECOL SOCIOBIOL, V45, P360, DOI 10.1007/s002650050572; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Lee JW, 2010, J ORNITHOL, V151, P483, DOI 10.1007/s10336-009-0484-1; Lessells CM, 1999, MG BEH ECOL, P75; Lifjeld JT, 1990, BEHAV ECOL, V1, P48, DOI 10.1093/beheco/1.1.48; Lozano GA, 1996, ANIM BEHAV, V51, P265, DOI 10.1006/anbe.1996.0027; MacColl ADC, 2003, ANIM BEHAV, V66, P955, DOI 10.1006/anbe.2003.2268; MacGregor NA, 2002, ANIM BEHAV, V63, P923, DOI 10.1006/anbe.2001.1991; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; McDonald PG, 2009, ANIM BEHAV, V77, P369, DOI 10.1016/j.anbehav.2008.10.009; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; McNamara JM, 2003, BEHAV ECOL, V14, P301, DOI 10.1093/beheco/14.3.301; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Moreno J, 1999, BEHAV ECOL SOCIOBIOL, V46, P244, DOI 10.1007/s002650050616; Raihani NJ, 2010, J ANIM ECOL, V79, P44, DOI 10.1111/j.1365-2656.2009.01606.x; SAINO N, 1995, BEHAV ECOL SOCIOBIOL, V36, P151, DOI 10.1007/s002650050135; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Schwagmeyer PL, 2002, BEHAV ECOL, V13, P713, DOI 10.1093/beheco/13.5.713; Shen SF, 2010, BIOL LETTERS, V6, P318, DOI 10.1098/rsbl.2009.0909; SLAGSVOLD T, 1990, ECOLOGY, V71, P1258, DOI 10.2307/1938263; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Stoehr AM, 2000, BEHAV ECOL SOCIOBIOL, V48, P407, DOI 10.1007/s002650000247; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WHITTINGHAM LA, 1994, ETHOLOGY, V96, P260; WOLF L, 1990, ANIM BEHAV, V39, P125, DOI 10.1016/S0003-3472(05)80732-8; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; Wright J, 1999, ANIM BEHAV, V58, P345, DOI 10.1006/anbe.1999.1152; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	43	27	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19684	10.1371/journal.pone.0019684	http://dx.doi.org/10.1371/journal.pone.0019684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611180	gold, Green Published, Green Accepted			2022-12-27	WOS:000290657500012
J	Wilcox, JT; Lai, JKY; Semple, E; Brisson, BA; Gartley, C; Armstrong, JN; Betts, DH				Wilcox, Jared T.; Lai, Jonathan K. Y.; Semple, Esther; Brisson, Brigitte A.; Gartley, Cathy; Armstrong, John N.; Betts, Dean H.			Synaptically-Competent Neurons Derived from Canine Embryonic Stem Cells by Lineage Selection with EGF and Noggin	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TIME RT-PCR; IN-VITRO; NEURAL DIFFERENTIATION; CLINICAL-TRIALS; TRANSPLANTATION; MODEL; DOGS; METHYLPREDNISOLONE; OLIGODENDROCYTES	Pluripotent stem cell lines have been generated in several domestic animal species; however, these lines traditionally show poor self-renewal and differentiation. Using canine embryonic stem cell (cESC) lines previously shown to have sufficient self-renewal capacity and potency, we generated and compared canine neural stem cell (cNSC) lines derived by lineage selection with epidermal growth factor (EGF) or Noggin along the neural default differentiation pathway, or by directed differentiation with retinoic acid (RA)-induced floating sphere assay. Lineage selection produced large populations of SOX2+ neural stem/progenitor cell populations and neuronal derivatives while directed differentiation produced few and improper neuronal derivatives. Primary canine neural lines were generated from fetal tissue and used as a positive control for differentiation and electrophysiology. Differentiation of EGF- and Noggin-directed cNSC lines in N2B27 with low-dose growth factors (BDNF/NT-3 or PDGF alpha alpha) produced phenotypes equivalent to primary canine neural cells including 3CB2+ radial progenitors, MOSP+ glia restricted precursors, VIM+/GFAP+ astrocytes, and TUBB3+/MAP2+/NFH+/SYN+ neurons. Conversely, induction with RA and neuronal differentiation produced inadequate putative neurons for further study, even though appropriate neuronal gene expression profiles were observed by RT-PCR (including Nestin, TUBB3, PSD95, STX1A, SYNPR, MAP2). Co-culture of cESC-derived neurons with primary canine fetal cells on canine astrocytes was used to test functional maturity of putative neurons. Canine ESC-derived neurons received functional GABA(A)- and AMPA-receptor mediated synaptic input, but only when co-cultured with primary neurons. This study presents established neural stem/progenitor cell populations and functional neural derivatives in the dog, providing the proof-of-concept required to translate stem cell transplantation strategies into a clinically relevant animal model.	[Wilcox, Jared T.; Lai, Jonathan K. Y.; Semple, Esther; Armstrong, John N.; Betts, Dean H.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Wilcox, Jared T.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Brisson, Brigitte A.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Gartley, Cathy] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Toronto; University of Guelph; University of Guelph	Wilcox, JT (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	jared.wilcox@utoronto.ca; dean.betts@schulich.uwo.ca	Wilcox, Jared/GLQ-9128-2022; Wilcox, Jared/AAK-6998-2020; Betts, Dean H/B-7414-2015	Wilcox, Jared/0000-0001-5484-7571; Betts, Dean H/0000-0002-5528-9142; Lai, Jonathan/0000-0002-3060-1232	Ontario Veterinary College Pet Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada	Ontario Veterinary College Pet Trust; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Ontario Veterinary College Pet Trust Fund and the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Brisson BA, 2010, VET CLIN N AM-SMALL, V40, P829, DOI 10.1016/j.cvsm.2010.06.001; Bruce CW, 2008, VET COMP ORTHOPAED, V21, P280; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2010, NAT REV NEUROSCI, P1; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Fiester A, 2004, CLONING STEM CELLS, V6, P3, DOI 10.1089/15362300460743772; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626; Lim JH, 2007, J VET SCI, V8, P275, DOI 10.4142/jvs.2007.8.3.275; Liour SS, 2006, GLIA, V53, P43, DOI 10.1002/glia.20257; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marler JR, 2007, STROKE, V38, P3302, DOI 10.1161/STROKEAHA.107.485144; Miller G, 2010, SCIENCE, V327, P1309, DOI 10.1126/science.327.5971.1309; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabinowitz RS, 2008, SPINE, V33, P2260, DOI 10.1097/BRS.0b013e31818786db; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Roybon L, 2006, STEM CELLS, V24, P1594, DOI 10.1634/stemcells.2005-0548; Samson K, 2010, ANN NEUROL, V68, pA11, DOI 10.1002/ana.22249; Schneider MR, 2007, STEM CELLS, V25, P1850, DOI 10.1634/stemcells.2006-0357; Schneider MR, 2009, THERIOGENOLOGY, P1; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Smith PM, 2002, EXP NEUROL, V176, P402, DOI 10.1006/exnr.2002.7936; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Techangamsuwan S, 2008, BRAIN RES, V1240, P31, DOI 10.1016/j.brainres.2008.08.092; Tecirlioglu RT, 2007, REPROD FERT DEVELOP, V19, P740, DOI 10.1071/RD07039; Tetzlaff W, 2010, J NEUROTRAUMA; Vaags AK, 2009, STEM CELLS, V27, P329, DOI 10.1634/stemcells.2008-0433; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Weiss S, 1996, J NEUROSCI, V16, P7599; WEWETZER K, 2010, EXP NEUROL; Wilcox JT, 2009, STEM CELLS DEV, V18, P1167, DOI 10.1089/scd.2008.0336; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	61	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19768	10.1371/journal.pone.0019768	http://dx.doi.org/10.1371/journal.pone.0019768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611190	Green Published, gold, Green Submitted			2022-12-27	WOS:000290657500019
J	Fortuna, K; van IJzendoorn, MH; Mankuta, D; Kaitz, M; Avinun, R; Ebstein, RP; Knafo, A				Fortuna, Keren; van IJzendoorn, Marinus H.; Mankuta, David; Kaitz, Marsha; Avinun, Reut; Ebstein, Richard P.; Knafo, Ariel			Differential Genetic Susceptibility to Child Risk at Birth in Predicting Observed Maternal Behavior	PLOS ONE			English	Article							PRETERM INFANTS; PARENTING STRESS; ENVIRONMENTAL-INFLUENCES; EXTERNALIZING BEHAVIOR; WEIGHT INFANT; MOTHER-CHILD; LIFE STRESS; POLYMORPHISM; TERM; DRD4	This study examined parenting as a function of child medical risks at birth and parental genotype (dopamine D4 receptor; DRD4). Our hypothesis was that the relation between child risks and later maternal sensitivity would depend on the presence/absence of a genetic variant in the mothers, thus revealing a gene by environment interaction (GXE). Risk at birth was defined by combining risk indices of children's gestational age at birth, birth weight, and admission to the neonatal intensive care unit. The DRD4-III 7-repeat allele was chosen as a relevant genotype as it was recently shown to moderate the effect of environmental stress on parental sensitivity. Mothers of 104 twin pairs provided DNA samples and were observed with their children in a laboratory play session when the children were 3.5 years old. Results indicate that higher levels of risk at birth were associated with less sensitive parenting only among mothers carrying the 7-repeat allele, but not among mothers carrying shorter alleles. Moreover, mothers who are carriers of the 7-repeat allele and whose children scored low on the risk index were observed to have the highest levels of sensitivity. These findings provide evidence for the interactive effects of genes and environment (in this study, children born at higher risk) on parenting, and are consistent with a genetic differential susceptibility model of parenting by demonstrating that some parents are inherently more susceptible to environmental influences, both good and bad, than are others.	[Fortuna, Keren; Kaitz, Marsha; Ebstein, Richard P.; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [van IJzendoorn, Marinus H.] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands; [Mankuta, David] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Avinun, Reut] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	Hebrew University of Jerusalem; Leiden University; Leiden University - Excl LUMC; Hebrew University of Jerusalem; Hebrew University of Jerusalem; National University of Singapore	Fortuna, K (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	keren.fortuna@mail.huji.ac.il	van IJzendoorn, Marinus/P-4907-2019; Knafo-Noam, Ariel/E-8067-2011	van IJzendoorn, Marinus/0000-0003-1144-454X; Knafo-Noam, Ariel/0000-0003-0613-1960; Avinun, Reut/0000-0002-3281-1268; Ebstein, Richard/0000-0002-3626-541X	Israel Science Foundation [31/06]; Science of Generosity Initiative; Center for the Study of Religion and Society; University of Notre Dame; European Research Council [240994]; Israel Ministry of Immigrant Absorption; Center for Absorption in Science	Israel Science Foundation(Israel Science Foundation); Science of Generosity Initiative; Center for the Study of Religion and Society; University of Notre Dame; European Research Council(European Research Council (ERC)European Commission); Israel Ministry of Immigrant Absorption; Center for Absorption in Science	This study was supported in part by grant No. 31/06 from the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (AK). Preparation of this manuscript was supported by a grant from The Science of Generosity Initiative, Center for the Study of Religion and Society, University of Notre Dame (AK) and by a European Research Council Grant (Starting Grant no. 240994) to the last author (AK). KF is the recipient of a post-doctoral fellowship awarded by the Israel Ministry of Immigrant Absorption, The Center for Absorption in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDIN RR, 1990, J CLIN CHILD PSYCHOL, V19, P298, DOI 10.1207/s15374424jccp1904_1; Ainsworth M., 1978, PATTERNS ATTACHMENT; Allhusen V, 2004, DEV PSYCHOPATHOL, V16, P43, DOI 10.1017/S0954579404040404; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; BARNARD KE, 1984, INFANT BEHAV DEV, V7, P101, DOI 10.1016/S0163-6383(84)80026-0; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Belsky J., 2005, ORIGINS SOCIAL MIND, P139; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Belsky J, 2009, PERSPECT PSYCHOL SCI, V4, P345, DOI 10.1111/j.1745-6924.2009.01136.x; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cassidy J., 1999, HDB ATTACHMENT THEOR; Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381; Darlow BA, 2009, J PAEDIATR CHILD H, V45, P181, DOI 10.1111/j.1440-1754.2009.01486.x; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Feeley N, 2005, J DEV BEHAV PEDIATR, V26, P24; Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223; Feldman R, 2004, CHILD DEV, V75, P1774, DOI 10.1111/j.1467-8624.2004.00816.x; Halpern LF, 2001, J PEDIATR PSYCHOL, V26, P93, DOI 10.1093/jpepsy/26.2.93; HARRISON MJ, 1990, RES NURS HEALTH, V13, P173, DOI 10.1002/nur.4770130306; Harrison MJ, 1996, RES NURS HEALTH, V19, P451, DOI 10.1002/(SICI)1098-240X(199612)19:6<451::AID-NUR1>3.0.CO;2-N; Hughes JR, 2004, CHILD ABUSE NEGLECT, V28, P1081, DOI 10.1016/j.chiabu.2004.02.004; Kaitz M, 2010, DEV PSYCHOBIOL, V52, P149, DOI 10.1002/dev.20423; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kochanska G, 1997, CHILD DEV, V68, P94, DOI 10.2307/1131928; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.2307/1131254; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Neiderhiser JM, 2004, DEV PSYCHOL, V40, P335, DOI 10.1037/0012-1649.40.3.335; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297; Rutter M., 2006, GENES BEHAV; Sameroff AJ, 1983, HDB CHILD PSYCHOL FO, P237; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Singer LT, 2007, J PEDIATR-US, V151, P463, DOI 10.1016/j.jpeds.2007.04.012; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; van Ijzendoorn MH, 2008, GENES BRAIN BEHAV, V7, P403, DOI 10.1111/j.1601-183X.2007.00362.x; Van Ijzendoorn MH, 2006, ATTACH HUM DEV, V8, P291, DOI 10.1080/14616730601048159; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; VOLLING BL, 1992, CHILD DEV, V63, P1209, DOI 10.2307/1131528; WASHINGTON J, 1986, J AM ACAD CHILD PSY, V25, P493, DOI 10.1016/S0002-7138(10)60008-8; Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I; Zuckerman M., 1999, VULNERABILITY PSYCHO	60	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19765	10.1371/journal.pone.0019765	http://dx.doi.org/10.1371/journal.pone.0019765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603618	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300024
J	Hung, TT; Chan, J; Russell, PJ; Power, CA				Hung, Tzong-Tyng; Chan, Jeffrey; Russell, Pamela J.; Power, Carl A.			Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model	PLOS ONE			English	Article							BREAST-CANCER; MULTIPLE-MYELOMA; OSTEOLYTIC METASTASES; CLINICAL-EVALUATION; IN-VIVO; IBANDRONATE; PROGRESSION; MARKERS; RADIOTHERAPY; TURNOVER	Background: The bisphosphonate, zoledronic acid (ZOL), can inhibit osteoclasts leading to decreased osteoclastogenesis and osteoclast activity in bone. Here, we used a mixed osteolytic/osteoblastic murine model of bone-metastatic prostate cancer, RM1(BM), to determine how inhibiting osteolysis with ZOL affects the ability of these cells to establish metastases in bone, the integrity of the tumour-bearing bones and the survival of the tumour-bearing mice. Methods: The model involves intracardiac injection for arterial dissemination of the RM1(BM) cells in C57BL/6 mice. ZOL treatment was given via subcutaneous injections on days 0, 4, 8 and 12, at 20 and 100 mu g/kg doses. Bone integrity was assessed by micro-computed tomography and histology with comparison to untreated mice. The osteoclast and osteoblast activity was determined by measuring serum tartrate-resistant acid phosphatase 5b (TRAP 5b) and osteocalcin, respectively. Mice were euthanased according to predetermined criteria and survival was assessed using Kaplan Meier plots. Findings: Micro-CT and histological analysis showed that treatment of mice with ZOL from the day of intracardiac injection of RM1(BM) cells inhibited tumour-induced bone lysis, maintained bone volume and reduced the calcification of tumour-induced endochondral osteoid material. ZOL treatment also led to a decreased serum osteocalcin and TRAP 5b levels. Additionally, treated mice showed increased survival compared to vehicle treated controls. However, ZOL treatment did not inhibit the cells ability to metastasise to bone as the number of bone-metastases was similar in both treated and untreated mice. Conclusions: ZOL treatment provided significant benefits for maintaining the integrity of tumour-bearing bones and increased the survival of tumour bearing mice, though it did not prevent establishment of bone-metastases in this model. From the mechanistic view, these observations confirm that tumour-induced bone lysis is not a requirement for establishment of these bone tumours.	[Hung, Tzong-Tyng; Power, Carl A.] Prince Wales Hosp, Prince Wales Clin Sch, Randwick, NSW 2031, Australia; [Chan, Jeffrey] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Hung, Tzong-Tyng; Chan, Jeffrey; Power, Carl A.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Russell, Pamela J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Princess Alexandra Hosp, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Queensland University of Technology (QUT)	Hung, TT (corresponding author), Prince Wales Hosp, Prince Wales Clin Sch, Randwick, NSW 2031, Australia.	c.power@unsw.edu.au	Russell, Pamela/O-8504-2019; Russell, Pamela J/G-1685-2010	Russell, Pamela J/0000-0002-3995-1239; Hung, Tzong/0000-0002-2904-2664	Novartis Australia; Prostate Cancer Foundation of Australia; Sydney Foundation of Medical Research	Novartis Australia(Novartis); Prostate Cancer Foundation of Australia; Sydney Foundation of Medical Research	The authors wish to declare that this work was funded in part by a research grant from Novartis Australia. Novartis also provided the zoledronic acid for this study. TH was partially supported by the Prostate Cancer Foundation of Australia. CAP was partially funded by the Sydney Foundation of Medical Research and is a fellow of the National Imaging Facility, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brubaker KD, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-15; Clezardin P, 2005, CANCER TREAT REV, V31, pS1, DOI 10.1016/j.ctrv.2005.09.002; Corey E, 2003, CLIN CANCER RES, V9, P295; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Dieli F, 2003, BLOOD, V102, P2310, DOI 10.1182/blood-2003-05-1655; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Generali D, 2008, BRIT J CANCER, V98, P1753, DOI 10.1038/sj.bjc.6604390; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hatoum HT, 2010, CURR MED RES OPIN; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Kouloulias V, 2003, INT J RADIAT ONCOL, V57, P143, DOI 10.1016/S0360-3016(03)00525-X; Lee Y, 2003, J ORTHOP RES, V21, P62, DOI 10.1016/S0736-0266(02)00095-5; Lein M, 2007, EUR UROL, V52, P1381, DOI 10.1016/j.eururo.2007.02.033; Liao JH, 2008, INT J CANCER, V123, P2267, DOI 10.1002/ijc.23602; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Menssen HD, 2002, J CLIN ONCOL, V20, P2353, DOI 10.1200/JCO.2002.02.032; Michigami T, 2002, BREAST CANCER RES TR, V75, P249, DOI 10.1023/A:1019905111666; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Power CA, 2009, PROSTATE; Quinn JE, 2005, PROSTATE CANCER P D, V8, P253, DOI 10.1038/sj.pcan.4500815; RALIS ZA, 1992, BIOTECH HISTOCHEM, V67, P339, DOI 10.3109/10520299209110046; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Rucci N, 2004, BONE, V34, P697, DOI 10.1016/j.bone.2003.07.012; Saad F, 2010, UROLOGY, V76, P1175, DOI 10.1016/j.urology.2010.05.026; Vassiliou V, 2007, CLIN EXP METASTAS, V24, P169, DOI 10.1007/s10585-007-9066-x; Vassiliou V, 2007, INT J RADIAT ONCOL, V67, P264, DOI 10.1016/j.ijrobp.2006.08.022; Wang G, 2009, CANCER RES, V69, P3433, DOI 10.1158/0008-5472.CAN-08-3506	28	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19389	10.1371/journal.pone.0019389	http://dx.doi.org/10.1371/journal.pone.0019389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603655	gold, Green Published, Green Submitted			2022-12-27	WOS:000290656300007
J	Southcombe, J; Tannetta, D; Redman, C; Sargent, I				Southcombe, Jennifer; Tannetta, Dionne; Redman, Christopher; Sargent, Ian			The Immunomodulatory Role of Syncytiotrophoblast Microvesicles	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ALKALINE-PHOSPHATASE; RECEPTOR EXPRESSION; NORMAL-PREGNANCY; HUMAN PLACENTA; PREECLAMPSIA; EXOSOMES; MICROPARTICLES; ANGIOGENESIS; CIRCULATION	Immune adaptation is a critical component of successful pregnancy. Of primary importance is the modification of cytokine production upon immune activation. With the discovery that normal pregnancy itself is a pro-inflammatory state, it was recognised that the classical Th1/Th2 cytokine paradigm, with a shift towards 'type 2' cytokine production (important for antibody production), and away from 'type 1' immunity (associated with cell mediated immunity and graft rejection), is too simplistic. It is now generally agreed that both arms of cytokine immunity are activated, but with a bias towards 'type 2' immunity. Many factors are released from the placenta that can influence the maternal cytokine balance. Here we focus on syncytiotrophoblast microvesicles (STBM) which are shed from the placenta into the maternal circulation. We show that STBM can bind to monocytes and B cells and induce cytokine release (TNF alpha, MIP-1 alpha, IL-1 alpha, IL-1 beta, IL-6, IL-8). Other cytokines are down-modulated, such as IP-10 which is associated with 'type 1' immunity. Therefore STBM may aid the 'type 2' skewed nature of normal pregnancy. We also observed that PBMC from third trimester normal pregnant women produce more TNF alpha and IL-6 in response to STBM than PBMC from non-pregnant women, confirming that maternal immune cells are primed by pregnancy, possibly through their interaction with STBM.	[Southcombe, Jennifer; Tannetta, Dionne; Redman, Christopher; Sargent, Ian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Southcombe, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	jen.southcombe@obs-gyn.ox.ac.uk		Southcombe, Jennifer/0000-0003-0699-650X	Wellcome Trust [GR079862MA]; Department of Health's National Institute for Health Research Biomedical Research Centres	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This study was supported by a grant from the Wellcome Trust (http://www.wellcome.ac.uk), Ref GR079862MA, and by the Oxford Partnership Comprehensive Biomedical Research Centre (http://www.oxfordbrc.org) with funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; ARKWRIGHT PD, 1994, GLYCOBIOLOGY, V4, P39, DOI 10.1093/glycob/4.1.39; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; CHAOUAT G, 1987, J REPROD IMMUNOL, V10, P179, DOI 10.1016/0165-0378(87)90085-4; Chaouat G, 2010, AM J REPROD IMMUNOL, V63, P624, DOI 10.1111/j.1600-0897.2010.00832.x; Christen U, 2004, AUTOIMMUNITY, V37, P273, DOI 10.1080/08916930410001713124; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAVIES JO, 1985, J ROY SOC MED, V78, P899, DOI 10.1177/014107688507801104; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; EATON BM, 1994, BBA-BIOMEMBRANES, V1193, P85, DOI 10.1016/0005-2736(94)90336-0; Gercel-Taylor C, 2002, J REPROD IMMUNOL, V56, P29, DOI 10.1016/S0165-0378(02)00025-6; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Gupta AK, 2005, J REPROD IMMUNOL, V68, P15, DOI 10.1016/j.jri.2005.05.003; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; KRAUS TA, 2010, AM J REPROD IMMUNOL; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Montagnana M, 2008, GYNECOL ENDOCRINOL, V24, P113, DOI 10.1080/09513590801895575; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sacks GP, 2003, CLIN EXP IMMUNOL, V131, P490, DOI 10.1046/j.1365-2249.2003.02082.x; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; SMARASON AK, 1993, BRIT J OBSTET GYNAEC, V100, P943, DOI 10.1111/j.1471-0528.1993.tb15114.x; SMITH NC, 1974, NATURE, V252, P302, DOI 10.1038/252302b0; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wurfel W, 2010, HUM REPROD, V25, P2151, DOI 10.1093/humrep/deq106	40	118	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20245	10.1371/journal.pone.0020245	http://dx.doi.org/10.1371/journal.pone.0020245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633494	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500048
J	Eloe, EA; Fadrosh, DW; Novotny, M; Allen, LZ; Kim, M; Lombardo, MJ; Yee-Greenbaum, J; Yooseph, S; Allen, EE; Lasken, R; Williamson, SJ; Bartlett, DH				Eloe, Emiley A.; Fadrosh, Douglas W.; Novotny, Mark; Allen, Lisa Zeigler; Kim, Maria; Lombardo, Mary-Jane; Yee-Greenbaum, Joyclyn; Yooseph, Shibu; Allen, Eric E.; Lasken, Roger; Williamson, Shannon J.; Bartlett, Douglas H.			Going Deeper: Metagenome of a Hadopelagic Microbial Community	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; NORTH-ATLANTIC; BATHYPELAGIC PLANKTON; FAMILIES DATABASE; SUBTROPICAL GYRE; MARINE-BACTERIA; GENOME SEQUENCE; ORGANIC-MATTER; SARGASSO SEA; LIFE-STYLES	The paucity of sequence data from pelagic deep-ocean microbial assemblages has severely restricted molecular exploration of the largest biome on Earth. In this study, an analysis is presented of a large-scale 454-pyrosequencing metagenomic dataset from a hadopelagic environment from 6,000 m depth within the Puerto Rico Trench (PRT). A total of 145 Mbp of assembled sequence data was generated and compared to two pelagic deep ocean metagenomes and two representative surface seawater datasets from the Sargasso Sea. In a number of instances, all three deep metagenomes displayed similar trends, but were most magnified in the PRT, including enrichment in functions for two-component signal transduction mechanisms and transcriptional regulation. Overrepresented transporters in the PRT metagenome included outer membrane porins, diverse cation transporters, and di- and tri-carboxylate transporters that matched well with the prevailing catabolic processes such as butanoate, glyoxylate and dicarboxylate metabolism. A surprisingly high abundance of sulfatases for the degradation of sulfated polysaccharides were also present in the PRT. The most dramatic adaptational feature of the PRT microbes appears to be heavy metal resistance, as reflected in the large numbers of transporters present for their removal. As a complement to the metagenome approach, single-cell genomic techniques were utilized to generate partial whole-genome sequence data from four uncultivated cells from members of the dominant phyla within the PRT, Alphaproteobacteria, Gammaproteobacteria, Bacteroidetes and Planctomycetes. The single-cell sequence data provided genomic context for many of the highly abundant functional attributes identified from the PRT metagenome, as well as recruiting heavily the PRT metagenomic sequence data compared to 172 available reference marine genomes. Through these multifaceted sequence approaches, new insights have been provided into the unique functional attributes present in microbes residing in a deeper layer of the ocean far removed from the more productive sun-drenched zones above.	[Eloe, Emiley A.; Allen, Eric E.; Bartlett, Douglas H.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Fadrosh, Douglas W.; Novotny, Mark; Allen, Lisa Zeigler; Lombardo, Mary-Jane; Yee-Greenbaum, Joyclyn; Yooseph, Shibu; Lasken, Roger] J Craig Venter Inst, La Jolla, CA USA; [Kim, Maria; Williamson, Shannon J.] J Craig Venter Inst, Rockville, MD USA; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute; J. Craig Venter Institute; University of California System; University of California San Diego	Eloe, EA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu	Eloe-Fadrosh, Emiley/AAP-8019-2021	Yooseph, Shibu/0000-0001-5581-5002	NSF [EF-0801793, EF-0827051]; NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology	NSF(National Science Foundation (NSF)); NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology	This work was supported by NSF grants EF-0801793 and EF-0827051 to D.H.B. and a NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology to E.A.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Bochdansky AB, 2010, P NATL ACAD SCI USA, V107, P8287, DOI 10.1073/pnas.0913744107; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084, DOI 10.4319/lo.1988.33.5.1084; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GEORGE RY, 1979, AMBIO SPECIAL REPORT, V6, P51; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; HEBEL D, 1986, J PLANKTON RES, V8, P819, DOI 10.1093/plankt/8.4.819; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Huang S, 2009, GEOCHIM COSMOCHIM AC, V73, P65, DOI 10.1016/j.gca.2008.08.023; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joyce TM, 1999, DEEP-SEA RES PT II, V46, P245, DOI 10.1016/S0967-0645(98)00102-7; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lauro FM, 2008, EXTREMOPHILES, V12, P15, DOI 10.1007/s00792-006-0059-5; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Martin-Cuadrado AB, 2009, APPL ENVIRON MICROB, V75, P7436, DOI 10.1128/AEM.01283-09; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Moffett JW, 2007, DEEP-SEA RES PT I, V54, P586, DOI 10.1016/j.dsr.2006.12.013; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Oh HM, 2009, J BACTERIOL, V191, P7144, DOI 10.1128/JB.01191-09; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Thrash JC, 2010, J BACTERIOL, V192, P2938, DOI 10.1128/JB.00208-10; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wecker P, 2010, MICROB BIOTECHNOL, V3, P583, DOI 10.1111/j.1751-7915.2010.00183.x; Welch TJ, 1996, J BACTERIOL, V178, P5027, DOI 10.1128/jb.178.16.5027-5031.1996; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woebken D, 2007, ISME J, V1, P419, DOI 10.1038/ismej.2007.63; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; YAYANOS AA, 1982, REV SCI INSTRUM, V53, P704, DOI 10.1063/1.1137011; Yoon JH, 2004, INT J SYST EVOL MICR, V54, P1829, DOI 10.1099/ijs.0.63156-0; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zeng YX, 2009, POLAR BIOL, V32, P1447, DOI 10.1007/s00300-009-0641-2	84	69	70	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20388	10.1371/journal.pone.0020388	http://dx.doi.org/10.1371/journal.pone.0020388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629664	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005800046
J	Hoefling, M; Lima, N; Haenni, D; Seidel, CAM; Schuler, B; Grubmuller, H				Hoefling, Martin; Lima, Nicola; Haenni, Dominik; Seidel, Claus A. M.; Schuler, Benjamin; Grubmueller, Helmut			Structural Heterogeneity and Quantitative FRET Efficiency Distributions of Polyprolines through a Hybrid Atomistic Simulation and Monte Carlo Approach	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE FRET; FLUORESCENCE ANISOTROPY; DYNAMICS SIMULATIONS; ORGANIC-MOLECULES; PROTEIN; CONFORMATIONS; REVEALS; PROLINE; SPECTROSCOPY	Forster Resonance Energy Transfer (FRET) experiments probe molecular distances via distance dependent energy transfer from an excited donor dye to an acceptor dye. Single molecule experiments not only probe average distances, but also distance distributions or even fluctuations, and thus provide a powerful tool to study biomolecular structure and dynamics. However, the measured energy transfer efficiency depends not only on the distance between the dyes, but also on their mutual orientation, which is typically inaccessible to experiments. Thus, assumptions on the orientation distributions and averages are usually made, limiting the accuracy of the distance distributions extracted from FRET experiments. Here, we demonstrate that by combining single molecule FRET experiments with the mutual dye orientation statistics obtained from Molecular Dynamics (MD) simulations, improved estimates of distances and distributions are obtained. From the simulated time-dependent mutual orientations, FRET efficiencies are calculated and the full statistics of individual photon absorption, energy transfer, and photon emission events is obtained from subsequent Monte Carlo (MC) simulations of the FRET kinetics. All recorded emission events are collected to bursts from which efficiency distributions are calculated in close resemblance to the actual FRET experiment, taking shot noise fully into account. Using polyproline chains with attached Alexa 488 and Alexa 594 dyes as a test system, we demonstrate the feasibility of this approach by direct comparison to experimental data. We identified cis-isomers and different static local environments as sources of the experimentally observed heterogeneity. Reconstructions of distance distributions from experimental data at different levels of theory demonstrate how the respective underlying assumptions and approximations affect the obtained accuracy. Our results show that dye fluctuations obtained from MD simulations, combined with MC single photon kinetics, provide a versatile tool to improve the accuracy of distance distributions that can be extracted from measured single molecule FRET efficiencies.	[Hoefling, Martin; Lima, Nicola; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Theoret & Computat Biophys Dept, Gottingen, Germany; [Haenni, Dominik; Schuler, Benjamin] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Seidel, Claus A. M.] Univ Dusseldorf, Inst Mol Phys Chem MPC, Dusseldorf, Germany	Max Planck Society; University of Zurich; Heinrich Heine University Dusseldorf	Hoefling, M (corresponding author), Max Planck Inst Biophys Chem, Theoret & Computat Biophys Dept, Gottingen, Germany.	hgrubmu@gwdg.de	Schuler, Benjamin/E-7342-2011; Hoefling, Martin/A-7495-2011; Seidel, Claus A.M./A-3682-2012	Schuler, Benjamin/0000-0002-5970-4251; Seidel, Claus A.M./0000-0002-5171-149X; Haenni, Dominik/0000-0002-2166-7109	German Israeli Foundation [1000.89.9/2008]; Elite Network of Bavaria; Swiss National Science Foundation; Volkswagen Stiftung	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Elite Network of Bavaria; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Volkswagen Stiftung(Volkswagen)	This work has been supported by the German Israeli Foundation grant (Agreement No. 1000.89.9/2008) (to MH), Elite Network of Bavaria (International Doctorate Program NanoBioTechnology) (to MH), the Swiss National Science Foundation (to BS) and the Volkswagen Stiftung (to HG, CS and BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082; Berglund AJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068101; Best RB, 2007, P NATL ACAD SCI USA, V104, P18964, DOI 10.1073/pnas.0709567104; Braslavsky SE, 2008, PHOTOCH PHOTOBIO SCI, V7, P1444, DOI 10.1039/b810620g; Brune R, 2007, PROC SPIE, V6633, DOI 10.1117/12.727853; Brunger AT, 2011, J STRUCT BIOL, V173, P497, DOI 10.1016/j.jsb.2010.09.004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CARLSON HA, 1993, J COMPUT CHEM, V14, P1240, DOI 10.1002/jcc.540141013; Corry B, 2008, BIOPHYS J, V95, P2711, DOI 10.1529/biophysj.107.126243; Corry B, 2006, BIOPHYS J, V91, P1032, DOI 10.1529/biophysj.106.080713; COWNAN PM, 1955, NATURE, V176, P501; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Fiori N, 2010, BIOPHYS J, V98, P2265, DOI 10.1016/j.bpj.2010.02.008; Dolghih E, 2009, J PHYS CHEM A, V113, P4639, DOI 10.1021/jp811395r; Doose S, 2007, P NATL ACAD SCI USA, V104, P17400, DOI 10.1073/pnas.0705605104; DORMAN DE, 1973, MACROMOLECULES, V6, P80, DOI 10.1021/ma60031a013; Duser MG, 2008, J BIOL CHEM, V283, P33602, DOI 10.1074/jbc.M805170200; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Feoktistov V., 2006, SEARCH SOLUTIONS; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FRISCH MJ, 2004, GAUSSIAN 03 B 04; Gopich I, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1812746; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Gopich IV, 2003, J PHYS CHEM B, V107, P5058, DOI 10.1021/jp027481o; GOPICH IV, 2010, J PHYS CHEM B; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HARRINGTON WF, 1958, BIOCHIM BIOPHYS ACTA, V27, P24, DOI 10.1016/0006-3002(58)90289-0; HENRY ER, 1987, P NATL ACAD SCI USA, V84, P6142, DOI 10.1073/pnas.84.17.6142; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hillger F, 2008, ANGEW CHEM INT EDIT, V47, P6184, DOI 10.1002/anie.200800298; HOFFMANN A, PHYS CHEM C IN PRESS; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Krueger BP, 1998, J PHYS CHEM B, V102, P9603, DOI 10.1021/jp983589l; LAKOWICZ CDG, 2006, REV FLUORESCENCE ANN; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Moradi M, 2009, P NATL ACAD SCI USA, V106, P20746, DOI 10.1073/pnas.0906500106; Neubauer H, 2007, J AM CHEM SOC, V129, P12746, DOI 10.1021/ja0722574; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ranjit S, 2009, J PHYS CHEM B, V113, P7861, DOI 10.1021/jp810842u; RINDERMANN JJ, 2011, J AM CHEM SOC, V13, P1857; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Rusinova E, 2002, ANAL BIOCHEM, V308, P18, DOI 10.1016/S0003-2697(02)00325-1; Saito M, 2008, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2006, P607, DOI 10.1007/978-3-540-74496-2_36; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; Santoso Y, 2010, CHEMPHYSCHEM, V11, P2209, DOI 10.1002/cphc.201000129; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Schroder GF, 2004, COMPUT PHYS COMMUN, V158, P150, DOI 10.1016/j.cpc.2004.02.001; Schroder GF, 2003, J CHEM PHYS, V119, P9920, DOI 10.1063/1.1616511; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Schuetz P, 2010, J PHYS CHEM B, V114, P15227, DOI 10.1021/jp1053698; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schuler Benjamin, 2007, V350, P115; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; SPEELMAN AL, 2011, J PHYS CH A IN PRESS; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Torella JP, 2010, BIOPHYS J, V98, p591A, DOI 10.1016/j.bpj.2009.12.3213; Unruh JR, 2009, J PHYS CHEM B, V113, P14381, DOI 10.1021/jp903302k; Uphoff S, 2010, NAT METHODS, V7, P831, DOI [10.1038/NMETH.1502, 10.1038/nmeth.1502]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Oort B, 2009, CHEM PHYS, V357, P113, DOI 10.1016/j.chemphys.2008.10.052; VanBeek DB, 2007, BIOPHYS J, V92, P4168, DOI 10.1529/biophysj.106.092650; VENKATACHALAM CM, 1975, BIOPOLYMERS, V14, P1121, DOI 10.1002/bip.1975.360140602; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759; Wozniak AK, 2005, RNA, V11, P1545, DOI 10.1261/rna.2950605; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; Yefimova S, 2008, J APPL SPECTROSC+, V75, P658, DOI 10.1007/s10812-008-9108-4; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	88	88	88	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19791	10.1371/journal.pone.0019791	http://dx.doi.org/10.1371/journal.pone.0019791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629703	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800009
J	Margalida, A; Colomer, MA; Sanuy, D				Margalida, Antoni; Angels Colomer, Ma; Sanuy, Delfi			Can Wild Ungulate Carcasses Provide Enough Biomass to Maintain Avian Scavenger Populations? An Empirical Assessment Using a Bio-Inspired Computational Model	PLOS ONE			English	Article							VULTURE AEGYPIUS-MONACHUS; GYPAETUS-BARBATUS; BEARDED VULTURE; FOOD PREFERENCES; DIET; DICLOFENAC; SYSTEM; LEAD; CONSERVATION; ECOSYSTEMS	Background: The reduction in the amount of food available for European avian scavengers as a consequence of restrictive public health policies is a concern for managers and conservationists. Since 2002, the application of several sanitary regulations has limited the availability of feeding resources provided by domestic carcasses, but theoretical studies assessing whether the availability of food resources provided by wild ungulates are enough to cover energetic requirements are lacking. Methodology/Findings: We assessed food provided by a wild ungulate population in two areas of NE Spain inhabited by three vulture species and developed a P System computational model to assess the effects of the carrion resources provided on their population dynamics. We compared the real population trend with to a hypothetical scenario in which only food provided by wild ungulates was available. Simulation testing of the model suggests that wild ungulates constitute an important food resource in the Pyrenees and the vulture population inhabiting this area could grow if only the food provided by wild ungulates would be available. On the contrary, in the Pre-Pyrenees there is insufficient food to cover the energy requirements of avian scavenger guilds, declining sharply if biomass from domestic animals would not be available. Conclusions/Significance: Our results suggest that public health legislation can modify scavenger population trends if a large number of domestic ungulate carcasses disappear from the mountains. In this case, food provided by wild ungulates could be not enough and supplementary feeding could be necessary if other alternative food resources are not available (i.e. the reintroduction of wild ungulates), preferably in European Mediterranean scenarios sharing similar and socioeconomic conditions where there are low densities of wild ungulates. Managers should anticipate the conservation actions required by assessing food availability and the possible scenarios in order to make the most suitable decisions.	[Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Angels Colomer, Ma] Univ Lleida, Dept Math, Lleida, Spain; [Sanuy, Delfi] Univ Lleida, Dept Anim Prod, Lleida, Spain	Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Universitat de Lleida; Universitat de Lleida	Margalida, A (corresponding author), Bearded Vulture Study & Protect Grp, El Pont De Suert Lleida, Spain.	margalida@inf.entorno.es	sanuy, delfi/ABC-4266-2020; castells, delfi sanuy/B-8414-2011; Margalida, Antoni/AAG-5337-2020; Cugat, Maria Angeles Colomer/O-2909-2015; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011	castells, delfi sanuy/0000-0002-2533-7588; Cugat, Maria Angeles Colomer/0000-0003-4469-9178; Margalida, Antoni/0000-0002-0576-3993; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya; Ministerio de Medio Ambiente	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Medio Ambiente(Spanish Government)	AM was supported by the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; Arlettaz R, 1996, NOS OISEAUX, V43, P369; Blanco G, 2009, ANIM CONSERV, V12, P571, DOI 10.1111/j.1469-1795.2009.00283.x; Blazquez M., 2009, MUNIBE S, P308; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Cardona M, 2010, LECT NOTES COMPUT SC, V5957, P182, DOI 10.1007/978-3-642-11467-0_14; Cardona M, 2009, LECT NOTES COMPUT SC, V5391, P137; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar J.A., 2009, MUNIBE S, V29; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; FERRER C, 2008, PASTOS PIRINEO, P37; Fillat F, 2006, PASTOS, V33, P171; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; GARCIA D, 2009, MUNIBE CIENCIAS NA S, V29, P116; Garcia-Gonzalez R, 2002, P 42 M SPAN SOC STUD, P245; Garcia-Martinez A, 2009, ANIMAL, V3, P152, DOI 10.1017/S1751731108003297; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2006, J APPL ECOL, V43, P949, DOI 10.1111/j.1365-2664.2006.01225.x; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Hernandez M, 2008, ECOTOXICOLOGY, V17, P264, DOI 10.1007/s10646-008-0193-1; Hernandez M, 2009, ENVIRON RES, V109, P837, DOI 10.1016/j.envres.2009.05.001; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Kleijnen JPC, 1998, HANDBOOK OF SIMULATION, P173, DOI 10.1002/9780470172445.ch6; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Lemus JA, 2009, P ROY SOC B-BIOL SCI, V276, P2307, DOI 10.1098/rspb.2009.0071; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Margalida A, 2007, J WILDLIFE MANAGE, V71, P1621, DOI 10.2193/2006-049; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Margalida A, 2009, IBIS, V151, P235; Mateo-Tomas P, 2010, EUR J WILDLIFE RES, V56, P519, DOI 10.1007/s10344-009-0341-9; Moreno-Opo R, 2010, WILDLIFE BIOL, V16, P25, DOI 10.2981/09-037; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Pun G., 2010, OXFORD HDB MEMBRANE; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Romero-Campero FJ, 2008, ARTIF LIFE, V14, P95, DOI 10.1162/artl.2008.14.1.95; Ruiz-Olmo J., 1995, ELS GRANS MAMIFERS C; Sanchez-Zapata JA, 2010, BIRD STUDY, V57, P352, DOI 10.1080/00063651003674946; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; Telleria JL, 2009, BIRD STUDY, V57, P352; THIBAULT JC, 1993, IBIS, V135, P42, DOI 10.1111/j.1474-919X.1993.tb02808.x; Thiollay JM, 2007, ORYX, V41, P322, DOI 10.1017/S0030605307000809; Xirouchakis Stavros, 2001, Ardeola, V48, P183	53	67	69	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20248	10.1371/journal.pone.0020248	http://dx.doi.org/10.1371/journal.pone.0020248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629647	Green Published, gold			2022-12-27	WOS:000291005800036
J	Tuya, F; Vanderklift, MA; Wernberg, T; Thomsen, MS				Tuya, Fernando; Vanderklift, Mathew A.; Wernberg, Thomas; Thomsen, Mads S.			Gradients in the Number of Species at Reef-Seagrass Ecotones Explained by Gradients in Abundance	PLOS ONE			English	Article							EDGE; PATTERNS; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; MACROALGAE; GASTROPODS; DISPERSAL; LANDSCAPE; SPILLOVER	Gradients in the composition and diversity (e. g. number of species) of faunal assemblages are common at ecotones between juxtaposed habitats. Patterns in the number of species, however, can be confounded by patterns in abundance of individuals, because more species tend to be found wherever there are more individuals. We tested whether proximity to reefs influenced patterns in the composition and diversity ('species density' = number of species per area and 'species richness' = number of species per number of individuals) of prosobranch gastropods in meadows of two seagrasses with different physiognomy: Posidonia and Amphibolis. A change in the species composition was observed from reef-seagrass edges towards the interiors of Amphibolis, but not in Posidonia meadows. Similarly, the abundance of gastropods and species density was higher at edges relative to interiors of Amphibolis meadows, but not in Posidonia meadows. However, species richness was not affected by proximity to reefs in either type of seagrass meadow. The higher number of species at the reef-Amphibolis edge was therefore a consequence of higher abundance, rather than species richness per se. These results suggest that patterns in the composition and diversity of fauna with proximity to adjacent habitats, and the underlying processes that they reflect, likely depend on the physiognomy of the habitat.	[Tuya, Fernando] Univ Las Palmas Gran Canaria, Marine Sci Fac, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Canary Islands, Spain; [Tuya, Fernando] Edith Cowan Univ, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Vanderklift, Mathew A.] CSIRO Marine & Atmospher Res, Wembley, WA, Australia; [Wernberg, Thomas; Thomsen, Mads S.] Univ Western Australia, Oceans Inst, Sch Plant Biol, Crawley, WA, Australia; [Wernberg, Thomas] Australian Inst Marine Sci, Crawley, WA, Australia	Universidad de Las Palmas de Gran Canaria; Edith Cowan University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Australian Institute of Marine Science	Tuya, F (corresponding author), Univ Las Palmas Gran Canaria, Marine Sci Fac, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Canary Islands, Spain.	f.tuya@ecu.edu.au	Wernberg, Thomas/B-4172-2010; Thomsen, Mads/B-1204-2011; Vanderklift, Mathew A/B-1003-2008	Wernberg, Thomas/0000-0003-1185-9745; Vanderklift, Mathew A/0000-0002-5170-7546	Spanish MCINN; Ramon y Cajal; ECU; Strategic Research Funds for the Marine Environment	Spanish MCINN(Spanish Government); Ramon y Cajal(Spanish Government); ECU; Strategic Research Funds for the Marine Environment	FT was supported by a postdoctoral research fellowship within the Spanish MCINN framework "Plan de Formacion y Perfeccionamiento" and the "Ramon y Cajal" program during writing. This work was funded by an ECU "Faculty Small Grant" and the Strategic Research Funds for the Marine Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Baker J, 2002, ECOLOGY, V83, P3048, DOI 10.1890/0012-9658(2002)083[3048:TEEAES]2.0.CO;2; Barros F, 2001, ESTUAR COAST SHELF S, V52, P191, DOI 10.1006/ecss.2000.0734; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 2000, ESTIMATES STAT ESTIM; Dangerfield JM, 2003, AUSTRAL ECOL, V28, P227, DOI 10.1046/j.1442-9993.2003.01240.x; Denys C, 2002, OECOLOGIA, V130, P315, DOI 10.1007/s004420100796; Doropoulos C, 2009, ESTUAR COAST SHELF S, V83, P13, DOI 10.1016/j.ecss.2009.03.011; Dutoit T, 2007, ACTA OECOL, V31, P127, DOI 10.1016/j.actao.2006.03.010; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P215, DOI 10.1016/0022-0981(90)90186-G; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jernakoff P, 1998, AQUAT BOT, V60, P359, DOI 10.1016/S0304-3770(97)00100-9; Jorgensen NM, 2003, HYDROBIOLOGIA, V503, P69, DOI 10.1023/B:HYDR.0000008491.89382.e5; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Lavery PS, 2002, MAR ECOL PROG SER, V236, P99, DOI 10.3354/meps236099; Magura T, 2002, FOREST ECOL MANAG, V157, P23, DOI 10.1016/S0378-1127(00)00654-X; Miller LP, 2007, J MAR BIOL ASSOC UK, V87, P735, DOI 10.1017/S0025315407055221; ODUM E P, 1971, P574; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; SERGEEV V N, 1988, Transactions of the Royal Society of South Australia, V112, P97; Talley DM., 2006, CONNECTIVITY CONSERV, P97, DOI DOI 10.1017/CBO9780511754821.006; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Tuya F, 2008, ESTUAR COAST SHELF S, V78, P774, DOI 10.1016/j.ecss.2008.02.017; Tuya F, 2010, MAR ECOL PROG SER, V405, P175, DOI 10.3354/meps08516; Tuya F, 2009, J MOLLUS STUD, V75, P27, DOI 10.1093/mollus/eyn032; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Valentine JF, 2008, ECOL APPL, V18, P1501, DOI 10.1890/07-1720.1; Van Elven BR, 2004, MAR ECOL PROG SER, V276, P71, DOI 10.3354/meps276071; Vanderklift MA, 2007, MAR ECOL PROG SER, V340, P235, DOI 10.3354/meps340235; Walker S, 2003, J VEG SCI, V14, P579, DOI 10.1111/j.1654-1103.2003.tb02185.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2006, OECOLOGIA, V147, P692, DOI 10.1007/s00442-005-0318-7; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20190	10.1371/journal.pone.0020190	http://dx.doi.org/10.1371/journal.pone.0020190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629654	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800032
J	Khoo, MLM; Tao, H; Meedeniya, ACB; Mackay-Sim, A; Ma, DDF				Khoo, Melissa L. M.; Tao, Helen; Meedeniya, Adrian C. B.; Mackay-Sim, Alan; Ma, David D. F.			Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian Rodents	PLOS ONE			English	Article							OLFACTORY ENSHEATHING CELLS; CENTRAL-NERVOUS-SYSTEM; STROMAL CELLS; PARKINSONS-DISEASE; RAT MODEL; IN-VITRO; DOPAMINERGIC-NEURONS; PROGENITOR CELLS; ADULT-RAT; NEUROECTODERMAL DIFFERENTIATION	Bone marrow-derived human mesenchymal stem cells (hMSCs) have shown promise in in vitro neuronal differentiation and in cellular therapy for neurodegenerative disorders, including Parkinson' disease. However, the effects of intracerebral transplantation are not well defined, and studies do not agreed on the optimal neuronal differentiation method. Here, we investigated three growth factor-based neuronal differentiation procedures (using FGF-2/EGF/PDGF/SHH/FGF-8/GDNF), and found all to be capable of eliciting an immature neural phenotype, in terms of cell morphology and gene/protein expression. The neuronal-priming (FGF-2/EGF) method induced neurosphere-like formation and the highest NES and NR4A2 expression by hMSCs. Transplantation of undifferentiated and neuronal-primed hMSCs into the striatum and substantia nigra of 6-OHDA-lesioned hemiparkinsonian rats revealed transient graft survival of 7 days, despite the reported immunosuppressive properties of MSCs and cyclosporine-immunosuppression of rats. Neither differentiation of hMSCs nor induction of host neurogenesis was observed at injection sites, and hMSCs continued producing mesodermal fibronectin. Strategies for improving engraftment and differentiation post-transplantation, such as prior in vitro neuronal-priming, nigral and striatal grafting, and co-transplantation of olfactory ensheathing cells that promote neural regeneration, were unable to provide advantages. Innate inflammatory responses (Iba-1-positive microglia/macrophage and GFAP-positive astrocyte activation and accumulation) were detected around grafts within 7 days. Our findings indicate that growth factor-based methods allow hMSC differentiation toward immature neuronal-like cells, and contrary to previous reports, only transient survival and engraftment of hMSCs occurs following transplantation in immunosuppressed hemiparkinsonian rats. In addition, suppression of host innate inflammatory responses may be a key factor for improving hMSC survival and engraftment.	[Khoo, Melissa L. M.; Tao, Helen; Ma, David D. F.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Khoo, Melissa L. M.; Tao, Helen; Ma, David D. F.] Univ New S Wales, Sydney, NSW, Australia; [Meedeniya, Adrian C. B.; Mackay-Sim, Alan] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Natl Ctr Adult Stem Cell Res, Brisbane, Qld 4111, Australia	University of New South Wales Sydney; Griffith University	Khoo, MLM (corresponding author), St Vincents Ctr Appl Med Res, Sydney, NSW, Australia.	d.ma@amr.org.au	Mackay-Sim, Alan/C-3431-2008	Mackay-Sim, Alan/0000-0003-4446-5371	St Vincent's Clinic Foundation; SVH Haematology Research Fund; New South Wales Ministry for Science and Medical Research; Australian Department of Health and Ageing; Australian Government; UNSW; HCC & Arrow Bone Marrow Transplant Foundation	St Vincent's Clinic Foundation; SVH Haematology Research Fund; New South Wales Ministry for Science and Medical Research; Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Government(Australian GovernmentCGIAR); UNSW; HCC & Arrow Bone Marrow Transplant Foundation	This study was supported by the St Vincent's Clinic Foundation, SVH Haematology Research Fund, the New South Wales Ministry for Science and Medical Research, and a grant to AMS from the Australian Department of Health and Ageing. MLMK is the recipient of the Australian Government Postgraduate Award, and the UNSW, and HCC & Arrow Bone Marrow Transplant Foundation scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2004, NEUROBIOL DIS, V16, P516, DOI 10.1016/j.nbd.2004.04.014; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; Barker RA, 2000, J NEUROSCI, V20, P3415, DOI 10.1523/JNEUROSCI.20-09-03415.2000; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Bertani N, 2005, J CELL SCI, V118, P3925, DOI 10.1242/jcs.02511; Bianco JI, 2004, GLIA, V45, P111, DOI 10.1002/glia.10298; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; BOREL JF, 1977, IMMUNOLOGY, V32, P1017; Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.3.CO;2-P; Bouchez G, 2008, NEUROCHEM INT, V52, P1332, DOI 10.1016/j.neuint.2008.02.003; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dewar D, 2007, ACTA NEUROCHIR, V149, P407, DOI 10.1007/s00701-007-1121-5; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Guo L, 2005, BIOMED ENVIRON SCI, V18, P36; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644; Kan I, 2007, NEUROSCI LETT, V419, P28, DOI 10.1016/j.neulet.2007.03.070; Kan I, 2007, J LIPID RES, V48, P513, DOI 10.1194/jlr.C600022-JLR200; Khoo MLM, 2008, STEM CELLS DEV, V17, P883, DOI 10.1089/scd.2007.0185; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kramer BC, 2006, BIOCHEM BIOPH RES CO, V343, P1045, DOI 10.1016/j.bbrc.2006.02.191; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Larsson LC, 2001, EXP NEUROL, V172, P100, DOI 10.1006/exnr.2001.7738; Larsson LC, 1999, TRANSPLANTATION, V68, P1153, DOI 10.1097/00007890-199910270-00016; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Mackay-Sim Alan, 2005, Keio Journal of Medicine, V54, P8; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Ruitenberg MJ, 2006, J NEUROTRAUM, V23, P468, DOI 10.1089/neu.2006.23.468; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Shetty P, 2009, CELL BIOL INT, V33, P830, DOI 10.1016/j.cellbi.2009.05.002; Shukla S, 2009, J NEUROCHEM, V109, P436, DOI 10.1111/j.1471-4159.2009.05983.x; Singhal S, 2008, STEM CELLS, V26, P1074, DOI 10.1634/stemcells.2007-0898; SMANN P, 2004, CELL TISSUE RES, V318, P149; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; STROMBERG I, 1986, NEUROSCI LETT, V71, P271, DOI 10.1016/0304-3940(86)90632-4; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suon S, 2004, STEM CELLS DEV, V13, P625, DOI 10.1089/scd.2004.13.625; Suon S, 2006, BRAIN RES, V1106, P46, DOI 10.1016/j.brainres.2006.05.109; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Tao H, 2005, DEV GROWTH DIFFER, V47, P423; Teng X, 2008, J NEUROSCI RES, V86, P3140, DOI 10.1002/jnr.21767; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; WALLGREN AC, 1995, TRANSPLANTATION, V60, P594, DOI 10.1097/00007890-199509270-00013; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4	87	67	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19025	10.1371/journal.pone.0019025	http://dx.doi.org/10.1371/journal.pone.0019025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625433	Green Published, gold, Green Submitted			2022-12-27	WOS:000291005200001
J	Breuer, S; Schievink, SI; Schulte, A; Blankenfeldt, W; Fackler, OT; Geyer, M				Breuer, Sebastian; Schievink, Simone I.; Schulte, Antje; Blankenfeldt, Wulf; Fackler, Oliver T.; Geyer, Matthias			Molecular Design, Functional Characterization and Structural Basis of a Protein Inhibitor Against the HIV-1 Pathogenicity Factor Nef	PLOS ONE			English	Article							I DOWN-REGULATION; HIGH-AFFINITY; SH3 DOMAIN; CRYSTAL-STRUCTURE; BINDING SURFACE; SUBUNIT-H; CD4; PEPTIDE; ENTRY; SPECIFICITY	Increased spread of HIV-1 and rapid emergence of drug resistance warrants development of novel antiviral strategies. Nef, a critical viral pathogenicity factor that interacts with host cell factors but lacks enzymatic activity, is not targeted by current antiviral measures. Here we inhibit Nef function by simultaneously blocking several highly conserved protein interaction surfaces. This strategy, referred to as "wrapping Nef'', is based on structure-function analyses that led to the identification of four target sites: (i) SH3 domain interaction, (ii) interference with protein transport processes, (iii) CD4 binding and (iv) targeting to lipid membranes. Screening combinations of Nef-interacting domains, we developed a series of small Nef interacting proteins (NIs) composed of an SH3 domain optimized for binding to Nef, fused to a sequence motif of the CD4 cytoplasmic tail and combined with a prenylation signal for membrane association. NIs bind to Nef in the low nM affinity range, associate with Nef in human cells and specifically interfere with key biological activities of Nef. Structure determination of the Nef-inhibitor complex reveals the molecular basis for binding specificity. These results establish Nef-NI interfaces as promising leads for the development of potent Nef inhibitors.	[Breuer, Sebastian; Schulte, Antje; Blankenfeldt, Wulf] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; [Schievink, Simone I.; Fackler, Oliver T.] Univ Klinikum Heidelberg, Dept Infektiol, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Breuer, S (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	oliver.fackler@med.uni-heidelberg.de; matthias.geyer@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668; Fackler, Oliver Till/0000-0003-2982-4209; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft [GE-976/1, FA-378/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft to MG (GE-976/1) and OTF (FA-378/4). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Geyer M, 2002, MOL BIOL CELL, V13, P2045, DOI 10.1091/mbc.02-02-0026; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hiipakka M, 2001, VIROLOGY, V286, P152, DOI 10.1006/viro.2001.0973; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Homann S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-6; Jere A, 2010, MICROBES INFECT, V12, P65, DOI 10.1016/j.micinf.2009.09.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDIG KP, 1995, J BIOMOL NMR, V6, P255, DOI 10.1007/BF00197807; Olszewski A, 2004, P NATL ACAD SCI USA, V101, P14079, DOI 10.1073/pnas.0406040101; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Szilluweit R, 2009, BIOPHYS J, V96, P3242, DOI 10.1016/j.bpj.2008.12.3947; Vollmuth F, 2010, ANGEW CHEM INT EDIT, V49, P6768, DOI 10.1002/anie.201002724; Yamamoto T, 2009, AIDS, V23, P2265, DOI 10.1097/QAD.0b013e328332817c; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066	62	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20033	10.1371/journal.pone.0020033	http://dx.doi.org/10.1371/journal.pone.0020033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625496	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400034
J	Pressler, H; Sissung, TM; Venzon, D; Price, DK; Figg, WD				Pressler, Heather; Sissung, Tristan M.; Venzon, David; Price, Douglas K.; Figg, William D.			Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; ANDROGEN; CARCINOMA; TRANSPORTERS; PROLIFERATION; POLYMORPHISMS; TESTOSTERONE	The organic anion transporting polypeptide (OATP) family of transporters has been implicated in prostate cancer disease progression probably by transporting hormones or drugs. In this study, we aimed to elucidate the expression, frequency, and relevance of OATPs as a biomarker in hormone-dependent cancers. We completed a study examining SLCO1B3, SLCO1B1 and SLCO2B1 mRNA expression in 381 primary, independent patient samples representing 21 cancers and normal tissues. From a separate cohort, protein expression of OATP1B3 was examined in prostate, colon, and bladder tissue. Based on expression frequency, SLCO2B1 was lower in liver cancer (P = 0.04) which also trended lower with decreasing differentiation (P = 0.004) and lower magnitude in pancreatic cancer (P = 0.05). SLCO2B1 also had a higher frequency in thyroid cancer (67%) than normal (0%) and expression increased with stage (P = 0.04). SLCO1B3 was expressed in 52% of cancerous prostate samples and increased SLCO1B3 expression trended with higher Gleason score (P = 0.03). SLCO1B3 expression was also higher in testicular cancer (P = 0.02). SLCO1B1 expression was lower in liver cancer (P = 0.04) which trended lower with liver cancer grade (P = 0.0004) and higher with colon cancer grade (P = 0.05). Protein expression of OATP1B3 was examined in normal and cancerous prostate, colon, and bladder tissue samples from an independent cohort. The results were similar to the transcription data, but showed distinct localization. OATPs correlate to differentiation in certain hormone-dependent cancers, thus may be useful as biomarkers for assessing clinical treatment and stage of disease.	[Pressler, Heather; Price, Douglas K.; Figg, William D.] NCI, Mol Pharmacol Sect, Bethesda, MD 20892 USA; [Sissung, Tristan M.; Figg, William D.] NCI, Clin Pharmacol Program, Med Oncol Branch, Bethesda, MD 20892 USA; [Venzon, David] NCI, Biostat & Data Management Sect, Bethesda, MD 20892 USA; [Pressler, Heather] Johns Hopkins Univ, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Pressler, H (corresponding author), NCI, Mol Pharmacol Sect, Bethesda, MD 20892 USA.	wdfigg@helix.nih.gov	Figg, William D/M-2411-2016		National Institutes of Health, National Cancer Institute, Bethesda, MD; National Science Foundation; Department of Defense [PC094258]; NATIONAL CANCER INSTITUTE [ZIABC010547, ZIDSC007202, ZIABC010453] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Bethesda, MD www.nih.gov. Stipend support was provided for Ms. Pressler by the National Science Foundation www.nsf.gov and Department of Defense Prostate Cancer Research Training Award #PC094258 www.grants.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baker SD, 2009, CLIN PHARMACOL THER, V85, P155, DOI 10.1038/clpt.2008.95; Blechet C, 2007, VIRCHOWS ARCH, V450, P433, DOI 10.1007/s00428-007-0379-6; Ferlin A, 2010, ENDOCR-RELAT CANCER, V17, P17, DOI 10.1677/ERC-09-0176; FRANKE RM, J CLINONCOL, V28, P4562; Giron RA, 2009, FEBS J, V276, P5598, DOI 10.1111/j.1742-4658.2009.07253.x; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; Ieiri I, 2009, EXPERT OPIN DRUG MET, V5, P703, DOI 10.1517/17425250902976854; Imada S, 1997, EUR UROL, V31, P360; JUSTENHOVEN C, 2010, BREAST CANC RES TREA; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Melvin WS, 1997, SURGERY, V121, P392, DOI 10.1016/S0039-6060(97)90308-1; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Sharifi N, 2008, BJU INT, V102, P617, DOI 10.1111/j.1464-410X.2008.07629.x; Sherman ME, 2007, GYNECOL ONCOL, V107, P431, DOI 10.1016/j.ygyno.2007.07.061; SISSUNG TM, MOL BIOTECHNOL, V44, P152; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Smith NF, 2005, CANCER BIOL THER, V4, P815, DOI 10.4161/cbt.4.8.1867; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; WRIGHT JL, 2011, CANC EPIDEMIOL BIOMA; YANG M, 2010, J CLIN ONCOLOG UNPUB	21	79	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20372	10.1371/journal.pone.0020372	http://dx.doi.org/10.1371/journal.pone.0020372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625523	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200057
J	Roffe, C; Ali, K; Warusevitane, A; Sills, S; Pountain, S; Allen, M; Hodsoll, J; Lally, F; Jones, P; Crome, P				Roffe, Christine; Ali, Khalid; Warusevitane, Anushka; Sills, Sheila; Pountain, Sarah; Allen, Martin; Hodsoll, John; Lally, Frank; Jones, Peter; Crome, Peter			The SOS Pilot Study: A RCT of Routine Oxygen Supplementation Early after Acute Stroke-Effect on Recovery of Neurological Function at One Week	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; CONSUMER INVOLVEMENT; NORMOBARIC HYPEROXIA; CEREBRAL-ISCHEMIA; PULSE OXIMETRY; RAT MODEL; BRAIN; SCALE; SATURATION	Mild hypoxia is common after stroke and associated with poor long-term outcome. Oxygen supplementation could prevent hypoxia and improve recovery. A previous study of routine oxygen supplementation showed no significant benefit at 7 and 12 months. This pilot study reports the effects of routine oxygen supplementation for 72 hours on oxygen saturation and neurological outcomes at 1 week after a stroke. Methods: Patients with a clinical diagnosis of acute stroke were recruited within 24 h of hospital admission between October 2004 and April 2008. Participants were randomized to oxygen via nasal cannulae (72 h) or control (room air, oxygen given only if clinically indicated). Clinical outcomes were assessed by research team members at 1 week. Baseline data for oxygen (n = 148) and control (n = 141) did not differ between groups. Results: The median (interquartile range) National Institutes of Health Stroke Scale (NIHSS) score for the groups at baseline was 6 (7) and 5 (7) respectively. The median Nocturnal Oxygen Saturation during treatment was 1.4% (0.3) higher in the oxygen than in the control group (p < 0.001) during the intervention. At 1 week, the median NIHSS score had reduced by 2 (3) in the oxygen and by 1 (2) in the control group. 31% of participants in the oxygen group and 14% in the control group had an improvement of >= 4 NIHSS points at 1 week doubling the odds of improvement in the oxygen group (OR: 2.9). Conclusion: Our data show that routine oxygen supplementation started within 24 hours of hospital admission with acute stroke led to a small, but statistically significant, improvement in neurological recovery at 1 week. However, the difference in NIHSS improvement may be due to baseline imbalance in stroke severity between the two groups and needs to be confirmed in a larger study and linked to longer-term clinical outcome.	[Roffe, Christine; Warusevitane, Anushka; Sills, Sheila; Pountain, Sarah; Hodsoll, John] N Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England; [Roffe, Christine; Lally, Frank] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Ali, Khalid] Brighton & Sussex Med Sch, Acad Dept Geriatr, Brighton, E Sussex, England; [Allen, Martin] Univ Hosp N Staffordshire, Dept Resp Med, Stoke On Trent, Staffs, England; [Jones, Peter] Keele Univ, Sch Comp & Math, Keele, Staffs, England; [Crome, Peter] Keele Univ, Inst Life Course Studies, Keele, Staffs, England	Keele University; University of Brighton; University of Sussex; Keele University; Keele University; Keele University	Roffe, C (corresponding author), N Staffordshire Combined Healthcare Trust, Stoke Stroke Res Grp, Stoke On Trent, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020; Hodsoll, John/I-3928-2012	Roffe, Christine/0000-0002-5259-6649; Hodsoll, John/0000-0001-7546-9901	British Geriatrics Society; North Staffordshire Medical Institute	British Geriatrics Society; North Staffordshire Medical Institute	We would like to thank the North Staffordshire Medical Institute for funding the purchase of the pulse oximeters, Professor R. Gray and his staff at the Birmingham Clinical Trials Unit (University of Birmingham) for supporting the trial with expert advice and for developing and running the web-based randomization, the British Geriatrics Society for supporting Dr KM Ali with an Specialist Registrar Research Start Up Grant, and staff at the University Hospital of North Staffordshire for ensuring that participants kept the oxygen and pulse oximeters in place. Finally, we would like to thank all of the patients and their families who very kindly consented to take part in this study.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; Ali K, 2005, NEUROCRIT CARE, V3, P24, DOI 10.1385/NCC:3:1:024; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; ASPLUND K, 1985, STROKE, V16, P885; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; Bennett MH, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004954.PUB2; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bruno A, 2006, STROKE, V37, P920, DOI 10.1161/01.STR.0000202679.88377.e4; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; *EUR STROK ORG, EUR STROK ORG GUID M; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kontos HA, 2001, STROKE, V32, P2712, DOI 10.1161/hs1101.098653; Koops L, 2002, BRIT MED J, V325, P415, DOI 10.1136/bmj.325.7361.415; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; LEWIS LD, 1973, ACTA PHYSIOL SCAND, V88, P284, DOI 10.1111/j.1748-1716.1973.tb05455.x; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; NAKAJIMA S, 1983, ARCH NEUROL-CHICAGO, V40, P271, DOI 10.1001/archneur.1983.04050050039004; Nuutinen J, 2006, ACTA NEUROL SCAND, V113, P100, DOI 10.1111/j.1600-0404.2005.00550.x; Rocco A, 2007, STROKE, V38, P1225, DOI 10.1161/01.STR.0000259659.91505.40; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Roffe C, 2001, STROKE, V32, P1808, DOI 10.1161/01.STR.32.8.1808; ROFFE C, 2009, CME J GERIATRIC MED, V11, P3; ROFFE C, STROKE OXYGEN STUDY; Roffe C, 2010, J STROKE CEREBROVASC, V19, P29, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.008; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rowat AM, 2006, CEREBROVASC DIS, V21, P166, DOI 10.1159/000090528; *ROY COLL PHYS, INT STROK WORK PART; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Silva Y, 2005, CEREBROVASC DIS, V19, P23, DOI 10.1159/000081908; SILVA Y, 2001, CEREBROVASC DIS, V11, P70; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Sulter G, 2000, J NEUROL SCI, V179, P65, DOI 10.1016/S0022-510X(00)00378-6; Sulter G, 2003, STROKE, V34, P101, DOI 10.1161/01.STR.0000048148.09143.6C; *THOR, BTS GUID EM OX US AD; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Wijesinghe M, 2009, HEART, V95, P198, DOI 10.1136/hrt.2008.148742; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; YAMAMOTO M, 1980, ARCH NEUROL-CHICAGO, V37, P489, DOI 10.1001/archneur.1980.00500570037005; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	49	42	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19113	10.1371/journal.pone.0019113	http://dx.doi.org/10.1371/journal.pone.0019113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625533	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000290771200004
J	Ye, L; Wen, ZY; Dong, K; Wang, X; Bu, ZG; Zhang, HZ; Compans, RW; Yang, CL				Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Bu, Zhigao; Zhang, Huizhong; Compans, Richard W.; Yang, Chinglai			Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; DEFICIENCY SYNDROME AIDS; CYTOPLASMIC DOMAIN; GP41 EPITOPE; GLYCOPROTEIN GP41; SURFACE-ANTIGEN; INFLUENZA-VIRUS; MEMBRANE; GP120	Several conserved neutralizing epitopes have been identified in the HIV Env protein and among these, the MPER of gp41 has received great attention and is widely recognized as a promising target. However, little success has been achieved in eliciting MPER-specific HIV neutralizing antibodies by a number of different vaccine strategies. We investigated the ability of HA/gp41 chimeric protein-based vaccines, which were designed to enhance the exposure of the MPER in its native conformation, to induce MPER-specific HIV neutralizing antibodies. In characterization of the HA/gp41 chimeric protein, we found that by mutating an unpaired Cys residue (Cys-14) in its HA1 subunit to a Ser residue, the modified chimeric protein HA-C14S/gp41 showed increased reactivity to a conformation-sensitive monoclonal antibody against HA and formed more stable trimers in VLPs. On the other hand, HA-C14S/gp41 and HA/gp41 chimeric proteins expressed on the cell surfaces exhibited similar reactivity to monoclonal antibodies 2F5 and 4E10. Immunization of guinea pigs using the HA-C14S/gp41 DNA or VLP vaccines induced antibodies against the HIV gp41 as well as to a peptide corresponding to a segment of MPER at higher levels than immunization by standard HIV VLPs. Further, sera from vaccinated guinea pigs were found to exhibit HIV neutralizing activities. Moreover, sera from guinea pigs vaccinated by HA-C14S/gp41 DNA and VLP vaccines but not the standard HIV VLPs, were found to neutralize HIV pseudovirions containing a SIV-4E10 chimeric Env protein. The virus neutralization could be blocked by a MPER-specific peptide, thus demonstrating induction of MPER-specific HIV neutralizing antibodies by this novel vaccine strategy. These results show that induction of MPER-specific HIV neutralizing antibodies can be achieved through a rationally designed vaccine strategy.	[Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Compans, Richard W.; Yang, Chinglai] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Compans, Richard W.; Yang, Chinglai] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Wen, Zhiyuan; Bu, Zhigao] Harbin Vet Res Inst, Minist Agr, Key Lab Vet Publ Hlth, Harbin, Peoples R China; [Dong, Ke; Wang, Xi; Zhang, Huizhong] Fourth Mil Med Univ, Tangdu Hosp, Cent Lab, Xian 710032, Peoples R China	Emory University; Emory University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Air Force Military Medical University	Ye, L (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	yling@emory.edu; chyang@emory.edu	Compans, Richard W/I-4087-2013; Yang, Chinglai/D-1409-2014; Wen, Zhiyuan/AAT-1639-2020	Compans, Richard W/0000-0003-2360-335X; Yang, Chinglai/0000-0002-9308-7760; Wen, Zhiyuan/0000-0003-3112-0243	National Institutes of Health [AI077446]; Emory University Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant AI077446 and by funding from the Emory University Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; Bu ZG, 2004, VIROLOGY, V328, P62, DOI 10.1016/j.virol.2004.06.041; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Cohen J, 2003, SCIENCE, V300, P28; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2008, J VIROL, V82, P2367, DOI 10.1128/JVI.02161-07; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Miedema F, 2008, AIDS, V22, P1699, DOI 10.1097/QAD.0b013e3283021a61; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; VanCott TC, 1999, J VIROL, V73, P4640, DOI 10.1128/JVI.73.6.4640-4650.1999; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Vzorov AN, 1996, VIROLOGY, V221, P22, DOI 10.1006/viro.1996.0349; Vzorov AN, 2000, J VIROL, V74, P8219, DOI 10.1128/JVI.74.18.8219-8225.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wen ZY, 2009, ANTIVIR RES, V84, P215, DOI 10.1016/j.antiviral.2009.09.005; WRIN T, 1994, AIDS, V8, P1622, DOI 10.1097/00002030-199411000-00017; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; YAMSHCHIKOV GV, 1995, VIROLOGY, V214, P50, DOI 10.1006/viro.1995.9955; Yao QZ, 2000, AIDS RES HUM RETROV, V16, P227, DOI 10.1089/088922200309322; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; Ye L, 2006, VIROLOGY, V352, P74, DOI 10.1016/j.virol.2006.04.012; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e14813	10.1371/journal.pone.0014813	http://dx.doi.org/10.1371/journal.pone.0014813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625584	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200002
J	Climent, N; Guerra, S; Garcia, F; Rovira, C; Miralles, L; Gomez, CE; Pique, N; Gil, C; Gatell, JM; Esteban, M; Gallart, T				Climent, Nuria; Guerra, Susana; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Elena Gomez, Carmen; Pique, Nuria; Gil, Cristina; Maria Gatell, Jose; Esteban, Mariano; Gallart, Teresa			Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8(+) T Cell Responses in HIV-1-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POXVIRUS VECTORS MVA; TEST-OF-CONCEPT; GENE-EXPRESSION; CANDIDATE VACCINE; IMMUNE-RESPONSES; INTERFERON-ALPHA; DOUBLE-BLIND; ANKARA MVA; INFECTION	Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-alpha, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1 alpha, MIP-1 beta, RANTES, IP-10, MIG, and IFN-alpha). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8(+) T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8(+) T cell response including proliferation, secretion of IFN-gamma, IL-2, TNF-alpha, MIP-1 beta, MIP-1 alpha, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4(+) T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.	[Climent, Nuria; Rovira, Cristina; Miralles, Laia; Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Climent, Nuria; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Gil, Cristina; Maria Gatell, Jose; Gallart, Teresa] IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Climent, Nuria; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Gil, Cristina; Maria Gatell, Jose; Gallart, Teresa] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Guerra, Susana; Elena Gomez, Carmen; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Garcia, Felipe; Gil, Cristina; Maria Gatell, Jose] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain; [Pique, Nuria] Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, E-08007 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Climent, N (corresponding author), Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain.	nucliment@yahoo.es	Gomez, Carmen Elena/K-1940-2014; , Felipe/F-4242-2014; Esteban, Mariano/ABG-5375-2020; guerra, susana/K-5972-2014; Climent, Núria/AAF-8161-2021	Gomez, Carmen Elena/0000-0002-5414-7935; , Felipe/0000-0001-7658-5832; Esteban, Mariano/0000-0003-0846-2827; guerra, susana/0000-0001-9067-2991; Climent, Núria/0000-0002-0791-656X; Miralles, Laia/0000-0002-0754-5607; Gil, Cristina/0000-0002-2692-8814; Pique, Nuria/0000-0002-7308-030X	Spanish Ministry of Health, RIS-Spanish Cooperative Network on AIDS Research [FIS 2006-1259, FIS 200980145, FIS 2009-11078]; Spanish Ministry of Education and Science [BIO2004-03954, SAF2005-05566, SAF2008-02036, SAF2008-04395]; Spanish Foundation for AIDS Research (FIPSE) [36344/02, 36536/05, 36551/06, 36750/08]; Fundacion Botin; EU [QLRT-PL-1999-01321, QLK2-CT-2002-01867]; Spanish Ministry of Health; Abbott Laboratories; Boehringer Ingelheim; Bristol Myers Squibb; GlaxoSmithKline; Merck Sharp; Dohme and Roche;  [MuNanoVac-EU-STREP-037200]	Spanish Ministry of Health, RIS-Spanish Cooperative Network on AIDS Research; Spanish Ministry of Education and Science(Spanish Government); Spanish Foundation for AIDS Research (FIPSE); Fundacion Botin; EU(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Abbott Laboratories(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp; Dohme and Roche; 	This work was supported by grants from the Spanish Ministry of Health (FIS 2006-1259, RIS-Spanish Cooperative Network on AIDS Research, FIS 200980145 and FIS 2009-11078), the Spanish Ministry of Education and Science (BIO2004-03954, SAF2005-05566, SAF2008-02036 and SAF2008-04395), the Spanish Foundation for AIDS Research (FIPSE 36344/02, 36536/05, 36551/06 and 36750/08), Fundacion Botin, the EU (EuroVac QLRT-PL-1999-01321 and QLK2-CT-2002-01867), MuNanoVac-EU-STREP-037200. FIPSE is a non-profit Foundation including: Spanish Ministry of Health, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme and Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2000, AM J RESP CRIT CARE, V162, P1466, DOI 10.1164/ajrccm.162.4.2003130; Aline F, 2007, MICROBES INFECT, V9, P536, DOI 10.1016/j.micinf.2007.01.021; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barat C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-30; Barouch DH, 2001, J VIROL, V75, P5151, DOI 10.1128/JVI.75.11.5151-5158.2001; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brandler S, 2010, J VIROL, V84, P5314, DOI 10.1128/JVI.02329-09; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carreno BM, 2009, IMMUNOL CELL BIOL, V87, P167, DOI 10.1038/icb.2008.80; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Greiner S, 2006, CLIN EXP IMMUNOL, V146, P344, DOI 10.1111/j.1365-2249.2006.03177.x; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Jenne L, 2001, TRENDS IMMUNOL, V22, P102, DOI 10.1016/S1471-4906(00)01813-5; Johnson LA, 2010, CURR NEUROL NEUROSCI, V10, P259, DOI 10.1007/s11910-010-0111-9; Karpov AV, 2001, EUR J MED RES, V6, P507; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Koff WC, 2010, NATURE, V464, P161, DOI 10.1038/464161a; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lapenta C, 2003, J EXP MED, V198, P361, DOI 10.1084/jem.20021924; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Promadej-Lanier N, 2010, JAIDS-J ACQ IMM DEF, V53, P574, DOI 10.1097/QAI.0b013e3181d3521f; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Stylianou E, 2002, CLIN EXP IMMUNOL, V130, P279, DOI 10.1046/j.1365-2249.2002.01980.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Wang Y, 2009, J IMMUNOL, V183, P3324, DOI 10.4049/jimmunol.0803985; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang R, 2010, CYTOKINE, V50, P195, DOI 10.1016/j.cyto.2010.02.017; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	86	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19644	10.1371/journal.pone.0019644	http://dx.doi.org/10.1371/journal.pone.0019644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625608	Green Published, Green Submitted, gold			2022-12-27	WOS:000290720200022
J	Lugade, AA; Bianchi-Smiraglia, A; Pradhan, V; Elkin, G; Murphy, TF; Thanavala, Y				Lugade, Amit A.; Bianchi-Smiraglia, Anna; Pradhan, Vandana; Elkin, Galina; Murphy, Timothy F.; Thanavala, Yasmin			Lipid Motif of a Bacterial Antigen Mediates Immune Responses via TLR2 Signaling	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; TOLL-LIKE RECEPTOR-2; T-CELL; VACCINE CANDIDATE; ANTIBODY-RESPONSE; DENDRITIC CELLS; P6 PROTEIN; B-CELLS; AGONIST; LIPOPEPTIDES	The cross-talk between the innate and the adaptive immune system is facilitated by the initial interaction of antigen with dendritic cells. As DCs express a large array of TLRs, evidence has accumulated that engagement of these molecules contributes to the activation of adaptive immunity. We have evaluated the immunostimulatory role of the highly-conserved outer membrane lipoprotein P6 from non-typeable Haemophilus influenzae (NTHI) to determine whether the presence of the lipid motif plays a critical role on its immunogenicity. We undertook a systematic analysis of the role that the lipid motif plays in the activation of DCs and the subsequent stimulation of antigen-specific T and B cells. To facilitate our studies, recombinant P6 protein that lacked the lipid motif was generated. Mice immunized with non-lipidated rP6 were unable to elicit high titers of anti-P6 Ig. Expression of the lipid motif on P6 was also required for proliferation and cytokine secretion by antigen-specific T cells. Upregulation of T cell costimulatory molecules was abrogated in DCs exposed to non-lipidated rP6 and in TLR2(-/-) DCs exposed to native P6, thereby resulting in diminished adaptive immune responses. Absence of either the lipid motif on the antigen or TLR2 expression resulted in diminished cytokine production from stimulated DCs. Collectively; our data suggest that the lipid motif of the lipoprotein antigen is essential for triggering TLR2 signaling and effective stimulation of APCs. Our studies establish the pivotal role of a bacterial lipid motif on activating both innate and adaptive immune responses to an otherwise poorly immunogenic protein antigen.	[Lugade, Amit A.; Bianchi-Smiraglia, Anna; Pradhan, Vandana; Elkin, Galina; Thanavala, Yasmin] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Bianchi-Smiraglia, Anna] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Murphy, Timothy F.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lugade, AA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	yasmin.thanavala@roswellpark.org		Murphy, Timothy/0000-0002-3496-2641; Bianchi-Smiraglia, Anna/0000-0002-5963-103X	NIAID [AI069379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069379] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI069379 from NIAID to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2002, AM J RESP CRIT CARE, V165, P967, DOI 10.1164/ajrccm.165.7.2109009; Adlowitz DG, 2005, INFECT IMMUN, V73, P6601, DOI 10.1128/IAI.73.10.6601-6607.2005; Badr WH, 1999, VACCINE, V18, P29, DOI 10.1016/S0264-410X(99)00166-8; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bettahi I, 2006, VIRAL IMMUNOL, V19, P220, DOI 10.1089/vim.2006.19.220; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Chandran SS, 2009, J IMMUNOL, V183, P7832, DOI 10.4049/jimmunol.0901683; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Chua Brendon Y., 2008, V494, P247, DOI 10.1007/978-1-59745-419-3_14; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; GREEN BA, 1990, INFECT IMMUN, V58, P3272, DOI 10.1128/IAI.58.10.3272-3278.1990; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Ishida Y, 2006, CLIN IMMUNOL, V121, P90, DOI 10.1016/j.clim.2006.06.005; Iweala OI, 2009, J IMMUNOL, V183, P2252, DOI 10.4049/jimmunol.0804011; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jin HL, 2009, J ALLERGY CLIN IMMUN, V123, P875, DOI 10.1016/j.jaci.2009.02.007; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Lombardi V, 2008, CLIN EXP ALLERGY, V38, P1819, DOI 10.1111/j.1365-2222.2008.03056.x; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; McMahon M, 2005, VACCINE, V23, P3590, DOI 10.1016/j.vaccine.2005.01.151; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mineo TWP, 2010, IMMUNOL CELL BIOL, V88, P825, DOI 10.1038/icb.2010.52; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Neary JM, 2001, INFECT IMMUN, V69, P773, DOI 10.1128/IAI.69.2.773-778.2001; Nomura Y, 2008, J CLIN IMMUNOL, V28, P361, DOI 10.1007/s10875-008-9189-0; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Punturieri A, 2006, J IMMUNOL, V177, P673, DOI 10.4049/jimmunol.177.1.673; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19781	10.1371/journal.pone.0019781	http://dx.doi.org/10.1371/journal.pone.0019781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611194	Green Submitted, gold, Green Published			2022-12-27	WOS:000290657500020
J	Polyzos, NP; Mauri, D; Ioannidis, JPA				Polyzos, Nikolaos P.; Mauri, Davide; Ioannidis, John P. A.			Guidelines on Chemotherapy in Advanced Stage Gynecological Malignancies: An Evaluation of 224 Professional Societies and Organizations	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; METHODOLOGICAL QUALITY; MULTIPLE-TREATMENTS; RANDOMIZED EVIDENCE; CANCER; SURVIVAL; METAANALYSIS; CARE; REGIMENS; THERAPY	Background: Clinical practice guidelines are important for guiding practice, but it is unclear if they are commensurate with available evidence. Methods: We examined guidelines produced by cancer and gynecological societies and organizations and evaluated their coverage of and stance towards chemotherapy for advanced stage disease among 4 gynecological malignancies (breast, ovarian, cervical, endometrial cancer) where the evidence for the use of chemotherapy is very different (substantial and conclusive for breast and ovarian cancer, limited and suggesting no major benefit for cervical and endometrial cancer). Eligible societies and organizations were identified through systematic internet searches (last update June 2009). Pertinent websites were scrutinized for presence of clinical practice guidelines, and relative guidelines were analyzed. Results: Among 224 identified eligible societies and organizations, 69 (31%) provided any sort of guidelines, while recommendations for chemotherapy on advanced stage gynecological malignancies were available in 20 of them. Only 14 had developed their own guideline, and only 5 had developed guidelines for all 4 malignancies. Use of levels of evidence and grades of recommendations, and aspects of the production, implementation, and timeliness of the guidelines did not differ significantly across malignancies. Guidelines on breast and ovarian cancer utilized significantly more randomized trials and meta-analyses. Guidelines differed across malignancies on their coverage of disease-free survival (p = 0.033), response rates (p = 0.024), symptoms relief (p = 0.005), quality of life (p = 0.001) and toxicity (p = 0.039), with breast and ovarian cancer guidelines typically covering more frequently these outcomes. All guidelines explicitly or implicitly endorsed the use of chemotherapy. Conclusions: Clinical practice guidelines are provided by the minority of professional societies and organizations. Available guidelines tend to recommend chemotherapy even for diseases where the effect of chemotherapy is controversial and recommendations are based on scant evidence.	[Polyzos, Nikolaos P.; Mauri, Davide; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Mauri, Davide] Gen Hosp Lamia, Dept Med Oncol, Lamia, Greece; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Tufts Med Ctr,Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; Stanford University; Tufts Medical Center; Tufts University	Polyzos, NP (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@stanford.edu	Polyzos, Nikolaos/D-8896-2011; Ioannidis, John P. A./G-9836-2011; Polyzos, Nikolaos P/O-5130-2014	Polyzos, Nikolaos/0000-0001-6161-0011				[Anonymous], HUMAN DEV REPORTS; Arnau JM, 2006, EUR SPINE J, V15, P543, DOI 10.1007/s00586-005-1027-y; Boluyt N, 2005, PEDIATRICS, V115, P1378, DOI 10.1542/peds.2004-0575; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Eden J, 2008, KNOW WHAT WORKS HLTH; Eikelboom J, 2008, LANCET, V371, P1559, DOI 10.1016/S0140-6736(08)60670-4; Giannakakis IA, 2002, J CLIN EPIDEMIOL, V55, P545, DOI 10.1016/S0895-4356(02)00395-5; Graham ID, 2001, CAN MED ASSOC J, V165, P157; Green JA, 2001, LANCET, V358, P781, DOI 10.1016/S0140-6736(01)05965-7; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Hall JC, 1997, LANCET, V350, P1752, DOI 10.1016/S0140-6736(05)63577-5; Harpole LH, 2003, CHEST, V123, p7S, DOI 10.1378/chest.123.1_suppl.7S; Hasenfeld R, 2003, QUAL SAF HEALTH CARE, V12, P428, DOI 10.1136/qhc.12.6.428; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V298, P2907, DOI 10.1001/jama.298.24.2907; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Mauri D, 2008, JNCI-J NATL CANCER I, V100, P1780, DOI 10.1093/jnci/djn414; Nelen WLDM, 2008, HUM REPROD, V23, P1786, DOI 10.1093/humrep/den120; Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA), 2004, COCHRANE DB SYST REV, V2; Patsopoulos N. A., 2009, OPEN MED, V3, P62; Peppercorn J, 2008, J CLIN ONCOL, V26, P5994, DOI 10.1200/JCO.2008.18.1420; Polyzos NP, 2006, EUR J CANCER, V42, P319, DOI 10.1016/j.ejca.2005.09.026; Poynard T, 2002, ANN INTERN MED, V136, P888, DOI 10.7326/0003-4819-136-12-200206180-00010; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Somerfield MR, 2008, J CLIN ONCOL, V26, P4022, DOI 10.1200/JCO.2008.17.7139; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Tzioras S, 2007, CANCER TREAT REV, V33, P24, DOI 10.1016/j.ctrv.2006.09.007; Woolf SH, 1998, CHEST, V113, p166S, DOI 10.1378/chest.113.3_Supplement.166S; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20106	10.1371/journal.pone.0020106	http://dx.doi.org/10.1371/journal.pone.0020106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611154	gold, Green Published, Green Submitted			2022-12-27	WOS:000290657500042
J	Krell, D; Assoku, M; Galloway, M; Mulholland, P; Tomlinson, I; Bardella, C				Krell, Daniel; Assoku, Mawuelikem; Galloway, Malcolm; Mulholland, Paul; Tomlinson, Ian; Bardella, Chiara			Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma	PLOS ONE			English	Article							NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; HELA-CELLS; GLIOMAS; 2-HYDROXYGLUTARATE; DIFFERENTIATION; SENSITIVITY; LEUKEMIA; ALPHA	Isocitrate dehydrogenases (IDHs) catalyse oxidative decarboxylation of isocitrate to a-ketoglutarate (a-KG). IDH1 functions in the cytosol and peroxisomes, whereas IDH2 and IDH3 are both localized in the mitochondria. Heterozygous somatic mutations in IDH1 occur at codon 132 in 70% of grade II-III gliomas and secondary glioblastomas (GBMs), and in 5% of primary GBMs. Mutations in IDH2 at codon 172 are present in grade II-III gliomas at a low frequency. IDH1 and IDH2 mutations cause both loss of normal enzyme function and gain-of-function, causing reduction of a-KG to D-2-hydroxyglutarate (D-2HG) which accumulates. Excess hydroxyglutarate (2HG) can also be caused by germline mutations in D-and L-2-hydroxyglutarate dehydrogenases (D2HGDH and L2HGDH). If loss of IDH function is critical for tumourigenesis, we might expect some tumours to acquire somatic IDH3 mutations. Alternatively, if 2HG accumulation is critical, some tumours might acquire somatic D2HGDH or L2HGDH mutations. We therefore screened 47 glioblastoma samples looking for changes in these genes. Although IDH1 R132H was identified in 12% of samples, no mutations were identified in any of the other genes. This suggests that mutations in IDH3, D2HGDH and L2HGDH do not occur at an appreciable frequency in GBM. One explanation is simply that mono-allelic IDH1 and IDH2 mutations occur more frequently by chance than the bi-allelic mutations expected at IDH3, D2HGDH and L2HGDH. Alternatively, both loss of IDH function and 2HG accumulation might be required for tumourigenesis, and only IDH1 and IDH2 mutations have these dual effects.	[Krell, Daniel; Assoku, Mawuelikem; Tomlinson, Ian; Bardella, Chiara] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Krell, Daniel; Assoku, Mawuelikem; Mulholland, Paul] Univ Coll London Hosp, Dept Med Oncol, London, England; [Galloway, Malcolm] Royal Free Hosp, Dept Cellular Pathol, London NW3 2QG, England	University of Oxford; Wellcome Centre for Human Genetics; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Krell, D (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	chiara.bardella@well.ox.ac.uk	bardella, chiara/AAG-6272-2021	Mulholland, Paul/0000-0002-7926-824X; Bardella, Chiara/0000-0002-7780-2541	Oxford Comprehensive Biomedical Core (BRC); charity Mothers and Daughters; University College London Hospitals, Experimental Cancer Medicine Centre; Wellcome Trust [075491/Z/04]	Oxford Comprehensive Biomedical Core (BRC); charity Mothers and Daughters; University College London Hospitals, Experimental Cancer Medicine Centre; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Oxford Comprehensive Biomedical Core (BRC), the charity Mothers and Daughters, the University College London Hospitals, Experimental Cancer Medicine Centre, and a core centre grant from the Wellcome Trust (075491/Z/04). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kil IS, 2007, FREE RADICAL BIO MED, V43, P1197, DOI 10.1016/j.freeradbiomed.2007.07.009; KLOOSTERHOF NK, 2010, LANCET ONCOL; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Lee SH, 2004, INT J RADIAT BIOL, V80, P635, DOI 10.1080/09553000400007680; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Minard KI, 1999, J BIOL CHEM, V274, P3402, DOI 10.1074/jbc.274.6.3402; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang ES, 2009, BIOCHIMIE, V91, P1020, DOI 10.1016/j.biochi.2009.05.008; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	24	59	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19868	10.1371/journal.pone.0019868	http://dx.doi.org/10.1371/journal.pone.0019868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625441	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200018
J	Moncini, S; Salvi, A; Zuccotti, P; Viero, G; Quattrone, A; Barlati, S; De Petro, G; Venturin, M; Riva, P				Moncini, Silvia; Salvi, Alessandro; Zuccotti, Paola; Viero, Gabriella; Quattrone, Alessandro; Barlati, Sergio; De Petro, Giuseppina; Venturin, Marco; Riva, Paola			Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL-SPECIFIC ACTIVATOR; MICRORNA EXPRESSION; NEURITE OUTGROWTH; MESSENGER-RNA; TAU-PROTEIN; MOUSE MODEL; GENES; P35; PRECURSOR	CDK5R1 encodes p35, a specific activator of the serine/threonine kinase CDK5, which plays crucial roles in CNS development and maintenance. CDK5 activity strongly depends on p35 levels and p35/CDK5 misregulation is deleterious for correct CNS function, suggesting that a tightly controlled regulation of CDK5R1 expression is needed for proper CDK5 activity. Accordingly, CDK5R1 expression was demonstrated to be controlled at both transcriptional and post-transcriptional levels, but a possible regulation through microRNAs (miRNAs) has never been investigated. We predicted, within the large CDK5R1 3'UTR several miRNA target sites. Among them, we selected for functional studies miR-103 and miR-107, whose expression has shown a strong inverse correlation with p35 levels in different cell lines. A significant reduction of CDK5R1 mRNA and p35 levels was observed after transfection of SK-N-BE neuroblastoma cells with the miR-103 or miR-107 precursor (pre-miR-103 or pre-miR-107). Conversely, p35 levels significantly increased following transfection of the corresponding antagonists (anti-miR-103 or anti-miR-107). Moreover, the level of CDK5R1 transcript shifts from the polysomal to the subpolysomal mRNA fraction after transfection with pre-miR-107 and, conversely, from the subpolysomal to the polysolmal mRNA fraction after transfection with anti-miR-107, suggesting a direct action on translation efficiency. We demonstrate, by means of luciferase assays, that miR-103 and miR-107 are able to directly interact with the CDK5R1 3'-UTR, in correspondence of a specific target site. Finally, miR-103 and miR-107 overexpression, as well as CDK5R1 silencing, caused a reduction in SK-N-BE migration ability, indicating that these miRNAs affect neuronal migration by modulating CDK5R1 expression. These findings indicate that miR-103 and miR-107 regulate CDK5R1 expression, allowing us to hypothesize that a miRNA-mediated mechanism may influence CDK5 activity and the associated molecular pathways.	[Moncini, Silvia; Zuccotti, Paola; Venturin, Marco; Riva, Paola] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Salvi, Alessandro; Barlati, Sergio; De Petro, Giuseppina] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, Brescia, Italy; [Viero, Gabriella; Quattrone, Alessandro] Univ Trento, CIBIO, Trento, Italy; [Viero, Gabriella] CNR, Inst Biophys, Trento, Italy	University of Milan; University of Brescia; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Moncini, S (corresponding author), Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy.	paola.riva@unimi.it	Venturin, Marco/J-8735-2017; Riva, Paola/K-7871-2016; Salvi, Alessandro/AAB-7896-2019; Viero, Gabriella/G-2096-2012; De Petro, Giuseppina/C-2719-2011	Venturin, Marco/0000-0002-5871-9689; Riva, Paola/0000-0001-6481-8467; Salvi, Alessandro/0000-0001-6993-1565; Viero, Gabriella/0000-0002-6755-285X; De Petro, Giuseppina/0000-0001-9306-0851; Quattrone, Alessandro/0000-0003-3333-7630	Italian Ministry of the University and Research [2007MWCEAL_003]; Italian Found in Basic Research (FIRB) [RBFR0895DC]; MIUR, University of Brescia	Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Found in Basic Research (FIRB); MIUR, University of Brescia(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of the University and Research by means of the following grants: Research Project of National Interest (PRIN contract number 2007MWCEAL_003 to PR, http://prin.miur.it/), Italian Found in Basic Research (FIRB contract number RBFR0895DC to MV, http://firb.miur.it/) and by local MIUR funds of the University of Brescia (to GDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bai Y, 2006, BBA-MOL CELL RES, V1763, P1076, DOI 10.1016/j.bbamcr.2006.08.009; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Humbert S, 2000, J CELL SCI, V113, P975; Jeong YG, 2003, NEUROSCIENCE, V118, P323, DOI 10.1016/S0306-4522(03)00002-2; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuss AW, 2008, CURR NEUROL NEUROSCI, V8, P190, DOI 10.1007/s11910-008-0031-0; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI X, 2010, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934.2010.01194.X; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Venturin M, 2006, NEUROGENETICS, V7, P59, DOI 10.1007/s10048-005-0026-9; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Weishaupt JH, 2003, CELL TISSUE RES, V312, P1, DOI 10.1007/s00441-003-0703-7; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	57	82	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20038	10.1371/journal.pone.0020038	http://dx.doi.org/10.1371/journal.pone.0020038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625387	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005200026
J	Genovesio, A; Giardini, MA; Kwon, YJ; Dossin, FD; Choi, SY; Kim, NY; Kim, HC; Jung, SY; Schenkman, S; Almeida, IC; Emans, N; Freitas, LH				Genovesio, Auguste; Giardini, Miriam A.; Kwon, Yong-Jun; Dossin, Fernando de Macedo; Choi, Seo Yeon; Kim, Nam Youl; Kim, Hi Chul; Jung, Sung Yong; Schenkman, Sergio; Almeida, Igor C.; Emans, Neil; Freitas-Junior, Lucio H.			Visual Genome-Wide RNAi Screening to Identify Human Host Factors Required for Trypanosoma cruzi Infection	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CHAGAS-DISEASE; MAMMALIAN-CELLS; SURFACE PROTEIN; GENE-EXPRESSION; E-CADHERIN; INVASION; RECEPTOR; BINDING; CA2+	The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a neglected tropical infection that affects millions of people in the Americas. Current chemotherapy relies on only two drugs that have limited efficacy and considerable side effects. Therefore, the development of new and more effective drugs is of paramount importance. Although some host cellular factors that play a role in T. cruzi infection have been uncovered, the molecular requirements for intracellular parasite growth and persistence are still not well understood. To further study these host-parasite interactions and identify human host factors required for T. cruzi infection, we performed a genome-wide RNAi screen using cellular microarrays of a printed siRNA library that spanned the whole human genome. The screening was reproduced 6 times and a customized algorithm was used to select as hits those genes whose silencing visually impaired parasite infection. The 162 strongest hits were subjected to a secondary screening and subsequently validated in two different cell lines. Among the fourteen hits confirmed, we recognized some cellular membrane proteins that might function as cell receptors for parasite entry and others that may be related to calcium release triggered by parasites during cell invasion. In addition, two of the hits are related to the TGF-beta signaling pathway, whose inhibition is already known to diminish levels of T. cruzi infection. This study represents a significant step toward unveiling the key molecular requirements for host cell invasion and revealing new potential targets for antiparasitic therapy.	[Genovesio, Auguste] Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea; [Giardini, Miriam A.; Dossin, Fernando de Macedo; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery, Songnam, Gyeonggi Do, South Korea; [Kwon, Yong-Jun; Choi, Seo Yeon; Kim, Nam Youl; Kim, Hi Chul; Jung, Sung Yong] Inst Pasteur Korea, Discovery Biol Grp, Songnam, Gyeonggi Do, South Korea; [Kwon, Yong-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kwon, Yong-Jun] Yonsei Univ, Natl Res Lab, Seoul 120749, South Korea; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Emans, Neil] CSIR Biosci, Synthet Biol ERA, High Throughput Biol Grp, Pretoria, South Africa	Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea; Yonsei University; Yonsei University; Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas El Paso; Council for Scientific & Industrial Research (CSIR) - South Africa	Genovesio, A (corresponding author), Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea.	neiljemans@gmail.com; freitasjunior@ip-korea.org	Giardini, Miriam/GWM-6512-2022; GENOVESIO, Auguste/I-1656-2017; Freitas-Junior, Lucio H/C-8677-2011; Dossin, Fernando/D-1503-2011; Almeida, Igor C./AAF-9409-2019; Emans, Neil/H-4299-2011; Schenkman, Sergio/A-9227-2013	Freitas-Junior, Lucio H/0000-0002-8904-7897; Almeida, Igor C./0000-0002-2443-8213; Schenkman, Sergio/0000-0001-9353-8480; Giardini, Miriam A./0000-0002-6510-2409; Genovesio, Auguste/0000-0003-1877-5595	Korean Government (MEST) [K204EA000001-09E0100-00110]; FAPESP; CNPq (Brazil); NIH [2S06GM00812, 1R01AI070655, 5G12RR008124-16A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070655] Funding Source: NIH RePORTER	Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Korea Research Foundation Grant provided by the Korean Government (MEST) (project number K204EA000001-09E0100-00110). S.S. was supported by FAPESP and CNPq (Brazil). I.C.A. was supported by the NIH grants 2S06GM00812, 1R01AI070655 and 5G12RR008124-16A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; Buscaglia CA, 2003, MICROBES INFECT, V5, P419, DOI 10.1016/S1286-4579(03)00050-9; Caler EV, 2000, INFECT IMMUN, V68, P6602, DOI 10.1128/IAI.68.12.6602-6610.2000; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Costales JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-252; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Docampo R, 1996, PARASITOL TODAY, V12, P61, DOI 10.1016/0169-4758(96)80656-9; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Erfle H, 2005, METHOD ENZYMOL, V404, P1, DOI 10.1016/S0076-6879(05)04001-2; Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Erfle Holger, 2007, Methods Mol Biol, V360, P155; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Hauck CR, 2002, MED MICROBIOL IMMUN, V191, P55, DOI 10.1007/s00430-002-0119-0; Imai K, 2005, MICROBIOL IMMUNOL, V49, P623, DOI 10.1111/j.1348-0421.2005.tb03654.x; Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Alves MJM, 2009, MEM I OSWALDO CRUZ, V104, P76, DOI 10.1590/S0074-02762009000900013; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Shigihara T, 2008, PARASITOL RES, V102, P715, DOI 10.1007/s00436-007-0819-x; Simmons KJ, 2006, FEBS LETT, V580, P2365, DOI 10.1016/j.febslet.2006.03.054; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Soler AP, 2001, HUM PATHOL, V32, P149, DOI 10.1053/hupa.2001.21562; TARDIEUX I, 1994, J EXP MED, V179, P1017, DOI 10.1084/jem.179.3.1017; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; VILLALTA F, 1993, MOL BIOCHEM PARASIT, V61, P217, DOI 10.1016/0166-6851(93)90068-9; Villalta F, 2008, FRONT BIOSCI-LANDMRK, V13, P3714, DOI 10.2741/2961; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	60	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19733	10.1371/journal.pone.0019733	http://dx.doi.org/10.1371/journal.pone.0019733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625474	Green Submitted, gold, Green Published			2022-12-27	WOS:000290793400009
J	Zvi, A; Rotem, S; Bar-Haim, E; Cohen, O; Shafferman, A				Zvi, Anat; Rotem, Shahar; Bar-Haim, Erez; Cohen, Ofer; Shafferman, Avigdor			Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response	PLOS ONE			English	Article							VACCINE DEVELOPMENT; HIV ENVELOPE; IDENTIFICATION; TULAREMIA; REGIONS; PROTEIN; CANDIDATES; PEPTIDES; ANTIGENS; VIRUS	The cellular arm of the immune response plays a central role in the defense against intracellular pathogens, such as F. tularensis. To date, whole genome immunoinformatic analyses were limited either to relatively small genomes (e.g. viral) or to preselected subsets of proteins in complex pathogens. Here we present, for the first time, an unbiased bacterial global immunoinformatic screen of the 1740 proteins of F. tularensis subs. holarctica (LVS), aiming at identification of immunogenic peptides eliciting a CTL response. The very large number of predicted MHC class I binders (about 100,000, IC(50) of 1000 nM or less) required the design of a strategy for further down selection of CTL candidates. The approach developed focused on mapping clusters rich in overlapping predicted epitopes, and ranking these "hotspot'' regions according to the density of putative binding epitopes. Limited by the experimental load, we selected to screen a library of 1240 putative MHC binders derived from 104 top-ranking highly dense clusters. Peptides were tested for their ability to stimulate IFN gamma secretion from splenocytes isolated from LVS vaccinated C57BL/6 mice. The majority of the clusters contained one or more CTL responder peptides and altogether 127 novel epitopes were identified, of which 82 are non-redundant. Accordingly, the level of success in identification of positive CTL responders was 17-25 fold higher than that found for a randomly selected library of 500 predicted MHC binders (IC(50) of 500 nM or less). Most proteins (ca. 2/3) harboring the highly dense hotspots are membrane-associated. The approach for enrichment of true positive CTL epitopes described in this study, which allowed for over 50% increase in the dataset of known T-cell epitopes of F. tularensis, could be applied in immunoinformatic analyses of many other complex pathogen genomes.	[Zvi, Anat; Rotem, Shahar; Bar-Haim, Erez; Cohen, Ofer; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Zvi, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdor@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	IIBR	IIBR	The study was funded by the IIBR research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Chakravarti DN, 2000, VACCINE, V19, P601, DOI 10.1016/S0264-410X(00)00256-5; Chitlaru T, 2009, FUTURE MICROBIOL, V4, P983, DOI [10.2217/fmb.09.73, 10.2217/FMB.09.73]; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan W, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P213, DOI 10.1007/978-90-481-9054-6_23; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Davies V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006948; Ginodi I, 2008, BIOINFORMATICS, V24, P477, DOI 10.1093/bioinformatics/btm616; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hepburn MJ, 2008, EXPERT REV ANTI-INFE, V6, P231, DOI 10.1586/14787210.6.2.231; Huster KM, 2006, CURR OPIN IMMUNOL, V18, P458, DOI 10.1016/j.coi.2006.05.008; Kim SK, 2001, CURR OPIN IMMUNOL, V13, P429, DOI 10.1016/S0952-7915(00)00237-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2006, TRENDS BIOTECHNOL, V24, P537, DOI 10.1016/j.tibtech.2006.10.001; Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3; Lundegaard C, 2010, IMMUNOLOGY, V130, P309, DOI 10.1111/j.1365-2567.2010.03300.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; McMurry Julie A, 2007, Med Health R I, V90, P311; Moise L, 2008, HUM VACCINES, V4, P219, DOI 10.4161/hv.4.3.5394; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Schmid BV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-184; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; SETTE A, 1994, J IMMUNOL, V153, P5586; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Shafferman A, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P295, DOI 10.1007/978-90-481-9054-6_32; Shankar P, 1996, IMMUNOL LETT, V52, P23, DOI 10.1016/0165-2478(96)02574-6; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Valmori D, 2007, CLIN IMMUNOL, V122, P163, DOI 10.1016/j.clim.2006.09.005; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zvi A, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P229, DOI 10.1007/978-90-481-9054-6_25	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20050	10.1371/journal.pone.0020050	http://dx.doi.org/10.1371/journal.pone.0020050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625462	Green Submitted, gold, Green Published			2022-12-27	WOS:000290793400037
J	Bell, SL; Chiang, AN; Brodsky, JL				Bell, Samantha L.; Chiang, Annette N.; Brodsky, Jeffrey L.			Expression of a Malarial Hsp70 Improves Defects in Chaperone-Dependent Activities in ssa1 Mutant Yeast	PLOS ONE			English	Article							SHOCK-PROTEIN COMPLEMENTS; PLASMODIUM-FALCIPARUM; MOLECULAR CHAPERONES; IMMUNOSUPPRESSANT DEOXYSPERGUALIN; FUNCTIONAL INTERACTION; TRANSLOCATION; PARASITE; HEAT-SHOCK-PROTEIN-70; DEGRADATION; HSC70	Plasmodium falciparum causes the most virulent form of malaria and encodes a large number of molecular chaperones. Because the parasite encounters radically different environments during its lifecycle, many members of this chaperone ensemble may be essential for P. falciparum survival. Therefore, Plasmodium chaperones represent novel therapeutic targets, but to establish the mechanism of action of any developed therapeutics, it is critical to ascertain the functions of these chaperones. To this end, we report the development of a yeast expression system for PfHsp70-1, a P. falciparum cytoplasmic chaperone. We found that PfHsp70-1 repairs mutant growth phenotypes in yeast strains lacking the two primary cytosolic Hsp70s, SSA1 and SSA2, and in strains harboring a temperature sensitive SSA1 allele. PfHsp70-1 also supported chaperone-dependent processes such as protein translocation and ER associated degradation, and ameliorated the toxic effects of oxidative stress. By introducing engineered forms of PfHsp70-1 into the mutant strains, we discovered that rescue requires PfHsp70-1 ATPase activity. Together, we conclude that yeast can be co-opted to rapidly uncover specific cellular activities mediated by malarial chaperones.	[Bell, Samantha L.; Chiang, Annette N.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bell, SL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Bell, Samantha L./AAZ-3080-2021	Bell, Samantha L./0000-0002-5453-3203	National Institutes of Health [GM75061]; Howard Hughes Medical Institute; Chancellor's Undergraduate Research Fellowship; University of Pittsburgh; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chancellor's Undergraduate Research Fellowship; University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant GM75061 (http://www.nih.gov/), a Howard Hughes Medical Institute Undergraduate Research Fellowship (to the Department of Biological Sciences at the University of Pittsburgh; http://www.hhmi.org/grants/institutions/colleges.html), a Chancellor's Undergraduate Research Fellowship and the Horowitz Fellowship (University of Pittsburgh, http://www.pitt.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Agarwal M, 2003, PLANT MOL BIOL, V51, P543, DOI 10.1023/A:1022324920316; ANG D, 1991, J BIOL CHEM, V266, P24233; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Baxter BK, 1998, CURR GENET, V33, P412, DOI 10.1007/s002940050354; Becker J, 1996, MOL CELL BIOL, V16, P4378; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BOTHA M, 2011, CELL STRESS IN PRESS; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Brodsky JL, 1999, BIOCHEM PHARMACOL, V57, P877, DOI 10.1016/S0006-2952(98)00376-1; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; HUNT NH, 1990, BLOOD CELLS, V16, P499; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; LEE YRJ, 1994, PLANT CELL, V6, P1889, DOI 10.1105/tpc.6.12.1889; Leng CH, 1998, PROTEIN SCI, V7, P1186, DOI 10.1002/pro.5560070513; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2000, GENETICS, V156, P501; Midorikawa Y, 1998, CHEMOTHERAPY, V44, P409, DOI 10.1159/000007152; Misra G, 2009, BIOPHYS CHEM, V142, P55, DOI 10.1016/j.bpc.2009.03.006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munder T, 1999, APPL MICROBIOL BIOT, V52, P311, DOI 10.1007/s002530051525; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NELSON RJ, 1992, GENETICS, V131, P277; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Ramya TNC, 2007, J BIOL CHEM, V282, P6388, DOI 10.1074/jbc.M610251200; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHIRMER EC, 1994, PLANT CELL, V6, P1899, DOI 10.1105/tpc.6.12.1899; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; SHARMA YD, 1992, COMP BIOCHEM PHYS B, V102, P437, DOI 10.1016/0305-0491(92)90033-N; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonkin CJ, 2006, CURR OPIN MICROBIOL, V9, P381, DOI 10.1016/j.mib.2006.06.015; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; Tutar Y, 2006, GENETICS, V172, P851, DOI 10.1534/genetics.105.048926; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wright CM, 2007, GENETICS, V175, P1649, DOI 10.1534/genetics.106.066274; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	71	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20047	10.1371/journal.pone.0020047	http://dx.doi.org/10.1371/journal.pone.0020047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625512	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000290771200042
J	Gal-Mor, O; Elhadad, D; Deng, WY; Rahav, G; Finlay, BB				Gal-Mor, Ohad; Elhadad, Dana; Deng, Wanyin; Rahav, Galia; Finlay, Brett B.			The Salmonella enterica PhoP Directly Activates the Horizontally Acquired SPI-2 Gene sseL and Is Functionally Different from a S. bongori Ortholog	PLOS ONE			English	Article							III SECRETION SYSTEM; HELIX TRANSCRIPTION FACTORS; ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND-2; 2-COMPONENT SYSTEM; MOLECULAR CHARACTERIZATION; HOST-CELLS; SEROVAR TYPHIMURIUM; SSRA-SSRB; VIRULENCE	To establish a successful infection within the host, a pathogen must closely regulate multiple virulence traits to ensure their accurate temporal and spatial expression. As a highly adapted intracellular pathogen, Salmonella enterica has acquired during its evolution various virulence genes via numerous lateral transfer events, including the acquisition of the Salmonella Pathogenicity Island 2 (SPI-2) and its associated effectors. Beneficial use of horizontally acquired genes requires that their expression is effectively coordinated with the already existing virulence programs and the regulatory set-up in the bacterium. As an example for such a mechanism, we show here that the ancestral PhoPQ system of Salmonella enterica is able to regulate directly the SPI-2 effector gene sseL (encoding a secreted deubiquitinase) in an SsrB-independent manner and that PhoP plays a part in a feed-forward regulatory loop, which fine-tunes the cellular level of SseL. Additionally, we demonstrate the presence of conserved cis regulatory elements in the promoter region of sseL and show direct binding of purified PhoP to this region. Interestingly, in contrast to the S. enterica PhoP, an ortholog regulator from a S. bongori SARC 12 strain was found to be impaired in promoting transcription of sseL and other genes from the PhoP regulon. These findings have led to the identification of a previously uncharacterized residue in the DNA-binding domain of PhoP, which is required for the transcriptional activation of PhoP regulated genes in Salmonella spp. Collectively our data demonstrate an interesting interface between the acquired SsrB regulon and the ancestral PhoPQ regulatory circuit, provide novel insights into the function of PhoP, and highlight a mechanism of regulatory integration of horizontally acquired genes into the virulence network of Salmonella enterica.	[Gal-Mor, Ohad; Elhadad, Dana; Rahav, Galia] Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel; [Gal-Mor, Ohad; Deng, Wanyin; Finlay, Brett B.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Elhadad, Dana; Rahav, Galia] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; University of British Columbia; Tel Aviv University; Sackler Faculty of Medicine	Gal-Mor, O (corresponding author), Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel.	Ohad.Gal-Mor@sheba.health.gov.il	Gal-Mor, Ohad/U-5025-2017	Gal-Mor, Ohad/0000-0002-2540-6790	Michael Smith Foundation for Health Research (MSFHR); Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals; European Community [PF7/2007-2013, 249241]; Israeli Ministry of Health; CIHR; Howard Hughes Medical Institute	Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); European Community(European Commission); Israeli Ministry of Health; CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	OG was supported by postdoctoral fellowships from the Michael Smith Foundation for Health Research (MSFHR) and the Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals. Research in OG's laboratory is supported by grants from the European Community's Seventh Framework Program (PF7/2007-2013) under grant agreement no. 249241 and from the Chief Scientist of the Israeli Ministry of Health. Work in BBF's laboratory was supported by grants from CIHR and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; KASAHARA M, 1992, J BACTERIOL, V174, P492, DOI 10.1128/jb.174.2.492-498.1992; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; KONG W, 2008, J BIOL CHEM; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miller JH, 1972, EXPT MOL BIOL; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Munson GP, 2000, MOL MICROBIOL, V36, P1391, DOI 10.1046/j.1365-2958.2000.01957.x; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SCHEERENGROOT EP, 1994, J BACTERIOL, V176, P6418, DOI 10.1128/JB.176.21.6418-6426.1994; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yamamoto K, 2002, MOL MICROBIOL, V45, P423, DOI 10.1046/j.1365-2958.2002.03017.x; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	61	11	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20024	10.1371/journal.pone.0020024	http://dx.doi.org/10.1371/journal.pone.0020024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625519	Green Submitted, gold, Green Published			2022-12-27	WOS:000290771200041
J	Gao, XC; Zhou, CJ; Zhou, ZR; Zhang, YH; Zheng, XM; Song, AX; Hu, HY				Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Zhang, Yu-Hang; Zheng, Xue-Ming; Song, Ai-Xin; Hu, Hong-Yu			Co-Chaperone HSJ1a Dually Regulates the Proteasomal Degradation of Ataxin-3	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; UBIQUITIN-DEPENDENT DEGRADATION; MACHADO-JOSEPH-DISEASE; NITRIC-OXIDE SYNTHASE; HSP70 ATPASE ACTIVITY; MOLECULAR CHAPERONES; J-DOMAIN; CHIP; AGGREGATION; LIGASE	Homo sapiens J domain protein (HSJ1) is a J-domain containing co-chaperone that is known to stimulate ATPase activity of HSP70 chaperone, while it also harbors two ubiquitin (Ub)-interacting motifs (UIMs) that may bind with ubiquitinated substrates and potentially function in protein degradation. We studied the effects of HSJ1a on the protein levels of both normal and the disease-related polyQ-expanded forms of ataxin-3 (Atx3) in cells. The results demonstrate that the N-terminal J-domain and the C-terminal UIM domain of HSJ1a exert opposite functions in regulating the protein level of cellular overexpressed Atx3. This dual regulation is dependent on the binding of the J-domain with HSP70, and the UIM domain with polyUb chains. The J-domain down-regulates the protein level of Atx3 through HSP70 mediated proteasomal degradation, while the UIM domain may alleviate this process via maintaining the ubiquitinated Atx3. We propose that cochaperone HSJ1a orchestrates the balance of substrates in stressed cells in a Yin-Yang manner.	[Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Zhang, Yu-Hang; Zheng, Xue-Ming; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gao, XC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Chou, Steven Ziren/M-1995-2014		National Basic Research Program of China [2006CB910305]; Sino Swiss Science and Technology Cooperation Program [GJHZ0909]; National Natural Science Foundation of China [30670431, 10979070]	National Basic Research Program of China(National Basic Research Program of China); Sino Swiss Science and Technology Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (2006CB910305), the Sino Swiss Science and Technology Cooperation Program (GJHZ0909), and the National Natural Science Foundation of China (30670431 and 10979070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chai YH, 1999, J NEUROSCI, V19, P10338; CHEETHAM ME, 1992, BIOCHEM J, V284, P469, DOI 10.1042/bj2840469; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fei EK, 2007, BIOCHEM BIOPH RES CO, V357, P487, DOI 10.1016/j.bbrc.2007.03.160; Gao XC, 2008, ACTA BIOCH BIOPH SIN, V40, P612, DOI 10.1111/j.1745-7270.2008.00441.x; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Malgaroli A, 2006, CURR OPIN NEUROBIOL, V16, P270, DOI 10.1016/j.conb.2006.05.009; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schnaider T, 2000, LIFE SCI, V67, P1455, DOI 10.1016/S0024-3205(00)00735-9; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; SONG AX, PLOS ONE, V5; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; ZIJLSTRA MP, EUR J NEUROSCI	58	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19763	10.1371/journal.pone.0019763	http://dx.doi.org/10.1371/journal.pone.0019763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625540	Green Published, gold, Green Submitted			2022-12-27	WOS:000290771200020
J	Simone, RE; Russo, M; Catalano, A; Monego, G; Froehlich, K; Boehm, V; Palozza, P				Simone, Rossella E.; Russo, Marco; Catalano, Assunta; Monego, Giovanni; Froehlich, Kati; Boehm, Volker; Palozza, Paola			RETRACTED: Lycopene Inhibits NF-kB-Mediated IL-8 Expression and Changes Redox and PPAR gamma Signalling in Cigarette Smoke-Stimulated Macrophages (Retracted article. See vol. 9, e102411, 2014)	PLOS ONE			English	Article; Retracted Publication							TUMOR-NECROSIS-FACTOR; PROLIFERATOR-ACTIVATED RECEPTORS; OBSTRUCTIVE PULMONARY-DISEASE; FACTOR-KAPPA-B; FACTOR-ALPHA; INFLAMMATORY MEDIATORS; RELEASE NEUTROPHIL; CYTOKINE RELEASE; EPITHELIAL-CELLS; PROTEIN-KINASES	Increasing evidence suggests that lycopene, the major carotenoid present in tomato, may be preventive against smoke-induced cell damage. However, the mechanisms of such a prevention are still unclear. The aim of this study was to investigate the role of lycopene on the production of the pro-inflammatory cytokine IL-8 induced by cigarette smoke and the possible mechanisms implicated. Therefore, human THP-1 macrophages were exposed to cigarette smoke extract (CSE), alone and following a 6-h pre-treatment with lycopene (0.5-2 mu M). CSE enhanced IL-8 production in a time-and a dose-dependent manner. Lycopene pre-treatment resulted in a significant inhibition of CSE-induced IL-8 expression at both mRNA and protein levels. NF-kB controlled the transcription of IL-8 induced by CSE, since PDTC prevented such a production. Lycopene suppressed CSE-induced NF-kB DNA binding, NF-kB/p65 nuclear translocation and phosphorylation of IKK alpha and IkB alpha. Such an inhibition was accompanied by a decrease in CSE-induced ROS production and NOX-4 expression. Lycopene further inhibited CSE-induced phosphorylation of the redox-sensitive ERK1/2, JNK and p38 MAPKs. Moreover, the carotenoid increased PPAR gamma levels which, in turn, enhanced PTEN expression and decreased pAKT levels in CSE-exposed cells. Such effects were abolished by the PPAR gamma inhibitor GW9662. Taken together, our data indicate that lycopene prevented CSE-induced IL-8 production through a mechanism involving an inactivation of NF-kB. NF-kB inactivation was accompanied by an inhibition of redox signalling and an activation of PPAR gamma signalling. The ability of lycopene in inhibiting IL-8 production, NF-kB/p65 nuclear translocation, and redox signalling and in increasing PPAR gamma expression was also found in isolated rat alveolar macrophages exposed to CSE. These findings provide novel data on new molecular mechanisms by which lycopene regulates cigarette smoke-driven inflammation in human macrophages.	[Simone, Rossella E.; Catalano, Assunta; Palozza, Paola] Catholic Univ, Inst Gen Pathol, Rome, Italy; [Russo, Marco; Froehlich, Kati; Boehm, Volker] Univ Jena, Inst Nutr, Jena, Germany; [Monego, Giovanni] Catholic Univ, Sch Med, Inst Anat, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Friedrich Schiller University of Jena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Palozza, P (corresponding author), Catholic Univ, Inst Gen Pathol, Rome, Italy.	p.palozza@rm.unicatt.it			LYCOCARD, European Integrated Project [016213]	LYCOCARD, European Integrated Project	This work was supported by LYCOCARD, European Integrated Project no 016213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 1998, CHEST, V113, P1257, DOI 10.1378/chest.113.5.1257; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Barton BE, 1997, CLIN IMMUNOL IMMUNOP, V85, P16, DOI 10.1006/clin.1997.4420; Bessler H, 2008, IMMUNOL INVEST, V37, P183, DOI 10.1080/08820130801967809; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Culpitt SV, 2003, THORAX, V58, P942, DOI 10.1136/thorax.58.11.942; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Demirjian L, 2006, BBA-MOL BASIS DIS, V1762, P592, DOI 10.1016/j.bbadis.2006.04.004; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Gesser B, 1996, J LEUKOCYTE BIOL, V59, P407, DOI 10.1002/jlb.59.3.407; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006; Huang CS, 2007, J NUTR BIOCHEM, V18, P449, DOI 10.1016/j.jnutbio.2006.08.007; Hughes DA, 2000, J INFECT DIS, V182, pS11, DOI 10.1086/315910; Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001; Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894; Janssen-Heininger YMW, 1999, AM J RESP CELL MOL, V20, P942, DOI 10.1165/ajrcmb.20.5.3452; Joo YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004562; JORENS PG, 1992, AM J PHYSIOL, V263, pL708, DOI 10.1152/ajplung.1992.263.6.L708; Karimi K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-66; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; KILTY SB, 2006, AM J PHYSIOL-LUNG C, V291, pL46; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1111/j.1365-2567.2004.01945.x; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Liu C, 2006, J NUTR, V136, P106, DOI 10.1093/jn/136.1.106; Liu XJ, 2007, ASIA PAC J CLIN NUTR, V16, P244; Luscinskas FW, 2000, ANN NY ACAD SCI, V902, P288; Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Napolitano M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1820, DOI 10.1152/ajpendo.00315.2007; Numanami H, 2003, AM J RESP CELL MOL, V29, P613, DOI 10.1165/rcmb.2003-0113OC; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Palozza P, 2005, APOPTOSIS, V10, P1445, DOI 10.1007/s10495-005-1393-2; Palozza P, 2002, FREE RADICAL BIO MED, V33, P1724, DOI 10.1016/S0891-5849(02)01168-1; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; PALOZZA P, 2011, J NUTR BIOC IN PRESS; PALOZZA P, 2010, J NUTR BIOC IN PRESS; Palozza P, 2008, CURR MED CHEM, V15, P844, DOI 10.2174/092986708783955400; Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031; Palozza P, 2010, J NUTR BIOCHEM, V21, P34, DOI 10.1016/j.jnutbio.2008.10.002; Pang BS, 2003, CHINESE MED J-PEKING, V116, P514; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239, DOI 10.1177/026119290503300310; Rahman I, 1996, THORAX, V51, P348, DOI 10.1136/thx.51.4.348; Raza MW, 1999, FEMS IMMUNOL MED MIC, V24, P387, DOI 10.1016/S0928-8244(99)00019-X; Rieusset J, 2001, FEBS LETT, V502, P98, DOI 10.1016/S0014-5793(01)02674-6; Rusznak C, 2001, CLIN EXP ALLERGY, V31, P226, DOI 10.1046/j.1365-2222.2001.01000.x; Sato E, 1999, AM J PHYSIOL-LUNG C, V277, pL1149, DOI 10.1152/ajplung.1999.277.6.L1149; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Sharoni Y, 2004, ARCH BIOCHEM BIOPHYS, V430, P89, DOI 10.1016/j.abb.2004.03.009; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Srinivasan S, 2003, CIRC RES, V92, P371, DOI 10.1161/01.RES.0000061714.74668.5C; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Touyz RM, 2006, VASC PHARMACOL, V45, P19, DOI 10.1016/j.vph.2005.11.014; Valenca SS, 2006, INT J EXP PATHOL, V87, P373, DOI 10.1111/j.1365-2613.2006.00492.x; Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; YANG CM, 2011, J NUTR BIOC IN PRESS; Yeh SL, 2009, CHEM-BIOL INTERACT, V179, P386, DOI 10.1016/j.cbi.2008.12.006; Zhang N, 2005, J BIOL CHEM, V280, P21400, DOI 10.1074/jbc.M411952200	75	78	83	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19652	10.1371/journal.pone.0019652	http://dx.doi.org/10.1371/journal.pone.0019652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625550	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200013
J	Wacklin, P; Makivuokko, H; Alakulppi, N; Nikkila, J; Tenkanen, H; Rabina, J; Partanen, J; Aranko, K; Matto, J				Wacklin, Pirjo; Makivuokko, Harri; Alakulppi, Noora; Nikkila, Janne; Tenkanen, Heli; Rabina, Jarkko; Partanen, Jukka; Aranko, Kari; Matto, Jaana			Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; BLOOD-GROUP; FECAL MICROBIOTA; CROHNS-DISEASE; SUSCEPTIBILITY; IMPACT; PCR; PHENOTYPE; INFECTION	Intestinal microbiota plays an important role in human health, and its composition is determined by several factors, such as diet and host genotype. However, thus far it has remained unknown which host genes are determinants for the microbiota composition. We studied the diversity and abundance of dominant bacteria and bifidobacteria from the faecal samples of 71 healthy individuals. In this cohort, 14 were non-secretor individuals and the remainders were secretors. The secretor status is defined by the expression of the ABH and Lewis histo-blood group antigens in the intestinal mucus and other secretions. It is determined by fucosyltransferase 2 enzyme, encoded by the FUT2 gene. Non-functional enzyme resulting from a nonsense mutation in the FUT2 gene leads to the non-secretor phenotype. PCR-DGGE and qPCR methods were applied for the intestinal microbiota analysis. Principal component analysis of bifidobacterial DGGE profiles showed that the samples of non-secretor individuals formed a separate cluster within the secretor samples. Moreover, bifidobacterial diversity (p < 0.0001), richness (p < 0.0003), and abundance (p < 0.05) were significantly reduced in the samples from the nonsecretor individuals as compared with those from the secretor individuals. The non-secretor individuals lacked, or were rarely colonized by, several genotypes related to B. bifidum, B. adolescentis and B. catenulatum/pseudocatenulatum. In contrast to bifidobacteria, several bacterial genotypes were more common and the richness (p < 0.04) of dominant bacteria as detected by PCR-DGGE was higher in the non-secretor individuals than in the secretor individuals. We showed that the diversity and composition of the human bifidobacterial population is strongly associated with the histo-blood group ABH secretor/non-secretor status, which consequently appears to be one of the host genetic determinants for the composition of the intestinal microbiota. This association can be explained by the difference between the secretor and non-secretor individuals in their expression of ABH and Lewis glycan epitopes in the mucosa.	[Wacklin, Pirjo; Makivuokko, Harri; Alakulppi, Noora; Nikkila, Janne; Tenkanen, Heli; Rabina, Jarkko; Partanen, Jukka; Aranko, Kari; Matto, Jaana] Finnish Red Cross Blood Serv, Helsinki, Finland		Wacklin, P (corresponding author), Finnish Red Cross Blood Serv, Helsinki, Finland.	pirjo.wacklin@bts.redcross.fi	Partanen, Jukka/B-7207-2014; Alakulppi, Noora/D-7839-2015	Partanen, Jukka/0000-0001-6681-4734; Alakulppi, Noora/0000-0002-2292-9342				Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boesten RJ, 2008, J CLIN GASTROENTEROL, V42, pS163, DOI 10.1097/MCG.0b013e31817dbd62; Brenner DM, 2009, REV GASTROENTEROL DI, V9, P7; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Chouraqui JP, 2004, J PEDIATR GASTR NUTR, V38, P288, DOI 10.1097/00005176-200403000-00011; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; Kirjavainen PV, 2009, CLIN VACCINE IMMUNOL, V16, P29, DOI 10.1128/CVI.00323-08; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Matto J, 2005, FEMS IMMUNOL MED MIC, V43, P213, DOI 10.1016/j.femsim.2004.08.009; Matto J, 2004, J APPL MICROBIOL, V97, P459, DOI 10.1111/j.1365-2672.2004.02340.x; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morrow AL, 2010, FASEB J, V24; Moulds JM, 1996, TRANSFUSION, V36, P362, DOI 10.1046/j.1537-2995.1996.36496226154.x; Nubel U, 1996, J BACTERIOL, V178, P5636; RAJILICSTOJANOV.M, 2007, THESIS WAGENINGENUNI; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Silva LM, 2010, GLYCOCONJUGATE J, V27, P61, DOI 10.1007/s10719-009-9255-8; THORN SM, 1989, FEMS MICROBIOL IMMUN, V47, P401; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, FRONT BIOSCI-LANDMRK, V14, P4673, DOI 10.2741/3559; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	46	181	193	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20113	10.1371/journal.pone.0020113	http://dx.doi.org/10.1371/journal.pone.0020113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625510	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200049
J	Khashan, AS; Kenny, LC; Laursen, TM; Mahmood, U; Mortensen, PB; Henriksen, TB; O'Donoghue, K				Khashan, Ali S.; Kenny, Louise C.; Laursen, Thomas M.; Mahmood, Uzma; Mortensen, Preben B.; Henriksen, Tine B.; O'Donoghue, Keelin			Pregnancy and the Risk of Autoimmune Disease	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FETAL CELL MICROCHIMERISM; RHEUMATOID-ARTHRITIS; MATERNAL BLOOD; DENMARK; COHORT; PREECLAMPSIA; LEGACY; WOMEN	Autoimmune diseases (AID) predominantly affect women of reproductive age. While basic molecular studies have implicated persisting fetal cells in the mother in some AID, supportive epidemiological evidence is limited. We investigated the effect of vaginal delivery, caesarean section (CS) and induced abortion on the risk of subsequent maternal AID. Using the Danish Civil Registration System (CRS) we identified women who were born between 1960 and1992. We performed data linkage between the CRS other Danish national registers to identify women who had a pregnancy and those who developed AID. Women were categorised into 4 groups; nulligravida (control group), women who had 1st child by vaginal delivery, whose 1st delivery was by CS and who had abortions. Log-linear Poisson regression with person-years was used for data analysis adjusting for several potential confounders. There were 1,035,639 women aged >14 years and 25,570 developed AID: 43.4% nulligravida, 44.3% had their first pregnancy delivered vaginally, 7.6% CS and 4.1% abortions. The risk of AID was significantly higher in the 1st year after vaginal delivery (RR = 1.1[1.0, 1.2]) and CS (RR = 1.3[1.1, 1.5]) but significantly lower in the 1st year following abortion (RR = 0.7[0.6, 0.9]). These results suggest an association between pregnancy and the risk of subsequent maternal AID. Increased risks of AID after CS may be explained by amplified fetal cell traffic at delivery, while decreased risks after abortion may be due to the transfer of more primitive fetal stem cells. The increased risk of AID in the first year after delivery may also be related to greater testing during pregnancy.	[Khashan, Ali S.; Kenny, Louise C.; Mahmood, Uzma; O'Donoghue, Keelin] Cork Univ Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland; [Laursen, Thomas M.; Mortensen, Preben B.] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, Dept Paediat, DK-8000 Aarhus, Denmark	University College Cork; Aarhus University; Aarhus University	Khashan, AS (corresponding author), Cork Univ Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland.	k.odonoghue@ucc.ie	Laursen, Thomas Munk/AFQ-8066-2022; Kenny, Louise/X-6329-2019; Mortensen, Preben B/D-2358-2015; Kenny, Louise C/G-1112-2011	Kenny, Louise/0000-0002-9011-759X; Mortensen, Preben B/0000-0002-5230-9865; Kenny, Louise C/0000-0002-9011-759X; O'Donoghue, Keelin/0000-0002-4616-2887; Laursen, Thomas Munk/0000-0001-6934-1784	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The study was funded by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, J NEUROL SCI, V286, P73, DOI 10.1016/j.jns.2009.04.038; AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; Andersen TF, 1999, DAN MED BULL, V46, P263; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianchi DW, 1997, AM J HUM GENET, V61, P822, DOI 10.1086/514885; Borchers AT, 2010, J AUTOIMMUN, V34, pJ287, DOI 10.1016/j.jaut.2009.11.015; Breslow NE, 1987, STAT METHODS CANC RE; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; HELIOVAARA M, 1995, BRIT J RHEUMATOL, V34, P625; Jansen MWJC, 2001, PRENATAL DIAG, V21, P1022, DOI 10.1002/pd.176; Jorgensen KT, 2010, ANN RHEUM DIS, V69, P358, DOI 10.1136/ard.2008.099945; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Klonisch T, 2009, TRENDS MOL MED, V15, P510, DOI 10.1016/j.molmed.2009.09.002; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lambert N, 2003, AUTOIMMUN REV, V2, P133, DOI 10.1016/S1568-9972(02)00149-0; Lissauer DM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001264; Miech RP, 2010, INT J CLIN EXP MED, V3, P164; Nelson J. Lee, 1998, Current Opinion in Rheumatology, V10, P564, DOI 10.1097/00002281-199811000-00010; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; Nelson JL, 2002, ARTHRITIS RHEUM-US, V46, P291, DOI 10.1002/art.501; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K., 2006, REV GYNAECOL PERINAT, V6, P87, DOI DOI 10.1016/J.RIGAPP.2005.11.001; Ostensen M, 2007, SEMIN IMMUNOPATHOL, V29, P185, DOI 10.1007/s00281-007-0072-5; Pedersen CB, 2006, DAN MED BULL, V53, P441; RUNMARKER B, 1995, BRAIN, V118, P253, DOI 10.1093/brain/118.1.253; Ulff-Moller CJ, 2009, J RHEUMATOL, V36, P1903, DOI 10.3899/jrheum.090002; Waldorf KMA, 2008, IMMUNOL INVEST, V37, P631, DOI 10.1080/08820130802205886; *WHO, MAN INT CLASS DIS IC; World Health Organization, ICD 10 CLASS MENT BE	33	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19658	10.1371/journal.pone.0019658	http://dx.doi.org/10.1371/journal.pone.0019658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611120	Green Published, gold			2022-12-27	WOS:000290720200023
J	Wahl, M; Link, H; Alexandridis, N; Thomason, JC; Cifuentes, M; Costello, MJ; da Gama, BAP; Hillock, K; Hobday, AJ; Kaufmann, MJ; Keller, S; Kraufvelin, P; Kruger, I; Lauterbach, L; Antunes, BL; Molis, M; Nakaoka, M; Nystrom, J; bin Radzi, Z; Stockhausen, B; Thiel, M; Vance, T; Weseloh, A; Whittle, M; Wiesmann, L; Wunderer, L; Yamakita, T; Lenz, M				Wahl, Martin; Link, Heike; Alexandridis, Nicolaos; Thomason, Jeremy C.; Cifuentes, Mauricio; Costello, Mark J.; da Gama, Bernardo A. P.; Hillock, Kristina; Hobday, Alistair J.; Kaufmann, Manfred J.; Keller, Stefanie; Kraufvelin, Patrik; Kruger, Ina; Lauterbach, Lars; Antunes, Bruno L.; Molis, Markus; Nakaoka, Masahiro; Nystrom, Julia; bin Radzi, Zulkamal; Stockhausen, Bjoern; Thiel, Martin; Vance, Thomas; Weseloh, Annika; Whittle, Mark; Wiesmann, Lisa; Wunderer, Laura; Yamakita, Takehisa; Lenz, Mark			Re-Structuring of Marine Communities Exposed to Environmental Change: A Global Study on the Interactive Effects of Species and Functional Richness	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; CLIMATE-CHANGE; BIODIVERSITY; DIVERSITY; STABILITY; INVASION; COMPLEMENTARITY; COMPETITION; REDUNDANCY; IMPACTS	Species richness is the most commonly used but controversial biodiversity metric in studies on aspects of community stability such as structural composition or productivity. The apparent ambiguity of theoretical and experimental findings may in part be due to experimental shortcomings and/or heterogeneity of scales and methods in earlier studies. This has led to an urgent call for improved and more realistic experiments. In a series of experiments replicated at a global scale we translocated several hundred marine hard bottom communities to new environments simulating a rapid but moderate environmental change. Subsequently, we measured their rate of compositional change (re-structuring) which in the great majority of cases represented a compositional convergence towards local communities. Re-structuring is driven by mortality of community components (original species) and establishment of new species in the changed environmental context. The rate of this re-structuring was then related to various system properties. We show that availability of free substratum relates negatively while taxon richness relates positively to structural persistence (i.e., no or slow re-structuring). Thus, when faced with environmental change, taxon-rich communities retain their original composition longer than taxon-poor communities. The effect of taxon richness, however, interacts with another aspect of diversity, functional richness. Indeed, taxon richness relates positively to persistence in functionally depauperate communities, but not in functionally diverse communities. The interaction between taxonomic and functional diversity with regard to the behaviour of communities exposed to environmental stress may help understand some of the seemingly contrasting findings of past research.	[Wahl, Martin; Alexandridis, Nicolaos; Lenz, Mark] IFM GEOMAR, Dept Benth Ecol, Kiel, Germany; [Link, Heike] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Thomason, Jeremy C.] Marine Ecol Serv, Paris, France; [Cifuentes, Mauricio] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Costello, Mark J.] Univ Auckland, Leigh Marine Lab, Leigh, New Zealand; [da Gama, Bernardo A. P.; Antunes, Bruno L.] Univ Fed Fluminense, Dept Marine Biol, Rio De Janeiro, Brazil; [Hillock, Kristina] Waikato Conservancy, Dept Conservat, Hamilton, New Zealand; [Hobday, Alistair J.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Hobday, Alistair J.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Kaufmann, Manfred J.] Univ Madeira, Ctr Life Sci, Funchal, Portugal; [Kaufmann, Manfred J.] CIMAR CIIMAR Ctr Marine & Environm Res, Porto, Portugal; [Keller, Stefanie] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany; [Kraufvelin, Patrik] Abo Akad Univ, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Kraufvelin, Patrik] Novia Univ Appl Sci, Ekenas, Finland; [Lauterbach, Lars] Humboldt Univ, Dept Mikrobiol, Berlin, Germany; [Molis, Markus] Biol Anstalt Helgoland, AWI Marine Stn, Helgoland, Germany; [Nakaoka, Masahiro] Hokkaido Univ, Akkeshi Marine Stn, Field Sci Ctr No Biosphere, Akkeshi, Hokkaido, Japan; [bin Radzi, Zulkamal] Univ Malaysia Terengganu, Inst Oceanog, Terengganu, Malaysia; [Stockhausen, Bjoern] Commiss European Communities, Joint Res Ctr, Maritime Affairs Unit, I-21020 Ispra, Italy; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] CEAZA, Coquimbo, Chile; [Vance, Thomas] Plymouth Marine Lab, Dept Marine Ecol, Plymouth, Devon, England; [Weseloh, Annika] Ozeaneum Stralsund GmbH, Dept Educ, Stralsund, Germany; [Whittle, Mark] Univ Tasmania, Dept Zool, Hobart, Tas 7001, Australia; [Wunderer, Laura] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Yamakita, Takehisa] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Japan	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Quebec; Victoria University Wellington; University of Auckland; Universidade Federal Fluminense; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Universidade da Madeira; Universidade do Porto; Abo Akademi University; Novia University of Applied Sciences; Humboldt University of Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Hokkaido University; Universiti Malaysia Terengganu; European Commission Joint Research Centre; EC JRC ISPRA Site; Universidad Catolica del Norte; Plymouth Marine Laboratory; University of Tasmania; University of Munich; Japan Fisheries Research & Education Agency (FRA)	Wahl, M (corresponding author), IFM GEOMAR, Dept Benth Ecol, Kiel, Germany.	mwahl@ifm-geomar.de	Hobday, Alistair/A-1460-2012; Da Gama, Bernardo A. P./A-7861-2008; Lauterbach, Lars/L-6671-2014; Nakaoka, Masahiro/I-9237-2019; Lauterbach, Lars/P-6741-2019; Wahl, Martin/D-2038-2016; Cifuentes, Marie/J-5546-2014; Keller, Stefanie/K-7724-2019; Lenz, Mark/AAG-1734-2021; Kaufmann, Manfred/A-7561-2013; Costello, Mark/C-9267-2013	Hobday, Alistair/0000-0002-3194-8326; Da Gama, Bernardo A. P./0000-0003-2256-9313; Lauterbach, Lars/0000-0002-6601-6473; Nakaoka, Masahiro/0000-0002-5722-3585; Lauterbach, Lars/0000-0002-6601-6473; Wahl, Martin/0000-0001-8703-3857; Cifuentes, Marie/0000-0002-1011-6918; Keller, Stefanie/0000-0003-4826-9511; Kaufmann, Manfred/0000-0001-6213-3229; Costello, Mark/0000-0003-2362-0328; Kraufvelin, Patrik/0000-0003-3224-8388; Link, Heike/0000-0002-8484-845X; Alexandridis, Nikolaos/0000-0001-6031-1175	Mercator Stiftung (Essen, Germany); Grants-in-Aid for Scientific Research [21241055] Funding Source: KAKEN	Mercator Stiftung (Essen, Germany); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was run as part of the international research and training programme GAME (Global Approach by Modular Experiments) of IFM-GEOMAR which was generously funded by the Mercator Stiftung (Essen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Baez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002332; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Borrvall C, 2008, ECOL COMPLEX, V5, P99, DOI 10.1016/j.ecocom.2008.02.004; Bremner J, 2006, ECOL INDIC, V6, P609, DOI 10.1016/j.ecolind.2005.08.026; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Crawley M. J., 2009, R BOOK; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gili JM, 2009, ECOL STUD-ANAL SYNTH, V206, P191, DOI 10.1007/978-3-540-92704-4_13; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jenkins SR, 2009, ECOL STUD-ANAL SYNTH, V206, P177, DOI 10.1007/978-3-540-92704-4_12; Joseph S, 2009, CURR SCI INDIA, V97, P142; Kraufvelin P, 2010, MAR BIOL, V157, P29, DOI 10.1007/s00227-009-1293-z; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Maindonald J, 2010, DATA ANAL GRAPHICS U; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mooney HA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P12; Moorthi SI, 2008, ESTUAR COAST, V31, P152, DOI 10.1007/s12237-007-9015-6; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Naeem S, 2006, MAR ECOL PROG SER, V311, P273, DOI 10.3354/meps311273; Petchey OL, 2002, OIKOS, V99, P231, DOI 10.1034/j.1600-0706.2002.990203.x; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2010, R LANG STAT COMP; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Rohde K, 1997, OIKOS, V79, P169, DOI 10.2307/3546102; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Thompson R, 2007, BIODIVERS CONSERV, V16, P1359, DOI 10.1007/s10531-005-6232-9; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Wahl M, 2009, ECOL STUD-ANAL SYNTH, V206, P7, DOI 10.1007/978-3-540-92704-4_l; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2010, FRONT ECOL ENVIRON, V8, P10, DOI 10.1890/10.WB.002; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Wootton JT, 2009, ECOL STUD-ANAL SYNTH, V206, P201, DOI 10.1007/978-3-540-92704-4_14	57	21	21	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19514	10.1371/journal.pone.0019514	http://dx.doi.org/10.1371/journal.pone.0019514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611170	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000290720200011
J	Guauque-Olarte, S; Gaudreault, N; Piche, ME; Fournier, D; Mauriege, P; Mathieu, P; Bosse, Y				Guauque-Olarte, Sandra; Gaudreault, Nathalie; Piche, Marie-Eve; Fournier, Dominique; Mauriege, Pascale; Mathieu, Patrick; Bosse, Yohan			The Transcriptome of Human Epicardial, Mediastinal and Subcutaneous Adipose Tissues in Men with Coronary Artery Disease	PLOS ONE			English	Article							PROSTAGLANDIN-D-SYNTHASE; GENE-EXPRESSION; FAT THICKNESS; CARDIOVASCULAR RISK; METABOLIC SYNDROME; RECEPTOR AGONISTS; VISCERAL OBESITY; ATHEROSCLEROSIS; OVEREXPRESSION; ADIPOCYTES	Background: The biological functions of epicardial adipose tissue (EAT) remain largely unknown. However, the proximity of EAT to the coronary arteries suggests a role in the pathogenesis of coronary artery disease (CAD). The objectives of this study were to identify genes differentially regulated among three adipose tissues, namely EAT, mediastinal (MAT) and subcutaneous (SAT) and to study their possible relationships with the development of cardiovascular diseases. Methods and Results: Samples were collected from subjects undergoing coronary artery bypass grafting surgeries. Gene expression was evaluated in the three adipose depots of six men using the Illumina(R) HumanWG-6 v3.0 expression BeadChips. Twenty-three and 73 genes were differentially up-regulated in EAT compared to MAT and SAT, respectively. Ninety-four genes were down-regulated in EAT compared to SAT. However, none were significantly down-regulated in EAT compared to MAT. More specifically, the expression of the adenosine A1 receptor (ADORA1), involved in myocardial ischemia, was significantly up-regulated in EAT. Levels of the prostaglandin D2 synthase (PTGDS) gene, recently associated with the progression of atherosclerosis, were significantly different in the three pairwise comparisons (EAT>MAT>SAT). The results of ADORA1 and PTGDS were confirmed by quantitative real-time PCR in 25 independent subjects. Conclusions: Overall, the transcriptional profiles of EAT and MAT were similar compared to the SAT. Despite this similarity, two genes involved in cardiovascular diseases, ADORA1 and PTGDS, were differentially up-regulated in EAT. These results provide insights about the biology of EAT and its potential implication in CAD.	[Guauque-Olarte, Sandra; Gaudreault, Nathalie; Piche, Marie-Eve; Fournier, Dominique; Mauriege, Pascale; Mathieu, Patrick; Bosse, Yohan] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Mauriege, Pascale] Univ Laval, Fac Med, Dept Social & Prevent Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada; [Bosse, Yohan] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Guauque-Olarte, S (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	yohan.bosse@crhl.ulaval.ca	Bosse, Yohan/C-7617-2012; 王, 强/F-4212-2011; Guauque-Olarte, Sandra/G-9977-2018	Guauque-Olarte, Sandra/0000-0003-0336-9682	Heart and Stroke Foundation of Canada; Fondation Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Canadian Institutes of Health [MOP161971]; Faculty of Medicine, Laval University	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fondation Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine, Laval University	This study was funded by grants from the Heart and Stroke Foundation of Canada (http://www.heartandstroke.ca) and the Fondation Institut Universitaire de Cardiologie et de Pneumologie de Quebec (http://www.criucpq.ulaval.ca). The study was also supported by the Canadian Institutes of Health Research grant MOP161971 (http://www.cihr-irsc.gc.ca/e/193.html). S. Guauque-Olarte is the recipient of a master degree recruitment scholarship from the Faculty of Medicine, Laval University. P. Mathieu is a research scholar from the Fonds de Recherche en Sante du Quebec. Y. Bosse is a research scholar from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2009, SEMIN IMMUNOPATHOL, V31, P23, DOI 10.1007/s00281-009-0143-x; Baker AR, 2009, J CLIN ENDOCR METAB, V94, P261, DOI 10.1210/jc.2007-2579; Barakat H, 2006, J CLIN ENDOCR METAB, V91, P1882, DOI 10.1210/jc.2005-2109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brede M, 2004, BIOL CELL, V96, P343, DOI 10.1016/j.biolcel.2004.03.006; Canoy D, 2010, CURR ATHEROSCLER REP, V12, P125, DOI 10.1007/s11883-010-0092-9; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen XZ, 2010, J HUAZHONG U SCI-MED, V30, P589, DOI 10.1007/s11596-010-0547-9; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dutour A, 2010, J CLIN ENDOCR METAB, V95, P963, DOI 10.1210/jc.2009-1222; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiras S, 2010, CYTOKINE, V51, P207, DOI 10.1016/j.cyto.2010.05.009; Elzein E, 2008, EXPERT OPIN INV DRUG, V17, P1901, DOI [10.1517/13543780802497284, 10.1517/13543780802497284 ]; Escary JL, 1999, J LIPID RES, V40, P397; Fain JN, 2010, METABOLISM, V59, P1379, DOI 10.1016/j.metabol.2009.12.027; Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Hirawa N, 2002, HYPERTENSION, V39, P449, DOI 10.1161/hy0202.102835; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2008, OBESITY, V16, P887, DOI 10.1038/oby.2008.6; Iacobellis G, 2009, J AM SOC ECHOCARDIOG, V22, P1311, DOI 10.1016/j.echo.2009.10.013; Iglesias MJ, 2006, REV ESP CARDIOL, V59, P1252, DOI 10.1016/S1885-5857(07)60081-4; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; Ishii T, 1998, J PATHOL, V185, P4, DOI 10.1002/(SICI)1096-9896(199805)185:1<4::AID-PATH50>3.0.CO;2-3; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Kim MK, 2009, NUTR METAB CARDIOVAS, V19, P760, DOI 10.1016/j.numecd.2009.01.010; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kurnik D, 2006, CLIN PHARMACOL THER, V79, P173, DOI 10.1016/j.clpt.2005.10.006; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Li JL, 2006, HYPERTENSION, V47, P1140, DOI 10.1161/01.HYP.0000217972.80731.ef; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Malavazos AE, 2007, INT J CARDIOL, V121, P132, DOI 10.1016/j.ijcard.2006.08.061; Matherne GP, 1997, P NATL ACAD SCI USA, V94, P6541, DOI 10.1073/pnas.94.12.6541; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; MAURIEGE P, 1995, J LIPID RES, V36, P672; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Miwa Y, 2008, HYPERTENS RES, V31, P1931, DOI 10.1291/hypres.31.1931; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Niederhoffer N, 2004, BRIT J PHARMACOL, V141, P851, DOI 10.1038/sj.bjp.0705636; Pezeshkian M, 2009, METAB SYNDR RELAT D, V7, P125, DOI 10.1089/met.2008.0056; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Ragolia L, 2003, J BIOL CHEM, V278, P22175, DOI 10.1074/jbc.M302769200; Regan SE, 2003, AM J PHYSIOL-HEART C, V284, pH859, DOI 10.1152/ajpheart.00251.2002; Reynisdottir S, 1997, J CLIN ENDOCR METAB, V82, P4162, DOI 10.1210/jc.82.12.4162; RICHELSEN B, 1991, METABOLISM, V40, P990, DOI 10.1016/0026-0495(91)90078-B; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urmaliya VB, 2009, J CARDIOVASC PHARM, V53, P424, DOI 10.1097/FJC.0b013e3181a443e2; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; VIKMAN HL, 1993, METABOLISM, V42, P739, DOI 10.1016/0026-0495(93)90242-G; VIKMAN HL, 1991, ACTA PHYSIOL SCAND, V142, P405, DOI 10.1111/j.1748-1716.1991.tb09174.x; Vikman HL, 1996, INT J OBESITY, V20, P185; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153	66	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19908	10.1371/journal.pone.0019908	http://dx.doi.org/10.1371/journal.pone.0019908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21603615	Green Published, Green Submitted, gold			2022-12-27	WOS:000290656300036
J	Nummenmaa, L; Hietanen, JK; Calvo, MG; Hyona, J				Nummenmaa, Lauri; Hietanen, Jari K.; Calvo, Manuel G.; Hyona, Jukka			Food Catches the Eye but Not for Everyone: A BMI-Contingent Attentional Bias in Rapid Detection of Nutriments	PLOS ONE			English	Article							VISUAL-ATTENTION; APPETITIVE MOTIVATION; MOVEMENT ASSESSMENT; EMOTIONAL FACES; BRAIN; SEARCH; IMAGES; DOPAMINE; OBESITY; SYSTEM	An organism's survival depends crucially on its ability to detect and acquire nutriment. Attention circuits interact with cognitive and motivational systems to facilitate detection of salient sensory events in the environment. Here we show that the human attentional system is tuned to detect food targets among nonfood items. In two visual search experiments participants searched for discrepant food targets embedded in an array of nonfood distracters or vice versa. Detection times were faster when targets were food rather than nonfood items, and the detection advantage for food items showed a significant negative correlation with Body Mass Index (BMI). Also, eye tracking during searching within arrays of visually homogenous food and nonfood targets demonstrated that the BMI-contingent attentional bias was due to rapid capturing of the eyes by food items in individuals with low BMI. However, BMI was not associated with decision times after the discrepant food item was fixated. The results suggest that visual attention is biased towards foods, and that individual differences in energy consumption - as indexed by BMI - are associated with differential attentional effects related to foods. We speculate that such differences may constitute an important risk factor for gaining weight.	[Nummenmaa, Lauri] Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland; [Hietanen, Jari K.] Univ Tampere, Dept Psychol, FIN-33101 Tampere, Finland; [Calvo, Manuel G.] Univ La Laguna, Dept Cognit Psychol, E-38207 San Cristobal la Laguna, Spain; [Hyona, Jukka] Univ Turku, Dept Psychol, Turku, Finland	Aalto University; Aalto University; University of Turku; Tampere University; Universidad de la Laguna; University of Turku	Nummenmaa, L (corresponding author), Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland.	nummenmaa@neuro.hut.fi	Hyönä, Jukka/K-5280-2019; CALVO, MANUEL/N-3042-2019; Nummenmaa, Lauri/G-6910-2012; Calvo, Manuel/K-6381-2014	Hyönä, Jukka/0000-0002-5950-3361; CALVO, MANUEL/0000-0003-1083-9929; Nummenmaa, Lauri/0000-0002-2497-9757; Calvo, Manuel/0000-0003-1083-9929	Aalto University	Aalto University	This study was supported by the AivoAALTO grant from the Aalto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Calvo MG, 2008, EXP PSYCHOL, V55, P359, DOI 10.1027/1618-3169.55.6.359; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; CHRISTIE J, 1995, MEM COGNITION, V23, P547, DOI 10.3758/BF03197256; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Dobson KS, 2004, CLIN PSYCHOL REV, V23, P1001, DOI 10.1016/j.cpr.2003.09.004; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kaurijoki S, 2008, CLIN PHYSIOL FUNCT I, V28, P270, DOI 10.1111/j.1475-097X.2008.00804.x; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; Mohanty A, 2008, CEREB CORTEX, V18, P2604, DOI 10.1093/cercor/bhn021; Nelson RA, 2007, PERCEPT PSYCHOPHYS, V69, P382, DOI 10.3758/BF03193759; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Nummenmaa L, 2010, J EXP PSYCHOL GEN, V139, P222, DOI 10.1037/a0018858; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Passamonti L, 2008, NEUROIMAGE, V43, P562, DOI 10.1016/j.neuroimage.2008.07.045; Placanica JL, 2002, INT J EAT DISORDER, V32, P79, DOI 10.1002/eat.10066; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	47	58	59	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19215	10.1371/journal.pone.0019215	http://dx.doi.org/10.1371/journal.pone.0019215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	764TP	21603657	Green Published, gold, Green Submitted			2022-12-27	WOS:000290656300003
J	Brown, K; Fraser, G; Ramsay, M; Shanley, R; Cowley, N; van Wijgerden, J; Toff, P; Falconer, M; Hudson, M; Green, J; Kroll, JS; Vincent, C; Sevdalis, N				Brown, Katrina; Fraser, Graham; Ramsay, Mary; Shanley, Ruth; Cowley, Noel; van Wijgerden, Johan; Toff, Penelope; Falconer, Michelle; Hudson, Michael; Green, John; Kroll, J. Simon; Vincent, Charles; Sevdalis, Nick			Attitudinal and Demographic Predictors of Measles-Mumps-Rubella Vaccine (MMR) Uptake during the UK Catch-Up Campaign 2008-09: Cross-Sectional Survey	PLOS ONE			English	Article							IMMUNIZATION; VACCINATIONS; DECISIONS; CHILDREN; REASONS	Background and Objective: Continued suboptimal measles-mumps-rubella (MMR) vaccine uptake has re-established measles epidemic risk, prompting a UK catch-up campaign in 2008-09 for children who missed MMR doses at scheduled age. Predictors of vaccine uptake during catch-ups are poorly understood, however evidence from routine schedule uptake suggests demographics and attitudes may be central. This work explored this hypothesis using a robust evidence-based measure. Design: Cross-sectional self-administered questionnaire with objective behavioural outcome. Setting and Participants: 365 UK parents, whose children were aged 5-18 years and had received < 2 MMR doses before the 2008-09 UK catch-up started. Main Outcome Measures: Parents' attitudes and demographics, parent-reported receipt of invitation to receive catch-up MMR dose(s), and catch-up MMR uptake according to child's medical record (receipt of MMR doses during year 1 of the catch-up). Results: Perceived social desirability/benefit of MMR uptake (OR = 1.76, 95% CI = 1.09-2.87) and younger child age (OR = 0.78, 95% CI = 0.68-0.89) were the only independent predictors of catch-up MMR uptake in the sample overall. Uptake predictors differed by whether the child had received 0 MMR doses or 1 MMR dose before the catch-up. Receipt of catch-up invitation predicted uptake only in the 0 dose group (OR = 3.45, 95% CI = 1.18-10.05), whilst perceived social desirability/benefit of MMR uptake predicted uptake only in the 1 dose group (OR = 9.61, 95% CI = 2.57-35.97). Attitudes and demographics explained only 28% of MMR uptake in the 0 dose group compared with 61% in the 1 dose group. Conclusions: Catch-up MMR invitations may effectively move children from 0 to 1 MMR doses (unimmunised to partially immunised), whilst attitudinal interventions highlighting social benefits of MMR may effectively move children from 1 to 2 MMR doses (partially to fully immunised). Older children may be best targeted through school-based programmes. A formal evaluation element should be incorporated into future catch-up campaigns to inform their continuing improvement.	[Brown, Katrina; Shanley, Ruth; Cowley, Noel; Vincent, Charles; Sevdalis, Nick] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Fraser, Graham] Hlth Protect Agcy, Reg Epidemiol Unit, London, England; [Ramsay, Mary] Hlth Protect Agcy, Ctr Infect, London, England; [van Wijgerden, Johan] NHS Ealing, London, England; [Toff, Penelope] NHS Brent, London, England; [Falconer, Michelle] NHS Halton & St Helens, Chester, Cheshire, England; [Green, John] Cent & NW London NHS Fdn Trust, London, England; [Kroll, J. Simon] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Imperial College London; Health Protection Agency; Health Protection Agency; Imperial College London	Brown, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	Katrina.Brown@imperial.ac.uk	SEVDALIS, NICK/A-8310-2008; Sevdalis, Nick/O-1419-2017; Sevdalis, Nick/AAJ-6280-2020; Vincent, Charles A/D-1134-2010; Ramsay, Mary Elizabeth/S-8281-2016	SEVDALIS, NICK/0000-0001-7560-8924; Sevdalis, Nick/0000-0001-7560-8924; Sevdalis, Nick/0000-0001-7560-8924; Vincent, Charles A/0000-0003-0270-0222; Ramsay, Mary Elizabeth/0000-0002-7156-7640	UK Health Protection Agency; Commissioning Support for London; National Institute for Health Research	UK Health Protection Agency; Commissioning Support for London; National Institute for Health Research(National Institute for Health Research (NIHR))	The research reported here was funded by the UK Health Protection Agency (http://www.hpa.org.uk/) and Commissioning Support for London (http://www.csl.nhs.uk/Pages/default.aspx). Brown, Sevdalis, Shanley, Cowley and Vincent are affiliated with the Imperial College Centre for Patient Safety and Service Quality, which is funded by the National Institute for Health Research (http://www.nihr.ac.uk/Pages/default.aspx). The researchers are independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; Brown KF, 2010, VACCINE; *CAP CATCH UP CAMP, 2007, CAPITAL CATCH UP MMR; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Department of Communities and Local Government, 2007, IND DEPR 2007; Department of Health, 2009, MMR CATCH UP CAMP VA; Department of Health, 2008, MMR CATCH UP PROGR; Dormandy E, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-2; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Elliman D, 2007, ARCH DIS CHILD, V92, P1055, DOI 10.1136/adc.2006.103531; Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692; Flynn M, 2004, BRIT J GEN PRACT, V54, P526; Gellatly J, 2005, FAM PRACT, V22, P658, DOI 10.1093/fampra/cmi066; Hadjikoumi I, 2006, ARCH DIS CHILD, V91, P621, DOI 10.1136/adc.2005.088898; Lashkari HP, 2010, EUROSURVEILLANCE, V15, P32; Lieu TA, 1997, PEDIATR INFECT DIS J, V16, P28, DOI 10.1097/00006454-199701000-00007; *LOND REG IMM STEE, 2009, CHILDH IMM PROGR LON; McCauley MM, 2008, J ADOLESCENT HEALTH, V43, P540, DOI 10.1016/j.jadohealth.2008.08.002; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Office for National Statistics, 2005, NATL STAT SOCIO EC C; Pearce A, 2008, BMJ-BRIT MED J, V336, P754, DOI 10.1136/bmj.39489.590671.25; Roberts KA, 2002, LANCET, V360, P1596, DOI 10.1016/S0140-6736(02)11560-1; ROBERTS RJ, 1995, BRIT MED J, V310, P1629, DOI 10.1136/bmj.310.6995.1629; Sevdalis N, 2007, PSYCHOL SCI, V18, P678, DOI 10.1111/j.1467-9280.2007.01958.x; Smith A, 2007, VACCINE, V25, P3996, DOI 10.1016/j.vaccine.2007.02.071	25	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19381	10.1371/journal.pone.0019381	http://dx.doi.org/10.1371/journal.pone.0019381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763LP	21602931	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500009
J	He, H; Nehete, PN; Nehete, B; Wieder, E; Yang, GJ; Buchl, S; Sastry, KJ				He, Hong; Nehete, Pramod N.; Nehete, Bharti; Wieder, Eric; Yang, Guojun; Buchl, Stephanie; Sastry, K. Jagannadha			Functional Impairment of Central Memory CD4 T Cells Is a Potential Early Prognostic Marker for Changing Viral Load in SHIV-Infected Rhesus Macaques	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; SIV; RESPONSES; DECLINE; VACCINE; AIDS; LYMPHOCYTES; GENERATION; PROTECTION	In HIV infection there is a paucity of literature about the degree of immune dysfunction to potentially correlate and/or predict disease progression relative to CD4(+) T cells count or viral load. We assessed functional characteristics of memory T cells subsets as potential prognostic markers for changing viral loads and/or disease progression using the SHIV-infected rhesus macaque model. Relative to long-term non-progressors with low/undetectable viral loads, those with chronic plasma viremia, but clinically healthy, exhibited significantly lower numbers and functional impairment of CD4(+) T cells, but not CD8(+) T cells, in terms of IL-2 production by central memory subset in response to PMA and ionomycine (PMA+I) stimulation. Highly viremic animals showed impaired cytokine-production by all T cells subsets. These results suggest that functional impairment of CD4(+) T cells in general, and of central memory subset in particular, may be a potential indicator/predictor of chronic infection with immune dysfunction, which could be assayed relatively easily using non-specific PMA+I stimulation.	[He, Hong; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Nehete, Pramod N.; Nehete, Bharti; Buchl, Stephanie; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Houston, TX 77030 USA; [Wieder, Eric] Univ Miami, Dept Med, Miami, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Miami	He, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jsastry@mdanderson.org		Sastry, Jagannadha/0000-0002-6987-4422; Nehete, Pramod/0000-0002-2815-2677	National Institute of Allergy and Infectious Diseases [AI 046969, AI 078898, AI 426969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046969, R21AI078898] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institute of Allergy and Infectious Diseases AI 046969, AI 078898, and AI 426969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno PM, 2006, J IMMUNOL, V176, P5338, DOI 10.4049/jimmunol.176.9.5338; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Cohen J, 2002, SCIENCE, V296, P2325, DOI 10.1126/science.296.5577.2325; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Mattapallil JJ, 2004, AIDS, V18, P13, DOI 10.1097/00002030-200401020-00002; Nehete PN, 2005, VACCINE, V23, P2154, DOI 10.1016/j.vaccine.2005.01.052; Nehete PN, 2008, VIROLOGY, V370, P130, DOI 10.1016/j.virol.2007.08.022; Nishimura Y, 2007, J VIROL, V81, P893, DOI 10.1128/JVI.01635-06; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Roederer M, 2004, CLIN IMMUNOL, V110, P199, DOI 10.1016/j.clim.2003.11.015; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Suryanarayana K, 1998, AIDS RES HUM RETROV, V14, P183, DOI 10.1089/aid.1998.14.183; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19607	10.1371/journal.pone.0019607	http://dx.doi.org/10.1371/journal.pone.0019607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602924	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500015
J	O'Donovan, A; Pantell, MS; Puterman, E; Dhabhar, FS; Blackburn, EH; Yaffe, K; Cawthon, RM; Opresko, PL; Hsueh, WC; Satterfield, S; Newman, AB; Ayonayon, HN; Rubin, SM; Harris, TB; Epel, ES				O'Donovan, Aoife; Pantell, Matthew S.; Puterman, Eli; Dhabhar, Firdaus S.; Blackburn, Elizabeth H.; Yaffe, Kristine; Cawthon, Richard M.; Opresko, Patricia L.; Hsueh, Wen-Chi; Satterfield, Suzanne; Newman, Anne B.; Ayonayon, Hilsa N.; Rubin, Susan M.; Harris, Tamara B.; Epel, Elissa S.		Hlth Aging Body Composition Study	Cumulative Inflammatory Load Is Associated with Short Leukocyte Telomere Length in the Health, Aging and Body Composition Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; CALORIE RESTRICTION; HUMAN HEPATOCYTES; DNA-DAMAGE; MORTALITY; RISK; INTERLEUKIN-6; CANCER; CELLS	Background: Leukocyte telomere length (LTL) is an emerging marker of biological age. Chronic inflammatory activity is commonly proposed as a promoter of biological aging in general, and of leukocyte telomere shortening in particular. In addition, senescent cells with critically short telomeres produce pro-inflammatory factors. However, in spite of the proposed causal links between inflammatory activity and LTL, there is little clinical evidence in support of their covariation and interaction. Methodology/Principal Findings: To address this issue, we examined if individuals with high levels of the systemic inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP) had increased odds for short LTL. Our sample included 1,962 high-functioning adults who participated in the Health, Aging and Body Composition Study (age range: 70-79 years). Logistic regression analyses indicated that individuals with high levels of either IL-6 or TNF-alpha had significantly higher odds for short LTL. Furthermore, individuals with high levels of both IL-6 and TNF-alpha had significantly higher odds for short LTL compared with those who had neither high (OR = 0.52, CI = 0.37-0.72), only IL-6 high (OR = 0.57, CI = 0.39-0.83) or only TNF-alpha high (OR = 0.67, CI = 0.46-0.99), adjusting for a wide variety of established risk factors and potential confounds. In contrast, CRP was not associated with LTL. Conclusions/Significance: Results suggest that cumulative inflammatory load, as indexed by the combination of high levels of IL-6 and TNF-alpha, is associated with increased odds for short LTL. In contrast, high levels of CRP were not accompanied by short LTL in this cohort of older adults. These data provide the first large-scale demonstration of links between inflammatory markers and LTL in an older population.	[O'Donovan, Aoife; Puterman, Eli; Yaffe, Kristine; Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [O'Donovan, Aoife; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, Berkeley, CA 94720 USA; [Pantell, Matthew S.] Univ Calif Berkeley, Univ Calif, San Francisco Joint Med Program, San Francisco, CA USA; [Dhabhar, Firdaus S.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine; Hsueh, Wen-Chi; Ayonayon, Hilsa N.; Rubin, Susan M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Opresko, Patricia L.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Hsueh, Wen-Chi] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN 38163 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Harris, Tamara B.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA	O'Donovan, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	aoife.odonovan@ucsf.edu	Puterman, Eli/AAA-5237-2022; Newman, Anne B./C-6408-2013	Puterman, Eli/0000-0002-5898-2348; Newman, Anne B./0000-0002-0106-1150; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health (NIH) National Institute on Aging (NIA) [AG-6-2101, AG-6-2103, AG-6-2106, AG021918]; Society in Science: The Branco Weiss Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021918, N01AG062103, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Society in Science: The Branco Weiss Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was conducted on behalf of the Health, Aging and Body Composition (Health ABC) Study and was funded by National Institutes of Health (NIH) National Institute on Aging (NIA) grants AG-6-2101, AG-6-2103, AG-6-2106, and AG021918. This work was also supported by the Intramural Research Program of the NIH, NIA as well as by Society in Science: The Branco Weiss Fellowship (AOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862; Akiyama M, 2004, BIOCHEM BIOPH RES CO, V316, P528, DOI 10.1016/j.bbrc.2004.02.080; AVIV A, 2004, TELOMERES HUMAN AGIN, pPE43; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Calabro P, 2003, CIRCULATION, V108, P1930, DOI 10.1161/01.CIR.0000096055.62724.C5; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Jaiswal M, 2000, CANCER RES, V60, P184; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; MANGAN DF, 1991, J IMMUNOL, V147, P3408; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Nishida H, 2011, CYTOKINE, V53, P342, DOI 10.1016/j.cyto.2010.12.005; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Parish ST, 2009, J IMMUNOL, V182, P4237, DOI 10.4049/jimmunol.0803449; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Volpato S, 2001, CIRCULATION, V103, P947; Weinhold B, 1997, BIOCHEM J, V325, P617, DOI 10.1042/bj3250617; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318	52	219	223	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19687	10.1371/journal.pone.0019687	http://dx.doi.org/10.1371/journal.pone.0019687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602933	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000290558500023
J	Omori, Y; Katoh, K; Sato, S; Muranishi, Y; Chaya, T; Onishi, A; Minami, T; Fujikado, T; Furukawa, T				Omori, Yoshihiro; Katoh, Kimiko; Sato, Shigeru; Muranishi, Yuki; Chaya, Taro; Onishi, Akishi; Minami, Takashi; Fujikado, Takashi; Furukawa, Takahisa			Analysis of Transcriptional Regulatory Pathways of Photoreceptor Genes by Expression Profiling of the Otx2-Deficient Retina	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; HOMEOBOX GENE; SYNAPSE FORMATION; HORMONE-RECEPTOR; CELL FATE; MUTATIONS; CRX; DISEASE; PROTEIN; IDENTIFICATION	In the vertebrate retina, the Otx2 transcription factor plays a crucial role in the cell fate determination of both rod and cone photoreceptors. We previously reported that Otx2 conditional knockout (CKO) mice exhibited a total absence of rods and cones in the retina due to their cell fate conversion to amacrine-like cells. In order to investigate the entire transcriptome of the Otx2 CKO retina, we compared expression profile of Otx2 CKO and wild-type retinas at P1 and P12 using microarray. We observed that expression of 101- and 1049-probe sets significantly decreased in the Otx2 CKO retina at P1 and P12, respectively, whereas, expression of 3- and 4149-probe sets increased at P1 and P12, respectively. We found that expression of genes encoding transcription factors involved in photoreceptor development, including Crx, Nrl, Nr2e3, Esrrb, and NeuroD, was markedly down-regulated in the Otx2 CKO at both P1 and P12. Furthermore, we identified three human retinal disease loci mapped in close proximity to certain down-regulated genes in the Otx2 CKO retina including Ccdc126, Tnfsf13 and Pitpnm1, suggesting that these genes are possibly responsible for these diseases. These transcriptome data sets of the Otx2 CKO retina provide a resource on developing rods and cones to further understand the molecular mechanisms underlying photoreceptor development, function and disease.	[Omori, Yoshihiro; Katoh, Kimiko; Sato, Shigeru; Muranishi, Yuki; Chaya, Taro; Onishi, Akishi; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Omori, Yoshihiro; Chaya, Taro; Onishi, Akishi; Furukawa, Takahisa] CREST, JST, Osaka, Japan; [Sato, Shigeru; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Sato, Shigeru; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Visual Sci, Osaka, Japan; [Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; University of Tokyo	Omori, Y (corresponding author), Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan.	furukawa@obi.or.jp			Japan Science and Technology Agency [4118]; Ministry of Education, Culture, Sports, Science and Technology [20390087, 21790295]; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Novartis Foundation [20-10]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation [S-2144]; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness; Grants-in-Aid for Scientific Research [23790348] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Japan National Society for the Prevention of Blindness(Japan National Society for the Prevention of Blindness); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST and PRESTO (#4118) from Japan Science and Technology Agency (http://www.jst.go.jp/), and a Grant for Molecular Brain Science, a Grant-in-Aid for Scientific Research (B) (#20390087), Young Scientists (B) (#21790295), from Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/), The Takeda Science Foundation (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (http://www.ueharazaidan.com/), Naito Foundation (http://www.naito-f.or.jp/), Novartis Foundation (#20-10, http://novartisfound.or.jp/), Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/), Senri Life Science Foundation (#S-2144, http://www.senri-life.or.jp/), Kato Memorial Bioscience Foundation (http://www.katokinen.or.jp/), and Japan National Society for the Prevention of Blindness (http://www.nichigan.or.jp/link/situmei.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hughes AE, 1998, J MED GENET, V35, P770, DOI 10.1136/jmg.35.9.770; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; TOKUYASU K, 1959, J BIOPHYS BIOCHEM CY, V6, P225, DOI 10.1083/jcb.6.2.225; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wakabayashi T, 2008, NEUROSCI LETT, V442, P249, DOI 10.1016/j.neulet.2008.07.030; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	53	50	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19685	10.1371/journal.pone.0019685	http://dx.doi.org/10.1371/journal.pone.0019685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602925	Green Published, Green Submitted, gold			2022-12-27	WOS:000290558500022
J	Dejean, A				Dejean, Alain			Prey Capture Behavior in an Arboreal African Ponerine Ant	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; PREDATORY BEHAVIOR; MANDIBULAR GLAND; HYMENOPTERA; FORMICIDAE; DIVERSIFICATION; EVOLUTION; COCOA	I studied the predatory behavior of Platythyrea conradti, an arboreal ponerine ant, whereas most species in this subfamily are ground-dwelling. The workers, which hunt solitarily only around dusk, are able to capture a wide range of prey, including termites and agile, nocturnal insects as well as diurnal insects that are inactive at that moment of the Nyctemeron, resting on tree branches or under leaves. Prey are captured very rapidly, and the antennal palpation used by ground-dwelling ponerine species is reduced to a simple contact; stinging occurs immediately thereafter. The venom has an instant, violent effect as even large prey (up to 30 times the weight of a worker) never struggled after being stung. Only small prey are not stung. Workers retrieve their prey, even large items, singly. To capture termite workers and soldiers defending their nest entrances, ant workers crouch and fold their antennae backward. In their role as guards, the termites face the crouching ants and end up by rolling onto their backs, their legs batting the air. This is likely due to volatile secretions produced by the ants' mandibular gland. The same behavior is used against competing ants, including territorially-dominant arboreal species that retreat further and further away, so that the P. conradti finally drive them from large, sugary food sources.	[Dejean, Alain] CNRS, Ecol Forets Guyane UMR 8172, Kourou, France; [Dejean, Alain] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr		Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique [2ID]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGER M, 1993, B ENTOMOL RES, V83, P475, DOI 10.1017/S0007485300039912; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; CERDA X, 2011, PREDATION HYMENOPTER, pCH4; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DAVIDSON DW, 1996, PUBLICATION U CALIFO, V1, P127; Dejean A, 1997, NATURWISSENSCHAFTEN, V84, P76, DOI 10.1007/s001140050352; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; DEJEAN A, 1990, WESTV STUD, P472; DEJEAN A, 1994, SOCIOBIOLOGY, V23, P293; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011331; Djieto-Lordon C, 2001, INSECT SOC, V48, P324, DOI 10.1007/PL00001784; Djieto-Lordon C, 2001, SOCIOBIOLOGY, V38, P765; Djieto-Lordon C., 2006, Selbyana, V27, P79; Grimaldi David, 2005, pi; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; Hunt JH, 2003, SCIENCE, V300, P916, DOI 10.1126/science.1085065; Kenne M, 2009, MYRMECOL NEWS, V12, P109; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; MAJER JD, 1972, B ENTOMOL RES, V62, P151, DOI 10.1017/S0007485300047593; Majer Jonathan D., 1993, P115; Molet M, 2006, INSECT SOC, V53, P177, DOI 10.1007/s00040-005-0856-3; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morgan ED, 1999, J CHEM ECOL, V25, P1395, DOI 10.1023/A:1020987028163; Orivel J, 2000, SOCIOBIOLOGY, V35, P131; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Orivel J, 2001, TOXICON, V39, P195, DOI 10.1016/S0041-0101(00)00113-6; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Schmidt CA, 2009, MOL PHYLOGENETICS TA; Tobin John E., 1994, P279; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Wood WF, 2006, BIOCHEM SYST ECOL, V34, P536, DOI 10.1016/j.bse.2006.01.002; Yeo K, 2006, INSECT SOC, V53, P435, DOI 10.1007/s00040-005-0890-9	41	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19837	10.1371/journal.pone.0019837	http://dx.doi.org/10.1371/journal.pone.0019837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589941	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600033
J	Ng, KM; Lee, YK; Lai, WH; Chan, YC; Fung, ML; Tse, HF; Siu, CW				Ng, Kwong-Man; Lee, Yee-Ki; Lai, Wing-Hon; Chan, Yau-Chi; Fung, Man-Lung; Tse, Hung-Fat; Siu, Chung-Wah			Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; CARDIOMYOCYTE DIFFERENTIATION; SIGNAL-TRANSDUCTION; MOUSE; HEART; HDL; CARDIOMYOGENESIS; TRANSCRIPTION	The cardioprotective effects of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (apoA-I) are well documented, but their effects in the direction of the cardiac differentiation of embryonic stem cells are unknown. We evaluated the effects of exogenous apoA-I expression on cardiac differentiation of ESCs and maturation of ESC-derived cardiomyocytes. We stably over-expressed full-length human apoA-I cDNA with lentivirus (LV)-mediated gene transfer in undifferentiated mouse ESCs and human induced pluripotent stem cells. Upon cardiac differentiation, we observed a significantly higher percentage of beating embryoid bodies, an increased number of cardiomyocytes as determined by flow cytometry, and expression of cardiac markers including alpha-myosin heavy chain, beta-myosin heavy chain and myosin light chain 2 ventricular transcripts in LV-apoA-I transduced ESCs compared with control (LV-GFP). In the presence of noggin, a BMP4 antagonist, activation of BMP4-SMAD signaling cascade in apoA-I transduced ESCs completely abolished the apoA-I stimulated cardiac differentiation. Furthermore, co-application of recombinant apoA-I and BMP4 synergistically increased the percentage of beating EBs derived from untransduced D3 ESCs. These together suggests that that pro-cardiogenic apoA-I is mediated via the BMP4-SMAD signaling pathway. Functionally, cardiomyocytes derived from the apoA-I-transduced cells exhibited improved calcium handling properties in both non-caffeine and caffeine-induced calcium transient, suggesting that apoA-I plays a role in enhancing cardiac maturation. This increased cardiac differentiation and maturation has also been observed in human iPSCs, providing further evidence of the beneficial effects of apoA-I in promoting cardiac differentiation. In Conclusion, we present novel experimental evidence that apoA-I enhances cardiac differentiation of ESCs and iPSCs and promotes maturation of the calcium handling property of ESC-derived cardiomyocytes via the BMP4/SMAD signaling pathway.	[Ng, Kwong-Man; Fung, Man-Lung; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Ageing, Stem Cell & Regenerat Med Program, Hong Kong, Hong Kong, Peoples R China; [Ng, Kwong-Man; Fung, Man-Lung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Ng, Kwong-Man; Lee, Yee-Ki; Lai, Wing-Hon; Chan, Yau-Chi; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Ng, KM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Ageing, Stem Cell & Regenerat Med Program, Hong Kong, Hong Kong, Peoples R China.	hftse@hkucc.hku.hk; cwdsiu@hkucc.hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Chan, Yau Chi/C-4547-2009; Lee, Yee Ki/C-8692-2011	Tse, Hung-Fat/0000-0002-9578-7808; Chan, Yau Chi/0000-0003-0854-0506	HKU [201007176133]; Sun Chieh Yeh Heart Foundation	HKU(University of Hong Kong); Sun Chieh Yeh Heart Foundation	This work was supported by the HKU Small Project Funding (201007176133) to Kwong-Man Ng, Chung-Wah Siu and Hung-Fat Tse, and research funding from Sun Chieh Yeh Heart Foundation to Chung-Wah Siu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au KW, 2009, BIOCHEM BIOPH RES CO, V379, P898, DOI 10.1016/j.bbrc.2008.12.160; Baroukh N, 2004, FEBS LETT, V557, P39, DOI 10.1016/S0014-5793(03)01429-7; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bers Donald M, 2006, Biochem J, V396, pe1; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DeGeorge BR, 2008, CTS-CLIN TRANSL SCI, V1, P116, DOI 10.1111/j.1752-8062.2008.00034.x; Frias M.A., CARDIOVASC RES, V85, P118; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Jamali M, 2001, FEBS LETT, V509, P126, DOI 10.1016/S0014-5793(01)03151-9; Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160; Lagostena L, 2005, CARDIOVASC RES, V66, P482, DOI 10.1016/j.cardiores.2005.01.018; Lane D M, 2001, Curr Opin Investig Drugs, V2, P1235; LEE YK, MOL ENDOCRINOL, V24, P1728; LIAO SY, HEART RHYTHM; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Liu J, 2009, AM J PHYSIOL-CELL PH, V297, pC152, DOI 10.1152/ajpcell.00060.2009; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MALTSEV VA, 1994, IMMUNOL LETT, V42, P41, DOI 10.1016/0165-2478(94)90033-7; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mineo C, 2003, TRENDS CARDIOVAS MED, V13, P226, DOI 10.1016/S1050-1738(03)00098-7; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moore JC, 2005, REPROD TOXICOL, V20, P377, DOI 10.1016/j.reprotox.2005.04.012; Nakajima Y, 2002, DEV BIOL, V245, P291, DOI 10.1006/dbio.2002.0637; NG KM, J MOL CELL CARDIOL; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Siu Chung Wah, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P145; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Tahaa MF, 2008, INT J CARDIOL, V127, P78, DOI 10.1016/j.ijcard.2007.04.173; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; TAO R, AM J PHYSL HEART CIR, V298, P1022; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu JZ, 2010, STEM CELLS DEV, V19, P1723, DOI 10.1089/scd.2010.0066; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang X, 1999, DEVELOPMENT, V126, P1571; Yao YC, 2008, ARTERIOSCL THROM VAS, V28, P2266, DOI 10.1161/ATVBAHA.108.176958; YEH BK, 1968, J GEN PHYSIOL, V52, P666; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2011	6	5							e19787	10.1371/journal.pone.0019787	http://dx.doi.org/10.1371/journal.pone.0019787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762MQ	21589943	Green Published, gold, Green Submitted			2022-12-27	WOS:000290483600030
J	Zang, LS; Liu, TX; Wan, FH				Zang, Lian-Sheng; Liu, Tong-Xian; Wan, Fang-Hao			Reevaluation of the Value of Autoparasitoids in Biological Control	PLOS ONE			English	Article							TABACI GENNADIUS HOMOPTERA; ENCARSIA-TRICOLOR; APHELINIDAE HYMENOPTERA; SEX DETERMINATION; HOST SELECTION; MALE EGGS; PARASITOIDS; ALEYRODIDAE; BEMISIA; HYPERPARASITISM	Autoparasitoids with the capacity of consuming primary parasitoids that share the same hosts to produce males are analogous to intraguild predators. The use of autoparasitoids in biological control programs is a controversial matter because there is little evidence to support the view that autoparasitoids do not disrupt and at times may promote suppression of insect pests in combination with primary parasitoids. We found that Encarsia sophia, a facultative autoparasitoid, preferred to use heterospecific hosts as secondary hosts for producing males. The autoparasitoids mated with males originated from heterospecifics may parasitize more hosts than those mated with males from conspecifics. Provided with an adequate number of males, the autoparasitoids killed more hosts than En. formosa, a commonly used parasitoid for biological control of whiteflies. This study supports the view that autoparasitoids in combination with primary parasitoids do not disrupt pest management and may enhance such programs. The demonstrated preference of an autoparasitoid for heterospecifics and improved performance of males from heterospecifics observed in this study suggests these criteria should be considered in strategies that endeavor to mass-produce and utilize autoparasitoids in the future.	[Zang, Lian-Sheng] Jilin Agr Univ, Inst Biol Control, Changchun, Peoples R China; [Liu, Tong-Xian] NW A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China; [Zang, Lian-Sheng; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Jilin Agricultural University; Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zang, LS (corresponding author), Jilin Agr Univ, Inst Biol Control, Changchun, Peoples R China.	txliu@nwsuaf.edu.cn; wanfangh@public3.bta.net.cn			National Natural Science Foundation of China [30930062, 31071735]; National Basic Research and Development Program of China [2009CB119200]; Northwest AF University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China); Northwest AF University	The research was partially supported by the National Natural Science Foundation of China (30930062 and 31071735) (provided partial support to the first author's research), the National Basic Research and Development Program of China (2009CB119200) (provided partial support the salary for LSZ and FHW) and Northwest A&F University (provided partial salary to TXL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2004, BIOL CONTROL, V30, P546, DOI 10.1016/j.biocontrol.2004.01.018; Antony B, 2003, ENVIRON ENTOMOL, V32, P584, DOI 10.1603/0046-225X-32.3.584; AVILLA J, 1991, ENTOMOL EXP APPL, V59, P219, DOI 10.1007/BF00189364; Bernal JS, 2001, BIOL CONTROL, V20, P210, DOI 10.1006/bcon.2000.0905; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; Briggs CJ, 2001, THEOR POPUL BIOL, V60, P33, DOI 10.1006/tpbi.2001.1529; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; CLARKE SR, 1989, CAN ENTOMOL, V121, P853, DOI 10.4039/Ent121853-10; DOWELL RV, 1979, ENVIRON ENTOMOL, V8, P595, DOI 10.1093/ee/8.4.595; EHLER LE, 1979, ENVIRON ENTOMOL, V8, P829, DOI 10.1093/ee/8.5.829; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; GERLING D, 1985, ENTOMOPHAGA, V30, P163, DOI 10.1007/BF02372249; Heinz KM, 1996, BIOL CONTROL, V6, P384, DOI 10.1006/bcon.1996.0049; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huang Y, 2009, BIOCONTROL, V54, P411, DOI 10.1007/s10526-008-9189-2; Hunter MS, 2002, ECOLOGY, V83, P1459, DOI 10.1890/0012-9658(2002)083[1459:DAADHS]2.0.CO;2; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Hunter MS, 1998, ENTOMOL EXP APPL, V89, P249, DOI 10.1023/A:1003555607725; HUNTER MS, 1989, ENTOMOPHAGA, V34, P265, DOI 10.1007/BF02372675; KENNETT CE, 1966, HILGARDIA, V37, P255, DOI 10.3733/hilg.v37n09p255; Loomans A. J. M., 2002, Bulletin OILB/SROP, V25, P143; Mills NJ, 1996, J APPL ECOL, V33, P1379, DOI 10.2307/2404778; NGUYEN R, 1983, Environmental Entomology, V12, P878; NGUYEN R, 1987, ANN ENTOMOL SOC AM, V80, P713, DOI 10.1093/aesa/80.6.713; Parkes GT, 2001, AUST J ENTOMOL, V40, P74, DOI 10.1046/j.1440-6055.2001.00208.x; Pedata PA, 1996, ENTOMOL EXP APPL, V81, P207, DOI 10.1007/BF00192146; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; *SAS I, 2006, SAS STAT VERS 9 1; THOMPSON CR, 1987, ENVIRON ENTOMOL, V16, P140, DOI 10.1093/ee/16.1.140; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Walter GH, 2006, ENTOMOL EXP APPL, V118, P97, DOI 10.1111/j.1570-7458.2006.00373.x; WALTER GH, 1983, BIOL J LINN SOC, V19, P63, DOI 10.1111/j.1095-8312.1983.tb00777.x; West SA, 2000, ECOL LETT, V3, P294, DOI 10.1046/j.1461-0248.2000.00153.x; WILK BM, 1981, ENTOMOPHAGA, V26, P313, DOI 10.1007/BF02371881; WILLIAMS JR, 1972, B ENTOMOL RES, V61, P463, DOI 10.1017/S0007485300047337; WILLIAMS JR, 1977, ENTOMOPHAGA, V22, P345, DOI 10.1007/BF02373258; WILLIAMS T, 1995, BIOL CONTROL, V5, P209, DOI 10.1006/bcon.1995.1026; WILLIAMS T, 1991, ECOL ENTOMOL, V16, P377, DOI 10.1111/j.1365-2311.1991.tb00230.x; Williams T, 1996, BIOCONTROL SCI TECHN, V6, P603, DOI 10.1080/09583159631244; YU DS, 1990, ECOL ENTOMOL, V15, P469, DOI 10.1111/j.1365-2311.1990.tb00830.x; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zang LS, 2010, ENVIRON ENTOMOL, V39, P912, DOI 10.1603/EN09266; Zang LS, 2009, BIOCONTROL SCI TECHN, V19, P573, DOI 10.1080/09583150902912673; ZANG LS, 2011, INSECT SCI IN PRESS	45	20	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20324	10.1371/journal.pone.0020324	http://dx.doi.org/10.1371/journal.pone.0020324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633501	Green Published, gold, Green Submitted			2022-12-27	WOS:000291006500056
J	Hernandez, R; Cabalceta, C; Saravia-Otten, P; Chaves, A; Gutierrez, JM; Rucavado, A				Hernandez, Rosario; Cabalceta, Carmen; Saravia-Otten, Patricia; Chaves, Alessandra; Maria Gutierrez, Jose; Rucavado, Alexandra			Poor Regenerative Outcome after Skeletal Muscle Necrosis Induced by Bothrops asper Venom: Alterations in Microvasculature and Nerves	PLOS ONE			English	Article							LOCAL TISSUE-DAMAGE; SNAKE-VENOM; HEMORRHAGIC METALLOPROTEINASES; PHOSPHOLIPASES A(2); IN-VITRO; APOPTOSIS; MECHANISMS; PATHOLOGY; MYOTOXIN; NEUROTOXINS	Background: Viperid snakebite envenoming is characterized by prominent local tissue damage, including muscle necrosis. A frequent outcome of such local pathology is deficient skeletal muscle regeneration, which causes muscle dysfunction, muscle loss and fibrosis, thus provoking permanent sequelae that greatly affect the quality of life of patients. The causes of such poor regenerative outcome of skeletal muscle after viperid snakebites are not fully understood. Methodology/Principal Findings: A murine model of muscle necrosis and regeneration was adapted to study the effects of the venom and isolated toxins of Bothrops asper, the medically most important snake in Central America. Gastrocnemius muscle was injected with either B. asper venom, a myotoxic phospholipase A(2) (Mtx), a hemorrhagic metalloproteinase (SVMP), or saline solution. At various time intervals, during one month, tissue samples were collected and analyzed by histology, and by immunocytochemical and immunohistochemical techniques aimed at detecting muscle fibers, collagen, endothelial cells, myoblasts, myotubes, macrophages, TUNEL-positive nuclei, and axons. A successful regenerative response was observed in muscle injected with Mtx, which induces myonecrosis but does not affect the microvasculature. In contrast, poor regeneration, with fibrosis and atrophic fibers, occurred when muscle was injected with venom or SVMP, both of which provoke necrosis, microvascular damage leading to hemorrhage, and poor axonal regeneration. Conclusions/Significance: The deficient skeletal muscle regeneration after injection of B. asper venom is likely to depend on the widespread damage to the microvasculature, which affects the removal of necrotic debris by phagocytes, and the provision of nutrients and oxygen required for regeneration. In addition, deficient axonal regeneration is likely to contribute to the poor regenerative outcome in this model.	[Hernandez, Rosario; Saravia-Otten, Patricia] Univ San Carlos, Fac Ciencias Quim & Farm, Finca San Isidro, Guatemala; [Hernandez, Rosario; Cabalceta, Carmen; Chaves, Alessandra; Maria Gutierrez, Jose; Rucavado, Alexandra] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica	Universidad de San Carlos de Guatemala; Universidad Costa Rica	Hernandez, R (corresponding author), Univ San Carlos, Fac Ciencias Quim & Farm, Finca San Isidro, Guatemala.	alexandra.rucavado@ucr.ac.cr	Rucavado, Alexandra/AGY-1867-2022; Gutiérrez, José/GSJ-1846-2022	Gutierrez, Jose Maria/0000-0001-8385-3081	NeTropica [2-N-2008]; Vicerrectoria de Investigacion, Universidad de Costa Rica [741-A7-604]	NeTropica; Vicerrectoria de Investigacion, Universidad de Costa Rica	This study was supported by NeTropica (grant 2-N-2008), by Vicerrectoria de Investigacion, Universidad de Costa Rica (project 741-A7-604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1; ARCE V, 1991, INT J EXP PATHOL, V72, P211; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; CANTINI M, 1995, J NEUROPATH EXP NEUR, V54, P121, DOI 10.1097/00005072-199501000-00014; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cintra-Francischinelli M, 2009, CELL MOL LIFE SCI, V66, P1718, DOI 10.1007/s00018-009-9053-2; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Fan H.W., 1995, HDB CLIN TOXICOLOGY, P667; Franca FOS, 2003, ANIMAIS PECONHENTOS, P72; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Gutierrez J.M, 1997, VENOM PHOSPHOLIPASE, P321; Gutierrez J. M., 2003, ANIMAIS PECONHENTOS, P310, DOI DOI 10.1590/S0036-46652003000600009; Gutierrez J.M., 2010, HDB VENOMS TOXINS RE, P491; GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, EXP MOL PATHOL, V62, P28, DOI 10.1006/exmp.1995.1004; GUTIERREZ JM, 1984, TOXICON, V22, P719, DOI 10.1016/0041-0101(84)90155-7; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Hamza L, 2010, TOXICON, V56, P381, DOI 10.1016/j.toxicon.2010.04.001; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HELUANY NF, 1992, TOXICON, V30, P1203, DOI 10.1016/0041-0101(92)90436-9; Kalhovde JM, 2005, J PHYSIOL-LONDON, V562, P847, DOI 10.1113/jphysiol.2004.073684; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Gutierrez JM, 2010, TOXICON, V55, P166, DOI 10.1016/j.toxicon.2009.08.006; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; Otero-Patino R, 2009, TOXICON, V54, P998, DOI 10.1016/j.toxicon.2009.07.001; Queiroz LD, 2002, TOXICON, V40, P1483, DOI 10.1016/S0041-0101(02)00166-6; QUEIROZ LS, 1984, TOXICON, V22, P339, DOI 10.1016/0041-0101(84)90077-1; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rucavado A, 1998, INT J EXP PATHOL, V79, P245; Salvini TF, 2001, TOXICON, V39, P641, DOI 10.1016/S0041-0101(00)00188-4; Sandri M, 1998, LAB INVEST, V78, P1005; Santo Neto H., 2005, Toxicon, V46, P814, DOI 10.1016/j.toxicon.2005.08.013; Schiaffino S., 2008, SKELETAL MUSCLE REPA; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Siu PM, 2009, FRONT BIOSCI-LANDMRK, V14, P432, DOI 10.2741/3253; Slater Clarke R., 2008, V3, P303; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; Tidball James G., 2008, V3, P243; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; Warrell D.A., 1996, ENVENOMINGS THEIR TR, P63; Warrell D.A., 2004, VENOMOUS REPTILES W, P709; WHO, 2007, RAB ENV NEGL PUBL HL	60	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19834	10.1371/journal.pone.0019834	http://dx.doi.org/10.1371/journal.pone.0019834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629691	gold, Green Published			2022-12-27	WOS:000291005800013
J	Buldu, JM; Bajo, R; Maestu, F; Castellanos, N; Leyva, I; Gil, P; Sendina-Nadal, I; Almendral, JA; Nevado, A; del-Pozo, F; Boccaletti, S				Buldu, Javier M.; Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Leyva, Inmaculada; Gil, Pablo; Sendina-Nadal, Irene; Almendral, Juan A.; Nevado, Angel; del-Pozo, Francisco; Boccaletti, Stefano			Reorganization of Functional Networks in Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMER-DISEASE; MEMORY TASK; CONNECTIVITY; ATTENTION	Whether the balance between integration and segregation of information in the brain is damaged in Mild Cognitive Impairment (MCI) subjects is still a matter of debate. Here we characterize the functional network architecture of MCI subjects by means of complex networks analysis. Magnetoencephalograms (MEG) time series obtained during a memory task were evaluated by synchronization likelihood (SL), to quantify the statistical dependence between MEG signals and to obtain the functional networks. Graphs from MCI subjects show an enhancement of the strength of connections, together with an increase in the outreach parameter, suggesting that memory processing in MCI subjects is associated with higher energy expenditure and a tendency toward random structure, which breaks the balance between integration and segregation. All features are reproduced by an evolutionary network model that simulates the degenerative process of a healthy functional network to that associated with MCI. Due to the high rate of conversion from MCI to Alzheimer Disease (AD), these results show that the analysis of functional networks could be an appropriate tool for the early detection of both MCI and AD.	[Buldu, Javier M.; Leyva, Inmaculada; Sendina-Nadal, Irene; Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Fuenlabrada, Spain; [Buldu, Javier M.; Leyva, Inmaculada; Sendina-Nadal, Irene; Almendral, Juan A.] Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain; [Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Nevado, Angel; del-Pozo, Francisco] Politecn Madrid, Ctr Biomed Technol, Cognit & Computat Neurosci Lab, Madrid, Spain; [Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Nevado, Angel; del-Pozo, Francisco] Complutense Univ Madrid UPM UCM, Madrid, Spain; [Gil, Pablo] Hosp Clin San Carlos, Memory Unit, Madrid, Spain; [Boccaletti, Stefano] Ctr Biomed Technol, Computat Syst Biol Grp, Madrid, Spain; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Florence, Italy	Universidad Rey Juan Carlos; Universidad Politecnica de Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Buldu, JM (corresponding author), Univ Rey Juan Carlos, Complex Syst Grp, Fuenlabrada, Spain.	javier.buldu@urjc.es	Castellanos, Nazareth/AAA-8812-2020; Buldu, Javier/N-5422-2014; Almendral, Juan/ABC-8025-2021; Boccaletti, Stefano/U-7603-2019; Maestu, Fernando/E-3213-2012; maestu, fernando/M-7480-2019; Buldu, Javier Martin/R-8167-2018; Nevado, Angel/O-1861-2013; Leyva, I./M-1820-2013; Nevado, Angel/H-8619-2015; Sendiña-Nadal, Irene/M-3083-2013; Bajo, Ricardo/AAA-5541-2019; POZO GUERRERO, FRANCISCO DEL/H-6668-2015	Buldu, Javier/0000-0002-9345-599X; Almendral, Juan/0000-0003-1100-7446; Boccaletti, Stefano/0000-0002-5758-7012; Maestu, Fernando/0000-0002-3195-0071; maestu, fernando/0000-0002-3195-0071; Leyva, I./0000-0001-9634-5385; Nevado, Angel/0000-0002-1660-8294; Sendiña-Nadal, Irene/0000-0003-0432-235X; POZO GUERRERO, FRANCISCO DEL/0000-0001-9919-9125; Bajo, Ricardo/0000-0003-0646-2962; Castellanos, Nazareth/0000-0002-3508-7316	Obra Social Caja Madrid; Spanish Ministry of ST [FIS2009-07072, PSI2009-14415-C03-01]; Community of Madrid [S2009ESP-1691]	Obra Social Caja Madrid; Spanish Ministry of ST; Community of Madrid(Comunidad de Madrid)	This work was supported by MADRI.B project, Obra Social Caja Madrid, by the Spanish Ministry of S&T [FIS2009-07072, PSI2009-14415-C03-01] and by the Community of Madrid under the R&D Program of activities MODELICO-CM [S2009ESP-1691]. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Ahnert SE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016101; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; DETOLEDOMORRELL L, 1991, ARCH NEUROL-CHICAGO, V48, P605, DOI 10.1001/archneur.1991.00530180061018; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Maestu F, 2001, NEUROREPORT, V12, P3917, DOI 10.1097/00001756-200112210-00013; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	87	89	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19584	10.1371/journal.pone.0019584	http://dx.doi.org/10.1371/journal.pone.0019584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625430	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005200004
J	Ren, TY; He, WX; Porsov, E				Ren, Tianying; He, Wenxuan; Porsov, Edward			Localization of the Cochlear Amplifier in Living Sensitive Ears	PLOS ONE			English	Article							BASILAR-MEMBRANE VIBRATION; HAIR-BUNDLE MOVEMENTS; MECHANICAL AMPLIFICATION; PRESTIN; PROPAGATION; ADAPTATION; CHANNELS; REGION; MODEL	Background: To detect soft sounds, the mammalian cochlea increases its sensitivity by amplifying incoming sounds up to one thousand times. Although the cochlear amplifier is thought to be a local cellular process at an area basal to the response peak on the spiral basilar membrane, its location has not been demonstrated experimentally. Methodology and Principal Findings: Using a sensitive laser interferometer to measure sub-nanometer vibrations at two locations along the basilar membrane in sensitive gerbil cochleae, here we show that the cochlea can boost soft sound-induced vibrations as much as 50 dB/mm at an area proximal to the response peak on the basilar membrane. The observed amplification works maximally at low sound levels and at frequencies immediately below the peak-response frequency of the measured apical location. The amplification decreases more than 65 dB/mm as sound levels increases. Conclusions and Significance: We conclude that the cochlea amplifier resides at a small longitudinal region basal to the response peak in the sensitive cochlea. These data provides critical information for advancing our knowledge on cochlear mechanisms responsible for the remarkable hearing sensitivity, frequency selectivity and dynamic range.	[Ren, Tianying; He, Wenxuan; Porsov, Edward] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol & Head & Neck Surg, Portland, OR 97201 USA; [Ren, Tianying] Xi An Jiao Tong Univ, Sch Med, Dept Physiol, Xian 710049, Shaanxi, Peoples R China	Oregon Health & Science University; Xi'an Jiaotong University	Ren, TY (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol & Head & Neck Surg, Portland, OR 97201 USA.	rent@ohsu.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) [DC04554]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004554] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) grant DC04554. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; COOPER NP, 1992, HEARING RES, V63, P191, DOI 10.1016/0378-5955(92)90084-Z; Cooper NP, 1999, J ACOUST SOC AM, V106, pL59, DOI 10.1121/1.428147; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; DEBOER E, 1983, J ACOUST SOC AM, V73, P577, DOI 10.1121/1.389004; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; He DZZ, 2003, J NEUROSCI, V23, P9089; He WX, 2008, P NATL ACAD SCI USA, V105, P2729, DOI 10.1073/pnas.0708103105; He WX, 2007, HEARING RES, V228, P112, DOI 10.1016/j.heares.2007.01.026; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KHANNA SM, 1986, HEARING RES, V23, P37, DOI 10.1016/0378-5955(86)90174-7; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; PETERSON LC, 1950, J ACOUST SOC AM, V22, P369, DOI 10.1121/1.1906615; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; Ren TY, 2004, NAT NEUROSCI, V7, P333, DOI 10.1038/nn1216; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Rhode WS, 2000, J ACOUST SOC AM, V107, P3317, DOI 10.1121/1.429404; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, HEARING RES, V51, P215, DOI 10.1016/0378-5955(91)90038-B; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; von Bekesy G, 1970, Nature, V225, P1207, DOI 10.1038/2251207a0; vonBekesy G., 1960, EXPT HEARING; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P986, DOI 10.1121/1.1907231; ZWISLOCKI J, 2002, AUDITORY SOUND TRANS	37	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20149	10.1371/journal.pone.0020149	http://dx.doi.org/10.1371/journal.pone.0020149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629790	Green Published, gold			2022-12-27	WOS:000291005200038
J	Xu, J; Lan, L; Bogard, N; Mattione, C; Cohen, RS				Xu, Jiang; Lan, Lan; Bogard, Nicholas; Mattione, Cristin; Cohen, Robert S.			Rab11 Is Required for Epithelial Cell Viability, Terminal Differentiation, and Suppression of Tumor-Like Growth in the Drosophila Egg Chamber	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; SOMATIC STEM-CELLS; FOLLICLE CELLS; CADHERIN TRAFFICKING; OOCYTE SPECIFICATION; ADHERENS JUNCTIONS; EXOCYST COMPONENTS; POLARITY; OOGENESIS; OVARY	Background: The Drosophila egg chamber provides an excellent system in which to study the specification and differentiation of epithelial cell fates because all of the steps, starting with the division of the corresponding stem cells, called follicle stem cells, have been well described and occur many times over in a single ovary. Methodology/Principal Findings: Here we investigate the role of the small Rab11 GTPase in follicle stem cells (FSCs) and in their differentiating daughters, which include main body epithelial cells, stalk cells and polar cells. We show that rab11-null FSCs maintain their ability to self renew, even though previous studies have shown that FSC self renewal is dependent on maintenance of E-cadherin-based intercellular junctions, which in many cell types, including Drosophila germline stem cells, requires Rab11. We also show that rab11-null FSCs give rise to normal numbers of cells that enter polar, stalk, and epithelial cell differentiation pathways, but that none of the cells complete their differentiation programs and that the epithelial cells undergo premature programmed cell death. Finally we show, through the induction of rab11-null clones at later points in the differentiation program, that Rab11 suppresses tumor-like growth of epithelial cells. Thus, rab11-null epithelial cells arrest differentiation early, assume an aberrant cell morphology, delaminate from the epithelium, and invade the neighboring germline cyst. These phenotypes are associated with defects in E-cadherin localization and a general loss of cell polarity. Conclusions/Significance: While previous studies have revealed tumor suppressor or tumor suppressor-like activity for regulators of endocytosis, our study is the first to identify such activity for regulators of endocytic recycling. Our studies also support the recently emerging view that distinct mechanisms regulate junction stability and plasticity in different tissues.	[Xu, Jiang; Lan, Lan; Bogard, Nicholas; Mattione, Cristin; Cohen, Robert S.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Xu, J (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	rcohen@ku.edu	LAN, LAN/N-8872-2018; Tsai, Yu-Chen/B-5852-2008	Bogard, Nicholas/0000-0001-9231-9382; Xu, Jiang/0000-0002-6933-5453	National Institutes of Health [P20 RR15563, R01 GM068022]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P20 RR15563 and R01 GM068022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2005, DROSOPHILA LAB HDB, pxxviii; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115; Besse F, 2003, DEVELOPMENT, V130, P1017, DOI 10.1242/dev.00313; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dollar G, 2002, DEVELOPMENT, V129, P517; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; Grammont M, 2001, DEVELOPMENT, V128, P2243; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Jankovics F, 2001, GENETICS, V158, P1177; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Larkin MK, 1996, DEVELOPMENT, V122, P3639; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; McGregor JR, 2002, DEVELOPMENT, V129, P705; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Tan LH, 2001, DEVELOPMENT, V128, P1159; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Vachias C, 2010, DEVELOPMENT, V137, P2703, DOI 10.1242/dev.052183; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20180	10.1371/journal.pone.0020180	http://dx.doi.org/10.1371/journal.pone.0020180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629779	Green Submitted, gold, Green Published			2022-12-27	WOS:000291005200042
J	Carmo, CR; Lyons-Lewis, J; Seckl, MJ; Costa-Pereira, AP				Carmo, Catarina R.; Lyons-Lewis, Janet; Seckl, Michael J.; Costa-Pereira, Ana P.			A Novel Requirement for Janus Kinases as Mediators of Drug Resistance Induced by Fibroblast Growth Factor-2 in Human Cancer Cells	PLOS ONE			English	Article							BCL-X-L; LUNG-CANCER; INTERFERON-GAMMA; DEPENDENT PATHWAY; POOR-PROGNOSIS; APOPTOSIS; CYTOKINES; STAT3; ACTIVATION; PREDICTOR	The development of resistance to chemotherapy is a major cause of cancer-related death. Elucidating the mechanisms of drug resistance should thus lead to novel therapeutic strategies. Fibroblast growth factor (FGF)-2 signaling induces the assembly of a multi-protein complex that provides tumor cells with the molecular machinery necessary for drug resistance. This complex, which involves protein kinase C (PKC) epsilon, v-raf murine sarcoma viral oncogene homolog B1 (B-RAF) and p70 S6 kinase beta (S6K2), enhances the selective translation of anti-apoptotic proteins such as B-cell leukaemia/lymphoma-2 (BCL-2) and inhibitors of apoptosis protein (IAP) family members and these are able to protect multiple cancer cell types from chemotherapy-induced cell death. The Janus kinases (JAKs) are most noted for their critical roles in mediating cytokine signaling and immune responses. Here, we show that JAKs have novel functions that support their consideration as new targets in therapies aimed at reducing drug resistance. As an example, we show that the Janus kinase TYK2 is phosphorylated downstream of FGF-2 signaling and required for the full phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. Moreover, TYK2 is necessary for the induction of key anti-apoptotic proteins, such as BCL-2 and myeloid cell leukemia sequence (MCL) 1, and for the promotion of cell survival upon FGF-2. Silencing JAK1, JAK2 or TYK2 using RNA interference (RNAi) inhibits FGF2-mediated proliferation and results in the sensitization of tumor cells to chemotherapy-induced killing. These effects are independent of activation of signal transducer and activator of transcription (STAT) 1, STAT3 and STAT5A/B, the normal targets of JAK signaling. Instead, TYK2 associates with the other kinases previously implicated in FGF-2-mediated drug resistance. In light of these findings we hypothesize that TYK2 and other JAKs are important modulators of FGF-2-driven cell survival and that inhibitors of these kinases will likely improve the effectiveness of other cancer therapies.	[Carmo, Catarina R.; Lyons-Lewis, Janet; Seckl, Michael J.; Costa-Pereira, Ana P.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Carmo, CR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp Campus, London, England.	a.costa-pereira@imperial.ac.uk	Costa-Pereira, Ana/AAE-8192-2020	Ramos do Carmo, Catarina/0000-0001-9717-6667	Cancer Treatment and Research Trust; Department of Health funded Experimental Cancer Medicine Centre; Cancer Research UK	Cancer Treatment and Research Trust; Department of Health funded Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK)	Cancer Treatment and Research Trust funded this work. MJS and JLL are also supported by a Department of Health funded Experimental Cancer Medicine Centre Grant, and APC-P and MJS by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Graeven U, 1999, J CANCER RES CLIN, V125, P577, DOI 10.1007/s004320050319; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kerr IM, 2003, FEBS LETT, V546, P1, DOI 10.1016/S0014-5793(03)00411-3; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Pardo OE, 2001, ONCOGENE, V20, P7658, DOI 10.1038/sj.onc.1204994; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ruotsalainen T, 2002, CANCER EPIDEM BIOMAR, V11, P1492; Sakai I, 1997, J BIOL CHEM, V272, P12350, DOI 10.1074/jbc.272.19.12350; Salven P, 1999, BLOOD, V94, P3334, DOI 10.1182/blood.V94.10.3334.422k18_3334_3339; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Watling D, 2008, P NATL ACAD SCI USA, V105, P6051, DOI 10.1073/pnas.0710814105; Wilks AF, 2008, SEMIN CELL DEV BIOL, V19, P319, DOI 10.1016/j.semcdb.2008.07.020; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	36	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19861	10.1371/journal.pone.0019861	http://dx.doi.org/10.1371/journal.pone.0019861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625473	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400015
J	Inoshita, T; Martin, JR; Marion-Poll, F; Ferveur, JF				Inoshita, Tsuyoshi; Martin, Jean-Rene; Marion-Poll, Frederic; Ferveur, Jean-Francois			Peripheral, Central and Behavioral Responses to the Cuticular Pheromone Bouquet in Drosophila melanogaster Males	PLOS ONE			English	Article							CIS-VACCENYL ACETATE; COURTSHIP BEHAVIOR; SEX-PHEROMONE; BITTER TASTE; BRAIN; HYDROCARBONS; NEURONS; FLY; BIOLUMINESCENCE; INHIBITION	Pheromonal communication is crucial with regard to mate choice in many animals including insects. Drosophila melanogaster flies produce a pheromonal bouquet with many cuticular hydrocarbons some of which diverge between the sexes and differently affect male courtship behavior. Cuticular pheromones have a relatively high weight and are thought to be - mostly but not only - detected by gustatory contact. However, the response of the peripheral and central gustatory systems to these substances remains poorly explored. We measured the effect induced by pheromonal cuticular mixtures on (i) the electrophysiological response of peripheral gustatory receptor neurons, (ii) the calcium variation in brain centers receiving these gustatory inputs and (iii) the behavioral reaction induced in control males and in mutant desat1 males, which show abnormal pheromone production and perception. While male and female pheromones induced inhibitory-like effects on taste receptor neurons, the contact of male pheromones on male fore-tarsi elicits a long-lasting response of higher intensity in the dedicated gustatory brain center. We found that the behavior of control males was more strongly inhibited by male pheromones than by female pheromones, but this difference disappeared in anosmic males. Mutant desat1 males showed an increased sensitivity of their peripheral gustatory neurons to contact pheromones and a behavioral incapacity to discriminate sex pheromones. Together our data indicate that cuticular hydrocarbons induce long-lasting inhibitory effects on the relevant taste pathway which may interact with the olfactory pathway to modulate pheromonal perception.	[Inoshita, Tsuyoshi; Ferveur, Jean-Francois] Univ Bourgogne, INRA, Ctr Sci Gout & Alimentat, UMR 6265,CNRS,UMR 1324, Dijon, France; [Martin, Jean-Rene] CNRS, Inst Neurobiol Alfred Fessard, Lab Neurobiol & Dev, Unite Propre Rech 3294, Gif Sur Yvette, France; [Marion-Poll, Frederic] Univ Paris 06, INRA, UMR 1272, Versailles, France; [Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; AgroParisTech	Inoshita, T (corresponding author), Univ Bourgogne, INRA, Ctr Sci Gout & Alimentat, UMR 6265,CNRS,UMR 1324, Dijon, France.	jean-francois.ferveur@u-bourgogne.fr	Frederic, Marion-Poll/I-1358-2019	Frederic, Marion-Poll/0000-0001-6824-0180	CNRS; Burgundy Regional Council; ANR (INSAVEL); ANR (Drosaequorin); Ministry of Agriculture	CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR)); ANR (Drosaequorin)(French National Research Agency (ANR)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by the CNRS, Burgundy Regional Council, and ANR (INSAVEL) to J-FF and TI, by the CNRS and ANR (Drosaequorin) to J-RM, and by the Ministry of Agriculture to FM-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Houot B, 2010, GENETICS, V185, P1297, DOI 10.1534/genetics.110.117226; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1989, CR ACAD SCI II, V309, P1551; KIMURA K, 1986, J EXP ZOOL, V239, P393, DOI 10.1002/jez.1402390310; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Martin JR, 2008, J NEUROGENET, V22, P285, DOI 10.1080/01677060802298517; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rybak F, 2002, P ROY SOC B-BIOL SCI, V269, P695, DOI 10.1098/rspb.2001.1919; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Siwicki KK, 2003, BEHAV PROCESS, V64, P225, DOI 10.1016/S0376-6357(03)00137-2; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; van der Goes van Naters W, 2007, CURR BIOL, V17, P606, DOI DOI 10.1016/J.CUB.2007.02.043; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	44	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19770	10.1371/journal.pone.0019770	http://dx.doi.org/10.1371/journal.pone.0019770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625481	Green Published, Green Submitted, gold			2022-12-27	WOS:000290793400010
J	Ramirez-Lazaro, MJ; Lario, S; Casalots, A; Sanfeliu, E; Boix, L; Garcia-Iglesias, P; Sanchez-Delgado, J; Montserrat, A; Bella-Cueto, MR; Gallach, M; Sanfeliu, I; Segura, F; Calvet, X				Jose Ramirez-Lazaro, Maria; Lario, Sergio; Casalots, Alex; Sanfeliu, Esther; Boix, Loreto; Garcia-Iglesias, Pilar; Sanchez-Delgado, Jordi; Montserrat, Antonia; Rosa Bella-Cueto, Maria; Gallach, Marta; Sanfeliu, Isabel; Segura, Ferran; Calvet, Xavier			Real-Time PCR Improves Helicobacter pylori Detection in Patients with Peptic Ulcer Bleeding	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-TREATMENT; BREATH TEST; UREASE TEST; INFECTION; DIAGNOSIS; TESTS; PREVALENCE; DISEASE; STOOL	Background and Aims: Histological and rapid urease tests to detect H. pylori in biopsy specimens obtained during peptic ulcer bleeding episodes (PUB) often produce false-negative results. We aimed to examine whether immunohistochemistry and real-time PCR can improve the sensitivity of these biopsies. Patients and Methods: We selected 52 histology-negative formalin-fixed paraffin-embedded biopsy specimens obtained during PUB episodes. Additional tests showed 10 were true negatives and 42 were false negatives. We also selected 17 histology-positive biopsy specimens obtained during PUB to use as controls. We performed immunohistochemistry staining and real-time PCR for 16S rRNA, ureA, and 23S rRNA for H. pylori genes on all specimens. Results: All controls were positive for H. pylori on all PCR assays and immunohistochemical staining. Regarding the 52 initially negative biopsies, all PCR tests were significantly more sensitive than immunohistochemical staining (p < 0.01). Sensitivity and specificity were 55% and 80% for 16S rRNA PCR, 43% and 90% for ureA PCR, 41% and 80% for 23S rRNA PCR, and 7% and 100% for immunohistochemical staining, respectively. Combined analysis of PCR assays for two genes were significantly more sensitive than ureA or 23S rRNA PCR tests alone (p < 0.05) and marginally better than 16S rRNA PCR alone. The best combination was 16S rRNA+ureA, with a sensitivity of 64% and a specificity of 80%. Conclusions: Real-time PCR improves the detection of H. pylori infection in histology-negative formalin-fixed paraffin-embedded biopsy samples obtained during PUB episodes. The low reported prevalence of H. pylori in PUB may be due to the failure of conventional tests to detect infection.	[Jose Ramirez-Lazaro, Maria; Lario, Sergio; Garcia-Iglesias, Pilar; Sanchez-Delgado, Jordi; Montserrat, Antonia; Gallach, Marta; Calvet, Xavier] Univ Autonoma Barcelona, Digest Dis Dept, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain; [Jose Ramirez-Lazaro, Maria; Lario, Sergio; Boix, Loreto; Sanchez-Delgado, Jordi; Montserrat, Antonia; Calvet, Xavier] Inst Salud Carlos III, IBERehd, Barcelona, Spain; [Boix, Loreto] Hosp Clin Barcelona, Liver Unit, BCLC Grp, Barcelona, Spain; [Casalots, Alex; Sanfeliu, Esther; Rosa Bella-Cueto, Maria] Hosp Sabadell, Dept Pathol, Sabadell, Spain; [Sanfeliu, Isabel; Segura, Ferran] Univ Autonoma Barcelona, Dept Infect Dis, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain; [Sanfeliu, Isabel; Segura, Ferran] Spanish Network Res Infect Dis REIPI RD06 0018, Seville, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Ramirez-Lazaro, MJ (corresponding author), Univ Autonoma Barcelona, Digest Dis Dept, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain.	xcalvet@tauli.cat	Calvet, Xavier/H-3288-2019; Lario, Sergio/G-1173-2016	Calvet, Xavier/0000-0002-6278-9663; Ramirez-Lazaro, Maria Jose/0000-0003-0534-6070; Sanfeliu Torres, Esther/0000-0002-7974-3346; Bella-Cueto, Maria Rosa/0000-0002-5144-0490; Calvet, Xavier/0000-0002-4413-4209; Lario, Sergio/0000-0001-9294-1585; Ramirez Lazaro, Maria Jose/0000-0002-7044-6126	Instituto de Salud Carlos III [PI 05/1157, PI 05/0664]; Societat Catalana de Digestologia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Societat Catalana de Digestologia	This study was supported by grants from the Instituto de Salud Carlos III (PI 05/1157 and PI 05/0664) and the Societat Catalana de Digestologia. Maria Jose Ramirez-Lazaro, Sergio Lario and Loreto Boix are CIBERehd staff researchers. CIBERehd is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo T, 2004, HELICOBACTER, V9, P249, DOI 10.1111/j.1083-4389.2004.00219.x; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Biswas B, 2006, FDA IND STAT WORKSH; Brullet E, 2009, GASTROENTEROLOGY, V136, pA43; Calvet X, 2010, CLIN INFECT DIS, V50, P323, DOI 10.1086/649860; Calvet X, 2009, CLIN INFECT DIS, V48, P1385, DOI 10.1086/598198; Castillo-Rojas G, 2002, EUR J GASTROEN HEPAT, V14, P1113, DOI 10.1097/00042737-200210000-00012; Castro-Fernandez M, 2004, REV ESP ENFERM DIG, V96, P395; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ciesielska U, 2002, FOLIA HISTOCHEM CYTO, V40, P129; de Argila CM, 2001, MED CLIN-BARCELONA, V117, P386, DOI 10.1016/S0025-7753(01)72122-7; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fantry GT, 1999, AM J GASTROENTEROL, V94, P1421, DOI 10.1111/j.1572-0241.1999.01421.x; Genta RM, 2010, AM J SURG PATHOL, V34, pE25, DOI 10.1097/PAS.0b013e3181e51067; Gisbert JP, 2007, HELICOBACTER, V12, P231, DOI 10.1111/j.1523-5378.2007.00492.x; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P923, DOI 10.1111/j.1365-2036.2004.01932.x; Gisbert JP, 2003, SCAND J GASTROENTERO, V38, P2, DOI 10.1080/00365521.2003.11800649; Gisbert JP, 2001, SCAND J GASTROENTERO, V36, P717, DOI 10.1080/003655201300191978; Graham DY, 2003, AM J GASTROENTEROL, V98, P1005, DOI 10.1111/j.1572-0241.2003.07426.x; Guell M, 2006, ALIMENT PHARM THER, V23, P53, DOI 10.1111/j.1365-2036.2006.02726.x; Hayat M, 1999, GUT, V45, pA77; He QA, 2002, J CLIN MICROBIOL, V40, P3720, DOI 10.1128/JCM.40.10.3720-3728.2002; Houghton J, 2002, GASTROINTEST ENDOSC, V55, P11, DOI 10.1067/mge.2002.120391; Hung LCT, 2005, GASTROENTEROLOGY, V128, P1845, DOI 10.1053/j.gastro.2005.03.026; Kobayashi D, 2002, J MED MICROBIOL, V51, P305, DOI 10.1099/0022-1317-51-4-305; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752, DOI 10.1128/JCM.33.10.2752-2756.1995; Lanas A, 2010, MED CLIN-BARCELONA, V135, P608, DOI 10.1016/j.medcli.2010.07.002; Lascols C, 2003, J CLIN MICROBIOL, V41, P4573, DOI 10.1128/JCM.41.10.4573-4577.2003; Lee JM, 2000, AM J GASTROENTEROL, V95, P1166, DOI 10.1111/j.1572-0241.2000.02004.x; Leung WK, 1998, AM J GASTROENTEROL, V93, P1914, DOI 10.1111/j.1572-0241.1998.00457.x; Lin HJ, 2005, WORLD J GASTROENTERO, V11, P382, DOI 10.3748/wjg.v11.i3.382; Lo CC, 2005, WORLD J GASTROENTERO, V11, P3909; Pilotto A, 1997, DIGEST DIS SCI, V42, P586, DOI 10.1023/A:1018807412030; Raderer M, 2006, GUT, V55, P616, DOI 10.1136/gut.2005.083022; Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Schabereiter-Gurtner C, 2004, J CLIN MICROBIOL, V42, P4512, DOI 10.1128/JCM.42.10.4512-4518.2004; Scholte GHA, 1997, DIAGN MOL PATHOL, V6, P238, DOI 10.1097/00019606-199708000-00008; Sotoudehmanesh Rasoul, 2005, Indian J Gastroenterol, V24, P59; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tankovic J, 2007, GASTROEN CLIN BIOL, V31, P792, DOI 10.1016/S0399-8320(07)73967-2; WEISS J, 1994, J CLIN MICROBIOL, V32, P1663, DOI 10.1128/JCM.32.7.1663-1668.1994; Wu CY, 1999, SCAND J GASTROENTERO, V34, P234, DOI 10.1080/00365529950173618	45	39	40	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20009	10.1371/journal.pone.0020009	http://dx.doi.org/10.1371/journal.pone.0020009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625499	gold, Green Submitted, Green Published			2022-12-27	WOS:000290793400030
J	Schmidt, AH; Solloch, UV; Baier, D; Grathwohl, A; Hofmann, J; Pingel, J; Stahr, A; Ehninger, G				Schmidt, Alexander H.; Solloch, Ute V.; Baier, Daniel; Grathwohl, Alois; Hofmann, Jan; Pingel, Julia; Stahr, Andrea; Ehninger, Gerhard			Support of Unrelated Stem Cell Donor Searches by Donor Center-Initiated HLA Typing of Potentially Matching Donors	PLOS ONE			English	Article							TRANSPLANTATION; PROGRAM; IMPACT	Large registries of potential unrelated stem cell donors have been established in order to enable stem cell transplantation for patients without HLA-identical related donors. Donor search is complicated by the fact that the stored HLA information of many registered donors is incomplete. We carried out a project that was aimed to improve chances of patients with ongoing donor searches to find an HLA-matched unrelated donor. For that purpose, we carried out additional donor center-initiated HLA-DRB1 typing of donors who were only typed for the HLA loci A and B so far and were potential matches for patients in need of a stem cell transplant. In total, 8,861 donors were contacted for donor center-initiated HLA-DRB1 typing within 1,089 donor searches. 12 of these donors have donated stem cells so far, 8 thereof for their respective target patients. We conclude that chances of patients with ongoing donor searches to find an HLA-matched unrelated donor can indeed be improved by donor-center initiated typing that is carried out in addition to the standard donor search process. Our results also raise questions regarding the appropriate use of incompletely typed donors within unrelated donor searches.	[Schmidt, Alexander H.; Solloch, Ute V.; Baier, Daniel; Grathwohl, Alois; Hofmann, Jan; Pingel, Julia; Stahr, Andrea] DKMS German Bone Marrow Donor Ctr, Tubingen, Germany; [Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dresden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmidt, AH (corresponding author), DKMS German Bone Marrow Donor Ctr, Tubingen, Germany.	schmidt@dkms.de						Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Bochtler W, 2008, TISSUE ANTIGENS, V71, P321; Bray RA, 2008, BIOL BLOOD MARROW TR, V14, P45, DOI 10.1016/j.bbmt.2008.06.014; Carreras E, 2006, BONE MARROW TRANSPL, V37, P33, DOI 10.1038/sj.bmt.1705195; Confer DL, 2001, CANCER, V91, P274, DOI 10.1002/1097-0142(20010101)91:1+<274::AID-CNCR18>3.0.CO;2-E; Foeken LM, 2010, BONE MARROW TRANSPL, V45, P811, DOI 10.1038/bmt.2010.9; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Schmidt AH, 2008, BONE MARROW TRANSPL, V41, P605, DOI 10.1038/sj.bmt.1705950; Schmidt AH, 2009, BONE MARROW TRANSPL, V44, P405, DOI 10.1038/bmt.2009.55; Schmidt AH, 2006, BLOOD, V108, p448B, DOI 10.1182/blood.V108.11.5415.5415; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shaw BE, 2010, BRIT J HAEMATOL, V150, P251, DOI 10.1111/j.1365-2141.2010.08224.x; Spellman S, 2008, BIOL BLOOD MARROW TR, V14, P37, DOI 10.1016/j.bbmt.2008.05.001; Tiercy M, 2007, BONE MARROW TRANSPL, V40, P515, DOI 10.1038/sj.bmt.1705787	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20268	10.1371/journal.pone.0020268	http://dx.doi.org/10.1371/journal.pone.0020268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625451	Green Submitted, gold, Green Published			2022-12-27	WOS:000290793400051
J	Geissler, R; Scholze, H; Hahn, S; Streubel, J; Bonas, U; Behrens, SE; Boch, J				Geissler, Rene; Scholze, Heidi; Hahn, Simone; Streubel, Jana; Bonas, Ulla; Behrens, Sven-Erik; Boch, Jens			Transcriptional Activators of Human Genes with Programmable DNA-Specificity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; DOUBLE-STRAND BREAKS; TAL EFFECTORS; III EFFECTORS; RESTRICTION ENZYMES; BINDING SPECIFICITY; BACTERIAL-BLIGHT; C-TERMINUS; ONE-POT; RECOGNITION	TAL (transcription activator-like) effectors are translocated by Xanthomonas bacteria into plant cells where they activate transcription of target genes. DNA target sequence recognition occurs in a unique mode involving a central domain of tandem repeats. Each repeat recognizes a single base pair in a contiguous DNA sequence and a pair of adjacent hypervariable amino acid residues per repeat specifies which base is bound. Rearranging the repeats allows the design of novel TAL proteins with predictable DNA-recognition specificities. TAL protein-based transcriptional activation in plant cells is mediated by a C-terminal activation domain (AD). Here, we created synthetic TAL proteins with designed repeat compositions using a novel modular cloning strategy termed "Golden TAL Technology". Newly programmed TAL proteins were not only functional in plant cells, but also in human cells and activated targeted expression of exogenous as well as endogenous genes. Transcriptional activation in different human cell lines was markedly improved by replacing the TAL-AD with the VP16-AD of herpes simplex virus. The creation of TAL proteins with potentially any desired DNA-recognition specificity allows their versatile use in biotechnology.	[Geissler, Rene; Behrens, Sven-Erik] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, Halle, Saale, Germany; [Scholze, Heidi; Hahn, Simone; Streubel, Jana; Bonas, Ulla; Boch, Jens] Univ Halle Wittenberg, Dept Genet, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Geissler, R (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, Halle, Saale, Germany.	sven.behrens@biochemtech.uni-halle.de; jens.boch@genetik.uni-halle.de		Streubel, Jana/0000-0001-8155-511X	Deutsche Forschungsgemeinschaft [SPP 1212, SFB 648, BE 1885/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1212 to J.B. and U.B., SFB 648 to U.B. and S.-E.B.; BE 1885/6 to S.-E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MILLER JC, 2010, NAT BIOTECHNOL, DOI DOI 10.1038/NBT.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Park KS, 2005, BIOTECHNOL PROGR, V21, P664, DOI 10.1021/bp049658x; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Reik A, 2007, BIOTECHNOL BIOENG, V97, P1180, DOI 10.1002/bit.21304; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Scholze H, 2010, VIRULENCE, V1, P428, DOI 10.4161/viru.1.5.12863; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824; Zhu WG, 1999, PLANT CELL, V11, P1665, DOI 10.1105/tpc.11.9.1665	38	113	203	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19509	10.1371/journal.pone.0019509	http://dx.doi.org/10.1371/journal.pone.0019509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625585	gold, Green Published, Green Submitted			2022-12-27	WOS:000290771200008
J	Giuliani, M; Fleury, M; Vernochet, A; Ketroussi, F; Clay, D; Azzarone, B; Lataillade, JJ; Durrbach, A				Giuliani, Massimo; Fleury, Maud; Vernochet, Amelia; Ketroussi, Farah; Clay, Denis; Azzarone, Bruno; Lataillade, Jean Jacques; Durrbach, Antoine			Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation	PLOS ONE			English	Article							MARROW STROMAL CELLS; HLA-G; IN-VITRO; EXPRESSION; DIFFERENTIATION; BLOOD; IDENTIFICATION; TRANSCRIPTS; SUPPRESSION; SURVIVAL	Human bone marrow mesenchymal stem cells (BM-MSC) are multipotent progenitor cells that have transient immunomodulatory properties on Natural Killer (NK) cells, Dendritic Cells (DC), and T cells. This study compared the use of MSC isolated from bone marrow and fetal liver (FL-MSC) to determine which displayed the most efficient immunosuppressive effects on T cell activation. Although both types of MSC exhibit similar phenotype profile, FL-MSC displays a much more extended in vitro life-span and immunomodulatory properties. When co-cultured with CD3/CD28-stimulated T cells, both BM-MSC and FL-MSC affected T cell proliferation by inhibiting their entry into the cell cycle, by inducing the down-regulation of phospho-retinoblastoma (pRb), cyclins A and D1, as well as up-regulating p27(kip1) expression. The T cell inhibition by MSC was not due to the soluble HLA-G5 isoform, but to the surface expression of HLA-G1, as shown by the need of cell-cell contact and by the use of neutralizing anti-HLA-G antibodies. To note, in a HLA-G-mediated fashion, MSC facilitated the expansion of a CD4(low)/CD8(low) T subset that had decreased secretion of IFN-gamma, and an induced secretion of the immunomodulatory cytokine IL-10. Because of their longer lasting in vitro immunosuppressive properties, mainly mediated by HLA-G, and their more efficient induction of IL-10 production and T cell apoptosis, fetal liver MSC could be considered a new tool for MSC therapy to prevent allograft rejection.	[Giuliani, Massimo; Vernochet, Amelia; Ketroussi, Farah; Azzarone, Bruno; Durrbach, Antoine] Hop Paul Brousse, INSERM, U1014, Villejuif, France; [Fleury, Maud] Hop Paul Brousse, INSERM, U602, Villejuif, France; [Vernochet, Amelia; Ketroussi, Farah; Azzarone, Bruno; Durrbach, Antoine] Univ Paris 11, Serv Nephrol, Le Kremlin Bicetre, France; [Clay, Denis] Hop Paul Brousse, IFR89, Villejuif, France; [Lataillade, Jean Jacques] Hop Percy, Lab Therapie Cellulaire, CTSA, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Giuliani, M (corresponding author), Hop Paul Brousse, INSERM, U1014, Villejuif, France.	giulianimas@hotmail.com	Azzarone, Bruno/AAH-9251-2019	Azzarone, Bruno/0000-0002-5962-3849	NRB-Vaincre le Cancer; DIM Stem-Pole; Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT)	NRB-Vaincre le Cancer; DIM Stem-Pole; Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT)	This work was supported by grants from the NRB-Vaincre le Cancer, DIM Stem-Pole, and Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4; Carosella ED, 2008, HUM IMMUNOL, V69, P700, DOI 10.1016/j.humimm.2008.08.280; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hayflick L, 1985, Clin Geriatr Med, V1, P15; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Le Rond S, 2004, EUR J IMMUNOL, V34, P649, DOI 10.1002/eji.200324266; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mikhelson V. M., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P269; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nasef A, 2007, GENE EXPRESSION, V13, P217; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramasamy R, 2008, CELL IMMUNOL, V251, P131, DOI 10.1016/j.cellimm.2008.04.009; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Rizzo R, 2008, CYTOTHERAPY, V10, P364, DOI 10.1080/14653240802105299; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Rouas-Freiss N, 2005, INT J CANCER, V117, P114, DOI 10.1002/ijc.21151; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Yao YQ, 2005, J IMMUNOL, V175, P8379, DOI 10.4049/jimmunol.175.12.8379; Zhou HP, 2006, TRANSPL P, V38, P3046, DOI 10.1016/j.transproceed.2006.10.002	45	68	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19988	10.1371/journal.pone.0019988	http://dx.doi.org/10.1371/journal.pone.0019988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625521	Green Published, Green Submitted, gold			2022-12-27	WOS:000290771200036
J	Delage, L; Leblanc, C; Collen, PN; Gschloessl, B; Oudot, MP; Sterck, L; Poulain, J; Aury, JM; Cock, JM				Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Oudot, Marie-Pierre; Sterck, Lieven; Poulain, Julie; Aury, Jean-Marc; Cock, J. Mark			In Silico Survey of the Mitochondrial Protein Uptake and Maturation Systems in the Brown Alga Ectocarpus siliculosus	PLOS ONE			English	Article							OUTER-MEMBRANE BIOGENESIS; DISULFIDE BOND FORMATION; AMINO-ACID-SEQUENCE; INNER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; PRECURSOR PROTEINS; SUBCELLULAR-LOCALIZATION; PROCESSING PEPTIDASE; YEAST MITOCHONDRIA	The acquisition of mitochondria was a key event in eukaryote evolution. The aim of this study was to identify homologues of the components of the mitochondrial protein import machinery in the brown alga Ectocarpus and to use this information to investigate the evolutionary history of this fundamental cellular process. Detailed searches were carried out both for components of the protein import system and for related peptidases. Comparative and phylogenetic analyses were used to investigate the evolution of mitochondrial proteins during eukaryote diversification. Key observations include phylogenetic evidence for very ancient origins for many protein import components (Tim21, Tim50, for example) and indications of differences between the outer membrane receptors that recognize the mitochondrial targeting signals, suggesting replacement, rearrangement and/or emergence of new components across the major eukaryotic lineages. Overall, the mitochondrial protein import components analysed in this study confirmed a high level of conservation during evolution, indicating that most are derived from very ancient, ancestral proteins. Several of the protein import components identified in Ectocarpus, such as Tim21, Tim50 and metaxin, have also been found in other stramenopiles and this study suggests an early origin during the evolution of the eukaryotes.	[Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Cock, J. Mark] Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Roscoff, France; [Delage, Ludovic; Leblanc, Catherine; Collen, Pi Nyvall; Gschloessl, Bernhard; Cock, J. Mark] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marine Specie, Stn Biol Roscoff, Roscoff, France; [Oudot, Marie-Pierre] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Sterck, Lieven] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Poulain, Julie; Aury, Jean-Marc] Commissariat Energie Atom, Direct Sci Vivant, Inst Genom, Evry, France; [Poulain, Julie; Aury, Jean-Marc] CNRS, UMR 8030, Evry, France; [Poulain, Julie; Aury, Jean-Marc] Univ Evry, Evry, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; Flanders Institute for Biotechnology (VIB); Ghent University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Delage, L (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, Roscoff, France.	cock@sb-roscoff.fr	Aury, Jean-Marc/N-1621-2019; Sterck, Lieven/A-9439-2016	Aury, Jean-Marc/0000-0003-1718-3010; Sterck, Lieven/0000-0001-7116-4000; Poulain, Julie/0000-0002-8744-3116; Cock, J. Mark/0000-0002-2650-0383	French GIS "Institut de la Genomique Marine"; Centre National de Recherche Scientifique; European Union network of excellence Marine Genomics Europe; GIS Europole Mer; University Pierre and Marie Curie	French GIS "Institut de la Genomique Marine"; Centre National de Recherche Scientifique; European Union network of excellence Marine Genomics Europe; GIS Europole Mer; University Pierre and Marie Curie	This work was supported by the French GIS "Institut de la Genomique Marine", the Centre National de Recherche Scientifique, the European Union network of excellence Marine Genomics Europe, the GIS Europole Mer, the University Pierre and Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; Burri L, 2006, FEBS J, V273, P1507, DOI 10.1111/j.1742-4658.2006.05171.x; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esser K, 2004, MOL GENET GENOMICS, V271, P616, DOI 10.1007/s00438-004-1011-y; Figueroa-Martinez F, 2008, GENETICS, V179, P149, DOI 10.1534/genetics.108.087965; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gaston D, 2009, METHOD ENZYMOL, V457, P21, DOI 10.1016/S0076-6879(09)05002-2; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Glaser E, 1998, PLANT MOL BIOL, V38, P311, DOI 10.1023/A:1006020208140; Glaser E, 1999, J BIOENERG BIOMEMBR, V31, P259, DOI 10.1023/A:1005475930477; Gray MW, 2001, GENOME BIOL, V2; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Hawkins John, 2006, Journal of Bioinformatics and Computational Biology, V4, P1, DOI 10.1142/S0219720006001771; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; ISAYA G, 1992, J BIOL CHEM, V267, P7904; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Juhola MK, 2000, FEBS LETT, V481, P91, DOI 10.1016/S0014-5793(00)01989-X; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitada S, 2007, J BACTERIOL, V189, P844, DOI 10.1128/JB.01261-06; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Li ZW, 2006, NUCLEIC ACIDS RES, V34, pD277, DOI 10.1093/nar/gkj124; Lionaki E, 2008, J BIOL CHEM, V283, P15747, DOI 10.1074/jbc.M800350200; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Luo WT, 2006, MOL GENET GENOMICS, V275, P431, DOI 10.1007/s00438-006-0099-7; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Marienfeld J, 1999, TRENDS PLANT SCI, V4, P495, DOI 10.1016/S1360-1385(99)01502-2; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mirus O, 2009, J MOL MODEL, V15, P971, DOI 10.1007/s00894-008-0449-y; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nargang FE, 1998, MOL CELL BIOL, V18, P3173, DOI 10.1128/MCB.18.6.3173; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; PRATJE E, 1986, EMBO J, V5, P1313, DOI 10.1002/j.1460-2075.1986.tb04361.x; PRATJE E, 1983, EMBO J, V2, P1049, DOI 10.1002/j.1460-2075.1983.tb01544.x; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Settles AM, 1998, TRENDS CELL BIOL, V8, P494, DOI 10.1016/S0962-8924(98)01387-7; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; TSAOUSIS AD, 2010, MOL BIOL EVOL; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; van der Merwe JA, 2007, J PLANT PHYSIOL, V164, P1231, DOI 10.1016/j.jplph.2006.11.009; van Lis R, 2003, PLANT PHYSIOL, V132, P318, DOI 10.1104/pp.102.018325; VANLOON APGM, 1988, J CELL BIOCHEM, V36, P59, DOI 10.1002/jcb.240360107; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Weber ER, 1996, MOL BIOL CELL, V7, P307, DOI 10.1091/mbc.7.2.307; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Yano M, 2004, J BIOL CHEM, V279, P10808, DOI 10.1074/jbc.M311710200; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang YJ, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-290, 10.1186/1471-2148-9-137]	133	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19540	10.1371/journal.pone.0019540	http://dx.doi.org/10.1371/journal.pone.0019540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611166	Green Submitted, Green Published, gold			2022-12-27	WOS:000290720200014
J	Hu, PS; Maiti, T				Hu, Pingsha; Maiti, Tapabrata			A Nonparametric Mean-Variance Smoothing Method to Assess Arabidopsis Cold Stress Transcriptional Regulator CBF2 Overexpression Microarray Data	PLOS ONE			English	Article							GENE-EXPRESSION; ACCLIMATION; NETWORK	Microarray is a powerful tool for genome-wide gene expression analysis. In microarray expression data, often mean and variance have certain relationships. We present a non-parametric mean-variance smoothing method (NPMVS) to analyze differentially expressed genes. In this method, a nonlinear smoothing curve is fitted to estimate the relationship between mean and variance. Inference is then made upon shrinkage estimation of posterior means assuming variances are known. Different methods have been applied to simulated datasets, in which a variety of mean and variance relationships were imposed. The simulation study showed that NPMVS outperformed the other two popular shrinkage estimation methods in some mean-variance relationships; and NPMVS was competitive with the two methods in other relationships. A real biological dataset, in which a cold stress transcription factor gene, CBF2, was overexpressed, has also been analyzed with the three methods. Gene ontology and cis-element analysis showed that NPMVS identified more cold and stress responsive genes than the other two methods did. The good performance of NPMVS is mainly due to its shrinkage estimation for both means and variances. In addition, NPMVS exploits a non-parametric regression between mean and variance, instead of assuming a specific parametric relationship between mean and variance. The source code written in R is available from the authors on request.	[Hu, Pingsha] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Maiti, Tapabrata] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hu, PS (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	phu@msu.edu			National Science Foundation (NSF)	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; CUI X, 2003, STAT APPL GENETICS M, V2; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Hu JH, 2007, BIOMETRICS, V63, P41, DOI 10.1111/j.1541-0420.2006.00675.x; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lonnstedt I, 2005, BIOSTATISTICS, V6, P279, DOI 10.1093/biostatistics/kxi009; Medina J, 2001, PLANT PHYSIOL, V125, P1655, DOI 10.1104/pp.125.4.1655; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; SMYTH GK, 2004, STAT APPL GENETICS M, V3; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Tong TJ, 2007, J AM STAT ASSOC, V102, P113, DOI 10.1198/016214506000001266; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; WEISER RL, 1990, PLANT PHYSIOL, V93, P1021, DOI 10.1104/pp.93.3.1021	20	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19640	10.1371/journal.pone.0019640	http://dx.doi.org/10.1371/journal.pone.0019640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21611181	gold, Green Submitted, Green Published			2022-12-27	WOS:000290657500010
J	Li, YC; Chen, CC; Chen, JH				Li, Yi-Chia; Chen, Chien-Chung; Chen, Jyh-Horng			Impact of Visual Repetition Rate on Intrinsic Properties of Low Frequency Fluctuations in the Visual Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; CEREBRAL HEMODYNAMICS; FMRI; SIGNAL; OSCILLATIONS; ACTIVATION; COHERENCE; AMPLITUDE; CORTEX	Background: Visual processing network is one of the functional networks which have been reliably identified to consistently exist in human resting brains. In our work, we focused on this network and investigated the intrinsic properties of low frequency (0.01-0.08 Hz) fluctuations (LFFs) during changes of visual stimuli. There were two main questions to be discussed in this study: intrinsic properties of LFFs regarding (1) interactions between visual stimuli and resting-state; (2) impact of repetition rate of visual stimuli. Methodology/Principal Findings: We analyzed scanning sessions that contained rest and visual stimuli in various repetition rates with a novel method. The method included three numerical approaches involving ICA (Independent Component Analyses), fALFF (fractional Amplitude of Low Frequency Fluctuation), and Coherence, to respectively investigate the modulations of visual network pattern, low frequency fluctuation power, and interregional functional connectivity during changes of visual stimuli. We discovered when resting-state was replaced by visual stimuli, more areas were involved in visual processing, and both stronger low frequency fluctuations and higher interregional functional connectivity occurred in visual network. With changes of visual repetition rate, the number of areas which were involved in visual processing, low frequency fluctuation power, and interregional functional connectivity in this network were also modulated. Conclusions/Significance: To combine the results of prior literatures and our discoveries, intrinsic properties of LFFs in visual network are altered not only by modulations of endogenous factors (eye-open or eye-closed condition; alcohol administration) and disordered behaviors (early blind), but also exogenous sensory stimuli (visual stimuli with various repetition rates). It demonstrates that the intrinsic properties of LFFs are valuable to represent physiological states of human brains.	[Li, Yi-Chia] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan; [Li, Yi-Chia; Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Li, YC (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan.	d97945006@ntu.edu.tw	; Chen, Zhiwei/B-7793-2019	Chen, Chien-Chung/0000-0002-3848-0180; Chen, Zhiwei/0000-0002-4511-2888	National Science Council [NSC 99-2321-B-002-007]	National Science Council(Ministry of Science and Technology, Taiwan)	The research was supported by the National Science Council grant NSC 99-2321-B-002-007 to Jyh-Horng Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, AM J NEURORADIOL, V29, P1722, DOI 10.3174/ajnr.A1220; Anderson SJ, 1996, P ROY SOC B-BIOL SCI, V263, P423, DOI 10.1098/rspb.1996.0064; Bartley S.H., 1968, CONTRIBUTIONS SENSOR, V3, P82; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Emir UE, 2008, NEUROSCI LETT, V436, P185, DOI 10.1016/j.neulet.2008.03.021; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Fylan F, 1997, NEUROIMAGE, V6, P47, DOI 10.1006/nimg.1997.0273; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GRUSSER OJ, 1957, PFLUG ARCH GES PHYS, V263, P668, DOI 10.1007/BF00362854; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Huk AC, 2002, J NEUROSCI, V22, P7195; Kikuchi M, 2000, CLIN ELECTROENCEPHAL, V31, P170, DOI 10.1177/155005940003100404; KOURTZI Z, 2005, FITTING MIND WORLD A, pCH6; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schopf V, 2010, MAGN RESON MATER PHY, V23, P317, DOI 10.1007/s10334-010-0212-0; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Singh M, 2003, MAGNET RESON MED, V49, P108, DOI 10.1002/mrm.10335; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tse CY, 2010, BIOL PSYCHOL, V85, P79, DOI 10.1016/j.biopsycho.2010.05.007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	40	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e18954	10.1371/journal.pone.0018954	http://dx.doi.org/10.1371/journal.pone.0018954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21966483	Green Published, Green Submitted, gold			2022-12-27	WOS:000291005800002
J	Chang, YJ; Yeh, ML; Li, YC; Hsu, CY; Lin, CC; Hsu, MS; Chiu, WT				Chang, Ying-Jui; Yeh, Min-Li; Li, Yu-Chuan; Hsu, Chien-Yeh; Lin, Chao-Cheng; Hsu, Meng-Shiuan; Chiu, Wen-Ta			Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; ADMINISTRATIVE CODING DATA; TRAUMATIC BRAIN-INJURY; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SURVEILLANCE; PREVENTION; MORTALITY; COSTS	Background: Hospital-acquired infections (HAI) are associated with increased attributable morbidity, mortality, prolonged hospitalization, and economic costs. A simple, reliable prediction model for HAI has great clinical relevance. The objective of this study is to develop a scoring system to predict HAI that was derived from Logistic Regression (LR) and validated by Artificial Neural Networks (ANN) simultaneously. Methodology/Principal Findings: A total of 476 patients from all the 806 HAI inpatients were included for the study between 2004 and 2005. A sample of 1,376 non-HAI inpatients was randomly drawn from all the admitted patients in the same period of time as the control group. External validation of 2,500 patients was abstracted from another academic teaching center. Sixteen variables were extracted from the Electronic Health Records (EHR) and fed into ANN and LR models. With stepwise selection, the following seven variables were identified by LR models as statistically significant: Foley catheterization, central venous catheterization, arterial line, nasogastric tube, hemodialysis, stress ulcer prophylaxes and systemic glucocorticosteroids. Both ANN and LR models displayed excellent discrimination (area under the receiver operating characteristic curve [AUC]: 0.964 versus 0.969, p = 0.507) to identify infection in internal validation. During external validation, high AUC was obtained from both models (AUC: 0.850 versus 0.870, p = 0.447). The scoring system also performed extremely well in the internal (AUC: 0.965) and external (AUC: 0.871) validations. Conclusions: We developed a scoring system to predict HAI with simple parameters validated with ANN and LR models. Armed with this scoring system, infectious disease specialists can more efficiently identify patients at high risk for HAI during hospitalization. Further, using parameters either by observation of medical devices used or data obtained from EHR also provided good prediction outcome that can be utilized in different clinical settings.	[Chang, Ying-Jui; Yeh, Min-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Ying-Jui] Far Eastern Mem Hosp, Dept Dermatol, New Taipei, Taiwan; [Yeh, Min-Li] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan; [Li, Yu-Chuan] Taipei Med Univ, Dept Dermatol, Wan Fang Hosp, Taipei, Taiwan; [Li, Yu-Chuan; Hsu, Chien-Yeh] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, CECR, Taipei, Taiwan; [Lin, Chao-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Meng-Shiuan] Far Eastern Mem Hosp, Infect Dis Sect, Dept Internal Med, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jack@tmu.edu.tw; cyhsu@tmu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657				Archibald LK, 2007, BENNETT BRACHMANS HO, P483; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chong Chee-Fah, 2003, AMIA Annu Symp Proc, P160; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Department of Health EY Taiwan, 2010, EL MED REC; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Goldstein Melissa M, 2010, Perspect Health Inf Manag, V7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kamp-Hopmans TEM, 2003, INFECT CONT HOSP EP, V24, P584, DOI 10.1086/502258; Kostadima E, 2006, EUR RESPIR J, V27, P437, DOI 10.1183/09031936.06.00127405; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2008, COMPUT METH PROG BIO, V91, P91, DOI 10.1016/j.cmpb.2008.02.004; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Shang J S, 2000, Health Care Manag Sci, V3, P287, DOI 10.1023/A:1019018129822; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Teramoto S, 2006, EUR RESPIR J, V27, P436, DOI 10.1183/09031936.06.00113405; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Wilson JS, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-47; Woeltje KF, 2010, CRIT CARE MED, V38, pS399, DOI 10.1097/CCM.0b013e3181e6d11d	42	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23137	10.1371/journal.pone.0023137	http://dx.doi.org/10.1371/journal.pone.0023137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887234	gold, Green Published, Green Submitted			2022-12-27	WOS:000295832000008
J	Zheng, BW; Zhang, QM; Gao, J; Han, HM; Li, M; Zhang, JR; Qi, JX; Yan, JH; Gao, GF				Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Zhang, Jingren; Qi, Jianxun; Yan, Jinghua; Gao, George F.			Insight into the Interaction of Metal Ions with TroA from Streptococcus suis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN ZNUA; ZINC-BINDING PROTEIN; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; IRON TRANSPORT; MANGANESE; VIRULENCE; REVEALS; PSAA	Background: The scavenging ability of sufficient divalent metal ions is pivotal for pathogenic bacteria to survive in the host. ATP-binding cassette (ABC)-type metal transporters provide a considerable amount of different transition metals for bacterial growth. TroA is a substrate binding protein for uptake of multiple metal ions. However, the function and structure of the TroA homologue from the epidemic Streptococcus suis isolates (SsTroA) have not been characterized. Methodology/Principal Findings: Here we determined the crystal structure of SsTroA from a highly pathogenic streptococcal toxic shock syndrome (STSS)-causing Streptococcus suis in complex with zinc. Inductively coupled plasma mass spectrometry (ICP-MS) analysis revealed that apo-SsTroA binds Zn2+ and Mn2+. Both metals bind to SsTroA with nanomolar affinity and stabilize the protein against thermal unfolding. Zn2+ and Mn2+ induce distinct conformational changes in SsTroA compared with the apo form as confirmed by both circular dichroism (CD) and nuclear magnetic resonance (NMR) spectra. NMR data also revealed that Zn2+/Mn2+ bind to SsTroA in either the same site or an adjacent region. Finally, we found that the folding of the metal-bound protein is more compact than the corresponding apoprotein. Conclusions/Significance: Our findings reveal a mechanism for uptake of metal ions in S. suis and this mechanism provides a reasonable explanation as to how SsTroA operates in metal transport.	[Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Qi, Jianxun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Zheng, Beiwen; Han, Huiming; Gao, George F.] Chinese Acad Sci, Coll Life Sci, Grad Univ, Beijing, Peoples R China; [Gao, Jia] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, Nanning, Guangxi, Peoples R China; [Zhang, Jingren] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Tsinghua University; Chinese Academy of Sciences	Zheng, BW (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021; Georgieva, Angelina/AAC-4823-2021	Georgieva, Angelina/0000-0003-0731-7775	Ministry of Science and Technology (MOST) [2011CB504003, 2006BAD06A04]; National Natural Science Fundation of China (NSFC) [30728014]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work was supported by grants from the Ministry of Science and Technology (MOST, Project 973 Grant No. 2011CB504003; National Key Technology R&D Program 2006BAD06A04); J.Z. and G. F. G. have a joint grant by National Natural Science Fundation of China (NSFC, Grant No. 30728014). G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2008, INFECT IMMUN, V76, P1590, DOI 10.1128/IAI.00987-07; Aranda J, 2009, MICROBIOL-SGM, V155, P1580, DOI 10.1099/mic.0.026278-0; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GARIEPY J, 1985, BIOCHEMISTRY-US, V24, P544, DOI 10.1021/bi00323a045; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Kamen DE, 2001, PROTEIN SCI, V10, P2123, DOI 10.1110/ps.19801; LANGFORD P, 1991, FEMS MICROBIOL LETT, V77, P347, DOI 10.1016/0378-1097(91)90578-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; McEwan AG, 2009, MOL MICROBIOL, V72, P812, DOI 10.1111/j.1365-2958.2009.06700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Sambrook J., 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	66	100	100	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19510	10.1371/journal.pone.0019510	http://dx.doi.org/10.1371/journal.pone.0019510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611125	gold, Green Published, Green Submitted			2022-12-27	WOS:000290720200010
J	Liu, CC; Guo, MS; Lin, FHY; Hsiao, KN; Chang, KHW; Chou, AH; Wang, YC; Chen, YC; Yang, CS; Chong, PCS				Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi; Chong, Pele Choi-Sing			Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71; PUBLIC-HEALTH; DISEASE VIRUS; PROTECTS MICE; POLIOVIRUS; INFECTION; VACCINE; STRAIN; VP1; IDENTIFICATION	Background: Enterovirus 71 (EV71) infections manifest most commonly as a childhood exanthema known as hand-foot-and-mouth disease (HFMD) and can cause neurological disease during acute infection. Principal Finding: In this study, we describe the production, purification and characterization of EV71 virus produced from Vero cells grown in a five-liter serum-free bioreactor system containing 5 g/L Cytodex 1 microcarrier. The viral titer was >10(6) TCID(50)/mL by 6 days post infection when a MOI of 10(-5) was used at the initial infection. Two EV71 virus fractions were separated and detected when the harvested EV71 virus concentrate was purified by sucrose gradient zonal ultracentrifugation. The EV71 viral particles detected in the 24-28% sucrose fractions had an icosahedral structure 30-31 nm in diameter and had low viral infectivity and RNA content. Three major viral proteins (VP0, VP1 and VP3) were observed by SDS-PAGE. The EV71 viral particles detected in the fractions containing 35-38% sucrose were 33-35 nm in size, had high viral infectivity and RNA content, and were composed of four viral proteins (VP1, VP2, VP3 and VP4), as shown by SDS-PAGE analyses. The two virus fractions were formalin-inactivated and induced high virus neutralizing antibody responses in mouse immunogenicity studies. Both mouse antisera recognized the immunodominant linear neutralization epitope of VP1 (residues 211-225). Conclusion: These results provide important information for cell-based EV71 vaccine development, particularly for the preparation of working standards for viral antigen quantification.	[Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Chong, Pele Choi-Sing] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan; [Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan Town, Miaoli County, Taiwan; [Chong, Pele Choi-Sing] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Liu, CC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Yang, Chung-Shi/E-3999-2010; Loos, Ruth/Q-2862-2016	Liu, Chia-Chyi/0000-0002-6257-0389; Loos, Ruth/0000-0002-8532-5087	Department of Health, the Taiwan CDC; National Science Council; National Health Research Institutes, Taiwan	Department of Health, the Taiwan CDC; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Department of Health, the Taiwan CDC, the National Science Council and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; FERGUSON M, 1990, J GEN VIROL, V71, P1271, DOI 10.1099/0022-1317-71-6-1271; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Guang DM, 2007, MICROBES INFECT, V9, P1299; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; HUMMELER K, 1962, VIROLOGY, V16, P84, DOI 10.1016/0042-6822(62)90205-2; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; MAYER MM, 1957, J IMMUNOL, V78, P435; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; MINOR PD, 1980, J GEN VIROL, V51, P147, DOI 10.1099/0022-1317-51-1-147; MINOR PD, 1991, J GEN VIROL, V72, P2475, DOI 10.1099/0022-1317-72-10-2475; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; VONSEEFRIED A, 1984, REV INFECT DIS, V6, pS345; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	35	139	164	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20005	10.1371/journal.pone.0020005	http://dx.doi.org/10.1371/journal.pone.0020005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603631	Green Submitted, Green Published, gold			2022-12-27	WOS:000290558500041
J	Chang, YT; Wu, CC; Shyr, YM; Chen, TC; Hwang, TL; Yeh, TS; Chang, KP; Liu, HP; Liu, YL; Tsai, MH; Chang, YS; Yu, JS				Chang, Ya-Ting; Wu, Chih-Ching; Shyr, Yi-Ming; Chen, Tse-Ching; Hwang, Tsann-Long; Yeh, Ta-Sen; Chang, Kai-Ping; Liu, Hao-Ping; Liu, Yu-Ling; Tsai, Ming-Hung; Chang, Yu-Sun; Yu, Jau-Song			Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CLINICAL-SIGNIFICANCE; PROTEOMIC ANALYSIS; NKG2D LIGANDS; CELL LINES; EXPRESSION; PROTEIN; BIOMARKERS; INDICATOR; DIAGNOSIS	Background: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a biomarker for PC detection because its mRNA level was also found to be significantly elevated in PC tissues. Methods: ULBP2 expression in PC tissues from 67 patients was studied by immunohistochemistry. ULBP2 serum levels in 154 PC patients and 142 healthy controls were measured by bead-based immunoassay, and the efficacy of serum ULBP2 for PC detection was compared with the widely used serological PC marker carbohydrate antigen 19-9 (CA 19-9). Results: Immunohistochemical analyses revealed an elevated expression of ULPB2 in PC tissues compared with adjacent non-cancerous tissues. Meanwhile, the serum levels of ULBP2 among all PC patients (n = 154) and in early-stage cancer patients were significantly higher than those in healthy controls (p < 0.0001). The combination of ULBP2 and CA 19-9 outperformed each marker alone in distinguishing PC patients from healthy individuals. Importantly, an analysis of the area under receiver operating characteristic curves showed that ULBP2 was superior to CA 19-9 in discriminating patients with early-stage PC from healthy controls. Conclusions: Collectively, our results indicate that ULBP2 may represent a novel and useful serum biomarker for pancreatic cancer primary screening.	[Chang, Ya-Ting; Tsai, Ming-Hung; Yu, Jau-Song] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Chih-Ching; Liu, Hao-Ping; Liu, Yu-Ling; Chang, Yu-Sun; Yu, Jau-Song] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shyr, Yi-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen & Transplantat Surg, Taipei, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Anat Pathol, Tao Yuan, Taiwan; [Hwang, Tsann-Long; Yeh, Ta-Sen] Chang Gung Mem Hosp, Dept Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Yu, Jau-Song] Chang Gung Univ, Dept Cell & Mol Biol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, YT (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	luckywu@mail.cgu.edu.tw; yusong@mail.cgu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657	Taiwan National Science Council [NSC 96-2320-B-182-031-MY3]; Department of Health [DOH-99-TD-C-111-006]; Ministry of Education [EMRPD180241, EMRPD180091]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Ministry of Education	This study was supported by the grants from the Taiwan National Science Council (NSC 96-2320-B-182-031-MY3), Department of Health (DOH-99-TD-C-111-006), and Ministry of Education (EMRPD180241 and EMRPD180091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan M, 2001, TUMORI, V87, P337, DOI 10.1177/030089160108700513; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; *DEP HLTH, 2009, STAND DEATH RAT LEAD; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo JH, 2009, CANCER SCI, V100, P2292, DOI 10.1111/j.1349-7006.2009.01324.x; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hoimes CJ, 2009, J PANCREAS, V10, P352; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Katz MH, 2005, PANCREATOLOGY, V5, P576, DOI 10.1159/000087500; Lee MX, 2009, J PANCREAS, V10, P104; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Maccalli C, 2007, CLIN CANCER RES, V13, P7459, DOI 10.1158/1078-0432.CCR-07-1166; MAGNANI JL, 1983, CANCER RES, V43, P5489; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Oto A, 2006, CURR PROBL DIAGN RAD, V35, P199, DOI 10.1067/j.cpradiol.2006.06.001; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pende D, 2002, CANCER RES, V62, P6178; Pliarchopoulou K, 2009, CANCER TREAT REV, V35, P431, DOI 10.1016/j.ctrv.2009.02.005; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; RAVN V, 1993, PATHOL RES PRACT, V189, P1015; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; TEMPERO MA, 1987, CANCER RES, V47, P5501; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	41	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20029	10.1371/journal.pone.0020029	http://dx.doi.org/10.1371/journal.pone.0020029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21887234	Green Submitted, Green Published, gold			2022-12-27	WOS:000290793400031
J	Sun, YC; Yin, J; Cao, HF; Li, CY; Kang, L; Ge, F				Sun, Yucheng; Yin, Jin; Cao, Haifeng; Li, Chuanyou; Kang, Le; Ge, Feng			Elevated CO2 Influences Nematode-Induced Defense Responses of Tomato Genotypes Differing in the JA Pathway	PLOS ONE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; SIGNALING PATHWAY; NATURAL ENEMIES; JASMONIC ACID; ROOT; RESISTANCE; HERBIVORY; COSTS; BIOSYNTHESIS	Rising atmospheric CO2 concentrations can affect the induced defense of plants against chewing herbivores but little is known about whether elevated CO2 can change the induced defense of plants against parasitic nematodes. This study examined the interactions between the root-knot nematode Meloidogyne incognita and three isogenic tomato (Lycopersicon esculentum) genotypes grown under ambient (390 ppm) and elevated (750 ppm) CO2 in growth chambers. In a previous study with open-top chambers in the field, we reported that elevated CO2 increased the number of nematode-induced root galls in a JA-defense-dominated genotype but not in a wild-type or JA-defense-recessive genotype. In the current study, we tested the hypothesis that elevated CO2 will favor the salicylic acid (SA)-pathway defense but repress the jasmonic acid (JA)-pathway defense of plants against plant-parasitic nematodes. Our data showed that elevated CO2 reduced the JA-pathway defense against M. incognita in the wild-type and in a genotype in which defense is dominated by the JA pathway (a JA-defense-dominated genotype) but up-regulated the SA-pathway defense in the wild type and in a JA-defense-recessive genotype (jasmonate-deficient mutant). Our results suggest that, in terms of defense genes, secondary metabolites, and volatile organic compounds, induced defense of nematode-infected plants could be affected by elevated CO2, and that CO2-induced changes of plant resistance may lead to genotype-specific responses of plants to nematodes under elevated CO2. The changes in resistance against nematodes, however, were small relative to those reported for chewing insects.	[Sun, Yucheng; Yin, Jin; Cao, Haifeng; Kang, Le; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Li, Chuanyou] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Sun, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Kang, Le/ABD-1116-2022; Li, Chuanyou/ABF-4143-2020; Jiang, Xingyu/U-3976-2018	Kang, Le/0000-0003-4262-2329; Jiang, Xingyu/0000-0002-5008-4703; Sun, Yi/0000-0002-1746-0404; Sun, Yucheng/0000-0003-2353-0218	National Basic Research Program of China (973 Program) [2009CB119200]; National Nature Science Fund of China [30970510, 31000854, 30921063]; Chinese Academy of Science [KSCX3-YW-N-005, 2010-Biols-CAS-0102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB119200), the National Nature Science Fund of China (No. 30970510, 31000854 and 30921063) and the Innovation Program of Chinese Academy of Science (KSCX3-YW-N-005, 2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Ayres E, 2008, SOIL BIOL BIOCHEM, V40, P978, DOI 10.1016/j.soilbio.2007.11.018; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bidart-Bouzat MG, 2005, OECOLOGIA, V145, P415, DOI 10.1007/s00442-005-0158-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; [陈法军 Chen Fajun], 2004, [昆虫知识, Entomological  Knowledge], V41, P279; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; HOWE GA, 2007, ANNU REV PLANT BIOL, V17, P41; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q; Lau JA, 2009, OECOLOGIA, V161, P401, DOI 10.1007/s00442-009-1384-z; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Loreto F, 2001, GLOBAL CHANGE BIOL, V7, P709, DOI 10.1046/j.1354-1013.2001.00442.x; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Sun YC, 2010, AGR ECOSYST ENVIRON, V135, P140, DOI 10.1016/j.agee.2009.09.011; TERRILL TH, 1992, J SCI FOOD AGR, V58, P321, DOI 10.1002/jsfa.2740580306; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; Vasyukova N. I., 2003, Doklady Akademii Nauk, V391, P419; Vuorinen T, 2004, PLANT PHYSIOL, V135, P1984, DOI 10.1104/pp.104.047084; Vuorinen T, 2004, ATMOS ENVIRON, V38, P675, DOI 10.1016/j.atmosenv.2003.10.029; Williamson VM, 1998, ANNU REV PHYTOPATHOL, V36, P277, DOI 10.1146/annurev.phyto.36.1.277; Yeates GW, 2003, BIOL FERT SOILS, V38, P319, DOI 10.1007/s00374-003-0659-5; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P5129, DOI 10.1073/pnas.0800568105; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	42	61	63	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19751	10.1371/journal.pone.0019751	http://dx.doi.org/10.1371/journal.pone.0019751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629688	Green Submitted, Green Published, gold			2022-12-27	WOS:000291005800007
J	He, S; Kato, K; Jiang, J; Wahl, DR; Mineishi, S; Fisher, EM; Murasko, DM; Glick, GD; Zhang, Y				He, Shan; Kato, Koji; Jiang, Jiu; Wahl, Daniel R.; Mineishi, Shin; Fisher, Erin M.; Murasko, Donna M.; Glick, Gary D.; Zhang, Yi			Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8(+) T Cells with Augmented Ability to Generate Long-Lasting Memory Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; HUMAN CEREBRAL GLIOMA; DONOR TH2 CELLS; ENERGY-METABOLISM; MAMMALIAN TARGET; VIRAL-INFECTION; IN-VIVO; RESISTANT PROLIFERATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS	Background: Cellular metabolism plays a critical role in regulating T cell responses and the development of memory T cells with long-term protections. However, the metabolic phenotype of antigen-activated T cells that are responsible for the generation of long-lived memory cells has not been characterized. Design and Methods: Using lymphocytic choriomeningitis virus (LCMV) peptide gp33-specific CD8(+) T cells derived from T cell receptor transgenic mice, we characterized the metabolic phenotype of proliferating T cells that were activated and expanded in vitro in the presence or absence of rapamycin, and determined the capability of these rapamycin-treated T cells to generate long-lived memory cells in vivo. Results: Antigen-activated CD8(+) T cells treated with rapamycin gave rise to 5-fold more long-lived memory T cells in vivo than untreated control T cells. In contrast to that control T cells only increased glycolysis, rapamycin-treated T cells upregulated both glycolysis and oxidative phosphorylation (OXPHOS). These rapamycin-treated T cells had greater ability than control T cells to survive withdrawal of either glucose or growth factors. Inhibition of OXPHOS by oligomycin significantly reduced the ability of rapamycin-treated T cells to survive growth factor withdrawal. This effect of OXPHOS inhibition was accompanied with mitochondrial hyperpolarization and elevation of reactive oxygen species that are known to be toxic to cells. Conclusions: Our findings indicate that these rapamycin-treated T cells may represent a unique cell model for identifying nutrients and signals critical to regulating metabolism in both effector and memory T cells, and for the development of new methods to improve the efficacy of adoptive T cell cancer therapy.	[He, Shan; Kato, Koji; Mineishi, Shin; Zhang, Yi] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Jiang, Jiu; Fisher, Erin M.; Murasko, Donna M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Wahl, Daniel R.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Glick, Gary D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Drexel University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	He, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	yizha@med.umich.edu	He, Shan/C-4989-2015; Ma, Zhonghua/J-6972-2014	Yin, Yanni/0000-0002-0798-3420; Ma, Zhonghua/0000-0002-5426-0997	Damon Runyon-Rachleff Innovation Award; American Cancer Society; NIH [R01 CA102464, R01 AI47450]; National Institutes of Health through the University of Michigan [P30CA46592]; NATIONAL CANCER INSTITUTE [R01CA102464, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047450] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Innovation Award; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Damon Runyon-Rachleff Innovation Award (YZ), American Cancer Society (YZ) and the NIH [R01 CA102464 (YZ) and R01 AI47450 (GDG)]. This research is supported in part by a grant from the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (P30CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; BENKE PJ, 1991, BIOCHEM MED METAB B, V45, P28, DOI 10.1016/0885-4505(91)90005-6; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DWARAKANATH BS, 1991, INDIAN J BIOCHEM BIO, V28, P203; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kuhnke A, 2003, ANN RHEUM DIS, V62, P133, DOI 10.1136/ard.62.2.133; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Slavik JM, 2004, J BIOL CHEM, V279, P910, DOI 10.1074/jbc.M209733200; Slavik JM, 2001, J IMMUNOL, V166, P3201, DOI 10.4049/jimmunol.166.5.3201; Sprent J, 2003, MICROBES INFECT, V5, P227, DOI 10.1016/S1286-4579(03)00015-7; Tejero-Taldo MI, 1999, J MOL CELL CARDIOL, V31, P1863, DOI 10.1006/jmcc.1999.1020; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Thoren FB, 2006, J IMMUNOL, V176, P7301, DOI 10.4049/jimmunol.176.12.7301; WAHL DR, LUPUS; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051; Zhang Y, 1998, BLOOD, V92, P118, DOI 10.1182/blood.V92.1.118.413a01_118_128; Zhang Y, 2004, BLOOD, V103, P3970, DOI 10.1182/blood-2003-09-3135; Zhang Y, 2002, J CLIN INVEST, V109, P1335, DOI 10.1172/JCI200214989; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	69	101	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e20107	10.1371/journal.pone.0020107	http://dx.doi.org/10.1371/journal.pone.0020107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	22140571	gold, Green Submitted, Green Published			2022-12-27	WOS:000290657500043
